PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Futai, E; Yagishita, S; Ishiura, S				Futai, Eugene; Yagishita, Sosuke; Ishiura, Shoichi			Nicastrin Is Dispensable for gamma-Secretase Protease Activity in the Presence of Specific Presenilin Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; AMYLOID PRECURSOR PROTEIN; TERMINAL PAL MOTIF; TRANSMEMBRANE DOMAIN-4; ALZHEIMERS-DISEASE; ASPARTIC PROTEASE; CATALYTIC PORE; C-TERMINUS; COMPLEX; BINDING	gamma-Secretase is a multisubunit membrane protein complex consisting of presenilin (PS1), nicastrin (NCT), anterior pharynx-1, and presenilin enhancer 2. To analyze the activity of familial Alzheimer disease mutants and to understand the roles of the subunits, we established a yeast transcriptional activator Gal4p system with artificial gamma-secretase substrates containing amyloid precursor protein or Notch fragments. The gamma-secretase activities were evaluated by transcriptional activation of reporter genes upon Gal4p release from the membrane-bound substrates, i.e. growth of yeast on histidine and adenine, or beta-galactosidase assay. We screened and evaluated gamma-secretase mutants using this reconstitution system in yeast, which does not possess endogenous gamma-secretase activity. When we introduced familial Alzheimer mutants of PS1 in this system, their activities were shown to be loss of function. Although the protease activity of wild type PS1 depends on the other three subunits introduced, we obtained 15 new PS1 mutants, which are active in the absence of NCT. They possessed a S438P mutation at the ninth transmembrane domain (TM9) together with one missense mutation distributed through transmembrane and loop regions. These mutations were not related to familial Alzheimer mutations of PS1 as identified so far. The S438P mutant was partially active but required other mutations for full activation. Results of the beta-galactosidase assay suggested that they have wild type protease activities, which were further confirmed by the endoproteolysis of PS1, amyloid beta peptides, and Notch intracellular domain production in mammalian cells. These results suggest that NCT is dispensable for the protease activity of gamma-secretase.	[Futai, Eugene; Yagishita, Sosuke; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Futai, E (corresponding author), 3-8-1 Komaba,Meguro Ku, Tokyo 1538902, Japan.	futai@bio.c.u-tokyo.ac.jp		Futai, Eugene/0000-0002-0879-6117	Human Frontier Science Program and the Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology; The Uehara Memorial Foundation; Takeda Chemical Science Foundation	Human Frontier Science Program and the Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Chemical Science Foundation	This work was supported by research grants from Human Frontier Science Program and the Ministry of Health, Labor, and Welfare, Japan (to S.I.), the Ministry of Education, Culture, Sports, Science, and Technology (to E. F. and S.Y.), The Uehara Memorial Foundation, and Takeda Chemical Science Foundation (to E. F.).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; *CLONT, 2001, YEAST PROT HDB; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; James P, 1996, GENETICS, V144, P1425; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Li T, 2003, J NEUROSCI, V23, P3272; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	45	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13013	13022		10.1074/jbc.M807653200	http://dx.doi.org/10.1074/jbc.M807653200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19254953	hybrid, Green Published			2022-12-27	WOS:000265688300049
J	Liu, Z; Wang, HR; Huang, CL				Liu, Zhen; Wang, Hao-Ran; Huang, Chou-Long			Regulation of ROMK Channel and K+ Homeostasis by Kidney-specific WNK1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; POTASSIUM CHANNEL; DEFECTIVE ISOFORM; MUTANT WNK4; ENDOCYTOSIS; GENE; HYPERKALEMIA; HYPERTENSION; EXPRESSION; PATHWAY	WNK kinases are serine-threonine kinases with an atypical placement of the catalytic lysine. WNK1, the first member discovered, has multiple alternatively spliced isoforms, including a ubiquitously expressed full-length long form (L-WNK1) and a kidney-specific form (KS-WNK1) predominantly expressed in the kidney. Intronic deletions of WNK1 that increase WNK1 transcript cause pseudohypoaldosteronism type 2, an autosomal-dominant disease characterized by hypertension and hyperkalemia. L-WNK1 inhibits renal K+ channel ROMK, likely contributing to hyperkalemia in PHAII. Previously, we reported that KS-WNK1 by itself has no effect on ROMK1 but antagonizes L-WNK1-mediated inhibition of ROMK1. Amino acids 1-253 of KS-WNK1 (KS-WNK1(1-253)) are sufficient for reversing the inhibition of ROMK1 caused by L-WNK1(1 491). Here, we further investigated the mechanisms by which KS-WNK1 counteracts L-WNK1 regulation of ROMK1. We reported that two regions of KS-WNK1(1-253) are involved in the antagonism of L-WNK1; one includes the first 30 amino acids unique for KS-WNK1 encoded by the alternatively spliced initiating exon 4A, and the other is equivalent to the autoinhibitory domain (AID) of L-WNK1. Mutations of two phenylalanine residues known to be critical for autoinhibitory function of AID abolish the ability of the AID region of KS-WNK1 to antagonize L-WNK1. To examine the physiological role of KS-WNK1 in the regulation of renal K+ secretion, we generated transgenic mice that overexpress amino acids 1-253 of KS-WNK1 under the control of a kidney-specific promoter. Transgenic mice have lower serum K+ levels and higher urinary fractional excretion of K+ compared with wild type littermates despite the same amount of daily urinary K+ excretion. Moreover, transgenic mice (compared with wild type littermates) displayed a higher abundance of ROMK on the apical membrane of distal nephron. Thus, KS-WNK1 is an important physiological regulator of renal K+ excretion, likely through its effects on the ROMK1 channel.	[Liu, Zhen; Wang, Hao-Ran; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chou-long.huang@utsouthwestern.edu	liu, zhen/B-3815-2011		National Institutes of Health [DK-59530, DK-079328]; American Heart Association Established Investigator award [0440019N]; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059530, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator award(American Heart Association); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59530 and DK-079328. This work was also supported by American Heart Association Established Investigator award 0440019N and a research fellowship award from the National Kidney Foundation (to Z. L.).	Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kohda Y, 1998, KIDNEY INT, V54, P1214, DOI 10.1046/j.1523-1755.1998.00120.x; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Naray-Fejes-Toth A, 2004, P NATL ACAD SCI USA, V101, P17434, DOI 10.1073/pnas.0408146101; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Palmer LG, 1999, AM J PHYSIOL-RENAL, V277, pF805, DOI 10.1152/ajprenal.1999.277.5.F805; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang HR, 2008, AM J PHYSIOL-RENAL, V295, pF438, DOI 10.1152/ajprenal.90287.2008; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	28	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12198	12206		10.1074/jbc.M806551200	http://dx.doi.org/10.1074/jbc.M806551200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244242	hybrid, Green Published			2022-12-27	WOS:000265494600051
J	Tran, QK; Leonard, J; Black, DJ; Nadeau, OW; Boulatnikov, IG; Persechini, A				Tran, Quang-Kim; Leonard, Jared; Black, D. J.; Nadeau, Owen W.; Boulatnikov, Igor G.; Persechini, Anthony			Effects of Combined Phosphorylation at Ser-617 and Ser-1179 in Endothelial Nitric-oxide Synthase on EC50(Ca2+) Values for Calmodulin Binding and Enzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; ELECTRON-TRANSFER; DEPENDENT REGULATION; CONTROL ELEMENT; NO SYNTHESIS; IDENTIFICATION; PROTEIN; CA2+; ENOS; AKT	We have investigated the possible biochemical basis for enhancements in NO production in endothelial cells that have been correlated with agonist- or shear stress-evoked phosphorylation at Ser-1179. We have found that a phosphomimetic substitution at Ser-1179 doubles maximal synthase activity, partially disinhibits cytochrome c reductase activity, and lowers the EC50(Ca2+) values for calmodulin binding and enzyme activation from the control values of 182 +/- 2 and 422 +/- 22 nMto 116 +/- 2 and 300 +/- 10 nM. These are similar to the effects of a phosphomimetic substitution at Ser-617 (Tran, Q. K., Leonard, J., Black, D. J., and Persechini, A. (2008) Biochemistry 47, 7557-7566). Although combining substitutions at Ser-617 and Ser-1179 has no additional effect on maximal synthase activity, cooperativity between the two substitutions completely disinhibits reductase activity and further reduces the EC50(Ca2+) values for calmodulin binding and enzyme activation to 77 +/- 2 and 130 +/- 5 nM. We have confirmed that specific Akt-catalyzed phosphorylation of Ser-617 and Ser- 1179 and phosphomimetic substitutions at these positions have similar functional effects. Changes in the biochemical properties of eNOS produced by combined phosphorylation at Ser- 617 and Ser- 1179 are predicted to substantially increase synthase activity in cells at a typical basal free Ca2+ concentration of 50-100 nM.	[Tran, Quang-Kim; Leonard, Jared; Black, D. J.; Persechini, Anthony] Univ Missouri Kansas City, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Nadeau, Owen W.; Boulatnikov, Igor G.] Univ Kansas, Med Ctr, Dept Mol Biol & Biochem, Kansas City, KS 66160 USA	University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center	Persechini, A (corresponding author), Univ Missouri Kansas City, Div Mol Biol & Biochem, 5007 Rockhill Rd, Kansas City, MO 64110 USA.	Persechinia@umkc.edu		Tran, Kim/0000-0003-1881-1357	National Institutes of Health [GM074887]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074887 (to A.P.).	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gao YT, 2007, J BIOL CHEM, V282, P7921, DOI 10.1074/jbc.M609814200; GEIGER RV, 1992, AM J PHYSIOL, V262, pC1411, DOI 10.1152/ajpcell.1992.262.6.C1411; KING MM, 1983, J BIOL CHEM, V258, P9925; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Matsubara M, 2003, J BIOCHEM, V133, P773, DOI 10.1093/jb/mvg099; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Nadeau OW, 2007, J MOL BIOL, V365, P1429, DOI 10.1016/j.jmb.2006.10.061; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Persechini A, 1997, CELL CALCIUM, V22, P209, DOI 10.1016/S0143-4160(97)90014-2; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; Persechini A, 1996, BIOCHEMISTRY-US, V35, P224, DOI 10.1021/bi952383x; Persechini A, 1996, J BIOL CHEM, V271, P32217, DOI 10.1074/jbc.271.50.32217; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; ZHANG MJ, 1994, J BIOL CHEM, V269, P981	35	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11892	11899		10.1074/jbc.M806205200	http://dx.doi.org/10.1074/jbc.M806205200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251696	hybrid, Green Published			2022-12-27	WOS:000265494600021
J	Newell, JL; Fay, PJ				Newell, Jennifer L.; Fay, Philip J.			Cleavage at Arg-1689 Influences Heavy Chain Cleavages during Thrombin-catalyzed Activation of Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN; FACTOR XA; A2 SUBUNIT; FACTOR-IXA; FACTOR-V; SITE; COFACTOR; A1; INACTIVATION; COAGULATION	The procofactor, factor VIII, is activated by thrombin or factor Xa-catalyzed cleavage at three P1 residues: Arg-372, Arg-740, and Arg-1689. The catalytic efficiency for thrombin cleavage at Arg-740 is greater than at either Arg-1689 or Arg-372 and influences reaction rates at these sites. Because cleavage at Arg-372 appears rate-limiting and dependent upon initial cleavage at Arg-740, we investigated whether cleavage at Arg-1689 influences catalysis at this step. Recombinant B-domainless factor VIII mutants, R1689H and R1689Q were prepared and stably expressed to slow and eliminate cleavage, respectively. Specific activity values for the His and Gln mutations were similar to 50 and similar to 10%, respectively, that of wild type. Thrombin activation of the R1689H variant showed an similar to 340-fold reduction in the rate of Arg-1689 cleavage, whereas the R1689Q variant was resistant to thrombin cleavage at this site. Examination of heavy chain cleavages showed similar to 4- and 11-fold reductions in A2 subunit generation and similar to 3- and 7-fold reductions in A1 subunit generation for the R1689H and R1689Q mutants, respectively. These results suggest a linkage between light chain cleavage and cleavages in heavy chain. Results obtained evaluating proteolysis of the factor VIII mutants by factor Xa revealed modest rate reductions (<5-fold) in generating A2 and A1 subunits and in cleaving light chain at Arg-1721 from either variant, suggesting little dependence upon prior cleavage at residue 1689 as compared with thrombin. Overall, these results are consistent with a competition between heavy and light chains for thrombin exosite binding and subsequent proteolysis with binding of the former chain preferred.	[Fay, Philip J.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199, HL76213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38199 and HL76213. An account of this work was presented at the 50th Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6, 2008.	Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; CASILLAS G, 1971, COAGULATION, V4, P107; Donath MJSH, 1996, EUR J BIOCHEM, V240, P365, DOI 10.1111/j.1432-1033.1996.0365h.x; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; HILLEUBANKS DC, 1990, J BIOL CHEM, V265, P17854; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MANN KG, 1990, BLOOD, V76, P1; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Newell JL, 2007, J BIOL CHEM, V282, P25367, DOI 10.1074/jbc.M703433200; Nogami K, 2005, BLOOD, V105, P4362, DOI 10.1182/blood-2004-10-3939; Nogami K, 2005, J BIOL CHEM, V280, P18476, DOI 10.1074/jbc.M412778200; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Parker ET, 1997, BIOCHEMISTRY-US, V36, P9365, DOI 10.1021/bi970599o; PIETERS J, 1989, BLOOD, V74, P1021; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	29	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11080	11089		10.1074/jbc.M900234200	http://dx.doi.org/10.1074/jbc.M900234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240027	hybrid, Green Published			2022-12-27	WOS:000265494500012
J	Li, WZ; Brudecki, LE; Senior, AE; Ahmad, Z				Li, Wenzong; Brudecki, Laura E.; Senior, Alan E.; Ahmad, Zulfiqar			Role of alpha-Subunit VISIT-DG Sequence Residues Ser-347 and Gly-351 in the Catalytic Sites of Escherichia coli ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-BINDING SUBDOMAIN; F1F0-ATP SYNTHASE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL ATPASE; HEART-MITOCHONDRIA; NUCLEOTIDE-BINDING; MUTANT STRAINS; PI BINDING; F-1-ATPASE; MECHANISM	This paper describes the role of alpha-subunit VISIT-DG sequence residues alpha Ser-347 and alpha Gly-351 in catalytic sites of Escherichia coli F1F0 ATP synthase. X-ray structures show the very highly conserved alpha-subunit VISIT-DG sequence in close proximity to the conserved phosphate-binding residues alpha Arg-376, beta Arg-182, beta Lys-155, and beta Arg-246 in the phosphate-binding subdomain. Mutations alpha S347Q and alpha G351Q caused loss of oxidative phosphorylation and reduced ATPase activity of F1F0 in membranes by 100- and 150-fold, respectively, whereas alpha S347A mutation showed only a 13-fold loss of activity and also retained some oxidative phosphorylation activity. The ATPase of alpha S347Q mutant was not inhibited, and the alpha S347A mutant was slightly inhibited by MgADP-azide, MgADP-fluoroaluminate, or MgADP-fluoroscandium, in contrast to wild type and alpha G351Q mutant. Whereas 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) inhibited wild type and alpha G351Q mutant ATPase essentially completely, ATPase in alpha S347A or alpha S347Q mutant was inhibited maximally by similar to 80-90%, although reaction still occurred at residue beta Tyr-297, proximal to the alpha-subunit VISIT-DG sequence, near the phosphate-binding pocket. Inhibition characteristics supported the conclusion that NBD-Cl reacts in beta E(empty) catalytic sites, as shown previously by x-ray structure analysis. Phosphate protected against NBD-Cl inhibition in wild type and alpha G351Q mutant but not in alpha S347Q or alpha S347A mutant. The results demonstrate that alpha Ser-347 is an additional residue involved in phosphate-binding and transition state stabilization in ATP synthase catalytic sites. In contrast, alpha Gly-351, although strongly conserved and clearly important for function, appears not to play a direct role.	[Li, Wenzong; Brudecki, Laura E.; Ahmad, Zulfiqar] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA; [Senior, Alan E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	East Tennessee State University; University of Rochester	Ahmad, Z (corresponding author), E Tennessee State Univ, Dept Biol Sci, Box 70703, Johnson City, TN 37614 USA.	ahmadz@etsu.edu		Ahmad, Zulfiqar/0000-0001-7306-8151	East Tennessee State University Major Research Development Committee [0061]; Honors College, East Tennessee State University	East Tennessee State University Major Research Development Committee; Honors College, East Tennessee State University	This work was partly supported by East Tennessee State University Major Research Development Committee Grant 0061 (to Z.A.) and Student-Faculty Collaborative Research Grants through Honors College, East Tennessee State University.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ahmad Z, 2005, J BIOENERG BIOMEMBR, V37, P437, DOI 10.1007/s10863-005-9486-8; Ahmad Z, 2006, FEBS LETT, V580, P517, DOI 10.1016/j.febslet.2005.12.057; Ahmad Z, 2005, J BIOL CHEM, V280, P27981, DOI 10.1074/jbc.M503955200; Ahmad Z, 2005, FEBS LETT, V579, P523, DOI 10.1016/j.febslet.2004.12.022; Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P886, DOI 10.1021/bi00118a034; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Brudecki LE, 2008, ARCH BIOCHEM BIOPHYS, V471, P168, DOI 10.1016/j.abb.2008.01.013; Chen C, 2006, J BIOL CHEM, V281, P13777, DOI 10.1074/jbc.M513369200; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; FERGUSON SJ, 1975, EUR J BIOCHEM, V54, P127, DOI 10.1111/j.1432-1033.1975.tb04121.x; FERGUSON SJ, 1975, EUR J BIOCHEM, V54, P117, DOI 10.1111/j.1432-1033.1975.tb04120.x; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; Frasch WD, 2000, BBA-BIOENERGETICS, V1458, P310, DOI 10.1016/S0005-2728(00)00083-9; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Karrasch S, 1999, J MOL BIOL, V290, P379, DOI 10.1006/jmbi.1999.2897; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, J BIOL CHEM, V274, P7052, DOI 10.1074/jbc.274.11.7052; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9; Pedersen PL, 2005, J BIOENERG BIOMEMBR, V37, P349, DOI 10.1007/s10863-005-9470-3; Penefsky HS, 2005, FEBS LETT, V579, P2250, DOI 10.1016/j.febslet.2005.02.072; PEREZ JA, 1986, FEBS LETT, V198, P113, DOI 10.1016/0014-5793(86)81195-4; RAO R, 1987, ARCH BIOCHEM BIOPHYS, V255, P309, DOI 10.1016/0003-9861(87)90398-5; Ren HM, 2000, BBA-BIOENERGETICS, V1458, P221, DOI 10.1016/S0005-2728(00)00075-X; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tombline G, 2004, J BIOL CHEM, V279, P5363, DOI 10.1074/jbc.M311964200; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; WEBER J, 1994, J BIOL CHEM, V269, P20462; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1995, J BIOL CHEM, V270, P12653, DOI 10.1074/jbc.270.21.12653; Weber J, 1998, BIOCHEMISTRY-US, V37, P608, DOI 10.1021/bi972370e; Weber J, 2007, TRENDS BIOCHEM SCI, V32, P53, DOI 10.1016/j.tibs.2006.12.006; YOSHIDA M, 1982, J BIOL CHEM, V257, P33	52	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10747	10754		10.1074/jbc.M809209200	http://dx.doi.org/10.1074/jbc.M809209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240022	Green Published, hybrid			2022-12-27	WOS:000265104600049
J	Singh, S; Manda, SM; Sikder, D; Birrer, MJ; Rothermel, BA; Garry, DJ; Mammen, PPA				Singh, Sarvjeet; Manda, Shilpa M.; Sikder, Devanjan; Birrer, Michael J.; Rothermel, Beverly A.; Garry, Daniel J.; Mammen, Pradeep P. A.			Calcineurin Activates Cytoglobin Transcription in Hypoxic Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE MUTANT; HUMAN MYOGLOBIN PROMOTER; C-JUN; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; ANGIOTENSIN-II; IN-VITRO; OVEREXPRESSION PROTECTS; ADULT CARDIOMYOCYTES; REGULATORY ELEMENTS	Cardiac hypertrophy develops in response to a variety of cardiovascular stresses and results in activation of numerous signaling cascades and proteins. In the present study, we demonstrate that cytoglobin is a stress-responsive hemoprotein in the hypoxia-induced hypertrophic myocardium and it is transcriptionally regulated by calcineurin-dependent transcription factors. The cytoglobin transcript level is abundantly expressed in the adult heart and in response to hypoxia cytoglobin expression is markedly up-regulated within the hypoxia-induced hypertrophic heart. To define the molecular mechanism resulting in the induction of cytoglobin, we undertook a transcriptional analysis of the 5' upstream regulatory region of the cytoglobin gene. Evolutionarily conserved binding elements for transcription factors HIF-1, AP-1, and NFAT are located within the upstream region of the cytoglobin gene. Transcriptional assays demonstrated that calcineurin activity modulates cytoglobin transcription. Increased calcineurin activity enhances the ability of NFAT and AP-1 to bind to the putative cytoglobin promoter, especially under hypoxic conditions. In addition, inhibition of calcineurin, NFAT, and/or AP-1 activities decreases endogenous cytoglobin transcript and protein levels. Thus, the regulation of cytoglobin transcription by calcineurin-dependent transcription factors suggests that cytoglobin may have a functional role in calcium-dependent events accompanying cardiac remodeling.	[Singh, Sarvjeet; Manda, Shilpa M.; Sikder, Devanjan; Rothermel, Beverly A.; Garry, Daniel J.; Mammen, Pradeep P. A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Garry, Daniel J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Garry, Daniel J.; Mammen, Pradeep P. A.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Birrer, Michael J.] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mammen, PPA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	pradeep.mammen@utsouthwestern.edu	singh, sarvjeet/F-1569-2015		National Institutes of Health [HL-63788, HL-076440]; American Heart Association-Texas; Donald W. Reynolds Clinical Cardiovascular Research Center; GlaxoSmithKline Research Foundation; NATIONAL CANCER INSTITUTE [ZIASC000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102478, K08HL076440, R01HL063788, R01HL072016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Texas(American Heart Association); Donald W. Reynolds Clinical Cardiovascular Research Center; GlaxoSmithKline Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by National Institutes of Health Grants HL-63788 (to D.J.G.) and HL-076440 (to P.P.A.M.). This study was also supported by grants from the American Heart Association-Texas Affiliate to (P.P.A.M.), the Donald W. Reynolds Clinical Cardiovascular Research Center (to D.J.G. and P.P.A.M.), and the GlaxoSmithKline Research Foundation (to P.P.A.M.).	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; BASSELDUBY R, 1993, CIRC RES, V73, P360, DOI 10.1161/01.RES.73.2.360; BROWN PH, 1994, ONCOGENE, V9, P791; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen BK, 2007, MOL BIOL CELL, V18, P1118, DOI 10.1091/mbc.E06-09-0797; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Coronella-Wood J, 2004, J BIOL CHEM, V279, P33567, DOI 10.1074/jbc.M404013200; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Erin N, 2003, NEUROSCIENCE, V117, P541, DOI 10.1016/S0306-4522(02)00933-8; Erin N, 2003, NEUROSCIENCE, V117, P557, DOI 10.1016/S0306-4522(02)00934-X; Fan MY, 2001, CANCER RES, V61, P4450; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Garry DJ, 2003, TRENDS CARDIOVAS MED, V13, P111, DOI 10.1016/S1050-1738(02)00256-6; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; GRAYSON J, 1995, MOL CELL BIOL, V15, P1870; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; Guo XM, 2006, BBA-GENE STRUCT EXPR, V1759, P208, DOI 10.1016/j.bbaexp.2006.04.002; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Im SH, 2004, MOL CELLS, V18, P1; Ito H, 1996, J MOL CELL CARDIOL, V28, P1271, DOI 10.1006/jmcc.1996.0117; Jacob MH, 2006, LIFE SCI, V79, P2187, DOI 10.1016/j.lfs.2006.07.015; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Koulmann N, 2006, AM J RESP CRIT CARE, V174, P699, DOI 10.1164/rccm.200512-1976OC; Kudoh S, 1997, CIRC RES, V80, P139, DOI 10.1161/01.RES.80.1.139; Laderoute KR, 2005, SEMIN CELL DEV BIOL, V16, P502, DOI 10.1016/j.semcdb.2005.03.005; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Maemura K, 1999, J BIOL CHEM, V274, P31565, DOI 10.1074/jbc.274.44.31565; Mammen PPA, 2003, AM J PHYSIOL-HEART C, V285, pH2132, DOI 10.1152/ajpheart.00147.2003; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Mammen PPA, 2006, J HISTOCHEM CYTOCHEM, V54, P1349, DOI 10.1369/jhc.6A7008.2006; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2001, CIRC RES, V88, P1220, DOI 10.1161/hh1201.093159; Oka T, 2005, MOL CELL BIOL, V25, P6649, DOI 10.1128/MCB.25.15.6649-6659.2005; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Paasinen-Sohns A, 2000, J CELL BIOL, V151, P801, DOI 10.1083/jcb.151.4.801; PARSONS WJ, 1993, P NATL ACAD SCI USA, V90, P1726, DOI 10.1073/pnas.90.5.1726; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Taimor G, 2001, FASEB J, V15, P2518, DOI 10.1096/fj.01-0353fje; Taimor G, 2001, J MOL CELL CARDIOL, V33, P503, DOI 10.1006/jmcc.2000.1324; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang NP, 1999, CIRC RES, V85, P387, DOI 10.1161/01.RES.85.5.387; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Wenzel S, 2001, FASEB J, V15, P2291, DOI 10.1096/fj.00-0827fje; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Yan Z, 2001, J BIOL CHEM, V276, P17361, DOI 10.1074/jbc.M101251200; Yousef Z, 2000, CARDIOVASC DRUG THER, V14, P243, DOI 10.1023/A:1007879205916	78	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10409	10421		10.1074/jbc.M809572200	http://dx.doi.org/10.1074/jbc.M809572200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19203999	hybrid, Green Published			2022-12-27	WOS:000265104600015
J	Bamming, D; Horvath, CM				Bamming, Darja; Horvath, Curt M.			Regulation of Signal Transduction by Enzymatically Inactive Antiviral RNA Helicase Proteins MDA5, RIG-I, and LGP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; INDUCIBLE GENE-I; INNATE IMMUNITY; ADAPTER PROTEIN; ATPASE ACTIVITY; RESPONSES; RECOGNITION; DOMAIN; ACID; BETA	Intracellular pattern recognition receptors MDA5, RIG-I, and LGP2 are essential components of the cellular response to virus infection and are homologous to the DEXH box subfamily of RNA helicases. However, the relevance of helicase activity in the regulation of interferon production remains elusive. To examine the importance of the helicase domain function for these signaling proteins, a series of mutations targeting conserved helicase sequence motifs were analyzed for enzymatic activity, RNA binding, interferon induction, and antiviral signaling. Results indicate that all targeted motifs are required for ATP hydrolysis, but a subset is involved in RNA binding. The enzymatically inactive mutants differed in their signaling ability. Notably, mutations to MDA5 motifs I, III, and VI and RIG-I motif III produced helicase proteins with constitutive antiviral activity, whereas mutations in RIG-I motif V retained ATP hydrolysis but failed to mediate signal transduction. These findings demonstrate that type I interferon production mediated by full-length MDA5 and RIG-I is independent of the helicase domain catalytic activity. In addition, neither enzymatic activity nor RNA binding was required for negative regulation of antiviral signaling by LGP2, supporting an RNA-independent interference mechanism.	[Bamming, Darja; Horvath, Curt M.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Horvath, Curt M.] Northwestern Univ, Dept Med, Evanston, IL 60208 USA; [Horvath, Curt M.] Evanston NW Healthcare, Dept Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; NorthShore University Health System	Horvath, CM (corresponding author), Pancoe ENH Pavil Rm 4401,2200 Campus Dr, Evanston, IL 60208 USA.	horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	National Institutes of Health [AI073919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI073919 ( to C. M. H.).	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503	43	132	138	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9700	9712		10.1074/jbc.M807365200	http://dx.doi.org/10.1074/jbc.M807365200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211564	Green Published, hybrid			2022-12-27	WOS:000264892900010
J	Eliseev, RA; Malecki, J; Lester, T; Zhang, Y; Humphrey, J; Gunter, TE				Eliseev, Roman A.; Malecki, Jonathan; Lester, Tobias; Zhang, Yu; Humphrey, John; Gunter, Thomas E.			Cyclophilin D Interacts with Bcl2 and Exerts an Anti-apoptotic Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PORE; MEMBRANE; CALCINEURIN; TRANSPORT; BAX; LOCALIZATION; SUPPRESSION; MECHANISM; PROTEIN	Cyclophilin D(CypD) is a mitochondrial immunophilin and a key positive regulator of the mitochondrial permeability transition (MPT). Several reports have shown that CypD is overexpressed in various tumors, where it has an anti-apoptotic effect. Because the MPT is a cell death-inducing phenomenon, we hypothesized that the anti-apoptotic effect of CypD is independent of the MPT but is due to its interaction with some key apoptosis regulator, such as Bcl2. Our data indicate that CypD indeed interacts with Bcl2 as confirmed with co-immunoprecipitation, pulldown, and mammalian two-hybrid assays. A cyclophilin D inhibitor, cyclosporine A, disrupts the CypD-Bcl2 interaction. CypD enhances the limiting effect of Bcl2 on the tBid-induced release of cytochrome c from mitochondria, which is not mediated via the MPT. Gain- and loss-of-function experiments confirm that CypD has a limiting effect on cytochrome c release from mitochondria and that such an effect of CypD is cyclosporine A- and Bcl2-dependent. On a cellular level, overexpression or knockdown of CypD respectively decreases or increases cytochrome c release from mitochondria and overall cell sensitivity to apoptosis progressing via the "intrinsic" pathway. Therefore, we here describe a novel function of CypD as a Bcl2 collaborator and an inhibitor of cytochrome c release from mitochondria independent of the MPT. This function of CypD may explain the anti-apoptotic effect of this protein observed in various cancer cells. The fact that some tumors overexpress CypD suggests that this may be an additional mechanism of suppression of apoptosis in cancer.	[Eliseev, Roman A.; Zhang, Yu; Humphrey, John] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Malecki, Jonathan; Lester, Tobias; Gunter, Thomas E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Eliseev, RA (corresponding author), 575 Elmwood Ave,Rm 1-8509, Rochester, NY 14642 USA.	Roman_Eliseev@urmc.rochester.edu			National Institutes of Health [RO1 ES10041]; Wilmot Foundation; Karen D'Amico Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilmot Foundation; Karen D'Amico Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES10041. This work was also supported by grants from the Wilmot Foundation and the Karen D'Amico Foundation.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKAO Y, 1994, CANCER RES, V54, P2468; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brdiczka DG, 2006, BBA-MOL BASIS DIS, V1762, P148, DOI 10.1016/j.bbadis.2005.09.007; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; CROMPTON M, 1988, BIOCHEM J, V255, P357; Dragovich T, 1998, ONCOGENE, V17, P3207, DOI 10.1038/sj.onc.1202587; Eliseev R, 2004, PROTEIN EXPRES PURIF, V35, P206, DOI 10.1016/j.pep.2004.01.015; Eliseev RA, 2002, MITOCHONDRION, V1, P361, DOI 10.1016/S1567-7249(01)00039-3; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Forte M, 2006, CELL DEATH DIFFER, V13, P1287, DOI 10.1038/sj.cdd.4401957; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gunter TE, 2004, J NEUROCHEM, V88, P266, DOI 10.1046/j.1471-4159.2003.02122.x; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; JONG D, 1994, CANCER RES, V54, P256; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; Motoyama S, 1998, BIOCHEM BIOPH RES CO, V249, P628, DOI 10.1006/bbrc.1998.9205; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Weischer M, 2007, EXP DERMATOL, V16, P385, DOI 10.1111/j.1600-0625.2007.00555.x; WINGROVE DE, 1986, J BIOL CHEM, V261, P5159	38	84	91	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9692	9699		10.1074/jbc.M808750200	http://dx.doi.org/10.1074/jbc.M808750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228691	hybrid, Green Published			2022-12-27	WOS:000264892900009
J	Iwata, A; Nagashima, Y; Matsumoto, L; Suzuki, T; Yamanaka, T; Date, H; Deoka, K; Nukina, N; Tsuji, S				Iwata, Atsushi; Nagashima, Yu; Matsumoto, Lumine; Suzuki, Takahiro; Yamanaka, Tomoyuki; Date, Hidetoshi; Deoka, Ken; Nukina, Nobuyuki; Tsuji, Shoji			Intranuclear Degradation of Polyglutamine Aggregates by the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN; AUTOPHAGIC DEGRADATION; CAG REPEAT; NP95; HUNTINGTIN; CELLS; LOCALIZATION; EXPRESSION; LIGASE; NEURODEGENERATION	Huntington disease and its related autosomal-dominant polyglutamine (pQ) neurodegenerative diseases are characterized by intraneuronal accumulation of protein aggregates. Studies on protein aggregates have revealed the importance of the ubiquitin-proteasome system as the front line of protein quality control (PQC) machinery against aberrant proteins. Recently, we have shown that the autophagy-lysosomal system is also involved in cytoplasmic aggregate degradation, but the nucleus lacked this activity. Consequently, the nucleus relies entirely on the ubiquitin-proteasome system for PQC. According to previous studies, nuclear aggregates possess a higher cellular toxicity than do their cytoplasmic counterparts, however degradation kinetics of nuclear aggregates have been poorly understood. Here we show that nuclear ubiquitin ligases San1p and UHRF-2 each enhance nuclear pQ aggregate degradation and rescued pQ-induced cytotoxicity in cultured cells and primary neurons. Moreover, UHRF-2 is associated with nuclear inclusion bodies in vitro and in vivo. Our data suggest that UHRF-2 is an essential molecule for nuclear pQ degradation as a component of nuclear PQC machinery in mammalian cells.	[Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, Tokyo 1138655, Japan; [Iwata, Atsushi; Nagashima, Yu; Matsumoto, Lumine; Date, Hidetoshi; Deoka, Ken; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Takahiro] Jichi Med Univ, Dept Hematol, Shimotsuke, Tochigi 3290498, Japan; [Yamanaka, Tomoyuki; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3500198, Japan	University of Tokyo; University of Tokyo; Jichi Medical University; RIKEN	Iwata, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	iwata-tky@umin.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013; Nukina, Nobuyuki/GPP-6265-2022	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314; Yamanaka, Tomoyuki/0000-0002-5378-4326	Japan Society for the Promotion of Science; Takeda science foundation (Osaka, Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Foundation for Life Science; Janssen Pharmaceutical K. K. (Tokyo, Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda science foundation (Osaka, Japan)(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Foundation for Life Science; Janssen Pharmaceutical K. K. (Tokyo, Japan)	This work was supported by a grant-in aid from the Japan Society for the Promotion of Science and by research funding from the Takeda science foundation (Osaka, Japan), the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Sankyo Foundation for Life Science, and Janssen Pharmaceutical K. K. (Tokyo, Japan).	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fujimori A, 1998, MAMM GENOME, V9, P1032, DOI 10.1007/s003359900920; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Muto M, 2006, RADIAT RES, V166, P723, DOI 10.1667/RR0459.1; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; ROSSI JM, 1989, J CELL BIOL, V108, P425, DOI 10.1083/jcb.108.2.425; Sakai A, 2003, BIOL PHARM BULL, V26, P347; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	36	68	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9796	9803		10.1074/jbc.M809739200	http://dx.doi.org/10.1074/jbc.M809739200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218238	Green Published, hybrid			2022-12-27	WOS:000264892900020
J	Pacheco, B; Malmstrom, A; Maccarana, M				Pacheco, Benny; Malmstrom, Anders; Maccarana, Marco			Two Dermatan Sulfate Epimerases Form Iduronic Acid Domains in Dermatan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE; CORE PROTEIN; BIOSYNTHESIS; IDENTIFICATION; BINDING; POLYSACCHARIDE; DESULFATION; SUBSTRATE; RESIDUES; EXT1	A second dermatan sulfate epimerase (DS-epi2) was identified as a homolog of the first epimerase (DS-epi1), which was previously described by our group. DS-epi2 is 1,222 amino acids long and has an similar to 700-amino acid N-terminal epimerase domain that is highly conserved between the two enzymes. In addition, the C-terminal portion is predicted to be an O-sulfotransferase domain. In this study we found that DS-epi2 has epimerase activity, which involves conversion of D-glucuronic acid to L-iduronic acid (EC 5.1.3.19), but no O-sulfotransferase activity was detected. In dermatan sulfate, iduronic acid residues are either clustered together in blocks or alternating with glucuronic acid, forming hybrid structures. By using a short interfering RNA approach, we found that DS-epi2 and DS-epi1 are both involved in the biosynthesis of the iduronic acid blocks in fibroblasts and that DS-epi2 can also synthesize the hybrid structures. Both iduronic acid-containing domains have been shown to bind to several growth factors, many of which have biological roles in brain development. DS-epi2 has been genetically linked to bipolar disorder, which suggests that the dermatan sulfate domains generated by a defective enzyme may be involved in the etiology of the disease.	[Pacheco, Benny; Malmstrom, Anders; Maccarana, Marco] Lund Univ, Biomed Ctr D12, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University	Maccarana, M (corresponding author), Lund Univ, Biomed Ctr D12, Dept Expt Med Sci, Tornavagen 10, SE-22184 Lund, Sweden.	marco.maccarana@med.lu.se	maccarana, marco/AAB-4764-2021	Maccarana, Marco/0000-0003-3549-8921; Malmstrom, Anders/0000-0002-6691-146X	Swedish Science Research Council; Medical Faculty of Lund University; Albert Osterlund Foundation; Greta and Johan Kock Foundation; Polysackaridforskning AB; Tissue in Motion Medical Faculty Program	Swedish Science Research Council; Medical Faculty of Lund University; Albert Osterlund Foundation; Greta and Johan Kock Foundation; Polysackaridforskning AB; Tissue in Motion Medical Faculty Program	This work was supported by grants from the Swedish Science Research Council, the Medical Faculty of Lund University, the Albert Osterlund Foundation, the Greta and Johan Kock Foundation, Polysackaridforskning AB, and the Tissue in Motion Medical Faculty Program.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Goossens D, 2003, MOL PSYCHIATR, V8, P83, DOI 10.1038/sj.mp.4001190; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; KANTOR TG, 1957, J AM CHEM SOC, V79, P152, DOI 10.1021/ja01558a040; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MALMSTROM A, 1984, J BIOL CHEM, V259, P161; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MIDURA RJ, 1994, GLYCOBIOLOGY, V4, P333, DOI 10.1093/glycob/4.3.333; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Munoz E, 2006, BIOCHEMISTRY-US, V45, P5122, DOI 10.1021/bi052403n; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Seidler DG, 2002, J BIOL CHEM, V277, P42409, DOI 10.1074/jbc.M208442200; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Tufvesson E, 2002, EUR J BIOCHEM, V269, P3688, DOI 10.1046/j.1432-1033.2002.03058.x; WLAD H, 1994, J BIOL CHEM, V269, P24538	31	62	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9788	9795		10.1074/jbc.M809339200	http://dx.doi.org/10.1074/jbc.M809339200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19188366	Green Published, hybrid			2022-12-27	WOS:000264892900019
J	Wrighton, KH; Lin, X; Yu, PB; Feng, XH				Wrighton, Katharine H.; Lin, Xia; Yu, Paul B.; Feng, Xin-Hua			Transforming Growth Factor beta Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; SPECIFICITY; ACTIVATION; ALK5; LOOP	Transforming growth factor-beta (TGF beta) superfamily ligands control a diverse set of cellular processes by activating type I and type II serine-threonine receptor kinases. Canonical TGF beta signaling is mediated via the T beta RI/ALK5 type I receptor that phosphorylates Smad2 and Smad3 in their SXS motif to facilitate their activation and subsequent role in transcriptional regulation. Canonical bone morphogenic protein (BMP) signaling is mediated via the ALK1/2/3/6 type I receptors that phosphorylate Smad1, Smad5, and Smad8 in their SXS motif. However, studies in endothelial cells have shown that TGF beta can also lead to the phosphorylation of Smad1, dependent on ALK1 receptor activity. Here we present data showing that TGF beta can significantly induce Smad1 phosphorylation in several non-endothelial cell lineages. Additionally, by using chemical inhibitors specific for the TGF beta/activin/nodal (ALK4/5/7) and BMP (ALK1/2/3/6) type I receptors, we show that in some cell types TGF beta induces Smad1 phosphorylation independently of the BMP type I receptors. Thus, TGF beta-mediated Smad1 phosphorylation appears to occur via different receptor complexes in a cell type-specific manner.	[Wrighton, Katharine H.; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wrighton, Katharine H.; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Yu, Paul B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr,Dept Med, Boston, MA 02114 USA; [Yu, Paul B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol,Dept Med, Boston, MA 02114 USA	Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,Rm 137D, Houston, TX 77030 USA.	xfeng@bcm.edu	Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Wrighton, Katharine/0000-0001-7075-3399	National Institutes of Health [R01DK073932, R01CA108454, R01AR053591, P50HL083794]; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083794, K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK073932 ( to X. L.) and R01CA108454, R01AR053591, and P50HL083794 ( X.- H. F.).	Bharathy S, 2008, CANCER RES, V68, P1656, DOI 10.1158/0008-5472.CAN-07-5089; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	20	107	114	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9755	9763		10.1074/jbc.M809223200	http://dx.doi.org/10.1074/jbc.M809223200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224917	Green Published, hybrid			2022-12-27	WOS:000264892900015
J	Morenilla-Palao, C; Pertusa, M; Meseguer, V; Cabedo, H; Viana, F				Morenilla-Palao, Cruz; Pertusa, Maria; Meseguer, Victor; Cabedo, Hugo; Viana, Felix			Lipid Raft Segregation Modulates TRPM8 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD RECEPTOR; ION CHANNELS; EPITHELIAL-CELLS; MEMBRANE RAFTS; CHOLESTEROL; PROTEIN; THERMOSENSATION; EXPRESSION; SENSATION; TRANSDUCTION	Transient receptor potential channels are a family of cation channels involved in diverse cellular functions. Most of these channels are expressed in the nervous system and play a key role in sensory physiology. TRPM8 (transient receptor potential melastatine 8), a member of this family, is activated by cold, cooling substances such menthol and icilin and voltage. Although TRPM8 is a thermosensitive channel highly expressed in cold sensory neurons, the mechanisms underlying its temperature sensitivity are still poorly understood. Here we show that, in sensory neurons, TRPM8 channel is localized in cholesterol-rich specialized membrane domains known as lipid rafts. We also show that, in heterologous expression systems, lipid raft segregation of TRPM8 is favored by glycosylation at the Asn(934) residue of the polypeptide. In electrophysiological and imaging experiments, using cold and menthol as agonists, we also demonstrate that lipid raft association modulates TRPM8 channel activity. We found that menthol- and cold-mediated responses of TRPM8 are potentiated when the lipid raft association of the channel is prevented. In addition, lipid raft disruption shifts the threshold for TRPM8 activation to a warmer temperature. In view of these data, we suggest a role for lipid rafts in the activity and temperature sensitivity of TRPM8. We propose a model wherein different lipid membrane environments affect the cold sensing properties of TRPM8, modulating the response of cold thermoreceptors.	[Morenilla-Palao, Cruz; Pertusa, Maria; Meseguer, Victor; Cabedo, Hugo; Viana, Felix] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant 03550, Spain; [Cabedo, Hugo] Unidad Invest Hosp San Juan de Alicante, Alacant 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Morenilla-Palao, C (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Apartado 18, Alacant 03550, Spain.	cruz@umh.es	Cabedo, Hugo/F-9404-2016; Viana, Felix/U-8533-2017	Cabedo, Hugo/0000-0002-1322-6290; Viana, Felix/0000-0003-1439-949X; Morenilla-Palao, Cruz/0000-0002-8159-1206; Pertusa, Maria/0000-0003-3856-9019	Spanish Ministry of Education and Science [BFU2007-61855]; Generalitat Valenciana [GV/2007/113]; CONSOLIDER-INGENIO [CSD2007-00023]	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Education and Science Grant BFU2007-61855 (to F. V.), Generalitat Valenciana Grant GV/2007/113 ( to C. M.-P.), and CONSOLIDER-INGENIO 2010 CSD2007-00023.	Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; BARD M, 1988, LIPIDS, V23, P534, DOI 10.1007/BF02535593; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Bergdahl A, 2003, CIRC RES, V93, P839, DOI 10.1161/01.RES.0000100367.45446.A3; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Cabedo H, 2004, J BIOL CHEM, V279, P33623, DOI 10.1074/jbc.M401962200; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Christian AE, 1997, J LIPID RES, V38, P2264; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Ding XQ, 2008, BIOCHEMISTRY-US, V47, P3677, DOI 10.1021/bi7019645; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Graziani A, 2006, BIOCHEM J, V396, P147, DOI 10.1042/BJ20051246; Hensel H, 1981, Monogr Physiol Soc, V38, P1; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pottosin II, 2007, PFLUG ARCH EUR J PHY, V454, P235, DOI 10.1007/s00424-007-0208-4; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Simen AA, 2001, J NEUROSCI, V21, P7587, DOI 10.1523/JNEUROSCI.21-19-07587.2001; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Tsavaler L, 2001, CANCER RES, V61, P3760; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	51	86	92	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9215	9224		10.1074/jbc.M807228200	http://dx.doi.org/10.1074/jbc.M807228200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19176480	Green Published, hybrid			2022-12-27	WOS:000264669100028
J	Hossain, MB; Ji, P; Anish, R; Jacobson, RH; Takada, S				Hossain, Mohammad B.; Ji, Ping; Anish, Ramakrishnan; Jacobson, Raymond H.; Takada, Shinako			Poly(ADP-ribose) Polymerase 1 Interacts with Nuclear Respiratory Factor 1 (NRF-1) and Plays a Role in NRF-1 Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIAL BIOGENESIS; THERMOGENIC COACTIVATOR PGC-1; DNA-BINDING; PARP-1; MODULATION; GENE; ACTIVATION; PROMOTERS; IDENTIFICATION; INITIATION	Nuclear respiratory factor 1 (NRF-1) is one of the key transcriptional activators for nuclear-coded genes involved in mitochondrial biogenesis and function as well as for many housekeeping genes. A transcriptional co-activator PGC-1 and its related family member PRC have previously been shown to interact with NRF-1 and co-activate NRF-1. We show here that NRF-1 can also directly interact with poly(ADP-ribose) polymerase 1 (PARP-1) and co-purify the PARP-1(.)DNA-PK(.)Ku80(.)Ku70(.)topoisomerase II beta-containing protein complex. Our in vitro binding experiments show that DNA-binding/dimerization domain of NRF-1 and the N-terminal half of PARP-1, which contains two Zinc fingers and the auto-modification domain, are responsible for the interaction, and that this interaction occurs with or without PARP-1 poly(ADP-ribosyl)ation (PARylation). DNA-bound NRF-1 can form a complex with PARP-1, suggesting that NRF-1 can recruit the PARP-1(.)DNA-PK(.)Ku80(.)Ku70(.)topoisomerase II beta-containing protein complex to the promoter. PARP-1 can also PARylate the DNA-binding domain of NRF-1 and negatively regulate NRF-1(.)PARP-1 interaction. Transient transfection and chromatin immunoprecipitation experiments suggest that PARP-1 plays a role during transcriptional activation by NRF-1. Our finding identifies a new aspect of transcriptional regulation used by NRF-1.	[Hossain, Mohammad B.; Ji, Ping; Anish, Ramakrishnan; Jacobson, Raymond H.; Takada, Shinako] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Genes & Dev Program, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Takada, S (corresponding author), Unit 1000,1515 Holcombe Blvd, Houston, TX 77030 USA.	stakada@mdanderson.org		Thachangattuthodi, Anish/0000-0002-8029-5421	National Institutes of Health [AI057504, GM069769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057504 ( to S. T.) and GM069769 ( to R. J.). This work was also supported by the DNA core facility at the M. D. Anderson Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; GOMEZCUADRADO A, 1995, MOL CELL BIOL, V15, P6670; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; Herzig RP, 2000, J CELL SCI, V113, P4263; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Li M, 2004, BIOCHEM J, V382, P323, DOI 10.1042/BJ20040593; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; OGATA N, 1980, J BIOL CHEM, V255, P7610; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlicker A, 1999, INT J RADIAT BIOL, V75, P91, DOI 10.1080/095530099140843; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SLATTERY E, 1983, J BIOL CHEM, V258, P5955; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tokusumi Y, 2004, J VIROL, V78, P10856, DOI 10.1128/JVI.78.20.10856-10864.2004; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	37	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8612	8623		10.1074/jbc.M807198200	http://dx.doi.org/10.1074/jbc.M807198200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19181665	Green Published, hybrid			2022-12-27	WOS:000264397800046
J	Muik, M; Fahrner, M; Derler, I; Schindl, R; Bergsmann, J; Frischauf, I; Groschner, K; Romanin, C				Muik, Martin; Fahrner, Marc; Derler, Isabella; Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Groschner, Klaus; Romanin, Christoph			A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; CRAC CHANNELS; CALCIUM-CHANNEL; EF-HAND; DEPLETION; ACTIVATION; SENSOR; OLIGOMERIZATION; INACTIVATION	In immune cells, generation of sustained Ca2+ levels is mediated by the Ca2+ release-activated Ca2+ (CRAC) current. Molecular key players in this process comprise the stromal interaction molecule 1 (STIM1) that functions as a Ca2+ sensor in the endoplasmic reticulum and ORAI1 located in the plasma membrane. Depletion of endoplasmic reticulum Ca2+ stores leads to STIM1 multimerization into discrete puncta, which co-cluster with ORAI1 to couple to and activate ORAI1 channels. The cytosolic C terminus of STIM1 is sufficient to activate ORAI1 currents independent of store depletion. Here we identified an ORAI1-activating small fragment (OASF, aminoacids 233-450/474) within STIM1 C terminus comprising the two coiled-coil domains and additional 50-74 amino acids that exhibited enhanced interaction with ORAI1, resulting in 3-fold increased Ca2+ currents. This OASF, similar to the complete STIM1 C terminus, displayed the ability to homomerize by a novel assembly domain that occurred subsequent to the coiled-coil domains. A smaller fragment (amino acids 233-420) generated by a further deletion of 30 amino acids substantially reduced the ability to homomerize concomitant to a loss of coupling to as well as activation of ORAI1. Extending OASF by 35 amino acids (233-485) did not alter homomerization but substantially decreased efficiency in coupling to and activation of ORAI1. Expressing OASF in rat basophilic leukemia (RBL) mast cells demonstrated its enhanced plasma membrane targeting associated with 2.5-fold larger CRAC currents in comparison with the complete STIM1 C terminus. In aggregate, we have identified two cytosolic key regions within STIM1 C terminus that control ORAI1/CRAC activation: a homomerization domain indispensable for coupling to ORAI1 and a modulatory domain that controls the extent of coupling to ORAI1.	[Muik, Martin; Fahrner, Marc; Derler, Isabella; Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Romanin, C (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	christoph.romanin@jku.at	Romanin, Christoph/D-5399-2009; Groschner, Klaus/A-2550-2010; Schindl, Rainer/V-4205-2019; Schindl, Rainer/E-3959-2013; Frischauf, Irene/AAG-2007-2019; Fahrner, Marc/AAI-7927-2021; Derler, Isabella/B-7871-2019	Romanin, Christoph/0000-0003-3756-4136; Groschner, Klaus/0000-0002-8659-377X; Schindl, Rainer/0000-0003-0896-8887; Frischauf, Irene/0000-0003-0661-2932; Derler, Isabella/0000-0002-4768-146X; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Foundation [P18280, P18169, P21118];  [W1201]	Austrian Science Foundation(Austrian Science Fund (FWF)); 	This work was supported by the Austrian Science Foundation (FWF) Project P18280 (to K. G.) and Projects P18169 and P21118 as well as subproject 11 within W1201 (to C. R.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; LEWIS RS, 1990, ANNU REV PHYSIOL, V52, P415; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	38	255	261	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8421	8426		10.1074/jbc.C800229200	http://dx.doi.org/10.1074/jbc.C800229200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19189966	hybrid, Green Published			2022-12-27	WOS:000264397800026
J	Rechter, S; Scott, GM; Eickhoff, J; Zielke, K; Auerochs, S; Muller, R; Stamminger, T; Rawlinson, WD; Marschall, M				Rechter, Sabine; Scott, Gillian M.; Eickhoff, Jan; Zielke, Katrin; Auerochs, Sabrina; Mueller, Regina; Stamminger, Thomas; Rawlinson, William D.; Marschall, Manfred			Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; OPEN READING FRAME; TRANSACTIVATOR PROTEIN; CELL-CYCLE; INFECTED-CELLS; UNSPLICED RNA; POLYMERASE-II; P-TEFB; RETINOBLASTOMA PROTEIN; VIRAL PROTEIN	Replication of human cytomegalovirus (HCMV) is subject to regulation by cellular protein kinases. Recently, we and others reported that inhibition of cyclin-dependent protein kinases (CDKs) or the viral CDK ortholog pUL97 can induce intranuclear speckled aggregation of the viral mRNA export factor, pUL69. Here we provide the first evidence for a direct regulatory role of CDKs on pUL69 functionality. Although replication of all HCMV strains was dependent on CDK activity, we found strain-specific differences in the amount of CDK inhibitor-induced pUL69 aggregate formation. In all cases analyzed, the inhibitor-induced pUL69 aggregates were clearly localized within viral replication centers but not subnuclear splicing, pore complex, or aggresome structures. The CDK9 and cyclin T1 proteins colocalized with these pUL69 aggregates, whereas other CDKs behaved differently. Phosphorylation analyses in vivo and in vitro demonstrated pUL69 was strongly phosphorylated in HCMV-infected fibroblasts and that CDKs represent a novel class of pUL69-phosphorylating kinases. Moreover, the analysis of CDK inhibitors in a pUL69-dependent nuclear mRNA export assay provided evidence for functional impairment of pUL69 under suppression of CDK activity. Thus, our data underline the crucial importance of CDKs for HCMV replication, and indicate a direct impact of CDK9-cyclin T1 on the nuclear localization and activity of the viral regulator pUL69.	[Rechter, Sabine; Zielke, Katrin; Auerochs, Sabrina; Mueller, Regina; Stamminger, Thomas; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Eickhoff, Jan] GPC Biotech AG, D-82152 Martinsried, Germany; [Scott, Gillian M.; Rawlinson, William D.] Univ New S Wales, SOMS BABS, Randwick, NSW 2031, Australia; [Scott, Gillian M.; Rawlinson, William D.] Univ New S Wales, Div Virol, SEALS POWH, Randwick, NSW 2031, Australia	University of Erlangen Nuremberg; GPC Biotech; University of New South Wales Sydney; University of New South Wales Sydney	Marschall, M (corresponding author), Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	manfred.marschall@viro.med.uni-erlangen.de		Rawlinson, William/0000-0003-0988-7827; Stamminger, Thomas/0000-0001-9878-3119	AIDS Research and Reference Reagent Program; Division of AIDS; NIAID; National Institutes of Health [759rD100, GDGrXbaF4, GDGrP53]	AIDS Research and Reference Reagent Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Marco Thomas and Jens Milbradt (University of Erlangen-Nuremberg, Erlangen, Germany) for scientific discussions and Luigi Lania (University of Monte S. Angelo, Italy) for kindly providing pACTII-T1. The following reagents were obtained from the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health: 759rD100, GDGrXbaF4, and GDGrP53 (originally provided by contributor Donald Coen).	Advani SJ, 2001, J VIROL, V75, P7904, DOI 10.1128/JVI.75.17.7904-7912.2001; ARLT H, 1994, J VIROL, V68, P4117, DOI 10.1128/JVI.68.7.4117-4125.1994; Bain M, 2007, REV MED VIROL, V17, P423, DOI 10.1002/rmv.551; BIRON KK, 1986, P NATL ACAD SCI USA, V83, P8769, DOI 10.1073/pnas.83.22.8769; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Dittmer D, 1997, J VIROL, V71, P1629, DOI 10.1128/JVI.71.2.1629-1634.1997; Farjot G, 2000, J VIROL, V74, P6068, DOI 10.1128/JVI.74.13.6068-6076.2000; Fortun J, 2003, J NEUROSCI, V23, P10672; Fortunato EA, 2000, TRENDS MICROBIOL, V8, P111, DOI 10.1016/S0966-842X(00)01699-1; FRALDI A, 2001, J CELL BIOCHEM, V36, pS247; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Hayashi ML, 2000, P NATL ACAD SCI USA, V97, P2692, DOI 10.1073/pnas.050587597; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herget T, 2006, NEW CONCEPTS OF ANTIVIRAL THERAPY, P351; Herget T, 2004, ANTIMICROB AGENTS CH, V48, P4154, DOI 10.1128/AAC.48.11.4154-4162.2004; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Lischka P, 2007, J GEN VIROL, V88, P405, DOI 10.1099/vir.0.82480-0; Lorz K, 2006, J VIROL, V80, P5423, DOI 10.1128/JVI.02585-05; Lu MS, 1999, J VIROL, V73, P676, DOI 10.1128/JVI.73.1.676-683.1999; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Marschall M, 2002, J GEN VIROL, V83, P1013, DOI 10.1099/0022-1317-83-5-1013; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Michel D, 2004, BBA-PROTEINS PROTEOM, V1697, P169, DOI 10.1016/j.bbapap.2003.11.022; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Napolitano G, 2003, J CELL PHYSIOL, V197, P1, DOI 10.1002/jcp.10376; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; Sanchez V, 2004, J VIROL, V78, P11219, DOI 10.1128/JVI.78.20.11219-11232.2004; Sanchez V, 2003, J VIROL, V77, P13214, DOI 10.1128/JVI.77.24.13214-13224.2003; Sanchez V, 2006, J VIROL, V80, P5886, DOI 10.1128/JVI.02656-05; Schang LM, 2004, BBA-PROTEINS PROTEOM, V1697, P197, DOI 10.1016/j.bbapap.2003.11.024; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Schleiss M, 2008, ANTIVIR RES, V79, P49, DOI 10.1016/j.antiviral.2008.01.154; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Smith-Donald BA, 2008, J VIROL, V82, P4533, DOI 10.1128/JVI.02022-07; Smith-Donald BA, 2008, J VIROL, V82, P4527, DOI 10.1128/JVI.02021-07; SULLIVAN V, 1993, ANTIMICROB AGENTS CH, V37, P19, DOI 10.1128/AAC.37.1.19; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; Tamrakar S, 2005, J VIROL, V79, P15477, DOI 10.1128/JVI.79.24.15477-15493.2005; Thomas M, 2009, J GEN VIROL, V90, P567, DOI 10.1099/vir.0.005827-0; Toth Z, 2006, NUCLEIC ACIDS RES, V34, P1237, DOI 10.1093/nar/gkl007; Winkler M, 2000, J VIROL, V74, P8053, DOI 10.1128/JVI.74.17.8053-8064.2000; WINKLER M, 1994, J VIROL, V68, P3943, DOI 10.1128/JVI.68.6.3943-3954.1994; Winkler M, 1996, J VIROL, V70, P8984, DOI 10.1128/JVI.70.12.8984-8987.1996; Wolf DG, 2001, P NATL ACAD SCI USA, V98, P1895, DOI 10.1073/pnas.98.4.1895; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	61	45	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8942	8950		10.1074/jbc.M805693200	http://dx.doi.org/10.1074/jbc.M805693200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179338	hybrid, Green Published			2022-12-27	WOS:000264397800077
J	Tsuboi, S; Takada, H; Hara, T; Mochizuki, N; Funyu, T; Saitoh, H; Terayama, Y; Yamaya, K; Ohyama, C; Nonoyama, S; Ochs, HD				Tsuboi, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Mochizuki, Naoki; Funyu, Tomihisa; Saitoh, Hisao; Terayama, Yuriko; Yamaya, Kanemitsu; Ohyama, Chikara; Nonoyama, Shigeaki; Ochs, Hans D.			FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; PLASMA-MEMBRANE INVAGINATION; SYNDROME PROTEIN WASP; ACTIN CYTOSKELETON; REGULATES PODOSOMES; DIFFERENTIAL ROLE; CELL-ADHESION; RHO GTPASES; DYNAMIN; WIP	Macrophages act to protect the body against inflammation and infection by engaging in chemotaxis and phagocytosis. In chemotaxis, macrophages use an actin-based membrane structure, the podosome, to migrate to inflamed tissues. In phagocytosis, macrophages form another type of actin-based membrane structure, the phagocytic cup, to ingest foreign materials such as bacteria. The formation of these membrane structures is severely affected in macrophages from patients with Wiskott-Aldrich syndrome (WAS), an X chromosome-linked immunodeficiency disorder. WAS patients lack WAS protein (WASP), suggesting that WASP is required for the formation of podosomes and phagocytic cups. Here we have demonstrated that formin-binding protein 17 (FBP17) recruits WASP, WASP-interacting protein (WIP), and dynamin-2 to the plasma membrane and that this recruitment is necessary for the formation of podosomes and phagocytic cups. The N-terminal EFC (extended FER-CIP4 homology)/F-BAR (FER-CIP4 homology and Bin-amphiphysin-Rvs) domain of FBP17 was previously shown to have membrane binding and deformation activities. Our results suggest that FBP17 facilitates membrane deformation and actin polymerization to occur simultaneously at the same membrane sites, which mediates a common molecular step in the formation of podosomes and phagocytic cups. These results provide a potential mechanism underlying the recurrent infections in WAS patients.	Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Takada, Hidetoshi; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Mochizuki, Naoki] Res Inst, Natl Cardiovasc Ctr, Dept Struct Anal, Osaka 5658565, Japan; [Tsuboi, Shigeru] Oyokyo Kidney Res Inst, Dept Biochem, Hirosaki, Aomori 0368243, Japan; [Ohyama, Chikara] Hirosaki Univ, Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan; [Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Saitama 3590042, Japan; [Ochs, Hans D.] Seattle Childrens Hosp, Res Inst, Res Ctr Immun & Immunotherapy, Dept Pediat, Seattle, WA 98101 USA	Sanford Burnham Prebys Medical Discovery Institute; Kyushu University; National Cerebral & Cardiovascular Center - Japan; Hirosaki University; National Defense Medical College - Japan; Seattle Children's Hospital	Tsuboi, S (corresponding author), Oyokyo Kidney Res Inst, Dept Biochem, 90 Yamazaki, Hirosaki, Aomori 0368243, Japan.	tsuboi@oyokyo.jp			National Institutes of Health [R01HD042752]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD042752 ( to S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALDRICH RA, 1954, PEDIATRICS, V13, P133; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Calle Y, 2008, J MICROSC-OXFORD, V231, P494, DOI 10.1111/j.1365-2818.2008.02062.x; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kato M, 2007, J IMMUNOL, V179, P6052, DOI 10.4049/jimmunol.179.9.6052; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; Notarangelo LD, 2008, CURR OPIN HEMATOL, V15, P30, DOI 10.1097/MOH.0b013e3282f30448; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takayama S, 1998, CANCER RES, V58, P3116; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212	42	51	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8548	8556		10.1074/jbc.M805638200	http://dx.doi.org/10.1074/jbc.M805638200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19155218	Green Published, hybrid			2022-12-27	WOS:000264397800039
J	Zhu, QS; Azimov, R; Kao, LY; Newman, D; Liu, WX; Abuladze, N; Pushkin, A; Kurtz, I				Zhu, Quansheng; Azimov, Rustam; Kao, Liyo; Newman, Debra; Liu, Weixin; Abuladze, Natalia; Pushkin, Alexander; Kurtz, Ira			NBCe1-A Transmembrane Segment 1 Lines the Ion Translocation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICARBONATE COTRANSPORTER PNBC1; MOLECULAR-BASIS; SCANNING MUTAGENESIS; CRYSTAL-STRUCTURE; CHANNEL; IDENTIFICATION; TOPOLOGY; RESIDUES; BAND-3; STOICHIOMETRY	The electrogenic Na+/HCO3- cotransporter (NBCe1-A) transports sodium and bicarbonate across the basolateral membrane of the renal proximal tubule. In this study the structural requirement of transmembrane segment 1 (TM1) residues in mediating NBCe1-A transport was investigated. Twenty-five introduced cysteine mutants at positions Gln-424 to Gly-448 were tested for their sensitivity to the methanethiosulfonate reagents (2-sulfonatoethyl) methanethiosulfonate (MTSES), [2-(trimethylammonium)ethyl] methanethiosulfonate (MTSET), and (2-aminoethyl) methanethiosulfonate (MTSEA). Two mutants, T442C and A435C, showed 100 and 70% sensitivity, respectively, to inhibition by all the three methanethiosulfonate (MTS) reagents, I441C had >50% sensitivity to MTSET and MTSEA, and A428C had 50% sensitivity to MTSEA inhibition. A helical wheel plot showed that mutants T442C, A435C, and A428C are clustered on one face of TM1 within a 100 arc. Topology analysis of TM1 with biotin maleimide and 2-((5(6)tetramethylrhodamine) carboxylamino) ethyl methanethiosulfonate (MTS-TAMRA) revealed Thr-442 marks the C-terminal end of TM1 and that extracellular FGGLLG stretch is in a small aqueous-accessible cavity. Functional studies indicated that Thr-442 resides in a narrow region of the ion translocation pore with strong delta(-) helical dipole influence. Analysis of the corresponding residue of NBCe1-A-Thr-442 in AE1 (Thr-422) shows it is functionally insensitive to MTSES and unlabeled with MTS-TAMRA, indicating that AE1-TM1 is oriented differently from NBCe1-A. In summary, we have identified residues Thr-442, Ala-435, and Ala-428 in TM1 lining the ion translocation pore of NBCe1-A. Our findings are suggestive of delta(-) helical dipole at the C-terminal end of TM1 involving Thr-442 that plays a critical role in the function of the cotransporter.	[Zhu, Quansheng; Azimov, Rustam; Kao, Liyo; Newman, Debra; Liu, Weixin; Abuladze, Natalia; Pushkin, Alexander; Kurtz, Ira] Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, Div Nephrol, David Geffen Sch Med, 10833 Le Conte Ave,Rm 7-155 Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563, DK063125, ES12935]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R01DK063125, R01DK058563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162, DK058563, DK063125, and ES12935. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Azimov R, 2007, FASEB J, V21, pA1283; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Cheung JC, 2005, BIOCHEM J, V390, P137, DOI 10.1042/BJ20050315; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Choi I, 2007, J PHYSIOL-LONDON, V578, P131, DOI 10.1113/jphysiol.2006.114959; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Gross E, 2001, J PHYSIOL-LONDON, V537, P659; Gross E, 2001, J PHYSIOL-LONDON, V531, P375, DOI 10.1111/j.1469-7793.2001.0375i.x; GROVES JD, 1993, FEBS LETT, V330, P186, DOI 10.1016/0014-5793(93)80270-5; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3311, DOI 10.1021/bi011678+; KURTZ I, 1987, J CLIN INVEST, V80, P928, DOI 10.1172/JCI113184; LODISH H, 2000, MOL CELL BIOL, P702; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	31	27	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8909	8920		10.1074/jbc.M806674200	http://dx.doi.org/10.1074/jbc.M806674200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158093	hybrid, Green Published			2022-12-27	WOS:000264397800074
J	Dierker, T; Dreier, R; Petersen, A; Bordych, C; Grobe, K				Dierker, Tabea; Dreier, Rita; Petersen, Arnd; Bordych, Christian; Grobe, Kay			Heparan Sulfate-modulated, Metalloprotease-mediated Sonic Hedgehog Release from Producing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; CHOLESTEROL MODIFICATION; LIPID RAFTS; CELLULAR CHOLESTEROL; CRYSTAL-STRUCTURE; TOUT-VELU; ADAM17; PROTEINS; MOVEMENT; SURFACE	The ectodomains of numerous proteins are released from cells by matrix metalloproteases to yield soluble intercellular regulators. A disintegrin and metalloprotease (ADAM) family members have often been found to be the responsible "sheddases," ADAM17/tumor necrosis factor-alpha-converting enzyme being its best characterized member. In this work, we show that ShhNp (lipidated and membrane-tethered Sonic hedgehog) is released from Bosc23 cells by metalloprotease-mediated ectodomain shedding, resulting in a soluble and biologically active morphogen. ShhNp shedding is increased by ADAM17 coexpression and cholesterol depletion of cells with methyl-beta-cyclodextrin and is reduced by metalloprotease inhibitors as well as ADAM17 RNA interference. We also show that the amount of shed ShhNp is modulated by extracellular heparan sulfate (HS) and that ShhNp shedding depends on specific HS sulfations. Based on those data, we suggest new roles for metalloproteases, including but not restricted to ADAM17, and for HS-proteoglycans in Hedgehog signaling.	[Dierker, Tabea; Dreier, Rita; Bordych, Christian; Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Dierker, Tabea] Univ Munster, Dept Gen Zool & Genet, D-48149 Munster, Germany; [Petersen, Arnd] Res Ctr Borstel, Dept Clin Med, D-23845 Borstel, Germany	University of Munster; University of Munster; Forschungszentrum Borstel	Grobe, K (corresponding author), Waldeyerstr 15, D-48149 Munster, Germany.	kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011	Dierker, Tabea/0000-0003-1991-2723	Deutsche Forschungsgemeinschaft (German Research Council) [SFB492-B15, SFB492-B18]; Ev. Studienwerk Villigst e.V	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); Ev. Studienwerk Villigst e.V	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) Grant SFB492-B15 (to K. G.) and SFB492-B18 (to R. D.). The costs of publication of this article were defrayed in part by the payment of page charges.; Supported by Ev. Studienwerk Villigst e.V.	Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Day ES, 1999, BIOCHEMISTRY-US, V38, P14868, DOI 10.1021/bi9910068; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marshall LJ, 2003, J IMMUNOL, V171, P2057, DOI 10.4049/jimmunol.171.4.2057; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Walev I, 2000, J LEUKOCYTE BIOL, V68, P865; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	47	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8013	8022		10.1074/jbc.M806838200	http://dx.doi.org/10.1074/jbc.M806838200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19176481	Green Published, hybrid			2022-12-27	WOS:000264195600064
J	Kang, J; Yu, HT				Kang, Jungseog; Yu, Hongtao			Kinase Signaling in the Spindle Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KINETOCHORE-MICROTUBULE INTERACTIONS; POLO-LIKE KINASE; MITOTIC CHECKPOINT; AURORA-B; CHROMOSOME ALIGNMENT; ASSEMBLY CHECKPOINT; CENP-E; ATTACHMENT STABILITY; INNER CENTROMERE; PROTEIN BUBR1	The spindle checkpoint is a cell cycle surveillance system that ensures the fidelity of chromosome segregation. In mitosis, it elicits the "wait anaphase" signal to inhibit the anaphase-promoting complex or cyclosome until all chromosomes achieve bipolar microtubule attachment and align at the metaphase plate. Because a single kinetochore unattached to microtubules activates the checkpoint, the wait anaphase signal is thought to be generated by this kinetochore and is then amplified and distributed throughout the cell to inhibit the anaphase-promoting complex/cyclosome. Several spindle checkpoint kinases participate in the generation and amplification of this signal. Recent studies have begun to reveal the activation mechanisms of these checkpoint kinases. Increasing evidence also indicates that the checkpoint kinases not only help to generate the wait anaphase signal but also actively correct kinetochore-microtubule attachment defects.	[Kang, Jungseog; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu		Yu, Hongtao/0000-0002-8861-049X				Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chen RH, 2004, EMBO J, V23, P3113, DOI 10.1038/sj.emboj.7600308; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	59	32	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15359	15363		10.1074/jbc.R900005200	http://dx.doi.org/10.1074/jbc.R900005200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19228686	hybrid, Green Published			2022-12-27	WOS:000266501000003
J	Babich, V; Knipe, L; Hewlett, L; Meli, A; Dempster, J; Hannah, MJ; Carter, T				Babich, Victor; Knipe, Laura; Hewlett, Lindsay; Meli, Athinoula; Dempster, John; Hannah, Matthew J.; Carter, Tom			Differential Effect of Extracellular Acidosis on the Release and Dispersal of Soluble and Membrane Proteins Secreted from the Weibel-Palade Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; PLATELET VONWILLEBRAND-FACTOR; HUMAN ENDOTHELIAL-CELLS; INTRACELLULAR PH; TISSUE PH; BODIES; ISCHEMIA; PROPOLYPEPTIDE; MICRODOMAINS; INFLAMMATION	Proteins secreted from Weibel-Palade bodies (WPBs) play important roles in regulating inflammatory and hemostatic responses. Inflammation is associated with the extracellular acidification of tissues and blood, conditions that can alter the behavior of secreted proteins. The effect of extracellular pH (pH(o)) on the release of von Willebrand factor (VWF), the VWF-propolypeptide (Proregion), interleukin-8, eotaxin-3, P-selectin, and CD63 from WPBs was investigated using biochemical approaches and by direct optical analysis of individual WPB fusion events in human endothelial cells expressing green or red fluorescent fusions of these different cargo proteins. Between pH(o) 7.4 and 7.0, ionomycin-evoked WPB exocytosis was characterized by the adhesion of VWF to the cell surface and the formation of long filamentous strands. The rapid dispersal of Proregion, interleukin-8, and eotaxin-3 into solution, and of P-selectin and CD63 into the plasma membrane, was unaltered over this pH(o) range. At pHo 6.8 or lower, Proregion remained associated with VWF, in many cases WPB failed to collapse fully and VWF failed to form filamentous strands. At pH(o) 6.5 dispersal of interleukin-8, eotaxin-3, and the membrane protein CD63 remained unaltered compared with that at pH(o) 7.4; however, P-selectin dispersal into the plasma membrane was significantly slowed. Thus, extracellular acidification to levels of pH(o) 6.8 or lower significantly alters the behavior of secreted VWF, Proregion, and P-selectin while rapid release of the small pro-inflammatory mediators IL-8 and eotaxin-3 is essentially unaltered. Together, these data suggest that WPB exocytosis during extracellular acidosis may favor the control of inflammatory processes.	[Babich, Victor; Knipe, Laura; Hewlett, Lindsay; Meli, Athinoula; Hannah, Matthew J.; Carter, Tom] Natl Inst Med Res, MRC, London NW7 1AA, England; [Dempster, John] Univ Strathclyde, Glasgow G40 NR, Lanark, Scotland	MRC National Institute for Medical Research; University of Strathclyde	Carter, T (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	tcarter@nimr.mrc.ac.uk	Carter, Tom/E-5035-2016	Carter, Tom/0000-0002-6248-7278; Dempster, John/0000-0003-2199-2945	MRC [MC_U117570589, MC_U117573808] Funding Source: UKRI; Medical Research Council [MC_U117570589, MC_U117573808] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andersson SE, 1999, J RHEUMATOL, V26, P2018; Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Christou H, 2005, AM J PHYSIOL-HEART C, V288, pH2647, DOI 10.1152/ajpheart.00937.2004; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; FOLEY ME, 1977, LANCET, V1, P1230; FRESSINAUD E, 1987, BLOOD, V70, P1214; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Goodis HE, 2006, J DENT RES, V85, P1046, DOI 10.1177/154405910608501114; GRALNICK HR, 1991, MAYO CLIN PROC, V66, P634, DOI 10.1016/S0025-6196(12)60524-2; HAGBERG H, 1985, PFLUG ARCH EUR J PHY, V404, P342, DOI 10.1007/BF00585346; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Huck V, 2007, J CELL PHYSIOL, V211, P399, DOI 10.1002/jcp.20947; Ihrcke NS, 1998, J CELL PHYSIOL, V175, P255, DOI 10.1002/(SICI)1097-4652(199806)175:3<255::AID-JCP3>3.0.CO;2-N; Isobe T, 1997, J BIOL CHEM, V272, P8447, DOI 10.1074/jbc.272.13.8447; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kiskin NI, 2005, BIOPHYS J, V88, p264A; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Marumo M, 2001, THROMB RES, V104, P353, DOI 10.1016/S0049-3848(01)00374-7; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Michaux G, 2006, BLOOD, V107, P3922, DOI 10.1182/blood-2005-09-3635; NEMOTO EM, 1981, STROKE, V12, P77, DOI 10.1161/01.STR.12.1.77; Radhakrishnan R, 2005, J PHARMACOL EXP THER, V313, P921, DOI 10.1124/jpet.104.082776; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; VISCHER UM, 1994, BLOOD, V83, P3536; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WATSON RM, 1984, AM J PHYSIOL, V246, pH232, DOI 10.1152/ajpheart.1984.246.2.H232; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZUCKER MB, 1979, J LAB CLIN MED, V94, P675	39	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12459	12468		10.1074/jbc.M809235200	http://dx.doi.org/10.1074/jbc.M809235200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258324	hybrid, Green Published			2022-12-27	WOS:000265494600075
J	Meng, Y; Katsuma, S; Daimon, T; Banno, Y; Uchino, K; Sezutsu, H; Tamura, T; Mita, K; Shimada, T				Meng, Yan; Katsuma, Susumu; Daimon, Takaaki; Banno, Yutaka; Uchino, Keiro; Sezutsu, Hideki; Tamura, Toshiki; Mita, Kazuei; Shimada, Toru			The Silkworm Mutant lemon (lemon lethal) Is a Potential Insect Model for Human Sepiapterin Reductase Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPA-RESPONSIVE DYSTONIA; BOMBYX-MORI; TETRAHYDROBIOPTERIN DEFICIENCIES; PARKINSONS-DISEASE; DROSOPHILA MODEL; PURIFICATION; ENZYME; HYPERPHENYLALANINEMIA; BIOSYNTHESIS; CARBONYL	Tetrahydrobiopterin (BH4) is an essential cofactor for aromatic acid hydroxylases, which control the levels of monoamine neurotransmitters. BH4 deficiency has been associated with many neuropsychological disorders. An inherited defect in BH4 biosynthesis is caused by the deficiency of sepiapterin reductase (SPR), which catalyzes the biosynthesis of BH4 from guanosine triphosphate at the terminal step. The human SPR gene has been mapped at the PARK3 locus, which is related to the onset of Parkinson disease. In this study, we report that mutant strains, lemon (lem) and its lethal allele lemon lethal (lem(1)) with yellow body coloration, of the silkworm Bombyx mori could be used as the first insect model for human SPR deficiency diseases. We demonstrated that mutations in the SPR gene (BmSpr) were responsible for the irregular body coloration of lem and lem(l). Moreover, biochemical analysis revealed that SPR activity in lem(l) larvae was almost completely diminished, resulting in a lethal phenotype that the larvae cannot feed and that die immediately after the first ecdysis. Oral administration of BH4 and dopamine to lem(l) larvae effectively increased their survival rates and feeding abilities. Our data demonstrate that BmSPR plays a crucial role in the generation of BH4, and monoamine neurotransmitters in silkworms and the lem (lem(l)) mutant strains will be an invaluable resource to address many questions regarding SPR and BH4 deficiencies.	[Meng, Yan; Katsuma, Susumu; Daimon, Takaaki; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Banno, Yutaka] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Inst Genet Resources, Higashi Ku, Fukuoka 8128581, Japan; [Uchino, Keiro; Sezutsu, Hideki; Tamura, Toshiki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Ctr, Tsukuba, Ibaraki 3058634, Japan; [Mita, Kazuei] Natl Inst Agrobiol Sci, Insect Sci Dept, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; Kyushu University; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Shimada, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp	meng, yan/GSE-2653-2022; Meng, Yan/HGC-0394-2022; Shimada, Toru/A-2033-2011; Shimada, Toru/AAZ-2703-2021	Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000; Daimon, Takaaki/0000-0002-8382-1132; Sezutsu, Hideki/0000-0001-8886-1611; Uchino, Keiro/0000-0003-3650-7359	Ministry of Education, Culture, Sports, Science, and Technology [17018007]; Japan Science and Technology Agency; Japan Society for the Promotion of Science [P07427]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-aid for Scientific Research 17018007 (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, the Professional Program for Agricultural Bioinformatics from Japan Science and Technology Agency, and Japan Society for the Promotion of Science Postdoctoral Fellowship for Foreign Researchers Grant P07427 (to Y.M.).	Abeling NG, 2006, MOL GENET METAB, V89, P116, DOI 10.1016/j.ymgme.2006.03.010; Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Banno YF., 2005, GUIDE SILKWORM MUTAN; Blau N, 1996, J INHERIT METAB DIS, V19, P8, DOI 10.1007/BF01799342; Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Daimon T, 2008, J BIOL CHEM, V283, P15271, DOI 10.1074/jbc.M709350200; Friedman J, 2006, NEUROLOGY, V67, P2032, DOI 10.1212/01.wnl.0000247274.21261.b4; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; GOTO M, 1966, B CHEM SOC JPN, V39, P929, DOI 10.1246/bcsj.39.929; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Iino T, 1996, BBA-PROTEIN STRUCT M, V1297, P191, DOI 10.1016/S0167-4838(96)00087-8; Iino T, 2000, ARCH BIOCHEM BIOPHYS, V373, P442, DOI 10.1006/abbi.1999.1561; IINO T, 1992, ZOOL SCI, V9, P119; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; KATOH S, 1971, ARCH BIOCHEM BIOPHYS, V146, P202, DOI 10.1016/S0003-9861(71)80057-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MATSUBARA M, 1963, NATURE, V199, P908, DOI 10.1038/199908a0; MAZDA T, 1980, INSECT BIOCHEM, V10, P357, DOI 10.1016/0020-1790(80)90003-7; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Ohashi M, 1983, J SERICULT SCI JPN, V52, P498; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; RuizVazquez P, 1996, COMP BIOCHEM PHYS B, V113, P131, DOI 10.1016/0305-0491(96)02005-6; SUEOKA T, 1982, BIOCHIM BIOPHYS ACTA, V717, P265, DOI 10.1016/0304-4165(82)90178-7; Takazawa C, 2008, BIOCHEM BIOPH RES CO, V367, P787, DOI 10.1016/j.bbrc.2008.01.028; TSUJITA MITSUO, 1955, JAPANESE JOUR GENETICS, V30, P107, DOI 10.1266/jjg.30.107; TSUSUE M, 1965, ZOOL MAG TOKYO, V74, P91; WSZOLEK ZK, 1993, NERVENARZT, V64, P331; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372	38	42	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11698	11705		10.1074/jbc.M900485200	http://dx.doi.org/10.1074/jbc.M900485200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19246455	hybrid, Green Published			2022-12-27	WOS:000265494500072
J	Yamaguchi, H; Woods, NT; Piluso, LG; Lee, HH; Chen, JD; Bhalla, KN; Monteiro, A; Liu, X; Hung, MC; Wang, HG				Yamaguchi, Hirohito; Woods, Nicholas T.; Piluso, Landon G.; Lee, Heng-Huan; Chen, Jiandong; Bhalla, Kapil N.; Monteiro, Alvaro; Liu, Xuan; Hung, Mien-Chie; Wang, Hong-Gang			p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; CELL-DEATH; APOPTOTIC RESPONSE; KU70 ACETYLATION; DNA-BINDING; IN-VIVO; BCL-2 FAMILY; ACTIVATION; BAX	Acetylation of p53 at carboxyl-terminal lysine residues enhances its transcriptional activity associated with cell cycle arrest and apoptosis. Here we demonstrate that p53 acetylation at Lys-320/Lys-373/Lys-382 is also required for its transcription-independent functions in BAX activation, reactive oxygen species production, and apoptosis in response to the histone deacetylase inhibitors (HDACi) suberoylanilide hydroxamic acid and LAQ824. Knock-out of p53 markedly reduced HDACi-induced apoptosis. Unexpectedly, expression of transactivation-deficient p53 variants sensitized p53-null cells to HDACi-mediated BAX-dependent apoptosis, whereas knockdown of endogenous mutant p53 in cancer cells reduced HDACi-mediated cytotoxicity. Evaluation of the mechanisms controlling this response led to the discovery of a novel interaction between p53 and Ku70. The association between these two proteins was acetylation-independent, but acetylation of p53 could prevent and disrupt the Ku70-BAX complex and enhance apoptosis. These results suggest a new mechanism of acetylated p53 transcription-independent regulation of apoptosis.	[Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Woods, Nicholas T.; Chen, Jiandong; Monteiro, Alvaro] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Yamaguchi, Hirohito; Lee, Heng-Huan; Hung, Mien-Chie] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Piluso, Landon G.; Liu, Xuan] Univ Calif Riverside, Riverside, CA 92521 USA; [Bhalla, Kapil N.] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of California System; University of California Riverside; University System of Georgia; Augusta University	Wang, HG (corresponding author), 500 Univ Dr,POB 850, Hershey, PA 17033 USA.	hwang3@hmc.psu.edu	Hung, Mien-Chie/ABD-5911-2021; Bhalla, Amar S/E-2203-2011; Wang, Hong-Gang/A-3018-2015; Monteiro, Alvaro N. A./A-7566-2009	Hung, Mien-Chie/0000-0003-4317-4740; Wang, Hong-Gang/0000-0003-0551-0571; Monteiro, Alvaro N. A./0000-0002-8448-4801; Woods, Nicholas/0000-0002-4962-9083; Bhalla, Kapil/0000-0001-5209-5126	National Institutes of Health; American Cancer Society and Flight Attendant Medical Research Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society and Flight Attendant Medical Research Institute(American Cancer Society)	This work was supported, in whole or in part, by National Institutes of Health grants. This work was also supported by grants from American Cancer Society and Flight Attendant Medical Research Institute.	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bissonnette N, 1997, BIOCHEM CELL BIOL, V75, P351, DOI 10.1139/bcb-75-4-351; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mahyar-Roemer M, 2004, ONCOGENE, V23, P6226, DOI 10.1038/sj.onc.1207637; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; MIYASHITA T, 1994, CANCER RES, V54, P3131; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nishita M, 1998, EXP CELL RES, V244, P357, DOI 10.1006/excr.1998.4203; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pietrzak M, 2008, BIOL CHEM, V389, P383, DOI 10.1515/BC.2008.039; Piluso LG, 2005, PROTEIN EXPRES PURIF, V40, P370, DOI 10.1016/j.pep.2004.12.015; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Raffo AJ, 2000, ONCOGENE, V19, P6216, DOI 10.1038/sj.onc.1203995; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Terui T, 2003, CANCER RES, V63, P8948; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	57	96	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11171	11183		10.1074/jbc.M809268200	http://dx.doi.org/10.1074/jbc.M809268200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19265193	hybrid, Green Published			2022-12-27	WOS:000265494500021
J	Bernard, A; Gao-Li, J; Franco, CA; Bouceba, T; Huet, A; Li, ZL				Bernard, Adrien; Gao-Li, Jacqueline; Franco, Claudio-Areias; Bouceba, Tahar; Huet, Alexis; Li, Zhenlin			Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; FACTOR PEDF; BINDING PROTEIN; NADPH OXIDASE; IDENTIFICATION; EXPRESSION; ISCHEMIA; VIRUS; MODEL; MECHANISMS	Pigment epithelium-derived factor (PEDF) is a multifunctional protein with neurotrophic, anti-oxidative, and anti-inflammatory properties. It is also one of the most potent endogenous inhibitors of angiogenesis, playing an important role in restricting tumor growth, invasion, and metastasis. Studies show that PEDF binds to cell surface proteins, but little is known about how it exerts its effects. Recently, research identified phospholipase A(2)/nutrin/patatin-like phospholipase domain-containing 2 as one PEDF receptor. To identify other receptors, we performed yeast two-hybrid screening using PEDF as bait and discovered that the non-integrin 37/67-kDa laminin receptor (LR) is another PEDF receptor. Co-immunoprecipitation, His tag pulldown, and surface plasmon resonance assays confirmed the interaction between PEDF and LR. Using the yeast two-hybrid method, we further restricted the LR-interacting domain on PEDF to a 34-amino acid (aa) peptide (aa 44-77) and the PEDF-interacting domain on LR to a 91-aa fragment (aa 120-210). A 25-mer peptide named P46 (aa 46-70), derived from 34-mer, interacts with LR in surface plasmon resonance assays and binds to endothelial cell (EC) membranes. This peptide induces EC apoptosis and inhibits EC migration, tube-like network formation in vitro, and retinal angiogenesis ex vivo, like PEDF. Our results suggest that LR is a real PEDF receptor that mediates PEDF angiogenesis inhibition.	[Bernard, Adrien; Gao-Li, Jacqueline; Franco, Claudio-Areias; Li, Zhenlin] Univ Paris 06, UR4, F-75252 Paris, France; [Bouceba, Tahar] Inst Federatif Rech 83, F-75252 Paris, France; [Huet, Alexis] Univ Paris 11, CNRS, IBBMC, Unite Mixte Rech 8619, F-91400 Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Li, ZL (corresponding author), Univ Paris 06, UR4, BP256,7 Quai St Bernard, F-75005 Paris, France.	zhenlin.li@upmc.fr	Li, Zhenlin/E-3937-2016; Franco, Claudio A/B-1060-2013; Huet, Alexis/AAU-5958-2021; Franco, Claudio A/D-8117-2015	Franco, Claudio A/0000-0002-2861-3883; Huet, Alexis/0000-0001-6069-4460; Franco, Claudio A/0000-0002-2861-3883; LI, Zhenlin/0000-0002-3706-4505	Association pour la Recherche sur le Cancer [3587]; Naturalia et Biological; Retina France; Fondation de Recherche Medicale	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Naturalia et Biological; Retina France; Fondation de Recherche Medicale	This work was supported by funds from the Association pour la Recherche sur le Cancer (ARC, 3587, to Z.L.) and by fellowships from ARC and Naturalia et Biological (to A.B.), Retina France (to J.G.), and Fondation de Recherche Medicale (to C.A.F.).	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Ardini E, 2002, CANCER RES, V62, P1321; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Becerra SP, 2008, J BIOL CHEM, V283, P33310, DOI 10.1074/jbc.M801287200; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Behling KC, 2002, MOL VIS, V8, P449; BERREIRO R, 2003, INVESTIG OPHTHALMOL, V44, P1282; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Chen LL, 2006, BIOCHEM BIOPH RES CO, V348, P1288, DOI 10.1016/j.bbrc.2006.07.188; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Donaldson Elaine A., 2000, Molecular Cell Biology Research Communications, V3, P53, DOI 10.1006/mcbr.2000.0191; Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821; Ek ETH, 2007, J ORTHOP RES, V25, P1671, DOI 10.1002/jor.20434; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gebarowska D, 2002, AM J PATHOL, V160, P307, DOI 10.1016/S0002-9440(10)64374-X; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Hutchings H, 2002, BIOCHEM BIOPH RES CO, V294, P764, DOI 10.1016/S0006-291X(02)00548-X; Kanda S, 2005, J CELL SCI, V118, P961, DOI 10.1242/jcs.01686; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KLEINMAN HK, 1988, P NATL ACAD SCI USA, V85, P1282, DOI 10.1073/pnas.85.4.1282; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; McKenna DJ, 2001, EXP EYE RES, V73, P81, DOI 10.1006/exer.2001.1013; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sasaki Y, 2005, ONCOGENE, V24, P5131, DOI 10.1038/sj.onc.1208695; Schweitzer KM, 1997, LAB INVEST, V76, P25; Scott WN, 2000, BBA-PROTEIN STRUCT M, V1481, P25, DOI 10.1016/S0167-4838(00)00120-5; Selleri C, 2006, BLOOD, V108, P2476, DOI 10.1182/blood-2005-11-012625; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Stitt AW, 1998, AM J PATHOL, V152, P1359; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; TERRANOVA VP, 1986, J CELL PHYSIOL, V127, P473, DOI 10.1002/jcp.1041270318; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Thibaut S, 2009, J INVEST DERMATOL, V129, P449, DOI 10.1038/jid.2008.231; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; Tombran-Tink J, 1996, Mol Vis, V2, P11; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; WEWER UM, 1987, CANCER RES, V47, P5691; Yamagishi S, 2005, CELL TISSUE RES, V320, P437, DOI 10.1007/s00441-005-1094-8; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V296, P877, DOI 10.1016/S0006-291X(02)00940-3; Yamagishi SI, 2004, J MOL CELL CARDIOL, V37, P497, DOI 10.1016/j.yjmcc.2004.04.007; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje	70	131	138	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10480	10490		10.1074/jbc.M809259200	http://dx.doi.org/10.1074/jbc.M809259200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224861	Green Published, hybrid			2022-12-27	WOS:000265104600022
J	Collins, R; Karlberg, T; Lehtio, L; Schutz, P; van den Berg, S; Dahlgren, LG; Hammarstrom, M; Weigelt, J; Schuler, H				Collins, Ruairi; Karlberg, Tobias; Lehtio, Lari; Schutz, Patrick; van den Berg, Susanne; Dahlgren, Lars-Goran; Hammarstrom, Martin; Weigelt, Johan; Schuler, Herwig			The DEXD/H-box RNA Helicase DDX19 Is Regulated by an alpha-Helical Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA; CRYSTAL-STRUCTURE; PROTEIN DBP5; EXPORT; SOFTWARE	DEXD/H-box RNA helicases couple ATP hydrolysis to RNA remodeling by an unknown mechanism. We used x-ray crystallography and biochemical analysis of the human DEXD/H-box protein DDX19 to investigate its regulatory mechanism. The crystal structures of DDX19, in its RNA-bound prehydrolysis and free posthydrolysis state, reveal an alpha-helix that inserts between the conserved domains of the free protein to negatively regulate ATPase activity. This finding was corroborated by biochemical data that confirm an autoregulatory function of the N-terminal region of the protein. This is the first study describing crystal structures of a DEXD/H-box protein in its open and closed cleft conformations.	[Collins, Ruairi; Karlberg, Tobias; Lehtio, Lari; Schutz, Patrick; van den Berg, Susanne; Dahlgren, Lars-Goran; Hammarstrom, Martin; Weigelt, Johan; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Schuler, H (corresponding author), Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501; Lehtio, Lari/0000-0001-7250-832X				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; DeLano W.L, PYMOL MOL GRAPHICS S; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424	29	106	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10296	10300		10.1074/jbc.C900018200	http://dx.doi.org/10.1074/jbc.C900018200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244245	Green Published, hybrid			2022-12-27	WOS:000265104600003
J	Nishimoto-Morita, K; Shin, HW; Mitsuhashi, H; Kitamura, M; Zhang, Q; Johannes, L; Nakayama, K				Nishimoto-Morita, Kirika; Shin, Hye-Won; Mitsuhashi, Hiroko; Kitamura, Masashi; Zhang, Qian; Johannes, Ludger; Nakayama, Kazuhisa			Differential Effects of Depletion of ARL1 and ARFRP1 on Membrane Trafficking between the trans-Golgi Network and Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTORS; EFFICIENT RETROGRADE TRANSPORT; NUCLEOTIDE EXCHANGE FACTOR; GRIP DOMAIN PROTEINS; PLASMA-MEMBRANE; SHIGA-TOXIN; EARLY/RECYCLING ENDOSOMES; CYTOPLASMIC DOMAIN; GTPASE ARL3P; LIVING CELLS	ARFRP1 and ARL1, which are both ARF-like small GTPases, are mammalian orthologs of yeast Arl3p and Arl1p, respectively. In yeast, Arl3p targeted to trans-Golgi network (TGN) membranes activates Arl1p, and the activated Arl1p in turn recruits a GRIP domain-containing protein; this complex regulates retrograde transport to the TGN and anterograde transport from the TGN. In the present study, using RNA interference-mediated knockdown of ARFRP1 and ARL1, we have examined whether the orthologs of Arl3p-Arl1p-GRIP story serve similar functions in mammalian cells. However, we have unexpectedly found differential roles of ARL1 and ARFRP1. Specifically, ARL1 and ARFRP1 regulate retrograde transport of Shiga toxin to the TGN and anterograde transport of VSVG from the TGN, respectively. Furthermore, we have obtained evidence suggesting that a SNARE complex containing Vti1a, syntaxin 6, and syntaxin 16 is involved in Shiga toxin transport downstream of ARL1.	[Nishimoto-Morita, Kirika; Shin, Hye-Won; Mitsuhashi, Hiroko; Kitamura, Masashi; Zhang, Qian; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Sci, Sakyo Ku, Kyoto 6068501, Japan; [Johannes, Ludger] Inst Curie, CNRS, UMR144, Traff & Signaling Lab, F-75248 Paris 05, France	Kyoto University; Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Johannes, Ludger/W-8593-2019; Johannes, Ludger/M-9778-2017; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science; Protein 3000 Project; Targeted Proteins Research Program; International Young Scientists Career Development Organization of Kyoto University; Uehara Memorial Foundation; NOVARTIS Foundation (Japan); Hayashi Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Protein 3000 Project; Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Young Scientists Career Development Organization of Kyoto University; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation (Japan)(Novartis); Hayashi Memorial Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for Promotion of Science, the Protein 3000 Project, the Targeted Proteins Research Program, the International Young Scientists Career Development Organization of Kyoto University, the Uehara Memorial Foundation, and the NOVARTIS Foundation (Japan) for the Promotion of Science, and the Hayashi Memorial Foundation for Female Natural Scientists.	Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Liu YW, 2006, J CELL SCI, V119, P3845, DOI 10.1242/jcs.03148; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; Mueller AG, 2002, MOL CELL BIOL, V22, P1488, DOI 10.1128/MCB.22.5.1488-1494.2002; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wang Y, 2005, MOL MEMBR BIOL, V22, P313, DOI 10.1080/09687860500143829; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Zahn C, 2008, J BIOL CHEM, V283, P27179, DOI 10.1074/jbc.M802108200; Zahn C, 2006, MOL MEMBR BIOL, V23, P475, DOI 10.1080/09687860600840100; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	40	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10583	10592		10.1074/jbc.M900847200	http://dx.doi.org/10.1074/jbc.M900847200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224922	Green Published, hybrid			2022-12-27	WOS:000265104600032
J	Ahuja, S; Crocker, E; Eilers, M; Hornak, V; Hirshfeld, A; Ziliox, M; Syrett, N; Reeves, PJ; Khorana, HG; Sheves, M; Smith, SO				Ahuja, Shivani; Crocker, Evan; Eilers, Markus; Hornak, Viktor; Hirshfeld, Amiram; Ziliox, Martine; Syrett, Natalie; Reeves, Philip J.; Khorana, H. Gobind; Sheves, Mordechai; Smith, Steven O.			Location of the Retinal Chromophore in the Activated State of Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGLE-SPINNING NMR; ASSISTED ROTATIONAL RESONANCE; PROTEIN-COUPLED RECEPTORS; HIGH-LEVEL EXPRESSION; MAMMALIAN-CELL LINES; METARHODOPSIN-II; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVATION; TRANSMEMBRANE HELICES; BOVINE RHODOPSIN	Rhodopsin is a highly specialized G protein-coupled receptor (GPCR) that is activated by the rapid photochemical isomerization of its covalently bound 11-cis-retinal chromophore. Using two-dimensional solid-state NMR spectroscopy, we defined the position of the retinal in the active metarhodopsin II intermediate. Distance constraints were obtained between amino acids in the retinal binding site and specific C-13-labeled sites located on the beta-ionone ring, polyene chain, and Schiff base end of the retinal. We show that the retinal C20 methyl group rotates toward the second extracellular loop (EL2), which forms a cap on the retinal binding site in the inactive receptor. Despite the trajectory of the methyl group, we observed an increase in the C20-Gly(188) (EL2) distance consistent with an increase in separation between the retinal and EL2 upon activation. NMR distance constraints showed that the beta-ionone ring moves to a position between Met(207) and Phe(208) on transmembrane helix H5. Movement of the ring toward H5 was also reflected in increased separation between the C epsilon carbons of Lys(296) (H7) and Met(44) (H1) and between Gly(121) (H3) and the retinal C18 methyl group. Helix-helix interactions involving the H3-H5 and H4-H5 interfaces were also found to change in the formation of metarhodopsin II reflecting increased retinal-protein interactions in the region of Glu(122) (H3) and His(211) (H5). We discuss the location of the retinal in metarhodopsin II and its interaction with sequence motifs, which are highly conserved across the pharmaceutically important class A GPCR family, with respect to the mechanism of receptor activation.	[Eilers, Markus; Hornak, Viktor; Ziliox, Martine; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Ahuja, Shivani; Crocker, Evan] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Hirshfeld, Amiram; Sheves, Mordechai] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Reeves, Philip J.; Khorana, H. Gobind] MIT, Dept Biol, Cambridge, MA 02139 USA; [Syrett, Natalie; Reeves, Philip J.] Univ Essex, Dept Biol Sci, Colchester C04 3SQ, Essex, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science; Massachusetts Institute of Technology (MIT); University of Essex	Smith, SO (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	steven.o.smith@sunysb.edu	Smith, Steven/HDM-9496-2022; Ahuja, Shivani/F-4537-2010		National Institutes of Health-National Science Foundation Instrumentation [S10 RR13889, DBI-9977553]; National Institutes of Health [GM-41412, EY-11716]; Israel Academy of Sciences and Humanities; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013889] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041412] Funding Source: NIH RePORTER	National Institutes of Health-National Science Foundation Instrumentation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Academy of Sciences and Humanities; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health-National Science Foundation Instrumentation Grants S10 RR13889 and DBI-9977553 and by National Institutes of Health Grants GM-41412 (to S. O. S.) and EY-11716 (to H. G. K.). This work was also supported by the Fund for Basic Research, administered by The Israel Academy of Sciences and Humanities (to M. S.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Beck M, 1998, FEBS LETT, V436, P304, DOI 10.1016/S0014-5793(98)01156-9; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; CHABRE M, 1979, PHOTOCHEM PHOTOBIOL, V30, P295, DOI 10.1111/j.1751-1097.1979.tb07150.x; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; Creemers AFL, 2002, P NATL ACAD SCI USA, V99, P9101, DOI 10.1073/pnas.112677599; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Crocker E, 2004, J BIOMOL NMR, V29, P11, DOI 10.1023/B:JNMR.0000019521.79321.3c; DULBECCO R, 1959, VIROLOGY, V8, P396, DOI 10.1016/0042-6822(59)90043-1; Eilers M, 1999, P NATL ACAD SCI USA, V96, P487, DOI 10.1073/pnas.96.2.487; Eilers M, 2002, METHOD ENZYMOL, V343, P212; EYRING G, 1982, BIOCHEMISTRY-US, V21, P384, DOI 10.1021/bi00531a028; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Getmanova E, 2004, BIOCHEMISTRY-US, V43, P1126, DOI 10.1021/bi030120u; GIBSON NJ, 1993, BIOCHEMISTRY-US, V32, P2438, DOI 10.1021/bi00060a040; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Han M, 1998, BIOCHEMISTRY-US, V37, P538, DOI 10.1021/bi972060w; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; HUBBARD R, 1952, J GEN PHYSIOL, V36, P269, DOI 10.1085/jgp.36.2.269; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Javitch JA, 1995, BIOCHEMISTRY-US, V34, P16433, DOI 10.1021/bi00050a026; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; LUGTENBURG J, 1985, PURE APPL CHEM, V57, P753, DOI 10.1351/pac198557050753; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Marjamaki A, 1998, MOL PHARMACOL, V53, P370, DOI 10.1124/mol.53.3.370; MARR K, 1991, BIOCHEMISTRY-US, V30, P1254, DOI 10.1021/bi00219a013; MATSUMOTO H, 1978, VISION RES, V18, P607, DOI 10.1016/0042-6989(78)90212-2; Meng EC, 2001, TRENDS PHARMACOL SCI, V22, P587, DOI 10.1016/S0165-6147(00)01825-3; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Patel AB, 2005, J MOL BIOL, V347, P803, DOI 10.1016/j.jmb.2005.01.069; PATEL AB, 2004, THESIS STONY BROOK U; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Rohrig UF, 2002, BIOCHEMISTRY-US, V41, P10799, DOI 10.1021/bi026011h; Salgado GFJ, 2004, BIOCHEMISTRY-US, V43, P12819, DOI 10.1021/bi0491191; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schreiber M, 2006, ANGEW CHEM INT EDIT, V45, P4274, DOI 10.1002/anie.200600585; Shapiro DA, 2000, MOL PHARMACOL, V58, P877, DOI 10.1124/mol.58.5.877; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Spooner PJR, 2004, J MOL BIOL, V343, P719, DOI 10.1016/j.jmb.2004.08.049; Spooner PJR, 2002, BIOCHEMISTRY-US, V41, P7549, DOI 10.1021/bi020007o; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Strassburger JM, 1997, BIOPHYS J, V72, P2294, DOI 10.1016/S0006-3495(97)78874-X; Struts AV, 2007, J MOL BIOL, V372, P50, DOI 10.1016/j.jmb.2007.03.046; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Vogel R, 2005, BIOCHEMISTRY-US, V44, P11684, DOI 10.1021/bi0508587; Yan ECY, 2002, BIOCHEMISTRY-US, V41, P3620, DOI 10.1021/bi0160011; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431	75	78	79	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10190	10201		10.1074/jbc.M805725200	http://dx.doi.org/10.1074/jbc.M805725200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176531	Green Published, hybrid			2022-12-27	WOS:000264892900061
J	Kuo, TT; de Muinck, EJ; Claypool, SM; Yoshida, M; Nagaishi, T; Aveson, VG; Lencer, WI; Blumberg, RS				Kuo, Timothy T.; de Muinck, Eric J.; Claypool, Steven M.; Yoshida, Masaru; Nagaishi, Takashi; Aveson, Victoria G.; Lencer, Wayne I.; Blumberg, Richard S.			N-Glycan Moieties in Neonatal Fc Receptor Determine Steady-state Membrane Distribution and Directional Transport of IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CANINE KIDNEY-CELLS; I-RELATED RECEPTOR; IMMUNOGLOBULIN-G; BIDIRECTIONAL TRANSCYTOSIS; CRYSTAL-STRUCTURE; SORTING SIGNALS; BINDING; ANTIGEN; ENDOCYTOSIS	The neonatal Fc receptor (FcRn) is a major histocompatibility complex class I-related molecule known to protect IgG and albumin from catabolism and transport IgG across polarized epithelial cells in a bidirectional manner. Previous studies have shown species-specific differences in ligand binding, IgG transport direction, and steady-state membrane distribution when expressed in polarized epithelial cells. We hypothesized that these differences may be due to the additional N-glycans expressed on the rat FcRn, because N-glycans have been proposed to function as apical targeting signals, and that two of the N-glycan moieties have been shown to contribute to the IgG binding of rat FcRn. A panel of mutant human FcRn variants was generated to resemble the N-glycan expression of rat FcRn in various combinations and subsequently transfected into Madin-Darby canine kidney II cells together with human beta(2)-microglobulin. Mutant human FcRn clones that contained additional N-glycan side-chain modifications, including that which was fully rodentized, still exhibited specificity for human IgG and failed to bind to mouse IgG. At steady state, the mutant human FcRn with additional N-glycans redistributed to the apical cell surface similar to that of rat FcRn. Furthermore, the rodentized human FcRn exhibited a reversal of IgG transport with predominant transcytosis from an apical-to-basolateral direction, which resembled that of the rat FcRn isoform. These studies show that the N-glycans in FcRn contribute significantly to the steady-state membrane distribution and direction of IgG transport in polarized epithelia.	[Kuo, Timothy T.; de Muinck, Eric J.; Claypool, Steven M.; Yoshida, Masaru; Nagaishi, Takashi; Aveson, Victoria G.; Blumberg, Richard S.] Brigham & Womens Hosp, Dept Gastroenterol, Boston, MA 02115 USA; [Kuo, Timothy T.; de Muinck, Eric J.; Claypool, Steven M.; Yoshida, Masaru; Nagaishi, Takashi; Aveson, Victoria G.; Lencer, Wayne I.; Blumberg, Richard S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lencer, Wayne I.] Childrens Hosp, Dept Gastroenterol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Blumberg, RS (corresponding author), Brigham & Womens Hosp, Div Gastroenterol, Dept Med, 75 Francis St, Boston, MA 02115 USA.	rblumberg@partners.org		Claypool, Steven/0000-0001-5316-1623; Lencer, Wayne/0000-0001-7346-2730; de Muinck, Eric/0000-0001-5606-3172	National Institutes of Health [DK071798, DK053056]; American Liver Foundation; Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center [P30 DK034854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK048106, P30DK040561, K08DK071798, R01DK053056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; Crohn's & Colitis Foundation of America; Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071798 (to T. T. K.) and DK053056 (to R. S. B. and W. I. L.). This work was also supported by the American Liver Foundation, the Crohn's & Colitis Foundation of America (to M. Y. and T. N.), and Harvard Digestive Diseases Center Grant P30 DK034854 (to R. S. B. and W. I. L.).	BRAMBELL FW, 1969, P NUTR SOC, V28, P35, DOI 10.1079/PNS19690007; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Dickinson BL, 2008, MOL BIOL CELL, V19, P414, DOI 10.1091/mbc.E07-07-0658; Gill RK, 1999, INDIAN J BIOCHEM BIO, V36, P252; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kim KJ, 2004, AM J PHYSIOL-LUNG C, V287, pL616, DOI 10.1152/ajplung.00121.2004; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Marzolo MP, 1997, P NATL ACAD SCI USA, V94, P1834, DOI 10.1073/pnas.94.5.1834; McCarthy KM, 2000, J CELL SCI, V113, P1277; McCarthy KM, 2001, J CELL SCI, V114, P1591; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RODEWALD R, 1983, CIBA F SYMP, V95, P287; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Stefaner I, 1999, J BIOL CHEM, V274, P8998, DOI 10.1074/jbc.274.13.8998; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yoshida M, 2006, SPRINGER SEMIN IMMUN, V28, P397, DOI 10.1007/s00281-006-0054-z; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014	29	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8292	8300		10.1074/jbc.M805877200	http://dx.doi.org/10.1074/jbc.M805877200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164298	Green Published, hybrid			2022-12-27	WOS:000264397800013
J	Matmati, N; Kitagaki, H; Montefusco, D; Mohanty, BK; Hannun, YA				Matmati, Nabil; Kitagaki, Hiroshi; Montefusco, David; Mohanty, Bidyut K.; Hannun, Yusuf A.			Hydroxyurea Sensitivity Reveals a Role for ISC1 in the Regulation of G(2)/M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE CONTROL; BUDDING YEAST; PROTEIN-KINASE; S-PHASE; CDC28; DNA; MORPHOGENESIS; ACTIVATION	Saccharomyces cerevisiae cells lacking ISC1 (inositol phosphosphingolipase C) exhibit sensitivity to genotoxic agents such as methyl methanesulfonate and hydroxyurea ( HU). Cell cycle analysis by flow cytometry revealed a G(2)/M block in isc1 Delta cells when treated with methyl methanesulfonate or HU. Further investigation revealed that the levels of Cdc28 phosphorylated on Tyr-19, which plays an essential role in the regulation of the G2/M checkpoint, were higher in synchronized and asynchronous cells lacking ISC1 in response to HU. Use of a Cdc28-Y19F mutant protected isc1 Delta from the G2/M block. In wild type cells, HU induced a loss of the Swe1p kinase, the enzyme that phosphorylates Cdc28-Tyr-19, correlating with resumption of the cell cycle. In the isc1 Delta cells, however, the levels of Swe1p remained at sustained high levels in response to HU. Significantly, deletion of SWE1 in an isc1 Delta background overcame the G(2)/M block in response to HU. The double isc1 Delta/swe1 Delta mutant also overcame the growth defect on HU. Taken together, these findings implicate Isc1p as an upstream regulator of Swe1p levels and stability and Cdc28-Tyr-19 phosphorylation, in effect signaling recovery from the effects of genotoxic stress and allowing G(2)/M progression.	[Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [Kitagaki, Hiroshi] Saga Univ, Fac Agr, Saga 8408502, Japan	Medical University of South Carolina; Saga University	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA.	hannun@musc.edu	Kitagaki, Hiroshi/N-1666-2019		National Institutes of Health [GM-43825, P20 RR-016461]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-43825 (to Y.A.H.) and P20 RR-016461 (to N.M.) (from the Post Doctoral Academic Career Development Program).	Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Betz C, 2002, EUR J BIOCHEM, V269, P4033, DOI 10.1046/j.1432-1033.2002.03096.x; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; LAWLEY PD, 1989, MUTAT RES, V213, P3, DOI 10.1016/0027-5107(89)90028-6; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mitchell DA, 2001, MOL CELL BIOL, V21, P488, DOI 10.1128/MCB.21.2.488-500.2001; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V	30	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8241	8246		10.1074/jbc.M900004200	http://dx.doi.org/10.1074/jbc.M900004200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158081	Green Published, hybrid			2022-12-27	WOS:000264397800007
J	Venkatachalam, K; Prabhu, SD; Reddy, VS; Boylston, WH; Valente, AJ; Chandrasekar, B				Venkatachalam, Kaliyamurthi; Prabhu, Sumanth D.; Reddy, Venkatapuram Seenu; Boylston, William H.; Valente, Anthony J.; Chandrasekar, Bysani			Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CCAAT/ENHANCER BINDING-PROTEIN; HUMAN CARDIAC FIBROBLASTS; ENDOTHELIAL-CELL DEATH; SMOOTH-MUSCLE-CELLS; C-REACTIVE PROTEIN; REPERFUSION INJURY; ISCHEMIA-REPERFUSION; TRANSCRIPTION FACTOR; LATE-PHASE	Ischemia/reperfusion (I/R) injury is characterized by the induction of oxidative stress and proinflammatory cytokine expression. Recently demonstrating that oxidative stress and TNF-alpha each stimulate interleukin (IL)-18 expression in cardiomyocytes, we hypothesized that I/R also induces IL-18 expression and thus exacerbates inflammation and tissue damage. Neutralization of IL-18 signaling should therefore diminish tissue injury following I/R. I/R studies were performed using a chronically instrumented closed chest mouse model. Male C57BL/6 mice underwent 30 min of ischemia by LAD coronary artery ligation followed by various periods of reperfusion. Sham-operated or ischemia-only mice served as controls. A sub-set of animals was treated with IL-18-neutralizing antibodies 1 h prior to LAD ligation. Ischemic LV tissue was used for analysis. Our results demonstrate that, compared with sham operation and ischemia alone, I/R significantly increased (i) oxidative stress (increased MDA/4-HNE levels), (ii) neutrophil infiltration (increased MPO activity), (iii) NF-kappa B DNA binding activity (p50, p65), and (iv) increased expression of IL-18R beta, but not IL-18R alpha or IL-18BP transcripts. Administration of IL-18-neutralizing antibodies significantly reduced I/R injury measured by reduced infarct size (versus control IgG). In isolated adult mouse cardiomyocytes, simulated ischemia/reperfusion enhanced oxidative stress and biologically active IL-18 expression via IKK-dependent NF-kappa B activation. These results indicate that IL-18 plays a critical role in I/R injury and thus represents a promising therapeutic target.	[Venkatachalam, Kaliyamurthi; Boylston, William H.; Chandrasekar, Bysani] Univ Texas Hlth Sci Ctr San Antonio, Dept Vet Affairs S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Venkatachalam, Kaliyamurthi; Boylston, William H.; Valente, Anthony J.; Chandrasekar, Bysani] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Reddy, Venkatapuram Seenu] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Prabhu, Sumanth D.] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA; [Prabhu, Sumanth D.] Louisville Vet Affairs Med Ctr, Med Serv, Louisville, KY 40206 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Louisville	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Vet Affairs S Texas Vet Hlth Care Syst, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Venkatachalam, Kaliyamurthi/GXM-4890-2022; Prabhu, Sumanth/D-5223-2009		Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Research Service of the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arenillas I, 2008, TERRA NOVA, V20, P38, DOI 10.1111/j.1365-3121.2007.00784.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; Chandrasekar B, 2000, FREE RADICAL BIO MED, V28, P1579, DOI 10.1016/S0891-5849(00)00273-2; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chandrasekar B, 2003, BIOCHEM BIOPH RES CO, V303, P1152, DOI 10.1016/S0006-291X(03)00496-0; Chandrasekar B, 1998, BBA-MOL BASIS DIS, V1406, P91, DOI 10.1016/S0925-4439(97)00062-8; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grisham MB, 1998, FREE RADICAL BIO MED, V25, P404, DOI 10.1016/S0891-5849(98)00094-X; Guo YR, 1998, AM J PHYSIOL-HEART C, V275, pH1375; Hernesniemi JA, 2008, ATHEROSCLEROSIS, V196, P643, DOI 10.1016/j.atherosclerosis.2007.07.018; Hewins P, 2006, KIDNEY INT, V69, P605, DOI 10.1038/sj.ki.5000167; Hulthe J, 2006, ATHEROSCLEROSIS, V188, P450, DOI 10.1016/j.atherosclerosis.2005.11.013; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; KILGORE KS, 1993, CLIN BIOCHEM, V26, P359, DOI 10.1016/0009-9120(93)90112-J; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Mallat Z, 2002, HEART, V88, P467, DOI 10.1136/heart.88.5.467; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Nossuli TO, 2001, AM J PHYSIOL-HEART C, V281, pH2549, DOI 10.1152/ajpheart.2001.281.6.H2549; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Tone M, 1997, J IMMUNOL, V159, P6156; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Wang MJ, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e318160f215; Westphal E, 2006, EUR CYTOKINE NETW, V17, P19; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Wyman TH, 2002, J LEUKOCYTE BIOL, V72, P401; Xuan YT, 1999, CIRC RES, V84, P1095, DOI 10.1161/01.RES.84.9.1095; Yuen CM, 2007, CIRC J, V71, P1691, DOI 10.1253/circj.71.1691; Zabalgoitia M, 2008, FREE RADICAL BIO MED, V44, P284, DOI 10.1016/j.freeradbiomed.2007.08.012	48	98	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7853	7865		10.1074/jbc.M808824200	http://dx.doi.org/10.1074/jbc.M808824200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164288	hybrid, Green Published			2022-12-27	WOS:000264195600047
J	Seif, E; Hallberg, BM				Seif, Elias; Hallberg, B. Martin			RNA-Protein Mutually Induced Fit STRUCTURE OF ESCHERICHIA COLI ISOPENTENYL-tRNA TRANSFERASE IN COMPLEX WITH tRNA(Phe)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIMETHYLALLYLTRANSFERASE; ANTICODON; RECOGNITION; MITOCHONDRIAL; TRANSLATION; SEQUENCES	tRNAs that read codons starting with U are usually modified at their A37 by isopentenyl-tRNA transferases to minimize peptidyl-tRNA slippage in translation. The consensus substrate requirements of the isopentenyl-tRNA transferase of Escherichia coli, MiaA, have been the focus of extensive study. However, the molecular basis of tRNA-MiaA recognition remains unknown. Here we describe the 2.5 angstrom crystal structure of MiaA in complex with substrate tRNA(Phe). Comparative structural analysis reveals that the enzymatic reaction involves an RNA-protein mutually induced fit mechanism in which large domain movements in MiaA provoke the partial unfolding of the substrate tRNA anticodon loop. In addition, we show how substrate tRNAs are recognized by MiaA through a combination of direct and indirect sequence readouts.	[Seif, Elias; Hallberg, B. Martin] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Hallberg, BM (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	Martin.Hallberg@ki.se	Hallberg, B. Martin/C-5361-2009	Hallberg, B. Martin/0000-0002-6781-0345	Swedish Research Council; Royal Swedish Academy of Sciences; Jeansson's Foundation; Langmanska kulturfonden; Helge Ax:son Johnson's Foundation; Magnus Bergvall's Foundation; O.E. and Edla Johansson's Foundation; Otto Sward's and Ulrika Eklund's Foundation; Karolinska Institutet; Wenner-Gren Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Jeansson's Foundation; Langmanska kulturfonden; Helge Ax:son Johnson's Foundation; Magnus Bergvall's Foundation; O.E. and Edla Johansson's Foundation; Otto Sward's and Ulrika Eklund's Foundation; Karolinska Institutet(Karolinska Institutet); Wenner-Gren Foundations	The work was supported by grants from the Swedish Research Council, the Royal Swedish Academy of Sciences, Jeansson's Foundation, Langmanska kulturfonden, Helge Ax:son Johnson's Foundation, Magnus Bergvall's Foundation, O.E. and Edla Johansson's Foundation, Otto Sward's and Ulrika Eklund's Foundation, and Karolinska Institutet ( to B. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported through a post-doctoral fellowship from the Wenner-Gren Foundations.	Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Batey RT, 2007, RNA, V13, P1384, DOI 10.1261/rna.528007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILLMAN EC, 1991, MOL CELL BIOL, V11, P2382, DOI 10.1128/MCB.11.5.2382; Golovko A, 2000, GENE, V258, P85, DOI 10.1016/S0378-1119(00)00421-2; GROSJEAN H, 1985, NUCLEIC ACIDS RES, V13, P5697, DOI 10.1093/nar/13.15.5697; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motorin Y, 1997, RNA, V3, P721; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; SIBLER AP, 1986, FEBS LETT, V194, P131, DOI 10.1016/0014-5793(86)80064-3; Soderberg T, 2000, BIOCHEMISTRY-US, V39, P6546, DOI 10.1021/bi992775u; Soderberg T, 2001, BIOCHEMISTRY-US, V40, P1734, DOI 10.1021/bi002149t; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Xie W, 2007, J MOL BIOL, V367, P872, DOI 10.1016/j.jmb.2007.01.048; Zhou C, 2008, P NATL ACAD SCI USA, V105, P16142, DOI 10.1073/pnas.0805680105	20	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6600	6604		10.1074/jbc.C800235200	http://dx.doi.org/10.1074/jbc.C800235200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19158097	Green Published, hybrid			2022-12-27	WOS:000263919000003
J	Okamura, T; Singh, S; Buolamwini, J; Haystead, T; Friedman, H; Bigner, D; Ali-Osman, F				Okamura, Tatsunori; Singh, Simendra; Buolamwini, John; Haystead, Timothy; Friedman, Henry; Bigner, Darell; Ali-Osman, Francis			Tyrosine Phosphorylation of the Human Glutathione S-Transferase P1 by Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC-ACTIVITY; GLIOBLASTOMA; KINASE; CELLS; EXPRESSION; PROTEIN; OVEREXPRESSION; METABOLISM; ACTIVATION; PREDICTION	Epidermal growth factor receptor (EGFR) gene amplification, mutations, and/or aberrant activation are frequent abnormalities in malignant gliomas and other human cancers and have been associated with an aggressive clinical course and a poor therapeutic outcome. Elevated glutathione S-transferase P1 (GSTP1), a major drug-metabolizing and stress response signaling protein, is also associated with drug resistance and poor clinical outcome in gliomas and other cancers. Here, we provide evidence that GSTP1 is a downstream EGFR target and that EGFR binds to and phosphorylates tyrosine residues in the GSTP1 protein in vitro and in vivo. Mass spectrometry and mutagenesis analyses in a cell-free system and in gliomas cells identified Tyr-7 and Tyr-198 as major EGFR-specific phospho-acceptor residues in the GSTP1 protein. The phosphorylation increased GSTP1 enzymatic activity significantly, and computer-based modeling showed a corresponding increase in electronegativity of the GSTP1 active site. In human glioma and breast cancer cells, epidermal growth factor stimulation rapidly increased GSTP1 tyrosine phosphorylation and decreased cisplatin sensitivity. Lapatinib, a clinically active EGFR inhibitor, significantly reversed the epidermal growth factor-induced cisplatin resistance. These data define phosphorylation and activation of GSTP1 by EGFR as a novel, heretofore unrecognized component of the EGFR signaling network and a novel mechanism of tumor drug resistance, particularly in tumors with elevated GSTP1 and/or activated EGFR.	[Ali-Osman, Francis] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Haystead, Timothy] Duke Univ, Dept Pharmacol, Durham, NC 27710 USA; [Bigner, Darell] Duke Univ, Dept Pathol, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Bigner, Darell] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Buolamwini, John] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA	Duke University; Duke University; Duke University; Duke University; University of Tennessee System; University of Tennessee Health Science Center	Ali-Osman, F (corresponding author), Duke Univ, Med Ctr, Dept Surg, 421 Med Sci Res Bldg 1, Durham, NC 27710 USA.	francis.aliosman@duke.edu			National Institutes of Health [RO1 CA127872, RO1 CA 112519, P50CA108786, P30-CA14236]; NATIONAL CANCER INSTITUTE [R01CA112519, R01CA127872, P30CA014236, P50CA108786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA127872, RO1 CA 112519, P50CA108786, and P30-CA14236.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Ali-Osman F, 2004, CONT CANC RES, P359; Ali-Osman F, 1997, CLIN CANCER RES, V3, P2253; AliOsman F, 1997, J BIOL CHEM, V272, P10004; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Barker FG, 2001, INT J RADIAT ONCOL, V51, P410, DOI 10.1016/S0360-3016(01)01609-1; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Chakravarti A, 2002, CANCER RES, V62, P4307; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Gurney JG, 2001, CURR OPIN ONCOL, V13, P160, DOI 10.1097/00001622-200105000-00005; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Halatsch ME, 2003, ANTICANCER RES, V23, P2315; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Kamata H, 2000, EUR J BIOCHEM, V267, P1933, DOI 10.1046/j.1432-1327.2000.01194.x; Kleihues P, 2000, PATHOLOGY GENETICS T; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; Lo Bello M, 1998, J MOL BIOL, V284, P1717; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lo HW, 2004, CANCER RES, V64, P9131, DOI 10.1158/0008-5472.CAN-04-0283; Narita Y, 2002, CANCER RES, V62, P6764; Nishiyama M, 1997, INT J CANCER, V72, P649; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Okamura T, 2000, INT J ONCOL, V16, P295; Orozco M, 1997, PROTEINS, V28, P530, DOI 10.1002/(SICI)1097-0134(199708)28:4<530::AID-PROT7>3.3.CO;2-U; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Raizer RJ, 2005, J NEURO-ONCOL, V74, P77, DOI 10.1007/s11060-005-0603-7; Ranganathan PN, 2005, BIOCHEM J, V386, P525, DOI 10.1042/BJ20041419; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Segel IH, 1976, BIOCH CALCULATIONS, P208; Shinojima N, 2003, CANCER RES, V63, P6962; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03	40	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16979	16989		10.1074/jbc.M808153200	http://dx.doi.org/10.1074/jbc.M808153200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19254954	Green Published, hybrid			2022-12-27	WOS:000266962400035
J	Ramirez, F; Dietz, HC				Ramirez, Francesco; Dietz, Harry C.			Extracellular Microfibrils in Vertebrate Development and Disease Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROWTH-FACTOR-BETA; THORACIC AORTIC-ANEURYSM; MOUSE MODEL; VASCULAR DEVELOPMENT; XENOPUS FIBRILLIN; MARFAN-SYNDROME; PATHOGENESIS; MATRIX; DOXYCYCLINE; ACTIVATION		[Ramirez, Francesco] Mt Sinai Hosp, Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10021 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Ramirez, F (corresponding author), Mt Sinai Hosp, Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10021 USA.	francesco.ramirez@mssm.edu			National Institutes of Health [AR049698]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR049698. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Atsawasuwan P, 2008, J BIOL CHEM, V283, P34229, DOI 10.1074/jbc.M803142200; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Carta L, 2009, J BIOL CHEM, V284, P5630, DOI 10.1074/jbc.M806962200; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Gansner JM, 2008, DEV DYNAM, V237, P2844, DOI 10.1002/dvdy.21705; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Jones JA, 2009, J VASC RES, V46, P119, DOI 10.1159/000151766; Katagiri Takenobu, 2008, P121; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Quondamatteo F, 2002, MATRIX BIOL, V21, P637, DOI 10.1016/S0945-053X(02)00100-2; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Skoglund P, 2006, DEV DYNAM, V235, P1974, DOI 10.1002/dvdy.20818; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165	37	33	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14677	14681		10.1074/jbc.R900004200	http://dx.doi.org/10.1074/jbc.R900004200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19188363	Green Published, hybrid			2022-12-27	WOS:000266288200002
J	Liu, JZ; Wang, SQ; Zhang, P; Said-Al-Naief, N; Michalek, SM; Feng, X				Liu, Jianzhong; Wang, Shunqing; Zhang, Ping; Said-Al-Naief, Nasser; Michalek, Suzanne M.; Feng, Xu			Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ALVEOLAR BONE DESTRUCTION; RANK CYTOPLASMIC MOTIF; RECEPTOR ACTIVATOR; TNF-ALPHA; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; FAMILY-MEMBER	Lipopolysaccharide (LPS), a common bacteria-derived product, has long been recognized as a key factor implicated in periodontal bone loss. However, the precise cellular and molecular mechanisms by which LPS induces bone loss still remains controversial. Here, we show that LPS inhibited osteoclastogenesis from freshly isolated osteoclast precursors but stimulated osteoclast formation from those pretreated with RANKL in vitro in tissue culture dishes, bone slices, and a co-culture system containing osteoblasts, indicating that RANKL-mediated lineage commitment is a prerequisite for LPS-induced osteoclastogenesis. Moreover, the RANKL-mediated lineage commitment is long term, irreversible, and TLR4-dependent. LPS exerts the dual function primarily by modulating the expression of NFATc1, a master regulator of osteoclastogenesis, in that it abolished RANKL-induced NFATc1 expression in freshly isolated osteoclast precursors but stimulated its expression in RANKL-pretreated cells. In addition, LPS prolonged osteoclast survival by activating the Akt, NF-kappa B, and ERK pathways. Our current work has not only unambiguously defined the role of LPS in osteoclastogenesis but also has elucidated the molecular mechanism underlying its complex functions in osteoclast formation and survival, thus laying a foundation for future delineation of the precise mechanism of periodontal bone loss.	[Liu, Jianzhong; Wang, Shunqing; Said-Al-Naief, Nasser; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhang, Ping] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Michalek, Suzanne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wang, Shunqing] First Municipal Peoples Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; South China University of Technology	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, Volker Hall G046B,1670 Univ Blvd, Birmingham, AL 35294 USA.	xufeng@uab.edu		Zhang, Ping/0000-0002-4585-9893	NIAMS [AR47830]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR47830 from NIAMS.	AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chung JY, 2002, J CELL SCI, V115, P679; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ebersole JL, 2003, PERIODONTOL 2000, V31, P135, DOI 10.1034/j.1600-0757.2003.03109.x; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Hayashi S, 2004, ENDOCRINOLOGY, V145, P2721, DOI 10.1210/en.2004-0172; Henderson B, 2003, TRENDS MICROBIOL, V11, P570, DOI 10.1016/j.tim.2003.10.005; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; Jiang YL, 2002, INFECT IMMUN, V70, P3143, DOI 10.1128/IAI.70.6.3143-3148.2002; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Jimi E, 1999, J IMMUNOL, V163, P434; JONES BW, 2001, ANN RHEUM DIS     S3, V60, P6; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawata T, 1999, J CRAN GENET DEV BIO, V19, P221; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kirkwood KL, 2007, PERIODONTOL 2000, V43, P294, DOI 10.1111/j.1600-0757.2006.00166.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nagasawa T, 2007, PERIODONTOL 2000, V43, P65, DOI 10.1111/j.1600-0757.2006.00185.x; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; ORCEL P, 1993, AM J PHYSIOL, V264, pE391, DOI 10.1152/ajpendo.1993.264.3.E391; ROSS FP, 2001, OSTEOPOROSIS, P73; ROWE DJ, 1977, CALC TISS RES, V23, P283, DOI 10.1007/BF02012798; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; SHIINA Y, 1986, CALCIFIED TISSUE INT, V39, P28, DOI 10.1007/BF02555737; SISMEYDURRANT HJ, 1987, ARCH ORAL BIOL, V32, P911, DOI 10.1016/0003-9969(87)90106-3; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Suda K, 2002, J CELL PHYSIOL, V190, P101, DOI 10.1002/jcp.10041; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SVEEN K, 1980, SCAND J DENT RES, V88, P535; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381, DOI 10.1002/jlb.61.4.381; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; UMEZU A, 1989, J PERIODONTAL RES, V24, P378, DOI 10.1111/j.1600-0765.1989.tb00886.x; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zambon J J, 1996, Ann Periodontol, V1, P879, DOI 10.1902/annals.1996.1.1.879; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	70	81	85	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12512	12523		10.1074/jbc.M809789200	http://dx.doi.org/10.1074/jbc.M809789200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258321	hybrid, Green Published			2022-12-27	WOS:000265494600080
J	Szargel, R; Rott, R; Eyal, A; Haskin, J; Shani, V; Balan, L; Wolosker, H; Engelender, S				Szargel, Raymonde; Rott, Ruth; Eyal, Allon; Haskin, Joseph; Shani, Vered; Balan, Livia; Wolosker, Herman; Engelender, Simone			Synphilin-1A Inhibits Seven in Absentia Homolog (SIAH) and Modulates alpha-Synuclein Monoubiquitylation and Inclusion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY FORMATION; APOPTOTIC CELL-DEATH; PARKINSONS-DISEASE; UBIQUITIN-LIGASE; PROTEASOME IMPAIRMENT; MAMMALIAN HOMOLOGS; TUMOR SUPPRESSION; SINA GENE; WILD-TYPE; PROTEIN	Parkinson disease (PD) is characterized by the presence of ubiquitylated inclusions and the death of dopaminergic neurons. Seven in absentia homolog (SIAH) is a ubiquitin-ligase that ubiquitylates alpha-synuclein and synphilin-1 and is present in Lewy bodies of PD patients. Understanding the mechanisms that regulate the ubiquitylation of PD-related proteins might shed light on the events involved in the formation of Lewy bodies and death of neurons. We show in this study that the recently described synphilin-1 isoform, synphilin-1A, interacts in vitro and in vivo with the ubiquitin-protein isopeptide ligase SIAH and regulates its activity toward alpha-synuclein and synphilin-1. SIAH promotes limited ubiquitylation of synphilin-1A that does not lead to its degradation by the proteasome. SIAH also increases the formation of synphilin-1A inclusions in the presence of proteasome inhibitors, supporting the participation of ubiquitylated synphilin-1A in the formation of Lewy body-like inclusions. Synphilin-1A/SIAH inclusions recruit PD-related proteins, such as alpha-synuclein, synphilin-1, Parkin, PINK1, and UCH-L1. We found that synphilin-1A robustly increases the steady-state levels of SIAH by decreasing its auto-ubiquitylation and degradation. In addition, synphilin-1A blocks the ubiquitylation and degradation of the SIAH substrates synphilin-1 and deleted in colon cancer protein. Furthermore, synphilin-1A strongly decreases the monoubiquitylation of alpha-synuclein by SIAH and the formation of alpha-synuclein inclusions, supporting a role for monoubiquitylation in alpha-synuclein inclusion formation. Our results suggest a novel function for synphilin-1A as a regulator of SIAH activity and formation of Lewy body-like inclusions.	[Szargel, Raymonde; Rott, Ruth; Eyal, Allon; Haskin, Joseph; Shani, Vered; Engelender, Simone] Technion Israel Inst Technol, Dept Pharmacol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Balan, Livia; Wolosker, Herman] Technion Israel Inst Technol, Dept Biochem, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Inst Med Res, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Engelender, S (corresponding author), Technion Israel Inst Technol, Dept Pharmacol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel.	simone@tx.technion.ac.il		Engelender, Simone/0000-0001-7401-6855; Wolosker, Herman/0000-0001-5508-9194	Israel Academy of Sciences; Ministry of Health/Ezvonot; The B. Rappaport Foundation; A.J. Berman Neurological Research Fund; Brauda Foundation; M. Rojek Memorial Fund for Lewy Body Research; Technion Research funds	Israel Academy of Sciences; Ministry of Health/Ezvonot; The B. Rappaport Foundation; A.J. Berman Neurological Research Fund; Brauda Foundation; M. Rojek Memorial Fund for Lewy Body Research; Technion Research funds	This work was supported by Israel Academy of Sciences, Ministry of Health/Ezvonot, The B. Rappaport Foundation, A.J. Berman Neurological Research Fund, Brauda Foundation Parkinson Disease Research Fund, M. Rojek Memorial Fund for Lewy Body Research, and the Technion Research funds (to S.E.).	Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Bandopadhyay R, 2005, NEUROBIOL DIS, V20, P401, DOI 10.1016/j.nbd.2005.03.021; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Colapinto M, 2006, BIOCHEM BIOPH RES CO, V349, P1294, DOI 10.1016/j.bbrc.2006.08.163; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Eyal A, 2006, P NATL ACAD SCI USA, V103, P5917, DOI 10.1073/pnas.0509707103; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Murray IVJ, 2003, ACTA NEUROPATHOL, V105, P177, DOI 10.1007/s00401-002-0629-2; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Park TJ, 2003, BIOCHEM BIOPH RES CO, V302, P671, DOI 10.1016/S0006-291X(03)00247-X; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Qian JJ, 2008, NEUROSCI LETT, V435, P142, DOI 10.1016/j.neulet.2008.02.021; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Szargel R, 2008, CELL MOL LIFE SCI, V65, P80, DOI 10.1007/s00018-007-7343-0; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Wakabayashi K, 2002, ACTA NEUROPATHOL, V103, P209, DOI 10.1007/s004010100451; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26	50	30	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11706	11716		10.1074/jbc.M805990200	http://dx.doi.org/10.1074/jbc.M805990200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19224863	Green Published, hybrid			2022-12-27	WOS:000265494500073
J	Gu, ZL; Liu, WH; Yan, Z				Gu, Zhenglin; Liu, Wenhua; Yan, Zhen			beta-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; DENDRITIC SPINE LOSS; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY-95; NATURAL OLIGOMERS; CORTICAL-NEURONS	A fundamental feature of Alzheimer disease (AD) is the accumulation of beta-amyloid (A beta), a peptide generated from the amyloid precursor protein (APP). Emerging evidence suggests that soluble A beta oligomers adversely affect synaptic function, which leads to cognitive failure associated with AD. The A beta-induced synaptic dysfunction has been attributed to the synaptic removal of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (AMPARs); however, it is unclear how A beta induces the loss of AMPARs at the synapses. In this study we have examined the potential involvement of Ca2+/calmodulin-dependent protein kinase II (CaMKII), a signaling molecule critical for AMPAR trafficking and function. We found that the synaptic pool of CaMKII was significantly decreased in cortical neurons from APP transgenic mice, and the density of CaMKII clusters at synapses was significantly reduced by A beta oligomer treatment. In parallel, the surface expression of GluR1 subunit as well as AMPAR-mediated synaptic response and ionic current was selectively decreased in APP transgenic mice and A beta-treated cultures. Moreover, the reducing effect of A beta on AMPAR current density was mimicked and occluded by knockdown of CaMKII and blocked by overexpression of CaMKII. These results suggest that the A beta-induced change in CaMKII subcellular distribution may underlie the removal of AMPARs from synaptic membrane by A beta.	[Gu, Zhenglin; Liu, Wenhua; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Liu, Wenhua/0000-0003-0903-8497	National Institutes of Health [AG21923, MH84233]; National Science Foundation of China [NSFC 30528009]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG21923 and MH84233. This work was also supported by National Science Foundation of China Grant NSFC 30528009 (to Z.Y.).	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Gu ZL, 2006, MOL PHARMACOL, V69, P813, DOI 10.1124/mol.105.018853; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tang KX, 2004, J NEUROCHEM, V91, P429, DOI 10.1111/j.1471-4159.2004.02733.x; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813	56	148	154	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10639	10649		10.1074/jbc.M806508200	http://dx.doi.org/10.1074/jbc.M806508200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240035	Green Published, hybrid			2022-12-27	WOS:000265104600038
J	Kang, YH; Kang, MJ; Kim, JH; Lee, CH; Cho, IT; Hurwitz, J; Seo, YS				Kang, Young-Hoon; Kang, Min-Jung; Kim, Jeong-Hoon; Lee, Chul-Hwan; Cho, Il-Taeg; Hurwitz, Jerard; Seo, Yeon-Soo			The MPH1 Gene of Saccharomyces cerevisiae Functions in Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-PROTEIN-A; DNA POLYMERASE-ALPHA; SINGLE-STRANDED-DNA; FLAP ENDONUCLEASE-1; HOMOLOGOUS RECOMBINATION; MUTATION AVOIDANCE; LAGGING-STRAND; YEAST DNA2; IN-VIVO; HELICASE	Saccharomyces cerevisiae MPH1 was first identified as a gene encoding a 3' to 5' DNA helicase, which when deleted leads to a mutator phenotype. In this study, we isolated MPH1 as a multicopy suppressor of the dna2K1080E helicase-negative lethal mutant. Purified Mph1 stimulated the endonuclease activities of both Fen1 and Dna2, which act faithfully in the processing of Okazaki fragments. This stimulation required neither ATP hydrolysis nor the helicase activity of Mph1. Multicopy expression of MPH1 also suppressed the temperature-sensitive growth defects in cells expressing dna2 Delta 405N, which lacks the N-terminal 405 amino acids of Dna2. However, Mph1 did not stimulate the endonuclease activity of the Dna2 Delta 405N mutant protein. The stimulation of Fen1 by Mph1 was limited to flap-structured substrates; Mph1 hardly stimulated the 5' to 3' exonuclease activity of Fen1. Mph1 binds to flap-structured substrate more efficiently than to nicked duplex structures, suggesting that the stimulatory effect of Mph1 is exerted through its binding to DNA substrates. In addition, we found that Mph1 reversed the inhibitory effects of replication protein A on Fen1 activity. Our biochemical and genetic data indicate that the in vivo suppression of Dna2 defects observed with both dna2K1080E and dna2 Delta 405N mutants occur via stimulation of Fen1 activity. These findings suggest that Mph1 plays an important, although not essential, role in processing of Okazaki fragments by facilitating the formation of ligatable nicks.	[Kang, Young-Hoon; Kang, Min-Jung; Kim, Jeong-Hoon; Lee, Chul-Hwan; Cho, Il-Taeg; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, DNA Replicat & Genome Instabil, Taejon 305701, South Korea; [Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Korea Advanced Institute of Science & Technology (KAIST); Memorial Sloan Kettering Cancer Center	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, DNA Replicat & Genome Instabil, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Lee, Chul-Hwan/0000-0003-0643-0100	Ministry of Education, Science and Technology	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Grants funded by the Ministry of Education, Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Brosh RM, 2001, EMBO J, V20, P5791; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BURGERS PMJ, 1988, NUCLEIC ACIDS RES, V16, P6297, DOI 10.1093/nar/16.14.6297; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hubscher U, 2001, MOL CELLS, V12, P149; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Maga G, 2000, J MOL BIOL, V295, P791, DOI 10.1006/jmbi.1999.3394; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Prakash R, 2005, J BIOL CHEM, V280, P7854, DOI 10.1074/jbc.M413898200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; SCHELLER J, 2000, GENETICS, V11, P61; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; SHIODA M, 1982, P NATL ACAD SCI-BIOL, V79, P7209, DOI 10.1073/pnas.79.23.7209; Sommer D, 2008, NUCLEIC ACIDS RES, V36, P4699, DOI 10.1093/nar/gkn446; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	52	22	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10376	10386		10.1074/jbc.M808894200	http://dx.doi.org/10.1074/jbc.M808894200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19181670	Green Published, hybrid			2022-12-27	WOS:000265104600012
J	Ficko-Blean, E; Gregg, KJ; Adams, JJ; Hehemann, JH; Czjzek, M; Smith, SP; Boraston, AB				Ficko-Blean, Elizabeth; Gregg, Katie J.; Adams, Jarrett J.; Hehemann, Jan-Hendrik; Czjzek, Mirjam; Smith, Steven P.; Boraston, Alisdair B.			Portrait of an Enzyme, a Complete Structural Analysis of a Multimodular beta-N-Acetylglucosaminidase from Clostridium perfringens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; VIBRIO-CHOLERAE NEURAMINIDASE; CARBOHYDRATE-BINDING MODULES; 84 GLYCOSIDE HYDROLASE; SMALL-ANGLE SCATTERING; MACROMOLECULAR STRUCTURES; HUMAN FIBRONECTIN; TOXIN; CRYSTALLIZATION; PATHOGENESIS	Common features of the extracellular carbohydrate-active virulence factors involved in host-pathogen interactions are their large sizes and modular complexities. This has made them recalcitrant to structural analysis, and therefore our understanding of the significance of modularity in these important proteins is lagging. Clostridium perfringens is a prevalent human pathogen that harbors a wide array of large, extracellular carbohydrate-active enzymes and is an excellent and relevant model system to approach this problem. Here we describe the complete structure of C. perfringens GH84C (NagJ), a 1001-amino acid multimodular homolog of the C. perfringens mu-toxin, which was determined using a combination of small angle x-ray scattering and x-ray crystallography. The resulting structure reveals unprecedented insight into how catalysis, carbohydrate-specific adherence, and the formation of molecular complexes with other enzymes via an ultra-tight protein-protein interaction are spatially coordinated in an enzyme involved in a host-pathogen interaction.	[Ficko-Blean, Elizabeth; Gregg, Katie J.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Adams, Jarrett J.; Smith, Steven P.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Hehemann, Jan-Hendrik; Czjzek, Mirjam] Univ Paris 06, CNRS, Stn Biol Roscoff Marine Plants & Biomol, F-29682 Roscoff, France	University of Victoria; Queens University - Canada; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Ficko-Blean, Elizabeth/N-1746-2013	Boraston, Alisdair/0000-0001-6417-0592; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Ficko-Blean, Elizabeth/0000-0002-3915-4715; Smith, Steven/0000-0003-2710-4400	Canadian Institutes of Health Research (CIHR); CNRS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported in part by a Canadian Institutes of Health Research (CIHR) operating grant ( to A. B. B. and S. P. S.) and the CNRS ( to M. C.).	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Adams JJ, 2008, P NATL ACAD SCI USA, V105, P12194, DOI 10.1073/pnas.0803154105; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bisig D, 1999, ACTA CRYSTALLOGR D, V55, P1069, DOI 10.1107/S090744499900284X; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bryant AE, 2005, J INFECT DIS, V192, P1014, DOI 10.1086/432729; CANARD B, 1994, MOL GEN GENET, V243, P215, DOI 10.1007/BF00280319; Chitayat S, 2008, J MOL BIOL, V381, P1202, DOI 10.1016/j.jmb.2008.06.050; Chitayat S, 2008, J MOL BIOL, V375, P20, DOI 10.1016/j.jmb.2007.10.031; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Figura N, 1997, J CLIN GASTROENTEROL, V25, pS149, DOI 10.1097/00004836-199700001-00025; Flores-Diaz M, 2005, J BIOL CHEM, V280, P26680, DOI 10.1074/jbc.M500278200; GALEN JE, 1992, INFECT IMMUN, V60, P406, DOI 10.1128/IAI.60.2.406-415.1992; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guinier A., 1955, SMALL ANGLE SCATTERI; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; Hansen SMM, 2008, J NEUROCHEM, V106, P2030, DOI 10.1111/j.1471-4159.2008.05544.x; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hynes W, 2004, FRONT BIOSCI-LANDMRK, V9, P3399, DOI 10.2741/1491; Johnson S., 1997, CLOSTRIDIA MOL BIOL, P117, DOI DOI 10.1016/B978-012595020-6/50010-3; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; ROMAN A, 1993, J APPL CRYSTALLOGR, V26, P283; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Sheldon WL, 2006, BIOCHEM J, V399, P241, DOI 10.1042/BJ20060307; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Stevens DL, 2002, CLIN INFECT DIS, V35, pS93, DOI 10.1086/341928; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	57	34	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9876	9884		10.1074/jbc.M808954200	http://dx.doi.org/10.1074/jbc.M808954200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193644	Green Published, hybrid			2022-12-27	WOS:000264892900029
J	Tuvim, MJ; Mospan, AR; Burns, KA; Chua, M; Mohler, PJ; Melicoff, E; Adachi, R; Ammar-Aouchiche, Z; Davis, CW; Dickey, BF				Tuvim, Michael J.; Mospan, Andrea Rossi; Burns, Kimberlie A.; Chua, Michael; Mohler, Peter J.; Melicoff, Ernestina; Adachi, Roberto; Ammar-Aouchiche, Zoulikha; Davis, C. William; Dickey, Burton F.			Synaptotagmin 2 Couples Mucin Granule Exocytosis to Ca2+ Signaling from Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY GOBLET CELLS; NEUROTRANSMITTER RELEASE; PC12 CELLS; VESICLE EXOCYTOSIS; INSULIN-SECRETION; OLIGOMERIC MUCINS; CLARA CELLS; ANKYRIN-B; MUCUS; IX	Synaptotagmin 2 (Syt2) functions as a low affinity, fast exocytic Ca2+ sensor in neurons, where it is activated by Ca2+ influx through voltage-gated channels. Targeted insertion of lacZ into the mouse syt2 locus reveals expression in mucin-secreting goblet cells of the airways. In these cells, rapid Ca2+ entry from the extracellular medium does not contribute significantly to stimulated secretion (Davis, C. W., and Dickey, B. F. (2008) Annu. Rev. Physiol. 70, 487-512). Nonetheless, Syt2(-/-) mice show a severe defect in acute agonist-stimulated airway mucin secretion, and Syt2(+/-) mice show a partial defect. In contrast to Munc13-2(-/-) mice (Zhu, Y., Ehre, C., Abdullah, L. H., Sheehan, J. K., Roy, M., Evans, C. M., Dickey, B. F., and Davis, C. W. ( 2008) J. Physiol. (Lond.) 586, 1977-1992), Syt2(-/-) mice show no spontaneous mucin accumulation, consistent with the inhibitory action of Syt2 at resting cytoplasmic Ca2+ in neurons. In human airway goblet cells, inositol trisphosphate receptors are found in rough endoplasmic reticulum that closely invests apical mucin granules, consistent with the known dependence of exocytic Ca2+ signaling on intracellular stores in these cells. Hence, Syt2 can serve as an exocytic sensor for diverse Ca2+ signaling systems, and its levels are limiting for stimulated secretory function in airway goblet cells.	[Tuvim, Michael J.; Melicoff, Ernestina; Adachi, Roberto; Ammar-Aouchiche, Zoulikha; Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Mospan, Andrea Rossi; Chua, Michael; Davis, C. William] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Mohler, Peter J.] Univ Iowa, Div Cardiol, Dept Internal Med, Iowa City, IA 52242 USA; [Burns, Kimberlie A.; Davis, C. William] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill	Dickey, BF (corresponding author), MD Anderson Canc Ctr, Unit 1462, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bdickey@mdanderson.org		Tuvim, Michael/0000-0001-8126-7716; Adachi, Roberto/0000-0002-0146-0768; Dickey, Burton/0000-0002-4780-1847; Melicoff, Ernestina/0000-0001-5696-7112	National Institutes of Health [HL072984, HL094848, CA105352, CA016672, HL063756]; North American Cystic Fibrosis Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [U01CA105352, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094848, R01HL063756, R01HL072984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Cystic Fibrosis Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL072984, HL094848, CA105352, CA016672, and HL063756. This work was also supported by grants from the North American Cystic Fibrosis Foundation and American Heart Association.	Bahra P, 2004, BRIT J PHARMACOL, V143, P91, DOI 10.1038/sj.bjp.0705913; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; DAVIS CW, 1992, AM J PHYSIOL, V262, pC1313, DOI 10.1152/ajpcell.1992.262.5.C1313; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Effros RM, 2005, J APPL PHYSIOL, V99, P1286, DOI 10.1152/japplphysiol.00362.2005; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fukuda M, 2004, BIOCHEM J, V380, P875, DOI 10.1042/BJ20040096; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Heidelberger R, 2007, NATURE, V450, P623, DOI 10.1038/450623a; Iezzi M, 2005, FEBS LETT, V579, P5241, DOI 10.1016/j.febslet.2005.08.047; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Li HG, 2008, GENESIS, V46, P300, DOI 10.1002/dvg.20396; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Perez-Vilar J, 2005, J HISTOCHEM CYTOCHEM, V53, P1305, DOI 10.1369/jhc.5B6713.2005; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rossi AH, 2004, J PHYSIOL-LONDON, V559, P555, DOI 10.1113/jphysiol.2004.070433; Rossi AH, 2007, AM J PHYSIOL-LUNG C, V292, pL92, DOI 10.1152/ajplung.00081.2006; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; WIDDICOMBE JG, 1989, EUR RESPIR J, V2, P107; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	47	43	43	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9781	9787		10.1074/jbc.M807849200	http://dx.doi.org/10.1074/jbc.M807849200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208631	Green Published, hybrid			2022-12-27	WOS:000264892900018
J	Li, SS; Shogren-Knaak, MA				Li, Shanshan; Shogren-Knaak, Michael A.			The Gcn5 Bromodomain of the SAGA Complex Facilitates Cooperative and Cross-tail Acetylation of Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL TAIL; HISTONE ACETYLTRANSFERASE; STRUCTURAL BASIS; CORE PARTICLE; RECOGNITION; COACTIVATORS; GRADIENT; PROMOTER; SIR2P; SAS2P	Bromodomains are acetyl lysine binding modules found in many complexes that regulate gene transcription. In budding yeast, the coactivator complex SAGA (Spt-Ada-Gcn5-acetyl-transferase) predominantly facilitates transcription of stress-activated genes and requires the bromodomain of the Gcn5 subunit for full activation of a number of these genes. This bromodomain has previously been shown to promote retention of the complex to H3 and H4 acetylated nucleosomes. Because the SAGA complex mediates histone H3 acetylation, we sought to determine to what extent the Gcn5 bromodomain directly modulates histone acetylation activity. Kinetic analysis of SAGA-mediated acetylation of nucleosomal substrates reveals that this bromodomain: 1) is required for the cooperative acetylation of nucleosomes, 2) enhances acetylation of an H3 histone tail when the other H3 tail within a nucleosome is already acetylated, and 3) augments the acetylation turnover of nucleosomes previously acetylated at lysine 16 of the histone H4 tails. These results indicate that the Gcn5 bromodomain promotes the establishment of nucleosome acetylation through multiple mechanisms and more generally show how chromatin recognition domains can modulate the enzymatic activity of chromatin modifying complexes.	[Li, Shanshan; Shogren-Knaak, Michael A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Shogren-Knaak, MA (corresponding author), 4214 Mol Biol Bldg, Ames, IA 50011 USA.	knaak@iastate.edu	Georgieva, Elena/C-2588-2012; Li, Shanshan/F-5607-2013; Li, Shanshan/AAF-4758-2020	Li, Shanshan/0000-0002-0359-2369; Li, Shanshan/0000-0002-6424-2792	National Institutes of Health [GM79663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79663 (to M. S. K.).	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Barrios A, 2007, METHODS, V41, P271, DOI 10.1016/j.ymeth.2006.08.007; Boukaba A, 2004, J BIOL CHEM, V279, P7678, DOI 10.1074/jbc.M310849200; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Fry CJ, 2004, COLD SPRING HARB SYM, V69, P219, DOI 10.1101/sqb.2004.69.219; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	33	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9411	9417		10.1074/jbc.M809617200	http://dx.doi.org/10.1074/jbc.M809617200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218239	Green Published, hybrid			2022-12-27	WOS:000264669100047
J	Pelzmann, A; Ferner, M; Gnida, M; Meyer-Klaucke, W; Maisel, T; Meyer, O				Pelzmann, Astrid; Ferner, Marion; Gnida, Manuel; Meyer-Klaucke, Wolfram; Maisel, Tobias; Meyer, Ortwin			The CoxD Protein of Oligotropha carboxidovorans Is a Predicted AAA plus ATPase Chaperone Involved in the Biogenesis of the CO Dehydrogenase [CuSMoO2] Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; IRON-MOLYBDENUM COFACTOR; RHODOBACTER-CAPSULATUS; MAGNESIUM CHELATASE; XANTHINE DEHYDROGENASE; PSEUDOMONAS-CARBOXYDOVORANS; MOLECULAR CHARACTERIZATION; MEGAPLASMID PHCG3; ESCHERICHIA-COLI; GENE-CLUSTER	CO dehydrogenase from the Gram-negative chemolithoautotrophic eubacterium Oligotropha carboxidovorans OM5 is a structurally characterized molybdenum-containing iron-sulfur flavoenzyme, which catalyzes the oxidation of CO (CO + H2O&RARR(3)CO(2) -> 2e(-) + 2H(+)). It accommodates in its active site a unique bimetallic [CuSMoO2] cluster, which is subject to post-translational maturation. Insertional mutagenesis of coxD has established its requirement for the assembly of the [CuSMoO2] cluster. Disruption of coxD led to a phenotype of the corresponding mutant OM5D::km with the following characteristics: (i) It was impaired in the utilization of CO, whereas the utilization of H-2 plus CO2 was not affected; (ii) Under appropriate induction conditions bacteria synthesized a fully assembled apo-CO dehydrogenase, which could not oxidize CO; (iii) Apo-CO dehydrogenase contained a [MoO3] site in place of the [CuSMoO2] cluster; and (iv) Employing sodium sulfide first and then the Cu(I)-(thiourea)(3) complex, the non-catalytic [MoO3] site could be reconstituted in vitro to a [CuSMoO2] cluster capable of oxidizing CO. Sequence information suggests that CoxD is a MoxR-like AAA + ATPase chaperone related to the hexameric, ring-shaped BchI component of Mg2+-chelatases. Recombinant CoxD, which appeared in Escherichia coli in inclusion bodies, occurs exclusively in cytoplasmic membranes of O. carboxidovorans grown in the presence of CO, and its occurrence coincided with GTPase activity upon sucrose density gradient centrifugation of cell extracts. The presumed function of CoxD is the partial unfolding of apo-CO dehydrogenase to assist in the stepwise introduction of sulfur and copper in the [MoO3] center of the enzyme.	[Pelzmann, Astrid; Ferner, Marion; Maisel, Tobias; Meyer, Ortwin] Univ Bayreuth, Chair Microbiol, D-95440 Bayreuth, Germany; [Gnida, Manuel; Meyer-Klaucke, Wolfram] Outstn Hamburg Deutsch Elekt Synchroton, European Mol Biol Lab, D-22603 Hamburg, Germany	University of Bayreuth; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Meyer, O (corresponding author), Univ Bayreuth, Chair Microbiol, Univ Str 30, D-95440 Bayreuth, Germany.	Ortwin.Meyer@uni-bayreuth.de	Meyer-Klaucke, Wolfram/G-1148-2010					ARPS PJ, 1987, J BACTERIOL, V169, P1061, DOI 10.1128/jb.169.3.1061-1070.1987; AULING G, 1988, SYST APPL MICROBIOL, V10, P264, DOI 10.1016/S0723-2020(88)80011-0; BEISENHERZ G, 1953, Z NATURFORSCH B, V8, P555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDENAS J, 1974, ANAL BIOCHEM, V60, P372, DOI 10.1016/0003-2697(74)90244-9; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Fuhrmann S, 2003, GENE, V322, P67, DOI 10.1016/j.gene.2003.08.027; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Gnida M, 2003, BIOCHEMISTRY-US, V42, P222, DOI 10.1021/bi026514n; Gremer L, 2000, J BIOL CHEM, V275, P1864, DOI 10.1074/jbc.275.3.1864; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; JOHNSON JL, 1990, ARCH BIOCHEM BIOPHYS, V283, P542, DOI 10.1016/0003-9861(90)90681-N; KRAUT M, 1989, ARCH MICROBIOL, V152, P335, DOI 10.1007/BF00425170; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leimkuhler S, 1999, J BACTERIOL, V181, P2745; Luo MZ, 1999, PLANT MOL BIOL, V41, P721, DOI 10.1023/A:1006335317876; MEYER O, 1984, J BIOL CHEM, V259, P5612; MEYER O, 1993, SYST APPL MICROBIOL, V16, P390, DOI 10.1016/S0723-2020(11)80271-7; MEYER O, 1983, ANNU REV MICROBIOL, V37, P277, DOI 10.1146/annurev.mi.37.100183.001425; MEYER O, 1990, FEMS MICROBIOL LETT, V87, P253, DOI 10.1016/0378-1097(90)90463-Z; Meyer OO, 2005, BERGEYS MANUAL SYSTE, V2, P468; Meyer Ortwin, 1993, P433; Neumann M, 2007, J BIOL CHEM, V282, P28493, DOI 10.1074/jbc.M704020200; Neumann M, 2007, BIOCHEMISTRY-US, V46, P9586, DOI 10.1021/bi700630p; Paul D, 2008, J BACTERIOL, V190, P5531, DOI 10.1128/JB.00614-08; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; SANTIAGO B, 1997, J BACTERIOL, V197, P6053; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; SIMON R, 1983, BIOTECHNOLOGY, V1, P7784; Snider J, 2006, J STRUCT BIOL, V156, P200, DOI 10.1016/j.jsb.2006.02.009; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019	41	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9578	9586		10.1074/jbc.M805354200	http://dx.doi.org/10.1074/jbc.M805354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189964	Green Published, hybrid			2022-12-27	WOS:000264669100064
J	Terrenoire, C; Houslay, MD; Baillie, GS; Kass, RS				Terrenoire, Cecile; Houslay, Miles D.; Baillie, George S.; Kass, Robert S.			The Cardiac I-Ks Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CAMP-SPECIFIC PHOSPHODIESTERASE; SIGNALING SCAFFOLD PROTEINS; RAT VENTRICULAR MYOCYTES; LONG-QT SYNDROME; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTORS; ATRIAL-FIBRILLATION; PKA PHOSPHORYLATION; RYANODINE-RECEPTOR	The cardiac I-Ks potassium channel is a macromolecular complex consisting of alpha-(KCNQ1) and beta-subunits (KCNE1) and the A kinase-anchoring protein (AKAP) Yotiao (AKAP-9), which recruits protein kinase A) and protein phosphatase 1 to the channel. Here, we have tested the hypothesis that specific cAMP phosphodiesterase (PDE) isoforms of the PDE4D family that are expressed in the heart are also part of the I-Ks signaling complex and contribute to its regulation by cAMP. PDE4D isoforms co-immunoprecipitated with I-Ks channels in hearts of mice expressing the I-Ks channel. In myocytes isolated from these mice, I-Ks was increased by pharmacological PDE inhibition. PDE4D3, but not PDE4D5, co-immunoprecipitated with the I-Ks channel only in Chinese hamster ovary cells co-expressing AKAP-9, and PDE4D3, but not PDE4D5, co-immunoprecipitated with AKAP-9. Functional experiments in Chinese hamster ovary cells expressing AKAP-9 and either PDE4D3 or PDE4D5 isoforms revealed modulation of the I-Ks response to cAMP by PDE4D3 but not PDE4D5. We conclude that PDE4D3, like protein kinase A and protein phosphatase 1, is recruited to the I-Ks channel via AKAP-9 and contributes to its critical regulation by cAMP.	[Terrenoire, Cecile; Kass, Robert S.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Houslay, Miles D.; Baillie, George S.] Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Columbia University; University of Glasgow	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	rsk20@columbia.edu	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020	Houslay, Miles/0000-0002-3826-8091	National Institutes of Health [5R01HL044365-16]; Medical Research Council [G0600765]; European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL044365-16 from the NHLBI (to R. S. K.). This work was also supported by Medical Research Council (U.K.) Grant G0600765 (to M. D. H. and G. S. B.), European Union Grant LSHB-CT-2006-037189 (M. D. H.), and Fondation Leducq Grant 06CVD02 (M. D. H. and G. S. B.).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BETHKE T, 1992, BRIT J PHARMACOL, V107, P127, DOI 10.1111/j.1476-5381.1992.tb14474.x; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 1997, BIOCHEM J, V328, P539; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dilly KW, 2004, J BIOL CHEM, V279, P40778, DOI 10.1074/jbc.M406010200; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Hong K, 2005, CARDIOVASC RES, V68, P433, DOI 10.1016/j.cardiores.2005.06.023; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Kajimoto K, 1997, BRIT J PHARMACOL, V121, P1549, DOI 10.1038/sj.bjp.0701297; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; KASS RS, 1982, J PHYSIOL-LONDON, V322, P541, DOI 10.1113/jphysiol.1982.sp014054; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; REEVES ML, 1987, BIOCHEM J, V241, P535, DOI 10.1042/bj2410535; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Sampson KJ, 2008, J PHYSIOL-LONDON, V586, P627, DOI 10.1113/jphysiol.2007.141333; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shimizu K, 2002, BRIT J PHARMACOL, V137, P127, DOI 10.1038/sj.bjp.0704843; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858	53	99	106	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9140	9146		10.1074/jbc.M805366200	http://dx.doi.org/10.1074/jbc.M805366200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218243	Green Published, hybrid			2022-12-27	WOS:000264669100018
J	Jin, ZG; Liu, L; Bian, W; Chen, YF; Xu, GL; Cheng, LP; Jing, NH				Jin, Zhigang; Liu, Li; Bian, Wei; Chen, Yongfeng; Xu, Guoliang; Cheng, Leping; Jing, Naihe			Different Transcription Factors Regulate nestin Gene Expression during P19 Cell Neural Differentiation and Central Nervous System Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT PROTEIN; EMBRYONIC CARCINOMA-CELLS; GFP TRANSGENIC MICE; CNS STEM-CELLS; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; PRECURSOR CELLS; 2ND INTRON; IN-VITRO; PROMOTER	Nestin is a molecular marker for neural progenitor cells. Rat and human nestin genes possess a central nervous system-specific enhancer within their second introns. However, the transcription factors that bind to the nestin enhancer have not been fully elucidated. Here, we show that the second intron of the mouse nestin gene is sufficient to drive reporter gene expression in the developing nervous system. The core sequence of this central nervous system-specific enhancer localizes to the 3' 320-bp region. The cis-elements for Sox and POU family transcription factors and the hormone-responsive element are essential for nestin expression during embryonic carcinoma P19 cell neural differentiation and in the developing chick neural tube. Interestingly, different transcription factors bind to the nestin enhancer at different stages of P19 cell neural differentiation and central nervous system development. Sox2 and SF1 may mediate basal nestin expression in undifferentiated P19EC cells, whereas Sox2, Brn1, and Brn2 bind to the enhancer in P19 neural progenitor cells. Similarly, in vivo, Oct1 binds to the nestin enhancer in embryonic day 8.5 (E8.5) mouse embryos, and Oct1, Brn1, and Brn2 bind to this enhancer in E10.5 and E12.5 mouse embryos. Our studies therefore suggest a temporal coordination of transcription factors in determining nestin gene expression.	[Jin, Zhigang; Liu, Li; Bian, Wei; Chen, Yongfeng; Cheng, Leping; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cheng, LP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	lpcheng@sibs.ac.cn; njing@sibs.ac.cn	Jin, Zhigang/T-7125-2019	Jin, Zhigang/0000-0001-7557-2968	National Natural Science Foundation of China [30623003, 30721065, 30830034]; National Key Basic Research and Development Program of China [2005CB522704, 2006CB943902, 2007CB947101, 2008KR0695, 2009CB941100, 2006CB943900, 2007CB947102]; National High-Tech Research and Development Program of China [2006AA02Z186]; Shanghai Key Project of Basic Science Research [06DJ14001, 06DZ22032, 08DJ1400501]; Council of Shanghai Municipal Government for Science and Technology [05814578, 07pj14098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Key Project of Basic Science Research; Council of Shanghai Municipal Government for Science and Technology	This work was supported by the National Natural Science Foundation of China (Grants 30623003, 30721065, and 30830034 to N.J.), the National Key Basic Research and Development Program of China (Grants 2005CB522704, 2006CB943902, 2007CB947101, 2008KR0695, and 2009CB941100 to N. J.; Grants 2006CB943900 and 2007CB947102 to L. C.), the National High-Tech Research and Development Program of China (Grant 2006AA02Z186 to N. J.), the Shanghai Key Project of Basic Science Research (Grants 06DJ14001, 06DZ22032, and 08DJ1400501 to N. J.), and the Council of Shanghai Municipal Government for Science and Technology (Grants 05814578 to N. J. and 07pj14098 to L. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Barnea E, 2000, J BIOL CHEM, V275, P6608, DOI 10.1074/jbc.275.9.6608; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Cheng LP, 2000, ACTA BIOCH BIOPH SIN, V32, P649; Cheng LP, 2004, FEBS LETT, V565, P195, DOI 10.1016/j.febslet.2004.03.097; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gu HY, 2002, BRAIN RES, V943, P174, DOI 10.1016/S0006-8993(02)02615-X; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hou QL, 2004, EUR J NEUROSCI, V20, P1593, DOI 10.1111/j.1460-9568.2004.03600.x; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Itoh K., 2007, PRINCIPLES DEV GENET, P241; Jin ZG, 2006, ACTA BIOCH BIOPH SIN, V38, P207, DOI 10.1111/j.1745-7270.2006.00149.x; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; LeersSucheta S, 1997, J BIOL CHEM, V272, P7960, DOI 10.1074/jbc.272.12.7960; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lenka N, 2002, J CELL SCI, V115, P1471; Lonigro R, 2001, J BIOL CHEM, V276, P47807, DOI 10.1074/jbc.M107692200; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lothian C, 1999, EXP CELL RES, V248, P509, DOI 10.1006/excr.1999.4417; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Pelizzoi R, 2008, INT J DEV BIOL, V52, P55, DOI 10.1387/ijdb.062196rp; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; TOMOOKA Y, 1993, P NATL ACAD SCI USA, V90, P9683, DOI 10.1073/pnas.90.20.9683; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Wakamatsu Y, 2007, DEVELOPMENT, V134, P2425, DOI 10.1242/dev.02862; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126; Yang J, 2000, MECH DEVELOP, V94, P287, DOI 10.1016/S0925-4773(00)00301-4; Yang J, 2001, BBA-GENE STRUCT EXPR, V1520, P251, DOI 10.1016/S0167-4781(01)00275-5; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Yeom YI, 1996, DEVELOPMENT, V122, P881; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	55	74	77	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8160	8173		10.1074/jbc.M805632200	http://dx.doi.org/10.1074/jbc.M805632200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147497	Green Published, hybrid			2022-12-27	WOS:000264195600078
J	Nam, S; Min, K; Hwang, H; Lee, HO; Lee, JH; Yoon, J; Lee, H; Park, S; Lee, J				Nam, Seunghee; Min, Kyoengwoo; Hwang, Hyejin; Lee, Hae-ock; Lee, Jung Hwa; Yoon, Jongbok; Lee, Hyunsook; Park, Sungsu; Lee, Junho			Control of Rapsyn Stability by the CUL-3-containing E3 Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR SYNAPSE FORMATION; UBIQUITIN LIGASE; GLUTAMATE RECEPTORS; RING-H2 FINGER; 43K PROTEIN; CELL-CYCLE; C-ELEGANS; AGRIN; DEGRADATION	Rapsyn is a postsynaptic protein required for clustering of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. Here we report the mechanism for posttranslational control of rapsyn protein stability. We confirmed that C18H9.7-encoded RPY-1 is a rapsyn homolog in Caenorhabditis elegans by showing that human rapsyn rescued rpy-1 mutant phenotypes in nematodes, as determined by levamisole assays and micropost array behavioral assays. We found that RPY-1 was degraded in the absence of functional UNC-29, a non-alpha subunit of the receptor, in an allele-specific manner, but not in the absence of other receptor subunits. The cytoplasmic loop of UNC-29 was found to be critical for RPY-1 stability. Through RNA interference screening, we found that UBC-1, UBC-12, NEDD-8, and RBX-1 were required for degradation of RPY-1. We identified cullin (CUL)-3 as a component of E3 ligase and KEL-8 as the substrate adaptor of RPY-1. Mammalian rapsyn was ubiquitinated by the CUL3/KLHL8-containing E3 ligase in vitro, and the knockdown of KLHL-8, a mammalian KEL-8 homolog, inhibited rapsyn ubiquitination in vivo, implying evolutionary conservation of the rapsyn stability control machinery. kel-8 suppression and rpy-1 overexpression in C. elegans produced a phenotype similar to that of a loss-of-function mutation of rpy-1, suggesting that control of rapsyn abundance is important for proper function of the receptor. Our results suggest a link between the control of rapsyn abundance and congenital myasthenic syndromes.	[Nam, Seunghee; Min, Kyoengwoo; Lee, Hae-ock; Lee, Jung Hwa; Lee, Hyunsook; Lee, Junho] Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Cellul, Seoul 151742, South Korea; [Hwang, Hyejin; Park, Sungsu] Ewha Womans Univ, Div Nano Sci BK21, Seoul 120750, South Korea; [Yoon, Jongbok] Yonsei Univ, Dept Biochem, Prot Network Res Ctr, Seoul 120749, South Korea	Seoul National University (SNU); Ewha Womans University; Yonsei University	Lee, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, Inst Mol Biol & Genet, Res Ctr Cellul, Seoul 151742, South Korea.	elegans@snu.ac.kr	Park, Sungsu/L-1920-2013; Park, Sungsu/AAF-4792-2020; Lee, Junho/AAO-4706-2021	Park, Sungsu/0000-0003-3062-1302; Lee, Hyunsook/0000-0002-2251-5019; Yoon, Jong-Bok/0000-0002-3563-0702	Korea Science and Engineering Foundation (KOSEF), South Korea; Ministry of Science and Technology, Korea [M10748000241-07N4800-24100]; KRF [KRF-2005C00097]; Korean government (MEST) [M10536090002-05N3609-00210]; Korean Research Foundation [2005-037-C00027]; BK21 program; Seoul R BD Program	Korea Science and Engineering Foundation (KOSEF), South Korea(Korea Science and Engineering Foundation); Ministry of Science and Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea); KRF(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean Research Foundation(National Research Foundation of Korea); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul R BD Program(Seoul RBD program)	This work was supported in part by Research Center for Cellulomics, Seoul National University funding from the Korea Science and Engineering Foundation (KOSEF), South Korea (to J. Lee), Molecular and Cellular BioDiscovery Research Program Grant M10748000241-07N4800-24100 from the Ministry of Science and Technology, Korea (to J. Lee), KRF grant KRF-2005C00097 (to J. Lee), and KOSEF Grant M10536090002-05N3609-00210 funded by the Korean government (MEST) (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a postdoctoral grant from KOSEF (2004), the BK21 program (2006), and the Seoul R&BD Program (2006).; Supported by a postdoctoral grant from the Korean Research Foundation Grant 2005-037-C00027, BK21 program (2007), and the Seoul R&BD Program (2007).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRENNER S, 1974, GENETICS, V77, P71; Brockhausen J, 2008, DEV NEUROBIOL, V68, P1153, DOI 10.1002/dneu.20654; Bruneau E, 2007, J BIOL CHEM, V282, P9932, DOI 10.1074/jbc.M608714200; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dunne V, 2003, J HUM GENET, V48, P204, DOI 10.1007/s10038-003-0005-7; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Engel AG, 2003, MUSCLE NERVE, V27, P4, DOI 10.1002/mus.10269; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Han H, 2000, J NEUROSCI RES, V60, P155, DOI 10.1002/(SICI)1097-4547(20000415)60:2<155::AID-JNR4>3.3.CO;2-E; Han H, 1999, J NEUROCYTOL, V28, P763, DOI 10.1023/A:1007098406748; Hantai D, 2004, CURR OPIN NEUROL, V17, P539, DOI 10.1097/00019052-200410000-00004; Hrus A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000731; HUBBARD JI, 1973, PHYSIOL REV, V53, P674, DOI 10.1152/physrev.1973.53.3.674; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jones D, 2002, GENOME BIOL, V3; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2003, CURR OPIN CLIN NUTR, V6, P271, DOI 10.1097/01.mco.0000068963.34812.e5; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; McConville J, 2002, CURR OPIN PHARMACOL, V2, P296, DOI 10.1016/S1471-4892(02)00156-X; MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441; Meier T, 1997, J NEUROSCI, V17, P6534; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rand James B, 2007, WormBook, P1; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; YOSHIHARA CM, 1993, J CELL BIOL, V122, P169, DOI 10.1083/jcb.122.1.169; YU XM, 1994, J NEUROSCI, V14, P785; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007	82	19	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8192	8206		10.1074/jbc.M808230200	http://dx.doi.org/10.1074/jbc.M808230200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158078	Green Published, hybrid			2022-12-27	WOS:000264195600081
J	Tamura, T; Smith, M; Kanno, T; Dasenbrock, H; Nishiyama, A; Ozato, K				Tamura, Tomohiko; Smith, Matthew; Kanno, Tomohiko; Dasenbrock, Hormuzdiyer; Nishiyama, Akira; Ozato, Keiko			Inducible Deposition of the Histone Variant H3.3 in Interferon-stimulated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE GENES; EPIGENETIC INHERITANCE; GENOME-WIDE; CHROMATIN; TRANSCRIPTION; METHYLATION; PROMOTERS; CELLS; MARKS; RNA	The H3.3 histone variant is synthesized throughout cell cycle and deposited onto chromatin in a replication-independent manner. It is enriched in transcriptionally active regions of chromatin and is implicated in epigenetic memory. The dynamics of H3.3 deposition during transcriptional activation, however, have not been fully studied so far. Here we examined H3.3 incorporation into interferon (IFN)-stimulated genes in confluent mouse NIH3T3 cells expressing H3.3 fused to the yellow fluorescent protein (YFP). Following IFN stimulation, H3.3-YFP was rapidly incorporated into all four IFN-activated genes tested, with the highest enrichment seen in the distal end of the coding region. Surprisingly, H3.3 enrichment in the coding region continued for an extended period of time, long after transcription ceased. The promoter region, although constitutively enriched with H3.3-YFP, did not show an increase in its deposition in response to IFN stimulation. Further, although H3.3-YFP deposition stably remained in non-dividing cells for days after IFN stimulation, it was rapidly diminished in dividing cells. Lastly, we examined the role of H3.3 in IFN-stimulated transcription by a short hairpin RNA approach and found that IFN-stimulated transcription was significantly impaired in H3.3 knockdown cells. Results indicate that H3.3 plays a role in IFN-mediated transcription, and its deposition leaves a prolonged post-transcriptional mark in these genes.	[Tamura, Tomohiko; Smith, Matthew; Kanno, Tomohiko; Dasenbrock, Hormuzdiyer; Nishiyama, Akira; Ozato, Keiko] Eunice Kennedy Shriver NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ozato, K (corresponding author), NICHD, Lab Mol Growth Regulat, NIH, Bldg 6,Rm 2A01,6 Ctr Dr,MSC 2753, Bethesda, MD 20892 USA.	ozatok@mail.nih.gov		Smith, Matthew/0000-0001-6614-569X	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant through the Intramural Research Program of Eunice Kennedy Shriver NICHD.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Lacoste N, 2008, NAT CELL BIOL, V10, P7, DOI 10.1038/ncb0108-7; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Placek BJ, 2009, J VIROL, V83, P1416, DOI 10.1128/JVI.01276-08; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011	42	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12217	12225		10.1074/jbc.M805651200	http://dx.doi.org/10.1074/jbc.M805651200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244243	hybrid, Green Published			2022-12-27	WOS:000265494600053
J	Thomas, S; Ritter, B; Verbich, D; Sanson, C; Bourbonniere, L; McKinney, RA; McPherson, PS				Thomas, Sebastien; Ritter, Brigitte; Verbich, David; Sanson, Claire; Bourbonniere, Lyne; McKinney, R. Anne; McPherson, Peter S.			Intersectin Regulates Dendritic Spine Development and Somatodendritic Endocytosis but Not Synaptic Vesicle Recycling in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PROTEIN INTERSECTIN; DOWN-SYNDROME; DROSOPHILA AMPHIPHYSIN; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; NERVE-TERMINALS; ADAPTER PROTEIN; EH DOMAIN; N-WASP	Intersectin-short (intersectin-s) is a multimodule scaffolding protein functioning in constitutive and regulated forms of endocytosis in non-neuronal cells and in synaptic vesicle (SV) recycling at the neuromuscular junction of Drosophila and Caenorhabditis elegans. In vertebrates, alternative splicing generates a second isoform, intersectin-long (intersectin-1), that contains additional modular domains providing a guanine nucleotide exchange factor activity for Cdc42. In mammals, intersectin-s is expressed in multiple tissues and cells, including glia, but excluded from neurons, whereas intersectin-1 is a neuron-specific isoform. Thus, intersectin-1 may regulate multiple forms of endocytosis in mammalian neurons, including SV endocytosis. We now report, however, that intersectin-1 is localized to somatodendritic regions of cultured hippocampal neurons, with some juxtanuclear accumulation, but is excluded from synaptophysin-labeled axon terminals. Consistently, intersectin-1 knockdown (KD) does not affect SV recycling. Instead intersectin-1 co-localizes with clathrin heavy chain and adaptor protein 2 in the somatodendritic region of neurons, and its KD reduces the rate of transferrin endocytosis. The protein also co-localizes with F-actin at dendritic spines, and intersectin-1 KD disrupts spine maturation during development. Our data indicate that intersectin-1 is indeed an important regulator of constitutive endocytosis and neuronal development but that it is not a prominent player in the regulated endocytosis of SVs.	[Thomas, Sebastien; Ritter, Brigitte; Sanson, Claire; Bourbonniere, Lyne; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Verbich, David; McKinney, R. Anne] McGill Univ, Dept Pharmacol & Therapeut, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Ritter, Brigitte/0000-0002-0094-0460; Thomas, Sebastien/0000-0002-9263-2296	Canadian Institutes of Health Research [MOP-15396, MOP-86724]; Canadian Institutes of Health Research; Natural Sciences and Engineering Rgpin [341942-07]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Rgpin	This work was supported by Grants MOP-15396 and MOP-86724 from the Canadian Institutes of Health Research (to P. S. M. and R. A. M.), respectively, and from Natural Sciences and Engineering Rgpin 341942-07 (to R. A. M.).	Adams A, 2000, J BIOL CHEM, V275, P27414; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Burman JL, 2005, FEBS LETT, V579, P2177, DOI 10.1016/j.febslet.2005.03.008; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Evergren E, 2006, NEUROSCIENCE, V141, P123, DOI 10.1016/j.neuroscience.2006.03.038; Evergren E, 2007, J NEUROSCI, V27, P379, DOI 10.1523/JNEUROSCI.4683-06.2007; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 1998, J NEUROSCI, V18, P8900; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Kobayashi T, 1998, SEMIN CELL DEV BIOL, V9, P517, DOI 10.1006/scdb.1998.0257; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Leventis PA, 2001, TRAFFIC, V2, P839; Ma YJ, 2003, J NEUROSCI RES, V71, P468, DOI 10.1002/jnr.10500; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martin NP, 2006, MOL PHARMACOL, V70, P1643, DOI 10.1124/mol.106.028274; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; McPherson PS, 1999, CELL SIGNAL, V11, P229, DOI 10.1016/S0898-6568(98)00059-X; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869, DOI 10.1093/oxfordjournals.jbchem.a022200; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; O'Bryan JP, 2001, ONCOGENE, V20, P6300, DOI 10.1038/sj.onc.1204773; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Pucharcos C, 1999, EUR J HUM GENET, V7, P704, DOI 10.1038/sj.ejhg.5200356; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tsyba L, 2004, GENOMICS, V84, P106, DOI 10.1016/j.ygeno.2004.02.005; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zelhof AC, 2001, DEVELOPMENT, V128, P5005	58	67	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12410	12419		10.1074/jbc.M809746200	http://dx.doi.org/10.1074/jbc.M809746200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258322	Green Published, hybrid			2022-12-27	WOS:000265494600071
J	Yau, MH; Wang, Y; Lam, KSL; Zhang, JL; Wu, DH; Xu, AM				Yau, Ming-hon; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Wu, Donghai; Xu, Aimin			A Highly Conserved Motif within the NH2-terminal Coiled-coil Domain of Angiopoietin-like Protein 4 Confers Its Inhibitory Effects on Lipoprotein Lipase by Disrupting the Enzyme Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-METABOLISM; ADIPOSE-TISSUE; TARGET GENE; ANGPTL4; MICE; PLASMA; OLIGOMERIZATION; TRIGLYCERIDE; HEART; OVEREXPRESSION	Lipoprotein lipase (LPL) is a principal enzyme responsible for the clearance of chylomicrons and very low density lipoproteins from the bloodstream. Two members of the Angptl (angiopoietin-like protein) family, namely Angptl3 and Angptl4, have been shown to inhibit LPL activity in vitro and in vivo. Here, we further investigated the structural basis underlying the LPL inhibition by Angptl3 and Angptl4. By multiple sequence alignment analysis, we have identified a highly conserved 12-amino acid consensus motif that is present within the coiled-coil domain (CCD) of both Angptl3 and Angptl4, but not other members of the Angptl family. Substitution of the three polar amino acid residues (His46, Gln50, and Gln53) within this motif with alanine abolishes the inhibitory effect of Angptl4 on LPL in vitro and also abrogates the ability of Angptl4 to elevate plasma triglyceride levels in mice. The CCD of Angptl4 interacts with LPL and converts the catalytically active dimers of LPL to its inactive monomers, whereas the mutant protein with the three polar amino acids being replaced by alanine loses such a property. Furthermore, a synthetic peptide consisting of the 12-amino acid consensus motif is sufficient to inhibit LPL activity, although the potency is much lower than the recombinant CCD of Angptl4. In summary, our data suggest that the 12-amino acid consensus motif within the CCD of Angptl4, especially the three polar residues within this motif, is responsible for its interaction with and inhibition of LPL by blocking the enzyme dimerization.	[Yau, Ming-hon; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Ming-hon; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 10663, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Xu, AM (corresponding author), Univ Hong Kong, Dept Med, L8-40,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940	General Research Fund of Hong Kong Research Council [HKU 7609/05M]; Outstanding Young Researcher award; University of Hong Kong; National 973 Program of China [2006CB910202]	General Research Fund of Hong Kong Research Council; Outstanding Young Researcher award; University of Hong Kong(University of Hong Kong); National 973 Program of China(National Basic Research Program of China)	This work was supported by the General Research Fund of Hong Kong Research Council Grant HKU 7609/05M, Outstanding Young Researcher award (to A. X.), a small project grant (to M. H. Y.) from the University of Hong Kong, and National 973 Program of China Grant 2006CB910202.	Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004; CHENG Q, 1990, BIOCHEM J, V269, P403, DOI 10.1042/bj2690403; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P4570; ENERBACK S, 1988, GENE, V64, P97, DOI 10.1016/0378-1119(88)90484-2; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Fujimoto K, 2006, EXP ANIM TOKYO, V55, P27, DOI 10.1538/expanim.55.27; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Katoh Y, 2006, INT J MOL MED, V17, P1145; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; RIMMER ANNE DAVENPORT, 1962, CLIN CHIM ACTA, V7, P877, DOI 10.1016/0009-8981(62)90075-X; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; VAINIO P, 1983, BIOCHEMISTRY-US, V22, P2270, DOI 10.1021/bi00278a033; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102; Zhang LY, 2005, J BIOL CHEM, V280, P42580, DOI 10.1074/jbc.M507252200	43	90	98	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11942	11952		10.1074/jbc.M809802200	http://dx.doi.org/10.1074/jbc.M809802200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246456	Green Published, hybrid			2022-12-27	WOS:000265494600026
J	Kong, YW; Jing, G; Yan, ZG; Li, CZ; Gong, NP; Zhu, FJ; Li, DX; Zhang, YR; Zheng, GL; Wang, HZ; Xie, LP; Zhang, RQ				Kong, Yawei; Jing, Gu; Yan, Zhenguang; Li, Changzhong; Gong, Ningping; Zhu, Fangjie; Li, Dongxian; Zhang, Yaorun; Zheng, Guilan; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			Cloning and Characterization of Prisilkin-39, a Novel Matrix Protein Serving a Dual Role in the Prismatic Layer Formation from the Oyster Pinctada fucata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLLUSK SHELL FORMATION; JAPANESE PEARL OYSTER; ORGANIC MATRIX; PINNA-NOBILIS; FRAMEWORK FORMATION; NACREOUS LAYER; EXPRESSION; ARAGONITE; CALCIUM; MACROMOLECULES	Molluscs form their shells out of CaCO3 and a matrix of biomacromolecules. Understanding the role of matrices may shed some light on the mechanism of biomineralization. Here, a 1401-bp full-length cDNA sequence encoding a novel matrix protein was cloned from the mantle of the bivalve oyster, Pinctada fucata. The deduced protein (Prisilkin-39), which has a molecular mass of 39.3 kDa and an isoelectric point of 8.83, was fully characterized, and its role in biomineralization was demonstrated using both in vivo and in vitro crystal growth assays. Prisilkin-39 is a highly repetitive protein with an unusual composition of Gly, Tyr, and Ser residues. Expression of Prisilkin-39 was localized to columnar epithelial cells of the mantle edge, corresponding to the calcitic prismatic layer formation. Immunostaining in situ and immunodetection in vitro revealed the presence of a characteristic pattern of Prisilkin-39 in the organic sheet and in sheaths around the prisms. Prisilkin-39 binds tightly with chitin, an insoluble polysaccharide that forms the highly structured framework of the shell. Antibody injection in vivo resulted in dramatic morphological deformities in the inner shell surface structure, where large amounts of CaCO3 were deposited in an uncontrolled manner. Moreover, Prisilkin-39 strictly prohibited the precipitation of aragonite in vitro. Taken together, Prisilkin-39 is the first protein shown to have dual function, involved both in the chitinous framework building and in crystal growth regulation during the prismatic layer mineralization. These observations may extend our view on the rare group of basic matrices and their functions during elaboration of the molluscan shell.	[Kong, Yawei; Jing, Gu; Yan, Zhenguang; Li, Changzhong; Gong, Ningping; Zhu, Fangjie; Li, Dongxian; Zhang, Yaorun; Zheng, Guilan; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Dept Biol Sci & Biotechnol, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn	Jing, Gu/B-7678-2011		National High Technology Research and Development Program of China [2006AA09Z441, 2006AA09Z413]; National Natural Science Foundation of China [30530600, 30221003, U0831001]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China Grants 2006AA09Z441 and 2006AA09Z413 and the National Natural Science Foundation of China Grants 30530600, 30221003 and U0831001 (Joint Fund with Guandong).	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; Andersen SO, 1998, COMP BIOCHEM PHYS A, V121, P375, DOI 10.1016/S1095-6433(98)10146-0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowen CE, 1996, COMP BIOCHEM PHYS A, V115, P269, DOI 10.1016/S0300-9629(96)00059-X; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Dauphin Y, 2003, J BIOL CHEM, V278, P15168, DOI 10.1074/jbc.M204375200; Faircloth LM, 2007, COMP BIOCHEM PHYS B, V146, P370, DOI 10.1016/j.cbpb.2006.11.008; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Feng QL, 2000, J CRYST GROWTH, V216, P459, DOI 10.1016/S0022-0248(00)00396-1; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hasegawa Y, 2005, FISHERIES SCI, V71, P1174, DOI 10.1111/j.1444-2906.2005.01078.x; Huang WQ, 2001, LIFE SCI, V68, P1727; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lakshminarayanan R, 2003, J BIOL CHEM, V278, P2928, DOI 10.1074/jbc.M201518200; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; Lowenstam HA, 1989, BIOMINERALIZATION; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; MANN S, 2001, BIOMINERALIZATION PR, P89; Marin F, 2005, MAT SCI ENG C-BIO S, V25, P105, DOI 10.1016/j.msec.2005.01.003; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matsushiro A, 2004, J BONE MINER METAB, V22, P163, DOI 10.1007/s00774-003-0484-9; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2007, FEBS J, V274, P5158, DOI 10.1111/j.1742-4658.2007.06036.x; Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140; Suzuki N, 2000, ENDOCRINOLOGY, V141, P4247, DOI 10.1210/en.141.11.4247; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wada K., 1976, MECH MINERALIZATION, P175; WADA K, 1966, B NATL PEARL RES, V20, P2209; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	62	80	86	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10841	10854		10.1074/jbc.M808357200	http://dx.doi.org/10.1074/jbc.M808357200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233851	Green Published, hybrid			2022-12-27	WOS:000265104600058
J	Choudhury, R; Noakes, CJ; McKenzie, E; Kox, C; Lowe, M				Choudhury, Rawshan; Noakes, Christopher J.; McKenzie, Edward; Kox, Corinne; Lowe, Martin			Differential Clathrin Binding and Subcellular Localization of OCRL1 Splice Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME PROTEIN OCRL1; INOSITOL POLYPHOSPHATE 5-PHOSPHATASE; TRANS-GOLGI NETWORK; LOWE-SYNDROME; ENDOCYTIC PATHWAY; RAC GTPASE; ENDOSOMES; TRAFFICKING; DEFICIENCY; ACTIVATION	Mutation of the inositol polyphosphate 5-phosphatase OCRL1 causes the X-linked disorder oculocerebrorenal syndrome of Lowe, characterized by defects in the brain, kidneys, and eyes. OCRL1 exists as two splice isoforms that differ by a single exon encoding 8 amino acids. The longer protein, termed isoform a, is the only form in brain, whereas both isoforms are present in all other tissues. The significance of OCRL1 splicing is currently unclear. Given its proximity to a clathrin-binding site, we hypothesized that splicing may alter the clathrin binding properties of OCRL1. Here we show that this is indeed the case. OCRL1 isoform a binds clathrin with higher affinity than isoform b and is significantly more enriched in clathrin-coated trafficking intermediates. We also identify a second clathrin-binding site in OCRL1 that contributes to clathrin binding of both isoforms. Association of OCRL1 with clathrin-coated intermediates requires membrane association through interaction with Rab GTPases but not binding to the clathrin adaptor AP2. Expression of OCRL1 isoform a lacking the 5-phosphatase domain impairs transferrin endocytosis, whereas an equivalent version of isoform b does not. Our results suggest that OCRL1 exists as two functional pools, one participating in clathrin-mediated trafficking events such as endocytosis and another that is much less or not involved in this process.	[Choudhury, Rawshan; Noakes, Christopher J.; McKenzie, Edward; Kox, Corinne; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lowe, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.lowe@manchester.ac.uk			Medical Research Council Senior Nonclinical Research Fellowship [G117/494]; Biotechnology and Biological Sciences Research Council Project [34/C17842]; MRC [G117/494] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [C17842] Funding Source: researchfish; Medical Research Council [G117/494] Funding Source: researchfish	Medical Research Council Senior Nonclinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Senior Nonclinical Research Fellowship G117/494 and Biotechnology and Biological Sciences Research Council Project Grant 34/C17842 ( to M. L.).	Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Faucherre A, 2005, HUM MOL GENET, V14, P1441, DOI 10.1093/hmg/ddi153; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lichter-Konecki U, 2006, MOL GENET METAB, V89, P121, DOI 10.1016/j.ymgme.2006.04.005; LOWE CU, 1952, AMA AM J DIS CHILD, V83, P164, DOI 10.1001/archpedi.1952.02040060030004; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; McCrea HJ, 2008, BIOCHEM BIOPH RES CO, V369, P493, DOI 10.1016/j.bbrc.2008.02.067; Nussbaum R., 2001, METABOLIC MOL BASIS, V4, P6257; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Ungewickell A, 2004, P NATL ACAD SCI USA, V101, P13501, DOI 10.1073/pnas.0405664101; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Williams C, 2007, J CELL SCI, V120, P3941, DOI 10.1242/jcs.014423	29	59	59	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9965	9973		10.1074/jbc.M807442200	http://dx.doi.org/10.1074/jbc.M807442200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211563	hybrid, Green Published			2022-12-27	WOS:000264892900039
J	Imamura, Y; Oda, A; Katahira, T; Bundo, K; Pike, KA; Ratcliffe, MJH; Kitamura, D				Imamura, Yasuhiro; Oda, Akihisa; Katahira, Takashi; Bundo, Kenji; Pike, Kelly A.; Ratcliffe, Michael J. H.; Kitamura, Daisuke			BLNK Binds Active H-Ras to Promote B Cell Receptor-mediated Capping and ERK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; JUN NH2-TERMINAL KINASE; ADAPTER PROTEIN BLNK; NON-ITAM TYROSINE; ANTIGEN-RECEPTOR; PHOSPHOLIPASE C-GAMMA-2; IG-ALPHA; LINKER PROTEIN; CUTTING EDGE; REQUIREMENT	Cross-linked B cell receptor (BCR) aggregates on the cell surface, then assembles into the "cap" where Ras is co-localized, and transduces various intracellular signals including Ras-ERK activation. BCR signals induce proliferation, differentiation, or apoptosis of B cells depending on their maturational stage. The adaptor protein BLNK binds various signaling proteins and Ig alpha, a signaling subunit of the BCR complex, and plays an important role in the BCR signal transduction. BLNK was shown to be required for activation of ERK, but not of Ras, after BCR cross-linking, raising a question how BLNK facilitates ERK activation. Here we demonstrate that BLNK binds the active form of H-Ras, and their binding is facilitated by BCR cross-linking. We have identified a 10-amino acid Ras-binding domain within BLNK that is necessary for restoration of BCR-mediated ERK activation in BLNK-deficient B cells and for anti-apoptotic signaling. The Ras-binding domain fused with a CD8 alpha-Ig alpha chimeric receptor could induce prolonged ERK phosphorylation, transcriptional activation of Elk1, as well as the capping of the receptor in BLNK-deficient B cells. These results indicate that BLNK recruits active H-Ras to the BCR complex, which is essential for sustained surface expression of BCR in the form of the cap and for the signal leading to functional ERK activation.	[Imamura, Yasuhiro; Oda, Akihisa; Katahira, Takashi; Bundo, Kenji; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Biol, Chiba 2780022, Japan; [Pike, Kelly A.; Ratcliffe, Michael J. H.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Pike, Kelly A.; Ratcliffe, Michael J. H.] Sunnybrook Hlth Sci Ctr, Discipline Mol & Cell Biol, Toronto, ON M5S 1A8, Canada	Tokyo University of Science; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kitamura, D (corresponding author), Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Biol, 2669 Yamazaki, Chiba 2780022, Japan.	kitamura@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Fonds de la Recherche en Sante du Quebec	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by Grants-in-Aid for Scientific Research ( B) from Ministry of Education, Culture, Sports, Science and Technology of Japan ( to D. K.).; Supported by a doctoral research award from the Fonds de la Recherche en Sante du Quebec.	Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Brezski RJ, 2007, J IMMUNOL, V179, P4464, DOI 10.4049/jimmunol.179.7.4464; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Goitsuka R, 1998, J IMMUNOL, V161, P5804; GRAZIADEI L, 1990, NATURE, V347, P396, DOI 10.1038/347396a0; HARWOOD AE, 1993, J IMMUNOL, V151, P4513; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Katahira T, 2006, INT IMMUNOL, V18, P545, DOI 10.1093/intimm/dxh395; Katsuta H, 1998, J IMMUNOL, V160, P1547; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LAZARUS AH, 1993, J EXP MED, V178, P1765, DOI 10.1084/jem.178.5.1765; Li WQ, 2000, GENE DEV, V14, P895; Marechal Y, 2007, P NATL ACAD SCI USA, V104, P13978, DOI 10.1073/pnas.0704312104; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Pike KA, 2005, J IMMUNOL, V174, P2012, DOI 10.4049/jimmunol.174.4.2012; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2006, J IMMUNOL, V176, P4690, DOI 10.4049/jimmunol.176.8.4690; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Yamamoto M, 2006, BLOOD, V108, P2703, DOI 10.1182/blood-2006-05-024968; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	57	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9804	9813		10.1074/jbc.M809051200	http://dx.doi.org/10.1074/jbc.M809051200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218240	Green Published, hybrid			2022-12-27	WOS:000264892900021
J	King, JB; West, MB; Cook, PF; Hanigan, MH				King, Jarrod B.; West, Matthew B.; Cook, Paul F.; Hanigan, Marie H.			A Novel, Species-specific Class of Uncompetitive Inhibitors of gamma-Glutamyl Transpeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; TRANSFERASE TRANSPEPTIDASE; ESCHERICHIA-COLI; B16 MELANOMA; ACTIVE-SITE; IN-VIVO; GLUTATHIONE; CELLS; MECHANISM; CYSTEINE	Expression of gamma-glutamyl transpeptidase (GGT) in tumors contributes to resistance to radiation and chemotherapy. GGT is inhibited by glutamine analogues that compete with the substrate for the gamma-glutamyl binding site. However, the glutamine analogues that have been evaluated in clinical trials are too toxic for use in humans. We have used high throughput screening to evaluate small molecules for their ability to inhibit GGT and have identified a novel class of inhibitors that are not glutamine analogues. These compounds are uncompetitive inhibitors, binding the gamma-glutamyl enzyme complex. OU749, the lead compound, has an intrinsic K-i of 17.6 mu M. It is a competitive inhibitor of the acceptor glycyl-glycine, which indicates that OU749 occupies the acceptor site while binding to the gamma-glutamyl substrate complex. OU749 is more than 150-fold less toxic than the GGT inhibitor acivicin toward dividing cells. Inhibition of GGT by OU749 is species-specific, inhibiting GGT isolated from human kidney with 7-10-fold greater potency than GGT isolated from rat or mouse kidney. OU749 does not inhibit GGT from pig cells. Human GGT expressed in mouse fibroblasts is inhibited by OU749 similarly to GGT from human cells, which indicates that the species specificity is determined by differences in the primary structure of the protein rather than species-specific, post-translational modifications. These studies have identified a novel class of inhibitors of GGT, providing the basis for further development of a new group of therapeutics that inhibit GGT by a mechanism distinct from the toxic glutamine analogues.	[King, Jarrod B.; West, Matthew B.; Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma - Norman	Hanigan, MH (corresponding author), Biomed Res Ctr, Rm 264,975 NE 10th St, OK City, OK 73104 USA.	marie-hanigan@ouhsc.edu			National Institutes of Health [RO1CA57530]; Oklahoma Center for the Advancement of Science and Technology [HR03-044]; NATIONAL CANCER INSTITUTE [R01CA057530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA57530 from the NCI (to M. H. H.) and by Grant HR03-044 from the Oklahoma Center for the Advancement of Science and Technology (to M. H. H.). This work was also supported by the Grayce B. Kerr endowment to the University of Oklahoma to support the research of P. F. C.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; AHMAD S, 1987, J CELL PHYSIOL, V131, P240, DOI 10.1002/jcp.1041310214; ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; Anders MW, 1998, ANNU REV PHARMACOL, V38, P501, DOI 10.1146/annurev.pharmtox.38.1.501; Bai FJ, 2001, CHEM RES TOXICOL, V14, P863, DOI 10.1021/tx010011l; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Bose RN, 1997, J INORG BIOCHEM, V65, P199, DOI 10.1016/S0162-0134(96)00133-X; Carter BZ, 1997, J BIOL CHEM, V272, P12305, DOI 10.1074/jbc.272.19.12305; Cook P. F., 2007, ENZYME KINETICS MECH; FOLK JE, 1969, J BIOL CHEM, V244, P3707; Han L, 2007, BIOCHEMISTRY-US, V46, P1432, DOI 10.1021/bi061890j; Han LY, 2006, BIOORGAN MED CHEM, V14, P6043, DOI 10.1016/j.bmc.2006.05.008; HANIGAN MH, 1994, CANCER RES, V54, P5925; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Hanigan MH, 2001, AM J PATHOL, V159, P1889, DOI 10.1016/S0002-9440(10)63035-0; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Henson SE, 1999, J IMMUNOL, V163, P1845; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1995, J BIOL CHEM, V270, P12471, DOI 10.1074/jbc.270.21.12471; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; KUMAGAI H, 1993, J MOL BIOL, V234, P1259, DOI 10.1006/jmbi.1993.1677; Lee CY, 2008, INT IMMUNOPHARMACOL, V8, P732, DOI 10.1016/j.intimp.2008.01.018; Lherbet C, 2004, BIOORG MED CHEM LETT, V14, P3451, DOI 10.1016/j.bmcl.2004.04.072; Lherbet C, 2004, ORG BIOMOL CHEM, V2, P238, DOI 10.1039/b310767a; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; LYONS SD, 1990, J BIOL CHEM, V265, P11377; Mena S, 2007, CLIN CANCER RES, V13, P2658, DOI 10.1158/1078-0432.CCR-06-2642; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; ODWYER PJ, 1992, J NATL CANCER I, V84, P264, DOI 10.1093/jnci/84.4.264; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; Ruoso P, 2004, CANCER CHEMOTH PHARM, V54, P49, DOI 10.1007/s00280-004-0776-3; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; TAYLOR SA, 1991, J CLIN ONCOL, V9, P1476, DOI 10.1200/JCO.1991.9.8.1476; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; YAMASHITA K, 1986, J BIOCHEM-TOKYO, V99, P55, DOI 10.1093/oxfordjournals.jbchem.a135479	42	43	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9059	9065		10.1074/jbc.M809608200	http://dx.doi.org/10.1074/jbc.M809608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19203993	hybrid, Green Published			2022-12-27	WOS:000264669100008
J	Wang, LK; Zhu, H; Shuman, S				Wang, Li Kai; Zhu, Hui; Shuman, Stewart			Structure-guided Mutational Analysis of the Nucleotidyltransferase Domain of Escherichia coli DNA Ligase (LigA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 RNA LIGASE; ADENYLATE INTERMEDIATE; CRYSTAL-STRUCTURE; NICK; POLYNUCLEOTIDES; ARCHITECTURE; RECOGNITION	NAD(+)-dependent DNA ligases (LigA) are ubiquitous in bacteria, where they are essential for growth and present attractive targets for antimicrobial drug discovery. LigA has a distinctive modular structure in which a nucleotidyltransferase catalytic domain is flanked by an upstream NMN-binding module and by downstream OB-fold, zinc finger, helix-hairpin-helix, and BRCT domains. Here we conducted a structure-function analysis of the nucleotidyltransferase domain of Escherichia coli LigA, guided by the crystal structure of the LigA-DNA-adenylate intermediate. We tested the effects of 29 alanine and conservative mutations at 15 amino acids on ligase activity in vitro and in vivo. We thereby identified essential functional groups that coordinate the reactive phosphates (Arg(136)), contact the AMP adenine (Lys(290)), engage the phosphodiester backbone flanking the nick (Arg(218), Arg(308), Arg(97) plus Arg(101)), or stabilize the active domain fold (Arg(171)). Finer analysis of the mutational effects revealed step-specific functions for Arg136, which is essential for the reaction of LigA with NAD(+) to form the covalent ligase-AMP intermediate (step 1) and for the transfer of AMP to the nick 5'-PO4 to form the DNA-adenylate intermediate (step 2) but is dispensable for phosphodiester formation at a preadenylylated nick (step 3).	[Wang, Li Kai; Zhu, Hui; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benarroch D, 2006, VIROLOGY, V353, P133, DOI 10.1016/j.virol.2006.04.032; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; GUMPORT RI, 1971, P NATL ACAD SCI USA, V68, P2559, DOI 10.1073/pnas.68.10.2559; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kaczmarek FS, 2001, J BACTERIOL, V183, P3016, DOI 10.1128/JB.183.10.3016-3024.2001; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Lim JH, 2001, ARCH BIOCHEM BIOPHYS, V388, P253, DOI 10.1006/abbi.2001.2291; LITTLE JW, 1967, P NATL ACAD SCI USA, V58, P2004, DOI 10.1073/pnas.58.5.2004; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; OLIVERA BM, 1968, P NATL ACAD SCI USA, V61, P237, DOI 10.1073/pnas.61.1.237; Raymond A, 2007, NUCLEIC ACIDS RES, V35, P839, DOI 10.1093/nar/gkl1090; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Singleton MR, 1999, STRUCTURE, V7, P35, DOI 10.1016/S0969-2126(99)80007-0; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 2001, J BIOL CHEM, V276, P36100, DOI 10.1074/jbc.M105643200; SRISKANDA V, 2002, J BIOL CHEM, V277, P9685; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Timson DJ, 1999, J MOL BIOL, V285, P73, DOI 10.1006/jmbi.1998.2302; Wang LK, 2008, J BIOL CHEM, V283, P23343, DOI 10.1074/jbc.M802945200; Wang LK, 2006, RNA, V12, P2126, DOI 10.1261/rna.271706; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Yin SM, 2003, J BIOL CHEM, V278, P17601, DOI 10.1074/jbc.M300817200; Zhao A, 2006, MOL MICROBIOL, V59, P743, DOI 10.1111/j.1365-2958.2005.04975.x; Zhu H, 2005, J BIOL CHEM, V280, P12137, DOI 10.1074/jbc.M413685200	28	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8486	8494		10.1074/jbc.M808476200	http://dx.doi.org/10.1074/jbc.M808476200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19150981	hybrid, Green Published			2022-12-27	WOS:000264397800033
J	Yamaoka, K; Inoue, M; Miyazaki, K; Hirama, M; Kondo, C; Kinoshita, E; Miyoshi, H; Seyama, I				Yamaoka, Kaoru; Inoue, Masayuki; Miyazaki, Keisuke; Hirama, Masahiro; Kondo, Chie; Kinoshita, Eiji; Miyoshi, Hiroshi; Seyama, Issei			Synthetic Ciguatoxins Selectively Activate Na(v)1.8-derived Chimeric Sodium Channels Expressed in HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; RESISTANT NA+ CURRENT; INFLAMMATORY PAIN; NEUROPATHIC PAIN; SENSORY NEURONS; RAT-BRAIN; BREVETOXIN RECEPTOR; HYPERALGESIA; NAV1.8; CTX3C	The synthetic ciguatoxin CTX3C has been shown to activate tetrodotoxin (TTX)-sensitive sodium channels (Na(v)1.2, Na(v)1.4, and Na(v)1.5) by accelerating activation kinetics and shifting the activation curve toward hyperpolarization (Yamaoka, K., Inoue, M., Miyahara, H., Miyazaki, K., and Hirama, M. (2004) Br. J. Pharmacol. 142, 879-889). In this study, we further explored the effects of CTX3C on the TTX-resistant sodium channel Na(v)1.8. TTX-resistant channels have been shown to be involved in transducing pain and related sensations (Akopian, A.N., Sivilotti, L., and Wood, J.N. (1996) Nature 379, 257-262). Thus, we hypothesized that ciguatoxin-induced activation of the Nav1.8 current would account for the neurological symptoms of ciguatera poisoning. We found that 0.1 mu M CTX3C preferentially affected the activation process of the Nav1.8 channel compared with those of the Nav1.2 and Na(v)1.4 channels. Importantly, without stimulation, 0.1 mu M CTX3C induced a large leakage current (I-L). The conductance of the I-L calculated relative to the maximum conductance (Gmax) was 10 times larger than that of Na(v)1.2 or Na(v)1.4. To determine the molecular domain of Na(v)1.8 responsible for conferring higher sensitivity to CTX3C, we made two chimeric constructs from Na(v)1.4 and Na(v)1.8. Chimeras containing the N-terminal half of Na(v)1.8 exhibited a large response similar to wild-type Na(v)1.8, indicating that the region conferring high sensitivity to ciguatoxin action is located in the D1 or D2 domains.	[Yamaoka, Kaoru] Hiroshima Int Univ, Fac Hlth Sci, Dept Phys Therapy, Higashihiroshima 7392695, Japan; [Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Miyazaki, Keisuke; Hirama, Masahiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Kondo, Chie] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kinoshita, Eiji] Hiroshima Univ, Grad Sch Biomed Sci, Div Med Chem, Dept Funct Mol Sci, Hiroshima 7348553, Japan; [Miyoshi, Hiroshi] Hiroshima Univ, Fac Med, Dept Obstet & Gynecol, Hiroshima 7348551, Japan; [Seyama, Issei] Hiroshima Jogakuin Univ, Fac Human Life Sci, Hiroshima 7320063, Japan	University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST); Hiroshima University; Hiroshima University	Yamaoka, K (corresponding author), Kurose Gakuendai 555-36, Hiroshima 7392695, Japan.	k-yamao@hs.hirokoku-u.ac.jp	Kinoshita, Eiji/H-2284-2019		Solution Oriented Research for Science and Technology, Japan Science and Technology Agency [17390056]; Ministry of Education and Culture of Japan	Solution Oriented Research for Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, and Grant 17390056 from the Ministry of Education and Culture of Japan	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Baker MD, 2003, J PHYSIOL-LONDON, V548, P373, DOI 10.1113/jphysiol.2003.039131; BENOIT E, 1986, TOXICON, V24, P357, DOI 10.1016/0041-0101(86)90195-9; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Cardenas LM, 2001, J NEUROPHYSIOL, V86, P241, DOI 10.1152/jn.2001.86.1.241; DUNN PM, 1991, BRAIN RES, V545, P80, DOI 10.1016/0006-8993(91)91272-3; Gold MS, 1999, P NATL ACAD SCI USA, V96, P7645, DOI 10.1073/pnas.96.14.7645; Gold MS, 2003, J NEUROSCI, V23, P158; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Hirama M, 2001, SCIENCE, V294, P1904, DOI 10.1126/science.1065757; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Inoue M, 2004, P NATL ACAD SCI USA, V101, P12013, DOI 10.1073/pnas.0401684101; Inoue M, 2006, J AM CHEM SOC, V128, P9352, DOI 10.1021/ja063041p; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; John VH, 2004, NEUROPHARMACOLOGY, V46, P425, DOI 10.1016/j.neuropharm.2003.09.018; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Laird JMA, 2002, J NEUROSCI, V22, P8352; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Roza C, 2003, J PHYSIOL-LONDON, V550, P921, DOI 10.1113/jphysiol.2003.046110; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; Tanaka M, 1998, NEUROREPORT, V9, P967, DOI 10.1097/00001756-199804200-00003; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; TRAINER VL, 1991, MOL PHARMACOL, V40, P988; TRAINER VL, 1994, J BIOL CHEM, V269, P19904; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Yamaoka K, 2004, BRIT J PHARMACOL, V142, P879, DOI 10.1038/sj.bjp.0705852; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yasumoto T, 2001, CHEM REC, V1, P228, DOI 10.1002/tcr.1010; Yoshimura N, 2001, Urology, V57, P116, DOI 10.1016/S0090-4295(01)01060-3	39	33	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7597	7605		10.1074/jbc.M806481200	http://dx.doi.org/10.1074/jbc.M806481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164297	Green Published, hybrid			2022-12-27	WOS:000264195600022
J	Damek-Poprawa, M; Diemer, T; Lopes, VS; Lillo, C; Harper, DC; Marks, MS; Wu, Y; Sparrow, JR; Rachel, RA; Williams, DS; Boesze-Battaglia, K				Damek-Poprawa, Monika; Diemer, Tanja; Lopes, Vanda S.; Lillo, Concepcion; Harper, Dawn C.; Marks, Michael S.; Wu, Yalin; Sparrow, Janet R.; Rachel, Rivka A.; Williams, David S.; Boesze-Battaglia, Kathleen			Melanoregulin (MREG) Modulates Lysosome Function in Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE DILUTE SUPPRESSOR; AGE-RELATED-CHANGES; COAT-COLOR PHENOTYPE; CATHEPSIN-D; OUTER SEGMENTS; DEGRADATIVE FUNCTIONS; RETINOID COMPONENT; RPE LIPOFUSCIN; GENE DSU; A2E	Melanoregulin (MREG), the product of the Mreg(dsu) gene, is a small highly charged protein, hypothesized to play a role in organelle biogenesis due to its effect on pigmentation in dilute, ashen, and leaden mutant mice. Here we provide evidence that MREG is required in lysosome-dependent phagosome degradation. In the Mreg(-/-) mouse, we show that loss of MREG function results in phagosome accumulation due to delayed degradation of engulfed material. Over time, the Mreg(-/-) mouse retinal pigment epithelial cells accumulate the lipofuscin component, A2E. MREG-deficient human and mouse retinal pigment epithelial cells exhibit diminished activity of the lysosomal hydrolase, cathepsin D, due to defective processing. Moreover, MREG localizes to small intracellular vesicles and associates with the endosomal phosphoinositide, phosphatidylinositol 3,5-biphosphate. Collectively, these studies suggest that MREG is required for lysosome maturation and support a role for MREG in intracellular trafficking.	[Damek-Poprawa, Monika; Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Sch Dent Med, Philadelphia, PA 19104 USA; [Diemer, Tanja; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Diemer, Tanja; Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Diemer, Tanja; Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Wu, Yalin; Sparrow, Janet R.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Rachel, Rivka A.] NEI, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania; Columbia University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Boesze-Battaglia, K (corresponding author), Univ Penn, Dept Biochem, Sch Dent Med, 240 S 40th St, Philadelphia, PA 19104 USA.	battagli@biochem.dental.upenn.edu	Marks, Michael S/Q-7223-2019; Lillo, Concepcion/A-6321-2009; 2009, Secribsal/A-1266-2012	Marks, Michael S/0000-0001-7435-7262; Lillo, Concepcion/0000-0001-5814-9826; 	National Institutes of Health [EY-10420]; NEI [P30 EY001583, EY07042, EY-12951]; NEI, National Institutes of Health Core [P30 EY12598, EY00331]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012598, R01EY015625, P30EY000331, P30EY001583, R01EY012951, R21EY018705, R01EY010420, R01EY007042, R29EY010420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI, National Institutes of Health Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Public Health Service Grant EY-10420 from the National Institutes of Health, NEI and services were available through a Vision Core Grant (P30 EY001583) (to K. B.-B. and M. D.- P.), Public Health Service grant EY07042 from the NEI and services available through NEI, National Institutes of Health Core Grants (P30 EY12598 and EY00331) (to D. S. W.), Public Health Service Grant EY-12951 from the NEI (to J. R. S. and Y. W.), and Public Health Service Grant EY-15625 from the NEI (to M. S. M.). This work was also supported by an E. Matilda Ziegler Vision Award and University of Pennsylvania Research Foundation Award (KB- B). (to J. R. S. and Y. W.).	Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bermann M, 2001, EXP EYE RES, V72, P191; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; BESHARSE JC, 1998, RETINAL PIGMENT EPIT, P152; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cingle KA, 1996, CURR EYE RES, V15, P433, DOI 10.3109/02713689608995834; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; Damek-Poprawa M, 2006, BIOCHEMISTRY-US, V45, P3325, DOI 10.1021/bi0515927; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; DEDUVE C, 1964, FED PROC, V23, P1045; DELAEY JJ, 1995, RETINA-J RET VIT DIS, V15, P399, DOI 10.1097/00006982-199515050-00005; DELBRUCK R, 1994, EUR J CELL BIOL, V64, P7; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; FEENEYBURNS L, 1983, T OPHTHAL SOC UK, V103, P416; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1115; Gibbs D, 2003, ADV EXP MED BIOL, V533, P347; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HAYASAKA S, 1975, J BIOCHEM-TOKYO, V78, P1365, DOI 10.1093/oxfordjournals.jbchem.a131034; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Hoppe G, 2004, CELL MOL LIFE SCI, V61, P1664, DOI 10.1007/s00018-004-4080-5; Hoppe G, 2004, BBA-MOL BASIS DIS, V1689, P33, DOI 10.1016/j.bbadis.2004.01.004; Hoppe G, 2001, INVEST OPHTH VIS SCI, V42, P2714; Jacobson SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/hmg/ddn140; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LEMANSKY P, 1984, J BIOL CHEM, V259, P129; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Marks MS, 2008, PIGM CELL MELANOMA R, V21, P11, DOI 10.1111/j.1755-148X.2007.00421.x; Massey AC, 2006, CELL CYCLE, V5, P1292, DOI 10.4161/cc.5.12.2865; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; MOORE KJ, 1994, GENETICS, V138, P491; MOORE KJ, 1988, GENETICS, V119, P933; MOORE KJ, 1990, GENETICS, V125, P421; NABI IR, 1993, J CELL SCI, V104, P37; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; NOVAK EK, 1979, GENETICS, V92, P189; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; PLANTNER JJ, 1991, EXP EYE RES, V53, P269, DOI 10.1016/0014-4835(91)90083-Q; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; RAKOCZY PE, 1994, INVEST OPHTH VIS SCI, V35, P4100; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; REGAN CM, 1980, EXP EYE RES, V30, P183, DOI 10.1016/0014-4835(80)90112-8; RICHO GR, 1994, J BIOL CHEM, V269, P14806; SIAKOTOS AN, 1978, INVEST OPHTH VIS SCI, V17, P618; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; SWEET HO, 1983, J HERED, V74, P305, DOI 10.1093/oxfordjournals.jhered.a109794; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Verdugo ME, 1997, EXP EYE RES, V65, P231, DOI 10.1006/exer.1997.0325; Volpicelli-Daley L, 2007, NAT MED, V13, P784, DOI 10.1038/nm0707-784; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X; WILCOX DK, 1988, INVEST OPHTH VIS SCI, V29, P1205; Yasuda Y, 1999, J BIOCHEM-TOKYO, V125, P1137, DOI 10.1093/oxfordjournals.jbchem.a022396; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	88	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10877	10889		10.1074/jbc.M808857200	http://dx.doi.org/10.1074/jbc.M808857200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240024	Green Published, hybrid			2022-12-27	WOS:000265104600061
J	Philominathan, STL; Koide, T; Hamada, K; Yasui, H; Seifert, S; Matsushita, O; Sakon, J				Philominathan, Sagaya Theresa Leena; Koide, Takaki; Hamada, Kentaro; Yasui, Hiroyuki; Seifert, Soenke; Matsushita, Osamu; Sakon, Joshua			Unidirectional Binding of Clostridial Collagenase to Triple Helical Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; PROTEIN INTERACTIONS; DUPUYTRENS-DISEASE; NMR-SPECTROSCOPY; DOMAIN; HISTOLYTICUM; ASSIGNMENTS; PEPTIDASE; AFFINITY; MODELS	Histotoxic clostridia produce collagenases responsible for extensive tissue destruction in gas gangrene. The C-terminal collagen-binding domain (CBD) of these enzymes is the minimal segment required to bind to collagen fibril. Collagen binding efficiency of CBD is more pronounced in the presence of Ca2+. We have shown that CBD can be functional to anchor growth factors in local tissue. A H-1-N-15 HSQC NMR titration study with three different tropocollagen analogues ((POG)(10))(3), ((GPOG)(7)PRG)(3), and (GPRG(POG)(7)C-carbamidomethyl)(3), mapped a saddle-like binding cleft on CBD. NMR titrations with three nitroxide spin-labeled analogues of collagenous peptide, (PROXYL-G(POG)(7)PRG)(3), (PROXYL-G(POG)(7))(3), and (GPRG(POG)(7)C-PROXYL)(3) (where PROXYL represents 2,2,5,5-tetramethyl-L-pyrrolidinyloxy), unambiguously demonstrated unidirectional binding of CBD to the tropocollagen analogues. Small angle x-rays cattering data revealed that CBD binds closer to a terminus for each of the five different tropocollagen analogues, which in conjunction with NMR titration studies, implies a binding mode where CBD binds to the C terminus of the triple helix.	[Philominathan, Sagaya Theresa Leena; Sakon, Joshua] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Koide, Takaki; Hamada, Kentaro] Waseda Univ, Dept Chem & Biochem, Sch Adv Sci & Engn, Tokyo 1698555, Japan; [Yasui, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto 6048414, Japan; [Seifert, Soenke] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Matsushita, Osamu] Kitasato Univ, Sch Med, Dept Microbiol & Parasitol, Kanagawa 2288555, Japan	University of Arkansas System; University of Arkansas Fayetteville; Waseda University; Kyoto Pharmaceutical University; United States Department of Energy (DOE); Argonne National Laboratory; Kitasato University	Philominathan, STL (corresponding author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.	pstleena@uark.edu	Sakon, Joshua/N-2289-2014; Yasui, Hiroyuki/AAW-7976-2020	Sakon, Joshua/0000-0002-8373-969X; Yasui, Hiroyuki/0000-0003-3317-3947	National Institutes of Health Center for Protein Structure and Function [NCRR COBRE 1 P20RR15569, INBRE P20RR16460.]; Japan Society for the Promotion of Science and Kagawa University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569, P20RR016460] Funding Source: NIH RePORTER	National Institutes of Health Center for Protein Structure and Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science and Kagawa University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by the National Institutes of Health Center for Protein Structure and Function Grants NCRR COBRE 1 P20RR15569 and INBRE P20RR16460. This work was also supported by the AR Biosciences Institute (ABI) and a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science and Kagawa University Project Research Fund 2005-2006.	Badalamente MA, 2000, J HAND SURG-AM, V25A, P629, DOI 10.1053/jhsu.2000.6918; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; DeLano WL, 2002, PYMOL USERS MANUAL; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Hajduk PJ, 1999, Q REV BIOPHYS, V32, P211, DOI 10.1017/S0033583500003528; Jain NU, 2001, PROTEIN SCI, V10, P2393, DOI 10.1110/ps.17401; Kelly JA, 2005, BIOCHEM J, V389, P569, DOI 10.1042/BJ20041722; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; KONIG S, 1992, BIOCHEMISTRY-US, V31, P8726; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643; Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Philominathan STL, 2008, BIOMOL NMR ASSIGN, V2, P127, DOI 10.1007/s12104-008-9102-z; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	30	24	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10868	10876		10.1074/jbc.M807684200	http://dx.doi.org/10.1074/jbc.M807684200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208618	Green Published, hybrid			2022-12-27	WOS:000265104600060
J	Capyk, JK; D'Angelo, I; Strynadka, NC; Eltis, LD				Capyk, Jenna K.; D'Angelo, Igor; Strynadka, Natalie C.; Eltis, Lindsay D.			Characterization of 3-Ketosteroid 9 alpha-Hydroxylase, a Rieske Oxygenase in the Cholesterol Degradation Pathway of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-ERYTHROPOLIS SQ1; TERMINAL OXYGENASE; NAPHTHALENE DIOXYGENASE; PHTHALATE DIOXYGENASE; CRYSTAL-STRUCTURE; DELTA(1)-DEHYDROGENASE ISOENZYME; FUNCTIONAL-CHARACTERIZATION; BRIDGING ASPARTATE-178; BIPHENYL DIOXYGENASE; STRAIN SQ1	KshAB (3-Ketosteroid 9 alpha-hydroxylase) is a two-component Rieske oxygenase (RO) in the cholesterol catabolic pathway of Mycobacterium tuberculosis. Although the enzyme has been implicated in pathogenesis, it has largely been characterized by bioinformatics and molecular genetics. Purified KshB, the reductase component, was a monomeric protein containing a plant-type [2Fe-2S] cluster and FAD. KshA, the oxygenase, was a homotrimer containing a Rieske [2Fe-2S] cluster and mononuclear ferrous iron. Of two potential substrates, reconstituted KshAB had twice the specificity for 1,4-androstadiene-3,17-dione as for 4-androstene-3,17-dione. The transformation of both substrates was well coupled to the consumption of O-2. Nevertheless, the reactivity of KshAB with O-2 was low in the presence of 1,4- androstadiene-3,17-dione, with a k(cat)/K-mO2 of 2450 +/- 80 M-1 s(-1). The crystallographic structure of KshA, determined to 2.3 angstrom, revealed an overall fold and a head-to-tail subunit arrangement typical of ROs. The central fold of the catalytic domain lacks all insertions found in characterized ROs, consistent with a minimal and perhaps archetypical RO catalytic domain. The structure of KshA is further distinguished by a C-terminal helix, which stabilizes subunit interactions in the functional trimer. Finally, the substrate-binding pocket extends farther into KshA than in other ROs, consistent with the large steroid substrate, and the funnel accessing the active site is differently orientated. This study provides a solid basis for further studies of a key steroid transforming enzyme of biotechnological and medical importance.	[Capyk, Jenna K.; D'Angelo, Igor; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6 1Z3, Canada; [Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Canadian Institute for Health Research; British Columbia Lung Association; Michael Smith Foundation for Health Research; Emerging Team programs.	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Emerging Team programs.	This work was supported by grants from the Canadian Institute for Health Research ( to L. D. E. and N. S.), the British Columbia Lung Association (to L. D. E.), and the Michael Smith Foundation for Health Research (MSFHR) Infrastructure ( to N. S.) and Emerging Team programs.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andor A, 2006, APPL ENVIRON MICROB, V72, P6554, DOI 10.1128/AEM.00941-06; BERNHARDT FH, 1981, EUR J BIOCHEM, V120, P547, DOI 10.1111/j.1432-1033.1981.tb05735.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cornish-Bowden A., 1994, ANAL ENZYME KINETIC; DeLano W.L, PYMOL MOL GRAPHICS S; Dong XS, 2005, J BACTERIOL, V187, P2483, DOI 10.1128/JB.187.7.2483-2490.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferraro DJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-10; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Furukawa K, 2003, TRENDS BIOTECHNOL, V21, P187, DOI 10.1016/S0167-7799(03)00054-4; Furusawa Y, 2004, J MOL BIOL, V342, P1041, DOI 10.1016/j.jmb.2004.07.062; Ge Y, 2002, J BACTERIOL, V184, P4096, DOI 10.1128/JB.184.15.4096-4103.2002; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee K, 1999, J BACTERIOL, V181, P2719, DOI 10.1128/JB.181.9.2719-2725.1999; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nojiri H, 2005, J MOL BIOL, V351, P355, DOI 10.1016/j.jmb.2005.05.059; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Pinto A, 2006, BIOCHEMISTRY-US, V45, P9032, DOI 10.1021/bi060216z; PULLEYBLANK D, 1983, MOL BIOL REP, V9, P191, DOI 10.1007/BF00775367; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; STRIJEWSKI A, 1982, EUR J BIOCHEM, V128, P125; Tarasev M, 2005, BIOCHEMISTRY-US, V44, P6197, DOI 10.1021/bi047724y; Tarasev M, 2006, BIOCHEMISTRY-US, V45, P10208, DOI 10.1021/bi060219b; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; van der Geize R, 2008, APPL ENVIRON MICROB, V74, P7197, DOI 10.1128/AEM.00888-08; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2000, APPL ENVIRON MICROB, V66, P2029, DOI 10.1128/AEM.66.5.2029-2036.2000; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; *WHO, 2008, 4 WHO, P14; YAM K, 2009, PLOS PATHOG IN PRESS; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012	62	109	115	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9937	9946		10.1074/jbc.M900719200	http://dx.doi.org/10.1074/jbc.M900719200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19234303	hybrid, Green Published			2022-12-27	WOS:000264892900036
J	Hiyama, A; Gajghate, S; Sakai, D; Mochida, J; Shapiro, IM; Risbud, MV				Hiyama, Akihiko; Gajghate, Sachin; Sakai, Daisuke; Mochida, Joji; Shapiro, Irving M.; Risbud, Makarand V.			Activation of TonEBP by Calcium Controls beta 1,3-Glucuronosyltransferase-I Expression, a Key Regulator of Glycosaminoglycan Synthesis in Cells of the Intervertebral Disc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEUS PULPOSUS CELLS; PROTEOGLYCAN SYNTHESIS; GLUCURONOSYLTRANSFERASE-I; CALCINEURIN; PATHWAY; ENZYME; TRANSCRIPTION; DEGENERATION; CHONDROCYTES; HIF-1-ALPHA	The goal of this investigation was to study the expression and regulation of beta 1,3-Glucuronosyltransferase-I (GlcAT-I), a key enzyme regulating GAG synthesis in cells of the intervertebral disc. There was a robust expression of GlcAT-I in the nucleus pulposus in vivo. Treatment with the calcium ionophore ionomycin resulted in increased GlcAT-I expression, whereas GlcAT-I promoter constructs lacking TonE site or a mutant TonE were unresponsive to the ionophore. Experiments using TonEBP and DN-TonEBP constructs showed that TonEBP positively regulated GlcAT-I promoter activity. ChIP analysis confirmed binding of TonEBP to the promoter. We further validated the role of TonEBP in controlling GlcAT-I expression using mouse embryo fibroblasts from TonEBP null mice. GlcAT-I promoter activity in null cells was significantly lower than the wild type cells. In contrast to wild type cells, treatment with ionomycin failed to increase GlcAT-I promoter activity in null cells. Wethen investigated if calcineurin (Cn)-NFAT signaling played a regulatory role in GlcAT-I expression. Inhibition of Cn following ionomycin treatment did not block GlcAT-I and tauT, a TonEBP-responsive reporter activity. GlcAT-I promoter activity was suppressed by co-expression of Cn, NFAT2, NFAT3, and NFAT4. Moreover, following ionomycin treatment, fibroblasts from CnA alpha and CnA beta null mice exhibited robust induction in GlcAT-I promoter activity compared with wild type cells. Results of these studies demonstrate that calcium regulates GlcAT-I expression in cells of the nucleus pulposus through a signaling network comprising both activator and suppressor molecules. The results suggest that by controlling both GAG and aggrecan synthesis, disc cells can autoregulate their osmotic environment and accommodate mechanical loading.	[Hiyama, Akihiko; Gajghate, Sachin; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Hiyama, Akihiko; Sakai, Daisuke; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped Surg, Kanagawa 2591193, Japan	Jefferson University; Tokai University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthoped Surg, 1015 Walnut St,Suite 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu	Sakai, Daisuke/X-9164-2019; Hiyama, Akihiko/AAW-7362-2021	Sakai, Daisuke/0000-0003-4189-9270; Hiyama, Akihiko/0000-0002-2474-9118	National Institutes of Health [AR050087, AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050087 and AR055655. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alford AI, 2003, J CELL BIOCHEM, V90, P938, DOI 10.1002/jcb.10715; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Barre L, 2006, FASEB J, V20, P1692, DOI 10.1096/fj.05-5073fje; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Fagnen G, 2000, J CELL BIOCHEM, V76, P322; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kitagawa H, 1996, J BIOL CHEM, V271, P6583, DOI 10.1074/jbc.271.12.6583; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Ng L, 2003, J STRUCT BIOL, V143, P242, DOI 10.1016/j.jsb.2003.08.006; Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; Venkatesan N, 2004, P NATL ACAD SCI USA, V101, P18087, DOI 10.1073/pnas.0404504102; Vijayagopal P, 2001, ATHEROSCLEROSIS, V157, P353, DOI 10.1016/S0021-9150(00)00742-5; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620	26	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9824	9834		10.1074/jbc.M807081200	http://dx.doi.org/10.1074/jbc.M807081200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19147493	Green Published, hybrid			2022-12-27	WOS:000264892900023
J	Kim, MS; Zeng, WZ; Yuan, JP; Shin, DM; Worley, PF; Muallem, S				Kim, Min Seuk; Zeng, Weizhong; Yuan, Joseph P.; Shin, Dong Min; Worley, Paul F.; Muallem, Shmuel			Native Store-operated Ca2+ Influx Requires the Channel Function of Orai1 and TRPC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; CALCIUM-CHANNELS; LIPID RAFTS; STIM1; ENTRY; RELEASE; ACTIVATION; SECRETION; PROTEINS; CURRENTS	With the discovery of STIM1 and Orai1 and gating of both TRPC and Orai1 channels by STIM1, a central question is the role of each of the channels in the native store-operated Ca2+ influx (SOCs). Here, we used a strategy of knockdown of Orai1 and of TRPC1 alone and in combination and rescue by small interfering RNA-protected mutants (sm) of smOrai1 and smTRPC1 to demonstrate that in human embryonic kidney (HEK) cells, rescue of SOCs required co-transfection of low levels of both smOrai1 and smTRPC1. The pore mutant Orai1(E106Q) failed to rescue the SOCs in the presence or absence of TRPC1 and, surprisingly, the pore mutant TRPC1(F562A) failed to rescue the SOCs in the presence or absence of Orai1. TRPC1 is gated by electrostatic interaction between TRPC1(D639D, D640D) with STIM1(K684K, K685K). Strikingly, the channel-dead TRPC1(D639K, D640K) that can be rescued only by the STIM1(K684E, K685E) mutant could restore SOCs only when expressed with Orai1 and STIM1( K684E, K685E). Accordingly, we found a mutual requirement of Orai1 and TRPC1 for their interaction with the native STIM1 in HEK cells. By contrast, SOC and the CRAC current in Jurkat cells were inhibited by knockdown of Orai1 but were not influenced by knockdown on TRPC1 or TRPC3. These findings define the molecular makeup of the native SOCs in HEK cells and the role of a STIM1-Orai1-TRPC1 complex in SOC activity.	[Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Shin, Dong Min] Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept Oral Biol, Seoul 120752, South Korea; [Kim, Min Seuk; Zeng, Weizhong; Yuan, Joseph P.; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Johns Hopkins University; Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	pworley@jhmi.edu; Shmuel.muallem@utsouthwestern.edu		Shin, Dong Min/0000-0001-6042-0435	National Institutes of Health [DE12309, DK38938]; National Institute on Drug Abuse [DA00266, DA10309]; National Institute of Mental Health [MH068830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010309, P50DA000266, R01DA010309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant Grants DE12309 and DK38938 and by the National Institute on Drug Abuse ( Grants DA00266 and DA10309) and the National Institute of Mental Health ( Grant MH068830) ( to P. F. W.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Petersen OH, 2006, CELL CALCIUM, V40, P593, DOI 10.1016/j.ceca.2006.08.020; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	40	126	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9733	9741		10.1074/jbc.M808097200	http://dx.doi.org/10.1074/jbc.M808097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228695	Green Published, hybrid			2022-12-27	WOS:000264892900013
J	Kumaran, S; Yi, H; Krishnan, HB; Jez, JM				Kumaran, Sangaralingam; Yi, Hankuil; Krishnan, Hari B.; Jez, Joseph M.			Assembly of the Cysteine Synthase Complex and the Regulatory Role of Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; SERINE ACETYLTRANSFERASE; SULFUR ASSIMILATION; MOLECULAR-CLONING; REACTION-MECHANISM; THIOL LYASE; ACTIVE-SITE; BIOSYNTHESIS; PLANTS; GLUTATHIONE	Macromolecular assemblies play critical roles in regulating cellular functions. The cysteine synthase complex (CSC), which is formed by association of serine O-acetyltransferase (SAT) and O-acetylserine sulfhydrylase (OASS), acts as a sensor and modulator of thiol metabolism by responding to changes in nutrient conditions. Here we examine the oligomerization and energetics of formation of the soybean CSC. Biophysical examination of the CSC by size exclusion chromatography and sedimentation ultracentrifugation indicates that this assembly (complex M-r similar to 330,000) consists of a single SAT trimer (trimer M-r similar to 110,000) and three OASS dimers (dimer M-r similar to 70,000). Analysis of the SAT-OASS interaction by isothermal titration calorimetry reveals negative cooperativity with three distinct binding events during CSC formation with K-d values of 0.3, 7.5, and 78 nM. The three binding events are also observed using surface plasmon resonance with comparable affinities. The stability of the CSC derives from rapid association and extremely slow dissociation of OASS with SAT and requires the C terminus of SAT for the interaction. Steady-state kinetic analysis shows that CSC formation enhances SAT activity and releases SAT from substrate inhibition and feedback inhibition by cysteine, the final product of the biosynthesis pathway. Cysteine inhibits SAT and the CSC with K-i values of 2 and 70 mu M, respectively. These results suggest a new model for the architecture of this regulatory complex and additional control mechanisms for biochemically controlling plant cysteine biosynthesis. Based on previous work and our results, we suggest that OASS acts as an enzyme chaperone of SAT in the CSC.	[Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kumaran, Sangaralingam; Yi, Hankuil; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Krishnan, Hari B.] Univ Missouri, Dept Agron, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			United States Department of Agriculture [NRI-2005-02518]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture Grant NRI-2005-02518 (to J. M. J.).	Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; Chronis D, 2003, CROP SCI, V43, P1819, DOI 10.2135/cropsci2003.1819; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; Dominguez-Solis JR, 2008, P NATL ACAD SCI USA, V105, P16386, DOI 10.1073/pnas.0808204105; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Gomez LD, 2004, PLANT PHYSIOL, V134, P1662, DOI 10.1104/pp.103.033027; Hell R, 2002, AMINO ACIDS, V22, P245, DOI 10.1007/s007260200012; Hell R, 2001, CURR OPIN BIOTECH, V12, P161, DOI 10.1016/S0958-1669(00)00193-2; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; HRAZDINA G, 1992, ANNU REV PLANT PHYS, V43, P241, DOI 10.1146/annurev.pp.43.060192.001325; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kocsy G, 2000, PLANTA, V210, P295, DOI 10.1007/PL00008137; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Kumaran Sangaralingam, 2008, P97, DOI 10.1007/978-3-540-76326-0_5; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Mino K, 2001, BIOSCI BIOTECH BIOCH, V65, P865, DOI 10.1271/bbb.65.865; NIETOSOTELO J, 1986, PLANT PHYSIOL, V82, P1031, DOI 10.1104/pp.82.4.1031; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wirtz M, 2007, PLANT CELL, V19, P625, DOI 10.1105/tpc.106.043125; Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950; Zhu X, 1998, BIOSCI BIOTECH BIOCH, V62, P947, DOI 10.1271/bbb.62.947	43	61	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10268	10275		10.1074/jbc.M900154200	http://dx.doi.org/10.1074/jbc.M900154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19213732	hybrid, Green Published			2022-12-27	WOS:000264892900068
J	Okrent, RA; Brooks, MD; Wildermuth, MC				Okrent, Rachel A.; Brooks, Matthew D.; Wildermuth, Mary C.			Arabidopsis GH3.12 (PBS3) Conjugates Amino Acids to 4-Substituted Benzoates and Is Inhibited by Salicylate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN TIR1; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; LITHOSPERMUM-ERYTHRORHIZON; ISOCHORISMATE SYNTHASE; DISEASE RESISTANCE; AUXIN RECEPTOR; CHORISMIC ACID; PLANTS; BIOSYNTHESIS	Salicylate ( SA, 2-hydroxybenzoate) is a phytohormone best known for its role as a critical mediator of local and systemic plant defense responses. In response to pathogens such as Pseudomonas syringae, SA is synthesized and activates widespread gene expression. In gh3.12/pbs3 mutants of Arabidopsis thaliana, induced total SA accumulation is significantly compromised as is SA-dependent gene expression and plant defense. AtGH3 subfamily I and II members have been shown to conjugate phytohormone acyl substrates to amino acids in vitro, with this role supported by in planta analyses. Here we sought to determine the in vitro biochemical activity and kinetic properties of GH3.12/avrPphB susceptible 3 (PBS3), a member of the uncharacterized AtGH3 subfamily III. Using a novel high throughput adenylation assay, we characterized the acyl substrate preference of PBS3. We found PBS3 favors 4-substituted benzoates such as 4-aminobenzoate and 4-hydroxybenzoate, with moderate activity on benzoate and no observed activity with 2-substituted benzoates. Similar to known GH3 enzymes, PBS3 catalyzes the conjugation of specific amino acids ( e. g. Glu) to its preferred acyl substrates. Kinetic analyses indicate 4-aminobenzoate and 4-hydroxybenzoate are preferred acyl substrates as PBS3 exhibits both higher affinities ( apparent K-m = 153 and 459 mu M, respectively) and higher catalytic efficiencies (k(cat)/K-m = 0.0179 and 0.0444 mu M-1 min(-1), respectively) with these acyl substrates compared with benzoate (apparent K-m = 867 mu M, k(cat)/K-m = 0.0046 mu M-1 min(-1)). Notably, SA specifically and reversibly inhibits PBS3 activity with an IC50 of 15 mu M. This suggests a general mechanism for the rapid, reversible regulation of GH3 activity and small molecule cross-talk. For PBS3, this may allow for coordination of flux through diverse chorismate-derived pathways.	[Okrent, Rachel A.; Brooks, Matthew D.; Wildermuth, Mary C.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wildermuth, MC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	wildermuth@nature.berkeley.edu		Brooks, Matthew D./0000-0002-6081-6103; Okrent, Rachel/0000-0002-8053-3223	National Science Foundation Arabidopsis [MCB-0420267]	National Science Foundation Arabidopsis(National Science Foundation (NSF))	This work was supported by National Science Foundation Arabidopsis 2010 Grant MCB-0420267 ( to M. C. W.).	Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Beuerle T, 2002, ARCH BIOCHEM BIOPHYS, V400, P258, DOI 10.1016/S0003-9861(02)00026-7; BOURNE DJ, 1991, PHYTOCHEMISTRY, V30, P4041, DOI 10.1016/0031-9422(91)83462-T; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chen F, 2003, PLANT J, V36, P577, DOI 10.1046/j.1365-313X.2003.01902.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; FIGULY G, 1996, ENCYCLOPEDIA; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GAJEWSKI JJ, 1987, J AM CHEM SOC, V109, P1170, DOI 10.1021/ja00238a029; GIBSON F, 1964, BIOCHEM J, V90, P256, DOI 10.1042/bj0900256; GLASS NL, 1988, J BACTERIOL, V170, P2367, DOI 10.1128/jb.170.5.2367-2373.1988; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; GLEITZ J, 1991, PLANTA, V184, P362, DOI 10.1007/BF00195338; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Holden MJ, 2002, BBA-PROTEIN STRUCT M, V1594, P160, DOI 10.1016/S0167-4838(01)00302-8; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Lee MW, 2008, PLANT J, V54, P452, DOI 10.1111/j.1365-313X.2008.03439.x; Lee MW, 2007, MOL PLANT MICROBE IN, V20, P1192, DOI 10.1094/MPMI-20-10-1192; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lu FC, 2004, ORG BIOMOL CHEM, V2, P2888, DOI 10.1039/b411428k; Muhlenweg A, 1998, PLANTA, V205, P407, DOI 10.1007/s004250050337; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; OBRIEN WE, 1976, ANAL BIOCHEM, V76, P423, DOI 10.1016/0003-2697(76)90337-7; Orsomando G, 2006, PLANT J, V46, P426, DOI 10.1111/j.1365-313X.2006.02685.x; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Quinlivan EP, 2006, ANAL BIOCHEM, V348, P163, DOI 10.1016/j.ab.2005.09.017; Rudolph F B, 1979, Methods Enzymol, V63, P138; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Shinohara R, 2005, APPL ENVIRON MICROB, V71, P417, DOI 10.1128/AEM.71.1.417-422.2005; Song JT, 2006, MOL CELLS, V22, P233; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; STEFFAN H, 1988, VITIS, V27, P79; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; SUZUKI Y, 1988, PLANT CELL PHYSIOL, V29, P439; Swiezewska E, 2004, METHOD ENZYMOL, V378, P124; Tan JW, 2004, PHYTOCHEMISTRY, V65, P691, DOI 10.1016/j.phytochem.2003.12.009; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; TRENNHEUSER F, 1994, PHYTOCHEMISTRY, V37, P899, DOI 10.1016/S0031-9422(00)90380-7; Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Warren RF, 1999, GENETICS, V152, P401; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200; Zhang GF, 2005, RAPID COMMUN MASS SP, V19, P963, DOI 10.1002/rcm.1878	59	108	111	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9742	9754		10.1074/jbc.M806662200	http://dx.doi.org/10.1074/jbc.M806662200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19189963	Green Published, hybrid			2022-12-27	WOS:000264892900014
J	Ren, GP; Stephan, D; Xu, ZH; Zheng, Y; Tang, DM; Harrison, RS; Kurz, M; Jarrott, R; Shouldice, SR; Hiniker, A; Martin, JL; Heras, B; Bardwell, JCA				Ren, Guoping; Stephan, Daniel; Xu, Zhaohui; Zheng, Ying; Tang, Danming; Harrison, Rosemary S.; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Hiniker, Annie; Martin, Jennifer L.; Heras, Begona; Bardwell, James C. A.			Properties of the Thioredoxin Fold Superfamily Are Modulated by a Single Amino Acid Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTAL-STRUCTURE; IN-VIVO; DESTABILIZING DISULFIDE; DIRECTED EVOLUTION; CXXC-MOTIF; DSBA; BOND	The ubiquitous thioredoxin fold proteins catalyze oxidation, reduction, or disulfide exchange reactions depending on their redox properties. They also play vital roles in protein folding, redox control, and disease. Here, we have shown that a single residue strongly modifies both the redox properties of thioredoxin fold proteins and their ability to interact with substrates. This residue is adjacent in three-dimensional space to the characteristic CXXC active site motif of thioredoxin fold proteins but distant in sequence. This residue is just N-terminal to the conservative cis-proline. It is isoleucine 75 in the case of thioredoxin. Our findings support the conclusion that a very small percentage of the amino acid residues of thioredoxin-related proteins are capable of dictating the functions of these proteins.	[Harrison, Rosemary S.; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Martin, Jennifer L.; Heras, Begona] Univ Queensland, Special Res Ctr Funct & Appl Gen, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Harrison, Rosemary S.; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Martin, Jennifer L.; Heras, Begona] Univ Queensland, Special Res Ctr Funct & Appl Gen, Australian Res Council, Brisbane, Qld 4072, Australia; [Ren, Guoping; Stephan, Daniel; Hiniker, Annie; Bardwell, James C. A.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ren, Guoping; Stephan, Daniel; Zheng, Ying; Tang, Danming; Hiniker, Annie; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Xu, Zhaohui] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Xu, Zhaohui] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Hiniker, Annie] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Hiniker, Annie] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA	University of Queensland; University of Queensland; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Heras, B (corresponding author), Univ Queensland, Special Res Ctr Funct & Appl Gen, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	b.heras@imb.uq.edu.au	Xu, Zhi Ping/G-4987-2011; Ren, Guoping/D-8601-2012; Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Heras, Begona/0000-0003-3469-7988; Martin, Jennifer L./0000-0002-9225-8863	National Institutes of Health; Australian Research Council; University of Queensland Early Career Research Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); University of Queensland Early Career Research Award(University of Queensland)	This work was supported, in whole or in part, by a grant from the National Institutes of Health (to J.C. A.B.). This work was also supported by the Australian Research Council (to B.H. and J.L.M.) and a University of Queensland Early Career Research Award (to B.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DeLano W.L, PYMOL MOL GRAPHICS S; Georgescu RE, 1998, BIOCHEMISTRY-US, V37, P10286, DOI 10.1021/bi9805083; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; HAHN J, 1986, SYST APPL MICROBIOL, V7, P178; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2007, CURR OPIN STRUC BIOL, V17, P691, DOI 10.1016/j.sbi.2007.08.009; Hibbert EG, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-29; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Johannes TW, 2006, CURR OPIN MICROBIOL, V9, P261, DOI 10.1016/j.mib.2006.03.003; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; WOYCECHOWSKY K, 2008, BIOCHEMISTRY-US, V42, P5387; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	55	88	89	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10150	10159		10.1074/jbc.M809509200	http://dx.doi.org/10.1074/jbc.M809509200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19181668	Green Published, hybrid			2022-12-27	WOS:000264892900057
J	Sanabria, H; Swulius, MT; Kolodziej, SJ; Liu, J; Waxham, MN				Sanabria, Hugo; Swulius, Matthew T.; Kolodziej, Steven J.; Liu, Jun; Waxham, M. Neal			beta CaMKII Regulates Actin Assembly and Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; 2-PHOTON CROSS-CORRELATION; DENDRITIC SPINES; CORRELATION SPECTROSCOPY; POSTSYNAPTIC DENSITY; EXCITATORY SYNAPSES; IN-VIVO; PLASTICITY; ORGANIZATION; MAINTENANCE	Ca2+-Calmodulin-dependent protein kinase II ( CaMKII) is an abundant synaptic protein that was recently shown to regulate the organization of actin filaments leading to structural modifications of synapses. CaMKII is a dodecameric complex with a special architecture that provides it with unique potential for organizing the actin cytoskeleton. We report using biochemical assays that the beta isoform of CaMKII binds to and bundles actin filaments, and the disposition of beta CaMKII within the actin bundles was revealed by cryoelectron tomography. In addition, beta CaMKII was found to inhibit actin polymerization, suggesting that it either serves as a capping protein or binds monomeric actin, reducing the amount of freely available monomers to nucleate polymer assembly. By means of fluorescent cross-correlation spectroscopy, we determined that beta CaMKII does indeed bind to monomeric actin, reaching saturation at a stoichiometry of 12: 1 actin monomers per beta CaMKII holoenzyme with a binding constant of 2.4 x 10(5) M-1. In cells, beta CaMKII has a dual functional role; it can sequester monomeric actin to reduce actin polymerization and can also bundle actin filaments. Together, these effects would impact both the dynamics of actin filament assembly and enhance the rigidity of the filaments once formed, significantly impacting the structure of synapses.	[Sanabria, Hugo; Swulius, Matthew T.; Kolodziej, Steven J.; Waxham, M. Neal] Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Liu, Jun] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Waxham, MN (corresponding author), Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, 6431 Fannin,Rm 7-254 MSB, Houston, TX 77030 USA.	m.n.waxham@uth.tmc.edu		Waxham, M. Neal/0000-0003-4801-1190; Sanabria, Hugo/0000-0001-7068-6827	NINDS [R01 NS26086]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026086, T32NS007467] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS26086 from NINDS ( to M. N. W.).	BEAN A, 2007, PROTEIN TRAFFICKING, P3; Caran N, 2001, J BIOL CHEM, V276, P42514, DOI 10.1074/jbc.M103013200; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Feuer G., 1948, HUNGARICA ACTA PHYSIOL, V1, P150; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Halpain S, 2003, NAT NEUROSCI, V6, P101, DOI 10.1038/nn0203-101; Harris ES, 2006, METHOD ENZYMOL, V406, P190, DOI 10.1016/S0076-6879(06)06015-0; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Iyer V, 2006, J OPT SOC AM B, V23, P1420, DOI 10.1364/JOSAB.23.001420; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim SA, 2005, BIOPHYS J, V88, P4319, DOI 10.1529/biophysj.104.055319; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Kohl T, 2002, P NATL ACAD SCI USA, V99, P12161, DOI 10.1073/pnas.192433499; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KREIS T, 1999, GUIDEBOOK CYTOSKELET, P3; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; OHTA Y, 1986, FEBS LETT, V208, P423, DOI 10.1016/0014-5793(86)81061-4; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanabria H, 2007, BIOPHYS J, V92, P313, DOI 10.1529/biophysj.106.090498; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Schwille P, 2001, CHEMPHYSCHEM, V2, P269, DOI 10.1002/1439-7641(20010518)2:5<269::AID-CPHC269>3.0.CO;2-Y; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007	38	54	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9770	9780		10.1074/jbc.M809518200	http://dx.doi.org/10.1074/jbc.M809518200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208632	Green Published, hybrid			2022-12-27	WOS:000264892900017
J	Beauchamp, E; Bulut, G; Abaan, O; Chen, K; Merchant, A; Matsui, W; Endo, Y; Rubin, JS; Toretsky, J; Uren, A				Beauchamp, Elspeth; Bulut, Gulay; Abaan, Ogan; Chen, Kevin; Merchant, Akil; Matsui, William; Endo, Yoshimi; Rubin, Jeffrey S.; Toretsky, Jeffrey; Ueren, Aykut			GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; HEDGEHOG SIGNALING PATHWAY; EWINGS-SARCOMA; PANCREATIC-CANCER; HUMAN HOMOLOG; IN-VITRO; GENE; MUTATIONS; ACTIVATION; EXPRESSION	Ewing sarcoma family of tumors (ESFT) is an undifferentiated neoplasm of the bone and soft tissue. ESFT is characterized by a specific chromosomal translocation occurring between chromosome 22 and (in most cases) chromosome 11, which generates an aberrant transcription factor, EWS-FLI1. The function of EWS-FLI1 is essential for the maintenance of ESFT cell survival and tumorigenesis. The Hedgehog pathway is activated in several cancers. Oncogenic potential of the Hedgehog pathway is mediated by increasing the activity of the GLI family of transcription factors. Recent evidence suggests that EWS-FLI1 increases expression of GLI1 by an unknown mechanism. Our data from chromatin immunoprecipitation and promoter reporter studies indicated GLI1 as a direct transcriptional target of EWS-FLI1. Expression of EWS-FLI1 in non-ESFT cells increased GLI1 expression and GLI-dependent transcription. We also detected high levels of GLI1 protein in ESFT cell lines. Pharmacological inhibition of GLI1 protein function decreased proliferation and soft agar colony formation of ESFT cells. Our results establish GLI1 as a direct transcriptional target of EWS-FLI1 and suggest a potential role for GLI1 in ESFT tumorigenesis.	[Beauchamp, Elspeth; Bulut, Gulay; Abaan, Ogan; Chen, Kevin; Toretsky, Jeffrey; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Merchant, Akil; Matsui, William] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Endo, Yoshimi; Rubin, Jeffrey S.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA	Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Uren, A (corresponding author), 3970 Reservoir Rd NW,NRB,Rm E312, Washington, DC 20057 USA.	au26@georgetown.edu	BULUT, GULAY/J-3180-2012; Matsui, William H/C-3383-2009	Matsui, William/0000-0002-3088-0964	National Institutes of Health [CA88004, CA10841]; Children's Cancer Foundation of Baltimore, MD; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA133662, T32CA009686, R01CA088004, ZIABC011224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Foundation of Baltimore, MD; Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA88004 (to J.T.) and CA10841 (to A.U.). This work was also supported by a grant from the Children's Cancer Foundation of Baltimore, MD, and the Intramural Research Program of the NCI, National Institutes of Health.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Chansky HA, 2004, J ORTHOPAED RES, V22, P910, DOI 10.1016/j.orthres.2003.12.008; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Dahlen A, 2004, AM J PATHOL, V164, P1645, DOI 10.1016/S0002-9440(10)63723-6; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Liu CZ, 1998, GENE, V209, P1, DOI 10.1016/S0378-1119(97)00668-9; MAO XH, 1994, J BIOL CHEM, V269, P18216; Nessling M, 2005, CANCER RES, V65, P439; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; OUCHIDA M, 1995, ONCOGENE, V11, P1049; Pietsch T, 1997, CANCER RES, V57, P2085; Reifenberger J, 1998, CANCER RES, V58, P1798; ROBERTS WM, 1989, CANCER RES, V49, P5407; Sacedon R, 2003, J HISTOCHEM CYTOCHEM, V51, P1557, DOI 10.1177/002215540305101115; Sandberg AA, 2000, CANCER GENET CYTOGEN, V123, P1, DOI 10.1016/S0165-4608(00)00295-8; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Uren A, 2004, BIOCHEMISTRY-US, V43, P13579, DOI 10.1021/bi048776q; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	42	123	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9074	9082		10.1074/jbc.M806233200	http://dx.doi.org/10.1074/jbc.M806233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189974	Green Published, hybrid			2022-12-27	WOS:000264669100010
J	Kovacs, JM; Hannan, JP; Eisenmesser, EZ; Holers, VM				Kovacs, James M.; Hannan, Jonathan P.; Eisenmesser, Elan Z.; Holers, V. Michael			Mapping of the C3d Ligand Binding Site on Complement Receptor 2 (CR2/CD21) Using Nuclear Magnetic Resonance and Chemical Shift Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; HUMAN LYMPHOCYTES-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY; ANTIGEN RECEPTOR; NMR-SPECTROSCOPY; CR-2 CD21; IDENTIFICATION; PROTEIN; EXPRESSION	Complement receptor 2 (CR2, CD21) is a cell membrane protein, with 15 or 16 extracellular short consensus repeats (SCRs), that promotes B lymphocyte responses and bridges innate and acquired immunity. The most distally located SCRs (SCR1-2) mediate the interaction of CR2 with its four known ligands (C3d, Epstein-Barr virus gp350, interferon-alpha, and CD23). Inhibitory monoclonal antibodies against SCR1-2 block binding of all ligands. To develop ligand-specific inhibitors that would also assist in identifying residues unique to each receptor-ligand interaction, phage were selected from randomly generated libraries by panning with recombinant SCR1-2, followed by specific ligand-driven elution. Derived peptides were tested by competition ELISA. One peptide, C3dp1 (APQHLSSQYSRT) exhibited ligand-specific inhibition at midmicromolar IC50. C3d was titrated into N-15-labeled SCR1-2, which revealed chemical shift changes indicative of specific intermolecular interactions. With backbone assignments made, the chemical shift changes were mapped onto the crystal structure of SCR1-2. With regard to C3d, the binding surface includes regions of SCR1, SCR2, and the inter-SCR linker, specifically residues Arg(13), Tyr(16), Arg(28), Tyr(29), Ser(32), Thr(34), Lys(48), Asp(56), Lys(57), Tyr(68), Arg(83), Gly(84), Asn(101), Asn(105), and Ser(109). SCR1 and SCR2 demonstrated distinct binding modes. The CR2 binding surface incorporating SCR1 is inconsistent with a previous x-ray CR2-C3d co-crystal analysis but consistent with mutagenesis, x-ray neutron scattering, and inhibitory monoclonal antibody epitope mapping. Titration with C3dp1 yielded chemical shift changes (Arg(13), Tyr(16), Thr(34), Lys(48), Asp(56), Lys(57), Tyr(68), Arg(83), Gly(84), Asn(105), and Ser(109)) overlapping with C3d, indicating that C3dp1 interacts at the same CR2 site as C3d.	[Kovacs, James M.; Hannan, Jonathan P.; Holers, V. Michael] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO 80045 USA; [Kovacs, James M.; Hannan, Jonathan P.; Holers, V. Michael] Univ Colorado Denver, Sch Med, Dept Immunol, Aurora, CO 80045 USA; [Eisenmesser, Elan Z.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Holers, VM (corresponding author), 1775 N Ursula St,M20-3102E Mail Stop B115, Aurora, CO 80045 USA.	michael.holers@ucdenver.edu		Hannan, Jonathan/0000-0003-3318-2341	National Institutes of Health [R0-1 CA053615]; American Heart Association; University of Colorado Denver-Rocky Mountain Regional [900-MHzNMR]; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Colorado Denver-Rocky Mountain Regional; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 CA053615 ( to V. M. H.). This work was also supported by an American Heart Association predoctoral fellowship ( to J. M. K.) and assisted by the University of Colorado Denver-Rocky Mountain Regional 900-MHzNMR Facility. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BOHNSACK JF, 1988, J IMMUNOL, V141, P2569; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1988, J IMMUNOL, V141, P457; CARTER RH, 1989, J IMMUNOL, V143, P1755; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELCAYRE AX, 1991, EMBO J, V10, P919, DOI 10.1002/j.1460-2075.1991.tb08025.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; FINGEROTH JD, 1988, J VIROL, V62, P1442, DOI 10.1128/JVI.62.4.1442-1447.1988; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FISCHER E, 1991, J IMMUNOL, V146, P865; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; Gilbert HE, 2006, J MOL BIOL, V362, P1132, DOI 10.1016/j.jmb.2006.08.012; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Guthridge JM, 2001, J IMMUNOL, V167, P5758, DOI 10.4049/jimmunol.167.10.5758; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; HOLERS VM, 1995, PRINCIPLES PRACTICES, P363; IIDA K, 1983, J EXP MED, V158, P1021, DOI 10.1084/jem.158.4.1021; LEVY E, 1992, CLIN EXP IMMUNOL, V90, P235; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; LUXEMBOURG AT, 1994, J IMMUNOL, V153, P4448; Lyubchenko T, 2005, J IMMUNOL, V174, P3264, DOI 10.4049/jimmunol.174.6.3264; MARTIN DR, 1991, J EXP MED, V174, P1299, DOI 10.1084/jem.174.6.1299; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOORE MD, 1987, P NATL ACAD SCI USA, V84, P9194, DOI 10.1073/pnas.84.24.9194; Morikis D, 2004, J IMMUNOL, V172, P7537, DOI 10.4049/jimmunol.172.12.7537; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; REYNES M, 1985, J IMMUNOL, V135, P2687; Sarrias MR, 2001, J IMMUNOL, V167, P1490, DOI 10.4049/jimmunol.167.3.1490; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; TEDDER TF, 1984, J IMMUNOL, V133, P678; Tolnay M, 1998, CLIN IMMUNOL IMMUNOP, V88, P123, DOI 10.1006/clin.1998.4552; TUVESON DA, 1991, J EXP MED, V173, P1083, DOI 10.1084/jem.173.5.1083; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881; WEIS JJ, 1988, J EXP MED, V167, P1047, DOI 10.1084/jem.167.3.1047; WEIS JJ, 1986, P NATL ACAD SCI USA, V83, P5639, DOI 10.1073/pnas.83.15.5639; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Young KA, 2008, J VIROL, V82, P11217, DOI 10.1128/JVI.01673-08; Young KA, 2007, J BIOL CHEM, V282, P36614, DOI 10.1074/jbc.M706324200; Zhang L, 2007, J MOL BIOL, V369, P567, DOI 10.1016/j.jmb.2007.02.101; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	55	19	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9513	9520		10.1074/jbc.M808404200	http://dx.doi.org/10.1074/jbc.M808404200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19164292	Green Published, hybrid			2022-12-27	WOS:000264669100057
J	Ning, K; Miller, LC; Laidlaw, HA; Watterson, KR; Gallagher, J; Sutherland, C; Ashford, MLJ				Ning, Ke; Miller, Lisa C.; Laidlaw, Hilary A.; Watterson, Kenneth R.; Gallagher, Jennifer; Sutherland, Calum; Ashford, Michael L. J.			Leptin-dependent Phosphorylation of PTEN Mediates Actin Restructuring and Activation of ATP-sensitive K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TUMOR-SUPPRESSOR PHOSPHATASE; SIGNALING PATHWAYS; INSULIN; INHIBITION; TYROSINE; NEURONS; CELLS; EXPLOITATION; STIMULATION	Leptin activates multiple signaling pathways in cells, including the phosphatidylinositol 3-kinase pathway, indicating a degree of cross-talk with insulin signaling. The exact mechanisms by which leptin alters this signaling pathway and how it relates to functional outputs are unclear at present. A previous study has established that leptin inhibits the activity of the phosphatase PTEN (phosphatase and tensin homolog deleted on chromosome 10), an important tumor suppressor and modifier of phosphoinositide signaling. In this study we demonstrate that leptin phosphorylates multiple sites on the C-terminal tail of PTEN in hypothalamic and pancreatic beta-cells, an action not replicated by insulin. Inhibitors of the protein kinases CK2 and glycogen synthase kinase 3 (GSK3) block leptin-mediated PTEN phosphorylation. PTEN phosphorylation mutants reveal the critical role these sites play in transmission of the leptin signal to F-actin depolymerization. CK2 and GSK3 inhibitors also prevent leptin-mediated F-actin depolymerization and consequent ATP-sensitive K+ channel opening. GSK3 kinase activity is inhibited by insulin but not leptin in hypothalamic cells. Both hormones increase N-terminal GSK3 serine phosphorylation, but in hypothalamic cells this action of leptin is transient. Leptin, not insulin, increases GSK3 tyrosine phosphorylation in both cell types. These results demonstrate a significant role for PTEN in leptin signal transmission and identify GSK3 as a potential important signaling node contributing to divergent outputs for these hormones.	[Ning, Ke; Miller, Lisa C.; Laidlaw, Hilary A.; Watterson, Kenneth R.; Gallagher, Jennifer; Sutherland, Calum; Ashford, Michael L. J.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	University of Dundee	Ashford, MLJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland.	m.l.j.ashford@dundee.ac.uk	Ning, Ke/E-7837-2010; Ning, Ke/B-4561-2009	Ashford, Michael/0000-0002-0861-7676; Ning, Ke/0000-0002-0771-1134; Sutherland, Calum/0000-0003-4398-7434	Wellcome Trust, Tenovus Scotland, [068692]; Biotechnology and Biological Sciences Research Council Studentship	Wellcome Trust, Tenovus Scotland,(Wellcome Trust); Biotechnology and Biological Sciences Research Council Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 068692 (to M.L.J.A.), Tenovus Scotland, and a Biotechnology and Biological Sciences Research Council Studentship (to L.C.M.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Downes CP, 2007, ADV ENZYME REGUL, V47, P184, DOI 10.1016/j.advenzreg.2006.12.018; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maroni P, 2005, CELL BIOL INT, V29, P542, DOI 10.1016/j.cellbi.2005.03.008; Maroni P, 2003, MOL CELL ENDOCRINOL, V201, P109, DOI 10.1016/S0303-7207(02)00427-6; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Mirshamsi S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-54; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Niswender KD, 2003, FRONT NEUROENDOCRIN, V24, P1, DOI 10.1016/S0091-3022(02)00105-X; O'Rahilly S, 2007, BIOCHEM SOC T, V35, P33, DOI 10.1042/BST0350033; Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; WANG QM, 1994, J BIOL CHEM, V269, P14566; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301	49	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9331	9340		10.1074/jbc.M806774200	http://dx.doi.org/10.1074/jbc.M806774200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208634	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000264669100039
J	Teertstra, WR; van der Velden, GJ; de Jong, JF; Kruijtzer, JAW; Liskamp, RMJ; Kroon-Batenburg, LMJ; Muller, WH; Gebbink, MFBG; Wosten, HAB				Teertstra, Wieke R.; van der Velden, Gisela J.; de Jong, Jan F.; Kruijtzer, John A. W.; Liskamp, Rob M. J.; Kroon-Batenburg, Loes M. J.; Muller, Wally H.; Gebbink, Martijn F. B. G.; Wosten, Han A. B.			The Filament-specific Rep1-1 Repellent of the Phytopathogen Ustilago maydis Forms Functional Surface-active Amyloid-like Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERIAL HYPHAE FORMATION; STREPTOMYCES-COELICOLOR; SCHIZOPHYLLUM-COMMUNE; FUNGAL HYDROPHOBIN; PROTEIN; PEPTIDE; IDENTIFICATION; GROWTH; LOCALIZATION; RECOGNITION	Repellents of the maize pathogen Ustilago maydis are involved in formation of hydrophobic aerial hyphae and in cellular attachment. These peptides, called Rep1-1 to Rep1-11, are encoded by the rep1 gene and result from cleavage of the precursor protein Rep1 during passage of the secretion pathway. Using green fluorescent protein as a reporter, we here show that rep1 is expressed in filaments and not in the yeast form of U. maydis. In situ hybridization localized rep1 mRNA in the apex of the filament, which correlates with the expected site of secretion of the repellents into the cell wall. We also produced a synthetic peptide, Rep1-1. This peptide reduced the water surface tension to as low as 36 mJ m(-2). In addition, it formed amyloid-like fibrils as was shown by negative staining, by thioflavin T fluorescence, and by x-ray diffraction. These fibrils were not soluble in SDS but could be dissociated with trifluoroacetic acid. The repellents in the hyphal cell wall had a similar solubility and also stained with thioflavin T, strongly indicating that they are present as amyloid fibrils. However, such fibrils could not be observed at the hyphal surface. This can be explained by the fact that the Rep1-1 filaments decrease in length at increasing concentrations. Taken together, we have identified the second class of fungal proteins that form functional amyloid-like filaments at the hyphal surface.	[Teertstra, Wieke R.; van der Velden, Gisela J.; de Jong, Jan F.; Wosten, Han A. B.] Univ Utrecht, Fac Sci, Dept Microbiol, Utrecht, Netherlands; [Kruijtzer, John A. W.; Liskamp, Rob M. J.] Univ Utrecht, Fac Sci, Dept Med Chem, Utrecht, Netherlands; [Kroon-Batenburg, Loes M. J.] Univ Utrecht, Fac Sci, Dept Crystal & Struct Chem, Utrecht, Netherlands; [Muller, Wally H.] Univ Utrecht, Fac Sci, Dept Cell Biol, Utrecht, Netherlands; [Gebbink, Martijn F. B. G.] Univ Med Ctr, Dept Haematol, NL-3584 CM Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Teertstra, WR (corresponding author), Univ Utrecht, Fac Sci, Dept Microbiol, Padualaan 8, Utrecht, Netherlands.	w.r.teertstra@uu.nl	Kroon-Batenburg, Loes/J-9058-2016; van der Velden, Gisela J./A-5133-2013; Wösten, Han AB/K-2769-2016; Müller, Wally/B-8215-2011; Liskamp, Rob M/I-5889-2012	Wösten, Han AB/0000-0002-0399-3648; Liskamp, Rob M/0000-0001-8897-8975				BANUETT F, 1992, TRENDS GENET, V8, P174, DOI 10.1016/0168-9525(92)90091-H; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; BOHLMANN R, 1996, THESIS U MUNICH; BOLKER M, 1995, CAN J BOT, V73, pS320; BOLKER M, 1992, CELL, V68, P441, DOI 10.1016/0092-8674(92)90182-C; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Butko P, 2001, BIOCHEM BIOPH RES CO, V280, P212, DOI 10.1006/bbrc.2000.4098; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; CHRISTENSEN J. J., 1963, Monogr. Amer. phyto-path. Soc.; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; de Vocht ML, 2000, J BIOL CHEM, V275, P28428, DOI 10.1074/jbc.M000691200; DEVRIES OMH, 1993, ARCH MICROBIOL, V159, P330, DOI 10.1007/BF00290915; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Duisenberg AJM, 2003, J APPL CRYSTALLOGR, V36, P220, DOI 10.1107/S0021889802022628; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; KAMPER J, 1995, CELL, V81, P73, DOI 10.1016/0092-8674(95)90372-0; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Lugones LG, 2004, MOL MICROBIOL, V53, P707, DOI 10.1111/j.1365-2958.2004.04187.x; MOUKHA SM, 1993, J GEN MICROBIOL, V139, P969, DOI 10.1099/00221287-139-5-969; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Perry-O'Keefe H, 2001, J MICROBIOL METH, V47, P281, DOI 10.1016/S0167-7012(01)00303-7; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Romeis T, 2000, MOL MICROBIOL, V37, P54, DOI 10.1046/j.1365-2958.2000.01978.x; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Teertstra WR, 2006, MICROBIOL-SGM, V152, P3607, DOI 10.1099/mic.0.29034-0; Teertstra WR, 2004, FUNGAL GENET BIOL, V41, P1099, DOI 10.1016/j.fgb.2004.08.010; Tillotson RD, 1998, MOL MICROBIOL, V30, P595, DOI 10.1046/j.1365-2958.1998.01093.x; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Wosten HAB, 1999, FUNGAL GENET BIOL, V27, P153, DOI 10.1006/fgbi.1999.1130; Wosten HAB, 1996, EMBO J, V15, P4274, DOI 10.1002/j.1460-2075.1996.tb00802.x; Wosten HAB, 1999, CURR BIOL, V9, P85, DOI 10.1016/S0960-9822(99)80019-0; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017; WOSTEN HAB, 1994, EUR J CELL BIOL, V63, P122; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; [No title captured]	48	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9153	9159		10.1074/jbc.M900095200	http://dx.doi.org/10.1074/jbc.M900095200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19164282	hybrid, Green Published			2022-12-27	WOS:000264669100020
J	Lauwers, A; Twyffels, L; Soin, R; Wauquier, C; Kruys, V; Gueydan, C				Lauwers, Aurelien; Twyffels, Laure; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril			Post-transcriptional Regulation of Genes Encoding Anti-microbial Peptides in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; AU-RICH ELEMENT; ACTIVATED PROTEIN-KINASE; P-BODY FORMATION; IMMUNE-RESPONSE; NUCLEOTIDE-SEQUENCE; TRISTETRAPROLIN; MELANOGASTER; DEGRADATION; PATHWAYS	Secretion of antimicrobial peptides (AMPep) is a central defense mechanism used by invertebrates to combat infections. In Drosophila the synthesis of these peptides is a highly regulated process allowing their rapid release in the hemolymph upon contact with pathogens and the arrest of their production after pathogen clearance. We observed that AMPep genes have either a transient or sustained expression profile in S2 Drosophila cells treated with peptidoglycan. Moreover, AMPep genes containing AU-rich elements (ARE) in their 3'-untranslated region (UTR) are subject to a post-transcriptional control affecting mRNA stability, thereby contributing to their transient expression profile. Cecropin A1 (CecA1) constitutes the prototype of this latter class of AMPeps. CecA1 mRNA bears in its 3'-UTR an ARE similar to class II AREs found in several short-lived mammalian mRNAs. In response to immune deficiency cascade signaling activated by Gram-negative peptidoglycans, CecA1 mRNA is transiently stabilized and subsequently submitted to deadenylation and decay mediated by the ARE present in its 3'-UTR. The functionality of CecA1 ARE relies on its ability to recruit TIS11 protein, which accelerates CecA1 mRNA deadenylation and decay. Moreover, we observed that CecA1 mRNA deadenylation is a biphasic process. Whereas early deadenylation is independent of TIS11, the later deadenylation phase depends on TIS11 and is mediated by CAF1 deadenylase. We also report that in contrast to tristetraprolin, its mammalian homolog, TIS11, is constitutively expressed in S2 cells and accumulates in cytoplasmic foci distinct from processing bodies, suggesting that the Drosophila ARE-mediated mRNA deadenylation and decay mechanism is markedly different in invertebrates and mammals.	[Lauwers, Aurelien; Twyffels, Laure; Soin, Romuald; Wauquier, Corinne; Kruys, Veronique; Gueydan, Cyril] Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles	Gueydan, C (corresponding author), Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	cgueydan@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403	 [GFP-DcP1];  [GFP-GW182]	; 	We thank Louis Delhaye for help with antibody production and Dr. E. Izaurralde for the GFP-DcP1 and GFP-GW182 constructs.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bonisch C, 2007, J BIOL CHEM, V282, P21818, DOI 10.1074/jbc.M702998200; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Celotto Alicia M, 2004, Methods Mol Biol, V257, P245, DOI 10.1385/1-59259-750-5:245; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P147; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levitin A, 2007, EUKARYOT CELL, V6, P658, DOI 10.1128/EC.00346-06; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; RYU JH, SCIENCE, V319, P777; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; VARNUM BC, 1989, ONCOGENE, V4, P119; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	42	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8973	8983		10.1074/jbc.M806778200	http://dx.doi.org/10.1074/jbc.M806778200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176529	Green Published, hybrid			2022-12-27	WOS:000264397800080
J	Li, B; Jackson, J; Simon, MD; Fleharty, B; Gogol, M; Seidel, C; Workman, JL; Shilatifard, A				Li, Bing; Jackson, Jessica; Simon, Matthew D.; Fleharty, Brian; Gogol, Madelaine; Seidel, Chris; Workman, Jerry L.; Shilatifard, Ali			Histone H3 Lysine 36 Dimethylation (H3K36me2) Is Sufficient to Recruit the Rpd3s Histone Deacetylase Complex and to Repress Spurious Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION STATES; SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; GENOME-WIDE; TRIMETHYLATION; CHROMODOMAIN; ACETYLATION; RECOGNITION; ELONGATION; BINDING	Histone methylation is associated with both transcription activation and repression. However, the functions of different states of methylation remain largely elusive. Here, using methyllysine analog technology, we demonstrate that the histone deacetylase complex, Rpd3S, can distinguish the nucleosomes methylated to different extents and that K36me2 is sufficient to target Rpd3S in vitro. Through a genome-wide survey, we identified a few mutants in which the level of K36me3 is significantly reduced, whereas the level of K36me2 is sustained. Transcription analysis and genome-wide histone modification studies on these mutants suggested that K36me2 is sufficient to target Rpd3S in vivo, thereby maintaining a functional Set2-Rpd3S pathway.	[Li, Bing; Jackson, Jessica; Fleharty, Brian; Gogol, Madelaine; Seidel, Chris; Workman, Jerry L.; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Stowers Institute for Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Simon, Matthew/ABF-9127-2020	Gogol, Madelaine/0000-0002-8738-0995; Simon, Matthew/0000-0001-7423-5265	National Institutes of Health [GM047867, 2R01GM069905]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905, R01GM047867, R37GM047867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM047867 through the NIGMS (to J. L. W.) and National Institutes of Health Grant 2R01GM069905 (to A. S.). This work was also supported by funding from the Stowers Institute for Medical Research.	Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Royce-Tolland M, 2008, CURR BIOL, V18, pR255, DOI 10.1016/j.cub.2008.01.039; Schneider J, 2004, METHOD ENZYMOL, V377, P227; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Steger DJ, 1997, METHODS, V12, P276, DOI 10.1006/meth.1997.0479; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572	33	115	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7970	7976		10.1074/jbc.M808220200	http://dx.doi.org/10.1074/jbc.M808220200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155214	hybrid, Green Published			2022-12-27	WOS:000264195600059
J	Nguyen, T; Nioi, P; Pickett, CB				Nguyen, Truyen; Nioi, Paul; Pickett, Cecil B.			The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTION FACTOR NRF2; PROTEIN-KINASE-C; YA-SUBUNIT GENE; CONTROLLING INDUCIBLE EXPRESSION; SUBSTRATE ADAPTER PROTEIN; CUL3-BASED E3 LIGASE; ANTIOXIDANT RESPONSE; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEASOMAL DEGRADATION; TERT-BUTYLHYDROQUINONE	A major mechanism in the cellular defense against oxidative or electrophilic stress is activation of the Nrf2-antioxidant response element signaling pathway, which controls the expression of genes whose protein products are involved in the detoxication and elimination of reactive oxidants and electrophilic agents through conjugative reactions and by enhancing cellular antioxidant capacity. At the molecular level, however, the regulatory mechanisms involved in mediating Nrf2 activation are not fully understood. It is well established that Nrf2 activity is controlled, in part, by the cytosolic protein Keap1, but the nature of this pathway and the mechanisms by which Keap1 acts to repress Nrf2 activity remain to be fully characterized and are the topics of discussion in this minireview. In addition, a possible role of the Nrf2-antioxidant response element transcriptional pathway in neuroprotection will also be discussed.	[Pickett, Cecil B.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Nguyen, Truyen; Nioi, Paul] Schering Plough Res Inst, Summit, NJ 07901 USA	Biogen; Merck & Company; Schering-Plough Research Institute	Pickett, CB (corresponding author), Biogen Idec Inc, Cambridge, MA 02142 USA.	cecil.pickett@biogenidec.com						Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; GROGER M, J INVESTIG DERMATOL, V117, P1363; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JOHNSON DA, 2007, SFN NEUR M PLANN SOC; Kang KW, 2001, MOL PHARMACOL, V59, P1147, DOI 10.1124/mol.59.5.1147; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; LI Y, 1992, J BIOL CHEM, V267, P15097; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; SCHMIERER K, 2008, LANCET, V372, P1463; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	52	1822	1888	7	234	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13291	13295		10.1074/jbc.R900010200	http://dx.doi.org/10.1074/jbc.R900010200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19182219	Green Published, hybrid			2022-12-27	WOS:000265877300003
J	Ben Mkaddem, S; Werts, C; Goujon, JM; Bens, M; Pedruzzi, E; Ogier-Denis, E; Vandewalle, A				Ben Mkaddem, Sanae; Werts, Catherine; Goujon, Jean-Michel; Bens, Marcelle; Pedruzzi, Eric; Ogier-Denis, Eric; Vandewalle, Alain			Heat Shock Protein gp96 Interacts with Protein Phosphatase 5 and Controls Toll-like Receptor 2 (TLR2)-mediated Activation of Extracellular Signal-regulated Kinase (ERK) 1/2 in Post-hypoxic Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 CHAPERONE COMPLEX; EPITHELIAL-CELLS; ISCHEMIA/REPERFUSION INJURY; PHOSPHOINOSITIDE 3-KINASE; RAF-1 ACTIVATION; IN-VIVO; APOPTOSIS; PROTEIN-PHOSPHATASE-5; PATHWAY; INHIBITION	Ischemia/reperfusion injury (IRI) induces an innate immune response, leading to an inflammatory reaction and tissue damage that have been attributed to engagement of the Toll-like receptor (TLR) 2 and 4. However, the respective roles of TLR2 and/or TLR4 in mediating downstream activation of mitogen-activated protein kinase (MAPK) pathways during IRI have not been fully elucidated. Here we show that extracellular signal-regulated kinase (ERK) 1/2 is activated in both intact kidneys and cultured renal tubule epithelial cells (RTECs) from wildtype and Tlr4 knockout mice, but not those from Tlr2 knockout mice subjected to transient ischemia. Geldanamycin (GA), an inhibitor of heat shock protein 90 and reticulum endoplasmic-resident gp96, and gp96mRNAsilencing (siRNA), did not affect ERK1/2 activation in either post-hypoxic wild-type or Tlr4-deficient RTECs, but did restore its activation in post-hypoxic Tlr2-deficient RTECs. Immunoprecipitation studies revealed that gp96 co-immunoprecipitates with the serine-threonine protein phosphatase 5 (PP5), identified as a negative modulator of the mitogen extracellular kinase (MEK)-ERK pathway, in unstressed wild-type and post-hypoxic Tlr2-deficient RTECs. In contrast, PP5 co-immunoprecipitation with gp96 was strikingly reduced in post-hypoxic wild-type RTECs, suggesting that the inactivation of PP5 resulting from the dissociation of PP5 from gp96 allows the activation of ERK1/2 to occur. Inhibition of PP5 by okadaic acid, and Pp5 siRNA also restored TLR2-mediated phosphorylation of ERK1/2, and apoptosis signal-regulating kinase 1 (ASK1)/c-Jun N-terminal kinase (JNK)-mediated apoptosis in post-hypoxic Tlr2-deficient RTECs. These findings indicate that gp96 interacts with PP5 and controls TLR2-mediated induction of ERK1/2 in post-hypoxic renal tubule cells.	[Ben Mkaddem, Sanae; Bens, Marcelle; Pedruzzi, Eric; Ogier-Denis, Eric; Vandewalle, Alain] Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, U773,UFR Med Xavier Bichat, F-75870 Paris 18, France; [Werts, Catherine] INSERM, Inst Pasteur, Grp Biol & Genet Parois Bacteriennes, Grp Avenir, F-75724 Paris 15, France; [Goujon, Jean-Michel] Ctr Hosp Univ Poitiers, Serv Anat & Cytol Pathol, F-86021 Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Poitiers; Universite de Poitiers	Vandewalle, A (corresponding author), Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, U773,UFR Med Xavier Bichat, Site Bichat,BP 416,16 Rue Henri Huchard, F-75870 Paris 18, France.	alain.vandewalle@inserm.fr	WERTS, Catherine/AAD-5447-2020; pedruzzi, eric/B-6050-2017; Ogier-Denis, Eric/E-5030-2016	WERTS, Catherine/0000-0003-3079-5476; Ben Mkaddem, Sanae/0000-0001-7919-2233; Ogier-Denis, Eric/0000-0002-0057-7593	INSERM; Agence Nationale de la Recherche [ANR-08-MIE-030]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM and in part by an Agence Nationale de la Recherche grant (ANR-08-MIE-030, to A. V.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hindley A, 2002, J CELL SCI, V115, P1575; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; LACAVE R, 1993, J CELL SCI, V104, P705; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Stefanelli C, 2002, FEBS LETT, V527, P223, DOI 10.1016/S0014-5793(02)03242-8; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; VANDEWALLE A, 1989, J CELL PHYSIOL, V141, P203, DOI 10.1002/jcp.1041410128; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang C, 2007, ARTERIOSCL THROM VAS, V27, P1760, DOI 10.1161/ATVBAHA.107.144881; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao SY, 1997, PHOTOCHEM PHOTOBIOL, V66, P727, DOI 10.1111/j.1751-1097.1997.tb03214.x; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	57	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12541	12549		10.1074/jbc.M808376200	http://dx.doi.org/10.1074/jbc.M808376200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265198	hybrid, Green Published			2022-12-27	WOS:000265494600083
J	Kissen, R; Bones, AM				Kissen, Ralph; Bones, Atle M.			Nitrile-specifier Proteins Involved in Glucosinolate Hydrolysis in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APHID BREVICORYNE-BRASSICAE; MYROSINASE-BINDING PROTEIN; MUSTARD OIL BOMB; EPITHIOSPECIFIER PROTEIN; CABBAGE APHID; THIOGLUCOSIDE GLUCOHYDROLASE; FORM 1-CYANOEPITHIOALKANES; FUNCTIONAL GENOMICS; NATURAL VARIATION; TRICHOPLUSIA-NI	Glucosinolates are plant secondary metabolites present in Brassicaceae plants such as the model plant Arabidopsis thaliana. Intact glucosinolates are believed to be biologically inactive, whereas degradation products after hydrolysis have multiple roles in growth regulation and defense. The degradation of glucosinolates is catalyzed by thioglucosidases called myrosinases and leads by default to the formation of isothiocyanates. The interaction of a protein called epithiospecifier protein ( ESP) with myrosinase diverts the reaction toward the production of epithionitriles or nitriles depending on the glucosinolate structure. Here we report the identification of a new group of nitrile-specifier proteins (AtNSPs) in A. thaliana able to generate nitriles in conjunction with myrosinase and a more detailed characterization of one member (AtNSP2). Recombinant AtNSP2 expressed in Escherichia coli was used to test its impact on the outcome of glucosinolate hydrolysis using a gas chromatography mass spectrometry approach. AtNSP proteins share 30-45% sequence homology with A. thaliana ESP. Although AtESP and AtNSP proteins can switch myrosinase-catalyzed degradation of 2-propenyl-glucosinolate from isothiocyanate to nitrile, only AtESP generates the corresponding epithionitrile. Using the aromatic benzylglucosinolate, recombinant AtNSP2 is also able to direct product formation to the nitrile. Analysis of glucosinolate hydrolysis profiles of transgenic A. thaliana plants overexpressing AtNSP2 confirms its nitrile-specifier activity in planta. In silico expression analysis reveals distinctive expression patterns of AtNSPs, which supports a biological role for these proteins. In conclusion, we show that AtNSPs belonging to a new family of A. thaliana proteins structurally related to AtESP divert product formation from myrosinase-catalyzed glucosinolate hydrolysis and, thereby, likely affect the biological consequences of glucosinolate degradation. We discuss similarities and properties of AtNSPs and related proteins and the biological implications.	[Kissen, Ralph; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, NTNU, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bones, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, NTNU, NO-7491 Trondheim, Norway.	atle.bones@bio.ntnu.no	Bones, Atle M/C-6202-2014	Bones, Atle M/0000-0003-0544-7437	Norwegian Research Council [143250, 151991]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Norwegian Research Council Grants 143250 and 151991.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ANDERSSON D, 2004, 15 INT C AR RES BERL; Bellostas N, 2008, J NAT PROD, V71, P76, DOI 10.1021/np070438d; BENN M, 1977, PURE APPL CHEM, V49, P197, DOI 10.1351/pac197749020197; Bernardi R, 2000, FEBS LETT, V467, P296, DOI 10.1016/S0014-5793(00)01179-0; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Borek V, 2005, J AGR FOOD CHEM, V53, P8650, DOI 10.1021/jf051570r; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burow M, 2008, PHYTOCHEMISTRY, V69, P663, DOI 10.1016/j.phytochem.2007.08.027; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; Burow M, 2007, PLANT MOL BIOL, V63, P49, DOI 10.1007/s11103-006-9071-5; Capella AN, 2001, PLANTA, V213, P691, DOI 10.1007/s004250100548; Chevalier F, 2004, PROTEOMICS, V4, P1372, DOI 10.1002/pmic.200300750; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAXENBICHLER ME, 1991, PHYTOCHEMISTRY, V30, P2623, DOI 10.1016/0031-9422(91)85112-D; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Foo HL, 2000, FEBS LETT, V468, P243, DOI 10.1016/S0014-5793(00)01176-5; Gardiner JB, 1999, J AGR FOOD CHEM, V47, P3837, DOI 10.1021/jf9812679; Geshi N, 1998, PLANTA, V204, P295, DOI 10.1007/s004250050259; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Husebye H, 2005, INSECT BIOCHEM MOLEC, V35, P1311, DOI 10.1016/j.ibmb.2005.07.004; Jander G, 2001, PLANT PHYSIOL, V126, P890, DOI 10.1104/pp.126.2.890; Jones AME, 2002, INSECT BIOCHEM MOLEC, V32, P275, DOI 10.1016/S0965-1748(01)00088-1; Jones AME, 2001, INSECT BIOCHEM MOLEC, V31, P1, DOI 10.1016/S0965-1748(00)00157-0; Kazana E, 2007, P ROY SOC B-BIOL SCI, V274, P2271, DOI 10.1098/rspb.2007.0237; Kissen R, 2009, PHYTOCHEM REV, V8, P69, DOI 10.1007/s11101-008-9109-1; KJAER A, 1963, ACTA CHEM SCAND, V17, P2143; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; MACLEOD AJ, 1987, PHYTOCHEMISTRY, V26, P669, DOI 10.1016/S0031-9422(00)84763-9; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; PETROSKI RJ, 1985, PHYTOCHEMISTRY, V24, P213; PETROSKI RJ, 1982, PHYTOCHEMISTRY, V21, P1903, DOI 10.1016/0031-9422(82)83011-2; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Rohloff J, 2005, PHYTOCHEMISTRY, V66, P1941, DOI 10.1016/j.phytochem.2005.06.021; SPENCER GF, 1980, J SCI FOOD AGR, V31, P359, DOI 10.1002/jsfa.2740310406; Taipalensuu J, 1997, EUR J BIOCHEM, V250, P680, DOI 10.1111/j.1432-1033.1997.00680.x; THANGSTAD OP, 1991, PROTOPLASMA, V161, P85, DOI 10.1007/BF01322721; TOOKEY HL, 1973, CAN J BIOCHEM CELL B, V51, P1654, DOI 10.1139/o73-222; Traka M, 2009, PHYTOCHEM REV, V8, P269, DOI 10.1007/s11101-008-9103-7; Ueda H, 2006, PLANT CELL PHYSIOL, V47, P164, DOI 10.1093/pcp/pci232; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Zabala MD, 2005, PHYTOCHEMISTRY, V66, P859, DOI 10.1016/j.phytochem.2005.02.026; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	62	101	107	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12057	12070		10.1074/jbc.M807500200	http://dx.doi.org/10.1074/jbc.M807500200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19224919	hybrid, Green Published			2022-12-27	WOS:000265494600038
J	Montero-Hadjadje, M; Elias, S; Chevalier, L; Benard, M; Tanguy, Y; Turquier, V; Galas, L; Yon, L; Malagon, MM; Driouich, A; Gasman, S; Anouar, Y				Montero-Hadjadje, Maite; Elias, Salah; Chevalier, Laurence; Benard, Magalie; Tanguy, Yannick; Turquier, Valerie; Galas, Ludovic; Yon, Laurent; Malagon, Maria M.; Driouich, Azeddine; Gasman, Stephane; Anouar, Youssef			Chromogranin A Promotes Peptide Hormone Sorting to Mobile Granules in Constitutively and Regulated Secreting Cells ROLE OF CONSERVED N- AND C-TERMINAL PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; TRANS-GOLGI NETWORK; SECRETOGRANIN-III; NEUROENDOCRINE CELLS; TARGETED ABLATION; CHROMAFFIN CELLS; STORAGE PROTEIN; ON/OFF SWITCH; BIOGENESIS; PITUITARY	Chromogranin A (CgA) has been proposed to play a major role in the formation of dense-core secretory granules (DCGs) in neuroendocrine cells. Here, we took advantage of unique features of the frog CgA (fCgA) to assess the role of this granin and its potential functional determinants in hormone sorting during DCG biogenesis. Expression of fCgA in the constitutively secreting COS-7 cells induced the formation of mobile vesicular structures, which contained cotransfected peptide hormones. The fCgA and the hormones coexpressed in the newly formed vesicles could be released in a regulated manner. The N- and C-terminal regions of fCgA, which exhibit remarkable sequence conservation with their mammalian counterparts were found to be essential for the formation of the mobile DCG-like structures in COS-7 cells. Expression of fCgA in the corticotrope AtT20 cells increased pro-opiomelanocortin levels in DCGs, whereas the expression of N- and C-terminal deletion mutants provoked retention of the hormone in the Golgi area. Furthermore, fCgA, but not its truncated forms, promoted pro-opiomelanocortin sorting to the regulated secretory pathway. These data demonstrate that CgA has the intrinsic capacity to induce the formation of mobile secretory granules and to promote the sorting and release of peptide hormones. The conserved terminal peptides are instrumental for these activities of CgA.	[Montero-Hadjadje, Maite; Elias, Salah; Tanguy, Yannick; Turquier, Valerie; Yon, Laurent; Anouar, Youssef] Univ Rouen, Equipe Associe Neuronal & Neuroendocrine Differen, INSERM, European Inst Peptide Res IFRMP 23,U413, F-76821 Mont St Aignan, France; [Chevalier, Laurence; Driouich, Azeddine] Univ Rouen, Format Rech Evolut CNRS 3090, IFRMP23, F-76821 Mont St Aignan, France; [Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba 14014, Spain; [Gasman, Stephane] Univ Strasbourg, Dept Neurotransmiss & Neuroendocrine Secret, Unite Proprede Rech 3212, CNRS,Inst Neurosci Cellulaires & Integrat, F-67084 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Universidad de Cordoba; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anouar, Y (corresponding author), Univ Rouen, Equipe Associe Neuronal & Neuroendocrine Differen, INSERM, European Inst Peptide Res IFRMP 23,U413, F-76821 Mont St Aignan, France.	youssef.anouar@univ-rouen.fr	Montero-Hadjadje, Maite/AAC-5692-2019; galas, ludovic/A-2500-2014; stéphane, gasman/Q-1145-2019; Malagon, Maria M/L-5386-2014; Anouar, Youssef/F-9683-2017; Gasman, Stephane/D-5113-2017; Yon, Laurent/E-1981-2016	Montero-Hadjadje, Maite/0000-0001-8859-893X; stéphane, gasman/0000-0001-8415-1276; Malagon, Maria M/0000-0002-2419-2727; Gasman, Stephane/0000-0001-8415-1276; Yon, Laurent/0000-0002-5420-5779; Elias, Salah/0000-0003-1005-438X	INSERM; Conseil Regional de Haute- Normandie; COMETE-3 Network [PHRC AOM-06179]; Ministere des Affaires Etrangeres; Ministerio de Educacion y Ciencia [HF2005-0053]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Haute- Normandie(Region Normandie); COMETE-3 Network; Ministere des Affaires Etrangeres; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by INSERM, the Conseil Regional de Haute- Normandie, the COMETE-3 Network (Grant PHRC AOM-06179), the Ministere des Affaires Etrangeres, and the Ministerio de Educacion y Ciencia (Grant HF2005-0053).	Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; CHANAT E, 1994, FEBS LETT, V351, P225, DOI 10.1016/0014-5793(94)00865-5; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Gorr SU, 1996, J BIOL CHEM, V271, P3575; Han L, 2008, MOL ENDOCRINOL, V22, P1935, DOI 10.1210/me.2008-0006; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; JEGOU S, 1983, GEN COMP ENDOCR, V51, P246, DOI 10.1016/0016-6480(83)90078-3; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Kim T, 2006, MOL BIOL CELL, V17, P789, DOI 10.1091/mbc.E05-08-0755; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Meldolesi J, 2004, TRENDS CELL BIOL, V14, P13, DOI 10.1016/j.tcb.2003.11.006; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Montero-Hadjadje M, 2002, CELL TISSUE RES, V310, P223, DOI 10.1007/s00441-002-0625-9; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; MOORE HPH, 1985, J CELL BIOL, V101, P1773, DOI 10.1083/jcb.101.5.1773; Morvan J, 2008, HISTOCHEM CELL BIOL, V129, P243, DOI 10.1007/s00418-008-0377-z; Natori S, 1996, P NATL ACAD SCI USA, V93, P4431, DOI 10.1073/pnas.93.9.4431; Peinado JR, 2006, ENDOCRINOLOGY, V147, P1408, DOI 10.1210/en.2005-0975; SEIDAH NG, 1987, FEBS LETT, V211, P144, DOI 10.1016/0014-5793(87)81425-4; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Turquier V, 1999, ENDOCRINOLOGY, V140, P4104, DOI 10.1210/en.140.9.4104; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; YOO SH, 1994, J BIOL CHEM, V269, P12001; Yoo SH, 2005, FEBS LETT, V579, P222, DOI 10.1016/j.febslet.2004.11.079; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8816, DOI 10.1021/bi00085a012; Yoo SH, 1996, J BIOL CHEM, V271, P1558; Yoo SH, 2000, J BIOL CHEM, V275, P15067, DOI 10.1074/jbc.M909391199	45	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12420	12431		10.1074/jbc.M805607200	http://dx.doi.org/10.1074/jbc.M805607200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19179339	Green Published, hybrid			2022-12-27	WOS:000265494600072
J	Bu, WY; Chou, AM; Lim, KB; Sudhaharan, T; Ahmed, S				Bu, Wenyu; Chou, Ai Mei; Lim, Kim Buay; Sudhaharan, Thankiah; Ahmed, Sohail			The Toca-1-N-WASP Complex Links Filopodial Formation to Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-WASP; MEMBRANE INVAGINATION; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; PLASMA-MEMBRANE; CDC42; DYNAMIN; PROTEIN; GROWTH; RHO	The transducer of Cdc42-dependent actin assembly (Toca-1)-N-WASP complex was isolated as an essential cofactor for Cdc42-driven actin polymerization in vitro. Toca-1 consists of an N-terminal F-BAR domain, followed by a Cdc42 binding site (HR1 domain) and an SH3 domain, (the N-WASP interacting site). N-WASP is an activator of actin nucleation through the Arp2/3 complex. The aim of the present study was to investigate the cellular function of the Toca-1-N-WASP complex. We report that Toca-1 induces filopodia and neurites as does N-WASP in N1E115 neuroblastoma cells. Toca-1 requires the F-BAR domain, Cdc42 binding site, and SH3 domain to induce filopodia. Toca-1 and N-WASP both require each other to induce filopodia. The expression of Toca-1 and N-WASP affects the distribution, size, and number of Rab5 positive membranes. Toca-1 interacts directly with N-WASP in filopodia and Rab5 membrane as seen by Forster resonance energy transfer. Thus the Toca-1-N-WASP complex localizes to and induces the formation of filopodia and endocytic vesicles. Last, three inhibitors of endocytosis, Dynamin-K44A, Eps15 Delta 95/295, and clathrin heavy chain RNA interference, block Toca-1-induced filopodial formation. Taken together, these data suggest that the Toca-1-N-WASP complex can link filopodial formation to endocytosis.	[Bu, Wenyu; Chou, Ai Mei; Lim, Kim Buay; Sudhaharan, Thankiah; Ahmed, Sohail] Inst Med Biol, Singapore 138665, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138665, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Chou, Amy/0000-0002-6831-0799				Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bray D., 2001, CELL MOVEMENT MOL MO; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Cotteret S, 2002, GENOME BIOL, V3; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kozma R, 1996, MOL CELL BIOL, V16, P5069; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Sarner S, 2000, MOL CELL BIOL, V20, P158, DOI 10.1128/MCB.20.1.158-172.2000; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	51	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11622	11636		10.1074/jbc.M805940200	http://dx.doi.org/10.1074/jbc.M805940200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19213734	Green Published, hybrid			2022-12-27	WOS:000265494500066
J	Meng, D; Lynch, MJ; Huston, E; Beyermann, M; Eichhorst, J; Adams, DR; Klussmann, E; Houslay, MD; Baillie, GS				Meng, Dong; Lynch, Martin J.; Huston, Elaine; Beyermann, Michael; Eichhorst, Jenny; Adams, David R.; Klussmann, Enno; Houslay, Miles D.; Baillie, George S.			MEK1 Binds Directly to beta Arrestin1, Influencing Both Its Phosphorylation by ERK and the Timing of Its Isoprenaline-stimulated Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; SIGNALING SCAFFOLD PROTEINS; COUPLED-RECEPTOR KINASES; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; MEMBRANE TRANSLOCATION; ADRENERGIC-RECEPTOR; REGULATED KINASES; TERMINAL REGION; MAP KINASE	beta Arrestin is a multifunctional signal scaffold protein. Using SPOT immobilized peptide arrays, coupled with scanning alanine substitution and mutagenesis, we show that the MAPK kinase, MEK1, interacts directly with beta arrestin1. Asp26 and Asp29 in the N-terminal domain of beta arrestin1 are critical for its binding to MEK1, whereas Arg47 and Arg49 in the N-terminal domain of MEK1 are critical for its binding to beta arrestin1. Wildtype FLAG-tagged beta arrestin1 co-immunopurifies with MEK1 in HEKB2 cells, whereas the D26A/D29A mutant does not. ERK-dependent phosphorylation at Ser412 was compromised in the D26A/D29A-beta arrestin1 mutant. A cell-permeable, 25-mer N-stearoylated beta arrestin1 peptide that encompassed the N-domain MEK1 binding site blocked beta arrestin1/MEK1 association in HEK cells and recapitulated the altered phenotype seen with the D26A/D29A-beta arrestin1 in compromising the ERK-dependent phosphorylation of beta arrestin1. In addition, the MEK disruptor peptide promoted the ability of beta arrestin1 to co-immunoprecipitate with endogenous c-Src and clathrin, facilitating the isoprenaline-stimulated internalization of the beta(2)-adrenergic receptor.	[Meng, Dong; Lynch, Martin J.; Huston, Elaine; Houslay, Miles D.; Baillie, George S.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Beyermann, Michael; Eichhorst, Jenny; Klussmann, Enno] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Adams, David R.] Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	University of Glasgow; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Heriot Watt University	Baillie, GS (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Wolfson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	gbma25@udcf.gla.ac.uk	Houslay, Miles/AAM-5281-2020; Adams, David R/E-3916-2010; Houslay, Miles D/A-6825-2011	Adams, David R/0000-0002-7154-7332; Houslay, Miles/0000-0002-3826-8091	Medical Research Council [G8604010, G0400053]; European Union [037189]; Fondation Leducq [06CVD02]; MRC [G8604010, G0600765, G0400053] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grants G8604010 and G0400053, European Union Grant 037189, and Fondation Leducq Grant 06CVD02. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Pelaia G, 2005, J CELL PHYSIOL, V202, P642, DOI 10.1002/jcp.20169; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; SONG X, 2008, J BIOL CHEM; Sweeney SE, 2006, ANN RHEUM DIS, V65, P83, DOI 10.1136/ard.2006.058388; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu TR, 2008, BIOCHEM J, V413, P51, DOI 10.1042/BJ20080685	46	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11425	11435		10.1074/jbc.M806395200	http://dx.doi.org/10.1074/jbc.M806395200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19153083	Green Published, hybrid			2022-12-27	WOS:000265494500047
J	Claperon, C; Banegas-Font, I; Iturrioz, X; Rozenfeld, R; Maigret, B; Llorens-Cortes, C				Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Maigret, Bernard; Llorens-Cortes, Catherine			Identification of Threonine 348 as a Residue Involved in Aminopeptidase A Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RENIN-ANGIOTENSIN SYSTEM; EXOPEPTIDASE SPECIFICITY; ENZYMATIC-ACTIVITY; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; BP-1/6C3 ANTIGEN; BLOOD-PRESSURE; BRAIN NUCLEI; INHIBITORS	Aminopeptidase A (APA; EC 3.4.11.7) is a membrane-bound zinc metalloprotease cleaving in the brain the N-terminal aspartyl residue of angiotensin II to generate angiotensin III, which exerts a tonic stimulatory effect on the central control of blood pressure in hypertensive animals. We docked the specific APA inhibitor, glutamate phosphonate, in the three-dimensional model of the mouse APA ectodomain in the presence of Ca2+. In the S1 subsite of this model, the Ca2+ atom was coordinated with Asp-213, Asp-218, y and Glu-215 and three water molecules, one of which formed a hydrogen bond with the carboxylate side chain of the inhibitor. We report here that the carboxylate side chain of glutamate phosphonate also formed a hydrogen bond with the alcohol side chain of Thr-348. Mutagenic replacement of Thr-348 with an aspartate, tyrosine, or serine residue led to a modification of the hydrolysis velocity, with no change in the affinity of the recombinant enzymes for the substrate GluNA, either in the absence or presence of Ca2+. In the absence of Ca2+, the mutations modified the substrate specificity of APA, which was nevertheless restored by the addition of Ca2+. An analysis of three-dimensional models of the corresponding Thr-348 mutants revealed that the interaction between this residue and the inhibitor was abolished or disturbed, leading to a change in the position of the inhibitor in the active site. These findings demonstrate a key role of Thr-348 in substrate specificity of APA for N-terminal acidic amino acids by insuring the optimal positioning of the substrate during catalysis.	[Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Llorens-Cortes, Catherine] INSERM, U691, F-75231 Paris 05, France; [Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Llorens-Cortes, Catherine] Coll France, FR-75005 Paris, France; [Claperon, Cedric; Banegas-Font, Inmaculada; Iturrioz, Xavier; Rozenfeld, Raphael; Llorens-Cortes, Catherine] Univ Paris 06, FR-75006 Paris, France; [Maigret, Bernard] CNRS, UMR 7503, FR-54506 Vandoeuvre Les Nancy, France; [Maigret, Bernard] Lab Lorrain Rech Informat & Ses Applicat, FR-54506 Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine	Llorens-Cortes, C (corresponding author), INSERM, U691, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	c.llorens-cortes@college-de-france.fr	Iturrioz, Xavier/AAS-3555-2020; ITURRIOZ, Xavier/Q-4406-2017; Font, Inmaculada Banegas/H-4290-2011; Llorens-Cortes, Catherine/E-5839-2016; Llorens-Cortès, catherine/AAL-3893-2021	Iturrioz, Xavier/0000-0001-7143-8323; ITURRIOZ, Xavier/0000-0001-7143-8323; Llorens-Cortes, Catherine/0000-0002-7667-0401; Llorens-Cortès, catherine/0000-0002-7667-0401; Banegas Font, Inmaculada/0000-0002-1910-3726	Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique institutes	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique institutes(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a grant from the Fondation pour la Recherche Medicale, by the Institut National de la Sante et de la Recherche Medicale, and by the Centre National de la Recherche Scientifique institutes.	Bodineau L, 2008, HYPERTENSION, V51, P1318, DOI 10.1161/HYPERTENSIONAHA.107.098772; CHAUVEL EN, 1994, J MED CHEM, V37, P2950, DOI 10.1021/jm00044a016; Claperon M, 2008, BIOCHEM J, V416, P37, DOI 10.1042/BJ20080471; DANIELSEN EM, 1980, BIOCHEM J, V189, P591, DOI 10.1042/bj1890591; de Mota N, 2008, J NEUROCHEM, V106, P416, DOI 10.1111/j.1471-4159.2008.05402.x; Ferreira AJ, 2008, HYPERTENSION, V51, P1273, DOI 10.1161/HYPERTENSIONAHA.107.109561; Fournie-Zaluski MC, 2004, P NATL ACAD SCI USA, V101, P7775, DOI 10.1073/pnas.0402312101; GLENNER GG, 1962, NATURE, V194, P867, DOI 10.1038/194867a0; Goto Y, 2007, J BIOL CHEM, V282, P37074, DOI 10.1074/jbc.M707251200; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; ITURRIOZ X, 2004, AMINOPEPTIDASE INHIB; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEJCZAK B, 1993, J ENZYM INHIB, V7, P97, DOI 10.3109/14756369309040752; LODJA Z, 1980, HISTOCHEMISTRY, V67, P267; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; NAGATSU I, 1970, BIOCHIM BIOPHYS ACTA, V198, P255, DOI 10.1016/0005-2744(70)90058-6; Reaux A, 2000, BIOCHEM SOC T, V28, P435, DOI 10.1042/0300-5127:0280435; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Rozenfeld R, 2004, J BIOL CHEM, V279, P43285, DOI 10.1074/jbc.M404369200; Rozenfeld R, 2003, BIOCHEMISTRY-US, V42, P14785, DOI 10.1021/bi034358u; Rozenfeld R, 2002, J BIOL CHEM, V277, P29242, DOI 10.1074/jbc.M204406200; Schottel BL, 2008, CHEM SOC REV, V37, P68, DOI 10.1039/b614208g; SONG LJ, 1994, AM J PHYSIOL-RENAL, V267, pF546, DOI 10.1152/ajprenal.1994.267.4.F546; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; WILK S, 1993, ADV NEUROIMMUNOL, V3, P195, DOI 10.1016/S0960-5428(05)80021-X; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; Zini S, 1997, NEUROSCIENCE, V78, P1187, DOI 10.1016/S0306-4522(96)00660-4; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	35	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10618	10626		10.1074/jbc.M806783200	http://dx.doi.org/10.1074/jbc.M806783200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228697	hybrid, Green Published			2022-12-27	WOS:000265104600036
J	Adinolfi, E; Callegari, MG; Cirillo, M; Pinton, P; Giorgi, C; Cavagna, D; Rizzuto, R; Di Virgilio, F				Adinolfi, Elena; Callegari, Maria Giulia; Cirillo, Maria; Pinton, Paolo; Giorgi, Carlotta; Cavagna, Dario; Rizzuto, Rosario; Di Virgilio, Francesco			Expression of the P2X(7) Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP RECEPTOR; MACROPHAGE CULTURES; INTRACELLULAR CA2+; OXIDIZED ATP; P2 RECEPTORS; CELL-DEATH; CANCER; GROWTH; TRANSCRIPTION; DIFFERENTIATION	The P2X(7) receptor is known for the cytotoxic activity because of its ability to cause opening of non-selective pores in the plasma membrane and activate apoptotic caspases. A key factor of P2X(7)-dependent cytotoxicity is the massive intracellular Ca2+ increase triggered by its activation. Here we show that P2X(7) transfection increased the ability of the endoplasmic reticulum to accumulate, store, and release Ca2+. This caused a larger agonist-stimulated increase in cytosol and mitochondrial Ca2+ in P2X(7) transfectants than in mock transfected cells. P2X(7) transfectants survived and even proliferated in serum-free conditions and were resistant to apoptosis triggered by ceramide, staurosporin, or intracellular Zn2+ chelation. Finally, the nuclear factor of activated T cells complex 1 (NFATc1) was strongly activated in the P2X(7) transfectants. These observations support our previous finding that the P2X(7) receptor under tonic conditions of stimulation, i.e. those observed in response to basal ATP release, has an anti-apoptotic or even growth promoting rather than cytotoxic activity.	[Adinolfi, Elena; Callegari, Maria Giulia] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Cirillo, Maria; Pinton, Paolo; Giorgi, Carlotta; Cavagna, Dario; Rizzuto, Rosario; Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara	Adinolfi, E (corresponding author), Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, Via Borsari 46, I-44100 Ferrara, Italy.	elena.adinolfi@unife.it	Adinolfi, Elena/F-9169-2010; Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016; Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	Adinolfi, Elena/0000-0001-8129-9929; Pinton, Paolo/0000-0001-7108-6508; Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Rizzuto, Rosario/0000-0001-7044-5097; Giorgi, Carlotta/0000-0002-2494-7405	National Institutes of Health [1P01AG025532-01A1]; Italian Association for Cancer Research; Italian Space Agency; Italian Ministry of University and Scientific Research; Commission of European Communities 7th Framework Program [HEALTH-F2-2007-202231]; PRRIITT program of the Emilia Romagna Region; United Mitochondrial Disease Foundation; University of Ferrara; Telethon of Italy; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Commission of European Communities 7th Framework Program(European Commission); PRRIITT program of the Emilia Romagna Region; United Mitochondrial Disease Foundation; University of Ferrara; Telethon of Italy(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01AG025532-01A1 (to R. R.). This work was also supported by grants from the Italian Association for Cancer Research (to F. D. V. and P. P.), Telethon of Italy (to F. D. V. and R. R.), the Italian Space Agency (to F. D. V. and R. R.), the Italian Ministry of University and Scientific Research (to F. D. V. and R. R.), the Commission of European Communities 7th Framework Program HEALTH-F2-2007-202231 (to F. D. V.), the PRRIITT program of the Emilia Romagna Region (to R. R and P. P.), the United Mitochondrial Disease Foundation (to P. P.), institutional funds from the University of Ferrara (to F. D. V., R. R., and P. P.), and the project young researchers of the University of Ferrara (to E. A.).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Barrero MJ, 1997, J BIOL CHEM, V272, P27694, DOI 10.1074/jbc.272.44.27694; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Chiozzi P, 1996, BIOCHEM BIOPH RES CO, V218, P176, DOI 10.1006/bbrc.1996.0031; CHOE CU, 2006, SCI STKE, pRE15; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Dumont FJ, 2000, CURR MED CHEM, V7, P731, DOI 10.2174/0929867003374723; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Fulgenzi A, 2008, INT J IMMUNOPATH PH, V21, P61, DOI 10.1177/039463200802100108; Gartland A, 2003, CALCIFIED TISSUE INT, V73, P361, DOI 10.1007/s00223-002-2098-y; Greig AVH, 2003, J INVEST DERMATOL, V121, P315, DOI 10.1046/j.1523-1747.2003.12379.x; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hillman KA, 2005, NEPHRON EXP NEPHROL, V101, pE24, DOI 10.1159/000086036; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lee M, 2006, MOL CELLS, V22, P1; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Slater M, 2005, HISTOPATHOLOGY, V47, P170, DOI 10.1111/j.1365-2559.2005.02155.x; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Viola JPB, 2005, BRAZ J MED BIOL RES, V38, P335, DOI 10.1590/S0100-879X2005000300003; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675	49	85	85	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10120	10128		10.1074/jbc.M805805200	http://dx.doi.org/10.1074/jbc.M805805200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19204004	hybrid, Green Published			2022-12-27	WOS:000264892900054
J	Kang, Y; Lee, JH; Hoan, NN; Sohn, HM; Chang, IY; You, HJ				Kang, Yoonsung; Lee, Jung-Hee; Hoan, Nguyen Ngoc; Sohn, Hong-Moon; Chang, In-Youb; You, Ho Jin			Protein Phosphatase 5 Regulates the Function of 53BP1 after Neocarzinostatin-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; TETRATRICOPEPTIDE REPEAT DOMAIN; HISTONE H2AX; CHECKPOINT ACTIVATION; V(D)J RECOMBINATION; TUMOR-SUPPRESSOR; REPAIR; ATM; PROTEIN-PHOSPHATASE-5	53BP1 (p53-binding protein 1) is a conserved nuclear protein that is phosphorylated in response to DNA damage and rapidly recruited to the site of DNA double strand breaks, demonstrating its role in the early events to DNA damage and repair of damaged DNA. In this study, we used the yeast two-hybrid system to identify proteins that interact with 53BP1. Identification and characterization of 53BP1 protein interactions may help to further elucidate the function and regulation of 53BP1. We identified protein phosphatase 5 (PP5), a serine/threonine phosphatase that has been implicated in multiple cellular function, as a 53BP1-binding protein. This interaction further confirmed that 53BP1 interacts with PP5 in PP5-overexpressing U2OS cells, after radiomimetic agent neocarzinostatin (NCS) treatment. 53BP1 dephosphorylation at Ser-25 and Ser-1778 was accelerated in PP5-overexpressing U2OS cells following NCS treatment, and its dephosphorylation was correlated with reduced phospho-53BP1 foci formation. In contrast, the overexpression of PP5 had no effect on NCS-activated BRCA1-Ser1524 phosphorylation. Additionally, PP5 down-regulation inhibited the dephosphorylation of 53BP1 on Ser-1778 and the disappearance of phospho-53BP1 foci following NCS treatment. Moreover, non-homologous end-joining activity was reduced in PP5-overexpressing U2OS cells. These findings indicate that PP5 plays an important role in the regulation of 53BP1 phosphorylation and activity in vivo.	[Kang, Yoonsung; Lee, Jung-Hee; Hoan, Nguyen Ngoc; You, Ho Jin] Chosun Univ, Dept Pharmacol, Kwangju 501759, South Korea; [Kang, Yoonsung; Lee, Jung-Hee; Hoan, Nguyen Ngoc; You, Ho Jin] Chosun Univ, Dept Biomat, Kwangju 501759, South Korea; [Sohn, Hong-Moon] Chosun Univ, Dept Orthoped Surg, Kwangju 501759, South Korea; [Chang, In-Youb] Chosun Univ, Dept Anat, Kwangju 501759, South Korea	Chosun University; Chosun University; Chosun University; Chosun University	You, HJ (corresponding author), 2F Chosun Univ, DNA Repair Res Ctr, BioEngn BD, Sch Med, 375 Seosuk Dong, Kwangju 501759, South Korea.	hjyou@chosun.ac.kr		Chang, In-Youb/0000-0002-8911-7541; You, Ho Jin/0000-0002-0530-4017	Ministry of Science and Technology, the Korean Government [M1063901, M20706000032]	Ministry of Science and Technology, the Korean Government(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported in part by Grants M1063901 and M20706000032 from the Ministry of Science and Technology, the Korean Government.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 2006, GENES CELLS, V11, P935, DOI 10.1111/j.1365-2443.2006.00989.x; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi J, 2008, J RADIAT RES, V49, P93, DOI 10.1269/jrr.07130; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Lee H, 2009, BIOCHEM BIOPH RES CO, V378, P32, DOI 10.1016/j.bbrc.2008.10.150; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Mochan TA, 2003, CANCER RES, V63, P8586; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nakamura A, 2006, METHOD ENZYMOL, V409, P236, DOI 10.1016/S0076-6879(05)09014-2; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Travesa A, 2008, J BIOL CHEM, V283, P17123, DOI 10.1074/jbc.M801402200; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward I, 2004, CURR TOP DEV BIOL, V63, P1, DOI 10.1016/S0070-2153(04)63001-8; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005	50	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9845	9853		10.1074/jbc.M809272200	http://dx.doi.org/10.1074/jbc.M809272200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176521	Green Published, hybrid			2022-12-27	WOS:000264892900025
J	Vonck, J; Pisa, KY; Morgner, N; Brutschy, B; Muller, V				Vonck, Janet; Pisa, Kim Y.; Morgner, Nina; Brutschy, Bernhard; Mueller, Volker			Three-dimensional Structure of A(1)A(0) ATP Synthase from the Hyperthermophilic Archaeon Pyrococcus furiosus by Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOSARCINA-MAZEI GO1; A-TYPE; NA+-ATPASE; ROTOR RING; V-ATPASE; MOLECULAR ARCHITECTURE; METHANOPYRUS-KANDLERI; THERMUS-THERMOPHILUS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE	The archaeal ATP synthase is a multisubunit complex that consists of a catalytic A(1) part and a transmembrane, ion translocation domain A(0). The A(1)A(0) complex from the hyperthermophile Pyrococcus furiosus was isolated. Mass analysis of the complex by laser-induced liquid bead ion desorption (LILBID) indicated a size of 730 +/- 10 kDa. A three-dimensional map was generated by electron microscopy from negatively stained images. The map at a resolution of 2.3 nm shows the A(1) and A(0) domain, connected by a central stalk and two peripheral stalks, one of which is connected to A(0), and both connected to A(1) via prominent knobs. X-ray structures of subunits from related proteins were fitted to the map. On the basis of the fitting and the LILBID analysis, a structural model is presented with the stoichiometry A(3)B(3)CDE(2)FH(2)ac(10).	[Vonck, Janet] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Pisa, Kim Y.; Mueller, Volker] Goethe Univ, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Morgner, Nina; Brutschy, Bernhard] Goethe Univ, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Vonck, J (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	janet.vonck@mpibp-frankfurt.mpg.de	Mueller, Volker/ABE-4305-2021; Morgner, Nina/I-7975-2012; Morgner, Nina/O-7021-2018	Mueller, Volker/0000-0001-7955-5508; Morgner, Nina/0000-0002-1872-490X; Vonck, Janet/0000-0001-5659-8863	Deutsche Forschungsgemeinschaft [SFB 472]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 472, to V. M. and Werner Kuhlbrandt).	Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Biukovic G, 2007, BIOCHEMISTRY-US, V46, P2070, DOI 10.1021/bi062123n; BODE C, 1968, Z KLIN CHEM KLIN BIO, V6, P418; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200; Coskun U, 2004, J BIOL CHEM, V279, P22759, DOI 10.1074/jbc.M313741200; Coskun U, 2002, J BIOL CHEM, V277, P17327, DOI 10.1074/jbc.M110407200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; CROSS RL, 1990, FEBS LETT, V259, P227, DOI 10.1016/0014-5793(90)80014-A; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Fritz M, 2008, FEBS J, V275, P1999, DOI 10.1111/j.1742-4658.2008.06354.x; Gayen S, 2007, BIOCHEMISTRY-US, V46, P11684, DOI 10.1021/bi701102n; Gregorini M, 2007, J STRUCT BIOL, V158, P445, DOI 10.1016/j.jsb.2007.01.002; Gruber G, 2001, J EXP BIOL, V204, P2597; Gruber G, 2001, BIOCHEMISTRY-US, V40, P1890, DOI 10.1021/bi002195t; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Lolkema JS, 2003, FEBS LETT, V543, P47, DOI 10.1016/S0014-5793(03)00398-3; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maeder DL, 1999, GENETICS, V152, P1299; Maegawa Y, 2006, ACTA CRYSTALLOGR D, V62, P483, DOI 10.1107/S0907444906006329; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Meier T, 2006, J BACTERIOL, V188, P7759, DOI 10.1128/JB.00934-06; Morgner N, 2008, INT J MASS SPECTROM, V277, P309, DOI 10.1016/j.ijms.2008.08.001; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Muller V, 2005, J BIOENERG BIOMEMBR, V37, P455, DOI 10.1007/s10863-005-9491-y; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Muller V, 1999, J BIOENERG BIOMEMBR, V31, P15, DOI 10.1023/A:1005451311009; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; Numoto N, 2004, ACTA CRYSTALLOGR D, V60, P810, DOI 10.1107/S0907444904003257; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; PUOPOLO K, 1991, J BIOL CHEM, V266, P24564; Ruppert C, 2001, FEMS MICROBIOL LETT, V195, P47, DOI 10.1016/S0378-1097(00)00544-9; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Ubbink-Kok T, 2000, J MOL BIOL, V296, P311, DOI 10.1006/jmbi.1999.3459; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	69	59	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10110	10119		10.1074/jbc.M808498200	http://dx.doi.org/10.1074/jbc.M808498200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203996	Green Published, hybrid			2022-12-27	WOS:000264892900053
J	Seelan, RS; Lakshmanan, J; Casanova, MF; Parthasarathy, RN				Seelan, Ratnam S.; Lakshmanan, Jaganathan; Casanova, Manuel F.; Parthasarathy, Ranga N.			Identification of myo-Inositol-3-phosphate Synthase Isoforms CHARACTERIZATION, EXPRESSION, AND PUTATIVE ROLE OF A 16-kDa gamma(c) ISOFORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOINOSITOL 1-PHOSPHATE SYNTHASE; OBSESSIVE-COMPULSIVE DISORDER; INTRON RETENTION; SACCHAROMYCES-CEREVISIAE; INOSITOL TREATMENT; MESSENGER-RNA; RAT TESTIS; L-MYO-INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHOLIPID BIOSYNTHESIS; 3-PHOSPHATE SYNTHASE	myo-Inositol is an important constituent of membrane phospholipids and is a precursor for the phosphoinositide signaling pathway. It is synthesized from glucose 6-phosphate by myoinositol-3-phosphate synthase (IP synthase), a homotrimer composed of a 68-kDa polypeptide in most mammalian tissues. It is a putative target for mood-stabilizing drugs such as lithium and valproate. Here, we show that the rat gene (Isyna1) encoding this enzyme generates a number of alternatively spliced transcripts in addition to the fully spliced form that encodes the 68-kDa subunit (the alpha isoform). Specifically, we identify a small 16-kDa subunit (the gamma(c) isoform) derived by an intron retention mechanism and provide evidence for its existence in rat tissues. The gamma(c) isoform is highly conserved in mammals, but it lacks the catalytic domain while retaining the NAD(+) binding domain. Both alpha and gamma(c) isoforms are predominantly expressed in many rat tissues and display apparent stoichiometry in purified enzyme preparations. An IP synthase polyclonal antibody not only detects the alpha and gamma(c) isoforms but also several other isoforms in pancreas, intestine, and testis suggesting that the holoenzyme is composed of unique subunits in various tissues. Interestingly, the alpha isoform is not expressed in the intestine. IP synthase activity assays using purified alpha and gamma(c) isoforms indicate that the latter negatively modulates alpha isoform activity, possibly by competing for NAD(+) molecules. Our findings have important ramifications for understanding the mood stabilization process and suggest that inositol biosynthesis is a highly regulated and dynamic process.	[Seelan, Ratnam S.; Lakshmanan, Jaganathan; Casanova, Manuel F.; Parthasarathy, Ranga N.] Univ Louisville, Dept Psychiat & Behav Sci, Louisville, KY 40202 USA; [Parthasarathy, Ranga N.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Mental Hlth Serv, Mol & Neurosci Lab, Louisville, KY 40206 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Behav Sci Serv, Louisville, KY 40206 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Res Serv, Louisville, KY 40206 USA; [Seelan, Ratnam S.; Lakshmanan, Jaganathan; Parthasarathy, Ranga N.] Vet Affairs Med Ctr, Mental Hlth Serv, Bioinformat Lab, Louisville, KY 40206 USA	University of Louisville; University of Louisville; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Seelan, RS (corresponding author), Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, 501 S Preston St, Louisville, KY 40202 USA.	rsseel01@louisville.edu	Casanova, Manuel F/G-8861-2016	Casanova, Manuel F/0000-0002-3874-844X; Seelan, Ratnam/0000-0002-8925-1070	COBRE program of the National Center for Research Resources (NCRR) [5P20RR017702]; NIH [MH69991, R24MH068855]; Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs, Washington, D. C; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069991, R24MH068855] Funding Source: NIH RePORTER	COBRE program of the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs, Washington, D. C(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P20RR017702 from the COBRE program of the National Center for Research Resources (NCRR), a component of NIH (to R. S. S.). This work was also supported by NIH Grant MH69991 (to M. F. C.) and by the Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs, Washington, D. C. (to R. N. P.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH. Human brain tissues were provided by the Harvard Brain Tissue Resource Center, which is supported in part by NIH Grant R24MH068855.	Acevedo LD, 1997, J MASS SPECTROM, V32, P395, DOI 10.1002/(SICI)1096-9888(199704)32:4<395::AID-JMS487>3.0.CO;2-#; ADHIKARI J, 1988, INDIAN J BIOCHEM BIO, V25, P408; Agam G, 2002, BIPOLAR DISORD, V4, P15, DOI 10.1034/j.1399-5618.4.s1.2.x; Auffray C, 2006, EXP CELL RES, V312, P233, DOI 10.1016/j.yexcr.2005.10.014; BENJAMIN J, 1995, AM J PSYCHIAT, V152, P1084; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N; Berry GT, 2004, MOL GENET METAB, V82, P87, DOI 10.1016/j.ymgme.2004.02.002; Blanco E, 2006, NEUROSCIENCE, V140, P1245, DOI 10.1016/j.neuroscience.2006.03.031; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chen J, 2002, J APPL PHYSIOL, V92, P1480, DOI 10.1152/japplphysiol.00077.2001; COCKROFT DL, 1988, TERATOLOGY, V38, P281, DOI 10.1002/tera.1420380312; CULBERTSON MR, 1976, J BACTERIOL, V126, P232, DOI 10.1128/JB.126.1.232-242.1976; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; Einat H, 2001, J AFFECT DISORDERS, V62, P113, DOI 10.1016/S0165-0327(00)00355-4; EISENBER.F, 1967, J BIOL CHEM, V242, P1375; EISENBERG F, 1964, BIOCHEM BIOPH RES CO, V14, P419, DOI 10.1016/0006-291X(64)90079-8; EISENBERG F, 1987, METHOD ENZYMOL, V141, P127; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Fux M, 1996, AM J PSYCHIAT, V153, P1219; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Greene NDE, 1997, NAT MED, V3, P60, DOI 10.1038/nm0197-60; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; Harvey BH, 2002, PROG NEURO-PSYCHOPH, V26, P21, DOI 10.1016/S0278-5846(01)00244-5; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; HASEGAWA R, 1981, P NATL ACAD SCI-BIOL, V78, P4863, DOI 10.1073/pnas.78.8.4863; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jensen ON, 1999, METH MOL B, V112, P513; Jin XS, 2004, J BIOL CHEM, V279, P13889, DOI 10.1074/jbc.M308986200; Ju SL, 2004, CLIN NEUROSCI RES, V4, P181, DOI 10.1016/j.cnr.2004.09.010; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; KINDL H, 1964, BIOCHEM Z, V339, P374; KLIG LS, 1984, P NATL ACAD SCI-BIOL, V81, P3816, DOI 10.1073/pnas.81.12.3816; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LEVINE J, 1995, AM J PSYCHIAT, V152, P792; LOEWUS FA, 1962, BIOCHEM BIOPH RES CO, V7, P204, DOI 10.1016/0006-291X(62)90175-4; Macri MA, 2006, NEUROBIOL AGING, V27, P98, DOI 10.1016/j.neurobiolaging.2005.01.007; MAEDA T, 1980, J BIOL CHEM, V255, P8458; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; MALHOTRA OP, 1973, P NATL ACAD SCI USA, V70, P2077, DOI 10.1073/pnas.70.7.2077; Mansilla A, 2005, EMBO REP, V6, P1182, DOI 10.1038/sj.embor.7400539; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; NACCARATO WF, 1974, ARCH BIOCHEM BIOPHYS, V164, P194, DOI 10.1016/0003-9861(74)90022-8; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Parthasarathy Latha K., 2006, V39, P293; Rivera-Gonzalez R, 1998, J STEROID BIOCHEM, V64, P13, DOI 10.1016/S0960-0760(97)00142-8; Rumpel H, 2003, J MAGN RESON IMAGING, V17, P11, DOI 10.1002/jmri.10233; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Seelan RS, 2004, ARCH BIOCHEM BIOPHYS, V431, P95, DOI 10.1016/j.abb.2004.08.002; Shamir A, 2003, MOL BRAIN RES, V115, P104, DOI 10.1016/S0169-328X(03)00120-7; Shamir A, 2007, BIPOLAR DISORD, V9, P766, DOI 10.1111/j.1399-5618.2007.00440.x; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Shimon H, 1997, AM J PSYCHIAT, V154, P1148; Silver SM, 2006, J NEUROPATH EXP NEUR, V65, P37, DOI 10.1097/01.jnen.0000195938.02292.39; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Stein AJ, 2002, J BIOL CHEM, V277, P9484, DOI 10.1074/jbc.M109371200; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; WHITING PH, 1979, BIOCHEM J, V179, P549, DOI 10.1042/bj1790549; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; WONG YHH, 1987, J NEUROCHEM, V48, P1434, DOI 10.1111/j.1471-4159.1987.tb05682.x; Xiao S, 2008, J NEUROSCI, V28, P1833, DOI 10.1523/JNEUROSCI.3222-07.2008; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	78	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9443	9457		10.1074/jbc.M900206200	http://dx.doi.org/10.1074/jbc.M900206200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19188364	Green Published, hybrid			2022-12-27	WOS:000264669100051
J	Suzuki, T; Sawaki, D; Aizawa, K; Munemasa, Y; Matsumura, T; Ishida, J; Nagai, R				Suzuki, Toru; Sawaki, Daigo; Aizawa, Kenichi; Munemasa, Yoshiko; Matsumura, Takayoshi; Ishida, Junichi; Nagai, Ryozo			Kruppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR KLF5/BTEB2; CYCLIN D1; FACTOR KLF5; EXPRESSION; CANCER; GENE; P21(WAF1/CIP1); PROGRESSION; REGULATOR	Kruppel-like factor 5 (KLF5), originally isolated as a regulator of phenotypic modulation of vascular smooth muscle cells, induces pathological cell growth and is expressed in the neointima. Although induction of KLF5 up-regulates growth factors like platelet derived growth factor-A chain, how KLF5 actually contributes to vascular remodeling, notably its direct effects on cell proliferation, had been poorly clarified. To investigate the effects of KLF5 on neointimal formation, we at first performed adenoviral overexpression of KLF5 to rats subjected to carotid balloon injury. Neointimal formation and proliferating cell nuclear antigen-positive rate were significantly increased at 14 days after injury in the KLF5-treated animals. At the cellular level, overexpression of KLF5 also resulted in markedly increased cell proliferation and cell cycle progression. As a molecular mechanism, we showed that KLF5 directly bound to the promoter and up-regulated gene expression of cyclin D1, as well as showing specific transactivation of cyclins and cyclin-dependent kinase inhibitors in cardiovascular cells. Conversely, knockdown of KLF5 by RNA interference specifically down-regulated cyclin D1 and impaired vascular smooth muscle cell proliferation. Furthermore, KLF5 attenuated cleavage of caspase-3 under conditions of apoptotic stimulation. Moreover, KLF5-administered animals exhibited a significant decrease in terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling positive cells in the medial layer, suggesting inhibition of apoptosis in the early phase after denudation. These findings collectively suggest that KLF5 plays a central role in cardiovascular pathologies through direct and specific stimulation of cell growth as well as inhibition of apoptosis.	[Suzuki, Toru; Sawaki, Daigo; Aizawa, Kenichi; Munemasa, Yoshiko; Matsumura, Takayoshi; Ishida, Junichi; Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Toru; Aizawa, Kenichi] Univ Tokyo, Dept Ubiquitous Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	torusuzu-tky@umin.ac.jp; nagai-tky@umin.ac.jp	SAWAKI, Daigo/T-6871-2018	SAWAKI, Daigo/0000-0003-1417-2033; Suzuki, Toru/0000-0002-8371-664X; , Junichi/0000-0001-9703-9419	Ministry of Education, Culture, Sports, Science, and Technology; New Energy Development Organization	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy Development Organization	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the New Energy Development Organization. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bennett MR, 2002, HEART, V87, P480, DOI 10.1136/heart.87.5.480; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hoshino Y, 2000, CIRCULATION, V102, P2528, DOI 10.1161/01.CIR.102.20.2528; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kang JH, 2006, DIABETOLOGIA, V49, P969, DOI 10.1007/s00125-006-0179-6; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Mayr M, 2001, EXP GERONTOL, V36, P969, DOI 10.1016/S0531-5565(01)00090-0; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Munemasa Y, 2008, MOL CELL BIOL, V28, P1171, DOI 10.1128/MCB.01396-07; Nagata D, 2001, J BIOL CHEM, V276, P662, DOI 10.1074/jbc.M005522200; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Ogata T, 2000, TRANSPLANTATION, V70, P1653, DOI 10.1097/00007890-200012150-00019; Perlman H, 1997, CIRCULATION, V95, P981; Sakamoto H, 2003, CARDIOLOGY, V100, P80, DOI 10.1159/000073043; Sata M, 2003, ARTERIOSCL THROM VAS, V23, P1548, DOI 10.1161/01.ATV.0000089327.48154.32; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sherr CJ, 2002, CELL CYCLE, V1, P36, DOI 10.4161/cc.1.1.106; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200	41	64	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9549	9557		10.1074/jbc.M806230200	http://dx.doi.org/10.1074/jbc.M806230200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189969	Green Published, hybrid			2022-12-27	WOS:000264669100061
J	Tawaratsumida, K; Furuyashiki, M; Katsumoto, M; Fujimoto, Y; Fukase, K; Suda, Y; Hashimoto, M				Tawaratsumida, Kazuki; Furuyashiki, Maiko; Katsumoto, Mami; Fujimoto, Yukari; Fukase, Koichi; Suda, Yasuo; Hashimoto, Masahito			Characterization of N-terminal Structure of TLR2-activating Lipoprotein in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GINGIVAL FIBROBLASTS; LIPOTEICHOIC ACID LTA; CELL-WALL COMPONENTS; TOLL-LIKE RECEPTOR-2; MYCOPLASMA-SALIVARIUM; ENTEROCOCCUS-HIRAE; HOST RECOGNITION; CUTTING EDGE; ACTIVATION; PEPTIDOGLYCAN	Staphylococcus aureus is known to activate mammalian immune cells through Toll-like receptor 2 (TLR2). We recently demonstrated that a lipoprotein fraction obtained from S. aureus by Triton X-114 phase partitioning is a potent activator of TLR2. In this study, we separated TLR2-activating lipoproteins expressed in S. aureus and characterized an N-terminal structure. The lipoprotein fraction of S. aureus was prepared by glass bead disruption followed by Triton X-114 phase partitioning. The TLR2-activating molecules were mainly detected in the mass range of 30-35 kDa. Seven lipoproteins were identified by the mass spectra of their tryptic digests. Among them, three lipoproteins were separated by preparative SDS-PAGE and proved to activate TLR2. After digestion with trypsin in the presence of sodium deoxycholate, the N terminus of the lipopeptide was isolated from lipoprotein SAOUHSC_02699 by normal phase high pressure liquid chromatography and characterized as an S-(diacyloxypropyl) cystein-containing peptide using tandem mass spectra. The synthetic lipopeptide counterpart also stimulated the cells via TLR2. These results showed that the diacylated lipoprotein from S. aureus acts as a TLR2 ligand in mammalian cells.	[Tawaratsumida, Kazuki; Suda, Yasuo; Hashimoto, Masahito] Kagoshima Univ, Dept Nanostruct & Adv Mat, Kagoshima 8900065, Japan; [Furuyashiki, Maiko] Kagoshima Univ, Venture Business Lab, Kagoshima 8900065, Japan; [Katsumoto, Mami; Fujimoto, Yukari; Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan	Kagoshima University; Kagoshima University; Osaka University	Hashimoto, M (corresponding author), Kagoshima Univ, Dept Nanostruct & Adv Mat, Korimoto 1-21-40, Kagoshima 8900065, Japan.	hassy@eng.kagoshima-u.ac.jp	Fujimoto, Yukari/M-7282-2014	Fujimoto, Yukari/0000-0001-5320-3192	Uehara Memorial Foundation	Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a research grant from The Uehara Memorial Foundation.	Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cockayne A, 1998, INFECT IMMUN, V66, P3767, DOI 10.1128/IAI.66.8.3767-3774.1998; Fisette PL, 2003, J BIOL CHEM, V278, P46252, DOI 10.1074/jbc.M306587200; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Hashimoto M, 1997, J BIOCHEM-TOKYO, V121, P779; Hashimoto M, 2000, BIOCHEM BIOPH RES CO, V273, P164, DOI 10.1006/bbrc.2000.2921; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jensen ON, 1999, METH MOL B, V112, P513; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE HK, 2002, J IMMUNOL, V8, P4007; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Shibata K, 1997, FEMS IMMUNOL MED MIC, V19, P275, DOI 10.1016/S0928-8244(97)00093-X; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; SUDA Y, 1995, FEMS IMMUNOL MED MIC, V12, P97, DOI 10.1111/j.1574-695X.1995.tb00181.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; WALLIS RS, 1990, P NATL ACAD SCI USA, V87, P3348, DOI 10.1073/pnas.87.9.3348; Wardenburg JB, 2006, P NATL ACAD SCI USA, V103, P13831, DOI 10.1073/pnas.0603072103	35	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9147	9152		10.1074/jbc.M900429200	http://dx.doi.org/10.1074/jbc.M900429200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218237	Green Published, hybrid			2022-12-27	WOS:000264669100019
J	Waggoner, SA; Johannes, GJ; Liebhaber, SA				Waggoner, Shelly A.; Johannes, Gregg J.; Liebhaber, Stephen A.			Depletion of the Poly(C)-binding Proteins alpha CP1 and alpha CP2 from K562 Cells Leads to p53-independent Induction of Cyclin-dependent Kinase Inhibitor (CDKN1A) and G(1) Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(RC) BINDING-PROTEIN; MESSENGER-RNA STABILITY; 5' UNTRANSLATED REGION; POLIOVIRUS RNA; POSTTRANSCRIPTIONAL REGULATION; 3'-UNTRANSLATED REGION; NONCODING REGION; NUCLEIC-ACID; CANCER CELLS; IDENTIFICATION	The alpha-globin poly(C)-binding proteins (alpha CPs) comprise an abundant and widely expressed set of K-homolog domain RNA-binding proteins. alpha CPs regulate the expression of a number of cellular and viral mRNAs at the levels of splicing, stability, and translation. Previous surveys have identified 160 mRNAs that are bound by alpha CP in the human hematopoietic cell line, K562. To explore the functions of these alpha CP/mRNA interactions, we identified mRNAs whose levels are altered in K562 cells acutely depleted of the two major alpha CP proteins, alpha CP1 and alpha CP2. Microarray analysis identified 27 mRNAs that are down-regulated and 14 mRNAs that are up-regulated in the alpha CP1/2-codepleted cells. This alpha CP1/2 co-depletion was also noted to inhibit cell proliferation and trigger a G(1) cell cycle arrest. Targeted analysis of genes involved in cell cycle control revealed a marked increase in p21(WAF) mRNA and protein. Analysis of mRNP complexes in K562 cells demonstrates in vivo association of p21WAF mRNA with alpha CP1 and alpha CP2. In vitro binding assays indicate that a 127-nucleotide region of the 3'-untranslated region of p21WAF interacts with both alpha CP1 and alpha CP2, and co-depletion of alpha CP1/2 results in a marked increase in p21WAF mRNA half-life. p21WAF induction and G1 arrest in the alpha CP1/2-co-depleted cells occur in the absence of p53 and are not observed in cells depleted of the individual alpha CP isoforms. The apparent redundancy in the actions of alpha CP1 and alpha CP2 upon p21WAF expression correlates with a parallel redundancy in their effects on cell cycle control. These data reveal a pivotal role for alpha CP1 and alpha CP2 in a p53-independent pathway of p21WAF control and cell cycle progression.	[Waggoner, Shelly A.; Liebhaber, Stephen A.] Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA; [Johannes, Gregg J.] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19102 USA	University of Pennsylvania; Drexel University	Liebhaber, SA (corresponding author), 415 Curie Blvd,560A CRB, Philadelphia, PA 19104 USA.	liebhabe@mail.med.upenn.edu			National Institutes of Health [PO1-CA72765, MERIT HL 65449, K01 DK-071137-04]; NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL065449, R01HL065449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1-CA72765, MERIT HL 65449, and K01 DK-071137-04.	AASHEIM HC, 1994, NUCLEIC ACIDS RES, V22, P959, DOI 10.1093/nar/22.6.959; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castano Z, 2008, INT J CANCER, V122, P1512, DOI 10.1002/ijc.23236; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; DelSal G, 1996, ONCOGENE, V12, P177; EL DW, 1993, CELL, V75, P817; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Funke B, 1996, NUCLEIC ACIDS RES, V24, P3821, DOI 10.1093/nar/24.19.3821; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gamarnik AV, 1997, RNA, V3, P882; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; HARPER JW, 1993, CELL, V75, P805; Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; Kim HS, 2005, MECH AGEING DEV, V126, P1255, DOI 10.1016/j.mad.2005.07.002; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Makeyev AV, 2000, GENOMICS, V67, P301, DOI 10.1006/geno.2000.6244; Murray KE, 2001, RNA, V7, P1126, DOI 10.1017/S1355838201010044; NEVINS JR, 1992, SCIENCE, V258, P424; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Paillard L, 2000, MECH DEVELOP, V93, P117, DOI 10.1016/S0925-4773(00)00279-3; Parsley TB, 1997, RNA, V3, P1124; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Spangberg K, 1999, J GEN VIROL, V80, P1371, DOI 10.1099/0022-1317-80-6-1371; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Tommerup N, 1996, GENOMICS, V32, P297, DOI 10.1006/geno.1996.0121; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Walter BL, 1999, RNA, V5, P1570, DOI 10.1017/S1355838299991483; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; WENGONG W, 2000, MOL CELL BIOL, V20, P760; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	52	49	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9039	9049		10.1074/jbc.M806986200	http://dx.doi.org/10.1074/jbc.M806986200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19211566	hybrid, Green Published			2022-12-27	WOS:000264669100006
J	Igaz, LM; Kwong, LK; Chen-Plotkin, A; Winton, MJ; Unger, TL; Xu, Y; Neumann, M; Trojanowski, JQ; Lee, VMY				Igaz, Lionel M.; Kwong, Linda K.; Chen-Plotkin, Alice; Winton, Matthew J.; Unger, Travis L.; Xu, Yan; Neumann, Manuela; Trojanowski, John Q.; Lee, Virginia M. -Y.			Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; TARDBP MUTATIONS; CFTR EXON-9; INCLUSIONS; REGULATOR; DISEASE; GENE; DETERMINANTS	The disease protein in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) was identified recently as the TDP-43 (TAR DNA-binding protein 43), thereby providing a molecular link between these two disorders. In FTLD-U and ALS, TDP-43 is redistributed from its normal nuclear localization to form cytoplasmic insoluble aggregates. Moreover, pathological TDP-43 is abnormally ubiquitinated, hyperphosphorylated, and N-terminally cleaved to generate C-terminal fragments (CTFs). However, the specific cleavage site(s) and the biochemical properties as well as the functional consequences of pathological TDP-43 CTFs remained unknown. Here we have identified the specific cleavage site, Arg(208), of a pathological TDP-43 CTF purified from FTLD-U brains and show that the expression of this and other TDP-43 CTFs in cultured cells recapitulates key features of TDP-43 proteinopathy. These include the formation of cytoplasmic aggregates that are ubiquitinated and abnormally phosphorylated at sites found in FTLD-U and ALS brain and spinal cord samples. Furthermore, we observed splicing abnormalities in a cell culture system expressing TDP-43 CTFs, and this is significant because the regulation of exon splicing is a known function of TDP-43. Thus, our results show that TDP-43 CTF expression recapitulates key biochemical features of pathological TDP-43 and support the hypothesis that the generation of TDP-43 CTFs is an important step in the pathogenesis of FTLD-U and ALS.	[Igaz, Lionel M.; Kwong, Linda K.; Chen-Plotkin, Alice; Winton, Matthew J.; Unger, Travis L.; Xu, Yan; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice] Univ Penn, Dept Neurol, Sch Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Inst Aging, Sch Med, Philadelphia, PA 19104 USA; [Neumann, Manuela] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Zurich; University Zurich Hospital	Lee, VMY (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Sch Med, 3600 Spruce St,3rd Floor,Maloney Bldg, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Neumann, Manuela/F-6558-2011; Igaz, Lionel/AAP-3059-2020	Neumann, Manuela/0000-0002-6232-4057; Igaz, Lionel Muller/0000-0001-9988-3242	National Institutes of Health [AG17586]; Deutsche Forschungsgemeinschaft [SFB 596]; Federal Ministry of Education and Research [01GI0704]; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586. This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 596 and Federal Ministry of Education and Research Grant 01GI0704. The costs of publication of this article were defrayed in part by the	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200	29	276	286	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8516	8524		10.1074/jbc.M809462200	http://dx.doi.org/10.1074/jbc.M809462200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164285	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000264397800036
J	Potet, F; Chagot, B; Anghelescu, M; Viswanathan, PC; Stepanovic, SZ; Kupershmidt, S; Chazin, WJ; Balser, JR				Potet, Franck; Chagot, Benjamin; Anghelescu, Mircea; Viswanathan, Prakash C.; Stepanovic, Svetlana Z.; Kupershmidt, Sabina; Chazin, Walter J.; Balser, Jeffrey R.			Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT; INACTIVATION GATE; LIDOCAINE BLOCK; CALCIUM; MECHANISMS; MUTATION; SCN5A; FLECAINIDE	Sodium channels are fundamental signaling molecules in excitable cells, and are molecular targets for local anesthetic agents and intracellular free Ca2+ ([Ca2+](i)). Two regions of Na(V)1.5 have been identified previously as [Ca2+]i-sensitive modulators of channel inactivation. These include a C-terminal IQ motif that binds calmodulin (CaM) in different modes depending on Ca2+ levels, and an immediately adjacent C-terminal EF-hand domain that directly binds Ca2+. Here we show that a mutation of the IQ domain (A1924T; Brugada Syndrome) that reduces CaM binding stabilizes Na(V)1.5 inactivation, similarly and more extensively than even reducing [Ca2+](i). Because the DIII-DIV linker is an essential structure in Na(V)1.5 inactivation, we evaluated this domain for a potential CaM binding interaction. We identified a novel CaM binding site within the linker, validated its interaction with CaM by NMR spectroscopy, and revealed its micromolar affinity by isothermal titration calorimetry. Mutation of three consecutive hydrophobic residues (Phe(1520)-Ile(1521)-Phe(1522)) to alanines in this CaM-binding domain recapitulated the electrophysiology phenotype observed with mutation of the C-terminal IQ domain: NaV1.5 inactivation was stabilized; moreover, mutations of either CaM-binding domain abolish the well described stabilization of inactivation by lidocaine. The direct physical interaction of CaM with the C-terminal IQ domain and the DIII-DIV linker, combined with the similarity in phenotypes when CaM-binding sites in either domain are mutated, suggests these cytoplasmic structures could be functionally coupled through the action of CaM. These findings have bearing upon Na+ channel function in genetically altered channels and under pathophysiologic conditions where [Ca2+](i) impacts cardiac conduction.	[Kupershmidt, Sabina; Balser, Jeffrey R.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Kupershmidt, Sabina; Balser, Jeffrey R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Chagot, Benjamin; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Viswanathan, Prakash C.] Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15213 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Potet, F (corresponding author), 2213 Garland Ave,Langford P445 MRB 4, Nashville, TN 37232 USA.	franck.potet@vanderbilt.edu	Chagot, Benjamin/AAC-6495-2019; Kupershmidt, Sabina/AAO-5464-2021; Chagot, Benjamin/H-3258-2011	Chagot, Benjamin/0000-0002-9153-0060; Kupershmidt, Sabina/0000-0002-8119-2723; 	National Institutes of Health NIGMS [GM56307-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056307] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant GM56307-11. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balser JR, 1996, J CLIN INVEST, V98, P2874, DOI 10.1172/JCI119116; Baroudi G, 2000, FEBS LETT, V487, P224, DOI 10.1016/S0014-5793(00)02360-7; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELUCA A, 1991, N-S ARCH PHARMACOL, V344, P596; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Fukuda K, 2005, CIRC RES, V97, P1262, DOI 10.1161/01.RES.0000195844.31466.e9; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kambouris NG, 2000, J CLIN INVEST, V105, P1133, DOI 10.1172/JCI9212; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; OPIE LH, 1990, ANNU REV MED, V41, P231; POGWIZD SM, 1987, CIRC RES, V61, P352, DOI 10.1161/01.RES.61.3.352; Rivolta I, 2002, PHYSIOL GENOMICS, V10, P191, DOI 10.1152/physiolgenomics.00039.2002; Robert E, 1999, AM J PHYSIOL-HEART C, V276, pH413, DOI 10.1152/ajpheart.1999.276.2.H413; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Stummann TC, 2005, EUR J PHARMACOL, V510, P197, DOI 10.1016/j.ejphar.2005.01.030; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Vedantham V, 1999, J GEN PHYSIOL, V113, P7, DOI 10.1085/jgp.113.1.7; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Viswanathan PC, 2001, CIRCULATION, V104, P1200, DOI 10.1161/hc3501.093797; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; Wei J, 1999, CIRCULATION, V99, P3165, DOI 10.1161/01.CIR.99.24.3165; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WILLIAMS EMV, 1989, AM J CARDIOL, V64, pJ5; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yogeeswari P, 2004, CURR DRUG TARGETS, V5, P589, DOI 10.2174/1389450043345227	40	62	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8846	8854		10.1074/jbc.M806871200	http://dx.doi.org/10.1074/jbc.M806871200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171938	Green Published, hybrid			2022-12-27	WOS:000264397800067
J	Susuki, S; Sato, T; Miyata, M; Momohara, M; Suico, MA; Shuto, T; Ando, Y; Kai, H				Susuki, Seiko; Sato, Takashi; Miyata, Masanori; Momohara, Mamiko; Suico, Mary Ann; Shuto, Tsuyoshi; Ando, Yukio; Kai, Hirofumi			The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; QUALITY-CONTROL; MOLECULAR CHAPERONES; SECRETORY PATHWAY; ER; PROTEINS; COMPLEX; EXPORT; RETROTRANSLOCATION; TRAFFICKING	Amyloid fibril formation of mutant transthyretin (TTR) that causes familial amyloid polyneuropathy occurs in the extracellular space. Thus, secretion of TTR variants contributes to the pathogenesis of amyloidosis. However, the molecular mechanisms underlying the endoplasmic reticulum (ER) exit or retention and subsequent degradation of TTR variants remain unclear. Here, we demonstrated that the nonsecreted TTR variants, such as D18G TTR and amyloidogenic TTRs with introduced monomeric mutation (M-TTRs), stably interact with the ER chaperone BiP in mammalian cells. These proteins were co-secreted with the secreted form of BiP in which the KDEL signal was removed, indicating that BiP partially contributes to the ER retention of nonsecreted TTR variants. More interestingly, the degradation efficiency of nonsecreted TTRs was increased when BiP was down-regulated by small interfering RNA. Thus, BiP protects the TTR variants from immediate degradation. Additionally, we showed that the stability of nonsecreted TTR variants is not disturbed in the coat complex II-deficient conditions, which are enough to inhibit the ER export of secreted TTR variants, including wild-type TTR. Therefore, the post-ER retrieval mechanism might not contribute to the ER-associated degradation of nonsecreted TTR variants. These findings suggest that the affinity to the ER-resident protein BiP regulates the fate of TTR variants in the ER.	[Susuki, Seiko; Sato, Takashi; Miyata, Masanori; Momohara, Mamiko; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Mol Med, Global Ctr Excellence Cell Fate Regulat Res & Edu, Kumamoto 8620973, Japan; [Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, Kumamoto 8600811, Japan	Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Mol Med, Global Ctr Excellence Cell Fate Regulat Res & Edu, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Sato, Takashi/AHB-5258-2022	Sato, Takashi/0000-0003-4203-0999; Ando, Yukio/0000-0001-7115-9105	Amyloidosis Research Committee; Pathogenesis and Therapy of Hereditary Neuropathy Research Committee; Surveys and Research on Specific Disease; Ministry of Health and Welfare of Japan; Charitable Trust Clinical Pathology Research Foundation of Japan; Ministry of Education, Science, Sports and Culture (MEXT) of Japan; Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Amyloidosis Research Committee; Pathogenesis and Therapy of Hereditary Neuropathy Research Committee; Surveys and Research on Specific Disease; Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Charitable Trust Clinical Pathology Research Foundation of Japan; Ministry of Education, Science, Sports and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Amyloidosis Research Committee, the Pathogenesis and Therapy of Hereditary Neuropathy Research Committee, Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan, the Charitable Trust Clinical Pathology Research Foundation of Japan, and grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture (MEXT) of Japan and from the Global Centers of Excellence Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan.	Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hashimoto Y, 2008, BBA-MOL CELL RES, V1783, P153, DOI 10.1016/j.bbamcr.2007.08.011; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lass A, 2008, INT J BIOCHEM CELL B, V40, P2865, DOI 10.1016/j.biocel.2008.06.003; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Okiyoneda T, 2004, J PHARMACOL SCI, V95, P471, DOI 10.1254/jphs.SC0040081; Sato T, 2007, EMBO J, V26, P2501, DOI 10.1038/sj.emboj.7601685; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Sorgjerd K, 2006, J MOL BIOL, V356, P469, DOI 10.1016/j.jmb.2005.11.051; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082	34	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8312	8321		10.1074/jbc.M809354200	http://dx.doi.org/10.1074/jbc.M809354200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19188365	hybrid, Green Published			2022-12-27	WOS:000264397800015
J	Yellaturu, CR; Deng, X; Cagen, LM; Wilcox, HG; Mansbach, CM; Siddiqi, SA; Park, EA; Raghow, R; Elam, MB				Yellaturu, Chandrahasa R.; Deng, Xiong; Cagen, Lauren M.; Wilcox, Henry G.; Mansbach, Charles M., II; Siddiqi, Shadab A.; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.			Insulin Enhances Post-translational Processing of Nascent SREBP-1c by Promoting Its Phosphorylation and Association with COPII Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; MAMMALIAN ENDOPLASMIC-RETICULUM; FATTY-ACID SYNTHESIS; TRANSCRIPTION FACTORS; RAT HEPATOCYTES; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; LIPID HOMEOSTASIS; MESSENGER-RNAS	The regulation of lipid homeostasis by insulin is mediated in part by the enhanced transcription of the gene encoding SREBP-1c (sterol regulatory element-binding protein-1c). Nascent SREBP-1c is synthesized and embedded in the endoplasmic reticulum (ER) and must be transported to the Golgi in coatomer protein II (COPII) vesicles where two sequential cleavages generate the transcriptionally active NH2-terminal fragment, nSREBP-1c. There is limited indirect evidence to suggest that insulin may also regulate the post-translational processing of the nascent SREBP-1c protein. Therefore, we designed experiments to directly assess the action of insulin on the post-translational processing of epitope-tagged full-length SREBP-1c and SREBP-2 proteins expressed in cultured hepatocytes. We demonstrate that insulin treatment led to enhanced post-translational processing of SREBP-1c, which was associated with phosphorylation of ER-bound nascent SREBP-1c protein that increased affinity of the SREBP-1c cleavage-activating protein (SCAP)-SREBP-1c complex for the Sec23/24 proteins of the COPII vesicles. Furthermore, chemical and molecular inhibitors of the phosphoinositide 3-kinase pathway and its downstream kinase protein kinase B (PKB)/Akt prevented both insulin-mediated phosphorylation of nascent SREBP-1c protein and its post-translational processing. Insulin had no effect on the proteolysis of nascent SREBP-2 under identical conditions. We also show that in vitro incubation of an active PKB/Akt enzyme with recombinant full-length SREBP-1c led to its phosphorylation. Thus, insulin selectively stimulates the processing of SREBP-1c in rat hepatocytes by enhancing the association between the SCAP-SREBP-1c complex and COPII proteins and subsequent ER to Golgi transport and proteolytic cleavage. This effect of insulin is tightly linked to phosphoinositide 3-kinase and PKB/Akt-dependent serine phosphorylation of the precursor SREBP-1c protein.	[Yellaturu, Chandrahasa R.; Deng, Xiong; Cagen, Lauren M.; Wilcox, Henry G.; Park, Edwards A.; Raghow, Rajendra; Elam, Marshall B.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Mansbach, Charles M., II; Siddiqi, Shadab A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Deng, Xiong; Raghow, Rajendra; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Yellaturu, CR (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	cyellatu@utmem.edu			National Institutes of Health [DK075504]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059368, R01DK075504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK075504 (to M.B.E., R.R., and C.R.Y.). This work was also supported by a postdoctoral fellowship grant, American Heart Association (to C.R.Y.),	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; CZECH MP, 1988, J BIOL CHEM, V263, P11017; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Elam MB, 2001, J LIPID RES, V42, P2039; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Peak M, 1998, DIABETOLOGIA, V41, P16, DOI 10.1007/s001250050861; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Ribaux PG, 2003, BIOCHEM J, V376, P697, DOI 10.1042/BJ20031287; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; TOBE K, 1992, J BIOL CHEM, V267, P21089; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yellaturu CR, 2005, BIOCHEM BIOPH RES CO, V332, P174, DOI 10.1016/j.bbrc.2005.04.112	55	100	107	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7518	7532		10.1074/jbc.M805746200	http://dx.doi.org/10.1074/jbc.M805746200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158095	hybrid, Green Published			2022-12-27	WOS:000264195600015
J	Hang, JQ; Yang, YL; Harris, SF; Leveque, V; Whittington, HJ; Rajyaguru, S; Ao-Ieong, G; McCown, MF; Wong, A; Giannetti, AM; Le Pogam, S; Talamas, F; Cammack, N; Najera, I; Klumpp, K				Hang, Julie Qi; Yang, Yanli; Harris, Seth F.; Leveque, Vincent; Whittington, Hannah J.; Rajyaguru, Sonal; Ao-Ieong, Gloria; McCown, Matthew F.; Wong, April; Giannetti, Anthony M.; Le Pogam, Sophie; Talamas, Francisco; Cammack, Nick; Najera, Isabel; Klumpp, Klaus			Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; HCVNS5B POLYMERASE; MOLECULAR-MECHANISM; ANTIVIRAL ACTIVITY; REPLICON VARIANTS; CRYSTAL-STRUCTURE; SERINE-PROTEASE; REPLICATION; DISCOVERY; IDENTIFICATION	The binding affinity of four palm and thumb site representative non-nucleoside inhibitors (NNIs) of HCV polymerase NS5B to wild-type and resistant NS5B polymerase proteins was determined, and the influence of RNA binding on NNI binding affinity was investigated. NNIs with high binding affinity potently inhibited HCV RNA polymerase activity and replicon replication. Among the compounds tested, HCV-796 showed slow binding kinetics to NS5B. The binding affinity of HCV-796 to NS5B increased 27-fold over a 3-h incubation period with an equilibrium K-d of 71 +/- 2 nM. Slow binding kinetics of HCV-796 was driven by slow dissociation from NS5B with a k(off) of 4.9 +/- 0.5 x 10(-4) s(-1). NS5B bound a long, 378-nucleotide HCV RNA oligonucleotide with high affinity (K-d = 6.9 +/- 0.3 nM), whereas the binding affinity was significantly lower for a short, 21-nucleotide RNA (K-d = 155.1 +/- 16.2 nM). The formation of the NS5B-HCV RNA complex did not affect the slow binding kinetics profile and only slightly reduced NS5B binding affinity of HCV-796. The magnitude of reduction of NNI binding affinity for the NS5B proteins with various resistance mutations in the palm and thumb binding sites correlated well with resistance-fold shifts in NS5B polymerase activity and replicon assays. Co-crystal structures of NS5B-Con1 and NS5B-BK with HCV-796 revealed a deep hydrophobic binding pocket at the palm region of NS5B. HCV-796 interaction with the induced binding pocket on NS5B is consistent with slow binding kinetics and loss of binding affinity with mutations at amino acid position 316.	[Hang, Julie Qi; Yang, Yanli; Harris, Seth F.; Leveque, Vincent; Whittington, Hannah J.; Rajyaguru, Sonal; Ao-Ieong, Gloria; McCown, Matthew F.; Wong, April; Giannetti, Anthony M.; Le Pogam, Sophie; Talamas, Francisco; Cammack, Nick; Najera, Isabel; Klumpp, Klaus] Roche Palo Alto LLC, Palo Alto, CA 94304 USA	Roche Holding	Hang, JQ (corresponding author), Roche Palo Alto LLC, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	julie.hang@roche.com; klaus.klumpp@roche.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; yang, yang/HGT-7999-2022					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Beaulieu PL, 2006, CURR OPIN DRUG DISC, V9, P618; Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chan L, 2004, BIOORG MED CHEM LETT, V14, P797, DOI 10.1016/j.bmcl.2003.10.068; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Dhanak D, 2002, J BIOL CHEM, V277, P38322, DOI 10.1074/jbc.M205566200; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Howe AYM, 2008, ANTIMICROB AGENTS CH, V52, P3327, DOI 10.1128/AAC.00238-08; Howe AYM, 2006, ANTIMICROB AGENTS CH, V50, P4103, DOI 10.1128/AAC.00365-06; Howe AYM, 2004, ANTIMICROB AGENTS CH, V48, P4813, DOI 10.1128/AAC.48.12.4813-4821.2004; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kukolj G, 2005, J BIOL CHEM, V280, P39260, DOI 10.1074/jbc.M506407200; LACKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P446; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Liu YY, 2003, BIOCHEMISTRY-US, V42, P8862, DOI 10.1021/bi034661v; Ma H, 2005, VIROLOGY, V332, P8, DOI 10.1016/j.virol.2004.11.024; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Mo HM, 2005, ANTIMICROB AGENTS CH, V49, P4305, DOI 10.1128/AAC.49.10.4305-4314.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TT, 2003, ANTIMICROB AGENTS CH, V47, P3525, DOI 10.1128/AAC.47.11.3525-3530.2003; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauwels F, 2007, J VIROL, V81, P6909, DOI 10.1128/JVI.01543-06; RAJAGOPALAN PTR, 2007, 58 ANN M AM ASS STUD; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tomei L, 2004, J VIROL, V78, P938, DOI 10.1128/JVI.78.2.938-946.2004; Tomei L, 2003, J VIROL, V77, P13225, DOI 10.1128/JVI.77.24.13225-13231.2003; Tomei Licia, 2005, Antiviral Chemistry & Chemotherapy, V16, P225; Villano S, 2007, HEPATOLOGY, V46, p815A; Villano S, 2006, HEPATOLOGY, V44, p607A	45	70	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15517	15529		10.1074/jbc.M808889200	http://dx.doi.org/10.1074/jbc.M808889200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19246450	hybrid, Green Published			2022-12-27	WOS:000266501000020
J	Chigaev, A; Waller, A; Amit, O; Halip, L; Bologa, CG; Sklar, LA				Chigaev, Alexandre; Waller, Anna; Amit, Or; Halip, Liliana; Bologa, Cristian G.; Sklar, Larry A.			Real-time Analysis of Conformation-sensitive Antibody Binding Provides New Insights into Integrin Conformational Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; SWISS-MODEL; ALPHA(4)BETA(1)-INTEGRIN AFFINITY; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; RECEPTOR; ACTIVATION; ALPHA-V-BETA-3; ENVIRONMENT; CHEMOKINES	Integrins are heterodimeric adhesion receptors that regulate immune cell adhesion. Integrin-dependent adhesion is controlled by multiple conformational states that include states with different affinity to the ligand, states with various degrees of molecule unbending, and others. Affinity change and molecule unbending play major roles in the regulation of cell adhesion. The relationship between different conformational states of the integrin is unclear. Here we have used conformationally sensitive antibodies and a small LDV-containing ligand to study the role of the inside-out signaling through formyl peptide receptor and CXCR4 in the regulation of alpha(4)beta(1) integrin conformation. We found that in the absence of ligand, activation by formyl peptide or SDF-1 did not result in a significant exposure of HUTS-21 epitope. Occupancy of the ligand binding pocket without cell activation was sufficient to induce epitope exposure. EC50 for HUTS-21 binding in the presence of LDV was identical to a previously reported ligand equilibrium dissociation constant at rest and after activation. Furthermore, the rate of HUTS-21 binding was also related to the VLA-4 activation state even at saturating ligand concentration. We propose that the unbending of the integrin molecule after guanine nucleotide-binding protein-coupled receptor-induced signaling accounts for the enhanced rate of HUTS-21 binding. Taken together, current results support the existence of multiple conformational states independently regulated by both inside-out signaling and ligand binding. Our data suggest that VLA-4 integrin hybrid domain movement does not depend on the affinity state of the ligand binding pocket.	[Chigaev, Alexandre; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Chigaev, Alexandre; Waller, Anna; Amit, Or; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Halip, Liliana; Bologa, Cristian G.] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Halip, Liliana] Acad Romana, Inst Chem, Timisoara 300223, Romania	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Romanian Academy of Sciences; Institute of Chemistry, Timisoara	Sklar, LA (corresponding author), MSC08 4630,915 Camino de Salud, Albuquerque, NM 87131 USA.	lsklar@salud.unm.edu	Bologa, Cristian G/A-7952-2010; BOLOGA, CRISTINA/T-8927-2017; Chigaev, Alexandre/A-3103-2010	Bologa, Cristian G/0000-0003-2232-4244; Chigaev, Alexandre/0000-0002-7726-638X; Halip, Liliana/0000-0002-2600-0186; Waller, Anna/0000-0003-3676-2501	National Institutes of Health [HL56384, HL081062]; Leukemia and Lymphoma Society [7388-06]; University of New Mexico School of Medicine [C-2297-RAC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062, P50HL056384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of New Mexico School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56384 and HL081062 (to L. A. S.). This work was also supported by Leukemia and Lymphoma Society Grant 7388-06 (to L. A. S.) and by Dedicated Health Research Funds of the University of New Mexico School of Medicine Grant C-2297-RAC (to A. C.).	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Barthel SR, 2006, J BIOL CHEM, V281, P32175, DOI 10.1074/jbc.M600943200; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2004, J BIOL CHEM, V279, P32435, DOI 10.1074/jbc.M404387200; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Escudero E, 2000, J AM SOC NEPHROL, V11, P1075, DOI 10.1681/ASN.V1161075; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutierrez-Lopez MD, 2003, J BIOL CHEM, V278, P208, DOI 10.1074/jbc.M207805200; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Lorentz A, 2002, BLOOD, V99, P966, DOI 10.1182/blood.V99.3.966; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Luque R, 2002, BRIT J HAEMATOL, V119, P70, DOI 10.1046/j.1365-2141.2002.03792.x; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sklar LA, 2002, ANNU REV BIOPH BIOM, V31, P97, DOI 10.1146/annurev.biophys.31.082901.134406; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	36	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14337	14346		10.1074/jbc.M901178200	http://dx.doi.org/10.1074/jbc.M901178200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19251697	Green Published, hybrid			2022-12-27	WOS:000266286100040
J	Wolfe, MS				Wolfe, Michael S.			Intramembrane-cleaving Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GAMMA-SECRETASE COMPLEX; RHOMBOID PROTEASE; SUBSTRATE-SPECIFICITY; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SERINE PROTEASES; CATALYTIC PORE; PROTEOLYSIS; PRESENILIN		[Wolfe, Michael S.] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Wolfe, Michael S.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Wolfe, MS (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu			NIA NIH HHS [AG17574] Funding Source: Medline; NIGMS NIH HHS [GM79555] Funding Source: Medline; NINDS NIH HHS [NS41355] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017574] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Kanehara K, 2001, GENE, V281, P71, DOI 10.1016/S0378-1119(01)00823-X; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zhou RB, 2005, MOL MICROBIOL, V58, P835, DOI 10.1111/j.1365-2958.2005.04870.x	46	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					13969	13973		10.1074/jbc.R800039200	http://dx.doi.org/10.1074/jbc.R800039200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19189971	Green Published, hybrid			2022-12-27	WOS:000266286100002
J	Brautigam, CA; Wynn, RM; Chuang, JL; Chuang, DT				Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Chuang, David T.			Subunit and Catalytic Component Stoichiometries of an in Vitro Reconstituted Human Pyruvate Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; SIZE-DISTRIBUTION ANALYSIS; MULTIENZYME COMPLEX; DIHYDROLIPOAMIDE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING-PROTEIN; ANALYTICAL ULTRACENTRIFUGATION; MAMMALIAN PYRUVATE; ESCHERICHIA-COLI	The human pyruvate dehydrogenase complex (PDC) is a 9.5-megadalton catalytic machine that employs three catalytic components, i.e. pyruvate dehydrogenase (E1p), dihydrolipoyl transacetylase (E2p), and dihydrolipoamide dehydrogenase (E3), to carry out the oxidative decarboxylation of pyruvate. The human PDC is organized around a 60-meric dodecahedral core comprising the C-terminal domains of E2p and a noncatalytic component, E3-binding protein (E3BP), which specifically tethers E3 dimers to the PDC. A central issue concerning the PDC structure is the subunit stoichiometry of the E2p/E3BP core; recent studies have suggested that the core is composed of 48 copies of E2p and 12 copies of E3BP. Here, using an in vitro reconstituted PDC, we provide densitometry, isothermal titration calorimetry, and analytical ultracentrifugation evidence that there are 40 copies of E2p and 20 copies of E3BP in the E2p/E3BP core. Reconstitution with saturating concentrations of E1p and E3 demonstrated 40 copies of E1p heterotetramers and 20 copies of E3 dimers associated with the E2p/E3BP core. To corroborate the 40/20 model of this core, the stoichiometries of E3 and E1p binding to their respective binding domains were reexamined. In these binding studies, the stoichiometries were found to be 1:1, supporting the 40/20 model of the core. The overall maximal stoichiometry of this in vitro assembled PDC for E2p:E3BP:E1p:E3 is 40:20:40:20. These findings contrast a previous report that implicated that two E3-binding domains of E3BP bind simultaneously to a single E3 dimer (Smolle, M., Prior, A. E., Brown, A. E., Cooper, A., Byron, O.,and Lindsay, J.G. (2006) J. Biol. Chem. 281, 19772-19780).	[Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brautigam, CA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chad.brautigam@utsouthwestern.edu; david.chuang@utsouthwestern.edu		Wynn, Richard/0000-0002-1879-2136; Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [DK26758, DK62306]; Welch Foundation [I-1286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062306, R01DK062306, R01DK026758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26758 and DK62306. This work was also supported by Grant I-1286 from the Welch Foundation.	Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; BARRERA CR, 1972, ARCH BIOCHEM BIOPHYS, V148, P343, DOI 10.1016/0003-9861(72)90152-X; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; DANSON MJ, 1978, P NATL ACAD SCI USA, V75, P5386, DOI 10.1073/pnas.75.11.5386; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Fries M, 2007, J MOL BIOL, V366, P132, DOI 10.1016/j.jmb.2006.11.018; GILBERT GA, 1959, PROC R SOC LON SER-A, V253, P420, DOI 10.1098/rspa.1959.0204; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; HACKERT ML, 1983, P NATL ACAD SCI-BIOL, V80, P2226, DOI 10.1073/pnas.80.8.2226; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Howard MJ, 1998, GASTROENTEROLOGY, V115, P139, DOI 10.1016/S0016-5085(98)70375-0; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; JILKA JM, 1986, J BIOL CHEM, V261, P1858; Jung HI, 2003, EUR J BIOCHEM, V270, P4488, DOI 10.1046/j.1432-1033.2003.03842.x; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MANDE SS, 1995, STRUCTURE LOND, V4, P277; MOMEN AZM, 2006, PROTEIN DATA BANK, DOI DOI 10.2210/PDB2DNE/PDB; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Sanderson SJ, 1996, EUR J BIOCHEM, V236, P68, DOI 10.1111/j.1432-1033.1996.00068.x; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Smolle M, 2006, BIOCHEM SOC T, V34, P815, DOI 10.1042/BST0340815; Smolle M, 2006, J BIOL CHEM, V281, P19772, DOI 10.1074/jbc.M601140200; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024	45	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13086	13098		10.1074/jbc.M806563200	http://dx.doi.org/10.1074/jbc.M806563200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240034	hybrid, Green Published			2022-12-27	WOS:000265688300056
J	Grininger, M; Staudt, H; Johansson, P; Wachtveitl, J; Oesterhelt, D				Grininger, Martin; Staudt, Heike; Johansson, Patrik; Wachtveitl, Josef; Oesterhelt, Dieter			Dodecin Is the Key Player in Flavin Homeostasis of Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBOFLAVIN-BINDING; LOWER LIGAND; LUMICHROME; PROTEIN; DOMAIN; PHOTOLYASE; DYNAMICS	Flavins are employed to transform physical input into biological output signals. In this function, flavins catalyze a variety of light-induced reactions and redox processes. However, nature also provides flavoproteins with the ability to uncouple the mediation of signals. Such proteins are the riboflavin-binding proteins (RfBPs) with their function to store riboflavin for fast delivery of FMN and FAD. Here we present in vitro and in vivo data showing that the recently discovered archaeal dodecin is an RfBP, and we reveal that riboflavin storage is not restricted to eukaryotes. However, the function of the prokaryotic RfBP dodecin seems to be adapted to the requirement of a monocellular organism. While in eukaryotes RfBPs are involved in trafficking riboflavin, and dodecin is responsible for the flavin homeostasis of the cell. Although only 68 amino acids in length, dodecin is of high functional versatility in neutralizing riboflavin to protect the cellular environment from uncontrolled flavin reactivity. Besides the predominant ultrafast quenching of excited states, dodecin prevents light-induced riboflavin reactivity by the selective degradation of riboflavin to lumichrome. Coordinated with the high affinity for lumichrome, the directed degradation reaction is neutral to the cellular environment and provides an alternative pathway for suppressing uncontrolled riboflavin reactivity. Intriguingly, the different structural and functional properties of a homologous bacterial dodecin suggest that dodecin has different roles in different kingdoms of life.	[Grininger, Martin; Johansson, Patrik; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany; [Staudt, Heike; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Grininger, M (corresponding author), Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	grininge@biochem.mpg.de; oesterhe@biochem.mpg.de	Grininger, Martin/D-5329-2011; Wachtveitl, Josef/A-7590-2017	Wachtveitl, Josef/0000-0002-8496-8240; Grininger, Martin/0000-0002-7269-0667				Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Bieger B, 2003, STRUCTURE, V11, P375, DOI 10.1016/S0969-2126(03)00048-0; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Foraker AB, 2003, ADV DRUG DELIVER REV, V55, P1467, DOI 10.1016/j.addr.2003.07.005; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Gray MJ, 2007, P NATL ACAD SCI USA, V104, P2921, DOI 10.1073/pnas.0609270104; Grininger M, 2006, J MOL BIOL, V357, P842, DOI 10.1016/j.jmb.2005.12.072; Grininger M, 2006, J MOL BIOL, V364, P561, DOI 10.1016/j.jmb.2006.08.083; Heelis P. F., 1991, CHEM BIOCH FLAVOENZY, VI, P171; Hemmerich P, 1976, Fortschr Chem Org Naturst, V33, P451; Holzer W, 2005, CHEM PHYS, V308, P69, DOI 10.1016/j.chemphys.2004.08.006; Huber R, 2005, BIOCHEMISTRY-US, V44, P1800, DOI 10.1021/bi048318h; Koch MK, 2005, MOL MICROBIOL, V55, P1681, DOI 10.1111/j.1365-2958.2005.04516.x; MacFarlane AW, 2001, BIOCHEMISTRY-US, V40, P15203, DOI 10.1021/bi0114224; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Marg BL, 2005, BIOCHEMISTRY-US, V44, P29, DOI 10.1021/bi0485169; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Mataga N, 2000, J PHYS CHEM B, V104, P10667, DOI 10.1021/jp002145y; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Meissner B, 2007, J BIOL CHEM, V282, P33142, DOI 10.1074/jbc.M704951200; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; MOORE WM, 1963, J AM CHEM SOC, V85, P3367, DOI 10.1021/ja00904a013; Muller F, 1991, CHEM BIOCH FLAVOENZY, V1, P1; Nissen MS, 2008, J BIOL CHEM, V283, P28710, DOI 10.1074/jbc.M804535200; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCARANO G, 1994, ANAL CHIM ACTA, V296, P277, DOI 10.1016/0003-2670(94)80247-5; Sikorski M, 2001, J PHOTOCH PHOTOBIO B, V60, P114, DOI 10.1016/S1011-1344(01)00134-8; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tanaka F, 2007, J PHYS CHEM B, V111, P5694, DOI 10.1021/jp066450g; Tsukamoto S, 1999, EUR J BIOCHEM, V264, P785, DOI 10.1046/j.1432-1327.1999.00642.x; Twellmeyer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001064; UENO K, 1987, J BIOL CHEM, V262, P12780; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; WALKER WH, 1970, EUR J BIOCHEM, V13, P258, DOI 10.1111/j.1432-1033.1970.tb00926.x; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	38	33	36	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13068	13076		10.1074/jbc.M808063200	http://dx.doi.org/10.1074/jbc.M808063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19224924	hybrid, Green Published			2022-12-27	WOS:000265688300054
J	Uchiki, T; Kim, HT; Zhai, B; Gygi, SP; Johnston, JA; O'Bryan, JP; Goldberg, AL				Uchiki, Tomoaki; Kim, Hyoung Tae; Zhai, Bo; Gygi, Steven P.; Johnston, Jennifer A.; O'Bryan, John P.; Goldberg, Alfred L.			The Ubiquitin-interacting Motif Protein, S5a, Is Ubiquitinated by All Types of Ubiquitin Ligases by a Mechanism Different from Typical Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; END RULE PATHWAY; COUPLED MONOUBIQUITINATION; CONJUGATING ENZYMES; PROTEASOME; DEGRADATION; IDENTIFICATION; SUBUNIT; COMPLEX; DOMAIN	S5a/Rpn10 is a ubiquitin (Ub)-binding protein that is a subunit of the 26S proteasome but also exists free in the cytosol. It binds poly-Ub chains through its two Ub-interacting motifs (UIMs). We discovered that, unlike typical substrates of Ub ligases (E3s), S5a can be ubiquitinated by all E3s tested including multimeric and monomeric Ring finger E3s (MuRF1, Siah2, Parkin, APC, and SCF beta TRCP1), the U-box E3, CHIP, and HECT domain E3s (E6AP and Nedd4) when assayed with UbcH5 or related Ub-conjugating enzymes. However, the E2s, UbcH1 and UbcH13/Uev1a, which function by distinct mechanisms, do not support S5a ubiquitination. Thus, S5a can be used for assay of probably all E3s with UbcH5. Ubiquitination of S5a results from its binding to Ub chains on the E3 (after self-ubiquitination) or on the substrate, as a mutant lacking the UIM domain was not ubiquitinated. Furthermore, if the S5a UIM domains were fused to GST, the protein was rapidly ubiquitinated by MuRF1 and CHIP. In addition, polyubiquitination (but not monoubiquitination) of MuRF1 allowed S5a to bind to MuRF1 and accelerated S5a ubiquitination. This tendency of S5a to associate with the growing Ub chain can explain how S5a, unlike typical substrates, which are recognized by certain E3s through specific motifs, is ubiquitinated by all E3s tested and is rapidly degraded in vivo.	[Uchiki, Tomoaki; Kim, Hyoung Tae; Zhai, Bo; Gygi, Steven P.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; [Johnston, Jennifer A.] Elan Pharmaceut Inc, San Francisco, CA 94080 USA; [O'Bryan, John P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu		Kim, Hyoung Tae/0000-0002-0270-2749; HyoungTae, Kim/0000-0002-2482-6064; Johnston, Jennifer/0000-0002-4867-9230; O'Bryan, John/0000-0001-5386-1080	National Institutes of Health [GM51923, AR055255, GM67945]; Fund for Innovation from Elan Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Innovation from Elan Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51923 and AR055255 (to A. L. G.) and Grant GM67945(to S. P. G.). This work was also supported by the Fund for Innovation from Elan Pharmaceuticals (to A. L. G.).	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Haglund K, 2006, NAT CELL BIOL, V8, P1218, DOI 10.1038/ncb1106-1218; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rubin DM, 1997, MOL BIOL REP, V24, P17; Sasiela CA, 2008, J BIOMOL SCREEN, V13, P229, DOI 10.1177/1087057108315038; Sato S, 2008, BIOORG MED CHEM LETT, V18, P3354, DOI 10.1016/j.bmcl.2008.04.031; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Timsit YE, 2005, BIOCHEM BIOPH RES CO, V328, P550, DOI 10.1016/j.bbrc.2005.01.022; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	54	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12622	12632		10.1074/jbc.M900556200	http://dx.doi.org/10.1074/jbc.M900556200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240029	Green Published, hybrid			2022-12-27	WOS:000265688300006
J	Ganley, IG; Lam, DH; Wang, JR; Ding, XJ; Chen, S; Jiang, XJ				Ganley, Ian G.; Lam, Du H.; Wang, Junru; Ding, Xiaojun; Chen, She; Jiang, Xuejun			ULK1 center dot ATG13 center dot FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR MACHINERY; YEAST AUTOPHAGY; MUTANTS; ULK1; MECHANISM; PATHWAY; FIP200; GENES	Autophagy is a degradative process that recycles long-lived and faulty cellular components. It is linked to many diseases and is required for normal development. ULK1, a mammalian serine/threonine protein kinase, plays a key role in the initial stages of autophagy, though the exact molecular mechanism is unknown. Here we report identification of a novel protein complex containing ULK1 and two additional protein factors, FIP200 and ATG13, all of which are essential for starvation-induced autophagy. Both FIP200 and ATG13 are critical for correct localization of ULK1 to the pre-autophagosome and stability of ULK1 protein. Additionally, we demonstrate by using both cellular experiments and a de novo in vitro reconstituted reaction that FIP200 and ATG13 can enhance ULK1 kinase activity individually but both are required for maximal stimulation. Further, we show that ATG13 and ULK1 are phosphorylated by the mTOR pathway in a nutrient starvation-regulated manner, indicating that the ULK1 center dot ATG13 center dot FIP200 complex acts as a node for integrating incoming autophagy signals into autophagosome biogenesis.	[Ganley, Ian G.; Wang, Junru; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Lam, Du H.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Ding, Xiaojun; Chen, She] Natl Inst Biol Sci, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institute of Biological Sciences, Beijing	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 522, New York, NY 10065 USA.	jiangx@mskcc.org		Ganley, Ian/0000-0003-1481-9407	National Institutes of Health [R01 CA113890]; NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA113890 (to X.J.).	Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Carrera AC, 2004, J CELL SCI, V117, P4615, DOI 10.1242/jcs.01311; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	33	983	1025	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12297	12305		10.1074/jbc.M900573200	http://dx.doi.org/10.1074/jbc.M900573200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258318	hybrid, Green Published			2022-12-27	WOS:000265494600061
J	Paul, AS; Pollard, TD				Paul, Aditya S.; Pollard, Thomas D.			Energetic Requirements for Processive Elongation of Actin Filaments by FH1FH2-formins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMIN HOMOLOGY-2 DOMAIN; CAPPING PROTEIN; ATP HYDROLYSIS; FISSION YEAST; MOUSE FORMIN; FH2 DOMAIN; ADP-ACTIN; PROFILIN; NUCLEATION; POLYMERIZATION	Formin-homology (FH) 2 domains from formin proteins associate processively with the barbed ends of actin filaments through many rounds of actin subunit addition before dissociating completely. Interaction of the actin monomer-binding protein profilin with the FH1 domain speeds processive barbed end elongation by FH2 domains. In this study, we examined the energetic requirements for fast processive elongation. In contrast to previous proposals, direct microscopic observations of single molecules of the formin Bni1p from Saccharomyces cerevisiae labeled with quantum dots showed that profilin is not required for formin-mediated processive elongation of growing barbed ends. ATP-actin subunits polymerized by Bni1p and profilin release the gamma-phosphate of ATP on average > 2.5 min after becoming incorporated into filaments. Therefore, the release of gamma-phosphate from actin does not drive processive elongation. We compared experimentally observed rates of processive elongation by a number of different FH2 domains to kinetic computer simulations and found that actin subunit addition alone likely provides the energy for fast processive elongation of filaments mediated by FH1FH2-formin and profilin. We also studied the role of FH2 structure in processive elongation. We found that the flexible linker joining the two halves of the FH2 dimer has a strong influence on dissociation of formins from barbed ends but only a weak effect on elongation rates. Because formins are most vulnerable to dissociation during translocation along the growing barbed end, we propose that the flexible linker influences the lifetime of this translocative state.	[Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Paul, Aditya S.; Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, KBT 548,POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			National Institutes of Health [GM026338]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026132, R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM026338 ( to T. D. P.). This work was also supported by a National Science Foundation predoctoral fellowship ( to A. S. P.).	Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Shemesh T, 2007, BIOPHYS J, V92, P1512, DOI 10.1529/biophysj.106.098459; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; VALENTINRANC C, 1989, J BIOL CHEM, V264, P20871; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	34	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12533	12540		10.1074/jbc.M808587200	http://dx.doi.org/10.1074/jbc.M808587200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251693	hybrid, Green Published			2022-12-27	WOS:000265494600082
J	Belmiro, CLR; Castelo-Branco, MTL; Melim, LMC; Schanaider, A; Elia, C; Madi, K; Pavao, MSG; de Souza, HSP				Belmiro, Celso L. R.; Castelo-Branco, Morgana T. L.; Melim, Leandra M. C.; Schanaider, Alberto; Elia, Celeste; Madi, Kalil; Pavao, Mauro S. G.; de Souza, Heitor S. P.			Unfractionated Heparin and New Heparin Analogues from Ascidians (Chordate-Tunicate) Ameliorate Colitis in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; CROHNS-DISEASE; FACTOR-ALPHA; ULCERATIVE-COLITIS; MOLECULAR-WEIGHT; ANTICOAGULANT ACTIVITY; INCREASED EXPRESSION; MAINTENANCE THERAPY	The anti-inflammatory effect of mammalian heparin analogues, named dermatan sulfate and heparin, isolated from the ascidian Styela plicata was accessed in a TNBS-induced colitis model in rats. Subcutaneous administration of the invertebrate compounds during a 7-day period drastically reduced inflammation as observed by the normalization of the macroscopic and histological characteristics of the colon. At the molecular level, a decrease in the production of TNF-alpha, TGF-beta, and VEGF was observed, as well as a reduction of NF-kappa B and MAPK kinase activation. At the cellular level, the heparin analogues attenuated lymphocyte and macrophage recruitment and epithelial cell apoptosis. Adrastic reduction in collagen-mediated fibrosis was also observed. No hemorrhagic events were observed after glycan treatment. These results strongly indicate the potential therapeutic use of these compounds for the treatment of colonic inflammation with a lower risk of hemorrhage when compared with mammalian heparin.	[Belmiro, Celso L. R.; Melim, Leandra M. C.; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Tecido Conjunt, BR-21941913 Rio De Janeiro, Brazil; [Belmiro, Celso L. R.; Melim, Leandra M. C.; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941913 Rio De Janeiro, Brazil; [Castelo-Branco, Morgana T. L.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embryol, BR-21941590 Rio de Janeiro, Brazil; [Schanaider, Alberto] Univ Fed Rio de Janeiro, HUCFF, Dept Cirurgia Expt, BR-21941590 Rio de Janeiro, Brazil; [Elia, Celeste; Madi, Kalil; de Souza, Heitor S. P.] Univ Fed Rio de Janeiro, HUCFF, Dept Clin Med, BR-21941913 Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Souza, HSP (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Multidisciplinar Pesquisa Sub Solo, Ilha Fundao, Rua Prof Rodolpho Paulo Rocco 255, BR-21941913 Rio de Janeiro, Brazil.	hsouza@hucff.ufrj.br	de Souza, Heitor Siffert Pereira/G-3297-2012; Pavao, Mauro Sergio Goncalves/B-1979-2010	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Pavao, Mauro Sergio Goncalves/0000-0002-1336-4271	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao JoseBonifacio (FUJB); Mizutani Foundation for Glycoscience	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao JoseBonifacio (FUJB); Mizutani Foundation for Glycoscience	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao JoseBonifacio (FUJB), Mizutani Foundation for Glycoscience (to M.S.G.P.).	Andoh A, 2005, AM J GASTROENTEROL, V100, P2042, DOI 10.1111/j.1572-0241.2005.50381.x; Ang YS, 2000, ALIMENT PHARM THERAP, V14, P1015, DOI 10.1046/j.1365-2036.2000.00802.x; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P975, DOI 10.1053/gast.1996.v110.pm8613031; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beddy DJ, 2004, J AM COLL SURGEONS, V199, P234, DOI 10.1016/j.jamcollsurg.2004.02.028; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Belmiro CLR, 2005, INT J COLORECTAL DIS, V20, P295, DOI 10.1007/s00384-004-0677-2; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Brass DM, 2007, AM J PHYSIOL-LUNG C, V293, pL77, DOI 10.1152/ajplung.00282.2006; Cardilo-Reis L, 2006, BRAZ J MED BIOL RES, V39, P1409, DOI 10.1590/S0100-879X2006001100004; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P137, DOI 10.1053/j.gastro.2007.04.069; Dignass AU, 1996, EXP CELL RES, V225, P422, DOI 10.1006/excr.1996.0193; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; DOLBER PC, 1987, STAIN TECHNOL, V62, P23, DOI 10.3109/10520298709107961; DZIARSKI R, 1994, J BIOL CHEM, V269, P2100; Elsayed E, 2003, J THROMB THROMBOLYS, V15, P11, DOI 10.1023/A:1026184100030; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Firestein GS, 1999, J CLIN INVEST, V103, P3, DOI 10.1172/JCI5929; Folwaczny C, 1999, AM J GASTROENTEROL, V94, P1551; GAFFNEY PR, 1995, AM J GASTROENTEROL, V90, P220; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Khorana AA, 2003, ARTERIOSCL THROM VAS, V23, P2110, DOI 10.1161/01.ATV.0000090671.56682.D7; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P16, DOI 10.1097/00054725-200102000-00003; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P226, DOI 10.1097/00054725-200108000-00008; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Marchetti M, 2008, THROMB RES, V121, P637, DOI 10.1016/j.thromres.2007.06.015; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Papa A, 2000, ALIMENT PHARM THER, V14, P1403, DOI 10.1046/j.1365-2036.2000.00860.x; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Pavao MSG, 1995, J BIOL CHEM, V270, P31027, DOI 10.1074/jbc.270.52.31027; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; Pavao MSG, 2002, AN ACAD BRAS CIENC, V74, P105, DOI 10.1590/S0001-37652002000100007; Perera PY, 1997, J IMMUNOL, V158, P4422; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; RODEN L, 1992, ADV EXP MED BIOL, V313, P1; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Santos JC, 2007, THROMB RES, V121, P213, DOI 10.1016/j.thromres.2007.03.025; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; SCHURMANN GM, 1995, GUT, V36, P411, DOI 10.1136/gut.36.3.411; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; VANDULLEMEN HM, 1995, J GASTROENTEROL, V109, P129; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Vicente CP, 2001, THROMB HAEMOSTASIS, V86, P1215, DOI 10.1055/s-0037-1616054; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	62	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11267	11278		10.1074/jbc.M807211200	http://dx.doi.org/10.1074/jbc.M807211200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258310	Green Published, hybrid			2022-12-27	WOS:000265494500030
J	Fisk, JC; Sayegh, J; Zurita-Lopez, C; Menon, S; Presnyak, V; Clarke, SG; Read, LK				Fisk, John C.; Sayegh, Joyce; Zurita-Lopez, Cecilia; Menon, Sarita; Presnyak, Vladimir; Clarke, Steven G.; Read, Laurie K.			A Type III Protein Arginine Methyltransferase from the Protozoan Parasite Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION EXCHANGE CHROMATOGRAPHY; INDUCIBLE EXPRESSION SYSTEM; RNA-BINDING PROTEIN; MESSENGER-RNA; SUBSTRATE-SPECIFICITY; GUIDE RNA; IN-VITRO; SUBCELLULAR-LOCALIZATION; N-METHYLTRANSFERASE; GENE-EXPRESSION	Arginine methylation is a widespread post-translational modification of proteins catalyzed by a family of protein arginine methyltransferases (PRMTs). The ancient protozoan parasite, Trypanosoma brucei, possesses five putative PRMTs, a relatively large number for a single-celled eukaryote. Trypanosomatids lack gene regulation at the level of transcription, instead relying on post-transcriptional control mechanisms that act at the levels of RNA turnover, translation, and editing, all processes that likely involve multiple RNA-binding proteins, which are common targets of arginine methylation. Here, we report the characterization of a trypanosome PRMT, TbPRMT7, which is homologous to human PRMT7. Interestingly, trypanosomatids are the only single-celled eukaryotes known to harbor a PRMT7 homologue. TbPRMT7 differs dramatically from all known metazoan PRMT7 homologues in lacking the second AdoMet binding-like domain that is required for activity of the human enzyme. Nevertheless, bacterially expressed TbPRMT7 exhibits robust methyltransferase activity toward multiple targets in vitro. High resolution ion exchange chromatography analysis of methylated substrates reveals that TbPRMT7 is a type III PRMT, catalyzing the formation of only monomethylarginine, thereby representing the only exclusively type III PRMT identified to date. TbPRMT7 is expressed in both mammalian and insect stage T. brucei and is apparently dispensable for growth in both life cycle stages. The enzyme is cytoplasmically localized and is a component of several higher order complexes in vivo. Together, our studies indicate that TbPRMT7 is a Type III PRMT, and its robust activity and presence in numerous complexes suggest it plays multiple roles during the complex T. brucei life cycle.	[Fisk, John C.; Menon, Sarita; Presnyak, Vladimir; Read, Laurie K.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14124 USA; [Sayegh, Joyce; Zurita-Lopez, Cecilia; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sayegh, Joyce; Zurita-Lopez, Cecilia; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Read, LK (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14124 USA.	lread@buffalo.edu	Menon, Sarita/B-5609-2012; Zurita-Lopez, Cecilia I./AAC-6509-2020	Menon, Sarita/0000-0001-9548-149X; Presnyak, Vladimir/0000-0001-6695-7102	National Institutes of Health [R01AI060260, R37GM026020]; American Heart Association [0725984T]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI060260 (to L.K.R.) and Grant R37GM026020 (to S.G.C.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725984T (to S.M.).	Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BOISVERT FM, 2005, SCI STKE, pRE2, DOI DOI 10.1126/STKE.2712005RE2; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Goulah CC, 2007, J BIOL CHEM, V282, P7181, DOI 10.1074/jbc.M609485200; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; KLEIN PD, 1967, ANAL CHEM, V39, P1276, DOI 10.1021/ac60255a005; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lake AN, 2007, MUTAT RES-FUND MOL M, V618, P91, DOI 10.1016/j.mrfmmm.2006.09.010; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Miranda TB, 2006, BIOCHEM J, V395, P563, DOI 10.1042/BJ20051771; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pasternack DA, 2007, EUKARYOT CELL, V6, P1665, DOI 10.1128/EC.00133-07; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; XIE HY, 1993, J BIOL CHEM, V268, P13364; Zeiner GM, 2003, EUKARYOT CELL, V2, P222, DOI 10.1128/EC.2.2.222-230.2003	57	46	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11590	11600		10.1074/jbc.M807279200	http://dx.doi.org/10.1074/jbc.M807279200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19254949	Green Published, hybrid			2022-12-27	WOS:000265494500063
J	Jana, SS; Kim, KY; Mao, J; Kawamoto, S; Sellers, JR; Adelstein, RS				Jana, Siddhartha S.; Kim, Kye-Young; Mao, Jian; Kawamoto, Sachiyo; Sellers, James R.; Adelstein, Robert S.			An Alternatively Spliced Isoform of Non-muscle Myosin II-C Is Not Regulated by Myosin Light Chain Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-BINDING LOOP; HEAVY-CHAIN; RHO; EXPRESSION; MEROMYOSIN; LOCALIZATION; CYTOKINESIS; MECHANISM; KINASES	We report a novel isoform of non-muscle myosin II-C (NM II-C), NM II-C2, that is generated by alternative splicing of an exon, C2, encoding 41 amino acids in mice (33 in humans). The 41 amino acids are inserted into loop 2 of the NM II-C heavy chain within the actin binding region. Unlike most vertebrate non-muscle and smooth muscle myosin IIs, baculovirus-expressed mouse heavy meromyosin (HMM) II-C2 demonstrates no requirement for regulatory myosin light chain(MLC20) phosphorylation for maximum actin-activated MgATPase activity or maximum in vitro motility as measured by the sliding actin filament assay. In contrast, noninserted HMM II-C0 and another alternatively spliced isoform HMM II-C1, which contains 8 amino acids inserted into loop 1, are dependent on MLC20 phosphorylation for both actin-activated MgATPase activity and in vitro motility (Kim, K. Y., Kovacs, M., Kawamoto, S., Sellers, J. R., and Adelstein, R. S. (2005) J. Biol. Chem. 280, 22769-22775). HMM II-C1C2, which contains both the C1 and C2 inserts, does not require MLC20 phosphorylation for full activity similar to HMM II-C2. These constitutively active C2-inserted isoforms of NM II-C are expressed only in neuronal tissue. This is in contrast to NM II-C1 and NM II-C0, both of which are ubiquitously expressed. Full-lengthNMII-C2-GFP expressed in COS-7 cells localizes to filaments in interphase cells and to the cytokinetic ring in dividing cells.	[Jana, Siddhartha S.; Kim, Kye-Young; Mao, Jian; Kawamoto, Sachiyo; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Jana, Siddhartha S.] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 700032, India	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Jana, SS (corresponding author), NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA.	bcssj@iacs.res.in		Adelstein, Robert/0000-0002-8683-2144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004235, ZIAHL004235, ZIAHL001786, ZICHL006019] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alhopuro P, 2008, P NATL ACAD SCI USA, V105, P5513, DOI 10.1073/pnas.0801213105; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Conti M, 2008, MYOS SUP MOL MOT, V7, P223; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Rovner AS, 1998, J BIOL CHEM, V273, P27939, DOI 10.1074/jbc.273.43.27939; Rovner AS, 1995, J BIOL CHEM, V270, P30260, DOI 10.1074/jbc.270.51.30260; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Takahashi M, 1999, BIOCHEM BIOPH RES CO, V259, P29, DOI 10.1006/bbrc.1999.0717; Takahashi M, 2001, J BIOL CHEM, V276, P1034, DOI 10.1074/jbc.M005370200; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Tullio AN, 2001, J COMP NEUROL, V433, P62, DOI 10.1002/cne.1125; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098	38	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11563	11571		10.1074/jbc.M806574200	http://dx.doi.org/10.1074/jbc.M806574200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240025	Green Published, hybrid			2022-12-27	WOS:000265494500060
J	Mares, J; Kumaran, S; Gobbo, M; Zerbe, O				Mares, Jiri; Kumaran, Sowmini; Gobbo, Marina; Zerbe, Oliver			Interactions of Lipopolysaccharide and Polymyxin Studied by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP ROUGH MUTANT; DODECYL-SULFATE MICELLES; GRAM-NEGATIVE BACTERIA; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; ORBITAL ELECTRONEGATIVITY; PARTIAL EQUALIZATION; HIGH-SENSITIVITY; ATOMIC CHARGES; FORCE-FIELD	In the light of occurrence of bacterial strains with multiple resistances against most antibiotics, antimicrobial peptides that interact with the outer layer of Gram-negative bacteria, such as polymyxin (PMX), have recently received increased attention. Here we present a study of the interactions of PMX-B, -E, and -M with lipopolysaccharide (LPS) from a deep rough mutant strain of Escherichia coli. A method for efficient purification of biosynthetically produced LPS using reversed-phase high-performance liquid chromatography in combination with ternary solvent mixtures was developed. LPS was incorporated into a membrane model, dodecylphosphocholine micelles, and its interaction with polymyxins was studied by heteronuclear NMR spectroscopy. Data from chemical shift mapping using isotope-labeled LPS or labeled polymyxin, as well as from isotope-filtered nuclear Overhauser effect spectroscopy experiments, reveal the mode of interaction of LPS with polymyxins. Using molecular dynamics calculations the complex of LPS with PMX-B in the presence of dodecylphosphocholine micelles was modeled using restraints derived from chemical shift mapping data and intermolecular nuclear Overhauser effects. In the modeled complex the macrocycle of PMX is centered around the phosphate group at GlcN-B, and additional contacts from polar side chains are formed to GlcN-A and Kdo-C, whereas hydrophobic side chains penetrate the acyl-chain region.	[Mares, Jiri; Kumaran, Sowmini; Zerbe, Oliver] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; [Gobbo, Marina] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy	University of Zurich; University of Padua	Zerbe, O (corresponding author), Univ Zurich, Inst Organ Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	oliver.zerbe@oci.uzh.ch	Mares, Jiri/ABA-4314-2020		Swiss National Science Foundation [3100A0-11173]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Grant 3100A0-11173).	Agrawal PK, 1998, MAGN RESON CHEM, V36, P1, DOI 10.1002/(SICI)1097-458X(199801)36:1<1::AID-OMR164>3.0.CO;2-J; Andra J, 2005, BIOCHEM J, V385, P135, DOI 10.1042/BJ20041270; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; BLOMMERS MJJ, 2003, BIONMR DRUG RES, P355; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; David SA, 2001, J MOL RECOGNIT, V14, P370, DOI 10.1002/jmr.549; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; GEMMECKER G, 2003, BIONMR DRUG RES, P373; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gobbo M, 2006, J PEPT SCI, V12, P132, DOI 10.1002/psc.695; Goddard TD, 2006, SPARKY 3 VERSION 3 1; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jarvet J, 1997, BIOCHEMISTRY-US, V36, P8153, DOI 10.1021/bi970193b; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEELER J, 1994, METHOD ENZYMOL, V239, P145; Keller R., 2004, COMPUTER AIDED RESON, V1; Koch PJ, 1999, J COLLOID INTERF SCI, V213, P557, DOI 10.1006/jcis.1999.6137; LIVE DH, 1984, J AM CHEM SOC, V106, P6104, DOI 10.1021/ja00332a071; MARCHIORO C, 2003, BIONMR DRUG RES, P321; Martin NI, 2003, J BIOL CHEM, V278, P13124, DOI 10.1074/jbc.M212364200; NO KT, 1990, J PHYS CHEM-US, V94, P4732, DOI 10.1021/j100374a066; OLEJNICZAK ET, 1992, J BIOMOL NMR, V2, P655, DOI 10.1007/BF02192854; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PAPAVOINE CHM, 1994, BIOCHEMISTRY-US, V33, P12990, DOI 10.1021/bi00248a007; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Pristovsek P, 2005, J MED CHEM, V48, P1666, DOI 10.1021/jm049217k; QURESHI N, 1988, J BIOL CHEM, V263, P11971; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; RANA FR, 1991, FEBS LETT, V293, P11, DOI 10.1016/0014-5793(91)81141-T; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yeagle P.L, 2016, MEMBRANES CELLS	52	76	82	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11498	11506		10.1074/jbc.M806587200	http://dx.doi.org/10.1074/jbc.M806587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244241	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000265494500054
J	Zakariassen, H; Aam, BB; Horn, SJ; Varum, KM; Sorlie, M; Eijsink, VGH				Zakariassen, Henrik; Aam, Berit Bjugan; Horn, Svein J.; Varum, Kjell M.; Sorlie, Morten; Eijsink, Vincent G. H.			Aromatic Residues in the Catalytic Center of Chitinase A from Serratia marcescens Affect Processivity, Enzyme Activity, and Biomass Converting Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLINE CELLULOSE DEGRADATION; CARBOHYDRATE-BINDING MODULES; VIBRIO-CARCHARIAE CHITINASE; TRICHODERMA-REESEI; SUBSTRATE-BINDING; FAMILY-18 CHITINASE; CELLOBIOHYDROLASE CEL6A; THERMOMONOSPORA-FUSCA; GLYCOSYL HYDROLASES; STRUCTURAL BASIS	The processive Serratia marcescens chitinases A(ChiA) and B (ChiB) are thought to degrade chitin in the opposite directions. A recent study of ChiB suggested that processivity is governed by aromatic residues in the +1 and +2 (aglycon) subsites close to the catalytic center. To further investigate the roles of aromatic residues in processivity and to gain insight into the structural basis of directionality, we have mutated Trp(167), Trp(275), and Phe(396) in the -3, +1, and +2 subsites of ChiA, respectively, and characterized the hydrolytic activities of the mutants toward beta-chitin and the soluble chitin-derivative chitosan. Although the W275A and F396A mutants showed only modest reductions in processivity, it was almost abolished by the W167A mutation. Thus, although aglycon subsites seem to steer processivity in ChiB, a glycon (-3) subsite seems to be adapted to do so in ChiA, in line with the notion that the two enzymes have different directionalities. Remarkably, whereas all three single mutants and the W167A/W275A double mutant showed reduced efficiency toward chitin, they showed up to 20-fold higher activities toward chitosan. These results show that the processive mechanism is essential for an efficient conversion of crystalline substrates but comes at a large cost in terms of intrinsic enzyme speed. This needs to be taken into account when devising enzymatic strategies for biomass turnover.	[Zakariassen, Henrik; Aam, Berit Bjugan; Horn, Svein J.; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Varum, Kjell M.] Norwegian Univ Sci & Technol, Norwegian Biopolymer Lab NOBIPOL, Dept Biotechnol, N-7491 Trondheim, Norway	Norwegian University of Life Sciences; Norwegian University of Science & Technology (NTNU)	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	vincent.eijsink@umb.no	Horn, Svein Jarle/C-6258-2008; Horn, Svein/F-9723-2010	Horn, Svein Jarle/0000-0002-1590-9001; 	Norwegian Research Council [164653, 174972]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Grants 164653 and 174972 from the Norwegian Research Council.	Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DRAGET KI, 1992, BIOMATERIALS, V13, P635, DOI 10.1016/0142-9612(92)90032-J; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; EPHRAIM C, 1993, ARCH INSECT BIOCH PH, V22, P245; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kim J, 2006, MACROMOLECULES, V39, P4202, DOI 10.1021/ma060261e; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Oliveira EN, 2008, MYCOPATHOLOGIA, V166, P163, DOI 10.1007/s11046-008-9125-0; Pantoom Supansa, 2008, BMC Biochemistry, V9, P2, DOI 10.1186/1471-2091-9-2; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; SANNAN T, 1978, POLYMER, V19, P458, DOI 10.1016/0032-3861(78)90256-2; SCHINDLER M, 1977, BIOCHIM BIOPHYS ACTA, V482, P386, DOI 10.1016/0005-2744(77)90252-2; Sikorski P, 2005, BIOPOLYMERS, V77, P273, DOI 10.1002/bip.20224; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2; Vinetz JM, 2000, J BIOL CHEM, V275, P10331, DOI 10.1074/jbc.275.14.10331; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Zhang S, 1997, J BIOTECHNOL, V57, P101, DOI 10.1016/S0168-1656(97)00093-X; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	62	129	130	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10610	10617		10.1074/jbc.M900092200	http://dx.doi.org/10.1074/jbc.M900092200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244232	Green Published, hybrid			2022-12-27	WOS:000265104600035
J	Bhatnagar, S; Damron, HA; Hillgartner, FB				Bhatnagar, Sushant; Damron, Holly A.; Hillgartner, F. Bradley			Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; ELEMENT-BINDING PROTEIN-1C; LIPOGENIC GENE-EXPRESSION; IMPROVES INSULIN SENSITIVITY; ORPHAN NUCLEAR RECEPTOR; TRANSCRIPTION FACTORS; LIPID-METABOLISM; NUTRITIONAL REGULATION; RAT HEPATOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE	Previous studies have shown that administration of fibroblast growth factor-19 (FGF-19) reverses diabetes, hepatic steatosis, hyperlipidemia, and adipose accretion in animal models of obesity. To investigate the mechanism for this effect, we determined whether FGF-19 modulated hepatic fatty acid synthesis, a key process controlling glucose tolerance and triacylglycerol accumulation in liver, blood, and adipose tissue. Incubating primary hepatocyte cultures with recombinant FGF-19 suppressed the ability of insulin to stimulate fatty acid synthesis. This effect was associated with a reduction in the expression of lipogenic enzymes. FGF-19 also suppressed the insulin-induced expression of sterol regulatory element-binding protein-1c (SREBP-1c), a key transcriptional activator of lipogenic genes. FGF-19 inhibition of lipogenic enzyme expression was not mediated by alterations in the activity of the insulin signal transduction pathway or changes in the activity of ERK, p38 MAPK, and AMP-activated protein kinase (AMPK). In contrast, FGF-19 increased the activity of STAT3, an inhibitor of SREBP-1c expression and decreased the expression of peroxisome proliferator-activated receptor-gamma coactivator-1 beta (PGC-1 beta), an activator of SREBP-1c activity. FGF-19 also increased the expression of small heterodimer partner (SHP), a transcriptional repressor that inhibits lipogenic enzyme expression via a SREBP-1c-independent mechanism. Inhibition of SREBP-1c activity by changes in STAT3 and PGC-1 beta activity and inhibition of gene transcription by an elevation in SHP expression can explain the inhibition of lipogenesis caused by FGF-19. In summary, the inhibitory effect of FGF-19 on insulin activation of hepatic fatty acid synthesis constitutes a mechanism that would explain the beneficial effect of FGF-19 on metabolic syndrome.	[Bhatnagar, Sushant; Damron, Holly A.; Hillgartner, F. Bradley] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University	Hillgartner, FB (corresponding author), W Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu			National Research Initiative Competitive [2007-35206-17845]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service	National Research Initiative Competitive(United States Department of Agriculture (USDA)); United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by National Research Initiative Competitive Grant 2007-35206-17845 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service.	Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gregori C, 2006, FEBS LETT, V580, P410, DOI 10.1016/j.febslet.2005.12.032; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lowenstein J M, 1975, Methods Enzymol, V35, P279, DOI 10.1016/0076-6879(75)35165-3; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NARKEWICZ MR, 1990, BIOCHEM J, V271, P585, DOI 10.1042/bj2710585; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; PETTY KJ, 1989, J BIOL CHEM, V264, P11483; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Salati LM, 2004, J NUTR, V134, p2437S, DOI 10.1093/jn/134.9.2437S; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Stabile LP, 1998, J LIPID RES, V39, P1951; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Streeper RS, 1998, MOL ENDOCRINOL, V12, P1778, DOI 10.1210/me.12.11.1778; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	66	144	149	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10023	10033		10.1074/jbc.M808818200	http://dx.doi.org/10.1074/jbc.M808818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233843	Green Published, hybrid			2022-12-27	WOS:000264892900045
J	Chen, N; Chen, XQ; Huang, R; Zeng, H; Gong, J; Meng, WT; Lu, YP; Zhao, F; Wang, L; Zhou, Q				Chen, Ni; Chen, Xueqin; Huang, Rui; Zeng, Hao; Gong, Jing; Meng, Wentong; Lu, Yiping; Zhao, Fang; Wang, Lin; Zhou, Qiao			BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; FACTOR 1-ALPHA; FACTOR-I; CELLULAR PROLIFERATION; INDUCED APOPTOSIS; RNA INTERFERENCE; DOWN-REGULATION; UP-REGULATION; LUNG-CANCER; EXPRESSION	The transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays pivotal roles in physiology and pathophysiology. Constitutive or hypoxia-induced HIF-1 alpha overexpression is observed in many types of cancers including prostate adenocarcinoma, in which it is associated with resistance to apoptosis and therapeutic agents. BCL-xL, a hypoxia-responsive, anti-apoptotic protein of the Bcl-2 family, is also overexpressed in prostate carcinoma and many other cancers. Despite this connection, whether BCL-xL expression is directly regulated by HIF-1 alpha is not known. We used prostate cancer PC-3 cell with constitutive high HIF-1 alpha level as a model to address this important question. We first generated prostate cancer PC-3 cells in which HIF-1 alpha was stably knocked-down (HIF-KD) by using small interference RNA. BCL-xL was dramatically decreased in HIF-KD PC-3 cells, in parallel with sensitization to apoptosis with caspase-3 activation as well as decreased cell proliferation. We then demonstrated that HIF-1 alpha directly regulated BCL-xL transcription by binding to a hypoxia-responsive element in the BCL-xL promoter (-865 to -847) by reporter gene assay, chromatin immunoprecipitation, and electrophoretic mobility shift and supershift assays. HIF-1 alpha dependent BCL-xL overexpression may be an important mechanism by which HIF-1 alpha protects prostate cancer cells from apoptosis and leads to treatment resistance.	[Chen, Ni; Chen, Xueqin; Huang, Rui; Gong, Jing; Zhou, Qiao] Sichuan Univ, W China Med Sch, W China Hosp, Dept Pathol, Chengdu 610041, Peoples R China; [Chen, Ni; Chen, Xueqin; Huang, Rui; Zeng, Hao; Gong, Jing; Zhou, Qiao] Sichuan Univ, W China Med Sch, W China Hosp, Pathol Lab, Chengdu 610041, Peoples R China; [Zeng, Hao; Lu, Yiping] Sichuan Univ, W China Med Sch, W China Hosp, Dept Urol, Chengdu 610041, Peoples R China; [Meng, Wentong] Sichuan Univ, W China Med Sch, W China Hosp, Dept Lab Stem Cell Res,State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Zhao, Fang] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; [Wang, Lin] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; University of Helsinki; University of Texas System; UTMD Anderson Cancer Center	Zhou, Q (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, Dept Pathol, Chengdu 610041, Peoples R China.	zhouqiao@mcwcums.com			Natural Science Foundation of China Grants NSFC [30570692, 30871383, 30800637]; Ministry of Education PhD Program Fund [20060610053]; Postdoctoral Fund of China [20060401022]; National Basic Research Program of China [2007CB947802]	Natural Science Foundation of China Grants NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education PhD Program Fund; Postdoctoral Fund of China(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China Grants NSFC 30570692, 30871383, and 30800637, Ministry of Education PhD Program Fund 20060610053, and Postdoctoral Fund 20060401022 of China. 1 Supported by National Basic Research Program of China Grant 2007CB947802.	Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Comerford KM, 2002, CANCER RES, V62, P3387; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gillespie DL, 2007, CLIN CANCER RES, V13, P2441, DOI 10.1158/1078-0432.CCR-06-2692; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hanze J, 2003, BIOCHEM BIOPH RES CO, V312, P571, DOI 10.1016/j.bbrc.2003.10.153; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kondo Y, 2005, J UROLOGY, V173, P1762, DOI 10.1097/01.ju.0000154343.35444.09; Lebedeva I, 2000, CANCER RES, V60, P6052; Liu XH, 2006, J CELL BIOCHEM, V97, P755, DOI 10.1002/jcb.20683; Liu YL, 2006, CANCER BIOL THER, V5, P1320, DOI 10.4161/cbt.5.10.3162; Margue CM, 2000, ONCOGENE, V19, P2921, DOI 10.1038/sj.onc.1203607; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Movsas B, 2002, UROLOGY, V60, P634, DOI 10.1016/S0090-4295(02)01858-7; Park SY, 2002, BIOCHEM BIOPH RES CO, V291, P150, DOI 10.1006/bbrc.2002.6421; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Rothermund Christy A, 2005, BMC Urol, V5, P5, DOI 10.1186/1471-2490-5-5; Saramaki OR, 2001, CANCER GENET CYTOGEN, V128, P31, DOI 10.1016/S0165-4608(01)00396-X; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; Sowter HM, 2001, CANCER RES, V61, P6669; Sugars KL, 2001, NUCLEIC ACIDS RES, V29, P4530, DOI 10.1093/nar/29.22.4530; Vilenchik M, 2002, CANCER RES, V62, P2175; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Yoshida D, 2006, J NEURO-ONCOL, V78, P217, DOI 10.1007/s11060-005-9017-9; Yu EZ, 2004, LAB INVEST, V84, P553, DOI 10.1038/labinvest.3700071; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhang QZ, 2004, INT J CANCER, V111, P849, DOI 10.1002/ijc.20334; Zhong H, 2004, CANCER DETECT PREV, V28, P88, DOI 10.1016/j.cdp.2003.12.009; Zhong H, 1998, CANCER RES, V58, P5280; Zhong H, 1999, CANCER RES, V59, P5830	40	135	141	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10004	10012		10.1074/jbc.M805997200	http://dx.doi.org/10.1074/jbc.M805997200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211554	hybrid, Green Published			2022-12-27	WOS:000264892900043
J	Vongsa, RA; Zimmerman, NP; Dwinell, MB				Vongsa, Rebecca A.; Zimmerman, Noah P.; Dwinell, Michael B.			CCR6 Regulation of the Actin Cytoskeleton Orchestrates Human Beta Defensin-2-and CCL20-mediated Restitution of Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIGHT-CHAIN KINASE; GROWTH-FACTOR-BETA; CROHNS-DISEASE; IN-VITRO; INTESTINAL PERMEABILITY; CHEMOKINE RECEPTORS; DENDRITIC CELLS; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2	Intestinal inflammation is exacerbated by defects in the epithelial barrier and subsequent infiltration of microbes and toxins into the underlying mucosa. Production of chemokines and antimicrobial peptides by an intact epithelium provide the first line of defense against invading organisms. In addition to its antimicrobial actions, human beta defensin-2 (HBD2) may also stimulate the migration of dendritic cells through binding the chemokine receptor CCR6. As human colonic epithelium expresses CCR6, we investigated the potential of HBD2 to stimulate intestinal epithelial migration. Using polarized human intestinal Caco2 and T84 cells and non-transformed IEC6 cells, HBD2 was equipotent to CCL20 in stimulating migration. Neutralizing antibodies confirmed HBD2 and CCL20 engagement to CCR6 were sufficient to induce epithelial cell migration. Consistent with restitution, motogenic concentrations of HBD2 and CCL20 did not induce proliferation. Stimulation with those CCR6 ligands leads to calcium mobilization and elevated active RhoA, phosphorylated myosin light chain, and F-actin accumulation. HBD2 and CCL20 were unable to stimulate migration in the presence of either Rho-kinase or phosphoinositide 3-kinase inhibitors or an intracellular calcium chelator. Together, these data indicate that the canonical wound healing regulatory pathway, along with calcium mobilization, regulates CCR6-directed epithelial cell migration. These findings expand the mechanistic role for chemokines and HBD2 in mucosal inflammation to include immunocyte trafficking and killing of microbes with the concomitant activation of restitutive migration and barrier repair.	[Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Bobbie Nick Voss Lab, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Bobbie Nick Voss Lab, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu			National Institutes of Health [DK062066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062066, R01DK062066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062066 from NIDDK.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Beck PL, 2003, AM J PATHOL, V162, P597, DOI 10.1016/S0002-9440(10)63853-9; BOUCEK MM, 1976, SCIENCE, V193, P905, DOI 10.1126/science.948752; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Commane DM, 2005, NUTR CANCER, V51, P102, DOI 10.1207/s15327914nc5101_14; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Ina K, 1997, AM J GASTROENTEROL, V92, P1342; Isomoto H, 2005, WORLD J GASTROENTERO, V11, P4782, DOI 10.3748/wjg.v11.i31.4782; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jia HP, 1999, INFECT IMMUN, V67, P4827, DOI 10.1128/IAI.67.9.4827-4833.1999; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Katchar K, 2007, AM J PHYSIOL-GASTR L, V292, pG1263, DOI 10.1152/ajpgi.00409.2006; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Khandaker MH, 1998, J IMMUNOL, V161, P1930; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Lotz MM, 1997, AM J PATHOL, V150, P747; MacDermott RP, 1998, INFLAMM BOWEL DIS, V4, P54, DOI 10.1097/00054725-199802000-00009; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Middel P, 2006, GUT, V55, P220, DOI 10.1136/gut.2004.063008; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nejdfors P, 2000, DIS COLON RECTUM, V43, P1582, DOI 10.1007/BF02236743; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pernet I, 2003, EXP DERMATOL, V12, P755, DOI 10.1111/j.0906-6705.2003.00086.x; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; REINECKER HC, 1995, GASTROENTEROLOGY, V108, P40, DOI 10.1016/0016-5085(95)90006-3; Riegler M, 1996, GASTROENTEROLOGY, V111, P28, DOI 10.1053/gast.1996.v111.pm8698221; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Rutgeerts Paul J, 2004, Rev Gastroenterol Disord, V4 Suppl 3, pS1; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Turner JR, 1999, AM J PHYSIOL-CELL PH, V277, pC554, DOI 10.1152/ajpcell.1999.277.3.C554; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2001, J LEUKOCYTE BIOL, V69, P691	73	59	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10034	10045		10.1074/jbc.M805289200	http://dx.doi.org/10.1074/jbc.M805289200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233848	hybrid, Green Published			2022-12-27	WOS:000264892900046
J	Banci, L; Bertini, I; Cantini, F; Massagni, C; Migliardi, M; Rosato, A				Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Massagni, Chiara; Migliardi, Manuele; Rosato, Antonio			An NMR Study of the Interaction of the N-terminal Cytoplasmic Tail of the Wilson Disease Protein with Copper(I)-HAH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; METAL-BINDING DOMAIN; P-TYPE ATPASE; MENKES-DISEASE; INTERMOLECULAR INTERACTIONS; INTRACELLULAR TRAFFICKING; CATALYTIC-ACTIVITY; CANDIDATE GENE; CHAPERONE; ATP7A	ATP7B is a human P-1B-type ATPase that has a crucial role in maintaining copper(I) homeostasis. Mutations in the corresponding gene are the cause of Wilson disease. Among its various distinguishing features is a long (similar to 630 amino acids) N-terminal cytosolic tail containing six domains that are individually folded and capable of binding one copper(I) ion each. We expressed the entire tail as a single construct in Escherichia coli and investigated its interaction with its copper chaperone (i.e. HAH1) by solution NMR spectroscopy. We observed that all six of the metal-binding domains were metallated by Cu(I)-HAH1, with the first, the second, and the fourth domains forming an adduct with it. This behavior is different from that of the highly similar human ATPase ATP7A, in which only two domains form such an adduct. The distinct behaviors of the different domains were analyzed in terms of the energetics of Cu(I) transfer, hinting at a specific role of the interaction with copper(I)-HAH1 in the overall functional process.	[Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Massagni, Chiara; Migliardi, Manuele; Rosato, Antonio] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Rosato, Antonio] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Massagni, Chiara] FIORGEN Fdn, I-50019 Sesto Fiorentino, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Rosato, Antonio/D-8548-2011; Rosato, Antonio/M-3250-2019; Cantini, Francesca/O-1220-2015	Rosato, Antonio/0000-0001-6172-0368; Rosato, Antonio/0000-0001-6172-0368; BANCI, LUCIA/0000-0003-0562-5774; Cantini, Francesca/0000-0003-0526-6732	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base) [RBLA032ZM7]; Ente Cassa di Risparmio di Firenze; European Commission [SPINE2-COMPLEXES-031220]	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base project RBLA032ZM7), Ente Cassa di Risparmio di Firenze (Projects "Basi Molecolari di Patologie Umane Correlate a Disfunzioni della Catena Respiratoria" and "Relazione Varianti Proteiche Strutturali-malattie Genetiche"), and the European Commission (Project SPINE2-COMPLEXES-031220).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; Anastassopoulou I, 2004, BIOCHEMISTRY-US, V43, P13046, DOI 10.1021/bi0487591; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2005, J MOL BIOL, V352, P409, DOI 10.1016/j.jmb.2005.07.034; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2007, J BIOL CHEM, V282, P23140, DOI 10.1074/jbc.M700695200; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Bunce J, 2006, BBA-GEN SUBJECTS, V1760, P907, DOI 10.1016/j.bbagen.2006.02.005; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; CAVANAGH J, 1996, PROTEIN NMR SPECTROS, P478; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jones CE, 2003, J STRUCT BIOL, V143, P209, DOI 10.1016/j.jsb.2003.08.008; Keller R., 2004, COMPUTER AIDED RESON, V1; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Mercer JFB, 2003, BIOMETALS, V16, P175, DOI 10.1023/A:1020719016675; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rice WJ, 2006, BIOCHEM BIOPH RES CO, V348, P124, DOI 10.1016/j.bbrc.2006.07.012; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; van Dongen EMWM, 2004, BIOCHEM BIOPH RES CO, V323, P789, DOI 10.1016/j.bbrc.2004.08.160; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	53	78	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9354	9360		10.1074/jbc.M805981200	http://dx.doi.org/10.1074/jbc.M805981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181666	hybrid, Green Published			2022-12-27	WOS:000264669100041
J	Muftuoglu, M; de Souza-Pinto, NC; Dogan, A; Aamann, M; Stevnsner, T; Rybanska, I; Kirkali, G; Dizdaroglu, M; Bohr, VA				Muftuoglu, Meltem; de Souza-Pinto, Nadja C.; Dogan, Arin; Aamann, Maria; Stevnsner, Tinna; Rybanska, Ivana; Kirkali, Gueldal; Dizdaroglu, Miral; Bohr, Vilhelm A.			Cockayne Syndrome Group B Protein Stimulates Repair of Formamidopyrimidines by NEIL1 DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; GENE-PRODUCT; SUBSTRATE-SPECIFICITY; XERODERMA-PIGMENTOSUM; HELICASE DOMAIN; OXIDIZED BASES; DAMAGE; CSB	Cockayne syndrome (CS) is a premature aging condition characterized by sensitivity to UV radiation. However, this phenotype does not explain the progressive neurodegeneration in CS patients. It could be due to the hypersensitivity of CSB-deficient cells to oxidative stress. So far most studies on the role of CSB in repair of oxidatively induced DNA lesions have focused on 7,8-dihydro-8-oxoguanine. This study examines the role of CSB in the repair of formamidopyrimidines 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua) and 4,6-diamino-5-formamidopyrimidine (FapyAde), which are substrates for endonuclease VIII-like (NEIL1) DNA glycosylase. Results presented here show that csb(-/-) mice have a higher level of endogenous FapyAde and FapyGua in DNA from brain and kidney than wild type mice as well as higher levels of endogenous FapyAde in genomic DNA and mtDNA from liver. In addition, CSB stimulates NEIL1 incision activity in vitro, and CSB and NEIL1 co-immunoprecipitate and co-localize in HeLa cells. When CSB and NEIL1 are depleted from HeLa cells by short hairpin RNA knockdown, repair of induced FapyGua is strongly inhibited. These results suggest that CSB plays a role in repair of formamidopyrimidines, possibly by interacting with and stimulating NEIL1, and that accumulation of such modifications may have a causal role in the pathogenesis of CS.	[Muftuoglu, Meltem; de Souza-Pinto, Nadja C.; Dogan, Arin; Aamann, Maria; Rybanska, Ivana; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Stevnsner, Tinna] Aarhus Univ, Dept Mol Biol, Danish Aging Res Ctr, DK-8000 Aarhus, Denmark; [Stevnsner, Tinna] Aarhus Univ, Danish Ctr Mol Gerontol, DK-8000 Aarhus, Denmark; [Kirkali, Gueldal; Dizdaroglu, Miral] NIST, Chem Sci & Technol Lab, Gaithersburg, MD 20899 USA; [Dogan, Arin; Kirkali, Gueldal] Dokuz Eylul Univ, Fac Med, Dept Biochem, TR-35340 Izmir, Turkey; [Muftuoglu, Meltem] Univ Copenhagen, Ctr Healthy Ageing, DK-2200 Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Aarhus University; Aarhus University; National Institute of Standards & Technology (NIST) - USA; Dokuz Eylul University; University of Copenhagen	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, Intramural Res Program, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	vbohr@nih.gov	Muftuoglu, Meltem/AAG-5004-2019; Souza-Pinto, Nadja/T-3050-2019; Souza-Pinto, Nadja C./C-3462-2013; Bohr, Vilhelm/AAP-5931-2020; Dogan, Arin/L-6443-2015	Muftuoglu, Meltem/0000-0001-5372-4780; Souza-Pinto, Nadja/0000-0003-4206-964X; Souza-Pinto, Nadja C./0000-0003-4206-964X; Dogan, Arin/0000-0002-5362-5501; Stevnsner, Tinna/0000-0003-1007-0427	National Institutes of Health; National Institute on Aging; National Institute of Standards and Technology; NATIONAL INSTITUTE ON AGING [Z01AG000722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Institute on Aging, and National Institute of Standards and Technology.	BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Christiansen M, 2003, NUCLEIC ACIDS RES, V31, P963, DOI 10.1093/nar/gkg164; de Souza-Pinto NC, 2002, INT REV NEUROBIOL, V53, P519; de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X; de Waard H, 2004, MOL CELL BIOL, V24, P7941, DOI 10.1128/MCB.24.18.7941-7948.2004; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DIZDAROGLU M, 1993, FEBS LETT, V315, P1, DOI 10.1016/0014-5793(93)81120-O; Dizdaroglu M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e12; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Ide H, 2004, BIOL PHARM BULL, V27, P480, DOI 10.1248/bpb.27.480; Imam SZ, 2007, NUCLEIC ACIDS RES, V35, P4941, DOI 10.1093/nar/gkm386; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jaruga P, 2004, BIOCHEMISTRY-US, V43, P15909, DOI 10.1021/bi048162l; Jiang YL, 2005, J ORG CHEM, V70, P141, DOI 10.1021/jo048253o; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muftuoglu M, 2006, NUCLEIC ACIDS RES, V34, P295, DOI 10.1093/nar/gkj410; Muftuoglu M, 2002, GENE, V283, P27, DOI 10.1016/S0378-1119(01)00870-8; Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002; Osterod M, 2002, ONCOGENE, V21, P8232, DOI 10.1038/sj.onc.1206027; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Rapin I, 2000, NEUROLOGY, V55, P1442, DOI 10.1212/WNL.55.10.1442; Reddy P, 2004, PROTEIN EXPRES PURIF, V34, P126, DOI 10.1016/j.pep.2003.11.019; Roy LM, 2007, J BIOL CHEM, V282, P15790, DOI 10.1074/jbc.M610626200; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selzer RR, 2002, NUCLEIC ACIDS RES, V30, P782, DOI 10.1093/nar/30.3.782; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; STEENKEN S, 1989, CHEM REV, V89, P503, DOI 10.1021/cr00093a003; Stefanini M, 1996, HUM GENET, V97, P418; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; SUN B, 1995, J BIOL CHEM, V270, P19501, DOI 10.1074/jbc.270.33.19501; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; Thorslund T, 2005, MOL CELL BIOL, V25, P7625, DOI 10.1128/MCB.25.17.7625-7636.2005; Trapp C, 2007, ONCOGENE, V26, P4044, DOI 10.1038/sj.onc.1210167; TROELSTRA C, 1990, MOL CELL BIOL, V10, P5806, DOI 10.1128/MCB.10.11.5806; Tuo J, 2001, J BIOL CHEM, V276, P45772, DOI 10.1074/jbc.M107888200; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; Tuo JS, 2002, DNA REPAIR, V1, P913, DOI 10.1016/S1568-7864(02)00116-7; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wilson DM, 2003, FRONT BIOSCI-LANDMRK, V8, pD963, DOI 10.2741/1109; Wong HK, 2007, NUCLEIC ACIDS RES, V35, P4103, DOI 10.1093/nar/gkm404; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	55	88	90	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9270	9279		10.1074/jbc.M807006200	http://dx.doi.org/10.1074/jbc.M807006200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19179336	hybrid, Green Published			2022-12-27	WOS:000264669100033
J	Sawallisch, C; Berhorster, K; Disanza, A; Mantoani, S; Kintscher, M; Stoenica, L; Dityatev, A; Sieber, S; Kindler, S; Morellini, F; Schweizer, M; Boeckers, TM; Korte, M; Scita, G; Kreienkamp, HJ				Sawallisch, Corinna; Berhoerster, Kerstin; Disanza, Andrea; Mantoani, Sara; Kintscher, Michael; Stoenica, Luminita; Dityatev, Alexander; Sieber, Sabrina; Kindler, Stefan; Morellini, Fabio; Schweizer, Michaela; Boeckers, Tobias M.; Korte, Martin; Scita, Giorgio; Kreienkamp, Hans-Juergen			The Insulin Receptor Substrate of 53 kDa (IRSp53) Limits Hippocampal Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; POSTSYNAPTIC SHANK; SPINE MORPHOLOGY; MICE DEFICIENT; SMALL GTPASES; PROTEIN; CDC42; DOMAIN; FILOPODIA; COMPLEX	IRSp53 is an essential intermediate between the activation of Rac and Cdc42 GTPases and the formation of cellular protrusions; it affects cell shape by coupling membrane-deforming activity with the actin cytoskeleton. IRSp53 is highly expressed in neurons where it is also an abundant component of the postsynaptic density (PSD). Here we analyze the physiological function of this protein in the mouse brain by generating IRSp53-deficient mice. Neurons in the hippocampus of young and adult knock-out (KO) mice do not exhibit morphological abnormalities in vivo. Conversely, primary cultured neurons derived from IRSp53 KO mice display retarded dendritic development in vitro. On a molecular level, Eps8 cooperates with IRSp53 to enhance actin bundling and interacts with IRSp53 in developing neurons. However, postsynaptic Shank proteins which are expressed at high levels in mature neurons compete with Eps8 to block actin bundling. In electrophysiological experiments the removal of IRSp53 increases synaptic plasticity as measured by augmented long term potentiation and paired-pulse facilitation. A primarily postsynaptic role of IRSp53 is underscored by the decreased size of the PSDs, which display increased levels of N-methyl-D-aspartate receptor subunits in IRSp53 KO animals. Our data suggest that the incorporation of IRSp53 into the PSD enables the protein to limit the number of postsynaptic glutamate receptors and thereby affect synaptic plasticity rather than dendritic morphology. Consistent with altered synaptic plasticity, IRSp53-deficient mice exhibit cognitive deficits in the contextual fear-conditioning paradigm.	[Sawallisch, Corinna; Berhoerster, Kerstin; Sieber, Sabrina; Kindler, Stefan; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Stoenica, Luminita; Dityatev, Alexander] Univ Klinikum Hamburg Eppendorf, Inst Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Schweizer, Michaela] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Disanza, Andrea; Mantoani, Sara; Scita, Giorgio] Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Disanza, Andrea; Mantoani, Sara; Scita, Giorgio] Univ Milan, I-20139 Milan, Italy; [Kintscher, Michael; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Dityatev, Alexander] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Boeckers, Tobias M.] Univ Ulm, Inst Anat & Zellbiol, D-89081 Ulm, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Braunschweig University of Technology; Istituto Italiano di Tecnologia - IIT; Ulm University	Kreienkamp, HJ (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Martinistr 52, D-20246 Hamburg, Germany.	kreienkamp@uke.de	Scita, Giorgio/J-9670-2012; Dityatev, Alexander/A-4034-2008	Dityatev, Alexander/0000-0002-0472-0553; Disanza, Andrea/0000-0001-5101-2907; Scita, Giorgio/0000-0001-7984-1889; Kintscher, Michael/0000-0003-2355-1369	Deutsche Forschungsgemeinschaft [Kr1321, FOR885, Di 702/4-1, Di 702/4-2, Di 702/4-3, SFB497/B8]; Associazione Italiana Ricerca sul Cancro and Progetti di Ricerca di Interesse Nazionale; Fondazione Italiana Ricerca sul Cancro	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Associazione Italiana Ricerca sul Cancro and Progetti di Ricerca di Interesse Nazionale; Fondazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Deutsche Forschungsgemeinschaft Kr1321 and FOR885 ( to H.-J.K.), Di 702/4-1,2,3 ( to A. Dityatev), and SFB497/B8 ( to T. M. B.), by Associazione Italiana Ricerca sul Cancro and Progetti di Ricerca di Interesse Nazionale 2007 ( to G. S.), and by Fondazione Italiana Ricerca sul Cancro ( to A. Disanza).	Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bast T, 2003, HIPPOCAMPUS, V13, P657, DOI 10.1002/hipo.10115; Bockmann J, 2002, J NEUROCHEM, V83, P1013, DOI 10.1046/j.1471-4159.2002.01204.x; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Freitag S, 2003, BEHAV BRAIN RES, V145, P189, DOI 10.1016/S0166-4328(03)00109-8; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Soltau M, 2002, MOL CELL NEUROSCI, V21, P575, DOI 10.1006/mcne.2002.1201; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Suetsugu S, 2006, J CELL BIOL, V173, P571, DOI 10.1083/jcb.200509067; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Thomas EA, 2001, NEUROSCI LETT, V309, P145, DOI 10.1016/S0304-3940(01)02064-X; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	38	62	62	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9225	9236		10.1074/jbc.M808425200	http://dx.doi.org/10.1074/jbc.M808425200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208628	Green Published, hybrid			2022-12-27	WOS:000264669100029
J	Walton, KL; Makanji, Y; Wilce, MC; Chan, KL; Robertson, DM; Harrison, CA				Walton, Kelly L.; Makanji, Yogeshwar; Wilce, Matthew C.; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.			A Common Biosynthetic Pathway Governs the Dimerization and Secretion of Inhibin and Related Transforming Growth Factor beta (TGF beta) Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMURATI-ENGELMANN-DISEASE; EXTRACELLULAR-MATRIX; ACTIVIN-A; BINDING-SITES; OVARIAN FAILURE; LATENT COMPLEX; BMP15 GENE; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; FOLLICULAR-FLUID	The assembly and secretion of transforming growth factor beta superfamily ligands is dependent upon non-covalent interactions between their pro- and mature domains. Despite the importance of this interaction, little is known regarding the underlying regulatory mechanisms. In this study, the binding interface between the pro- and mature domains of the inhibin alpha-subunit was characterized using in vitro mutagenesis. Three hydrophobic residues near the N terminus of the prodomain (Leu(30), Phe(37), Leu(41)) were identified that, when mutated to alanine, disrupted heterodimer assembly and secretion. It is postulated that these residues mediate dimerization by interacting non-covalently with hydrophobic residues (Phe(271), Ile(280), Pro(283), Leu(338), and Val(340)) on the outer convex surface of the mature alpha-subunit. Homology modeling indicated that these mature residues are located at the interface between two beta-sheets of the alpha-subunit and that their side chains form a hydrophobic packing core. Mutation of these residues likely disturbs the conformation of this region, thereby disrupting non-covalent interactions with the prodomain. A similar hydrophobic interface was identified spanning the pro- and mature domains of the inhibin beta(A)-subunit. Mutation of key residues, including Ile(62), Leu(66), Phe(329), and Pro(341), across this interface was disruptive for the production of both inhibin A and activin A. In addition, mutation of Ile(62) and Leu(66) in the beta(A)-propeptide reduced its ability to bind, or inhibit the activity of, activin A. Conservation of the identified hydrophobic motifs in the pro- and mature domains of other transforming growth factor beta superfamily ligands suggests that we have identified a common biosynthetic pathway governing dimer assembly.	[Walton, Kelly L.; Makanji, Yogeshwar; Chan, Karen L.; Robertson, David M.; Harrison, Craig A.] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia; [Makanji, Yogeshwar] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Wilce, Matthew C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University; Monash University	Harrison, CA (corresponding author), Prince Henrys Inst Med Res, 246 Clayton Rd, Clayton, Vic 3168, Australia.	Craig.Harrison@princehenrys.org	Walton, Kelly/ABF-7282-2020; Chan, Karen/E-4041-2015	Walton, Kelly/0000-0003-0627-2958; Harrison, Craig/0000-0003-1059-3682; Chan, Karen/0000-0001-9947-4713	National Health and Medical Research Council of Australia Project [388920, 494804, 241000]; Monash Postgraduate Scholarship	National Health and Medical Research Council of Australia Project(National Health and Medical Research Council (NHMRC) of Australia); Monash Postgraduate Scholarship	This work was supported by National Health and Medical Research Council of Australia Project Grants 388920 (to K. L. W.) and 494804 (to C. A. H.) and Program Grant 241000 (to D. M. R.).; Supported by a Monash Postgraduate Scholarship.	Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Campos-Xavier AB, 2001, HUM GENET, V109, P653, DOI 10.1007/s00439-001-0644-8; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; del Re E, 2004, J BIOL CHEM, V279, P53126, DOI 10.1074/jbc.M408090200; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Farnworth PG, 2006, J ENDOCRINOL, V188, P451, DOI 10.1677/joe.1.06444; Farnworth PG, 2001, MOL CELL ENDOCRINOL, V180, P63, DOI 10.1016/S0303-7207(01)00499-3; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Harrison CA, 2006, ENDOCRINOLOGY, V147, P2744, DOI 10.1210/en.2006-0131; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Maeda S, 2002, CALCIFIED TISSUE INT, V70, P54, DOI 10.1007/s002230010032; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Makanji Y, 2007, ENDOCRINOLOGY, V148, P2309, DOI 10.1210/en.2006-1612; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; ROBERTSON DM, 1986, MOL CELL ENDOCRINOL, V46, P29, DOI 10.1016/0303-7207(86)90066-3; Robertson DM, 2002, MOL CELL ENDOCRINOL, V191, P97, DOI 10.1016/S0303-7207(02)00060-6; RUSSELL DL, 1994, J REPROD FERTIL, V100, P115, DOI 10.1530/jrf.0.1000115; Saika S, 2001, GRAEF ARCH CLIN EXP, V239, P234, DOI 10.1007/s004170100275; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Sunada Yoshihide, 2006, Rinsho Shinkeigaku, V46, P942; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; WOODRUFF TK, 1993, ENDOCRINOLOGY, V132, P2332, DOI 10.1210/en.132.6.2332; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Wu SL, 2007, BONE, V40, P1630, DOI 10.1016/j.bone.2007.02.025; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	50	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9311	9320		10.1074/jbc.M808763200	http://dx.doi.org/10.1074/jbc.M808763200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193648	hybrid, Green Published			2022-12-27	WOS:000264669100037
J	Novakovic, B; Sibson, M; Ng, HK; Manuelpillai, U; Rakyan, V; Down, T; Beck, S; Fournier, T; Evain-Brion, D; Dimitriadis, E; Craig, JM; Morley, R; Saffery, R				Novakovic, Boris; Sibson, Mandy; Ng, Hong Kiat; Manuelpillai, Ursula; Rakyan, Vardhman; Down, Thomas; Beck, Stephan; Fournier, Thierry; Evain-Brion, Danielle; Dimitriadis, Eva; Craig, Jeffrey M.; Morley, Ruth; Saffery, Richard			Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 DIABETES-MELLITUS; D-RESISTANT RICKETS; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; DNA METHYLATION; EARLY-PREGNANCY; EPIGENETIC REGULATION; METABOLIC-CLEARANCE; ADDISONS-DISEASE	Plasma concentrations of biologically active vitamin D (1,25(OH)(2)D) are tightly controlled via feedback regulation of renal 1 alpha-hydroxylase (CYP27B1; positive) and 24-hydroxylase (CYP24A1; catabolic) enzymes. In pregnancy, this regulation is uncoupled, and 1,25-(OH)(2)D levels are significantly elevated, suggesting a role in pregnancy progression. Epigenetic regulation of CYP27B1 and CYP24A1 has previously been described in cell and animal models, and despite emerging evidence for a critical role of epigenetics in placentation generally, little is known about the regulation of enzymes modulating vitamin D homeostasis at the fetomaternal interface. In this study, we investigated the methylation status of genes regulating vitamin D bioavailability and activity in the placenta. No methylation of the VDR (vitamin D receptor) and CYP27B1 genes was found in any placental tissues. In contrast, the CYP24A1 gene is methylated in human placenta, purified cytotrophoblasts, and primary and cultured chorionic villus sampling tissue. No methylation was detected in any somatic human tissue tested. Methylation was also evident in marmoset and mouse placental tissue. All three genes were hypermethylated in choriocarcinoma cell lines, highlighting the role of vitamin D deregulation in this cancer. Gene expression analysis confirmed a reduced capacity for CYP24A1 induction with promoter methylation in primary cells and in vitro reporter analysis demonstrated that promoter methylation directly down-regulates basal promoter activity and abolishes vitamin D-mediated feedback activation. This study strongly suggests that epigenetic decoupling of vitamin D feedback catabolism plays an important role in maximizing active vitamin D bioavailability at the fetomaternal interface.	[Novakovic, Boris; Sibson, Mandy; Ng, Hong Kiat; Craig, Jeffrey M.; Morley, Ruth; Saffery, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Ng, Hong Kiat; Craig, Jeffrey M.; Morley, Ruth; Saffery, Richard] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Rakyan, Vardhman] Barts & London, Inst Cell & Mol Sci, London E1 2AT, England; [Down, Thomas] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; [Down, Thomas] Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; [Beck, Stephan] UCL, UCL Canc Inst, London WC1E 6BT, England; [Fournier, Thierry; Evain-Brion, Danielle] Univ Paris 05, INSERM, U427, Fac Sci Pharmaceut & Biol, F-75006 Paris, France; [Dimitriadis, Eva] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of London; Queen Mary University London; University of Cambridge; University of Cambridge; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Prince Henry's Institute of Medical Research	Saffery, R (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	richard.saffery@mcri.edu.au	Craig, Jeffrey M/B-3484-2012; Fournier, Thierry C/E-5836-2016; dimitriadis, e/AAD-7601-2021; Saffery, Richard/GLS-1976-2022; Novakovic, Boris/D-8018-2013	Craig, Jeffrey M/0000-0003-3979-7849; Saffery, Richard/0000-0002-9510-4181; Novakovic, Boris/0000-0002-5623-9008; dimitriadis, eva/0000-0003-1425-950X; Fournier, Thierry/0000-0002-7515-339X	Wellcome Trust [084071]; National Health and Medical Research Council Research Fellowships	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	Supported by Wellcome Trust Grant 084071.; Supported by National Health and Medical Research Council Research Fellowships.	Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; Avila E, 2007, J STEROID BIOCHEM, V103, P90, DOI 10.1016/j.jsbmb.2006.07.010; Barrera D, 2007, J STEROID BIOCHEM, V103, P529, DOI 10.1016/j.jsbmb.2006.12.097; Barrera D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-3; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chung I, 2007, J BIOL CHEM, V282, P8704, DOI 10.1074/jbc.M608894200; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; d'Alesio A, 2005, HUM MOL GENET, V14, P3539, DOI 10.1093/hmg/ddi382; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DELVIN EE, 1985, J CLIN ENDOCR METAB, V60, P880, DOI 10.1210/jcem-60-5-880; DELVIN EE, 1982, ARCH DIS CHILD, V57, P754, DOI 10.1136/adc.57.10.754; Diaz L, 2002, J CLIN ENDOCR METAB, V87, P3876, DOI 10.1210/jc.87.8.3876; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Dodds L, 2008, CLIN CHEM, V54, P326, DOI 10.1373/clinchem.2007.097469; Du HL, 2005, MOL ENDOCRINOL, V19, P2222, DOI 10.1210/me.2004-0336; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Fischer D, 2007, CLIN EXP OBSTET GYN, V34, P80; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Holick CN, 2007, CANCER EPIDEM BIOMAR, V16, P1990, DOI 10.1158/1055-9965.EPI-07-0487; Jennings CE, 2005, J MOL ENDOCRINOL, V34, P859, DOI 10.1677/jme.1.01760; Kim S, 2008, Pac Symp Biocomput, P315; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; KUMAR R, 1984, PHYSIOL REV, V64, P478, DOI 10.1152/physrev.1984.64.2.478; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lechner D, 2007, MOL CELL ENDOCRINOL, V263, P55, DOI 10.1016/j.mce.2006.08.009; Li HW, 2002, PLACENTA, V23, P20, DOI 10.1053/plac.2001.0744; Liu N, 2009, BIOL REPROD, V80, P398, DOI 10.1095/biolreprod.108.073577; LOHNES D, 1987, J BIOL CHEM, V262, P14394; Lopez ER, 2004, J STEROID BIOCHEM, V89-90, P155, DOI 10.1016/j.jsbmb.2004.03.095; Lopez ER, 2004, EUR J ENDOCRINOL, V151, P193, DOI 10.1530/eje.0.1510193; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Malloy PJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P285, DOI 10.1016/j.abb.2006.09.027; Masuda S, 2006, MOL CANCER THER, V5, P797, DOI 10.1158/1535-7163.MCT-05-0539; Muller K, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996, V1, P68; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nelen WLDM, 2000, FERTIL STERIL, V74, P1196, DOI 10.1016/S0015-0282(00)01595-8; Nelen WLDM, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(97)24038-9; Nelen WLDM, 1998, J NUTR, V128, P1336, DOI 10.1093/jn/128.8.1336; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; OHYAMA Y, 2002, NUCL ACIDS RES S, V2, P249; PATTILLO RA, 1968, CANCER RES, V28, P1231; PATTILLO RA, 1971, ANN NY ACAD SCI, V172, P288, DOI 10.1111/j.1749-6632.1971.tb34942.x; PAULSON SK, 1990, AM J PHYSIOL, V258, pE158, DOI 10.1152/ajpendo.1990.258.1.E158; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; PEEHL DM, 1994, CANCER RES, V54, P805; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; RON M, 1984, AM J OBSTET GYNECOL, V148, P370, DOI 10.1016/0002-9378(84)90709-9; ROSS R, 1989, PEDIATR RES, V26, P633, DOI 10.1203/00006450-198912000-00024; ROSS R, 1990, PEDIATR RES, V27, pA192; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Seely EW, 2007, J CLIN ENDOCR METAB, V92, P3402, DOI 10.1210/jc.2007-1554; Serman L, 2007, PLACENTA, V28, P803, DOI 10.1016/j.placenta.2007.04.001; Shih Ie-Ming, 2002, Current Molecular Medicine (Hilversum), V2, P1; Sikora J, 2007, NEUROENDOCRINOL LETT, V28, P507; SIUCALDERA ML, 1995, ENDOCRINOLOGY, V136, P4195, DOI 10.1210/en.136.10.4195; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; STEPHANOU A, 1994, ENDOCRINOLOGY, V135, P2651, DOI 10.1210/en.135.6.2651; Sung V, 2000, MOL CELL ENDOCRINOL, V164, P133, DOI 10.1016/S0303-7207(00)00226-4; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tashiro K, 2007, BIOCHEM BIOPH RES CO, V358, P259, DOI 10.1016/j.bbrc.2007.04.103; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; TSANG RC, 1981, CLIN PERINATOL, V8, P287, DOI 10.1016/S0095-5108(18)31081-9; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; van der Molen EF, 2000, AM J OBSTET GYNECOL, V182, P1258, DOI 10.1067/mob.2000.105199; Vigano P, 2006, J MOL ENDOCRINOL, V36, P415, DOI 10.1677/jme.1.01946; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Wietrzyk J, 2008, ONCOL REP, V20, P941, DOI 10.3892/or_00000094; Wong NC, 2008, CANCER LETT, V268, P56, DOI 10.1016/j.canlet.2008.03.033; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Xie ZJ, 2002, J BIOL CHEM, V277, P36987, DOI 10.1074/jbc.M201404200; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhou YL, 2009, J BONE MINER RES, V24, P643, DOI 10.1359/JBMR.081216	89	187	194	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14838	14848		10.1074/jbc.M809542200	http://dx.doi.org/10.1074/jbc.M809542200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19237542	Green Published, hybrid			2022-12-27	WOS:000266288200019
J	Yuan, HJ; Vance, KM; Junge, CE; Geballe, MT; Snyder, JP; Hepler, JR; Yepes, M; Low, CM; Traynelis, SF				Yuan, Hongjie; Vance, Katie M.; Junge, Candice E.; Geballe, Matthew T.; Snyder, James P.; Hepler, John R.; Yepes, Manuel; Low, Chian-Ming; Traynelis, Stephen F.			The Serine Protease Plasmin Cleaves the Amino-terminal Domain of the NR2A Subunit to Relieve Zinc Inhibition of the N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; HUMAN-FIBRINOGEN; BINDING-SITE; NR1 SUBUNIT; ACTIVATOR; THROMBIN	Zinc is hypothesized to be co-released with glutamate at synapses of the central nervous system. Zinc binds to NR1/NR2A N-methyl-D-aspartate (NMDA) receptors with high affinity and inhibits NMDAR function in a voltage-independent manner. The serine protease plasmin can cleave a number of substrates, including protease activated receptors, and may play an importantrole in several disorders of the central nervous system, including ischemia and spinal cord injury. Here, we demonstrate that plasmin can cleave the native NR2A amino-terminal domain (NR2A(ATD)), removing the functional high affinity Zn2+ binding site. Plasmin also cleaves recombinant NR2A(ATD) at lysine 317 (Lys(317)), thereby producing a similar to 40-kDa fragment, consistent with plasmin-induced NR2A cleavage fragments observed in rat brain membrane preparations. A homology model of the NR2AATD predicts that Lys317 is near the surface of the protein and is accessible to plasmin. Recombinant expression of NR2A with an amino-terminal deletion at Lys(317) is functional and Zn2+ insensitive. Whole cell voltage-clamp recordings show that Zn2+ inhibition of agonist-evoked NMDA receptor currents of NR1/NR2A-transfected HEK 293 cells and cultured cortical neurons is significantly reduced by plasmin treatment. Mutating the plasmin cleavage site Lys317 on NR2A to alanine blocks the effect of plasmin on Zn2+ inhibition. The relief of Zn2+ inhibition by plasmin occurs in PAR1(-/-) cortical neurons and thus is independent of interaction with protease-activated receptors. These results suggest that plasmin can directly interact with NMDA receptors, and plasmin may increase NMDA receptor responses through disruption or removal of the amino-terminal domain and relief of Zn2+ inhibition.	[Yuan, Hongjie; Vance, Katie M.; Junge, Candice E.; Hepler, John R.; Traynelis, Stephen F.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Pharmacol, Atlanta, GA 30322 USA; [Geballe, Matthew T.; Snyder, James P.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Chem, Atlanta, GA 30322 USA; [Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Neurol, Atlanta, GA 30322 USA; [Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore S117597, Singapore	Emory University; Emory University; Emory University; National University of Singapore	Traynelis, SF (corresponding author), Emory Univ, Rollins Res Ctr 5062, 1510 Clifton Rd, Atlanta, GA 30322 USA.	strayne@emory.edu	Yepes, Manuel/C-3576-2011; Low, Chian-Ming/V-9271-2017	Low, Chian-Ming/0000-0002-1154-4842; Yuan, Hongjie/0000-0002-8127-7145	National Institutes of Health NINDS [NS39419, NS36654]; National Alliance for Research on Schizophrenia and Depression; Michael J. Fox Foundation for Parkinson's Research; National Medical Research Council; Biomedical Research Council; Academic Research Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036654, R01NS036654, R01NS039419] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Michael J. Fox Foundation for Parkinson's Research; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Academic Research Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grants NS39419 and NS36654 (to S. F. T.). This work was also supported by grants from National Alliance for Research on Schizophrenia and Depression (to S.F.T.), the Michael J. Fox Foundation for Parkinson's Research (toS. F. T.), National Medical Research Council (to C. M. L.), Biomedical Research Council (to C. M. L.), and Academic Research Funds (to C. M. L.).	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Biswas N, 2008, ENDOCRINOLOGY, V149, P749, DOI 10.1210/en.2007-0838; Bokesch PM, 2006, STROKE, V37, P1432, DOI 10.1161/01.STR.0000221295.14547.c8; Carmeliet P, 1997, CURR OPIN LIPIDOL, V8, P118, DOI 10.1097/00041433-199704000-00010; CHAIN D, 1991, FEBS LETT, V285, P251, DOI 10.1016/0014-5793(91)80810-P; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Dambinova SA, 2002, STROKE, V33, P1181, DOI 10.1161/01.STR.0000014922.83673.86; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Gray K, 2008, FEBS LETT, V582, P907, DOI 10.1016/j.febslet.2008.02.026; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kidwell CS, 2008, CEREBROVASC DIS, V25, P338, DOI 10.1159/000118379; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LIOTTA LA, 1981, CANCER RES, V41, P4629; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Mannaioni G, 2008, J BIOL CHEM, V283, P20600, DOI 10.1074/jbc.M803015200; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P351, DOI 10.1113/jphysiol.1989.sp017725; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Novak JF, 1997, J BONE MINER RES, V12, P1035, DOI 10.1359/jbmr.1997.12.7.1035; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Pryzdial ELG, 1999, J BIOL CHEM, V274, P8500, DOI 10.1074/jbc.274.13.8500; Qureshi N, 1996, NEW ENGL J MED, V334, P1406; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; SOUTHAN C, 1985, J BIOL CHEM, V260, P3095; Stys PK, 2007, TRENDS PHARMACOL SCI, V28, P561, DOI 10.1016/j.tips.2007.10.003; TAKAGI T, 1975, BIOCHEMISTRY-US, V14, P5149, DOI 10.1021/bi00694a020; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tsirka SE, 1997, J MOL MED, V75, P341, DOI 10.1007/s001090050119; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Wong E, 2005, PROTEIN SCI, V14, P2275, DOI 10.1110/ps.051509905; Woodburn V L, 1994, Adv Pharmacol, V30, P1, DOI 10.1016/S1054-3589(08)60170-2; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408	76	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12862	12873		10.1074/jbc.M805123200	http://dx.doi.org/10.1074/jbc.M805123200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240037	Green Published, hybrid			2022-12-27	WOS:000265688300032
J	Abbott, DW; Macauley, MS; Vocadlo, DJ; Boraston, AB				Abbott, D. Wade; Macauley, Matthew S.; Vocadlo, David J.; Boraston, Alisdair B.			Streptococcus pneumoniae Endohexosaminidase D, Structural and Mechanistic Insight into Substrate-assisted Catalysis in Family 85 Glycoside Hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; X-RAY-DIFFRACTION; HUMAN O-GLCNACASE; TRANSGLYCOSYLATION ACTIVITY; NAG-THIAZOLINE; ACTIVE-SITE; COMPLEX; OLIGOSACCHARIDES; GLUCOSAMINIDASE; IDENTIFICATION	Endo-beta-D-glucosaminidases from family 85 of glycoside hydrolases (GH85 endohexosaminidases) act to cleave the glycosidic linkage between the two N-acetylglucosamine units that make up the chitobiose core of N-glycans. Endohexosaminidase D (Endo-D), produced by Streptococcus pneumoniae, is believed to contribute to the virulence of this organism by playing a role in the deglycosylation of IgG antibodies. Endohexosaminidases have received significant attention for this reason and, moreover, because they are powerful tools for chemoenzymatic synthesis of proteins having defined glycoforms. Here we describe mechanistic and structural studies of the catalytic domain (SpGH85) of Endo-D that provide compelling support for GH85 enzymes using a catalytic mechanism involving substrate-assisted catalysis. Furthermore, the structure of SpGH85 in complex with the mechanism-based competitive inhibitor NAG-thiazoline (K-d = 28 mu M) provides a coherent rationale for previous mutagenesis studies of Endo-D and other related GH85 enzymes. We also find GH85, GH56, and GH18 enzymes have a similar configuration of catalytic residues. Notably, GH85 enzymes have an asparagine in place of the aspartate residue found in these other families of glycosidases. We propose that this residue, as the imidic acid tautomer, acts analogously to the key catalytic aspartate of GH56 and GH18 enzymes. This topographically conserved arrangement of the asparagine residue and a conserved glutamic acid, coupled with previous kinetic studies, suggests these enzymes may use an unusual proton shuttle to coordinate effective general acid and base catalysis to aid cleavage of the glycosidic bond. These results collectively provide a blueprint that may be used to facilitate protein engineering of these enzymes to improve their function as biocatalysts for synthesizing glycoproteins having defined glycoforms and also may serve as a guide for generating inhibitors of GH85 enzymes.	[Macauley, Matthew S.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Abbott, D. Wade; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	Simon Fraser University; University of Victoria	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Boraston, Alisdair/0000-0001-6417-0592; Macauley, Matthew/0000-0003-4579-1048; Abbott, Wade/0000-0003-4893-5799	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to A.B.B. and D. J.V.).	Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Busca P, 1998, TETRAHEDRON LETT, V39, P8101, DOI 10.1016/S0040-4039(98)01838-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cunha AC, 1999, J CHEM EDUC, V76, P79, DOI 10.1021/ed076p79; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON MAL, 1995, BIOPHYS J, V69, P329, DOI 10.1016/S0006-3495(95)79905-2; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greig IR, 2008, J AM CHEM SOC, V130, P17620, DOI 10.1021/ja805640c; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Hansch C, 1979, SUBSTITUENT CONSTANT; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Heidecke CD, 2008, CHEMBIOCHEM, V9, P2045, DOI 10.1002/cbic.200800214; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES CS, 1980, J BIOL CHEM, V255, P1861; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; KOIDE N, 1977, BIOCHEM BIOPH RES CO, V75, P838, DOI 10.1016/0006-291X(77)91458-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2008, BIOORGAN MED CHEM, V16, P4670, DOI 10.1016/j.bmc.2008.02.032; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Mizuno M, 1999, J AM CHEM SOC, V121, P284, DOI 10.1021/ja9831305; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rising TWDF, 2006, CARBOHYD RES, V341, P1574, DOI 10.1016/j.carres.2006.03.007; Rising TWDF, 2006, CHEMBIOCHEM, V7, P1177, DOI 10.1002/cbic.200600183; ROY R, 1991, CAN J CHEM, V69, P817, DOI 10.1139/v91-121; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YAMAMOTO K, 1974, J BIOCHEM-TOKYO, V75, P931, DOI 10.1093/oxfordjournals.jbchem.a130467; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Yamamoto S, 2005, GLYCOCONJUGATE J, V22, P35, DOI 10.1007/s10719-005-0847-7; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	69	76	83	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11676	11689		10.1074/jbc.M809663200	http://dx.doi.org/10.1074/jbc.M809663200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19181667	hybrid, Green Published			2022-12-27	WOS:000265494500070
J	Desmazieres, A; Charnay, P; Gilardi-Hebenstreit, P				Desmazieres, Anne; Charnay, Patrick; Gilardi-Hebenstreit, Pascale			Krox20 Controls the Transcription of Its Various Targets in the Developing Hindbrain According to Multiple Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; ZINC-FINGER GENE; RECEPTOR TYROSINE KINASE; CHICK-EMBRYO HINDBRAIN; HOST-CELL FACTOR; SEGMENTAL EXPRESSION; NERVOUS-SYSTEM; NAB PROTEINS; HOMEOTIC TRANSFORMATION; ACTIVATION DOMAIN	The zinc finger transcription factor Krox20 plays an essential role in the vertebrate hindbrain segmentation process. It positively or negatively controls a large variety of other regulatory genes, coordinating delimitation of segmental territories, specification of their identity, and maintenance of their integrity. We have investigated the molecular mechanisms of Krox20 transcriptional control by performing a detailed structure-function analysis of the protein in the developing chick hindbrain. This revealed an unsuspected diversity in the modes of action of a transcription factor in a single tissue, since regulation of each of the five tested target genes requires different parts of the protein and/or presumably different co-factors. The multiplicity of Krox20 functions might rely on this diversity. Investigation of known Krox20 co-factors was initiated in relation to this analysis. Nab was shown to act as a negative feedback modulator of the different Krox20 activating functions in the hindbrain. HCF-1 was found to bind to a Krox20 N-terminal region, which was shown to rely on multiple elements, including acidic domains, to convey Nab activation and Krox20 autoregulation.	[Desmazieres, Anne; Charnay, Patrick; Gilardi-Hebenstreit, Pascale] INSERM, U784, F-75230 Paris 05, France; [Desmazieres, Anne; Charnay, Patrick; Gilardi-Hebenstreit, Pascale] Ecole Normale Super, F-75230 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Charnay, P (corresponding author), INSERM, U784, 46 Rue Ulm, F-75230 Paris 05, France.	charnay@biologie.ens.fr		Desmazieres, Anne/0000-0001-6542-4566; Charnay, Patrick/0000-0002-3847-6042	Institut National de la Sante et de la Recherche Medicale, Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, and Association Francaise contre les Myopathies	Institut National de la Sante et de la Recherche Medicale, Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, and Association Francaise contre les Myopathies(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT), Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, and Association Francaise contre les Myopathies.	Barrow JR, 2000, DEVELOPMENT, V127, P933; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; BIRGBAUER E, 1995, DEVELOPMENT, V121, P935; BRONNERFRASER M, 1995, PERSPECT DEV NEUROBI, V3, P53; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Choe SK, 2004, DEV BIOL, V271, P350, DOI 10.1016/j.ydbio.2004.04.007; Chomette D, 2006, DEVELOPMENT, V133, P1253, DOI 10.1242/dev.02289; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; DAS G, 1995, NATURE, V374, P657, DOI 10.1038/374657a0; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Desmazieres A, 2008, J NEUROSCI, V28, P5891, DOI 10.1523/JNEUROSCI.5187-07.2008; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; FROHMAN MA, 1993, DEVELOPMENT, V117, P925; Garcia-Dominguez M, 2006, EMBO J, V25, P2432, DOI 10.1038/sj.emboj.7601122; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; Ghislain J, 2003, DEVELOPMENT, V130, P941, DOI 10.1242/dev.00318; GILARDIHEBENSTREIT P, 1992, ONCOGENE, V7, P2499; Gillian AL, 2004, J BIOL CHEM, V279, P9056, DOI 10.1074/jbc.M309308200; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; Giudicelli F, 2003, DEV BIOL, V253, P150, DOI 10.1006/dbio.2002.0864; Graham A, 1996, DEVELOPMENT, V122, P473; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; LaBoissiere S, 1997, MOL CELL BIOL, V17, P7108, DOI 10.1128/MCB.17.12.7108; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lu R, 1998, J VIROL, V72, P6291, DOI 10.1128/JVI.72.8.6291-6297.1998; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mahajan SS, 2002, J BIOL CHEM, V277, P44292, DOI 10.1074/jbc.M205440200; Manzanares M, 2002, EMBO J, V21, P365, DOI 10.1093/emboj/21.3.365; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; Mellitzer G, 2000, CURR OPIN NEUROBIOL, V10, P400, DOI 10.1016/S0959-4388(00)00095-7; Nonchev S, 1996, DEVELOPMENT, V122, P543; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Rossel M, 1999, DEVELOPMENT, V126, P5027; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SAJJADI FG, 1993, ONCOGENE, V8, P1807; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Seitanidou T, 1997, MECH DEVELOP, V65, P31, DOI 10.1016/S0925-4773(97)00051-8; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; Srinivasan R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-117; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Taneja R, 1996, DEV BIOL, V177, P397, DOI 10.1006/dbio.1996.0173; Theil T, 1998, DEVELOPMENT, V125, P443; Trainor PA, 2002, DEVELOPMENT, V129, P433; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; Wingate RJT, 1996, DEVELOPMENT, V122, P2143; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	74	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10831	10840		10.1074/jbc.M808683200	http://dx.doi.org/10.1074/jbc.M808683200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218566	Green Published, hybrid			2022-12-27	WOS:000265104600057
J	Hishiki, A; Hashimoto, H; Hanafusa, T; Kamei, K; Ohashi, E; Shimizu, T; Ohmori, H; Sato, M				Hishiki, Asami; Hashimoto, Hiroshi; Hanafusa, Tomo; Kamei, Keijiro; Ohashi, Eiji; Shimizu, Toshiyuki; Ohmori, Haruo; Sato, Mamoru			Structural Basis for Novel Interactions between Human Translesion Synthesis Polymerases and Proliferating Cell Nuclear Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-BINDING DOMAINS; HUMAN PCNA; IN-VITRO; Y-FAMILY; REPLICATION MACHINERY; XERODERMA-PIGMENTOSUM; FLAP ENDONUCLEASE-1; DNA-SYNTHESIS; ERROR-FREE; POL-KAPPA	Translesion synthesis (TLS) is a DNA damage tolerance mechanism that allows continued DNA synthesis, even in the presence of damaged DNA templates. Mammals have multiple DNA polymerases specialized for TLS, including Pol eta, Pol iota, and Pol kappa. These enzymes show preferential bypass for different lesions. Proliferating cell nuclear antigen (PCNA), which functions as a sliding clamp for the replicative polymerase Pol delta, also interacts with the three TLS polymerases. Although many PCNA-binding proteins have a highly conserved sequence termed the PCNA-interacting protein box (PIP-box), Pol eta, Pol iota, and Pol kappa have a noncanonical PIP-box sequence. In response to DNA damage, Lys-164 of PCNA undergoes ubiquitination by the RAD6-RAD18 complex, and the ubiquitination is considered to facilitate TLS. Consistent with this, these three TLS polymerases have one or two ubiquitin binding domains and are recruited to replication forks via interactions with ubiquitinated PCNA involving the noncanonical PIP-box and ubiquitin binding domain. However, it is unclear how these TLS polymerases interact with PCNA. To address the structural basis for interactions between different TLS polymerases and PCNA, we determined crystal structures of PCNA bound to peptides containing the noncanonical PIP-box of these polymerases. We show that the three PIP-box peptides interact with PCNA in different ways, both from one another and from canonical PIP-box peptides. Especially, the PIP-box of Pol iota adopts a novel structure. Furthermore, these structures enable us to speculate how these TLS polymerases interact with Lys-164-monoubiquitinated PCNA. Our results will provide clues to understanding the mechanism of preferential recruitment of TLS polymerases to the stalled forks.	[Hishiki, Asami; Hashimoto, Hiroshi; Shimizu, Toshiyuki; Sato, Mamoru] Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hanafusa, Tomo; Kamei, Keijiro; Ohashi, Eiji; Ohmori, Haruo] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Yokohama City University; Kyoto University	Hashimoto, H (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp; hohmori@virus1.virus.kyoto-u.ac.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; Hashimoto, Hiroshi/0000-0003-1503-6789	Japan Society of the Promotion of Science [16770080, 18770091]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [16048226, 17048023, 19036025, 20052023, 18054026, 20051020, 16370077, 17013041]	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Young Scientists (B) from the Japan Society of the Promotion of Science 16770080 and 18770091 (to H. H.), Grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 16048226, 17048023, and 19036025 (to H. H.), 20052023 (to T. S.), 18054026 and 20051020 (to M. S.), and 16370077 and 17013041 (to H.O.), and the national projects on protein structural and functional analyses (Protein 3000 Project) and the Target Protein Research Programs from MEXT (to M. S., T. S., and H. H.).	Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Haracska L, 2005, MOL CELL BIOL, V25, P1183, DOI 10.1128/MCB.25.3.1183-1190.2005; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hishiki A, 2008, ACTA CRYSTALLOGR F, V64, P954, DOI 10.1107/S1744309108028522; Hishiki A, 2008, ACTA CRYSTALLOGR F, V64, P819, DOI 10.1107/S174430910802277X; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2002, EMBO J, V21, P6246, DOI 10.1093/emboj/cdf618; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohmori H, 2004, ADV PROTEIN CHEM, V69, P265; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaisman A, 2004, ADV PROTEIN CHEM, V69, P205; Vaisman A, 2003, DNA REPAIR, V2, P991, DOI 10.1016/S1568-7864(03)00094-6; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	48	112	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10552	10560		10.1074/jbc.M809745200	http://dx.doi.org/10.1074/jbc.M809745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208623	Green Published, hybrid			2022-12-27	WOS:000265104600029
J	Kabaleeswaran, V; Shen, H; Symersky, J; Walker, JE; Leslie, AGW; Mueller, DM				Kabaleeswaran, Venkataraman; Shen, Hong; Symersky, Jindrich; Walker, John E.; Leslie, Andrew G. W.; Mueller, David M.			Asymmetric Structure of the Yeast F-1 ATPase in the Absence of Bound Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART MITOCHONDRIAL ATPASE; CATALYTIC SITES; BINDING-SITES; COOPERATIVE INTERACTIONS; F-1-ATPASE; HYDROLYSIS; F1-ATPASE; CRYSTALLIZATION; RESOLUTION; MECHANISM	The crystal structure of nucleotide-free yeast F-1 ATPase has been determined at a resolution of 3.6 angstrom. The overall structure is very similar to that of the ground state enzyme. In particular, the beta(DP) and beta(TP) subunits both adopt the closed conformation found in the ground state structure despite the absence of bound nucleotides. This implies that interactions between the gamma and beta subunits are as important as nucleotide occupancy in determining the conformational state of the beta subunits. Furthermore, this result suggests that for the mitochondrial enzyme, there is no state of nucleotide occupancy that would result in more than one of the beta subunits adopting the open conformation. The adenine-binding pocket of the beta(TP) subunit is disrupted in the apoenzyme, suggesting that the beta(DP) subunit is responsible for unisite catalytic activity.	[Mueller, David M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Walker, John E.] Med Res Council MRC Dunn Human Nutr, Cambridge CB2 0XY, England; [Leslie, Andrew G. W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Chicago Medical School; Rosalind Franklin University Medical & Science; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; MRC Laboratory Molecular Biology	Mueller, DM (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	David.Mueller@RosalindFranklin.edu		Walker, John/0000-0001-7929-2162	National Institutes of Health [R01-GM067091]; Medical Research Council; Medical Research Council [MC_U105184325, MC_U105663150] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066223] Funding Source: NIH RePORTER; MRC [MC_U105663150, MC_U105184325] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM067091) (to D.M.M.). This work was also supported by a grant from the Medical Research Council (to J.E.W. and A.G.W.L.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; CROSS RL, 1982, J BIOL CHEM, V257, P2101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; Groth G, 2001, J BIOL CHEM, V276, P1345, DOI 10.1074/jbc.M008015200; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; HOWARD A, 2000, ACTA CRYSTALLOGR D, V54, P905; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; KALASHNIKOVA TY, 1988, EUR J BIOCHEM, V177, P213, DOI 10.1111/j.1432-1033.1988.tb14364.x; KAYALAR C, 1977, J BIOL CHEM, V252, P2486; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; Milgrom YM, 2005, P NATL ACAD SCI USA, V102, P13831, DOI 10.1073/pnas.0507139102; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Mueller DM, 2004, ACTA CRYSTALLOGR D, V60, P1441, DOI 10.1107/S0907444904012661; MURATALIEV MB, 1992, BIOCHEMISTRY-US, V31, P12885, DOI 10.1021/bi00166a025; SHIRAKIHARA Y, 1991, J BIOCHEM-TOKYO, V109, P466, DOI 10.1093/oxfordjournals.jbchem.a123405; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1995, J BIOL CHEM, V270, P12653, DOI 10.1074/jbc.270.21.12653	22	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10546	10551		10.1074/jbc.M900544200	http://dx.doi.org/10.1074/jbc.M900544200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233840	Green Published, hybrid			2022-12-27	WOS:000265104600028
J	Knauth, K; Cartwright, E; Freund, S; Bycroft, M; Buchberger, A				Knauth, Katja; Cartwright, Edward; Freund, Stefan; Bycroft, Mark; Buchberger, Alexander			VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; PRIMARY CILIUM-MAINTENANCE; RENAL-CELL CARCINOMA; FAMILIAL PHEOCHROMOCYTOMA; PROLYL HYDROXYLATION; GERMLINE MUTATIONS; UBIQUITIN LIGASES; REGULATE HIF; COMPLEX	pVHL (von Hippel-Lindau tumor suppressor protein) is the substrate recognition subunit of the CBCVHL ubiquitin ligase complex promoting the degradation of hypoxia-inducible factor subunits, HIF-1/2 alpha. Mutational inactivation of pVHL causes the hereditary von Hippel-Lindau tumor syndrome, which predisposes affected individuals to hemangioblastomas, renal cell carcinomas, and pheochromocytomas. Whereas the development of hemangioblastomas and renal cell carcinomas has been attributed to impaired HIF-1/2 alpha down-regulation by pVHL mutant proteins, the molecular defects underlying the development of pheochromocytomas are still unknown. Here, we present a detailed biochemical analysis of pVHL mutant proteins linked to type 2C (pheochromocytoma only) von Hippel-Lindau disease. Type 2C-associated mutations caused extensive structural perturbations of pVHL, as revealed by the reduced stability, increased proteolytic susceptibility, and dramatically altered NMR spectrum of recombinant, mutant pVHL-ElonginC-ElonginB complexes in vitro. In human cell lines, type 2C-linked mutations destabilized the CBCVHL ubiquitin ligase complex and resulted in reduced cellular pVHL levels. Together, our data reveal unexpectedly strong structural defects of type 2C-associated pVHL mutant proteins that are likely to affect both HIF-1/2 alpha-related and -unrelated pVHL functions in the pathogenesis of pheochromocytomas.	[Knauth, Katja; Buchberger, Alexander] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Cartwright, Edward; Freund, Stefan; Bycroft, Mark] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	Max Planck Society; University of Cambridge	Buchberger, A (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	buchberg@biochem.mpg.de	Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019; Bycroft, Mark/D-9446-2017	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820; Bycroft, Mark/0000-0002-0673-2216	Deutsche Forschungsgemeinschaft Emmy Noether [Bu 951/1-3, Bu 951/1-4]; MRC [MC_U105459896] Funding Source: UKRI; Medical Research Council [MC_U105459896] Funding Source: researchfish	Deutsche Forschungsgemeinschaft Emmy Noether(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Emmy Noether Grants Bu 951/1-3 and Bu 951/1-4 (to A.B.).	Abbott MA, 2006, AM J MED GENET A, V140A, P685, DOI 10.1002/ajmg.a.31116; Bex C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm932; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Brauch H, 2004, TOXICOL LETT, V151, P301, DOI 10.1016/j.toxlet.2003.12.074; Brauch H, 1999, JNCI-J NATL CANCER I, V91, P854, DOI 10.1093/jnci/91.10.854; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; CROSSEY PA, 1995, J MED GENET, V32, P885, DOI 10.1136/jmg.32.11.885; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hes FJ, 2000, J MED GENET, V37, P939, DOI 10.1136/jmg.37.12.939; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2002, J BIOL CHEM, V277, P30388, DOI 10.1074/jbc.M203344200; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 2005, CANCER CELL, V8, P91, DOI 10.1016/j.ccr.2005.07.012; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neumann Hartmut P. H., 1995, JAMA (Journal of the American Medical Association), V274, P1149, DOI 10.1001/jama.274.14.1149; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ritter MM, 1996, J CLIN ENDOCR METAB, V81, P1035, DOI 10.1210/jc.81.3.1035; Roberts AM, 2008, CURR OPIN ONCOL, V20, P83, DOI 10.1097/CCO.0b013e3282f310de; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Thoma CR, 2007, CELL CYCLE, V6, P1809, DOI 10.4161/cc.6.15.4518; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Weirich G, 2002, J CLIN ENDOCR METAB, V87, P5241, DOI 10.1210/jc.2002-020651; Xie L, 2005, J CELL BIOL, V168, P911, DOI 10.1083/jcb.200407079	55	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10514	10522		10.1074/jbc.M809056200	http://dx.doi.org/10.1074/jbc.M809056200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228690	Green Published, hybrid			2022-12-27	WOS:000265104600025
J	Wang, CK; Hu, SH; Martin, JL; Sjogren, T; Hajdu, J; Bohlin, L; Claeson, P; Goransson, U; Rosengren, KJ; Tang, J; Tan, NH; Craik, DJ				Wang, Conan K.; Hu, Shu-Hong; Martin, Jennifer L.; Sjogren, Tove; Hajdu, Janos; Bohlin, Lars; Claeson, Per; Goransson, Ulf; Rosengren, K. Johan; Tang, Jun; Tan, Ning-Hua; Craik, David J.			Combined X-ray and NMR Analysis of the Stability of the Cyclotide Cystine Knot Fold That Underpins Its Insecticidal Activity and Potential Use as a Drug Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-HIV ACTIVITY; SPIN COUPLING-CONSTANTS; KALATA B1; PLANT CYCLOTIDES; OLDENLANDIA-AFFINIS; SPATIAL STRUCTURE; CIRCULAR PROTEIN; CYCLIC PEPTIDE; MEMBRANE INTERACTION; STRUCTURAL MOTIF	Cyclotides are a family of plant defense proteins that are highly resistant to adverse chemical, thermal, and enzymatic treatment. Here, we present the first crystal structure of a cyclotide, varv F, from the European field pansy, Viola arvensis, determined at a resolution of 1.8 angstrom. The solution state NMR structure was also determined and, combined with measurements of biophysical parameters for several cyclotides, provided an insight into the structural features that account for the remarkable stability of the cyclotide family. The x-ray data confirm the cystine knot topology and the circular backbone, and delineate a conserved network of hydrogen bonds that contribute to the stability of the cyclotide fold. The structural role of a highly conserved Glu residue that has been shown to regulate cyclotide function was also determined, verifying its involvement in a stabilizing hydrogen bond network. We also demonstrate that varv F binds to dodecylphosphocholine micelles, defining the binding orientation and showing that its structure remains unchanged upon binding, further demonstrating that the cyclotide fold is rigid. This study provides a biological insight into the mechanism by which cyclotides maintain their native activity in the unfavorable environment of predator insect guts. It also provides a structural basis for explaining how a cluster of residues important for bioactivity may be involved in self-association interactions in membranes. As well as being important for their bioactivity, the structural rigidity of cyclotides makes them very suitable as a stable template for peptide-based drug design.	[Wang, Conan K.; Hu, Shu-Hong; Martin, Jennifer L.; Rosengren, K. Johan; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sjogren, Tove; Hajdu, Janos] Uppsala Univ, Dept Cellular & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Bohlin, Lars; Claeson, Per; Goransson, Ulf; Rosengren, K. Johan] Uppsala Univ, Dept Med Chem, Biomed Ctr, SE-75123 Uppsala, Sweden; [Tang, Jun; Tan, Ning-Hua] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Yunnan, Peoples R China	University of Queensland; Uppsala University; Uppsala University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS		d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Wang, Conan K/D-1481-2010; Rosengren, K. Johan/P-4450-2016; Martin, Jennifer L./A-6039-2010	Craik, David/0000-0003-0007-6796; Wang, Conan K/0000-0002-7973-7632; Rosengren, K. Johan/0000-0002-5007-8434; Martin, Jennifer L./0000-0002-9225-8863; Goransson, Ulf/0000-0002-5005-9612	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by a grant from the Australian Research Council (to D.J.C.).	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Andersen NH, 1997, J AM CHEM SOC, V119, P8547, DOI 10.1021/ja963250h; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Barry DG, 2004, STRUCTURE, V12, P85, DOI 10.1016/j.str.2003.11.019; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen B, 2005, J BIOL CHEM, V280, P22395, DOI 10.1074/jbc.M501737200; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2007, MOL BIOSYST, V3, P257, DOI 10.1039/b616856f; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; Dubovskii PV, 2001, J MOL BIOL, V305, P137, DOI 10.1006/jmbi.2000.4283; Goddard T. D., 2005, SPARKY 3; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, LLOYDIA, V36, P174; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Koltay A, 2005, INT J PEPT RES THER, V11, P99, DOI 10.1007/s10989-004-1722-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindholm P, 2002, MOL CANCER THER, V1, P365; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; LUZZATI D, 1953, ANN I PASTEUR PARIS, V85, P277; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MINOR W, 1993, XDISPLAYF; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Nair SS, 2006, BBA-PROTEINS PROTEOM, V1764, P1568, DOI 10.1016/j.bbapap.2006.07.009; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Pauling L., 1960, NATURE CHEM BOND; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RANCE M, 1983, BIOCHEM BIOPH RES CO, V27, P157; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Shenkarev ZO, 2008, J INORG BIOCHEM, V102, P1246, DOI 10.1016/j.jinorgbio.2008.01.018; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Shenkarev ZO, 2002, BIOPHYS J, V82, P762, DOI 10.1016/S0006-3495(02)75438-6; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Svangard E, 2003, PHYTOCHEMISTRY, V64, P135, DOI 10.1016/S0031-9422(03)00218-8; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	72	85	87	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10672	10683		10.1074/jbc.M900021200	http://dx.doi.org/10.1074/jbc.M900021200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19211551	Green Published, hybrid			2022-12-27	WOS:000265104600041
J	Radhakrishnan, GK; Yu, Q; Harms, JS; Splitter, GA				Radhakrishnan, Girish K.; Yu, Qiqi; Harms, Jerome S.; Splitter, Gary A.			Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; VIRULENCE FACTOR; INNATE IMMUNITY; FAMILY; MOLECULE; IDENTIFICATION	Toll-like receptors (TLRs) play essential roles in the activation of innate immune responses against microbial infections. TLRs and downstream adaptor molecules contain a conserved cytoplasmic TIR domain. TIRAP is a TIR domain-containing adaptor protein that recruits the signaling adaptor MyD88 to a subset of TLRs. Many pathogenic microorganisms subvert TLR signaling pathways to suppress host immune responses to benefit their survival and persistence. Brucella encodes a TIR domain-containing protein (TcpB) that inhibits TLR2- and TLR4-mediated NF-kappa B activation. Sequence analysis indicated a moderate level of similarity between TcpB and the TLR adaptor molecule TIRAP. We found that TcpB could efficiently block TIRAP-induced NF-kappa B activation. Subsequent studies revealed that by analogy to TIRAP, TcpB interacts with phosphoinositides through its N-terminal domain and colocalizes with the plasma membrane and components of the cytoskeleton. Our findings suggest that TcpB targets the TIRAP-mediated pathway to subvert TLR signaling. In vivo mouse studies indicated that TcpB-deficient Brucella is defective in systemic spread at the early stages of infection.	[Radhakrishnan, Girish K.; Yu, Qiqi; Harms, Jerome S.; Splitter, Gary A.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Splitter, GA (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	Splitter@svm.vetmed.wisc.edu		Radhakrishnan, Girish/0000-0001-9088-0029	National Institutes of Health/NIAID GLRCE for Biodefense and Emerging Infectious Disease Research Program [1U54-AI-057153]; National Institutes of Health [1R01AI073558]; Binational Agricultural Research and Development [US-3829-06 R]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073558, R21AI088038, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health/NIAID GLRCE for Biodefense and Emerging Infectious Disease Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Agricultural Research and Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health/NIAID GLRCE for Biodefense and Emerging Infectious Disease Research Program Grant 1U54-AI-057153 and National Institutes of Health Grant 1R01AI073558. This work was also supported by Binational Agricultural Research and Development Grant US-3829-06 R.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bowie AG, 2007, CLIN EXP IMMUNOL, V147, P217, DOI 10.1111/j.1365-2249.2006.03301.x; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	31	118	124	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9892	9898		10.1074/jbc.M805458200	http://dx.doi.org/10.1074/jbc.M805458200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19196716	hybrid, Green Published			2022-12-27	WOS:000264892900031
J	Sarnovsky, R; Rea, J; Makowski, M; Hertle, R; Kelly, C; Antignani, A; Pastrana, DV; FitzGerald, DJ				Sarnovsky, Robert; Rea, Jennifer; Makowski, Matt; Hertle, Ralf; Kelly, Colleen; Antignani, Antonella; Pastrana, Diana V.; FitzGerald, David J.			Proteolytic Cleavage of a C-terminal Prosequence, Leading to Autoprocessing at the N Terminus, Activates Leucine Aminopeptidase from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; IDENTIFICATION; RESISTANCE; ELASTASE; PROTEASE	At high bacterial cell density the gene expression program of Pseudomonas aeruginosa is regulated by quorum sensing. Among the gene products highly up-regulated by this system is an exoprotease, leucine aminopeptidase (PA-LAP), which is co-expressed with several known virulence factors and secreted as a proenzyme. We undertook a study of its activation by expressing the full-length proform of PA-LAP recombinantly in Escherichia coli (here termed, rLAP55) and characterizing individual steps in its conversion to an active enzyme. Activation is initiated with the proteolytic removal of a C-terminal prosequence. Removal of similar to 20 amino acids is accomplished by Pseudomonas elastase, which is also positively regulated by quorum sensing. Activation is also mediated by other proteases that cleave rLAP55 near its C terminus. The importance of the C terminus was confirmed by showing that C-terminal deletions of 1-24 amino acids produce a fully active enzyme. The removal of C-terminal prosequences either by proteolysis or deletion leads to an unusual autoprocessing event at the N terminus. Autoprocessing is apparently an intramolecular event, requires the active site of LAP, and results in the removal of 12 N-terminal amino acids. Furthermore, a detailed analysis of the C-terminal prosequence suggests that the proenzyme state is dependent on the presence of a basic side chain contributed by the last amino acid, lysine 536. Our data support a model whereby full-length PA-LAP is activated in a two-step process; proteolytic cleavage at the C terminus is followed by an intramolecular autocatalytic removal of a 12-amino acid propeptide at the N terminus.	[FitzGerald, David J.] NCI, Mol Biol Lab, CCR, Natl Inst Hlth,HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	FitzGerald, DJ (corresponding author), NCI, Mol Biol Lab, CCR, Natl Inst Hlth,HHS, 37 Convent Dr,Rm 5124, Bethesda, MD 20892 USA.	djpf@helix.nih.gov	Pastrana, Diana/ABD-6830-2020	Pastrana, Diana V./0000-0002-8084-5665	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC008757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, Intramural Research Program, NCI, Center for Cancer Research.	Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Braun P, 1998, J BACTERIOL, V180, P3467, DOI 10.1128/JB.180.13.3467-3469.1998; Cahan R, 2001, J BIOL CHEM, V276, P43645, DOI 10.1074/jbc.M106950200; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Endo H, 2002, J BIOL CHEM, V277, P26396, DOI 10.1074/jbc.M202244200; FUQUA WC, 1992, BIOTECHNIQUES, V12, P223; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; KRAMER MD, 1986, J IMMUNOL, V136, P4644; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Prince AS, 2002, NEW ENGL J MED, V347, P1110, DOI 10.1056/NEJMcibr021776; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Smith L, 2006, J MED MICROBIOL, V55, P1641, DOI 10.1099/jmm.0.46845-0; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tokuhara T, 2006, CLIN CANCER RES, V12, P3971, DOI 10.1158/1078-0432.CCR-06-0338; VASIL ML, 1990, INFECT IMMUN, V58, P4020, DOI 10.1128/IAI.58.12.4020-4029.1990; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wagner VE, 2004, VACCINE, V22, pS15, DOI 10.1016/j.vaccine.2004.08.011; Wieland CW, 2002, INFECT IMMUN, V70, P1352, DOI 10.1128/IAI.70.3.1352-1358.2002; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982	22	14	14	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10243	10253		10.1074/jbc.M808686200	http://dx.doi.org/10.1074/jbc.M808686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19213733	Green Published, hybrid			2022-12-27	WOS:000264892900066
J	Bisbal, M; Wojnacki, J; Peretti, D; Ropolo, A; Sesma, J; Jausoro, I; Caceres, A				Bisbal, Mariano; Wojnacki, Jose; Peretti, Diego; Ropolo, Andrea; Sesma, Juliana; Jausoro, Ignacio; Caceres, Alfredo			KIF4 Mediates Anterograde Translocation and Positioning of Ribosomal Constituents to Axons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL RNA GRANULES; ACTIN MESSENGER-RNA; PROTEIN-SYNTHESIS; INTRACELLULAR TRAFFICKING; SYMPATHETIC NEURONS; MIDZONE FORMATION; GROWTH CONES; KINESIN; TRANSPORT; TRANSLATION	In this study, we have used a combination of biochemical and molecular biology techniques to demonstrate that the C-terminal tail domain of KIF4 directly interacts with P0, a major protein component of ribosomes. Besides, in dorsal root ganglion neurons, KIF4 and P0, as well as other ribosomal constituents, colocalize in clusters distributed along axons and neuritic tips. RNA interference suppression of KIF4 or expression of KIF4 variants lacking the tail domain or mutations of the ATP-binding site result in accumulation of P0 and other ribosomal proteins at the cell body and in their disappearance from axons. Our results also show one additional function for KIF4 involving an Ezrin-Radixin-Moesin-like domain in the second coiled-coiled region of KIF4. Expression of a KIF4 mutant lacking this domain abolishes the clustering of ribosomal constituents and prevents the anterograde translocation of the cell adhesion molecule L1. Taken together, the present results suggest that by binding to P0 through its tail domain and by using its motor activity, KIF4 is involved in the anterograde trafficking of ribosomal constituents to axons and that by means of its Ezrin-Radixin-Moesin-like domain interacts and transports L1.	[Caceres, Alfredo] Consejo Nacl Invest Cient & Tecn, Inst Invest Med Mercedes & Martin Ferreyra, INIMEC, Lab Neurobiol & Cell Biol, RA-5016 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Caceres, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Med Mercedes & Martin Ferreyra, INIMEC, Lab Neurobiol & Cell Biol, Av Friuli 2434 5016, RA-5016 Cordoba, Argentina.	acaceres@immf.uncor.edu	Bisbal, Mariano/AAE-9308-2021	Bisbal, Mariano/0000-0002-3870-6151	Agencia Nacional Promocion CientIfica y Tecnica [PICT 05-14398]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 6463]; Howard Hughes Medical Institute	Agencia Nacional Promocion CientIfica y Tecnica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Agencia Nacional Promocion CientIfica y Tecnica Grant PICT 05-14398), Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 6463, and a Howard Hughes Medical Institute grant awarded under the International Research Scholar Program (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eng H, 1999, J NEUROSCI, V19, P1; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; Knowles RB, 1996, J NEUROSCI, V16, P7812; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kun A, 2007, J NEUROSCI RES, V85, P2087, DOI 10.1002/jnr.21340; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lee YM, 2004, EXP MOL MED, V36, P93, DOI 10.1038/emm.2004.13; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Rehbein M, 2000, MOL BRAIN RES, V79, P192, DOI 10.1016/S0169-328X(00)00114-5; Rodriguez-Gabriel MA, 2000, J BIOL CHEM, V275, P2130, DOI 10.1074/jbc.275.3.2130; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Sotelo-Silveira JR, 2006, TRAFFIC, V7, P508, DOI 10.1111/j.1600-0854.2006.00405.x; Sotelo-Silveira JR, 2004, J NEUROBIOL, V60, P187, DOI 10.1002/neu.20015; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	48	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9489	9497		10.1074/jbc.M808586200	http://dx.doi.org/10.1074/jbc.M808586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158085	Green Published, hybrid			2022-12-27	WOS:000264669100055
J	Harita, Y; Kurihara, H; Kosako, H; Tezuka, T; Sekine, T; Igarashi, T; Ohsawa, I; Ohta, S; Hattori, S				Harita, Yutaka; Kurihara, Hidetake; Kosako, Hidetaka; Tezuka, Tohru; Sekine, Takashi; Igarashi, Takashi; Ohsawa, Ikuroh; Ohta, Shigeo; Hattori, Seisuke			Phosphorylation of Nephrin Triggers Ca2+ Signaling by Recruitment and Activation of Phospholipase C-gamma 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR SLIT DIAPHRAGM; II RECEPTOR BLOCKADE; MICE LACKING; NEPHROTIC SYNDROME; KIDNEY; PROTEINURIA; COMPONENT; DISEASE; KINASE; RATS	A specialized intercellular junction between podocytes, known as the slit diaphragm (SD), forms the essential structural framework for glomerular filtration in the kidney. In addition, mounting evidence demonstrates that the SD also plays a crucial role as a signaling platform in physiological and pathological states. Nephrin, the major component of the SD, is tyrosine-phosphorylated by a Src family tyrosine kinase, Fyn, in developing or injured podocytes, recruiting Nck to Nephrin via its Src homology 2 domain to regulate dynamic actin remodeling. Dysregulated Ca2+ homeostasis has also been implicated in podocyte damage, but the mechanism of how podocytes respond to injury is largely unknown. Here we have identified phospholipase C-gamma 1 (PLC-gamma 1) as a novel phospho-Nephrin-binding protein. When HEK293T cells expressing a chimeric protein consisting of CD8 and Nephrin cytoplasmic domain (CD) were treated with anti-CD8 and anti-mouse antibodies, clustering of Nephrin and phosphorylation of Nephrin-CD were induced. Upon this clustering, PLC-gamma 1 was bound to phosphorylated Nephrin Tyr-1204, which induced translocation of PLC-gamma 1 from cytoplasm to the CD8/Nephrin cluster on the plasma membrane. The recruitment of PLC-gamma 1 to Nephrin activated PLC-gamma 1, as detected by phosphorylation of PLC-gamma 1 Tyr-783 and increase in inositol 1,4,5-trisphosphate level. We also found that Nephrin Tyr-1204 phosphorylation triggers the Ca2+ response in a PLC-gamma 1-dependent fashion. Furthermore, PLC-gamma 1 is significantly phosphorylated in injured podocytes in vivo. Given the profound effect of PLC-gamma in diverse cellular functions, regulation of the Ca2+ signaling by Nephrin may be important in modulating the glomerular filtration barrier function.	[Harita, Yutaka; Hattori, Seisuke] Univ Tokyo, Div Cellular Prote BML, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Tezuka, Tohru] Univ Tokyo, Dept Oncol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Harita, Yutaka; Sekine, Takashi; Igarashi, Takashi] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anaesthesia, Bunkyo Ku, Tokyo 1138421, Japan; [Ohsawa, Ikuroh; Ohta, Shigeo] Nippon Med Sch, Grad Sch Med, Inst Dev & Aging Sci, Dept Biochem & Cell Biol, Tokyo 1138602, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1088641, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Juntendo University; Nippon Medical School; Kitasato University	Hattori, S (corresponding author), Univ Tokyo, Div Cellular Prote BML, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hattoris@ims.u-tokyo.ac.jp						Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dowden J, 2006, CHEM BIOL, V13, P659, DOI 10.1016/j.chembiol.2006.05.005; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; KURIHARA H, 1995, AM J PHYSIOL-RENAL, V268, pF514, DOI 10.1152/ajprenal.1995.268.3.F514; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; Litjens T, 2007, BIOCHEM J, V405, P269, DOI 10.1042/BJ20061762; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; REMUZZI A, 1993, J AM SOC NEPHROL, V4, P40; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tu CL, 2005, J INVEST DERMATOL, V124, P187, DOI 10.1111/j.0022-202X.2004.23544.x; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5	50	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8951	8962		10.1074/jbc.M806851200	http://dx.doi.org/10.1074/jbc.M806851200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179337	Green Published, hybrid			2022-12-27	WOS:000264397800078
J	Her, YR; Chung, IK				Her, Yoon Ra; Chung, In Kwon			Ubiquitin Ligase RLIM Modulates Telomere Length Homeostasis through a Proteolysis of TRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; HUMAN-CELLS; PROTEIN COMPLEX; DNA; KINASE; TIN2; END; PHOSPHORYLATION; RECRUITMENT; MAINTENANCE	The telomeric protein TRF1 negatively regulates telomere length by inhibiting telomerase access at the telomere termini, suggesting that the protein level of TRF1 at telomeres is tightly regulated. Regulation of TRF1 protein abundance is essential for proper telomere function and occurs primarily through post-translational modifications of TRF1. Here we describe RLIM, a RING H2 zinc finger protein with intrinsic ubiquitin ligase activity, as a TRF1-interacting protein. RLIM increases TRF1 turnover by targeting it for degradation by the proteasome in a ubiquitin-dependent manner, independently of Fbx4, which is known to interact with and negatively regulate TRF1. Whereas overexpression of RLIM decreases the level of TRF1 protein, depletion of endogenous RLIM expression by small hairpin RNA increases the level of TRF1 and leads to telomere shortening, thereby impairing cell growth. These results demonstrate that RLIM is involved in the negative regulation of TRF1 function through physical interaction and ubiquitin-mediated proteolysis. Hence, RLIM represents a new pathway for telomere maintenance by modulating the level of TRF1 at telomeres.	[Her, Yoon Ra; Chung, In Kwon] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, IK (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, 134 Shinchon Dong, Seoul 120749, South Korea.	topoviro@yonsei.ac.kr			Molecular Aging Research Center, Korean Ministry of Health and Welfare; the Research Program on Dual Regulation Mechanisms of Aging and Cancer, Korea Science and Engineering Foundation [M1075604000107N560400110]; Korea Research Foundation [KRF-2005-C00097]; Seoul Development Institute	Molecular Aging Research Center, Korean Ministry of Health and Welfare; the Research Program on Dual Regulation Mechanisms of Aging and Cancer, Korea Science and Engineering Foundation; Korea Research Foundation(National Research Foundation of Korea); Seoul Development Institute	This work was supported by grants from the Molecular Aging Research Center, Korean Ministry of Health and Welfare; the Research Program on Dual Regulation Mechanisms of Aging and Cancer, Korea Science and Engineering Foundation (M1075604000107N560400110); Korea Research Foundation (KRF-2005-C00097); and the Seoul Development Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harrington L, 2005, CHROMOSOME RES, V13, P493, DOI 10.1007/s10577-005-0994-5; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	40	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8557	8566		10.1074/jbc.M806702200	http://dx.doi.org/10.1074/jbc.M806702200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164295	hybrid, Green Published			2022-12-27	WOS:000264397800040
J	Wang, LY; Tao, MF; Wendt-Pienkoski, E; Galm, U; Coughlin, JM; Shen, B				Wang, Liyan; Tao, Meifeng; Wendt-Pienkoski, Evelyn; Galm, Ute; Coughlin, Jane M.; Shen, Ben			Functional Characterization of tlmK Unveiling Unstable Carbinolamide Intermediates in the Tallysomycin Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; ANTITUMOR ANTIBIOTICS; BLEOMYCIN FAMILY; PHASE-II; COMPLEX; BICYCLOMYCIN; BINDING; DERIVATIVES; CLEAVAGE; SEQUENCE	Tallysomycins (TLMs) belong to the bleomycin family of anticancer antibiotics. TLMs differ from bleomycins primarily by the presence of a 4-amino-4,6-dideoxy-L-talose sugar attached to C-41 as part of a glycosylcarbinolamide. We previously proposed, on the basis of bioinformatics analysis of the tlm biosynthetic gene cluster from Streptoalloteichus hindustanus E465-94 ATCC 31158, that the tlmK gene is responsible for the attachment of this sugar moiety. We now report that inactivation of tlmK in S. hindustanus abolished TLM A and TLM B production, the resultant Delta tlmK mutant instead accumulated five new metabolites, and introduction of a functional copy of tlmK to the Delta tlmK mutant restored TLM A and TLM B production. Two major metabolites, TLM K-1 and TLM K-2, together with three minor metabolites, TLM K-3, TLM K-4, and TLM K-5, were isolated from the Delta tlmK mutant, and their structures were elucidated. These findings provide experimental evidence supporting the previous functional assignment of tlmK to encode a glycosyltransferase and unveil two carbinolamide pseudoaglycones as key intermediates in the TLM biosynthetic pathway. TlmK stabilizes the carbinolamide intermediates by glycosylating their hemiaminal hydroxyl groups, thereby protecting them from hydrolysis during TLM biosynthesis. In the absence of TlmK, the carbinolamide intermediates fragment to produce an amide TLM K-1 and aldehyde intermediates, which undergo further oxidative fragmentation to afford carboxylic acids TLM K-2, TLM K-3, TLM K-4, and TLM K-5.	[Wang, Liyan; Tao, Meifeng; Wendt-Pienkoski, Evelyn; Galm, Ute; Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; [Coughlin, Jane M.; Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu			National Institutes of Health [CA94426]; NATIONAL CANCER INSTITUTE [R01CA094426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94426.	BIBB MJ, 1994, MOL MICROBIOL, V14, P533, DOI 10.1111/j.1365-2958.1994.tb02187.x; Biggins JB, 2000, P NATL ACAD SCI USA, V97, P13537, DOI 10.1073/pnas.240460997; BOGER DL, 1995, J AM CHEM SOC, V117, P7338, DOI 10.1021/ja00133a007; Boger DL, 1999, ANGEW CHEM INT EDIT, V38, P448, DOI 10.1002/(SICI)1521-3773(19990215)38:4<448::AID-ANIE448>3.0.CO;2-W; Calafat AM, 1997, J AM CHEM SOC, V119, P3656, DOI 10.1021/ja963392b; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; DEBONO M, 1995, J MED CHEM, V38, P3271, DOI 10.1021/jm00017a012; DOWELL J, 2003, INT C ANT AG CHEM CH; FUJII A, 1974, J ANTIBIOT, V27, P73, DOI 10.7164/antibiotics.27.73; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Goodwin KD, 2008, P NATL ACAD SCI USA, V105, P5052, DOI 10.1073/pnas.0708143105; GREENAWAY FT, 1980, ORG MAGN RESONANCE, V13, P270, DOI 10.1002/mrc.1270130410; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; JAMES D, 2005, J CLIN PHARMACOL, V45, P227; KAKEYA H, 1995, J ANTIBIOT, V48, P733, DOI 10.7164/antibiotics.48.733; KAMIYA T, 1972, J ANTIBIOT, V25, P576, DOI 10.7164/antibiotics.25.576; KAWAGUCHI H, 1977, J ANTIBIOT, V30, P779, DOI 10.7164/antibiotics.30.779; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KONISHI M, 1977, J ANTIBIOT, V30, P789, DOI 10.7164/antibiotics.30.789; Leitheiser CJ, 2003, J AM CHEM SOC, V125, P8218, DOI 10.1021/ja021388w; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; MANSOURI K, 1991, MOL GEN GENET, V228, P459, DOI 10.1007/BF00260640; MIYAKI T, 1981, J ANTIBIOT, V34, P658, DOI 10.7164/antibiotics.34.658; MIYAMURA S, 1973, J ANTIBIOT, V26, P479, DOI 10.7164/antibiotics.26.479; MIYOSHI T, 1972, J ANTIBIOT, V25, P569, DOI 10.7164/antibiotics.25.569; NICAISE C, 1990, INVEST NEW DRUG, V8, P325; NICAISE C, 1990, CANCER CHEMOTH PHARM, V26, P221, DOI 10.1007/BF02897203; OKA S, 1980, RECENT RES CANCER, V74, P163; Sambrook J., 2001, MOL CLONING LAB MANU; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; SHIPLEY B, 1998, CHEM RES TOXICOL, V1, P25; SINGH SB, 1995, J ORG CHEM, V60, P7040, DOI 10.1021/jo00126a071; Smith AB, 2002, J AM CHEM SOC, V124, P11102, DOI 10.1021/ja020635t; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; Tawara S, 2000, ANTIMICROB AGENTS CH, V44, P57, DOI 10.1128/AAC.44.1.57-62.2000; Troast DM, 2002, ORG LETT, V4, P991, DOI 10.1021/ol025558l; UMEZAWA H, 1981, J ANTIBIOT, V34, P1622, DOI 10.7164/antibiotics.34.1622; Zuber G, 1998, J AM CHEM SOC, V120, P9368, DOI 10.1021/ja981937r	39	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8256	8264		10.1074/jbc.M900640200	http://dx.doi.org/10.1074/jbc.M900640200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19189972	hybrid, Green Published			2022-12-27	WOS:000264397800009
J	Lizunov, VA; Lisinski, I; Stenkula, K; Zimmerberg, J; Cushman, SW				Lizunov, Vladimir A.; Lisinski, Ivonne; Stenkula, Karin; Zimmerberg, Joshua; Cushman, Samuel W.			Insulin Regulates Fusion of GLUT4 Vesicles Independent of Exo70-mediated Tethering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; GLUCOSE-TRANSPORTER GLUT4; PLASMA-MEMBRANE; SIGNALING PATHWAY; TRANSLOCATION; TRAFFICKING; EXOCYST; ADIPOCYTES; INTERACTS; COMPLEX	Insulin regulates cellular glucose uptake by changing the amount of glucose transporter-4 (GLUT4) in the plasma membrane through stimulation of GLUT4 exocytosis. However, how the particular trafficking, tethering, and fusion steps are regulated by insulin is still debated. In a 3T3-L1 adipocyte cell line, the Exocyst complex and its Exo70 subunit were shown to critically affect GLUT4 exocytosis. Here we investigated the effects of Exo70 on tethering and fusion of GLUT4 vesicles in primary isolated rat adipose cells. We found that Exo70 wild type was sequestered away from the plasma membrane in non-stimulated cells, and its overexpression had no effect on GLUT4 trafficking. The addition of insulin increased the amount of Exo70 in the vicinity of the plasma membrane and stimulated the tethering and fusion of GLUT4 vesicles, but the rates of fusion and GLUT4 exposure were not affected by overexpression of Exo70. Surprisingly, the Exo70-N mutant induced insulin-independent tethering of GLUT4 vesicles, which, however, did not lead to fusion and exposure of GLUT4 at the plasma membrane. Upon insulin stimulation, the stationary pretethered GLUT4 vesicles in Exo70-N mutant cells underwent fusion without relocation. Taken together, our data suggest that fusion of GLUT4 vesicles is the rate-limiting step regulated by insulin downstream of Exo70-mediated tethering.	[Lizunov, Vladimir A.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Mol Biophys, Program Phys Biol, Bethesda, MD 20892 USA; [Lisinski, Ivonne; Stenkula, Karin; Cushman, Samuel W.] NIDDK, Expt Diabet Metab & Nutr Sect, Diabet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Mol Biophys, Program Phys Biol, Bethesda, MD 20892 USA.	joshz@mail.nih.gov	Lizunov, Vladimir/B-5468-2009	Stenkula, Karin/0000-0002-0739-1150	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055118, Z01DK055118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by an National Institutes of Health grant through the Intramural Research Programs of the NICHD and NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges.	Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bao Y, 2008, J BIOL CHEM, V283, P324, DOI 10.1074/jbc.M706873200; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sparling DP, 2008, J BIOL CHEM, V283, P7429, DOI 10.1074/jbc.M800481200; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	28	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7914	7919		10.1074/jbc.M806460200	http://dx.doi.org/10.1074/jbc.M806460200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155211	hybrid, Green Published			2022-12-27	WOS:000264195600053
J	Pfisterer, C; Gruia, A; Fischer, S				Pfisterer, Christoph; Gruia, Andreea; Fischer, Stefan			The Mechanism of Photo-energy Storage in the Halorhodopsin Chloride Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRONOBACTERIUM-PHARAONIS; FTIR SPECTROSCOPY; BACTERIORHODOPSIN; TRANSPORT; DYNAMICS	The light-driven pump Halorhodopsin (hR) uses the energy stored in an initial meta-stable state (K), in which the bound retinal chromophore has been photoisomerized from all-trans to 13-cis, to drive the translocation of one chloride anion across the membrane. Thus far it was unclear whether retinal twisting or charge separation between the positive Schiff base of the retinal and the chloride anion is the primary mechanism of energy storage. Here, combined quantum mechanical/molecular mechanical (QM/MM) simulations show that the energy is predominantly stored by charge separation. However, a large variability in retinal twisting is observed, thus reconciling the contradictory hypotheses for storage. Surprisingly, the energy stored in the K-state amounts to only one-fifth of the photon energy. We explain why the protein cannot store more: even though this would accelerate chloride pumping, raising the K-state also reduces the relative energy barriers against unproductive decay, in particular via the premature cis to trans back-isomerization. Indeed, the protein has maximized its storage so that the back-isomerization barriers are just high enough (>= 18 kcal/mol) to keep the decay rate (1/100 ms) slower than the remaining photocycle (1/20 ms). This need to stabilize the captured photon-energy until it can be used in subsequent steps is inherent to light-driven proteins.	[Pfisterer, Christoph; Gruia, Andreea; Fischer, Stefan] Heidelberg Univ, IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Heidelberg Univ, IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany.	Stefan.Fischer@iwr.uni-heidelberg.de	Gruia, Andreea Karina/AAQ-8978-2020		Deutsche Forschungsgemeinschaft [SF63/7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SF63/7.	ALSHUTH T, 1985, FEBS LETT, V179, P55, DOI 10.1016/0014-5793(85)80190-3; Bondar AN, 2005, J PHYS CHEM B, V109, P14786, DOI 10.1021/jp0531255; Bondar AN, 2004, STRUCTURE, V12, P1281, DOI 10.1016/j.str.2004.04.016; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DER A, 1992, J PHOTOCH PHOTOBIO B, V15, P299, DOI 10.1016/1011-1344(92)85136-I; Dioumaev AK, 1997, PHOTOCHEM PHOTOBIOL, V66, P755, DOI 10.1111/j.1751-1097.1997.tb03220.x; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Gascon JA, 2004, BIOPHYS J, V87, P2931, DOI 10.1529/biophysj.104.048264; Gruia AD, 2005, STRUCTURE, V13, P617, DOI 10.1016/j.str.2005.01.021; Guijarro J, 2006, BIOCHEMISTRY-US, V45, P11578, DOI 10.1021/bi060753j; Herzfeld J, 2000, BBA-BIOENERGETICS, V1460, P95, DOI 10.1016/S0005-2728(00)00132-8; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Losi A, 2001, PHOTOCHEM PHOTOBIOL, V74, P495, DOI 10.1562/0031-8655(2001)074<0495:TOTESI>2.0.CO;2; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mukohata Y, 1999, J BIOCHEM-TOKYO, V125, P649, DOI 10.1093/oxfordjournals.jbchem.a022332; Muneyuki E, 2002, BIOPHYS J, V83, P1749, DOI 10.1016/S0006-3495(02)73941-6; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Oesterhelt D, 1995, ISR J CHEM, V35, P475; Paizs B, 1999, J PHYS CHEM B, V103, P5388, DOI 10.1021/jp982624l; ROTHSCHILD KJ, 1988, BIOCHEMISTRY-US, V27, P2420, DOI 10.1021/bi00407a026; Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2; Schwarzl SM, 2005, J COMPUT CHEM, V26, P1359, DOI 10.1002/jcc.20274; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Spudich JL, 2000, SCIENCE, V288, P1358, DOI 10.1126/science.288.5470.1358; VARO G, 1995, BIOCHEMISTRY-US, V34, P14500, DOI 10.1021/bi00044a028; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Zhou HY, 2002, CHEM PHYS, V277, P91, DOI 10.1016/S0301-0104(01)00695-4	32	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13562	13569		10.1074/jbc.M808787200	http://dx.doi.org/10.1074/jbc.M808787200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19211559	Green Published, hybrid			2022-12-27	WOS:000265877300033
J	Neuman, NA; Ma, S; Schnitzler, GR; Zhu, Y; Lagna, G; Hata, A				Neuman, Nicole A.; Ma, Susan; Schnitzler, Gavin R.; Zhu, Yan; Lagna, Giorgio; Hata, Akiko			The Four-and-a-half LIM Domain Protein 2 Regulates Vascular Smooth Muscle Phenotype and Vascular Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PRIMARY PULMONARY-HYPERTENSION; ONLY PROTEIN; TRANSCRIPTION FACTOR; ALPHA-ACTIN; IN-VIVO; BMPR-II; GENE; MYOCARDIN; FHL2	In response to vascular injury, differentiated vascular smooth muscle cells (vSMCs) undergo a unique process known as "phenotype modulation," transitioning from a quiescent, "contractile" phenotype to a proliferative, "synthetic" state. We have demonstrated previously that the signaling pathway of bone morphogenetic proteins, members of the transforming growth factor beta family, play a role in the induction and maintenance of a contractile phenotype in human primary pulmonary artery smooth muscle cells. In this study, we show that a four-and-a-half LIM domain protein 2 (FHL2) inhibits transcriptional activation of vSMC-specific genes mediated by the bone morphogenetic protein signaling pathway through the CArG box-binding proteins, such as serum response factor and members of the myocardin (Myocd) family. Interestingly, FHL2 does not affect recruitment of serum response factor or Myocd, however, it inhibits recruitment of a component of the SWI/SNF chromatin remodeling complex, Brg1, and RNA polymerase II, which are essential for the transcriptional activation. This is a novel mechanism of regulation of SMC-specific contractile genes by FHL2. Finally, aortic rings from homozygous FHL2-null mice display abnormalities in both endothelial-dependent and -independent relaxation, suggesting that FHL2 is essential for the regulation of vasomotor tone.	[Neuman, Nicole A.; Ma, Susan; Zhu, Yan; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Neuman, Nicole A.; Schnitzler, Gavin R.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Hata, A (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 8486, Boston, MA 02111 USA.	akiko.hata@tufts.edu	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936	National Institutes of Health [HL082854]; NHLBI [HL086572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082854, R21HL086572, R01HL108317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082854 (to A. H.) and HL086572 (to G. L.) from NHLBI.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Chang DF, 2007, P NATL ACAD SCI USA, V104, P157, DOI 10.1073/pnas.0605635103; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kong YF, 2001, CIRCULATION, V103, P2731; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Ngo P, 2006, METH MOL B, V341, P103; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; RUBIN LJ, 1997, PRIMARY PULMONARY HY, P19; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Sundberg-Smith LJ, 2008, CIRC RES, V102, P1502, DOI 10.1161/CIRCRESAHA.107.170357; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	50	26	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13202	13212		10.1074/jbc.M900282200	http://dx.doi.org/10.1074/jbc.M900282200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19265191	Green Published, hybrid			2022-12-27	WOS:000265688300067
J	Gitcho, MA; Strider, J; Carter, D; Taylor-Reinwald, L; Forman, MS; Goate, AM; Cairns, NJ				Gitcho, Michael A.; Strider, Jeffrey; Carter, Deborah; Taylor-Reinwald, Lisa; Forman, Mark S.; Goate, Alison M.; Cairns, Nigel J.			VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING-PROTEIN; INCLUSION-BODY MYOPATHY; RETICULUM-ASSOCIATED DEGRADATION; UBIQUITIN-POSITIVE INCLUSIONS; AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN NEUROBLASTOMA-CELLS; TAU-NEGATIVE INCLUSIONS; MOTOR-NEURON DISEASE; AAA ATPASE P97/VCP; ENDOPLASMIC-RETICULUM	Frontotemporal lobar degeneration (FTLD) with inclusion body myopathy and Paget disease of bone is a rare, autosomal dominant disorder caused by mutations in the VCP (valosin-containing protein) gene. The disease is characterized neuropathologically by frontal and temporal lobar atrophy, neuron loss and gliosis, and ubiquitin-positive inclusions (FTLD-U), which are distinct from those seen in other sporadic and familial FTLD-U entities. The major component of the ubiquitinated inclusions of FTLD with VCP mutation is TDP-43 (TAR DNA-binding protein of 43 kDa). TDP-43 proteinopathy links sporadic amyotrophic lateral sclerosis, sporadic FTLD-U, and most familial forms of FTLD-U. Understanding the relationship between individual gene defects and pathologic TDP-43 will facilitate the characterization of the mechanisms leading to neurodegeneration. Using cell culture models, we have investigated the role of mutant VCP in intracellular trafficking, proteasomal function, and cell death and demonstrate that mutations in the VCP gene 1) alter localization of TDP-43 between the nucleus and cytosol, 2) decrease proteasome activity, 3) induce endoplasmic reticulum stress, 4) increase markers of apoptosis, and 5) impair cell viability. These results suggest that VCP mutation-induced neurodegeneration is mediated by several mechanisms.	[Strider, Jeffrey; Carter, Deborah; Taylor-Reinwald, Lisa; Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gitcho, Michael A.; Strider, Jeffrey; Carter, Deborah; Taylor-Reinwald, Lisa; Goate, Alison M.; Cairns, Nigel J.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Gitcho, Michael A.; Goate, Alison M.; Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Forman, Mark S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania	Cairns, NJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118, St Louis, MO 63110 USA.	cairns@wustl.edu	Cairns, Nigel/AAB-9713-2020	Cairns, Nigel/0000-0001-9858-3344; Gitcho, Michael/0000-0002-9223-5426; Goate, Alison/0000-0002-0576-2472	National Institutes of Health, NIA [P50-AG05681, 01-AG03991, P30-NS057105]; Buchanan Fund; Charles and Joanne Knight Alzheimer Research Initiative; Barnes- Jewish Hospital Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Buchanan Fund; Charles and Joanne Knight Alzheimer Research Initiative; Barnes- Jewish Hospital Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grants P50-AG05681, P01-AG03991, and P30-NS057105. This work was also supported by the Buchanan Fund, the Charles and Joanne Knight Alzheimer Research Initiative, and the Barnes- Jewish Hospital Foundation (St. Louis, MO). A preliminary report of these data was presented (81).	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Aravindan N, 2008, MOL CELL BIOCHEM, V310, P167, DOI 10.1007/s11010-007-9678-0; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Bertram C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-12; Bird T, 2003, ANN NEUROL, V54, pS29, DOI 10.1002/ana.10572; Bursztajn S, 2001, MOL BRAIN RES, V91, P57, DOI 10.1016/S0169-328X(01)00123-1; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Daroszewska A, 2006, NAT CLIN PRACT RHEUM, V2, P270, DOI 10.1038/ncprheum0172; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; GITCHO MA, 2008, 6 INT C FRONT DEM RO; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Hui L, 2005, BRAIN RES, V1052, P1, DOI 10.1016/j.brainres.2005.05.043; Ito M, 2007, BIOCHEM BIOPH RES CO, V360, P615, DOI 10.1016/j.bbrc.2007.06.087; JU JS, 2008, J BIOL CHEM; Kano F, 2005, GENES CELLS, V10, P333, DOI 10.1111/j.1365-2443.2005.00837.x; Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Lass A, 2008, INT J BIOCHEM CELL B, V40, P2865, DOI 10.1016/j.biocel.2008.06.003; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Li XP, 2007, NEUROCHEM INT, V50, P959, DOI 10.1016/j.neuint.2007.04.014; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meares GP, 2008, CELL SIGNAL, V20, P347, DOI 10.1016/j.cellsig.2007.10.032; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Miyachi K, 2004, CLIN EXP IMMUNOL, V136, P568, DOI 10.1111/j.1365-2249.2004.02456.x; Mukherjee O, 2008, HUM MUTAT, V29, P512, DOI 10.1002/humu.20681; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nilbratt M, 2007, J NEUROSCI RES, V85, P504, DOI 10.1002/jnr.21156; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Peng Y, 2008, MOL BIOL CELL, V19, P546, DOI 10.1091/mbc.E07-08-0774; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Schmitz A, 2004, EUR J CELL BIOL, V83, P501, DOI 10.1078/0171-9335-00412; Shenkman M, 2007, CELL STRESS CHAPERON, V12, P373, DOI 10.1379/CSC-281.1; Shenkman M, 2007, BIOCHEM J, V404, P509, DOI 10.1042/BJ20061854; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; Shiozawa K, 2006, FEBS J, V273, P4959, DOI 10.1111/j.1742-4658.2006.05494.x; Snider BJ, 2002, EUR J NEUROSCI, V15, P419, DOI 10.1046/j.0953-816x.2001.01867.x; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Xing CG, 2008, ACTA BIOCH BIOPH SIN, V40, P194, DOI 10.1111/j.1745-7270.2008.00393.x; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Zhang HT, 2000, DNA CELL BIOL, V19, P253, DOI 10.1089/10445490050021168; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhivotosky B, 2001, CURRENT PROTOCOLS CE; Zucchini C, 2008, INT J ONCOL, V32, P17	81	88	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12384	12398		10.1074/jbc.M900992200	http://dx.doi.org/10.1074/jbc.M900992200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19237541	Green Published, hybrid			2022-12-27	WOS:000265494600069
J	Kish-Trier, E; Wilkens, S				Kish-Trier, Erik; Wilkens, Stephan			Domain Architecture of the Stator Complex of the A(1)A(0)-ATP Synthase from Thermoplasma acidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT-E; ATP SYNTHASE; PERIPHERAL STALK; STRUCTURAL-CHARACTERIZATION; SECONDARY STRUCTURE; B-SUBUNIT; V-TYPE; F-TYPE; A-TYPE; PROTEINS	A key structural element in the ion translocating F-, A-, and V-ATPases is the peripheral stalk, an assembly of two polypeptides that provides a structural link between the ATPase and ion channel domains. Previously, we have characterized the peripheral stalk forming subunits E and H of the A-ATPase from Thermoplasma acidophilum and demonstrated that the two polypeptides interact to form a stable heterodimer with 1:1 stoichiometry (Kish-Trier, E., Briere, L. K., Dunn, S. D., and Wilkens, S. (2008) J. Mol. Biol. 375, 673-685). To define the domain architecture of the A- ATPase peripheral stalk, we have now generated truncated versions of the E and H subunits and analyzed their ability to bind each other. The data show that the N termini of the subunits form an alpha-helical coiled-coil, similar to 80 residues in length, whereas the C-terminal residues interact to form a globular domain containing alpha- and beta-structure. We find that the isolated C-terminal domain of the E subunit exists as a dimer in solution, consistent with a recent crystal structure of the related Pyrococcus horikoshii A- ATPase E subunit (Lokanath, N. K., Matsuura, Y., Kuroishi, C., Takahashi, N., and Kunishima, N. (2007) J. Mol. Biol. 366, 933-944). However, upon the addition of a peptide comprising the C-terminal 21 residues of the H subunit (or full-length H subunit), dimeric E subunit C-terminal domain dissociates to form a 1: 1 heterodimer. NMR spectroscopy was used to show that H subunit C terminal peptide binds to E subunit C-terminal domain via the terminal alpha-helices, with little involvement of the beta-sheet region. Based on these data, we propose a structural model of the A-ATPase peripheral stalk.	[Kish-Trier, Erik; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM58600, CA100246]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58600 and CA100246 (to S.W.)	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Dunn SD, 2000, J BIOENERG BIOMEMBR, V32, P347, DOI 10.1023/A:1005571818730; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gayen S, 2008, FEBS J, V275, P1803, DOI 10.1111/j.1742-4658.2008.06338.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Neukirch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038105; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; SUPEKOVA L, 1995, J BIOL CHEM, V270, P13726; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wise JG, 2008, BIOPHYS J, V94, P5040, DOI 10.1529/biophysj.107.121012; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	37	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12031	12040		10.1074/jbc.M808962200	http://dx.doi.org/10.1074/jbc.M808962200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19234304	Green Published, hybrid			2022-12-27	WOS:000265494600035
J	Bartholomeeusen, K; Christ, F; Hendrix, J; Rain, JC; Emiliani, S; Benarous, R; Debyser, Z; Gijsbers, R; De Rijck, J				Bartholomeeusen, Koen; Christ, Frauke; Hendrix, Jelle; Rain, Jean-Christophe; Emiliani, Stephane; Benarous, Richard; Debyser, Zeger; Gijsbers, Rik; De Rijck, Jan			Lens Epithelium-derived Growth Factor/p75 Interacts with the Transposase-derived DDE Domain of PogZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRASE-BINDING DOMAIN; HIV-1 INTEGRASE; NUP98-LEDGF FUSION; COMPLEX-FORMATION; LEDGF/P75; PROTEIN; IDENTIFICATION; NUCLEAR; GENE; RECOGNITION	Lens epithelium-derived growth factor/p75 (LEDGF/p75) is a prominent cellular interaction partner of human immunodeficiency virus-1 (HIV-1) integrase, tethering the preintegration complex to the host chromosome. In light of the development of LEDGF/p75-integrase interaction inhibitors, it is essential to understand the cell biology of LEDGF/p75. We identified pogZ as new cellular interaction partner of LEDGF/p75. Analogous to lentiviral integrase, pogZ, a domesticated transposase, carries a DDE domain, the major determinant for LEDGF/p75 interaction. Using different in vitro and in vivo approaches, we corroborated the interaction between the C terminus of LEDGF/p75 and the DDE domain of pogZ, revealing an overlap in the binding of pogZ and HIV-1 integrase. Competition experiments showed that integrase is efficient in displacing pogZ from LEDGF/p75. Moreover, pogZ does not seem to play a role as a restriction factor of HIV. The finding that LEDGF/p75 is capable of interacting with a DDE domain protein that is not a lentiviral integrase points to a profound role of LEDGF/p75 in DDE domain protein function.	[Bartholomeeusen, Koen; Christ, Frauke; Debyser, Zeger; Gijsbers, Rik; De Rijck, Jan] Katholieke Univ Leuven, Div Mol Med, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Flanders, Belgium; [Bartholomeeusen, Koen; Christ, Frauke; Debyser, Zeger; Gijsbers, Rik; De Rijck, Jan] Katholieke Univ Leuven, Interdisciplinary Res Ctr, B-3000 Louvain, Belgium; [Hendrix, Jelle] Katholieke Univ Leuven, Dept Chem, Lab Biomol Dynam, B-3000 Louvain, Belgium; [Emiliani, Stephane; Benarous, Richard] Inst Cochin Genet Mol, CNRS, INSERM,UMR8104, Dept Infect Dis,U567, F-75104 Paris, France; [Rain, Jean-Christophe] Hybrigen SA, F-75014 Paris, France	KU Leuven; KU Leuven; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Debyser, Z (corresponding author), Katholieke Univ Leuven, Div Mol Med, Lab Mol Virol & Gene Therapy, Campus Kortrijk,Kapucijnenvoer 33, B-3000 Louvain, Flanders, Belgium.	zeger.debyser@med.kuleuven.be	HENDRIX, Jelle/H-1721-2018; De Rijck, Jan/A-2729-2013; Christ, Frauke/H-7513-2018; bartholomeeusen, koen/J-1843-2015	HENDRIX, Jelle/0000-0001-5731-1297; bartholomeeusen, koen/0000-0001-9576-2400; Christ, Frauke/0000-0001-9580-3874; RAIN, Jean-Christophe/0000-0001-8110-0641	European Union [LSHB-CT-2003-503480]; THINC [HEALTH-2007-2.3.2-1]; Institute for the Promotion of Innovation by Science and Technology in Flanders	European Union(European Commission); THINC; Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the FP6 and FP7 framework of the European Union (TRIoH, LSHB-CT-2003-503480 and THINC, HEALTH-2007-2.3.2-1) and the CellCoVir SBO project of the Institute for the Promotion of Innovation by Science and Technology in Flanders.	Al-Mawsawi LQ, 2008, FEBS LETT, V582, P1425, DOI 10.1016/j.febslet.2008.02.076; Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Capy P, 1996, J MOL EVOL, V42, P359, DOI 10.1007/BF02337546; Capy P, 1997, GENETICA, V100, P63, DOI 10.1023/A:1018300721953; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Fromont-Racine M, 2002, METHOD ENZYMOL, V350, P513, DOI 10.1016/S0076-6879(02)50982-4; Ganapathy V, 2003, AUTOIMMUN REV, V2, P290, DOI 10.1016/S1568-9972(03)00063-6; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Grand FH, 2005, LEUKEMIA RES, V29, P1469, DOI 10.1016/j.leukres.2005.05.002; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Hussey DJ, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-20; Hwang Y, 2000, NUCLEIC ACIDS RES, V28, P4884, DOI 10.1093/nar/28.24.4884; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Morerio C, 2005, LEUKEMIA RES, V29, P467, DOI 10.1016/j.leukres.2004.09.002; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; PLASTERK RHA, 1995, NAT STRUCT BIOL, V2, P87, DOI 10.1038/nsb0295-87; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	50	72	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11467	11477		10.1074/jbc.M807781200	http://dx.doi.org/10.1074/jbc.M807781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244240	hybrid, Green Published			2022-12-27	WOS:000265494500051
J	Bergsdorf, EY; Zdebik, AA; Jentsch, TJ				Bergsdorf, Eun-Yeong; Zdebik, Anselm A.; Jentsch, Thomas J.			Residues Important for Nitrate/Proton Coupling in Plant and Mammalian CLC Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CHLORIDE CHANNEL; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; ANION; VOLTAGE; DISRUPTION; GENE; ARABIDOPSIS; ANTIPORTER; MECHANISM	Members of the CLC gene family either function as chloride channels or as anion/proton exchangers. The plant AtClC-a uses the pH gradient across the vacuolar membrane to accumulate the nutrient NO3- in this organelle. When AtClC-a was expressed in Xenopus oocytes, it mediated NO3-/H+ exchange and less efficiently mediated Cl-/H+ exchange. Mutating the "gating glutamate" Glu-203 to alanine resulted in an uncoupled anion conductance that was larger for Cl- than NO3-. Replacing the "proton glutamate" Glu-270 by alanine abolished currents. These could be restored by the uncoupling E203A mutation. Whereas mammalian endosomal ClC-4 and ClC-5 mediate stoichiometrically coupled 2Cl(-)/H+ exchange, their NO3-transport is largely uncoupled from protons. By contrast, the AtClC-amediated NO3- accumulation in plant vacuoles requires tight NO3-/H+ coupling. Comparison of AtClC-a and ClC-5 sequences identified a proline in AtClC-a that is replaced by serine in all mammalian CLC isoforms. When this proline was mutated to serine (P160S), Cl-/H+ exchange of AtClC-a proceeded as efficiently as NO3-/H+ exchange, suggesting a role of this residue in NO3-/H+ exchange. Indeed, when the corresponding serine of ClC-5 was replaced by proline, this Cl-/H+ exchanger gained efficient NO3-/H+ coupling. When inserted into the model Torpedo chloride channel ClC-0, the equivalent mutation increased nitrate relative to chloride conductance. Hence, proline in the CLC pore signature sequence is important for NO3-/H+ exchange and NO3- conductance both in plants and mammals. Gating and proton glutamates play similar roles in bacterial, plant, and mammalian CLC anion/proton exchangers.	[Bergsdorf, Eun-Yeong; Zdebik, Anselm A.; Jentsch, Thomas J.] Leibniz Inst Mol Pharmacol, Dept Physiol & Pathol Ion Transport, D-13125 Berlin, Germany; [Bergsdorf, Eun-Yeong; Zdebik, Anselm A.; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Zdebik, Anselm A.] UCL, London Epithelial Grp, Dept Neurosci Physiol & Pharmacol, London NW3 2PF, England	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of London; University College London	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmacol, Dept Physiol & Pathol Ion Transport, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft; Leibniz Graduate School of Biophysics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Graduate School of Biophysics	This work was supported by a Deutsche Forschungsgemeinschaft grant ( to A.A.Z. and T.J.J.) and by the Leibniz Graduate School of Biophysics.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hechenberger M, 1996, J BIOL CHEM, V271, P33632, DOI 10.1074/jbc.271.52.33632; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Lurin C, 1996, PLANT CELL, V8, P701, DOI 10.1105/tpc.8.4.701; Marmagne A, 2007, J EXP BOT, V58, P3385, DOI 10.1093/jxb/erm187; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; von der Fecht-Bartenbach J, 2007, PLANT J, V50, P466, DOI 10.1111/j.1365-313X.2007.03061.x; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2008, BIOPHYS J, V94, P53, DOI 10.1529/biophysj.107.111310; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284; Zuniga L, 2004, J PHYSIOL-LONDON, V555, P671, DOI 10.1113/jphysiol.2003.060046	45	79	85	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11184	11193		10.1074/jbc.M901170200	http://dx.doi.org/10.1074/jbc.M901170200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261613	Green Published, hybrid			2022-12-27	WOS:000265494500022
J	Deshmane, SL; Mukerjee, R; Fan, SS; Del Valle, L; Michiels, C; Sweet, T; Rom, I; Khalili, K; Rappaport, J; Amini, S; Sawaya, BE				Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Del Valle, Luis; Michiels, Carine; Sweet, Thersa; Rom, Inna; Khalili, Kamel; Rappaport, Jay; Amini, Shohreh; Sawaya, Bassel E.			Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; VIRAL PROTEIN-R; FACTOR-KAPPA-B; TAT PROTEIN; GENE-TRANSCRIPTION; MODULATES TRANSCRIPTION; NEURONAL APOPTOSIS; HUMAN ASTROCYTES; CELL-LINES; STABILIZATION	The detection of biomarkers of oxidative stress in brain tissue and cerebrospinal fluid of patients with human immunodeficiency virus, type 1 (HIV)-associated dementia indicates the involvement of stress pathways in the neuropathogenesis of AIDS. Although the biological importance of oxidative stress on events involved in AIDS neuropathogenesis and the HIV-1 proteins responsible for oxidative stress remain to be elucidated, our results point to the activation of hypoxia-inducible factor 1 (HIF-1) upon HIV-1 infection and its elevation in brain cells of AIDS patients with dementia. HIF-1 is a transcription factor that is responsive to oxygen. Under hypoxic conditions, HIF-1 alpha becomes stable and translocates to the nucleus where it dimerizes with aryl hydrocarbon receptor nuclear translocator and modulates gene transcription. Activation of HIF-1 can also be mediated by the HIV-1 accessory protein Vpr. In addition, cellular components, including reactive oxygen species, contribute to the induction of HIF-1 alpha. Our results show that Vpr induces reactive oxygen species by increasing H2O2 production, which can contribute to HIF-1 alpha accumulation. Interestingly, increased levels of HIF-1 alpha stimulated HIV-1 gene transcription through HIF-1 association with HIV-1 long terminal repeat. These observations point to the existence of a positive feedback interplay between HIF-1 alpha and Vpr and that, by inducing oxidative stress via activation of HIF-1, Vpr can induce HIV-1 gene expression and dysregulate multiple host cellular pathways.	[Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Del Valle, Luis; Sweet, Thersa; Rom, Inna; Khalili, Kamel; Rappaport, Jay; Amini, Shohreh; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Del Valle, Luis; Sweet, Thersa; Rom, Inna; Khalili, Kamel; Rappaport, Jay; Amini, Shohreh; Sawaya, Bassel E.] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Michiels, Carine] Univ Namur, Fac Univ Notre Dame Paix, Unite Rech Biol Cellulaire, B-5000 Namur, Belgium; [Sweet, Thersa; Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Namur; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sawaya, BE (corresponding author), Temple Univ, Sch Med, Dept Neurol, Mol Virol Lab, 3400 N Broad St, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Del Valle, Luis/J-4085-2015	Del Valle, Luis/0000-0003-3894-9206	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to B. E. S. and S. A.).	Aksenov MY, 2001, NEUROSCI LETT, V305, P5, DOI 10.1016/S0304-3940(01)01786-4; Amini S, 2004, J BIOL CHEM, V279, P46046, DOI 10.1074/jbc.M403792200; Amini S, 2004, DNA CELL BIOL, V23, P249, DOI 10.1089/104454904773819833; Antal J, 2006, FOLIA MICROBIOL, V51, P406, DOI 10.1007/BF02931584; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Chintapalli J, 2007, AM J PHYSIOL-RENAL, V292, pF523, DOI 10.1152/ajprenal.00215.2006; Eldeen MB, 2006, J NEUROIMMUNOL, V176, P174, DOI 10.1016/j.jneuroim.2006.04.004; FLORES SC, 1993, P NATL ACAD SCI USA, V90, P7632, DOI 10.1073/pnas.90.16.7632; Foga IO, 1997, J ACQ IMMUN DEF SYND, V16, P223, DOI 10.1097/00042560-199712010-00001; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Haddad JJ, 2004, INT IMMUNOPHARMACOL, V4, P1249, DOI 10.1016/j.intimp.2004.06.006; Hervouet E, 2007, BIOCHIMIE, V89, P1080, DOI 10.1016/j.biochi.2007.03.010; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kimura H., 2005, Current Drug Targets - Inflammation and Allergy, V4, P489, DOI 10.2174/1568010054526287; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kurata SI, 1996, J BIOL CHEM, V271, P21798, DOI 10.1074/jbc.271.36.21798; LE BM, 2005, HISTOL HISTOPATHOL, V20, P205; Lungu GF, 2008, J NEUROVIROL, V14, P239, DOI 10.1080/13550280802093919; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Minet E, 1999, BIOCHEM BIOPH RES CO, V261, P534, DOI 10.1006/bbrc.1999.0995; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Mukerjee R, 2007, J CELL BIOCHEM, V100, P1210, DOI 10.1002/jcb.21109; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Sacktor N, 2004, J NEUROIMMUNOL, V157, P176, DOI 10.1016/j.jneuroim.2004.08.037; Saunders M, 2005, APOPTOSIS, V10, P1419, DOI 10.1007/s10495-005-2467-x; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Schweppe RE, 2006, J BIOL CHEM, V281, P20993, DOI 10.1074/jbc.M604208200; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Sweet T, 2003, J CELL BIOCHEM, V90, P884, DOI 10.1002/jcb.10701; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Tomita M, 2007, BIOCHEM J, V406, P317, DOI 10.1042/BJ20070286; Valcour V, 2004, MITOCHONDRION, V4, P119, DOI 10.1016/j.mito.2004.05.009; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Viviani B, 2001, NEUROSCIENCE, V107, P51, DOI 10.1016/S0306-4522(01)00332-3; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598	54	80	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11364	11373		10.1074/jbc.M809266200	http://dx.doi.org/10.1074/jbc.M809266200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19204000	Green Published, hybrid			2022-12-27	WOS:000265494500041
J	Sun, JM; Pedersen, M; Ronnstrand, L				Sun, Jianmin; Pedersen, Malin; Ronnstrand, Lars			The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR/C-KIT; 2 SPLICE FORMS; TYROSINE KINASE; ACTIVATING MUTATION; NEGATIVE REGULATION; STRUCTURAL BASIS; GENE-MUTATIONS; MUTANT; CELLS; CBL	The receptor tyrosine kinase c-Kit plays a critical role in hematopoiesis, and gain-of-function mutations of the receptor are frequently seen in several malignancies, including acute myeloid leukemia, gastrointestinal stromal tumors, and testicular carcinoma. The most common mutation of c-Kit in these disorders is a substitution of the aspartic acid residue in position 816 to a valine (D816V), leading to constitutive activation of the receptor. In this study, we aimed to investigate the role of Src family kinases in c-Kit/D816V signaling. Src family kinases are necessary for the phosphorylation of wild-type c-Kit as well as of activation of downstream signaling pathways including receptor ubiquitination and the Ras/Mek/Erk pathway. Our data demonstrate that, unlike wild-type c-Kit, the phosphorylation of c-Kit/D816V is not dependent on Src family kinases. In addition, we found that neither receptor ubiquitination nor Erk activation by c-Kit/D816V required activation of Src family kinases. In vitro kinase assay using synthetic peptides revealed that c-Kit/D816V had an altered substrate specificity resembling Src and Abl tyrosine kinases. We further present evidence that, in contrast to wild-type c-Kit, Src family kinases are dispensable for c-Kit/D816V cell survival, proliferation, and colony formation. Taken together, we demonstrate that the signal transduction pathways mediated by c-Kit/D816V are markedly different from those activated by wild-type c-Kit and that altered substrate specificity of c-Kit circumvents a need for Src family kinases in signaling of growth and survival, thereby contributing to the transforming potential of c-Kit/D816V.	[Ronnstrand, Lars] Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Dept Lab Med, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Dept Lab Med, SE-20502 Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Ronnstrand, Lars/A-2429-2011; Sun, Jianmin/AAX-5094-2021	Ronnstrand, Lars/0000-0003-1275-5809; Sun, Jianmin/0000-0003-2327-4285	Swedish Cancer Society; Swedish Research Council; Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society; Wallenberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society(Royal Society of London); Wallenberg Foundation(European Commission)	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Gunnar Nilsson Cancer Foundation, the Alfred Osterlund Foundation, the Malmo University Hospital Foundation, the Malmo University Hospital Cancer Foundation, the Royal Physiographical Society, and the Wallenberg Foundation.	Beghini A, 2000, BLOOD, V95, P726, DOI 10.1182/blood.V95.2.726; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Hashimoto K, 2003, BLOOD, V101, P1094, DOI 10.1182/blood-2002-01-0177; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hongyo T, 2000, CANCER RES, V60, P2345; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Michieli P, 1999, ONCOGENE, V18, P5221, DOI 10.1038/sj.onc.1202899; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Nakaigawa N, 2000, ONCOGENE, V19, P2996, DOI 10.1038/sj.onc.1203628; Ning ZQ, 2001, LEUKEMIA LYMPHOMA, V41, P513, DOI 10.3109/10428190109060342; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pauls K, 2004, VIRCHOWS ARCH, V445, P651, DOI 10.1007/s00428-004-1112-3; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; SCHMIDTARRAS D, 2009, BLOOD IN PRESS; SERVE H, 1994, J BIOL CHEM, V269, P6026; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shivakrupa R, 2005, CELL SIGNAL, V17, P103, DOI 10.1016/j.cellsig.2004.06.004; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Taylor ML, 2001, BLOOD, V98, P1195, DOI 10.1182/blood.V98.4.1195; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Wollberg P, 2003, BIOCHEM J, V370, P1033, DOI 10.1042/BJ20020716; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768	44	51	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11039	11047		10.1074/jbc.M808058200	http://dx.doi.org/10.1074/jbc.M808058200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19265199	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000265494500008
J	Atkinson, J; Guy, CP; Cadman, CJ; Moolenaar, GF; Goosen, N; McGlynn, P				Atkinson, John; Guy, Colin P.; Cadman, Chris J.; Moolenaar, Geri F.; Goosen, Nora; McGlynn, Peter			Stimulation of UvrD Helicase by UvrAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI UVRD; POLYMERASE-I; REPLICATION FORK; PHYSICAL INTERACTION; PROTEIN COMPLEX; DAMAGE RECOGNITION; PRIA HELICASE; MISMATCH	Helicases play critical roles in all aspects of nucleic acid metabolism by catalyzing the remodeling of DNA and RNA structures. UvrD is an abundant helicase in Escherichia coli with well characterized functions in mismatch and nucleotide excision repair and a possible role in displacement of proteins such as RecA from single-stranded DNA. The mismatch repair protein MutL is known to stimulate UvrD. Here we show that the nucleotide excision repair proteins UvrA and UvrB can together stimulate UvrD-catalyzed unwinding of a range of DNA substrates containing strand discontinuities, including forked DNA substrates. The stimulation is specific for UvrD, as UvrAB failed to stimulate Rep helicase, a UvrD homologue. Moreover, although UvrAB can promote limited strand displacement, stimulation of UvrD did not require the strand displacement function of UvrAB. We conclude that UvrAB, like MutL, modulate UvrD helicase activity. This stimulation likely plays a role in DNA strand and protein displacement by UvrD in nucleotide excision repair. Promotion of UvrD-catalyzed unwinding of nicked duplexes by UvrAB may also explain the need for UvrAB and UvrD in Okazaki fragment processing in cells lacking DNA polymerase I. More generally, these data support the idea that helicase activity is regulated in vivo, with helicases acting as part of multisubunit complexes rather than in isolation.	[Atkinson, John; Guy, Colin P.; Cadman, Chris J.; McGlynn, Peter] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Moolenaar, Geri F.; Goosen, Nora] Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Mol Genet Lab, NL-2300 RA Leiden, Netherlands	University of Aberdeen; Leiden University; Leiden University - Excl LUMC	McGlynn, P (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	p.mcglynn@abdn.ac.uk		McGlynn, Peter/0000-0001-8629-4713	Medical Research Council and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; BBSRC [BB/C008316/1] Funding Source: UKRI; MRC [G0501626] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C008316/1] Funding Source: researchfish; Medical Research Council [G0501626] Funding Source: researchfish	Medical Research Council and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (to P. M.).	Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; ARTHUR HM, 1983, GENE, V25, P309, DOI 10.1016/0378-1119(83)90235-4; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Goosen N, 2001, RES MICROBIOL, V152, P401, DOI 10.1016/S0923-2508(01)01211-6; Gordienko I, 1997, EMBO J, V16, P889, DOI 10.1093/emboj/16.4.889; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; HORIUCHI T, 1974, MOL GEN GENET, V128, P105, DOI 10.1007/BF02654484; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Janion C, 2001, ACTA BIOCHIM POL, V48, P599; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Malta E, 2006, J BIOL CHEM, V281, P2184, DOI 10.1074/jbc.M508901200; Malta E, 2007, BIOCHEMISTRY-US, V46, P9080, DOI 10.1021/bi7002235; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1986, J BIOL CHEM, V261, P169; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Moolenaar GF, 2005, DNA REPAIR, V4, P699, DOI 10.1016/j.dnarep.2005.03.001; Moolenaar GF, 1997, MUTAT RES-DNA REPAIR, V385, P195, DOI 10.1016/S0921-8777(97)00042-6; Moolenaar GF, 2001, EMBO J, V20, P6140, DOI 10.1093/emboj/20.21.6140; Moolenaar GF, 2000, J BACTERIOL, V182, P5706, DOI 10.1128/JB.182.20.5706-5714.2000; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; MORIMYO M, 1976, MOL GEN GENET, V147, P243, DOI 10.1007/BF00582875; OH EY, 1989, J BIOL CHEM, V264, P1336; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; ORREN DK, 1992, J BIOL CHEM, V267, P780; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; PARSONS CA, 1990, J BIOL CHEM, V265, P9285; Payne BTI, 2006, NUCLEIC ACIDS RES, V34, P5194, DOI 10.1093/nar/gkl682; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SEELEY TW, 1990, J BIOL CHEM, V265, P7158; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; SHIZUYA H, 1972, J BACTERIOL, V112, P676, DOI 10.1128/JB.112.2.676-681.1972; SIEGEL EC, 1973, J BACTERIOL, V113, P161, DOI 10.1128/JB.113.1.161-166.1973; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Skorvaga M, 2004, J BIOL CHEM, V279, P51574, DOI 10.1074/jbc.M409266200; Skorvaga M, 2002, J BIOL CHEM, V277, P1553, DOI 10.1074/jbc.M108847200; Slocum SL, 2007, J MOL BIOL, V367, P647, DOI 10.1016/j.jmb.2007.01.007; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Truglio JJ, 2006, NAT STRUCT MOL BIOL, V13, P360, DOI 10.1038/nsmb1072; UYEMURA D, 1976, J BIOL CHEM, V251, P4085; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; VISSE R, 1992, J BIOL CHEM, V267, P6736; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713	71	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9612	9623		10.1074/jbc.M808030200	http://dx.doi.org/10.1074/jbc.M808030200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208629	Green Published, hybrid			2022-12-27	WOS:000264669100067
J	Burrows, JF; Kelvin, AA; McFarlane, C; Burden, RE; McGrattan, MJ; De la Vega, M; Govender, U; Quinn, DJ; Dib, K; Gadina, M; Scott, CJ; Johnston, JA				Burrows, James F.; Kelvin, Alyson A.; McFarlane, Cheryl; Burden, Roberta E.; McGrattan, Michael J.; De la Vega, Michelle; Govender, Ureshnie; Quinn, Derek J.; Dib, Karim; Gadina, Massimo; Scott, Christopher J.; Johnston, James A.			USP17 Regulates Ras Activation and Cell Proliferation by Blocking RCE1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME; FAMILIAL CYLINDROMATOSIS; PARKINSONS-DISEASE; ALPHA-SUBUNIT; RHO GTPASES; A-FACTOR; UBIQUITIN; GENE; PATHWAY	The proto-oncogene Ras undergoes a series of post-translational modifications at its carboxyl-terminal CAAX motif that are essential for its proper membrane localization and function. One step in this process is the cleavage of the CAAX motif by the enzyme Ras-converting enzyme 1 (RCE1). Here we show that the deubiquitinating enzyme USP17 negatively regulates the activity of RCE1. We demonstrate that USP17 expression blocks Ras membrane localization and activation, thereby inhibiting phosphorylation of the downstream kinases MEK and ERK. Furthermore, we show that this effect is caused by the loss of RCE1 catalytic activity as a result of its deubiquitination by USP17. We also show that USP17 and RCE1 co-localize at the endoplasmic reticulum and that USP17 cannot block proliferation or Ras membrane localization in RCE1 null cells. These studies demonstrate that USP17 modulates Ras processing and activation, at least in part, by regulating RCE1 activity.	[Burrows, James F.; Kelvin, Alyson A.; McFarlane, Cheryl; McGrattan, Michael J.; De la Vega, Michelle; Govender, Ureshnie; Dib, Karim; Gadina, Massimo; Johnston, James A.] Queens Univ Belfast, Fac Med Hlth & Life Sci, Div Infect & Immunity, Ctr Canc Res & Cell Biol,Sch Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland; [Burrows, James F.; Burden, Roberta E.; Quinn, Derek J.; Scott, Christopher J.] Queens Univ Belfast, Fac Med Hlth & Life Sci, Sch Pharm, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Johnston, JA (corresponding author), Rm 226,Whitla Med Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	jim.johnston@qub.ac.uk	Gadina, Massimo/R-4195-2019		Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Bergo MO, 2004, J BIOL CHEM, V279, P4729, DOI 10.1074/jbc.M310081200; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bowen S, 2005, J INVEST DERMATOL, V124, P919, DOI 10.1111/j.0022-202X.2005.23688.x; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Dolence JM, 2000, BIOCHEMISTRY-US, V39, P4096, DOI 10.1021/bi9923611; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Goalstone M, 1997, ENDOCRINOLOGY, V138, P5119, DOI 10.1210/en.138.12.5119; GRAY DA, 1995, ONCOGENE, V10, P2179; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kumar A, 1997, NEUROSCI LETT, V231, P143, DOI 10.1016/S0304-3940(97)00549-1; Kumar A, 1996, BIOCHEM BIOPH RES CO, V222, P445, DOI 10.1006/bbrc.1996.0764; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Migone TS, 2001, BLOOD, V98, P1935, DOI 10.1182/blood.V98.6.1935; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Overall CM, 2004, BIOL CHEM, V385, P493, DOI 10.1515/BC.2004.058; Pan JX, 2005, CANCER RES, V65, P9109, DOI 10.1158/0008-5472.CAN-05-2635; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Plummer LJ, 2006, J BIOL CHEM, V281, P4596, DOI 10.1074/jbc.M506284200; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang J, 2000, PARKINSONISM RELAT D, V6, P195, DOI 10.1016/S1353-8020(00)00015-8; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275; Zhu Y, 1996, MOL CELL BIOL, V16, P4808; Zhu YA, 1997, J BIOL CHEM, V272, P51	51	64	66	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9587	9595		10.1074/jbc.M807216200	http://dx.doi.org/10.1074/jbc.M807216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19188362	hybrid, Green Published			2022-12-27	WOS:000264669100065
J	Gilman, B; Drullinger, LF; Kugel, JF; Goodrich, JA				Gilman, Benjamin; Drullinger, Linda F.; Kugel, Jennifer F.; Goodrich, James A.			TATA-binding Protein and Transcription Factor IIB Induce Transcript Slipping during Early Transcription by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR LATE PROMOTER; ABORTIVE INITIATION; DNA; ELONGATION; COMPLEXES; ESCAPE; ATP; CLEARANCE; STEPS; TFIIB	To better understand the mechanism of steps in early transcription by RNA polymerase II (pol II), we investigated the molecular determinants of transcript slipping within complexes assembled on promoters containing a pre-melted transcription bubble from -9 to +3. Transcript slippage occurs when an RNA transcript contains a repetitive sequence that allows the transcript to slip back and pair with the template strand of the DNA at a new register before transcription continues. We established the contributions of individual transcription factors, DNA elements, and RNA length to slipping on a heteroduplex template using a highly purified human pol II transcription system. We found that transcripts slip at a very defined point in the transcription reaction, after pol II completes phosphodiester bond synthesis at register +5. This point is set by the position of the polymerase active site on the DNA template, as opposed to the length of the transcript, as well as by a repetitive CUCU sequence that must occur from +2 to +5. Interestingly, slipping at this juncture is induced by TATA-binding protein and transcription factor IIB and requires a TATA box but not a transcription factor IIB recognition sequence. We propose a model in which transcribing complexes, upon completing phosphodiester bond synthesis at register +5, enter one of two branches in which they either complete productive synthesis of the transcript or undergo multiple rounds of transcript slipping.	[Gilman, Benjamin; Drullinger, Linda F.; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kugel, JF (corresponding author), Univ Colorado, Dept Chem & Biochem, 215 UCB, Boulder, CO 80309 USA.	jennifer.kugel@colorado.edu; james.goodrich@colorado.edu			National Science Foundation [MCB-0517296]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB-0517296 from the National Science Foundation.	Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JACOB GA, 1991, J BIOL CHEM, V266, P22537; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kugel JF, 1998, P NATL ACAD SCI USA, V95, P9232, DOI 10.1073/pnas.95.16.9232; Kugel JF, 2002, MOL CELL BIOL, V22, P762, DOI 10.1128/MCB.22.3.762-773.2002; Kugel JF, 2000, J BIOL CHEM, V275, P40483, DOI 10.1074/jbc.M006401200; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Pal M, 2002, MOL CELL BIOL, V22, P30, DOI 10.1128/MCB.22.1.30-40.2002; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Weaver JR, 2005, J BIOL CHEM, V280, P39860, DOI 10.1074/jbc.M509376200; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	26	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9093	9098		10.1074/jbc.M900019200	http://dx.doi.org/10.1074/jbc.M900019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193635	hybrid, Green Published			2022-12-27	WOS:000264669100012
J	Jacobs, AT; Marnett, LJ				Jacobs, Aaron T.; Marnett, Lawrence J.			HSF1-mediated BAG3 Expression Attenuates Apoptosis in 4-Hydroxynonenal-treated Colon Cancer Cells via Stabilization of Anti-apoptotic Bcl-2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; PEROXIDATION END-PRODUCTS; LIPID-PEROXIDATION; OXIDATIVE STRESS; X-L; GENE-EXPRESSION; MICROARRAY DATA; MCL-1; ACTIVATION; DISEASE	4-Hydroxynonenal (HNE) is a pro-apoptotic electrophile generated during the spontaneous decomposition of oxidized lipids. We have previously shown that HNE activates the transcription factor, heat shock factor 1 (HSF1), and promotes cytoprotective heat shock gene expression and that silencing HSF1 sensitizes the colon cancer cell line RKO to HNE-induced apoptosis. Here we report a reduction in the anti-apoptotic proteins Bcl-X-L, Mcl-1, and Bcl-2 in HSF1-silenced RKO cells, and we examine the underlying mechanism. To investigate the regulation of the Bcl-2 family by HSF1, microarray analysis of gene expression was performed. We observed that the Hsp70 co-chaperone, BAG3 (Bcl-2-associated athanogene domain 3), is strongly induced by HNE in control but not in HSF1-silenced colon cancer cells. Silencing BAG3 expression with small interfering RNA caused a dramatic reduction in Bcl-XL, Mcl-1, and Bcl-2 protein levels in colon cancer cells and increased apoptosis, similar to the effect of silencing HSF1. Also, immunoprecipitation experiments indicate specific interactions between BAG3, Hsp70, and the Bcl-2 family member, Bcl-XL. Overall, our data reveal that BAG3 is HSF1-inducible and has a unique role facilitating cancer cell survival during pro-apoptotic stress by stabilizing the level of Bcl-2 family proteins.	[Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu			National Institutes of Health [P01ES013125]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01ES013125 from NIEHS (Program Project Grant).	Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Antoku K, 2001, BIOCHEM BIOPH RES CO, V286, P1003, DOI 10.1006/bbrc.2001.5512; Arnold AA, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-20; Bartsch H, 2005, MUTAT RES-FUND MOL M, V591, P34, DOI 10.1016/j.mrfmmm.2005.04.013; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Brocardo M, 2008, J BIOL CHEM, V283, P5950, DOI 10.1074/jbc.M708775200; CAJONE F, 1992, CHEM-BIOL INTERACT, V84, P97, DOI 10.1016/0009-2797(92)90071-R; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Fleischer B, 2006, INT J ONCOL, V28, P25; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gleave M, 2005, ANN NY ACAD SCI, V1058, P1, DOI 10.1196/annals.1359.001; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Ji C, 2001, CHEM RES TOXICOL, V14, P1090, DOI 10.1021/tx000186f; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Liu W, 2000, J CELL SCI, V113, P635; Manion MK, 2006, CURR OPIN INVEST DR, V7, P1077; Montine KS, 1998, J NEUROPATH EXP NEUR, V57, P415, DOI 10.1097/00005072-199805000-00005; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Paradis V, 1997, HEPATOLOGY, V26, P135; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Romano MF, 2003, CANCER BIOL THER, V2, P508, DOI 10.4161/cbt.2.5.524; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; Vila A, 2008, CHEM RES TOXICOL, V21, P432, DOI 10.1021/tx700347w; Volkel W, 2005, FREE RADICAL BIO MED, V38, P1526, DOI 10.1016/j.freeradbiomed.2005.02.015; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yang ZQ, 2007, J VASC RES, V44, P483, DOI 10.1159/000106466; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zhang W, 2001, FREE RADICAL BIO MED, V30, P699, DOI 10.1016/S0891-5849(01)00465-8; Zheng B, 2007, J IMMUNOL, V179, P7087, DOI 10.4049/jimmunol.179.10.7087	52	130	133	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9176	9183		10.1074/jbc.M808656200	http://dx.doi.org/10.1074/jbc.M808656200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19179333	Green Published, hybrid			2022-12-27	WOS:000264669100023
J	Schwarzer, D; Stummeyer, K; Haselhorst, T; Freiberger, F; Rode, B; Grove, M; Scheper, T; von Itzstein, M; Muhlenhoff, M; Gerardy-Schahn, R				Schwarzer, David; Stummeyer, Katharina; Haselhorst, Thomas; Freiberger, Friedrich; Rode, Bastian; Grove, Melanie; Scheper, Thomas; von Itzstein, Mark; Muehlenhoff, Martina; Gerardy-Schahn, Rita			Proteolytic Release of the Intramolecular Chaperone Domain Confers Processivity to Endosialidase F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K1; TRICHODERMA-REESEI CELLOBIOHYDROLASE; POLYSIALIC ACID; CRYSTAL-STRUCTURE; ACTIVE-SITE; POLYSACCHARIDE CAPSULES; SERRATIA-MARCESCENS; AROMATIC RESIDUES; MOLECULAR-CLONING; FIBER PROTEINS	Endosialidases (endoNs), as identified so far, are tailspike proteins of bacteriophages that specifically bind and degrade the alpha 2,8-linked polysialic acid (polySia) capsules of their hosts. The crystal structure solved for the catalytic domain of endoN from coliphage K1F (endoNF) revealed a functional trimer. Folding of the catalytic trimer is mediated by an intramolecular C-terminal chaperone domain. Release of the chaperone from the folded protein confers kinetic stability to endoNF. In mutant c(S), the replacement of serine 911 by alanine prevents proteolysis and generates an enzyme that varies in activity from wild type. Using soluble polySia as substrate a 3-times higher activity was detected while evaluation with immobilized polySia revealed a 190-fold reduced activity. Importantly, activity of c(S) did not differ from wild type with tetrameric sialic acid, the minimal endoNF substrate. Furthermore, we show that the presence of the chaperone domain in c(S) destabilizes binding to polySia in a similar way as did selective disruption of a polySia binding site in the stalk domain. The improved catalytic efficiency toward soluble polySia observed in these mutants can be explained by higher dissociation and association probabilities, whereas inversely, an impaired processivity was found. The fact that endoNF is a processive enzyme introduces a new molecular basis to explain capsule degradation by bacteriophages, which until now has been regarded as a result of cooperative interaction of tailspike proteins. Moreover, knowing that release of the chaperone domain confers kinetic stability and processivity, conservation of the proteolytic process can be explained by its importance in phage evolution.	[Schwarzer, David; Stummeyer, Katharina; Freiberger, Friedrich; Grove, Melanie; Muehlenhoff, Martina; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Zellulare Chem, Zentrum Biochem, D-30625 Hannover, Germany; [Haselhorst, Thomas; von Itzstein, Mark] Griffith Univ, Inst Glyc, Griffith, Qld 4222, Australia; [Rode, Bastian; Scheper, Thomas] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany	Hannover Medical School; Griffith University; Leibniz University Hannover	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Zellulare Chem, Zentrum Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de	von Itzstein, Mark/E-4823-2010; Scheper, Thomas/H-8143-2013; Schwarzer, David/C-1939-2012; Haselhorst, Thomas/A-5066-2015	Haselhorst, Thomas/0000-0002-3373-8680	Deutsche Forschungsgemeinschaft (DFG) [Ge801/7-1, 7-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) in the framework of DFG Research Unit 548 (Grants Ge801/7-1 and 7-2).	Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; BAYER ME, 1979, VIROLOGY, V94, P95, DOI 10.1016/0042-6822(79)90441-0; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; DECHER G, 1990, BIOCHIM BIOPHYS ACTA, V1023, P357, DOI 10.1016/0005-2736(90)90127-A; FROSCH M, 1987, MICROB PATHOGENESIS, V2, P319, DOI 10.1016/0882-4010(87)90074-X; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; GERARDYSCHAHN R, 1995, MOL MICROBIOL, V16, P441, DOI 10.1111/j.1365-2958.1995.tb02409.x; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; HILDEBRANDT H, 2008, NEUROCHEM RES, DOI DOI 10.1007/S11064-008-9724-7; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Jakobsson E, 2007, BIOCHEM J, V405, P465, DOI 10.1042/BJ20070177; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Lindberg AA, 1977, SURFACE CARBOHYDRATE, P289; LONG GS, 1995, BIOCHEM J, V309, P543, DOI 10.1042/bj3090543; Machida Y, 2000, J BIOSCI BIOENG, V90, P62, DOI 10.1016/S1389-1723(00)80035-3; Muhlenhoff M, 2003, J BIOL CHEM, V278, P12634, DOI 10.1074/jbc.M212048200; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; ROBBINS JB, 1974, NEW ENGL J MED, V290, P1216, DOI 10.1056/NEJM197405302902202; Rode B, 2008, J BIOTECHNOL, V135, P202, DOI 10.1016/j.jbiotec.2008.03.012; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SARFF LD, 1975, LANCET, V1, P1099; SCHNAITMAN CA, 2001, MOL MED MICROBIOLOGY, V1, P93; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; Scholl D, 2001, J VIROL, V75, P2509, DOI 10.1128/JVI.75.6.2509-2515.2001; Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200; SKOZA L, 1976, BIOCHEM J, V159, P457, DOI 10.1042/bj1590457; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sutherland IW, 1977, SURFACE CARBOHYDRATE, P209; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Weigele PR, 2003, J BACTERIOL, V185, P4022, DOI 10.1128/JB.185.14.4022-4030.2003; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	44	23	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9465	9474		10.1074/jbc.M808475200	http://dx.doi.org/10.1074/jbc.M808475200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189967	Green Published, hybrid			2022-12-27	WOS:000264669100053
J	Xie, BB; Bian, F; Chen, XL; He, HL; Guo, J; Gao, X; Zeng, YX; Chen, B; Zhou, BC; Zhang, YZ				Xie, Bin-Bin; Bian, Fei; Chen, Xiu-Lan; He, Hai-Lun; Guo, Jun; Gao, Xiang; Zeng, Yin-Xin; Chen, Bo; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Cold Adaptation of Zinc Metalloproteases in the Thermolysin Family from Deep Sea and Arctic Sea Ice Bacteria Revealed by Catalytic and Structural Properties and Molecular Dynamics NEW INSIGHTS INTO RELATIONSHIP BETWEEN CONFORMATIONAL FLEXIBILITY AND HYDROGEN BONDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; PSYCHROPHILIC ENZYMES; ACTIVE ENZYME; SEQUENCE; TEMPERATURES; STABILITY; STRATEGY; PROTEASE; STRAIN	Increased conformational flexibility is the prevailing explanation for the high catalytic efficiency of cold-adapted enzymes at low temperatures. However, less is known about the structural determinants of flexibility. We reported two novel cold-adapted zinc metalloproteases in the thermolysin family, vibriolysin MCP-02 from a deep sea bacterium and vibriolysin E495 from an Arctic sea ice bacterium, and compared them with their mesophilic homolog, pseudolysin from a terrestrial bacterium. Their catalytic efficiencies, k(cat)/K-m (10-40 degrees C), followed the order pseudolysin < MCP-02 < E495 with a ratio of similar to 1:2:4. MCP-02 and E495 have the same optimal temperature (T-opt, 57 degrees C, 5 degrees C lower than pseudolysin) and apparent melting temperature (T-m = 64 degrees C, similar to 10 degrees C lower than pseudolysin). Structural analysis showed that the slightly lower stabilities resulted from a decrease in the number of salt bridges. Fluorescence quenching experiments and molecular dynamics simulations showed that the flexibilities of the proteins were pseudolysin < MCP-02 < E495, suggesting that optimization of flexibility is a strategy for cold adaptation. Molecular dynamics results showed that the ordinal increase in flexibility from pseudolysin to MCP-02 and E495, especially the increase from MCP-02 to E495, mainly resulted from the decrease of hydrogen-bond stability in the dynamic structure, which was due to the increase in asparagine, serine, and threonine residues. Finally, a model for the cold adaptation of MCP-02 and E495 was proposed. This is the first report of the optimization of hydrogen-bonding dynamics as a strategy for cold adaptation and provides new insights into the structural basis underlying conformational flexibility.	[Xie, Bin-Bin; Bian, Fei; Chen, Xiu-Lan; He, Hai-Lun; Guo, Jun; Gao, Xiang; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zeng, Yin-Xin; Chen, Bo] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai 200136, Peoples R China	Shandong University; Polar Research Institute of China	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn						Adekoya OA, 2006, PROTEINS, V62, P435, DOI 10.1002/prot.20773; Aghajari N, 2003, PROTEINS, V50, P636, DOI 10.1002/prot.10264; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; BARRETT AJ, 2004, HDB PROTEOLYTIC ENZY, P374; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brandsdal BO, 2001, FEBS LETT, V499, P171, DOI 10.1016/S0014-5793(01)02552-2; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Chessa JP, 2000, BBA-PROTEIN STRUCT M, V1479, P265, DOI 10.1016/S0167-4838(00)00018-2; Collins T, 2003, J MOL BIOL, V328, P419, DOI 10.1016/S0022-2836(03)00287-0; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEDER J, 1968, BIOCHEM BIOPH RES CO, V32, P326, DOI 10.1016/0006-291X(68)90389-6; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SO, 2002, BIOSCI BIOTECH BIOCH, V66, P1366, DOI 10.1271/bbb.66.1366; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Moe E, 2004, J MOL BIOL, V343, P1221, DOI 10.1016/j.jmb.2004.09.004; Olufsen M, 2005, J BIOL CHEM, V280, P18042, DOI 10.1074/jbc.M500948200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Svingor A, 2001, J BIOL CHEM, V276, P28121, DOI 10.1074/jbc.M104432200; THAYER MM, 1991, J BIOL CHEM, V266, P2864; TRONRUD DE, 1986, EUR J BIOCHEM, V157, P261, DOI 10.1111/j.1432-1033.1986.tb09664.x; Wintrode PL, 2000, J BIOL CHEM, V275, P31635, DOI 10.1074/jbc.M004503200; Xu Y, 2003, J BACTERIOL, V185, P2161, DOI 10.1128/JB.185.7.2161-2168.2003	44	57	61	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9257	9269		10.1074/jbc.M808421200	http://dx.doi.org/10.1074/jbc.M808421200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181663	hybrid, Green Published			2022-12-27	WOS:000264669100032
J	Agne, B; Infanger, S; Wang, F; Hofstetter, V; Rahim, G; Martin, M; Lee, DW; Hwang, I; Schnell, D; Kessler, F				Agne, Birgit; Infanger, Sibylle; Wang, Fei; Hofstetter, Valere; Rahim, Gwendoline; Martin, Meryll; Lee, Dong Wook; Hwang, Inhwan; Schnell, Danny; Kessler, Felix			A Toc159 Import Receptor Mutant, Defective in Hydrolysis of GTP, Supports Preprotein Import into Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; ARABIDOPSIS CHLOROPLASTS; OUTER-MEMBRANE; ATTOC159; TRANSLOCON; PLASTIDS; FAMILY; DOMAIN; DIMERIZATION; BIOGENESIS	The heterotrimeric Toc core complex of the chloroplast protein import apparatus contains two GTPases, Toc159 and Toc34, together with the protein-conducting channel Toc75. Toc159 and Toc34 are exposed at the chloroplast surface and function in preprotein recognition. Together, they have been shown to facilitate the import of photosynthetic proteins into chloroplasts in Arabidopsis. Consequently, the ppi2 mutant lacking at Toc159 has a non-photosynthetic albino phenotype. Previous mutations in the conserved G1 and G3 GTPase motifs abolished the function of Toc159 in vivo by disrupting targeting of the receptor to chloroplasts. Here, we demonstrate that a mutant in a conserved G1 lysine (atToc159 K868R) defective in GTP binding and hydrolysis can target and assemble into Toc complexes. We show that atToc159 K868R can support protein import into isolated chloroplasts, albeit at lower preprotein binding and import efficiencies compared with the wild-type receptor. Considering the absence of measurable GTPase activity in the K868R mutant, we conclude that GTP hydrolysis at atToc159 is not strictly required for preprotein translocation. The data also indicate that preprotein import requires at least one additional GTPase other than Toc159.	[Kessler, Felix] Univ Neuchatel, Lab Physiol Vegetale, CH-2007 Neuchatel, Switzerland; [Wang, Fei; Schnell, Danny] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Wang, Fei; Schnell, Danny] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Lee, Dong Wook; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	University of Neuchatel; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Pohang University of Science & Technology (POSTECH)	Kessler, F (corresponding author), Univ Neuchatel, Lab Physiol Vegetale, Rue Emile Argand 11, CH-2009 Neuchatel, Switzerland.	felix.kessler@unine.ch		Kessler, Felix/0000-0001-6409-5043	National Institutes of Health [GM61893]; Grant Crop Functional Genomics Research Center [M107KG010003-07K0701-00330]; Ministry of Education, Science, and Technology, Korea; Swiss National Science Foundation [3100A0-109667]; University of Neuchatel; National Centre of Competence in Research (NCCR) Plant Survival; research program of the Swiss National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Crop Functional Genomics Research Center; Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Neuchatel; National Centre of Competence in Research (NCCR) Plant Survival(Swiss National Science Foundation (SNSF)); research program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61893 (to D.J.S.). This work was also supported by Grant Crop Functional Genomics Research Center (M107KG010003-07K0701-00330), Ministry of Education, Science, and Technology, Korea (to I. H.), the Swiss National Science Foundation (3100A0-109667), the University of Neuchatel, and the National Centre of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S. C. Section 1734 solely to indicate this fact.	Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fitzpatrick LM, 2001, PLANT J, V27, P59, DOI 10.1046/j.0960-7412.2001.01061.x; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Hiltbrunner A, 2001, BIOCHEM CELL BIOL, V79, P629, DOI 10.1139/bcb-79-5-629; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Kubis S, 2003, PLANT CELL, V15, P1859, DOI 10.1105/tpc.012955; Lee KH, 2003, J BIOL CHEM, V278, P36794, DOI 10.1074/jbc.M304457200; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Sun YJ, 2002, NAT STRUCT BIOL, V9, P95, DOI 10.1038/nsb744; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Weibel P, 2003, J BIOL CHEM, V278, P37321, DOI 10.1074/jbc.M305946200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yeh YH, 2007, J BIOL CHEM, V282, P13845, DOI 10.1074/jbc.M608385200	35	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8661	8670		10.1074/jbc.M804235200	http://dx.doi.org/10.1074/jbc.M804235200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19188370	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000264397800051
J	Ahn, S; Kim, J; Hara, MR; Ren, XR; Lefkowitz, RJ				Ahn, Seungkirl; Kim, Jihee; Hara, Makoto R.; Ren, Xiu-Rong; Lefkowitz, Robert J.			beta-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RIBOSOMAL S6 KINASE; BETA-ARRESTIN; ANGIOTENSIN-II; CELL-SURVIVAL; AKT PHOSPHORYLATION; ERK1/2 ACTIVATION; DEATH; MITOCHONDRIA; TRANSCRIPTION	beta-Arrestins, originally discovered as terminators of G protein-coupled receptor signaling, have more recently been appreciated to also function as signal transducers in their own right, although the consequences for cellular physiology have not been well understood. Here we demonstrate that beta-arrestin-2 mediates anti-apoptotic cytoprotective signaling stimulated by a typical 7-transmembrane receptor the angiotensin ATII 1A receptor, expressed endogenously in rat vascular smooth muscle cells or by transfection in HEK-293 cells. Receptor stimulation leads to concerted activation of two pathways, ERK/p90RSK and PI3K/AKT, which converge to phosphorylate and inactivate the pro-apoptotic protein BAD. Anti-apoptotic effects as well as pathway activities can be stimulated by an angiotensin analog (SII), which has been previously shown to activate beta-arrestin but not G protein-dependent signaling, and are abrogated by beta-arrestin-2 small interfering RNA. These findings establish a key role for beta-arrestin-2 in mediating cellular cytoprotective functions by a 7-transmembrane receptor and define the biochemical pathways involved.	[Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		National Institutes of Health [HL16037, HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037, R37HL016037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL16037 and HL70631. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Archacki SR, 2003, PHYSIOL GENOMICS, V15, P65, DOI 10.1152/physiolgenomics.00181.2002; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DEL PL, 1997, SCIENCE, V278, P687; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Korshunov VA, 2008, CURR OPIN HEMATOL, V15, P250, DOI 10.1097/MOH.0b013e3282f97d71; Lee KW, 2008, CANCER RES, V68, P1916, DOI 10.1158/0008-5472.CAN-07-3195; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nakashima Hidekatsu, 2006, Current Vascular Pharmacology, V4, P67, DOI 10.2174/157016106775203126; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Pollman MJ, 1996, CIRC RES, V79, P748, DOI 10.1161/01.RES.79.4.748; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XP, 2005, CANCER RES, V65, P7338, DOI 10.1158/0008-5472.CAN-04-2263; Zhao M, 2004, J BIOL CHEM, V279, P49259, DOI 10.1074/jbc.M405118200	50	122	126	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8846	8856		10.1074/jbc.M808463200	http://dx.doi.org/10.1074/jbc.M808463200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171933	hybrid, Green Published			2022-12-27	WOS:000264397800068
J	Bafna, PA; Jha, A; Auerbach, A				Bafna, Pallavi A.; Jha, Archana; Auerbach, Anthony			Aromatic Residues epsilon Trp-55 and delta Trp-57 and the Activation of Acetylcholine Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN INTERFACE; LIGAND-BINDING DOMAIN; GATED ION-CHANNEL; X-RAY-STRUCTURE; AGONIST BINDING; CYS-LOOP; EXTRACELLULAR DOMAIN; GAMMA-SUBUNIT; AFFINITY; SITE	The two transmitter binding sites of the neuromuscular acetylcholine (ACh) receptor channel contain several aromatic residues, including a tryptophan located on the complementary, negative face of each binding pocket. These two residues, Trp-55 in the epsilon subunit and Trp-57 in the delta subunit, were mutated (AEFHILRVY), and for most constructs the rate constants for acetylcholine binding and channel gating were estimated by using single channel kinetic analyses. The rate constants for unliganded channel opening and closing were also estimated for some mutants. From these measurements we calculated all of the equilibrium constants of the "allosteric" cycle as follows: diliganded gating, unliganded gating, dissociation from the C(losed) conformation, and dissociation from the O(pen) conformation. The results indicate the following. (i) These aromatic side chains play a relatively minor role in ACh receptor channel activation. (ii) The main consequence of mutations is to reduce the affinity of the O conformation of the binding site for ACh, with the effect being greater at the epsilon subunit. (iii) In epsilon (but not delta) the aromatic nature of the side chain is important in determining affinity, to a slightly greater degree in the O conformation. Phi value analyses (of both tryptophan residues) show Phi similar to 1 for both the ACh binding and diliganded gating reactions. (iv) This suggests that the structural boundaries of the dynamic elements of the gating conformational change may not be subunit-delimited, and (v) the mutated tryptophan residues experience energy changes that occur relatively early in both the ligand-binding and channel-gating reactions.	[Bafna, Pallavi A.; Jha, Archana; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu	jha, archana/AAQ-2120-2020		National Institutes of Health [NS-23513]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023513, R37NS023513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-23513. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akk G, 2002, J PHYSIOL-LONDON, V544, P695, DOI 10.1113/jphysiol.2002.029413; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; Bafna PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002515; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chiara DC, 1998, FEBS LETT, V423, P223, DOI 10.1016/S0014-5793(98)00093-3; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Karlin A, 1977, Methods Enzymol, V46, P582; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li LT, 2001, CHEM BIOL, V8, P47, DOI 10.1016/S1074-5521(00)00055-7; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Stewart DS, 2006, BIOCHEMISTRY-US, V45, P10641, DOI 10.1021/bi060686t; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xie Y, 2001, J BIOL CHEM, V276, P2417, DOI 10.1074/jbc.M009085200; Yan D, 1999, J BIOL CHEM, V274, P5537, DOI 10.1074/jbc.274.9.5537; ZHANG YN, 1995, J PHYSIOL-LONDON, V486, P189, DOI 10.1113/jphysiol.1995.sp020802; ZHOU M, 1999, THESIS STATE U NEW Y; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	39	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8582	8588		10.1074/jbc.M807152200	http://dx.doi.org/10.1074/jbc.M807152200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171937	hybrid, Green Published			2022-12-27	WOS:000264397800042
J	Liu, J; Fujisawa, M; Hicks, DB; Krulwich, TA				Liu, Jun; Fujisawa, Makoto; Hicks, David B.; Krulwich, Terry A.			Characterization of the Functionally Critical AXAXAXA and PXXEXXP Motifs of the ATP Synthase c-Subunit from an Alkaliphilic Bacillus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL ENERGY-CONVERSION; SP STRAIN TA2.A1; ESCHERICHIA-COLI; FIRMUS OF4; F1F0-ATP SYNTHASE; OXIDATIVE-PHOSPHORYLATION; MOLECULAR ARCHITECTURE; ADENOSINE-TRIPHOSPHATE; PROTON TRANSLOCATION; NA+/H+ ANTIPORTER	The membrane-embedded rotor in the F-0 sector of proton-translocating ATP synthases is formed from hairpin-like c-subunits that are protonated and deprotonated during energization of ATP synthesis. This study focuses on two c-subunit motifs that are unique to synthases of extremely alkaliphilic Bacillus species. One motif is the AXAXAXA sequence found in the N-terminal helix-1 instead of the GXGXGXG of non-alkaliphiles. Quadruple A -> G chromosomal mutants of alkaliphilic Bacillus pseudofirmus OF4 retain 50% of the wild-type hydrolytic activity (ATPase) but <18% of the ATP synthase capacity at high pH. Consistent with a structural impact of the four alanine replacements, the mutant ATPase activity showed enhanced inhibition by dicyclohexylcarbodiimide, which blocks the helix-2 carboxylate. Single, double, or triple A -> G mutants exhibited more modest defects, as monitored by malate growth. The key carboxylate is in the second motif, which is (PXXEXXP)-X-51-X-54 in extreme alkaliphiles instead of the (A/G) XX(E/D) XXP found elsewhere. Mutation of Pro(51) to alanine had been shown to severely reduce malate growth and ATP synthesis at high pH. Here, two Pro51 to glycine mutants of different severities retained ATP synthase capacity but exhibited growth deficits and proton leakiness. A Glu(54) to Asp(54) change increased proton leakiness and reduced malate growth 79-90%. The Pro(51) and the Glu(54) mutants were both more dicyclohexylcarbodiimide-sensitive than wild type. The results highlight the requirement for c-subunit adaptations to achieve alkaliphile ATP synthesis with minimal cytoplasmic proton loss and suggest partial suppression of some mutations by changes outside the atp operon.	[Liu, Jun; Fujisawa, Makoto; Hicks, David B.; Krulwich, Terry A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Krulwich, TA (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl, New York, NY 10029 USA.	terry.krulwich@mssm.edu			National Institutes of Health [GM28454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28454 (to T. A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Arechaga I, 2001, FEBS LETT, V494, P1, DOI 10.1016/S0014-5793(01)02300-6; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; GUFFANTI AA, 1994, J BIOL CHEM, V269, P21576; GUFFANTI AA, 1991, J GEN MICROBIOL, V137, P2375, DOI 10.1099/00221287-137-10-2375; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0; HICKS DB, 1990, J BIOL CHEM, V265, P20547; HOPPE J, 1980, EUR J BIOCHEM, V112, P17, DOI 10.1111/j.1432-1033.1980.tb04981.x; Ito M, 1997, J BACTERIOL, V179, P3851, DOI 10.1128/jb.179.12.3851-3857.1997; IVEY DM, 1991, MOL GEN GENET, V229, P292, DOI 10.1007/BF00272169; IVEY DM, 1992, RES MICROBIOL, V143, P467, DOI 10.1016/0923-2508(92)90092-3; Kosono S, 2004, FEMS MICROBIOL LETT, V232, P93, DOI 10.1016/S0378-1097(04)00037-0; Krulwich TA, 1997, EXTREMOPHILES, V1, P163, DOI 10.1007/s007920050030; KRULWICH TA, 1995, MOL MICROBIOL, V15, P403, DOI 10.1111/j.1365-2958.1995.tb02253.x; KRULWICH TA, 1985, J BIOL CHEM, V260, P4055; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; Liu XY, 2007, BIOCHEMISTRY-US, V46, P306, DOI 10.1021/bi0619167; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Mellwig C, 2003, J BIOL CHEM, V278, P18544, DOI 10.1074/jbc.M212852200; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P913, DOI 10.1016/j.bbabio.2006.02.015; Mulkidjanian AY, 2005, BIOCHEMISTRY-MOSCOW+, V70, P251, DOI 10.1007/s10541-005-0108-1; Olsson K, 2003, J BACTERIOL, V185, P461, DOI 10.1128/JB.185.2.461-465.2003; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Rivera-Torres IO, 2004, FEBS LETT, V575, P131, DOI 10.1016/j.febslet.2004.08.049; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; STURR MG, 1994, J BACTERIOL, V176, P3111, DOI 10.1128/jb.176.11.3111-3116.1994; Valiyaveetil F, 2002, BBA-BIOENERGETICS, V1553, P296, DOI 10.1016/S0005-2728(01)00251-1; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	54	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8714	8725		10.1074/jbc.M808738200	http://dx.doi.org/10.1074/jbc.M808738200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176524	Green Published, hybrid			2022-12-27	WOS:000264397800055
J	Wu, Q; Hu, HX; Lan, JP; Emenari, C; Wang, ZY; Chang, KS; Huang, H; Yao, XB				Wu, Quan; Hu, Haixiang; Lan, Jianping; Emenari, Chibuzo; Wang, Zhiyong; Chang, Kang-sang; Huang, He; Yao, Xuebiao			PML3 Orchestrates the Nuclear Dynamics and Function of TIP60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; RAR-ALPHA; BODIES; ACETYLATION; ONCOPROTEIN; RECEPTOR; P53; ACETYLTRANSFERASES; IDENTIFICATION; DEGRADATION	The promyelocytic leukemia (PML) protein is a major component to govern the PML nuclear body (NB) assembly and function. Although it is well defined that PML NB is a site recruiting sumoylated proteins, the mechanism by which PML protein regulates the process remains unclear. Here we show that PML3, a specific PML isoform, interacts with and recruits TIP60 to PML NBs. Our biochemical characterization demonstrates that PML3 physically interacts with TIP60 via its N-terminal 364 amino acids. Importantly, this portion of TIP60 is sufficient to target to the PMLNBs, suggesting that PML3-TIP60 interaction is sufficient for targeting TIP60 to the NBs. The PML3-TIP60 interaction is specific, since the region of TIP60 binding is not conserved in other PML isoforms. The physical interaction between PML3 and TIP60 protects TIP60 from Mdm2-mediated degradation, suggesting that PML3 competes with MDM2 for binding to TIP60. Fluorescence recovery after photobleaching analysis indicates that the PML3-TIP60 interaction modulates the nuclear body distribution and mobility of TIP60. Conversely, the distribution and mobility of TIP60 are perturbed in PML3-deficient cells, accompanied by aberrations in DNA damage-repairing response. Thus, PML3 orchestrates the distribution, dynamics, and function of TIP60. Our findings suggest a novel regulatory mechanism by which the PML3 and TIP60 tumor suppressors cooperate to ensure genomic stability.	[Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Yao, Xuebiao] Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Hu, Haixiang] Airforce Gen Hosp, Dept Radiobiol, Beijing 100036, Peoples R China; [Lan, Jianping; Huang, He] Zhejiang Prov Peoples Hosp, Dept Hematol, Hangzhou 310014, Zhejiang, Peoples R China; [Lan, Jianping; Huang, He] Zhejiang Univ, Sch Med, Hangzhou 310014, Zhejiang, Peoples R China; [Wu, Quan; Emenari, Chibuzo] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Chang, Kang-sang] MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Zhejiang Provincial People's Hospital; Zhejiang University; Morehouse School of Medicine; University of Texas System; UTMD Anderson Cancer Center	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014		National Institutes of Health/NCRR/RCM1 [G-12RR03034]; Chinese Academy of Science [KSCX1-YW-R65, KSCX2-YW-H-10]; Chinese 973 Project [2002CB713700, 2007CB914503]; Chinese 863 Project [2001AA215331, 2006AA02A247]; Anhui Science and Technology [08040102005]; Natural Science Foundation of China [39925018, 9050800290, 90813008];  [DK56292];  [CA92080];  [CA118948]; NATIONAL CANCER INSTITUTE [U54CA118948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health/NCRR/RCM1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); Chinese 863 Project(National High Technology Research and Development Program of China); Anhui Science and Technology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grants DK56292, CA92080, and CA118948. The facilities used were supported in part by National Institutes of Health/NCRR/RCM1 Grant G-12RR03034. This work was also supported by Chinese Academy of Science Grants KSCX1-YW-R65 and KSCX2-YW-H-10, Chinese 973 Project Grants 2002CB713700 and 2007CB914503, Chinese 863 Project Grants 2001AA215331 and 2006AA02A247, Anhui Science and Technology Project Grant 08040102005, and Natural Science Foundation of China Grants 39925018 and 9050800290 (to X.Y. and 90813008 (to Z.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lemercier C, 2003, J BIOL CHEM, V278, P4713, DOI 10.1074/jbc.M211811200; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, BLOOD, V92, P4308, DOI 10.1182/blood.V92.11.4308.423k36_4308_4316; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu HY, 2003, J BIOL CHEM, V278, P49286, DOI 10.1074/jbc.M308302200	47	21	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8738	8750		10.1074/jbc.M807590200	http://dx.doi.org/10.1074/jbc.M807590200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19150978	Green Published, hybrid			2022-12-27	WOS:000264397800058
J	Griffero, F; Daga, A; Marubbi, D; Capra, MC; Melotti, A; Pattarozzi, A; Gatti, M; Bajetto, A; Porcile, C; Barbieri, F; Favoni, RE; Lo Casto, M; Zona, G; Spaziante, R; Florio, T; Corte, G				Griffero, Fabrizio; Daga, Antonio; Marubbi, Daniela; Capra, Maria Cristina; Melotti, Alice; Pattarozzi, Alessandra; Gatti, Monica; Bajetto, Adriana; Porcile, Carola; Barbieri, Federica; Favoni, Roberto E.; Lo Casto, Michele; Zona, Gianluigi; Spaziante, Renato; Florio, Tullio; Corte, Giorgio			Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; BRAIN-TUMORS; IN-VITRO; NEURAL PRECURSORS; HUMAN MENINGIOMAS; GENE-EXPRESSION; SIDE-POPULATION; NERVOUS-SYSTEM; PROLIFERATION; EGF	Because a subpopulation of cancer stem cells (tumor-initiating cells, TICs) is believed to be responsible for the development, progression, and recurrence of many tumors, we evaluated the in vitro sensitivity of human glioma TICs to epidermal growth factor receptor (EGFR) kinase inhibitors (erlotinib and gefitinib) and possible molecular determinants for their effects. Cells isolated from seven glioblastomas (GBM 1-7) and grown using neural stem cell permissive conditions were characterized for in vivo tumorigenicity, expression of tumor stem cell markers (CD133, nestin), and multilineage differentiation properties, confirming that these cultures are enriched in TICs. TIC cultures were challenged with increasing concentrations of erlotinib and gefitinib, and their survival was evaluated after 1-4 days. In most cases, a time- and concentration-dependent cell death was observed, although GBM 2 was completely insensitive to both drugs, and GBM 7 was responsive only to the highest concentrations tested. Using a radioligand binding assay, we show that all GBM TICs express EGFR. Erlotinib and gefitinib inhibited EGFR and ERK1/2 phosphorylation/activation in all GBMs, irrespective of the antiproliferative response observed. However, under basal conditions GBM 2 showed a high Akt phosphorylation that was completely insensitive to both drugs, whereas GBM 7 was completely insensitive to gefitinib, and Akt inactivation occurred only for the highest erlotinib concentration tested, showing a precise relationship with the antiproliferative effects of the drug. Interestingly, in GBM 2, phosphatase and tensin homolog expression was significantly down-regulated, possibly accounting for the insensitivity to the drugs. In conclusion, glioma TICs are responsive to anti-EGFR drugs, but phosphatase and tensin homolog expression and Akt inhibition seem to be necessary for such effect.	[Florio, Tullio] Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Lab, I-16132 Genoa, Italy; [Griffero, Fabrizio; Daga, Antonio; Capra, Maria Cristina; Melotti, Alice; Favoni, Roberto E.; Lo Casto, Michele; Corte, Giorgio] Natl Inst Canc Res, Dept Translat Oncol, I-16132 Genoa, Italy; [Zona, Gianluigi; Spaziante, Renato] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Florio, T (corresponding author), Univ Genoa, Dept Oncol Biol & Genet, Pharmacol Lab, Viale Benedetto 15,2, I-16132 Genoa, Italy.	tullio.florio@unige.it; giorgio.corte@istge.it	FLORIO, TULLIO/ABG-3182-2020; Barbieri, Federica/L-8753-2015; Daga, Antonio/Z-2417-2019; Florio, Tullio/A-2211-2012; Daga, Antonio/C-3041-2008; zona, gianluigi/AAF-8235-2021	Barbieri, Federica/0000-0001-8988-6896; Daga, Antonio/0000-0001-5845-8530; Florio, Tullio/0000-0002-2394-996X; Monica, Gatti/0000-0002-2016-0285; ZONA, GIANLUIGI/0000-0002-3577-7894	Fondazione Carige; MIUR-PRIN; Ministero della Salute	Fondazione Carige(Fondazione Carige); MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy)	This work was supported by grants from Fondazione Carige, MIUR-PRIN, and Ministero della Salute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arena S, 2004, J NEURO-ONCOL, V66, P155, DOI 10.1023/B:NEON.0000013498.19981.55; Bajetto A, 2007, NEURO-ONCOLOGY, V9, P3, DOI 10.1215/15228517-2006-023; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dowlati A, 2004, MOL CANCER THER, V3, P459; Florio T, 2006, MOL PHARMACOL, V69, P539, DOI 10.1124/mol.105.015255; Florio T, 2008, ENDOCR-RELAT CANCER, V15, P583, DOI 10.1677/ERC-07-0271; Florio T, 2008, MOL CELL ENDOCRINOL, V286, P40, DOI 10.1016/j.mce.2007.08.012; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GANGEMI RM, 2008, STEM CELLS, V23, P23; Gangemi RMR, 2006, EUR J NEUROSCI, V23, P325, DOI 10.1111/j.1460-9568.2005.04559.x; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Gritti A, 1999, J NEUROSCI, V19, P3287; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kari C, 2003, CANCER RES, V63, P1; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ono M, 2004, MOL CANCER THER, V3, P465; Palmer TD, 1999, J NEUROSCI, V19, P8487; PAN MG, 1992, SCIENCE, V256, P1215, DOI 10.1126/science.256.5060.1215; Pattarozzi A, 2008, MOL PHARMACOL, V73, P191, DOI 10.1124/mol.107.039974; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	54	122	122	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7138	7148		10.1074/jbc.M807111200	http://dx.doi.org/10.1074/jbc.M807111200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19147502	hybrid, Green Published			2022-12-27	WOS:000263919000061
J	Razidlo, GL; Johnson, HJ; Stoeger, SM; Cowan, KH; Bessho, T; Lewis, RE				Razidlo, Gina L.; Johnson, Heidi J.; Stoeger, Scott M.; Cowan, Kenneth H.; Bessho, Tadayoshi; Lewis, Robert E.			KSR1 Is Required for Cell Cycle Reinitiation Following DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INTERSTRAND CROSS-LINKS; DOUBLE-STRAND BREAKS; MAP KINASE; GENOTOXIC STRESS; MITOMYCIN-C; IN-VITRO; SUPPRESSOR; RAS; CHECKPOINT	KSR1 (kinase suppressor of Ras 1) is a molecular scaffold and positive regulator of the Raf/MEK/ERK phosphorylation cascade. KSR1 is required for maximal ERK activation induced by growth factors and by some cytotoxic agents. We show here that KSR1 is also required for maximal ERK activation induced by UV light, ionizing radiation, or the DNA interstrand cross-linking agent mitomycin C (MMC). We further demonstrate a role for KSR1 in the reinitiation of the cell cycle and proliferation following cell cycle arrest induced by MMC. Cells lacking KSR1 underwent but did not recover from MMC-induced G(2)/M arrest. Expression of KSR1 allowed KSR1(-/-) cells to re-enter the cell cycle following MMC treatment. However, cells expressing a mutated form of KSR1 unable to bind ERK did not recover from MMC-induced cell cycle arrest, demonstrating the requirement for the KSR1-ERK interaction. In addition, constitutive activation of ERK was not sufficient to promote cell cycle reinitiation in MMC-treated KSR1(-/-) cells. Only cells expressing KSR1 recovered from MMC-induced cell cycle arrest. Importantly, MMC-induced DNA damage was repaired in KSR1(-/-) cells, as determined by resolution of gamma-H2AX-containing foci. These data indicate that cell cycle reinitiation is not actively signaled in the absence of KSR1, even when DNA damage has been resolved. These data reveal a specific role for the molecular scaffold KSR1 and KSR1-mediated ERK signaling in the cellular response to DNA interstrand cross-links.	[Razidlo, Gina L.; Johnson, Heidi J.; Stoeger, Scott M.; Cowan, Kenneth H.; Bessho, Tadayoshi; Lewis, Robert E.] Univ Nebraska, Med Ctr, Eppley Inst, Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Lewis, RE (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst, Res Canc & Allied Dis, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	rlewis@unmc.edu	Lewis, Robert E./H-3404-2019	Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health [CA90400]; Nebraska Dept. of Health and Human Services; Cancer Center Support [CA036727]; Training Grant [CA009476]; National Science Foundation; University of Nebraska Medical Center Graduate Studies; NATIONAL CANCER INSTITUTE [P30CA036727, T32CA009476, R01CA090400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Dept. of Health and Human Services; Cancer Center Support; Training Grant; National Science Foundation(National Science Foundation (NSF)); University of Nebraska Medical Center Graduate Studies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA90400 ( to R. E. L.). This work was also supported by a grant from the Nebraska Dept. of Health and Human Services ( to R. E. L.) and Cancer Center Support Grant CA036727.; Supported by Training Grant CA009476.; Supported by a predoctoral fellowship from the National Science Foundation.; Supported by a Widaman Fellowship from University of Nebraska Medical Center Graduate Studies.	Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; BODE AM, 2003, SCI STKE, pRE2; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Chou SF, 2007, INVEST OPHTH VIS SCI, V48, P2009, DOI 10.1167/iovs.06-0835; Cipak L, 2006, NAT STRUCT MOL BIOL, V13, P729, DOI 10.1038/nsmb1120; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Friedberg EC, 2005, DNA REPAIR MUTAGENES; KANO Y, 1981, MUTAT RES, V81, P365, DOI 10.1016/0027-5107(81)90123-8; Kim M, 2005, CANCER RES, V65, P3986, DOI 10.1158/0008-5472.CAN-03-2334; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lozano J, 2003, CANCER RES, V63, P4232; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Mckay MM, 2007, J BIOL CHEM, V282, P26225, DOI 10.1074/jbc.M702692200; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROOTS R, 1985, INT J RADIAT ONCOL, V11, P259, DOI 10.1016/0360-3016(85)90147-6; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SETLOW RB, 1966, SCIENCE, V153, P379, DOI 10.1126/science.153.3734.379; SHIBUYA EK, 1992, EMBO J, V11, P3963, DOI 10.1002/j.1460-2075.1992.tb05490.x; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Szatmari E, 2007, J NEUROSCI, V27, P11389, DOI 10.1523/JNEUROSCI.3473-07.2007; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Wu D, 2006, ONCOGENE, V25, P1153, DOI 10.1038/sj.onc.1209148; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P8668; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yang J, 2003, MUTAT RES-REV MUTAT, V543, P31, DOI 10.1016/S1383-5742(02)00069-8; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	76	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6705	6715		10.1074/jbc.M806457200	http://dx.doi.org/10.1074/jbc.M806457200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19147494	Green Published, hybrid			2022-12-27	WOS:000263919000015
J	Dawid, IB				Dawid, Igor B.			Differential Gene Expression in Vertebrate Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							XENOPUS-LAEVIS; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; ZEBRAFISH EMBRYOGENESIS; SYNTHESIZE HYALURONAN; POLYADENYLATED RNA; RIBOSOMAL-RNA; CDNA LIBRARY; DG42 GENE; DNA		Eunice Kennedy Shriver NICHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver NICHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov			Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001002] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001002] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baldessari D, 2005, MECH DEVELOP, V122, P441, DOI 10.1016/j.mod.2004.11.007; BAULCOMBE DC, 1980, J BIOL CHEM, V255, P8907; BOLTON ET, 1962, P NATL ACAD SCI USA, V48, P1390, DOI 10.1073/pnas.48.8.1390; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1976, P NATL ACAD SCI USA, V73, P415, DOI 10.1073/pnas.73.2.415; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Davidson E. H., 1986, GENE ACTIVITY EARLY; Dawid I, 2006, CURR BIOL, V16, pR391, DOI 10.1016/j.cub.2006.05.016; DAWID IB, 1965, J MOL BIOL, V12, P581, DOI 10.1016/S0022-2836(65)80313-8; DAWID IB, 1966, P NATL ACAD SCI USA, V56, P269, DOI 10.1073/pnas.56.1.269; DINOCERA PP, 1983, J MOL BIOL, V168, P715; DWORKIN MB, 1980, DEV BIOL, V76, P449, DOI 10.1016/0012-1606(80)90393-0; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GALL JG, 1968, P NATL ACAD SCI USA, V60, P553, DOI 10.1073/pnas.60.2.553; Gawantka V, 1998, MECH DEVELOP, V77, P95, DOI 10.1016/S0925-4773(98)00115-4; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; HAFEN E, 1983, EMBO J, V2, P617, DOI 10.1002/j.1460-2075.1983.tb01472.x; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; HAYNES SR, 1989, DEV BIOL, V134, P246, DOI 10.1016/0012-1606(89)90094-8; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; JAMRICH M, 1987, GENE DEV, V1, P124, DOI 10.1101/gad.1.2.124; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KAFATOS FC, 1979, NUCLEIC ACIDS RES, V7, P1541, DOI 10.1093/nar/7.6.1541; KAY BK, 1983, J MOL BIOL, V170, P583, DOI 10.1016/S0022-2836(83)80122-3; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; KRAMER RA, 1980, P NATL ACAD SCI-BIOL, V77, P6541, DOI 10.1073/pnas.77.11.6541; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; LANE CD, 1971, J MOL BIOL, V61, P73, DOI 10.1016/0022-2836(71)90207-5; LASKY LA, 1980, P NATL ACAD SCI-BIOL, V77, P5317, DOI 10.1073/pnas.77.9.5317; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; LOCKARD RE, 1969, BIOCHEM BIOPH RES CO, V37, P204, DOI 10.1016/0006-291X(69)90720-7; MANIATIS T, 1976, CELL, V8, P163, DOI 10.1016/0092-8674(76)90001-5; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; MORROW JF, 1974, P NATL ACAD SCI USA, V71, P1743, DOI 10.1073/pnas.71.5.1743; NYGAARD AP, 1963, BIOCHEM BIOPH RES CO, V12, P98, DOI 10.1016/0006-291X(63)90242-0; PARDUE ML, 1970, SCIENCE, V168, P1356, DOI 10.1126/science.168.3937.1356; Pummill PE, 1998, J BIOL CHEM, V273, P4976, DOI 10.1074/jbc.273.9.4976; ROSA F, 1988, DEV BIOL, V129, P114, DOI 10.1016/0012-1606(88)90166-2; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; ROWEKAMP W, 1980, DEV BIOL, V79, P409, DOI 10.1016/0012-1606(80)90126-8; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; SARGENT T D, 1983, Science (Washington D C), V222, P135, DOI 10.1126/science.6688681; SARGENT TD, 1987, METHOD ENZYMOL, V152, P423; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRADLING AC, 1980, P NATL ACAD SCI-BIOL, V77, P1096, DOI 10.1073/pnas.77.2.1096; SUZUKI Y, 1972, J MOL BIOL, V63, P409, DOI 10.1016/0022-2836(72)90437-8; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Varki A, 1996, P NATL ACAD SCI USA, V93, P4523, DOI 10.1073/pnas.93.10.4523; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; WAHLI W, 1978, DEV BIOL, V67, P371, DOI 10.1016/0012-1606(78)90207-5; WAHLI W, 1979, CELL, V16, P535, DOI 10.1016/0092-8674(79)90028-X; WELLAUER PK, 1973, P NATL ACAD SCI USA, V70, P2827, DOI 10.1073/pnas.70.10.2827; WELLAUER PK, 1978, J MOL BIOL, V126, P769, DOI 10.1016/0022-2836(78)90019-0; WILLIAMS JG, 1979, J MOL BIOL, V129, P19, DOI 10.1016/0022-2836(79)90056-1; WINKLES JA, 1985, MOL CELL BIOL, V5, P2575, DOI 10.1128/MCB.5.10.2575; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073; ZIMMERMANN CR, 1980, CELL, V21, P709, DOI 10.1016/0092-8674(80)90434-1	76	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13277	13283		10.1074/jbc.X800018200	http://dx.doi.org/10.1074/jbc.X800018200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19158075	Green Published, hybrid			2022-12-27	WOS:000265877300001
J	Choi, YE; Butterworth, M; Malladi, S; Duckett, CS; Cohen, GM; Bratton, SB				Choi, Young Eun; Butterworth, Michael; Malladi, Srinivas; Duckett, Colin S.; Cohen, Gerald M.; Bratton, Shawn B.			The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and-7 via Unique Mechanisms at Distinct Steps in Their Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; INDUCED CELL-DEATH; APAF-1 APOPTOSOME; STRUCTURAL BASIS; PROTEIN LIGASE; IAP PROTEINS; IN-VITRO; XIAP; ACTIVATION; INHIBITION	Inhibitor of apoptosis (IAP) proteins are widely expressed throughout nature and suppress cell death under a variety of circumstances. X-linked IAP, the prototypical IAP in mammals, inhibits apoptosis largely through direct inhibition of the initiator caspase-9 and the effector caspase-3 and -7. Two additional IAP family members, cellular IAP1 (cIAP1) and cIAP2, were once thought to also inhibit caspases, but more recent studies have suggested otherwise. Here we demonstrate that cIAP1 does not significantly inhibit the proteolytic activities of effector caspases on fluorogenic or endogenous substrates. However, cIAP1 does bind to caspase-3 and -7 and does so, remarkably, at distinct steps prior to or following the removal of their prodomains, respectively. Indeed, cIAP1 bound to an exposed IAP-binding motif, AKPD, on the N terminus of the large subunit of fully mature caspase-7, whereas cIAP1 bound to partially processed caspase-3 in a manner that required its prodomain and cleavage between its large and small subunits but did not involve a classical IAP-binding motif. As a ubiquitin-protein isopeptide ligase, cIAP1 ubiquitinated caspase-3 and -7, concomitant with binding, in a reaction catalyzed by members of the UbcH5 subfamily (ubiquitin carrier protein/ubiquitin-conjugating enzymes), and in the case of caspase-3, differentially by UbcH8. Moreover, wild-type caspase-7 and a chimeric caspase-3 (bearing the AKPD motif) were degraded in vivo in a proteasome-dependent manner. Thus, cIAPs likely suppress apoptosis, at least in part, by facilitating the ubiquitination and turnover of active effector caspases in cells.	[Choi, Young Eun; Malladi, Srinivas; Duckett, Colin S.; Bratton, Shawn B.] Univ Texas Austin, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Choi, Young Eun; Bratton, Shawn B.] Univ Texas Austin, Div Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; [Malladi, Srinivas; Bratton, Shawn B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Butterworth, Michael; Cohen, Gerald M.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Leicester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bratton, SB (corresponding author), Univ Texas Austin, Ctr Mol & Cellular Toxicol, 1 Univ Stn A1915, Austin, TX 78712 USA.	sbbratton@mail.utexas.edu		Duckett, Colin/0000-0001-9413-2263; Bratton, Shawn/0000-0003-2895-5020	NCI [CA129521]; American Cancer Society [RSG-05-029-01-CCG]; PhRMA Foundation; Medical Research Council [MC_U132615750] Funding Source: researchfish; MRC [MC_U132615750] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); PhRMA Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129521 from NCI (to S. B. B.). This work was also supported by American Cancer Society Grant RSG-05-029-01-CCG and PhRMA Foundation (to S. B. B.).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Bratton SB, 2003, CELL DEATH DIFFER, V10, P4, DOI 10.1038/sj.cdd.4401176; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2003, NAT STRUCT BIOL, V10, P892, DOI 10.1038/nsb989; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Imoto I, 2002, CANCER RES, V62, P4860; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Krauss SW, 2005, BLOOD, V106, P2200, DOI 10.1182/blood-2005-04-1357; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Rumble JM, 2008, BIOCHEM J, V415, P21, DOI 10.1042/BJ20081188; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2005, CANCER RES, V65, P210; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361	63	109	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12772	12782		10.1074/jbc.M807550200	http://dx.doi.org/10.1074/jbc.M807550200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19258326	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000265688300022
J	Abreu, RD; Sanchez-Diaz, PC; Vogel, C; Burns, SC; Ko, DJ; Burton, TL; Vo, DT; Chennasamudaram, S; Le, SY; Shapiro, BA; Penalva, LOF				Abreu, Raquel de Sousa; Sanchez-Diaz, Patricia C.; Vogel, Christine; Burns, Suzanne C.; Ko, Daijin; Burton, Tarea L.; Vo, Dat T.; Chennasamudaram, Soudhamini; Le, Shu-Yun; Shapiro, Bruce A.; Penalva, Luiz O. F.			Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; ARF TUMOR-SUPPRESSOR; MESSENGER-RNA; STEM-CELLS; RIBONUCLEOPROTEIN COMPLEXES; POSTTRANSCRIPTIONAL OPERONS; STATISTICAL-MODEL; GENE-EXPRESSION; P53; MDM2	Musashi1 (Msi1) is a highly conserved RNA-binding protein with pivotal functions in stem cell maintenance, nervous system development, and tumorigenesis. Despite its importance, only three direct mRNA targets have been characterized so far: m-numb, CDKN1A, and c-mos. Msi1 has been shown to affect their translation by binding to short elements located in the 3'-untranslated region. To better understand Msi1 functions, we initially performed an RIP-Chip analysis in HEK293T cells; this method consists of isolation of specific RNA-protein complexes followed by identification of the RNA component via microarrays. A group of 64 mRNAs was found to be enriched in the Msi1-associated population compared with controls. These genes belong to two main functional categories pertinent to tumorigenesis: 1) cell cycle, cell proliferation, cell differentiation, and apoptosis and 2) protein modification (including ubiquitination and ubiquitin cycle). To corroborate our findings, we examined the impact of Msi1 expression on both mRNA (transcriptomic) and protein (proteomic) expression levels. Genes whose mRNA levels were affected by Msi1 expression have a Gene Ontology distribution similar to RIP-Chip results, reinforcing Msi1 participation in cancer-related processes. The proteomics study revealed that Msi1 can have either positive or negative effects on gene expression of its direct targets. In summary, our results indicate that Msi1 affects a network of genes and could function as a master regulator during development and tumor formation.	[Burton, Tarea L.; Vo, Dat T.; Chennasamudaram, Soudhamini; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Vogel, Christine] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ko, Daijin] Univ Texas San Antonio, Dept Management Sci & Stat, San Antonio, TX 78229 USA; [Le, Shu-Yun; Shapiro, Bruce A.] NCI, Ctr Canc Res Nanobiol Program, Computat RNA Struct Grp, NIH, Frederick, MD 21702 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Austin; University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Penalva, LOF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Childrens Canc Res Inst, Mail Code 7784,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	penalva@uthscsa.edu		de Sousa Abreu, Raquel/0000-0002-8211-6052; Penalva, Luiz/0000-0003-4491-6769	National Institutes of Health Intramural Research Program; NCI; Center for Cancer Research; San Antonio Area Foundation [PGID122760]; San Antonio Cancer Institute; American Cancer Society [PGID 124139]; Tengg Foundation [PGID 127793]; International Human Frontier Science Program; NATIONAL CANCER INSTITUTE [ZIABC008382, Z01BC008382] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); San Antonio Area Foundation; San Antonio Cancer Institute; American Cancer Society(American Cancer Society); Tengg Foundation; International Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research. This work was also supported by the San Antonio Area Foundation (Grant PGID122760), the San Antonio Cancer Institute, the American Cancer Society (Grant PGID 124139), and the Tengg Foundation (Grant PGID 127793).; Supported by the International Human Frontier Science Program.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Clarke RB, 2005, CELL PROLIFERAT, V38, P375, DOI 10.1111/j.1365-2184.2005.00357.x; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Crosetto N, 2006, MOL CANCER RES, V4, P899, DOI 10.1158/1541-7786.MCR-06-0328; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobson NR, 2008, GLIA, V56, P318, DOI 10.1002/glia.20615; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Higuchi S, 2008, MECH DEVELOP, V125, P631, DOI 10.1016/j.mod.2008.03.002; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Le SY, 2003, BIOINFORMATICS, V19, P354, DOI 10.1093/bioinformatics/btf826; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mckee AE, 2007, CELL RES, V17, P581, DOI 10.1038/cr.2007.54; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Penalva LOF, 2004, BIOTECHNIQUES, V37, P604, DOI 10.2144/04374ST05; Penalva LOF, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-24; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Yoon KH, 2008, RNA BIOL, V5, P255, DOI 10.4161/rna.7116; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	48	73	76	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12125	12135		10.1074/jbc.M809605200	http://dx.doi.org/10.1074/jbc.M809605200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258308	Green Published, hybrid			2022-12-27	WOS:000265494600044
J	Kitagaki, H; Cowart, LA; Matmati, N; Montefusco, D; Gandy, J; de Avalos, SV; Novgorodo, SA; Zheng, J; Obeid, LM; Hannun, YA				Kitagaki, Hiroshi; Cowart, L. Ashley; Matmati, Nabil; Montefusco, David; Gandy, Jason; de Avalos, Silvia Vaena; Novgorodo, Sergei A.; Zheng, Jim; Obeid, Lina M.; Hannun, Yusuf A.			ISC1-dependent Metabolic Adaptation Reveals an Indispensable Role for Mitochondria in Induction of Nuclear Genes during the Diauxic Shift in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; SPHINGOLIPID BIOSYNTHESIS; RETROGRADE RESPONSE; LINKS METABOLISM; GENOME STABILITY; YEAST LONGEVITY; RTG2 PROTEIN; EXPRESSION; ACTIVATION; KINASE	Growth of Saccharomyces cerevisiae following glucose depletion ( the diauxic shift) depends on a profound metabolic adaptation accompanied by a global reprogramming of gene expression. In this study, we provide evidence for a heretofore unsuspected role for Isc1p in mediating this reprogramming. Initial studies revealed that yeast cells deleted in ISC1, the gene encoding inositol sphingolipid phospholipase C, which resides in mitochondria in the post-diauxic phase, showed defective aerobic respiration in the post-diauxic phase but retained normal intrinsic mitochondrial functions, including intact mitochondrial DNA, normal oxygen consumption, and normal mitochondrial polarization. Microarray analysis revealed that the Delta isc1 strain failed to up-regulate genes required for nonfermentable carbon source metabolism during the diauxic shift, thus suggesting a mechanism for the defective supply of respiratory substrates into mitochondria in the post-diauxic phase. This defect in regulating nuclear gene induction in response to a defect in a mitochondrial enzyme raised the possibility that mitochondria may initiate diauxic shift-associated regulation of nucleus-encoded genes. This was established by demonstrating that in respiratory-deficient petite cells these genes failed to be upregulated across the diauxic shift in a manner similar to the Delta isc1 strain. Isc1p- and mitochondrial function-dependent genes significantly overlapped with Adr1p-, Snf1p-, and Cat8p-dependent genes, suggesting some functional link among these factors. However, the retrograde response was not activated in Delta isc1, suggesting that the response of Delta isc1 cannot be simply attributed to mitochondrial dysfunction. These results suggest a novel role for Isc1p in allowing the reprogramming of gene expression during the transition from anaerobic to aerobic metabolism.	[Kitagaki, Hiroshi; Cowart, L. Ashley; Matmati, Nabil; Montefusco, David; Gandy, Jason; de Avalos, Silvia Vaena; Zheng, Jim; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Kitagaki, Hiroshi; Cowart, L. Ashley; Matmati, Nabil; Montefusco, David; Gandy, Jason; de Avalos, Silvia Vaena; Zheng, Jim; Hannun, Yusuf A.] Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; [Novgorodo, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Cowart, L. Ashley; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Kitagaki, Hiroshi] Saga Univ, Fac Agr, Saga 8408502, Japan	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Saga University	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Kitagaki, Hiroshi/N-1666-2019	obeid, lina/0000-0002-0734-0847	National Institutes of Health [GM43825, R01 AG016583]; Veterans Affairs Merit Award; Merit Review Entry Program Award; Department of Veterans Affairs, Office of Research and Development; Noda Institute for Scientific Research; NATIONAL CANCER INSTITUTE [R24CA095841] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696, P20RR016434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Merit Review Entry Program Award; Department of Veterans Affairs, Office of Research and Development(US Department of Veterans Affairs); Noda Institute for Scientific Research(Noda Institute for Scientific Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM43825 ( to Y. A. H.) and Grant R01 AG016583 ( to L. M. O.). This work was also supported by a Veterans Affairs Merit Award ( to L. M. O.), a Merit Review Entry Program Award ( to L. A. C.) from the Department of Veterans Affairs, Office of Research and Development, and in part by an NISR research grant from the Noda Institute for Scientific Research ( to H. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Borghouts C, 2004, GENETICS, V166, P765, DOI 10.1534/genetics.166.2.765; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Butow RA, 2002, CELL DEATH DIFFER, V9, P1043, DOI 10.1038/sj.cdd.4401083; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; Cowart LA, 2003, J BIOL CHEM, V278, P30328, DOI 10.1074/jbc.M300656200; de Avalos SV, 2005, J BIOL CHEM, V280, P7170, DOI 10.1074/jbc.M411058200; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dunn CD, 2006, MOL BIOL CELL, V17, P213, DOI 10.1091/mbc.e05-06-0585; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040; Jazwinski SM, 2005, FEMS YEAST RES, V5, P1253, DOI 10.1016/j.femsyr.2005.07.001; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Machida K, 1998, J BACTERIOL, V180, P4460, DOI 10.1128/JB.180.17.4460-4465.1998; Nishizawa M, 2004, YEAST, V21, P903, DOI 10.1002/yea.1138; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Okamoto Y, 2002, J BIOL CHEM, V277, P46470, DOI 10.1074/jbc.M207779200; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schlame M, 1997, BBA-LIPID LIPID MET, V1348, P201, DOI 10.1016/S0005-2760(97)00117-3; Schneider-Berlin KR, 2005, MUTAT RES-FUND MOL M, V572, P84, DOI 10.1016/j.mrfmmm.2004.12.010; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trotter PJ, 2005, ARCH BIOCHEM BIOPHYS, V442, P21, DOI 10.1016/j.abb.2005.07.016; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	45	48	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10818	10830		10.1074/jbc.M805029200	http://dx.doi.org/10.1074/jbc.M805029200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19179331	hybrid, Green Published			2022-12-27	WOS:000265104600056
J	Padmanabhan, U; Dollins, DE; Fridy, PC; York, JD; Downes, CP				Padmanabhan, Usha; Dollins, D. Eric; Fridy, Peter C.; York, John D.; Downes, C. Peter			Characterization of a Selective Inhibitor of Inositol Hexakisphosphate Kinases USE IN DEFINING BIOLOGICAL ROLES AND METABOLIC RELATIONSHIPS OF INOSITOL PYROPHOSPHATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; 1,4,5-TRISPHOSPHATE 3-KINASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; PHOSPHATE MULTIKINASE; HYPEROSMOTIC STRESS; CRYSTAL-STRUCTURE; PROTEIN; FAMILY; PENTAKISPHOSPHATE; IDENTIFICATION	Inositol hexakisphosphate kinases (IP6Ks) phosphorylate inositol hexakisphosphate (InsP(6)) to yield 5-diphosphoinositol pentakisphosphate (5-[PP]-InsP(5) or InsP(7)). In this study, we report the characterization of a selective inhibitor, N-2-(m-(trifluoromethy)lbenzyl) N-6-(p-nitrobenzyl) purine (TNP), for these enzymes. TNP dose-dependently and selectively inhibited the activity of IP6K in vitro and inhibited InsP(7) and InsP(8) synthesis in vivo without affecting levels of other inositol phosphates. TNP did not inhibit either human or yeast Vip/PPIP5K, a newly described InsP(6)/InsP(7) 1/3-kinase. Overexpression of IP6K1, -2, or -3 in cells rescued TNP inhibition of InsP(7) synthesis. TNP had no effect on the activity of a large number of protein kinases, suggesting that it is selective for IP6Ks. TNP reversibly reduced InsP(7)/InsP(8) levels. TNP in combination with genetic studies was used to implicate the involvement of two pathways for synthesis of InsP(8) in yeast. TNP induced a fragmented vacuole phenotype in yeast, consistent with inhibition of Kcs1, a Saccharomyces cerevisiae IP6K. In addition, it also inhibited insulin release from Min6 cells in a dose-dependent manner further implicating InsP(7) in this process. TNP thus provides a means of selectively and rapidly modulating cellular InsP(7) levels, providing a new and versatile tool to study the biological function and metabolic relationships of inositol pyrophosphates.	[Padmanabhan, Usha; Downes, C. Peter] Univ Dundee, Div Mol Physiol, James Black Ctr, Dundee DD1 5EH, Scotland; [Dollins, D. Eric; Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Durham, NC 27710 USA; [Dollins, D. Eric; Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Dept Canc Biol, Howard Hughes Med Inst, Durham, NC 27710 USA; [Dollins, D. Eric; Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Dept Biochem, Howard Hughes Med Inst, Durham, NC 27710 USA	University of Dundee; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Downes, CP (corresponding author), Univ Dundee, Div Mol Physiol, James Black Ctr, Dundee DD1 5EH, Scotland.	c.p.downes@dundee.ac.uk		Fridy, Peter/0000-0002-8208-9154	Division of Signal Transduction Therapy consortium (University of Dundee); MRC [G9403619] Funding Source: UKRI; Medical Research Council [G9403619] Funding Source: researchfish	Division of Signal Transduction Therapy consortium (University of Dundee); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Division of Signal Transduction Therapy consortium (University of Dundee).	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Chang SC, 2002, J BIOL CHEM, V277, P43836, DOI 10.1074/jbc.M206134200; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; DASILVA CP, 1994, J BIOL CHEM, V269, P12521; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; HUANG KN, 1995, GENETICS, V141, P1275; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Poinas A, 2005, CHEMBIOCHEM, V6, P1449, DOI 10.1002/cbic.200400443; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Saiardi A, 2001, P NATL ACAD SCI USA, V98, P2306, DOI 10.1073/pnas.041614598; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; THASTRUP O, 1994, AGENTS ACTIONS, V43, P187, DOI 10.1007/BF01986687; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	36	78	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10571	10582		10.1074/jbc.M900752200	http://dx.doi.org/10.1074/jbc.M900752200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208622	Green Published, hybrid			2022-12-27	WOS:000265104600031
J	Ben-Yona, A; Kanner, BI				Ben-Yona, Assaf; Kanner, Baruch I.			Transmembrane Domain 8 of the gamma-Aminobutyric Acid Transporter GAT-1 Lines a Cytoplasmic Accessibility Pathway into Its Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; CL-COTRANSPORT FUNCTION; GABA TRANSPORTER; RAT-BRAIN; SEROTONIN TRANSPORTER; ALTERNATING ACCESS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; SODIUM SYMPORTER; XENOPUS OOCYTES	GAT-1 is a sodium- and chloride-coupled gamma-aminobutyric acid (GABA) transporter, which fulfills an essential role in the synaptic transmission by this neurotransmitter. Cysteine-399 is the major site of inhibition of GAT-1 by membrane-permeant sulfhydryl reagents. This cysteine residue was previously thought to reside on a cytoplasmic loop connecting transmembrane domains (TMs) 8 and 9. However, the crystal structure of LeuT, a bacterial homologue of the mammalian neurotransmitter: sodium symporters, revealed that the residue corresponding to Cys-399 is in fact located in the middle of TM 8. This residue is located to the cytoplasmic side of Asp-395 and Ser-396, whose side chains are thought to ligand one of the two cotransported sodium ions. To determine how the sulfhydryl reagents approach cysteine-399, a cysteine scan of all 35 residues of TM 8 was performed. Sulfhydryl reagents inhibited transport when a cysteine residue was present at either of the positions 399, 402, 406, and 410. SKF-89976A and other non-transportable analogues, which are expected to lock the transporter in a conformation facing the extracellular medium, protected against the sulfhydryl modification at positions 399, 402, and 406. Such a protection was not seen by GABA itself, which actually modestly potentiated the modification at positions 399 and 402. Our results point to an alpha-helical stripe on TM8 lining an aqueous access pathway from the cytoplasm into the binding pocket, which gets occluded in the conformation of the transporter where the binding pocket is exposed to the extracellular medium.	[Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters.	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters.(European Commission)	This work was supported by the Israel Science Foundation and the European Union Consortium European Drug Initiative on Channels and Transporters.	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	33	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9727	9732		10.1074/jbc.M809423200	http://dx.doi.org/10.1074/jbc.M809423200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19201752	hybrid, Green Published			2022-12-27	WOS:000264892900012
J	Huang, WY; Li, ZG; Rus, H; Wang, XY; Jose, PA; Chen, SY				Huang, Wen-Yan; Li, Zu-Guo; Rus, Horea; Wang, Xiaoyan; Jose, Pedro A.; Chen, Shi-You			RGC-32 Mediates Transforming Growth Factor-beta-induced Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNILATERAL URETERAL OBSTRUCTION; SMOOTH-MUSCLE DIFFERENTIATION; TGF-BETA; MYOFIBROBLAST TRANSITION; INTERSTITIAL FIBROSIS; N-CADHERIN; EXPRESSION; CANCER; SNAIL; TRANSCRIPTION	Epithelial-mesenchymal transition (EMT) occurs in several disease states, including renal fibrosis and carcinogenesis. Myo-fibroblasts produced from EMT of renal tubular cells are responsible for the deposition of extracellular matrix components in a large portion of renal interstitial fibrosis. Transforming growth factor-beta (TGF-beta) plays an essential role in the EMT of renal tubular cells, but the molecular mechanism governing this process remains largely unknown. In this study, we found that RGC-32 ( response gene to complement 32) is critical for TGF-beta-induced EMT of human renal proximal tubular cells (HPTCs). RGC-32 is not normally expressed in the HPTCs. However, TGF-beta stimulation markedly activates RGC-32 while inducing an EMT, as shown by the induction of smooth muscle alpha-actin (alpha-SMA) and extracellular matrix proteins collagen I and fibronectin, as well as the reduction of epithelial marker E-cadherin. TGF-beta function is mediated by several signaling pathways, but RGC-32 expression in HPTCs appears to be mainly regulated by Smad. Functionally, RGC-32 appears to mediate TGF-beta-induced EMT of HPTCs. Blockage of RGC-32 using short hairpin interfering RNA significantly inhibits TGF-beta induction of myofibroblast marker gene alpha-SMA while repressing the expression of E-cadherin. In contrast, overexpression of RGC-32 induces alpha-SMA expression while restoring E-cadherin. RGC-32 also inhibits the expression of another adherens junction protein, N-cadherin, suggesting that RGC-32 alone induces the phenotypic conversion of renal epithelial cells to myofibroblasts. Additional studies show that RGC-32 stimulates the production of extracellular matrix components fibronectin and collagen I. Mechanistically, RGC-32 induces EMT via the activation of other transcription factors such as Snail and Slug. RGC-32 knockdown inhibits the expression of Snail and Slug during TGF-beta-induced EMT. Taken together, our data demonstrate for the first time that RGC-32 plays a critical role in TGF-beta-induced EMT of renal tubular cells.	[Huang, Wen-Yan; Li, Zu-Guo; Chen, Shi-You] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Huang, Wen-Yan] Fudan Univ, Childrens Hosp, Dept Pediat Nephrol, Shanghai 200032, Peoples R China; [Rus, Horea] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Huang, Wen-Yan; Wang, Xiaoyan; Jose, Pedro A.] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20057 USA	University System of Georgia; University of Georgia; Fudan University; University System of Maryland; University of Maryland Baltimore; Georgetown University	Chen, SY (corresponding author), Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Rus, Horea/AAF-2583-2020; Wang, Xiaoyan/GOK-1663-2022	Wang, Xiaoyan/0000-0001-7406-5008	National Institutes of Health [HL093429, DK39308, HL23081]; American Heart Association [0765265U]; Chinese National Nature Science Foundation [30871177]; Veterans Administration Merit Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Veterans Administration Merit Award	This work was supported, in whole or in part, by National Institutes of Health Grants HL093429 ( to S.-Y.C.) and DK39308 and HL23081 ( to P.A.J.). This work was also supported by American Heart Association Beginning Grant-in-aid 0765265U ( to S.-Y.C.), Chinese National Nature Science Foundation Grant 30871177 ( to W.-Y.H.), and a Veterans Administration Merit Award ( to H. R.).	Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fosbrink M, 2005, IMMUNOL RES, V31, P37, DOI 10.1385/IR:31:1:37; HEWITSON TD, 1995, AM J NEPHROL, V15, P111, DOI 10.1159/000168813; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sanada H, 1999, HYPERTENSION, V33, P1036, DOI 10.1161/01.HYP.33.4.1036; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Tomita K, 2000, CANCER RES, V60, P3650; Tsuchiya B, 2006, ARCH HISTOL CYTOL, V69, P135, DOI 10.1679/aohc.69.135; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3	46	62	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9426	9432		10.1074/jbc.M900039200	http://dx.doi.org/10.1074/jbc.M900039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158077	hybrid, Green Published			2022-12-27	WOS:000264669100049
J	Zhang, L; Bharadwaj, AG; Casper, A; Barkley, J; Barycki, JJ; Simpson, MA				Zhang, Ling; Bharadwaj, Alamelu G.; Casper, Andrew; Barkley, Joel; Barycki, Joseph J.; Simpson, Melanie A.			Hyaluronidase Activity of Human Hyal1 Requires Active Site Acidic and Tyrosine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; PROSTATE-CANCER; ESCHERICHIA-COLI; ANGIOGENESIS; EXPRESSION; GROWTH; GLYCOSYLATION; HYDROLYSIS; MECHANISMS; ENZYMES	Hyaluronidases are a family of endolytic glycoside hydrolases that cleave the beta 1-4 linkage between N-acetylglucosamine and glucuronic acid in hyaluronan polymers via a substrate-assisted mechanism. In humans, turnover of hyaluronan by this enzyme family is critical for normal extracellular matrix remodeling. However, elevated expression of the Hyal1 isozyme accelerates tumor growth and metastatic progression. In this study, we used structural information, site-directed mutagenesis, and steady state enzyme kinetics to probe molecular determinants of human Hyal1 function. Mutagenesis of active site residues Glu(131) and Tyr(247) to Gln and Phe, respectively, eliminated activity at all hyaluronan concentrations (to 125 mu M or 2.5 mg/ml). Conservative mutagenesis of Asp(129) and Tyr(202) significantly impaired catalysis by increases of 5- and 10-fold in apparent Km and reductions in V-max of 95 and 50%, respectively. Tyr(247) and Asp(129) are required for stabilization of the catalytic nucleophile, which arises as a resonance intermediate of N-acetylglucosamine on the substrate. Glu(131) is a likely proton donor for the hydroxyl leaving group. Tyr(202) is a substrate binding determinant. General disulfide reduction had no effect on activity in solution, but enzymatic deglycosylation reduced Hyal1 activity in a time-dependent fashion. Mutagenesis identified Asn(350) glycosylation as the requisite modification. Deletion of the C-terminal epidermal growth factor-like domain, in which Asn(350) is located, also eliminated activity, irrespective of glycosylation. Collectively, these studies define key components of Hyal1 active site catalysis, and structural factors critical for stability. Such detailed understanding will allow rational design of enzyme modulators.	[Zhang, Ling; Bharadwaj, Alamelu G.; Casper, Andrew; Barkley, Joel; Barycki, Joseph J.; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Simpson, MA (corresponding author), N246 Beadle Ctr, Lincoln, NE 68588 USA.	msimpson2@unl.edu			National Institutes of Health [R01 CA106584]; NCRR [P20 RR018759]; NATIONAL CANCER INSTITUTE [R01CA106584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA106584 and NCRR P20 RR018759 ( to M. A. S.).	Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Coutinho PM, 1999, ROY SOC CH, P3; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Hofinger ESA, 2008, GLYCOCONJUGATE J, V25, P101, DOI 10.1007/s10719-007-9058-8; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P963, DOI 10.1093/glycob/cwm070; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P444, DOI 10.1093/glycob/cwm003; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jedrzejas MJ, 2005, PROTEINS, V61, P227, DOI 10.1002/prot.20592; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Li MW, 2002, J ANDROL, V23, P211; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lokeshwar VB, 1996, CANCER RES, V56, P651; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PISZKIEWICZ D, 1968, J AM CHEM SOC, V90, P2156, DOI 10.1021/ja01010a038; PRASAD ARS, 1983, BIOCHEMISTRY-US, V22, P4272, DOI 10.1021/bi00287a017; Rao V, 1999, PROTEIN SCI, V8, P2338; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Shiftan L, 2005, CANCER RES, V65, P10316, DOI 10.1158/0008-5472.CAN-04-3947; Shiftan L, 2006, CONTRAST MEDIA MOL I, V1, P106, DOI 10.1002/cmmi.96; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; West D. C., 1989, CIBA F SYMP, V143, P201; West D. C., 1989, CIBA F SYMP, V143, P281; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1989, CIBA F SYMP, V143, P187; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340	41	37	41	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9433	9442		10.1074/jbc.M900210200	http://dx.doi.org/10.1074/jbc.M900210200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19201751	Green Published, hybrid			2022-12-27	WOS:000264669100050
J	Ruiz-Duenas, FJ; Pogni, R; Morales, M; Giansanti, S; Mate, MJ; Romero, A; Martinez, MJ; Basosi, R; Martinez, AT				Ruiz-Duenas, Francisco J. y; Pogni, Rebecca; Morales, Maria; Giansanti, Stefania; Mate, Maria J.; Romero, Antonio; Jesus Martinez, Maria; Basosi, Riccardo; Martinez, Angel T.			Protein Radicals in Fungal Versatile Peroxidase CATALYTIC TRYPTOPHAN RADICAL IN BOTH COMPOUND I AND COMPOUND II AND STUDIES ON W164Y, W164H, AND W164S VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FIELD EPR; SITE-DIRECTED MUTAGENESIS; LIGNIN PEROXIDASE; MULTIFREQUENCY EPR; PLEUROTUS-ERYNGII; RIBONUCLEOTIDE REDUCTASE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CYTOCHROME-C	Lignin-degrading peroxidases, a group of biotechnologically interesting enzymes, oxidize high redox potential aromatics via an exposed protein radical. Low temperature EPR of Pleurotus eryngii versatile peroxidase (VP) revealed, for the first time in a fungal peroxidase, the presence of a tryptophanyl radical in both the two-electron (VPI) and the one-electron (VPII) activated forms of the enzyme. Site-directed mutagenesis was used to substitute this tryptophan (Trp-164) by tyrosine and histidine residues. No changes in the crystal structure were observed, indicating that the modified behavior was due exclusively to the mutations introduced. EPR revealed the formation of tyrosyl radicals in both VPI and VPII of the W164Y variant. However, no protein radical was detected in the W164H variant, whose VPI spectrum indicated a porphyrin radical identical to that of the inactive W164S variant. Stopped-flow spectrophotometry showed that the W164Y mutation reduced 10-fold the apparent second-order rate constant for VPI reduction (k(2app)) by veratryl alcohol (VA), when compared with over 50-fold reduction in W164S, revealing some catalytic activity of the tyrosine radical. Its first-order rate constant (k(2)) was more affected than the dissociation constant (K-D2). Moreover, VPII reduction by VA was impaired by the above mutations, revealing that the Trp-164 radical was involved in catalysis by both VPI and VPII. The low first-order rate constant (k(3)) values were similar for the W164Y, W164H, and W164S variants, indicating that the tyrosyl radical in VPII was not able to oxidize VA (in contrast with that observed for VPI). VPII self-reduction was also suppressed, revealing that Trp-164 is involved in this autocatalytic process.	[Ruiz-Duenas, Francisco J. y; Morales, Maria; Mate, Maria J.; Romero, Antonio; Jesus Martinez, Maria; Martinez, Angel T.] CSIC, CIB, E-28040 Madrid, Spain; [Pogni, Rebecca; Giansanti, Stefania; Basosi, Riccardo] Univ Siena, Dept Chem, I-53100 Siena, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Siena	Pogni, R (corresponding author), CSIC, CIB, Ramiro de Maeztu 9, E-28040 Madrid, Spain.	pogni@unisi.it; ATMartinez@cib.csic.es	Basosi, Riccardo/E-7497-2011; Martínez, Angel T/G-7284-2017; Martinez, Maria Jesus/F-9147-2015; Romero, Antonio/K-5754-2014; Ruiz-Dueñas, Francisco J/L-9837-2015	Basosi, Riccardo/0000-0003-1026-7668; Martínez, Angel T/0000-0002-1584-2863; Martinez, Maria Jesus/0000-0003-2166-1097; Romero, Antonio/0000-0002-6990-6973; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665	Spanish projects [BIO2005-03569, BIO2008-01533]; Italian Miur PRIN 2007; BIORENEW project of the European Union [NMP2-CT-2006-026456]	Spanish projects(Spanish Government); Italian Miur PRIN 2007(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); BIORENEW project of the European Union(European Commission)	This work was supported by the Spanish projects BIO2005-03569 and BIO2008-01533, Italian Miur PRIN 2007, and the BIORENEW project of the European Union (Contract NMP2-CT-2006-026456).	Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENECKY MJ, 1993, BIOCHEMISTRY-US, V32, P11929, DOI 10.1021/bi00095a024; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Blodig W, 2001, J MOL BIOL, V305, P851, DOI 10.1006/jmbi.2000.4346; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Detweiler CD, 2005, FREE RADICAL BIO MED, V38, P969, DOI 10.1016/j.freeradbiomed.2004.12.031; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Dunford H. B., 1999, HEME PEROXIDASES; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelpke MDS, 2002, BIOCHEMISTRY-US, V41, P3498, DOI 10.1021/bi011930d; Gerini MF, 2003, BIOPHYS J, V84, P3883, DOI 10.1016/S0006-3495(03)75116-9; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HO PS, 1983, J BIOL CHEM, V258, P4356; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Ivancich A, 1997, BIOCHEMISTRY-US, V36, P9356, DOI 10.1021/bi970886s; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; MCCONNELL HM, 1957, J PHYS CHEM-US, V61, P1018, DOI 10.1021/j150553a048; Mester T, 2001, J BIOL CHEM, V276, P22985, DOI 10.1074/jbc.M010739200; Miki Y, 2006, J FAC AGR KYUSHU U, V51, P99; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Pogni R, 2007, APPL MAGN RESON, V31, P509, DOI 10.1007/BF03166599; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Pogni R, 2005, BIOCHEMISTRY-US, V44, P4267, DOI 10.1021/bi047474l; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Sasaki S, 2008, PHYTOCHEMISTRY, V69, P348, DOI 10.1016/j.phytochem.2007.08.020; Schoemaker H E, 1994, Bioorg Med Chem, V2, P509, DOI 10.1016/0968-0896(94)80021-9; SCHOEMAKER HE, 1990, RECL TRAV CHIM PAY B, V109, P255; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Smith AT, 1998, CURR OPIN CHEM BIOL, V2, P269, DOI 10.1016/S1367-5931(98)80069-0; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; UN S, 1995, J AM CHEM SOC, V117, P10713, DOI 10.1021/ja00148a013; Un S, 2001, J AM CHEM SOC, V123, P3048, DOI 10.1021/ja003650b; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	52	54	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7986	7994		10.1074/jbc.M808069200	http://dx.doi.org/10.1074/jbc.M808069200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158088	Green Published, hybrid			2022-12-27	WOS:000264195600061
J	Gomis-Ruth, FX				Xavier Gomis-Rueth, F.			Catalytic Domain Architecture of Metzincin Metalloproteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MATRIX METALLOPROTEINASES; CRYSTAL-STRUCTURE; CYSTEINE SWITCH; SNAKE-VENOM; STRUCTURAL BASIS; ACTIVE-SITE; ASTACIN; FAMILY; ACTIVATION; PROTEASE	Metalloproteases cleave proteins and peptides, and deregulation of their function leads to pathology. An understanding of their structure and mechanisms of action is necessary to the development of strategies for their regulation. Among metallopeptidases are the metzincins, which are mostly multidomain proteins with similar to 130-260-residue globular catalytic domains showing a common core architecture characterized by a long zinc-binding consensus motif, HEXXHXXGXX(H/D), and a methionine-containing Met-turn. Metzincins participate in unspecific protein degradation such as digestion of intake proteins and tissue development, maintenance, and remodeling, but they are also involved in highly specific cleavage events to activate or inactivate themselves or other (pro)enzymes and bioactive peptides. Metzincins are subdivided into families, and seven such families have been analyzed at the structural level: the astacins, ADAMs/adamalysins/reprolysins, serralysins, matrix metalloproteinases, snapalysins, leishmanolysins, and pappalysins. These families are reviewed from a structural point of view.	CSIC, Proteolysis Lab, Mol Biol Inst Barcelona, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Gomis-Ruth, FX (corresponding author), CSIC, Proteolysis Lab, Mol Biol Inst Barcelona, Barcelona Sci Pk,Helix Bldg,C Baldiri Reixac 15-2, E-08028 Barcelona, Spain.	fxgr@ibmb.csic.es		Gomis-Ruth, F. Xavier/0000-0002-6848-6874	Spanish Public Agencies; European Union [LSHG-2006-018830]; European Union [223101]; National Catalan Government [2005SGR00280];  [BIO2006-02668];  [BIO2009-10334]	Spanish Public Agencies; European Union; European Union(European Commission); National Catalan Government; ; 	This work was supported by Grants BIO2006-02668 and BIO2009-10334 and the CONSOLIDER-INGENIO 2010 Project "La Factoria de Cristalizacion" (CSD2006-00015) from Spanish Public Agencies; European Union FP6 Strep Project LSHG-2006-018830 "CAMP"; European Union FP7 Collaborative Project 223101 "AntiPathoGN"; and Grant 2005SGR00280 from the National Catalan Government.	BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; Baumann U., 2004, HDB PROTEOLYTIC ENZY, V1, P579; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Domingues FS, 2000, J MOL BIOL, V297, P1003, DOI 10.1006/jmbi.2000.3615; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Garcia-Castellanos R, 2007, ARCH BIOCHEM BIOPHYS, V457, P57, DOI 10.1016/j.abb.2006.10.004; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; GRAMS F, 1993, FEBS LETT, V335, P76, DOI 10.1016/0014-5793(93)80443-X; Hege T, 2001, J MOL BIOL, V314, P187, DOI 10.1006/jmbi.2001.5124; Hege T, 2001, J MOL BIOL, V314, P181, DOI 10.1006/jmbi.2001.5125; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Kurisu G, 1997, J BIOCHEM, V121, P304; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mac Sweeney A, 2008, J MOL BIOL, V384, P228, DOI 10.1016/j.jmb.2008.09.029; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McHugh B, 2004, J CELL BIOL, V167, P673, DOI 10.1083/jcb.200405155; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 2008, CONNECT TISSUE RES, V49, P169, DOI 10.1080/03008200802151698; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schlagenhauf E, 1998, STRUCTURE, V6, P1035, DOI 10.1016/S0969-2126(98)00104-X; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; STOCKER W, 1995, PROTEIN SCI, V4, P823; TAKEDA S, 2009, SEMIN CELL IN PRESS; TALLANT C, 2009, BIOCH BIOPH IN PRESS; Tallant C, 2007, BIOL CHEM, V388, P1243, DOI 10.1515/BC.2007.143; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3	45	154	162	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15353	15357		10.1074/jbc.R800069200	http://dx.doi.org/10.1074/jbc.R800069200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19201757	Green Published, hybrid			2022-12-27	WOS:000266501000002
J	Ahn, J; Byeon, IJL; Byeon, CH; Gronenborn, AM				Ahn, Jinwoo; Byeon, In-Ja L.; Byeon, Chang-Hyeock; Gronenborn, Angela M.			Insight into the Structural Basis of Pro- and Antiapoptotic p53 Modulation by ASPP Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; APOPTOTIC FUNCTION; P53-DEPENDENT APOPTOSIS; SV40-TRANSFORMED CELLS; TUMOR-ANTIGEN; DEATH; 53BP2; MUTANTS; BINDING; ACETYLATION	p53-dependent apoptosis is modulated by the ASPP family of proteins (apoptosis-stimulating proteins of p53; also called ankyrin repeat-, Src homology 3 domain-, and Pro-rich region-containing proteins). Its three known members, ASPP1, ASPP2, and iASPP, were previously found to interact with p53, influencing the apoptotic response of cells without affecting p53-induced cell cycle arrest. More specifically, the bona fide tumor suppressors, ASPP1 and ASPP2, bind to the core domain of p53 and stimulate transcription of apoptotic genes, whereas oncogenic iASPP also binds to the p53 core domain but inhibits p53-dependent apoptosis. Although the general interaction regions are known, details of the interfaces for each p53-ASPP complex have not been evaluated. We undertook a comprehensive biophysical characterization of ASPP-p53 complex formation and mapped the binding interfaces by NMR. We found that the interaction interface on p53 for the proapoptotic protein ASPP2 is distinct from that for the antiapoptotic iASPP. ASPP2 primarily binds to the core domain of p53, whereas iASPP predominantly interacts with a linker region adjacent to the core domain. Our detailed structural analyses of the ASPP-p53 interactions provide insight into the structural basis of the differential behavior of pro-and antiapoptotic ASPP family members.	[Ahn, Jinwoo; Byeon, In-Ja L.; Byeon, Chang-Hyeock; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), 3501 5th Ave, Pittsburgh, PA 15260 USA.	amg100@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525				Ao Y, 2001, ONCOGENE, V20, P2720, DOI 10.1038/sj.onc.1204352; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; LINZER DIH, 1979, VIROLOGY, V98, P308, DOI 10.1016/0042-6822(79)90554-3; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu ZJ, 2004, LEUKEMIA, V18, P880, DOI 10.1038/sj.leu.2403300; Lopez CD, 2000, MOL CELL BIOL, V20, P8018, DOI 10.1128/MCB.20.21.8018-8025.2000; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Olivier Magali, 2004, IARC Sci Publ, P247; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Smith BO, 1996, J BIOMOL NMR, V8, P360, DOI 10.1007/BF00410335; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tidow H, 2006, J BIOL CHEM, V281, P32526, DOI 10.1074/jbc.M604725200; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	46	42	49	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13812	13822		10.1074/jbc.M808821200	http://dx.doi.org/10.1074/jbc.M808821200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19246451	Green Published, hybrid			2022-12-27	WOS:000265877300058
J	Vanlandingham, PA; Ceresa, BP				Vanlandingham, Phillip A.; Ceresa, Brian P.			Rab7 Regulates Late Endocytic Trafficking Downstream of Multivesicular Body Biogenesis and Cargo Sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ESCRT-II; FACTOR RECEPTORS; RILP INTERACTS; PROTEIN RILP; TRANSPORT; DEGRADATION; ENDOSOMES; LYSOSOMES; COMPLEX	The small molecular weight G-protein RAB7 is localized to both early and late endosomes and has been shown to be critical for trafficking through the endocytic pathway. The role of RAB7 in the endocytic pathway has been controversial, with some groups reporting that it regulates trafficking from early to late endosomes and others ascribing its role to trafficking between late endosomes and lysosomes. In this study, we use RNA interference to identify the exact step RAB7 regulates in the movement of the epidermal growth factor receptor (EGFR) from the cell surface to the lysosome. In the absence of RAB7, trafficking of the EGF center dot EGFR complex through the early endosome to the late endosome/multivesicular body (LE/MVB) does not change, but exiting from the LE/MVB is blocked. Ultrastructural analysis reveals that RAB7 is not required for formation of intraluminal vesicles of the LE/MVB, since RAB7-deficient cells have an increased number of enlarged LE/MVBs densely packed with intraluminal vesicles. Biochemical data indicate that the EGFR complex is sequestered in these intraluminal vesicles. Together, these data provide evidence that RAB7 is required for the transfer of cargo from the LE/MVB to the lysosome and for endocytic organelle maintenance.	[Vanlandingham, Phillip A.; Ceresa, Brian P.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, Oklahoma City, OK 73126 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ceresa, BP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, POB 26901,Biomed Sci Bldg,Rm 553, Oklahoma City, OK 73126 USA.	Brian-Ceresa@ouhsc.edu			National Institutes of Health [P20 RR017703]; National Institutes of Health, NEI [EY09391]; American Cancer Society [RSG-03-021-01]; Oklahoma Center for the Advancement of Science and Technology [HR03-014]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Cancer Society(American Cancer Society); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR017703. The Fluoview 1000 microscope was funded through National Institutes of Health, NEI, Grant EY09391 (to J. A. Summers Rada, Principal Investigator). This work was also supported by American Cancer Society Grant RSG-03-021-01 and Oklahoma Center for the Advancement of Science and Technology Grant HR03-014.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fullmon R.L, 1953, J MET, V5, P447; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; KING AC, 1984, BIOCHEM BIOPH RES CO, V124, P585, DOI 10.1016/0006-291X(84)91594-8; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; MERESSE S, 1995, J CELL SCI, V108, P3349; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301; Progida C, 2006, BIOCHEM BIOPH RES CO, V347, P1074, DOI 10.1016/j.bbrc.2006.07.007; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; ROBBINS AR, 1979, P NATL ACAD SCI USA, V76, P1911, DOI 10.1073/pnas.76.4.1911; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shah AH, 2007, J CELL BIOL, V179, P965, DOI 10.1083/jcb.200702187; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Van Meel E, 2008, HISTOCHEM CELL BIOL, V129, P253, DOI 10.1007/s00418-008-0384-0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; WILLIAMS MA, 1985, QUANTITATIVE METHODS, P52; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	53	272	276	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12110	12124		10.1074/jbc.M809277200	http://dx.doi.org/10.1074/jbc.M809277200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265192	Green Published, hybrid			2022-12-27	WOS:000265494600043
J	Lin, EA; Kong, L; Bai, XH; Luan, Y; Liu, CJ				Lin, Edward A.; Kong, Li; Bai, Xiao-Hui; Luan, Yi; Liu, Chuan-ju			miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; INDUCIBLE P204 PROTEIN; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; MICROMASS CULTURES; MESSENGER-RNA; STEM-CELLS; SKELETOGENESIS	MicroRNAs (miRNA) are short non-coding RNA molecules that regulate a variety of biological processes. The role of miRNAs in BMP2-mediated biological processes is of considerable interest. A comparative miRNA array led to the isolation of several BMP2-responsive miRNAs. Among them, miR-199a* is of particular interest, because it was reported to be specifically expressed in the skeletal system. Here we demonstrate that miR-199a* is an early responsive target of BMP2: its level was dramatically reduced at 5 h, quickly increased at 24 h and remained higher thereafter in the course of BMP2-triggered chondrogenesis of a micromass culture of pluripotent C3H10T1/2 stem cells. miR-199a* significantly inhibited early chondrogenesis, as revealed by the reduced expression of early marker genes for chondrogenesis such as cartilage oligomeric matrix protein (COMP), type II collagen, and Sox9, whereas anti-miR-199a* increased the expression of these chondrogenic marker genes. A computer-based prediction algorithm led to the identification of Smad1, a well established downstream molecule of BMP-2 signaling, as a putative target of miR-199a*. The pattern of Smad1 mRNA expression exhibited the mirror opposite of miR-199a* expression following BMP-2 induction. Furthermore, miR-199a* demonstrated remarkable inhibition of both endogenous Smad1 as well as a reporter construct bearing the 3-un-translated region of Smad1 mRNA. In addition, mutation of miR-199a* binding sites in the 3'-untranslated region of Smad1 mRNA abolished miR-199a*-mediated repression of reporter gene activity. Mechanism studies revealed that miR-199a* inhibits Smad1/Smad4-mediated transactivation of target genes, and that overexpression of Smad1 completely corrects miR-199a*-mediated repression of early chondrogenesis. Taken together, miR-199a* is the first BMP2 responsive microRNA found to adversely regulate early chondrocyte differentiation via direct targeting of the Smad1 transcription factor.	[Lin, Edward A.; Kong, Li; Bai, Xiao-Hui; Luan, Yi; Liu, Chuan-ju] NYU, Sch Med, Dept Orthopaed Surg, New York, NY 10003 USA; [Liu, Chuan-ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Liu, CJ (corresponding author), NYU, Sch Med, Dept Orthopaed Surg, 301 E 17th St, New York, NY 10003 USA.	Chuanju.liu@med.nyu.edu	Liu, Chuan-ju/AAT-8165-2021	liu, chuanju/0000-0002-7181-8032; Bai, Xiaohui/0000-0002-4027-7798	National Institutes of Health [AR050620, AR053210, AG029388]; Arthritis National Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050620, AR053210, and AG029388. This work was also supported by a grant from the Arthritis National Research Foundation. 1 Both authors contributed equally to this work.	Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan Shih-Peng, 2006, RNA Biol, V3, P97; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Chimal-Monroy J, 2002, DEV DYNAM, V224, P314, DOI 10.1002/dvdy.10110; Church VL, 2002, INT J DEV BIOL, V46, P927; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hatakeyama Y, 2003, J BONE JOINT SURG AM, V85A, P13, DOI 10.2106/00004623-200300003-00004; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kong L, 2008, CELL MOL LIFE SCI, V65, P3494, DOI 10.1007/s00018-008-8342-5; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lin EA, 2009, FRONT BIOSCI-LANDMRK, V14, P2757, DOI 10.2741/3412; Liu C., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P340; Liu CJ, 2007, FRONT BIOSCI, V12, P3899, DOI 10.2741/2359; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Luan Y, 2008, MOL BIOL CELL, V19, P2113, DOI 10.1091/mbc.E07-10-1057; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yates KE, 2004, OSTEOARTHR CARTILAGE, V12, P497, DOI 10.1016/j.joca.2004.02.009; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang Y, 2008, CELL DEATH DIFFER, V15, P1760, DOI 10.1038/cdd.2008.112; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	57	195	213	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11326	11335		10.1074/jbc.M807709200	http://dx.doi.org/10.1074/jbc.M807709200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251704	hybrid, Green Published			2022-12-27	WOS:000265494500037
J	Widenmaier, SB; Sampaio, AV; Underhill, TM; McIntosh, CHS				Widenmaier, Scott B.; Sampaio, Arthur V.; Underhill, T. Michael; McIntosh, Christopher H. S.			Noncanonical Activation of Akt/Protein Kinase B in beta-Cells by the Incretin Hormone Glucose-dependent Insulinotropic Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; SURVIVAL; AKT; MECHANISM; RECEPTOR; PROLIFERATION; STIMULATION	Therapeutics based on the actions of the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), have recently been introduced for the treatment of type 2 diabetes mellitus. The serine/threonine kinase Akt is a major mediator of incretin action on the pancreatic islet, increasing beta-cell mass and function and promoting beta-cell survival. The mechanisms underlying incretin activation of Akt are thought to involve an essential phosphoinositide 3-kinase-mediated phosphorylation of threonine 308, similar to the prototypical Akt activator, insulin-like growth factor-I (IGF-I). In this study, using activity assays on immunoprecipitated Akt, we discovered that GIP and GLP-1 were capable of stimulating Akt in the INS-1 beta-cell line and isolated mouse islets via a mechanism that did not require phosphoinositide 3-kinase or phosphorylation of Thr(308) and Ser(473), and this pathway involved the production of cAMP. Furthermore, we found that GIP stimulated anti-apoptotic signaling via this alternate mode of Akt activation. We conclude that incretins can activate Akt via a novel noncanonical mechanism that may provide an alternative therapeutic target for the treatment of type 2 diabetes mellitus and have broader implications for Akt physiology in human health and disease.	[McIntosh, Christopher H. S.] Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Diabet Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca		Widenmaier, Scott/0000-0001-5684-2707	Canadian Institutes of Health Research and the Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research and the Canadian Foundation for Innovation(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Institutes of Health Research and the Canadian Foundation for Innovation ( to C. H. S. M.) and scholarships from the Natural Sciences and Engineering Research Council of Canada and the Michael Smith Foundation for Health Research ( to S. W.).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Balas B, 2007, J CLIN ENDOCR METAB, V92, P1249, DOI 10.1210/jc.2006-1882; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Elghazi L, 2006, INT J BIOCHEM CELL B, V38, P157, DOI 10.1016/j.biocel.2005.08.017; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Leech CA, 1996, ANN NY ACAD SCI, V805, P81; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McIntosh CHS, 2008, FRONT BIOSCI-LANDMRK, V13, P1753, DOI 10.2741/2797; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Rao P, 2005, DIABETES, V54, P1664, DOI 10.2337/diabetes.54.6.1664; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; SIEGEL EG, 1985, DIABETOLOGIA, V28, P857, DOI 10.1007/BF00291078; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tews D, 2008, HORM METAB RES, V40, P172, DOI 10.1055/s-2008-1042426; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	57	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10764	10773		10.1074/jbc.M809116200	http://dx.doi.org/10.1074/jbc.M809116200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233842	Green Published, hybrid			2022-12-27	WOS:000265104600051
J	Hayes, MJ; Moss, SE				Hayes, Matthew J.; Moss, Stephen E.			Annexin 2 Has a Dual Role as Regulator and Effector of v-Src in Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; ENDOCYTIC VESICLES; ACTIN; CALPACTIN; BINDING; COMPLEX; PROTEIN; P36; IDENTIFICATION	Cell transformation by v-Src involves rearrangement of the actin cytoskeleton, disassembly of focal adhesions, and the development of anchorage-independent growth. Here, we report that this is dependent on annexin 2, a v-Src substrate and calcium-dependent regulator of actin dynamics. Using a thermoactivatable mutant of v-Src, we show that at the permissive temperature, annexin 2 becomes phosphorylated and colocalizes with activated v-Src and focal adhesion kinase both at the plasma membrane and in a Rab11-positive compartment of the endosomal pathway. In cells depleted of annexin 2 by small interfering RNA, v-Src becomes activated at the permissive temperature but does not target to the plasma membrane or to perinuclear vesicles, and cell transformation does not occur. Our findings reveal a dual role for annexin 2, first as a regulator of v-Src trafficking and targeting and second as a v-Src effector in the reorganization of actin.	[Hayes, Matthew J.; Moss, Stephen E.] UCL, Univ Coll London Inst Ophthalmol, Div Cell Biol, London EC1V 9EL, England	University of London; University College London	Moss, SE (corresponding author), UCL, Univ Coll London Inst Ophthalmol, Div Cell Biol, 11-43 Bath St, London EC1V 9EL, England.	s.moss@ucl.ac.uk			Wellcome Trust Program [GR072694MF]	Wellcome Trust Program(Wellcome Trust)	This work was supported by Wellcome Trust Program Grant GR072694MF.	Araki N, 2007, EXP CELL RES, V313, P1496, DOI 10.1016/j.yexcr.2007.02.012; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; de Diesbach P, 2008, EXP CELL RES, V314, P1465, DOI 10.1016/j.yexcr.2008.01.015; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Frame MC, 2002, CURR OPIN GENET DEV, V12, P36, DOI 10.1016/S0959-437X(01)00261-1; GARBER EA, 1983, VIROLOGY, V126, P73, DOI 10.1016/0042-6822(83)90462-2; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY J, 1986, P NATL ACAD SCI USA, V83, P4258, DOI 10.1073/pnas.83.12.4258; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; HAYES MJ, 2008, BIOCH BIOPH IN PRESS; Hilbig A., 2008, V177, P179; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; MARTIN F, 1988, BIOCHEM J, V251, P777, DOI 10.1042/bj2510777; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Meijne AML, 1997, EXP CELL RES, V234, P477, DOI 10.1006/excr.1997.3637; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SARIS CJM, 1986, CELL, V46, P201, DOI 10.1016/0092-8674(86)90737-3; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Trischler M, 1999, J CELL SCI, V112, P4773; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yamada A, 2005, J BIOL CHEM, V280, P6016, DOI 10.1074/jbc.M408215200; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; YAO H, 2008, LUNG CANC IN PRESS; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	52	39	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10202	10210		10.1074/jbc.M807043200	http://dx.doi.org/10.1074/jbc.M807043200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193640	Green Published, hybrid			2022-12-27	WOS:000264892900062
J	Poulsen, BE; Rath, A; Deber, CM				Poulsen, Bradley E.; Rath, Arianna; Deber, Charles M.			The Assembly Motif of a Bacterial Small Multidrug Resistance Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ESCHERICHIA-COLI; TRANSPORTER EMRE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEIN; OLIGOMERIC STATE; TOPOLOGY; SEQUENCE; PARALLEL; REVEALS	Multidrug transporters such as the small multidrug resistance (SMR) family of bacterial integral membrane proteins are capable of conferring clinically significant resistance to a variety of common therapeutics. As antiporter proteins of similar to 100 amino acids, SMRs must self-assemble into homo-oligomeric structures for efflux of drug molecules. Oligomerization centered at transmembrane helix four (TM4) has been implicated in SMR assembly, but the full complement of residues required to mediate its self-interaction remains to be characterized. Here, we use Hsmr, the 110-residue SMR family member of the archaebacterium Halobacterium salinarum, to determine the TM4 residue motif required to mediate drug resistance and SMR self-association. Twelve single point mutants that scan the central portion of the TM4 helix (residues 85-104) were constructed and were tested for their ability to confer resistance to the cytotoxic compound ethidium bromide. Six residues were found to be individually essential for drug resistance activity (Gly(90), Leu(91), Leu(93), Ile(94), Gly(97), and Val(98)), defining a minimum activity motif of (90)GLXLIXXGV(98) within TM4. When the propensity of these mutants to dimerize on SDS-PAGE was examined, replacements of all but Ile resulted in similar to 2-fold reduction of dimerization versus the wild-type antiporter. Our work defines a minimum activity motif of 90GLXLIXXGV98 within TM4 and suggests that this sequence mediates TM4-based SMR dimerization along a single helix surface, stabilized by a small residue heptad repeat sequence. These TM4-TM4 interactions likely constitute the highest affinity locus for disruption of SMR function by directly targeting its self-assembly mechanism.	[Poulsen, Bradley E.; Rath, Arianna; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Poulsen, Bradley E.; Rath, Arianna; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca	Poulsen, Bradley/AAW-9750-2020		Canadian Institutes of Health Research (CIHR) [CIHR FRN-5810]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (CIHR) ( Grant CIHR FRN-5810) ( to C. M. D.).	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Heir E, 1999, INT J FOOD MICROBIOL, V48, P211, DOI 10.1016/S0168-1605(99)00044-6; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; LITTLEJOHN TG, 1992, FEMS MICROBIOL LETT, V95, P259; Liu Y, 2002, GENOME BIOL, V3; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nara T, 2007, J BIOCHEM, V142, P621, DOI 10.1093/jb/mvm169; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Rath A, 2007, FEBS LETT, V581, P1335, DOI 10.1016/j.febslet.2007.02.050; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; SMITH SO, 1995, P NATL ACAD SCI USA, V92, P488, DOI 10.1073/pnas.92.2.488; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2004, FEBS LETT, V564, P234, DOI 10.1016/S0014-5793(04)00228-5; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044	41	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9870	9875		10.1074/jbc.M900182200	http://dx.doi.org/10.1074/jbc.M900182200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224913	hybrid, Green Published			2022-12-27	WOS:000264892900028
J	Rigel, NW; Gibbons, HS; McCann, JR; McDonough, JA; Kurtz, S; Braunstein, M				Rigel, Nathan W.; Gibbons, Henry S.; McCann, Jessica R.; McDonough, Justin A.; Kurtz, Sherry; Braunstein, Miriam			The Accessory SecA2 System of Mycobacteria Requires ATP Binding and the Canonical SecA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; STREPTOCOCCUS-PARASANGUIS; IN-VIVO; SECRETION SYSTEMS; WILD-TYPE; MEMBRANE; TUBERCULOSIS; SMEGMATIS; BACILLUS	In bacteria, the majority of exported proteins are transported by the general Sec pathway from their site of synthesis in the cytoplasm across the cytoplasmic membrane. The essential SecA ATPase powers this Sec-mediated export. Mycobacteria possess two nonredundant SecA homologs: SecA1 and SecA2. In pathogenic Mycobacterium tuberculosis and the nonpathogenic model mycobacterium Mycobacterium smegmatis, SecA1 is essential for protein export and is the "housekeeping" SecA, whereas SecA2 is an accessory SecA that exports a specific subset of proteins. In M. tuberculosis the accessory SecA2 pathway plays a role in virulence. In this study, we uncovered basic properties of the mycobacterial SecA2 protein and its pathway for exporting select proteins. By constructing secA2 mutant alleles that encode proteins defective in ATP binding, we showed that ATP binding is required for SecA2 function. SecA2 mutant proteins unable to bind ATP were nonfunctional and dominant negative. By evaluating the subcellular distribution of each SecA, SecA1 was shown to be equally divided between cytosolic and cell envelope fractions, whereas SecA2 was predominantly localized to the cytosol. Finally, we showed that the canonical SecA1 has a role in the process of SecA2-dependent export. The accessory SecA2 export system is important to the physiology and virulence of mycobacteria. These studies help establish the mechanism of this new type of specialized protein export pathway.	[Rigel, Nathan W.; Gibbons, Henry S.; McCann, Jessica R.; McDonough, Justin A.; Kurtz, Sherry; Braunstein, Miriam] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Braunstein, M (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, CB 7920,804 Mary Ellen Jones Bldg, Chapel Hill, NC 27599 USA.	braunste@med.unc.edu		Kurtz, Sherry/0000-0002-2281-8984; Gibbons, Henry/0000-0002-5603-8679; McCann, Jessica/0000-0001-6139-7089	National Institutes of Health [AI054540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI054540.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Appling DR, 1999, METHODS, V19, P338, DOI 10.1006/meth.1999.0861; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Chen Q, 2006, FEMS MICROBIOL LETT, V264, P174, DOI 10.1111/j.1574-6968.2006.00455.x; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Das S, 2008, J BACTERIOL, V190, P7302, DOI 10.1128/JB.00593-08; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hou JM, 2008, J BACTERIOL, V190, P4880, DOI 10.1128/JB.00412-08; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; KLOSE M, 1993, J BIOL CHEM, V268, P4504; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Or E, 2007, FEBS LETT, V581, P2616, DOI 10.1016/j.febslet.2007.04.083; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Sakai D, 2001, J BIOL CHEM, V276, P17968, DOI 10.1074/jbc.M010652200; Sambrook J., 2001, MOL CLONING LAB MANU; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; SUN Y, 1993, FASEB J, V7, P944, DOI 10.1096/fasebj.7.10.8344492; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; VANDERWOLK J, 1993, MOL MICROBIOL, V8, P31; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004	49	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9927	9936		10.1074/jbc.M900325200	http://dx.doi.org/10.1074/jbc.M900325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19240020	Green Published, hybrid			2022-12-27	WOS:000264892900035
J	Metchat, A; Akerfelt, M; Bierkamp, C; Delsinne, V; Sistonen, L; Alexandre, H; Christians, ES				Metchat, Aicha; Akerfelt, Malin; Bierkamp, Christiane; Delsinne, Virginie; Sistonen, Lea; Alexandre, Henri; Christians, Elisabeth S.			Mammalian Heat Shock Factor 1 Is Essential for Oocyte Meiosis and Directly Regulates Hsp90 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE DISRUPTION; MOUSE OOCYTES; TRANSCRIPTION FACTOR-1; DOWN-REGULATION; CYCLIN B1; MICE; HSF1; MATURATION; THERMOTOLERANCE; TRANSITION	Heat shock transcription factor 1 (HSF1) is the main regulator of the stress response that triggers the transcription of several genes encoding heat shock proteins (Hsps). Hsps act as molecular chaperones involved in protein folding, stability, and trafficking. HSF1 is highly expressed in oocytes and Hsf1 knock-out in mice revealed that in the absence of stress this factor plays an important role in female reproduction. We previously reported that Hsf1(-/-) females produce oocytes but no viable embryos. Consequently, we asked whether oocytes require HSF1 to regulate a particular set of Hsps necessary for them to develop. We find that Hsp90 alpha (Hspaa1) is the major HSF1-dependent chaperone inasmuch as Hsf1 knock-out resulted in Hsp90-depleted oocytes. These oocytes exhibited delayed germinal vesicle breakdown (or G(2)/M transition), partial meiosis I block, and defective asymmetrical division. To probe the role of Hsp90 alpha in this meiotic syndrome, we analyzed meiotic maturation in wildtype oocytes treated with a specific inhibitor of Hsp90, 17-allylamino-17-demethoxy-geldanamycin, and observed similar defects. At the molecular level we showed that, together with these developmental anomalies, CDK1 and MAPK, key meiotic kinases, were significantly disturbed. Thus, our data demonstrate that HSF1 is a maternal transcription factor essential for normal progression of meiosis.	[Metchat, Aicha; Bierkamp, Christiane; Christians, Elisabeth S.] Univ Toulouse, 4R3B3, Ctr Dev Biol, UPS,UMR5547, F-31062 Toulouse, France; [Akerfelt, Malin; Sistonen, Lea] Abo Akad Univ, Univ Turku, Turku Ctr Biotechnol, Dept Biol, FIN-20520 Turku, Finland; [Delsinne, Virginie; Alexandre, Henri] Univ Mons, Dept Biol, Fac Med Pharm, B-7000 Mons, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Abo Akademi University; University of Turku; University of Mons	Christians, ES (corresponding author), Univ Toulouse, 4R3B3, Ctr Dev Biol, UPS,UMR5547, 118 Route Narbonne, F-31062 Toulouse, France.	Elisabeth.Christians@cict.fr		Akerfelt, Malin/0000-0003-4810-7862; Sistonen, Lea/0000-0003-1341-2867				Anger M, 2005, BIOL REPROD, V72, P188, DOI 10.1095/biolreprod.104.035451; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Christians ES, 2006, HANDB EXP PHARM, V172, P139; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dale EC, 1997, CELL STRESS CHAPERON, V2, P87, DOI 10.1379/1466-1268(1997)002<0087:MKHSPG>2.3.CO;2; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Fisher DL, 2000, EMBO J, V19, P1516, DOI 10.1093/emboj/19.7.1516; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Hamatani T, 2008, REPRODUCTION, V135, P581, DOI 10.1530/REP-07-0430; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Inoue T, 2006, DEV GROWTH DIFFER, V48, P25, DOI [10.1111/j.1440-169x.2006.00841.x, 10.1111/j.1440-169X.2006.00841.x]; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Kanatsu-Shinohara M, 2000, BIOL REPROD, V63, P1610, DOI 10.1095/biolreprod63.6.1610; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Nomura N, 2007, BIOCHEM PHARMACOL, V73, P1528, DOI 10.1016/j.bcp.2007.01.022; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Van Cauwenberge A, 2000, INT J DEV BIOL, V44, P409; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Voss AK, 2000, DEVELOPMENT, V127, P1; Wang L, 2008, DEV BIOL, V313, P155, DOI 10.1016/j.ydbio.2007.10.009; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yu LZ, 2007, CELL CYCLE, V6, P330, DOI 10.4161/cc.6.3.3805; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	45	69	75	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9521	9528		10.1074/jbc.M808819200	http://dx.doi.org/10.1074/jbc.M808819200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158073	hybrid, Green Published			2022-12-27	WOS:000264669100058
J	Zhong, XM; Jin, Y				Zhong, Xiaomin; Jin, Ying			Critical Roles of Coactivator p300 in Mouse Embryonic Stem Cell Differentiation and Nanog Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR OCT-4; EPIGENETIC REGULATION; DISTINCT ROLES; SELF-RENEWAL; GENE; PLURIPOTENCY; CBP; PROTEIN; ACETYLTRANSFERASE; BINDING	p300 is a well known histone acetyltransferase and coactivator that plays pivotal roles in many physiological processes. Despite extensive research for the functions of p300 in embryogenesis and transcription regulation, its roles in regulating embryonic stem (ES) cell pluripotency are poorly understood. To address this issue, we investigated the self-renewal ability and early differentiation process in both wild-type mouse ES cells and ES cells derived from p300 knock-out (p300(-/-)) mice. We found that p300 ablation did not affect self-renewal capacity overtly when ES cells were maintained under undifferentiated conditions. However, the absence of p300 caused a significantly abnormal expression pattern of germ layer markers when differentiation was induced by embryoid body (EB) formation. Interestingly, the expression level of pluripotency marker Nanog but not Oct4 was markedly lower in EBs from p300(-/-) ES cells compared with that in EBs from wild-type ES cells. Exogenous expression of Nanog rescued abnormal expression of extra-embryonic endoderm marker partially but not mesoderm and ectoderm markers. Furthermore, we demonstrate that p300 was directly involved in modulating Nanog expression. Importantly, epigenetic modification of histone acetylation at the distal regulatory region of Nanog was found to be dependent on the presence of p300, which could contribute to the mechanism of regulating Nanog expression by p300. Collectively, our results show that p300 plays an important role in the differentiation process of ES cells and provide the first evidence for the involvement of p300 in regulating Nanog expression during differentiation, probably through epigenetic modification of histone on Nanog.	[Zhong, Xiaomin; Jin, Ying] Chinese Acad Sci, Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci,Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci, Beijing 100000, Peoples R China; [Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Beijing 100000, Peoples R China; [Zhong, Xiaomin] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, Y (corresponding author), Inst Hlth Sci, 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn		, jin ying/0000-0003-0070-2048	National High Technology Research and Development Program of China [2006CB943901, 2007CB947904]; National Natural Science Foundation [3057907, 30730051]; Shanghai Leading Academic Discipline Project [S30201]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National High Technology Research and Development Program of China Grants 2006CB943901 and 2007CB947904, National Natural Science Foundation Grants 3057907 and 30730051, and Shanghai Leading Academic Discipline Project Grant S30201. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.SC. Section 1734 solely to indicate this fact.	Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan HM, 2001, J CELL SCI, V114, P2363; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Goodman RH, 2000, GENE DEV, V14, P1553; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Partanen M, 1999, INT J DEV BIOL, V43, P487; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Wu DY, 2005, CELL RES, V15, P317, DOI 10.1038/sj.cr.7290300; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com	36	54	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9168	9175		10.1074/jbc.M805562200	http://dx.doi.org/10.1074/jbc.M805562200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19150979	Green Published, hybrid			2022-12-27	WOS:000264669100022
J	Asong, J; Wolfert, MA; Maiti, KK; Miller, D; Boons, GJ				Asong, Jinkeng; Wolfert, Margreet A.; Maiti, Kaustabh K.; Miller, Douglas; Boons, Geert-Jan			Binding and Cellular Activation Studies Reveal That Toll-like Receptor 2 Can Differentially Recognize Peptidoglycan from Gram-positive and Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; SURFACE-PLASMON RESONANCE; STAPHYLOCOCCUS-AUREUS; EXPERIMENTAL-DESIGN; PROTEINS PGRPS; ACID; WALL; INFLAMMATION; FRAGMENTS; ENDOTOXIN	Although much progress has been made toward the identification of innate immune receptors, far less is known about how these receptors recognize specific microbial products. Such studies have been hampered by the need to purify compounds from microbial sources and a reliance on biological assays rather than direct binding to monitor recognition. We have employed surface plasmon resonance (SPR) binding studies using a wide range of well defined synthetic muropeptides derived from Gram-positive (lysine-containing) and Gram-negative (diaminopimelic acid (DAP)-containing) bacteria to demonstrate that Toll-like receptor 2 can recognize peptidoglycan (PGN). In the case of lysine-containing muropeptides, a limited number of compounds, which were derived from PGN remodeled by bacterial autolysins, was recognized. However, a wider range of DAP-containing muropeptides was bound with high affinity, and these compounds were derived from nascent and remodeled PGN. The difference in recognition of the two classes of muropeptides is proposed to be a strategy by the host to respond appropriately to Gram-negative and -positive bacteria, which produce vastly different quantities of PGN. It was also found that certain modifications of the carboxylic acids of isoglutamine and DAP can dramatically reduce binding, and thus, bacterial strains may employ such modifications to evade innate immune detection. Cellular activation studies employing highly purified PGN from Bacillus licheniformis, Bacillus subtilis, Escherichia coli, Lactobacillus plantarum, Micrococcus luteus, and Staphylococcus aureus support the structure binding relationship. The data firmly establish Toll-like receptor 2 as an innate immune sensor for PGN and provides an understanding of host-pathogen interactions at the molecular level.	[Asong, Jinkeng; Wolfert, Margreet A.; Maiti, Kaustabh K.; Miller, Douglas; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Boons, Geert-Jan P H/J-3211-2016; Wolfert, Margreet A/J-1726-2016	Boons, Geert-Jan P H/0000-0003-3111-5954; Wolfert, Margreet A/0000-0003-4864-0026	National Institutes of Health [GM065248]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065248, R01GM061761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065248. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement"	Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chowdhury AR, 2005, TETRAHEDRON LETT, V46, P1675, DOI 10.1016/j.tetlet.2005.01.062; Chowdhury AR, 2002, TETRAHEDRON LETT, V43, P7805; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Doyle R.J., 2001, MOL MED MICROBIOLOGY, P137; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Ganz T, 2003, BLOOD, V101, P2388, DOI 10.1182/blood-2002-07-2319; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123; Hoijer MA, 1997, EUR CYTOKINE NETW, V8, P375; Inamura S, 2006, ORG BIOMOL CHEM, V4, P232, DOI 10.1039/b511866b; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; JANUSZ MJ, 1986, INFECT IMMUN, V52, P459, DOI 10.1128/IAI.52.2.459-467.1986; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Lipschultz CA, 2000, METHODS, V20, P310, DOI 10.1006/meth.1999.0924; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Myhre AE, 2006, SHOCK, V25, P227, DOI 10.1097/01.shk.0000191378.55274.37; Myhre AE, 2004, INFECT IMMUN, V72, P1311, DOI 10.1128/IAI.72.3.1311-1317.2004; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Roychowdhury A, 2005, CHEMBIOCHEM, V6, P2088, DOI 10.1002/cbic.200500181; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Thomas CJ, 1999, J BIOL CHEM, V274, P29624, DOI 10.1074/jbc.274.42.29624; TIPPER DJ, 1967, BIOCHEMISTRY-US, V6, P921, DOI 10.1021/bi00855a036; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a	47	73	74	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8634	8644		10.1074/jbc.M806633200	http://dx.doi.org/10.1074/jbc.M806633200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164296	hybrid, Green Published			2022-12-27	WOS:000264397800048
J	Avval, FZ; Holmgren, A				Avval, Farnaz Zahedi; Holmgren, Arne			Molecular Mechanisms of Thioredoxin and Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEOSIDE TRIPHOSPHATE POOLS; ESCHERICHIA-COLI; DNA-DAMAGE; DIPHOSPHATE REDUCTASE; CALF THYMUS; ALLOSTERIC REGULATION; TISSUE DISTRIBUTION; RECOMBINANT MOUSE; MIXED DISULFIDE; RESTING CELLS	Ribonucleotide reductase (RNR) catalyzes the rate-limiting step in deoxyribonucleotide synthesis essential for DNA replication and repair. RNR in S phase mammalian cells comprises a weak cytosolic complex of the catalytic R1 protein containing redox active cysteine residues and the R2 protein harboring the tyrosine free radical. Each enzyme turnover generates a disulfide in the active site of R1, which is reduced by C-terminally located shuttle dithiols leaving a disulfide to be reduced. Electrons for reduction come ultimately from NADPH via thioredoxin reductase and thioredoxin (Trx) or glutathione reductase, glutathione, and glutaredoxin (Grx), but the mechanism has not been clarified for mammalian RNR. Using recombinant mouse RNR, we found that Trx1 and Grx1 had similar catalytic efficiency (kcat/Km). With 4mM GSH, Grx1 showed a higher affinity (apparent Km value, 0.18 mu M) compared with Trx1 which displayed a higher apparent k(cat), suggesting its major role in S phase DNA replication. Surprisingly, Grx activity was strongly dependent on GSH concentrations (apparent Km value, 3 mM) and a Grx2 C40S mutant was active despite only one cysteine residue in the active site. This demonstrates a GSH-mixed disulfide mechanism for glutaredoxin catalysis in contrast to the dithiol mechanism for thioredoxin. This may be an advantage with the low levels of RNR for DNA repair or in tumor cells with high RNR and no or low Trx expression. Our results demonstrate mechanistic differences between the mammalian and canonical Escherichia coli RNR enzymes, which may offer an explanation for the nonconserved shuttle dithiol sequences in the C terminus of the R1.	[Avval, Farnaz Zahedi; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se		Zahedi Avval, Farnaz/0000-0001-8915-3596	Swedish Research Council Medicine [3529]; Swedish Cancer Society [961]; K. A. Wallenberg Foundation; Ministry of Health and Medical Education of Iran	Swedish Research Council Medicine(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ministry of Health and Medical Education of Iran	This work was supported in part by Swedish Research Council Medicine Grant 3529, Swedish Cancer Society Grant 961, and funds from the K. A. Wallenberg Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a scholarship from the Ministry of Health and Medical Education of Iran.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Berardi MJ, 1998, BIOCHEMISTRY-US, V37, P5849, DOI 10.1021/bi972924d; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Camier S, 2007, FREE RADICAL BIO MED, V42, P1008, DOI 10.1016/j.freeradbiomed.2006.12.027; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; DAVIS R, 1994, J BIOL CHEM, V269, P23171; ENGSTROM Y, 1979, BIOCHEMISTRY-US, V18, P2941, DOI 10.1021/bi00581a004; ERIKSSON S, 1975, EUR J BIOCHEM, V56, P289, DOI 10.1111/j.1432-1033.1975.tb02232.x; Gallardo-Madueno R, 1998, J BIOL CHEM, V273, P18382, DOI 10.1074/jbc.273.29.18382; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HANSSON HA, 1986, EXP CELL RES, V163, P363, DOI 10.1016/0014-4827(86)90067-4; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOPPER S, 1983, J BIOL CHEM, V258, P3453; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kasrayan A, 2004, J BIOL CHEM, V279, P31050, DOI 10.1074/jbc.M400693200; Koc A, 2006, J BIOL CHEM, V281, P15058, DOI 10.1074/jbc.M601968200; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; KUCERA R, 1982, ARCH BIOCHEM BIOPHYS, V214, P102, DOI 10.1016/0003-9861(82)90012-1; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; REDDY GPV, 1982, J BIOL CHEM, V257, P2526; Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rojas E, 2000, MUTAT RES-FUND MOL M, V447, P305, DOI 10.1016/S0027-5107(99)00191-8; ROZELL B, 1993, EUR J CELL BIOL, V62, P314; Sjoberg BM, 2002, METHOD ENZYMOL, V348, P1; SLABAUGH MB, 1984, J VIROL, V52, P501, DOI 10.1128/JVI.52.2.501-506.1984; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Xue LJ, 2003, CANCER RES, V63, P980; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112	62	110	114	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8233	8240		10.1074/jbc.M809338200	http://dx.doi.org/10.1074/jbc.M809338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176520	Green Published, hybrid			2022-12-27	WOS:000264397800006
J	Yonetani, M; Nonaka, T; Masuda, M; Inukai, Y; Oikawa, T; Hisanaga, S; Hasegawa, M				Yonetani, Motokuni; Nonaka, Takashi; Masuda, Masami; Inukai, Yuki; Oikawa, Takayuki; Hisanaga, Shin-ichi; Hasegawa, Masato			Conversion of Wild-type alpha-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY BODIES; GENE DUPLICATION; KINETIC-ANALYSIS; IN-VITRO; MUTATION; CONFORMATION; AGGREGATION; FILAMENTS; MECHANISM	Fibrillization or conformational change of alpha-synuclein is central in the pathogenesis of alpha-synucleinopathies, such as Parkinson disease. We found that the A30P mutant accelerates nucleation-dependent fibrillization of wild type (WT) alpha-synuclein. Electron microscopy observation and ultracentrifugation experiments revealed that shedding of fragments occurs from A30P fibrils and that these fragments accelerate fibrillization by serving as seeds. Immunochemical analysis using epitope-specific antibodies and biochemical analyses of protease-resistant cores demonstrated that A30P fibrils have a distinct conformation. Interestingly, WT fibrils formed with A30P seeds exhibited the same character as A30P fibrils, as did A30P fibrils formed with WT seeds, indicating that the A30P mutation affects the conformation and fibrillization of both WT and A30P. These effects of A30P mutation may explain the apparent conflict between the association of A30P with Parkinson disease and the slow fibrillization of A30P itself and therefore provide new insight into the molecular mechanisms of alpha-synucleinopathies.	[Hasegawa, Masato] Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, Tokyo 1568585, Japan; [Yonetani, Motokuni; Masuda, Masami; Inukai, Yuki; Oikawa, Takayuki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Mol Neurosci Lab, Hachioji, Tokyo 1920397, Japan	Tokyo Institute of Psychiatry; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Hasegawa, M (corresponding author), Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, 2-1-8 Kamikitazawa, Tokyo 1568585, Japan.	masato@prit.go.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Priority Areas, Research on Pathomechanisms of Brain Disorders; Ministry of Education, Culture, Sports, Science and Technology of Japan	Priority Areas, Research on Pathomechanisms of Brain Disorders; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas, Research on Pathomechanisms of Brain Disorders (to M. H.), a Grant-in-Aid for Scientific Research (B) (to M. H.), and a Grant-in-Aid for Scientific Research (C) (to M. H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Baba M, 1998, AM J PATHOL, V152, P879; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1991, LAB INVEST, V65, P104; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	49	77	79	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7940	7950		10.1074/jbc.M807482200	http://dx.doi.org/10.1074/jbc.M807482200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164293	hybrid, Green Published			2022-12-27	WOS:000264195600056
J	Fluhrer, R; Steiner, H; Haass, C				Fluhrer, Regina; Steiner, Harald; Haass, Christian			Intramembrane Proteolysis by Signal Peptide Peptidases: A Comparative Discussion of GXGD-type Aspartyl Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GAMMA-SECRETASE ACTIVITY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRESENILIN HOMOLOGS; CAENORHABDITIS-ELEGANS; TNF-ALPHA; CLEAVAGE; NICASTRIN; INHIBITOR; PROTEIN; SPPL2B	Intramembrane-cleaving proteases are required for reverse signaling and membrane protein degradation. A major class of these proteases is represented by the GXGD-type aspartyl proteases. GXGD describes a novel signature sequence that distinguishes these proteases from conventional aspartyl proteases. Members of the family of the GXGD-type aspartyl proteases are the Alzheimer disease-related gamma-secretase, the signal peptide peptidases and their homologs, and the bacterial type IV prepilin peptidases. We will describe the major biochemical and functional properties of the signal peptide peptidases and their relatives. We then compare these properties with those of gamma-secretase and discuss common mechanisms but also point out a number of substantial differences.	[Fluhrer, Regina] Univ Munich, DZNE, D-80336 Munich, Germany; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Fluhrer, R (corresponding author), Univ Munich, DZNE, D-80336 Munich, Germany.	regina.fluhrer@med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011		Deutsche Forschungsgemeinschaft; Collaborative Research Center [SFB596]; Bundesministerium fur Bildung und Forschung;  [HA1737-11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); 	This work was supported in part by the Deutsche Forschungsgemeinschaft (a Gottfried Wilhelm Leibniz award (to C. H.), Collaborative Research Center (SFB596) "Molecular Mechanisms of Neurodegeneration" (to H. S. and C. H.), and Grant HA1737-11 (to C. H. and R. F.)), the Bundesministerium fur Bildung und Forschung ("Degenerative Dementias: Target Identification, Validation and Translation into Treatment Strategies" (to C. H. and H. S.)), the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.), and Boehringer Ingelheim PharmaGmbH&Co.KG. The first article in this minireview series on proteases was published in the November 7, 2008 issue; the second and third articles are published in this issue. Additional articles will be published in future issues. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Baumeister R, 1997, Genes Funct, V1, P149; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	44	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					13975	13979		10.1074/jbc.R800040200	http://dx.doi.org/10.1074/jbc.R800040200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19189970	Green Published, hybrid			2022-12-27	WOS:000266286100003
J	Wu, YW; Goody, RS; Abagyan, R; Alexandrov, K				Wu, Yao-Wen; Goody, Roger S.; Abagyan, Ruben; Alexandrov, Kirill			Structure of the Disordered C Terminus of Rab7 GTPase Induced by Binding to the Rab Geranylgeranyl Transferase Catalytic Complex Reveals the Mechanism of Rab Prenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; AB-INITIO PREDICTION; ESCORT PROTEIN; CONFORMATIONAL SEARCHES; PEPTIDES; FARNESYLTRANSFERASE; EVOLUTION; RABGGTASE; INSIGHTS; DOCKING	Protein prenylation is a widespread process that involves the transfer of either a farnesyl or a geranylgeranyl moiety to one or more C-terminal cysteines of the target protein. Rab geranylgeranyl transferase (RabGGTase) is responsible for the largest number of individual protein prenylation events in the cell. A decade-long effort to crystallize the catalytic ternary complex of RabGGTase has remained fruitless, prompting us to use a computational approach to predict the structure of this 200-kDa assembly. On the basis of high resolution structures of two sub-complexes, we have generated a composite model where the rigid parts of the protein are represented by precomputed grid potentials, whereas the mobile parts are described in atomic details using Internal Coordinate Mechanics. Selection of the best docking solution of the flexible parts on the grid is followed by explicit atomistic refinement of the lowest energy conformations enabling realistic modeling of complex structures. Using this approach we demonstrate that the flexible C terminus of Rab7 substrate forms a series of progressively weaker and less specific interactions that channel it into the active site of RabGGTase. We have validated the computational model through biochemical experiments and demonstrated that to be prenylated RabGTPase must possess at least nine amino acids between the prenylation motif and the hydrophobic sequence anchoring the beginning of the Rab C terminus on the enzyme. This sequence, known as the C-terminal interacting motif is shown to play a dual role in Rab prenylation by contributing a significant fraction of binding energy to the catalytic complex assembly and by orienting the C terminus of RabGTPase in the vicinity of the active site of RabGGTase. This mechanism is unique to RabGGTase when compared with other prenyltransferases, which encode the specificity for their cognate substrates directly at their active site.	[Abagyan, Ruben] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wu, Yao-Wen; Goody, Roger S.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Alexandrov, Kirill] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia	Scripps Research Institute; Max Planck Society; University of Queensland; University of Queensland	Abagyan, R (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	abagyan@scripps.edu; k.alexandrov@imb.uq.edu.au	Wu, Yaowen/N-9802-2015; Goody, Roger S/J-8845-2014; Alexandrov, Kirill/A-5830-2013	Wu, Yaowen/0000-0002-2573-8736; Goody, Roger S/0000-0002-0772-0444; Alexandrov, Kirill/0000-0002-0957-6511	Deutsche Forschungsgemeinschaft [AL 484/7-2, SFB 642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AL 484/7-2 (to K. A.) and SFB 642 (to K. A., R. S. G., and H. W.).	ABAGYAN R, 1992, J MOL BIOL, V225, P519, DOI 10.1016/0022-2836(92)90936-E; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alexandrov K, 1999, EUR J BIOCHEM, V265, P160, DOI 10.1046/j.1432-1327.1999.00699.x; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; Alory C, 2003, MOL BIOL CELL, V14, P3857, DOI 10.1091/mbc.E03-04-0227; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; Lawson MA, 2008, BIOCHEM BIOPH RES CO, V377, P453, DOI 10.1016/j.bbrc.2008.09.157; Maurer-Stroh S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-212; Neu M, 1997, PROTEINS, V27, P204, DOI 10.1002/(SICI)1097-0134(199702)27:2<204::AID-PROT6>3.0.CO;2-F; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rak A, 2002, PROTEIN EXPRES PURIF, V25, P23, DOI 10.1006/prep.2001.1605; Roelofs AJ, 2006, INT J CANCER, V119, P1254, DOI 10.1002/ijc.21977; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; Szewczuk LM, 2007, J MED CHEM, V50, P5330, DOI 10.1021/jm0706463; Thoma NH, 2001, J BIOL CHEM, V276, P48631, DOI 10.1074/jbc.M106470200; TOTROV M, 1994, NAT STRUCT BIOL, V1, P259, DOI 10.1038/nsb0494-259; Totrov M, 1997, PROTEINS, P215; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2006, CHEMBIOCHEM, V7, P1859, DOI 10.1002/cbic.200600377; Yokoyama K, 1997, J BIOL CHEM, V272, P3944, DOI 10.1074/jbc.272.7.3944; Zhou YY, 1998, FOLD DES, V3, P513, DOI 10.1016/S1359-0278(98)00067-4	34	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13185	13192		10.1074/jbc.M900579200	http://dx.doi.org/10.1074/jbc.M900579200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240028	Green Published, hybrid			2022-12-27	WOS:000265688300065
J	McCourt, PC; Morgan, JM; Nickels, JT				McCourt, Paula C.; Morgan, Jeanelle M.; Nickels, Joseph T., Jr.			Stress-induced Ceramide-activated Protein Phosphatase Can Compensate for Loss of Amphiphysin-like Activity In Saccharomyces cerevisiae and Functions to Reinitiate Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-FACTOR RECEPTOR; ADENOVIRUS E4ORF4 PROTEIN; HIGH-CURVATURE MEMBRANES; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; YEAST RVS161; CELL-CYCLE; SPHINGOLIPID FUNCTIONS; SIGNAL-TRANSDUCTION; REGULATORY SUBUNIT	Saccharomyces cerevisiae cells lacking the amphiphysin-like orthologs, Rvs161 or Rvs167, are unable to thrive under many stress conditions. Here we show cells lacking Rvs161 require Cdc55, the B subunit of the yeast ceramide-activated protein phosphatase, for viability under heat stress. By using specific rvs mutant alleles, we linked this lethal genetic interaction to loss of Rvs161 endocytic domain function. Recessive mutations in the sphingolipid pathway, such as deletion of the very long-chain fatty acid elongase, Sur4, suppress the osmotic growth defect of rvs161 cells. We demonstrate that Cdc55 is required for sur4-dependent suppressor activity and that protein phosphatase activation, through overexpression of CDC55 alone, can also remediate this defect. Loss of SUR4 in rvs161 cells reinitiates Ste3 a-factor receptor endocytosis and requires Cdc55 function to do so. Moreover, overexpression of CDC55 reinitiates Ste3 endocytic-dependent degradation and restores fluid phase endocytosis in rvs161 cells. In contrast, loss of SUR4 or CDC55 overexpression does not remediate the actin polarization defects of osmotic stressed rvs161 cells. Importantly, remediation of rvs161 defects by protein phosphatase activation requires the ceramide-activated protein phosphatase catalytic subunit, Sit4, and the protein phosphatase 2A catalytic subunits, Pph21/Pph22. Finally, genetic analyses reveal a synthetic lethal interaction between loss of CDC55 and gene deletions lethal with rvs161, all of which function in endocytosis.	[McCourt, Paula C.; Nickels, Joseph T., Jr.] Med Diagnost Labs LLC, Pharmacogenom Div, Hamilton, NJ 08690 USA; [McCourt, Paula C.; Morgan, Jeanelle M.; Nickels, Joseph T., Jr.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Nickels, JT (corresponding author), Med Diagnost Labs LLC, Pharmacogenom Div, 2439 Kuser Rd, Hamilton, NJ 08690 USA.	jnickels@mdlab.com			National Institutes of Health [HL67401]; Medical Diagnostics Laboratories, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Diagnostics Laboratories, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL67401. This work was also supported by Medical Diagnostics Laboratories, LLC.	ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Bastians H, 1996, J CELL SCI, V109, P2865; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; Breton AM, 2001, YEAST, V18, P1053, DOI 10.1002/yea.755; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Chalfant CE, 2000, METHOD ENZYMOL, V312, P420; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200; CROUZET M, 1991, YEAST, V7, P727, DOI 10.1002/yea.320070708; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DESFARGES L, 1993, YEAST, V9, P267, DOI 10.1002/yea.320090306; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; DURRENS P, 1995, CURR GENET, V27, P213, DOI 10.1007/BF00326151; Efendiev R, 2002, J BIOL CHEM, V277, P44108, DOI 10.1074/jbc.M205173200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Germann M, 2005, J BIOL CHEM, V280, P4270, DOI 10.1074/jbc.M412454200; Gurunathan S, 2002, MOL BIOL CELL, V13, P1594, DOI 10.1091/mbc.01-11-0541; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jangati GR, 2006, BIOCHEM BIOPH RES CO, V348, P649, DOI 10.1016/j.bbrc.2006.07.100; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2003, CELL MOL LIFE SCI, V60, P701, DOI 10.1007/s00018-003-2239-0; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Li YK, 2008, J VIROL, V82, P3612, DOI 10.1128/JVI.02435-07; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; LIU J, 1994, J BIOL CHEM, V269, P3047; Liu JB, 2005, BREAST CANCER RES TR, V94, P161, DOI 10.1007/s10549-005-6942-4; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Masserini M, 2001, BBA-MOL CELL BIOL L, V1532, P149, DOI 10.1016/S1388-1981(01)00128-7; Mott DM, 2008, AM J PHYSIOL-ENDOC M, V294, pE444, DOI 10.1152/ajpendo.00386.2007; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Naqvi SN, 1998, CURR BIOL, V8, P959, DOI 10.1016/S0960-9822(98)70396-3; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shu YM, 1997, MOL CELL BIOL, V17, P3242, DOI 10.1128/MCB.17.6.3242; Sivadon P, 1997, FEBS LETT, V417, P21, DOI 10.1016/S0014-5793(97)01248-9; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Skrzypek MS, 1998, J BIOL CHEM, V273, P2829, DOI 10.1074/jbc.273.5.2829; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; SNEDDON AA, 1990, EMBO J, V9, P4339, DOI 10.1002/j.1460-2075.1990.tb07883.x; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; VANZYL W, 1992, MOL CELL BIOL, V12, P4946, DOI 10.1128/MCB.12.11.4946; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	93	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11930	11941		10.1074/jbc.M900857200	http://dx.doi.org/10.1074/jbc.M900857200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254955	Green Published, hybrid			2022-12-27	WOS:000265494600025
J	Feng, DJ; Witkowski, A; Smith, S				Feng, Dejiang; Witkowski, Andrzej; Smith, Stuart			Down-regulation of Mitochondrial Acyl Carrier Protein in Mammalian Cells Compromises Protein Lipoylation and Respiratory Complex I and Results in Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; ALPHA-LIPOIC ACID; PYRUVATE-DEHYDROGENASE COMPLEX; BOVINE HEART-MITOCHONDRIA; NEUROSPORA-CRASSA MITOCHONDRIA; NUCLEAR-ENCODED SUBUNITS; SACCHAROMYCES-CEREVISIAE; KETOGLUTARATE DEHYDROGENASE; SPECTROPHOTOMETRIC ASSAY; ESCHERICHIA-COLI	The objective of this study was to evaluate the physiological importance of the mitochondrial fatty acid synthesis pathway in mammalian cells using the RNA interference strategy. Transfection of HEK293T cells with small interfering RNAs targeting the acyl carrier protein (ACP) component reduced ACP mRNA and protein levels by >85% within 24 h. The earliest phenotypic changes observed were a marked decrease in the proportion of post-translationally lipoylated mitochondrial proteins recognized by anti-lipoate antibodies and a reduction in their catalytic activity, and a slowing of the cell growth rate. Later effects observed included a reduction in the specific activity of respiratory complex I, lowered mitochondrial membrane potential, the development of cytoplasmic membrane blebs containing high levels of reactive oxygen species and ultimately, cell death. Supplementation of the culture medium with lipoic acid offered some protection against oxidative damage but did not reverse the protein lipoylation defect. These observations are consistent with a dual role for ACP in mammalian mitochondrial function. First, as a key component of the mitochondrial fatty acid biosynthetic pathway, ACP plays an essential role in providing the octanoyl-ACP precursor required for the protein lipoylation pathway. Second, as one of the subunits of complex I, ACP is required for the efficient functioning of the electron transport chain and maintenance of normal mitochondrial membrane potential.	[Feng, Dejiang; Witkowski, Andrzej; Smith, Stuart] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Smith, S (corresponding author), 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	ssmith@chori.org		Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [GM069717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069717.	Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Casciari JJ, 2001, BRIT J CANCER, V84, P1544, DOI 10.1054/bjoc.2001.1814; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Crawford MJ, 2006, EMBO J, V25, P3214, DOI 10.1038/sj.emboj.7601189; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Ewald R, 2007, PLANT PHYSIOL, V145, P41, DOI 10.1104/pp.107.104000; Finucane DM, 1999, EXP CELL RES, V251, P166, DOI 10.1006/excr.1999.4527; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 1997, J BIOL CHEM, V272, P31974, DOI 10.1074/jbc.272.51.31974; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; Hinttala R, 2005, J MOL MED, V83, P786, DOI 10.1007/s00109-005-0712-y; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Huang HM, 2003, J NEUROSCI RES, V74, P309, DOI 10.1002/jnr.10756; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Mayer B, 2003, NEWS PHYSIOL SCI, V18, P89, DOI 10.1152/nips.01433.2002; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; MIKOLAJCZYK S, 1990, EUR J BIOCHEM, V187, P431, DOI 10.1111/j.1432-1033.1990.tb15322.x; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Moungjaroen J, 2006, J PHARMACOL EXP THER, V319, P1062, DOI 10.1124/jpet.106.110965; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Pack RA, 2002, MOL IMMUNOL, V38, P733, DOI 10.1016/S0161-5890(01)00110-9; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; RAHMATULLAH M, 1990, J BIOL CHEM, V265, P14512; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Sen CK, 1999, CELL DEATH DIFFER, V6, P481, DOI 10.1038/sj.cdd.4400514; SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triepels R, 1999, J INHERIT METAB DIS, V22, P163, DOI 10.1023/A:1005402020569; Trinkaus J P, 1973, Ciba Found Symp, V14, P233; TSUNODA JN, 1967, ARCH BIOCHEM BIOPHYS, V118, P395, DOI 10.1016/0003-9861(67)90366-9; Van de Mark K, 2003, J CELL PHYSIOL, V194, P325, DOI 10.1002/jcp.10205; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; WEINBERG MB, 1980, BIOCHEM J, V188, P601, DOI 10.1042/bj1880601; Wenzel U, 2005, APOPTOSIS, V10, P359, DOI 10.1007/s10495-005-0810-x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; ZENSEN R, 1992, FEBS LETT, V310, P179, DOI 10.1016/0014-5793(92)81324-F; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zheng JB, 1999, BIOCHEM BIOPH RES CO, V261, P499, DOI 10.1006/bbrc.1999.1063	73	63	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11436	11445		10.1074/jbc.M806991200	http://dx.doi.org/10.1074/jbc.M806991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19221180	Green Published, hybrid			2022-12-27	WOS:000265494500048
J	Hozoji, M; Kimura, Y; Kioka, N; Ueda, K				Hozoji, Masako; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu			Formation of Two Intramolecular Disulfide Bonds Is Necessary for ApoA-I-dependent Cholesterol Efflux Mediated by ABCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER 1; STARGARDT-DISEASE; TANGIER-DISEASE; ALLELIC VARIATION; GENE; MUTATIONS; IDENTIFICATION; TOPOLOGY; RELEASE; CELLS	ABCA1 plays a major role in cholesterol homeostasis and high density lipoprotein (HDL) metabolism. ABCA1 contains disulfide bond(s) between its N- and C-terminal halves, but it remains unclear whether disulfide bond formation is important for the functions of ABCA1 and which cysteines are involved in disulfide bond formation. To answer these questions, we constructed >30 ABCA1 mutants in which 16 extracellular domain (ECD) cysteines were replaced with serines and examined disulfide bond formation, apoA-I binding, and HDL formation in these mutants. From the single cysteine replacements, two cysteines (Cys(75) and Cys(309)) in ECD1 were found to be essential for apoA-I binding. In contrast, in ECD2, only Cys(1477) was found to be essential for HDL formation, and no single cysteine replacement impaired apoA-I binding. The concurrent replacement of two cysteines, Cys(1463) and Cys(1465), impaired apoA-I binding and HDL formation, suggesting that four of five extracellular cysteines (Cys(75), Cys(309), Cys(1463), Cys(1465), and Cys(1477)) are involved in these functions of ABCA1. Trypsin digestion experiments suggested that one disulfide bond is not sufficient and that two intramolecular disulfide bonds (between Cys(75) and Cys(309) in ECD1 and either Cys(1463) or Cys(1465) and Cys(1477) in ECD2) are required for ABCA1 to be fully functional.	[Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068502, Japan; [Hozoji, Masako; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Cellular Biochem, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X; Kimura, Yasuhisa/0000-0001-6466-1324	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation; World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by the World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Denis M, 2004, J BIOL CHEM, V279, P41529, DOI 10.1074/jbc.M406881200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	25	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11293	11300		10.1074/jbc.M900580200	http://dx.doi.org/10.1074/jbc.M900580200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258317	Green Published, hybrid			2022-12-27	WOS:000265494500033
J	Kwong, J; Hong, LX; Liao, R; Deng, QD; Han, JH; Sun, PQ				Kwong, Jinny; Hong, Lixin; Liao, Rong; Deng, Qingdong; Han, Jiahuai; Sun, Peiqing			p38 alpha and p38 gamma Mediate Oncogenic ras-induced Senescence through Differential Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; P38 MAP-KINASES; PREMATURE SENESCENCE; GROWTH ARREST; ACTIVATION; P53; TRANSFORMATION; PATHWAYS; SUPPRESSION; FIBROBLASTS	Oncogene-induced senescence is a tumor-suppressive defense mechanism triggered upon activation of certain oncogenes in normal cells. Recently, the senescence response to oncogene activation has been shown to act as a bona fide barrier to cancer development in vivo. Multiple previous studies have implicated the importance of the p38 MAPK pathway in oncogene-induced senescence. However, the contribution of each of the four p38 isoforms (encoded by different genes) to senescence induction is unclear. In the current study, we demonstrated that p38 alpha and p38 gamma, but not p38 beta, play an essential role in oncogenic ras-induced senescence. Both p38 alpha and p38 gamma are expressed in primary human fibroblasts and are activated upon transduction of oncogenic ras. Small hairpin RNA-mediated silencing of p38 alpha or p38 gamma expression abrogated ras-induced senescence, whereas constitutive activation of p38 alpha and p38 gamma caused premature senescence. Furthermore, upon activation by oncogenic ras, p38 gamma stimulated the transcriptional activity of p53 by phosphorylating p53 at Ser33, suggesting that the ability of p38 gamma to mediate senescence is at least partly achieved through p53. However, p38 alpha contributed to ras-inducted senescence via a p53-indepdendent mechanism in cells by mediating ras-induced expression of p16(INK4A), another key senescence effector. These findings have identified p38 alpha and p38 gamma as essential components of the signaling pathway that regulates the tumor-suppressing senescence response, providing insights into the molecular mechanisms underlying the differential involvement of the p38 isoforms in senescence induction.	[Kwong, Jinny; Liao, Rong; Deng, Qingdong; Sun, Peiqing] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 91037 USA; [Kwong, Jinny; Sun, Peiqing] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 91037 USA; [Hong, Lixin; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China	Scripps Research Institute; Scripps Research Institute; Xiamen University	Sun, PQ (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-41,10550 N Torrey Pines Rd, La Jolla, CA 91037 USA.	pqsun@scripps.edu	Han, J/G-4671-2010		National Institutes of Health [CA106768]; NATIONAL CANCER INSTITUTE [R01CA106768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637, R01AI068896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Grant CA106768 from the National Institutes of Health (to P.S.). This is Scripps Manuscript 19841.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Haq R, 2002, CANCER RES, V62, P5076; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; RULEY HE, 1990, CANCER CELL-MON REV, V2, P258; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; WEINBERG RA, 1989, CANCER RES, V49, P3713; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	69	57	59	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11237	11246		10.1074/jbc.M808327200	http://dx.doi.org/10.1074/jbc.M808327200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251701	hybrid, Green Published			2022-12-27	WOS:000265494500027
J	Shelton, SN; Shawgo, ME; Robertson, JD				Shelton, Shary N.; Shawgo, Mary E.; Robertson, John D.			Cleavage of Bid by Executioner Caspases Mediates Feed Forward Amplification of Mitochondrial Outer Membrane Permeabilization during Genotoxic Stress-induced Apoptosis in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; DNA-DAMAGE RESPONSE; BCL-2 PROTEIN FAMILY; DEATH; ACTIVATION; BAK; PATHWAYS; DRUG; TRANSLOCATION; REQUIREMENT	The extent to which the BH3-only protein Bid is important for intrinsic (mitochondria-mediated) apoptotic cell death induced by genotoxic stress remains controversial. In the present study, we examine this issue using a panel of gene-manipulated Bax-deficient Jurkat T-lymphocytes. Cells stably depleted of Bid were far less sensitive than control-transfected cells to etoposide-induced apoptosis. In particular, drug-induced Bak activation, cytochrome c release, loss of mitochondrial membrane potential, and caspase activation were all decreased in cells lacking Bid. Reconstitution experiments using recombinant proteins and permeabilized Bid-deficient cells demonstrated that truncated Bid (tBid), but not full-length Bid, potently induced Bak activation and the release of cytochrome c. Further, caspase-8-deficient Jurkat cells efficiently cleaved Bid and were sensitive to drug-induced apoptosis. By comparison, Apaf-1-deficient cells, as well as cells overexpressing full-length X-linked inhibitor of apoptosis protein (XIAP) or the BIR1/BIR2 domains of XIAP, failed to cleave Bid in response to genotoxic stress. These data suggest that tBid plays an important regulatory role in the execution of DNA damage-induced cytochrome c release and apoptosis. However, the fact that cleavage of Bid to tBid is mediated by executioner caspases suggests that a self-amplifying feed forward loop involving caspases, Bid, and mitochondria may help determine irreversible commitment to apoptosis.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647, P20 RR016443]; National Center for Research Resources [T32 ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647, T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 (to J.D.R.), P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources, and T32 ES007079. The Flow Cytometry Core is supported in part by NIH Grant P20 RR016443 from the NCRR.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Petak I, 2000, CANCER RES, V60, P2643; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	49	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11247	11255		10.1074/jbc.M809392200	http://dx.doi.org/10.1074/jbc.M809392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19233849	Green Published, hybrid			2022-12-27	WOS:000265494500028
J	Tsoi, BM; Beckhouse, AG; Gelling, CL; Raftery, MJ; Chiu, J; Tsoi, AM; Lauterbach, L; Rogers, PJ; Higgins, VJ; Dawes, IW				Tsoi, Bonny M.; Beckhouse, Anthony G.; Gelling, Cristy L.; Raftery, Mark J.; Chiu, Joyce; Tsoi, Abraham M.; Lauterbach, Lars; Rogers, Peter J.; Higgins, Vincent J.; Dawes, Ian W.			Essential Role of One-carbon Metabolism and Gcn4p and Bas1p Transcriptional Regulators during Adaptation to Anaerobic Growth of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; CHEMOSTAT CULTURES; MANNOPROTEIN GENES; YEAST; PROTEIN; IDENTIFICATION; EXPRESSION; GLYCINE	The transcriptional activator Gcn4p is considered the master regulator of amino acid metabolism in Saccharomyces cerevisiae and is required for the transcriptional response to amino acid starvation. Here it is shown that Gcn4p plays a previously undescribed role in regulating adaptation to anaerobic growth. A gcn4 mutant exhibited a highly extended lag phase after a shift to anaerobiosis that was the result of L-serine depletion. In addition, the one-carbon metabolism and purine biosynthesis transcriptional regulator Bas1p were strictly required for anaerobic growth on minimal medium, and this was similarly due to L-serine limitation in bas1 mutants. The induction of one-carbon metabolism during anaerobiosis is needed to increase the supply of L-serine from the glycine and threonine pathways. Using a number of experimental approaches, we demonstrate that these transcription regulators play vital roles in regulating L-serine biosynthesis in the face of increased demand during adaptation to anaerobiosis. This increased L-serine requirement is most likely due to anaerobic remodeling of the cell wall, involving de novo synthesis of a large number of very serine-rich mannoproteins and an increase in the total serine content of the cell wall. During anaerobic starvation for L-serine, this essential amino acid is preferentially directed to the cell wall, indicating the existence of a regulatory mechanism to balance competing cellular demands.	[Tsoi, Bonny M.; Beckhouse, Anthony G.; Gelling, Cristy L.; Chiu, Joyce; Tsoi, Abraham M.; Lauterbach, Lars; Dawes, Ian W.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Raftery, Mark J.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Tsoi, Bonny M.; Higgins, Vincent J.] Univ Western Sydney, Sch Biomed & Hlth Sci, Penrith, NSW 1791, Australia; [Rogers, Peter J.] Fosters Grp Ltd, Abbotsford 3067, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Western Sydney University	Dawes, IW (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Beckhouse, Anthony G/A-2601-2010; Lauterbach, Lars/L-6671-2014; Chiu, Joyce/H-7772-2017	Beckhouse, Anthony G/0000-0002-5141-8250; Lauterbach, Lars/0000-0002-6601-6473; Chiu, Joyce/0000-0001-8910-8664	Australian Research Council; Australian Research Council Postgraduate Awards	Australian Research Council(Australian Research Council); Australian Research Council Postgraduate Awards(Australian Research Council)	This work was supported by Linkage and Discovery Grants from the Australian Research Council (to I. W. D., V. J. H., and P. J. R.) and by Australian Research Council Postgraduate Awards (to B. M. T., C. L. G., A. M. T., and A. G. B.).	Abramova N, 2001, J BACTERIOL, V183, P2881, DOI 10.1128/JB.183.9.2881-2887.2001; Abramova NE, 2001, GENETICS, V157, P1169; Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; Alic N, 2004, FREE RADICAL BIO MED, V37, P23, DOI 10.1016/j.freeradbiomed.2004.04.014; BECKHOUSE AG, 2006, THESIS U NEW S WALES; Beckhouse AG, 2008, FEMS YEAST RES, V8, P1214, DOI 10.1111/j.1567-1364.2008.00439.x; Cohen BD, 2001, NUCLEIC ACIDS RES, V29, P799, DOI 10.1093/nar/29.3.799; Cook RJ, 2000, AM J CLIN NUTR, V72, P1419; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; de Groot MJL, 2007, MICROBIOL-SGM, V153, P3864, DOI 10.1099/mic.0.2007/009969-0; Denis V, 1998, MOL GEN GENET, V259, P246, DOI 10.1007/s004380050810; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Gelling C. L., 2008, THESIS U NEW S WALES; Gelling CL, 2004, J BIOL CHEM, V279, P7072, DOI 10.1074/jbc.M309178200; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HERMANN H, 1992, GENE, V119, P137, DOI 10.1016/0378-1119(92)90079-5; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hong SP, 1999, J BIOL CHEM, V274, P10523, DOI 10.1074/jbc.274.15.10523; Horie T, 2001, YEAST, V18, P1493, DOI 10.1002/yea.790; Kitagaki H, 1997, EUR J BIOCHEM, V249, P343, DOI 10.1111/j.1432-1033.1997.t01-1-00343.x; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; KONDO K, 1991, J BIOL CHEM, V266, P17537; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Lai LC, 2005, MOL CELL BIOL, V25, P4075, DOI 10.1128/MCB.25.10.4075-4091.2005; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; Piper MDW, 2002, FEMS YEAST RES, V2, P59, DOI 10.1016/S1567-1356(01)00061-7; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Rosenfeld E, 2003, YEAST, V20, P1115, DOI 10.1002/yea.1026; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Sood R, 2000, GENETICS, V154, P787; STOVER P, 1991, J BIOL CHEM, V266, P1543; Subramanian M, 2005, MOL MICROBIOL, V57, P53, DOI 10.1111/j.1365-2958.2005.04663.x; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; Wiebe MG, 2008, FEMS YEAST RES, V8, P140, DOI 10.1111/j.1567-1364.2007.00234.x; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11205	11215		10.1074/jbc.M809225200	http://dx.doi.org/10.1074/jbc.M809225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19224916	hybrid, Green Published			2022-12-27	WOS:000265494500024
J	Boesze-Battaglia, K; Brown, A; Walker, L; Besack, D; Zekavat, A; Wrenn, S; Krummenacher, C; Shenker, BJ				Boesze-Battaglia, Kathleen; Brown, Angela; Walker, Lisa; Besack, Dave; Zekavat, Ali; Wrenn, Steve; Krummenacher, Claude; Shenker, Bruce J.			Cytolethal Distending Toxin-induced Cell Cycle Arrest of Lymphocytes Is Dependent upon Recognition and Binding to Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; LIPID RAFTS; G(2) ARREST; 3 SUBUNITS; CDTB; PROTEIN; IDENTIFICATION; APOPTOSIS; SHIGELLA; SEQUENCE	Induction of cell cycle arrest in lymphocytes after exposure to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is dependent upon the integrity of lipid membrane microdomains. In this study we further demonstrate that the association of Cdt with lymphocyte plasma membranes is dependent upon binding to cholesterol. Depletion of cholesterol resulted in reduced toxin binding, whereas repletion of cholesterol-depleted cells restored binding. We employed fluorescence resonance energy transfer and surface plasmon resonance to demonstrate that toxin association with model membranes is dependent upon the concentration of cholesterol; moreover, these interactions were cholesterol-specific as the toxin failed to interact with model membranes containing stigmasterol, ergosterol, or lanosterol. Further analysis of the toxin indicated that the CdtC subunit contains a cholesterol recognition/interaction amino acid consensus (CRAC) region. Mutation of the CRAC site resulted in decreased binding of the holotoxin to cholesterol-containing model membranes as well as to the surface of Jurkat cells. The mutant toxin also exhibited reduced capacity for intracellular transfer of the active toxin subunit, CdtB, as well as reduced toxicity. Collectively, these observations indicate that membrane cholesterol serves as an essential ligand for Cdt and that this association can be blocked by either depleting membranes of cholesterol or mutation of the CRAC site.	[Brown, Angela; Walker, Lisa; Besack, Dave; Zekavat, Ali; Shenker, Bruce J.] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA; [Boesze-Battaglia, Kathleen; Krummenacher, Claude] Univ Penn, Dept Biochem, Sch Dent Med, Philadelphia, PA 19104 USA; [Wrenn, Steve] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Shenker, BJ (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, 240 S 40th St, Philadelphia, PA 19104 USA.	shenker@pobox.upenn.edu		Krummenacher, Claude/0000-0002-3492-4987	USPHS [DE06014]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY010420, R21EY018705, R01EY010420] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant DE06014 from the USPHS.	Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; De Rycke J, 2001, FEMS MICROBIOL LETT, V203, P141, DOI 10.1016/S0378-1097(01)00344-5; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Dlakic M, 2001, Science, V291, P547; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; LAFKOWICZ J, 1999, PRINCIPLES FLUORESCE, P345; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lencer WI, 2001, AM J PHYSIOL-GASTR L, V280, pG781, DOI 10.1152/ajpgi.2001.280.5.G781; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Ohara M, 2004, INFECT IMMUN, V72, P871, DOI 10.1128/IAI.72.2.871-879.2004; Okuda J, 1997, INFECT IMMUN, V65, P428, DOI 10.1128/IAI.65.2.428-433.1997; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; SHENKER B, 1976, J IMMUNOL METHODS, V13, P161, DOI 10.1016/0022-1759(76)90154-X; Shenker BJ, 2006, INFECT IMMUN, V74, P2080, DOI 10.1128/IAI.74.4.2080-2092.2006; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506	49	60	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10650	10658		10.1074/jbc.M809094200	http://dx.doi.org/10.1074/jbc.M809094200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240023	Green Published, hybrid			2022-12-27	WOS:000265104600039
J	McNutt, MC; Kwon, HJ; Chen, CY; Chen, JR; Horton, JD; Lagace, TA				McNutt, Markey C.; Kwon, Hyock Joo; Chen, Chiyuan; Chen, Justin R.; Horton, Jay D.; Lagace, Thomas A.			Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED ENDOCYTOSIS; MOLECULAR-BASIS; GENE; MUTATIONS; BINDING; MUTANTS; IDENTIFICATION; DEGRADATION	PCSK9 is a secreted protein that degrades low density lipoprotein receptors (LDLRs) in liver by binding to the epidermal growth factor-like repeat A (EGF-A) domain of the LDLR. It is not known whether PCSK9 causes degradation of LDLRs within the secretory pathway or following secretion and reuptake via endocytosis. Here we show that a mutation in the LDLR EGF-A domain associated with familial hypercholesterolemia, H306Y, results in increased sensitivity to exogenous PCSK9-mediated cellular degradation because of enhanced PCSK9 binding affinity. The crystal structure ofthePCSK9-EGF-A(H306Y) complex shows that Tyr-306 forms a hydrogen bond with Asp-374 in PCSK9 at neutral pH, which strengthens the interaction with PCSK9. To block secreted PCSK9 activity, LDLR (H306Y) subfragments were added to the medium of HepG2 cells stably overexpressing wild-type PCSK9 or gain-of-function PCSK9 mutants associated with hypercholesterolemia (D374Y or S127R). These subfragments blocked secreted PCSK9 binding to cell surface LDLRs and resulted in the recovery of LDLR levels to those of control cells. We conclude that PCSK9 acts primarily as a secreted factor to cause LDLR degradation. These studies support the concept that pharmacological inhibition of the PCSK9-LDLR interaction extracellularly will increase hepatic LDLR expression and lower plasma low density lipoprotein levels.	[McNutt, Markey C.; Chen, Chiyuan; Chen, Justin R.; Horton, Jay D.; Lagace, Thomas A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kwon, Hyock Joo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Horton, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jay.horton@utsouthwestern.edu			National Institutes of Health [HL-38049, HL-20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038049, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK066141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-38049 and HL-20948 (to J.D.H.). This work was also supported by The Perot Family Foundation.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1974, J BIOL CHEM, V249, P789; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Day INM, 1997, HUM MUTAT, V10, P116; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Homer VM, 2008, ATHEROSCLEROSIS, V196, P659, DOI 10.1016/j.atherosclerosis.2007.07.022; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lambert G, 2008, CLIN CHEM, V54, P1038, DOI 10.1373/clinchem.2007.099747; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	47	127	179	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10561	10570		10.1074/jbc.M808802200	http://dx.doi.org/10.1074/jbc.M808802200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224862	hybrid, Green Published			2022-12-27	WOS:000265104600030
J	Quintero-Monzon, O; Jonasson, EM; Bertling, E; Talarico, L; Chaudhry, F; Sihvo, M; Lappalainen, P; Goode, BL				Quintero-Monzon, Omar; Jonasson, Erin M.; Bertling, Enni; Talarico, Lou; Chaudhry, Faisal; Sihvo, Maarit; Lappalainen, Pekka; Goode, Bruce L.			Reconstitution and Dissection of the 600-kDa Srv2/CAP Complex ROLES FOR OLIGOMERIZATION AND COFILIN-ACTIN BINDING IN DRIVING ACTIN TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ASSOCIATED PROTEIN; N-TERMINAL DOMAIN; CEREVISIAE ADENYLYL CYCLASE; DICTYOSTELIUM-DISCOIDEUM; FILAMENT TURNOVER; PORCINE BRAIN; ADP-ACTIN; CAP; YEAST; MECHANISM	Srv2/cyclase-associated protein is expressed in virtually all plant, animal, and fungal organisms and has a conserved role in promoting actin depolymerizing factor/cofilin-mediated actin turnover. This is achieved by the abilities of Srv2 to recycle cofilin from ADP-actin monomers and to promote nucleotide exchange (ATP for ADP) on actin monomers. Despite this important and universal role in facilitating actin turnover, the mechanism underlying Srv2 function has remained elusive. Previous studies have demonstrated a critical functional role for the G-actin-binding C-terminal half of Srv2. Here we describe an equally important role in vivo for the N-terminal half of Srv2 in driving actin turnover. We pinpoint this activity to a conserved patch of surface residues on the N-terminal dimeric helical folded domain of Srv2, and we show that this functional site interacts with cofilin-actin complexes. Furthermore, we show that this site is essential for Srv2 acceleration of cofilin-mediated actin turnover in vitro. A cognate Srv2-binding site is identified on a conserved surface of cofilin, suggesting that this function likely extends to other organisms. In addition, our analyses reveal that higher order oligomerization of Srv2 depends on its N-terminal predicted coiled coil domain and that oligomerization optimizes Srv2 function in vitro and in vivo. Based on these data, we present a revised model for the mechanism by which Srv2 promotes actin turnover, in which coordinated activities of its N- and C-terminal halves catalyze sequential steps in recycling cofilin and actin monomers.	[Quintero-Monzon, Omar; Jonasson, Erin M.; Talarico, Lou; Chaudhry, Faisal; Goode, Bruce L.] Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Bertling, Enni; Sihvo, Maarit; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland	Brandeis University; University of Helsinki	Goode, BL (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	goode@brandeis.edu		Lappalainen, Pekka/0000-0001-6227-0354	National Institutes of Health [GM63691]; Academy of Finland and Sigrid Juselius Foundation; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, T32GM007596, R01GM063691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland and Sigrid Juselius Foundation(Academy of Finland); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63691 (to B. G.). This work was also supported by grants from the Academy of Finland and Sigrid Juselius Foundation (to P. L.) and from the American Cancer Society.	Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chaudhry F, 2007, MOL BIOL CELL, V18, P3002, DOI 10.1091/mbc.E06-11-1041; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harlow E., 1988, USING ANTIBODIES LAB; Hubberstey A, 1996, J CELL BIOCHEM, V61, P459, DOI 10.1002/(SICI)1097-4644(19960601)61:3<459::AID-JCB13>3.0.CO;2-E; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Ksiazek D, 2003, STRUCTURE, V11, P1171, DOI 10.1016/S0969-2126(03)00180-1; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Mavoungou C, 2004, J BIOMOL NMR, V29, P73, DOI 10.1023/B:JNMR.0000019513.86120.98; Moriyama K, 2002, J CELL SCI, V115, P1591; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Nishida Y, 1998, J BIOL CHEM, V273, P28019, DOI 10.1074/jbc.273.43.28019; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Quintero-Monzon O, 2005, MOL BIOL CELL, V16, P3128, DOI 10.1091/mbc.E05-01-0059; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; WANG J, 1992, MOL CELL BIOL, V12, P4937, DOI 10.1128/MCB.12.11.4937; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; Yu J, 1999, J BIOL CHEM, V274, P19985, DOI 10.1074/jbc.274.28.19985; Yusof AM, 2005, PROTEINS, V58, P255, DOI 10.1002/prot.20314; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243	44	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10923	10934		10.1074/jbc.M808760200	http://dx.doi.org/10.1074/jbc.M808760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19201756	Green Published, hybrid			2022-12-27	WOS:000265104600065
J	Ratovitski, T; Gucek, M; Jiang, HB; Chighladze, E; Waldron, E; D'Ambola, J; Hou, ZP; Liang, YD; Poirier, MA; Hirschhorn, RR; Graham, R; Hayden, MR; Cole, RN; Ross, CA				Ratovitski, Tamara; Gucek, Marjan; Jiang, Haibing; Chighladze, Ekaterine; Waldron, Elaine; D'Ambola, James; Hou, Zhipeng; Liang, Yideng; Poirier, Michelle A.; Hirschhorn, Ricky R.; Graham, Rona; Hayden, Michael R.; Cole, Robert N.; Ross, Christopher A.			Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE CLEAVAGE; TRANSGENIC MICE; INTRANUCLEAR INCLUSIONS; PALLIDOLUYSIAN ATROPHY; DEPENDENT PROTEOLYSIS; REDUCES TOXICITY; REPEAT LENGTH; MU-CALPAIN; WILD-TYPE; IN-VIVO	Huntingtin proteolysis is implicated in Huntington disease pathogenesis, yet, the nature of huntingtin toxic fragments remains unclear. Huntingtin undergoes proteolysis by calpains and caspases within an N-terminal region between amino acids 460 and 600. We have focused on proteolytic steps producing shorter N-terminal fragments, which we term cp-1 and cp-2 (distinct from previously described cp-A/cp-B). We used HEK293 cells to express the first 511 residues of huntingtin and further define the cp-1 and cp-2 cleavage sites. Based on epitope mapping with huntingtin-specific antibodies, we found that cp-1 cleavage occurs between residues 81 and 129 of huntingtin. Affinity and size exclusion chromatography were used to further purify huntingtin cleavage products and enrich for the cp-1/cp-2 fragments. Using mass spectrometry, we found that the cp-2 fragment is generated by cleavage of huntingtin at position Arg(167). This site was confirmed by deletion analysis and specific detection with a custom-generated cp-2 site neo-epitope antibody. Furthermore, alterations of this cleavage site resulted in a decrease in toxicity and an increase in aggregation of huntingtin in neuronal cells. These data suggest that cleavage of huntingtin at residue Arg(167) may mediate mutant huntingtin toxicity in Huntington disease.	[Ratovitski, Tamara; Jiang, Haibing; Chighladze, Ekaterine; Waldron, Elaine; D'Ambola, James; Hou, Zhipeng; Liang, Yideng; Poirier, Michelle A.; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Psychiat, Baltimore, MD 21287 USA; [Gucek, Marjan; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Cellular & Mol Med, Baltimore, MD 21287 USA; [Hirschhorn, Ricky R.] Hood Coll, Dept Biol, Frederick, MD 21701 USA; [Graham, Rona; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Child & Family Research Institute; University of British Columbia	Ratovitski, T (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Psychiat, Baltimore, MD 21287 USA.	tratovi1@jhmi.edu; caross@jhu.edu	Graham, Rona K/R-7358-2018; Ross, Christopher A/H-8395-2013; Hayden, Michael R/D-8581-2011	Graham, Rona K/0000-0003-3722-6241; Hayden, Michael R/0000-0001-5159-1419	National Institutes of Health [16375]; NINDS [NS038144-08]; Huntington Disease Society of America Coalition for the Cure,; High Q Foundation; Canadian Institutes of Health Research, and the HSC (Huntington Society of Canada); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Huntington Disease Society of America Coalition for the Cure,; High Q Foundation; Canadian Institutes of Health Research, and the HSC (Huntington Society of Canada)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 16375 from the NINDS and NS038144-08. This work was also supported by the Huntington Disease Society of America Coalition for the Cure, High Q Foundation, Canadian Institutes of Health Research, and the HSC (Huntington Society of Canada).	Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bizat N, 2003, J NEUROSCI, V23, P5020; Coombe DR, 1998, J IMMUNOL METHODS, V215, P145, DOI 10.1016/S0022-1759(98)00081-7; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kim M, 1999, J NEUROSCI, V19, P964; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wen Y, 2000, CANCER RES, V60, P6841; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	43	104	105	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10855	10867		10.1074/jbc.M804813200	http://dx.doi.org/10.1074/jbc.M804813200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19204007	hybrid, Green Published			2022-12-27	WOS:000265104600059
J	Yoon, YS; Seo, WY; Lee, MW; Kim, ST; Koo, SH				Yoon, Young-Sil; Seo, Woo-Young; Lee, Min-Woo; Kim, Seong-Tae; Koo, Seung-Hoi			Salt-inducible Kinase Regulates Hepatic Lipogenesis by Controlling SREBP-1c Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY LIVER-DISEASE; ELEMENT-BINDING PROTEIN-1; CREB COACTIVATOR TORC2; GENE-EXPRESSION; RAT-LIVER; ACID SYNTHASE; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL CONTROL; MESSENGER-RNA	Liver plays a major role in regulating energy homeostasis in mammals. During feeding conditions, excessive glucose is converted into a preferred storage form of energy sources as triacylglycerol in liver via a collective metabolic pathway termed lipogenesis. Sterol regulatory element-binding protein 1c is a master regulator for this process by activating number of enzyme genes, such as Fasn or Acaca, that are involved in this pathway at the transcriptional level. Here we show that the salt-inducible kinase (SIK) family of proteins regulates the hepatic lipogenesis by modulating SREBP-1c activity. Overexpression of SIK1 inhibits hepatic expression of lipogenic genes, such as Fasn, whereas knockdown of SIK1 in liver greatly enhances their expression. Regulation of the Fasn gene by SIK kinases is mediated at the level of transcription via phosphorylation and inactivation of nuclear SREBP-1c. Among candidate sites for SIK-dependent regulation of SREBP-1c, the serine 329 residue is shown to be a critical regulatory site for SIK-mediated repression of SREBP-1c activity by in vitro kinase assay and reverse transcription-PCR analysis in primary hepatocytes. Finally, reduced hepatic triacylglycerol levels and lipogenic gene expression by adenoviral SIK1 transgenic expression are restored to normal levels by co-infection of mutant SREBP-1c, suggesting that SIK-dependent regulation of hepatic lipogenesis is indeed mediated through the phosphorylation of SREBP-1c in vivo. The process for the development of nonalcoholic fatty liver involves de novo lipogenesis via the activation of SREBP-1c. Modulation of SREBP-1c activity by SIK proteins would provide an attractive means for the regulation of such diseases.	[Yoon, Young-Sil; Seo, Woo-Young; Lee, Min-Woo; Kim, Seong-Tae; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU)	Koo, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, 300 Chunchun Dong, Suwon 440746, Gyeonggi Do, South Korea.	shkoo@med.skku.ac.kr	Kim, Seong-Tae/A-9917-2013; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	Research Program for New Drug Target Discovery [M10648000089-08N4800-08910]; Korea Science and Engineering Foundation [R01-2008-000-11935-0]; Ministry of Education, Science and Technology [2006-E00037]; Ministry of Land, Transport, and Maritime Affairs, Republic of Korea	Research Program for New Drug Target Discovery(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Land, Transport, and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea)	This work was supported by Research Program for New Drug Target Discovery Grant M10648000089-08N4800-08910, Korea Science and Engineering Foundation Grant R01-2008-000-11935-0, and Korea Research Foundation Grant 2006-E00037 from the Ministry of Education, Science and Technology and a grant from the Marine Biotechnology Program funded by the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Clarke SD, 1996, J NUTR, V126, pS1105, DOI 10.1093/jn/126.suppl_4.1105S; CLARKE SD, 1990, J NUTR, V120, P218, DOI 10.1093/jn/120.2.218; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; CUIF MH, 1992, MOL CELL BIOL, V12, P4852, DOI 10.1128/MCB.12.11.4852; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; IYNEDJIAN PB, 1987, J BIOL CHEM, V262, P6032; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Kohjima M, 2008, INT J MOL MED, V21, P507; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; MINDEROP RH, 1987, EUR J BIOCHEM, V164, P181, DOI 10.1111/j.1432-1033.1987.tb11009.x; Morais ADS, 2009, J HEPATOL, V50, P489, DOI 10.1016/j.jhep.2008.10.027; Nakamuta M, 2005, INT J MOL MED, V16, P631; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; VAULONT S, 1986, J BIOL CHEM, V261, P7621; VAULONT S, 1994, FASEB J, V8, P28, DOI 10.1096/fasebj.8.1.8299888; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	43	43	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10446	10452		10.1074/jbc.M900096200	http://dx.doi.org/10.1074/jbc.M900096200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244231	Green Published, hybrid			2022-12-27	WOS:000265104600018
J	Andersen, J; Taboureau, O; Hansen, KB; Olsen, L; Egebjerg, J; Stromgaard, K; Kristensen, AS				Andersen, Jacob; Taboureau, Olivier; Hansen, Kasper B.; Olsen, Lars; Egebjerg, Jan; Stromgaard, Kristian; Kristensen, Anders S.			Location of the Antidepressant Binding Site in the Serotonin Transporter IMPORTANCE OF SER-438 IN RECOGNITION OF CITALOPRAM AND TRICYCLIC ANTIDEPRESSANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIES-SCANNING MUTAGENESIS; HIGH-AFFINITY RECOGNITION; TRANSMEMBRANE DOMAIN-I; NEUROTRANSMITTER TRANSPORTERS; 5-HYDROXYTRYPTAMINE UPTAKE; SUBSTRATE RECOGNITION; IMIPRAMINE-BINDING; BACTERIAL HOMOLOG; ACCURATE DOCKING; AMINO-ACID	The serotonin transporter (SERT) regulates extracellular levels of serotonin (5-hydroxytryptamine, 5HT) in the brain by transporting 5HT into neurons and glial cells. The human SERT (hSERT) is the primary target for drugs used in the treatment of emotional disorders, including depression. hSERT belongs to the solute carrier 6 family that includes a bacterial leucine transporter (LeuT), for which a high resolution crystal structure has become available. LeuT has proved to be an excellent model for human transporters and has advanced the understanding of solute carrier 6 transporter structure-function relationships. However, the precise structural mechanism by which antidepressants inhibit hSERT and the location of their binding pockets are still elusive. We have identified a residue (Ser-438) located within the 5HT-binding pocket in hSERT to be a critical determinant for the potency of several antidepressants, including the selective serotonin reuptake inhibitor citalopram and the tricyclic antidepressants imipramine, clomipramine, and amitriptyline. A conservative mutation of Ser-438 to threonine (S438T) selectively increased the K-i values for these antidepressants up to 175-fold. The effects of introducing a protein methyl group into the 5HT-binding pocket by S438T were absent or reduced for analogs of these antidepressants lacking a single methyl group. This suggests that these antidepressants interact directly with Ser-438 during binding to hSERT, implying an overlapping localization of substrate- and inhibitor-binding sites in hSERT suggesting that antidepressants function by a mechanism that involves direct occlusion of the 5HT-binding site.	[Andersen, Jacob; Taboureau, Olivier; Olsen, Lars; Stromgaard, Kristian; Kristensen, Anders S.] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Taboureau, Olivier] Tech Univ Denmark, BioCentrum DTU, DK-2800 Lyngby, Denmark; [Hansen, Kasper B.; Egebjerg, Jan] H Lundbeck & Co AS, Lundbeck Res Denmark, DK-2500 Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Lundbeck Corporation	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Med Chem, Univ Parken 2, DK-2100 Copenhagen, Denmark.	krst@farma.ku.dk; ask@farma.ku.dk	Andersen, Jacob/B-7768-2016; Olsen, Lars/AAY-8278-2020; Hansen, Kasper B/C-4062-2008; Olsen, Lars/C-9706-2010; Stromgaard, Kristian/E-3380-2010; Kristensen, Anders Skov/B-4414-2009	Andersen, Jacob/0000-0002-8067-3074; Hansen, Kasper B/0000-0002-3303-4819; Kristensen, Anders Skov/0000-0001-8955-6790; Olsen, Lars/0000-0002-7607-7130; Stromgaard, Kristian/0000-0003-2206-4737	Carlsberg Foundation; Danish Medical Research Council; Lundbeck Foundation; Danish Council for Strategic Research NABIIT Programme; Drug Research Academy	Carlsberg Foundation(Carlsberg Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research NABIIT Programme(Danske Strategiske Forskningsrad (DSF)); Drug Research Academy	This work was supported by the Carlsberg Foundation and the Danish Medical Research Council (to L. O.), the Lundbeck Foundation (to K. B. H.), the Danish Council for Strategic Research NABIIT Programme (to O. T.), and the Drug Research Academy (to J. A.).	Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; ANDERSEN J, 2007, SOC NEUR ABSTR, V248, P15; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1996, MOL PHARMACOL, V50, P957; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GRAHAM D, 1989, BIOCHEM PHARMACOL, V38, P3819, DOI 10.1016/0006-2952(89)90591-1; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, NEURON, V49, P791, DOI 10.1016/j.neuron.2006.03.002; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; HUMPHREYS CJ, 1988, MOL PHARMACOL, V33, P657; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; Larsen MB, 2004, J BIOL CHEM, V279, P42147, DOI 10.1074/jbc.M405579200; MARCUSSON JO, 1986, MOL PHARMACOL, V30, P121; Mortensen OV, 2001, J NEUROCHEM, V79, P237, DOI 10.1046/j.1471-4159.2001.00587.x; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Rudnick G, 2007, ACS CHEM BIOL, V2, P606, DOI 10.1021/cb7001818; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sur C, 1997, P NATL ACAD SCI USA, V94, P7639, DOI 10.1073/pnas.94.14.7639; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; WENNOGLE LP, 1982, EUR J PHARMACOL, V86, P303, DOI 10.1016/0014-2999(82)90333-8; Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	43	93	93	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10276	10284		10.1074/jbc.M806907200	http://dx.doi.org/10.1074/jbc.M806907200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19213730	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000264892900069
J	Chang, KY; Shen, MR; Lee, MY; Wang, WL; Su, WC; Chang, WC; Chen, BK				Chang, Kwang-Yu; Shen, Meng-Ru; Lee, Mei-Yi; Wang, Wen-Lin; Su, Wu-Chou; Chang, Wen-Chang; Chen, Ben-Kuen			Epidermal Growth Factor-activated Aryl Hydrocarbon Receptor Nuclear Translocator/HIF-1 beta Signal Pathway Up-regulates Cyclooxygenase-2 Gene Expression Associated with Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; LUNG-CANCER; CERVICAL-CANCER; POOR SURVIVAL; VASCULAR ENDOTHELIUM; TUMOR ANGIOGENESIS; BINDING PROTEINS; A431 CELLS; PHASE-II; C-JUN	Hypoxia-inducible factor (HIF) accumulates when tumors grow under hypoxic conditions. The genesis of tumors, however, usually involves normoxic conditions. In this study, we were interested in examining the potential role of aryl hydrocarbon receptor nuclear translocator (ARNT)/HIF-1 beta in tumor growth under normoxic conditions, specifically when cells are treated with epidermal growth factor (EGF),which is known to affect the gene expression of tumor growth-related protein COX-2 (cyclooxygenase-2). The results showed that EGF receptor inhibitor, AG1478, abolished EGF-induced nuclear accumulation of ARNT as well as the expression of COX-2. ARNT small interfering RNA inhibited the promoter activity, mRNA level, and protein expression of COX-2 in cells treated with EGF. In contrast, CoCl2-induced HIF-1 beta exhibited no effect on COX-2 expression. EGF also stimulated the formation of the ARNT.c-Jun complex as well as the complex binding to the COX-2 promoter. ARNT small interfering RNAs blocked EGF-activated cell migration. Moreover, COX-2 and ARNT were cohorts present distinctively in clinical specimens of human cervical squamous cell carcinoma and were almost nondetectable in adjacent normal or noncancerous cervical tissues. Our results revealed that ARNT plays an important role in EGF-regulated COX-2 gene expression and may thus be related to either a cause or a consequence of tumorigenesis in cervical cancer.	[Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Shen, Meng-Ru] Natl Cheng Kung Univ, Dept Obstet & Gynecol, Tainan 701, Taiwan; [Shen, Meng-Ru; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 701, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct, Tainan 701, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biosignal Transduct, Tainan 701, Taiwan; [Chang, Kwang-Yu; Su, Wu-Chou] Natl Cheng Kung Univ, Dept Internal Med, Tainan 701, Taiwan; [Chang, Kwang-Yu] Natl Inst Canc Res, Natl Hlth Res Inst, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan	Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan.	bkchen58@mail.ncku.edu.tw	Chang, Kwang-Yu/G-9161-2011	Su, Wu-Chou/0000-0003-2953-4105	National Science Council of the Republic of China [NSC 95-2320-B-006-071-MY2]; National Cheng Kung University Project of Promoting Academic Excellence and Developing World- Class Research Centers	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Cheng Kung University Project of Promoting Academic Excellence and Developing World- Class Research Centers	This work was supported in part by National Science Council of the Republic of China Grant NSC 95-2320-B-006-071-MY2 and by the National Cheng Kung University Project of Promoting Academic Excellence and Developing World- Class Research Centers.	Agarwala A, 2008, J THORAC ONCOL, V3, P374, DOI 10.1097/JTO.0b013e3181693869; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chang JHT, 2007, CLIN CANCER RES, V13, P38, DOI 10.1158/1078-0432.CCR-06-1166; Chen HHW, 2005, INT J RADIAT ONCOL, V63, P1093, DOI 10.1016/j.ijrobp.2005.03.062; Chen LC, 2005, MOL PHARMACOL, V67, P2057, DOI 10.1124/mol.104.010900; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Csiki I, 2006, CANCER RES, V66, P143, DOI 10.1158/0008-5472.CAN-05-1357; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Gadgeel SM, 2007, J THORAC ONCOL, V2, P299, DOI 10.1097/01.JTO.0000263712.61697.69; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Half E, 2002, CANCER RES, V62, P1676; Itoh S, 2003, ORAL ONCOL, V39, P829, DOI 10.1016/S1368-8375(03)00105-2; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim GE, 2004, CLIN CANCER RES, V10, P1366, DOI 10.1158/1078-0432.CCR-0497-03; Konturek SJ, 2005, J PHYSIOL PHARMACOL, V56, P507; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Liu YW, 1997, BIOCHEM J, V324, P133, DOI 10.1042/bj3240133; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Reckamp KL, 2006, CLIN CANCER RES, V12, P3381, DOI 10.1158/1078-0432.CCR-06-0112; Richardson CM, 2005, LUNG CANCER, V48, P47, DOI 10.1016/j.lungcan.2004.09.007; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Subbaramaiah K, 2008, J BIOL CHEM, V283, P33955, DOI 10.1074/jbc.M805490200; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Wirth LJ, 2005, J CLIN ONCOL, V23, P6976, DOI 10.1200/JCO.2005.02.4182; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhong H, 2000, CANCER RES, V60, P1541; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	49	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9908	9916		10.1074/jbc.M806210200	http://dx.doi.org/10.1074/jbc.M806210200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203995	Green Published, hybrid			2022-12-27	WOS:000264892900033
J	Funke, T; Yang, Y; Han, H; Healy-Fried, M; Olesen, S; Becker, A; Schonbrunn, E				Funke, Todd; Yang, Yan; Han, Huijong; Healy-Fried, Martha; Olesen, Sanne; Becker, Andreas; Schoenbrunn, Ernst			Structural Basis of Glyphosate Resistance Resulting from the Double Mutation Thr(97) -> Ile and Pro(101) -> Ser in 5-Enolpyruvylshikimate-3-phosphate Synthase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHEDRAL REACTION INTERMEDIATE; KLEBSIELLA-PNEUMONIAE; HERBICIDE GLYPHOSATE; 3-PHOSPHATE SYNTHASE; CONFERS RESISTANCE; SHIKIMATE PATHWAY; SUBSTITUTION; INHIBITION; IDENTIFICATION; MECHANISMS	The shikimate pathway enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) is the target of the broad spectrum herbicide glyphosate. The genetic engineering of EPSPS led to the introduction of glyphosate-resistant crops worldwide. The genetically engineered corn lines NK603 and GA21 carry distinct EPSPS enzymes. CP4 EPSPS, expressed in NK603 corn and transgenic soybean, cotton, and canola, belongs to class II EPSPS, glyphosate-insensitive variants of this enzyme isolated from certain Gram-positive bacteria. GA21 corn, on the other hand, was created by point mutations of class I EPSPS, such as the enzymes from Zea mays or Escherichia coli, which are sensitive to low glyphosate concentrations. The structural basis of the glyphosate resistance resulting from these point mutations has remained obscure. We studied the kinetic and structural effects of the T97I/P101S double mutation, the molecular basis for GA21 corn, using EPSPS from E. coli. The T97I/P101S enzyme is essentially insensitive to glyphosate (K-i = 2.4 mM) but maintains high affinity for the substrate phosphoenolpyruvate (PEP) (K-m = 0.1 mM). The crystal structure at 1.7-angstrom resolution revealed that the dual mutation causes a shift of residue Gly(96) toward the glyphosate binding site, impairing efficient binding of glyphosate, while the side chain of Ile(97) points away from the substrate binding site, facilitating PEP utilization. The single site T97I mutation renders the enzyme sensitive to glyphosate and causes a substantial decrease in the affinity for PEP. Thus, only the concomitant mutations of Thr(97) and Pro(101) induce the conformational changes necessary to produce catalytically efficient, glyphosate-resistant class I EPSPS.	[Yang, Yan; Han, Huijong; Olesen, Sanne; Becker, Andreas; Schoenbrunn, Ernst] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Funke, Todd; Healy-Fried, Martha; Schoenbrunn, Ernst] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	H Lee Moffitt Cancer Center & Research Institute; University of Kansas	Schonbrunn, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	ernst.schonbrunn@moffitt.org		Han, Huijong/0000-0002-1197-3014; Schonbrunn, Ernst/0000-0002-3589-3510	National Institutes of Health (NIH) [5R01GM070633]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008545, R01GM070633] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant 5R01GM070633.	ALBERG DG, 1992, J AM CHEM SOC, V114, P3535, DOI 10.1021/ja00035a058; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; BOOCOCK MR, 1983, FEBS LETT, V154, P127, DOI 10.1016/0014-5793(83)80888-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; Dill GM, 2008, PEST MANAG SCI, V64, P326, DOI 10.1002/ps.1501; Du WS, 2000, BIOCHEMISTRY-US, V39, P10140, DOI 10.1021/bi000890v; Eichholtz D.A., 2001, U.S. Patent, Patent No. 6225114; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Eschenburg S, 2003, J BIOL CHEM, V278, P49215, DOI 10.1074/jbc.M309741200; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANZ JE, 1997, GLYPHOSATE UNIQUE GL, P596; Funke T, 2007, BIOCHEMISTRY-US, V46, P13344, DOI 10.1021/bi701095u; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; HASLAM E, 1993, SHIKIMIC ACID METABO, P1; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lebrun M., 2003, Mutated 5-enolpyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene, Patent No. [US 6566587, 6566587]; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Padgette SR, 1995, HERBICIDE RESISTANT, P53; Park H, 2004, MOL MICROBIOL, V51, P963, DOI 10.1046/j.1365-2958.2003.03885.x; Perez-Jones A, 2007, PLANTA, V226, P395, DOI 10.1007/s00425-007-0490-6; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Priestman MA, 2005, BIOCHEMISTRY-US, V44, P3241, DOI 10.1021/bi048198d; Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; SMITH EA, 1992, VET HUM TOXICOL, V34, P531; SOST D, 1990, ARCH BIOCHEM BIOPHYS, V282, P433, DOI 10.1016/0003-9861(90)90140-T; STALKER DM, 1985, J BIOL CHEM, V260, P4724; STEINRUCKEN HC, 1984, EUR J BIOCHEM, V143, P351, DOI 10.1111/j.1432-1033.1984.tb08379.x; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; Williams GM, 2000, REGUL TOXICOL PHARM, V31, P117, DOI 10.1006/rtph.1999.1371; Yu Q, 2007, PLANTA, V225, P499, DOI 10.1007/s00425-006-0364-3; [No title captured], Patent No. 6040497	47	99	115	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9854	9860		10.1074/jbc.M809771200	http://dx.doi.org/10.1074/jbc.M809771200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211556	hybrid, Green Published			2022-12-27	WOS:000264892900026
J	Wang, GN; Matsuura, I; He, DM; Liu, F				Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang			Transforming Growth Factor-beta-inducible Phosphorylation of Smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; GLYCOGEN-SYNTHASE KINASE-3-BETA; FAMILY MEDIATOR SMAD1; TGF-BETA; MAP KINASE; SIGNALING PATHWAYS; CELL-CYCLE; IN-VIVO; ANTIPROLIFERATIVE FUNCTION; NEURAL INDUCTION	Smad proteins transduce the transforming growth factor-beta (TGF-beta) signal at the cell surface into gene regulation in the nucleus. Upon TGF-beta treatment, the highly homologous Smad2 and Smad3 are phosphorylated by the TGF-beta receptor at the SSXS motif in the C-terminal tail. Here we show that in addition to the C-tail, three (S/T)-P sites in the Smad3 linker region, Ser(208), Ser(204), and Thr(179) are phosphorylated in response to TGF-beta. The linker phosphorylation peaks at 1 h after TGF-beta treatment, behind the peak of the C-tail phosphorylation. We provide evidence suggesting that the C-tail phosphorylation by the TGF-beta receptor is necessary for the TGF-beta-induced linker phosphorylation. Although the TGF-beta receptor is necessary for the linker phosphorylation, the receptor itself does not phosphorylate these sites. We further show that ERK is not responsible for TGF-beta-dependent phosphorylation of these three sites. We show that GSK3 accounts for TGF-beta-inducible Ser(204) phosphorylation. Flavopiridol, a pan-CDK inhibitor, abolishes TGF-beta-induced phosphorylation of Thr(179) and Ser(208), suggesting that the CDK family is responsible for phosphorylation of Thr(179) and Ser(208) in response to TGF-beta. Mutation of the linker phosphorylation sites to nonphosphorylatable residues increases the ability of Smad3 to activate a TGF-beta/Smad-target gene as well as the growth-inhibitory function of Smad3. Thus, these observations suggest that TGF-beta-induced phosphorylation of Smad3 linker sites inhibits its antiproliferative activity.	[Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Wang, Guannan; Matsuura, Isao; He, Dongming; Liu, Fang] Rutgers State Univ, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Wang, Guannan; Liu, Fang] Rutgers State Univ, Grad Program Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick	Liu, F (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	fangliu@cabm.rutgers.edu			National Institutes of Health [CA93771]; NATIONAL CANCER INSTITUTE [R01CA093771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA93771 (to F. L.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Carlson BA, 1996, CANCER RES, V56, P2973; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DE AWJ, 1996, P NATL ACAD SCI USA, V93, P2735; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eivers E, 2008, CURR OPIN GENET DEV, V18, P304, DOI 10.1016/j.gde.2008.06.001; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Liu F, 2003, FRONT BIOSCI-LANDMRK, V8, pS1280, DOI 10.2741/1149; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; LOSIEWICZ MD, 1994, BIOCHEM BIOPH RES CO, V201, P589, DOI 10.1006/bbrc.1994.1742; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Meijer L, 1999, PHARMACOL THERAPEUT, V82, P279, DOI 10.1016/S0163-7258(98)00057-6; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Pagano M, 2004, CELL, V118, P535, DOI 10.1016/j.cell.2004.08.013; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Prokova V, 2005, NUCLEIC ACIDS RES, V33, P3708, DOI 10.1093/nar/gki679; Roberts AB, 2003, ANN NY ACAD SCI, V995, P1, DOI 10.1111/j.1749-6632.2003.tb03205.x; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sater AK, 2003, DIFFERENTIATION, V71, P434, DOI 10.1046/j.1432-0436.2003.7107006.x; Senderowicz AM, 2005, PROG DRUG RES, V63, P183; Shchemelinin I, 2006, FOLIA BIOL-PRAGUE, V52, P137; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Wang GN, 2005, BIOCHEM J, V386, P29, DOI 10.1042/BJ20041820; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Yamagata H, 2005, CANCER RES, V65, P157; Yonekura A, 1999, ENDOCR J, V46, P545, DOI 10.1507/endocrj.46.545; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	76	101	105	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9663	9673		10.1074/jbc.M809281200	http://dx.doi.org/10.1074/jbc.M809281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218245	Green Published, hybrid			2022-12-27	WOS:000264892900006
J	Yuan, C; Sidhu, RS; Kuklev, DV; Kado, Y; Wada, M; Song, I; Smith, WL				Yuan, Chong; Sidhu, Ranjinder S.; Kuklev, Dmitry V.; Kado, Yuji; Wada, Masayuki; Song, Inseok; Smith, William L.			Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); ENDOPEROXIDE-H SYNTHASE-1; PROSTAGLANDIN PRODUCTION; PROTEIN; OXYGENATION; INHIBITION; PATHWAYS; EXPRESSION; GENERATION; MECHANISM	Prostaglandin endoperoxide H synthases (PGHSs) 1 and 2, also known as cyclooxygenases (COXs), catalyze the oxygenation of arachidonic acid ( AA) in the committed step in prostaglandin (PG) biosynthesis. PGHSs are homodimers that display half of sites COX activity with AA; thus, PGHSs function as conformational heterodimers. Here we show that, during catalysis, fatty acids (FAs) are bound at both COX sites of a PGHS-2 dimer. Initially, an FA binds with high affinity to one COX site of an unoccupied homodimer. This monomer becomes an allosteric monomer, and it causes the partner monomer to become the catalytic monomer that oxygenates AA. A variety of FAs can bind with high affinity to the COX site of the monomer that becomes the allosteric monomer. Importantly, the efficiency of AA oxygenation is determined by the nature of the FA bound to the allosteric monomer. When tested with low concentrations of saturated and monounsaturated FAs ( e. g. oleic acid), the rates of AA oxygenation are typically 1.5-2 times higher with PGHS-2 than with PGHS-1. These different kinetic behaviors of PGHSs may account for the ability of PGHS-2 but not PGHS-1 to efficiently oxygenate AA in intact cells when AA is a small fraction of the FA pool such as during "late phase" PG synthesis.	[Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kuklev, Dmitry V.] Cayman Chem Co, Ann Arbor, MI 48108 USA; [Song, Inseok] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Michigan System; University of Michigan; University of Seoul	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	smithww@umich.edu			National Institutes of Health [GM68848]; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68848 ( to W. L. S.). This work was also supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada ( to R. S. S.).	Bala M, 2008, BIOCHEM PHARMACOL, V75, P1472, DOI 10.1016/j.bcp.2007.12.005; Bingham CO, 1996, J BIOL CHEM, V271, P25936, DOI 10.1074/jbc.271.42.25936; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; KENNEDY TA, 1994, J BIOL CHEM, V269, P27357; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kuklev DV, 2006, CHEM PHYS LIPIDS, V144, P172, DOI 10.1016/j.chemphyslip.2006.09.002; Kuklev DV, 2004, CHEM PHYS LIPIDS, V131, P215, DOI 10.1016/j.chemphyslip.2004.06.001; Kuklev DV, 2003, J LIPID RES, V44, P1060, DOI 10.1194/jlr.D200046-JLR200; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kuwata H, 2000, J IMMUNOL, V165, P4024, DOI 10.4049/jimmunol.165.7.4024; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; PACEASCIAK C, 1968, BIOCHIM BIOPHYS ACTA, V152, P784, DOI 10.1016/0005-2760(68)90126-4; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; TOJO G, 2006, OXIDATION ALCOHOLS A, P50; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103	40	91	91	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10046	10055		10.1074/jbc.M808634200	http://dx.doi.org/10.1074/jbc.M808634200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218248	hybrid, Green Published			2022-12-27	WOS:000264892900047
J	Zhou, J; Vos, CC; Gjyrezi, A; Yoshida, M; Khuri, FR; Tamanoi, F; Giannakakou, P				Zhou, Jun; Vos, Chantal Chanel; Gjyrezi, Ada; Yoshida, Minoru; Khuri, Fadlo R.; Tamanoi, Fuyuhiko; Giannakakou, Paraskevi			The Protein Farnesyltransferase Regulates HDAC6 Activity in a Microtubule-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL TRANSFERASE INHIBITORS; HISTONE DEACETYLASE INHIBITORS; OVARIAN-CANCER CELLS; GLUCOCORTICOID-RECEPTOR; IN-VIVO; PACLITAXEL; ACETYLATION; EXPRESSION; CHAPERONE; TUBULIN	The cytoplasmic deacetylase HDAC6 is an important regulator of cellular pathways that include response to stress, protein folding, microtubule stability, and cell migration, thus representing an attractive target for cancer chemotherapy. However, little is known about its upstream regulation. Our previous work has implicated HDAC6 as a new protein target for the farnesyltransferase inhibitors (FTIs), although HDAC6 lacks a farnesylation motif. Here we show that the protein farnesyltransferase (FTase) and HDAC6 are present in a protein complex together with microtubules in vivo and in vitro. FTase binds microtubules directly via its alpha subunit, and this association requires the C terminus of tubulin. Treatment with an FTI removed FTase, but not HDAC6, from the protein complex, suggesting that the active form of FTase is bound to microtubules. Importantly, the removal of FTase from microtubules abrogated HDAC6 activity, as did a stable knockdown of the alpha subunit of FTase (FT alpha KD). Interestingly, the FT alpha KD cells showed increased sensitivity to the antiproliferative effects of Taxol and the FTI lonafarnib when used either as single agents or in combination as compared with parental cells. Altogether, these data suggest that FTase, via its tubulin-association, is a critical upstream regulator of HDAC6 activity and that FTase expression could help stratify cancer patients that would most benefit from this treatment.	[Vos, Chantal Chanel; Gjyrezi, Ada; Giannakakou, Paraskevi] Weill Cornell Med Coll, Div Hematol Clin Oncol, Dept Med, New York, NY 10065 USA; [Zhou, Jun; Khuri, Fadlo R.; Giannakakou, Paraskevi] Emory Univ, Winship Canc Inst, Sch Med, Atlanta, GA 30322 USA; [Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genet Lab, Chem Genom Grp, Wako, Saitama 3510198, Japan; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol, Los Angeles, CA 90095 USA; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Immunol, Los Angeles, CA 90095 USA; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Mol Genet, Los Angeles, CA 90095 USA	Cornell University; Emory University; RIKEN; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Giannakakou, P (corresponding author), Weill Cornell Med Coll, Div Hematol Clin Oncol, Dept Med, 1300 York Ave, New York, NY 10065 USA.	pag2015@med.cornell.edu	Khuri, Fadlo R./AAU-4942-2020; Yoshida, Minoru/C-8049-2014	Khuri, Fadlo R./0000-0002-8638-7618; Yoshida, Minoru/0000-0002-4376-5674	National Institutes of Health [CA100202, CA114335, 1F32CA134148-01, CA041996]; NATIONAL CANCER INSTITUTE [R01CA100202, R01CA041996, R01CA114335, F32CA134148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100202 and CA114335 ( to P. G.), 1F32CA134148-01 ( to C. C. V.), and CA041996 ( to F. T.).	Adjei AA, 2003, LUNG CANCER-J IASLC, V41, pS55, DOI 10.1016/S0169-5002(03)00143-0; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; CHEN WJ, 1991, P NATL ACAD SCI USA, V88, P11368, DOI 10.1073/pnas.88.24.11368; Del Villar K, 1999, J BIOL CHEM, V274, P27010, DOI 10.1074/jbc.274.38.27010; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kamath K, 2003, CANCER RES, V63, P6026; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khan SG, 1996, BIOCHEM BIOPH RES CO, V220, P795, DOI 10.1006/bbrc.1996.0483; Kim ES, 2005, CANCER, V104, P561, DOI 10.1002/cncr.21188; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; Marcus AI, 2005, CANCER RES, V65, P3883, DOI 10.1158/0008-5472.CAN-04-3757; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Moasser MM, 1998, P NATL ACAD SCI USA, V95, P1369, DOI 10.1073/pnas.95.4.1369; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun JZ, 1999, CANCER RES, V59, P4919; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200	36	29	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9648	9655		10.1074/jbc.M808708200	http://dx.doi.org/10.1074/jbc.M808708200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228685	Green Published, hybrid			2022-12-27	WOS:000264892900004
J	Abdel-Hafiz, H; Dudevoir, ML; Horwitz, KB				Abdel-Hafiz, Hany; Dudevoir, Michelle L.; Horwitz, Kathryn B.			Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; ANDROGEN RECEPTOR; SUMO-1 MODIFICATION; B-RECEPTORS; KAPPA-B; BINDING PROTEINS; TERMINAL DOMAIN; HINGE REGION; A-RECEPTORS; DNA-BINDING	Posttranslational modification by small ubiquitin-like modifier ( SUMO) is a major regulator of transcription. We previously showed that progesterone receptors ( PR) have a single consensus psi KXE SUMO-conjugation motif centered at Lys-388 in the N-terminal domain of PR-B and a homologous site of PR-A. SUMOylation of the PR is hormone-dependent and has a suppressive effect on transcription of an exogenous promoter. Here we show that repression of PR activity by SUMOylation at Lys-388 is uncoupled from phosphorylation, involves synergy between tandem progesterone response elements, and is associated with lowered ligand sensitivity and slowed ligand-dependent down-regulation. However, paradoxically, cellular overexpression of SUMO-1 increases PR transcriptional activity even if Lys-388 is mutated, suggesting that the receptors are activated indirectly by other SUMOylated proteins. One of these is the coactivator SRC-1, whose binding to PR and enhancement of agonist-dependent N-/C-terminal interactions is augmented by the presence of SUMO-1. Increased transcription due to SRC-1 is independent of PR SUMOylation based on assays with the Lys-388 mutants and the pure antiprogestin ZK98299, which blocks N-/C-terminal interactions. In summary, SUMOylation tightly regulates the transcriptional activity of PR by repressing the receptors directly while activating them indirectly through augmented SRC-1 coactivation.	[Abdel-Hafiz, Hany; Dudevoir, Michelle L.; Horwitz, Kathryn B.] Univ Colorado Denver, Div Endocrinol, Dept Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Abdel-Hafiz, H (corresponding author), MS 8106,POB 6511, Aurora, CO 80045 USA.	hany.abdel-hafiz@ucdenver.edu		Horwitz, Kathryn/0000-0001-7402-6455	National Institutes of Health, NCI [CA26869-29]; National Foundation for Cancer Research; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE [R37CA026869, R01CA026869] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA26869-29. This work was also supported by the National Foundation for Cancer Research, the Breast Cancer Research Foundation, and the Avon Foundation.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Bamberger AM, 1996, P NATL ACAD SCI USA, V93, P6169, DOI 10.1073/pnas.93.12.6169; Beck CA, 1996, J BIOL CHEM, V271, P1209, DOI 10.1074/jbc.271.2.1209; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Dong X, 2004, J MOL ENDOCRINOL, V32, P843, DOI 10.1677/jme.0.0320843; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Hay RT, 1999, PHILOS T R SOC B, V354, P1601, DOI 10.1098/rstb.1999.0504; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heneghan AF, 2006, BIOCHEMISTRY-US, V45, P3285, DOI 10.1021/bi052046g; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Kalkhoven E, 1996, INT J CANCER, V65, P682, DOI 10.1002/(SICI)1097-0215(19960301)65:5<682::AID-IJC20>3.0.CO;2-8; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knotts TA, 2001, J BIOL CHEM, V276, P8475, DOI 10.1074/jbc.M009805200; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; LE DY, 2002, ENDOCRINOLOGY, V143, P3482; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; SARTORIUS CA, 1994, CANCER RES, V54, P3868; SARTORIUS CA, 1993, J BIOL CHEM, V268, P9262; Sathya G, 2002, MOL CELL ENDOCRINOL, V192, P171, DOI 10.1016/S0303-7207(01)00673-6; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; SHERIDAN PL, 1989, J BIOL CHEM, V264, P7054; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Takimoto GS, 1996, J BIOL CHEM, V271, P13308, DOI 10.1074/jbc.271.23.13308; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Tirard M, 2007, MOL CELL ENDOCRINOL, V268, P20, DOI 10.1016/j.mce.2007.01.010; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256; Tung L, 2001, J BIOL CHEM, V276, P39843, DOI 10.1074/jbc.M106843200; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; Tyulmenkov VV, 2000, MOL CELL ENDOCRINOL, V165, P151, DOI 10.1016/S0303-7207(00)00250-1; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; WEI LL, 1990, MOL ENDOCRINOL, V4, P1833, DOI 10.1210/mend-4-12-1833; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Zhang PJ, 2007, EMBO J, V26, P1831, DOI 10.1038/sj.emboj.7601602	76	31	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9099	9108		10.1074/jbc.M805226200	http://dx.doi.org/10.1074/jbc.M805226200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19211567	hybrid, Green Published			2022-12-27	WOS:000264669100013
J	Kizuka, Y; Tonoyama, Y; Oka, S				Kizuka, Yasuhiko; Tonoyama, Yasuhiro; Oka, Shogo			Distinct Transport and Intracellular Activities of Two GlcAT-P Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNK-1 CARBOHYDRATE EPITOPE; GOLGI LOCALIZATION; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; EXPRESSION; GLYCOSYLATION; GLUCURONOSYLTRANSFERASES; GLYCOPROTEINS	A neural glycotope, human natural killer-1 carbohydrate, is involved in synaptic plasticity. The key biosynthetic enzyme is a glucuronyltransferase, GlcAT-P, a type II membrane protein comprising an N-terminal cytoplasmic tail, transmembrane domain, stem region, and C-terminal catalytic domain. Previously, we reported that GlcAT-P has two isoforms differing in only the presence or absence of the N-terminal 13 amino acids (P-N13) in the cytoplasmic tail, but the functional distinction of these two isoforms has not been reported. Herein, we show that when expressed in Neuro2A cells, short form GlcAT-P (sGlcAT-P) exhibited significantly higher glucuronylation activity than the longer form (1GlcAT-P), despite their comparable specific activities in vitro. In addition, sGlcAT-P was strictly localized in Golgi apparatus, whereas lGlcAT-P was mainly localized in Golgi but partly in the endoplasmic reticulum. We demonstrated that the small GTPase, Sar1, recognized a dibasic motif in the cytoplasmic tail near P-N13 that was important for exiting the endoplasmic reticulum, and Sar1 interacted with sGlcAT-P more strongly than 1GlcAT-P. Finally, the attachment of P-N13 to another glycosyltransferase, poly-sialyltransferase-I (ST8Sia-IV), had similar effects, such as reduced activity and entrapment within endoplasmic reticulum. These results suggest that P-N13 can control glycosyltransferase transport through Sar1 binding interference.	[Kizuka, Yasuhiko] Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068507, Japan; [Tonoyama, Yasuhiro; Oka, Shogo] Kyoto Univ, Dept Biol Chem, Grad Sch Med, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Creative Scientific Research [16GS0313]; JSPS Fellows; Ministry of Education, Culture, Sports, Science, and Technology	Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Creative Scientific Research 16GS0313 (to S. O.) and a Grant-in-Aid for JSPS Fellows (to Y. K.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; GERBER AC, 1979, EUR J BIOCHEM, V93, P453, DOI 10.1111/j.1432-1033.1979.tb12843.x; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hathaway HJ, 2003, J CELL SCI, V116, P4319, DOI 10.1242/jcs.00720; Kakuda S, 2005, GLYCOBIOLOGY, V15, P203, DOI 10.1093/glycob/cwi001; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kojima N, 1997, J BIOCHEM-TOKYO, V122, P1265; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Ma JY, 1997, J BIOL CHEM, V272, P672; Mitsumoto Y, 2000, GENOMICS, V65, P166, DOI 10.1006/geno.2000.6152; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Opat AS, 2001, BIOCHIMIE, V83, P763, DOI 10.1016/S0300-9084(01)01312-8; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Stroud WJ, 2003, TRAFFIC, V4, P631, DOI 10.1034/j.1600-0854.2003.00122.x; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; VIRTANEN I, 1980, J CELL BIOL, V85, P429, DOI 10.1083/jcb.85.2.429; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamamoto S, 2002, J BIOCHEM, V131, P337, DOI 10.1093/oxfordjournals.jbchem.a003108	36	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9247	9256		10.1074/jbc.M807517200	http://dx.doi.org/10.1074/jbc.M807517200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181664	Green Published, hybrid			2022-12-27	WOS:000264669100031
J	Park, AYJ; Shen, TL; Chien, S; Guan, JL				Park, Ann Y. J.; Shen, Tang-Long; Chien, Shu; Guan, Jun-Lin			Role of Focal Adhesion Kinase Ser-732 Phosphorylation in Centrosome Function during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; FAK PHOSPHORYLATION; ENDOTHELIAL-CELLS; TYR-397 PHOSPHORYLATION; SERINE PHOSPHORYLATION; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; EPITHELIAL-CELLS; AURORA-A	Focal adhesion kinase (FAK) is the major cytoplasmic tyrosine kinase in focal adhesions and a critical mediator of integrin signaling in a variety of cells, including endothelial cells (ECs). Here we describe a new function for FAK in the regulation of centrosome functions in a Ser-732 phosphorylation-dependent manner during mitosis. Deletion of FAK in primary ECs causes increases in centrosome numbers, multipolar and disorganized spindles, and unaligned chromosomes during mitosis. Re-expression of wild-type FAK, but not S732A mutant, rescued these mitotic defects, suggesting a role for Ser-732 phosphorylation in the regulation of centrosomal functions. Consistent with this possibility, Ser-732-phosphorylated FAK was found to co-localize in centrosomes in mitotic cells. FAK also associated with cytoplasmic dynein in a Ser-732 phosphorylation-dependent manner. Further analysis in FAK-null primary ECs showed that S732A mutant could rescue EC migration but not proliferation or tubulogenesis in vitro. Last, we showed that deletion of FAK in ECs reduced tumor angiogenesis in vivo, which could be restored by re-expression of wild-type FAK but not S732A mutant. Together, these studies demonstrated a novel role for Ser-732 phosphorylation of FAK in the regulation of centrosome function during mitosis, which may contribute to EC proliferation and angiogenesis.	[Park, Ann Y. J.; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Mol Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Park, Ann Y. J.; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Park, Ann Y. J.; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Park, Ann Y. J.] Cornell Univ, Coll Vet Med, Grad Program Pharmacol, Ithaca, NY 14853 USA; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 106, Taiwan; [Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; National Taiwan University; University of California System; University of California San Diego	Guan, JL (corresponding author), Univ Michigan, Sch Med, Div Mol Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Shen, Tang-Long/C-7460-2011		National Institutes of Health [HL73394, HL64382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394, R01HL064382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73394 (to J.- L. G.) and HL64382 (to S. C.).	BENZEEV A, 1981, CELL, V26, P107, DOI 10.1016/0092-8674(81)90038-6; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary LA, 1996, J CELL SCI, V109, P1787; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Haskell H, 2003, CLIN CANCER RES, V9, P2157; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jacamo R, 2007, J CELL PHYSIOL, V210, P436, DOI 10.1002/jcp.20870; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Ma A, 2001, MOL BIOL CELL, V12, P1; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; ORLY J, 1979, CELL, V17, P295, DOI 10.1016/0092-8674(79)90155-7; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng X, 2004, CARDIOVASC RES, V64, P421, DOI 10.1016/j.cardiores.2004.07.012; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Villa-Moruzzi E, 2007, BIOCHEM J, V408, P7, DOI 10.1042/BJ20070058; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; WINKLBAUER R, 1986, DEV BIOL, V118, P70, DOI 10.1016/0012-1606(86)90074-6; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Xie ZG, 2004, CELL CYCLE, V3, P108; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yamakita Y, 1999, J CELL BIOL, V144, P315, DOI 10.1083/jcb.144.2.315; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	51	42	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9418	9425		10.1074/jbc.M809040200	http://dx.doi.org/10.1074/jbc.M809040200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19201755	Green Published, hybrid			2022-12-27	WOS:000264669100048
J	Sajish, M; Kalayil, S; Verma, SK; Nandicoori, VK; Prakash, B				Sajish, Mathew; Kalayil, Sissy; Verma, Sunil Kumar; Nandicoori, Vinay Kumar; Prakash, Balaji			The Significance of EXDD and RXKD Motif Conservation in Rel Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRINGENT RESPONSE; GUANOSINE 5'-DIPHOSPHATE-3'-MONOPHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; STRUCTURAL BASIS; (P)PPGPP; PPGPP; RIBOSOME; TETRAPHOSPHATE; 5-DIPHOSPHATE	Monofunctional and bifunctional classes of Rel proteins catalyze pyrophosphoryl transfer from ATP to 3'-OH of GTP/GDP to synthesize (p) ppGpp, which is essential for normal microbial physiology and survival. Bifunctional proteins additionally catalyze the hydrolysis of (p) ppGpp. We have earlier demonstrated that although both catalyze identical the (p) ppGpp synthesis reaction, they exhibit a differential response to Mg2+ due to a unique charge reversal in the synthesis domain; an RXKD motif in the synthesis domain of bifunctional protein is substituted by an EXDD motif in that of the monofunctional proteins. Here, we show that these motifs also determine substrate specificities (GTP/GDP), cooperativity, and regulation of catalytic activities at the N-terminal region through the C-terminal region. Most importantly, a mutant bifunctional Rel carrying an EXDD instigates a novel catalytic reaction, resulting in the synthesis of pGpp by an independent hydrolysis of the 5'P-alpha-O-P-beta bond of GTP/GDP or (p) ppGpp. Further experiments with RelA from Escherichia coli wherein EXDD is naturally present also revealed the presence of pGpp, albeit at low levels. This work brings out the biological significance of RXKD/EXDD motif conservation in Rel proteins and reveals an additional catalytic activity for the monofunctional proteins, prompting an extensive investigation for the possible existence and role of pGpp in the biological system.	[Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Sajish, Mathew; Kalayil, Sissy; Verma, Sunil Kumar; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in; bprakash@iitk.ac.in	Thekkel, Sajish Mathew/AAM-3548-2021; Verma, Sunil Kumar/J-8838-2019	Thekkel, Sajish Mathew/0000-0001-6715-5953; Verma, Sunil Kumar/0000-0001-9443-2493; Nandicoori, Vinay/0000-0002-5682-4178; Kalayil, Sissy/0000-0002-6731-2055	Wellcome Trust, United Kingdom International Senior Research Fellowship; Department of Biotechnology, New Delhi	Wellcome Trust, United Kingdom International Senior Research Fellowship(Wellcome Trust); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by a Wellcome Trust, United Kingdom International Senior Research Fellowship (to B. P.) and generous support provided by the Department of Biotechnology, New Delhi (to B. P. and V. K. N.).	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Avarbock D, 1999, GENE, V233, P261, DOI 10.1016/S0378-1119(99)00114-6; CASHEL M, 1970, J BIOL CHEM, V245, P2309; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; COCHRAN JW, 1974, J BIOL CHEM, V249, P353; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HASELTIN.WA, 1972, NATURE, V238, P381, DOI 10.1038/238381a0; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; NEGRE D, 1989, BIOCHEMISTRY-US, V28, P1814, DOI 10.1021/bi00430a058; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PAO CC, 1979, J BIOL CHEM, V254, P688; PAO CC, 1980, J BIOL CHEM, V255, P1830; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sajish M, 2007, J BIOL CHEM, V282, P34977, DOI 10.1074/jbc.M704828200; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SY J, 1973, P NATL ACAD SCI USA, V70, P306, DOI 10.1073/pnas.70.2.306; SY J, 1975, BIOCHEMISTRY-US, V14, P970, DOI 10.1021/bi00676a015; WAGNER EGH, 1980, MOL GEN GENET, V180, P139, DOI 10.1007/BF00267363; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1	30	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9115	9123		10.1074/jbc.M807187200	http://dx.doi.org/10.1074/jbc.M807187200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19201753	hybrid, Green Published			2022-12-27	WOS:000264669100015
J	Gingras, AR; Ziegler, WH; Bobkov, AA; Joyce, MG; Fasci, D; Himmel, M; Rothemund, S; Ritter, A; Grossmann, JG; Patel, B; Bate, N; Goult, BT; Emsley, J; Barsukov, IL; Roberts, GCK; Liddington, RC; Ginsberg, MH; Critchley, DR				Gingras, Alexandre R.; Ziegler, Wolfgang H.; Bobkov, Andrey A.; Joyce, M. Gordon; Fasci, Domenico; Himmel, Mirko; Rothemund, Sven; Ritter, Anett; Grossmann, J. Guenter; Patel, Bipin; Bate, Neil; Goult, Benjamin T.; Emsley, Jonas; Barsukov, Igor L.; Roberts, Gordon C. K.; Liddington, Robert C.; Ginsberg, Mark H.; Critchley, David R.			Structural Determinants of Integrin Binding to the Talin Rod	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; ACTIN-BINDING; MOLECULAR-GRAPHICS; FERM DOMAIN; VINCULIN; SITE; ACTIVATION; CYTOSKELETON; INTERACTS; CONTAINS	The adaptor protein talin serves both to activate the integrin family of cell adhesion molecules and to couple integrins to the actin cytoskeleton. Integrin activation has been shown to involve binding of the talin FERM domain to membrane proximal sequences in the cytoplasmic domain of the integrin beta-subunit. However, a second integrin-binding site (IBS2) has been identified near the C-terminal end of the talin rod. Here we report the crystal structure of IBS2 (residues 1974-2293), which comprises two five-helix bundles, "IBS2-A" (1974-2139) and "IBS2-B" (2140-2293), connected by a continuous helix with a distinct kink at its center that is stabilized by side-chain H-bonding. Solution studies using small angle x-ray scattering and NMR point to a fairly flexible quaternary organization. Using pull-down and enzyme-linked immunosorbent assays, we demonstrate that integrin binding requires both IBS2 domains, as does binding to acidic phospholipids and robust targeting to focal adhesions. We have defined the membrane proximal region of the integrin cytoplasmic domain as the major binding region, although more membrane distal regions are also required for strong binding. Alanine-scanning mutagenesis points to an important electrostatic component to binding. Thermal unfolding experiments show that integrin binding induces conformational changes in the IBS2 module, which we speculate are linked to vinculin and membrane binding.	[Gingras, Alexandre R.; Joyce, M. Gordon; Patel, Bipin; Bate, Neil; Goult, Benjamin T.; Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England; [Grossmann, J. Guenter; Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Ziegler, Wolfgang H.; Himmel, Mirko; Rothemund, Sven; Ritter, Anett] Univ Leipzig, Fac Med, Klin Forsch Leipzig, Interdisziplinares Zentrum, D-04103 Leipzig, Germany; [Bobkov, Andrey A.; Liddington, Robert C.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Fasci, Domenico; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Emsley, Jonas] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Leicester; University of Liverpool; Leipzig University; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of Nottingham	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk	Gingras, Alexandre R/E-1867-2011; Goult, Benjamin T/B-3127-2009; emsley, jonas/A-8509-2016	Gingras, Alexandre R/0000-0002-5373-0176; Goult, Benjamin T/0000-0002-3438-2807; emsley, jonas/0000-0002-8949-8030; Roberts, Gordon/0000-0001-6200-1373; Ziegler, Wolfgang H./0000-0003-4529-1916; Himmel, Mirko/0000-0001-7872-8016	National Institutes of Health Cell Migration Consortium from NIGMS [U54GM64346]; Wellcome Trust; Cancer Research UK; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health Cell Migration Consortium from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Cell Migration Consortium Grant U54GM64346 from NIGMS. This work was also supported by the Wellcome Trust and Cancer Research UK. The work in Leipzig was supported by the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GILMORE AP, 1993, J CELL BIOL, V122, P337, DOI 10.1083/jcb.122.2.337; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hemmings L, 1996, J CELL SCI, V109, P2715; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liddington RC, 2003, CURR BIOL, V13, pR94, DOI 10.1016/S0960-9822(03)00035-6; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; MCLACHLAN AD, 1994, J MOL BIOL, V235, P1278, DOI 10.1006/jmbi.1994.1081; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200; Xu WM, 1998, DEVELOPMENT, V125, P327; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	45	61	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8857	8867		10.1074/jbc.M805937200	http://dx.doi.org/10.1074/jbc.M805937200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176533	Green Published, hybrid			2022-12-27	WOS:000264397800069
J	Legardinier, S; Legrand, B; Raguenes-Nicol, C; Bondon, A; Hardy, S; Tascon, C; Le Rumeur, E; Hubert, JF				Legardinier, Sebastien; Legrand, Baptiste; Raguenes-Nicol, Celine; Bondon, Arnaud; Hardy, Serge; Tascon, Christophe; Le Rumeur, Elisabeth; Hubert, Jean-Francois			A Two-amino Acid Mutation Encountered in Duchenne Muscular Dystrophy Decreases Stability of the Rod Domain 23 (R23) Spectrin-like Repeat of Dystrophin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STRUCTURES; CONFORMATIONAL UNIT; CONTAINING FRAGMENT; ERYTHROID SPECTRIN; STRUCTURAL REPEATS; BETA-DYSTROGLYCAN; POINT MUTATIONS; TANDEM REPEATS; ALPHA-SPECTRIN; GENE	Lack of functional dystrophin causes severe Duchenne muscular dystrophy. The subsarcolemmal location of dystrophin, as well as its association with both cytoskeleton and membrane, suggests a role in the mechanical regulation of muscular membrane stress. In particular, phenotype rescue in a Duchenne muscular dystrophy mice model has shown that some parts of the central rod domain of dystrophin, constituted by 24 spectrin-like repeats, are essential. In this study, we made use of rare missense pathogenic mutations in the dystrophin gene and analyzed the biochemical properties of the isolated repeat 23 bearing single or double mutations E2910V and N2912D found in muscle dystrophy with severity grading. No dramatic effect on secondary and tertiary structure of the repeat was found in mutants compared with wild type as revealed by circular dichroism and NMR. Thermal and chemical unfolding data from circular dichroism and tryptophan fluorescence show significant decrease of stability for the mutants, and stopped-flow spectroscopy shows decreased refolding rates. The most deleterious single mutation is the N2912D replacement, although we observe additive effects of the two mutations on repeat stability. Based on three-dimensional structures built by homology molecular modeling, we discuss the modifications of the mutation-induced repeat stability. We conclude that the main forces involved in repeat stability are electrostatic inter-helix interactions that are disrupted following mutations. This study represents the first analysis at the protein level of the consequences of missense mutations in the human dystrophin rod domain. Our results suggest that it may participate in mechanical weakening of dystrophin-deficient muscle.	[Legardinier, Sebastien; Legrand, Baptiste; Raguenes-Nicol, Celine; Bondon, Arnaud; Tascon, Christophe; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Univ Rennes 1, CNRS, UMR Interact Cellulaires & Mol 6026, Fac Med,Equipe RMN & Interact Lipides Prot,IFR 14, F-35043 Rennes, France; [Hardy, Serge] Univ Rennes 1, CNRS, UMR Genet & Dev 6061, Fac Med,IFR 140, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Hubert, JF (corresponding author), Univ Rennes 1, CNRS, UMR Interact Cellulaires & Mol 6026, Fac Med,Equipe RMN & Interact Lipides Prot,IFR 14, CS 34317, F-35043 Rennes, France.	jfhubert@univ-rennes1.fr	Raguenes-Nicol, Celine/I-2693-2015; Legrand, Baptiste/ABB-2552-2021	Raguenes-Nicol, Celine/0000-0001-8428-9558; bondon, arnaud/0000-0002-9229-6317; Legrand, Baptiste/0000-0001-8931-7757	Association Francaise Contre les Myopathies	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported in part by the Association Francaise Contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Baker RD, 2001, LIFETIME DATA ANAL, V7, P65, DOI 10.1023/A:1009677227030; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Calvert R, 1996, BIOPHYS J, V71, P1605, DOI 10.1016/S0006-3495(96)79363-3; Chaturvedi LS, 2001, EXP MOL MED, V33, P251, DOI 10.1038/emm.2001.41; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Ervasti JM, 1993, CURR OPIN CELL BIOL, V5, P82, DOI 10.1016/S0955-0674(05)80012-2; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hnia K, 2007, BIOCHEM J, V401, P667, DOI 10.1042/BJ20061051; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hofstra RMW, 2004, HUM MUTAT, V23, P57, DOI 10.1002/humu.10283; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAHANA E, 1994, J MOL BIOL, V235, P1271, DOI 10.1006/jmbi.1994.1080; KAHANA E, 1995, BIOCHEMISTRY-US, V34, P8110, DOI 10.1021/bi00025a017; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Legardinier S, 2008, BBA-PROTEINS PROTEOM, V1784, P672, DOI 10.1016/j.bbapap.2007.12.014; LENK U, 1994, NEUROMUSCULAR DISORD, V4, P411, DOI 10.1016/0960-8966(94)90080-9; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MACDONALD RI, 1994, P NATL ACAD SCI USA, V91, P1299, DOI 10.1073/pnas.91.4.1299; MacDonald RI, 2001, BIOCHEMISTRY-US, V40, P3974, DOI 10.1021/bi0025159; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; PARRY DAD, 1992, BIOPHYS J, V61, P858, DOI 10.1016/S0006-3495(92)81893-3; PRIOR TW, 1995, HUM MUTAT, V5, P263, DOI 10.1002/humu.1380050312; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; Saadat L, 2006, BBA-PROTEINS PROTEOM, V1764, P943, DOI 10.1016/j.bbapap.2006.02.012; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; WINOGRAD E, 1991, P NATL ACAD SCI USA, V88, P10788, DOI 10.1073/pnas.88.23.10788; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	55	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8822	8832		10.1074/jbc.M805846200	http://dx.doi.org/10.1074/jbc.M805846200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158079	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000264397800065
J	Han, S; Mistry, A; Chang, JS; Cunningham, D; Griffor, M; Bonnette, PC; Wang, H; Chrunyk, BA; Aspnes, GE; Walker, DP; Brosius, AD; Buckbinder, L				Han, Seungil; Mistry, Anil; Chang, Jeanne S.; Cunningham, David; Griffor, Matt; Bonnette, Peter C.; Wang, Hong; Chrunyk, Boris A.; Aspnes, Gary E.; Walker, Daniel P.; Brosius, Arthur D.; Buckbinder, Leonard			Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; PROTEIN-KINASES; BINDING; MICE; MECHANISM; DENSITY; CELLS; SITE	Proline-rich tyrosine kinase 2 (PYK2) is a cytoplasmic, nonreceptor tyrosine kinase implicated in multiple signaling pathways. It is a negative regulator of osteogenesis and considered a viable drug target for osteoporosis treatment. The high-resolution structures of the human PYK2 kinase domain with different inhibitor complexes establish the conventional bilobal kinase architecture and show the conformational variability of the DFG loop. The basis for the lack of selectivity for the classical kinase inhibitor, PF-431396, within the FAK family is explained by our structural analyses. Importantly, the novel DFG-out conformation with two diarylurea inhibitors (BIRB796, PF-4618433) reveals a distinct subclass of non-receptor tyrosine kinases identifiable by the gatekeeper Met-502 and the unique hinge loop conformation of Leu-504. This is the first example of a leucine residue in the hinge loop that blocks the ATP binding site in the DFG-out conformation. Our structural, biophysical, and pharmacological studies suggest that the unique features of the DFG motif, including Leu-504 hinge-loop variability, can be exploited for the development of selective protein kinase inhibitors.	[Han, Seungil; Mistry, Anil; Chang, Jeanne S.; Cunningham, David; Griffor, Matt; Bonnette, Peter C.; Wang, Hong; Chrunyk, Boris A.; Aspnes, Gary E.; Walker, Daniel P.; Brosius, Arthur D.; Buckbinder, Leonard] Pfizer Global Res & Dev, Groton, CT 06340 USA	Pfizer	Han, S (corresponding author), Pfizer Global Res & Dev, Eastern Point Rd, Groton, CT 06340 USA.	seungil.han@pfizer.com						Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Casper D, 2004, ANAL BIOCHEM, V325, P126, DOI 10.1016/j.ab.2003.10.025; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HANKS SK, 2004, ENCY BIOL CHEM, V2, P80; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manley PW, 2004, BBA-PROTEINS PROTEOM, V1697, P17, DOI 10.1016/j.bbapap.2003.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noble MEM, 1999, PHARMACOL THERAPEUT, V82, P269, DOI 10.1016/S0163-7258(98)00051-5; Nordin H, 2005, ANAL BIOCHEM, V340, P359, DOI 10.1016/j.ab.2005.02.027; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Regan J, 2003, BIOORG MED CHEM LETT, V13, P3101, DOI 10.1016/S0960-894X(03)00656-5; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Traxler P, 1999, PHARMACOL THERAPEUT, V82, P195, DOI 10.1016/S0163-7258(98)00044-8; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Yu Y, 2005, BIOCHEM BIOPH RES CO, V334, P1085, DOI 10.1016/j.bbrc.2005.06.198	28	75	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13193	13201		10.1074/jbc.M809038200	http://dx.doi.org/10.1074/jbc.M809038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19244237	Green Published, hybrid			2022-12-27	WOS:000265688300066
J	Kim, J; Ahn, S; Rajagopal, K; Lefkowitz, RJ				Kim, Jihee; Ahn, Seungkirl; Rajagopal, Keshava; Lefkowitz, Robert J.			Independent beta-Arrestin2 and G(q)/Protein Kinase C zeta Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; MEDIATED ACTIVATION; CARDIAC MYOCYTES; TYROSINE KINASE; EGF RECEPTOR; SRC-FAMILY; PKC-XI; PROLIFERATION; PHOSPHORYLATION	Recent studies in receptor-transfected cell lines have demonstrated that extracellular signal-regulated kinase (ERK) activation by angiotensin type 1A receptor and other G protein-coupled receptors can be mediated by both G protein-dependent and beta-arrestin-dependent mechanisms. However, few studies have explored these mechanisms in primary cultured cells expressing endogenous levels of receptors. Accordingly, here we utilized the beta-arrestin biased agonist for the angiotensin type 1A receptor, SII-angiotensin (SII), and RNA interference techniques to investigate angiotensin II (ANG)-activated beta-arrestin-mediated mitogenic signaling pathways in rat vascular smooth muscle cells. Both ANG and SII induced DNA synthesis via the ERK activation cascade. Even though SII cannot induce calcium influx (G protein activation) after receptor stimulation, it does cause ERK activation, although less robustly than ANG. Activation by both ligands is diminished by depletion of beta-arrestin2 by small interfering RNA, although the effect is more complete with SII. ERK activation at early time points but not later time points is strongly inhibited by those protein kinase C inhibitors that can block protein kinase C zeta. Moreover, ANG- and SII-mediated ERK activation require transactivation of the epidermal growth factor receptor via metalloprotease 2/9 and Src kinase. beta-Arrestin2 facilitates ANG and SII stimulation of Src-mediated phosphorylation of Tyr-845 on the EGFR, a known site for Src phosphorylation. These studies delineate a convergent mechanism by which G protein-dependent and beta-arrestin-dependent pathways can independently mediate ERK-dependent transactivation of the EGFR in vascular smooth muscle cells thus controlling cellular proliferative responses.	[Kim, Jihee; Ahn, Seungkirl; Rajagopal, Keshava; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		National Institutes of Health [HL 16037, HL 70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037, R01HL070631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 16037 and HL 70631 (to R. J. L.).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; ASSENDER JW, 1994, FEBS LETT, V342, P76, DOI 10.1016/0014-5793(94)80588-1; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Demoliou-Mason CD, 1998, BIOL SIGNAL RECEPT, V7, P90; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1297, DOI 10.1152/ajpcell.00617.2005; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; KARIYA K, 1991, J BIOL CHEM, V266, P10023; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Nakashima H, 2008, HYPERTENSION, V51, P232, DOI 10.1161/HYPERTENSIONAHA.107.101253; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Nozawa Y, 1999, LIFE SCI, V64, P2061, DOI 10.1016/S0024-3205(99)00153-8; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V291, pH1602, DOI 10.1152/ajpheart.01363.2005; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; PORRECA E, 1993, ATHEROSCLEROSIS, V104, P137, DOI 10.1016/0021-9150(93)90184-V; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Saito S, 2002, BIOCHEM BIOPH RES CO, V294, P1023, DOI 10.1016/S0006-291X(02)00595-8; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Wassmann S, 2006, J HYPERTENS, V24, pS15, DOI 10.1097/01.hjh.0000220402.53869.72; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361; Yu PJ, 2007, CELL SIGNAL, V19, P1359, DOI 10.1016/j.cellsig.2007.03.002; Zhou CH, 2006, EUR J PHARMACOL, V535, P61, DOI 10.1016/j.ejphar.2006.02.027; Zou YZ, 1998, CIRC RES, V82, P337, DOI 10.1161/01.RES.82.3.337	44	94	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11953	11962		10.1074/jbc.M808176200	http://dx.doi.org/10.1074/jbc.M808176200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254952	Green Published, hybrid			2022-12-27	WOS:000265494600027
J	Lu, HQ; Leung, HT; Wang, N; Pak, WL; Shieh, BH				Lu, Haiqin; Leung, Hung-Tat; Wang, Ning; Pak, William L.; Shieh, Bih-Hwa			Role of Ca2+/Calmodulin-dependent Protein Kinase II in Drosophila Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT PHOSPHORYLATION; PHOSPHATASE 2A; SUBCELLULAR TRANSLOCATION; RETINAL DEGENERATION; VISUAL ARRESTIN; PHOSRESTIN-I; TRPL-CHANNEL; PHOTOTRANSDUCTION; EXPRESSION; RHODOPSIN	Ca2+ modulates the visual response in both vertebrates and invertebrates. In Drosophila photoreceptors, an increase of cytoplasmic Ca2+ mimics light adaptation. Little is known regarding the mechanism, however. We explored the role of the sole Drosophila Ca2+/calmodulin-dependent protein kinase II (CaMKII) to mediate light adaptation. CaMKII has been implicated in the phosphorylation of arrestin 2 (Arr2). However, the functional significance of Arr2 phosphorylation remains debatable. We identified retinal CaMKII by anti-CaMKII antibodies and by its Ca2+-dependent autophosphorylation. Moreover, we show that phosphorylation of CaMKII is greatly enhanced by okadaic acid, and indeed, purified PP2A catalyzes the dephosphorylation of CaMKII. Significantly, we demonstrate that anti-CaMKII antibodies co-immunoprecipitate, and CaMKII fusion proteins pull down the catalytic subunit of PP2A from fly extracts, indicating that PP2A interacts with CaMKII to form a protein complex. To investigate the function of CaMKII in photoreceptors, we show that suppression of CaMKII in transgenic flies affects light adaptation and increases prolonged depolarizing afterpotential amplitude, whereas a reduced PP2A activity brings about reduced prolonged depolarizing afterpotential amplitude. Taken together, we conclude that CaMKII is involved in the negative regulation of the visual response affecting light adaptation, possibly by catalyzing phosphorylation of Arr2. Moreover, the CaMKII activity appears tightly regulated by the co-localized PP2A.	[Shieh, Bih-Hwa] Vanderbilt Univ, Vis Res Ctr, Nashville, TN 37232 USA; [Lu, Haiqin; Wang, Ning] Vanderbilt Univ, Ctr Mol Neurosci, Dept Pharmacol, Nashville, TN 37232 USA; [Leung, Hung-Tat; Pak, William L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Vanderbilt University; Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shieh, BH (corresponding author), Vanderbilt Univ, Vis Res Ctr, Nashville, TN 37232 USA.	bih-hwa.shieh@vanderbilt.edu			National Institutes of Health [EY09743, EY00033]; NATIONAL EYE INSTITUTE [R56EY000033, R01EY009743, R01EY000033, R37EY000033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY09743 (to B.-H. S.) and EY00033 (to W. L. P.).	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; Cronin MA, 2004, J CELL SCI, V117, P4797, DOI 10.1242/jcs.01371; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; GuptaRoy B, 2000, MOL BRAIN RES, V80, P26, DOI 10.1016/S0169-328X(00)00115-7; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kahn ES, 1998, COMP BIOCHEM PHYS B, V119, P739, DOI 10.1016/S0305-0491(98)00050-9; Kahn ES, 1997, J NEUROCHEM, V68, P169; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Morimoto-Tanifuji T, 2004, NEUROSCIENCE, V128, P797, DOI 10.1016/j.neuroscience.2004.07.018; O'Tousa JE, 2002, ADV EXP MED BIOL, V514, P493; OHSAKO S, 1993, J BIOL CHEM, V268, P2052; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shakiryanova D, 2007, J NEUROSCI, V27, P7799, DOI 10.1523/JNEUROSCI.1879-07.2007; Shoju H, 2005, J BIOCHEM, V138, P605, DOI 10.1093/jb/mvi161; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang Z, 1998, J NEUROCHEM, V71, P378; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671	48	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11100	11109		10.1074/jbc.M806956200	http://dx.doi.org/10.1074/jbc.M806956200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19254957	Green Published, hybrid			2022-12-27	WOS:000265494500014
J	Yuan, ZQ; Lehtinen, MK; Merlo, P; Villen, J; Gygi, S; Bonni, A				Yuan, Zengqiang; Lehtinen, Maria K.; Merlo, Paola; Villen, Judit; Gygi, Steven; Bonni, Azad			Regulation of Neuronal Cell Death by MST1-FOXO1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; CEREBELLAR GRANULE CELLS; POSTMITOTIC NEURONS; NERVOUS-SYSTEM; APOPTOSIS; CYCLE; ACTIVATION; SURVIVAL; PATHWAY; PHOSPHORYLATION	The protein kinase mammalian Sterile 20-like kinase 1 (MST1) plays a critical role in the regulation of cell death. Recent studies suggest that MST1 mediates oxidative stress-induced neuronal cell death by phosphorylating the transcription factor FOXO3 at serine 207, a site that is conserved in other FOXO family members. Here, we show that MST1-induced phosphorylation of FOXO1 at serine 212, corresponding to serine 207 in FOXO3, disrupts the association of FOXO1 with 14-3-3 proteins. Accordingly, MST1 mediates the nuclear translocation of FOXO1 in primary rat cerebellar granule neurons that are deprived of neuronal activity. We also find a requirement for MST1 in cell death of granule neurons upon withdrawal of growth factors and neuronal activity, and MST1 induces cell death in a FOXO1-dependent manner. Finally, we show that the MST1-regulatory, scaffold protein Nore1 is required for survival factor deprivation induced neuronal death. Collectively, these findings define MST1-FOXO1 signaling as an important link survival factor deprivation-induced neuronal cell death with implications for our understanding of brain development and neurological diseases.	[Yuan, Zengqiang; Lehtinen, Maria K.; Merlo, Paola; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Villen, Judit; Gygi, Steven] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Yuan, Zengqiang/G-5245-2017; Merlo, Paola/K-5330-2014	Merlo, Paola/0000-0003-0105-7044; Yuan, Zengqiang/0000-0001-5739-2867; Villen, Judit/0000-0002-1005-1739	National Institutes of Health [NS047188, NS41021]; Paul Glenn laboratories; Lefler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188, R01NS041021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Glenn laboratories; Lefler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047188 and NS41021 (to A.B.). This work was also supported by a pilot grant from the Paul Glenn laboratories (to A.B.) and a grant from the Lefler Foundation (to Z.Y.).	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Becker EBE, 2005, SEMIN CELL DEV BIOL, V16, P439, DOI 10.1016/j.semcdb.2005.02.006; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim AH, 2008, CELL CYCLE, V7, P3819, DOI 10.4161/cc.7.24.7215; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lehtinen MK, 2008, CURR MOL MED, V8, P313, DOI 10.2174/156652408784533805; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Miller TM, 1996, J NEUROSCI, V16, P7487; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shalizi A, 2003, J NEUROSCI, V23, P7326; Suh YS, 2002, NEUROSCI LETT, V325, P1, DOI 10.1016/S0304-3940(02)00216-1; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	37	140	148	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11285	11292		10.1074/jbc.M900461200	http://dx.doi.org/10.1074/jbc.M900461200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19221179	Green Published, hybrid			2022-12-27	WOS:000265494500032
J	Busch, A; Guazzaroni, ME; Lacal, J; Ramos, JL; Krell, T				Busch, Andreas; Guazzaroni, Maria-Eugenia; Lacal, Jesus; Luis Ramos, Juan; Krell, Tino			The Sensor Kinase TodS Operates by a Multiple Step Phosphorelay Mechanism Involving Two Autokinase Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION SYSTEM; RESPONSE REGULATOR; FUNCTIONAL-CHARACTERIZATION; TOLUENE METABOLISM; RECOGNITION SITES; IN-VITRO; PHOSPHORYLATION; BINDING; STRAIN; DIMERIZATION	Expression of the Pseudomonas putida tod operon, which encodes enzymes for toluene metabolism, takes place from the P-todX promoter and is mediated by the TodS/TodT two component system. The sensor kinase TodS has a complex domain arrangement containing two functional modules, each harboring a sensor- and an autokinase domain and separated by a receiver domain. Based on site-directed mutagenesis of phosphoaccepting His-190, Asp-500, and His-760 and in vitro transphosphorylation experiments with recombinant TodS fragments, we show that TodS uses a multiple step phosphorelay mechanism to activate TodT. Toluene binding stimulates exclusively phosphorylation of His-190, which is followed by phosphotransfer to Asp-500 and subsequently to His-760 prior to phosphorylation of TodT Asp-57. Mutation of His-190, Asp-500, and H760A prevented up-regulation of toluene-mediated stimulation of TodT transphosphorylation in vitro and reduced in vivo expression of PtodX to the basal level. Calorimetric studies support that TodT binds to the C-terminal kinase module with a K-D of similar to 200 nM and 1:1 stoichiometry. This is the first report of a multiple step phosphorelay mechanism of a sensor kinase that involves two autokinase domains.	[Busch, Andreas; Guazzaroni, Maria-Eugenia; Lacal, Jesus; Luis Ramos, Juan; Krell, Tino] CSIC, Estac Expt Zaidin, Environm Protect Dept, Granada 18008, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Krell, T (corresponding author), CSIC, Estac Expt Zaidin, Environm Protect Dept, C Prof Albareda 1, Granada 18008, Spain.	tino.krell@eez.csic.es	Lacal Romero, Jesus/G-8041-2015; Lacal, Jesus/B-1511-2019; Guazzaroni, María-Eugenia/Y-9268-2019; Guazzaroni, María Eugenia MEG/E-2599-2013; Krell, Tino/G-7296-2015	Lacal Romero, Jesus/0000-0002-2751-7291; Lacal, Jesus/0000-0002-2751-7291; Guazzaroni, María-Eugenia/0000-0002-4657-3731; Guazzaroni, María Eugenia MEG/0000-0002-4657-3731; Krell, Tino/0000-0002-9040-3166; Ramos, Juan L./0000-0002-8731-7435	Spanish Ministry of Science and Education [CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 200700010]; Junta de Andalucia [CIV344, CIV1912]	Spanish Ministry of Science and Education(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Science and Education (CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 200700010) and Grants CIV344 and CIV1912 from the Junta de Andalucia (to J.L.R. and T.K.), respectively.	Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Coschigano PW, 1997, APPL ENVIRON MICROB, V63, P652, DOI 10.1128/AEM.63.2.652-660.1997; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Lacal J, 2008, J MOL BIOL, V376, P325, DOI 10.1016/j.jmb.2007.12.004; Lacal J, 2006, P NATL ACAD SCI USA, V103, P8191, DOI 10.1073/pnas.0602902103; Lacal J, 2008, J MOL BIOL, V384, P1037, DOI 10.1016/j.jmb.2008.10.011; Lau PCK, 1997, P NATL ACAD SCI USA, V94, P1453, DOI 10.1073/pnas.94.4.1453; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mosqueda G, 1999, GENE, V232, P69, DOI 10.1016/S0378-1119(99)00113-4; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Perraud AL, 2000, BBA-PROTEIN STRUCT M, V1478, P341, DOI 10.1016/S0167-4838(00)00052-2; RALEIGH EA, 1989, GENETICS, V122, P279; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos-Gonzalez MI, 2002, J BACTERIOL, V184, P7062, DOI 10.1128/JB.184.24.7062-7067.2002; Rampioni G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-92; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sousa EHS, 2005, BIOCHEMISTRY-US, V44, P15359, DOI 10.1021/bi051661h; Stewart RC, 2004, BIOCHEMISTRY-US, V43, P8766, DOI 10.1021/bi0495735; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tomenius H, 2005, J BACTERIOL, V187, P7317, DOI 10.1128/JB.187.21.7317-7324.2005; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Velasco A, 1998, J BACTERIOL, V180, P1063, DOI 10.1128/JB.180.5.1063-1071.1998; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang WW, 2005, MICROBIOL-SGM, V151, P2159, DOI 10.1099/mic.0.27987-0	41	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10353	10360		10.1074/jbc.M900521200	http://dx.doi.org/10.1074/jbc.M900521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240030	Green Published, hybrid			2022-12-27	WOS:000265104600009
J	Menze, MA; Boswell, L; Toner, M; Hand, SC				Menze, Michael A.; Boswell, Leaf; Toner, Mehmet; Hand, Steven C.			Occurrence of Mitochondria-targeted Late Embryogenesis Abundant (LEA) Gene in Animals Increases Organelle Resistance to Water Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTEMIA-FRANCISCANA EMBRYOS; SHOCK/ALPHA-CRYSTALLIN PROTEIN; MAMMALIAN-CELLS; INTRACELLULAR TREHALOSE; DESICCATION TOLERANCE; ENHANCED PROTECTION; MEMBRANE INTEGRITY; DIVALENT-CATIONS; IMPORT MACHINERY; IN-VITRO	Anhydrobiotic animals survive virtually complete loss of cellular water. The mechanisms that explain this phenomenon are not fully understood but often include the accumulation of low molecular weight solutes such as trehalose and macromolecules like Late Embryogenesis Abundant (LEA) proteins. Here we report for the first time the occurrence of a mitochondria-targeted LEA gene (Afrlea3m) product in an animal species. The deduced molecular mass of the 307-amino acid polypeptide from the brine shrimp Artemia franciscana is 34 kDa. Bioinformatic analyses reveal features typical of a Group 3 LEA protein, and subcellular localization programs predict targeting of the mature peptide to the mitochondrial matrix, based on an N-terminal, amphipathic presequence. Real-time quantitative PCR shows that Afralea3m mRNA is expressed manyfold higher in desiccation-tolerant embryonic stages when compared with intolerant nauplius larvae. Mitochondrial localization of the protein was confirmed by transfection of human hepatoma cells (HepG2/C3A) with a nucleotide construct encoding the first 70 N-terminal amino acids of AfrLEA3m in-frame with the nucleotide sequence for green fluorescence protein. The chimeric protein was readily incorporated into mitochondria of these cells. Successful targeting of a protein to human mitochondria by use of an arthropod signaling sequence clearly reveals the highly conserved nature of such presequences, as well as of the import machinery. Finally, mitochondria isolated from A. franciscana embryos, which naturally contain AfrLEA3m and trehalose, exhibit resistance to water stress (freezing) as evidenced by an unchanged capacity for oxidative phosphorylation on succinate + rotenone, a resistance that is absent in mammalian mitochondria lacking AfrLEA3m.	[Menze, Michael A.; Boswell, Leaf; Hand, Steven C.] Louisiana State Univ, Dept Biol Sci, Div Cellular Dev & Integrat Biol, Baton Rouge, LA 70803 USA; [Toner, Mehmet] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med & Surg Serv, Charlestown, MA 02129 USA	Louisiana State University System; Louisiana State University; Harvard University; Massachusetts General Hospital	Menze, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Div Cellular Dev & Integrat Biol, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	menze@lsu.edu	Menze, Michael/AAP-8165-2020	Menze, Michael/0000-0003-1072-5462	National Institutes of Health [2 RO1 DK046270-14A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 RO1 DK046270-14A1.	Acker JP, 2002, CELL PRESERV TECHNOL, V1, P129; Bolen D W, 2001, Methods Mol Biol, V168, P17; BROWN AD, 1972, J GEN MICROBIOL, V72, P589, DOI 10.1099/00221287-72-3-589; Buchanan S. S., 2005, CELL PRESERV TECHNOL, V3, P212, DOI DOI 10.1089/CPT.2005.3.212; CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V250, P505, DOI 10.1016/0003-9861(86)90755-1; CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4; CARPENTER JF, 1987, CRYOBIOLOGY, V24, P455, DOI 10.1016/0011-2240(87)90049-6; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; CLARK ME, 1977, BIOL BULL, V153, P468, DOI 10.2307/1540601; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; CLOSE TJ, 1993, PLANT PHYSIOL, V101, P773, DOI 10.1104/pp.101.3.773; CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Covi JA, 2005, J EXP BIOL, V208, P2783, DOI 10.1242/jeb.01680; Crowe J.H., 1973, ANHYDROBIOSIS; Crowe JH, 2004, INTEGR COMP BIOL, V44, P542; Crowe JH, 2002, INTEGR COMP BIOL, V42, P497, DOI 10.1093/icb/42.3.497; Cuming AC, 1999, SEED PROTEINS, P753; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Elliott GD, 2006, CRYOBIOLOGY, V52, P114, DOI 10.1016/j.cryobiol.2005.10.009; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4; FOLKERT A, 2005, INTEGR COMP BIOL, V45, P725; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; HAND SC, 2008, OCEANS HUMAN HLTH RI, P611; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592, DOI 10.1128/AEM.61.10.3592-3597.1995; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Liu XH, 2005, BBA-BIOMEMBRANES, V1717, P21, DOI 10.1016/j.bbamem.2005.09.012; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Reynolds JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P366, DOI 10.1086/420950; Rosgen J, 2007, PROTEIN SCI, V16, P733, DOI 10.1110/ps.062671607; Somero G. N., 1992, Water and life: comparative analysis of water relationships at the organismic, cellular and molecular level. Tenth international conference on comparative physiology, Grans-sur-Serre, Switzerland, 15-17 Sep 1990., P3; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; VANLEEUWENHOEK A, 1807, SELECTED WORK A VANL, V2, P207; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Willsie JK, 2001, J EXP BIOL, V204, P2339; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zheng Y, 1998, BBA-GENE STRUCT EXPR, V1442, P419, DOI 10.1016/S0167-4781(98)00192-4	59	55	58	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10714	10719		10.1074/jbc.C900001200	http://dx.doi.org/10.1074/jbc.C900001200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228698	Green Published, hybrid			2022-12-27	WOS:000265104600045
J	Salowe, SP; Wiltsie, J; Hawkins, JC; Sonatore, LM				Salowe, Scott P.; Wiltsie, Judyann; Hawkins, Julio C.; Sonatore, Lisa M.			The Catalytic Flexibility of tRNA(Ile)-lysidine Synthetase Can Generate Alternative tRNA Substrates for Isoleucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SPECIFICITIES; ESCHERICHIA-COLI-B; CODON RECOGNITION; STRUCTURAL BASIS; ANTICODON CAT; 1ST POSITION; LYSIDINE; LYSINE; GENES; IDENTIFICATION	Bacteria decode the isoleucine codon AUA using a tRNA species that is posttranscriptionally modified at the wobble position of the anticodon with a lysine-containing cytidine derivative called lysidine. The lysidine modification of tRNA(Ile2) is an essential identity determinant for proper aminoacylation by isoleucyl tRNA synthetase (IleRS) and codon recognition on the ribosome. The ATP- and lysine-dependent formation of lysidine is catalyzed by tRNA(Ile)-lysidine synthetase. Using the purified recombinant enzyme from Escherichia coli and an in vitro transcribed tRNA substrate, we have confirmed that lysidine modification is both necessary and sufficient to convert tRNA(Ile2) into a substrate for IleRS. A series of lysine analogs were tested as potential inhibitors during the mechanistic characterization of tRNA(Ile)-lysidine synthetase. Gel electrophoresis revealed that many of these analogs, including some simple alkyl amines, were alternative substrates. Incorporation of these amines into alternative tRNA products was confirmed by mass spectrometry. The availability of tRNA(Ile2) with differential modifications enabled an exploration of the structural requirements of the anticodon for aminoacylation by methionyl tRNA synthetase and IleRS. All of the modifications were effective at creating negative determinants for methionyl tRNA synthetase and positive determinants for IleRS, although the tolerance of IleRS differed between the enzymes from E. coli and Bacillus subtilis.	[Salowe, Scott P.; Wiltsie, Judyann; Hawkins, Julio C.; Sonatore, Lisa M.] Merck Res Labs, Dept Infect Dis Res, Rahway, NJ 07065 USA	Merck & Company	Salowe, SP (corresponding author), Merck & Co Inc, RY80Y-340,POB 2000, Rahway, NJ 07065 USA.	scott_salowe@merck.com						ANDACHI Y, 1989, J MOL BIOL, V209, P37, DOI 10.1016/0022-2836(89)90168-X; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Grosjean H, 2004, TRENDS BIOCHEM SCI, V29, P165, DOI 10.1016/j.tibs.2004.02.009; GUPTA R, 1984, J BIOL CHEM, V259, P9461; HARADA F, 1974, BIOCHEMISTRY-US, V13, P300, DOI 10.1021/bi00699a011; HUGHES J, 1980, BIOCHEM J, V191, P209, DOI 10.1042/bj1910209; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kohrer C, 2008, RNA, V14, P117, DOI 10.1261/rna.795508; Kuratani M, 2007, STRUCTURE, V15, P1642, DOI 10.1016/j.str.2007.09.020; Macarron R, 2000, ANAL BIOCHEM, V284, P183, DOI 10.1006/abio.2000.4665; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Matsugi J, 1996, J BIOCHEM, V119, P811; MURAMATSU T, 1992, NUCLEOS NUCLEOT NUCL, V11, P719, DOI 10.1080/07328319208021736; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; MURAMATSU T, 1988, J BIOL CHEM, V263, P9261; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P7487, DOI 10.1073/pnas.0501003102; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Silva FJ, 2006, NUCLEIC ACIDS RES, V34, P6015, DOI 10.1093/nar/gkl739; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0	23	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9656	9662		10.1074/jbc.M809013200	http://dx.doi.org/10.1074/jbc.M809013200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233850	hybrid, Green Published			2022-12-27	WOS:000264892900005
J	Couturier, J; Koh, CS; Zaffagnini, M; Winger, AM; Gualberto, JM; Corbier, C; Decottignies, P; Jacquot, JP; Lemaire, SD; Didierjean, C; Rouhier, N				Couturier, Jeremy; Koh, Cha San; Zaffagnini, Mirko; Winger, Alison M.; Gualberto, Jose Manuel; Corbier, Catherine; Decottignies, Paulette; Jacquot, Jean-Pierre; Lemaire, Stephane D.; Didierjean, Claude; Rouhier, Nicolas			Structure-Function Relationship of the Chloroplastic Glutaredoxin S12 with an Atypical WCSYS Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; ESCHERICHIA-COLI GLUTAREDOXIN; IRON-SULFUR CLUSTER; MIXED DISULFIDE; BIOCHEMICAL-CHARACTERIZATION; MONOTHIOL GLUTAREDOXINS; PLANT GLUTAREDOXIN; THIOREDOXIN; PROTEIN; BINDING	Glutaredoxins (Grxs) are efficient catalysts for the reduction of mixed disulfides in glutathionylated proteins, using glutathione or thioredoxin reductases for their regeneration. Using GFP fusion, we have shown that poplar GrxS12, which possesses a monothiol (WCSYS32)-W-28 active site, is localized in chloroplasts. In the presence of reduced glutathione, the recombinant protein is able to reduce in vitro substrates, such as hydroxyethyldisulfide and dehydroascorbate, and to regenerate the glutathionylated glyceraldehyde-3-phosphate dehydrogenase. Although the protein possesses two conserved cysteines, it is functioning through a monothiol mechanism, the conserved C terminus cysteine (Cys(87)) being dispensable, since the C87S variant is fully active in all activity assays. Biochemical and crystallographic studies revealed that Cys(87) exhibits a certain reactivity, since its pK(a) is around 5.6. Coupled with thiol titration, fluorescence, and mass spectrometry analyses, the resolution of poplar GrxS12 x-ray crystal structure shows that the only oxidation state is a glutathionylated derivative of the active site cysteine (Cys(29)) and that the enzyme does not form inter-or intramolecular disulfides. Contrary to some plant Grxs, GrxS12 does not incorporate an iron-sulfur cluster in its wild-type form, but when the active site is mutated into YCSYS, it binds a [2Fe-2S] cluster, indicating that the single Trp residue prevents this incorporation.	[Koh, Cha San; Didierjean, Claude] Nancy Univ, Fac Sci & Tech, CNRS,UHP, LCM3B,Equipe Biocristallog, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Winger, Alison M.; Jacquot, Jean-Pierre; Rouhier, Nicolas] Nancy Univ, Fac Sci, IFR GEEF 110, Unite Mixte Rech UHP INRA Interact Arbres Microor, F-54506 Vandoeuvre Les Nancy, France; [Zaffagnini, Mirko; Lemaire, Stephane D.] Univ Paris 11, Inst Biotechnol Plantes, F-91405 Orsay, France; [Gualberto, Jose Manuel] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Corbier, Catherine] Nancy Univ, Fac Sci & Tech, Equipe PB2P, URAFPA, F-54506 Vandoeuvre Les Nancy, France; [Decottignies, Paulette] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; INRAE; Universite de Lorraine; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Didierjean, C (corresponding author), Nancy Univ, Fac Sci & Tech, CNRS,UHP, LCM3B,Equipe Biocristallog, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Claude.Didierjean@lcm3b.uhp-nancy.fr; nrouhier@scbiol.uhp-nancy.fr	Gualberto, José/I-5016-2015; Couturier, Jérémy/AAF-6588-2020; Jacquot, Jean-Pierre/A-1571-2012; DIDIERJEAN, Claude/L-1493-2013; Lemaire, Stéphane D/A-3530-2008	Gualberto, José/0000-0002-7296-2618; Couturier, Jérémy/0000-0003-3127-2669; Jacquot, Jean-Pierre/0000-0003-4975-8587; DIDIERJEAN, Claude/0000-0002-3176-8974; Lemaire, Stéphane D/0000-0001-6442-0547; Rouhier, Nicolas/0000-0002-2036-7884; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche [GNP05010G, JC07_204825, JC-45751]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grants GNP05010G and JC07_204825 ( to N.R. and J.C.) and Grant JC-45751 ( to M.Z. and S. D. L.).	Aslund F, 1996, J BIOL CHEM, V271, P6736, DOI 10.1074/jbc.271.12.6736; Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Belli G, 2002, J BIOL CHEM, V277, P37590, DOI 10.1074/jbc.M201688200; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; DeLano W, 2002, PYMOL 0 99; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Gama F, 2008, PHYSIOL PLANTARUM, V133, P599, DOI 10.1111/j.1399-3054.2008.01097.x; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; Morel M, 2008, NEW PHYTOL, V180, P391, DOI 10.1111/j.1469-8137.2008.02498.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIKKOLA M, 1991, J BIOL CHEM, V266, P16105; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Saviano M, 2000, BIOPOLYMERS, V53, P200, DOI 10.1002/(SICI)1097-0282(200002)53:2<200::AID-BIP10>3.0.CO;2-L; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; SODANO P, 1991, J MOL BIOL, V221, P1311; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; XIA TH, 1992, PROTEIN SCI, V1, P310; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	52	71	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9299	9310		10.1074/jbc.M807998200	http://dx.doi.org/10.1074/jbc.M807998200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158074	hybrid, Green Published			2022-12-27	WOS:000264669100036
J	Matzner, U; Breiden, B; Schwarzmann, G; Yaghootfam, A; Fluharty, AL; Hasilik, A; Sandhoff, K; Gieselmann, V				Matzner, Ulrich; Breiden, Bernadette; Schwarzmann, Guenter; Yaghootfam, Afshin; Fluharty, Arvan L.; Hasilik, Andrej; Sandhoff, Konrad; Gieselmann, Volkmar			Saposin B-dependent Reconstitution of Arylsulfatase A Activity in Vitro and in Cell Culture Models of Metachromatic Leukodystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBROSIDE SULFATE ACTIVATOR; LIPID-EXTRACTION CAPACITY; MOBILIZES LIPIDS; KIDNEY-CELLS; PROTEIN; ENZYME; PATIENT; STORAGE; PURIFICATION; DEGRADATION	Arylsulfatase A (ASA) catalyzes the intralysosomal desulfation of 3-O-sulfogalactosylceramide (sulfatide) to galactosylceramide. The reaction requires saposin B (Sap B), a non-enzymatic protein-aceous cofactor which presents sulfatide to the catalytic site of ASA. The lack of either ASA or Sap B results in a block of sulfatide degradation, progressive intralysosomal accumulation of sulfatide, and the fatal lysosomal storage disease metachromatic leukodystrophy. We studied the coupled Sap B-ASA reaction in vitro using detergent-free micellar and liposomal assay systems and in vivo using cell culture models of metachromatic leukodystrophy. Under in vitro conditions, the reaction had a narrowpHoptimum around pH 4.3 and was inhibited by mono- and divalent cations, phosphate and sulfite. Bis(monoacylglycero) phosphate and phosphatidic acid were activators of the reaction, underscoring a significant role of acidic phosphoglycerolipids in sphingolipid degradation. Desulfation was negligible when Sap B was substituted by Sap A, C, or D. Up to a molar ratio between Sap B and sulfatide of 1: 5, an elevation of Sap B concentrations caused a sharp increase of sulfatide hydrolysis, indicating the requirement of unexpected high Sap B levels for maximum turnover. Feeding of ASA-deficient, sulfatide-storing primary mouse kidney cells with ASA caused partial clearance of sulfatide. Co-feeding of Sap B or its precursor prosaposin resulted in the lysosomal uptake of the cofactor but did not promote ASA-catalyzed sulfatide hydrolysis. This suggests that Sap B is not a limiting factor of the coupled Sap B-ASA reaction in mouse kidney cells even if sulfatide has accumulated to unphysiologically high levels.	[Matzner, Ulrich; Yaghootfam, Afshin; Gieselmann, Volkmar] Univ Bonn, Inst Physiol Chem, D-53115 Bonn, Germany; [Breiden, Bernadette; Schwarzmann, Guenter; Sandhoff, Konrad] Univ Bonn, LIMES, Membrane Biol & Lipid Biochem Unit, Kekule Inst Organ Chem & Biochem, D-53115 Bonn, Germany; [Fluharty, Arvan L.] Univ Calif Los Angeles, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; [Hasilik, Andrej] Univ Marburg, Inst Physiol Chem, D-35032 Marburg, Germany	University of Bonn; University of Bonn; University of California System; University of California Los Angeles; Philipps University Marburg	Matzner, U (corresponding author), Nussallee 11, D-53115 Bonn, Germany.	matzner@institut.physiochem.uni-bonn.de	Breiden, Bernadette/S-3005-2019; Breiden, Bernadette/F-2422-2014	Breiden, Bernadette/0000-0002-4838-4109; Breiden, Bernadette/0000-0002-4838-4109	European Leukodystrophy Association; Bundesministerium fur Bildung und Forschung (Leukonet); Deutsche Forschungsgemeinschaft [Sa 257/21, SFB 645, 202272]	European Leukodystrophy Association; Bundesministerium fur Bildung und Forschung (Leukonet)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research grants from the European Leukodystrophy Association, the Bundesministerium fur Bildung und Forschung (Leukonet), Deutsche Forschungsgemeinschaft Grants Sa 257/21 and SFB 645, and the seventh framework program of the EU-funded "Lipidomic-Net" (proposal 202272).	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CESTARO B, 1984, ITAL J BIOCHEM, V33, P381; Ciaffoni F, 2006, J LIPID RES, V47, P1045, DOI 10.1194/jlr.M500547-JLR200; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; DOLLY JO, 1981, BIOCHEM J, V193, P919, DOI 10.1042/bj1930919; FLUHARTY AL, 1992, BIOCHEM MED METAB B, V47, P66, DOI 10.1016/0885-4505(92)90009-N; Fluharty CB, 2001, J NEUROSCI RES, V63, P82, DOI 10.1002/1097-4547(20010101)63:1<82::AID-JNR10>3.0.CO;2-D; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Gopalakrishnan MM, 2004, BIOCHEM J, V383, P507, DOI 10.1042/BJ20040175; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; Henseler M, 1996, J BIOL CHEM, V271, P8416, DOI 10.1074/jbc.271.14.8416; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; JEFFREY HJ, 1977, AUST J EXP BIOL MED, V55, P339, DOI 10.1038/icb.1977.28; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; Klein D, 2005, BIOCHEM BIOPH RES CO, V327, P663, DOI 10.1016/j.bbrc.2004.12.054; Klein D, 2009, BIOL CHEM, V390, P41, DOI 10.1515/BC.2009.009; Kolodny E.H., 1995, METABOLIC MOL BASES, V7th, P2693; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KOSHY KM, 1982, LIPIDS, V17, P998, DOI 10.1007/BF02534598; LAPIDOT Y, 1967, J LIPID RES, V8, P142; Locatelli-Hoops S, 2006, J BIOL CHEM, V281, P32451, DOI 10.1074/jbc.M607281200; Matzner U, 2005, HUM MOL GENET, V14, P1139, DOI 10.1093/hmg/ddi126; Matzner U, 2008, J MOL MED, V86, P433, DOI 10.1007/s00109-008-0309-3; Norris AJ, 2005, J LIPID RES, V46, P2254, DOI 10.1194/jlr.M500188-JLR200; PORTER MT, 1972, BIOCHIM BIOPHYS ACTA, V258, P769, DOI 10.1016/0005-2744(72)90178-7; Remmel N, 2007, FEBS J, V274, P3405, DOI 10.1111/j.1742-4658.2007.05873.x; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Sandhoff K., 2001, METABOLIC ANDMOLECUL, P3371; Schierau A, 1999, J BIOL CHEM, V274, P3651, DOI 10.1074/jbc.274.6.3651; SCHWARZMANN G, 1987, METHOD ENZYMOL, V138, P319; SOMMERLADE HJ, 1994, BIOCHEM J, V297, P123, DOI 10.1042/bj2970123; STINSHOFF K, 1975, BIOCHIM BIOPHYS ACTA, V377, P126, DOI 10.1016/0005-2744(75)90293-4; Sun Y, 2002, MOL GENET METAB, V76, P271, DOI 10.1016/S1096-7192(02)00114-2; VOGEL A, 1991, EUR J BIOCHEM, V200, P591, DOI 10.1111/j.1432-1033.1991.tb16222.x; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695; YAO JK, 1985, ANAL BIOCHEM, V150, P111, DOI 10.1016/0003-2697(85)90447-6	41	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9372	9381		10.1074/jbc.M809457200	http://dx.doi.org/10.1074/jbc.M809457200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19224915	Green Published, hybrid			2022-12-27	WOS:000264669100043
J	Chen, Q; Zhang, H; Li, QM; An, Y; Herkenham, M; Lai, WM; Popovich, P; Agarwal, S; Quan, N				Chen, Qun; Zhang, Hao; Li, Qiming; An, Ying; Herkenham, Miles; Lai, Wenmin; Popovich, Phillip; Agarwal, Sudha; Quan, Ning			Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; IL-1 RECEPTOR; MOUSE-BRAIN; INFLAMMATION; INDUCTION; GENE; LIPOPOLYSACCHARIDE; GLUCOCORTICOIDS; POLYMORPHISMS; TRANSCRIPTION	The type 1 interleukin-1 receptor (IL-1R1) mediates diverse functions of interleukin-1 (IL-1) in the nervous, immune, and neuroendocrine systems. It has been suggested previously that the versatile functions of IL-1 may in part be conferred by the multiple promoters of IL-1R1 that have been identified for the human IL-1R1 gene. Promoters for murine IL-1R1 (mIL-1R1) gene have not been studied in detail. We performed 5'-rapid amplification of cDNA ends to determine the transcription start sites (TSS) in mIL-1R1, using mRNAs derived from 24 different tissues. The results revealed three putative TSSs of mIL-1R1. Three full-length cDNAs containing these distinct TSSs were recovered in screens of cloned cDNA libraries. Translation of these cDNAs produced IL-1R1 proteins that were verified by Western blot analysis. IL-1 stimulation of the individual IL-1R1 proteins resulted in the activation of NF-kappa B. Promoter-reporter assay for genomic DNA sequences immediately upstream of the three TSSs validated that the sequences possess promoter activity in a cell type-specific manner. These promoters are termed P1, P2, and P3 of the mIL-1R1, in 5' to 3' order. Quantitative PCR analysis of P1-, P2-, and P3-specific mIL-1R1 mRNAs showed that there is tissue-specific distribution of these mRNAs in vivo, and there are distinct patterns of P1, P2, and P3 mRNA expression in different cell lines. In the brain, P3 mRNA is expressed preferentially in the dentate gyrus. Further, glucocorticoids differentially regulate these promoters in a cell type-specific manner. Together, these results suggest that the different IL-1R1 promoters contribute to the discrete and diverse actions of IL-1.	[Quan, Ning] Ohio State Univ, Dept Oral Biol, Columbus, OH 43210 USA; [Herkenham, Miles] NIMH, Funct Neuroanat Sect, Bethesda, MD 20892 USA; [Lai, Wenmin; Popovich, Phillip] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Ohio; Ohio State University	Quan, N (corresponding author), 4179 Postle Hall,305 W 12th Ave, Columbus, OH 43210 USA.	quan.14@osu.edu	Popovich, Phillip/C-9187-2009	Popovich, Phillip/0000-0003-1329-7395; Herkenham, Miles/0000-0003-2228-4238	National Institutes of Health [R01 AI076926]; Intramural Research Program of the National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH001090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI076926 (to N.Q.). This work was also supported by the Intramural Research Program of the National Institute of Mental Health.	AKAHOSHI T, 1988, J EXP MED, V167, P924, DOI 10.1084/jem.167.3.924; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; BAN E, 1993, NEUROENDOCRINOLOGY, V58, P581, DOI 10.1159/000126594; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BERGHOLDT R, 1995, CYTOKINE, V7, P727, DOI 10.1006/cyto.1995.0086; BOMSZTYK K, 1989, P NATL ACAD SCI USA, V86, P8034, DOI 10.1073/pnas.86.20.8034; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; D'Amora P, 2006, AM J REPROD IMMUNOL, V56, P178, DOI 10.1111/j.1600-0897.2006.00415.x; DUBOIS CM, 1993, EXP HEMATOL, V21, P303; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Ito A, 1997, J INTERF CYTOK RES, V17, P413, DOI 10.1089/jir.1997.17.413; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Lynch MA, 2002, VITAM HORM, V64, P185, DOI 10.1016/S0083-6729(02)64006-3; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Quan N, 2002, HISTOL HISTOPATHOL, V17, P273, DOI 10.14670/HH-17.273; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; SHIEH JH, 1993, BLOOD, V81, P1745; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; SIMS JE, 1994, EUR CYTOKINE NETW, V5, P539; SIMS JE, 1995, CYTOKINE, V7, P483, DOI 10.1006/cyto.1995.0066; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SPRIGGS MK, 1990, J BIOL CHEM, V265, P22499; Wu H, 2007, FEBS J, V274, P3218, DOI 10.1111/j.1742-4658.2007.05891.x; Ye K, 1996, CYTOKINE, V8, P421, DOI 10.1006/cyto.1996.0058; YE K, 1993, P NATL ACAD SCI USA, V90, P2295, DOI 10.1073/pnas.90.6.2295; Zhang H, 2008, NEUROSCIENCE, V157, P895, DOI 10.1016/j.neuroscience.2008.09.038; ZHANG H, 2008, BRAIN BEHAV IMMUN, V22, P31	31	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8694	8704		10.1074/jbc.M808261200	http://dx.doi.org/10.1074/jbc.M808261200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19196714	Green Published, hybrid			2022-12-27	WOS:000264397800054
J	Wilson, CL; Schmidt, AP; Pirila, E; Valore, EV; Ferri, N; Sorsa, T; Ganz, T; Parks, WC				Wilson, Carole L.; Schmidt, Amy P.; Pirilae, Emma; Valore, Erika V.; Ferri, Nicola; Sorsa, Timo; Ganz, Tomas; Parks, William C.			Differential Processing of alpha- and beta-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN NK CELLS; EPITHELIAL-CELLS; HUMAN-NEUTROPHILS; ANTIMICROBIAL PEPTIDE; HUMAN BETA-DEFENSIN-1; MATRILYSIN EXPRESSION; INDUCIBLE PEPTIDE; GENE-EXPRESSION; INNATE IMMUNITY	Proteolytic processing of defensins is a critical mode of post-translational regulation of peptide activity. Because mouse alpha-defensin precursors are cleaved and activated by matrix metalloproteinase-7 (MMP-7), we determined if additional defensin molecules, namely human neutrophil defensin pro-HNP-1 and beta-defensins, are targets for MMP-7. We found that MMP-7 cleaves within the pro-domain of the HNP-1 precursor, a reaction that does not generate the mature peptide but produces a 59-amino acid intermediate. This intermediate, which retains the carboxyl-terminal end of the pro-domain, had antimicrobial activity, indicating that the residues important for masking defensin activity reside in the amino terminus of this domain. Mature HNP-1 was resistant to processing by MMP-7 unless the peptide was reduced and alkylated, demonstrating that only the pro-domain of alpha-defensins is normally accessible for cleavage by this enzyme. From the 47-residue HBD-1 precursor, MMP-7 catalyzed removal of 6 amino acids from the amino terminus. Neither a 39-residue intermediate form of HBD-1 nor the mature 36-residue form of HBD-1 was cleaved by MMP-7. In addition, both pro-HBD-2, with its shorter amino-terminal extension, and pro-HBD-3 were resistant to MMP-7. However, human and mouse beta-defensin precursors that lack disulfide bonding contain a cryptic MMP-7-sensitive site within the mature peptide moiety. These findings support and extend accumulating evidence that the native three-dimensional structure of both alpha- and beta-defensins protects the mature peptides against proteolytic processing by MMP-7. We also conclude that sites for MMP-7 cleavage are more common at the amino termini of beta-defensin rather than beta-defensin precursors, and that catalysis at these sites in beta-defensin pro-domains results in acquisition of defensin activity.	[Wilson, Carole L.] Univ Washington, Dept Pathol, Seattle, WA 98104 USA; [Parks, William C.] Univ Washington, Ctr Lung Biol, Seattle, WA 98104 USA; [Schmidt, Amy P.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Pirilae, Emma; Sorsa, Timo] Univ Helsinki, Inst Dent, Dept Periodontol, FIN-00014 Helsinki, Finland; [Valore, Erika V.; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Ferri, Nicola] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Helsinki; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Milan	Wilson, CL (corresponding author), Univ Washington, Dept Pathol, 325 9th Ave,Box 359675, Seattle, WA 98104 USA.	carolew2@u.washington.edu	ferri, nicola/K-7085-2019; Ganz, Tomas/AAN-3308-2020; Ferri, Nicola/F-4879-2013; Parks, William C./AAH-6786-2021; Ganz, Tomas/D-4567-2009	ferri, nicola/0000-0001-8898-7441; Ferri, Nicola/0000-0001-8898-7441; Ganz, Tomas/0000-0002-2830-5469	National Institutes of Health [DE14040, HL29594]; Academy of Finland and Helsinki University Central Hospital Research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland and Helsinki University Central Hospital Research grant(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14040 (to C. L. W.) and HL29594 (to W. C. P.). This work was also supported by an Academy of Finland and Helsinki University Central Hospital Research grant (to T. S. and E. P.).	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; Cha JH, 1996, BIOCHEMISTRY-US, V35, P15831, DOI 10.1021/bi962085f; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Cunliffe RN, 2002, J CLIN PATHOL, V55, P298, DOI 10.1136/jcp.55.4.298; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Faurschou M, 2005, J LEUKOCYTE BIOL, V78, P785, DOI 10.1189/jlb.1104688; Frye M, 2000, J CLIN PATHOL, V53, P770, DOI 10.1136/jcp.53.10.770; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Garton KJ, 2002, BIOTECHNIQUES, V32, P830, DOI 10.2144/02324rr01; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; HARWIG SSL, 1992, BLOOD, V79, P1532; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Krishnakumari V, 2003, BIOCHEMISTRY-US, V42, P9307, DOI 10.1021/bi034403y; Krishnakumari V, 2006, PEPTIDES, V27, P2607, DOI 10.1016/j.peptides.2006.06.004; Kuula H, 2008, ARCH ORAL BIOL, V53, P175, DOI 10.1016/j.archoralbio.2007.09.010; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; Lopez-Boado YS, 2001, J BIOL CHEM, V276, P41417, DOI 10.1074/jbc.M107121200; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Morrison GM, 1998, MAMM GENOME, V9, P453, DOI 10.1007/s003359900795; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Ogle CK, 2002, CRIT CARE MED, V30, P428, DOI 10.1097/00003246-200202000-00027; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Paulsen F, 2002, J PATHOL, V198, P369, DOI 10.1002/path.1224; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Quayle AJ, 1998, AM J PATHOL, V152, P1247; RICE WG, 1987, BLOOD, V70, P757; Rodriguez-Garcia M, 2007, J LEUKOCYTE BIOL, V82, P1143, DOI 10.1189/jlb.0507295; SAARIALHOKERE UK, 1995, J INVEST DERMATOL, V105, P190, DOI 10.1111/1523-1747.ep12317104; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Svinarich DM, 1997, AM J OBSTET GYNECOL, V176, P470, DOI 10.1016/S0002-9378(97)70517-9; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wehkamp J, 2002, DIGEST DIS SCI, V47, P1349, DOI 10.1023/A:1015334917273; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yamaguchi Y, 2001, J BIOL CHEM, V276, P31510, DOI 10.1074/jbc.M104149200; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zucht H D, 1998, Eur J Med Res, V3, P315	62	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8301	8311		10.1074/jbc.M809744200	http://dx.doi.org/10.1074/jbc.M809744200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19181662	Green Published, hybrid			2022-12-27	WOS:000264397800014
J	Fukushima, K; Matsumura, I; Ezoe, S; Tokunaga, M; Yasumi, M; Satoh, Y; Shibayama, H; Tanaka, H; Iwama, A; Kanakura, Y				Fukushima, Kentaro; Matsumura, Itaru; Ezoe, Sachiko; Tokunaga, Masahiro; Yasumi, Masato; Satoh, Yusuke; Shibayama, Hirohiko; Tanaka, Hirokazu; Iwama, Atsushi; Kanakura, Yuzuru			FIP1L1-PDGFR alpha Imposes Eosinophil Lineage Commitment on Hematopoietic Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CYTOKINE-DEPENDENT GROWTH; ACTIVATED PROTEIN-KINASE; PROTOONCOGENE C-KIT; HYPEREOSINOPHILIC SYNDROME; RECEPTOR-ALPHA; IN-VIVO; CATALYTIC DOMAIN; FUSION GENE; STEM-CELLS	Although leukemogenic tyrosine kinases (LTKs) activate a common set of downstream molecules, the phenotypes of leukemia caused by LTKs are rather distinct. Here we report the molecular mechanism underlying the development of hypereosinophilic syndrome/chronic eosinophilic leukemia by FIP1L1-PDGFR alpha. When introduced into c-Kit(high)Sca-1(+)Lineage(-) cells, FIP1L1-PDGFR alpha conferred cytokine-independent growth on these cells and enhanced their self-renewal, whereas it did not immortalize common myeloid progenitors in in vitro replating assays and transplantation assays. Importantly, FIP1L1-PDGFR alpha but not TEL-PDGFR beta enhanced the development of Gr-1(+)IL-5R alpha(+) eosinophil progenitors from c-Kit(high)Sca-1(+)Lineage(-) cells. FIP1L1-PDGFR alpha also promoted eosinophil development from common myeloid progenitors. Furthermore, when expressed in megakaryocyte/erythrocyte progenitors and common lymphoid progenitors, FIP1L1-PDGFR alpha not only inhibited differentiation toward erythroid cells, megakaryocytes, and B-lymphocytes but aberrantly developed eosinophil progenitors from megakaryocyte/erythrocyte progenitors and common lymphoid progenitors. As for the mechanism of FIP1L1-PDGFR alpha-induced eosinophil development, FIP1L1-PDGFR alpha was found to more intensely activate MEK1/2 and p38MAPK than TEL-PDGFR beta. In addition, a MEK1/2 inhibitor and a p38MAPK inhibitor suppressed FIP1L1-PDGFR alpha-promoted eosinophil development. Also, reverse transcription-PCR analysis revealed that FIP1L1-PDGFR alpha augmented the expression of C/EBP alpha, GATA-1, and GATA-2, whereas it hardly affected PU.1 expression. In addition, short hairpin RNAs against C/EBP alpha and GATA-2 and GATA-3KRR, which can act as a dominant-negative form over all GATA members, inhibited FIP1L1-PDGFR alpha-induced eosinophil development. Furthermore, FIP1L1-PDGFR alpha and its downstream Ras inhibited PU.1 activity in luciferase assays. Together, these results indicate that FIP1L1-PDGFR alpha enhances eosinophil development by modifying the expression and activity of lineage-specific transcription factors through Ras/MEK and p38MAPK cascades.	[Fukushima, Kentaro; Matsumura, Itaru; Ezoe, Sachiko; Tokunaga, Masahiro; Yasumi, Masato; Satoh, Yusuke; Shibayama, Hirohiko; Tanaka, Hirokazu; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Ezoe, Sachiko] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan; [Iwama, Atsushi] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan	Osaka University; Osaka University; Chiba University	Ezoe, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	sezoe@bldon.med.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture and Technology of Japan	Ministry of Education, Science, Sports, and Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abkowitz JL, 2000, BLOOD, V96, P3399, DOI 10.1182/blood.V96.10.3399.h8003399_3399_3405; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arcasoy MO, 2001, EUR J HAEMATOL, V67, P77, DOI 10.1034/j.1600-0609.2001.t01-1-00491.x; Bene MC, 1998, BLOOD, V92, P596, DOI 10.1182/blood.V92.2.596.414k05_596_599; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buitenhuis M, 2008, BLOOD, V111, P112, DOI 10.1182/blood-2006-07-037572; Buitenhuis N, 2007, CANCER RES, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183; Capovilla M, 2008, EUR J HAEMATOL, V80, P81, DOI 10.1111/j.1600-0609.2007.00973.x; Cools J, 2003, CANCER CELL, V3, P459, DOI 10.1016/S1535-6108(03)00108-9; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Ezoe S, 2005, J BIOL CHEM, V280, P13163, DOI 10.1074/jbc.M413461200; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fritsche-Polanz R, 2001, BRIT J HAEMATOL, V113, P357, DOI 10.1046/j.1365-2141.2001.02783.x; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Griffin JH, 2003, P NATL ACAD SCI USA, V100, P7830, DOI 10.1073/pnas.0932698100; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hsu CL, 2007, BLOOD, V110, P1420, DOI 10.1182/blood-2007-02-071761; Huang S, 1999, BLOOD, V94, P2595, DOI 10.1182/blood.V94.8.2595.420k37_2595_2604; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; IKEDA H, 1991, BLOOD, V78, P2962; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jovanovic JV, 2007, BLOOD, V109, P4635, DOI 10.1182/blood-2006-10-050054; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; La Starza R, 2005, HAEMATOLOGICA, V90, P596; Levis M, 2001, BLOOD, V98, P885, DOI 10.1182/blood.V98.3.885; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Matsumura I, 2000, BLOOD, V96, P2440; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; McNagny K, 2002, J EXP MED, V195, pf43, DOI 10.1084/jem.20020636; McNagny KM, 2003, BLOOD, V101, P1103, DOI 10.1182/blood-2002-04-1050; McPherson T, 2006, BRIT J DERMATOL, V155, P824, DOI 10.1111/j.1365-2133.2006.07416.x; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Okitsu Y, 2007, BIOCHEM BIOPH RES CO, V364, P383, DOI 10.1016/j.bbrc.2007.10.031; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Robyn J, 2006, BRIT J HAEMATOL, V132, P286, DOI 10.1111/j.1365-2141.2005.05863.x; Roufosse F, 2003, ANNU REV MED, V54, P169, DOI 10.1146/annurev.med.54.101601.152431; Roufosse FE, 2003, NEW ENGL J MED, V348, P2687; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; Stover EH, 2005, BLOOD, V106, P3206, DOI 10.1182/blood-2005-05-1932; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Sutherland HJ, 1996, BLOOD, V87, P4754, DOI 10.1182/blood.V87.11.4754.bloodjournal87114754; Tanaka H, 2006, STEM CELLS, V24, P2592, DOI 10.1634/stemcells.2005-0434; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wong CK, 2002, CLIN EXP IMMUNOL, V128, P483, DOI 10.1046/j.1365-2249.2002.01880.x; Yamada Y, 2006, BLOOD, V107, P4071, DOI 10.1182/blood-2005-08-3153; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	69	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7719	7732		10.1074/jbc.M807489200	http://dx.doi.org/10.1074/jbc.M807489200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147501	Green Published, hybrid			2022-12-27	WOS:000264195600034
J	Murata, T; Sato, Y; Nakayama, S; Kudoh, A; Iwahori, S; Isomura, H; Tajima, M; Hishiki, T; Ohshima, T; Hijikata, M; Shimotohno, K; Tsurumi, T				Murata, Takayuki; Sato, Yoshitaka; Nakayama, Sanae; Kudoh, Ayumi; Iwahori, Satoko; Isomura, Hiroki; Tajima, Masako; Hishiki, Takayuki; Ohshima, Takayuki; Hijikata, Makoto; Shimotohno, Kunitada; Tsurumi, Tatsuya			TORC2, a Coactivator of cAMP-response Element-binding Protein, Promotes Epstein-Barr Virus Reactivation from Latency through Interaction with Viral BZLF1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; SWITCH GENE BZLF1; LYTIC SWITCH; SIGNAL-TRANSDUCTION; CYCLOSPORINE-A; CELL-LINE; CREB; REPLICATION; IDENTIFICATION; TRANSCRIPTION	Reactivation of the Epstein-Barr virus from latency is dependent on expression of the viral BZLF1 protein. The BZLF1 promoter (Zp) normally exhibits only low basal activity but is activated in response to chemical inducers such as 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. We found here that Transducer of Regulated cAMP-response Element-binding Protein (CREB) (TORC) 2 enhances Zp activity 10-fold and more than 100-fold with co-expression of the BZLF1 protein. Mutational analysis of Zp revealed that the activation by TORC is dependent on ZII and ZIII cis elements, binding sites for CREB family transcriptional factors and the BZLF1 protein, respectively. Immunoprecipitation, chromatin immunoprecipitation, and reporter assay using Gal4-luc and Gal4BD-BZLF1 fusion protein indicate that TORC2 interacts with BZLF1, and that the complex is efficiently recruited onto Zp. These observations clearly indicate that TORC2 activates the promoter through interaction with the BZLF1 protein as well as CREB family transcriptional factors. Induction of the lytic replication resulted in the translocation of TORC2 from cytoplasm to viral replication compartments in nuclei, and furthermore, activation of Zp by TORC2 was augmented by calcium-regulated phosphatase, calcineurin. Silencing of endogenous TORC2 gene expression by RNA interference decreased the levels of the BZLF1 protein in response to 12-O-tetradecanoylphorbol-13-acetate/ionophore. Based on these results, we conclude that Epstein-Barr virus exploits the calcineurin-TORC signaling pathway through interactions between TORC and the BZLF1 protein in reactivation from latency.	[Murata, Takayuki; Sato, Yoshitaka; Nakayama, Sanae; Kudoh, Ayumi; Iwahori, Satoko; Isomura, Hiroki; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hishiki, Takayuki] Teikyo Univ, Sch Med, Cent Clin Lab, Tokyo 1730003, Japan; [Hishiki, Takayuki; Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba 2750016, Japan; [Hishiki, Takayuki; Shimotohno, Kunitada] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Hishiki, Takayuki; Ohshima, Takayuki] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan	Aichi Cancer Center; Teikyo University; Chiba Institute of Technology; Keio University; Kyoto University	Tsurumi, T (corresponding author), Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Iwahori, Satoko/L-1948-2019; Sato, Yoshitaka/P-9728-2015; Murata, Takayuki/I-2621-2013	Sato, Yoshitaka/0000-0002-8541-6413; Murata, Takayuki/0000-0001-7228-0839; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Education, Science, Sports, Culture, and Technology of Japan [20012056, 19041078, 20390137, 20790362]	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from Ministry of Education, Science, Sports, Culture, and Technology of Japan Grants 20012056, 19041078, and 20390137 (to T. T.) and 20790362 (to T. M.).	Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bryant H, 2002, J VIROL, V76, P10290, DOI 10.1128/JVI.76.20.10290-10298.2002; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; GOLDFELD AE, 1995, VIROLOGY, V209, P225, DOI 10.1006/viro.1995.1247; Gruffat H, 2002, EMBO REP, V3, P141, DOI 10.1093/embo-reports/kvf031; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kanamori M, 2000, VIRUS GENES, V20, P117, DOI 10.1023/A:1008110312661; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Kuraishy AI, 2007, P NATL ACAD SCI USA, V104, P10175, DOI 10.1073/pnas.0704170104; LANG D, 1992, NUCLEIC ACIDS RES, V20, P3287, DOI 10.1093/nar/20.13.3287; Liu PF, 1998, J VIROL, V72, P8230, DOI 10.1128/JVI.72.10.8230-8239.1998; Liu SF, 1997, VIROLOGY, V228, P11, DOI 10.1006/viro.1996.8371; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; Morrison TE, 2004, VIROLOGY, V328, P219, DOI 10.1016/j.virol.2004.07.020; Murata T, 2006, J BIOL CHEM, V281, P20788, DOI 10.1074/jbc.M600563200; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; RUF IK, 1995, J VIROL, V69, P7648, DOI 10.1128/JVI.69.12.7648-7657.1995; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; TAYLOR N, 1991, J VIROL, V65, P4033, DOI 10.1128/JVI.65.8.4033-4041.1991; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wu FY, 2003, J VIROL, V77, P1481, DOI 10.1128/JVI.77.2.1481-1500.2003; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Zerby D, 1999, MOL CELL BIOL, V19, P1617; ZHANG Q, 1994, MOL CELL BIOL, V14, P1929, DOI 10.1128/MCB.14.3.1929	45	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8033	8041		10.1074/jbc.M808466200	http://dx.doi.org/10.1074/jbc.M808466200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164291	Green Published, hybrid			2022-12-27	WOS:000264195600066
J	Wilkinson, TA; Januszyk, K; Phillips, ML; Tekeste, SS; Zhang, M; Miller, JT; Le Grice, SFJ; Clubb, RT; Chow, SA				Wilkinson, Thomas A.; Januszyk, Kurt; Phillips, Martin L.; Tekeste, Shewit S.; Zhang, Min; Miller, Jennifer T.; Le Grice, Stuart F. J.; Clubb, Robert T.; Chow, Samson A.			Identifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROVIRAL DNA FORMATION; VIRAL NUCLEIC-ACIDS; DOUBLE-STRANDED DNA; PREINTEGRATION COMPLEXES; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; IN-VITRO; NONDIVIDING CELLS; GENETIC-ANALYSIS	Integrase (IN) from human immunodeficiency virus, type 1 (HIV-1) exerts pleiotropic effects in the viral replication cycle. Besides integration, IN mutations can impact nuclear import, viral maturation, and reverse transcription. IN and reverse transcriptase (RT) interact in vitro, and the IN C-terminal domain (CTD) is both necessary and sufficient for binding RT. We used nuclear magnetic resonance spectroscopy to identify a putative RT-binding surface on the IN CTD, and surface plasmon resonance to obtain kinetic parameters and the binding affinity for the IN-RT interaction. An IN K258A substitution that disrupts reverse transcription in infected cells is located at the putative RT-binding surface, and we found that this substitution substantially weakens IN CTD-RT interactions. We also identified two additional IN amino acid substitutions located at the putative RT-binding surface (W243E and V250E) that significantly impair viral replication in tissue culture. These results strengthen the notion that IN-RT interactions are biologically relevant during HIV-1 replication and also provide insights into this interaction at the molecular level.	[Wilkinson, Thomas A.; Tekeste, Shewit S.; Zhang, Min; Chow, Samson A.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Januszyk, Kurt; Phillips, Martin L.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Miller, Jennifer T.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chow, SA (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, CHS 23-133,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	schow@mednet.ucla.edu	zhang, min/C-6300-2011		National Institutes of Health [CA68859, AI077386]; UCLA AIDS Institute; UCLA Center for AIDS Researc [AI28697]; State of California Universitywide AIDS Research Program [CC95 LA 137, 05-LA-021]; Intramural Research Program of the Center for Cancer Research; NCI; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA068859, ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077386, P30AI028697, R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA AIDS Institute; UCLA Center for AIDS Researc; State of California Universitywide AIDS Research Program; Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA68859 and AI077386 (to S. A. C.). This work was also supported by the UCLA AIDS Institute, UCLA Center for AIDS Research (AI28697 to T. A. W.), State of California Universitywide AIDS Research Program Grants CC95 LA 137 (to T. A. W.) and 05-LA-021 (to S. A. C.), and by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to S. F. J. L.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Appa RS, 2001, J BIOL CHEM, V276, P45848, DOI 10.1074/jbc.M107365200; Brown P. O., 1997, P161; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; De Luca L, 2003, BIOCHEM BIOPH RES CO, V310, P1083, DOI 10.1016/j.bbrc.2003.09.120; DeLano W.L, PYMOL MOL GRAPHICS S; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Divita G, 1995, BIOCHEMISTRY-US, V34, P16337, DOI 10.1021/bi00050a014; Dobard CW, 2007, J VIROL, V81, P10037, DOI 10.1128/JVI.00519-07; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gleenberg IO, 2005, J BIOL CHEM, V280, P21987, DOI 10.1074/jbc.M414679200; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Herschhorn A, 2008, BIOCHEM J, V412, P163, DOI 10.1042/BJ20071279; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Holmes-Son M L, 2001, Adv Genet, V43, P33, DOI 10.1016/S0065-2660(01)43003-3; HU SC, 1986, J VIROL, V60, P267, DOI 10.1128/JVI.60.1.267-274.1986; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lai LL, 2001, J VIROL, V75, P11365, DOI 10.1128/JVI.75.23.11365-11372.2001; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; MASUDA T, 1995, J VIROL, V69, P6687, DOI 10.1128/JVI.69.11.6687-6696.1995; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Oz I, 2002, BIOCHEM J, V361, P557, DOI 10.1042/0264-6021:3610557; Padow M, 2003, J VIROL, V77, P11050, DOI 10.1128/JVI.77.20.11050-11059.2003; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Quillent C, 1996, VIROLOGY, V219, P29, DOI 10.1006/viro.1996.0219; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; SHIN CG, 1994, J VIROL, V68, P1633, DOI 10.1128/JVI.68.3.1633-1642.1994; Tasara T, 2001, FEBS LETT, V507, P39, DOI 10.1016/S0014-5793(01)02945-3; Temiz NA, 2002, PROTEINS, V49, P61, DOI 10.1002/prot.10183; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004	65	51	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7931	7939		10.1074/jbc.M806241200	http://dx.doi.org/10.1074/jbc.M806241200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150986	Green Published, hybrid			2022-12-27	WOS:000264195600055
J	Wiederhold, K; Fasshauer, D				Wiederhold, Katrin; Fasshauer, Dirk			Is Assembly of the SNARE Complex Enough to Fuel Membrane Fusion?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-SNARE; NEURONAL SNARES; HIV-1 GP120; PROTEINS; MECHANISMS; EXOCYTOSIS; ENERGETICS; BIND; CORE	The three key players in the exocytotic release of neurotransmitters from synaptic vesicles are the SNARE (soluble N-ethylmaleimidesensitive factor attachment protein receptor) proteins synaptobrevin 2, syntaxin 1a, and SNAP-25. Their assembly into a tight four-helix bundle complex is thought to pull the two membranes into close proximity. It is debated, however, whether the energy generated suffices for membrane fusion. Here, we have determined the thermodynamic properties of the individual SNARE assembly steps by isothermal titration calorimetry. We found extremely large favorable enthalpy changes counterbalanced by positive entropy changes, reflecting the major conformational changes upon assembly. To circumvent the fact that ternary complex formation is essentially irreversible, we used a stabilized syntaxin-SNAP-25 heterodimer to study synaptobrevin binding. This strategy revealed that the N-terminal synaptobrevin coil binds reversibly with nanomolar affinity. This suggests that individual, membrane-bridging SNARE complexes can provide much less pulling force than previously claimed.	[Wiederhold, Katrin; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Fasshauer, Dirk/B-1563-2013	Fasshauer, Dirk/0000-0002-1040-4282	Deutsche Forschungsgemeinschaft [SFB523]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant the SFB523.	Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Durrieu MP, 2008, BIOPHYS J, V94, P3436, DOI 10.1529/biophysj.107.123117; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Frey G, 2006, P NATL ACAD SCI USA, V103, P13938, DOI 10.1073/pnas.0601036103; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim CS, 2002, BIOCHEMISTRY-US, V41, P10928, DOI 10.1021/bi026266v; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Leavitt SA, 2004, CURR PROTEIN PEPT SC, V5, P1; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu W, 2008, BIOPHYS J, V95, P419, DOI 10.1529/biophysj.107.127886; Liu W, 2006, BIOPHYS J, V91, P744, DOI 10.1529/biophysj.105.073312; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parpura V, 2008, TRENDS NEUROSCI, V31, P435, DOI 10.1016/j.tins.2008.06.003; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2008, STRUCTURE, V16, P163, DOI 10.1016/j.str.2008.01.001; Rizo J, 2007, NAT STRUCT MOL BIOL, V14, P880, DOI 10.1038/nsmb1007-880; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weiss Carol D, 2003, AIDS Rev, V5, P214; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yersin A, 2003, P NATL ACAD SCI USA, V100, P8736, DOI 10.1073/pnas.1533137100; Yoon TY, 2009, CELL MOL LIFE SCI, V66, P460, DOI 10.1007/s00018-008-8372-z; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Zhang F, 2002, J BIOL CHEM, V277, P24294, DOI 10.1074/jbc.M201200200	57	55	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13143	13152		10.1074/jbc.M900703200	http://dx.doi.org/10.1074/jbc.M900703200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19258315	Green Published, hybrid			2022-12-27	WOS:000265688300061
J	Zhang, Y; Wang, YG; Zhang, Q; Liu, XJ; Liu, X; Jiao, L; Zhu, W; Zhang, ZH; Zhao, XL; He, C				Zhang, Yong; Wang, Yong-Gang; Zhang, Qi; Liu, Xiu-Jie; Liu, Xuan; Jiao, Li; Zhu, Wei; Zhang, Zhao-Huan; Zhao, Xiao-Lin; He, Cheng			Interaction of Mint2 with TrkA Is Involved in Regulation of Nerve Growth Factor-induced Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; PHOSPHOTYROSINE-BINDING DOMAIN; SYNAPTIC VESICLE EXOCYTOSIS; ACTIVATION LOOP TYROSINES; FACTOR RECEPTOR TRKA; SIGNAL-TRANSDUCTION; SYMPATHETIC NEURONS; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN	TrkA receptor signaling is essential for nerve growth factor (NGF)-induced survival and differentiation of sensory neurons. To identify possible effectors or regulators of TrkA signaling, yeast two-hybrid screening was performed using the intracellular domain of TrkA as bait. We identified muc18-1-interacting protein 2 (Mint2) as a novel TrkA-binding protein and found that the phosphotyrosine binding domain of Mint2 interacted with TrkA in a phosphorylation-and ligand-independent fashion. Coimmunoprecipitation assays showed that endogenous TrkA interacted with Mint2 in rat tissue homogenates, and immunohistochemical evidence revealed that Mint2 and TrkA colocalized in rat dorsal root ganglion neurons. Furthermore, Mint2 overexpression inhibited NGF-induced neurite outgrowth in both PC12 and cultured dorsal root ganglion neurons, whereas inhibition of Mint2 expression by RNA interference facilitated NGF-induced neurite outgrowth. Moreover, Mint2 was found to promote the retention of TrkA in the Golgi apparatus and inhibit its surface sorting. Taken together, our data provide evidence that Mint2 is a novel TrkA-regulating protein that affects NGF-induced neurite outgrowth, possibly through a mechanism involving retention of TrkA in the Golgi apparatus.	[Zhang, Yong; Wang, Yong-Gang; Zhang, Qi; Liu, Xiu-Jie; Liu, Xuan; Jiao, Li; Zhu, Wei; Zhang, Zhao-Huan; Zhao, Xiao-Lin; He, Cheng] Second Mil Med Univ, Minist Educ, Inst Neurosci, Shanghai 200433, Peoples R China; [Zhang, Yong; Wang, Yong-Gang; Zhang, Qi; Liu, Xiu-Jie; Liu, Xuan; Jiao, Li; Zhu, Wei; Zhang, Zhao-Huan; Zhao, Xiao-Lin; He, Cheng] Second Mil Med Univ, Minist Educ, Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China; [Wang, Yong-Gang] Tongji Univ, Dept Neurol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China	Naval Medical University; Naval Medical University; Tongji University	He, C (corresponding author), Second Mil Med Univ, Minist Educ, Inst Neurosci, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn		Zhang, Zhaohuan/0000-0001-6882-9761	National Natural Science Foundation of China [30400123, 30570939, 30770657, 30530240]; National Key Basic Research Program [2006CB500702, 2007CB947100]; Program for Changjiang Scholars and Innovative Research Team [IRT0528]; Shanghai Rising- Star Program [05QMX1469]; Shanghai Metropolitan Fund for Research and Development [07DJ14005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai Rising- Star Program; Shanghai Metropolitan Fund for Research and Development	This work was supported by National Natural Science Foundation of China Grants 30400123, 30570939, 30770657, and 30530240, National Key Basic Research Program Grants 2006CB500702 and 2007CB947100, Program for Changjiang Scholars and Innovative Research Team Grant IRT0528, Shanghai Rising- Star Program Grant 05QMX1469, and Shanghai Metropolitan Fund for Research and Development Grant 07DJ14005.	Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; Eggert A, 2000, ONCOGENE, V19, P2043, DOI 10.1038/sj.onc.1203518; FRITSCH A, 1973, ANAL BIOCHEM, V55, P57, DOI 10.1016/0003-2697(73)90290-X; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Gennuso F, 2004, P NATL ACAD SCI USA, V101, P2470, DOI 10.1073/pnas.0308452100; Grimes ML, 1996, J NEUROSCI, V16, P7950; Gryz EA, 2000, ONCOGENE, V19, P417, DOI 10.1038/sj.onc.1203330; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ide N, 1998, BIOCHEM BIOPH RES CO, V244, P258, DOI 10.1006/bbrc.1998.8243; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Jullien J, 2003, J BIOL CHEM, V278, P8706, DOI 10.1074/jbc.M202401200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; MacDonald JIS, 2000, J BIOL CHEM, V275, P18225, DOI 10.1074/jbc.M001862200; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; McLoughlin DM, 1996, FEBS LETT, V397, P197; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; NAGATAKUNO K, 1990, EXP CELL RES, V191, P273, DOI 10.1016/0014-4827(90)90014-2; Nakajima Y, 2001, MOL BRAIN RES, V92, P27, DOI 10.1016/S0169-328X(01)00126-7; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Ramoino P, 2001, EUR BIOPHYS J BIOPHY, V30, P305, DOI 10.1007/s002490100166; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Tanahashi H, 1999, NEUROREPORT, V10, P2575, DOI 10.1097/00001756-199908200-00025; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Wolf DE, 1998, BIOCHEMISTRY-US, V37, P3178, DOI 10.1021/bi9719253; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	63	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12469	12479		10.1074/jbc.M809214200	http://dx.doi.org/10.1074/jbc.M809214200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265194	hybrid, Green Published			2022-12-27	WOS:000265494600076
J	Amir, S; Wang, RX; Simons, JW; Mabjeesh, NJ				Amir, Sharon; Wang, Ruoxiang; Simons, Jonathan W.; Mabjeesh, Nicola J.			SEPT9_v1 Up-regulates Hypoxia-inducible Factor 1 by Preventing Its RACK1-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HUMAN BREAST-CANCER; FACTOR 1-ALPHA; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; EXPRESSION; HSP90; HIF-1-ALPHA; PATHWAY; GENE	A critical mediator of the cellular response to hypoxia is hypoxia-inducible factor 1 (HIF-1). Increased levels of HIF-1 alpha are often associated with increased tumor metastasis, therapeutic resistance, and poorer prognosis. We recently identified a novel interaction between HIF-1 alpha and the mammalian septin family member, SEPT9_v1. Septins are a highly conserved family of GTP-binding cytoskeletal proteins that are implicated in multiple cellular functions, including cell division and oncogenesis. SEPT9_v1 binds and stabilizes HIF-1 alpha protein and stimulates HIF-1 transcriptional activity. SEPT9_v1-HIF-1 activation promotes tumor growth and angiogenesis. The structural and functional relationships between SEPT9_v1 and HIF-1 alpha were analyzed. We found that SEPT9_v1 binds specifically with HIF-1 alpha but not with HIF2 alpha. The GTPase domain of SEPT9_v1 was identified as essential for HIF-1 alpha binding. A GTPase domain-derived polypeptide, corresponding to amino acids 252-379, was able to disrupt HIF-1 alpha-SEPT9_v1 interaction and to inhibit HIF-1 transcriptional activity. SEPT9_v1 also protected HIF-1 alpha from degradation induced by HSP90 inhibition by preventing the interaction of HIF-1 alpha with the RACK1 protein, which promotes its oxygen-independent proteasomal degradation. In conclusion, a new mechanism of oxygen-independent activation of HIF-1 has been identified that is mediated by SEPT9_v1 blockade of RACK1 activity on HIF-1 alpha degradation.	[Amir, Sharon; Mabjeesh, Nicola J.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Dept Urol,Prostate Canc Res Lab, IL-64239 Tel Aviv, Israel; [Wang, Ruoxiang] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30332 USA; [Simons, Jonathan W.] Prostate Canc Fdn, Santa Monica, CA 90401 USA; [Simons, Jonathan W.] Emory Univ, Dept Biomed Engn, NCI Ctr Nanotechnol Excellence, Atlanta, GA 30322 USA; [Simons, Jonathan W.] Georgia Inst Technol, Atlanta, GA 30322 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Georgia; Georgia Institute of Technology	Mabjeesh, NJ (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Dept Urol,Prostate Canc Res Lab, 6 Weizmann St, IL-64239 Tel Aviv, Israel.	nicolam@tasmc.health.gov.il		Simons, Jonathan/0000-0001-7660-0748	M. K. Humanitarian Foundation; Prostate Cancer Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	M. K. Humanitarian Foundation; Prostate Cancer Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	This work was supported by the M. K. Humanitarian Foundation, Prostate Cancer Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Taki T, 1999, CANCER RES, V59, P4261; Woelfle U, 2003, CANCER RES, V63, P5679; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05; Zhong H, 1999, CANCER RES, V59, P5830	37	44	46	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11142	11151		10.1074/jbc.M808348200	http://dx.doi.org/10.1074/jbc.M808348200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251694	Green Published, hybrid			2022-12-27	WOS:000265494500018
J	Beranek, A; Rechberger, G; Knauer, H; Wolinski, H; Kohlwein, SD; Leber, R				Beranek, Andreas; Rechberger, Gerald; Knauer, Heide; Wolinski, Heimo; Kohlwein, Sepp D.; Leber, Regina			Identification of a Cardiolipin-specific Phospholipase Encoded by the Gene CLD1 (YGR110W) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; LIPID-COMPOSITION; BIOSYNTHESIS; MITOCHONDRIA; SYNTHASE; MUTANT	The mitochondrial dimeric phospholipid cardiolipin is characterized by a high degree of unsaturation of its acyl chains, which is important for its functional interaction with mitochondrial enzymes. The unusual fatty acid composition of cardiolipin molecular species emerges from a de novo synthesized "premature" species by extensive acyl chain remodeling that involves as yet only partially identified acyltransferases and phospholipases. Recently, the yeast protein Taz1p was shown to function as a transacylase, which catalyzes the reacylation of monolysocardiolipin to mature cardiolipin. A defect in the orthologous human TAZ gene is associated with Barth syndrome, a severe genetic disorder, which may lead to cardiac failure and death in childhood. We now identified the protein encoded by reading frame YGR110W as a mitochondrial phospholipase, which deacylates de novo synthesized cardiolipin. Ygr110wp has a strong substrate preference for palmitic acid residues and functions upstream of Taz1p, to generate monolysocardiolipin for Taz1p-dependent reacylation with unsaturated fatty acids. We therefore rename the Ygr110wp as Cld1p (cardiolipin-specific deacylase 1).	[Beranek, Andreas; Rechberger, Gerald; Knauer, Heide; Wolinski, Heimo; Kohlwein, Sepp D.; Leber, Regina] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Leber, R (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-2, A-8010 Graz, Austria.	regina.leber@uni-graz.at		Kohlwein, Sepp Dieter/0000-0002-1030-0598; Wolinski, Heimo/0000-0002-1583-6092; Leber, Regina/0000-0001-5306-5834; Rechberger, Gerald N./0000-0002-0071-317X	Austrian Science Fund [P19041, F3005]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Project Number P19041 to R. L.) and Special Research Area lipotox (Grant F3005 to S. D. K.).	Brachmann CB, 1998, YEAST, V14, P115; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HAID A, 1983, METHOD ENZYMOL, V96, P192; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; MORRISON WR, 1964, J LIPID RES, V5, P600; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Tanaka K, 2008, BBA-MOL CELL BIOL L, V1781, P391, DOI 10.1016/j.bbalip.2008.06.001; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	33	99	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11572	11578		10.1074/jbc.M805511200	http://dx.doi.org/10.1074/jbc.M805511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244244	Green Published, hybrid			2022-12-27	WOS:000265494500061
J	Fei, L; Perrett, S				Fei, Li; Perrett, Sarah			Disulfide Bond Formation Significantly Accelerates the Assembly of Ure2p Fibrils because of the Proximity of a Potential Amyloid Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PRION URE2P; SACCHAROMYCES-CEREVISIAE; PROTEIN URE2; FOLDING PATHWAY; IN-VITRO; NEURODEGENERATIVE DISEASES; GLUTAMINE REPEATS; ESCHERICHIA-COLI; POLAR ZIPPERS; DOMAINS FORM	Aggregation of the Ure2 protein is at the origin of the [URE3] prion trait in the yeast Saccharomyces cerevisiae. The N-terminal region of Ure2p is necessary and sufficient to induce the [URE3] phenotype in vivo and to polymerize into amyloid-like fibrils in vitro. However, as the N-terminal region is poorly ordered in the native state, making it difficult to detect structural changes in this region by spectroscopic methods, detailed information about the fibril assembly process is therefore lacking. Short fibril-forming peptide regions (4-7 residues) have been identified in a number of prion and other amyloid-related proteins, but such short regions have not yet been identified in Ure2p. In this study, we identify a unique cysteine mutant (R17C) that can greatly accelerate the fibril assembly kinetics of Ure2p under oxidizing conditions. We found that the segment QVNI, corresponding to residues 18-21 in Ure2p, plays a critical role in the fast assembly properties of R17C, suggesting that this segment represents a potential amyloid-forming region. A series of peptides containing the QVNI segment were found to form fibrils in vitro. Furthermore, the peptide fibrils could seed fibril formation for wild-type Ure2p. Preceding the QVNI segment with a cysteine or a hydrophobic residue, instead of a charged residue, caused the rate of assembly into fibrils to increase greatly for both peptides and full-length Ure2p. Our results indicate that the potential amyloid stretch and its preceding residue can modulate the fibril assembly of Ure2p to control the initiation of prion formation.	[Fei, Li; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Fei, Li] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@iname.com	Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997	National Natural Science Foundation of China [30470363, 30620130109, 30670428, 30870482]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences Knowledge Innovation [KSCX2-YW-R-119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences Knowledge Innovation(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30470363, 30620130109, 30670428, and 30870482; Chinese Ministry of Science and Technology Grants 2006CB500703 and 2006CB910903; and Chinese Academy of Sciences Knowledge Innovation Project KSCX2-YW-R-119.	Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baxa U, 2004, J MOL BIOL, V339, P259, DOI 10.1016/j.jmb.2004.03.033; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Catharino S, 2005, BIOL CHEM, V386, P633, DOI 10.1515/BC.2005.074; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; CREIGHTON TE, 1992, SCIENCE, V256, P111, DOI 10.1126/science.1373519; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fayard B, 2006, J MOL BIOL, V356, P843, DOI 10.1016/j.jmb.2005.12.011; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Knowles TPJ, 2006, BIOPHYS J, V91, P1494, DOI 10.1529/biophysj.106.081653; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mason JM, 2005, J BIOL CHEM, V280, P40494, DOI 10.1074/jbc.M509281200; Mason JM, 2002, BIOCHEMISTRY-US, V41, P12093, DOI 10.1021/bi026398o; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Parrini C, 2008, J MOL BIOL, V379, P1107, DOI 10.1016/j.jmb.2008.04.051; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200; STRAUSBERG S, 1993, BIOCHEMISTRY-US, V32, P10371, DOI 10.1021/bi00090a012; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	53	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11134	11141		10.1074/jbc.M809673200	http://dx.doi.org/10.1074/jbc.M809673200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258323	hybrid, Green Published			2022-12-27	WOS:000265494500017
J	Wawrzynow, B; Pettersson, S; Zylicz, A; Bramham, J; Worrall, E; Hupp, TR; Ball, KL				Wawrzynow, Bartosz; Pettersson, Susanne; Zylicz, Alicja; Bramham, Janice; Worrall, Erin; Hupp, Ted R.; Ball, Kathryn L.			A Function for the RING Finger Domain in the Allosteric Control of MDM2 Conformation and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; SMALL-MOLECULE ANTAGONISTS; ONCOPROTEIN MDM2; IN-VIVO; LIGASE ACTIVITY; BINDING-SITE; PROTEIN; ACTIVATION; PATHWAY; UBIQUITINATION	The MDM2 oncoprotein plays multiple regulatory roles in the control of p53-dependent gene expression. A picture of MDM2 is emerging where structurally discrete but interdependent functional domains are linked through changes in conformation. The domain structure includes: (i) a hydrophobic pocket at the N terminus of MDM2 that is involved in both its transrepressor and E3-ubiqutin ligase functions, (ii) a central acid domain that recognizes a ubiquitination signal in the core DNA binding domain of p53, and (iii) a C-terminal C2H2C4 RING finger domain that is required for E2 enzyme-binding and ATP-dependent molecular chaperone activity. Here we show that the binding affinity of MDM2s hydrophobic pocket can be regulated through the RING finger domain and that increases in pocket affinity are reflected by a gain in MDM2 transrepressor activity. Thus, mutations within the RING domain that affect zinc coordination, but not one that inhibits ATP binding, produce MDM2 proteins that have a higher affinity for the BOX-I transactivation domain of p53 and a reduced I-0.5 for p53 transrepression. An allosteric model for regulation of the hydrophobic pocket is supported by differences in protein conformation and pocket accessibility between wild-type and the RING domain mutant MDM2 proteins. Additionally the data demonstrate that the complex relationship between different domains of MDM2 can impact on the efficacy of anticancer drugs directed toward its hydrophobic pocket.	[Wawrzynow, Bartosz; Pettersson, Susanne; Ball, Kathryn L.] Univ Edinburgh, Canc Res UK Interferon & Cell Signalling Grp, Edinburgh EH4 2SR, Midlothian, Scotland; [Worrall, Erin; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Cell Signalling Unit, CRUK Signal Transduct Grp P53, Edinburgh EH4 2SR, Midlothian, Scotland; [Zylicz, Alicja] Int Inst Mol & Cell Biol Warsaw, Warsaw, Poland; [Bramham, Janice] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Edinburgh	Ball, KL (corresponding author), Univ Edinburgh, Canc Res UK Interferon & Cell Signalling Grp, Edinburgh EH4 2SR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk		Zylicz, Alicja/0000-0003-4174-3073	Cancer Research UK; Polish Ministry of Science and Higher Education [NN301 032534]	Cancer Research UK(Cancer Research UK); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Cancer Research UK (to S. P. and B. W.).; Supported by the Polish Ministry of Science and Higher Education (Grant NN301 032534).	Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; BODDY MN, 1994, TRENDS BIOCHEM SCI, V19, P198, DOI 10.1016/0968-0004(94)90020-5; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Bottger V, 1996, ONCOGENE, V13, P2141; Bowman AL, 2007, J AM CHEM SOC, V129, P12809, DOI 10.1021/ja073687x; Brooks CL, 2004, CELL CYCLE, V3, P895; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Espinoza-Fonseca LM, 2006, BIOPOLYMERS, V83, P365, DOI 10.1002/bip.20566; Espinoza-Fonseca LM, 2008, BIOCHEM BIOPH RES CO, V370, P547, DOI 10.1016/j.bbrc.2008.03.053; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Ganguli G, 2003, MOL CANCER RES, V1, P1027; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Knights CD, 2003, J BIOL CHEM, V278, P52890, DOI 10.1074/jbc.M300279200; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Stoll R, 2001, BIOCHEMISTRY-US, V40, P336, DOI 10.1021/bi000930v; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	46	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11517	11530		10.1074/jbc.M809294200	http://dx.doi.org/10.1074/jbc.M809294200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19188367	Green Published, hybrid			2022-12-27	WOS:000265494500056
J	Kato-Takagaki, K; Mizukoshi, Y; Yoshizawa, Y; Akazawa, D; Torii, Y; Ono, K; Tanimura, R; Shimada, I; Takahashi, H				Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Torii, Yuichi; Ono, Katsuki; Tanimura, Ryuji; Shimada, Ichio; Takahashi, Hideo			Structural and Interaction Analysis of Glycoprotein VI-binding Peptide Selected from a Phage Display Library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; PLATELET-COLLAGEN; NMR-SPECTROSCOPY; IN-VIVO; RECEPTOR; PROTEINS; PROGRAM; CHAIN; IDENTIFICATION; AGGREGATION	Glycoprotein VI (GPVI) is a major collagen receptor on the platelet surface that recognizes the glycine-proline-hydroxyproline (GPO) sequence in the collagen molecule and plays a crucial role in thrombus formation. Inhibitors that block the interaction of GPVI with collagen have potential for use as antithrombotic drugs. For low molecular weight drug design for GPVI, it is essential to obtain precise structural and interaction information about GPVI-binding ligands. However, experimentally obtained structural and interaction information of small ligands, such as peptides, in the GPVI-bound state has not been reported. In this study, by screening a phage-displayed peptide library, we discovered a novel peptide ligand (pep-10L; YSDTDWLYFSTS) without any similarities to the sequence of collagen that inhibits GPVI-GPO binding. Systematic Ala scanning in surface plasmon resonance experiments and a saturation transfer difference NMR experiment revealed that Trp(6), Leu(7), Phe(9), and Ser(10) residues in the pep-10L peptide interacted with GPVI. Furthermore, the GPVI-bound conformation of the pep-10L peptide was determined using transferred nuclear Overhauser effect analysis. The obtained structure has revealed that the central part of pep-10L (Asp(5)-Phe(9)) has a helical conformation, the side chains of Trp(6), Leu(7), and Phe(9) form a hydrophobic side in the helix, and the Tyr(8) side chain faces the opposite direction from the hydrophobic side. Computational docking prediction has shown that the hydrophobic side of pep-10L sticks in the hydrophobic groove on the GPVI surface, which corresponds to the putative collagen-related peptide binding groove. These data could enable the structure-guided development of a small molecule GPVI antagonist.	[Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Ono, Katsuki; Shimada, Ichio; Takahashi, Hideo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Kato-Takagaki, Kozue; Mizukoshi, Yumiko; Yoshizawa, Yoshitaka; Akazawa, Daisuke; Ono, Katsuki] JBIC, Tokyo 1350064, Japan; [Torii, Yuichi; Tanimura, Ryuji] JBIC, Toray Branch Off, Kanagawa 2488555, Japan; [Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Shimada, I (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Aomi 2-41-6, Tokyo 1350064, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp; hid.takahashi@aist.go.jp	Akazawa, Daisuke/S-5596-2019; Tanimura, Ryuji/GOH-0166-2022	Tanimura, Ryuji/0000-0002-7865-5686	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from the New Energy and Industrial Technology Development Organization.	ARAI M, 1995, BRIT J HAEMATOL, V89, P124, DOI 10.1111/j.1365-2141.1995.tb08900.x; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bigalke B, 2006, EUR HEART J, V27, P2165, DOI 10.1093/eurheartj/ehl192; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Cosemans JMEM, 2005, ATHEROSCLEROSIS, V181, P19, DOI 10.1016/j.atherosclerosis.2004.12.037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GIEBEL LB, 1995, BIOCHEMISTRY-US, V34, P15430, DOI 10.1021/bi00047a006; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Lecut C, 2004, J BIOL CHEM, V279, P52293, DOI 10.1074/jbc.M406342200; Leduc AM, 2003, P NATL ACAD SCI USA, V100, P11273, DOI 10.1073/pnas.1934759100; Li HQ, 2007, ARTERIOSCL THROM VAS, V27, P1199, DOI 10.1161/ATVBAHA.107.140590; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Mizukoshi Y, 2006, J BIOMOL NMR, V34, P23, DOI 10.1007/s10858-005-5054-0; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RYO R, 1992, AM J HEMATOL, V39, P25, DOI 10.1002/ajh.2830390107; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Smethurst PA, 2004, BLOOD, V103, P903, DOI 10.1182/blood-2003-01-0308; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Tam EM, 2009, J MOL BIOL, V385, P79, DOI 10.1016/j.jmb.2008.09.091; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	36	26	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10720	10727		10.1074/jbc.M808563200	http://dx.doi.org/10.1074/jbc.M808563200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228693	Green Published, hybrid			2022-12-27	WOS:000265104600046
J	Sulka, B; Lortat-Jacob, H; Terreux, R; Letourneur, F; Rousselle, P				Sulka, Beatrice; Lortat-Jacob, Hugues; Terreux, Raphael; Letourneur, Francois; Rousselle, Patricia			Tyrosine Dephosphorylation of the Syndecan-1 PDZ Binding Domain Regulates Syntenin-1 Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; CRYSTAL-STRUCTURE; SHORT ARM; LAMININ; PHOSPHORYLATION; PROTEIN; INTEGRIN; IDENTIFICATION; RECOGNITION; MEMBRANE	Heparan sulfate proteoglycan receptor syndecan-1 interacts with the carboxyl-terminal LG4/5 domain in laminin 332 (alpha 3LG4/5) and participates in cell adhesion and spreading. To dissect the function of syndecan-1 in these processes, we made use of a cell adhesion model in which syndecan-1 exclusively interacts with a recombinantly expressed alpha 3LG4/5 fragment. Plating HT1080 cells on this fragment induces the formation of actin-containing protrusive structures in an integrin-independent manner. Here we show that syndecan-1-mediated formation of membrane protrusions requires dephosphorylation of tyrosine residues in syndecan-1. Accordingly, inhibition of phosphatases with orthovanadate decreases cell adhesion to the alpha 3LG4/5 fragment. We demonstrate that the PDZ-containing protein syntenin-1, known to connect cytoskeletal proteins, binds to syndecan-1 in cells plated on the alpha 3LG4/5 fragment and participates in the formation of membrane protrusions. We further show that syntenin-1 recruitment depends on the dephosphorylation of Tyr-309 located within syndecan-1 PDZ binding domain EFYA. We propose that tyrosine dephosphorylation of syndecan-1 may regulate its association with cytoskeleton components.	[Sulka, Beatrice; Terreux, Raphael; Letourneur, Francois; Rousselle, Patricia] Univ Lyon 1, IFR Biosci Gerland Lyon Sud 128, IBCP, CNRS,UMR 5086, F-69367 Lyon 07, France; [Lortat-Jacob, Hugues] UJF, CNRS, UMR Commissariat Energie Atom 5075, Inst Biol Struct, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Rousselle, P (corresponding author), Univ Lyon 1, IFR Biosci Gerland Lyon Sud 128, IBCP, CNRS,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	patricia.rousselle@ibcp.fr		terreux, raphael/0000-0003-1243-7413; Letourneur, Francois/0000-0003-2232-6127	European Economic Community [NMP2-CT-2003-504017]; Association pour la Recherche sur le Cancer [1128, 3985]; Ligue Nationale contre le Cancer; Rhone-Alpes region; Agence Nationale de la Recherche Chemispike program	European Economic Community; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche Chemispike program(French National Research Agency (ANR))	This work was supported by grants from European Economic Community Contract NMP2-CT-2003-504017, the Association pour la Recherche sur le Cancer (Grants 1128 (to P. R.) and 3985 (to F. L.), the Ligue Nationale contre le Cancer (Loire, Drome, Savoie), a "Program Cible" Grant from the Rhone-Alpes region, and the Agence Nationale de la Recherche Chemispike program.	Asundi VK, 1997, BIOCHEM BIOPH RES CO, V240, P502, DOI 10.1006/bbrc.1997.7684; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Belin V, 2006, PROTEIN EXPRES PURIF, V48, P43, DOI 10.1016/j.pep.2006.02.014; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; CARTER BZ, 1991, LAB INVEST, V65, P610; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Helmke BM, 2004, ONCOL REP, V12, P221; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sasaki T, 2001, J MOL BIOL, V314, P751, DOI 10.1006/jmbi.2001.5176; SONNENBERG A, 1993, J CELL SCI, V106, P1083; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Utani A, 2003, J BIOL CHEM, V278, P34483, DOI 10.1074/jbc.M304827200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Vivinus-Nebot M, 1999, J CELL BIOL, V144, P563, DOI 10.1083/jcb.144.3.563; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Yokoyama F, 2005, BIOCHEMISTRY-US, V44, P9581, DOI 10.1021/bi050598t; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	58	42	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10659	10671		10.1074/jbc.M807643200	http://dx.doi.org/10.1074/jbc.M807643200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228696	Green Published, hybrid			2022-12-27	WOS:000265104600040
J	van Dijk, TH; Grefhorst, A; Oosterveer, MH; Bloks, VW; Staels, B; Reijngoud, DJ; Kuipers, F				van Dijk, Theo H.; Grefhorst, Aldo; Oosterveer, Maaike H.; Bloks, Vincent W.; Staels, Bart; Reijngoud, Dirk-Jan; Kuipers, Folkert			An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption in Fxr(-/-) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; PERIPHERAL INSULIN SENSITIVITY; BILE-ACID; GENE-EXPRESSION; ENTEROHEPATIC CIRCULATION; NONSTEADY STATE; DEFICIENT MICE; OB/OB MICE; FXR; HOMEOSTASIS	The farnesoid X receptor (FXR) is involved in regulation of bile acid and lipid metabolism. Recently, a role for FXR in control of glucose metabolism became evident. Because FXR is expressed along the length of the small intestine, we evaluated the potential role of FXR in glucose absorption and processing. During intravenous infusion of a trace amount of D-[6,6-H-2(2)] glucose, a D-[U-C-13] glucose-enriched oral glucose bolus was given, and glucose kinetics were determined in wild-type and Fxr(-/-) mice. Compared with wild-type mice, Fxr(-/-) mice showed a delayed plasma appearance of orally administered glucose. Multicompartmental kinetic modeling revealed that this delay was caused by an increased flux through the glucose 6-phosphate pool in enterocytes. Thus, our results show involvement of FXR in intestinal glucose absorption, representing a novel physiological function for this nuclear receptor.	[van Dijk, Theo H.; Reijngoud, Dirk-Jan; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Grefhorst, Aldo; Oosterveer, Maaike H.; Bloks, Vincent W.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, NL-9700 RB Groningen, Netherlands; [Staels, Bart] Univ Lille 2, Inst Pasteur Lille, INSERM, U545, F-59019 Lille, France	University of Groningen; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Grefhorst, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab,Dept Pediat, POB 30-001, NL-9700 RB Groningen, Netherlands.	A.Grefhorst@med.umcg.nl	Staels, Bart/N-9497-2016; Bloks, Vincent/A-7609-2012; oosterveer, maaike h/C-3374-2013	Staels, Bart/0000-0002-3784-1503; Bloks, Vincent/0000-0001-6493-7482; Kuipers, Folkert/0000-0003-2518-737X; Reijngoud, Dirk-Jan/0000-0003-1157-4491	European Union [018734]; Dutch Diabetes Foundation [2002.00.041]; Daiichi Sankyo, Inc.; Agence Nationale de la Recherche [A05056GS, PPV06217NSA, ANR-06-PHYSIO-027-01]	European Union(European Commission); Dutch Diabetes Foundation; Daiichi Sankyo, Inc.(Daiichi Sankyo Company Limited); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by European Union Hepadip Grant 018734, Dutch Diabetes Foundation Grant 2002.00.041, an unrestricted research grant from Daiichi Sankyo, Inc. (Parsippany, NJ), and Agence Nationale de la Recherche Grants A05056GS, PPV06217NSA, and ANR-06-PHYSIO-027-01 (Project R06510NS).	Bandsma RHJ, 2004, DIABETOLOGIA, V47, P2022, DOI 10.1007/s00125-004-1571-8; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Claudel T, 2002, J CLIN INVEST, V109, P961; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; COBELLI C, 1987, AM J PHYSIOL, V252, pE679, DOI 10.1152/ajpendo.1987.252.5.E679; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Higashiyama H, 2008, ACTA HISTOCHEM, V110, P86, DOI 10.1016/j.acthis.2007.08.001; HOHORST HJ, 1970, METHODEN ENZYMATISCH, P1200; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; KEPPLER D, 1970, METHODEN ENZYMATISCH, P1089; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; MARI A, 1992, AM J PHYSIOL, V263, pE400, DOI 10.1152/ajpendo.1992.263.2.E400; PROIETTO J, 1987, AM J PHYSIOL, V252, pE77, DOI 10.1152/ajpendo.1987.252.1.E77; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; TISSOT S, 1990, DIABETOLOGIA, V33, P449, DOI 10.1007/BF00405104; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; van der Leij FR, 2007, GENOMICS, V90, P680, DOI 10.1016/j.ygeno.2007.08.004; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200	29	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10315	10323		10.1074/jbc.M807317200	http://dx.doi.org/10.1074/jbc.M807317200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19204003	Green Published, hybrid			2022-12-27	WOS:000265104600005
J	Zhang, Y; Kozlov, G; Pocanschi, CL; Brockmeier, U; Ireland, BS; Maattanen, P; Howe, C; Elliott, T; Gehring, K; Williams, DB				Zhang, Yinan; Kozlov, Guennadi; Pocanschi, Cosmin L.; Brockmeier, Ulf; Ireland, Breanna S.; Maattanen, Pekka; Howe, Chris; Elliott, Tim; Gehring, Kalle; Williams, David B.			ERp57 Does Not Require Interactions with Calnexin and Calreticulin to Promote Assembly of Class I Histocompatibility Molecules, and It Enhances Peptide Loading Independently of Its Redox Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; PROTEIN-DISULFIDE-ISOMERASE; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODIES; CHAPERONE CALRETICULIN; FUNCTIONAL-PROPERTIES; PROLYL 4-HYDROXYLASE; OXIDOREDUCTASE ERP57; CRYSTAL-STRUCTURE	ERp57 is a thiol oxidoreductase that catalyzes disulfide formation in heavy chains of class I histocompatibility molecules. It also forms a mixed disulfide with tapasin within the class I peptide loading complex, stabilizing the complex and promoting efficient binding of peptides to class I molecules. Since ERp57 associates with the lectin chaperones calnexin and calreticulin, it is thought that ERp57 requires these chaperones to gain access to its substrates. To test this idea, we examined class I biogenesis in cells lacking calnexin or calreticulin or that express an ERp57 mutant that fails to bind to these chaperones. Remarkably, heavy chain disulfides formed at the same rate in these cells as in wild type cells. Moreover, ERp57 formed a mixed disulfide with tapasin and promoted efficient peptide loading in the absence of interactions with calnexin and calreticulin. These findings suggest that ERp57 has the capacity to recognize its substrates directly in addition to being recruited through lectin chaperones. We also found that calreticulin could be recruited into the peptide loading complex in the absence of interactions with both ERp57 and substrate oligosaccharides, demonstrating the importance of its polypeptide binding site in substrate recognition. Finally, by inactivating the redox-active sites of ERp57, we demonstrate that its enzymatic activity is dispensable in stabilizing the peptide loading complex and in supporting efficient peptide loading. Thus, ERp57 appears to play a structural rather than catalytic role within the peptide loading complex.	[Zhang, Yinan; Pocanschi, Cosmin L.; Brockmeier, Ulf; Ireland, Breanna S.; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Zhang, Yinan; Pocanschi, Cosmin L.; Brockmeier, Ulf; Ireland, Breanna S.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kozlov, Guennadi; Maattanen, Pekka; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Howe, Chris; Elliott, Tim] Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England	University of Toronto; University of Toronto; McGill University; University of Southampton	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,Rm 5316, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca	Gehring, Kalle/I-4403-2013; Zhang, Yinan/N-6432-2014; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Zhang, Yinan/0000-0002-3471-6598; Gehring, Kalle/0000-0001-6500-1184; Elliott, Tim/0000-0003-1097-0222	Canadian Institutes of Health Research [MOP-53310, MOP-74567]; Canadian Cancer Society; MRC [G0400767] Funding Source: UKRI; Cancer Research UK [10601] Funding Source: researchfish; Medical Research Council [G0400767] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Canadian Institutes of Health Research Grants MOP-53310 and MOP-74567 (to D.B.W. and K.G.) and a grant from the Canadian Cancer Society (to D.B.W.).	Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DEVIRGILIO C, 1993, YEAST, V9, P185, DOI 10.1002/yea.320090209; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Harris MR, 1998, J IMMUNOL, V160, P5404; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; Suh WK, 1999, J IMMUNOL, V162, P1530; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tolstrup AB, 2001, GENE, V263, P77; Walker KW, 1997, J BIOL CHEM, V272, P8845; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	57	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10160	10173		10.1074/jbc.M808356200	http://dx.doi.org/10.1074/jbc.M808356200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19196713	hybrid, Green Published			2022-12-27	WOS:000264892900058
J	Crawford, J; Grujic, O; Bruic, E; Czjzek, M; Grigg, ME; Boulanger, MJ				Crawford, Joanna; Grujic, Ognjen; Bruic, Ekaterina; Czjzek, Mirjam; Grigg, Michael E.; Boulanger, Martin J.			Structural Characterization of the Bradyzoite Surface Antigen (BSR4) from Toxoplasma gondii, a Unique Addition to the Surface Antigen Glycoprotein 1-related Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; SCATTERING; ENCEPHALITIS; DIFFRACTION; ALIGNMENT; PROTEINS	Toxoplasma gondii is an obligate intracellular protozoan parasite that infects nearly one-third of the human population. The success of T. gondii is based on its complex life cycle; a lytic tachyzoite form disseminates infection, whereas an encysted bradyzoite form establishes a latent, chronic infection. Persistence and transmissibility is central to the survival of the parasite and is, in part, mediated by a family of antigenically distinct surface antigen glycoprotein (SAG)-related sequences (SRS) adhesins that play a dual role in host cell attachment and host immune evasion. More than 160 members of the SRS family have been identified with only the tachyzoite-expressed SAG1 structurally characterized. Here we report the first structural description of the bradyzoite adhesin BSR4 using x-ray crystallography and small angle x-ray scattering. The 1.90-angstrom crystal structure of BSR4 reveals an architecture comprised of tandem beta sandwich domains organized in a head to tail fashion with the N-terminal domain responsible for dimer formation. A restructured topology in BSR4 results in a ligand-binding site that is significantly reorganized in both structure and chemistry relative to SAG1, consistent with BSR4 binding a distinct physiological ligand. The small angle x-ray scattering solution structure of BSR4 highlights a potentially important structural role for the interdomain polymorphic linker that imparts significant flexibility that may promote structural adaptation during ligand binding. This study reveals an unexpected level of structural diversity within the SRS superfamily and provides important insight into the role of these virulence factors.	[Crawford, Joanna; Grujic, Ognjen; Bruic, Ekaterina; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Czjzek, Mirjam] Univ Paris 06, CNRS, Stn Biol Roscoff, UMR7139, F-29682 Roscoff, France; [Grigg, Michael E.] NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of Victoria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca	Crawford, Joanna/F-9135-2013	Crawford, Joanna/0000-0003-0786-6889	Canadian Institutes for Health Research; Intramural Research Program of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001017, ZIAAI001017] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a research grant from the Canadian Institutes for Health Research (to M.J.B.) and by the Intramural Research Program of the NIAID, National Institutes of Health (to M.E.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; CESBRONDELAUW MF, 1994, J BIOL CHEM, V269, P16217; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; DeLano W.L, PYMOL MOL GRAPHICS S; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graille M, 2005, J MOL BIOL, V354, P447, DOI 10.1016/j.jmb.2005.09.028; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Grujic O, 2008, ACTA CRYSTALLOGR F, V64, P425, DOI 10.1107/S1744309108010920; Guinier A., 1955, SMALL ANGLE SCATTERI; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jackson M. H., 1989, Advances in Parasitology, V28, P55, DOI 10.1016/S0065-308X(08)60331-0; Jacquet A, 2001, MOL BIOCHEM PARASIT, V116, P35, DOI 10.1016/S0166-6851(01)00297-3; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lekutis C, 2000, EXP PARASITOL, V96, P89, DOI 10.1006/expr.2000.4556; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MCCABE RE, 1983, EUR J CLIN MICROBIOL, V2, P95, DOI 10.1007/BF02001573; MCDONALD JC, 1990, J INFECT DIS, V161, P769, DOI 10.1093/infdis/161.4.769; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200	44	26	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9192	9198		10.1074/jbc.M808714200	http://dx.doi.org/10.1074/jbc.M808714200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19155215	Green Published, hybrid			2022-12-27	WOS:000264669100025
J	Meshki, J; Douglas, SD; Lai, JP; Schwartz, L; Kilpatrick, LE; Tuluc, F				Meshki, John; Douglas, Steven D.; Lai, Jian-Ping; Schwartz, Lynnae; Kilpatrick, Laurie E.; Tuluc, Florin			Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN LIGHT-CHAIN; RHO-ASSOCIATED KINASE; SUBSTANCE-P RECEPTOR; SMOOTH-MUSCLE; ROCK-I; SIGNAL-TRANSDUCTION; HUMAN-MONOCYTES; PHOSPHORYLATION; ACTIVATION; PHOSPHATASE	We have investigated the effect of neurokinin 1 receptor (NK1R) agonists on HEK293 cells transfected with the NK1R receptor. The NK1R receptor mediates dramatic shape changes that include contractions of the membrane cortex resulting in membrane bleb formation. We have found that the cell shape changes correlate with changes in electrical impedance measured in cellular monolayers. The shape and impedance changes were prevented after preincubation with NK1R antagonists aprepitant and L-73060. Although bleb formation usually heralds apoptotic cell death, we have found that NK1R-mediated cellular blebbing does not associate with apoptosis. Preincubation with a cell-permeable derivative of C3 transferase that blocks Rho or with the Rho-associated coiled-coil kinase inhibitor Y27632 completely prevented NK1R-induced shape and impedance changes. Blebbing was also completely inhibited by ML-9, a myosin light chain kinase inhibitor. Furthermore, the phospholipase C inhibitor U73,122 did not interfere with the effect of Substance P(SP) on cellular morphology and cellular impedance but completely blocked SP-induced intracellular calcium increase, indicating that the blebbing is a process independent of intracellular calcium elevations. Blebbing is a protein kinase C-independent process, since the nonselective protein kinase C inhibitor GF109203X did not interfere with SP-induced effects. Based on these results, we provide the first evidence that NK1R receptor-ligand interaction can cause apoptosis-independent cellular blebbing and that this process is mediated by the Rho/Rho-associated coiled-coil kinase pathway.	[Meshki, John; Douglas, Steven D.; Lai, Jian-Ping; Kilpatrick, Laurie E.; Tuluc, Florin] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Schwartz, Lynnae] Childrens Hosp Philadelphia, Div Anesthesiol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; [Douglas, Steven D.; Kilpatrick, Laurie E.; Tuluc, Florin] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Tuluc, F (corresponding author), 3615 Civ Ctr Blvd,Abramson Res Bldg,Rm 1208C, Philadelphia, PA 19104 USA.	tuluc@email.chop.edu	Lai, Jianping/E-3583-2015; Tuluc, Petronel/C-2527-2011	Lai, Jianping/0000-0002-3217-692X; Douglas, Steven/0000-0002-3748-3603	National Institutes of Health [P01-MH076388, R01-MH049981]; Joseph Stokes Jr. Research Institute Foerderer-Murray; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049981, P01MH076388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph Stokes Jr. Research Institute Foerderer-Murray; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-MH076388 and R01-MH049981 (to S. D. D.). This work was also supported by the Joseph Stokes Jr. Research Institute Foerderer-Murray research award (to F. T.).	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amantini C, 2008, J PHARMACOL EXP THER, V327, P215, DOI 10.1124/jpet.108.138719; Barr AJ, 1997, J BIOL CHEM, V272, P2223; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chernova I, 2009, J LEUKOCYTE BIOL, V85, P154, DOI 10.1189/jlb.0408260; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; Esteban F, 2006, CANCER METAST REV, V25, P137, DOI 10.1007/s10555-006-8161-9; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Feistritzer C, 2003, REGUL PEPTIDES, V116, P119, DOI 10.1016/S0167-0115(03)00193-9; FONG TM, 1992, MOL PHARMACOL, V41, P24; Gao SY, 2004, NEPHRON EXP NEPHROL, V97, pE49, DOI 10.1159/000078406; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudima S, 2007, J VIROL, V81, P3608, DOI 10.1128/JVI.02277-06; Guo CJ, 2002, J NEUROIMMUNOL, V131, P160, DOI 10.1016/S0165-5728(02)00277-1; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Ho WZ, 2002, FASEB J, V16, P616, DOI 10.1096/fj.01-0655fje; Ho WZ, 1997, J IMMUNOL, V159, P5654; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; Koga Y, 2008, MOL BIOL CELL, V19, P1062, DOI 10.1091/mbc.E07-07-0668; Koyama S, 1998, J APPL PHYSIOL, V84, P1528, DOI 10.1152/jappl.1998.84.5.1528; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; Lai JP, 2006, P NATL ACAD SCI USA, V103, P7771, DOI 10.1073/pnas.0602563103; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; LANIYONU A, 1988, FEBS LETT, V240, P186, DOI 10.1016/0014-5793(88)80365-X; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL523, DOI 10.1152/ajplung.00328.2007; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Reed KL, 2004, P NATL ACAD SCI USA, V101, P9115, DOI 10.1073/pnas.0403210101; Riddick N, 2008, J CELL BIOCHEM, V103, P1158, DOI 10.1002/jcb.21488; Rittner HL, 2007, ANESTHESIOLOGY, V107, P1009, DOI 10.1097/01.anes.0000291454.90754.de; RUFF MR, 1985, PEPTIDES, V6, P107, DOI 10.1016/0196-9781(85)90142-1; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schratzberger P, 1997, J IMMUNOL, V158, P3895; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Velmuri GS, 1996, BIOCHEM J, V314, P805, DOI 10.1042/bj3140805; Weinstock JV, 2003, J IMMUNOL, V171, P3762, DOI 10.4049/jimmunol.171.7.3762; Weisman Gary A, 2006, Biotechnol Genet Eng Rev, V22, P171; WILLIAMS M, 1987, ANNU REV PHARMACOL, V27, P315; Yang YL, 2003, BRAIN RES, V991, P18, DOI 10.1016/S0006-8993(03)03451-6; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	60	66	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9280	9289		10.1074/jbc.M808825200	http://dx.doi.org/10.1074/jbc.M808825200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19179340	hybrid, Green Published			2022-12-27	WOS:000264669100034
J	Stuttmann, J; Lechner, E; Guerois, R; Parker, JE; Nussaume, L; Genschik, P; Noel, LD				Stuttmann, Johannes; Lechner, Esther; Guerois, Raphael; Parker, Jane E.; Nussaume, Laurent; Genschik, Pascal; Noel, Laurent D.			COP9 Signalosome- and 26S Proteasome-dependent Regulation of SCFTIR1 Accumulation in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; F-BOX PROTEIN; NEUROSPORA CIRCADIAN CLOCK; PLANT DEVELOPMENT; AUXIN; CUL1; COP9/SIGNALOSOME; DEGRADATION; COMPLEXES; FAMILY	Ubiquitination and proteasome-mediated degradation of proteins are crucial for eukaryotic physiology and development. The largest class of E3 ubiquitin ligases is made up of the cullin-RING ligases (CRLs), which themselves are positively regulated through conjugation of the ubiquitin-like peptide RUB/NEDD8 to cullins. RUB modification is antagonized by the COP9 signalosome (CSN), an evolutionarily conserved eight-subunit complex that is essential in most eukaryotes and cleaves RUB from cullins. The CSN behaves genetically as an activator of CRLs, although it abolishes CRL activity in vitro. This apparent paradox was recently reconciled in different organisms, as the CSN was shown to prevent autocatalytic degradation of several CRL substrate adaptors. We tested for such a mechanism in the model plant Arabidopsis by measuring the impact of a newly identified viable csn2 mutant on the activity and stability of SCFTIR1, a receptor to the phytohormone auxin and probably the best characterized plant CRL. Our analysis reveals that not only the F-box protein TIR1 but also relevant cullins are destabilized in csn2 and other Arabidopsis csn mutants. These results provide an explanation for the auxin resistance of csn mutants. We further observed in vivo a post-translational modification of TIR1 dependent on the proteasome inhibitor MG-132 and provide evidence for proteasome-mediated degradation of TIR1, CUL1, and ASK1 (Arabidopsis SKP1 homolog). These results are consistent with CSN-dependent protection of Arabidopsis CRLs from autocatalytic degradation, as observed in other eukaryotes, and provide evidence for antagonist roles of the CSN and 26S proteasome in modulating accumulation of the plant CRL SCFTIR1.	[Stuttmann, Johannes; Nussaume, Laurent; Noel, Laurent D.] Univ Aix Marseille 2, CEN Cadarache, CNR,CEA, Inst Biol Environm & Biotechnol,UMR 6191, F-13108 St Paul Les Durance, France; [Stuttmann, Johannes; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Lechner, Esther; Genschik, Pascal] CNRS, Inst Biol Mol Plantes, UPR 2357, F-67084 Strasbourg, France; [Guerois, Raphael] CEA, Inst Biol & Technol Saclay, Lab Biol Struct & Radiobiol, F-91191 Gif Sur Yvette, France; [Guerois, Raphael] CNRS, URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Noel, LD (corresponding author), INRA, CNRS, UMR 2594 441, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France.	laurent.noel@toulouse.inra.fr	NUSSAUME, Laurent/AAB-8312-2020; NUSSAUME, Laurent/AAA-5980-2022; noel, laurent/A-4885-2009; , raph/AAF-4380-2019	NUSSAUME, Laurent/0000-0002-9445-2563; noel, laurent/0000-0002-0110-1423; Stuttmann, Johannes/0000-0002-6207-094X; GENSCHIK, Pascal/0000-0002-4107-5071	Deutsche Forschungsgemeinschaft [SFB 635]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Grant SFB 635 from the Deutsche Forschungsgemeinschaft during work performed at the Max-Plank-Institut fur Zuchtungsforschung.	Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dieterle M, 2005, PLANT J, V41, P386, DOI 10.1111/j.1365-313X.2004.02302.x; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gingerich DJ, 2005, J BIOL CHEM, V280, P18810, DOI 10.1074/jbc.M413247200; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; He Q, 2005, BIOCHEM SOC T, V33, P953, DOI 10.1042/BST0330953; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; MISERA S, 1994, MOL GEN GENET, V244, P242, DOI 10.1007/BF00285451; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; MURRAY JM, 1992, NUCLEIC ACIDS RES, V20, P2673, DOI 10.1093/nar/20.11.2673; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thomann A, 2005, PLANT J, V43, P437, DOI 10.1111/j.1365-313X.2005.02467.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Weigel D, 2002, ARABIDOPSIS LAB MANU, P24; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yan N, 2000, PLANT PHYSIOL, V124, P1828, DOI 10.1104/pp.124.4.1828; Zhang WJ, 2008, P NATL ACAD SCI USA, V105, P8470, DOI 10.1073/pnas.0804144105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	78	46	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7920	7930		10.1074/jbc.M809069200	http://dx.doi.org/10.1074/jbc.M809069200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147500	Green Published, hybrid			2022-12-27	WOS:000264195600054
J	Hoffert, JD; Chou, CL; Knepper, MA				Hoffert, Jason D.; Chou, Chung-Lin; Knepper, Mark A.			Aquaporin-2 in the "-omics" Era	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MEDULLARY COLLECTING DUCT; VASOPRESSIN-STIMULATED INCREASE; CAMP-DEPENDENT PHOSPHORYLATION; WATER CHANNEL; PLASMA-MEMBRANE; CYCLIC-AMP; INTRACELLULAR CA2+; AQP2 TRAFFICKING; RENAL-CELLS; RAT-KIDNEY	Vasopressin controls renal water excretion largely through actions to regulate the water channel aquaporin-2 in collecting duct principal cells. Our knowledge of the mechanisms involved has increased markedly in recent years with the advent of methods for large-scale systems-level profiling such as protein mass spectrometry, yeast two-hybrid analysis, and oligonucleotide microarrays. Here we review this progress.	[Hoffert, Jason D.; Chou, Chung-Lin; Knepper, Mark A.] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Knepper, MA (corresponding author), NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	knep@helix.nih.gov	Knepper, Mark/AAF-8412-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285, Z01HL001285] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 2008, CURR OPIN NEPHROL HY, V17, P491, DOI 10.1097/MNH.0b013e3283094eb1; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Chou CL, 2008, AM J PHYSIOL-RENAL, V295, pF192, DOI 10.1152/ajprenal.00011.2008; Chou CL, 2004, J BIOL CHEM, V279, P49026, DOI 10.1074/jbc.M408565200; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; GRANTHAM JJ, 1966, AM J PHYSIOL, V211, P255, DOI 10.1152/ajplegacy.1966.211.1.255; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hoffert JD, 2005, J BIOL CHEM, V280, P13624, DOI 10.1074/jbc.M500040200; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Kamsteeg EJ, 2007, P NATL ACAD SCI USA, V104, P16696, DOI 10.1073/pnas.0708023104; Katsura T, 1997, Am J Physiol, V272, pF817; KNEPPER MA, 1993, AM J PHYSIOL, V265, pF214, DOI 10.1152/ajprenal.1993.265.2.F214; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Noda Y, 2005, BIOCHEM BIOPH RES CO, V330, P1041, DOI 10.1016/j.bbrc.2005.03.079; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Okutsu R, 2008, KIDNEY INT, V74, P1429, DOI 10.1038/ki.2008.402; PISITKUN T, 2006, PHYSIOL GENOMICS, V5, P760; Pisitkun T, 2008, AM J PHYSIOL-RENAL, V295, pF1030, DOI 10.1152/ajprenal.90339.2008; Procino G, 2003, FASEB J, V17, P1886, DOI 10.1096/fj.02-0870fje; SIMON H, 1993, AM J PHYSIOL, V265, pC757, DOI 10.1152/ajpcell.1993.265.3.C757; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; VANBALKOM BW, 2009, J AM SOC NE IN PRESS, V20; WALL SM, 1992, AM J PHYSIOL, V262, pF989, DOI 10.1152/ajprenal.1992.262.6.F989; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zwang NA, 2009, J PROTEOME RES, V8, P1540, DOI 10.1021/pr800894p	50	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14683	14687		10.1074/jbc.R900006200	http://dx.doi.org/10.1074/jbc.R900006200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19193633	Green Published, hybrid			2022-12-27	WOS:000266288200003
J	Kudrnac, M; Beyl, S; Hohaus, A; Stary, A; Peterbauer, T; Timin, E; Hering, S				Kudrnac, Michaela; Beyl, Stanislav; Hohaus, Annette; Stary, Anna; Peterbauer, Thomas; Timin, Eugen; Hering, Steffen			Coupled and Independent Contributions of Residues in IS6 and IIS6 to Activation Gating of Ca(V)1.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; DEPENDENT K+ CHANNEL; CA2+ CHANNELS; CRYSTAL-STRUCTURE; RETINAL DISORDER; MUTANT CYCLES; INNER PORE; ARCHITECTURE; DOMAIN; DETERMINANTS	Voltage dependence and kinetics of Ca(V)1.2 activation are affected by structural changes in pore-lining S6 segments of the alpha(1)-subunit. Significant effects are induced by either proline or threonine substitutions in the lower third of segment IIS6 ("bundle crossing region"), where S6 segments are likely to seal the channel in the closed conformation (Hohaus, A., Beyl, S., Kudrnac, M., Berjukow, S., Timin, E. N., Marksteiner, R., Maw, M. A., and Hering, S. (2005) J. Biol. Chem. 280, 38471-38477). Here we report that S435P in IS6 results in a large shift of the activation curve (-25.9 +/- 1.2 mV) and slower current kinetics. Threonine substitutions at positions Leu-429 and Leu-434 induced a similar kinetic phenotype with shifted activation curves (L429T by -6.6 +/- 1.2 and L434T by -12.1 +/- 1.7 mV). Inactivation curves of all mutants were shifted to comparable extents as the activation curves. Interdependence of IS6 and IIS6 mutations was analyzed by means of mutant cycle analysis. Double mutations in segments IS6 and IIS6 induce either additive (L429T/I781T, -34.1 +/- 1.4 mV; L434T/I781T, -40.4 +/- 1.3 mV; L429T/L779T, -12.6 +/- 1.3 mV; and L434T/L779T, -22.4 +/- 1.3 mV) or nonadditive shifts of the activation curves along the voltage axis (S435P/I781T, -33.8 +/- 1.4 mV). Mutant cycle analysis revealed energetic coupling between residues Ser-435 and Ile-781, whereas other paired mutations in segments IS6 and IIS6 had independent effects on activation gating.	[Kudrnac, Michaela; Beyl, Stanislav; Hohaus, Annette; Peterbauer, Thomas; Timin, Eugen; Hering, Steffen] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria; [Stary, Anna] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany	University of Vienna; Max Planck Society	Hering, S (corresponding author), Univ Vienna, Dept Pharmacol & Toxicol, Althanstr 14, A-1090 Vienna, Austria.	steffen.hering@univie.ac.at	Peterbauer, Thomas/A-8001-2008; Stary-Weinzinger, Anna/A-3629-2014	Peterbauer, Thomas/0000-0002-2362-5711; Stary-Weinzinger, Anna/0000-0002-9202-0484	Austrian Science Fund [15914]; GenBankTM/EBI Data Bank [X15539]	Austrian Science Fund(Austrian Science Fund (FWF)); GenBankTM/EBI Data Bank	This work was supported by Austrian Science Fund 15914 (to S. H.). The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) X15539.	Beyl S, 2007, J BIOL CHEM, V282, P3864, DOI 10.1074/jbc.M609153200; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hering S, 2008, CHANNELS, V2, P61, DOI 10.4161/chan.2.2.5999; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Lipkind GM, 2003, MOL PHARMACOL, V63, P499, DOI 10.1124/mol.63.3.499; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shafrir Y, 2008, BIOPHYS J, V95, P3650, DOI 10.1529/biophysj.108.135327; Shrivastava IH, 2000, BIOPHYS J, V78, P79, DOI 10.1016/S0006-3495(00)76574-X; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stary A, 2008, CHANNELS, V2, P216, DOI 10.4161/chan.2.3.6160; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Stotz SC, 2001, J BIOL CHEM, V276, P33001, DOI 10.1074/jbc.M104387200; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	40	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12276	12284		10.1074/jbc.M808402200	http://dx.doi.org/10.1074/jbc.M808402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265197	hybrid, Green Published			2022-12-27	WOS:000265494600059
J	Wang, QL; Chen, B; Liu, P; Zheng, MZ; Wang, YQ; Cui, SJ; Sun, DY; Fang, XH; Liu, CM; Lucas, WJ; Lin, JX				Wang, Qinli; Chen, Bo; Liu, Peng; Zheng, Maozhong; Wang, Yuqing; Cui, Sujuan; Sun, Daye; Fang, Xiaohong; Liu, Chun-Ming; Lucas, William J.; Lin, Jinxing			Calmodulin Binds to Extracellular Sites on the Plasma Membrane of Plant Cells and Elicits a Rise in Intracellular Calcium Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; SUSPENSION-CULTURED CELLS; QUANTUM DOTS; CA2+ INFLUX; PROTOPLASTS; EXPRESSION; DYNAMICS; SYSTEM; PROBES	Calmodulin (CaM) is a highly conserved intracellular calcium sensor. In plants, CaM also appears to be present in the apoplasm, and application of exogenous CaM has been shown to influence a number of physiological functions as a polypeptide signal; however, the existence and localization of its corresponding apoplasmic binding sites remain controversial. To identify the site(s) of action, a CaM-conjugated quantum dot (QD) system was employed for single molecule level detection at the surface of plant cells. Using this approach, we show that QD-CaM binds selectively to sites on the outer surface of the plasma membrane, which was further confirmed by high resolution transmission electron microscopy. Measurements of Ca2+ fluxes across the plasma membrane, using ion-selective microelectrodes, demonstrated that exogenous CaM induces a net influx into protoplasts. Consistent with these flux studies, calcium-green-dextran and FRET experiments confirmed that applied CaM/QD-CaM elicited an increase in cytoplasmic Ca2+ levels. These results support the hypothesis that apoplasmic CaM can act as a signaling agent. These findings are discussed in terms of CaM acting as an apoplasmic peptide ligand to mediate transmembrane signaling in the plant kingdom.	[Wang, Qinli; Liu, Peng; Zheng, Maozhong; Wang, Yuqing; Liu, Chun-Ming; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing 100093, Peoples R China; [Chen, Bo; Fang, Xiaohong] Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China; [Cui, Sujuan; Sun, Daye] Hebei Normal Univ, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei Province, Peoples R China; [Lucas, William J.] Univ Calif Davis, Dept Plant Biol, Coll Biol Sci, Davis, CA 95616 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Chemistry, CAS; Hebei Normal University; University of California System; University of California Davis	Lin, JX (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing 100093, Peoples R China.	linjx@ibcas.ac.cn	chen, bo/G-4459-2013; Wang, yuqing/HIR-1604-2022; Liu, Chun-Ming/G-1006-2010; 刘, 春明/GLU-4320-2022	chen, bo/0000-0003-3935-305X; Liu, Chun-Ming/0000-0002-7271-362X; 刘, 春明/0000-0002-7271-362X; Lin, Jinxing/0000-0001-9338-1356	MOST [2006CB910600]; Key Program Grant [30730009]; National Science Fund of China [30600030]	MOST; Key Program Grant; National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grant 2006CB910600 from MOST, Key Program Grant 30730009, and General Program Grant 30600030 from the National Science Fund of China.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; ADACHI T, 2008, BIOCHEM BIOPH RES CO, V283, P5972; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Bahyrycz A, 2007, J PEPT SCI, V13, P787, DOI 10.1002/psc.915; BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Chalmers NI, 2007, APPL ENVIRON MICROB, V73, P630, DOI 10.1128/AEM.02164-06; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; CHEN B, 2005, ANAL BIOANAL CHEM, V381, P98; Chen YL, 2004, PLANT PHYSIOL, V136, P4096, DOI 10.1104/pp.104.047837; Cui SJ, 2005, J BIOL CHEM, V280, P31420, DOI 10.1074/jbc.M501349200; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DeSilva NS, 2003, AM J RESP CELL MOL, V29, P757, DOI 10.1165/rcmb.2003-0186OC; Duval FD, 2002, PLANT J, V32, P481, DOI 10.1046/j.1365-313X.2002.01409.x; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; Goddard H, 2000, P NATL ACAD SCI USA, V97, P1932, DOI 10.1073/pnas.020516397; Grecco HE, 2004, MICROSC RES TECHNIQ, V65, P169, DOI 10.1002/jemt.20129; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; KOCHIAN LV, 1992, PLANTA, V188, P601, DOI 10.1007/BF00197055; Lundstrom P, 2004, J AM CHEM SOC, V126, P928, DOI 10.1021/ja037529r; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; Mao GH, 2005, PLANTA, V222, P428, DOI 10.1007/s00425-005-1558-9; Marx J, 1996, SCIENCE, V273, P1338, DOI 10.1126/science.273.5280.1338; Matsubayashi Y, 2003, J CELL SCI, V116, P3863, DOI 10.1242/jcs.00733; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Ravindran S, 2005, NANOTECHNOLOGY, V16, P1, DOI 10.1088/0957-4484/1/001; REDDY ASN, 2001, PLANT SCI, V15, P59; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Shang ZL, 2003, PROG NAT SCI, V13, P678, DOI 10.1080/10020070312331344230; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Vos JW, 1998, PROTOPLASMA, V201, P158, DOI 10.1007/BF01287412; WALTERSSON Y, 1993, BIOCHEMISTRY-US, V32, P7866, DOI 10.1021/bi00082a005; Wu XQ, 2008, J PROTEOME RES, V7, P4299, DOI 10.1021/pr800241u; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007; Zielinski Raymond E, 2002, Methods Mol Biol, V172, P143	39	27	35	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12000	12007		10.1074/jbc.M808028200	http://dx.doi.org/10.1074/jbc.M808028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254956	Green Published, hybrid			2022-12-27	WOS:000265494600032
J	Chou, CY; Yu, LPC; Tong, L				Chou, Chi-Yuan; Yu, Linda P. C.; Tong, Liang			Crystal Structure of Biotin Carboxylase in Complex with Substrates and Implications for Its Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A CARBOXYLASE; ACETYL-COA CARBOXYLASE; PYRUVATE-CARBOXYLASE; PROPIONIC ACIDEMIA; INDUCED SYNERGISM; DOMAIN; MUTATIONS; EXPRESSION; RESIDUES; ANGSTROM	Biotin-dependent carboxylases are widely distributed in nature and have important functions in many cellular processes. These enzymes share a conserved biotin carboxylase (BC) component, which catalyzes the ATP-dependent carboxylation of biotin using bicarbonate as the donor. Despite the availability of a large amount of biochemical and structural information on BC, the molecular basis for its catalysis is currently still poorly understood. We report here the crystal structure at 2.0 angstrom resolution of wild-type Escherichia coli BC in complex with its substrates biotin, bicarbonate, and Mg-ADP. The structure suggests that Glu(296) is the general base that extracts the proton from bicarbonate, and Arg(338) is the residue that stabilizes the enolate biotin intermediate in the carboxylation reaction. The B domain of BC is positioned closer to the active site, leading to a 2-angstrom shift in the bound position of the adenine nucleotide and bringing it near the bicarbonate for catalysis. One of the oxygen atoms of bicarbonate is located in the correct position to initiate the nucleophilic attack on ATP to form the carboxyphosphate intermediate. This oxygen is also located close to the N1' atom of biotin, providing strong evidence that the phosphate group, derived from decomposition of carboxyphosphate, is the general base that extracts the proton on this N1' atom. The structural observations are supported by mutagenesis and kinetic studies. Overall, this first structure of BC in complex with substrates offers unprecedented insights into the molecular mechanism for the catalysis by this family of enzymes.	[Chou, Chi-Yuan; Yu, Linda P. C.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Columbia University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Chou, Chi-Yuan/0000-0002-3400-171X; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [DK067238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK067238 (to L. T.).	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Artymiuk PJ, 1996, NAT STRUCT BIOL, V3, P128, DOI 10.1038/nsb0296-128; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng D, 2007, PROTEIN EXPRES PURIF, V51, P11, DOI 10.1016/j.pep.2006.06.005; Cho YS, 2008, PROTEINS, V70, P268, DOI 10.1002/prot.21611; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; DeLano W.L., 2002, PYMOL MANUAL; Desviat LR, 2003, MOL GENET METAB, V80, P315, DOI 10.1016/S1096-7192(03)00130-6; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; FRY DC, 1985, J AM CHEM SOC, V107, P7659, DOI 10.1021/ja00311a072; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Jiang H, 2005, J BIOL CHEM, V280, P27719, DOI 10.1074/jbc.M413281200; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khayat R, 2001, BIOCHEMISTRY-US, V40, P6344, DOI 10.1021/bi010158b; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Kondo S, 2004, ACTA CRYSTALLOGR D, V60, P486, DOI 10.1107/S0907444904000423; Kondo S, 2007, ACTA CRYSTALLOGR D, V63, P885, DOI 10.1107/S0907444907029423; Levert KL, 2000, BIOCHEMISTRY-US, V39, P4122, DOI 10.1021/bi992662a; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Sloane V, 2004, J BIOL CHEM, V279, P15772, DOI 10.1074/jbc.M311982200; Sloane V, 2001, J BIOL CHEM, V276, P24991, DOI 10.1074/jbc.M101472200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; WILSON NA, 1995, BIOCHEMISTRY-US, V34, P8931, DOI 10.1021/bi00028a001; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	44	48	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11690	11697		10.1074/jbc.M805783200	http://dx.doi.org/10.1074/jbc.M805783200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19213731	Green Published, hybrid			2022-12-27	WOS:000265494500071
J	Medrek, C; Landberg, G; Andersson, T; Leandersson, K				Medrek, Catharina; Landberg, Goran; Andersson, Tommy; Leandersson, Karin			Wnt-5a-CKI alpha Signaling Promotes beta-Catenin/E-Cadherin Complex Formation and Intercellular Adhesion in Human Breast Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CATENIN; WNT-5A; PHOSPHORYLATION; PROTEIN; DEGRADATION; EXPRESSION; MUTATIONS; MECHANISM; PATHWAY; BINDING	Wnt-5a is a non-transforming Wnt protein that is implicated in cell polarity, adhesion, and motility. We have previously shown that low expression of Wnt-5a is a predictor of shorter disease-free survival in human breast cancer. Here, we investigated whether beta-catenin/E-cadherin-mediated cell-cell adhesion was affected by loss of Wnt-5a in breast carcinomas, thereby promoting a metastatic behavior of the tumor. We show that Wnt-5a stimulation of human breast epithelial cells leads to an increased Ca2+-dependent cell-cell adhesion. Furthermore, Wnt-5a/casein kinase I alpha (CKI alpha)-specific Ser-45 phosphorylation of beta-catenin is associated with an increased complex formation of beta-catenin/E-cadherin. Mutation of Ser-45 decreases the beta-catenin/E-cadherin association. Also, the inhibitory effect of Wnt-5a on breast epithelial cell invasion is reduced upon mutation of beta-catenin-Ser-45. The Wnt-5a-CKI alpha-induced Ser-45 phosphorylation does not lead to degradation of beta-catenin. Finally we show that human breast cancers lacking Wnt-5a protein have a significantly lower level of membrane-associated beta-catenin. Down-regulation of Wnt-5a expression and subsequent reduction of membrane-associated beta-catenin in invasive breast cancer, can therefore contribute to a decreased cell-cell adhesion and increased motility resulting in a higher probability for metastatic disease.	[Landberg, Goran; Leandersson, Karin] Lund Univ, Univ Sjukhuset Malmo Allmanna Sjukhus, Ctr Mol Pathol, Dept Lab Med, S-20502 Malmo, Sweden	Lund University	Leandersson, K (corresponding author), Lund Univ, Univ Sjukhuset Malmo Allmanna Sjukhus, Ctr Mol Pathol, Dept Lab Med, S-20502 Malmo, Sweden.	Karin.Leandersson@med.lu.se			Swedish Cancer Foundation; Universitetssjukhuset-Malmo Allmanna Sjukhus Research Foundations; Universitetssjukhuset Malmo r Allmanna Sjukhus Cancer Foundation; Gunnar Nilsson's Cancer Foundation; Crafoord Foundation; Royal Physiographic Society in Lund	Swedish Cancer Foundation; Universitetssjukhuset-Malmo Allmanna Sjukhus Research Foundations; Universitetssjukhuset Malmo r Allmanna Sjukhus Cancer Foundation; Gunnar Nilsson's Cancer Foundation; Crafoord Foundation; Royal Physiographic Society in Lund	This work was supported in part by grants from the Swedish Cancer Foundation (to G. L., T. A., and K. L.), the Universitetssjukhuset-Malmo Allmanna Sjukhus Research Foundations (to T. A. and K. L.), Universitetssjukhuset Malmo r Allmanna Sjukhus Cancer Foundation (to T. A. and K. L.), The Swedish Research Council (to T. A.), Gunnar Nilsson's Cancer Foundation (to T. A. and K. L.), the Crafoord Foundation (to K. L.), and the Royal Physiographic Society in Lund (to K. L.).	Berx G, 1998, CELL ADHES COMMUN, V6, P171, DOI 10.3109/15419069809004474; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Catimel B, 2006, ANAL BIOCHEM, V357, P277, DOI 10.1016/j.ab.2006.07.034; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Dejmek J, 2003, INT J CANCER, V103, P344, DOI 10.1002/ijc.10752; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Jansson M, 2001, J CELL SCI, V114, P2043; Jonsson M, 2002, CANCER RES, V62, P409; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lei HX, 2002, INT J CANCER, V98, P199, DOI 10.1002/ijc.10176; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; MOON RT, 1993, DEVELOPMENT, V119, P97; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; OSBORNE MP, 2000, BREAST ANATOMY DEV; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Provost E, 2003, J BIOL CHEM, V278, P31781, DOI 10.1074/jbc.M304953200; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; SHORE EM, 1991, J BIOL CHEM, V266, P19672; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	42	65	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10968	10979		10.1074/jbc.M804923200	http://dx.doi.org/10.1074/jbc.M804923200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244247	Green Published, hybrid			2022-12-27	WOS:000265104600069
J	Radziszewska, A; Schroer, SA; Choi, D; Tajmir, P; Radulovich, N; Ho, JC; Wang, LY; Liadis, N; Hakem, R; Tsao, MS; Penn, LZ; Evan, GI; Woo, M				Radziszewska, Anna; Schroer, Stephanie A.; Choi, Diana; Tajmir, Panteha; Radulovich, Nikolina; Ho, James C.; Wang, Linyuan; Liadis, Nicole; Hakem, Razqallah; Tsao, Ming-Sound; Penn, Linda Z.; Evan, Gerard I.; Woo, Minna			Absence of Caspase-3 Protects Pancreatic beta-Cells from c-Myc-induced Apoptosis without Leading to Tumor Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GENE-EXPRESSION; DOWN-REGULATION; CULTURE; MICE; REQUIREMENT; ACTIVATION; RECEPTOR; CYCLE; FAS	c-Myc is a powerful trigger of beta-cell apoptosis, proliferation, and dedifferentiation in rodent islets in vivo. In a transgenic mouse model, c-Myc induction causes rapid beta-cell apoptosis and overt diabetes. When suppression of apoptosis is achieved by overexpression of Bcl-xL in an inducible model of c-Myc activation, a full spectrum of tumor development, including distant metastasis, occurs. Caspase-3 is a key pro-apoptotic protein involved in the execution phase of multiple apoptotic pathways. To test whether caspase-3 is an essential mediator of apoptosis in this model of tumorigenesis, we generated caspase-3 knock-out mice containing the inducible c-myc transgene (c-Myc(+) Casp3(-/-)). In contrast to Bcl-x(L)-overexpressing c-Myc(+) mice, c-Myc(+) Casp3(-/-) mice remained euglycemic for up to 30 days of c-Myc activation, and there was no evidence of tumor formation. Interestingly, caspase-3 deletion also led to the suppression of proliferation, perhaps through regulation of the cell cycle inhibitory protein p27, suggesting a possible mechanism for maintaining a balance between suppression of apoptosis and excessive proliferation in the context of c-Myc activation. Additionally, c-Myc-activated Casp3(-/-) mice were protected from streptozotocin-induced diabetes. Our studies demonstrate that caspase-3 deletion confers protection from c-Myc-induced apoptosis and diabetes development without unwanted tumorigenic effects. These results may lead to further elucidation of the mechanisms of c-Myc biology relevant to beta-cells, which may result in novel therapeutic strategies for diabetes.	[Radziszewska, Anna; Schroer, Stephanie A.; Tajmir, Panteha; Radulovich, Nikolina; Ho, James C.; Wang, Linyuan; Liadis, Nicole; Hakem, Razqallah; Tsao, Ming-Sound; Penn, Linda Z.; Woo, Minna] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Choi, Diana; Woo, Minna] Univ Toronto, Ontario Canc Inst, Inst Med Sci, Toronto, ON M5G 2M9, Canada; [Evan, Gerard I.] Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA; [Evan, Gerard I.] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Pharmacol, San Francisco, CA 94143 USA; [Woo, Minna] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Woo, Minna] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Woo, M (corresponding author), Univ Toronto, Ontario Canc Inst, Dept Med Biophys, 610 Univ Ave,Rm 8-113, Toronto, ON M5G 2M9, Canada.	mwoo@uhnres.utoronto.ca	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; Radziszewska, Ania/0000-0002-3885-3477; Penn, Linda/0000-0001-8133-5459; Hakem, Razqallah/0000-0001-5948-7931	Canadian Institutes for Health Research; Canadian Diabetes Association	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported in part by grants from the Canadian Institutes for Health Research and the Canadian Diabetes Association (to M. W.).	Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Finch A, 2006, CANCER CELL, V10, P113, DOI 10.1016/j.ccr.2006.06.017; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Klefstrom J, 2002, J BIOL CHEM, V277, P43224, DOI 10.1074/jbc.M206967200; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Li J, 2007, CARCINOGENESIS, V28, P1163, DOI 10.1093/carcin/bgm025; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; MOUGNEAU E, 1984, P NATL ACAD SCI-BIOL, V81, P5758, DOI 10.1073/pnas.81.18.5758; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Woo M, 1999, J IMMUNOL, V163, P4909; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Woo M, 2000, CELL RES, V10, P267, DOI 10.1038/sj.cr.7290054; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamada K, 1999, DIABETES, V48, P478, DOI 10.2337/diabetes.48.3.478; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245	50	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10947	10956		10.1074/jbc.M806960200	http://dx.doi.org/10.1074/jbc.M806960200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19213729	Green Published, hybrid			2022-12-27	WOS:000265104600067
J	Wang, J; Rajput, A; Kan, JLC; Rose, R; Liu, XQ; Kuropatwinski, K; Hauser, J; Beko, A; Dominquez, I; Sharratt, EA; Brattain, L; Levea, C; Sun, FL; Keane, DM; Gibson, NW; Brattain, MG				Wang, Jing; Rajput, Ashwani; Kan, Julie L. C.; Rose, Rebecca; Liu, Xiao-Qiong; Kuropatwinski, Karen; Hauser, Jennie; Beko, Alexander; Dominquez, Ivan; Sharratt, Elizabeth A.; Brattain, Lisa; LeVea, Charles; Sun, Feng-Lei; Keane, David M.; Gibson, Neil W.; Brattain, Michael G.			Knockdown of Ron Kinase Inhibits Mutant Phosphatidylinositol 3-Kinase and Reduces Metastasis in Human Colon Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MACROPHAGE-STIMULATING PROTEIN; GROWTH-FACTOR; COLORECTAL-CANCER; SCATTER-FACTOR; BREAST-CANCER; PIK3CA GENE; CELL-LINES; TIGHT JUNCTIONS; HIGH-FREQUENCY	Abnormal accumulation and activation of receptor tyrosine kinase Ron (recepteur d'origine nantais) has been demonstrated in a variety of primary human cancers. We show that RNA interference-mediated knockdown of Ron kinase in a highly tumorigenic colon cancer cell line led to reduced proliferation as compared with the control cells. Decreased Ron expression sensitized HCT116 cells to growth factor deprivation stress-induced apoptosis as reflected by increased DNA fragmentation and caspase 3 activation. In addition, cell motility was decreased in Ron knockdown cells as measured by wound healing assays and transwell assays. HCT116 cells are heterozygous for gain of function mutant PIK3CA H1047R. Analysis of signaling proteins that are affected by Ron knockdown revealed that phosphatidylinositol 3-kinase (PI3K) activity of the mutant PI3K as well as AKT phosphorylation was substantially reduced in the Ron knockdown cells compared with the control cells. Moreover, we demonstrated in vivo that knockdown of Ron expression significantly reduced lung metastasis as compared with the control cells in the orthotopic models. In summary, our results demonstrate that Ron plays an essential role in maintaining malignant phenotypes of colon cancer cells through regulating mutant PI3K activity. Therefore, targeting Ron kinase could be a potential strategy for colon cancer treatment, especially in patients bearing gain of function mutant PI3K activity.	[Wang, Jing; Liu, Xiao-Qiong; Brattain, Lisa; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Rajput, Ashwani] Univ New Mexico, Div Surg Oncol, Dept Surg, Albuquerque, NM 87131 USA; [Rose, Rebecca; Kuropatwinski, Karen; Hauser, Jennie; Beko, Alexander; Dominquez, Ivan; Sharratt, Elizabeth A.] Roswell Pk Canc Inst, Dept Pharm & Therapeut, Buffalo, NY 14263 USA; [LeVea, Charles] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Kan, Julie L. C.; Sun, Feng-Lei; Keane, David M.; Gibson, Neil W.] OSI Pharmaceut, Farmingdale, NY 11735 USA	University of Nebraska System; University of Nebraska Medical Center; University of New Mexico; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Astellas Pharmaceuticals; OSI Pharmaceuticals	Wang, J (corresponding author), 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu			National Institutes of Health [CA34432, CA54807]; Eppley Cancer Institute; Ralph Wilson Foundation; Buswell Research Foundation; NATIONAL CANCER INSTITUTE [R01CA034432, R01CA054807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eppley Cancer Institute; Ralph Wilson Foundation; Buswell Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA34432 and CA54807 (to M. G. B.) from the NCI. This work was also supported by a pilot project grant from Eppley Cancer Institute (to J. W.) and by grants from the Ralph Wilson Foundation and the Buswell Research Foundation (to A. R.).	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; BOYD DD, 1988, CANCER RES, V48, P2469; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cereijido M, 2000, AM J PHYSIOL-GASTR L, V279, pG477, DOI 10.1152/ajpgi.2000.279.3.G477; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers AF, 2000, BREAST CANCER RES, V2, P400, DOI 10.1186/bcr86; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Danilkovitch-Miagkova A, 2001, HISTOL HISTOPATHOL, V16, P623, DOI 10.14670/HH-16.623; DelBufalo D, 1997, FASEB J, V11, P947, DOI 10.1096/fasebj.11.12.9337147; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Greene F, 2002, CANC STAGING HDB, P127; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; LI BQ, 1995, BIOCHEM BIOPH RES CO, V216, P110, DOI 10.1006/bbrc.1995.2598; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu QP, 1999, J IMMUNOL, V163, P6606; Lowney JK, 1998, SURGERY, V124, P1043, DOI 10.1067/msy.1998.92561; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Morrow CJ, 2005, FEBS LETT, V579, P5123, DOI 10.1016/j.febslet.2005.07.096; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NAKANE PK, 1975, ANN NY ACAD SCI, V254, P203, DOI 10.1111/j.1749-6632.1975.tb29170.x; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Portera CA, 1998, SURG ONCOL, V7, P183, DOI 10.1016/S0960-7404(99)00020-1; RONSIN C, 1993, ONCOGENE, V8, P1195; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santoro MM, 2000, ONCOGENE, V19, P5208, DOI 10.1038/sj.onc.1203819; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; Wang D, 2004, ONCOGENE, V23, P1668, DOI 10.1038/sj.onc.1207282; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang MH, 1996, ONCOGENE, V13, P2167; Wang MH, 1996, EXP CELL RES, V226, P39, DOI 10.1006/excr.1996.0200; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; WOLMARK N, 1983, CANCER, V51, P1315, DOI 10.1002/1097-0142(19830401)51:7<1315::AID-CNCR2820510723>3.0.CO;2-0; Xiao ZQ, 2000, BIOCHEM BIOPH RES CO, V267, P669, DOI 10.1006/bbrc.1999.2011; Xu XM, 2004, ONCOGENE, V23, P8464, DOI 10.1038/sj.onc.1207907; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; ZARNEGAR R, 1989, CANCER RES, V49, P3314; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhou YQ, 2002, J BIOL CHEM, V277, P38104, DOI 10.1074/jbc.M206167200; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	65	69	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10912	10922		10.1074/jbc.M809551200	http://dx.doi.org/10.1074/jbc.M809551200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224914	Green Published, hybrid			2022-12-27	WOS:000265104600064
J	Kragh, CL; Lund, LB; Febbraro, F; Hansen, HD; Gai, WP; El-Agnaf, O; Richter-Landsberg, C; Jensen, PH				Kragh, Christine L.; Lund, Louise B.; Febbraro, Fabia; Hansen, Hanne D.; Gai, Wei-Ping; El-Agnaf, Omar; Richter-Landsberg, Christiane; Jensen, Poul Henning			alpha-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SYSTEM ATROPHY; UNFOLDED PROTEIN RESPONSE; PARKINSONS-DISEASE; INCLUSION FORMATION; RAT-BRAIN; CYTOPLASMIC INCLUSIONS; NEURONAL DEGENERATION; TYROSINE KINASE; SH-SY5Y CELLS; LEWY BODIES	Multiple system atrophy is a neurodegenerative disorder characterized by accumulation of aggregated Ser-129-phosphorylated alpha-synuclein in oligodendrocytes. p25 alpha is an oligodendroglial protein that potently stimulates alpha-synuclein aggregation in vitro. To model multiple system atrophy, we coexpressed human p25 alpha and alpha-synuclein in the rat oligodendroglial cell line OLN-93 and observed a cellular response characterized by a fast retraction of microtubules from the cellular processes to the perinuclear region followed by a protracted development of apoptosis. This response was dependent on phosphorylation at Ser-129 in alpha-synuclein as demonstrated by site-directed mutagenesis. Treatment of the cells with the kinase inhibitor 2-dimethylamino-4,5,6,7-tetrabromo-1H benzimidazole that targets kinases like casein kinase 2, and polo-like kinases abrogated the toxicity. The polo-like kinase inhibitor BI 2536 caused apoptosis in the model. Ser-129 phosphorylation was linked to the formation of phosphorylated oligomers detectable by immunoblotting, and their formation was inhibited by 2-dimethylamino-4,5,6,7-tetrabromo-1H benzimidazole. The process of microtubule retraction was also dependent on aggregation as demonstrated by the protective effect of treating the cells with the specific peptide inhibitor of alpha-synuclein aggregation ASI1D and the non-selective inhibitors Congo Red and baicalein. The fast microtubule retraction was followed by the development of the apoptotic markers: activated caspase-3, phosphatidylserine externalization, nuclear condensation, and fragmentation. These markers could all be blocked by the inhibitors of phosphorylation, aggregation, and caspase-3. Hence, the model predicts that both Ser-129 phosphorylation and aggregation control the toxic alpha-syn pathway in oligodendroglial cells and may represent therapeutic intervention points in multiple system atrophy.	[Kragh, Christine L.; Lund, Louise B.; Febbraro, Fabia; Hansen, Hanne D.; Jensen, Poul Henning] Univ Aarhus, Dept Biochem Med, DK-8000 Aarhus, Denmark; [Lund, Louise B.] Lundbeck AS, DK-2500 Copenhagen, Denmark; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Adelaide, SA 5042, Australia; [El-Agnaf, Omar] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, Dept Biol, D-26111 Oldenburg, Germany	Aarhus University; Lundbeck Corporation; Flinders University South Australia; United Arab Emirates University; Carl von Ossietzky Universitat Oldenburg	Jensen, PH (corresponding author), Univ Aarhus, Dept Biochem Med, Ole Worms 1170, DK-8000 Aarhus, Denmark.	phj@biokemi.au.dk	Febbraro, Fabia/AAO-9454-2020; Gai, Wei-Ping/A-3700-2008; Hansen, Hanne Demant/C-9029-2013; Febbraro, Fabia/G-9097-2016	Hansen, Hanne Demant/0000-0001-5564-7627; Jensen, Poul Henning/0000-0002-4439-9020; Febbraro, Fabia/0000-0001-8336-2776	Lundbeck Foundation, Danish Research Council for Health and Disease [271-05-0166]; Aarhus University Research Foundation; Danish Parkinson's Disease Foundation; Wacherhausen Foundation; National Health and Medical Research Council [275528]; Nordic Center of Excellence for Neurodegenerative Disorders; Foundation of 2/7-1984; innovation consortium CureND	Lundbeck Foundation, Danish Research Council for Health and Disease(Lundbeckfonden); Aarhus University Research Foundation; Danish Parkinson's Disease Foundation; Wacherhausen Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Nordic Center of Excellence for Neurodegenerative Disorders; Foundation of 2/7-1984; innovation consortium CureND	This work was supported by the Lundbeck Foundation, Danish Research Council for Health and Disease Grant 271-05-0166, the Aarhus University Research Foundation, The Danish Parkinson's Disease Foundation, Wacherhausen Foundation, National Health and Medical Research Council Grant 275528, Nordic Center of Excellence for Neurodegenerative Disorders, the Foundation of 2/7-1984 to Treatment of Parkinson's Disease, and the innovation consortium CureND.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feldman JD, 1998, J NEUROSCI RES, V53, P502, DOI 10.1002/(SICI)1097-4547(19980815)53:4<502::AID-JNR13>3.0.CO;2-3; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gai WP, 1999, J NEUROCHEM, V73, P2093; Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066; Goldbaum O, 2003, J NEUROSCI, V23, P8872; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hirsch C, 2006, TRENDS CELL BIOL, V16, P657, DOI 10.1016/j.tcb.2006.10.006; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; JAYASURIYA H, 1992, J NAT PROD, V55, P696, DOI 10.1021/np50083a026; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Konietzko U, 1999, EMBO J, V18, P3359, DOI 10.1093/emboj/18.12.3359; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li JY, 2002, NEUROSCIENCE, V113, P463, DOI 10.1016/S0306-4522(02)00143-4; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Oda T, 2008, NEUROSCI RES, V60, P29, DOI 10.1016/j.neures.2007.09.005; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Omri B, 1998, ONCOGENE, V16, P2351, DOI 10.1038/sj.onc.1201761; Omri B, 1996, J NEUROCHEM, V67, P1360; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Troy CM, 2002, J NEUROSCI RES, V69, P145, DOI 10.1002/jnr.10294; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wakabayashi K, 2006, NEUROPATHOLOGY, V26, P338, DOI 10.1111/j.1440-1789.2006.00713.x; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200; Zhu XW, 2000, NEUROBIOL AGING, V21, P807, DOI 10.1016/S0197-4580(00)00217-7	77	105	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10211	10222		10.1074/jbc.M809671200	http://dx.doi.org/10.1074/jbc.M809671200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203998	Green Published, hybrid			2022-12-27	WOS:000264892900063
J	Covian, R; Trumpower, BL				Covian, Raul; Trumpower, Bernard L.			Ilicicolin Inhibition and Binding at Center N of the Dimeric Cytochrome bc(1) Complex Reveal Electron Transfer and Regulatory Interactions between Monomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION; SACCHAROMYCES-CEREVISIAE; MECHANISM; PURIFICATION; ANTIMYCIN; MUTANTS; SITES; HEMES	We have determined the kinetics of ilicicolin binding and dissociation at center N of the yeast bc(1) complex and its effect on the reduction of cytochrome b with center P blocked. The addition of ilicicolin to the oxidized complex resulted in a non-linear inhibition of the extent of cytochrome b reduction by quinol together with a shift of the reduced b(H) heme spectrum, indicating electron transfer between monomers. The possibility of a fast exchange of ilicicolin between center N sites was excluded in two ways. First, kinetic modeling showed that fast movement of an inhibitor between monomers would result in a linear inhibition of the extent of cytochrome b reduction through center N. Second, we determined a very slow dissociation rate for ilicicolin (k = 1.2 x 10(-3) s(-1)) as calculated from its displacement by antimycin. Ilicicolin binding to the reduced bc1 complex occurred in a single phase (k(on) = 1.5-1.7 x 10(5) M-1 s(-1)) except in the presence of stigmatellin, where a second slower binding phase comprising similar to 50% of the spectral change was observed. This second kinetic event was weakly dependent on ilicicolin concentration, which suggests that binding of ilicicolin to one center N in the dimer transmits a slow (k = 2-3 s(-1)) conformational change that allows binding of the inhibitor in the other monomer. These results, together with the evidence for inter-monomeric electron transfer, provide further support for a dimeric model of regulatory interactions between center P and center N sites in the bc1 complex.	[Covian, Raul; Trumpower, Bernard L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Trumpower, BL (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			National Institutes of Health [GM 20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020379, R37GM020379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 20379. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BECHMANN G, 1992, EUR J BIOCHEM, V208, P315, DOI 10.1111/j.1432-1033.1992.tb17189.x; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Covian R, 2005, J BIOL CHEM, V280, P22732, DOI 10.1074/jbc.M413592200; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1044, DOI 10.1016/j.bbabio.2008.04.008; Covian R, 2007, J BIOL CHEM, V282, P24198, DOI 10.1074/jbc.M700662200; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Ding MG, 2006, J BIOL CHEM, V281, P36036, DOI 10.1074/jbc.M608026200; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; KAMENSKY Y, 1985, FEBS LETT, V181, P95, DOI 10.1016/0014-5793(85)81120-0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LENEFSKY EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; RICH PR, 1990, BIOCHIM BIOPHYS ACTA, V1018, P29, DOI 10.1016/0005-2728(90)90106-E; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P211, DOI 10.1016/j.bbabio.2007.10.011; Shinkarev VP, 2007, FEBS LETT, V581, P1535, DOI 10.1016/j.febslet.2007.03.037; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YU CA, 1972, J BIOL CHEM, V247, P1012; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	29	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8605	8611		10.1074/jbc.M808914200	http://dx.doi.org/10.1074/jbc.M808914200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176478	Green Published, hybrid			2022-12-27	WOS:000264397800045
J	Hoe, HS; Fu, ZY; Makarova, A; Lee, JY; Lu, CY; Feng, L; Pajoohesh-Ganji, A; Matsuoka, Y; Hyman, BT; Ehlers, MD; Vicini, S; Pak, DTS; Rebeck, GW				Hoe, Hyang-Sook; Fu, Zhanyan; Makarova, Alexandra; Lee, Ji-Yun; Lu, Congyi; Feng, Li; Pajoohesh-Ganji, Ahdeah; Matsuoka, Yasuji; Hyman, Bradley T.; Ehlers, Michael D.; Vicini, Stefano; Pak, Daniel T. S.; Rebeck, G. William			The Effects of Amyloid Precursor Protein on Postsynaptic Composition and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR SUBUNITS; SYNAPTIC PLASTICITY; DIFFERENTIAL ROLES; NR2A SUBUNIT; APP; ENDOCYTOSIS; TRAFFICKING; EXPRESSION; LOCALIZATION; ACTIVATION	The amyloid precursor protein (APP) is cleaved to produce the Alzheimer disease-associated peptide A beta, but the normal functions of uncleaved APP in the brain are unknown. We found that APP was present in the postsynaptic density of central excitatory synapses and coimmunoprecipitated with N-methyl-D-aspartate receptors (NMDARs). The presence of APP in the postsynaptic density was supported by the observation that NMDARs regulated trafficking and processing of APP; overexpression of the NR1 subunit increased surface levels of APP, whereas activation of NMDARs decreased surface APP and promoted production of A beta. We transfected APP or APP RNA interference into primary neurons and used electrophysiological techniques to explore the effects of APP on postsynaptic function. Reduction of APP decreased (and overexpression of APP increased) NMDAR whole cell current density and peak amplitude of spontaneous miniature excitatory postsynaptic currents. The increase in NMDAR current by APP was due to specific recruitment of additional NR2B-containing receptors. Consistent with these findings, immunohistochemical experiments demonstrated that APP increased the surface levels and decreased internalization of NR2B subunits. These results demonstrate a novel physiological role of postsynaptic APP in enhancing NMDAR function.	[Pajoohesh-Ganji, Ahdeah; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Fu, Zhanyan; Lu, Congyi; Feng, Li; Vicini, Stefano] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA; [Lee, Ji-Yun; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20057 USA; [Matsuoka, Yasuji] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA; [Makarova, Alexandra; Hyman, Bradley T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Disorders, Charlestown, MA 02129 USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Harvard University; Massachusetts General Hospital; Duke University; Howard Hughes Medical Institute	Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	gwr2@georgetown.edu	Feng, Li Rebekah/Y-9204-2019; Feng, Li Rebekah/A-5678-2009; Rebeck, George William/J-2192-2012; Lu, Congyi/G-3984-2013; Lee, Ji-Yun/F-8127-2013	Feng, Li Rebekah/0000-0003-0445-4088; Rebeck, George William/0000-0001-6276-248X; Lee, Ji-Yun/0000-0002-4053-6577; Vicini, Stefano/0000-0001-8671-5194	National Institutes of Health Grants [AG14473, NS48085, AG032330]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047700, R01NS048085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG014473, R01AG012406, R01AG014473, R03AG032330, R37AG012406] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14473 ( to G. W. R.), NS48085 ( to D. T. S. P.), NS047700 ( to S. V.), AG12406 ( to B. T. H.), AG032330 ( to H. S. H.). This work is also supported by the Alzheimer's Research Fund in memory of Bill and Marie Drach. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anliker B, 2006, NEURODEGENER DIS, V3, P239, DOI 10.1159/000095262; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Fu ZY, 2005, J PHYSIOL-LONDON, V563, P867, DOI 10.1113/jphysiol.2004.079467; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; *I LAB RES COMM CA, 1996, GUID CAR US LAB AN; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; KIM TW, 1995, MOL BRAIN RES, V32, P36, DOI 10.1016/0169-328X(95)00328-P; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005	48	83	85	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8495	8506		10.1074/jbc.M900141200	http://dx.doi.org/10.1074/jbc.M900141200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164281	Green Published, hybrid			2022-12-27	WOS:000264397800034
J	Mahoney, CM; Morgan, MR; Harrison, A; Humphries, MJ; Bass, MD				Mahoney, Claire M.; Morgan, Mark R.; Harrison, Andrew; Humphries, Martin J.; Bass, Mark D.			Therapeutic Ultrasound Bypasses Canonical Syndecan-4 Signaling to Activate Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTENSITY PULSED ULTRASOUND; CUTANEOUS WOUND REPAIR; NF-KAPPA-B; CELL-ADHESION; CYCLOOXYGENASE-2 EXPRESSION; ALPHA(5)BETA(1) INTEGRIN; DIRECTIONAL MIGRATION; HUMAN OSTEOBLASTS; IN-VITRO; FIBRONECTIN	The application of pulsed, low intensity ultrasound is emerging as a potent therapy for the treatment of complex bone fractures and tissue damage. Ultrasonic stimuli accelerate fracture healing by up to 40% and enhance tendon and ligament healing by promoting cell proliferation, migration, and matrix synthesis through an unresolved mechanism. Ultrasound treatment also induces closure of nonunion fractures, at a success rate (85% of cases) similar to that of surgical intervention (68-96%) while avoiding the complications associated with surgery. The regulation of cell adhesion necessary for wound healing depends on cooperative engagement of the extracellular matrix receptors, integrin and syndecan, as exemplified by the wound healing defects observed in syndecan-and integrin-knock-out mice. This report distinguishes the influence of ultrasound on signals downstream of the prototypic fibronectin receptors, alpha(5)beta(1) integrin and syndecan-4, which cooperate to regulate Rac1 and RhoA. Ultrasonic stimulation fails to activate integrins or induce cell spreading on poor, electrostatic ligands. By contrast, ultrasound treatment overcomes the necessity of engagement or expression of syndecan-4 during the process of focal adhesion formation, which normally requires simultaneous engagement of both receptors. Ultrasound exerts an influence downstream of syndecan-4 and PKC alpha to specifically activate Rac1, itself a critical regulator of tissue repair, and to a lesser extent RhoA. The ability of ultrasound to bypass syndecan-4 signaling, which is known to facilitate efficient tissue repair, explains the reduction in healing times observed in ultrasound-treated patients. By substituting for one of the key axes of adhesion-dependent signaling, ultrasound therapy has considerable potential as a clinical technique.	[Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Harrison, Andrew] Smith & Nephew, York YO10 5DF, N Yorkshire, England	University of Manchester; Smith & Nephew	Humphries, MJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.humphries@manchester.ac.uk		Humphries, Martin/0000-0002-4331-6967; Morgan, Mark/0000-0001-7728-9883	Wellcome Trust [045225, 074941]; Biotechnology and Biological Sciences Research Council; University of Manchester Strategic Fund	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund	This work was supported by Wellcome Trust Grants 045225 and 074941 (to M.J.H.). The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and the University of Manchester Strategic Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALKURDI D, 2008, COCHRANE DB SYST REV, V1; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; BASS MD, 2007, EUR PHYS J E, V3, P372; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CAVANI A, 1993, J INVEST DERMATOL, V101, P600, DOI 10.1111/1523-1747.ep12366057; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chen YJ, 2003, FEBS LETT, V554, P154, DOI 10.1016/S0014-5793(03)01157-8; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; COUCHMAN JR, 1983, J CELL BIOL, V96, P177, DOI 10.1083/jcb.96.1.177; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Doan N, 1999, J ORAL MAXIL SURG, V57, P409, DOI 10.1016/S0278-2391(99)90281-1; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Gebauer D, 2005, ULTRASOUND MED BIOL, V31, P1391, DOI 10.1016/j.ultrasmedbio.2005.06.002; Grenache DG, 2007, J INVEST DERMATOL, V127, P455, DOI 10.1038/sj.jid.5700611; Grose R, 2002, DEVELOPMENT, V129, P2303; Hassanain HH, 2005, SURGERY, V137, P92, DOI 10.1016/j.surg.2004.06.012; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Hsu HC, 2007, CELL SIGNAL, V19, P2317, DOI 10.1016/j.cellsig.2007.07.006; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; MAKAREM R, 1994, J BIOL CHEM, V269, P4005; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Ng COY, 2003, ULTRASOUND MED BIOL, V29, P1501, DOI 10.1016/S0301-5629(03)01018-4; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9; Praemer A., 1992, MUSCULOSKELETAL COND, P85; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Saoncella S, 2004, J BIOL CHEM, V279, P47172, DOI 10.1074/jbc.C400299200; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Tang CH, 2006, MOL PHARMACOL, V69, P2047, DOI 10.1124/mol.105.022160; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Wang FS, 2004, BONE, V35, P114, DOI 10.1016/j.bone.2004.02.012; Warden SJ, 2006, AM J SPORT MED, V34, P1094, DOI 10.1177/0363546505286139; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Zhou SX, 2008, CELL SIGNAL, V20, P695, DOI 10.1016/j.cellsig.2007.12.005; Zhou SX, 2004, J BIOL CHEM, V279, P54463, DOI 10.1074/jbc.M404786200; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	55	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8889	8900		10.1074/jbc.M804281200	http://dx.doi.org/10.1074/jbc.M804281200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147498	hybrid, Green Published			2022-12-27	WOS:000264397800072
J	Ishii, H; Du, H; Zhang, Z; Henderson, A; Sen, R; Pazin, MJ				Ishii, Haruhiko; Du, Hansen; Zhang, Zhaoqing; Henderson, Angus; Sen, Ranjan; Pazin, Michael J.			Mi2 beta Shows Chromatin Enzyme Specificity by Erasing a DNase I-hypersensitive Site Established by ACF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; TRANSCRIPTIONAL ACTIVATION; REMODELING COMPLEX; NUCLEOSOMAL DNA; HISTONE DEACETYLASE; FUNCTIONAL DIFFERENCES; REGULATORY PROTEINS; BINDING PROTEINS; B-CELLS; ENHANCER	ATP-dependent chromatin-remodeling enzymes are linked to changes in gene expression; however, it is not clear how the multiple remodeling enzymes found in eukaryotes differ in function and work together. In this report, we demonstrate that the ATP-dependent remodeling enzymes ACF and Mi2 beta can direct consecutive, opposing chromatin-remodeling events, when recruited to chromatin by different transcription factors. In a cell-free system based on the immunoglobulin heavy chain gene enhancer, we show that TFE3 induces a DNase I-hypersensitive site in an ATP-dependent reaction that requires ACF following transcription factor binding to chromatin. In a second step, PU.1 directs Mi2 beta to erase an established DNase I-hypersensitive site, in an ATP-dependent reaction subsequent to PU.1 binding to chromatin, whereas ACF will not support erasure. Erasure occurred without displacing the transcription factor that initiated the site. Other tested enzymes were unable to erase the DNase I-hypersensitive site. Establishing and erasing the DNase I-hypersensitive site required transcriptional activation domains from TFE3 and PU.1, respectively. Together, these results provide important new mechanistic insight into the combinatorial control of chromatin structure.	[Du, Hansen; Sen, Ranjan; Pazin, Michael J.] NIA, Lab Cellular & Mol Biol, NIH, Baltimore, MD 21224 USA; [Ishii, Haruhiko] Brandeis Univ, Grad Program Biophys & Struct Biol, Waltham, MA 02454 USA; [Zhang, Zhaoqing; Pazin, Michael J.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Henderson, Angus] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Brandeis University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Pazin, MJ (corresponding author), NIA, Lab Cellular & Mol Biol, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	pazinm@mail.nih.gov		Pazin, Michael/0000-0002-7561-3640; Ishii, Haruhiko/0000-0002-1593-096X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038925, R01GM061011, R29GM038925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000374, ZIAAG000377, ZIAAG000524] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AG000524-05] Funding Source: Medline; NIGMS NIH HHS [GM61011, GM38925] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; ARTANDI SE, 1995, NUCLEIC ACIDS RES, V23, P3865, DOI 10.1093/nar/23.19.3865; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Erman B, 1996, EMBO J, V15, P4665, DOI 10.1002/j.1460-2075.1996.tb00843.x; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; FYODOROV DV, 2002, CURR PROTOC MOL BIOL, pCH21; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Ikeda K, 1999, MOL CELL BIOL, V19, P855; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ishii H, 2004, J BIOL CHEM, V279, P7331, DOI 10.1074/jbc.M308973200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kal AJ, 2000, GENE DEV, V14, P1058; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Klemsz MJ, 1996, MOL CELL BIOL, V16, P390; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MILLS FC, 1983, NATURE, V306, P809, DOI 10.1038/306809a0; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; Nikolajczyk BS, 1997, MOL CELL BIOL, V17, P3527, DOI 10.1128/MCB.17.7.3527; Pazin MJ, 1997, SCIENCE, V276, P809, DOI 10.1126/science.276.5313.809; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Pazin MJ, 1998, J BIOL CHEM, V273, P34653, DOI 10.1074/jbc.273.51.34653; Pazin MJ, 1998, CHROMATIN PRACTICAL, P173; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Pongubala JMR, 1997, P NATL ACAD SCI USA, V94, P127, DOI 10.1073/pnas.94.1.127; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rao E, 1997, J BIOL CHEM, V272, P6722, DOI 10.1074/jbc.272.10.6722; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Ryan MP, 1998, MOL CELL BIOL, V18, P1774, DOI 10.1128/MCB.18.4.1774; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Tian G, 1999, MOL CELL BIOL, V19, P2946; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	79	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7533	7541		10.1074/jbc.M807617200	http://dx.doi.org/10.1074/jbc.M807617200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158090	hybrid, Green Published			2022-12-27	WOS:000264195600016
J	Pace, CN; Grimsley, GR; Scholtz, JM				Pace, C. Nick; Grimsley, Gerald R.; Scholtz, J. Martin			Protein Ionizable Groups: pK Values and Their Contribution to Protein Stability and Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHARGE-CHARGE INTERACTIONS; ELECTROSTATIC INTERACTIONS; STAPHYLOCOCCAL NUCLEASE; TITRATION CURVES; STRUCTURAL BASIS; PH-DEPENDENCE; PK(A) VALUES; RNASE-SA; SURFACE; DENATURATION	The structure, stability, solubility, and function of proteins depend on their net charge and on the ionization state of the individual residues. Consequently, biochemists are interested in the pK values of the ionizable groups in proteins and how these pK values depend on their environment. We review what has been learned about pK values of ionizable groups in proteins from experimental studies and discuss the important contributions they make to protein stability and solubility.	[Pace, C. Nick; Grimsley, Gerald R.; Scholtz, J. Martin] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Pace, CN (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	nickpace@tamu.edu						ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Baran KL, 2008, J MOL BIOL, V379, P1045, DOI 10.1016/j.jmb.2008.04.021; Berisio R, 1999, J MOL BIOL, V292, P845, DOI 10.1006/jmbi.1999.3093; Bi Y, 2007, BIOCHEMISTRY-US, V46, P7497, DOI 10.1021/bi6026314; Chakrabarti P, 2007, PROG BIOPHYS MOL BIO, V95, P83, DOI 10.1016/j.pbiomolbio.2007.03.016; Cho JH, 2008, ARCH BIOCHEM BIOPHYS, V469, P20, DOI 10.1016/j.abb.2007.08.004; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Debye P, 1923, PHYS Z, V24, P185; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kajander T, 2000, STRUCTURE, V8, P1203, DOI 10.1016/S0969-2126(00)00520-7; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Kim J, 2005, J MOL BIOL, V348, P1283, DOI 10.1016/j.jmb.2005.03.051; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Laurents DV, 2003, J MOL BIOL, V325, P1077, DOI 10.1016/S0022-2836(02)01273-1; LESSER GJ, 1990, PROTEINS, V8, P6, DOI 10.1002/prot.340080104; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; lindestrmlang K, 1924, C R TRAVAUX LAB CARL, V15, P1; MARKLEY JL, 1975, ACCOUNTS CHEM RES, V8, P70, DOI 10.1021/ar50086a004; Mason PE, 2003, P NATL ACAD SCI USA, V100, P4557, DOI 10.1073/pnas.0735920100; MATTHEW JB, 1985, CRC CR REV BIOCH MOL, V18, P91, DOI 10.3109/10409238509085133; Pace CN, 2000, NAT STRUCT BIOL, V7, P345, DOI 10.1038/75100; PACE CN, 1990, BIOCHEMISTRY-US, V29, P2564, DOI 10.1021/bi00462a019; Pace CN, 2004, PHILOS T ROY SOC B, V359, P1225, DOI 10.1098/rstb.2004.1500; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Roca M, 2007, FEBS LETT, V581, P2065, DOI 10.1016/j.febslet.2007.04.025; Sawano M, 2008, BIOCHEMISTRY-US, V47, P721, DOI 10.1021/bi701761m; Schwehm JM, 2003, BIOCHEMISTRY-US, V42, P1118, DOI 10.1021/bi0266434; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sorensen S. P. L., 1917, COMPTES RENDUS TRAV, V12, P68; Spassov VZ, 2008, PROTEIN SCI, V17, P1955, DOI 10.1110/ps.036335.108; SPASSOV VZ, 1994, PROTEIN SCI, V3, P1556, DOI 10.1002/pro.5560030921; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Takano K, 2003, J BIOL CHEM, V278, P31790, DOI 10.1074/jbc.M304177200; TANFORD C, 1962, ADV PROTEIN CHEM, V17, P69; TANFORD C, 1957, J AM CHEM SOC, V79, P5333, DOI 10.1021/ja01577a001; Thurlkill RL, 2006, J MOL BIOL, V362, P594, DOI 10.1016/j.jmb.2006.07.056; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tollinger M, 2003, P NATL ACAD SCI USA, V100, P4545, DOI 10.1073/pnas.0736600100; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Trevino SR, 2005, J MOL BIOL, V354, P967, DOI 10.1016/j.jmb.2005.09.091; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007	50	310	314	5	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13285	13289		10.1074/jbc.R800080200	http://dx.doi.org/10.1074/jbc.R800080200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19164280	Green Published, hybrid			2022-12-27	WOS:000265877300002
J	Paris, I; Perez-Pastene, C; Couve, E; Caviedes, P; LeDoux, S; Segura-Aguilar, J				Paris, Irmgard; Perez-Pastene, Carolina; Couve, Eduardo; Caviedes, Pablo; LeDoux, Susan; Segura-Aguilar, Juan			Copper center dot Dopamine Complex Induces Mitochondrial Autophagy Preceding Caspase-independent Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SUBSTANTIA-NIGRA; DEPENDENT IRON TOXICITY; ALPHA-SYNUCLEIN; MOLECULAR-MECHANISMS; CARCINOMA-CELLS; DISEASE; NECROSIS; NEUROTOXICITY; INHIBITION; PATHWAYS	Parkinsonism is one of the major neurological symptoms in Wilson disease, and young workers who worked in the copper smelting industry also developed Parkinsonism. We have reported the specific neurotoxic action of copper center dot dopamine complex in neurons with dopamine uptake. Copper center dot dopamine complex (100 mu M) induces cell death in RCSN-3 cells by disrupting the cellular redox state, as demonstrated by a 1.9-fold increase in oxidized glutathione levels and a 56% cell death inhibition in the presence of 500 mu M ascorbic acid; disruption of mitochondrial membrane potential with a spherical shape and well preserved morphology determined by transmission electron microscopy; inhibition (72%, p < 0.001) of phosphatidylserine externalization with 5 mu M cyclosporine A; lack of caspase-3 activation; formation of autophagic vacuoles containing mitochondria after 2 h; transfection of cells with green fluorescent protein-light chain 3 plasmid showing that 68% of cells presented autophagosome vacuoles; colocalization of positive staining for green fluorescent protein-light chain 3 and Rhod-2AM, a selective indicator of mitochondrial calcium; and DNA laddering after 12-h incubation. These results suggest that the copper center dot dopamine complex induces mitochondrial autophagy followed by caspase-3-independent apoptotic cell death. However, a different cell death mechanism was observed when 100 mu M copper center dot dopamine complex was incubated in the presence of 100 mu M dicoumarol, an inhibitor of NAD(P) H quinone: oxidoreductase (EC 1.6.99.2, also known as DT-diaphorase and NQ01), because a more extensive and rapid cell death was observed. In addition, cyclosporine A had no effect on phosphatidylserine externalization, significant portions of compact chromatin were observed within a vacuolated nuclear membrane, DNA laddering was less pronounced, the mitochondria morphology was more affected, and the number of cells with autophagic vacuoles was a near 4-fold less.	[Segura-Aguilar, Juan] Fac Med, Dept Mol & Clin Pharmacol, Programme Mol & Clin Pharmacol, Santiago 7, Chile; [Paris, Irmgard] Univ Santo Tomas, Dept Basic Sci, Vina Del Mar 2561780, Chile; [Paris, Irmgard] Univ Andres Bello, Dept Biol Sci, Vina Del Mar 2561156, Chile; [Couve, Eduardo] Univ Valparaiso, Dept Biol, Valparaiso, Chile; [LeDoux, Susan] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36608 USA	Universidad Santo Tomas; Universidad Andres Bello; Universidad de Valparaiso; University of South Alabama	Segura-Aguilar, J (corresponding author), Fac Med, Dept Mol & Clin Pharmacol, Programme Mol & Clin Pharmacol, Independencia 1027,Casilla 70000, Santiago 7, Chile.	jsegura@med.uchile.cl	Segura-Aguilar, Juan/H-8839-2013; Paris, Irmgard/AAM-7272-2020	Segura-Aguilar, Juan/0000-0002-1018-673X; Paris, Irmgard/0000-0003-2331-7513	Fogarty International Research Collaboration Award [R03 TW07044-01]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1020672, 1061083]; FOGARTY INTERNATIONAL CENTER [R03TW007044] Funding Source: NIH RePORTER	Fogarty International Research Collaboration Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Fogarty International Research Collaboration Award Grant R03 TW07044-01 and Fondo Nacional de Desarrollo Cientifico y Tecnologico Grants 1020672 and 1061083.	Argaud L, 2004, CARDIOVASC RES, V61, P115, DOI 10.1016/j.cardiores.2003.11.003; Arriagada C, 2004, NEUROBIOL DIS, V16, P468, DOI 10.1016/j.nbd.2004.03.014; Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Barthel H, 2003, AM J NEURORADIOL, V24, P234; Bredesen DE, 2007, STROKE, V38, P652, DOI 10.1161/01.STR.0000257802.82826.a7; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Bursch W, 2004, FEMS YEAST RES, V5, P101, DOI 10.1016/j.femsyr.2004.07.006; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cardenas S.P., 2008, NEUROTOX RES, V13, P136; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Caviedes P, 2001, NEUROREPORT, V12, pA25, DOI 10.1097/00001756-200103260-00004; Chikira M, 1997, J INORG BIOCHEM, V66, P131, DOI 10.1016/S0162-0134(96)00193-6; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dagnino-Subiabre A, 2000, MOL CELL BIOCHEM, V212, P131, DOI 10.1023/A:1007129609928; Diaz-Veliz G, 2004, NEUROTOX RES, V5, P629; Diaz-Veliz G, 2008, CHEM RES TOXICOL, V21, P1180, DOI 10.1021/tx8001143; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fuentes P, 2007, CHEM RES TOXICOL, V20, P776, DOI 10.1021/tx600325u; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Higuchi Y, 2003, BIOCHEM PHARMACOL, V66, P1527, DOI 10.1016/S0006-2952(03)00508-2; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hwang SO, 2008, BIOTECHNOL BIOENG, V99, P678, DOI 10.1002/bit.21589; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KISS T, 1985, J INORG BIOCHEM, V25, P247, DOI 10.1016/0162-0134(85)80024-6; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lepretre C, 2009, INT J BIOCHEM CELL B, V41, P1046, DOI 10.1016/j.biocel.2008.09.026; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moreira PI, 2007, AUTOPHAGY, V3, P614, DOI 10.4161/auto.4872; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; ODER W, 1993, NEUROLOGY, V43, P120, DOI 10.1212/WNL.43.1_Part_1.120; Paris I, 2005, CHEM RES TOXICOL, V18, P415, DOI 10.1021/tx0497144; Paris I, 2005, J NEUROCHEM, V92, P1021, DOI 10.1111/j.1471-4159.2004.02931.x; Paris I, 2001, J NEUROCHEM, V77, P519, DOI 10.1046/j.1471-4159.2001.00243.x; Paris I, 2008, NEUROTOX RES, V13, P221, DOI 10.1007/BF03033505; Paris I, 2007, NEUROTOX RES, V12, P125, DOI 10.1007/BF03033921; Park SY, 2005, CANCER LETT, V224, P123, DOI 10.1016/j.canlet.2004.10.009; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rickmann M, 2007, GASTROENTEROLOGY, V132, P2518, DOI 10.1053/j.gastro.2007.03.107; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Segura-Aguilar J, 2002, NEUROTOX RES, V4, P127, DOI 10.1080/10298420290015926; Shrivastava A, 2006, J BIOL CHEM, V281, P19762, DOI 10.1074/jbc.M600746200; Taly AB, 2007, MEDICINE, V86, P112, DOI 10.1097/MD.0b013e318045a00e; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tettamanti G, 2008, CURR PHARM DESIGN, V14, P116, DOI 10.2174/138161208783378716; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Xilouri M, 2008, AUTOPHAGY, V4, P917, DOI 10.4161/auto.6685; Yu Wen-Ran, 2008, Neurosci Bull, V24, P73, DOI 10.1007/s12264-008-0073-y	60	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13306	13315		10.1074/jbc.M900323200	http://dx.doi.org/10.1074/jbc.M900323200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19265190	Green Published, hybrid			2022-12-27	WOS:000265877300006
J	Schmid, A; Neumayer, W; Trulzsch, K; Israel, L; Imhof, A; Roessle, M; Sauer, G; Richter, S; Lauw, S; Eylert, E; Eisenreich, W; Heesemann, J; Wilharm, G				Schmid, Annika; Neumayer, Wibke; Truelzsch, Konrad; Israel, Lars; Imhof, Axel; Roessle, Manfred; Sauer, Guido; Richter, Susanna; Lauw, Susan; Eylert, Eva; Eisenreich, Wolfgang; Heesemann, Juergen; Wilharm, Gottfried			Cross-talk between Type Three Secretion System and Metabolism in Yersinia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-CALCIUM RESPONSE; TARGET-CELL CONTACT; PROTON MOTIVE FORCE; III SECRETION; PHOSPHOENOLPYRUVATE CARBOXYLASE; ESCHERICHIA-COLI; YOP SECRETION; PSEUDOMONAS-AERUGINOSA; PASTEURELLA-PESTIS; CARBON METABOLISM	Pathogenic yersiniae utilize a type three secretion system (T3SS) to inject Yop proteins into host cells in order to undermine their immune response. YscM1 and YscM2 proteins have been reported to be functionally equivalent regulators of the T3SS in Yersinia enterocolitica. Here, we show by affinity purification, native gel electrophoresis and small angle x-ray scattering that both YscM1 and YscM2 bind to phosphoenolpyruvate carboxylase (PEPC) of Y. enterocolitica. Under in vitro conditions, YscM1, but not YscM2, was found to inhibit PEPC with an apparent IC50 of 4 mu M (K-i = 1 mu M). To analyze the functional roles of PEPC, YscM1, and YscM2 in Yop-producing bacteria, cultures of Y. enterocolitica wild type and mutants defective in the formation of PEPC, YscM1, or YscM2, respectively, were grown under low calcium conditions in the presence of [U-C-13(6)] glucose. The isotope compositions of secreted Yop proteins and nine amino acids from cellular proteins were analyzed by mass spectrometry. The data indicate that a considerable fraction of oxaloacetate used as precursor for amino acids was derived from[ C-13(3)] phosphoenolpyruvate by the catalytic action of PEPC in the wild-type strain but not in the PEPC- mutant. The data imply that PEPC is critically involved in replenishing the oxaloacetate pool in the citrate cycle under virulence conditions. In the YscM1(-) and YscM2(-) mutants, increased rates of pyruvate formation via glycolysis or the Entner-Doudoroff pathway, of oxaloacetate formation via the citrate cycle, and of amino acid biosynthesis suggest that both regulators trigger the central metabolism of Y. enterocolitica. We propose a "load-and-shoot cycle" model to account for the cross-talk between T3SS and metabolism in pathogenic yersiniae.	[Wilharm, Gottfried] Robert Koch Inst, Bereich Wernigerode, D-38855 Wernigerode, Germany; [Schmid, Annika; Neumayer, Wibke; Truelzsch, Konrad; Richter, Susanna; Heesemann, Juergen; Wilharm, Gottfried] Max Von Pettenkofer Inst Hyg & Med Microbiol, Dept Bacteriol, D-80336 Munich, Germany; [Israel, Lars; Imhof, Axel] Adolf Butenandt Inst, D-80336 Munich, Germany; [Roessle, Manfred] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Sauer, Guido] Natl Res Ctr Environm & Hlth, Forschungszentrum Umwelt & Gesundheit, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; [Sauer, Guido] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Lauw, Susan; Eylert, Eva; Eisenreich, Wolfgang] Tech Univ Munich, Dept Chem, Lehrstuhl Biochem, D-85747 Garching, Germany	Robert Koch Institute; University of Munich; University of Munich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Munich; Max Planck Society; Technical University of Munich	Wilharm, G (corresponding author), Robert Koch Inst, Bereich Wernigerode, Burgstr 37, D-38855 Wernigerode, Germany.	wilharmg@rki.de	Imhof, Axel/AAU-5313-2021; Eisenreich, Wolfgang/A-1258-2013	Imhof, Axel/0000-0003-2993-8249; Eisenreich, Wolfgang/0000-0002-9832-8279; Trulzsch, Konrad/0000-0002-1937-5043; Rossle, Manfred/0000-0003-4196-0430; Wilharm, Gottfried/0000-0002-1771-6799	Deutsche Forschungsgemeinschaft [SFB 594, B6, GRK 303, SPP 1316]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 594, Teilprojekt B6, GRK 303, and SPP 1316.	Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; ALLAOUI A, 1995, MOL MICROBIOL, V18, P343, DOI 10.1111/j.1365-2958.1995.mmi_18020343.x; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; BAUGH CL, 1964, J BACTERIOL, V88, P553, DOI 10.1128/JB.88.3.553-558.1964; Brubaker RR, 2005, INFECT IMMUN, V73, P4743, DOI 10.1128/IAI.73.8.4743-4752.2005; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; CARTER PB, 1980, INFECT IMMUN, V28, P638; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DELWICHE EA, 1959, J BACTERIOL, V77, P355, DOI 10.1128/JB.77.3.355-360.1959; Dittmann S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-67; DREYFUS LA, 1978, J BACTERIOL, V136, P757, DOI 10.1128/JB.136.2.757-764.1978; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; FOWLER JM, 1994, INFECT IMMUN, V62, P5234, DOI 10.1128/IAI.62.12.5234-5241.1994; Garcia-Alles LF, 2002, EUR J BIOCHEM, V269, P3226, DOI 10.1046/j.1432-1033.2002.02995.x; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1984, INFECT IMMUN, V46, P105, DOI 10.1128/IAI.46.1.105-110.1984; HEESEMANN J, 1986, INFECT IMMUN, V54, P561, DOI 10.1128/IAI.54.2.561-567.1986; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; IZUI K, 1983, J BIOCHEM-TOKYO, V94, P1789, DOI 10.1093/oxfordjournals.jbchem.a134530; Kai Y, 1999, P NATL ACAD SCI USA, V96, P823, DOI 10.1073/pnas.96.3.823; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; MICHIELS T, 1991, J BACTERIOL, V173, P4994, DOI 10.1128/jb.173.16.4994-5009.1991; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; RIMPILAINEN M, 1992, J BACTERIOL, V174, P3355, DOI 10.1128/jb.174.10.3355-3363.1992; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schlee M, 2004, J VIROL, V78, P3941, DOI 10.1128/JVI.78.8.3941-3952.2004; Schmid A, 2006, PROTEIN EXPRES PURIF, V49, P176, DOI 10.1016/j.pep.2006.04.012; SMITH TE, 1968, ARCH BIOCHEM BIOPHYS, V128, P611, DOI 10.1016/0003-9861(68)90071-4; Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; TERADA K, 1991, J BIOCHEM-TOKYO, V109, P49; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wiley DJ, 2007, J MOL BIOL, V373, P27, DOI 10.1016/j.jmb.2007.07.077; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Wilharm G, 2003, PROTEIN EXPRES PURIF, V31, P167, DOI 10.1016/S1046-5928(03)00183-9; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x	62	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12165	12177		10.1074/jbc.M900773200	http://dx.doi.org/10.1074/jbc.M900773200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244229	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000265494600048
J	Hamdane, D; Xia, CW; Im, SC; Zhang, HM; Kim, JJP; Waskell, L				Hamdane, Djemel; Xia, Chuanwu; Im, Sang-Choul; Zhang, Haoming; Kim, Jung-Ja P.; Waskell, Lucy			Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SYNTHASE REDUCTASE; ELECTRON-TRANSFER; BINDING-SITE; NADPH-CYTOCHROME-P-450 REDUCTASE; MACROMOLECULAR MOTIONS; P-450; KINETICS; FMN; MECHANISM; FAD	NADPH-cytochrome P450 oxidoreductase (CYPOR) catalyzes the transfer of electrons to all known microsomal cytochromes P450. A CYPOR variant, with a 4-amino acid deletion in the hinge connecting the FMN domain to the rest of the protein, has been crystallized in three remarkably extended conformations. The variant donates an electron to cytochrome P450 at the same rate as the wild-type, when provided with sufficient electrons. Nevertheless, it is defective in its ability to transfer electrons intramolecularly from FAD to FMN. The three extended CYPOR structures demonstrate that, by pivoting on the C terminus of the hinge, the FMN domain of the enzyme undergoes a structural rearrangement that separates it from FAD and exposes the FMN, allowing it to interact with its redox partners. A similar movement most likely occurs in the wild-type enzyme in the course of transferring electrons from FAD to its physiological partner, cytochrome P450. A model of the complex between an open conformation of CYPOR and cytochrome P450 is presented that satisfies mutagenesis constraints. Neither lengthening the linker nor mutating its sequence influenced the activity of CYPOR. It is likely that the analogous linker in other members of the diflavin family functions in a similar manner.	[Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Hamdane, Djemel; Im, Sang-Choul; Zhang, Haoming; Waskell, Lucy] Univ Michigan, Sch Med, Ann Arbor, MI 48105 USA; [Hamdane, Djemel; Im, Sang-Choul; Zhang, Haoming; Waskell, Lucy] Vet Affairs Med Res Ctr, Ann Arbor, MI 48105 USA	Medical College of Wisconsin; University of Michigan System; University of Michigan	Kim, JJP (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jjkim@mcw.edu; waskell@umich.edu	Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394	National Institutes of Health [GM35533, GM52682]; Veterans Affairs Merit Review; U.S. Dept. of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035533, R01GM052682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); U.S. Dept. of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM35533 (to L. W.) and GM52682 (to J. J. K.). This work was also supported by a Veterans Affairs Merit Review Grant (to L. W.). Use of the Advanced Photon Source was supported by the U.S. Dept. of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38 and Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be here by marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHATTACHARYYA AK, 1991, BIOCHEMISTRY-US, V30, P759, DOI 10.1021/bi00217a027; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DAVYDOV DR, 1992, ARCH BIOCHEM BIOPHYS, V297, P304, DOI 10.1016/0003-9861(92)90677-O; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GRAY RD, 1982, J BIOL CHEM, V257, P1086; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; LANGE R, 1994, BIOPHYS J, V66, P89, DOI 10.1016/S0006-3495(94)80772-6; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; MASTERS BSS, 1980, PHARMACOL THERAPEUT, V9, P227; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; OPRIAN DD, 1979, J BIOL CHEM, V254, P8895; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; VERMILION JL, 1981, J BIOL CHEM, V256, P266; VERMILION JL, 1978, J BIOL CHEM, V253, P8812; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wiehe Kevin, 2008, V413, P283; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u	49	162	164	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11374	11384		10.1074/jbc.M807868200	http://dx.doi.org/10.1074/jbc.M807868200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19171935	hybrid, Green Published			2022-12-27	WOS:000265494500042
J	Lee, BL; Li, XJ; Liu, YS; Sykes, BD; Fliegel, L				Lee, Brian L.; Li, Xiuju; Liu, Yongsheng; Sykes, Brian D.; Fliegel, Larry			Structural and Functional Analysis of Transmembrane XI of the NHE1 Isoform of the Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN STRUCTURE; AMINO-ACIDS; SEGMENT-IV; ANTIPORTER; EXPRESSION; MODEL; INHIBITION; MUTATIONS; MECHANISM; PEPTIDES	The Na+/H+ exchanger isoform 1 is a ubiquitously expressed integral membrane protein that regulates intracellular pH in mammals by extruding an intracellular H+ in exchange for one extracellular Na+. We characterized structural and functional aspects of the critical transmembrane (TM) segment XI (residues 449-470) by using cysteine scanning mutagenesis and high resolution NMR. Each residue of TM XI was mutated to cysteine in the background of the cysteine-less protein and the sensitivity to water-soluble sulfhydryl reactive compounds MTSET ((2-(trimethylammonium) ethyl) methanethiosulfonate) and MTSES ((2-sulfonatoethyl) methanethiosulfonate) was determined for those residues with at least moderate activity remaining. Of the residues tested, only proteins with mutations L457C, I461C, and L465C were inhibited by MTSET. The activity of the L465C mutant was almost completely eliminated, whereas that of the L457C and I461C mutants was partially affected. The structure of a peptide representing TM XI (residues Lys(447)-Lys(472)) was determined using high resolution NMR spectroscopy in dodecylphosphocholine micelles. The structure consisted of helical regions between Asp(447)-Tyr(454) and Phe(460)-Lys(471) at the N and C termini of the peptide, respectively, connected by a region with poorly defined, irregular structure consisting of residues Gly(455)-Gly(459). TM XI of NHE1 had a structural similarity to TM XI of the Escherichia coli Na+/H+ exchanger NhaA. The results suggest that TM XI is a discontinuous helix, with residue Leu(465) contributing to the pore.	[Lee, Brian L.; Li, Xiuju; Liu, Yongsheng; Sykes, Brian D.; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca			NANUC; Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; University of Alberta	NANUC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta(University of Alberta)	This work was supported in part by NANUC, Canadian Institutes of Health Research, Natural Science and Engineering Research Council of Canada, the University of Alberta, and a grant from the Canadian Institutes of Health Research (to L. F. and B. D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Cunningham F, 2007, METHODS, V41, P370, DOI 10.1016/j.ymeth.2006.07.003; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Pedersen SF, 2007, J BIOL CHEM, V282, P19716, DOI 10.1074/jbc.M701637200; Rainey JK, 2006, BIOCHEM CELL BIOL, V84, P918, DOI 10.1139/O06-178; Reddy T, 2008, J BIOL CHEM, V283, P22018, DOI 10.1074/jbc.M803447200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Wakabayashi S, 2000, FEBS LETT, V487, P257, DOI 10.1016/S0014-5793(00)02348-6; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yeagle PL, 2001, BIOCHEMISTRY-US, V40, P11932, DOI 10.1021/bi015543f; [No title captured]	46	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11546	11556		10.1074/jbc.M809201200	http://dx.doi.org/10.1074/jbc.M809201200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19176522	Green Published, hybrid			2022-12-27	WOS:000265494500058
J	Tousseyn, T; Thathiah, A; Jorissen, E; Raemaekers, T; Konietzko, U; Reiss, K; Maes, E; Snellinx, A; Serneels, L; Nyabi, O; Annaert, W; Saftig, P; Hartmann, D; De Strooper, B				Tousseyn, Thomas; Thathiah, Amantha; Jorissen, Ellen; Raemaekers, Tim; Konietzko, Uwe; Reiss, Karina; Maes, Elke; Snellinx, An; Serneels, Lutgarde; Nyabi, Omar; Annaert, Wim; Saftig, Paul; Hartmann, Dieter; De Strooper, Bart			ADAM10, the Rate-limiting Protease of Regulated Intramembrane Proteolysis of Notch and Other Proteins, Is Processed by ADAMS-9, ADAMS-15, and the gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; METALLOPROTEASE-DISINTEGRIN PROTEIN; CELL-CELL ADHESION; ALPHA-SECRETASE; INTRACELLULAR DOMAIN; MEMBRANE-PROTEINS; CONVERTING-ENZYME; PROSTATE-CANCER; GROWTH-FACTOR; MICE LACKING	ADAM10 is involved in the proteolytic processing and shedding of proteins such as the amyloid precursor protein (APP), cadherins, and the Notch receptors, thereby initiating the regulated intramembrane proteolysis (RIP) of these proteins. Here, we demonstrate that the sheddase ADAM10 is also subject to RIP. We identify ADAM9 and -15 as the proteases responsible for releasing the ADAM10 ectodomain, and Presenilin/gamma-Secretase as the protease responsible for the release of the ADAM10 intracellular domain (ICD). This domain then translocates to the nucleus and localizes to nuclear speckles, thought to be involved in gene regulation. Thus, ADAM10 performs a dual role in cells, as a metalloprotease when it is membrane-bound, and as a potential signaling protein once cleaved by ADAM9/15 and the gamma-Secretase.	[Hartmann, Dieter] Univ Bonn, Inst Anat, D-53115 Bonn, Germany; [Tousseyn, Thomas; Thathiah, Amantha; Jorissen, Ellen; Raemaekers, Tim; Maes, Elke; Snellinx, An; Serneels, Lutgarde; Nyabi, Omar; Annaert, Wim; Hartmann, Dieter; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Tousseyn, Thomas; Thathiah, Amantha; Jorissen, Ellen; Raemaekers, Tim; Maes, Elke; Snellinx, An; Serneels, Lutgarde; Nyabi, Omar; Annaert, Wim; Hartmann, Dieter; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Dev & Mol Genet, B-3000 Louvain, Belgium; [Raemaekers, Tim; Annaert, Wim] Katholieke Univ Leuven VIB, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Reiss, Karina; Saftig, Paul] Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; [Konietzko, Uwe] Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland	University of Bonn; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Kiel; University of Zurich	Hartmann, D (corresponding author), Univ Bonn, Inst Anat, Nussallee 10, D-53115 Bonn, Germany.	dhartman@uni-bonn.de; Bart.destrooper@med.kuleuven.be	Saftig, Paul/A-7966-2010; Reiss, Karina/B-3175-2010; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Serneels, Lutgarde/0000-0002-5463-4231; Tousseyn, Thomas/0000-0002-0397-1086	Alzheimer's Association; Fonds voor Wetenschappelijik Onderzoek; Stichting Alzheimer Onderzoek-Fondation sur la Recherche sur la Maladie d'Alzheimer-2006; Deutsche Forschungsgemeinschaft [SFB415-TPB9]; Bristol Myers Squib; Flemish Government; Federal Office for Scientific Affairs [IUAP P6/43/]	Alzheimer's Association(Alzheimer's Association); Fonds voor Wetenschappelijik Onderzoek; Stichting Alzheimer Onderzoek-Fondation sur la Recherche sur la Maladie d'Alzheimer-2006; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bristol Myers Squib; Flemish Government(European Commission); Federal Office for Scientific Affairs	This work was supported in part by grants from the Alzheimer's Association and the Fonds voor Wetenschappelijik Onderzoek (F.W.O.) (to D.H.), a Stichting Alzheimer Onderzoek-Fondation sur la Recherche sur la Maladie d'Alzheimer-2006 grant (to W.A.), the Deutsche Forschungsgemeinschaft SFB415-TPB9 (to P.S. and K.R.), and a Freedom to Discover grant from Bristol Myers Squib, a Methusalem grant of the Flemish Government(to B.D.S.), and grants from the F.W.O., K.U. Leuven (to G.O.A.), VIB, and Federal Office for Scientific Affairs (IUAP P6/43/), Belgium (to W.A. and B.D.S.).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Arima T, 2007, CANCER SCI, V98, P1720, DOI 10.1111/j.1349-7006.2007.00601.x; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; DE SB, 1999, NATURE, V398, P518; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; Fleischer S, 1974, Methods Enzymol, V31, P6; Gaultier A, 2002, J BIOL CHEM, V277, P23336, DOI 10.1074/jbc.M201792200; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Hartmann D, 2001, J MOL NEUROSCI, V17, P171, DOI 10.1385/JMN:17:2:171; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kang TB, 2002, J BIOL CHEM, V277, P48514, DOI 10.1074/jbc.M208961200; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; KONIETZKO U, 2008, NEUROBIOL A IN PRESS; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Mancia F, 2005, CELL, V123, P185, DOI 10.1016/j.cell.2005.10.004; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Martin J, 2002, J BIOL CHEM, V277, P33683, DOI 10.1074/jbc.M200988200; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Moss ML, 2002, ESSAYS BIOCHEM, V38, P141, DOI 10.1042/bse0380141; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wen CH, 1997, DEVELOPMENT, V124, P4759; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	70	138	140	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11738	11747		10.1074/jbc.M805894200	http://dx.doi.org/10.1074/jbc.M805894200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19213735	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000265494500076
J	Li, ZY; Chen, LH; Kabra, NH; Wang, CG; Fang, J; Chen, JD				Li, Zhenyu; Chen, Lihong; Kabra, Neha; Wang, Chuangui; Fang, Jia; Chen, Jiandong			Inhibition of SUV39H1 Methyltransferase Activity by DBC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; PANCREATIC BETA-CELLS; CALORIE RESTRICTION; INSULIN-SECRETION; SIRT1 DEACETYLASE; LIFE-SPAN; HETEROCHROMATIN; SURVIVAL; PROTEIN; PGC-1-ALPHA	SUV39H1 is a histone H3K9-specific methyltransferase important for heterochromatin formation, regulation of gene expression, and induction of senescence in premalignant cells. SUV39H1 forms a complex with SirT1, and its activity is stimulated by SirT1 binding. Here we present evidence that the product of the DBC1 (deleted in breast cancer 1) gene disrupts the SUV39H1-SirT1 complex. Furthermore, DBC1 binds to the SUV39H1 catalytic domain and inhibits its ability to methylate histone H3 in vitro and in vivo. Knockdown of endogenous DBC1 increased the level of cellular H3K9 methylation. As expected, DBC1 also binds to SirT1 and inhibits the deacetylase activity of SirT1. These results identify DBC1 as a novel cellular inhibitor of SUV39H1 activity. DBC1 may be an important regulator of heterochromatin formation and genomic stability by disrupting the SUV39H1-SirT1 complex and inactivating both enzymes.	[Li, Zhenyu; Chen, Lihong; Kabra, Neha; Fang, Jia; Chen, Jiandong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; East China Normal University	Chen, JD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org		Fang, Jia/0000-0001-8583-1652	National Institutes of Health [CA121291]; NATIONAL CANCER INSTITUTE [R01CA121291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA121291 (to J.C.).	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	30	63	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10361	10366		10.1074/jbc.M900956200	http://dx.doi.org/10.1074/jbc.M900956200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218236	hybrid, Green Published			2022-12-27	WOS:000265104600010
J	Pearce, MMP; Wormer, DB; Wilkens, S; Wojcikiewicz, RJH				Pearce, Margaret M. P.; Wormer, Duncan B.; Wilkens, Stephan; Wojcikiewicz, Richard J. H.			An Endoplasmic Reticulum (ER) Membrane Complex Composed of SPFH1 and SPFH2 Mediates the ER-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; P97-UFD1-NPL4 COMPLEX; UBIQUITIN LIGASES; ION CHANNELS; PROTEINS; DOMAIN; MITOCHONDRIA; CHOLESTEROL; PROTEASOME; PATHWAYS	How endoplasmic reticulum (ER) proteins that are substrates for the ER-associated degradation (ERAD) pathway are recognized for polyubiquitination and proteasomal degradation is largely unresolved. Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) form tetrameric calcium channels in ER membranes, whose primary role is to control the release of ER calcium stores, but whose levels are also regulated, in an activation-dependent manner, by the ERAD pathway. Here we report that the ER membrane protein SPFH1 and its homolog SPFH2 form a heteromeric similar to 2 MDa complex that binds to IP3R tetramers immediately after their activation and is required for their processing. The complex is ring-shaped (diameter similar to 250 angstrom), and RNA interference-mediated depletion of SPFH1 and SPFH2 blocks IP3R polyubiquitination and degradation. We propose that this novel SPFH1/2 complex is a recognition factor that targets IP(3)Rs and perhaps other substrates for ERAD.	[Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Pearce, Margaret M. P.; Wormer, Duncan B.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Panning Pearce, Margaret/0000-0002-5846-9632	National Institutes of Health [DK49194, GM58600, CA100246]; PhRMA Foundation; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49194 (to R.J.H.W.) and GM58600 and CA100246 (to S.W.). This work was also supported by a predoctoral fellowship from the PhRMA Foundation (to M.M.P.P.).	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hoegg MB, 2009, J BIOL CHEM, V284, P7766, DOI 10.1074/jbc.M809127200; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Huh YH, 2007, BIOCHEMISTRY-US, V46, P14032, DOI 10.1021/bi701364p; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Prinz W, 2002, SEMIN CELL DEV BIOL, V13, P197, DOI 10.1016/S1084-9521(02)00048-4; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xu Q, 2004, MOL CANCER THER, V3, P1263; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024	45	66	68	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10433	10445		10.1074/jbc.M809801200	http://dx.doi.org/10.1074/jbc.M809801200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240031	Green Published, hybrid			2022-12-27	WOS:000265104600017
J	Huff, J; Pavlenok, M; Sukumaran, S; Niederweis, M				Huff, Jason; Pavlenok, Mikhail; Sukumaran, Suja; Niederweis, Michael			Functions of the Periplasmic Loop of the Porin MspA from Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; OMPF PORIN; CHARGED RESIDUES; CELL-WALL; CHANNEL; VOLTAGE; PROTEIN; GROWTH; PERMEABILITY	MspA is the major porin of Mycobacterium smegmatis and mediates diffusion of small and hydrophilic solutes across the outer membrane. The octameric structure of MspA, its sharply defined constriction zone, and a large periplasmic loop L6 represent novel structural features. L6 consists of 13 amino acids and is directly adjacent to the constriction zone. Deletion of 3, 5, 7, 9, and 11 amino acids of the L6 loop resulted in functional pores that restored glucose uptake and growth of a porin mutant of M. smegmatis. Lipid bilayer experiments revealed that all mutant channels were noisier than wild type (wt) MspA, indicating that L6 is required for pore stability in vitro. Voltage gating of the Escherichia coli porin OmpF was attributed to loops that collapse into the channel in response to a strong electrical field. Here, we show that deletion mutants Delta 7, Delta 9, and Delta 11 had critical voltages similar to wt MspA. This demonstrated that the L6 loop is not the primary voltage-dependent gating mechanism of MspA. Surprisingly, large deletions in L6 resulted in 3-6-fold less extractable pores, whereas small deletions did not alter expression levels of MspA. Pores with large deletions in L6 were more permissive for glucose than smaller deletion mutants, whereas their single channel conductance was similar to that of wt MspA. These results indicate that translocation of ions through the MspA pore is governed by different mechanisms than that of neutral solutes. This is the first study identifying a molecular determinant of solute translocation in a mycobacterial porin.	[Huff, Jason; Pavlenok, Mikhail; Sukumaran, Suja; Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Niederweis, M (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 609 Bevill Biomed Res Bldg,845 19th St S, Birmingham, AL 35294 USA.	mnieder@uab.edu		Niederweis, Michael/0000-0003-4068-8092	National Institutes of Health [HG004145, T32 HL07553]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HG004145 (to M. N.).; Supported by a fellowship from the National Institutes of Health "Basic Mechanisms of Lung Diseases" Training Grant T32 HL07553.	Bainbridge G, 1998, FEBS LETT, V431, P305, DOI 10.1016/S0014-5793(98)00761-3; Basle A, 2004, PROTEIN ENG DES SEL, V17, P665, DOI 10.1093/protein/gzh078; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bredin J, 2002, BIOCHEM J, V363, P521, DOI 10.1042/0264-6021:3630521; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Heinz C, 2000, ANAL BIOCHEM, V285, P113, DOI 10.1006/abio.2000.4728; Heinz C, 2003, J BIOL CHEM, V278, P8678, DOI 10.1074/jbc.M212280200; HOENGER A, 1993, J MOL BIOL, V233, P400, DOI 10.1006/jmbi.1993.1520; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; KOEBNIK R, 1995, MOL MICROBIOL, V16, P1269, DOI 10.1111/j.1365-2958.1995.tb02348.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; KORCHEV YE, 1995, J MEMBRANE BIOL, V143, P143; Korkmaz F, 2008, BIOCHEMISTRY-US, V47, P12126, DOI 10.1021/bi801224y; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; Mahfoud M, 2006, J BIOL CHEM, V281, P5908, DOI 10.1074/jbc.M511642200; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Niederweis M, 2008, MYCOBACTERIAL CELL ENVELOPE, P153; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Robertson KM, 2002, BIOCHEM CELL BIOL, V80, P517, DOI 10.1139/O02-145; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SEN K, 1988, J BIOL CHEM, V263, P1182; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Stahl C, 2005, MOL MICROBIOL, V57, P1509, DOI 10.1111/j.1365-2958.2005.04766.x; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; VanGelder P, 1997, J MOL BIOL, V269, P468, DOI 10.1006/jmbi.1997.1063; VanGelder P, 1997, PROTEIN ENG, V10, P699, DOI 10.1093/protein/10.6.699; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Worner M, 2007, SMALL, V3, P1084, DOI 10.1002/smll.200600559	42	8	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10223	10231		10.1074/jbc.M808599200	http://dx.doi.org/10.1074/jbc.M808599200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208627	Green Published, hybrid			2022-12-27	WOS:000264892900064
J	Lawton, TJ; Sayavedra-Soto, LA; Arp, DJ; Rosenzweig, AC				Lawton, Thomas J.; Sayavedra-Soto, Luis A.; Arp, Daniel J.; Rosenzweig, Amy C.			Crystal Structure of a Two-domain Multicopper Oxidase IMPLICATIONS FOR THE EVOLUTION OF MULTICOPPER BLUE PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING NITRITE REDUCTASE; ALCALIGENES-FAECALIS; STREPTOMYCES-COELICOLOR; STRUCTURE ALIGNMENT; COPPER OXIDASES; SMALL LACCASE; WEB SERVER; SITE; SEQUENCE; REVEALS	The two-domain multicopper oxidases are proposed to be key intermediates in the evolution of three-domain multicopper oxidases. A number of two-domain multicopper oxidases have been identified from genome sequences and are classified as type A, type B, or type C on the basis of the predicted location of the type 1 copper center. The crystal structure of blue copper oxidase, a type C two-domain multicopper oxidase from Nitrosomonas europaea, has been determined to 1.9 angstrom resolution. Blue copper oxidase is a trimer, of which each subunit comprises two cupredoxin domains. Each subunit houses a type 1 copper site in domain 1 and a type 2/type 3 trinuclear copper cluster at the subunit-subunit interface. The coordination geometry at the trinuclear copper site is consistent with reduction of the copper ions. Although the overall architecture of blue copper oxidase is similar to nitrite reductases, detailed structural alignments show that the fold and domain orientation more closely resemble the three-domain multicopper oxidases. These observations have important implications for the evolution of nitrite reductases and multicopper oxidases.	[Lawton, Thomas J.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Lawton, Thomas J.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Sayavedra-Soto, Luis A.; Arp, Daniel J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Northwestern University; Northwestern University; Oregon State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	amyr@northwestern.edu			National Institutes of Health [GM070473]; Oregon Agricultural Experimental Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Agricultural Experimental Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070473 (to A. C. R.). This work was also supported by a grant from the Oregon Agricultural Experimental Station (to O. S. U.).	ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bento I, 2005, DALTON T, P3507, DOI 10.1039/b504806k; Boulanger MJ, 2002, J MOL BIOL, V315, P1111, DOI 10.1006/jmbi.2001.5251; BOURBONNAIS R, 1995, APPL ENVIRON MICROB, V61, P1876, DOI 10.1128/AEM.61.5.1876-1880.1995; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; DeLano W.L, PYMOL MOL GRAPHICS S; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V827, P320, DOI 10.1016/0167-4838(85)90217-1; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Ellis MJ, 2007, J BIOL INORG CHEM, V12, P1119, DOI 10.1007/s00775-007-0282-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Ferraroni M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-60; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; HYMAN MR, 1992, J BIOL CHEM, V267, P1534; Inoue T, 1998, J BIOCHEM, V124, P876, DOI 10.1093/oxfordjournals.jbchem.a022201; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kukimoto M, 1996, J BIOL CHEM, V271, P13680, DOI 10.1074/jbc.271.23.13680; KUKIMOTO M, 1995, PROTEIN ENG, V8, P153, DOI 10.1093/protein/8.2.153; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; Lyashenko AV, 2006, J BIOL INORG CHEM, V11, P963, DOI 10.1007/s00775-006-0158-x; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; MESSERSCHMIDT A, 1993, J MOL BIOL, V230, P997, DOI 10.1006/jmbi.1993.1215; Messerschmidt A., 2006, HDB METALLOPROTEINS; Messerschmidt A., 1997, MULTICOPPER OXIDASES; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murphy LM, 2002, J MOL BIOL, V315, P859, DOI 10.1006/jmbi.2001.5253; MURPHY MEP, 1995, BIOCHEMISTRY-US, V34, P12107, DOI 10.1021/bi00038a003; Murphy MEP, 1997, PROTEIN SCI, V6, P761; Murphy MEP, 1997, J BIOL CHEM, V272, P28455, DOI 10.1074/jbc.272.45.28455; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Skalova T, 2009, J MOL BIOL, V385, P1165, DOI 10.1016/j.jmb.2008.11.024; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Stein LY, 1998, APPL ENVIRON MICROB, V64, P1514; Suzuki S, 2000, ACCOUNTS CHEM RES, V33, P728, DOI 10.1021/ar9900257; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zhukhlistova NE, 2008, CRYSTALLOGR REP+, V53, P92, DOI 10.1134/S1063774508010124; Zhukova YN, 2007, CRYSTALLOGR REP+, V52, P826, DOI 10.1134/S1063774507050124	58	55	57	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10174	10180		10.1074/jbc.M900179200	http://dx.doi.org/10.1074/jbc.M900179200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224923	hybrid, Green Published			2022-12-27	WOS:000264892900059
J	Kahle, J; Piaia, E; Neimanis, S; Meisterernst, M; Doenecke, D				Kahle, Joerg; Piaia, Elisa; Neimanis, Sonja; Meisterernst, Michael; Doenecke, Detlef			Regulation of Nuclear Import and Export of Negative Cofactor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; TRANSCRIPTION IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; GLUCOCORTICOID-RECEPTOR; SEQUENCE REQUIREMENTS; LOCALIZATION SIGNALS; GENE-TRANSCRIPTION; MULTIPLE PATHWAYS; PORE COMPLEX	The negative cofactor 2 (NC2) is a protein complex composed of two subunits, NC2 alpha and NC2 beta, and plays a key role in transcription regulation. Here we investigate whether each subunit contains a nuclear localization signal (NLS) that permits individual crossing of the nuclear membrane or whether nuclear import of NC2 alpha and NC2 beta depends on heterodimerization. Our results from in vitro binding studies and transfection experiments in cultured cells show that each subunit contains a classical NLS (cNLS) that is recognized by the importin alpha/beta heterodimer. Regardless of the individual cNLSs the two NC2 subunits are translocated as a preassembled complex as co-transfection experiments with wild-type and cNLS- deficient NC2 subunits demonstrate. Ran-dependent binding of the nuclear export receptor Crm1/exportin 1 confirmed the presence of a leucine-rich nuclear export signal (NES) in NC2 beta. In contrast, NC2 alpha does not exhibit a NES. Our results from interspecies heterokaryon assays suggest that heterodimerization with NC2 alpha masks the NES in NC2 beta, which prevents nuclear export of the NC2 complex. A mutation in either one of the two cNLSs decreases the extent of importin alpha/beta-mediated nuclear import of the NC2 complex. In addition, the NC2 complex can enter the nucleus via a second pathway, facilitated by importin 13. Because importin 13 binds exclusively to the NC2 complex but not to the individual subunits this alternative import pathway depends on sequence elements distributed among the two subunits.	[Kahle, Joerg; Neimanis, Sonja; Doenecke, Detlef] Univ Gottingen, Dept Mol Biol, Inst Biochem & Mol Cell Biol, D-37073 Gottingen, Germany; [Piaia, Elisa; Meisterernst, Michael] GSF, Natl Res Ctr Environm & Hlth, Dept Gene Express, D-81377 Munich, Germany; [Meisterernst, Michael] Univ Munster, Dept Med, Inst Cell & Tumor Biol, D-48149 Munster, Germany; [Piaia, Elisa] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munster; University of Lausanne	Doenecke, D (corresponding author), Univ Gottingen, Dept Mol Biol, Inst Biochem & Mol Cell Biol, Humboldtalle 23, D-37073 Gottingen, Germany.	ddoenec@gwdg.de			Deutsche Forschungsgemeinschaft Sonderforschungsbereich [523]	Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 523: Protein und Membrantransport zwischen zellularen Kompartimenten.	Albert TK, 2007, P NATL ACAD SCI USA, V104, P10000, DOI 10.1073/pnas.0703490104; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti Elena, 2002, Results Probl Cell Differ, V35, P93; Creton S, 2002, GENE DEV, V16, P3265, DOI 10.1101/gad.234002; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Gilfillan S, 2005, J BIOL CHEM, V280, P6222, DOI 10.1074/jbc.M406343200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; INOSTROZA JA, 1992, CELL, V70, P477; Iratni R, 2002, SCIENCE, V298, P1996, DOI 10.1126/science.1073405; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; JANS DA, 1995, BIOCHEM J, V311, P705, DOI 10.1042/bj3110705; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; MICHAEL WM, 1995, CELL, V83, P415; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao T, 2004, AM J RESP CELL MOL, V30, P350, DOI 10.1165/rcmb.2003-0126OC; Tao T, 2006, AM J RESP CELL MOL, V35, P668, DOI 10.1165/rcmb.2006-0073OC; Titov AA, 1999, J CELL BIOL, V147, P235, DOI 10.1083/jcb.147.2.235; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; WHITE RJ, 1994, SCIENCE, V266, P448, DOI 10.1126/science.7939686; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	71	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9382	9393		10.1074/jbc.M805694200	http://dx.doi.org/10.1074/jbc.M805694200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19204005	Green Published, hybrid			2022-12-27	WOS:000264669100044
J	Estrada, DF; Boudreaux, DM; Zhong, DL; Jeor, SCS; De Guzman, RN				Estrada, D. Fernando; Boudreaux, Daniel M.; Zhong, Dalian; Jeor, Stephen C. St.; De Guzman, Roberto N.			The Hantavirus Glycoprotein G1 Tail Contains Dual CCHC-type Classical Zinc Fingers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IIIA; CYTOPLASMIC TAIL; NUCLEOCAPSID PROTEIN; INTERFERON RESPONSES; UUKUNIEMI-VIRUS; NMR; RECOGNITION; DOMAIN; COMPLEX; SPECTROSCOPY	Hantaviruses are distributed worldwide and can cause a hemorrhagic fever or a cardiopulmonary syndrome in humans. Mature virions consist of RNA genome, nucleocapsid protein, RNA polymerase, and two transmembrane glycoproteins, G1 and G2. The ectodomain of G1 is surface-exposed; however, it has a 142-residue C-terminal cytoplasmic tail that plays important roles in viral assembly and host-pathogen interaction. Here we show by NMR, circular dichroism spectroscopy, and mutagenesis that a highly conserved cysteine/histidine-rich region in the G1 tail of hantaviruses forms two CCHC-type classical zinc fingers. Unlike classical zinc fingers, however, the two G1 zinc fingers are intimately joined together, forming a compact domain with a unique fold. We discuss the implication of the hantaviral G1 zinc fingers in viral assembly and host-pathogen interaction.	[De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Boudreaux, Daniel M.; Jeor, Stephen C. St.] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA	University of Kansas; Nevada System of Higher Education (NSHE); University of Nevada Reno	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	Pacific-Southwest, RCE/B-6155-2009		National Institutes of Health [AI065359, AI057160]; American Heart Association [0755724Z]; National Science Foundation [0326999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI065359 ( to S. C. S. J.) and AI057160 ( to R. N. D.). This work was also supported by American Heart Association Grant 0755724Z ( to R. N. D.), National Science Foundation Grant 0326999 ( to S. C. S.), the Madison and Lila Self Graduate Fellowship ( to D. F. E.), and the Reno Cancer Foundation ( to D. M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement"	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Elliot R.M., 2000, VIRUS TAXONOMY, P599; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; FLINT SJ, 2000, PRINCIPLES VIROLOGY, P92; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Geimonen E, 2003, J VIROL, V77, P10760, DOI 10.1128/JVI.77.20.10760-10768.2003; Geimonen E, 2003, J VIROL, V77, P1638, DOI 10.1128/JVI.77.2.1638-1643.2003; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOFFMAN RC, 1993, J MAGN RESON SER B, V102, P61, DOI 10.1006/jmrb.1993.1062; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huth JR, 1997, PROTEIN SCI, V6, P2359; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; PELTON JG, 1993, PROTEIN SCI, V2, P543; Sen N, 2007, J VIROL, V81, P4323, DOI 10.1128/JVI.02279-06; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; VONBONSDORFF CH, 1975, J VIROL, V16, P1296, DOI 10.1128/JVI.16.5.1296-1307.1975; Wang Y, 2008, J BIOL CHEM, V283, P28297, DOI 10.1074/jbc.M804869200; Wang ZH, 2006, J MOL BIOL, V357, P1167, DOI 10.1016/j.jmb.2006.01.010; Westman BJ, 2004, BIOCHEMISTRY-US, V43, P13318, DOI 10.1021/bi049506a; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291	50	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8645	8651		10.1074/jbc.M808081200	http://dx.doi.org/10.1074/jbc.M808081200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179334	Green Published, hybrid			2022-12-27	WOS:000264397800049
J	Gallagher, DT; Smith, N; Kim, SK; Robinson, H; Reddy, PT				Gallagher, D. Travis; Smith, Natasha; Kim, Sook-Kyung; Robinson, Howard; Reddy, Prasad T.			Profound Asymmetry in the Structure of the cAMP-free cAMP Receptor Protein (CRP) from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; FAMILY	The cyclic AMP receptor protein (CRP, also called catabolite gene activator protein or CAP) plays a key role in metabolic regulation in bacteria and has become a widely studied model allosteric transcription factor. On binding its effector cAMP in the N-terminal domain, CRP undergoes a structural transition to a conformation capable of specific DNA binding in the C-terminal domain and transcription initiation. The crystal structures of Escherichia coli CRP (EcCRP) in the cAMP-bound state, both with and without DNA, are known, although its structure in the off state (cAMP-free, apoCRP) remains unknown. We describe the crystal structure at 2.0 angstrom resolution of the cAMP-free CRP homodimer from Mycobacterium tuberculosis H37Rv (MtbCRP), whose sequence is 30% identical with EcCRP, as the first reported structure of an off-state CRP. The overall structure is similar to that seen for the cAMP- bound EcCRP, but the apo MtbCRP homodimer displays a unique level of asymmetry, with a root mean square deviation of 3.5 angstrom between all C alpha positions in the two subunits. Unlike structures of on-state EcCRP and other homologs in which the C-domains are asymmetrically positioned but possess the same internal conformation, the two C-domains of apo MtbCRP differ both in hinge structure and in internal arrangement, with numerous residues that have completely different local environments and hydrogen bond interactions, especially in the hinge and DNA-binding regions. Comparison of the structures of apo MtbCRP and DNA-bound EcCRP shows how DNA binding would be inhibited in the absence of cAMP and supports a mechanism involving functional asymmetry in apoCRP.	[Gallagher, D. Travis; Smith, Natasha; Reddy, Prasad T.] Natl Inst Stand & Technol, Div Biol Sci, Gaithersburg, MD 20899 USA; [Kim, Sook-Kyung] Korea Res Inst Stand & Sci, Div Metrol Qual Life, Ctr Bioanal, Taejon 305340, South Korea; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	National Institute of Standards & Technology (NIST) - USA; Korea Research Institute of Standards & Science (KRISS); United States Department of Energy (DOE); Brookhaven National Laboratory	Gallagher, DT (corresponding author), Natl Inst Stand & Technol, Div Biol Sci, 100 Bur Rd,NIST Mailstop 8310, Gaithersburg, MD 20899 USA.	gallaghe@umbi.umd.edu			U. S. Department of Energy; National Institutes of Health; Northeast Collaborative Access Team (NECAT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Collaborative Access Team (NECAT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We gratefully acknowledge the gift of M. tuberculosis H<INF>37</INF>R<INF>v</INF> chromosomal DNA from Drs. John Belisle and Patrick Brennan, Colorado State University, the technical and logistical support of Darwin Diaz and Dawn Rode, the support of the U. S. Department of Energy (Biological and Environmental Research) and the National Institutes of Health (National Center for Research Resources) for data collected at NSLS beamline X29, and the support of the Northeast Collaborative Access Team (NECAT) at Argonne National Laboratories Advanced Photon Source.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Akhter Y, 2007, INT J MED MICROBIOL, V297, P451, DOI 10.1016/j.ijmm.2007.04.009; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; DeLano W.L., 2002, PYMOL MOL VISUALIZAT; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Joyce MG, 2006, J BIOL CHEM, V281, P28318, DOI 10.1074/jbc.M602654200; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leu SF, 1999, BIOCHEMISTRY-US, V38, P6222, DOI 10.1021/bi982938z; MASURE HR, 1987, MICROBIOL REV, V51, P60, DOI 10.1128/MMBR.51.1.60-65.1987; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napoli AA, 2006, J MOL BIOL, V357, P173, DOI 10.1016/j.jmb.2005.12.051; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Youn H, 2006, J BIOL CHEM, V281, P1119, DOI 10.1074/jbc.M509421200	27	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8228	8232		10.1074/jbc.C800215200	http://dx.doi.org/10.1074/jbc.C800215200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19193643	Green Published, hybrid			2022-12-27	WOS:000264397800005
J	Torres, MP; Lee, MJ; Ding, F; Purbeck, C; Kuhlman, B; Dokholyan, NV; Dohlman, HG				Torres, Matthew P.; Lee, Michael J.; Ding, Feng; Purbeck, Carrie; Kuhlman, Brian; Dokholyan, Nikolay V.; Dohlman, Henrik G.			G Protein Mono-ubiquitination by the Rsp5 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED UBIQUITINATION; YEAST SACCHAROMYCES-CEREVISIAE; ALPHA-SUBUNIT; DOWN-REGULATION; SIGNAL-TRANSDUCTION; PHEROMONE RESPONSE; N-MYRISTOYLATION; PLASMA-MEMBRANE; ESSENTIAL GENE; A-FACTOR	Emerging evidence suggests that ubiquitination serves as a protein trafficking signal in addition to its well characterized role in promoting protein degradation. The yeast G protein alpha subunit Gpa1 represents a rare example of a protein that undergoes both mono- and poly-ubiquitination. Whereas mono-ubiquitinated Gpa1 is targeted to the vacuole, poly-ubiquitinated Gpa1 is directed instead to the proteasome. Here we investigate the structural requirements for mono- and poly-ubiquitination of Gpa1. We find that variants of Gpa1 engineered to be unstable are more likely to be poly-ubiquitinated and less likely to be mono-ubiquitinated. In addition, mutants that cannot be myristoylated are no longer mono-ubiquitinated but are still poly-ubiquitinated. Finally, we show that the ubiquitin ligase Rsp5 is necessary for Gpa1 mono-ubiquitination in vivo and that the purified enzyme is sufficient to catalyze Gpa1 mono-ubiquitination in vitro. Taken together, these data indicate that mono-and poly-ubiquitination have distinct enzyme and substrate recognition requirements; whereas poly-ubiquitination targets misfolded protein for degradation, a distinct ubiquitination apparatus targets the fully mature, fully myristoylated G protein for mono-ubiquitination and delivery to the vacuole.	[Torres, Matthew P.; Lee, Michael J.; Ding, Feng; Purbeck, Carrie; Kuhlman, Brian; Dokholyan, Nikolay V.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Genet Med Bldg,Suite 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Ding, Feng/G-6029-2011; Dokholyan, Nikolay/B-2238-2009; Dokholyan, Nikolay/D-8081-2018	Ding, Feng/0000-0003-1850-6336; Dokholyan, Nikolay/0000-0002-8225-4025; Dokholyan, Nikolay/0000-0002-8225-4025; Lee, Michael/0000-0003-3378-6196; Dohlman, Henrik/0000-0003-2443-0729; Torres, Matthew/0000-0001-7296-4536	NIGMS NIH HHS [R01 GM080739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; MITCHELL DA, 1994, J BIOL CHEM, V269, P21540; MIYAJIMA I, 1987, CELL, V50, P1011, DOI 10.1016/0092-8674(87)90167-X; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Naviglio S, 2004, CELL SIGNAL, V16, P1229, DOI 10.1016/j.cellsig.2004.03.012; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Song JP, 1996, BIOCHEMISTRY-US, V35, P14806, DOI 10.1021/bi961846b; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Wang YQ, 2006, CIRC RES, V99, P1305, DOI 10.1161/01.RES.0000251641.57410.81; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466	63	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8931	8941		10.1074/jbc.M809058200	http://dx.doi.org/10.1074/jbc.M809058200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176477	Green Published, hybrid			2022-12-27	WOS:000264397800076
J	Forsee, WT; Cartee, RT; Yother, J				Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet			Characterization of the Lipid Linkage Region and Chain Length of the Cellubiuronic Acid Capsule of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN SYNTHASES; POLYSACCHARIDE BIOSYNTHESIS; TYPE-3 POLYSACCHARIDE; ENZYMATIC-SYNTHESIS; ESCHERICHIA-COLI; MECHANISM; OLIGOSACCHARIDE; MODULATION; STRAINS	The processive reaction mechanisms of beta-glycosyl-polymerases are poorly understood. The cellubiuronan synthase of Streptococcus pneumoniae catalyzes the synthesis of the type 3 capsular polysaccharide through the alternate additions of beta-1,3-Glc and beta-1,4-GlcUA. The processive multistep reaction involves the sequential binding of two nucleotide sugar donors in coordination with the extension of a polysaccharide chain associated with the carbohydrate acceptor recognition site. Degradation analysis using cellubiuronan-specific depolymerase demonstrated that the oligosaccharide-lipid and polysaccharide-lipid products synthesized in vitro with recombinant cellubiuronan synthase had a similar oligosaccharyl-lipid at their reducing termini, providing definitive evidence for a precursor-product relationship and also confirming that growth occurred at the nonreducing end following initiation on phosphatidylglycerol. The presence of a lipid marker at the reducing end allowed the quantitative determination of cellubiuronic acid polysaccharide chain lengths. As the UDP-GlcUA concentration was increased from 1 to 11.5 mu M, the level of synthase in the transitory processive state decreased, with the predominant oligosaccharide-lipid product containing 3 uronic acid residues, whereas the proportion of synthase in the fully processive state increased and the polysaccharide chain length increased from 320 to 6700 monosaccharide units. In conjunction with other kinetic data, these results suggest that the formation of a complex between a tetrauronosyl oligomer and the carbohydrate acceptor recognition site plays a central role in coordinating the repetitive interaction of the synthase with the nucleotide sugar donors and modulating the chain length of cellubiuronan polysaccharide.	[Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Yother, J (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB 661-12, Birmingham, AL 35294 USA.	jyother@uab.edu			National Institutes of Health [R01 GM 53017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01 GM 53017.	Arrecubieta C, 1996, J EXP MED, V184, P449, DOI 10.1084/jem.184.2.449; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Bodevin-Authelet S, 2005, J BIOL CHEM, V280, P8813, DOI 10.1074/jbc.M412803200; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; CABIB E, 1983, P NATL ACAD SCI-BIOL, V80, P3318, DOI 10.1073/pnas.80.11.3318; CAMPBELL JH, 1966, IMMUNOCHEMISTRY, V3, P195, DOI 10.1016/0019-2791(66)90184-4; Cartee RT, 2005, J BACTERIOL, V187, P4470, DOI 10.1128/JB.187.13.4470-4479.2005; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Cartee RT, 2001, J BIOL CHEM, V276, P48831, DOI 10.1074/jbc.M106481200; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; Davies GJ, 2001, TRENDS GLYCOSCI GLYC, V13, P105, DOI 10.4052/tigg.13.105; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; FernandezLopez M, 1996, MOL MICROBIOL, V20, P993, DOI 10.1111/j.1365-2958.1996.tb02540.x; Forsee WT, 2009, J BIOL CHEM, V284, P11836, DOI 10.1074/jbc.M900379200; Forsee WT, 2000, J BIOL CHEM, V275, P25972, DOI 10.1074/jbc.M002613200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Hoshi H, 2004, J BIOL CHEM, V279, P2341, DOI 10.1074/jbc.M305723200; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; PREHM P, 1983, BIOCHEM J, V211, P191, DOI 10.1042/bj2110191; Reeves RE, 1941, J BIOL CHEM, V139, P511; Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6; SMITH EEB, 1960, J GEN MICROBIOL, V22, P265, DOI 10.1099/00221287-22-1-265; STOOLMILLER AC, 1969, J BIOL CHEM, V244, P236; SUGAHARA K, 1979, J BIOL CHEM, V254, P6252; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; TORRIANI A, 1962, J BIOL CHEM, V237, P3; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WRIGHT A, 1965, BIOCHIM BIOPHYS ACTA, V104, P594, DOI 10.1016/0304-4165(65)90366-1	38	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11826	11835		10.1074/jbc.M900386200	http://dx.doi.org/10.1074/jbc.M900386200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19228688	Green Published, hybrid			2022-12-27	WOS:000265494600014
J	Verma, NK; Dourlat, J; Davies, AM; Long, A; Liu, WQ; Garbay, C; Kelleher, D; Volkov, Y				Verma, Navin K.; Dourlat, Jennifer; Davies, Anthony M.; Long, Aideen; Liu, Wang-Qing; Garbay, Christiane; Kelleher, Dermot; Volkov, Yuri			STAT3-Stathmin Interactions Control Microtubule Dynamics in Migrating T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; TUBULIN TYROSINATION; SIGNAL TRANSDUCER; PEPTIDE-SYNTHESIS; CROSS-LINKING; IN-VITRO; STAT3; STATHMIN; TRANSCRIPTION; EXPRESSION	T-cell migration is a complex highly coordinated process that involves cell adhesion to the high endothelial venules or to the extracellular matrix by surface receptor/ligand interactions, cytoskeletal rearrangements, and phosphorylation-dependent signaling cascades. The mechanism(s) that regulates T-cell migration is of considerable relevance for understanding the pathogenesis of various diseases, such as chronic inflammatory diseases and cancer metastasis. This study was designed to identify potential involvement of STAT3, a latent transcription factor, in mediating integrin-induced T-cell migration. Using our previously characterized in vitro model for lymphocyte migration, we demonstrate that STAT3 is activated and translocated to the nucleus during the process of active motility of Hut78 T-lymphoma cells triggered via LFA-1. Blocking STAT3 signaling by multiple approaches inhibitedLFA1- induced T-cell locomotion via destabilization of microtubules and post-translational modification of tubulin. Here, we show that STAT3 physically interacts with stathmin to regulate microtubule dynamics in migrating T-cells. These observations strongly indicate that STAT3 is critically important for T-cell migration and associated signaling events.	[Verma, Navin K.; Davies, Anthony M.; Long, Aideen; Kelleher, Dermot; Volkov, Yuri] Trinity Coll Dublin, Dept Clin Med, Inst Mol Med, Dublin 8, Ireland; [Dourlat, Jennifer; Liu, Wang-Qing; Garbay, Christiane] Univ Paris 05, Lab Pharmacochim Mol & Cellulaire, INSERM, U648, F-75270 Paris 06, France	Trinity College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Verma, NK (corresponding author), Trinity Coll Dublin, Dept Clin Med, Inst Mol Med, Dublin 8, Ireland.	verman@tcd.ie	Verma, Navin Kumar/B-7641-2008; Long, Aideen/HGB-4149-2022; Volkov, Yuri/N-6774-2014; LIU, Wang-Qing/V-5422-2017	Verma, Navin Kumar/0000-0002-5940-6633; Volkov, Yuri/0000-0001-7406-518X; LIU, Wang-Qing/0000-0003-0511-3058	Higher Education Authority of Ireland under the department of Education and Science's Program	Higher Education Authority of Ireland under the department of Education and Science's Program	This work was supported by a Grant from the Higher Education Authority of Ireland under the department of Education and Science's Program for Research in Third Level Institutions and the Health Research Board of Ireland.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; BULINSKI JC, 1987, NATURE, V328, P676, DOI 10.1038/328676a0; CHAO HG, 1994, J ORG CHEM, V59, P6687, DOI 10.1021/jo00101a029; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Debidda M, 2005, J BIOL CHEM, V280, P17275, DOI 10.1074/jbc.M413187200; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dunican DJ, 2001, BIOPOLYMERS, V60, P45, DOI 10.1002/1097-0282(2001)60:1<45::AID-BIP1003>3.3.CO;2-0; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Freeley M, 2005, BIOCHEM BIOPH RES CO, V334, P619, DOI 10.1016/j.bbrc.2005.06.136; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Hauzenberger D, 1995, CRIT REV IMMUNOL, V15, P285, DOI 10.1615/CritRevImmunol.v15.i3-4.60; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Long A, 2001, J IMMUNOL, V167, P636, DOI 10.4049/jimmunol.167.2.636; Luduena RF, 1998, INT REV CYTOL, V178, P207; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sellin ME, 2008, MOL BIOL CELL, V19, P2897, DOI 10.1091/mbc.E08-01-0058; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Verma NK, 2006, DIABETOLOGIA, V49, P1656, DOI 10.1007/s00125-006-0260-1; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Volkov Y, 2006, GASTROENTEROLOGY, V130, P482, DOI 10.1053/j.gastro.2005.10.047; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Wiederkehr-Adam M, 2003, J BIOL CHEM, V278, P16117, DOI 10.1074/jbc.M300261200; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	54	75	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12349	12362		10.1074/jbc.M807761200	http://dx.doi.org/10.1074/jbc.M807761200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251695	hybrid, Green Published			2022-12-27	WOS:000265494600066
J	Katsuyama, Y; Kita, T; Funa, N; Horinouchi, S				Katsuyama, Yohei; Kita, Tomoko; Funa, Nobutaka; Horinouchi, Sueharu			Curcuminoid Biosynthesis by Two Type III Polyketide Synthases in the Herb Curcuma longa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINGER ZINGIBER-OFFICINALE; CHALCONE SYNTHASE; ANIGOZANTHOS-PREISSII; ACID; DECARBOXYLATION; PATHWAY; COA; (S)-3,5-DIHYDROXYPHENYLGLYCINE; PHENYLPHENALENONES; INTERMEDIATE	Curcuminoids found in the rhizome of turmeric, Curcuma longa, possess various biological activities. Despite much attention regarding the biosynthesis of curcuminoids because of their pharmaceutically important properties and biosynthetically intriguing structures, no enzyme systems have been elucidated. Here we propose a pathway for curcuminoid biosynthesis in the herb C. longa, which includes two novel type III polyketide synthases. One of the type III polyketide synthases, named diketide-CoA synthase (DCS), catalyzed the formation of feruloyldiketide-CoA by condensing feruloyl-CoA and malonyl-CoA. The other, named curcumin synthase (CURS), catalyzed the in vitro formation of curcuminoids from cinnamoyldiketide-N-acetylcysteamine (a mimic of the CoA ester) and feruloyl-CoA. Co-incubation of DCS and CURS in the presence of feruloyl-CoA and malonyl-CoA yielded curcumin at high efficiency, although CURS itself possessed low activity for the synthesis of curcumin from feruloyl-CoA and malonyl-CoA. These findings thus revealed the curcumin biosynthetic route in turmeric, in which DCS synthesizes feruloyldiketide-CoA, and CURS then converts the diketide-CoA esters into a curcuminoid scaffold.	[Katsuyama, Yohei; Funa, Nobutaka; Horinouchi, Sueharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Kita, Tomoko] House Foods Corp, Somatech Ctr, Chiba 2840033, Japan	University of Tokyo; House Foods Corporation	Horinouchi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asuhori@mail.ecc.u-tokyo.ac.jp		Katsuyama, Yohei/0000-0003-4905-5320	Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan; Scientific Research on Priority Area "Applied Genomics" from Monkasho	Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan; Scientific Research on Priority Area "Applied Genomics" from Monkasho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan and a Grant-in-Aid for Scientific Research on Priority Area "Applied Genomics" from Monkasho.	Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Blecher M, 1981, Methods Enzymol, V72, P404; Brand S, 2006, PLANTA, V224, P413, DOI 10.1007/s00425-006-0228-x; Cao H, 2001, BIOL PHARM BULL, V24, P1389, DOI 10.1248/bpb.24.1389; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; DENNIFF P, 1980, J CHEM SOC PERK T 1, P2637, DOI 10.1039/p19800002637; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Guthrie JP, 2002, BIOORG CHEM, V30, P32, DOI 10.1006/bioo.2001.1231; HAMMES GG, 1974, ANNU REV BIOPHYS BIO, V3, P1, DOI 10.1146/annurev.bb.03.060174.000245; Hiserodt R, 1996, J CHROMATOGR A, V740, P51, DOI 10.1016/0021-9673(96)00103-3; HOLSCHER D, 1995, J CHEM SOC CHEM COMM, P525, DOI 10.1039/c39950000525; Holtz E, 2007, TETRAHEDRON, V63, P3293, DOI 10.1016/j.tet.2007.02.062; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kamo T, 2000, BIOSCI BIOTECH BIOCH, V64, P2089, DOI 10.1271/bbb.64.2089; Katsuyama Y, 2007, J BIOL CHEM, V282, P37702, DOI 10.1074/jbc.M707569200; Katsuyama Y, 2008, MICROBIOL-SGM, V154, P2620, DOI 10.1099/mic.0.2008/018721-0; Kita T, 2008, BIOSCI BIOTECH BIOCH, V72, P1789, DOI 10.1271/bbb.80075; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; MARCUS JP, 1993, BIOCHEM BIOPH RES CO, V190, P1066, DOI 10.1006/bbrc.1993.1157; MATSUMURA S, 1985, B CHEM SOC JPN, V3, P310; Pfeifer V, 2001, J BIOL CHEM, V276, P38370, DOI 10.1074/jbc.M106580200; Ramirez-Ahumada MD, 2006, PHYTOCHEMISTRY, V67, P2017, DOI 10.1016/j.phytochem.2006.06.028; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; ROUGHLEY PJ, 1973, J CHEM SOC PERK T 1, P2379, DOI 10.1039/p19730002379; Schmitt B, 2000, PHYTOCHEMISTRY, V53, P331, DOI 10.1016/S0031-9422(99)00544-0; Schroder J, 1998, BIOCHEMISTRY-US, V37, P8417, DOI 10.1021/bi980204g; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Tayyem RR, 2006, NUTR CANCER, V55, P126, DOI 10.1207/s15327914nc5502_2; Weber WM, 2005, BIOORGAN MED CHEM, V13, P3811, DOI 10.1016/j.bmc.2005.03.035	34	110	121	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11160	11170		10.1074/jbc.M900070200	http://dx.doi.org/10.1074/jbc.M900070200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258320	Green Published, hybrid			2022-12-27	WOS:000265494500020
J	Tong, L; Lee, S; Denu, JM				Tong, Lei; Lee, Susan; Denu, John M.			Hydrolase Regulates NAD(+) Metabolites and Modulates Cellular Redox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-ADP-RIBOSE; LIFE-SPAN EXTENSION; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE-1; NUDIX HYDROLASES; GLOBAL ANALYSIS; YEAST; NICOTINAMIDE; GENERATION; SIRTUINS	Although the classical redox functions of co-enzyme NAD(+) are firmly established in metabolism, there are numerous enzymes that catalyze cleavage of NAD(+) to yield free ADP-ribose (ADPr) or related metabolites, whose functions remain largely unknown. Here we show that the Nudix (nucleoside diphosphate linked to another moiety X) hydrolase Ysa1 from Saccharomyces cerevisiae is a major regulator of cellular ADPr and O-acetyl-ADP-ribose (OAADPr). OAADPr is the direct product of NAD(+)-dependent protein deacetylases (sirtuins) and is readily converted to ADPr. Ysa1 cleaves ADPr/OAADPr into ribose phosphate/acetyl-ribose phosphate and AMP. In cells lacking Ysa1 (Delta ysa1), ADPr and OAADPr levels increased similar to 50%, with a corresponding decrease in AMP. Strikingly, Delta ysa1 cells display higher resistance to exogenous reactive oxygen species (ROS) and 40% lower basal levels of endogenous ROS, compared with wild type. The biochemical basis for these differences in ROS-related phenotypes was investigated, and the results provide evidence that increased ADPr/OAADPr levels protect cells via the following two pathways: (i) lower ROS production through inhibition of complex I of the mitochondrial electron transport chain, and (ii) generation of higher levels of NADPH to suppress ROS damage. The latter occurs through diverting glucose into the pentose phosphate pathway by ADPr inhibition of glyceraldehyde-3-phosphate dehydrogenase, a central enzyme of glycolysis.	[Tong, Lei; Lee, Susan; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu			NIGMS NIH HHS [R01 GM065386-07, R01 GM065386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; AUSUBEL FM, 2002, SHORT PROTOCOLS MOL, V2, P9; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERGMEYER HU, 1985, METHOD ENZYMATIC ANA, V7, P253; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Du L, 2007, FEMS YEAST RES, V7, P860, DOI 10.1111/j.1567-1364.2007.00274.x; Dumitriu IE, 2004, CELL DEATH DIFFER, V11, P314, DOI 10.1038/sj.cdd.4401348; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; EBY D, 1971, BIOCHEMISTRY-US, V10, P2677; Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghosh HS, 2008, CURR OPIN INVEST DR, V9, P1095; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hoff KG, 2005, NAT STRUCT MOL BIOL, V12, P560, DOI 10.1038/nsmb0705-560; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lee S, 2008, ANAL BIOCHEM, V383, P174, DOI 10.1016/j.ab.2008.08.033; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; McClure JM, 2008, GENETICS, V180, P797, DOI 10.1534/genetics.108.091090; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MIWA M, 1971, J BIOL CHEM, V246, P6362; NELSON DL, 2000, LEHNINGER PRINCIPLES, P666; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; ROSKAMS J, 2002, LAB REF HDB RECIPES, P196; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shanmuganathan A, 2004, FEBS LETT, V556, P253, DOI 10.1016/S0014-5793(03)01428-5; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Shull NP, 2005, NUCLEIC ACIDS RES, V33, P650, DOI 10.1093/nar/gki211; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Zharova TV, 1997, BBA-BIOENERGETICS, V1320, P256, DOI 10.1016/S0005-2728(97)00029-7; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	71	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11256	11266		10.1074/jbc.M809790200	http://dx.doi.org/10.1074/jbc.M809790200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251690	Green Published, hybrid			2022-12-27	WOS:000265494500029
J	Baillif, V; Robins, RJ; Le Feunteun, S; Lesot, P; Billault, I				Baillif, Vincent; Robins, Richard J.; Le Feunteun, Steven; Lesot, Philippe; Billault, Isabelle			Investigation of Fatty Acid Elongation and Desaturation Steps in Fusarium lateritium by Quantitative Two-dimensional Deuterium NMR Spectroscopy in Chiral Oriented Media	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE LIQUID-CRYSTALS; NATURAL-ABUNDANCE; H-2 NMR; CLADOSPORIUM-CLADOSPORIOIDES; GLUCOSE FERMENTATION; HYDROGEN-TRANSFER; OLEIC-ACID; BIOSYNTHESIS; REDUCTASE; STEREOCHEMISTRY	The origin of hydrogen atoms during fatty acid biosynthesis in Fusarium lateritium has been quantified by isotope tracking close to natural abundance. Methyl linoleate was isolated from F. lateritium grown in natural abundance medium or in medium slightly enriched with labeled water, glucose, or acetate, and the H-2 incorporation was determined by quantitative H-2-{H-1} NMR in isotropic and chiral oriented solvents. Thus, the individual (H-2/H-1)(i) ratio at each pro-R and pro-S hydrogen position of the CH2 groups along the chain can be analyzed. These values allow the isotope redistribution coefficients (a(ij)) that characterize the specific source of each hydrogen atom to be related to the nonexchangeable hydrogen atoms in glucose and to the medium water. In turn, these can be related to the stereoselectivity that operates during the introduction or removal of hydrogens along the fatty acid chain. First, at even CH2 the pro-S hydrogen comes only from water by protonation, whereas the pro-R hydrogen is introduced partly via acetate but principally from water. Second, the nonexchangeable hydrogens of glucose ( positions H-6,6 and H-1) are shown to be introduced to the odd CH2 via the NAD(P) H pool used by both reductases involved in the elongation steps of the fatty acid chain. Third, it is proved that hydrogens removed at sites 9,10 and 12,13 during desaturation by Delta(9)- and Delta(12)-desaturases are pro-R, and that during these desaturation steps alpha-secondary kinetic isotope effects occur at the 9 and 12 positions and not at the 10 and 13 positions.	[Billault, Isabelle] Univ Nantes, Elucidat Biosynth Isotop Spectrometry Grp, UMR 6230, CEISAM,UFR Sci & Tech,CNRS, F-44322 Nantes 3, France; [Lesot, Philippe] Univ Paris 11, CNRS, Lab Struct Organ, RMN Milieu Oriente,ICMMO,UMR 8182, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Billault, I (corresponding author), Univ Nantes, Elucidat Biosynth Isotop Spectrometry Grp, UMR 6230, CEISAM,UFR Sci & Tech,CNRS, Bat 9,2 Rue Houssiniere,BP 92208, F-44322 Nantes 3, France.	isabelle.billault@univ-nantes.fr	Le Feunteun, Steven/AAA-9521-2021; Lesot, Philippe/M-3390-2017	Le Feunteun, Steven/0000-0002-4476-2811; Lesot, Philippe/0000-0002-5811-7530; Robins, Richard/0000-0002-5325-8983				Aroulanda C, 2001, J AM CHEM SOC, V123, P12059, DOI 10.1021/ja011685l; Baillif V, 2006, J AM CHEM SOC, V128, P11180, DOI 10.1021/ja0617892; Behrouzian B, 2001, CHEM COMMUN, P401, DOI 10.1039/b008972i; Billault I, 2005, J BIOL CHEM, V280, P17645, DOI 10.1074/jbc.M500909200; Billault I, 2004, J AM CHEM SOC, V126, P3250, DOI 10.1021/ja038814d; Buist PH, 1996, J AM CHEM SOC, V118, P6295, DOI 10.1021/ja953262n; Buist PH, 1998, J AM CHEM SOC, V120, P871, DOI 10.1021/ja971362i; Duan JR, 2002, CHEMBIOCHEM, V3, P752, DOI 10.1002/1439-7633(20020802)3:8<752::AID-CBIC752>3.0.CO;2-G; DUAN JR, 2002, THESIS U NANTES NANT; GORBIK L T, 1980, Mikrobiologicheskii Zhurnal (Kiev), V42, P191; Guiet S, 2003, PHYTOCHEMISTRY, V64, P227, DOI 10.1016/S0031-9422(03)00278-4; Kawaguchi A., 1999, COMPR NAT PROD CHEM, P23, DOI [10.1016/B978-0-08-091283-7.00001-1, DOI 10.1016/B978-0-08-091283-7.00001-1]; Lafon O, 2004, J MAGN RESON, V171, P135, DOI 10.1016/j.jmr.2004.08.010; Lesot P, 2004, ANAL CHEM, V76, P2827, DOI 10.1021/ac030385e; Lesot P, 2003, CHEM-EUR J, V9, P1724, DOI 10.1002/chem.200390199; Lesot P, 2008, ANAL CHEM, V80, P2963, DOI 10.1021/ac702443b; Marcinkeviciene J, 2001, ARCH BIOCHEM BIOPHYS, V390, P101, DOI 10.1006/abbi.2001.2349; Martin M, 1990, NMR BASIC PRINCIPLES, P1; MCINNES AG, 1983, TETRAHEDRON, V39, P3515, DOI 10.1016/S0040-4020(01)88661-0; MIZUGAKI M, 1984, J BIOCHEM-TOKYO, V95, P311, DOI 10.1093/oxfordjournals.jbchem.a134610; MORRIS LJ, 1970, BIOCHEM J, V118, P681, DOI 10.1042/bj1180681g; OHAGAN D, 1992, POLYKETIDE METABOLIT, P19; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pionnier S, 2003, J AGR FOOD CHEM, V51, P2076, DOI 10.1021/jf0259617; Rawlings BJ, 1998, NAT PROD REP, V15, P275; RAWLINGS BJ, 1989, J AM CHEM SOC, V111, P3382, DOI 10.1021/ja00191a041; REESE PB, 1988, J AM CHEM SOC, V110, P316, DOI 10.1021/ja00209a065; Robins RJ, 2008, J BIOL CHEM, V283, P9704, DOI 10.1074/jbc.M710272200; Robins Richard J., 2003, Phytochemistry Reviews, V2, P87, DOI 10.1023/B:PHYT.0000004301.52646.a8; Roger O, 2004, J BIOL CHEM, V279, P24923, DOI 10.1074/jbc.M401232200; SAITO K, 1982, BIOCHEM BIOPH RES CO, V108, P995, DOI 10.1016/0006-291X(82)92098-8; SAITO K, 1981, J BIOCHEM-TOKYO, V90, P1697, DOI 10.1093/oxfordjournals.jbchem.a133646; Sarfati M, 2000, CHEM COMMUN, P2069, DOI 10.1039/b006244h; Schmidt Hanns-Ludwig, 2003, Phytochemistry Reviews, V2, P61, DOI 10.1023/B:PHYT.0000004185.92648.ae; SCHROEPF.GJ, 1965, J BIOL CHEM, V240, P54; SEDGWICK B, 1977, EUR J BIOCHEM, V75, P465, DOI 10.1111/j.1432-1033.1977.tb11549.x; SEDGWICK B, 1980, J CHEM SOC CHEM COMM, P96, DOI 10.1039/c39800000096; SEDGWICK B, 1977, EUR J BIOCHEM, V75, P481, DOI 10.1111/j.1432-1033.1977.tb11550.x; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; TOWNSEND CA, 1988, J AM CHEM SOC, V110, P318, DOI 10.1021/ja00209a066; Zhang BL, 2006, EUR J LIPID SCI TECH, V108, P125, DOI 10.1002/ejlt.200500294; Zhang BL, 2003, CHEM-EUR J, V9, P3604, DOI 10.1002/chem.200304761; Zhang BL, 2002, J AGR FOOD CHEM, V50, P1574, DOI 10.1021/jf010776z; ZHANG HL, 1995, J BIOL CHEM, V270, P16023, DOI 10.1074/jbc.270.27.16023	44	34	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10783	10792		10.1074/jbc.M807826200	http://dx.doi.org/10.1074/jbc.M807826200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19213728	Green Published, hybrid			2022-12-27	WOS:000265104600053
J	Barylko, B; Mao, YS; Wlodarski, P; Jung, G; Binns, DD; Sun, HQ; Yin, HL; Albanesi, JP				Barylko, Barbara; Mao, Yuntao S.; Wlodarski, Pawel; Jung, Gwanghyun; Binns, Derk D.; Sun, Hui-Qiao; Yin, Helen L.; Albanesi, Joseph P.			Palmitoylation Controls the Catalytic Activity and Subcellular Distribution of Phosphatidylinositol 4-Kinase II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; LOCALIZATION; DOMAIN; PHOSPHOINOSITIDES; SUPERFAMILY; ACTIVATION; COMPLEXES; REVEALS; ENZYMES	Phosphatidylinositol 4-kinases play essential roles in cell signaling and membrane trafficking. They are divided into type II and III families, which have distinct structural and enzymatic properties and are essentially unrelated in sequence. Mammalian cells express two type II isoforms, phosphatidylinositol 4-kinase II alpha (PI4KII alpha) and II beta (PI4KII beta). Nearly all of PI4KII alpha, and about half of PI4KII beta, associates integrally with membranes, requiring detergent for solubilization. This tight membrane association is because of palmitoylation of a cysteine-rich motif, CCPCC, located within the catalytic domains of both type II isoforms. Deletion of this motif from PI4KII alpha converts the kinase from an integral to a tightly bound peripheral membrane protein and abrogates its catalytic activity (Barylko, B., Gerber, S. H., Binns, D. D., Grichine, N., Khvotchev, M., Sudhof, T. C., and Albanesi, J. P. ( 2001) J. Biol. Chem. 276, 7705-7708). Here we identify the first two cysteines in the CCPCC motif as the principal sites of palmitoylation under basal conditions, and we demonstrate the importance of the central proline for enzymatic activity, although not for membrane binding. We further show that palmitoylation is critical for targeting PI4KII alpha to the trans-Golgi network and for enhancement of its association with low buoyant density membrane fractions, commonly termed lipid rafts. Replacement of the four cysteines in CCPCC with a hydrophobic residue, phenylalanine, substantially restores catalytic activity of PI4KII alpha in vitro and in cells without restoring integral membrane binding. Although this FFPFF mutant displays a perinuclear distribution, it does not strongly co-localize with wild-type PI4KII alpha and associates more weakly with lipid rafts.	[Mao, Yuntao S.; Sun, Hui-Qiao; Yin, Helen L.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Barylko, Barbara; Wlodarski, Pawel; Jung, Gwanghyun; Binns, Derk D.; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wlodarski, Pawel] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, Warsaw, Poland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of Warsaw	Yin, HL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Helen.Yin@UTSouthwestern.edu; Joseph.Albanesi@UTSouthwestern.edu	Mao, Yuntao/E-9168-2012	Wlodarski, Pawel/0000-0002-0683-1791	National Institutes of Health [RO1 GM75401, R01 GM66110]; American Heart Association Texas Affiliate [0455005Y]; National Science Foundation [9982061]; Welch Foundation [I-1200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075401, R01GM066110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Texas Affiliate(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM75401 ( to J. P. A.) and R01 GM66110 ( to H. L. Y.). This work was also supported by American Heart Association Texas Affiliate Grant 0455005Y ( to J. P. A. in recognition of HCA Hospitals, North Richland Hills, TX), National Science Foundation Grant 9982061 ( to B. B.), and the Welch Foundation Grant I-1200 ( to H. L. Y.).	Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Bijlmakers MJ, 2009, MOL MEMBR BIOL, V26, P93, DOI 10.1080/09687680802650481; BLIGH EG, 1959, CAN J MED SCI, V37, P911, DOI DOI 10.1139/O59-099; Chang FS, 2005, J CELL BIOL, V171, P133, DOI 10.1083/jcb.200501086; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; de Matteis MA, 2007, BIOCHEM SOC SYMP, V74, P107, DOI 10.1042/BSS2007c10; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heilmeyer LMG, 2003, IUBMB LIFE, V55, P59, DOI 10.1080/1521654031000090896; Jung G, 2008, BIOCHEM J, V409, P501, DOI 10.1042/BJ20070821; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LINDER ME, 1995, METHOD ENZYMOL, V250, P314; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Wang J, 2007, MOL BIOL CELL, V18, P2646, DOI 10.1091/mbc.E06-10-0897; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Waugh MG, 2003, BIOCHEM J, V373, P57, DOI 10.1042/BJ20030089; Waugh MG, 2001, BIOCHEM SOC T, V29, P509, DOI 10.1042/BST0290509; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101	43	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9994	10003		10.1074/jbc.M900724200	http://dx.doi.org/10.1074/jbc.M900724200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211550	hybrid, Green Published			2022-12-27	WOS:000264892900042
J	Zaas, DW; Swan, ZD; Brown, BJ; Li, G; Randell, SH; Degan, S; Sunday, ME; Wright, JR; Abraham, SN				Zaas, David W.; Swan, Zachary D.; Brown, Bethany J.; Li, Guojie; Randell, Scott H.; Degan, Simone; Sunday, Mary E.; Wright, Jo Rae; Abraham, Soman N.			Counteracting Signaling Activities in Lipid Rafts Associated with the Invasion of Lung Epithelial Cells by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; PLASMA-MEMBRANE; GOLGI-COMPLEX; SHOW EVIDENCE; IN-VIVO; CAVEOLIN-1; PHOSPHORYLATION; EXPRESSION; PROTEIN; MICE	Pseudomonas aeruginosa has the capacity to invade lung epithelial cells by co-opting the intrinsic endocytic properties of lipid rafts, which are rich in cholesterol, sphingolipids, and proteins, such as caveolin-1 and -2. We compared intratracheal Pseudomonas infection in wild type and caveolin-deficient mice to investigate the role of caveolin proteins in the pathogenesis of Pseudomonas pneumonia. Unlike wild type mice, which succumb to pneumonia, caveolin-deficient mice are resistant to Pseudomonas. We observed that Pseudomonas invasion of lung epithelial cells is dependent on caveolin-2 but not caveolin-1. Phosphorylation of caveolin-2 by Src family kinases is an essential event for Pseudomonas invasion. Our studies also reveal the existence of a distinct signaling mechanism in lung epithelial cells mediated by COOH-terminal Src kinase (Csk) that negatively regulates Pseudomonas invasion. Csk migrates to lipid raft domains, where it decreases phosphorylation of caveolin-2 by inactivating c-Src. Whereas Pseudomonas co-opts the endocytic properties of caveolin-2 for invasion, there also exists in these cells an intrinsic Csk-dependent cellular defense mechanism aimed at impairing this activity. The success of Pseudomonas in co-opting lipid raft-mediated endocytosis to invade lung epithelial cells may depend on the relative strengths of these counteracting signaling activities.	[Zaas, David W.; Swan, Zachary D.] Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Brown, Bethany J.; Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Li, Guojie; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Degan, Simone; Sunday, Mary E.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Randell, Scott H.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zaas, DW (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, DUMC Box 3501,Bell Bldg,Rm 350, Durham, NC 27710 USA.	david.zaas@duke.edu		Sunday, Mary E./0000-0002-6788-1469; Degan, Simone/0000-0001-5417-1196	National Institutes of Health [HL083092, HL084917, HL-30923, DK050814-28, DK065988]; Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084917, K08HL083092, R01HL030923, R23HL030923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050814, P30DK065988, R37DK050814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083092 ( to D. W. Z.), HL084917 ( to M. S.), HL-30923 ( to J. R. W.), DK050814-28 ( to S. N. A.), and DK065988 ( for mouse tracheal epithelial cell culture) ( to S. H. R.). This research was also supported by the Parker B. Francis Foundation.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; Davidson Donald J, 2004, J Cyst Fibros, V3 Suppl 2, P59, DOI 10.1016/j.jcf.2004.05.013; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; DUNN M, 1995, CLIN CHEST MED, V16, P95; Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; Li SW, 1996, J BIOL CHEM, V271, P3863; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; MERCER AA, 1979, J BACTERIOL, V140, P37, DOI 10.1128/JB.140.1.37-42.1979; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2001, J BIOL CHEM, V276, P38121; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Schlegel A, 2001, CYTOKINE GROWTH F R, V12, P41, DOI 10.1016/S1359-6101(00)00022-8; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Vang T, 2003, J BIOL CHEM, V278, P17597, DOI 10.1074/jbc.C300077200; Wang XB, 2004, BIOCHEMISTRY-US, V43, P13694, DOI 10.1021/bi049295+; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200	35	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9955	9964		10.1074/jbc.M808629200	http://dx.doi.org/10.1074/jbc.M808629200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211560	Green Published, hybrid			2022-12-27	WOS:000264892900038
J	Blot, N; Wu, XJ; Thomas, JC; Zhang, J; Garczarek, L; Bohm, S; Tu, JM; Zhou, M; Ploscher, M; Eichacker, L; Partensky, F; Scheer, H; Zhao, KH				Blot, Nicolas; Wu, Xian-Jun; Thomas, Jean-Claude; Zhang, Juan; Garczarek, Laurence; Boehm, Stephan; Tu, Jun-Ming; Zhou, Ming; Ploescher, Matthias; Eichacker, Lutz; Partensky, Frederic; Scheer, Hugo; Zhao, Kai-Hong			Phycourobilin in Trichromatic Phycocyanin from Oceanic Cyanobacteria Is Formed Post-translationally by a Phycoerythrobilin Lyase-Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYCOBILIPROTEIN BETA-SUBUNITS; MARINE UNICELLULAR CYANOBACTERIA; ANABAENA SP PCC-7120; CHROMOPHORE ATTACHMENT; ENERGY-TRANSFER; ALPHA-SUBUNIT; R-PHYCOCYANIN; BILIN LYASE; CPCS-I; SYNECHOCOCCUS	Most cyanobacteria harvest light with large antenna complexes called phycobilisomes. The diversity of their constituting phycobiliproteins contributes to optimize the photosynthetic capacity of these microorganisms. Phycobiliprotein biosynthesis, which involves several post-translational modifications including covalent attachment of the linear tetrapyrrole chromophores (phycobilins) to apoproteins, begins to be well understood. However, the biosynthetic pathway to the blue-green-absorbing phycourobilin (lambda(max) similar to 495 nm) remained unknown, although it is the major phycobilin of cyanobacteria living in oceanic areas where blue light penetrates deeply into the water column. We describe a unique trichromatic phycocyanin, R-PC V, extracted from phycobilisomes of Synechococcus sp. strain WH8102. It is evolutionarily remarkable as the only chromoprotein known so far that absorbs the whole wavelength range between 450 and 650 nm. R-PC V carries a phycourobilin chromophore on its alpha-subunit, and this can be considered an extreme case of adaptation to blue-green light. We also discovered the enzyme, RpcG, responsible for its biosynthesis. This monomeric enzyme catalyzes binding of the green-absorbing phycoerythrobilin at cysteine 84 with concomitant isomerization to phycourobilin. This reaction is analogous to formation of the orange-absorbing phycoviolobilin from the red-absorbing phycocyanobilin that is catalyzed by the lyase-isomerase PecE/F in some freshwater cyanobacteria. The fusion protein, RpcG, and the heterodimeric PecE/F are mutually interchangeable in a heterologous expression system in Escherichia coli. The novel R-PC V likely optimizes rod-core energy transfer in phycobilisomes and thereby adaptation of a major phytoplankton group to the blue-green light prevailing in oceanic waters.	[Wu, Xian-Jun; Zhang, Juan; Tu, Jun-Ming; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Blot, Nicolas; Garczarek, Laurence; Partensky, Frederic] Univ Paris 06, Biol Stn, F-29682 Roscoff, France; [Blot, Nicolas; Garczarek, Laurence; Partensky, Frederic] CNRS, UMR7144, Grp Plancton Ocean, F-29682 Roscoff, France; [Wu, Xian-Jun; Zhang, Juan; Tu, Jun-Ming; Zhou, Ming; Zhao, Kai-Hong] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Thomas, Jean-Claude] CNRS, F-75230 Paris, France; [Thomas, Jean-Claude] Ecole Normale Super, UMR 8186, Dept Biol Mol Organismes Photosynthet, F-75230 Paris, France; [Boehm, Stephan; Tu, Jun-Ming; Ploescher, Matthias; Eichacker, Lutz; Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany; [Eichacker, Lutz] Univ Stavanger, CORE, N-4036 Stavanger, Norway	Huazhong Agricultural University; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Huazhong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Munich; Universitetet i Stavanger	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com	Partensky, Frédéric/AAH-1170-2021; Partensky, Frédéric/B-9194-2018	Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Garczarek, Laurence/0000-0002-8191-8395	Volkswagen Foundation [I/77900]; National Natural Science Foundation of China [30670489, 30870519]; French Agence Nationale de la Recherche (ANR) [ANR-05-BLAN-0122-01]; Deutsche Forschungsgemeinschaft [SFB 533]	Volkswagen Foundation(Volkswagen); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a partnership grant of the Volkswagen Foundation (Grant I/77900) (to H. S. and K. H. Z.), Grants 30670489 and 30870519 from the National Natural Science Foundation of China (to K. H. Z. and M. Z.), Grant ANR-05-BLAN-0122-01 from the French Agence Nationale de la Recherche (ANR) program PhycoSyn (to J. C. T., N. B., L. G., and F. P.), and Grant SFB 533, TPA1 from the Deutsche Forschungsgemeinschaft (to H. S.).	BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; BISHOP JE, 1987, J AM CHEM SOC, V109, P875, DOI 10.1021/ja00237a039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANAANI O, 1980, FEBS LETT, V115, P225, DOI 10.1016/0014-5793(80)81174-4; Dammeyer T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1121, DOI 10.1039/b807209b; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; GANTT E, 1986, PHOTOSYNTHESIS, V3, P260; Garcia-Pichel F., 2003, ALGOLOGICAL STUDIES, V109, P213, DOI DOI 10.1127/1864-1318/2003/0109-0213; GLAZER AN, 1977, J BIOL CHEM, V252, P32; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1975, J BIOL CHEM, V250, P5487; GLAZER AN, 1973, J BIOL CHEM, V248, P659; Green B. R., 2003, LIGHT HARVESTING ANT; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LIPSCHULTZ CA, 1981, BIOCHEMISTRY-US, V20, P3371, DOI 10.1021/bi00515a010; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; MacColl R, 1996, J BIOL CHEM, V271, P17157, DOI 10.1074/jbc.271.29.17157; Miller CA, 2008, J BIOL CHEM, V283, P19293, DOI 10.1074/jbc.M802734200; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; ONG LJ, 1984, SCIENCE, V224, P80, DOI 10.1126/science.224.4644.80; ONG LJ, 1988, LIGHT ENERGY TRANSDU, P102; Partensky F., 1999, MARINE CYANOBACTERIA, V19, P457; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter W.M., 2002, HEME CHLOROPHYLL BIL, P311, DOI DOI 10.1385/1-59259-243-0:311; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; Shen GZ, 2008, J BACTERIOL, V190, P4808, DOI 10.1128/JB.00436-08; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Six C, 2005, J BACTERIOL, V187, P1685, DOI 10.1128/JB.187.5.1685-1694.2005; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P608, DOI 10.4319/lo.1999.44.3.0608; SWANSON RV, 1991, J BIOL CHEM, V266, P9528; THOMAS BA, 1993, BIOCHIM BIOPHYS ACTA, V1143, P104, DOI 10.1016/0005-2728(93)90222-2; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; YU MH, 1981, PLANT PHYSIOL, V68, P482, DOI 10.1104/pp.68.2.482; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P235, DOI 10.1016/0005-2728(94)00181-4	54	65	73	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9290	9298		10.1074/jbc.M809784200	http://dx.doi.org/10.1074/jbc.M809784200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19182270	Green Published, hybrid			2022-12-27	WOS:000264669100035
J	Huertas, P; Jackson, SP				Huertas, Pablo; Jackson, Stephen P.			Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; HOMOLOGOUS RECOMBINATION; CHECKPOINT CONTROL; DAMAGE RESPONSE; SAE2; PHOSPHORYLATION; COMPLEX; HYPERPHOSPHORYLATION; PATHWAY; GENE	In G(0) and G(1), DNA double strand breaks are repaired by non-homologous end joining, whereas in S and G(2), they are also repaired by homologous recombination. The human CtIP protein controls double strand break (DSB) resection, an event that occurs effectively only in S/G(2) and that promotes homologous recombination but not non-homologous end joining. Here, we mutate a highly conserved cyclin-dependent kinase (CDK) target motif in CtIP and reveal that mutating Thr-847 to Ala impairs resection, whereas mutating it to Glu to mimic constitutive phosphorylation does not. Moreover, we show that unlike cells expressing wild-type CtIP, cells expressing the Thr-to-Glu mutant resect DSBs even after CDK inhibition. Finally, we establish that Thr-847 mutations to either Ala or Glu affect DSB repair efficiency, cause hypersensitivity toward DSB-generating agents, and affect the frequency and nature of radiation-induced chromosomal rearrangements. These results suggest that CDK-mediated control of resection in human cells operates by mechanisms similar to those recently established in yeast.	[Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Huertas, Pablo/N-2245-2016; Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Huertas, Pablo/0000-0002-1756-4449; Jackson, Stephen Philip/0000-0001-9317-7937; 	Cancer Research UK; European Community [LSHG-CT-2005512113]; Genomic Instability in Cancer and Precancer [HEALTH-F22007-201630]; Biotechnology and Biological Sciences Research Council Research [BBF0016651]; Biotechnology and Biological Sciences Research Council [BB/F001665/1] Funding Source: researchfish; BBSRC [BB/F001665/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Community(European Commission); Genomic Instability in Cancer and Precancer; Biotechnology and Biological Sciences Research Council Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Cancer Research UK and the European Community (Integrated Project DNA repair, Grant LSHG-CT-2005512113, and Genomic Instability in Cancer and Precancer, Grant HEALTH-F22007-201630) (to S. P. J.) and Biotechnology and Biological Sciences Research Council Research Grant BBF0016651 (to P. H.).	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Cruet-Hennequart S, 2008, DNA REPAIR, V7, P582, DOI 10.1016/j.dnarep.2007.12.012; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; HARRINGTON J, 1992, MOL CELL BIOL, V12, P4758, DOI 10.1128/MCB.12.10.4758; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Vilkki S, 2002, J MED GENET, V39, P785, DOI 10.1136/jmg.39.11.785; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu GK, 2006, CELL CYCLE, V5, P1592, DOI 10.4161/cc.5.15.3127; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Xu JM, 2007, BBA-GEN SUBJECTS, V1770, P273, DOI 10.1016/j.bbagen.2006.09.025; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	35	345	352	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9558	9565		10.1074/jbc.M808906200	http://dx.doi.org/10.1074/jbc.M808906200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19202191	Green Published, hybrid			2022-12-27	WOS:000264669100062
J	Liao, CP; Lasbury, ME; Wang, SH; Zhang, C; Durant, PJ; Murakami, Y; Matsufuji, S; Lee, CH				Liao, Chung-Ping; Lasbury, Mark E.; Wang, Shao-Hung; Zhang, Chen; Durant, Pamela J.; Murakami, Yasuko; Matsufuji, Senya; Lee, Chao-Hung			Pneumocystis Mediates Overexpression of Antizyme Inhibitor Resulting in Increased Polyamine Levels and Apoptosis in Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE DEPOLARIZATION; DL-ALPHA-DIFLUOROMETHYLORNITHINE; ORNITHINE-DECARBOXYLASE; HELICOBACTER-PYLORI; CARINII PNEUMONIA; RAT MODEL; INTRACELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBE; CELLS	Pneumocystis pneumonia (PcP) is the most common opportunistic disease in immunocompromised patients. Alveolar macrophages are responsible for the clearance of Pneumocystis organisms; however, they undergo a high rate of apoptosis during PcP due to increased intracellular polyamine levels. In this study, the sources of polyamines and mechanisms of polyamine increase and polyamine-induced apoptosis were investigated. The level of ornithine decarboxylase (ODC) was elevated in alveolar macrophages, and the number of alveolar macrophages that took up exogenous polyamines was increased 20-fold during PcP. Monocytes, B lymphocytes, and CD8+ T lymphocytes that were recruited into the lung during PcP expressed high levels of ornithine decarboxylase, suggesting that these cells are sources of polyamines. Both protein and mRNA levels of antizyme inhibitor (AZI) were increased in alveolar macrophages during PcP. This AZI overexpression correlated with increased polyamine uptake by alveolar macrophages, because AZI expression knockdown decreased the polyamine uptake ability of these cells. AZI expression knockdown also decreased the apoptosis rate of alveolar macrophages. Pneumocystis organisms and zymosan A were found to induce AZI overexpression in alveolar macrophages, suggesting that beta-glucan, which is the major component of the Pneumocystis cell wall, induces AZI overexpression. The levels of mRNA, protein, and activity of polyamine oxidase were increased in alveolar macrophages during PcP, indicating that the H2O2 generated during polyamine catabolism caused alveolar macrophages to undergo apoptosis. Taken together, results of this study indicate that Pneumocystis organisms induce AZI overexpression in alveolar macrophages, leading to increased polyamine synthesis and uptake and apoptosis rate of these cells.	[Liao, Chung-Ping; Lasbury, Mark E.; Wang, Shao-Hung; Zhang, Chen; Durant, Pamela J.; Lee, Chao-Hung] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Murakami, Yasuko] Musashino Univ, Sch Pharm, Dept Genet & Mol Biol, Nishi Tokyo 2028585, Japan; [Matsufuji, Senya] Jikei Univ, Sch Med, Dept Mol Biol, Tokyo 1058461, Japan	Indiana University System; Indiana University-Purdue University Indianapolis; Jikei University	Lee, CH (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, 1120 South Dr,FH419, Indianapolis, IN 46202 USA.	chlee@iupui.edu	Liao, Chung-Ping/E-2344-2015; wang, shaohung/E-4017-2015	Liao, Chung-Ping/0000-0001-8787-7291; wang, shaohung/0000-0002-6824-0372	National Institutes of Health [RO1 HL65170, RO1 AI062259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL65170 and RO1 AI062259. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aziz SM, 1998, J PHARMACEUT BIOMED, V17, P307, DOI 10.1016/S0731-7085(98)00016-8; BARTLETT MS, 1988, J CLIN MICROBIOL, V26, P1100, DOI 10.1128/JCM.26.6.1100-1102.1988; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Chin K, 1996, ANTIMICROB AGENTS CH, V40, P2318, DOI 10.1128/AAC.40.10.2318; CLARKSON AB, 1988, ANTIMICROB AGENTS CH, V32, P1158, DOI 10.1128/AAC.32.8.1158; Cullis PM, 1999, CHEM BIOL, V6, P717, DOI 10.1016/S1074-5521(00)80019-8; ERWIN BG, 1983, BIOCHEM BIOPH RES CO, V114, P944, DOI 10.1016/0006-291X(83)90651-4; EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0; FLEURY J, 1985, ACTA CYTOL, V29, P721; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Heiskala M, 1999, EMBO J, V18, P1214, DOI 10.1093/emboj/18.5.1214; Hoet PHM, 2000, AM J PHYSIOL-LUNG C, V278, pL417, DOI 10.1152/ajplung.2000.278.3.L417; Huang L, 2004, EMERG INFECT DIS, V10, P1721, DOI 10.3201/eid1010.030994; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kaur N, 2008, J MED CHEM, V51, P1393, DOI 10.1021/jm070794t; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KUFE DW, 1984, CANCER RES, V44, P4281; Lasbury ME, 2007, J BIOL CHEM, V282, P11009, DOI 10.1074/jbc.M611686200; Lasbury ME, 2006, J IMMUNOL, V176, P6443, DOI 10.4049/jimmunol.176.11.6443; Lasbury ME, 2003, J EUKARYOT MICROBIOL, V50, P630, DOI 10.1111/j.1550-7408.2003.tb00658.x; Lasbury ME, 2003, CLIN DIAGN LAB IMMUN, V10, P293, DOI 10.1128/CDLI.10.2.293-302.2003; Limper AH, 1997, J CLIN INVEST, V99, P2110, DOI 10.1172/JCI119384; Liu GY, 2006, APOPTOSIS, V11, P1773, DOI 10.1007/s10495-006-9512-2; MATSUFUJI S, 1990, J BIOCHEM, V107, P87, DOI 10.1093/oxfordjournals.jbchem.a123018; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; Merali S, 1999, J BIOL CHEM, V274, P21017, DOI 10.1074/jbc.274.30.21017; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nahimana A, 2004, ANTIMICROB AGENTS CH, V48, P4301, DOI 10.1128/AAC.48.11.4301-4305.2004; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Roy UKB, 2008, MOL CARCINOGEN, V47, P538, DOI 10.1002/mc.20414; Schipper RG, 2004, J HISTOCHEM CYTOCHEM, V52, P1259, DOI 10.1369/jhc.4C6389.2004; Schipper RG, 2000, SEMIN CANCER BIOL, V10, P55, DOI 10.1006/scbi.2000.0308; Soulet D, 2004, J BIOL CHEM, V279, P49355, DOI 10.1074/jbc.M401287200; Soulet D, 2002, BIOCHEM J, V367, P347, DOI 10.1042/BJ20020764; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Stein CR, 2004, EMERG INFECT DIS, V10, P1760, DOI 10.3201/eid1010.040362; SUZUKI O, 1984, EXPERIENTIA, V40, P838, DOI 10.1007/BF01951981; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; VERMA DS, 1982, CANCER RES, V42, P3046; Wang SH, 2008, MICROBES INFECT, V10, P334, DOI 10.1016/j.micinf.2007.12.014; Wang YL, 2006, J BIOCHEM, V139, P17, DOI 10.1093/jb/mvj021; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Zhang C, 2006, INFECT IMMUN, V74, P1857, DOI 10.1128/IAI.74.3.1857-1864.2006	53	17	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8174	8184		10.1074/jbc.M805787200	http://dx.doi.org/10.1074/jbc.M805787200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158080	Green Published, hybrid			2022-12-27	WOS:000264195600079
J	Liavonchanka, A; Rudolph, MG; Tittmann, K; Hamberg, M; Feussner, I				Liavonchanka, Alena; Rudolph, Markus G.; Tittmann, Kai; Hamberg, Mats; Feussner, Ivo			On the Mechanism of a Polyunsaturated Fatty Acid Double Bond Isomerase from Propionibacterium acnes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATED LINOLEIC-ACID; ALGA PTILOTA-FILICINA; BUTYRIVIBRIO-FIBRISOLVENS; DIPHOSPHATE ISOMERASE; SUBSTRATE; FLAVOPROTEINS; BIOSYNTHESIS; BACTERIA; STEREOSPECIFICITY; BIOHYDROGENATION	The catalytic mechanism of Propionibacterium acnes polyunsaturated fatty acid isomerase (PAI) is explored by kinetic, spectroscopic, and thermodynamic studies. The PAI-catalyzed double bond isomerization takes place by selective removal of the pro-R hydrogen from C-11 followed by suprafacial transfer of this hydrogen to C-9 as shown by conversion of C-9-deuterated substrate isotopologs. Data on the midpoint potential, photoreduction, and cofactor replacement suggest PAI to operate via an ionic mechanism with the formation of FADH(2) and linoleic acid carbocation as intermediates. In line with this proposal, no radical intermediates were detected neither by stopped flow absorption nor by EPR spectroscopy. The substrate preference toward free fatty acids is determined by the interaction between Arg-88 and Phe-193, and the reaction rate is strongly affected by replacement of these amino acids, indicating that the efficiency of the hydrogen transfer relies on a fixed distance between the free carboxyl group and the N-5 atom of FAD. Combining data obtained for PAI from the structural studies and experiments described here suggests that at least two different prototypical active site geometries exist among polyunsaturated fatty acid double bond isomerases.	[Liavonchanka, Alena] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-377077 Gottingen, Germany; [Tittmann, Kai; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Bioanalyt, D-377077 Gottingen, Germany; [Rudolph, Markus G.] Univ Gottingen, Inst Microbiol & Genet, Dept Biol Struct, D-377077 Gottingen, Germany; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden	University of Gottingen; University of Gottingen; University of Gottingen; Karolinska Institutet	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-377077 Gottingen, Germany.	ifeussn@gwdg.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Hamberg, Mats/0000-0002-8910-7810; Rudolph, Markus/0000-0003-0447-1101	international master/Ph.D. program Molecular Biology; International Max Planck Research School in Molecular Biology, Goettingen	international master/Ph.D. program Molecular Biology; International Max Planck Research School in Molecular Biology, Goettingen	Supported by a Georg-Christoph-Lichtenberg stipend from the international master/Ph.D. program Molecular Biology and the International Max Planck Research School in Molecular Biology, Goettingen.	Basran J, 2003, J BIOL CHEM, V278, P43973, DOI 10.1074/jbc.M305983200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Chapman S.K., 1999, FLAVOPROTEIN PROTOCO; Christie WW, 1998, LIPIDS, V33, P343, DOI 10.1007/s11745-998-0214-x; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Hamberg M, 2005, FEBS J, V272, P736, DOI 10.1111/j.1742-4658.2004.04510.x; Hornung E, 2005, BBA-MOL CELL BIOL L, V1738, P105, DOI 10.1016/j.bbalip.2005.11.004; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; KEPLER CR, 1970, J BIOL CHEM, V245, P3612; KEPLER CR, 1971, J BIOL CHEM, V246, P2765; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; Liavonchanka A, 2006, P NATL ACAD SCI USA, V103, P2576, DOI 10.1073/pnas.0510144103; Liavonchanka A, 2006, ACTA CRYSTALLOGR F, V62, P153, DOI 10.1107/S1744309106001229; Liavonchanka A, 2008, CHEMBIOCHEM, V9, P1867, DOI 10.1002/cbic.200800141; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Muh U, 1996, BIOCHEMISTRY-US, V35, P11710, DOI 10.1021/bi9601363; Murthy YVSN, 1997, METHOD ENZYMOL, V280, P436; Ogawa J, 2005, J BIOSCI BIOENG, V100, P355, DOI 10.1263/jbb.100.355; Rothman SC, 2007, BIOCHEMISTRY-US, V46, P5437, DOI 10.1021/bi0616347; Saenger AK, 2005, BIOCHEMISTRY-US, V44, P16043, DOI 10.1021/bi051048y; SCHROEPF.GJ, 1965, J BIOL CHEM, V240, P54; Wallace RJ, 2007, J LIPID RES, V48, P2247, DOI 10.1194/jlr.M700271-JLR200; Wise ML, 1997, BIOCHEMISTRY-US, V36, P2985, DOI 10.1021/bi962158v; WISE ML, 1994, BIOCHEMISTRY-US, V33, P15223, DOI 10.1021/bi00255a002	29	24	27	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8005	8012		10.1074/jbc.M809060200	http://dx.doi.org/10.1074/jbc.M809060200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164287	hybrid, Green Published			2022-12-27	WOS:000264195600063
J	Lin, Y; Liu, XJ; Cheng, YH; Yang, J; Huo, YQ; Zhang, CX				Lin, Ying; Liu, Xiaojun; Cheng, Yunhui; Yang, Jian; Huo, Yuqing; Zhang, Chunxiang			Involvement of MicroRNAs in Hydrogen Peroxide-mediated Gene Regulation and Cellular Injury Response in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; NEOINTIMA FORMATION; GROWTH; AP-1; EXPRESSION; CANCER; DEATH; PDCD4; IDENTIFICATION; PROLIFERATION	MicroRNAs (miRNAs) comprise a novel class of endogenous, small, noncoding RNAs that negatively regulate similar to 30% of genes in a cell via degradation or translational inhibition of their target mRNAs. However, the effects of reactive oxygen species (ROS) on miRNA expression and the roles of miRNAs in ROS-mediated gene regulation and biological functions of vascular cells are unclear. Using microarray analysis, we demonstrated that miRNAs are aberrantly expressed in vascular smooth muscle cells (VSMCs) after treatment with hydrogen peroxide (H2O2). H2O2-mediated up-regulation of microRNA-21 (miR-21) was further confirmed by quantitative real-time PCR. To determine the potential roles of miRNAs in H2O2-mediated gene regulation and cellular effects, miR-21 expression was down-regulated by miR-21 inhibitor and up-regulated by pre-miR-21. H2O2-induced VSMC apoptosis and death were increased by miR-21 inhibitor and decreased by pre-miR-21. Programmed cell death 4 (PDCD4) was a direct target of miR-21 that was involved in miR-21-mediated effects on VSMCs. Pre-miR-21-mediated protective effect on VSMC apoptosis and death was blocked via adenovirus-mediated overexpression of PDCD4 without the miR-21 binding site. Moreover, activator protein 1 was a downstream signaling molecule of PDCD4 in miR-21-modulated VSMCs. The results suggest that miRNAs in VSMCs are sensitive to H2O2 stimulation. miRN-21 participates in H2O2-mediated gene regulation and cellular injury response through PDCD4 and the activator protein 1 pathway. miRNAs might play a role in vascular diseases related to ROS.	[Lin, Ying; Liu, Xiaojun; Cheng, Yunhui; Yang, Jian; Zhang, Chunxiang] Univ Med & Dent New Jersey, RNA, Newark, NJ 07103 USA; [Lin, Ying; Liu, Xiaojun; Cheng, Yunhui; Yang, Jian; Zhang, Chunxiang] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol, Cardiovasc Res Lab, Newark, NJ 07103 USA; [Huo, Yuqing] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Zhang, CX (corresponding author), 185 S Orange Ave,MSB E548, Newark, NJ 07101 USA.	zhangc3@umdnj.edu	Liu, Xiaojun/C-1650-2009; Cheng, Yunhui/D-3922-2012; zhang, xiang chun/HCH-7063-2022; Cheng, Yunhui/A-4683-2011	Liu, Xiaojun/0000-0003-4758-7040; zhang, xiang chun/0000-0001-8303-6495; 	National Institutes of Health [HL080133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080133.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cho MA, 2007, J ENDOCRINOL, V195, P255, DOI 10.1677/JOE-06-0193; Delles C, 2008, ANTIOXID REDOX SIGN, V10, P1061, DOI 10.1089/ars.2007.2008; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Karin M, 2001, IUBMB LIFE, V52, P17; Kong Yong, 2005, GeoActa, V3, P62; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Movahed A, 1996, CAN J CARDIOL, V12, P138; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shi Y, 2001, CIRCULATION, V103, P2408; Son Seok Man, 2004, Curr Diab Rep, V4, P247; Tardif Jean-Claude, 2002, Am J Cardiovasc Drugs, V2, P323, DOI 10.2165/00129784-200202050-00005; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619; Zhang Li-Jun, 2008, Acta Zootaxonomica Sinica, V33, P147	43	189	216	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7903	7913		10.1074/jbc.M806920200	http://dx.doi.org/10.1074/jbc.M806920200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158092	Green Published, hybrid			2022-12-27	WOS:000264195600052
J	Toth, M; Chow, JW; Mobashery, S; Vakulenko, SB				Toth, Marta; Chow, Joseph W.; Mobashery, Shahriar; Vakulenko, Sergei B.			Source of Phosphate in the Enzymic Reaction as a Point of Distinction among Aminoglycoside 2 ''-Phosphotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE ANALYSIS; GENTAMICIN RESISTANCE GENE; MYCOBACTERIUM-TUBERCULOSIS; KINETIC MECHANISM; ESCHERICHIA-COLI; ANTIBIOTICS; SPECIFICITY; APH(2'')-IB; ENZYMES; IIIA	Aminoglycoside 2 ''-phosphotransferases are clinically important enzymes that cause high levels of resistance to aminoglycoside antibiotics by the organisms that harbor them. These enzymes phosphorylate aminoglycosides, and the modified antibiotics show significant reduction in the binding ability to target the bacterial ribosome. This report presents a detailed characterization of the antibiotic resistance profile and the aminoglycoside and nucleotide triphosphate substrate profiles of four common aminoglycoside 2 ''-phosphotransferases widely distributed in clinically important Gram-positive microorganisms. Although the antibiotic resistance phenotypes exhibited by these enzymes are similar, their aminoglycoside and nucleotide triphosphate substrate profiles are distinctive. Contrary to the dogma that these enzymes use ATP as the source of phosphate in their reactions, two of the four aminoglycoside 2 ''-phosphotransferases utilize GTP as the phosphate donor. Of the other two enzymes, one exhibits preference for ATP, and the other can utilize either ATP or GTP as nucleotide triphosphate substrate. A new nomenclature for these enzymes is put forth that takes into account the differences among these enzymes based on their respective substrate preferences. These nucleotide triphosphate preferences should have ramifications for understanding of the evolution, selection, and dissemination of the genes for these important resistance enzymes.	[Toth, Marta; Mobashery, Shahriar; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Chow, Joseph W.] Merck Res Labs, Dept Infect Dis Clin Res, N Wales, PA 19454 USA	University of Notre Dame; Merck & Company	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu	Chow, Joseph W/W-4164-2017	Chow, Joseph W/0000-0002-5934-5877	National Institutes of Health [AI 057393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 057393.	Akova M, 1999, ANTIMICROB AGENTS CH, V43, P1298, DOI 10.1128/AAC.43.5.1298; Azucena E, 1997, J AM CHEM SOC, V119, P2317, DOI 10.1021/ja964278w; Badarau A, 2008, J BIOL CHEM, V283, P7638, DOI 10.1074/jbc.M709645200; BAKER CN, 1985, J CLIN MICROBIOL, V22, P212, DOI 10.1128/JCM.22.2.212-215.1985; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Chow JW, 1997, ANTIMICROB AGENTS CH, V41, P511, DOI 10.1128/AAC.41.3.511; Chow JW, 2001, ANTIMICROB AGENTS CH, V45, P2691, DOI 10.1128/AAC.45.10.2691-2694.2001; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; Craig W, 1996, ANTIBIOTICS LAB MED, P296; Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63; CRAIG WA, 1987, ANN INTERN MED, V106, P900, DOI 10.7326/0003-4819-106-6-900; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; DRUSANO GL, 1988, ANTIMICROB AGENTS CH, V32, P289, DOI 10.1128/AAC.32.3.289; EBERT SC, 1990, INFECT CONT HOSP EP, V11, P319; FERRETTI JJ, 1986, J BACTERIOL, V167, P631, DOI 10.1128/jb.167.2.631-638.1986; FOSTER TJ, 1983, MICROBIOL REV, V47, P361, DOI 10.1128/MMBR.47.3.361-409.1983; Gilbert DN, 2005, PRINCIPLES PRACTICE, P328; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Heinzl B, 2002, PEDIATR PULM, V33, P32, DOI 10.1002/ppul.10019; Kao SJ, 2000, ANTIMICROB AGENTS CH, V44, P2876, DOI 10.1128/AAC.44.10.2876-2879.2000; Kim C, 2004, BIOCHEMISTRY-US, V43, P2373, DOI 10.1021/bi036095+; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; MCDONALD PJ, 1977, J INFECT DIS, V135, P217, DOI 10.1093/infdis/135.2.217; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MOORE RD, 1987, J INFECT DIS, V155, P93, DOI 10.1093/infdis/155.1.93; Nicolau DP, 1999, ANTIMICROBIAL, P621; Schatz A, 1944, P SOC EXP BIOL MED, V57, P244, DOI 10.3181/00379727-57-14769; SHAW KJ, 1993, ANTIMICROB AGENTS CH, V37, P708, DOI 10.1128/AAC.37.4.708; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Tsai SF, 1998, ANTIMICROB AGENTS CH, V42, P1229, DOI 10.1128/AAC.42.5.1229; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; VANPELT JE, 1984, ARCH BIOCHEM BIOPHYS, V230, P250, DOI 10.1016/0003-9861(84)90106-1; WAKSMAN SA, 1949, ANN NY ACAD SCI, V52, P750, DOI 10.1111/j.1749-6632.1949.tb53965.x; WAKSMAN SA, 1949, SCIENCE, V109, P305, DOI 10.1126/science.109.2830.305; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Wright GD, 1998, ADV EXP MED BIOL, V456, P27	39	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6690	6696		10.1074/jbc.M808148200	http://dx.doi.org/10.1074/jbc.M808148200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19158087	Green Published, hybrid			2022-12-27	WOS:000263919000013
J	Sarmann, J; Hegermann, J; von Gromoff, E; Eimer, S; Baumeister, R; Schmidt, E				Saermann, Julia; Hegermann, Jan; von Gromoff, Erika; Eimer, Stefan; Baumeister, Ralf; Schmidt, Enrico			Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL PATHOLOGY; RECESSIVE PARKINSONISM; CELL-MIGRATION; PROTEIN; MUTATIONS; LRRK2; TUNICAMYCIN; KINASE	Mutations in two genes encoding the putative kinases LRRK2 and PINK1 have been associated with inherited variants of Parkinson disease. The physiological role of both proteins is not known at present, but studies in model organisms have linked their mutants to distinct aspects of mitochondrial dysfunction, increased vulnerability to oxidative and endoplasmic reticulum stress, and intracellular protein sorting. Here, we show that a mutation in the Caenorhabditits elegans homologue of the PTEN-induced kinase pink-1 gene resulted in reduced mitochondrial cristae length and increased paraquat sensitivity of the nematode. Moreover, the mutants also displayed defects in axonal outgrowth of a pair of canal-associated neurons. We demonstrate that in the absence of lrk-1, the C. elegans homologue of human LRRK2, all phenotypic aspects of pink-1 loss-of-function mutants were suppressed. Conversely, the hypersensitivity of lrk-1 mutant animals to the endoplasmic reticulum stressor tunicamycin was reduced in a pink-1 mutant background. These results provide the first evidence of an antagonistic role of PINK-1 and LRK-1. Due to the similarity of the C. elegans proteins to human LRRK2 and PINK1, we suggest a common role of both factors in cellular functions including stress response and regulation of neurite outgrowth. This study might help to link pink-1/PINK1 and lrk-1/LRRK2 function to the pathological processes resulting from Parkinson disease-related mutants in both genes, the first manifestations of which are cytoskeletal defects in affected neurons.	[Saermann, Julia; von Gromoff, Erika; Baumeister, Ralf; Schmidt, Enrico] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, ZBMZ Fac Med, D-79104 Freiburg, Germany; [Saermann, Julia; von Gromoff, Erika; Baumeister, Ralf; Schmidt, Enrico] Univ Freiburg, ZBSA Ctr Syst Biol, D-79104 Freiburg, Germany; [Baumeister, Ralf] Sch Life Sci LIFENET, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Baumeister, Ralf] Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Hegermann, Jan; Eimer, Stefan] Univ Med Fac, ENI, D-37077 Gottingen, Germany; [Hegermann, Jan; Eimer, Stefan] Univ Med Fac, Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37077 Gottingen, Germany	University of Freiburg; University of Freiburg; Eni SpA	Baumeister, R (corresponding author), Bio 3,Schaenzlestr 1, D-79104 Freiburg, Brsg, Germany.	baumeister@celegans.de	Eimer, Stefan/B-1865-2013		FORSYS [03139219]; Freiburg Initiative in Systems Biology (a program of the German Federal Ministry in Research and Education); Deutsche Forschungsgemeinschaft [SFB780]; European Community [LSHG-CT-2007-036894, HEALTH-F2-2007-200611]	FORSYS; Freiburg Initiative in Systems Biology (a program of the German Federal Ministry in Research and Education); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by FORSYS Grant 03139219, the Freiburg Initiative in Systems Biology (a program of the German Federal Ministry in Research and Education), Deutsche Forschungsgemeinschaft Grant SFB780, European Community 6th Framework Network of Excellence LIFESPAN Grant LSHG-CT-2007-036894, the Deutsche Forschungsgemeinschaft German Excellence Initiative (FRIAS LIFENET, EXC 294 BIOSS), and the European Community 7th Framework MEMOSAD Grant HEALTH-F2-2007-200611.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; BRENNER S, 1974, GENETICS, V77, P71; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Finnie JW, 2000, VET PATHOL, V37, P677, DOI 10.1354/vp.37-6-677; Forrester WC, 1998, GENETICS, V148, P151; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hess DT, 1999, J NEUROBIOL, V38, P105, DOI 10.1002/(SICI)1097-4695(199901)38:1<105::AID-NEU8>3.0.CO;2-M; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lin TY, 1999, J CELL BIOCHEM, V74, P638, DOI 10.1002/(SICI)1097-4644(19990915)74:4<638::AID-JCB13>3.0.CO;2-C; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; PATTERSON SI, 1995, METHOD ENZYMOL, V250, P284; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Springer W, 2005, HUM MOL GENET, V14, P3407, DOI 10.1093/hmg/ddi371; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; WONG A, 1995, GENETICS, V139, P1247; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	43	137	144	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16482	16491		10.1074/jbc.M808255200	http://dx.doi.org/10.1074/jbc.M808255200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19251702	hybrid, Green Published			2022-12-27	WOS:000266730900045
J	Lawrence, CM; Menon, S; Eilers, BJ; Bothner, B; Khayat, R; Douglas, T; Young, MJ				Lawrence, C. Martin; Menon, Smita; Eilers, Brian J.; Bothner, Brian; Khayat, Reza; Douglas, Trevor; Young, Mark J.			Structural and Functional Studies of Archaeal Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TURRETED ICOSAHEDRAL VIRUS; SPINDLE-SHAPED VIRUS-1; SULFOLOBUS-SOLFATARICUS; INTRACELLULAR PROTEINS; DNA VIRUSES; TRANSCRIPTION; PARTICLE; SSV1; CRISPR; RESISTANCE	Viruses populate virtually every ecosystem on the planet, including the extreme acidic, thermal, and saline environments where archaeal organisms can dominate. For example, recent studies have identified crenarchaeal viruses in the hot springs of Yellowstone National Park and other high temperature environments worldwide. These viruses are often morphologically and genetically unique, with genomes that show little similarity to genes of known function, complicating efforts to understand their viral life cycles. Here, we review progress in understanding these fascinating viruses at the molecular level and the evolutionary insights coming from these studies.	[Lawrence, C. Martin; Menon, Smita; Eilers, Brian J.; Bothner, Brian; Douglas, Trevor] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Young, Mark J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Khayat, Reza] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Scripps Research Institute	Lawrence, CM (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	lawrence@chemistry.montana.edu; myoung@montana.edu	Douglas, Trevor/GRS-0012-2022; Menon, Smita/F-3666-2015; Lawrence, C. Martin/AAH-3420-2020; Douglas, Trevor/F-2748-2011	Douglas, Trevor/0000-0002-7882-2704; Menon, Smita/0000-0001-5842-594X; Lawrence, C. Martin/0000-0002-5398-466X; 	National Science Foundation [MCB-0236344, MCB-0132156, MCB-0646499]; National Aeronautics and Space Administration [NAG5-8807]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by National Science Foundation Grants MCB-0236344, MCB-0132156, and MCB-0646499 and National Aeronautics and Space Administration Grant NAG5-8807. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Ahn DG, 2006, VIROLOGY, V351, P280, DOI 10.1016/j.virol.2006.03.039; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arnold HP, 2000, VIROLOGY, V272, P409, DOI 10.1006/viro.2000.0375; Arnold HP, 2000, VIROLOGY, V267, P252, DOI 10.1006/viro.1999.0105; Bamford DH, 2005, J VIROL, V79, P9097, DOI 10.1128/JVI.79.14.9097-9107.2005; Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bell PJL, 2001, J MOL EVOL, V53, P251; Bettstetter M, 2003, VIROLOGY, V315, P68, DOI 10.1016/S0042-6822(03)00481-1; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Clore AJ, 2007, VIROLOGY, V361, P103, DOI 10.1016/j.virol.2006.11.003; Forterre P, 2006, P NATL ACAD SCI USA, V103, P3669, DOI 10.1073/pnas.0510333103; Frols S, 2007, VIROLOGY, V365, P48, DOI 10.1016/j.virol.2007.03.033; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Haring M, 2005, J VIROL, V79, P9904, DOI 10.1128/JVI.79.15.9904-9911.2005; Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105; Jonuscheit M, 2003, MOL MICROBIOL, V48, P1241, DOI 10.1046/j.1365-2958.2003.03509.x; Keller J, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-12; Kessler A, 2004, J BACTERIOL, V186, P7745, DOI 10.1128/JB.186.22.7745-7753.2004; Kessler A, 2006, NUCLEIC ACIDS RES, V34, P4837, DOI 10.1093/nar/gkl502; Khayat R, 2005, P NATL ACAD SCI USA, V102, P18944, DOI 10.1073/pnas.0506383102; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1143, DOI 10.1093/nar/20.5.1143; Kraft P, 2004, J VIROL, V78, P11544, DOI 10.1128/JVI.78.21.11544-11550.2004; Kraft P, 2004, J VIROL, V78, P7438, DOI 10.1128/JVI.78.14.7438-7442.2004; Larson ET, 2007, VIROLOGY, V368, P249, DOI 10.1016/j.virol.2007.06.040; Larson ET, 2007, VIROLOGY, V363, P387, DOI 10.1016/j.virol.2007.01.027; Larson ET, 2006, J VIROL, V80, P7636, DOI 10.1128/JVI.00567-06; Maaty WSA, 2006, J VIROL, V80, P7625, DOI 10.1128/JVI.00522-06; Mallick P, 2002, P NATL ACAD SCI USA, V99, P9679, DOI 10.1073/pnas.142310499; MARTIN A, 1984, EMBO J, V3, P2165, DOI 10.1002/j.1460-2075.1984.tb02107.x; Menon SK, 2008, VIROLOGY, V376, P270, DOI 10.1016/j.virol.2008.03.026; Ortmann AC, 2008, J VIROL, V82, P4874, DOI 10.1128/JVI.02583-07; Ortmann AC, 2006, NAT REV MICROBIOL, V4, P520, DOI 10.1038/nrmicro1444; PALM P, 1991, VIROLOGY, V185, P242, DOI 10.1016/0042-6822(91)90771-3; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Prangishvili D, 2006, J MOL BIOL, V359, P1203, DOI 10.1016/j.jmb.2006.04.027; REITER WD, 1987, MOL GEN GENET, V209, P270, DOI 10.1007/BF00329653; REITER WD, 1988, NUCLEIC ACIDS RES, V16, P1, DOI 10.1093/nar/16.1.1; REITER WD, 1987, MOL GEN GENET, V206, P144, DOI 10.1007/BF00326550; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; Shapiro L, 2000, CURR OPIN BIOTECH, V11, P31, DOI 10.1016/S0958-1669(99)00064-6; Snyder JC, 2007, P NATL ACAD SCI USA, V104, P19102, DOI 10.1073/pnas.0709445104; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; Vestergaard G, 2008, J VIROL, V82, P371, DOI 10.1128/JVI.01410-07; Xiang XY, 2005, J VIROL, V79, P8677, DOI 10.1128/JVI.79.14.8677-8686.2005; Zillig W, 1996, FEMS MICROBIOL REV, V18, P225, DOI 10.1111/j.1574-6976.1996.tb00239.x	48	71	73	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12599	12603		10.1074/jbc.R800078200	http://dx.doi.org/10.1074/jbc.R800078200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19158076	hybrid, Green Published			2022-12-27	WOS:000265688300003
J	Kutter, S; Weiss, MS; Wille, G; Golbik, R; Spinka, M; Konig, S				Kutter, Steffen; Weiss, Manfred S.; Wille, Georg; Golbik, Ralph; Spinka, Michael; Koenig, Stephan			Covalently Bound Substrate at the Regulatory Site of Yeast Pyruvate Decarboxylases Triggers Allosteric Enzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; ACID-BASE GROUPS; CRYSTAL-STRUCTURE; ZYMOMONAS-MOBILIS; DIRECTED MUTAGENESIS; THIAMINE DIPHOSPHATE; INFORMATION-TRANSFER; ALPHA-KETOGLUTARATE; ACTIVE-SITE; DEHYDROGENASE	The mechanism by which the enzyme pyruvate decarboxylase from two yeast species is activated allosterically has been elucidated. A total of seven three-dimensional structures of the enzyme, of enzyme variants, or of enzyme complexes from two yeast species, three of them reported here for the first time, provide detailed atomic resolution snapshots along the activation coordinate. The prime event is the covalent binding of the substrate pyruvate to the side chain of cysteine 221, thus forming a thiohemiketal. This reaction causes the shift of a neighboring amino acid, which eventually leads to the rigidification of two otherwise flexible loops, one of which provides two histidine residues necessary to complete the enzymatically competent active site architecture. The structural data are complemented and supported by kinetic investigations and binding studies, providing a consistent picture of the structural changes occurring upon enzyme activation.	[Kutter, Steffen; Wille, Georg; Golbik, Ralph; Spinka, Michael; Koenig, Stephan] Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, D-06120 Halle, Saale, Germany; [Weiss, Manfred S.] DESY, European Mol Biol Lab Outstn, D-22603 Hamburg, Germany	Martin Luther University Halle Wittenberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Konig, S (corresponding author), Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Saale, Germany.	stephan.koenig@biochemtech.uni-halle.de	Weiss, Manfred S/B-6857-2013; Koenig, Stephan/GRX-2480-2022	Kutter, Steffen/0000-0002-0349-8161; Wille, Georg/0000-0002-8948-611X; Weiss, Manfred S/0000-0002-2362-7047				ALVAREZ FJ, 1995, J AM CHEM SOC, V117, P1678, DOI 10.1021/ja00111a002; ALVAREZ ME, 1993, GENE, V130, P253, DOI 10.1016/0378-1119(93)90427-5; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Baburina I, 1998, BIOCHEMISTRY-US, V37, P1235, DOI 10.1021/bi970990+; BABURINA I, 1994, BIOCHEMISTRY-US, V33, P5630, DOI 10.1021/bi00184a035; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bera AK, 2007, J AM CHEM SOC, V129, P4120, DOI 10.1021/ja068636z; Biryukov AI, 1996, FEBS LETT, V382, P167, DOI 10.1016/0014-5793(96)00166-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNIK VI, 1992, FEBS LETT, V303, P197, DOI 10.1016/0014-5793(92)80518-L; Candy JM, 1996, BIOCHEM J, V315, P745, DOI 10.1042/bj3150745; CROSBY J, 1970, J AM CHEM SOC, V92, P5707, DOI 10.1021/ja00722a027; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; Furey W, 1998, BBA-PROTEIN STRUCT M, V1385, P253, DOI 10.1016/S0167-4838(98)00073-9; HOLZER H, 1956, BIOCHEM Z, V327, P331; Huang CY, 2001, EUR J BIOCHEM, V268, P3558, DOI 10.1046/j.1432-1327.2001.02260.x; HUBNER G, 1988, BIOMED BIOCHIM ACTA, V47, P9; HUBNER G, 1990, FEBS LETT, V266, P17, DOI 10.1016/0014-5793(90)81495-A; HUBNER G, 1978, EUR J BIOCHEM, V92, P175, DOI 10.1111/j.1432-1033.1978.tb12735.x; HUBNER G, 1986, BIOCHEM INT, V13, P767; Joseph E, 2006, BIOCHEMISTRY-US, V45, P13517, DOI 10.1021/bi0615588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Killenberg-Jabs M, 2001, EUR J BIOCHEM, V268, P1698; KillenbergJabs M, 1996, BIOL CHEM H-S, V377, P313; KillenbergJabs M, 1997, BIOCHEMISTRY-US, V36, P1900, DOI 10.1021/bi961341l; KLUGER R, 1981, J AM CHEM SOC, V103, P1214, DOI 10.1021/ja00395a038; KLUGER R, 1974, BIOCHEMISTRY-US, V13, P910, DOI 10.1021/bi00702a013; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krieger F, 2002, EUR J BIOCHEM, V269, P3256, DOI 10.1046/j.1432-1033.2002.03006.x; Kutter S, 2007, PROTEIN J, V26, P585, DOI 10.1007/s10930-007-9101-4; Kutter S, 2006, FEBS J, V273, P4199, DOI 10.1111/j.1742-4658.2006.05415.x; Li H, 1999, BIOCHEMISTRY-US, V38, P10004, DOI 10.1021/bi9902440; Li HJ, 1999, BIOCHEMISTRY-US, V38, P9992, DOI 10.1021/bi9902438; Liu M, 2001, BIOCHEMISTRY-US, V40, P7355, DOI 10.1021/bi002855u; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; MUCKE U, 1995, BIOL CHEM H-S, V376, P111, DOI 10.1515/bchm3.1995.376.2.111; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Schenk G, 1997, EUR J BIOCHEM, V248, P63, DOI 10.1111/j.1432-1033.1997.t01-1-00063.x; Schowen RL, 2007, ISOT ENVIRON HEALT S, V43, P1, DOI 10.1080/10256010600990393; Schutz A, 2003, EUR J BIOCHEM, V270, P2312, DOI 10.1046/j.1432-1033.2003.03601.x; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7369, DOI 10.1021/bi002856m; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Wang J, 2001, BIOCHEMISTRY-US, V40, P1755, DOI 10.1021/bi001003r; WASHABAUGH MW, 1988, BIOCHEMISTRY-US, V27, P5044, DOI 10.1021/bi00414a015; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Werther T, 2008, J BIOL CHEM, V283, P5344, DOI 10.1074/jbc.M706569200; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788; ZEHENDER H, 1987, EUR J BIOCHEM, V167, P149, DOI 10.1111/j.1432-1033.1987.tb13316.x; ZENG XP, 1993, BIOCHEMISTRY-US, V32, P2704, DOI 10.1021/bi00061a031	54	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12136	12144		10.1074/jbc.M806228200	http://dx.doi.org/10.1074/jbc.M806228200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246454	hybrid, Green Published			2022-12-27	WOS:000265494600045
J	Zullo, AJ; Michaud, M; Zhang, WP; Grusby, MJ				Zullo, Alfred J.; Michaud, Monia; Zhang, Weiping; Grusby, Michael J.			Identification of the Small Protein Rich in Arginine and Glycine (SRAG) A NEWLY IDENTIFIED NUCLEOLAR PROTEIN THAT CAN REGULATE CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMICS	The characterization of new proteins will aid in our explanation of normal biology and disease. Toward that goal, we describe the initial characterization of the small protein rich in arginine and glycine (SRAG). Human and mouse SRAG are 248/249-amino acid arginine-and glycine-rich proteins that are widely expressed in tissues and cell lines. Two SRAG isoforms, SRAG-5 and SRAG-3, which are truncations of full-length SRAG, were also identified. Although all SRAG proteins reside in the nucleus, they were also found within the nucleolus. Localization within the nucleolus was regulated by the N terminus of the protein. Our initial studies indicated that SRAG can interact with RNA. Full-length SRAG protein levels were highest in resting cells and were reduced in proliferating cells. The reduction in SRAG protein that occurs in proliferating cells was mapped with inhibitors to the G(2)/M phase of the cell cycle. As expected, the overexpression of SRAG reduced the percentage of cells in the G(2)/M phase and increased cell death. In sum, we have identified a new and intriguing member of the nucleolar proteome.	[Zullo, Alfred J.; Michaud, Monia; Grusby, Michael J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Zhang, Weiping] Second Mil Med Univ, Dept Pathophysiol, Shanghai 200433, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Naval Medical University	Grusby, MJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, FXB Rm 205,651 Huntington Ave, Boston, MA 02115 USA.	mgrusby@hsph.harvard.edu			G. Harold and L. Mathers Charitable Foundation; Arthritis Foundation	G. Harold and L. Mathers Charitable Foundation; Arthritis Foundation	The work was supported by a gift from the G. Harold and L. Mathers Charitable Foundation ( to M. J. G.) and an Arthritis Foundation postdoctoral fellowship ( to A. J. Z.).	ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martin RM, 2007, HISTOCHEM CELL BIOL, V127, P243, DOI 10.1007/s00418-006-0256-4; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101	15	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12504	12511		10.1074/jbc.M809436200	http://dx.doi.org/10.1074/jbc.M809436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254951	Green Published, hybrid			2022-12-27	WOS:000265494600079
J	de Bernabe, DBV; Inamori, K; Yoshida-Moriguchi, T; Weydert, CJ; Harper, HA; Willer, T; Henry, MD; Campbell, KP				de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Weydert, Christine J.; Harper, Hollie A.; Willer, Tobias; Henry, Michael D.; Campbell, Kevin P.			Loss of alpha-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; HUMAN LARGE GENE; ABNORMAL GLYCOSYLATION; EXTRACELLULAR-MATRIX; ABERRANT EXPRESSION; MUTATIONS; GLYCOSYLTRANSFERASE; RECEPTOR; BREAST	The interaction between epithelial cells and the extracellular matrix is crucial for tissue architecture and function and is compromised during cancer progression. Dystroglycan is a membrane receptor that mediates interactions between cells and basement membranes in various epithelia. In many epithelium-derived cancers, beta-dystroglycan is expressed, but alpha-dystroglycan is not detected. Here we report that alpha-dystroglycan is correctly expressed and trafficked to the cell membrane but lacks laminin binding as a result of the silencing of the like-acetylglucosaminyltransferase (LARGE) gene in a cohort of highly metastatic epithelial cell lines derived from breast, cervical, and lung cancers. Exogenous expression of LARGE in these cancer cells restores the normal glycosylation and laminin binding of alpha-dystroglycan, leading to enhanced cell adhesion and reduced cell migration in vitro. Our findings demonstrate that LARGE repression is responsible for the defects in dystroglycan-mediated cell adhesion that are observed in epithelium-derived cancer cells and point to a defect of dystroglycan glycosylation as a factor in cancer progression.	[de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Harper, Hollie A.; Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Weydert, Christine J.; Harper, Hollie A.; Willer, Tobias; Henry, Michael D.; Campbell, Kevin P.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Harper, Hollie A.; Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Harper, Hollie A.; Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Henry, Michael D.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Campbell, KP (corresponding author), 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Inamori, Kei-ichiro/ABA-2926-2020	Inamori, Kei-ichiro/0000-0002-5947-3633; Campbell, Kevin/0000-0003-2066-5889; Henry, Michael/0000-0002-7871-245X	National Institutes of Health [RO1 CA130916]; NATIONAL CANCER INSTITUTE [R01CA130916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA130916 (to M.D.H.).	Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Giancotti FG, 1996, J CELL SCI, V109, P1165; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Henry MD, 2001, HUM PATHOL, V32, P791, DOI 10.1053/hupa.2001.26468; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Jing J, 2004, EUR J CANCER, V40, P2143, DOI 10.1016/j.ejca.2004.05.018; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muschler J, 1999, MOL BIOL CELL, V10, P2817, DOI 10.1091/mbc.10.9.2817; Muschler J, 2002, CANCER RES, V62, P7102; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Satz JS, 2008, J NEUROSCI, V28, P10567, DOI 10.1523/JNEUROSCI.2457-08.2008; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Sgambato A, 2006, GYNECOL ONCOL, V103, P397, DOI 10.1016/j.ygyno.2006.03.059; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	33	80	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11279	11284		10.1074/jbc.C900007200	http://dx.doi.org/10.1074/jbc.C900007200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244252	hybrid, Green Published			2022-12-27	WOS:000265494500031
J	Noh, JY; Lee, H; Song, SM; Kim, NS; Im, W; Kim, M; Seo, H; Chung, CW; Chang, JW; Ferrante, RJ; Yoo, YJ; Ryu, H; Jung, YK				Noh, Jee-Yeon; Lee, Huikyong; Song, Sungmin; Kim, Nam Soon; Im, Wooseok; Kim, Manho; Seo, Hyemyung; Chung, Chul-Woong; Chang, Jae-Woong; Ferrante, Robert J.; Yoo, Young-Jun; Ryu, Hoon; Jung, Yong-Keun			SCAMP5 Links Endoplasmic Reticulum Stress to the Accumulation of Expanded Polyglutamine Protein Aggregates via Endocytosis Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; NEURONAL CELL-DEATH; ER STRESS; MUTANT HUNTINGTIN; AUTOPHAGIC CLEARANCE; PRONE PROTEINS; TOXICITY; BODY; E2-25K/HIP-2; DYSFUNCTION	Accumulation of expanded polyglutamine proteins is considered to be a major pathogenic biomarker of Huntington disease. We isolated SCAMP5 as a novel regulator of cellular accumulation of expanded polyglutamine track protein using cell-based aggregation assays. Ectopic expression of SCAMP5 augments the formation of ubiquitin-positive and detergent-resistant aggregates of mutant huntingtin (mtHTT). Expression of SCAMP5 is markedly increased in the striatum of Huntington disease patients and is induced in cultured striatal neurons by endoplasmic reticulum (ER) stress or by mtHTT. The increase of SCAMP5 impairs endocytosis, which in turn enhances mtHTT aggregation. On the contrary, down-regulation of SCAMP5 alleviates ER stress-induced mtHTT aggregation and endocytosis inhibition. Moreover, stereotactic injection into the striatum and intraperitoneal injection of tunicamycin significantly increase mtHTT aggregation in the striatum of R6/2 mice and in the cortex of N171-82Q mice, respectively. Taken together, these results suggest that exposure to ER stress increases SCAMP5 in the striatum, which positively regulates mtHTT aggregation via the endocytosis pathway.	[Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, BioMAX Inst, Creat Res Initiat Accelerat Res, Seoul 151742, South Korea; [Noh, Jee-Yeon; Chung, Chul-Woong; Yoo, Young-Jun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Kim, Nam Soon] Korea Res Inst Biosci & Biotechnol, Taejon 305600, South Korea; [Im, Wooseok; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Seo, Hyemyung] Hanyang Univ, Dept Mol & Life Sci, Ansan 426791, South Korea; [Ferrante, Robert J.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Bedford, MA 01730 USA	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Boston University	Jung, YK (corresponding author), Seoul Natl Univ, Sch Biol Sci, BioMAX Inst, Creat Res Initiat Accelerat Res, Gwanakro 599, Seoul 151742, South Korea.	ykjung@snu.ac.kr	Longo, Kenneth A/A-5631-2010; Kim, Manho/J-2738-2012; Yoo, Yung Joon/AAH-5002-2020	Ryu, Hoon/0000-0001-6544-3732; Jung, Yong-Keun/0000-0002-9686-3120	Brain Research Center of the 21st Century Frontier Research Program; Korean Government (Ministry of Education and Science Technology);  [R17-2008-038-01000]	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Government (Ministry of Education and Science Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); 	This work was supported in part by Creative Research Initiative Grant R17-2008-038-01000, the Brain Research Center of the 21st Century Frontier Research Program, and Ubiquitom projects funded by the Korea Science and Engineering Foundation of the Korean Government (Ministry of Education and Science Technology).	Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Chang JW, 2007, HUM MOL GENET, V16, P317, DOI 10.1093/hmg/ddl466; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kim M, 1999, J NEUROSCI, V19, P964; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Truckenmiller ME, 2002, EXP NEUROL, V175, P318, DOI 10.1006/exnr.2002.7898; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	46	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11318	11325		10.1074/jbc.M807620200	http://dx.doi.org/10.1074/jbc.M807620200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240033	Green Published, hybrid			2022-12-27	WOS:000265494500036
J	Kim, JH; Zhao, YS; Pan, XW; He, XW; Gilbert, HF				Kim, Jai-Hyun; Zhao, Yinsuo; Pan, Xuewen; He, Xiangwei; Gilbert, Hiram F.			The Unfolded Protein Response Is Necessary but Not Sufficient to Compensate for Defects in Disulfide Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMERASE; DOMAINS	Pdi1p (protein-disulfide isomerase) is a folding assistant of the endoplasmic reticulum (ER) that catalyzes disulfide formation and the isomerization of incorrect disulfides. Its disulfide forming activity is its essential function in Saccharomyces cerevisiae. A truncation mutant (Pdi1a')that is competent in disulfide formation but deficient in catalyzing isomerization has only a small effect on growth, although the maturation of isomerase-requiring substrates (carboxypeptidase Y) is impaired (Xiao, R., Wilkinson, B., Solovyov, A., Winther, J. R., Holmgren, A., Lundstrom-Ljung, J., and Gilbert, H. F. (2004) J. Biol. Chem. 279, 49780-49786). We show here that there are multiple ways to compensate for defects in disulfide formation and isomerization in the ER. Genes of the unfolded protein response are induced, and deletions of the nonessential IRE1 or HAC1 genes are synthetically lethal. Diploid synthetic lethality analysis by microarray (dSLAM) using PDIa' and a temperature-sensitive mutant of PDIa' as query mutations reveals a group of 130 synthetically lethal genes. Only 10 of these correspond to genes clearly associated with the unfolded protein response. More than half are involved in vesicle traffic, not only out of and into the ER but anterograde and retrograde traffic from most cellular compartments. This suggests that defects in protein maturation in one intracellular compartment may be compensated for by adjusting vesicular traffic patterns throughout the cell.	[Kim, Jai-Hyun; Zhao, Yinsuo; Pan, Xuewen; Gilbert, Hiram F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [He, Xiangwei] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Gilbert, HF (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	hgilbert@bcm.edu	Longo, Kenneth A/A-5631-2010	Kim, Jai-Hyun/0000-0002-6546-0142	National Institutes of Health [GM040379-19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM040379-19.	Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Amberg DC., 2005, METHODS YEAST GENETI; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Rachlin J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100103; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Solovyov A, 2004, J BIOL CHEM, V279, P34095, DOI 10.1074/jbc.M405640200; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Xiao R, 2001, J BIOL CHEM, V276, P27975, DOI 10.1074/jbc.M104203200; Xiao RY, 2004, J BIOL CHEM, V279, P49780, DOI 10.1074/jbc.M409210200; Xu Qikai, 2005, Appl Bioinformatics, V4, P281, DOI 10.2165/00822942-200504040-00008	26	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10400	10408		10.1074/jbc.M900377200	http://dx.doi.org/10.1074/jbc.M900377200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233841	Green Published, hybrid			2022-12-27	WOS:000265104600014
J	Ishida, T; Fushinobu, S; Kawai, R; Kitaoka, M; Igarashi, K; Samejima, M				Ishida, Takuya; Fushinobu, Shinya; Kawai, Rie; Kitaoka, Motomitsu; Igarashi, Kiyohiko; Samejima, Masahiro			Crystal Structure of Glycoside Hydrolase Family 55 beta-1,3-Glucanase from the Basidiomycete Phanerochaete chrysosporium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; PARALLEL BETA-HELICES; CLOSTRIDIUM-CELLULOLYTICUM; INULIN FRUCTOTRANSFERASE; TRICHODERMA-HARZIANUM; PROCESSIVE ACTION; CELLULASE CE148F; ACTIVE-SITE; CLONING; GLUCAN	Glycoside hydrolase family 55 consists of beta-1,3-glucanases mainly from filamentous fungi. A beta-1,3-glucanase (Lam55A) from the Basidiomycete Phanerochaete chrysosporium hydrolyzes beta-1,3-glucans in the exo-mode with inversion of anomeric configuration and produces gentiobiose in addition to glucose from beta-1,3/1,6-glucans. Here we report the crystal structure of Lam55A, establishing the three-dimensional structure of a member of glycoside hydrolase 55 for the first time. Lam55A has two beta-helical domains in a single polypeptide chain. These two domains are separated by a long linker region but are positioned side by side, and the overall structure resembles a rib cage. In the complex, a gluconolactone molecule is bound at the bottom of a pocket between the two beta-helical domains. Based on the position of the gluconolactone molecule, Glu-633 appears to be the catalytic acid, whereas the catalytic base residue could not be identified. The substrate binding pocket appears to be able to accept a gentiobiose unit near the cleavage site, and a long cleft runs from the pocket, in accordance with the activity of this enzyme toward various beta-1,3-glucan oligosaccharides. In conclusion, we provide important features of the substrate-binding site at the interface of the two beta-helical domains, demonstrating an unexpected variety of carbohydrate binding modes.	[Ishida, Takuya; Kawai, Rie; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Fushinobu, Shinya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Samejima, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amsam@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Igarashi, Kiyohiko/E-6799-2016; Kitaoka, Motomitsu/R-1536-2019	Fushinobu, Shinya/0000-0003-1346-6435; Igarashi, Kiyohiko/0000-0001-5152-7177; Kitaoka, Motomitsu/0000-0002-0083-1838	Japanese Ministry of Education, Culture, Sports, and Technology [17380102]; Graduate School of Agricultural and Life Sciences; University of Tokyo	Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Graduate School of Agricultural and Life Sciences; University of Tokyo	This work was supported by Grant-in-Aid for Scientific Research 17380102 (to M. S.) from the Japanese Ministry of Education, Culture, Sports, and Technology and by a Grant for the Research Collaboration of Assistant Professors (to K. I. and S. F.) from Graduate School of Agricultural and Life Sciences, the University of Tokyo.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; BIELECKI S, 1991, CRIT REV BIOTECHNOL, V10, P275, DOI 10.3109/07388559109038212; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P59, DOI 10.1016/S0968-0004(01)02046-1; Cohen-Kupiec R, 1999, GENE, V226, P147, DOI 10.1016/S0378-1119(98)00583-6; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DELACRUZ J, 1995, J BACTERIOL, V177, P6937, DOI 10.1128/jb.177.23.6937-6945.1995; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Donzelli BGG, 2001, GENE, V277, P199, DOI 10.1016/S0378-1119(01)00681-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giczey G, 2001, APPL ENVIRON MICROB, V67, P865, DOI 10.1128/AEM.67.2.865-871.2001; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; KASAHARA S, 1992, J FERMENT BIOENG, V74, P238, DOI 10.1016/0922-338X(92)90118-E; Kawai R, 2006, BIOTECHNOL LETT, V28, P365, DOI 10.1007/s10529-005-6179-7; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Kawai R, 2006, APPL MICROBIOL BIOT, V71, P898, DOI 10.1007/s00253-005-0214-4; Kim CS, 2007, J MICROBIOL BIOTECHN, V17, P37; Koga D, 1998, BIOSCI BIOTECH BIOCH, V62, P1643, DOI 10.1271/bbb.62.1643; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Larsson AM, 2003, STRUCTURE, V11, P1111, DOI 10.1016/S0969-2126(03)00147-3; Martin K, 2007, FEMS MICROBIOL REV, V31, P168, DOI 10.1111/j.1574-6976.2006.00055.x; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nobe R, 2004, BIOSCI BIOTECH BIOCH, V68, P2111, DOI 10.1271/bbb.68.2111; Nobe R, 2003, BIOSCI BIOTECH BIOCH, V67, P1349, DOI 10.1271/bbb.67.1349; OHNO N, 1986, CARBOHYD RES, V158, P217, DOI 10.1016/0008-6215(86)84019-8; OHNO N, 1989, CARBOHYD RES, V194, P261, DOI 10.1016/0008-6215(89)85024-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PITSON SM, 1995, BIOCHEM J, V308, P733, DOI 10.1042/bj3080733; PITSON SM, 1993, ENZYME MICROB TECH, V15, P178, DOI 10.1016/0141-0229(93)90136-P; Rigden DJ, 2002, FEBS LETT, V530, P225, DOI 10.1016/S0014-5793(02)03490-7; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; RUEL K, 1991, APPL ENVIRON MICROB, V57, P374, DOI 10.1128/AEM.57.2.374-384.1991; SCHAEFFER HJ, 1994, APPL ENVIRON MICROB, V60, P594, DOI 10.1128/AEM.60.2.594-598.1994; STONE BA, 1992, CHEM BIOL 1 ARROW 3, P283; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TSUJISAKA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1201, DOI 10.1080/00021369.1981.10864682; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; YAMAMOTO R, 1983, CARBOHYD RES, V122, P217, DOI 10.1016/0008-6215(83)88333-5; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; Yoshida M, 2001, BIOSCI BIOTECH BIOCH, V65, P2050, DOI 10.1271/bbb.65.2050; ZEVENHUI.LP, 1970, J GEN MICROBIOL, V61, P183, DOI 10.1099/00221287-61-2-183	59	41	42	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10100	10109		10.1074/jbc.M808122200	http://dx.doi.org/10.1074/jbc.M808122200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193645	hybrid, Green Published			2022-12-27	WOS:000264892900052
J	Baba, A; Akagi, K; Takayanagi, M; Flanagan, JG; Kobayashi, T; Hattori, M				Baba, Atsushi; Akagi, Koshiro; Takayanagi, Mai; Flanagan, John G.; Kobayashi, Toshihide; Hattori, Mitsuharu			Fyn Tyrosine Kinase Regulates the Surface Expression of Glycosylphosphatidylinositol-linked Ephrin via the Modulation of Sphingomyelin Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; GROWTH-FACTOR RECEPTOR; LIPID RAFTS; INTRACELLULAR TRAFFICKING; NEUTRAL SPHINGOMYELINASES; ACID SPHINGOMYELINASE; FAMILY; HETEROGENEITY; CELLS; SRC	Glycosylphosphatidylinositol-linked ephrin-As play important roles in various biological events, such as neuronal development and immune responses. Because the surface amount of ephrin-As is critical in these events, the trafficking of ephrin-As must be regulated by intracellular machinery. In particular, Src family protein-tyrosine kinases regulate the intracellular trafficking of several membrane molecules and act downstream of ephrin-As; whether they affect the trafficking of ephrin-As, however, has remained unexplored. Here, we report that the activity of Src family protein-tyrosine kinases, particularly Fyn, negatively regulates the cell-surface amount of ephrin-As. The expression of constitutively active Fyn decreases the surface amount of ephrin-As. Conversely, the expression of dominant-negative Fyn or the application of a Src-family inhibitor increases the surface amount of ephrin-A2. The total cellular amount of ephrin-A is inversely correlated with its amount on the surface, suggesting that ephrin-As are more stable in the intracellular compartment. The expression of constitutively active Fyn increases the amount of sphingomyelin clusters on the plasma membrane, whereas inhibiting Fyn decreases it. Moreover, the inhibition of sphingomyelin synthesis greatly increases the surface amount of ephrin-As. Altogether, these results suggest that Fyn regulates the surface amount of ephrin-As by modulating the metabolism of sphingomyelin, which presumably inhibits the trafficking of ephrin-As from endosomes to the plasma membrane. The signaling cascade described here may function as part of the negative feedback loop of ephrin-A function.	[Baba, Atsushi; Akagi, Koshiro; Takayanagi, Mai; Hattori, Mitsuharu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, Aichi 4678603, Japan; [Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Kobayashi, Toshihide] RIKEN Frontier Res Syst, Suprabiomol Syst Res Grp, Wako, Saitama 3510198, Japan	Nagoya City University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; RIKEN	Baba, A (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, 3-1 Tanabe Dori, Aichi 4678603, Japan.	atbaba@phar.nagoya-cu.ac.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Hattori, Mitsuharu/F-3859-2010	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Hattori, Mitsuharu/0000-0002-0503-4969; Baba, Atsushi/0000-0002-6871-7249	Ministry of Education, Science, Sports, and Culture	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aids for Scientific Research from the Ministry of Education, Science, Sports, and Culture (to A. B. and M. H.).	Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cheng H, 2008, CURR BIOL, V18, P705, DOI 10.1016/j.cub.2008.04.043; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DITTMER JC, 1964, J LIPID RES, V5, P126; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; FUSAKI N, 1994, INT IMMUNOL, V6, P1245, DOI 10.1093/intimm/6.8.1245; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ishitsuka R, 2005, J BIOCHEM, V137, P249, DOI 10.1093/jb/mvi041; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mishra S, 2007, J NEUROCHEM, V103, P135, DOI 10.1111/j.1471-4159.2007.04720.x; Morimura T, 2005, J BIOL CHEM, V280, P16901, DOI 10.1074/jbc.M409048200; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Rijnboutt S, 1996, J CELL BIOL, V132, P35, DOI 10.1083/jcb.132.1.35; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; TAKEUCHI M, 1993, J BIOL CHEM, V268, P27413; WANG E, 1991, J BIOL CHEM, V266, P14486; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185	46	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9206	9214		10.1074/jbc.M809401200	http://dx.doi.org/10.1074/jbc.M809401200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19181669	hybrid, Green Published			2022-12-27	WOS:000264669100027
J	Park, CY; Jun, HJ; Wakita, T; Cheong, JH; Hwang, SB				Park, Chul-Yong; Jun, Hyun-Jeong; Wakita, Takaji; Cheong, Jae Hun; Hwang, Soon B.			Hepatitis C Virus Nonstructural 4B Protein Modulates Sterol Regulatory Element-binding Protein Signaling via the AKT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; LIVER-X-RECEPTOR; HEPATOCELLULAR-CARCINOMA; RNA REPLICATION; TRANSCRIPTION FACTOR; LIPID-ACCUMULATION; SYNTHASE GENE; PPAR-GAMMA; STEATOSIS; INFECTION	Hepatitis C virus (HCV) infection is often associated with hepatic steatosis and yet the molecular mechanisms of HCV-associated steatosis are poorly understood. Because sterol regulatory element-binding proteins (SREBPs) are the major transcriptional factors in lipogenic gene expression including fatty acid synthase (FAS), we examined the effects of HCV nonstructural proteins on the signaling pathways of SREBP. In this study, we demonstrated that HCV nonstructural 4B (NS4B) protein increased the transcriptional activities of SREBPs. We also showed that HCV NS4B enhanced the protein expression levels of SREBPs and FAS. This was further confirmed in the context of viral RNA replication and HCV infection. The up-regulation of both SREBP and FAS by NS4B protein required phosphatidylinositol 3-kinase activity. We also demonstrated that NS4B protein induced a lipid accumulation in hepatoma cells. In addition, NS4B protein synergistically elevated the transcriptional activity of HCV core-mediated SREBP-1. These results strongly suggest that NS4B may play an important role in HCV-associated liver pathogenesis by modulating the SREBP signaling pathway.	[Park, Chul-Yong; Jun, Hyun-Jeong; Hwang, Soon B.] Hallym Univ, Natl Res Lab Hepatitis C Virus, Anyang 431060, South Korea; [Park, Chul-Yong; Jun, Hyun-Jeong; Hwang, Soon B.] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, South Korea; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Cheong, Jae Hun] Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea	Hallym University; Hallym University; National Institute of Infectious Diseases (NIID); Pusan National University	Hwang, SB (corresponding author), 1605-4 Gwanyang Dong, Anyang 431060, South Korea.	sbhwang@hallym.ac.kr			Cancer Control, Ministry of Health and Welfare [0620100]; New Drug Target Discovery [M10601000044-06N0100-04410]; Ministry of Education, Science and Technology, Korea [ROA-2007-000-20051-0]	Cancer Control, Ministry of Health and Welfare; New Drug Target Discovery; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National R&D Program for Cancer Control, Ministry of Health and Welfare Grant 0620100, Korea, the Research Program for New Drug Target Discovery (M10601000044-06N0100-04410) and Biotechnology Development (2008-04100), and National Research Laboratory Grant ROA-2007-000-20051-0 from the Ministry of Education, Science and Technology, Korea.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHO YG, 1993, MOL CELLS, V3, P195; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Choi SH, 2007, GASTROENTEROLOGY, V132, P343, DOI 10.1053/j.gastro.2006.10.038; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2008, HEPATOLOGY, V47, P827, DOI 10.1002/hep.22108; Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004; Fartoux L, 2005, HEPATOLOGY, V41, P82, DOI 10.1002/hep.20519; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kim SS, 2007, GASTROENTEROLOGY, V132, P311, DOI 10.1053/j.gastro.2006.10.032; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lundin M, 2006, J GEN VIROL, V87, P3263, DOI 10.1099/vir.0.82211-0; Mihm S, 1997, HEPATOLOGY, V25, P735, DOI 10.1002/hep.510250340; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Ramalho F, 2003, ANTIVIR RES, V60, P125, DOI 10.1016/j.antiviral.2003.08.007; Rubbia-Brandt L, 2004, GUT, V53, P406, DOI 10.1136/gut.2003.018770; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	50	110	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9237	9246		10.1074/jbc.M808773200	http://dx.doi.org/10.1074/jbc.M808773200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19204002	Green Published, hybrid			2022-12-27	WOS:000264669100030
J	Telford, JE; Kilbride, SM; Davey, GP				Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.			Complex I Is Rate-limiting for Oxygen Consumption in the Nerve Terminal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ELECTRON-TRANSPORT CHAIN; OXIDATIVE-PHOSPHORYLATION; PARKINSONS-DISEASE; BRAIN MITOCHONDRIA; SYNAPTOSOMES; RESPIRATION; INHIBITION; DEFICIENCY; MUTATIONS	Metabolic control analysis was used to determine the spread of control exerted by the electron transport chain complexes over oxygen consumption rates in the nerve terminal. Oxygen consumption rates and electron transport chain complex activities were titrated with appropriate inhibitors to determine the flux control coefficients and the inhibition thresholds in rat brain synaptosomes. The flux control coefficients for complex I, complex II/III, complex III, and complex IV were found to be 0.30 +/- 0.07, 0.20 +/- 0.03, 0.20 +/- 0.05, and 0.08 +/- 0.05, respectively. Inhibition thresholds for complex I, complex II/III, complex III, and complex IV activities were determined to be similar to 10, similar to 30, similar to 35, and 50-65%, respectively, before major changes in oxygen consumption rates were observed. These results indicate that, of the electron transport chain components, complex I exerts a high level of control over synaptosomal bioenergetics, suggesting that complex I deficiencies that are present in neurodegenerative disorders, such as Parkinson disease, are sufficient to compromise oxygen consumption in the synaptosomal model of the nerve terminal.	[Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.] Trin Coll Dublin, Trin Coll Inst Neurosci, Dublin 2, Ireland; [Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.] Trin Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Davey, GP (corresponding author), Trin Coll Dublin, Trin Coll Inst Neurosci, Dublin 2, Ireland.	gdavey@tcd.ie	Davey, Gavin/HGB-4233-2022		Programme for Research in Third-Level Institutions, Science Foundation Ireland; Marie Curie Transfer of Knowledge [MTKD-CT-2005-030005]	Programme for Research in Third-Level Institutions, Science Foundation Ireland(Science Foundation Ireland); Marie Curie Transfer of Knowledge(European Commission)	This work was supported in part by the Programme for Research in Third-Level Institutions, Science Foundation Ireland, and Marie Curie Transfer of Knowledge Grant MTKD-CT-2005-030005.	ALMEIDA A, 1995, DEV NEUROSCI-BASEL, V17, P212, DOI 10.1159/000111289; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN WA, 1985, J NEUROCHEM, V44, P1948, DOI 10.1111/j.1471-4159.1985.tb07192.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davey GP, 1996, J NEUROCHEM, V66, P1617; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Joyce OJP, 2003, J NEUROCHEM, V86, P1032, DOI 10.1046/j.1471-4159.2003.01915.x; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; King T., 1967, METHOD ENZYMOL, V10, P217; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093; PAUWELS PJ, 1985, J NEUROCHEM, V44, P143, DOI 10.1111/j.1471-4159.1985.tb07123.x; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Sipos I, 2003, J NEUROCHEM, V84, P112, DOI 10.1046/j.1471-4159.2003.01513.x; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Wharton DC., 1967, METHOD ENZYMOL, P245	28	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9109	9114		10.1074/jbc.M809101200	http://dx.doi.org/10.1074/jbc.M809101200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193637	Green Published, hybrid			2022-12-27	WOS:000264669100014
J	Shi, XF; Zaia, J				Shi, Xiaofeng; Zaia, Joseph			Organ-specific Heparan Sulfate Structural Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-UNSUBSTITUTED GLUCOSAMINE; MOLECULAR DIVERSITY; MASS-SPECTROMETRY; GLUCURONIC ACID; GLYPICAN-1; PROTEOGLYCANS; RESIDUES; LINKAGE; CELLS; DEGRADATION	The functions of heparan sulfate (HS) depend on the expression of structural domains that interact with protein partners. Glycosaminoglycans (GAGs) exhibit a high degree of polydispersity in their composition, chain length, sulfation, acetylation, and epimerization patterns. It is essential for the understanding of GAG biochemistry to produce detailed structural information as a function of spatial and temporal factors in biological systems. Toward this end, we developed a set of procedures to extract GAGs from various rat organ tissues and examined and compared HS expression levels using liquid chromatography/mass spectrometry. Here we demonstrate detailed variations in HS GAG chains as a function of organ location. These studies shed new light on the structural variation of GAG chains with respect to average length, disaccharide composition, and expression of low abundance structural epitopes, including unsubstituted amino groups and lyase-resistant oligosaccharides. The data show the presence of a disaccharide with an unsubstituted amino group that is endogenous and widely expressed in mammalian organ tissues.	[Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019; Shi, Xiaofeng/B-8700-2011	Zaia, Joseph/0000-0001-9497-8701; Abraham, Carmela/0000-0002-6649-1960; Wang, Cong-Yi/0000-0001-7914-168X	National Institutes of Health [P41RR10888, HL74197]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR10888 and HL74197.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Behr JR, 2005, RAPID COMMUN MASS SP, V19, P2553, DOI 10.1002/rcm.2079; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chai WG, 2004, BIOCHEMISTRY-US, V43, P8590, DOI 10.1021/bi036250k; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Conrad H. E., 1998, HEPARIN BINDING PROT; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hitchcock AM, 2007, GLYCOBIOLOGY, V17, P25, DOI 10.1093/glycob/cwl046; Hitchcock AM, 2008, PROTEOMICS, V8, P1384, DOI 10.1002/pmic.200700787; Hitchcock AM, 2008, ELECTROPHORESIS, V29, P4538, DOI 10.1002/elps.200800335; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINDAHL U, 1964, BIOCHEM BIOPH RES CO, V17, P254, DOI 10.1016/0006-291X(64)90393-6; LINDAHL U, 1965, J BIOL CHEM, V240, P2821; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Rees M, 2005, FREE RADICAL BIO MED, V39, pS129; Rees MD, 2006, J AM CHEM SOC, V128, P3085, DOI 10.1021/ja0577239; Rees MD, 2005, BIOCHEM J, V391, P125, DOI 10.1042/BJ20050630; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; SHIVELY JE, 1970, BIOCHEMISTRY-US, V9, P33, DOI 10.1021/bi00803a005; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; TOOLE BP, 2000, PROTEOGLYCANS STRUCT, P61; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; Zaia J, 2001, ANAL CHEM, V73, P6030, DOI 10.1021/ac015577t; Zaia J, 2005, J BIOMACROMOL MASS S, V1, P3; Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016; Ziegler A, 2006, J CHROMATOGR B, V837, P76, DOI 10.1016/j.jchromb.2006.04.013	61	107	111	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11806	11814		10.1074/jbc.M809637200	http://dx.doi.org/10.1074/jbc.M809637200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244235	hybrid, Green Published			2022-12-27	WOS:000265494600012
J	Mnatsakanyan, N; Krishnakumar, AM; Suzuki, T; Weber, J				Mnatsakanyan, Nelli; Krishnakumar, Arathianand M.; Suzuki, Toshiharu; Weber, Joachim			The Role of the beta DELSEED-loop of ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F-1-ATPASE; BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; 3 CATALYTIC SITES; EPSILON-SUBUNIT; NUCLEOTIDE-BINDING; F1F0-ATP SYNTHASE; MUTANT STRAINS; F1-ATPASE; HYDROLYSIS	ATP synthase uses a unique rotational mechanism to convert chemical energy into mechanical energy and back into chemical energy. The helix-turn-helix motif, termed "DELSEED-loop," in the C-terminal domain of the beta subunit was suggested to be involved in coupling between catalysis and rotation. Here, the role of the DELSEED-loop was investigated by functional analysis of mutants of Bacillus PS3 ATP synthase that had 3-7 amino acids within the loop deleted. All mutants were able to catalyze ATP hydrolysis, some at rates several times higher than the wild-type enzyme. In most cases ATP hydrolysis in membrane vesicles generated a transmembrane proton gradient, indicating that hydrolysis occurred via the normal rotational mechanism. Except for two mutants that showed low activity and low abundance in the membrane preparations, the deletion mutants were able to catalyze ATP synthesis. In general, the mutants seemed less well coupled than the wild-type enzyme, to a varying degree. Arrhenius analysis demonstrated that in the mutants fewer bonds had to be rearranged during the rate-limiting catalytic step; the extent of this effect was dependent on the size of the deletion. The results support the idea of a significant involvement of the DELSEED-loop in mechanochemical coupling in ATP synthase. In addition, for two deletion mutants it was possible to prepare an alpha(3)beta(3)gamma subcomplex and measure nucleotide binding to the catalytic sites. Interestingly, both mutants showed a severely reduced affinity for MgATP at the high affinity site.	[Mnatsakanyan, Nelli; Krishnakumar, Arathianand M.; Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Suzuki, Toshiharu] Japan Sci & Technol Agcy, ATP Synth Regulat Project, ICORP, Tokyo 1350064, Japan	Texas Tech University System; Texas Tech University; Japan Science & Technology Agency (JST)	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health [GM071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (to J.W.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19640; Bandyopadhyay S, 2002, BIOCHEMISTRY-US, V41, P14421, DOI 10.1021/bi026243g; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dou C, 1998, BIOCHEMISTRY-US, V37, P16757, DOI 10.1021/bi981717q; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GOELZ SE, 1982, BIOCHEMISTRY-US, V21, P189, DOI 10.1021/bi00530a032; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Lowry DS, 2005, BIOCHEMISTRY-US, V44, P7275, DOI 10.1021/bi047293j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao HZ, 2008, J BIOL CHEM, V283, P24781, DOI 10.1074/jbc.M804142200; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitome N, 2002, EUR J BIOCHEM, V269, P53, DOI 10.1046/j.0014-2956.2002.02623.x; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Ono S, 2003, BBA-BIOENERGETICS, V1607, P35, DOI 10.1016/j.bbabio.2003.08.006; Oster G, 1999, STRUCTURE, V7, pR67, DOI 10.1016/S0969-2126(99)80046-X; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Sambrook J., 2001, MOL CLONING LAB MANU; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	52	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11336	11345		10.1074/jbc.M900374200	http://dx.doi.org/10.1074/jbc.M900374200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19246448	Green Published, hybrid			2022-12-27	WOS:000265494500038
J	Sharifmoghadam, MR; Valdivieso, MH				Sharifmoghadam, Mohammad Reza; Valdivieso, M. -Henar			The Fission Yeast SEL1 Domain Protein Cfh3p A NOVEL REGULATOR OF THE GLUCAN SYNTHASE Bgs1p WHOSE FUNCTION IS MORE RELEVANT UNDER STRESS CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,3-BETA-GLUCAN SYNTHASE SUBUNIT; CELL-WALL; ASCOSPORE WALL; DIVISION SITE; MAP KINASE; GENE; CHITIN; LOCALIZATION; HOMOLOG; INTEGRITY	In Schizosaccharomyces pombe, Bgs1/Cps1p is a beta(1,3)-glucan synthase required for linear beta(1,3)-glucan synthesis and primary septum formation. Here, we have studied the regulation of Bgs1p by Cfh3/Chr4p, a member of a family of conserved adaptor proteins, which resembles the chitin synthase regulator Chs4p from Saccharomyces cerevisiae and Candida albicans. cfh3 Delta cells showed a genetic interaction with cps1-191, and Cfh3p co-immunoprecipitated with Bgs1/Cps1p. In the absence of cfh3(+), cells were more sensitive to digestion by glucanases, and both Calcofluor staining and glucan synthesis were reduced. We found that in a wild-type strain, beta(1,3)-glucan synthesis was reduced under stress conditions. In the cfh3 Delta, cps1-191, and cfh3 Delta cps1-191 strains, beta(1,3)-glucan synthesis was further reduced, and growth was impaired under stress conditions, suggesting that Cfh3p and Bgs1p might play a role in ensuring growth in unfavorable environments. In a cfh3 Delta mutant, Bgs1p was delocalized when the cells were distressed, but a blockade in endocytosis prevented this delocalization. Finally, we found that the SEL1 repeats are required for Cfh3p function. These results show that Cfh3p is a regulatory protein for Bgs1p and that its function is particularly necessary when the cells are undergoing stress.	[Sharifmoghadam, Mohammad Reza; Valdivieso, M. -Henar] Univ Salamanca, CSIC, Dept Microbiol & Genet, Inst Microbiol Bioquim, Salamanca 37007, Spain; [Sharifmoghadam, Mohammad Reza] Zabol Univ, Fac Vet Med, Zabol 98615, Iran	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Valdivieso, MH (corresponding author), Edificio Dept,Campus Miguel Unamuno, Salamanca 37007, Spain.	henar@usal.es	Valdivieso, M.-Henar/B-5199-2017; Sharifmoghadam, Mohammad Reza/AAI-8210-2021	Valdivieso, M.-Henar/0000-0002-6857-7493; Sharifmoghadam, Mohammad Reza/0000-0002-3638-0653	CICYT [BFU2007-61866]; Junta de Castilla y Leon, Spain [SA104A/07, GR231]	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon)	This work was supported by Grant BFU2007-61866 from the CICYT and Grants SA104A/07 and GR231 from the Junta de Castilla y Leon, Spain.	An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Arellano M, 2000, MOL MICROBIOL, V35, P79, DOI 10.1046/j.1365-2958.2000.01678.x; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bao SL, 2001, J BIOL CHEM, V276, P14549, DOI 10.1074/jbc.C100096200; Cartagena-Lirola H, 2006, YEAST, V23, P375, DOI 10.1002/yea.1361; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Coll PM, 2007, EMBO J, V26, P1865, DOI 10.1038/sj.emboj.7601641; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Grabinska KA, 2007, EUKARYOT CELL, V6, P328, DOI 10.1128/EC.00203-06; HORISBERGER M, 1985, EXPERIENTIA, V41, P748, DOI 10.1007/BF02012578; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Iwaki T, 2004, YEAST, V21, P867, DOI 10.1002/yea.1134; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kinnunen PKJ, 2000, CELL PHYSIOL BIOCHEM, V10, P243, DOI 10.1159/000016360; KREGER DR, 1954, BIOCHIM BIOPHYS ACTA, V13, P1, DOI 10.1016/0006-3002(54)90264-4; Le Goff X, 1999, MOL GEN GENET, V262, P163; Liu JH, 2000, FEBS LETT, V478, P105, DOI 10.1016/S0014-5793(00)01828-7; Liu JH, 2000, J CELL SCI, V113, P1223; Liu JH, 2002, MOL BIOL CELL, V13, P989, DOI 10.1091/mbc.01-12-0581; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Martin-Garcia R, 2003, FEBS LETT, V549, P176, DOI 10.1016/S0014-5793(03)00812-3; Martin-Garcia R, 2006, J CELL SCI, V119, P2768, DOI 10.1242/jcs.02998; Matsuo Y, 2004, YEAST, V21, P1005, DOI 10.1002/yea.1145; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulvihill DP, 2006, CELL MOTIL CYTOSKEL, V63, P149, DOI 10.1002/cm.20113; Onishi J, 2000, ANTIMICROB AGENTS CH, V44, P368, DOI 10.1128/AAC.44.2.368-377.2000; Ono N, 2000, MICROBIOL-UK, V146, P385, DOI 10.1099/00221287-146-2-385; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; Pelaez F, 2000, SYST APPL MICROBIOL, V23, P333, DOI 10.1016/S0723-2020(00)80062-4; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Perez P, 2004, METHODS, V33, P245, DOI 10.1016/j.ymeth.2003.11.020; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SIETSMA JH, 1990, J GEN MICROBIOL, V136, P2261, DOI 10.1099/00221287-136-11-2261; Sudoh M, 1999, MICROBIOL-UK, V145, P1613, DOI 10.1099/13500872-145-7-1613; Toda T, 1996, MOL CELL BIOL, V16, P6752; Trilla JA, 1997, YEAST, V13, P795, DOI 10.1002/(SICI)1097-0061(199707)13:9<795::AID-YEA139>3.3.CO;2-C; Yang PR, 1999, J BIOL CHEM, V274, P36052, DOI 10.1074/jbc.274.51.36052; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	55	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11070	11079		10.1074/jbc.M808353200	http://dx.doi.org/10.1074/jbc.M808353200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19237545	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000265494500011
J	Siliceo, M; Merida, I				Siliceo, Maria; Merida, Isabel			T Cell Receptor-dependent Tyrosine Phosphorylation of beta 2-Chimaerin Modulates Its Rac-GAP Function in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; GROWTH-CONE COLLAPSE; SRC-FAMILY KINASES; ACTIN CYTOSKELETON; ADAPTER PROTEIN; NEUROBLASTOMA-CELLS; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; RHO-FAMILY; C1 DOMAINS	The actin cytoskeleton has an important role in the organization and function of the immune synapse during antigen recognition. Dynamic rearrangement of the actin cytoskeleton in response to T cell receptor (TCR) triggering requires the coordinated activation of Rho family GTPases that cycle between active and inactive conformations. This is controlled by GTPase-activating proteins (GAP), which regulate inactivation of Rho GTPases, and guanine exchange factors, which mediate their activation. Whereas much attention has centered on guanine exchange factors for Rho GTPases in T cell activation, the identity and functional roles of the GAP in this process are largely unknown. We previously reported beta 2-chimaerin as a diacylglycerol-regulated Rac-GAP that is expressed in T cells. We now demonstrate Lck-dependent phosphorylation of beta 2-chimaerin in response to TCR triggering. We identify Tyr-153 as the Lck-dependent phosphorylation residue and show that its phosphorylation negatively regulates membrane stabilization of beta 2-chimaerin, decreasing its GAP activity to Rac. This study establishes the existence of TCR-dependent regulation of beta 2-chimaerin and identifies a novel mechanism for its inactivation.	[Siliceo, Maria; Merida, Isabel] Consejo Super Invest Cient, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Merida, I (corresponding author), Consejo Super Invest Cient, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,UAM Campus Cantoblanco, E-28049 Madrid, Spain.	imerida@cnb.csic.es	Merida, Isabel/A-9713-2014	Merida, Isabel/0000-0003-2762-6241	Carlos III Institute (Spanish Ministry of Health) [RD067002071035]; Spanish Ministry of Education [BFU2007-62639]; Comunidad de Madrid [S-SAL-0311]	Carlos III Institute (Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Education(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported in part by Grants RD067002071035 from the Carlos III Institute (Spanish Ministry of Health), BFU2007-62639 (Spanish Ministry of Education), and S-SAL-0311 from Comunidad de Madrid.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Anton IM, 1998, J BIOL CHEM, V273, P20992, DOI 10.1074/jbc.273.33.20992; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Hall C, 2005, TRENDS BIOCHEM SCI, V30, P169, DOI 10.1016/j.tibs.2005.02.003; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Jones DR, 2002, FASEB J, V16, P595, DOI 10.1096/fj.01-0762fje; Kai M, 2007, BBA-MOL CELL RES, V1773, P1407, DOI 10.1016/j.bbamcr.2007.05.004; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Penninger JM, 1999, EUR J IMMUNOL, V29, P1709, DOI 10.1002/(SICI)1521-4141(199905)29:05<1709::AID-IMMU1709>3.3.CO;2-F; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Salojin KV, 1999, J IMMUNOL, V163, P844; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang H, 2006, BIOCHEM SOC T, V34, P855, DOI 10.1042/BST0340855; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; YUAN SX, 1995, CANCER RES, V55, P3456; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360	58	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11354	11363		10.1074/jbc.M806098200	http://dx.doi.org/10.1074/jbc.M806098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19201754	hybrid, Green Published			2022-12-27	WOS:000265494500040
J	Kiefer, H; Mizutani, A; Iemura, SI; Natsume, T; Ando, H; Kuroda, Y; Mikoshiba, K				Kiefer, Helene; Mizutani, Akihiro; Iemura, Shun-Ichiro; Natsume, Tohru; Ando, Hideaki; Kuroda, Yukiko; Mikoshiba, Katsuhiko			Inositol 1,4,5-Triphosphate Receptor-binding Protein Released with Inositol 1,4,5-Triphosphate (IRBIT) Associates with Components of the mRNA 3 ' Processing Machinery in a Phosphorylation-dependent Manner and Inhibits Polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) POLYMERASE; SPECIFICITY FACTOR; 1,4,5-TRISPHOSPHATE RECEPTOR; 3'-END FORMATION; MULTIPLE FORMS; 160-KD SUBUNIT; FACTOR CPSF-73; IP3 RECEPTOR; CLEAVAGE; SIGNAL	IRBIT is a recently identified protein that modulates the activities of both inositol 1,4,5-triphosphate receptor and pancreas-type Na+/HCO3- cotransporter 1, and the multi-site phosphorylation of IRBIT is required for achieving this modulatory action. Here, we report the identification of the cleavage and polyadenylation specificity factor (CPSF), which is a multi-protein complex involved in 3' processing of mRNA precursors, as an additional binding partner for IRBIT. We found that IRBIT interacted with CPSF and was recruited to an exogenous polyadenylation signal-containing RNA. The main target for IRBIT in CPSF was Fip1 subunit, and the phosphorylation of the serine-rich region of IRBIT was required both for direct association with Fip1 in vitro and for redistribution of Fip1 into the cytoplasm of intact cells. Furthermore, tert-butylhydroquinone (tBHQ), an agent that induces oxidative stress, increased the phosphorylation level of IRBIT in vivo and in parallel enhanced the interaction between IRBIT and CPSF and promoted the cytoplasmic distribution of endogenous Fip1. In addition to CPSF, IRBIT interacted in vitro with poly(A) polymerase (PAP), which is the enzyme recruited by CPSF to elongate the poly(A) tail, and inhibited PAP activity in a phosphorylation-dependent manner. These findings raise the possibility that IRBIT modulates the polyadenylation state of specific mRNAs, both by controlling the cytoplasmic/nuclear partitioning of Fip1 and by inhibiting PAP activity, in response to a stimulus that alters its phosphorylation state.	[Kiefer, Helene; Mizutani, Akihiro; Ando, Hideaki; Kuroda, Yukiko; Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Iemura, Shun-Ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Syst Control Team, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Kawaguchi, Saitama 3320012, Japan	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Dev Neurobiol Lab, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mikosiba@brain.riken.jp	Kiefer, Hélène/Q-2752-2018; Mizutani, Akihiro/GPS-4809-2022; Ando, Hideaki/D-3876-2017; Mikoshiba, Katsuhiko/N-7943-2015; Kiefer, Helene/AAY-9185-2020; Natsume, Tohru/M-7627-2018; Kuroda, Yukiko/L-6332-2013; Kuroda, Yukiko/L-6332-2013	Kiefer, Hélène/0000-0002-6631-741X; Mizutani, Akihiro/0000-0003-4155-802X; Natsume, Tohru/0000-0002-1510-2582; Kuroda, Yukiko/0000-0002-5335-4238; Kuroda, Yukiko/0000-0001-7713-9471	Ministry of Education, Science, and Culture of Japan; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Inoue Foundation for Science; Moritani Scholarship Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inoue Foundation for Science(Inoue Foundation for Science); Moritani Scholarship Foundation	This work was supported by the Ministry of Education, Science, and Culture of Japan, the Japan Science and Technology Agency, the Japan Society for the Promotion of Science, the Inoue Foundation for Science, and the Moritani Scholarship Foundation.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Ando H, 2009, J NEUROCHEM, V109, P539, DOI 10.1111/j.1471-4159.2009.05979.x; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183; JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629; Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kim H, 2003, EMBO J, V22, P5208, DOI 10.1093/emboj/cdg486; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; RYNER LC, 1989, MOL CELL BIOL, V9, P4229, DOI 10.1128/MCB.9.10.4229; SCHEK N, 1992, MOL CELL BIOL, V12, P5386, DOI 10.1128/MCB.12.12.5386; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; THURESSON AC, 1994, P NATL ACAD SCI USA, V91, P979, DOI 10.1073/pnas.91.3.979; WAHLE E, 1991, J BIOL CHEM, V266, P3131; Weber M, 2005, CIRC RES, V96, P1161, DOI 10.1161/01.RES.0000170651.72198.fa; Xing HY, 2004, J BIOL CHEM, V279, P10551, DOI 10.1074/jbc.M311719200; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002410; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	44	23	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10694	10705		10.1074/jbc.M807136200	http://dx.doi.org/10.1074/jbc.M807136200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224921	Green Published, hybrid			2022-12-27	WOS:000265104600043
J	Amarneh, B; Matthews, KA; Rawson, RB				Amarneh, Bilal; Matthews, Krista A.; Rawson, Robert B.			Activation of Sterol Regulatory Element-binding Protein by the Caspase Drice in Drosophila Larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; BIOCHEMICAL-ANALYSIS; CYSTEINE PROTEASE; DRONC; DIAP1; PURIFICATION; MELANOGASTER; APOPTOSIS; CLEAVES; GENOME	During larval development in Drosophila melanogaster, transcriptional activation of target genes by sterol regulatory element-binding protein (dSREBP) is essential for survival. In all cases studied to date, activation of SREBPs requires sequential proteolysis of the membrane-bound precursor by site-1 protease (S1P) and site-2 protease (S2P). Cleavage by S2P, within the first membrane-spanning helix of SREBP, releases the transcription factor. In contrast to flies lacking dSREBP, flies lacking dS2P are viable. The Drosophila effector caspase Drice cleaves dSREBP, and cleavage requires an Asp residue at position 386, in the cytoplasmic juxtamembrane stalk. The initiator caspase Dronc does not cleave dSREBP, but animals lacking dS2P require both drice and dronc to complete development. They do not require Dcp1, although this effector caspase also can cleave dSREBP in vitro. Cleavage of dSREBP by Drice releases the amino-terminal transcription factor domain of dSREBP to travel to the nucleus where it mediates the increased transcription of target genes needed for lipid synthesis and uptake. Drice-dependent activation of dSREBP explains why flies lacking dS2P are viable, and flies lacking dSREBP itself are not.	[Amarneh, Bilal; Matthews, Krista A.; Rawson, Robert B.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rawson, RB (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Rob.Rawson@UTSouthwestern.Edu			National Institutes of Health [R01 GM07145701A1]; The Perot Family Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Perot Family Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM07145701A1. This work was also supported by The Perot Family Foundation.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; CHURCH RB, 1966, GENET RES, V7, P383, DOI 10.1017/S0016672300009836; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Dorstyn L, 2008, CELL DEATH DIFFER, V15, P461, DOI 10.1038/sj.cdd.4402288; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Higgins ME, 2001, J LIPID RES, V42, P1939; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Laundrie B, 2003, GENETICS, V165, P1881; Matthews KA, 2009, GENETICS, V181, P119, DOI 10.1534/genetics.108.093450; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; SANG JH, 1956, J EXP BIOL, V33, P45; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Theopold U, 1996, P NATL ACAD SCI USA, V93, P1195, DOI 10.1073/pnas.93.3.1195; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044	33	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9674	9682		10.1074/jbc.M900346200	http://dx.doi.org/10.1074/jbc.M900346200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19224859	hybrid, Green Published			2022-12-27	WOS:000264892900007
J	Ding, MG; di Rago, JP; Trumpower, BL				Ding, Martina G.; di Rago, Jean-Paul; Trumpower, Bernard L.			Combining Inhibitor Resistance-conferring Mutations in Cytochrome b Creates Conditional Synthetic Lethality in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; BC(1) COMPLEX; MOLECULAR-BASIS; ILICICOLIN-H; REGULATORY INTERACTIONS; ATOVAQUONE RESISTANCE; UBIQUINOL OXIDATION; MUTANTS RESISTANT; C REDUCTASE; Q(O) SITE	The mitochondrial cytochrome bc(1) complex is an essential respiratory enzyme in oxygen-utilizing eukaryotic cells. Its core subunit, cytochrome b, contains two sites, center P and center N, that participate in the electron transfer activity of the bc(1) complex and that can be blocked by specific inhibitors. In yeast, there are various point mutations that confer inhibitor resistance at center P or center N. However, there are no yeast strains in which the bc(1) complex is resistant to both center P and center N inhibitors. We attempted to create such strains by crossing yeast strains with inhibitor-resistant mutations at center P with yeast strains with inhibitor-resistant mutations at center N. Characterization of yeast colonies emerging from the cross revealed that there were multiple colonies resistant against either inhibitor alone but that the mutational changes were ineffective when combined and when the yeast were grown in the presence of both inhibitors. Inhibitor titrations of bc(1) complex activities in mitochondrial membranes from the various yeast mutants showed that a mutation that confers resistance to an inhibitor at center P, when combined with a mutation that confers resistance to an inhibitor at center N, eliminates or markedly decreases the resistance conferred by the center N mutation. These results indicate that there is a pathway for structural communication between the two active sites of cytochrome b and open new possibilities for the utilization of center N as a potential drug target.	[Ding, Martina G.; Trumpower, Bernard L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [di Rago, Jean-Paul] Univ Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, F-33077 Bordeaux, France	Dartmouth College; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Trumpower, BL (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			National Institutes of Health [GM 20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 20379. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baggish AL, 2002, ANTIMICROB AGENTS CH, V46, P1163, DOI 10.1128/AAC.46.5.1163-1173.2002; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Ding MG, 2006, J BIOL CHEM, V281, P36036, DOI 10.1074/jbc.M608026200; DIRAGO JP, 1990, FEBS LETT, V263, P93, DOI 10.1016/0014-5793(90)80713-S; DIRAGO JP, 1989, J BIOL CHEM, V264, P14543; ENDO T, 1970, J ANTIBIOT, V23, P91, DOI 10.7164/antibiotics.23.91; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; GERTH K, 1980, J ANTIBIOT, V33, P1474, DOI 10.7164/antibiotics.33.1474; Gutierrez-Cirlos EB, 2004, J BIOL CHEM, V279, P8708, DOI 10.1074/jbc.M311805200; Hill P, 2003, ANTIMICROB AGENTS CH, V47, P2725, DOI 10.1128/AAC.47.9.2725-2731.2003; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; Kessl JJ, 2004, J BIOL CHEM, V279, P2817, DOI 10.1074/jbc.M309984200; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; RAPER KB, 1949, AMANUAL PENICILLIA, P616; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P211, DOI 10.1016/j.bbabio.2007.10.011; SCHMITT ME, 1991, J BIOL CHEM, V266, P14958; THIERBACH G, 1982, MOL GEN GENET, V186, P501, DOI 10.1007/BF00337956; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P102; TRUMPOWER BL, 2004, ENCY BIOL CHEM, V1, P528; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wenz T, 2006, BIOCHEMISTRY-US, V45, P9042, DOI 10.1021/bi060280g; YANG XH, 1988, J BIOL CHEM, V263, P11962; YU CA, 1972, J BIOL CHEM, V247, P1012	34	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8478	8485		10.1074/jbc.M809278200	http://dx.doi.org/10.1074/jbc.M809278200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179332	Green Published, hybrid			2022-12-27	WOS:000264397800032
J	Heupel, WM; Muller, T; Efthymiadis, A; Schmidt, E; Drenckhahn, D; Waschke, J				Heupel, Wolfgang-Moritz; Mueller, Thomas; Efthymiadis, Athina; Schmidt, Enno; Drenckhahn, Detlev; Waschke, Jens			Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; STRUCTURAL BASIS; CELL ADHESION; VULGARIS; CADHERIN; DISEASE; DISSOCIATION; PLAKOGLOBIN; ENDOCYTOSIS; INHIBITION	Pemphigus vulgaris (PV) autoantibodies directly inhibit desmoglein (Dsg) 3-mediated transinteraction. Because cellular signaling also seems to be required for PV pathogenesis, it is important to characterize the role of direct inhibition in pemphigus acantholysis to allow establishment of new therapeutic approaches. Therefore, we modeled the Dsg1 and Dsg3 sequences into resolved cadherin structures and predicted peptides targeting the adhesive interface of both Dsg3 and Dsg1. In atomic force microscopy single molecule experiments, the self-designed cyclic single peptide specifically blocked homophilic Dsg3 and Dsg1 transinteraction, whereas a tandem peptide (TP) consisting of two combined single peptides did not. TP did not directly block binding of pemphigus IgG to their target Dsg antigens but prevented PV-IgG-induced inhibition of Dsg3 transinteraction in cell-free (atomic force microscopy) and cell-based (laser tweezer) experiments, indicating stabilization of Dsg3 bonds. Similarly, PV-IgG-mediated acantholysis and disruption of Dsg3 localization in HaCaT keratinocytes was partially blocked by TP. This is the first evidence that direct inhibition of Dsg3 binding is important for PV pathogenesis and that peptidomimetics stabilizing Dsg transinteraction may provide a novel approach for PV treatment.	[Waschke, Jens] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany; [Schmidt, Enno] Univ Wurzburg, Dept Dermatol, D-97082 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Drenckhahn, D (corresponding author), Univ Wurzburg, Dept Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	drenckhahn@uni-wuerzburg.de; jens.waschke@mail.uni-wuerzburg.de	Schmidt, Enno/C-4008-2009; Heupel, Wolfgang-Moritz/B-7788-2009	Schmidt, Enno/0000-0002-1206-8913; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487, TP B5, B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (Grants SFB 487, TP B5, and B2) and the IZKF Wurzburg (Grant TP A-51). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; JONES JCR, 1984, P NATL ACAD SCI-BIOL, V81, P2781, DOI 10.1073/pnas.81.9.2781; Lanza A, 2008, J BIOL CHEM, V283, P8736, DOI 10.1074/jbc.M702186200; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sharma P, 2007, J DERMATOL SCI, V48, P1, DOI 10.1016/j.jdermsci.2007.05.005; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Tong JC, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-30; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Tsukasaki Y, 2007, J MOL BIOL, V367, P996, DOI 10.1016/j.jmb.2006.12.022; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williams G, 2002, J BIOL CHEM, V277, P4361, DOI 10.1074/jbc.M109185200; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200	30	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8589	8595		10.1074/jbc.M808813200	http://dx.doi.org/10.1074/jbc.M808813200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164289	Green Published, hybrid			2022-12-27	WOS:000264397800043
J	Vernia, S; Solaz-Fuster, MC; Gimeno-Alcaniz, JV; Rubio, T; Garcia-Haro, L; Foretz, M; de Cordoba, SR; Sanz, P				Vernia, Santiago; Carmen Solaz-Fuster, M.; Vicente Gimeno-Alcaniz, Jose; Rubio, Teresa; Garcia-Haro, Luisa; Foretz, Marc; Rodriguez de Cordoba, Santiago; Sanz, Pascual			AMP-activated Protein Kinase Phosphorylates R5/PTG, the Glycogen Targeting Subunit of the R5/PTG-Protein Phosphatase 1 Holoenzyme, and Accelerates Its Down-regulation by the Laforin-Malin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; AMINO-ACID-SEQUENCE; SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; CELLULAR-ENERGY; PTG; ACCUMULATION; METABOLISM; DISEASE; SYSTEM	R5/PTG is one of the glycogen targeting subunits of type 1 protein phosphatase, a master regulator of glycogen synthesis. R5/PTG recruits the phosphatase to the places where glycogen synthesis occurs, allowing the activation of glycogen synthase and the inactivation of glycogen phosphorylase, thus increasing glycogen synthesis and decreasing its degradation. In this report, we show that the activity of R5/PTG is regulated by AMP-activated protein kinase (AMPK). We demonstrate that AMPK interacts physically with R5/PTG and modifies its basal phosphorylation status. We have also mapped the major phosphorylation sites of R5/PTG by mass spectrometry analysis, observing that phosphorylation of Ser-8 and Ser-268 increased upon activation of AMPK. We have recently described that the activity of R5/PTG is down- regulated by the laforin-malin complex, composed of a dual specificity phosphatase (laforin) and an E3-ubiquitin ligase (malin). We now demonstrate that phosphorylation of R5/PTG at Ser-8 by AMPK accelerates its laforin/malin-dependent ubiquitination and subsequent proteasomal degradation, which results in a decrease of its glycogenic activity. Thus, our results define a novel role of AMPK in glycogen homeostasis.	[Vernia, Santiago; Carmen Solaz-Fuster, M.; Vicente Gimeno-Alcaniz, Jose; Rubio, Teresa; Garcia-Haro, Luisa; Sanz, Pascual] CSIC, Inst Biomed, Valencia 46010, Spain; [Vernia, Santiago; Carmen Solaz-Fuster, M.; Vicente Gimeno-Alcaniz, Jose; Rubio, Teresa; Garcia-Haro, Luisa; Sanz, Pascual] CIBERER, Valencia 46010, Spain; [Foretz, Marc] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Foretz, Marc] INSERM, U567, F-75014 Paris, France; [Rodriguez de Cordoba, Santiago] CIBERER, Ctr Invest Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Sanz, P (corresponding author), CSIC, Inst Biomed, Jaime Roig 11, Valencia 46010, Spain.	sanz@ibv.csic.es	Sanz, Pascual/K-2751-2014; Rubio, Teresa/ABC-6384-2020; Vernia, Santiago/Q-7038-2017; FORETZ, Marc/O-7334-2017; de Cordoba, Santiago Rodriguez/K-6727-2014	Sanz, Pascual/0000-0002-2399-4103; Rubio, Teresa/0000-0003-0843-528X; Vernia, Santiago/0000-0001-6728-5555; FORETZ, Marc/0000-0001-7017-9032; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; , Luisa/0000-0003-0519-9322	Fundacio'n Marato TV3; Spanish Ministry of Education and Science [SAF2005-00852]; European Commission [LSHM-CT-2004-005272]	Fundacio'n Marato TV3; Spanish Ministry of Education and Science(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Fundacio'n Marato TV3, the Spanish Ministry of Education and Science ( Grant SAF2005-00852), and the European Commission ( Grant LSHM-CT-2004-005272).	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; CHEN YH, 1994, DIABETES, V43, P1234, DOI 10.2337/diabetes.43.10.1234; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cohen PTW, 2002, J CELL SCI, V115, P241; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Doherty MJ, 1996, FEBS LETT, V399, P339, DOI 10.1016/S0014-5793(96)01357-9; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; LEGRAIN P, 1994, NUCLEIC ACIDS RES, V22, P3241, DOI 10.1093/nar/22.15.3241; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Solaz-Fuster MC, 2006, CELL SIGNAL, V18, P1702, DOI 10.1016/j.cellsig.2006.01.021; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200	35	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8247	8255		10.1074/jbc.M808492200	http://dx.doi.org/10.1074/jbc.M808492200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19171932	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000264397800008
J	Meng, H; Zhang, XJ; Hankenson, KD; Wang, MM				Meng, He; Zhang, Xiaojie; Hankenson, Kurt D.; Wang, Michael M.			Thrombospondin 2 Potentiates Notch3/Jagged1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH1 EXTRACELLULAR DOMAIN; HUMAN LUNG CANCERS; ALAGILLE-SYNDROME; HUMAN JAGGED1; IN-VIVO; RECEPTOR; CELLS; EXPRESSION; MUTATIONS; PATHWAY	Extracellular thrombospondins (TSP or THBS) and the Notch family of transmembrane receptors share a role in multiple, overlapping cellular functions and participate in developmental signaling and pathological reactions to tissue injury. We demonstrate that TSP2, but not TSP1, enhances the potency of Notch3 signal transduction. In addition, TSP2 reduces cancer cell proliferation in a Notch-ligand dependent fashion. The loss of TSP2 in knock-out mice reduces Notch target gene expression. TSP2 binds directly to Notch3 and Jagged1. TSP1 also binds to Notch3 and Jagged1; however, only TSP2 augments the interaction between Notch3 and Jagged1. These studies demonstrate that the diverse functions of TSP2 may also include a role as an intermediary protein that facilitates transcellular receptor-ligand interactions.	[Meng, He; Zhang, Xiaojie; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania	Wang, MM (corresponding author), 7629 Med Sci Bldg 2,Box 5622,1137 Catherine St, Ann Arbor, MI 48109 USA.	micwang@umich.edu	Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020	Hankenson, Kurt/0000-0001-6361-143X; 	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS052681, K02NS054724] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR049682] Funding Source: Medline; NINDS NIH HHS [NS054724, NS052681] Funding Source: Medline; Wellcome Trust [1000990] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Aho S, 1998, MATRIX BIOL, V17, P401, DOI 10.1016/S0945-053X(98)90100-7; Albizu L, 2007, J MED CHEM, V50, P4976, DOI 10.1021/jm061404q; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen H, 1996, J BIOL CHEM, V271, P15993, DOI 10.1074/jbc.271.27.15993; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kazuno M, 1999, EUR J CANCER, V35, P502, DOI 10.1016/S0959-8049(98)00374-8; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kunnimalaiyaan M, 2006, J BIOL CHEM, V281, P39819, DOI 10.1074/jbc.M603578200; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Monet M, 2007, HUM MOL GENET, V16, P982, DOI 10.1093/hmg/ddm042; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Oshika Y, 1998, CLIN CANCER RES, V4, P1785; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sriuranpong V, 2001, CANCER RES, V61, P3200; Tokunaga T, 1999, BRIT J CANCER, V79, P354, DOI 10.1038/sj.bjc.6690056; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Zhang YM, 2007, BIOCHEM BIOPH RES CO, V355, P245, DOI 10.1016/j.bbrc.2007.01.151	47	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7866	7874		10.1074/jbc.M803650200	http://dx.doi.org/10.1074/jbc.M803650200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147503	Green Published, hybrid			2022-12-27	WOS:000264195600048
J	Wang, G; Olczak, A; Forsberg, LS; Maier, RJ				Wang, Ge; Olczak, Adriana; Forsberg, Lennart S.; Maier, Robert J.			Oxidative Stress-induced Peptidoglycan Deacetylase in Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE DEACETYLASE; DNA-DAMAGE; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-MENINGITIDIS; LYSOZYME RESISTANCE; HOST COLONIZATION; VIRULENCE FACTOR; GASTRIC-MUCOSA; PROTEINS; MUTANTS	Structural modification of peptidoglycan (PG) is one of the mechanisms that pathogenic bacteria use to evade the host innate immune system. For the noninvasive human gastric pathogen Helicobacter pylori, PG delivery to the host cells is one trigger of the immune response. H. pylori HP310 was markedly up-expressed upon cell exposure to oxidative stress. However, disruption of HP310 did not produce a phenotype distinguishable from the parent, including oxidative stress resistance characteristics. HP310 shows very weak homology to a known gene pgdA encoding PG deacetylase in Streptococcous pneumoniae. PGs from wild type H. pylori and the HP310 mutant were purified and analyzed by matrix-assisted laser desorption ionization time-of-flight and high pressure liquid chromatography. The parent strain PG is partially deacetylated, whereas several major PG-deacetylated muropeptides are absent or significantly reduced in the HP310 mutant. PG deacetylase activity was directly demonstrated by use of pure PG and HP310 protein by measuring the release of acetic acid. The Gram-negative bacterium H. pylori is highly resistant to lysozyme (up to 50 mg/ml), but the HP310 mutant is less resistant to lysozyme compared with the parent strain. Complementation of an hp310 strain with the wild type gene restored lysozyme resistance. The purified PG from the mutant is more susceptible to lysozyme (0.3 mg/ml) digestion than the wild type PG. The PG deacetylation appears to confer lysozyme resistance to escape immune detection. HP310 is representative of anew subfamily of bacterial PG deacetylases.	[Wang, Ge; Olczak, Adriana; Maier, Robert J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Forsberg, Lennart S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, 815 Biol Sci Bldg, Athens, GA 30602 USA.	rmaier@uga.edu			University of Georgia Foundation; Department of Energy [DE-FG02-93ER20097]	University of Georgia Foundation; Department of Energy(United States Department of Energy (DOE))	This work was supported by the University of Georgia Foundation and in part by Department of Energy Grant DE-FG02-93ER20097 ( to Complex Carbohydrate Research Center).	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; Antignac A, 2003, J BIOL CHEM, V278, P31521, DOI 10.1074/jbc.M304749200; Baik SC, 1996, CANCER RES, V56, P1279; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Harris AG, 2003, MICROBIOL-SGM, V149, P665, DOI 10.1099/mic.0.26012-0; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Loughlin MF, 2003, INFECT IMMUN, V71, P2022, DOI 10.1128/IAI.71.4.2022-2031.2003; McGee DJ, 1999, CURR TOP MICROBIOL, V241, P155; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Nardone G, 2004, ALIMENT PHARM THER, V20, P261, DOI 10.1111/j.1365-2036.2004.02075.x; O'Rourke EJ, 2003, P NATL ACAD SCI USA, V100, P2789, DOI 10.1073/pnas.0337641100; Olczak AA, 2002, J BACTERIOL, V184, P3186, DOI 10.1128/JB.184.12.3186-3193.2002; Olczak ANA, 2005, FREE RADICAL RES, V39, P1173, DOI 10.1080/10715760500306729; Park AM, 2004, FREE RADICAL BIO MED, V36, P1126, DOI 10.1016/j.freeradbiomed.2004.02.001; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Seyler RW, 2001, INFECT IMMUN, V69, P4034, DOI 10.1128/IAI.69.6.4034-4040.2001; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Wang G, 2006, BBA-GEN SUBJECTS, V1760, P1596, DOI 10.1016/j.bbagen.2006.05.005; Wang G, 2006, INFECT IMMUN, V74, P6839, DOI 10.1128/IAI.00991-06; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x	38	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6790	6800		10.1074/jbc.M808071200	http://dx.doi.org/10.1074/jbc.M808071200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19147492	Green Published, hybrid			2022-12-27	WOS:000263919000024
J	Andersson, FI; Tryggvesson, A; Sharon, M; Diemand, AV; Classen, M; Best, C; Schmidt, R; Schelin, J; Stanne, TM; Bukau, B; Robinson, CV; Witt, S; Mogk, A; Clarke, AK				Andersson, Fredrik I.; Tryggvesson, Anders; Sharon, Michal; Diemand, Alexander V.; Classen, Mirjam; Best, Christoph; Schmidt, Ronny; Schelin, Jenny; Stanne, Tara M.; Bukau, Bernd; Robinson, Carol V.; Witt, Susanne; Mogk, Axel; Clarke, Adrian K.			Structure and Function of a Novel Type of ATP-dependent Clp Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; ESCHERICHIA-COLI CLPP; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; 20S PROTEASOME; CYANOBACTERIUM SYNECHOCOCCUS; HIGHER-PLANTS; CHLOROPLAST; IDENTIFICATION; ARABIDOPSIS	The Clp protease is conserved among eubacteria and most eukaryotes, and uses ATP to drive protein substrate unfolding and translocation into a chamber of sequestered proteolytic active sites. The main constitutive Clp protease in photosynthetic organisms has evolved into a functionally essential and structurally intricate enzyme. The model Clp protease from the cyanobacterium Synechococcus consists of the HSP100 molecular chaperone ClpC and a mixed proteolytic core comprised of two distinct subunits, ClpP3 and ClpR. We have purified the ClpP3/R complex, the first for a Clp proteolytic core comprised of heterologous subunits. The ClpP3/R complex has unique functional and structural features, consisting of twin heptameric rings each with an identical ClpP3(3)ClpR(4) configuration. As predicted by its lack of an obvious catalytic triad, the ClpR subunit is shown to be proteolytically inactive. Interestingly, extensive modification to ClpR to restore proteolytic activity to this subunit showed that its presence in the core complex is not rate-limiting for the overall proteolytic activity of the ClpCP3/R protease. Altogether, the ClpP3/R complex shows remarkable similarities to the 20 S core of the proteasome, revealing a far greater degree of convergent evolution than previously thought between the development of the Clp protease in photosynthetic organisms and that of the eukaryotic 26 S proteasome.	[Andersson, Fredrik I.; Tryggvesson, Anders; Stanne, Tara M.; Clarke, Adrian K.] Univ Gothenburg, Dept Plant & Environm Sci, S-40530 Gothenburg, Sweden; [Sharon, Michal; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Diemand, Alexander V.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Classen, Mirjam; Best, Christoph; Witt, Susanne] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Schmidt, Ronny; Bukau, Bernd; Mogk, Axel] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Schelin, Jenny] Lund Inst Technol, Dept Appl Microbiol, S-22100 Lund, Sweden	University of Gothenburg; University of Cambridge; Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg; Lund University	Clarke, AK (corresponding author), Box 461, S-40530 Gothenburg, Sweden.	adrian.clarke@dpes.gu.se		Sharon, Michal/0000-0003-3933-0595; Bukau, Bernd/0000-0003-0521-7199; robinson, carol/0000-0001-7829-5505				Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Clarke AK, 2005, PHYSIOL PLANTARUM, V123, P406, DOI 10.1111/j.1399-3054.2005.00452.x; Clarke AK, 1996, PLANT MOL BIOL, V31, P721, DOI 10.1007/BF00019460; CLARKE AK, 1992, PLANT PHYSIOL, V100, P2081, DOI 10.1104/pp.100.4.2081; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Diemand AV, 2004, NUCLEIC ACIDS RES, V32, pW512, DOI 10.1093/nar/gkh403; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Namikoshi M, 1996, J IND MICROBIOL BIOT, V17, P373, DOI 10.1007/BF01574768; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Peltier JB, 2001, J BIOL CHEM, V276, P16318, DOI 10.1074/jbc.M010503200; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schelin J, 2002, MICROBIOL-SGM, V148, P2255, DOI 10.1099/00221287-148-7-2255; Schiener J, 2005, BIOCHEM BIOPH RES CO, V328, P477, DOI 10.1016/j.bbrc.2005.01.005; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Tanaka K, 1998, IMMUNOL REV, V163, P161; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang JM, 1998, J STRUCT BIOL, V124, P151, DOI 10.1006/jsbi.1998.4058	48	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13519	13532		10.1074/jbc.M809588200	http://dx.doi.org/10.1074/jbc.M809588200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19237538	hybrid, Green Published			2022-12-27	WOS:000265877300029
J	Bardwell, AJ; Frankson, E; Bardwell, L				Bardwell, A. Jane; Frankson, Erlynn; Bardwell, Lee			Selectivity of Docking Sites in MAPK Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-AFFINITY INTERACTION; C-JUN; SUBSTRATE-SPECIFICITY; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; BINDING; PHOSPHORYLATION; INHIBITION; ERK2	Protein kinases often recognize their substrates and regulators through docking interactions that occur outside of the active site; these interactions can help us to understand kinase networks, and to target kinases with drugs. During mitogen-activated protein kinase (MAPK) signaling, the ability of MAPK kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The extent to which docking contributes to the specificity of MAPK transactions is incompletely understood. Here we characterize the selectivity of the interaction between MKK-derived D-sites and MAPKs by measuring the ability of D-site peptides to inhibit MAPK-mediated phosphorylation of D-site-containing substrates. We find that all MKK D-sites bind better to their cognate MAPKs than they do to non-cognate MAPKs. For instance, the MKK3 D-site peptide, which is a remarkably potent inhibitor of p38 alpha (IC50 < 10 nM), does not inhibit JNK1 or JNK2. Likewise, MAPKs generally bind as well or better to cognate D-sites than to non-cognate D-sites. For instance, JNK1 and JNK2 do not appreciably bind to any D-sites other than their cognate D-sites from MKK4 and MKK7. In general, cognate, within-pathway interactions are preferred about an order of magnitude over non-cognate interactions. However, the selectivity of MAPKs and their cognate MKK-derived D-sites for each other is limited in some cases; in particular, ERK2 is not very selective. We conclude that MAPK-docking sites in MAPK kinases bind selectively to their cognate MAPKs.	[Bardwell, A. Jane; Frankson, Erlynn; Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363	NIGMS [GM60366]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060366, P50GM076516] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60366 from the NIGMS.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bardwell AJ, 2003, BIOCHEM J, V370, P1077, DOI 10.1042/BJ20021806; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bogoyevitch MA, 2007, DRUG DISCOV TODAY, V12, P622, DOI 10.1016/j.drudis.2007.06.008; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Ember B, 2008, BIOCHEMISTRY-US, V47, P3076, DOI 10.1021/bi701852z; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Force T, 2004, CIRCULATION, V109, P1196, DOI 10.1161/01.CIR.0000118538.21306.A9; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Jiang Y, 1997, J BIOL CHEM, V272, P11096; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Johnson L, 2007, BIOCHEM SOC T, V35, P7, DOI 10.1042/BST0350007; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; Molina DM, 2005, J BIOL CHEM, V280, P42051, DOI 10.1074/jbc.M510590200; Niu LH, 2007, BIOCHEMISTRY-US, V46, P4775, DOI 10.1021/bi602423e; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Parang K, 2004, CURR OPIN DRUG DISC, V7, P617; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Senawong T, 2008, HUM MOL GENET, V17, P419, DOI 10.1093/hmg/ddm319; Seyfried J, 2005, MOL CELL BIOL, V25, P9820, DOI 10.1128/MCB.25.22.9820-9828.2005; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wilsbacher JL, 1999, J BIOL CHEM, V274, P16988, DOI 10.1074/jbc.274.24.16988; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	69	94	95	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13165	13173		10.1074/jbc.M900080200	http://dx.doi.org/10.1074/jbc.M900080200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19196711	hybrid, Green Published			2022-12-27	WOS:000265688300063
J	Leulliot, N; Cladiere, L; Lecointe, F; Durand, D; Hubscher, U; van Tilbeurgh, H				Leulliot, Nicolas; Cladiere, Lionel; Lecointe, Francois; Durand, Dominique; Huebscher, Ulrich; van Tilbeurgh, Herman			The Family X DNA Polymerase from Deinococcus radiodurans Adopts a Non-standard Extended Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; ANGLE SCATTERING DATA; CRYSTAL-STRUCTURES; REPAIR POLYMERASE; BETA; EXONUCLEASE; MECHANISM; LAMBDA; SOFTWARE; PHENIX	Deinococcus radiodurans is an extraordinarily radioresistant bacterium that is able to repair hundreds of radiation-induced double-stranded DNA breaks. One of the players in this pathway is an X family DNA polymerase (PolX(Dr)). Deletion of PolXDr has been shown to decrease the rate of repair of double-stranded DNA breaks and increase cell sensitivity to gamma-rays. A 3'-> 5' exonuclease activity that stops cutting close to DNA loops has also been demonstrated. The present crystal structure of PolXDr solved at 2.46-angstrom resolution reveals that PolXDr has a novel extended conformation in stark contrast to the closed "right hand" conformation commonly observed for DNA polymerases. This extended conformation is stabilized by the C-terminal PHP domain, whose putative nuclease active site is obstructed by its interaction with the polymerase domain. The overall conformation and the presence of non standard residues in the active site of the polymerase X domain makes PolXDr the founding member of a novel class of polymerases involved in DNA repair but whose detailed mode of action still remains enigmatic.	[Leulliot, Nicolas; Cladiere, Lionel; Lecointe, Francois; Durand, Dominique; van Tilbeurgh, Herman] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, IFR115, CNRS,UMR8619, F-91405 Orsay, France; [Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Zurich	van Tilbeurgh, H (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, IFR115, CNRS,UMR8619, Bat 430, F-91405 Orsay, France.	Herman.Van-Tilbeurgh@u-psud.fr	Leulliot, Nicolas/AAA-7160-2019	Leulliot, Nicolas/0000-0003-0283-4298; Lecointe, Francois/0000-0002-9596-2514	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	Supported by the Swiss National Science Foundation and by the University of Zurich.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Banos B, 2008, NUCLEIC ACIDS RES, V36, P5736, DOI 10.1093/nar/gkn526; Banos B, 2008, J MOL BIOL, V384, P1019, DOI 10.1016/j.jmb.2008.09.081; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Guinier A., 1955, SMALL ANGLE SCATTERI; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Leslie A., 1992, JOINT CCP4 EACMB NEW; Maciejewski MW, 2001, NAT STRUCT BIOL, V8, P936, DOI 10.1038/nsb1101-936; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ramadan K, 2004, J MOL BIOL, V339, P395, DOI 10.1016/j.jmb.2004.03.056; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Showalter AK, 2001, NAT STRUCT BIOL, V8, P942, DOI 10.1038/nsb1101-942; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	35	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11992	11999		10.1074/jbc.M809342200	http://dx.doi.org/10.1074/jbc.M809342200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251692	Green Published, hybrid			2022-12-27	WOS:000265494600031
J	Misra, S; Hascall, VC; De Giovanni, C; Markwald, RR; Ghatak, S				Misra, Suniti; Hascall, Vincent C.; De Giovanni, Carla; Markwald, Roger R.; Ghatak, Shibnath			Delivery of CD44 shRNA/Nanoparticles within Cancer Cells PERTURBATION OF HYALURONAN/CD44v6 INTERACTIONS AND REDUCTION IN ADENOMA GROWTH IN Apc Min/ plus MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVELY REGULATES ACTIVATION; MULTIPLE INTESTINAL NEOPLASIA; HUMAN COLON CARCINOMAS; COLORECTAL-CANCER; GENE-TRANSFER; VARIANT 6; POLYETHYLENIMINE/DNA COMPLEXES; ADHESION MOLECULES; INFLUENCES GROWTH; HYALURONAN	Our studies have shown that constitutive interactions between hyaluronan and CD44 on tumor cells induces various anti-apoptotic cell survival pathways through the formation of a multimeric signaling complex that contains activated receptor tyrosine kinases. Inhibition of the hyaluronan-CD44 interactions on tumor cells by hyaluronan-CD44 interaction antagonists suppresses these activities by disassembling the complex. Although the anti-tumor activity of hyaluronan-oligosaccharides, a hyaluronan-CD44 interaction antagonist, is effective in sensitizing tumor cells to chemotherapeutic agents and reducing tumor growth in xenografts, hyaluronan-oligosaccharide alone was not effective in reducing tumor progression in Apc Min/+ mice. We now show in vitro and in vivo that targeted inhibition of the expression of CD44v6 depletes the ability of the colon tumor cells to signal through hyaluronan-CD44v6 interactions. First, we cloned oligonucleotides coding CD44v6 shRNA into a conditionally silenced pSico vector. Second, using pSico-CD44v6 shRNA and a colon-specific Fabpl promoter-driven Cre recombinase expression vector packaged into transferrin-coated nanoparticles, we successfully delivered the CD44v6 shRNA within pre-neoplastic and neoplastic colon malignant cells. Third, using the Apc Min/+ mice model, we demonstrated that inhibition of the CD44v6 expression reduces the signaling through a hyaluronan/CD44v6-pErbB2-Cox-2 interaction pathway and reduced adenoma number and growth. Together, these data provide insight into the novel therapeutic strategies of short hairpin RNA/nanoparticle technology and its potential for silencing genes associated with colon tumor cells.	[Misra, Suniti; Markwald, Roger R.; Ghatak, Shibnath] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Misra, Suniti; Ghatak, Shibnath] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA; [De Giovanni, Carla] Univ Bologna, Canc Res Sect, Dept Expt Pathol, I-40126 Bologna, Italy	Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation; University of Bologna	Ghatak, S (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, 171 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu	De Giovanni, Carla/B-1312-2009	DE GIOVANNI, CARLA/0000-0003-4388-4988	National Institutes of Health [P20 RR016434, HLRO133756, Mitral-07CVD 04, 1 P30AR050953, P20RR017698, RO1 CA073839, RO1 CA082867]; Hollings Cancer Center Department of Defense [GC-3319-0544598]; Medical University of South Carolina URC [2204000-24330, 2204000-24329]; NATIONAL CANCER INSTITUTE [R01CA073839, R01CA082867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center Department of Defense(United States Department of Defense); Medical University of South Carolina URC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR016434 (to S. M., S. G., and R. R. M.), HLRO133756, Mitral-07CVD 04 (to R. R. M.), 1 P30AR050953 (to V. C. H.), and P20RR017698 (to S. M.), RO1 CA073839 and RO1 CA082867 (to S. M. and S. G.). This work was also supported by Hollings Cancer Center Department of Defense Grant GC-3319-0544598 (to S. M. and R. R. M.) and Medical University of South Carolina URC Projects 2204000-24330 (to S. M.) and 2204000-24329 (to S. G.).	Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; Ayhan A, 2001, GYNECOL ONCOL, V80, P355, DOI 10.1006/gyno.2000.6014; Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f; Boeckle S, 2004, J GENE MED, V6, P1102, DOI 10.1002/jgm.598; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chen QZ, 2004, J UROLOGY, V172, P2153, DOI 10.1097/01.ju.0000143440.08760.3a; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; De Giovanni C, 2004, INT J CANCER, V109, P200, DOI 10.1002/ijc.11690; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Holloway K, 2007, J MOL BIOL, V365, P1271, DOI 10.1016/j.jmb.2006.10.071; Ishida T, 2000, SURG TODAY, V30, P28, DOI 10.1007/PL00010042; Kaczmarczyk SJ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e56; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2; Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351; Kurozumi K, 1998, WORLD J SURG, V22, P853, DOI 10.1007/s002689900481; Kursa M, 2003, BIOCONJUGATE CHEM, V14, P222, DOI 10.1021/bc0256087; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MARKWALD RR, 1978, DEV BIOL, V62, P292, DOI 10.1016/0012-1606(78)90218-X; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Miyake H, 1998, J UROLOGY, V160, P1562, DOI 10.1016/S0022-5347(01)62613-2; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakazawa Hideaki, 2006, Cancer Chemother Pharmacol, V57, P165, DOI 10.1007/s00280-005-0016-5; Naor D, 1998, CURR TOP MICROBIOL, V231, P143; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Ochiai S, 1997, Nihon Kyobu Shikkan Gakkai Zasshi, V35, P1179; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Ropponen KM, 1998, SCAND J GASTROENTERO, V33, P301; Roy CN, 2000, BLOOD, V96, P4020, DOI 10.1182/blood.V96.13.4020.h8004020_4020_4027; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; SaporitoIrwin SM, 1997, BIOTECHNIQUES, V23, P424, DOI 10.2144/97233bm16; Sasai H, 2000, CARCINOGENESIS, V21, P953, DOI 10.1093/carcin/21.5.953; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; Sprenger CC, 2008, BRIT J CANCER, V98, P250, DOI 10.1038/sj.bjc.6604144; Takahashi K, 1995, ONCOGENE, V11, P2223; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tucker JA, 2002, CANCER LETT, V187, P153, DOI 10.1016/S0304-3835(02)00402-0; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; YOSHIDA K, 1995, CANCER RES, V55, P4273; Yu Q, 1996, J BIOL CHEM, V271, P20603, DOI 10.1074/jbc.271.34.20603; YU Q, 1995, BIOTECHNIQUES, V19, P122; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	72	70	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12432	12446		10.1074/jbc.M806772200	http://dx.doi.org/10.1074/jbc.M806772200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246453	Green Published, hybrid			2022-12-27	WOS:000265494600073
J	Yoshihara, T; Sugihara, K; Kizuka, Y; Oka, S; Asano, M				Yoshihara, Toru; Sugihara, Kazushi; Kizuka, Yasuhiko; Oka, Shogo; Asano, Masahide			Learning/Memory Impairment and Reduced Expression of the HNK-1 Carbohydrate in beta 4-Galactosyltransferase-II-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; POLYSIALIC ACID; KNOCKOUT MICE; N-GLYCANS; DEFICIENT; GENE; DIFFERENTIATION; GLYCOSYLATION; GLYCOPROTEINS; BIOSYNTHESIS	The glycosylation of glycoproteins and glycolipids is important for central nervous system development and function. Although the roles of several carbohydrate epitopes in the central nervous system, including polysialic acid, the human natural killer-1 (HNK-1) carbohydrate, alpha 2,3-sialic acid, and oligomannosides, have been investigated, those of the glycan backbone structures, such as Gal beta 1-4GlcNAc and Gal beta 1-3GlcNAc, are not fully examined. Here we report the generation of mice deficient in beta 4-galactosyltransferase-II (beta 4GalT-II). This galactosyltransferase transfers Gal from UDP-Gal to a nonreducing terminal GlcNAc to synthesize the Gal beta 1-4GlcNAc structure, and it is strongly expressed in the central nervous system. In behavioral tests, the beta 4GalT-II-/- mice showed normal spontaneous activity in a novel environment, but impaired spatial learning/memory and motor coordination/learning. Immunohistochemistry showed that the amount of HNK-1 carbohydrate was markedly decreased in the brain of beta 4GalT-II-/- mice, whereas the expression of polysialic acid was not affected. Furthermore, mice deficient in glucuronyltransferase (GlcAT-P), which is responsible for the biosynthesis of the HNK-1 carbohydrate, also showed impaired spatial learning/memory as described in our previous report, although their motor coordination/learning was normal as shown in this study. Histological examination showed abnormal alignment and reduced number of Purkinje cells in the cerebellum of beta 4GalT-II-/- mice. These results suggest that the Gal beta 1-4GlcNAc structure in the HNK-1 carbohydrate is mainly synthesized by beta 4GalT-II and that the glycans synthesized by beta 4GalT-II have essential roles in higher brain functions, including some that are HNK-1-dependent and some that are not.	[Yoshihara, Toru; Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan; [Kizuka, Yasuhiko] Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Yoshihara, Toru; Asano, Masahide] Kanazawa Univ, 21st Century COE Program Innovat Brain Sci Dev Le, Kanazawa, Ishikawa 9208640, Japan; [Yoshihara, Toru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University; Kyoto University; Kyoto University; Kanazawa University; Kanazawa University	Asano, M (corresponding author), 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	asano@kiea.m.kanazawa-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Ministry of Education, Culture, Sports, Science and Technology of Japan [19300144]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid 19300144 and the 21st Century COE Program K-1 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Biellmann F, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-109; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Bukalo O, 2007, J NEUROSCI, V27, P6019, DOI 10.1523/JNEUROSCI.1022-07.2007; CARTER RJ, 2003, CURRENT PROTOCOLS NE; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Kido M, 1998, BIOCHEM BIOPH RES CO, V245, P860, DOI 10.1006/bbrc.1998.8537; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078; Li QX, 1997, DEV BIOL, V181, P257, DOI 10.1006/dbio.1996.8444; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Lu QX, 1997, DEVELOPMENT, V124, P4121; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mori R, 2004, AM J PATHOL, V164, P1303, DOI 10.1016/S0002-9440(10)63217-8; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Saghatelyan AK, 2003, MOL CELL NEUROSCI, V24, P271, DOI 10.1016/S1044-7431(03)00163-5; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Strekalova T, 2001, MOL CELL NEUROSCI, V17, P1102, DOI 10.1006/mcne.2001.0991; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	44	38	38	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12550	12561		10.1074/jbc.M809188200	http://dx.doi.org/10.1074/jbc.M809188200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265195	Green Published, hybrid			2022-12-27	WOS:000265494600084
J	Cummings, CM; Bentley, CA; Perdue, SA; Baas, PW; Singer, JD				Cummings, Cristina M.; Bentley, Cornelia A.; Perdue, Sarah A.; Baas, Peter W.; Singer, Jeffrey D.			The Cul3/Klhdc5 E3 Ligase Regulates p60/Katanin and Is Required for Normal Mitosis in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; UBIQUITIN-LIGASE; CAENORHABDITIS-ELEGANS; PROTEASOMAL DEGRADATION; AURORA-B; F-BOX; MICROTUBULE DYNAMICS; INTERACTING PROTEIN; SPASTIC PARAPLEGIA; SUBSTRATE ADAPTER	The proper regulation of factors involved in mitosis is crucial to ensure normal cell division. Levels and activities of proteins are regulated in many ways, one of which is ubiquitin-mediated protein degradation. E3 ubiquitin ligases are involved in targeting specific substrates for degradation by facilitating their ubiquitination. In seeking to elucidate additional biological roles for Cul3 we performed a two-hybrid screen and identified Ctb9/KLHDC5 as a Cul3-interacting protein. Overexpression of Ctb9/KLHDC5 resulted in an increase in microtubule density as well as persistent microtubule bridges between post-mitotic cells. Conversely, down-regulation of Ctb9/KLHDC5 showed a pronounced reduction in microtubule density. Based on these observations, we examined the interactions between Cul3, Ctb9/KLHDC5, and the microtubule-severing protein, p60/katanin. Here we show that p60/katanin interacts with a complex consisting of Cul3 and Ctb9/KLHDC5, which results in ubiquitin laddering of p60/katanin. Also, Cul3-deficient cells or Ctb9/KLHDC5-deficient cells show an increase in p60/katanin levels, indicating that Cul3/Ctb9/KLHDC5 is required for efficient p60/katanin removal. We demonstrate a novel regulatory mechanism for p60/katanin that occurs at the level of targeted proteolysis to allow normal mitotic progression in mammalian cells.	[Cummings, Cristina M.; Bentley, Cornelia A.; Perdue, Sarah A.; Singer, Jeffrey D.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02903 USA; [Cummings, Cristina M.; Bentley, Cornelia A.; Perdue, Sarah A.; Singer, Jeffrey D.] Brown Univ, Ctr Genom & Proteom, Providence, RI 02903 USA; [Baas, Peter W.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA	Brown University; Brown University; Drexel University	Singer, JD (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	jsinger@pdx.edu			National Institutes of Health [7R01GM082940-0208]; Emerald Foundation; Leukemia and Lymphoma Society; Rhode Island Biomedical Research Infrastructure Network; Center of Biological Research Excellence; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Rhode Island Biomedical Research Infrastructure Network; Center of Biological Research Excellence; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 7R01GM082940-0208 (to J.D.S.). This work was also supported by the Emerald Foundation (to J.D.S.), the Leukemia and Lymphoma Society (to J.D.S.), the Rhode Island Biomedical Research Infrastructure Network (National Center for Research Resources, NIH to J.D.S.), and the Center of Biological Research Excellence (National Center for Research Resources, NIH to J.D.S.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Baas PW, 2005, TRENDS CELL BIOL, V15, P183, DOI 10.1016/j.tcb.2005.02.001; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Earnshaw WC, 2001, CURR BIOL, V11, pR683, DOI 10.1016/S0960-9822(01)00407-9; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; GODT D, 1993, DEVELOPMENT, V119, P799; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; He H, 2001, P NATL ACAD SCI USA, V98, P11979, DOI 10.1073/pnas.221452098; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; MAINS PE, 1990, GENETICS, V126, P593; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2000, J CELL SCI, V113, P1623; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; SCHOLEY JM, 1985, NATURE, V318, P483, DOI 10.1038/318483a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Srayko M, 2000, GENE DEV, V14, P1072; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu J, 2003, MOL BIOL REP, V30, P239, DOI 10.1023/A:1026372901766; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yamanaka A, 2002, CURR BIOL, V12, P267, DOI 10.1016/S0960-9822(02)00657-7; Yan Q, 2004, J BIOL CHEM, V279, P43019, DOI 10.1074/jbc.M408018200; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou JL, 2005, J EXP ZOOL PART A, V303A, P227, DOI 10.1002/jez.a.150; ZOLLMAN TM, 1994, PROTEIN EXPRES PURIF, V5, P291, DOI 10.1006/prep.1994.1044	69	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11663	11675		10.1074/jbc.M809374200	http://dx.doi.org/10.1074/jbc.M809374200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261606	Green Published, hybrid			2022-12-27	WOS:000265494500069
J	Spitale, RC; Torelli, AT; Krucinska, J; Bandarian, V; Wedekind, JE				Spitale, Robert C.; Torelli, Andrew T.; Krucinska, Jolanta; Bandarian, Vahe; Wedekind, Joseph E.			The Structural Basis for Recognition of the PreQ(0) Metabolite by an Unusually Small Riboswitch Aptamer Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; METAL-BINDING; RNA; RIBOZYME; PROTEIN; CRYSTALLOGRAPHY; CLASSIFICATION; REDUCTASE; SOFTWARE	Riboswitches are RNA elements that control gene expression through metabolite binding. The preQ(1) riboswitch exhibits the smallest known ligand-binding domain and is of interest for its economical organization and high affinity interactions with guanine-derived metabolites required to confer tRNA wobbling. Here we present the crystal structure of a preQ(1) aptamer domain in complex with its precursor metabolite preQ(0). The structure is highly compact with a core that features a stem capped by a well organized decaloop. The metabolite is recognized within a deep pocket via Watson-Crick pairing with C15. Additional hydrogen bonds are made to invariant bases U6 and A29. The ligand-bound state confers continuous helical stacking throughout the core fold, thus providing a platform to promote Watson-Crick base pairing between C9 of the decaloop and the first base of the ribosome-binding site, G33. The structure offers insight into the mode of ribosome-binding site sequestration by a minimal RNA fold stabilized by metabolite binding and has implications for understanding the molecular basis by which bacterial genes are regulated.	[Torelli, Andrew T.; Krucinska, Jolanta; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Spitale, Robert C.; Wedekind, Joseph E.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Bandarian, Vahe] Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA	University of Rochester; University of Rochester; University of Arizona	Wedekind, JE (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu			National Institutes of Health [GM63162]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63162 (to J.E.W.).	Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Alam S, 2005, BIOCHEMISTRY-US, V44, P14396, DOI 10.1021/bi051550i; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; BIENZ M, 1981, NATURE, V294, P188, DOI 10.1038/294188a0; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cochrane JC, 2008, RNA, V14, P993, DOI 10.1261/rna.908408; DELANO WL, 2002, PYMOL MOL GRAPHICS; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Klosterman PS, 2002, NUCLEIC ACIDS RES, V30, P392, DOI 10.1093/nar/30.1.392; Klostermeier D, 2002, BIOCHEMISTRY-US, V41, P14095, DOI 10.1021/bi025551b; Lea CR, 2007, NAT CHEM BIOL, V3, P15, DOI 10.1038/nchembio0107-16; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; MEIER F, 1985, EMBO J, V4, P823, DOI 10.1002/j.1460-2075.1985.tb03704.x; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1997, METHOD ENZYMOL, V276, P530; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Wedekind JE, 1999, NAT STRUCT BIOL, V6, P261, DOI 10.1038/6700; Wedekind JE, 2000, METHOD ENZYMOL, V317, P149; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529	42	79	81	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11012	11016		10.1074/jbc.C900024200	http://dx.doi.org/10.1074/jbc.C900024200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261617	Green Published, hybrid			2022-12-27	WOS:000265494500005
J	Tian, P; Bernstein, HD				Tian, Pu; Bernstein, Harris D.			Identification of a Post-targeting Step Required for Efficient Cotranslational Translocation of Proteins across the Escherichia coli Inner Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; MALTOSE-BINDING PROTEIN; CYTOPLASMIC MEMBRANE; SEQUENCE RECOGNITION; MATURE SEQUENCE; SECY COMPLEX; EXPORT; PEPTIDE; SECRETION; PATHWAY	Recent studies have shown that cytoplasmic proteins are exported efficiently in Escherichia coli only if they are attached to signal peptides that are recognized by the signal recognition particle and are thereby targeted to the SecYEG complex cotranslationally. The evidence suggests that the entry of these proteins into the secretory pathway at an early stage of translation is necessary to prevent them from folding into a translocation-incompetent conformation. We found, however, that several glycolytic enzymes attached to signal peptides that are recognized by the signal recognition particle were exported inefficiently. Based on previous studies of post-translational export, we hypothesized that the export block was due to the presence of basic residues at the extreme N terminus of each enzyme. Consistent with our hypothesis, we found that the introduction of negatively charged residues into this segment increased the efficiency of export. Export efficiency was sensitive to the number, position, and sequence context of charged residues. The importance of charge for efficient export was underscored by an in silico analysis that revealed a conserved negative charge bias at the N terminus of the mature region of bacterial presecretory proteins. Our results demonstrate that cotranslational targeting of a protein to the E. coli SecYEG complex does not ensure its export but that export also depends on a subsequent event (most likely the initiation of translocation) that involves sequences both within and just beyond the signal peptide.	[Tian, Pu; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bldg 5,Rm 201, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov	TIAN, PU/F-5739-2012		National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052022, ZIADK052022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health.	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; BELIN D, 1996, EMBO J, V15, P469; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; CAMMACK KA, 1965, BIOCHEM J, V96, P671, DOI 10.1042/bj0960671; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Frate MC, 2000, EUR J BIOCHEM, V267, P3836, DOI 10.1046/j.1432-1327.2000.01422.x; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kajava AV, 2000, J BACTERIOL, V182, P2163, DOI 10.1128/JB.182.8.2163-2169.2000; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; Mallik I, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-32; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MORENO F, 1980, NATURE, V286, P356, DOI 10.1038/286356a0; Moser Michael, 2007, V390, P63; Nesmeyanova MA, 1997, FEBS LETT, V403, P203, DOI 10.1016/S0014-5793(97)00052-5; Newitt JA, 1998, J BIOL CHEM, V273, P12451, DOI 10.1074/jbc.273.20.12451; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PUZISS JW, 1992, J BACTERIOL, V174, P92, DOI 10.1128/jb.174.1.92-101.1992; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; SUMMERS RG, 1989, J BIOL CHEM, V264, P20074; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; YAMANE K, 1988, J BIOL CHEM, V263, P19690	44	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11396	11404		10.1074/jbc.M900375200	http://dx.doi.org/10.1074/jbc.M900375200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19211555	Green Published, hybrid			2022-12-27	WOS:000265494500044
J	Lee, H; Lee, YJ; Choi, H; Ko, EH; Kim, JW				Lee, Haemi; Lee, Yoo Jeong; Choi, Hyeonjin; Ko, Eun Hee; Kim, Jae-Woo			Reactive Oxygen Species Facilitate Adipocyte Differentiation by Accelerating Mitotic Clonal Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; 3T3-L1 PREADIPOCYTES; OXIDATIVE STRESS; DNA-BINDING; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; ADIPOSE CONVERSION; GENE PROMOTER; MICE LACKING; ADIPOGENESIS	Growth-arrested 3T3-L1 preadipocytes rapidly express CCAAT/enhancer-binding protein-beta (C/EBP beta) upon hormonal induction of differentiation. However, the DNA binding activity of C/EBP beta is not activated until the cells synchronously reenter S phase during the mitotic clonal expansion (MCE) phase of differentiation. In this period, C/EBP beta is sequentially phosphorylated by MAPK and glycogen synthase kinase-3 beta, inducing C/EBP beta DNA binding activity and transcription of its target genes. Because the DNA binding activity of C/EBP beta is further enhanced by oxidation in vitro, we investigated how redox state affects C/EBP beta DNA binding and MCE during adipogenesis. When 3T3-L1 cells were treated with H2O2 and hormonal stimuli, differentiation was accelerated with increased expression of peroxisome proliferator-activated receptor gamma. Interestingly, cell cycle progression (S to G2/M phase) was markedly enhanced by H2O2, whereas antioxidants caused an S phase arrest during the MCE. H2O2 treatment resulted in the early appearance of a punctate pattern observed by immunofluorescent staining of C/EBP beta, which is a hallmark for C/EBP beta binding to regulatory elements, whereas a short antioxidant treatment rapidly dispersed the centromeric localization of C/EBP beta. Consistently, reactive oxygen species production was increased during 3T3-L1 differentiation. Our results indicate that redox-induced C/EBP beta DNA binding activity, along with the dual phosphorylation of C/EBP beta, is required for the MCE and terminal differentiation of adipocytes.	[Lee, Haemi; Lee, Yoo Jeong; Choi, Hyeonjin; Ko, Eun Hee; Kim, Jae-Woo] Yonsei Univ, Dept Biochem & Mol Biol, Ctr Chron Metab Dis Res, Inst Genet Sci,Coll Med,Brain Korea Project Med S, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Kim, JW (corresponding author), 134 Shinchon Dong, Seoul 120752, South Korea.	japol13@yumc.yonsei.ac.kr		Choi, Hyeonjin/0000-0002-5055-5093; Kim, Jae-woo/0000-0001-5456-9495	Korea Science and Engineering Foundation [R13-2002-054-04000-0, R01-2007-000-10641-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grants R13-2002-054-04000-0 and R01-2007-000-10641-0 funded by the Korean government.	AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; AMRI EZ, 1986, BIOCHEM BIOPH RES CO, V137, P903, DOI 10.1016/0006-291X(86)91165-4; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Castro-Munozledo F, 2003, EXP CELL RES, V284, P163, DOI 10.1016/S0014-4827(02)00036-8; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Entenmann G, 1996, AM J PHYSIOL-CELL PH, V270, pC1011, DOI 10.1152/ajpcell.1996.270.4.C1011; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lane M D, 1981, Prog Clin Biol Res, V66 Pt A, P523; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; REED BC, 1977, P NATL ACAD SCI USA, V74, P4876, DOI 10.1073/pnas.74.11.4876; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tell G, 1998, J BIOL CHEM, V273, P25062, DOI 10.1074/jbc.273.39.25062; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	45	284	291	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10601	10609		10.1074/jbc.M808742200	http://dx.doi.org/10.1074/jbc.M808742200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19237544	hybrid, Green Published			2022-12-27	WOS:000265104600034
J	Lee, J; Sperandio, V; Frantz, DE; Longgood, J; Camilli, A; Phillips, MA; Michael, AJ				Lee, Jeongmi; Sperandio, Vanessa; Frantz, Doug E.; Longgood, Jamie; Camilli, Andrew; Phillips, Margaret A.; Michael, Anthony J.			An Alternative Polyamine Biosynthetic Pathway Is Widespread in Bacteria and Essential for Biofilm Formation in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; ESCHERICHIA-COLI; ORNITHINE-DECARBOXYLASE; SIDEROPHORE BIOSYNTHESIS; PETROBACTIN BIOSYNTHESIS; ACINETOBACTER-BAUMANNII; SPERMIDINE SYNTHASE; BACILLUS-SUBTILIS; GENE; NORSPERMIDINE	Polyamines are small organic cations found in all cells, and the biosynthetic pathway is well described in eukaryotes and Escherichia coli. The characterized pathway uses decarboxylated S-adenosylmethionine as the aminopropyl group donor to form spermidine from putrescine by the key enzymes S-adenosylmethionine decarboxylase and spermidine synthase. We report here the in vivo characterization of an alternative polyamine biosynthetic pathway from Vibrio cholerae, the causative agent of human cholera. The pathway uses aspartate beta-semialdehyde as the aminopropyl group donor and consists of a fused protein containing L-2,4-diaminobutyrate aminotransferase and L-2,4-diaminobutyrate decarboxylase, a carboxynorspermidine dehydrogenase (CANSDH), and a carboxynorspermidine decarboxylase (CANSDC). We show that in V. cholerae, this pathway is required for synthesis of both sym-norspermidine and spermidine. Heterologous expression of the V. cholerae pathway in E. coli results in accumulation of the nonnative polyamines diaminopropane and sym-norspermidine. Genetic deletion of the V. cholerae CANSDC led to accumulation of carboxynorspermidine, whereas deletion of either CANSDC or the putative CANSDH led to loss of sym-norspermidine and spermidine. These results allowed unambiguous identification of the gene encoding CANSDH. Furthermore, deletion of either CANSDH or CANSDC led to a 50-60% reduction in growth rate of planktonic cells and severely reduced biofilm formation, which could be rescued by exogenously supplied sym-norspermidine but not spermidine. The pathway was not required for infectivity in a mouse model of V. cholerae infection. Notably, the alternative polyamine biosynthetic pathway is widespread in bacteria and is likely to play a previously unrecognized role in the biology of these organisms.	[Michael, Anthony J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Lee, Jeongmi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Frantz, Doug E.; Longgood, Jamie] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Camilli, Andrew] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Tufts University; Tufts University	Michael, AJ (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	tony.michael@bbsrc.ac.uk	Lee, Jeongmi/AAJ-7720-2020	Lee, Jeongmi/0000-0002-9948-7554	National Institutes of Health [R01 AI34432, RO1 AI55058]; Biotechnology and Biological Sciences Research Council, United Kingdom; Institute Development Fellowship [BB/E024467/1]; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI055058, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Development Fellowship; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI34432 ( to M. A. P.) and RO1 AI55058 ( to A. C.). This work was also supported by Biotechnology and Biological Sciences Research Council, United Kingdom, Institute Development Fellowship BB/E024467/1 ( to A. J. M.) and Welch Foundation Grant I-1257 ( to M. A. P.)	ANTON DL, 1987, J BIOL CHEM, V262, P2817; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; BARTIG D, 1992, EUR J BIOCHEM, V204, P751, DOI 10.1111/j.1432-1033.1992.tb16690.x; Brickman TJ, 1996, J BACTERIOL, V178, P54, DOI 10.1128/jb.178.1.54-60.1996; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; HIGASHI K, 2008, J BIOL CHEM; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ikai H, 1997, J BACTERIOL, V179, P5118, DOI 10.1128/jb.179.16.5118-5125.1997; IKAI H, 1994, FEMS MICROBIOL LETT, V124, P225, DOI 10.1111/j.1574-6968.1994.tb07288.x; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kim AD, 2000, J BACTERIOL, V182, P6667, DOI 10.1128/JB.182.23.6667-6672.2000; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; NAKAO H, 1991, J GEN MICROBIOL, V137, P1737, DOI 10.1099/00221287-137-7-1737; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; Oves-Costales D, 2008, CHEM COMMUN, P4034, DOI 10.1039/b809353a; PARK MH, 1984, J BIOL CHEM, V259, P2123; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; SRIVENUGOPAL KS, 1980, FEBS LETT, V112, P260, DOI 10.1016/0014-5793(80)80193-1; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1986, P NATL ACAD SCI USA, V83, P6040, DOI 10.1073/pnas.83.16.6040; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Vandenende CS, 2004, J BACTERIOL, V186, P5596, DOI 10.1128/JB.186.17.5596-5602.2004; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021	43	128	133	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9899	9907		10.1074/jbc.M900110200	http://dx.doi.org/10.1074/jbc.M900110200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19196710	Green Published, hybrid			2022-12-27	WOS:000264892900032
J	Waschbusch, D; Born, S; Niediek, V; Kirchgessner, N; Tamboli, IY; Walter, J; Merkel, R; Hoffmann, B				Waschbuesch, Dieter; Born, Simone; Niediek, Verena; Kirchgessner, Norbert; Tamboli, Irfan Y.; Walter, Jochen; Merkel, Rudolf; Hoffmann, Bernd			Presenilin 1 Affects Focal Adhesion Site Formation and Cell Force Generation via c-Src Transcriptional and Posttranslational Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EPHRIN-B LIGANDS; TYROSINE PHOSPHORYLATION; BETA-CATENIN; INTRAMEMBRANE PROTEOLYSIS; GENE-EXPRESSION; KINASE-ACTIVITY; ENDOCYTOSIS; PAXILLIN; NOTCH	Presenilin 1 and 2 (PS) are critical components of the gamma-secretase complex that cleaves type I transmembrane proteins within their transmembrane domains. This process leads to release of proteolytically processed products from cellular membranes and plays an essential role in signal transduction or vital functions as cell adhesion. Here we studied the function of presenilins in cell-matrix interaction of wild-type and PS knock-out mouse embryonic fibroblasts. We found for PS1(-/-) cells an altered morphology with significantly reduced sizes of focal adhesion sites compared with wild type. Cell force analyses on micropatterned elastomer films revealed PS1(-/-) cell forces to be reduced by 50%. Pharmacological inhibition confirmed this function of gamma-secretase in adhesion site and cell force formation. On the regulatory level, PS1 deficiency was associated with strongly decreased phosphotyrosine levels of focal adhesion site-specific proteins. The reduced tyrosine phosphorylation was caused by a down-regulation of c-Src kinase activity primarily at the level of c-Src transcription. The direct regulatory connection between PS1 and c-Src could be identified with ephrinB2 as PS1 target protein. Overexpression of ephrinB2 cytoplasmic domain resulted in its nuclear translocation with increased levels of c-Src and a full complementation of the PS1(-/-) adhesion and phosphorylation phenotype. Cleavage of full-length EB2 and subsequent intracellular domain translocation depended on PS1 as these processes were only found in WT cells. Therefore, we conclude that gamma-secretase is vital for controlling cell adhesion and force formation by transcriptional regulation of c-Src via ephrinB2 cleavage.	[Waschbuesch, Dieter; Born, Simone; Niediek, Verena; Kirchgessner, Norbert; Hoffmann, Bernd] Res Ctr Julich GmbH, Inst Bio & Nanosyst Biomech 4, D-52425 Julich, Germany; [Tamboli, Irfan Y.; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	Helmholtz Association; Research Center Julich; University of Bonn	Merkel, R (corresponding author), Res Ctr Julich, Inst Bio & Nanosyst, IBN 4, D-52425 Julich, Germany.	b.hoffmann@fz-juelich.de	Hoffmann, Bernd/I-7237-2013; Wang, Caihong/T-5837-2019; Merkel, Rudolf/G-3647-2013; Walter, Jochen/B-3677-2014	Wang, Caihong/0000-0002-6808-3709; Merkel, Rudolf/0000-0003-3178-3282; Hoffmann, Bernd/0000-0002-3803-8835; Waschbusch, Dieter/0000-0002-8953-2585; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 645	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 645(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 645. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; BADLEY RA, 1980, J CELL SCI, V43, P379; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Battaglia AA, 2003, NAT NEUROSCI, V6, P339, DOI 10.1038/nn1034; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Cesa CM, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712870; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dehm SM, 2004, BIOCHEM CELL BIOL, V82, P263, DOI 10.1139/o03-077; Dembo M, 1996, BIOPHYS J, V70, P2008, DOI 10.1016/S0006-3495(96)79767-9; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fortini ME, 2001, CURR OPIN CELL BIOL, V13, P627, DOI 10.1016/S0955-0674(00)00261-1; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ingley E., 2007, BIOCHIM BIOPHYS ACTA, V1784, P56; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; Parker M, 2004, BIOCHEM BIOPH RES CO, V323, P17, DOI 10.1016/j.bbrc.2004.07.209; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Prager K, 2007, J BIOL CHEM, V282, P14083, DOI 10.1074/jbc.M608437200; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Singh N, 2001, EXP CELL RES, V263, P1, DOI 10.1006/excr.2000.5098; Slack S, 2008, NEUROSCIENCE, V156, P175, DOI 10.1016/j.neuroscience.2008.07.023; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Volberg T, 2001, J CELL SCI, V114, P2279; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	64	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10138	10149		10.1074/jbc.M806825200	http://dx.doi.org/10.1074/jbc.M806825200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176482	hybrid, Green Published			2022-12-27	WOS:000264892900056
J	Welinder, KG; Jorgensen, M				Welinder, Karen G.; Jorgensen, Malene			Covalent Structures of Potato Tuber Lipases (Patatins) and Implications for Vacuolar Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC TOBACCO; STORAGE PROTEIN; CV KURAS; GLYCOSYLATION; GLYCOPROTEIN; PEROXIDASE; EXPRESSION; STABILITY; GENE	Proteome data of potato (Solanum tuberosum) tuber juice and of purified potato tuber vacuoles indicated that mature patatins may perhaps lack a C-terminal propeptide. We have confirmed this by complete mass spectrometric sequencing of a number of patatin variants as well as their N-linked complex-type glycans from the starch-rich cultivar Kuras. For this cultivar full-length patatin cDNAs have also been sequenced, as the patatin locus is highly polymorphous. It is well known that patatins are located in the vacuoles of potato tubers. Furthermore, the complex glycan structures show that the path is via the Golgi apparatus. However, the vacuolar targeting signal has never been identified for this storage and defense protein, which amounts to 25-40% of tuber protein. We propose that a six-residue C-terminal propeptide, -ANKASY-COO- comprises this signal. The crystallographic structure of a recombinant patatin (Rydel, T. J., Williams, J. M., Krieger, E., Moshiri, F., Stallings, W. C., Brown, S. M., Pershing, J. C., Prucell, J. P., and Alibhai, M. F. (2003) Biochemistry 42, 6696-6708), which included this propeptide thus, for the first time, shows the structure of a putative ligand of the vacuolar sorting receptor and processing enzyme responsible for patatin import.	[Welinder, Karen G.; Jorgensen, Malene] Aalborg Univ, Sect Biotechnol, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark	Aalborg University	Welinder, KG (corresponding author), Aalborg Univ, Sect Biotechnol, Dept Biotechnol Chem & Environm Engn, Sohngaardsholmsvej 49, DK-9000 Aalborg, Denmark.	kgw@bio.aau.dk; mj@bio.aau.dk	Joergensen, Malene/AFS-0738-2022	Welinder, Karen Gjesing/0000-0002-5409-0131; Jorgensen, Malene Moller/0000-0003-1381-3863	Danish Research Council for Technology and Production [274-06-0331]; Danish Research Agency [2052-03-0022]	Danish Research Council for Technology and Production; Danish Research Agency	The work was supported by Grant 274-06-0331 ( to M. J.) from the Danish Research Council for Technology and Production, and Grant 2052-03-0022 from the Danish Research Agency.	Bauw G, 2006, FEBS J, V273, P3569, DOI 10.1111/j.1742-4658.2006.05364.x; Crookshanks M, 2001, FEBS LETT, V506, P123, DOI 10.1016/S0014-5793(01)02888-5; Emmersen Jeppe, 2007, Methods Mol Biol, V367, P77; GANAL MW, 1991, MOL GEN GENET, V225, P501, DOI 10.1007/BF00261693; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Jekel PA, 2003, PHYTOCHEMISTRY, V63, P517, DOI 10.1016/S0031-9422(03)00224-3; Jorgensen M, 2006, J AGR FOOD CHEM, V54, P9389, DOI 10.1021/jf0623945; Kim YS, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-36; Knudsen SK, 2008, BIOCHEM J, V412, P563, DOI 10.1042/BJ20071497; Matthiesen R, 2004, PROTEOMICS, V4, P2583, DOI 10.1002/pmic.200300792; Muntz K, 2007, J EXP BOT, V58, P2391, DOI 10.1093/jxb/erm089; PARK WD, 1983, PLANT PHYSIOL, V71, P156, DOI 10.1104/pp.71.1.156; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pots AM, 1999, J AGR FOOD CHEM, V47, P4587, DOI 10.1021/jf981180n; ROSAHL S, 1987, EMBO J, V6, P1155, DOI 10.1002/j.1460-2075.1987.tb02348.x; ROSAHL S, 1986, MOL GEN GENET, V203, P214, DOI 10.1007/BF00333957; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; SONNEWALD U, 1989, PLANTA, V179, P171, DOI 10.1007/BF00393687; SONNEWALD U, 1989, PLANTA, V178, P176, DOI 10.1007/BF00393192; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; Tams JW, 1998, FEBS LETT, V421, P234, DOI 10.1016/S0014-5793(97)01573-1; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261	26	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9764	9769		10.1074/jbc.M809674200	http://dx.doi.org/10.1074/jbc.M809674200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211558	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000264892900016
J	Halligan, KE; Jourd'heuil, FL; Jourd'heuil, D				Halligan, Katharine E.; Jourd'heuil, Frances L.; Jourd'heuil, David			Cytoglobin Is Expressed in the Vasculature and Regulates Cell Respiration and Proliferation via Nitric Oxide Dioxygenation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; MITOCHONDRIAL RESPIRATION; HUMAN NEUROGLOBIN; CONSUMPTION; ACTIVATION; NO; SENSITIVITY; INHIBITION; MYOGLOBIN; PROTECTS	Disposition of the second messenger nitric oxide (NO) in mammalian tissues occurs through multiple pathways including dioxygenation by erythrocyte hemoglobin and red muscle myoglobin. Metabolism by a putative NO dioxygenase activity in non-striated tissues has also been postulated, but the exact nature of this activity is unknown. In the present study, we tested the hypothesis that cytoglobin, a newly discovered hexacoordinated globin, participates in cell-mediated NO consumption. Stable expression of small hairpin RNA targeting cytoglobin in fibroblasts resulted in decreased NO consumption and intracellular nitrate production. These cells were more sensitive to NO-induced inhibition of cell respiration and proliferation, which could be restored by re-expression of human cytoglobin. We also demonstrated cytoglobin expression in adventitial fibroblasts as well as vascular smooth muscle cells from various species including human and found that cytoglobin was expressed in the adventitia and media of intact rat aorta. These results indicate that cytoglobin contributes to cell-mediated NO dioxygenation and represents an important NO sink in the vascular wall.	[Halligan, Katharine E.; Jourd'heuil, Frances L.; Jourd'heuil, David] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Jourd'heuil, D (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave MC8, Albany, NY 12208 USA.	jourdhd@mail.amc.edu		Jourd'heuil, David/0000-0002-6555-5061	National Institutes of Health [CA-89366]; NATIONAL CANCER INSTITUTE [R01CA089366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-89366 from the NCI ( to D. J.). This work was also supported by Philip Morris USA, Inc. and Philip Morris International ( to D. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bellamy TC, 2002, J BIOL CHEM, V277, P31801, DOI 10.1074/jbc.M205936200; Borutaite V, 2001, AM J PHYSIOL-HEART C, V281, pH2256, DOI 10.1152/ajpheart.2001.281.6.H2256; Bove PF, 2006, FREE RADICAL BIO MED, V41, P515, DOI 10.1016/j.freeradbiomed.2006.05.011; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; CLARKSON RB, 1995, BBA-GEN SUBJECTS, V1243, P496, DOI 10.1016/0304-4165(94)00181-V; Coffey MJ, 2001, P NATL ACAD SCI USA, V98, P8006, DOI 10.1073/pnas.141136098; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; Godecke A, 2003, J BIOL CHEM, V278, P21761, DOI 10.1074/jbc.M302573200; Griffiths C, 2001, J PHYSIOL-LONDON, V536, P855, DOI 10.1111/j.1469-7793.2001.00855.x; Griffiths C, 2002, BIOCHEM J, V362, P459, DOI 10.1042/0264-6021:3620459; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Jourd'heuil D, 2003, J BIOL CHEM, V278, P15720, DOI 10.1074/jbc.M300203200; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Lu Q, 2007, J CELL PHYSIOL, V212, P827, DOI 10.1002/jcp.21079; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; O'Donnell VB, 1999, J BIOL CHEM, V274, P20083, DOI 10.1074/jbc.274.29.20083; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rodriguez-Juarez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033; Schmidt K, 2004, FEBS LETT, V577, P199, DOI 10.1016/j.febslet.2004.10.010; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schmidt M, 2005, NEUROSCI LETT, V374, P207, DOI 10.1016/j.neulet.2004.10.071; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Torres J, 2000, FEBS LETT, V475, P263, DOI 10.1016/S0014-5793(00)01682-3; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; ZHAO XJ, 1995, BIOCHEM BIOPH RES CO, V212, P1054, DOI 10.1006/bbrc.1995.2076	39	83	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8539	8547		10.1074/jbc.M808231200	http://dx.doi.org/10.1074/jbc.M808231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147491	Green Published, hybrid			2022-12-27	WOS:000264397800038
J	Mckee, KK; Capizzi, S; Yurchenco, PD				McKee, Karen K.; Capizzi, Stephanie; Yurchenco, Peter D.			Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; GAMMA-1 CHAIN; GLOBULAR DOMAINS; SCHWANN-CELLS; ALPHA-CHAIN; LG MODULES; AGRIN; DYSTROGLYCAN; SITES; MICE	Laminins that possess three short arms contribute to basement membrane assembly by anchoring to cell surfaces, polymerizing, and binding to nidogen and collagen IV. Although laminins containing the alpha 4 and alpha 5 subunits are expressed in alpha 2-deficient congenital muscular dystrophy, they may be ineffective substitutes because they bind weakly to cell surfaces and/or because they lack the third arm needed for polymerization. We asked whether linker proteins engineered to bind to deficient laminins that provide such missing activities would promote basement membrane assembly in a Schwann cell model. A chimeric fusion protein (alpha LNNd) that adds a short arm terminus to laminin through the nidogen binding locus was generated and compared with the dystrophy-ameliorating protein miniagrin (mAgrin) that binds to the laminin coiled-coil dystroglycan and sulfatides. alpha LNNd was found to mediate laminin binding to collagen IV, to bind to galactosyl sulfatide, and to selectively convert alpha-short arm deletion-mutant laminins Lm Delta alpha LN and Lm Delta alpha LN-L4b into polymerizing laminins. This protein enabled polymerization-deficient laminin but not an adhesion-deficient laminin lacking LG domains (Lm Delta LG) to assemble an extracellular matrix on Schwann cell surfaces. mAgrin, on the other hand, enabled Lm Delta LG to form an extracellular matrix on cell surfaces without increasing accumulation of non-polymerizing laminins. These gain-of-function studies reveal distinct polymerization and anchorage contributions to basement membrane assembly in which the three different LN domains mediate the former, and the LG domains provide primary anchorage with secondary contributions from the alpha LN domain. These findings may be relevant for an understanding of the pathogenesis and treatment of laminin deficiency states.	[McKee, Karen K.; Capizzi, Stephanie; Yurchenco, Peter D.] Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Yurchenco, PD (corresponding author), Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, 675 Hoes Lane, Piscataway, NJ 08854 USA.	yurchenc@umdnj.edu		Yurchenco, Peter/0000-0003-0387-2317	National Institutes of Health [R01-NS38469, R37-DK36425]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK036425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS38469 and R37-DK36425. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2006, HUM MOL GENET, V15, P2690, DOI 10.1093/hmg/ddl201; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; KALB E, 1991, J BIOL CHEM, V266, P19047; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Smirnov SP, 2005, J BIOL CHEM, V280, P41449, DOI 10.1074/jbc.M508939200; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Tsiper MV, 2002, J CELL SCI, V115, P1005; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Willem M, 2002, DEVELOPMENT, V129, P2711; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500; YURCHENCO P, 2009, CURR PHARM IN PRESS; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636	45	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8984	8994		10.1074/jbc.M809719200	http://dx.doi.org/10.1074/jbc.M809719200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19189961	Green Published, hybrid			2022-12-27	WOS:000264397800081
J	Kekatpure, VD; Dannenberg, AJ; Subbaramaiah, K				Kekatpure, Vikram D.; Dannenberg, Andrew J.; Subbaramaiah, Kotha			RETRACTED: HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling (Retracted article. See vol. 295, pg. 297, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							HEAT-SHOCK-PROTEIN; LIGAND-DEPENDENT RECRUITMENT; CARCINOMA CELL-LINES; DIOXIN RECEPTOR; TOBACCO-SMOKE; AH RECEPTOR; CIGARETTE-SMOKE; GENE; TRANSCRIPTION; BINDING	The aryl hydrocarbon receptor (AhR), a ligand-activated member of the basic helix-loop-helix family of transcription factors, binds with high affinity to polycyclic aromatic hydrocarbons (PAH) and the environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin). Most of the biochemical, biological, and toxicological responses caused by exposure to PAHs and polychlorinated dioxins are mediated, at least in part, by the AhR. The AhR is a client protein of Hsp90, a molecular chaperone that can be reversibly acetylated with functional consequences. The main objective of this study was to determine whether modulating Hsp90 acetylation would affect ligand-mediated activation of AhR signaling. Trichostatin A and suberoylanilide hydroxamic acid, two broad spectrum HDAC inhibitors, blocked PAH and dioxin-mediated induction of CYP1A1 and CYP1B1 in cell lines derived from the human aerodigestive tract. Silencing HDAC6 or treatment with tubacin, a pharmacological inhibitor of HDAC6, also suppressed the induction of CYP1A1 and CYP1B1. Inhibiting HDAC6 led to hyperacetylation of Hsp90 and loss of complex formation with AhR, cochaperone p23, and XAP-2. Inactivation or silencing of HDAC6 also led to reduced binding of ligand to the AhR and decreased translocation of the AhR from cytosol to nucleus in response to ligand. Ligand-induced recruitment of the AhR to the CYP1A1 and CYP1B1 promoters was inhibited when HDAC6 was inactivated. Mutation analysis of Hsp90 Lys(294) shows that its acetylation status is a strong determinant of interactions with AhR and p23 in addition to ligand-mediated activation of AhR signaling. Collectively, these results show that HDAC6 activity regulates the acetylation of Hsp90, the ability of Hsp90 to chaperone the AhR, and the expression of AhR-dependent genes. Given the established link between activation of AhR signaling and xenobiotic metabolism.	[Kekatpure, Vikram D.; Dannenberg, Andrew J.; Subbaramaiah, Kotha] Weill Cornell Med Coll, Weill Cornell Canc Ctr, New York, NY 10065 USA; [Kekatpure, Vikram D.; Dannenberg, Andrew J.; Subbaramaiah, Kotha] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Kekatpure, Vikram D.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Kekatpure, Vikram D.] Mem Sloan Kettering Canc Ctr, Head & Neck Serv, New York, NY 10065 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kekatpure, VD (corresponding author), Weill Cornell Med Coll, Dept Med, 525 E 68th St,Rm F-203A, New York, NY 10065 USA.	ksubba@med.cornell.edu			National Institutes of Health [P01 CA106451]; FAMRI; the Center for Cancer Prevention Research; NATIONAL CANCER INSTITUTE [P01CA106451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; the Center for Cancer Prevention Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA106451. This work was also supported by FAMRI and the Center for Cancer Prevention Research.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Chen HS, 1997, ARCH BIOCHEM BIOPHYS, V348, P190, DOI 10.1006/abbi.1997.0398; Cox MB, 2004, CELL STRESS CHAPERON, V9, P4, DOI 10.1379/1466-1268(2004)009<0004:COHSPA>2.0.CO;2; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Dertinger SD, 2001, CARCINOGENESIS, V22, P171, DOI 10.1093/carcin/22.1.171; Du BH, 2005, CANCER RES, V65, P5982, DOI 10.1158/0008-5472.CAN-05-0628; Fiskus W, 2007, CLIN CANCER RES, V13, P4882, DOI 10.1158/1078-0432.CCR-06-3093; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Gumus ZH, 2008, CANCER PREV RES, V1, P100, DOI 10.1158/1940-6207.CAPR-08-0007; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Harrigan JA, 2004, TOXICOL SCI, V77, P307, DOI 10.1093/toxsci/kfh030; Hughes D, 2008, CANCER PREV RES, V1, P485, DOI 10.1158/1940-6207.CAPR-08-0149; HUNT SN, 1976, CLIN PHARMACOL THER, V19, P546; Kang HJ, 2006, J BIOL CHEM, V281, P14654, DOI 10.1074/jbc.M601613200; Kawajiri K, 2007, ARCH BIOCHEM BIOPHYS, V464, P207, DOI 10.1016/j.abb.2007.03.038; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSH KA, 1993, J PATHOL, V170, P441, DOI 10.1002/path.1711700407; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; POLAND A, 1976, J BIOL CHEM, V251, P4936; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; Port JL, 2004, CARCINOGENESIS, V25, P2275, DOI 10.1093/carcin/bgh243; PROBST MR, 1993, MOL PHARMACOL, V44, P511; Puppala D, 2008, MOL PHARMACOL, V73, P1064, DOI 10.1124/mol.107.040840; Ramadoss Preeti, 2005, Expert Opin Drug Metab Toxicol, V1, P9, DOI 10.1517/17425255.1.1.9; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; SACKS PG, 1988, CANCER RES, V48, P2858; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shehin SE, 2000, J BIOL CHEM, V275, P6770, DOI 10.1074/jbc.275.10.6770; Shimada T, 2001, DRUG METAB DISPOS, V29, P1176; Shimada T, 1996, CANCER RES, V56, P2979; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Tanaka H, 1996, INT J CANCER, V65, P372, DOI 10.1002/(SICI)1097-0215(19960126)65:3<372::AID-IJC16>3.3.CO;2-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Volk DE, 2003, BIOCHEMISTRY-US, V42, P1410, DOI 10.1021/bi026745u; WHITELAW M, 1993, MOL CELL BIOL, V13, P2504, DOI 10.1128/MCB.13.4.2504; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; Yu XD, 2002, J NATL CANCER I, V94, P504	50	94	97	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7436	7445		10.1074/jbc.M808999200	http://dx.doi.org/10.1074/jbc.M808999200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158084	Green Published, hybrid			2022-12-27	WOS:000264195600007
J	Thoreen, CC; Kang, SA; Chang, JW; Liu, QS; Zhang, JM; Gao, Y; Reichling, LJ; Sim, TB; Sabatini, DM; Gray, NS				Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.			An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 4E-BINDING PROTEIN-1; CAP-DEPENDENT TRANSLATION; INITIATION-FACTOR 4E; KINASE-ACTIVITY; AMINO-ACIDS; EARLY G1; PHOSPHORYLATION; 4E-BP1; MEDIATE; COMPLEX	The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1 inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.	[Thoreen, Carson C.; Kang, Seong A.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Thoreen, Carson C.; Kang, Seong A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Sim, Taebo; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Gao, Yi; Reichling, Laurie J.] Invitrogen Corp, Madison, WI 53719 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Thermo Fisher Scientific	Sabatini, DM (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Liu, Qingsong/AFS-0714-2022; Chang, Jae Won/AAN-4139-2020; 刘, 青松/AEM-1932-2022	Liu, Qingsong/0000-0002-7829-2547; 刘, 青松/0000-0002-7829-2547; Zhang, Jianming/0000-0001-6326-3906; /0000-0002-1446-7256	National Institutes of Health [R01 AI47389, R01 CA103866]; Dana Farber Cancer Institute; Barr Foundation; Damon Runyon Cancer Research Foundation; Keck Foundation; LAM Foundation; Department of Defense [W81XWH-07-1-0448]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Farber Cancer Institute; Barr Foundation; Damon Runyon Cancer Research Foundation; Keck Foundation(W.M. Keck Foundation); LAM Foundation; Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI47389 and R01 CA103866. This work was also supported by start-up funding from the Dana Farber Cancer Institute, the Barr Foundation, and the Damon Runyon Cancer Research Foundation (to N. S. G.), Keck Foundation, LAM Foundation, and Department of Defense Grant W81XWH-07-1-0448 (to D. M. S.), and a fellowship from the American Cancer Society (to S. A. K.).	ALBERS MW, 1993, J BIOL CHEM, V268, P22825; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pedersen S, 1997, EUR J BIOCHEM, V247, P449, DOI 10.1111/j.1432-1033.1997.00449.x; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005	43	1322	1369	1	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8023	8032		10.1074/jbc.M900301200	http://dx.doi.org/10.1074/jbc.M900301200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150980	Green Published, hybrid			2022-12-27	WOS:000264195600065
J	Hirano, I; Nakamura, S; Yokota, D; Ono, T; Shigeno, K; Fujisawa, S; Shinjo, K; Ohnishi, K				Hirano, Isao; Nakamura, Satoki; Yokota, Daisuke; Ono, Takaaki; Shigeno, Kazuyuki; Fujisawa, Shinya; Shinjo, Kaori; Ohnishi, Kazunori			Depletion of Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatases 1 and 2 by Bcr-Abl Promotes Chronic Myelogenous Leukemia Cell Proliferation through Continuous Phosphorylation of Akt Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; PROSTATE-CANCER; KINASE-C; TRANSFORMATION; PATHWAY; GENE; ACTIVATION; ONCOGENE; BCR/ABL	The constitutive activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway commonly occurs in cancers and is a crucial event in tumorigenesis. Chronic myelogenous leukemia (CML) is characterized by a reciprocal chromosomal translocation (9;22) that generates the Bcr-Abl fusion gene. The PI3K/Akt pathway is activated by Bcr-Abl chimera protein and mediates the leukemogenesis in CML. However, the mechanism by which Bcr-Abl activates the PI3K/Akt pathway is not completely understood. In the present study, we found that pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 (PHLPP1 and PHLPP2) were depleted in CML cells. We investigated the interaction between PHLPPs and Bcr-Abl in CML cell lines and Bcr-Abl(+) progenitor cells from CML patients. The Abl kinase inhibitors and depletion of Bcr- Abl induced the expression of PHLPP1 and PHLPP2, which dephosphorylated Ser-473 on Akt1, -2, and -3, resulting in inhibited proliferation of CML cells. The reduction of PHLPP1 and PHLPP2 expression by short interfering RNA in CML cells weakened the Abl kinase inhibitor-mediated inhibition of proliferation. In colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte; colony-forming unit-granulocyte, macrophage; and burst-forming unit-erythroid, treatment with the Abl kinase inhibitors and depletion of Bcr- Abl induced PHLPP1 and PHLPP2 expression and inhibited colony formation of Bcr-Abl(+) progenitor cells, whereas depletion of PHLPP1 and PHLPP2 weakened the inhibition of colony formation activity by the Abl kinase inhibitors in Bcr-Abl(+) progenitor cells. Thus, Bcr- Abl represses the expression of PHLPP1 and PHLPP2 and continuously activates Akt1, -2, and -3 via phosphorylation on Ser-473, resulting in the proliferation of CML cells.	[Hirano, Isao; Nakamura, Satoki; Yokota, Daisuke; Ono, Takaaki; Shigeno, Kazuyuki; Shinjo, Kaori; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Shizuoka 4313192, Japan; [Hirano, Isao; Yokota, Daisuke; Ono, Takaaki; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Canc, Higashi Ku, Shizuoka 4313192, Japan; [Fujisawa, Shinya] Hamamatsu Med Ctr, Div Hematol, Naka Ku, Shizuoka 4328580, Japan		Nakamura, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, 1-20-1 Handayama, Shizuoka 4313192, Japan.	satonaka@hama-med.ac.jp		Ono, Takaaki/0000-0003-3922-7432	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590987]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research 17590987 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel A, 2003, CANCER RES, V63, P1608; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MARX JL, 1989, SCIENCE, V244, P654, DOI 10.1126/science.2566202; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Patael-Karasik Y, 2000, CANCER GENET CYTOGEN, V121, P26, DOI 10.1016/S0165-4608(00)00224-7; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; RUDKIN GT, 1964, SCIENCE, V144, P1229, DOI 10.1126/science.144.3623.1229; Safford SD, 2003, ANN SURG ONCOL, V10, P136, DOI 10.1245/ASO.2003.03.038; Sattler M, 1996, ONCOGENE, V12, P839; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Torring N, 2007, BRIT J CANCER, V96, P499, DOI 10.1038/sj.bjc.6603476; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	31	22	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22155	22165		10.1074/jbc.M808182200	http://dx.doi.org/10.1074/jbc.M808182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19261608	Green Published, hybrid			2022-12-27	WOS:000268783700040
J	Lingwood, D; Schuck, S; Ferguson, C; Gerl, MJ; Simons, K				Lingwood, Daniel; Schuck, Sebastian; Ferguson, Charles; Gerl, Mathias J.; Simons, Kai			Generation of Cubic Membranes by Controlled Homotypic Interaction of Membrane Proteins in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMEBA CHAOS-CAROLINENSIS; LIPID-CONTAINING SYSTEMS; SELECTIVE AUTOPHAGY; UT-1 CELLS; HII-PHASE; ER; MITOCHONDRIA; ORGANIZATION; CHOLESTEROL; TRAFFICKING	Cell membranes predominantly consist of lamellar lipid bilayers. When studied in vitro, however, many membrane lipids can exhibit non-lamellar morphologies, often with cubic symmetries. An open issue is how lipid polymorphisms influence organelle and cell shape. Here, we used controlled dimerization of artificial membrane proteins in mammalian tissue culture cells to induce an expansion of the endoplasmic reticulum (ER) with cubic symmetry. Although this observation emphasizes ER architectural plasticity, we found that the changed ER membrane became sequestered into large autophagic vacuoles, positive for the autophagy protein LC3. Autophagy may be targeting irregular membrane shapes and/or aggregated protein. We suggest that membrane morphology can be controlled in cells.	[Lingwood, Daniel; Schuck, Sebastian; Ferguson, Charles; Gerl, Mathias J.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schuck, Sebastian] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ferguson, Charles] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Max Planck Society; University of California System; University of California San Francisco; University of Queensland	Simons, K (corresponding author), Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de		Gerl, Mathias/0000-0002-8074-7221; Schuck, Sebastian/0000-0002-6388-0661; Simons, Kai/0000-0002-9231-9996	European Union FP6 PRISM grant; Deutsche Forschungsgemeinschaft [SP1175]	European Union FP6 PRISM grant(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a European Union FP6 PRISM grant and Grant SP1175 from the Deutsche Forschungsgemeinschaft (to K. S.).	Almsherqi ZA, 2005, REDOX REP, V10, P167, DOI 10.1179/135100005X57373; Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; ANDERSON RGW, 1983, J CELL SCI, V63, P1; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; BOULIGAND Y, 1991, GEOMETRY CONDENSED M, P193; BOULIGAND Y, 1990, J PHYSIQUE COLL, V7, P35; BRANDENBURG K, 1992, J STRUCT BIOL, V108, P93, DOI 10.1016/1047-8477(92)90010-8; Bulbarelli A, 2002, J CELL SCI, V115, P1689; CAFFREY M, 1993, LIPIDAT; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; Deng YR, 1999, J STRUCT BIOL, V127, P231, DOI 10.1006/jsbi.1999.4147; Deng YR, 2002, PROTOPLASMA, V219, P160, DOI 10.1007/s007090200017; Deng YR, 1998, PROTOPLASMA, V203, P16, DOI 10.1007/BF01280583; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Dunn WA, 2005, AUTOPHAGY, V1, P75; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; FELDMAN D, 1981, CANCER RES, V41, P2151; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; HUI SW, 1987, COMMENTS MOL CELL BI, V4, P233; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; LANDH T, 1995, FEBS LETT, V369, P13, DOI 10.1016/0014-5793(95)00660-2; LANDH T, 1996, THESIS LUND U LUND S; LARSSON K, 1989, J PHYS CHEM-US, V93, P7304, DOI 10.1021/j100358a010; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LUZZATI V, 1993, J MOL BIOL, V229, P540, DOI 10.1006/jmbi.1993.1053; Luzzati V., 1968, BIOL MEMBR, P71; MARIANI P, 1988, J MOL BIOL, V204, P165, DOI 10.1016/0022-2836(88)90607-9; MARSH D, 1990, HDB LIPID LAYERS; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; PARRISH ML, 1995, MOL BIOL CELL, V6, P1535, DOI 10.1091/mbc.6.11.1535; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; SMITH S, 1994, P NATL ACAD SCI USA, V91, P10124, DOI 10.1073/pnas.91.21.10124; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zacchetti D, 1995, FEBS LETT, V377, P465, DOI 10.1016/0014-5793(95)01396-2; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	63	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12041	12048		10.1074/jbc.M900220200	http://dx.doi.org/10.1074/jbc.M900220200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258319	Green Published, hybrid			2022-12-27	WOS:000265494600036
J	Yamamoto, Y; Mochida, S; Kurooka, T; Sakisaka, T				Yamamoto, Yasunori; Mochida, Sumiko; Kurooka, Takao; Sakisaka, Toshiaki			Reciprocal Intramolecular Interactions of Tomosyn Control Its Inhibitory Activity on SNARE Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL-GIANT-LARVAE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; PROTEIN; EXOCYTOSIS; MECHANISM; POLARITY; SYNTAXIN; DOCKING; SYNAPSE	Neurotransmitter release from presynaptic nerve terminals is regulated by SNARE complex-mediated synaptic vesicle fusion. Tomosyn, a negative regulator of neurotransmitter release, which is composed of N-terminal WD40 repeats, a tail domain, and a C-terminal VAMP-like domain, is known to inhibit SNARE complex formation by sequestering target SNAREs (t-SNAREs) upon interaction of its C-terminal VAMP-like domain with t-SNAREs. However, it remains unclear how the inhibitory activity of tomosyn is regulated. Here we show that the tail domain functions as a regulator of the inhibitory activity of tomosyn through intramolecular interactions. The binding of the tail domain to the C-terminal VAMP-like domain interfered with the interaction of the C-terminal VAMP-like domain with t-SNAREs, and thereby repressed the inhibitory activity of tomosyn on the SNARE complex formation. The repressed inhibitory activity of tomosyn was restored by the binding of the tail domain to the N-terminal WD40 repeats. These results indicate that the probable conformational change of tomosyn mediated by the intramolecular interactions of the tail domain controls its inhibitory activity on the SNARE complex formation, leading to a regulated inhibition of neurotransmitter release.	[Yamamoto, Yasunori; Kurooka, Takao; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	Kobe University; Tokyo Medical University	Sakisaka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp			National Project on Targeted Proteins Research Program; Scientific Research C; Ministry of Education, Culture, Sports, Science, and Technology, Japan	National Project on Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research C(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for the National Project on Targeted Proteins Research Program (to T. S.), for Scientific Research C (to T. S.), for Scientific Research on Priority Areas-Elucidation of neural network function in the brain (to T. S. and S. M.), for Scientific Research B (to S. M.), and for the Global COE Program F11 (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 2007, NAT STRUCT MOL BIOL, V14, P360, DOI 10.1038/nsmb0507-360; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x	27	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12480	12490		10.1074/jbc.M807182200	http://dx.doi.org/10.1074/jbc.M807182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258327	Green Published, hybrid			2022-12-27	WOS:000265494600077
J	de Almagro, MC; Coma, S; Noe, V; Ciudad, CJ				Cristina de Almagro, M.; Coma, Silvia; Noe, Veronique; Ciudad, Carlos J.			Polypurine Hairpins Directed against the Template Strand of DNA Knock Down the Expression of Mammalian Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX FORMATION; OLIGONUCLEOTIDE TARGET SEQUENCES; FORMING OLIGONUCLEOTIDES; TRANSCRIPTION ELONGATION; INTERFERING RNAS; 3RD STRAND; INHIBITION; PROMOTER; PURINE; CELLS	We analyzed whether polypurine hairpins (PPRHs) had the ability to knock down gene expression. These hairpins are formed by two antiparallel purine domains linked by a loop that allows the formation of Hoogsteen bonds between both domains and Watson-Crick bonds with the target polypyrimidine sequence, forming triplex structures. To set up the experimental conditions, the human dhfr gene was used as a model. The PPRHs were designed toward the template strand of DNA. The transfection of the human breast cancer cell line SKBR3 with these template hairpins against the dhfr gene produced higher than 90% of cell mortality. Template PPRHs produced a decrease in DHFR mRNA, protein, and its corresponding enzymatic activity. In addition, the activity of DHFR PPRHs was tested against breast cancer cells resistant to methotrexate, observing high cell mortality. Given the difficulty in finding long polypyrimidine stretches, we studied how to compensate for the presence of purine interruptions in the polypyrimidine target sequence. The stability of PPRH was measured, resulting in a surprisingly long half-life of about 5 days. Finally, to test the generality of usage, template PPRHs were employed against two important genes involved in cell proliferation, telomerase and survivin, producing 80 and 95% of cell death, respectively. Taken together our results show the ability of antiparallel purine hairpins to bind the template strand of double strand DNA and to decrease gene transcription. Thus, PPRHs can be considered as a new type of molecules to modulate gene expression.	[Cristina de Almagro, M.; Coma, Silvia; Noe, Veronique; Ciudad, Carlos J.] Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, E-08028 Barcelona, Spain	University of Barcelona	Ciudad, CJ (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, Av Diagonal 643, E-08028 Barcelona, Spain.	cciudad@ub.edu	Noe, Veronique/K-3615-2014; Ciudad, Carlos J./D-7917-2014	Noe, Veronique/0000-0001-7937-8038; Ciudad, Carlos J./0000-0002-7855-392X	Plan Nacional de Investigacion Cientifica (Spain) [SAF05-0247, SAF08-43]; ISCIII-RETIC [RD06/0020/0046]	Plan Nacional de Investigacion Cientifica (Spain); ISCIII-RETIC(Instituto de Salud Carlos III)	The work was supported by Grants SAF05-0247 and SAF08-43 from "Plan Nacional de Investigacion Cientifica" (Spain) and ISCIII-RETIC RD06/0020/0046. Our research group holds the Quality mention from the "Generalitat de Catalunya."	Avino A, 2003, J AM CHEM SOC, V125, P16127, DOI 10.1021/ja035039t; Avino A, 2002, NUCLEIC ACIDS RES, V30, P2609, DOI 10.1093/nar/gkf374; Avino A, 2001, BIOORG MED CHEM LETT, V11, P1761, DOI 10.1016/S0960-894X(01)00295-5; Brunet E, 2005, NUCLEIC ACIDS RES, V33, P4223, DOI 10.1093/nar/gki726; CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; Casey BP, 2001, PROG NUCLEIC ACID RE, V67, P163, DOI 10.1016/S0079-6603(01)67028-4; Chan PP, 1997, J MOL MED, V75, P267, DOI 10.1007/s001090050112; CHASIN L, 1985, MOL CELL GENETICS, P449; CIUDAD CJ, 1988, J BIOL CHEM, V263, P16274; Coma S, 2005, OLIGONUCLEOTIDES, V15, P269, DOI 10.1089/oli.2005.15.269; Cronstein BN, 1996, ARTHRITIS RHEUM-US, V39, P1951, DOI 10.1002/art.1780391203; Cubero E, 2002, J AM CHEM SOC, V124, P3133, DOI 10.1021/ja011928+; Faria M, 2000, P NATL ACAD SCI USA, V97, P3862, DOI 10.1073/pnas.97.8.3862; Faucon B, 1996, NUCLEIC ACIDS RES, V24, P3181, DOI 10.1093/nar/24.16.3181; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; GIOVANNANGELI C, 1991, J AM CHEM SOC, V113, P7775, DOI 10.1021/ja00020a058; Giovannangeli C, 1997, ANTISENSE NUCLEIC A, V7, P413, DOI 10.1089/oli.1.1997.7.413; Goni JR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-63; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Hewett PW, 2006, MOL MED, V12, P8, DOI 10.2119/2005-00046.Hewett; KANDIMALLA ER, 1995, J AM CHEM SOC, V117, P6416, DOI 10.1021/ja00128a055; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim HG, 1998, BIOCHEMISTRY-US, V37, P2299, DOI 10.1021/bi9718191; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Mills M, 2002, BIOCHEMISTRY-US, V41, P357, DOI 10.1021/bi011122m; Peyman A, 1997, ANTIVIR RES, V33, P135, DOI 10.1016/S0166-3542(96)01003-0; POSTEL EH, 1991, P NATL ACAD SCI USA, V88, P8227, DOI 10.1073/pnas.88.18.8227; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Rodriguez M, 1999, INT J CANCER, V81, P785; Ryan K, 1998, CHEM BIOL, V5, P59, DOI 10.1016/S1074-5521(98)90140-5; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sorensen JJ, 2004, NUCLEIC ACIDS RES, V32, P6078, DOI 10.1093/nar/gkh942; VASQUEZ KM, 1995, BIOCHEMISTRY-US, V34, P7243, DOI 10.1021/bi00021a040; YOUNG SL, 1991, P NATL ACAD SCI USA, V88, P10023, DOI 10.1073/pnas.88.22.10023	35	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11579	11589		10.1074/jbc.M900981200	http://dx.doi.org/10.1074/jbc.M900981200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261618	Green Published, hybrid			2022-12-27	WOS:000265494500062
J	Nayak, A; Glockner-Pagel, J; Vaeth, M; Schumann, JE; Buttmann, M; Bopp, T; Schmitt, E; Serfling, E; Berberich-Siebelt, F				Nayak, Arnab; Gloeckner-Pagel, Judith; Vaeth, Martin; Schumann, Julia E.; Buttmann, Mathias; Bopp, Tobias; Schmitt, Edgar; Serfling, Edgar; Berberich-Siebelt, Friederike			Sumoylation of the Transcription Factor NFATc1 Leads to Its Subnuclear Relocalization and Interleukin-2 Repression by Histone Deacetylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML NUCLEAR-BODIES; EFFECTOR T-CELLS; NF-ATC; ACTIVATION; SUMO; EXPRESSION; DIFFERENTIATION; PROTEINS; BINDING; IL-2	The family of NFAT (nuclear factor of activated T-cells) transcription factors plays an important role in cytokine gene regulation. In peripheral T-cells NFATc1 and -c2 are predominantly expressed. Because of different promoter and poly(A) site usage as well as alternative splicing events, NFATc1 is synthesized in multiple isoforms. The highly inducible NFATc1/A contains a relatively short C terminus, whereas the longer, constitutively expressed isoform NFATc1/C spans an extra C-terminal peptide of 246 amino acids. Interestingly, this NFATc1/C-specific terminus can be highly sumoylated. Upon sumoylation, NFATc1/C, but not the unsumoylated NFATc1/A, translocates to promyelocytic leukemia nuclear bodies. This leads to interaction with histone deacetylases followed by deacetylation of histones, which in turn induces transcriptionally inactive chromatin. As a consequence, expression of the NFATc1 target gene interleukin-2 is suppressed. These findings demonstrate that the modification by SUMO (small ubiquitin-like modifier) converts NFATc1 from an activator to a site-specific transcriptional repressor, revealing a novel regulatory mechanism for NFATc1 function.	[Berberich-Siebelt, Friederike] Univ Wurzburg, Dept Mol Pathol, Inst Pathol, D-97080 Wurzburg, Germany; [Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Bopp, Tobias; Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany	University of Wurzburg; University of Wurzburg; Johannes Gutenberg University of Mainz	Berberich-Siebelt, F (corresponding author), Univ Wurzburg, Dept Mol Pathol, Inst Pathol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	path230@mail.uni-wuerzburg.de	Buttmann, Mathias/R-7301-2019; Serfling, Edgar/X-7212-2019; Buttmann, Mathias/AAD-7488-2021; Bopp, Tobias/A-4328-2018	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685; Bopp, Tobias/0000-0002-3232-8065; Vaeth, Martin/0000-0001-8974-7052	Deutsche Forschungsgemeinschaft [SFB 466/B3, BE 2309/2-1, SPP1365]; Wilhelm-Sander-Foundation; Mildred-Scheel-Foundation for Cancer Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander-Foundation; Mildred-Scheel-Foundation for Cancer Research(Deutsche Krebshilfe)	This work was further by supported by Deutsche Forschungsgemeinschaft Grants SFB 466/B3, BE 2309/2-1, and SPP1365, by the Wilhelm-Sander-Foundation, and the Mildred-Scheel-Foundation for Cancer Research.	Altschmied J, 1997, BIOTECHNIQUES, V23, P436, DOI 10.2144/97233bm19; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Dienz O, 2007, P NATL ACAD SCI USA, V104, P7175, DOI 10.1073/pnas.0610442104; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Gall JG, 2001, FEBS LETT, V498, P164, DOI 10.1016/S0014-5793(01)02461-9; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kuss AW, 1999, EUR J IMMUNOL, V29, P3077, DOI 10.1002/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seeler JS, 1999, CURR OPIN GENET DEV, V9, P362, DOI 10.1016/S0959-437X(99)80054-9; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	41	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10935	10946		10.1074/jbc.M900465200	http://dx.doi.org/10.1074/jbc.M900465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218564	Green Published, hybrid			2022-12-27	WOS:000265104600066
J	Zarelli, VEP; Ruete, MC; Roggero, CM; Mayorga, LS; Tomes, CN				Zarelli, Valeria E. P.; Ruete, Maria C.; Roggero, Carlos M.; Mayorga, Luis S.; Tomes, Claudia N.			PTP1B Dephosphorylates N-Ethylmaleimide-sensitive Factor and Elicits SNARE Complex Disassembly during Human Sperm Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ACROSOMAL EXOCYTOSIS; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; HUMAN SPERMATOZOA; S-NITROSYLATION; PHOSPHORYLATION; NEUROTOXINS; RAB3A; SYNAPTOBREVIN	The reversible phosphorylation of tyrosyl residues in proteins is a cornerstone of the signaling pathways that regulate numerous cellular responses. Protein tyrosine phosphorylation is controlled through the concerted actions of protein-tyrosine kinases and phosphatases. The goal of the present study was to unveil the mechanisms by which protein tyrosine dephosphorylation modulates secretion. The acrosome reaction, a specialized type of regulated exocytosis undergone by sperm, is initiated by calcium and carried out by a number of players, including tyrosine kinases and phosphatases, and fusion-related proteins such as Rab3A, alpha-SNAP, N-ethylmaleimide-sensitive factor (NSF), SNAREs, complexin, and synaptotagmin VI. We report here that inducers were unable to elicit the acrosome reaction when permeabilized human sperm were loaded with anti-PTP1B antibodies or with the dominant-negative mutant PTP1B D181A; subsequent introduction of wild type PTP1B or NSF rescued exocytosis. Wild type PTP1B, but not PTP1B D181A, caused cis SNARE complex dissociation during the acrosome reaction through a mechanism involving NSF. Unlike its non-phosphorylated counterpart, recombinant phospho-NSF failed to dissociate SNARE complexes from rat brain membranes. These results strengthen our previous observation that NSF activity is regulated rather than constitutive during sperm exocytosis and indicate that NSF must be dephosphorylated by PTP1B to disassemble SNARE complexes. Interestingly, phospho-NSF served as a substrate for PTP1B in an in vitro assay. Our findings demonstrate that phosphorylation of NSF on tyrosine residues prevents its SNARE complex dissociation activity and establish for the first time a role for PTP1B in the modulation of the membrane fusion machinery.	[Zarelli, Valeria E. P.; Ruete, Maria C.; Roggero, Carlos M.; Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol IHEM CONICET, Lab Biol Celular & Mol, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Tomes, CN (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol IHEM CONICET, Lab Biol Celular & Mol, CC 56, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar	Roggero, Carlos/AAX-4354-2020	Mayorga, Luis S/0000-0002-5995-0671; Ruete, Maria Celeste/0000-0002-8183-5637	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina).	AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Arabaci G, 1999, J AM CHEM SOC, V121, P5085, DOI 10.1021/ja9906756; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; MAYORGA L, 2007, IUBMB LIFE, V59, P1; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; SCHULTE RJ, 1994, J IMMUNOL, V153, P5465; Seligman J, 2004, BIOL REPROD, V71, P1009, DOI 10.1095/biolreprod.104.028035; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOMES C, 2006, MOL MECH EXOCYTOSIS, P117; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Valdez SR, 2007, SYNAPSE, V61, P124, DOI 10.1002/syn.20353; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; YAMASAKI S, 1994, P NATL ACAD SCI USA, V91, P4688, DOI 10.1073/pnas.91.11.4688; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Yunes R, 2002, FEBS LETT, V525, P126, DOI 10.1016/S0014-5793(02)03102-2; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	46	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10491	10503		10.1074/jbc.M807614200	http://dx.doi.org/10.1074/jbc.M807614200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208619	Green Published, hybrid			2022-12-27	WOS:000265104600023
J	Baniulis, D; Yamashita, E; Whitelegge, JP; Zatsman, AI; Hendrich, MP; Hasan, SS; Ryan, CM; Cramer, WA				Baniulis, Danas; Yamashita, Eiki; Whitelegge, Julian P.; Zatsman, Anna I.; Hendrich, Michael P.; Hasan, S. Saif; Ryan, Christopher M.; Cramer, William A.			Structure-Function, Stability, and Chemical Modification of the Cyanobacterial Cytochrome b(6)f Complex from Nostoc sp PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; OXIDOREDUCTASE ACTIVITY; SPINACH-CHLOROPLASTS; ANGSTROM RESOLUTION; ELECTRON-TRANSFER; PHOTOSYSTEM-II; ACETYLATION; ANABAENA; HEME; PHOTOSYNTHESIS	The crystal structure of the cyanobacterial cytochrome b(6)f complex has previously been solved to 3.0-angstrom resolution using the thermophilic Mastigocladus laminosus whose genome has not been sequenced. Several unicellular cyanobacteria, whose genomes have been sequenced and are tractable for mutagenesis, do not yield b(6)f complex in an intact dimeric state with significant electron transport activity. The genome of Nostoc sp. PCC 7120 has been sequenced and is closer phylogenetically to M. laminosus than are unicellular cyanobacteria. The amino acid sequences of the large core subunits and four small peripheral subunits of Nostoc are 88 and 80% identical to those in the M. laminosus b(6)f complex. Purified b6f complex from Nostoc has a stable dimeric structure, eight subunits with masses similar to those of M. laminosus, and comparable electron transport activity. The crystal structure of the native b6f complex, determined to a resolution of 3.0 angstrom (PDB id: 2ZT9), is almost identical to that of M. laminosus. Two unique aspects of the Nostoc complex are: (i) a dominant conformation of heme b(p) that is rotated 180 about the alpha- and gamma-meso carbon axis relative to the orientation in the M. laminosus complex and (ii) acetylation of the Rieske iron-sulfur protein (PetC) at the N terminus, a post-translational modification unprecedented in cyanobacterial membrane and electron transport proteins, and in polypeptides of cytochrome bc complexes from any source. The high spin electronic character of the unique heme c(n) is similar to that previously found in the b(6)f complex from other sources.	[Baniulis, Danas; Hasan, S. Saif; Cramer, William A.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Yamashita, Eiki] Osaka Univ, Inst Prot Res, Osaka 5600043, Japan; [Zatsman, Anna I.; Hendrich, Michael P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Whitelegge, Julian P.; Ryan, Christopher M.] Univ Calif Los Angeles, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Osaka University; Carnegie Mellon University; University of California System; University of California Los Angeles	Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	waclab@purdue.edu	Baniulis, Danas/AAA-9458-2021; Hasan, Syed Saif/A-3400-2015; Yamashita, Eiki/V-6758-2019	Baniulis, Danas/0000-0002-2693-2020; Hasan, Syed Saif/0000-0002-0759-7511; Yamashita, Eiki/0000-0002-4278-0039	National Institutes of Health Grants [GM-38323, GM-077387]; NIH/NCRR [R21RR021913-01A2]; U. S. DOE [W31-109-ENG-389]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR021913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077387, R01GM038323, R56GM038323] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U. S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-38323 ( to W. A. C.) and GM-077387 ( to M. P. H.) and by NIH/NCRR Grant R21RR021913-01A2 ( to J.P.W.). The x-ray structure analysis was carried out at the Advanced Photon Source, Argonne National Laboratory was supported by U. S. DOE Grant W31-109-ENG-389.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barak R, 2004, J MOL BIOL, V342, P383, DOI 10.1016/j.jmb.2004.07.020; Baymann F, 2007, P NATL ACAD SCI USA, V104, P519, DOI 10.1073/pnas.0606369104; Boronowsky U, 2001, BBA-BIOENERGETICS, V1506, P55, DOI 10.1016/S0005-2728(01)00184-0; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cramer W, 2008, PHOTOSYNTHETIC PROTE, P155, DOI [10.1002/9783527623464.ch7, DOI 10.1002/9783527623464.CH7]; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; ELLEFSON WL, 1980, METHOD ENZYMOL, V69, P223; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Gomez SM, 2003, MOL CELL PROTEOMICS, V2, P1068, DOI 10.1074/mcp.M300062-MCP200; Hurley JK, 2002, BBA-BIOENERGETICS, V1554, P5, DOI 10.1016/S0005-2728(02)00188-3; HURT E, 1981, EUR J BIOCHEM, V117, P591; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KRINNER M, 1982, BIOCHIM BIOPHYS ACTA, V681, P110, DOI 10.1016/0005-2728(82)90284-5; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Mackay DT, 2007, MOL MICROBIOL, V64, P1540, DOI 10.1111/j.1365-2958.2007.05752.x; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Metzger SU, 1997, BBA-BIOENERGETICS, V1319, P233, DOI 10.1016/S0005-2728(96)00164-8; MICHEL H, 1988, J BIOL CHEM, V263, P1123; MICHEL H, 1991, J BIOL CHEM, V266, P17584; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson ME, 2005, J BIOL CHEM, V280, P10395, DOI 10.1074/jbc.M410948200; PECK HD, 1965, BIOCHIM BIOPHYS ACTA, V96, P429, DOI 10.1016/0005-2787(65)90561-7; Pesaresi P, 2003, PLANT CELL, V15, P1817, DOI 10.1105/tpc.012377; Porra RJ., 1991, CHLOROPHYLLS, P31; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schneider D, 2002, J BIOL CHEM, V277, P10949, DOI 10.1074/jbc.M104076200; Schneider D, 2007, RES MICROBIOL, V158, P45, DOI 10.1016/j.resmic.2006.10.002; Shalev-Malul G, 2008, ENVIRON MICROBIOL, V10, P988, DOI 10.1111/j.1462-2920.2007.01519.x; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; TAKEMURA R, 1992, J CELL SCI, V103, P953; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMITANI A, 2006, FRONT RES EARTH EVOL, V2, P1; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; WALKER FA, 1988, J AM CHEM SOC, V110, P6234, DOI 10.1021/ja00226a045; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Yan JS, 2003, J BIOL CHEM, V278, P20925, DOI 10.1074/jbc.M212616200; Zatsman AI, 2006, J AM CHEM SOC, V128, P14246, DOI 10.1021/ja065798m; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang Huamin, 2005, Journal of Structural and Functional Genomics, V6, P219, DOI 10.1007/s10969-005-1912-y; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	56	79	81	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9861	9869		10.1074/jbc.M809196200	http://dx.doi.org/10.1074/jbc.M809196200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19189962	hybrid, Green Published			2022-12-27	WOS:000264892900027
J	Doern, A; Cao, XJ; Sereno, A; Reyes, CL; Altshuler, A; Huang, F; Hession, C; Flavier, A; Favis, M; Tran, H; Ailor, E; Levesque, M; Murphy, T; Berquist, L; Tamraz, S; Snipas, T; Garber, E; Shestowsky, WS; Rennard, R; Graff, CP; Wu, XF; Snyder, W; Cole, L; Gregson, D; Shields, M; Ho, SN; Reff, ME; Glaser, SM; Dong, JY; Demarest, SJ; Hariharan, K				Doern, Adam; Cao, Xianjun; Sereno, Arlene; Reyes, Christopher L.; Altshuler, Angelina; Huang, Flora; Hession, Cathy; Flavier, Albert; Favis, Michael; Tran, Hon; Ailor, Eric; Levesque, Melissa; Murphy, Tracey; Berquist, Lisa; Tamraz, Susan; Snipas, Tracey; Garber, Ellen; Shestowsky, William S.; Rennard, Rachel; Graff, Christilyn P.; Wu, Xiufeng; Snyder, William; Cole, Lindsay; Gregson, David; Shields, Michael; Ho, Steffan N.; Reff, Mitchell E.; Glaser, Scott M.; Dong, Jianying; Demarest, Stephen J.; Hariharan, Kandasamy			Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties IMPLICATIONS FOR MECHANISM OF ACTION IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE SCANNING MUTAGENESIS; MONOCLONAL-ANTIBODIES; DOWN-REGULATION; IGF-1 RECEPTOR; EWINGS-SARCOMA; SOMATOMEDIN-C; BINDING-SITE; TUMOR-GROWTH; CANCER; PROTEIN	Therapeutic antibodies directed against the type 1 insulin-like growth factor receptor (IGF-1R) have recently gained significant momentum in the clinic because of preliminary data generated in human patients with cancer. These antibodies inhibit ligand-mediated activation of IGF-1R and the resulting downstream signaling cascade. Here we generated a panel of antibodies against IGF-1R and screened them for their ability to block the binding of both IGF-1 and IGF-2 at escalating ligand concentrations (> 1 mu M) to investigate allosteric versus competitive blocking mechanisms. Four distinct inhibitory classes were found as follows: 1) allosteric IGF-1 blockers, 2) allosteric IGF-2 blockers, 3) allosteric IGF-1 and IGF-2 blockers, and 4) competitive IGF-1 and IGF-2 blockers. The epitopes of representative antibodies from each of these classes were mapped using a purified IGF-1R library containing 64 mutations. Most of these antibodies bound overlapping surfaces on the cysteine-rich repeat and L2 domains. One class of allosteric IGF-1 and IGF-2 blocker was identified that bound a separate epitope on the outer surface of the FnIII-1 domain. Using various biophysical techniques, we show that the dual IGF blockers inhibit ligand binding using a spectrum of mechanisms ranging from highly allosteric to purely competitive. Binding of IGF-1 or the inhibitory antibodies was associated with conformational changes in IGF-1R, linked to the ordering of dynamic or unstructured regions of the receptor. These results suggest IGF-1R uses disorder/order within its polypeptide sequence to regulate its activity. Interestingly, the activity of representative allosteric and competitive inhibitors on H322M tumor cell growth in vitro was reflective of their individual ligand-blocking properties. Many of the antibodies in the clinic likely adopt one of the inhibitory mechanisms described here, and the outcome of future clinical studies may reveal whether a particular inhibitory mechanism leads to optimal clinical efficacy.	[Doern, Adam; Cao, Xianjun; Sereno, Arlene; Reyes, Christopher L.; Altshuler, Angelina; Huang, Flora; Hession, Cathy; Flavier, Albert; Favis, Michael; Tran, Hon; Ailor, Eric; Levesque, Melissa; Murphy, Tracey; Berquist, Lisa; Tamraz, Susan; Snipas, Tracey; Garber, Ellen; Shestowsky, William S.; Rennard, Rachel; Graff, Christilyn P.; Wu, Xiufeng; Snyder, William; Shields, Michael; Ho, Steffan N.; Reff, Mitchell E.; Glaser, Scott M.; Dong, Jianying; Demarest, Stephen J.; Hariharan, Kandasamy] Biogen Idec, San Diego, CA 92130 USA; [Cole, Lindsay; Gregson, David] Appl Photophys Ltd, Leatherhead KT22 7PB, Surrey, England	Biogen	Demarest, SJ (corresponding author), Biogen Idec, Dept Prot Chem, 5200 Res Pl, San Diego, CA 92122 USA.	stephen.demarest@biogenidec.com	Altshuler, Angelina/I-8023-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105373] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams TE, 2004, GROWTH FACTORS, V22, P89, DOI 10.1080/08977190410001700998; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Burtrum D, 2003, CANCER RES, V63, P8912; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Demarest SJ, 2006, J BIOL CHEM, V281, P30755, DOI 10.1074/jbc.M605190200; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; HARIHARAN K, 2007, Patent No. 20070243194; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hudson P.J., 2001, CURRENT PROTOCOLS IM; JACOBS S, 1986, ENDOCRINOLOGY, V118, P223, DOI 10.1210/endo-118-1-223; JANNSON M, 1997, J BIOL CHEM, V272, P8189; Karnieli E, 1996, J BIOL CHEM, V271, P19304, DOI 10.1074/jbc.271.32.19304; KULL FC, 1983, J BIOL CHEM, V258, P6561; KULL FC, 1982, BIOCHEM BIOPH RES CO, V106, P1019, DOI 10.1016/0006-291X(82)91813-7; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Leavey PJ, 2008, EXPERT REV ANTICANC, V8, P617, DOI 10.1586/14737140.8.4.617; Main ERG, 2005, CURR OPIN STRUC BIOL, V15, P464, DOI 10.1016/j.sbi.2005.07.003; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McKern NM, 1997, PROTEIN SCI, V6, P2663; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; ROTH RA, 1983, ENDOCRINOLOGY, V112, P1865, DOI 10.1210/endo-112-5-1865; ROTH RA, 1982, P NATL ACAD SCI-BIOL, V79, P7312, DOI 10.1073/pnas.79.23.7312; Shang YL, 2008, MOL CANCER THER, V7, P2599, DOI 10.1158/1535-7163.MCT-07-2401; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; Zhan SL, 1995, ONCOGENE, V11, P2503	42	21	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10254	10267		10.1074/jbc.M809709200	http://dx.doi.org/10.1074/jbc.M809709200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211557	Green Published, hybrid			2022-12-27	WOS:000264892900067
J	Unno, H; Yamashita, S; Ikeda, Y; Sekiguchi, S; Yoshida, N; Yoshimura, T; Kusunoki, M; Nakayama, T; Nishino, T; Hemmi, H				Unno, Hideaki; Yamashita, Satoshi; Ikeda, Yosuke; Sekiguchi, Shin-ya; Yoshida, Norie; Yoshimura, Tohru; Kusunoki, Masami; Nakayama, Toru; Nishino, Tokuzo; Hemmi, Hisashi			New Role of Flavin as a General Acid-Base Catalyst with No Redox Function in Type 2 Isopentenyl-diphosphate Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; THERMUS-THERMOPHILUS; MECHANISM; COFACTOR; PYROPHOSPHATE; BIOSYNTHESIS; INACTIVATION; FLAVOENZYMES; VERSATILITY	Using FMN and a reducing agent such as NAD(P) H, type 2 isopentenyl-diphosphate isomerase catalyzes isomerization between isopentenyl diphosphate and dimethylallyl diphosphate, both of which are elemental units for the biosynthesis of highly diverse isoprenoid compounds. Although the flavin cofactor is expected to be integrally involved in catalysis, its exact role remains controversial. Here we report the crystal structures of the substrate-free and complex forms of type 2 isopentenyl-diphosphate isomerase from the thermoacidophilic archaeon Sulfolobus shibatae, not only in the oxidized state but also in the reduced state. Based on the active-site structures of the reduced FMN-substrate-enzyme ternary complexes, which are in the active state, and on the data from site-directed mutagenesis at highly conserved charged or polar amino acid residues around the active site, we demonstrate that only reduced FMN, not amino acid residues, can catalyze proton addition/elimination required for the isomerase reaction. This discovery is the first evidence for this long suspected, but previously unobserved, role of flavins just as a general acid-base catalyst without playing any redox roles, and thereby expands the known functions of these versatile coenzymes.	[Sekiguchi, Shin-ya; Yoshida, Norie; Yoshimura, Tohru; Hemmi, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Unno, Hideaki] Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528521, Japan; [Yamashita, Satoshi; Ikeda, Yosuke; Nakayama, Toru; Nishino, Tokuzo] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Kusunoki, Masami] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan	Nagoya University; Nagasaki University; Tohoku University; Osaka University	Hemmi, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hhemmi@agr.nagoya-u.ac.jp	Hideaki, UNNO/ABG-9471-2020; Hemmi, Hisashi/I-6868-2014	Hideaki, UNNO/0000-0001-5917-269X; Hemmi, Hisashi/0000-0002-9538-809X	Ministry of Education, Culture, Sports, Science and Technology of Japan [15370049, 18780053]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part Ministry of Education, Culture, Sports, Science and Technology of Japan by Grants-in-aid for Scientific Research 15370049 (to T. N.) and 18780053 (to H. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barkley SJ, 2004, ORG LETT, V6, P5019, DOI 10.1021/ol0477273; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Christianson DW, 2007, SCIENCE, V316, P60, DOI 10.1126/science.1141630; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; de Ruyck J, 2005, BIOCHEM BIOPH RES CO, V338, P1515, DOI 10.1016/j.bbrc.2005.10.114; de Ruyck J, 2008, BIOCHEMISTRY-US, V47, P9051, DOI 10.1021/bi801159x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hemmi H, 2004, BIOCHEM BIOPH RES CO, V322, P905, DOI 10.1016/j.bbrc.2004.08.013; Hoshino T, 2006, BIOORGAN MED CHEM, V14, P6555, DOI 10.1016/j.bmc.2006.06.011; Johnston JB, 2007, J AM CHEM SOC, V129, P7740, DOI 10.1021/ja072501r; Kaneda K, 2001, P NATL ACAD SCI USA, V98, P932, DOI 10.1073/pnas.020472198; Kao CL, 2005, ORG LETT, V7, P5677, DOI 10.1021/ol0524050; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Laupitz R, 2004, CHEM BIODIVERS, V1, P1367, DOI 10.1002/cbdv.200490099; Lennon BW, 1999, PROTEIN SCI, V8, P2366; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; Macheroux Peter, 2005, BMC Biochem, V6, P26, DOI 10.1186/1471-2091-6-26; Maclean J, 2003, STRUCTURE, V11, P1499, DOI 10.1016/j.str.2003.11.005; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Miller SM, 2004, NAT STRUCT MOL BIOL, V11, P497, DOI 10.1038/nsmb0604-497; Miura R, 2001, CHEM REC, V1, P183, DOI 10.1002/tcr.1007; MUEHLBACHER M, 1988, BIOCHEMISTRY-US, V27, P7315, DOI 10.1021/bi00419a021; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RamosValdivia AC, 1997, NAT PROD REP, V14, P591, DOI 10.1039/np9971400591; REARDON JE, 1986, BIOCHEMISTRY-US, V25, P5609, DOI 10.1021/bi00367a040; Rothman SC, 2008, J AM CHEM SOC, V130, P4906, DOI 10.1021/ja7108954; Rothman SC, 2007, BIOCHEMISTRY-US, V46, P5437, DOI 10.1021/bi0616347; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; Steinbacher S, 2003, J MOL BIOL, V329, P973, DOI 10.1016/S0022-2836(03)00527-8; Thibodeaux CJ, 2008, BIOCHEMISTRY-US, V47, P2547, DOI 10.1021/bi701467g; Yamashita S, 2004, EUR J BIOCHEM, V271, P1087, DOI 10.1111/j.1432-1033.2004.04010.x; Zheng W, 2007, J MOL BIOL, V366, P1447, DOI 10.1016/j.jmb.2006.12.055	39	38	40	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9160	9167		10.1074/jbc.M808438200	http://dx.doi.org/10.1074/jbc.M808438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158086	Green Published, hybrid			2022-12-27	WOS:000264669100021
J	Zhu, DH; Wu, J; Spee, C; Ryan, SJ; Hinton, DR				Zhu, DanHong; Wu, Jian; Spee, Christine; Ryan, Stephen J.; Hinton, David R.			BMP4 Mediates Oxidative Stress-induced Retinal Pigment Epithelial Cell Senescence and Is Overexpressed in Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN FIBROBLASTS; PROTEIN-KINASE PATHWAY; MAP KINASE; IN-VITRO; SIGNALING PATHWAYS; ARPE-19 CELLS; GROWTH ARREST; UV-RADIATION; EXPRESSION; P53	The retinal pigment epithelium is a primary site of pathology in age-related macular degeneration. Oxidative stress and senescence are both thought to be important mediators of macular degeneration pathogenesis. We demonstrate here that bone morphogenetic protein-4 is highly expressed in the retinal pigment epithelium and adjacent extracellular matrix of patients with dry age-related macular degeneration. In vitro studies revealed that sublethal oxidative stress increased bone morphogenetic protein-4 expression in retinal pigment epithelial cells, and both bone morphogenetic protein-4 and persistent mild oxidative stress can induce retinal pigment epithelial cell senescence through p53-p21(Cip1/WAF1)-Rb pathway. We further demonstrate that bone morphogenetic protein-4 acts as a mediator in oxidative stress-induced senescence and that this mediator function is via Smad and the p38 signaling pathway to increase and activate p53 and p21(Cip1/WAF1) and decrease phospho-Rb. Oxidative stress-induced senescence can be blocked by Chordin-like, an antagonist of bone morphogenetic protein-4, or SB203580, a phospho-p38 inhibitor. Our results suggest that oxidative stress and bone morphogenetic protein-4 may interact to promote retinal pigment epithelial cell senescence and that bone morphogenetic protein-4 may represent a novel therapeutic target to inhibit the progressive effects of oxidative stress and senescence in dry age-related macular degeneration.	[Zhu, DanHong; Wu, Jian; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Zhu, DanHong; Spee, Christine; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Zhu, DanHong; Spee, Christine; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Ryan, Stephen J.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Doheny Eye Institute; University of Southern California; University of Southern California	Hinton, DR (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 2011 Zonal Ave,HMR209, Los Angeles, CA 90033 USA.	dhinton@usc.edu			National Institutes of Health [EY01545]; Core [EY03040]; NATIONAL EYE INSTITUTE [R01EY001545, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core(Luxembourg National Research Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part by National Institutes of Health Grants EY01545 (to S. J. R.) and Core grant EY03040.	Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Barnouin K, 2002, J BIOL CHEM, V277, P13761, DOI 10.1074/jbc.M111123200; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chretien A, 2008, FREE RADICAL BIO MED, V44, P1732, DOI 10.1016/j.freeradbiomed.2008.01.026; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; EL DW, 1993, CELL, V75, P817; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Glotin AL, 2008, FREE RADICAL BIO MED, V44, P1348, DOI 10.1016/j.freeradbiomed.2007.12.023; Goswami M, 2001, DEV BIOL, V236, P259, DOI 10.1006/dbio.2001.0338; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Honda S, 2001, INVEST OPHTH VIS SCI, V42, P2419; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kendall SE, 2005, MOL CELL BIOL, V25, P7711, DOI 10.1128/MCB.25.17.7711-7724.2005; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Klein ML, 2008, OPHTHALMOLOGY, V115, P1026, DOI 10.1016/j.ophtha.2007.08.030; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Matsunaga H, 1999, INVEST OPHTH VIS SCI, V40, P197; Mishima K, 1999, INVEST OPHTH VIS SCI, V40, P1590; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Nagata Y, 2007, MACROMOLECULES, V40, P6, DOI 10.1021/ma062007s; Nakayama N, 2001, DEV BIOL, V232, P372, DOI 10.1006/dbio.2001.0200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; SCHATZ H, 1975, International Ophthalmology Clinics, V15, P169, DOI 10.1097/00004397-197501510-00014; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Seomun Y, 2005, MOL VIS, V11, P764; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Smith RT, 2006, INVEST OPHTH VIS SCI, V47, P5495, DOI 10.1167/iovs.05-1318; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Wachi H, 2005, CLIN BIOCHEM, V38, P643, DOI 10.1016/j.clinbiochem.2005.04.006; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; WHEATLEY HM, 1995, ARCH OPHTHALMOL-CHIC, V113, P103, DOI 10.1001/archopht.1995.01100010105028; Yu JD, 2004, J BIOL CHEM, V279, P42211, DOI 10.1074/jbc.M408223200; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	70	67	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9529	9539		10.1074/jbc.M809393200	http://dx.doi.org/10.1074/jbc.M809393200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19158083	Green Published, hybrid			2022-12-27	WOS:000264669100059
J	Natalizio, BJ; Robson-Dixon, ND; Garcia-Blanco, MA				Natalizio, Barbara J.; Robson-Dixon, Nicole D.; Garcia-Blanco, Mariano A.			The Carboxyl-terminal Domain of RNA Polymerase II Is Not Sufficient to Enhance the Efficiency of Pre-mRNA Capping or Splicing in the Context of a Different Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROCESSING FACTORS; EXON DEFINITION; RPB7 SUBUNIT; TRANSCRIPTION; PHOSPHORYLATION; RECRUITMENT; ENZYME; CTD; ELONGATION	Eukaryotic messenger RNA precursors (pre-mRNAs) synthesized by RNA polymerase II (RNAP II) are processed co-transcriptionally. The carboxyl-terminal domain (CTD) of the largest subunit of RNA polymerase II is thought to mediate the coupling of transcription with pre-mRNA processing by coordinating the recruitment of processing factors during synthesis of nascent transcripts. Previous studies have demonstrated that the phosphorylated CTD is required for efficient co-transcriptional processing. In the study presented here we investigated whether the CTD is sufficient to coordinate transcription with pre-mRNA capping and splicing in the context of two other DNA-dependent RNA polymerases, mammalian RNAP III and bacteriophage T7 RNAP. Our results indicate that the CTD fused to the largest subunit of RNAP III (POLR3A) is not sufficient to enhance co-transcriptional pre-mRNA splicing or capping in vivo. Additionally, we analyzed a T7 RNAP-CTD fusion protein and examined its ability to enhance pre-mRNA splicing and capping of both constitutively and alternatively spliced substrates. We observed that the CTD in the context of T7 RNAP was not sufficient to enhance pre-mRNA splicing or capping either in vitro or in vivo. We propose that the efficient coupling of transcription to pre-mRNA processing requires not only the phosphorylated CTD but also other RNAP II specific subunits or associated factors.	[Natalizio, Barbara J.; Robson-Dixon, Nicole D.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Natalizio, Barbara J.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Garcia-Blanco, MA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Box 3053 424 CARL, Durham, NC 27710 USA.	garci001@mc.duke.edu			National Institutes of Health [R01 GM071037]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM071037 (to M. A. G.-B). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; Borodulina OR, 2008, RNA, V14, P1865, DOI 10.1261/rna.1006608; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; EDERY I, 1995, MOL CELL BIOL, V15, P3363; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Ghosh S, 2000, RNA, V6, P1325, DOI 10.1017/S1355838200992537; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Hirose Y, 2000, GENE DEV, V14, P1415; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; McCracken S, 1998, COLD SPRING HARB SYM, V63, P301, DOI 10.1101/sqb.1998.63.301; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Mitsuzawa H, 2003, NUCLEIC ACIDS RES, V31, P4696, DOI 10.1093/nar/gkg688; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; Natalizio BJ, 2005, METHODS, V37, P314, DOI 10.1016/j.ymeth.2005.07.013; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Sepehri S, 1997, GENOME RES, V7, P1006, DOI 10.1101/gr.7.10.1006; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Wagner EJ, 2003, RNA, V9, P1552, DOI 10.1261/rna.5840803; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Zeng CQ, 2000, MOL CELL BIOL, V20, P8290, DOI 10.1128/MCB.20.21.8290-8301.2000	51	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8683	8693		10.1074/jbc.M806919200	http://dx.doi.org/10.1074/jbc.M806919200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176527	Green Published, hybrid			2022-12-27	WOS:000264397800053
J	Stewart, JA; Campbell, JL; Bambara, RA				Stewart, Jason A.; Campbell, Judith L.; Bambara, Robert A.			Significance of the Dissociation of Dna2 by Flap Endonuclease 1 to Okazaki Fragment Processing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; POLYMERASE-DELTA; YEAST DNA2; ENZYMATIC-PROPERTIES; PRIMER REMOVAL; STRANDED DNA; HELICASE/NUCLEASE; HELICASE; CLEAVAGE; METABOLISM	Okazaki fragments are initiated by short RNA/DNA primers, which are displaced into flap intermediates for processing. Flap endonuclease 1 (FEN1) and Dna2 are responsible for flap cleavage. Replication protein A (RPA)-bound flaps inhibit cleavage by FEN1 but stimulate Dna2, requiring that Dna2 cleaves prior to FEN1. Upon cleavage, Dna2 leaves a short flap, which is then cut by FEN1 forming a nick for ligation. Both enzymes require a flap with a free 5'- end for tracking to the cleavage sites. Previously, we demonstrated that FEN1 disengages the tracking mechanism of Dna2 to remove it from the flap. To determine why the disengagement mechanism evolved, we measured FEN1 dissociation of Dna2 on short RNA and DNA flaps, which occur during flap processing. Dna2 tracked onto these flaps but could not cleave, presenting a block to FEN1 entry. However, FEN1 disengaged these nonproductively bound Dna2 molecules, proceeding on to conduct proper cleavage. These results clarify the importance of disengagement. Additional results showed that flap substrate recognition and tracking by FEN1, as occur during fragment processing, are required for effective displacement of the flap-bound Dna2. Dna2 was recently shown to dissociate flap-bound RPA, independent of cleavage. Using a nuclease-defective Dna2 mutant, we reconstituted the sequential dissociation reactions in the proposed RPA/Dna2/FEN1 pathway showing that, even without cutting, Dna2 enables FEN1 to cleave RPA-coated flaps. In summary, RPA, Dna2, and FEN1 have evolved highly coordinated binding properties enabling one protein to succeed the next for proper and efficient Okazaki flap processing.	[Stewart, Jason A.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441, T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 to R. A. B.), with additional support from Grant GM087666 ( to J. L. C.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kunkel TA, 1997, CELL, V88, P155, DOI 10.1016/S0092-8674(00)81832-2; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Subramanian A, 2006, BIOSENS BIOELECTRON, V21, P998, DOI 10.1016/j.bios.2005.03.007; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	40	22	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8283	8291		10.1074/jbc.M809189200	http://dx.doi.org/10.1074/jbc.M809189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179330	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-27	WOS:000264397800012
J	Wang, ZC; Wijewickrama, GT; Peng, KW; Dietz, BM; Yuan, L; van Breemen, RB; Bolton, JL; Thatcher, GRJ				Wang, Zhican; Wijewickrama, Gihani T.; Peng, Kuan-wei; Dietz, Birgit M.; Yuan, Long; van Breemen, Richard B.; Bolton, Judy L.; Thatcher, Gregory R. J.			Estrogen Receptor alpha Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; POSTMENOPAUSAL HORMONE-THERAPY; RANDOMIZED CONTROLLED-TRIAL; TANDEM MASS-SPECTROMETRY; SINGLE-STRAND BREAKS; SCREENING MAMMOGRAPHY; GENE-EXPRESSION; PLUS PROGESTIN; IN-VITRO; CARCINOGENESIS	Exposure to estrogens increases the risk of breast and endometrial cancer. It is proposed that the estrogen receptor ( ER) may contribute to estrogen carcinogenesis by transduction of the hormonal signal and as a "Trojan horse" concentrating genotoxic estrogen metabolites in the nucleus to complex with DNA, enhancing DNA damage. 4-Hydroxyequilenin (4-OHEN), the major catechol metabolite of equine estrogens present in estrogen replacement formulations, autoxidizes to a redox-cycling quinone that has been shown to cause DNA damage. 4-OHEN was found to be an estrogen of nanomolar potency in cell culture using a luciferase reporter assay and, using a chromatin immunoprecipitation assay, was found to activate ER alpha binding to estrogen-responsive genes in MCF-7 cells. DNA damage was measured in cells by comparing ER alpha(+) versus ER alpha(-) cells and 4-OHEN versus menadione, a reactive oxygen species (ROS)-generating, but non-estrogenic, quinone. 4-OHEN selectively induced DNA damage in ER alpha(+) cells, whereas menadione-induced damage was not dependent on cellular ER status. The rate of 4-OHEN-induced DNA damage was significantly enhanced in ER alpha(+) cells, whereas ER status had no effect on the rate of menadione-induced damage. Imaging of ROSinduced by 4-OHEN showed accumulation selective for the nucleus of ER alpha(+) cells within 5 min, whereas in ER alpha(-) or menadione-treated cells, no selectivity was observed. These data support ER alpha acting as a Trojan horse concentrating 4-OHEN in the nucleus to accelerate the rate of ROS generation and thereby amplify DNA damage. The Trojan horse mechanism may be of general importance beyond estrogen genotoxins.	[Wang, Zhican; Wijewickrama, Gihani T.; Peng, Kuan-wei; Dietz, Birgit M.; Yuan, Long; van Breemen, Richard B.; Bolton, Judy L.; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy MC 781, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bolton, JL (corresponding author), 833 S Wood St, Chicago, IL 60612 USA.	judyb@uic.edu; thatcher@uic.edu	Yuan, Long/H-9552-2013; van Breemen, Richard/AAO-2875-2020	Yuan, Long/0000-0003-1863-2308; van Breemen, Richard/0000-0003-2016-0063	National Institutes of Health [CA130037]; NATIONAL CANCER INSTITUTE [R01CA130037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA130037 ( to J. L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; Bolton JL, 2002, TOXICOLOGY, V177, P55, DOI 10.1016/S0300-483X(02)00195-6; Bolton JL, 1998, CHEM RES TOXICOL, V11, P1113, DOI 10.1021/tx9801007; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Burczynski ME, 2000, CANCER RES, V60, P908; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Chang MS, 2007, ENDOCRINOLOGY, V148, P4793, DOI 10.1210/en.2006-1568; Chen YM, 1998, CHEM RES TOXICOL, V11, P1105, DOI 10.1021/tx980083l; Chen YM, 2000, CHEM RES TOXICOL, V13, P342, DOI 10.1021/tx990186j; CHO HS, 1991, MOL ENDOCRINOL, V5, P1323, DOI 10.1210/mend-5-9-1323; Cobleigh MA, 1999, JAMA-J AM MED ASSOC, V281, P1528, DOI 10.1001/jama.281.16.1528; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Collins AR, 1997, MUTAT RES-FUND MOL M, V375, P183, DOI 10.1016/S0027-5107(97)00013-4; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Embrechts J, 2003, J AM SOC MASS SPECTR, V14, P482, DOI 10.1016/S1044-0305(03)00130-2; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Fischer WH, 2001, MUTAGENESIS, V16, P209, DOI 10.1093/mutage/16.3.209; Flototto T, 2001, HORM METAB RES, V33, P451, DOI 10.1055/s-2001-16936; Gaikwad NW, 2008, INT J CANCER, V122, P1949, DOI 10.1002/ijc.23329; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; HAN XL, 1995, CARCINOGENESIS, V16, P2571, DOI 10.1093/carcin/16.10.2571; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hua YS, 2001, J AM SOC MASS SPECTR, V12, P80, DOI 10.1016/S1044-0305(00)00191-4; JEFCOATE CR, 2000, J NATL CANC I MONOGR; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LI JJ, 1995, CANCER RES, V55, P4347; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Liu XM, 2003, CHEM RES TOXICOL, V16, P832, DOI 10.1021/tx030004s; Liu XM, 2002, CHEM RES TOXICOL, V15, P512, DOI 10.1021/tx0101649; LUPULESCU A, 1995, CANCER INVEST, V13, P287, DOI 10.3109/07357909509094464; Mitra K, 2002, J AM CHEM SOC, V124, P1862, DOI 10.1021/ja017344p; Mobley JA, 2004, CARCINOGENESIS, V25, P3, DOI 10.1093/carcin/bgg175; Mueck AO, 2003, CLIMACTERIC, V6, P221, DOI 10.1080/713605415; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; *NIH, 1981, NIH GUID LAB US CHEM; NUTTER LM, 1992, J BIOL CHEM, V267, P2474; Okamoto Y, 2008, CHEM RES TOXICOL, V21, P1120, DOI 10.1021/tx700428m; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Pisha E, 2001, CHEM RES TOXICOL, V14, P82, DOI 10.1021/tx000168y; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rosenberg LU, 2006, CANCER EPIDEM BIOMAR, V15, P2482, DOI 10.1158/1055-9965.EPI-06-0489; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Service RF, 1998, SCIENCE, V279, P1631, DOI 10.1126/science.279.5357.1631; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma U, 2004, BIOORG MED CHEM LETT, V14, P3829, DOI 10.1016/j.bmcl.2004.04.064; Shen L, 1998, CHEM RES TOXICOL, V11, P94, DOI 10.1021/tx970181r; Shen L, 1997, CARCINOGENESIS, V18, P1093, DOI 10.1093/carcin/18.5.1093; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stopper H, 2003, MUTAGENESIS, V18, P243, DOI 10.1093/mutage/18.3.243; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; VOGEL VG, 1993, BREAST CANCER RES TR, V28, P195, DOI 10.1007/BF00666431; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhang F, 2001, CHEM RES TOXICOL, V14, P1654, DOI 10.1021/tx010158c; Zhang FG, 1999, CHEM RES TOXICOL, V12, P204, DOI 10.1021/tx980217v; Zhang QA, 2008, CHEM RES TOXICOL, V21, P1509, DOI 10.1021/tx8001737; Zumoff B, 1998, P SOC EXP BIOL MED, V217, P30	64	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8624	8633		10.1074/jbc.M807860200	http://dx.doi.org/10.1074/jbc.M807860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158089	Green Published, hybrid			2022-12-27	WOS:000264397800047
J	Zaia, KA; Reimer, RJ				Zaia, Kimberly A.; Reimer, Richard J.			Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GLUTAMATE-GLUTAMINE CYCLE; NEUROTRANSMITTER TRANSPORTER; ORPHAN TRANSPORTER; V7-3 SLC6A15; RAT-BRAIN; FAMILY; LOCALIZATION; PROLINE; TRANSMISSION	The SLC6 family of structurally related, Na+-dependent transporter proteins is responsible for presynaptic reuptake of the majority of neurotransmitters. Within this family are a number of orphan transporters, including NTT4/XT1 (SLC6A17), a protein first identified over 15 years ago. NTT4/XT1 is expressed exclusively in the nervous system and specifically on synaptic vesicles in glutamatergic and some GABAergic neurons. Despite extensive efforts by a number of groups, no substrate has been reported for NTT4/XT1. Here we use a combination of molecular manipulations to increase expression of the NTT4/XT1 protein at the plasma membrane and to directly demonstrate that it catalyzes neutral amino acid transport. The substrate profile of the NTT4/XT1-dependent activity is similar to that of the closely related B(0)AT2/SBAT1 (SLC6A15), including a submillimolar apparent affinity for proline and leucine and a low millimolar apparent affinity for glutamine. The transport activity is Na+-dependent and Cl--independent and is inhibited by low pH as is SLC6A15, suggesting redundant roles for these proteins. This characterization of NTT4/XT1 offers important insights into neurotransmitter metabolism as well as the mechanistic differences among the structurally related, but functionally divergent, SLC6 proteins.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Reimer, RJ (corresponding author), P211 MSLS,1201 Welch Rd, Stanford, CA 94305 USA.	rjreimer@stanford.edu			National Institutes of Health [K02 NS045634.]; National Defense Science and Engineering Graduate fellowship; The Dana Foundation Brain and Immuno- Imaging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS045634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; The Dana Foundation Brain and Immuno- Imaging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant K02 NS045634. This work was also supported by a National Defense Science and Engineering Graduate fellowship ( to K. A. Z.) and a grant from The Dana Foundation Brain and Immuno- Imaging ( to R. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement"	Albrecht J, 2007, FRONT BIOSCI-LANDMRK, V12, P332, DOI 10.2741/2067; Aubrey KR, 2000, MOL PHARMACOL, V58, P129, DOI 10.1124/mol.58.1.129; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 2006, NEUROCHEM INT, V48, P559, DOI 10.1016/j.neuint.2005.11.021; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; ELMESTIKAWY S, 1994, J NEUROCHEM, V62, P445; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Garcia-Espinosa MA, 2007, J NEUROCHEM, V100, P1458, DOI 10.1111/j.1471-4159.2006.04332.x; Grossman TR, 2002, FEBS LETT, V527, P125, DOI 10.1016/S0014-5793(02)03194-0; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; LIU QR, 1993, FEBS LETT, V315, P114, DOI 10.1016/0014-5793(93)81145-P; Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; PAPINI E, 1995, J BIOL CHEM, V270, P1332, DOI 10.1074/jbc.270.3.1332; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; POZZAN T, 1984, J CELL BIOL, V99, P628, DOI 10.1083/jcb.99.2.628; Sambrook J., 2001, MOL CLONING LAB MANU; Sur C, 2007, CURR DRUG TARGETS, V8, P643, DOI 10.2174/138945007780618535; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; Thompson GA, 1996, PHARMACOL THERAPEUT, V72, P25, DOI 10.1016/S0163-7258(96)00097-6; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	33	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8439	8448		10.1074/jbc.M806407200	http://dx.doi.org/10.1074/jbc.M806407200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147495	Green Published, hybrid			2022-12-27	WOS:000264397800028
J	Yamasaki, K; Muto, J; Taylor, KR; Cogen, AL; Audish, D; Bertin, J; Grant, EP; Coyle, AJ; Misaghi, A; Hoffman, HM; Gallo, RL				Yamasaki, Kenshi; Muto, Jun; Taylor, Kristen R.; Cogen, Anna L.; Audish, David; Bertin, John; Grant, Ethan P.; Coyle, Anthony J.; Misaghi, Amirhossein; Hoffman, Hal M.; Gallo, Richard L.			NLRP3/Cryopyrin Is Necessary for Interleukin-1 beta (IL-1 beta) Release in Response to Hyaluronan, an Endogenous Trigger of Inflammation in Response to Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; MUCKLE-WELLS-SYNDROME; ANGIOGENIC OLIGOSACCHARIDES; MURINE MACROPHAGES; MOUSE MACROPHAGES; MEDIATED ENDOCYTOSIS; DIAMINOPIMELIC ACID; DEPENDENT MECHANISM; CROHNS-DISEASE; CD44	Inflammation under sterile conditions is a key event in autoimmunity and following trauma. Hyaluronan, a glycosaminoglycan released from the extracellular matrix after injury, acts as an endogenous signal of trauma and can trigger chemokine release in injured tissue. Here, we investigated whether NLRP3/cryopyrin, a component of the inflammasome, participates in the inflammatory response to injury or the cytokine response to hyaluronan. Mice with a targeted deletion in cryopyrin showed a normal increase in Cxcl2 in response to sterile injuries but had decreased inflammation and release of interleukin-1 beta (IL-1 beta). Similarly, the addition of hyaluronan to macrophages derived from cryopyrin-deficient mice increased release of Cxcl2 but did not increase IL-1 beta release. To define the mechanism of hyaluronan-mediated activation of cryopyrin, elements of the hyaluronan recognition process were studied in detail. IL-1 beta release was inhibited in peritoneal macrophages derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or by inhibitors of lysosome function. The requirement for CD44 binding and hyaluronan internalization could be bypassed by intracellular administration of hyaluronan oligosaccharides (10-18-mer) in lipopolysaccharide-primed macrophages. Therefore, the action of CD44 and subsequent hyaluronan catabolism trigger the intracellular cryopyrin -> IL-1 beta pathway. These findings support the hypothesis that hyaluronan works through IL-1 beta and the cryopyrin system to signal sterile inflammation.	[Yamasaki, Kenshi; Muto, Jun; Taylor, Kristen R.; Cogen, Anna L.; Audish, David; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92161 USA; [Yamasaki, Kenshi; Muto, Jun; Taylor, Kristen R.; Cogen, Anna L.; Audish, David; Gallo, Richard L.] Vet Affairs San Diego Hlth Care Syst, San Diego, CA 92161 USA; [Misaghi, Amirhossein; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92161 USA; [Hoffman, Hal M.] Ludwig Inst Canc Res, San Diego, CA 92161 USA; [Bertin, John; Grant, Ethan P.; Coyle, Anthony J.] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Gallo, RL (corresponding author), MC 9111B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	rgallo@ucsd.edu	Grant, Ethan/GQP-2720-2022; Yamasaki, Kenshi/C-8905-2018; Gallo, Richard L/A-8931-2009	Yamasaki, Kenshi/0000-0002-5495-4956; Gallo, Richard L/0000-0002-1401-7861	National Institutes of Health [P01-HL057345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL057345 (to R. L. G.).	AFIFY AM, 1993, ARCH BIOCHEM BIOPHYS, V305, P434, DOI 10.1006/abbi.1993.1443; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; *APPL BIOS, 2001, US B APPL BIOS, V2; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Berg S, 1997, J INTERN MED, V242, P73, DOI 10.1046/j.1365-2796.1997.00177.x; BERG S, 1988, SCAND J CLIN LAB INV, V48, P727, DOI 10.3109/00365518809088752; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horton MR, 1999, J IMMUNOL, V162, P4171; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; HUA Q, 1993, J CELL SCI, V106, P365; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kile RL., 1940, J AM MED ASS, V114, P1067, DOI [10.1001/jama.1940.62810120003010b, DOI 10.1001/JAMA.1940.62810120003010B]; Lago G, 2005, CARBOHYD POLYM, V62, P321, DOI 10.1016/j.carbpol.2005.04.014; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; ONARHEIM H, 1992, CIRC SHOCK, V37, P159; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Vachon E, 2006, BLOOD, V107, P4149, DOI 10.1182/blood-2005-09-3808; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	76	214	221	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12762	12771		10.1074/jbc.M806084200	http://dx.doi.org/10.1074/jbc.M806084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19258328	Green Published, hybrid			2022-12-27	WOS:000265688300021
J	Zhou, XD; Agazie, YM				Zhou, Xiangdong; Agazie, Yehenew M.			Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; GROWTH-FACTOR RECEPTOR; ACUTE MYELOID-LEUKEMIA; BASEMENT-MEMBRANE CULTURES; SUBSTRATE-TRAPPING MUTANT; PDGF-BETA-RECEPTOR; PTPN11 MUTATIONS; NOONAN-SYNDROME; BREAST-CANCER; FOCAL ADHESION	The Src homology phosphotyrosyl phosphatase 2 (SHP2) plays a positive role in HER2-induced signaling and transformation, but its mechanism of action is poorly understood. Given the significance of HER2 in breast cancer, defining a mechanism for SHP2 in the HER2 signaling pathway is of paramount importance. In the current report we show that SHP2 positively modulates the Ras-extracellular signal-regulated kinase 1 and 2 and the phospoinositide-3-kinase-Akt pathways downstream of HER2 by increasing the half-life the activated form of Ras. This is accomplished by dephosphorylating an autophosphorylation site on HER2 that serves as a docking platform for the SH2 domains of the Ras GTPase-activating protein (RasGAP). The net effect is an increase in the intensity and duration of GTP-Ras levels with the overall impact of enhanced HER2 signaling and cell transformation. In conformity to these findings, the HER2 mutant that lacks the SHP2 target site exhibits an enhanced signaling and cell transformation potential. Therefore, SHP2 promotes HER2-induced signaling and transformation at least in part by dephosphorylating a negative regulatory autophosphorylation site. These results suggest that SHP2 might serve as a therapeutic target against breast cancer and other cancers characterized by HER2 overexpression.	[Zhou, Xiangdong; Agazie, Yehenew M.] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Agazie, Yehenew M.] W Virginia Univ, Marry Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Agazie, YM (corresponding author), W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA.	yagazie@hsc.wvu.edu			National Institutes of Health [CA124940]; NATIONAL CANCER INSTITUTE [R01CA124940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124940 (NCI, to Y. M. A.).	Agazie Y, 2002, ONCOGENE, V21, P697, DOI 10.1038/sj.onc.1205115; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Badache A, 2006, J MAMMARY GLAND BIOL, V11, P13, DOI 10.1007/s10911-006-9009-1; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Burks J, 2006, ONCOGENE, V25, P7166, DOI 10.1038/sj.onc.1209728; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; DI FP, 1987, CELL, V51, P1063; FENG GS, 1994, ONCOGENE, V9, P1545; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; GERLACH MS, 1995, J BIOL CHEM, V270, P24635, DOI 10.1074/jbc.270.42.24635; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Manes S, 1999, MOL CELL BIOL, V19, P3125; Merritt R, 2006, BBA-MOL CELL RES, V1763, P45, DOI 10.1016/j.bbamcr.2005.11.013; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; PASLEAU F, 1993, ONCOGENE, V8, P849; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	49	46	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12226	12234		10.1074/jbc.M900020200	http://dx.doi.org/10.1074/jbc.M900020200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261604	Green Published			2022-12-27	WOS:000265494600054
J	Chen, KF; Yeh, PY; Hsu, C; Hsu, CH; Lu, YS; Hsieh, HP; Chen, PJ; Cheng, AL				Chen, Kuen-Feng; Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Hsieh, Hsing-Pang; Chen, Pei-Jer; Cheng, Ann-Lii			Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; PROSTATE-CANCER CELLS; NF-KAPPA-B; RECEPTOR-MEDIATED APOPTOSIS; PROTEASOME INHIBITOR; C-FLIP; MULTIPLE-MYELOMA; DOWN-REGULATION; UP-REGULATION; DEATH	Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies. Recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anti-tumor agent. However, many HCC cells show resistance to TRAIL-induced apoptosis. In this study, we showed that bortezomib, a proteasome inhibitor, overcame TRAIL resistance in HCC cells, including Huh-7, Hep3B, and Sk-Hep1. The combination of bortezomib and TRAIL restored the sensitivity of HCC cells to TRAIL-induced apoptosis. Comparing the molecular change in HCC cells treated with these agents, we found that down-regulation of phospho-Akt (P-Akt) played a key role in mediating TRAIL sensitization of bortezomib. The first evidence was that bortezomib down-regulated P-Akt in a dose-and time-dependent manner in TRAIL-treated HCC cells. Second, LY294002, a PI3K inhibitor, also sensitized resistant HCC cells to TRAIL-induced apoptosis. Third, knocking down Akt1 by small interference RNA also enhanced TRAIL-induced apoptosis in Huh-7 cells. Finally, ectopic expression of mutant Akt (constitutive active) in HCC cells abolished TRAIL sensitization effect of bortezomib. Moreover, okadaic acid, a protein phosphatase 2A (PP2A) inhibitor, reversed down-regulation of P-Akt in bortezomib-treated cells, and PP2A knockdown by small interference RNA also reduced apoptosis induced by the combination of TRAIL and bortezomib, indicating that PP2A may be important in mediating the effect of bortezomib on TRAIL sensitization. Together, bortezomib overcame TRAIL resistance at clinically achievable concentrations in hepatocellular carcinoma cells, and this effect is mediated at least partly via inhibition of the PI3K/Akt pathway.	[Chen, Kuen-Feng; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Chen, Kuen-Feng; Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Chen, Pei-Jer; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Chen, Kuen-Feng; Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Chen, Pei-Jer; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei, Taiwan; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Canc Res, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Cheng, AL (corresponding author), 7 Chung Shan S Rd, Taipei, Taiwan.	alcheng@ntu.edu.tw	Hsieh, Hsing-Pang/B-2649-2010	Hsieh, Hsing-Pang/0000-0002-1332-005X; Chen, Kuen-Feng/0000-0002-4686-7019; Chen, Pei-Jer/0000-0001-8316-3785; Hsu, Chiun/0000-0002-1122-0055; Lu, Yen-Shen/0000-0001-7461-1291; HSU, CHIH-HUNG/0000-0003-0495-973X; Cheng, Ann-Lii/0000-0002-9152-6512	National Taiwan University [NTUH (95-96) A11, NTUH97A07, NTU95R0066-BM-1-02]; National Science Council, Taiwan, Republic of China [NSC95-2314-B-002-072]; Department of Health, Executive Yuan, Republic of China [DOH (94-96) TD-B-111-001]	National Taiwan University(National Taiwan University); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Republic of China	This work was supported by National Taiwan University Grant NTUH (95-96) A11, NTUH97A07; National Science Council, Taiwan, Republic of China, Grant NSC95-2314-B-002-072; National Taiwan University Grant NTU95R0066-BM-1-02; and Department of Health, Executive Yuan, Republic of China, Grant DOH (94-96) TD-B-111-001.	Burns TF, 2001, J BIOL CHEM, V276, P37879; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; Conticello C, 2007, J CLIN ENDOCR METAB, V92, P1938, DOI 10.1210/jc.2006-2157; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Hallett WHD, 2008, J IMMUNOL, V180, P163, DOI 10.4049/jimmunol.180.1.163; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hideshima T, 2001, CANCER RES, V61, P3071; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Koschny R, 2007, CLIN CANCER RES, V13, P3403, DOI 10.1158/1078-0432.CCR-07-0251; Koschny R, 2007, HEPATOLOGY, V45, P649, DOI 10.1002/hep.21555; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Liu FT, 2008, BLOOD, V111, P2797, DOI 10.1182/blood-2007-08-110445; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lu GR, 2008, CANCER BIOL THER, V7, P603, DOI 10.4161/cbt.7.4.5564; Lundqvist A, 2006, CANCER RES, V66, P7317, DOI 10.1158/0008-5472.CAN-06-0680; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Nagy K, 2006, PATHOL ONCOL RES, V12, P133, DOI 10.1007/BF02893359; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Nencioni A, 2005, CLIN CANCER RES, V11, P4259, DOI 10.1158/1078-0432.CCR-04-2496; Nikrad M, 2005, MOL CANCER THER, V4, P443; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Smith MR, 2007, CLIN CANCER RES, V13, p5528S, DOI 10.1158/1078-0432.CCR-07-0982; Strauss SJ, 2007, CANCER RES, V67, P2783, DOI 10.1158/0008-5472.CAN-06-3254; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Thorpe JA, 2008, PROSTATE, V68, P200, DOI 10.1002/pros.20706; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Zhao XX, 2008, LEUKEMIA RES, V32, P275, DOI 10.1016/j.leukres.2007.05.024; Zhu HB, 2005, CANCER BIOL THER, V4, P781, DOI 10.4161/cbt.4.7.1897; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683	48	83	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11121	11133		10.1074/jbc.M806268200	http://dx.doi.org/10.1074/jbc.M806268200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261616	Green Published, hybrid			2022-12-27	WOS:000265494500016
J	Garantziotis, S; Li, ZW; Potts, EN; Kimata, K; Zhuo, LS; Morgan, DL; Savani, RC; Noble, PW; Foster, WM; Schwartz, DA; Hollingsworth, JW				Garantziotis, Stavros; Li, Zhuowei; Potts, Erin N.; Kimata, Koji; Zhuo, Lisheng; Morgan, Daniel L.; Savani, Rashmin C.; Noble, Paul W.; Foster, W. Michael; Schwartz, David A.; Hollingsworth, John W.			Hyaluronan Mediates Ozone-induced Airway Hyperresponsiveness in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; LUNG INFLAMMATION; HEAVY-CHAINS; MORTALITY; HEALTH; INJURY; TSG-6; CD44; BRONCHOCONSTRICTION; POLLUTION	Ozone is a common urban environmental air pollutant and significantly contributes to hospitalizations for respiratory illness. The mechanisms, which regulate ozone-induced broncho-constriction, remain poorly understood. Hyaluronan was recently shown to play a central role in the response to noninfectious lung injury. Therefore, we hypothesized that hyaluronan contributes to airway hyperreactivity (AHR) after exposure to ambient ozone. Using an established model of ozone-induced airways disease, we characterized the role of hyaluronan in airway hyperresponsiveness. The role of hyaluronan in response to ozone was determined by using therapeutic blockade, genetically modified animals, and direct challenge to hyaluronan. Ozone-exposed mice demonstrate enhanced AHR associated with elevated hyaluronan levels in the lavage fluid. Mice deficient in either CD44 (the major receptor for hyaluronan) or inter-alpha-trypsin inhibitor (molecule that facilitates hyaluronan binding) show similar elevations in hyaluronan but are protected from ozone-induced AHR. Mice pretreated with hyaluronan-binding peptide are protected from the development of ozone-induced AHR. Overexpression of hyaluronan enhances the airway response to ozone. Intratracheal instillation of endotoxin-free low molecular weight hyaluronan induces AHR dependent on CD44, whereas instillation of high molecular weight hyaluronan protects against ozone-induced AHR. In conclusion, we demonstrate that hyaluronan mediates ozone-induced AHR, which is dependent on the fragment size and both CD44 and inter-alpha-trypsin inhibitor. These data support the conclusion that pulmonary matrix can contribute to the development of airway hyperresponsiveness.	[Garantziotis, Stavros; Morgan, Daniel L.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Li, Zhuowei; Potts, Erin N.; Noble, Paul W.; Foster, W. Michael; Hollingsworth, John W.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA; [Kimata, Koji; Zhuo, Lisheng] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Pulm & Vasc Biol, Dallas, TX 75390 USA; [Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Div Neonatal Perinatal Med, Dallas, TX 75390 USA; [Schwartz, David A.] Natl Jewish Med & Res Ctr, Div Pulm Med, Denver, CO 80206 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Aichi Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Jewish Health	Hollingsworth, JW (corresponding author), DUMC Box 103004, Durham, NC 27710 USA.	holli017@mc.duke.edu	Rashmin C. Savani, MBChB/AAG-2041-2021; Garantziotis, Stavros/A-6903-2009	Rashmin C. Savani, MBChB/0000-0002-9533-5422; Garantziotis, Stavros/0000-0003-4007-375X	National Institutes of Health [ES11961]; NIEHS [ES16126]; NHLBI [HL91335, HL62472, HL73896]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073896, R01HL062472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES011961, ZIAES102605, R01ES016126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES11961 and ES16126 from the NIEHS, Grants HL91335, HL62472, and HL73896 from the NHLBI, and grants from the NIEHS (Intramural Research Program). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Hollingsworth John W, 2007, Proc Am Thorac Soc, V4, P240, DOI 10.1513/pats.200701-023AW; Hollingsworth JW, 2005, AM J RESP CRIT CARE, V171, P806, DOI 10.1164/rccm.200407-953OC; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; HOLLINGSWORTH JW, 2007, AM J RESP CELL MOL B, V120, P121; Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Petrigni G, 2006, PULM PHARMACOL THER, V19, P166, DOI 10.1016/j.pupt.2005.03.002; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; SCHMUT O, 1994, OPHTHALMIC RES, V26, P340, DOI 10.1159/000267499; Scuri M, 2001, AM J RESP CRIT CARE, V164, P1855, DOI 10.1164/ajrccm.164.10.2011115; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; WIESTER MJ, 1988, TOXICOL APPL PHARM, V96, P140, DOI 10.1016/0041-008X(88)90256-6; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	32	95	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11309	11317		10.1074/jbc.M802400200	http://dx.doi.org/10.1074/jbc.M802400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19164299	Green Published, hybrid			2022-12-27	WOS:000265494500035
J	Gobert, RP; van den Eijnden, M; Szyndralewiez, C; Jorand-Lebrun, C; Swinnen, D; Chen, LF; Gillieron, C; Pixley, F; Juillard, P; Gerber, P; Johnson-Leger, C; Halazy, S; Camps, M; Bombrun, A; Shipp, M; Vitte, PA; Ardissone, V; Ferrandi, C; Perrin, D; Rommel, C; van Huijsduijnen, RH				Gobert, Rosanna Pescini; van den Eijnden, Monique; Szyndralewiez, Cedric; Jorand-Lebrun, Catherine; Swinnen, Dominique; Chen, Linfeng; Gillieron, Corine; Pixley, Fiona; Juillard, Pierre; Gerber, Patrick; Johnson-Leger, Caroline; Halazy, Serge; Camps, Montserrat; Bombrun, Agnes; Shipp, Margaret; Vitte, Pierre-Alain; Ardissone, Vittoria; Ferrandi, Chiara; Perrin, Dominique; Rommel, Christian; van Huijsduijnen, Rob Hooft			GLEPP1/Protein-tyrosine Phosphatase phi Inhibitors Block Chemotaxis in Vitro and in Vivo and Improve Murine Ulcerative Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR-TYPE-O; GROWTH-HORMONE RECEPTOR; MOLECULAR-CLONING; IMMUNE-RESPONSE; PTP-OC; EXPRESSION; IDENTIFICATION; SYK; PROMOTER	We describe novel, cell-permeable, and bioavailable salicylic acid derivatives that are potent and selective inhibitors of GLEPP1/protein-tyrosine phosphatase phi. Two previously described GLEPP1 substrates, paxillin and Syk, are both required for cytoskeletal rearrangement and cellular motility of leukocytes in chemotaxis. We show here that GLEPP1 inhibitors prevent dephosphorylation of Syk1 and paxillin in resting cells and block primary human monocyte and mouse bone marrow-derived macrophage chemotaxis in a gradient of monocyte chemotactic protein-1. In mice, the GLEPP1 inhibitors also reduce thioglycolate-induced peritoneal chemotaxis of neutrophils, lymphocytes, and macrophages. In murine disease models, the GLEPP1 inhibitors significantly reduce severity of contact hypersensitivity, a model for allergic dermatitis, and dextran sulfate sodium-induced ulcerative colitis, a model for inflammatory bowel disease. Taken together, our data provide confirmation that GLEPP1 plays an important role in controlling chemotaxis of multiple types of leukocytes and that pharmacological inhibition of this phosphatase may have therapeutic use.	[Gobert, Rosanna Pescini; van den Eijnden, Monique; Szyndralewiez, Cedric; Jorand-Lebrun, Catherine; Swinnen, Dominique; Gillieron, Corine; Juillard, Pierre; Gerber, Patrick; Johnson-Leger, Caroline; Halazy, Serge; Camps, Montserrat; Bombrun, Agnes; Vitte, Pierre-Alain; Perrin, Dominique; Rommel, Christian; van Huijsduijnen, Rob Hooft] Merck Serono Int, CH-1211 Geneva, Switzerland; [Chen, Linfeng; Shipp, Margaret] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pixley, Fiona] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Ardissone, Vittoria; Ferrandi, Chiara] Merck Serono Ist Ric Biomed Antoine Marxer, I-10010 Colleretto Giacosa, TO, Italy	Merck KGaA; EMD Serono Inc.; Harvard University; Dana-Farber Cancer Institute; University of Western Australia; Merck KGaA; EMD Serono Inc.	van Huijsduijnen, RH (corresponding author), Merck Serono Int, 9 Chemin Mines, CH-1211 Geneva, Switzerland.	rob.hooft@merckserono.net	Pixley, Fiona/ABD-5567-2020; van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	Pixley, Fiona/0000-0002-1571-2532; van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Camps, Montserrat/0000-0002-9849-8657	European Union Research Training Network [MRTN-CT-2006-035830]	European Union Research Training Network(European Commission)	Supported by European Union Research Training Network Grant MRTN-CT-2006-035830.	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Amoui M, 2003, J BIOL CHEM, V278, P44273, DOI 10.1074/jbc.M303933200; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; DENOTTER W, 1982, EXP MOL PATHOL, V36, P403; Dolton GM, 2006, BIOCHEM SOC T, V34, P1041, DOI 10.1042/BST0341041; Erbe DV, 2005, MOL PHARMACOL, V67, P69, DOI 10.1124/mol.104.005553; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Garaczi E, 2004, INT IMMUNOL, V16, P1781, DOI 10.1093/intimm/dxh179; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Jinquan T, 2001, J IMMUNOL, V167, P4405, DOI 10.4049/jimmunol.167.8.4405; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Luangdilok S, 2007, CANCER RES, V67, P7907, DOI 10.1158/0008-5472.CAN-07-0331; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mori Y, 2004, CANCER RES, V64, P2434, DOI 10.1158/0008-5472.CAN-03-3508; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Mustelin T, 2003, IMMUNOL REV, V191, P139, DOI 10.1034/j.1600-065X.2003.00014.x; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Pilecka I, 2007, J BIOL CHEM, V282, P35405, DOI 10.1074/jbc.M705814200; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; PIXLEY FJ, 1995, J BIOL CHEM, V270, P27339, DOI 10.1074/jbc.270.45.27339; Pixley FJ, 2001, MOL CELL BIOL, V21, P1795, DOI 10.1128/MCB.21.5.1795-1809.2001; SEIMIYA H, 1993, CELL GROWTH DIFFER, V4, P1033; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Stepanek L, 2005, J NEUROSCI, V25, P3813, DOI 10.1523/JNEUROSCI.4531-04.2005; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suhr SM, 2001, J BONE MINER RES, V16, P1795, DOI 10.1359/jbmr.2001.16.10.1795; THOMAS PE, 1994, J BIOL CHEM, V269, P19953; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van Huijsduijnen RH, 2004, J MED CHEM, V47, P4142, DOI 10.1021/jm030629n; van Huijsduijnen RH, 2002, DRUG DISCOV TODAY, V7, P1013, DOI 10.1016/S1359-6446(02)02438-8; van Huijsduijnen RH, 2006, J MOL MED, V84, P802, DOI 10.1007/s00109-006-0080-2; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; Wu LW, 1996, BIOCHEM J, V316, P515, DOI 10.1042/bj3160515; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001; Yang JH, 2007, ARCH BIOCHEM BIOPHYS, V465, P72, DOI 10.1016/j.abb.2007.04.032; Yang JH, 2007, FEBS LETT, V581, P2503, DOI 10.1016/j.febslet.2007.04.063; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	53	11	12	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11385	11395		10.1074/jbc.M807241200	http://dx.doi.org/10.1074/jbc.M807241200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19233845	Green Published, hybrid			2022-12-27	WOS:000265494500043
J	Ogilvie, RL; SternJohn, JR; Rattenbacher, B; Vlasova, IA; Williams, DA; Hau, HH; Blackshear, PJ; Bohjanen, PR				Ogilvie, Rachel L.; SternJohn, Julius R.; Rattenbacher, Bernd; Vlasova, Irina A.; Williams, Darlisha A.; Hau, Heidi H.; Blackshear, Perry J.; Bohjanen, Paul R.			Tristetraprolin Mediates Interferon-gamma mRNA Decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; GENOME-WIDE ANALYSIS; RICH ELEMENT; HUMAN-MONOCYTES; BINDING PROTEIN; GENE-EXPRESSION; ELAV PROTEIN; STABILITY; PATHWAY; STABILIZATION	Tristetraprolin (TTP) regulates expression at the level of mRNA decay of several cytokines, including the T cell-specific cytokine, interleukin-2. We performed experiments to determine whether another T cell-specific cytokine, interferon-gamma (IFN-gamma), is also regulated by TTP and found that T cell receptoractivatedTcells fromTTPknock-out mice overproduced IFN-gamma mRNA and protein compared with activated T cells from wild-type mice. The half-life of IFN-gamma mRNA was 23 min in anti-CD3-stimulated T cells from wild-type mice, whereas it was 51 min in anti-CD3-stimulated T cells from TTP knock-out mice, suggesting that the overexpression of IFN-gamma mRNA in TTP knock-out mice was due to stabilization of IFN-gamma mRNA. Insertion of a 70-nucleotide AU-rich sequence from the murine IFN-gamma 3'-untranslated region, which contained a high affinity binding site for TTP, into the 3'-untranslated region of a beta-globin reporter transcript conferred TTP-dependent destabilization on the beta-globin transcript. Together these results suggest that TTP binds to a functional AU-rich element in the 3'-untranslated region of IFN-gamma mRNA and mediates rapid degradation of the IFN-gamma transcript. Thus, TTP plays an important role in turning off IFN-gamma expression at the appropriate time during an immune response.	[SternJohn, Julius R.; Rattenbacher, Bernd; Vlasova, Irina A.; Williams, Darlisha A.; Bohjanen, Paul R.] Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Ogilvie, Rachel L.; Vlasova, Irina A.; Hau, Heidi H.; Bohjanen, Paul R.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Ogilvie, Rachel L.; SternJohn, Julius R.; Rattenbacher, Bernd; Vlasova, Irina A.; Williams, Darlisha A.; Hau, Heidi H.; Bohjanen, Paul R.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bohjanen, Paul R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Blackshear, Perry J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bohjanen, PR (corresponding author), Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, 2001 6th St S E,Rm 3-214,Delivery Code 2873, Minneapolis, MN 55455 USA.	bohja001@umn.edu	Louis, Vlasova-St./ABC-1933-2020; Blackshear, Perry J./C-6206-2019; Bohjanen, Paul/B-2329-2015	Blackshear, Perry J./0000-0002-9561-8529; Bohjanen, Paul/0000-0002-2772-3597; Rattenbacher, Bernd/0000-0003-1435-0100; Vlasova-St. Louis, Irina/0000-0003-0795-4723	National Institutes of Health [R56AI057484, R01AI072068, T32AI007313, T32DE007288]; Lymphoma Research Foundation; Swiss National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072068, T32AI007313, R56AI057484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R56AI057484, R01AI072068, T32AI007313, and T32DE007288. This work was also supported by fellowships from the Lymphoma Research Foundation and the Swiss National Science Foundation.	Atasoy U, 1998, J CELL SCI, V111, P3145; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Briscoe J, 1996, TRENDS CELL BIOL, V6, P336, DOI 10.1016/0962-8924(96)10028-3; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; COLTEN HR, 1986, CIBA F SYMP, V118, P141, DOI 10.1002/9780470720998.ch10; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; Spoelstra FM, 1999, EUR RESPIR J, V14, P759, DOI 10.1034/j.1399-3003.1999.14d06.x; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; STRUNK RC, 1985, J BIOL CHEM, V260, P5280; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; VINCENT F, 1993, DNA CELL BIOL, V12, P415, DOI 10.1089/dna.1993.12.415; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	59	92	95	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11216	11223		10.1074/jbc.M901229200	http://dx.doi.org/10.1074/jbc.M901229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258311	hybrid, Green Published			2022-12-27	WOS:000265494500025
J	Bilokapic, S; Ivic, N; Godinic-Mikulcic, V; Piantanida, I; Ban, N; Weygand-Durasevic, I				Bilokapic, Silvija; Ivic, Nives; Godinic-Mikulcic, Vlatka; Piantanida, Ivo; Ban, Nenad; Weygand-Durasevic, Ivana			Idiosyncratic Helix-Turn-Helix Motif in Methanosarcina barkeri Seryl-tRNA Synthetase Has a Critical Architectural Role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; TERNARY COMPLEX; ACTIVE-SITE; YEAST; AMINOACYLATION; TRNA(SER); BINDING	All seryl-tRNA synthetases (SerRSs) are functional homodimers with a C-terminal active site domain typical for class II aminoacyl-tRNA synthetases and an N-terminal domain involved in tRNA binding. The recently solved three-dimensional structure of Methanosarcina barkeri SerRS revealed the idiosyncratic features of methanogenic-type SerRSs; that is, an active site zinc ion, a unique tRNA binding domain, and an insertion of similar to 30 residues in the catalytic domain, which adopt a helix-turn-helix (HTH) fold. Here, we present biochemical evidence for multiple roles of the HTH motif; it is important for dimerization of the enzyme, contributes to the overall stability, and is critical for the proper positioning of the tRNA binding domain relative to the catalytic domain. The changes in intrinsic fluorescence during denaturation of the wild-type M. barkeri SerRS and of the mutated variant lacking the HTH motif combined with cross-linking and gel analysis of protein subunits during various stages of the unfolding process revealed significantly reduced stability of the mutant dimers. In vitro kinetic analysis of enzymes, mutated in one of the N-terminal helices and the HTH motif, shows impaired tRNA binding and aminoacylation and emphasizes the importance of this domain for the overall architecture of the enzyme. The role of the idiosyncratic HTH motif in dimer stabilization and association between the catalytic and tRNA binding domain has been additionally confirmed by a yeast two-hybrid approach. Furthermore, we provide experimental evidence that tRNA binds across the dimer.	[Bilokapic, Silvija; Godinic-Mikulcic, Vlatka; Weygand-Durasevic, Ivana] Univ Zagreb, Dept Chem, Fac Sci, Zagreb 41000, Croatia; [Ivic, Nives] Rudjer Boskovic Inst, Div Phys Chem, HR-10000 Zagreb, Croatia; [Piantanida, Ivo] Rudjer Boskovic Inst, Div Organ Chem & Biochem, HR-10000 Zagreb, Croatia; [Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	University of Zagreb; Rudjer Boskovic Institute; Rudjer Boskovic Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Weygand-Durasevic, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, Zagreb 41000, Croatia.	weygand@chem.pmf.hr	Piantanida, Ivo/J-3868-2012; Piantanida, Ivo/L-9230-2019; Bilokapic, Silvija/H-5108-2018	Piantanida, Ivo/0000-0002-9933-446X; Piantanida, Ivo/0000-0002-9933-446X; Godinic Mikulcic, Vlatka/0000-0003-0319-8035	Ministry of Science, Education, and Sports of the Republic of Croatia [119-0982913-1358]; Swiss National Science Foundation (SNSF); SNSF; Unity through Knowledge Fund [10/07]	Ministry of Science, Education, and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); Unity through Knowledge Fund	This work was supported by grants from the Ministry of Science, Education, and Sports of the Republic of Croatia (Project 119-0982913-1358), the Swiss National Science Foundation (SNSF), and the Scientific Co-operation between the Eastern Europe and Switzerland (SCOPES) program of the SNSF and the Unity through Knowledge Fund (UKF Project 10/07).	Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; Bilokapic S, 2008, FEBS J, V275, P2831, DOI 10.1111/j.1742-4658.2008.06423.x; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; BUECHTER DD, 1995, BIOCHEMISTRY-US, V34, P6014, DOI 10.1021/bi00018a002; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DOCKBREGEON AC, 1990, EUR J BIOCHEM, V188, P283, DOI 10.1111/j.1432-1033.1990.tb15401.x; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; FRUGIER M, 1992, P NATL ACAD SCI USA, V89, P3990, DOI 10.1073/pnas.89.9.3990; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Gruic-Sovulj I, 2006, J MOL BIOL, V361, P128, DOI 10.1016/j.jmb.2006.06.008; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Korencic D, 2004, J BIOL CHEM, V279, P48780, DOI 10.1074/jbc.M408753200; Mandal AK, 1998, PROTEIN SCI, V7, P1046; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; Rees B, 2000, J MOL BIOL, V299, P1157, DOI 10.1006/jmbi.2000.3792; Rocak S, 2002, FEMS MICROBIOL LETT, V214, P101, DOI 10.1111/j.1574-6968.2002.tb11331.x; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; SENGER B, 1995, J MOL BIOL, V249, P45, DOI 10.1006/jmbi.1995.0279; Sherman JM, 1996, BIOCHEMISTRY-US, V35, P601, DOI 10.1021/bi951602b; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; Tang SN, 2005, FEBS LETT, V579, P1441, DOI 10.1016/j.febslet.2005.01.045; Tumbula D, 1999, GENETICS, V152, P1269; Tworowski D, 2005, J MOL BIOL, V350, P866, DOI 10.1016/j.jmb.2005.05.051; Tworowski D, 2003, PROTEIN SCI, V12, P1247, DOI 10.1110/ps.0301203; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; VINCENT C, 1995, NUCLEIC ACIDS RES, V23, P1113, DOI 10.1093/nar/23.7.1113; WEYGANDDURASEVI.I, 2005, AMINOACYL TRNA SYNTH, P177; YAN W, 1994, J BIOL CHEM, V269, P10022; Zhang CM, 2005, BIOCHEMISTRY-US, V44, P7240, DOI 10.1021/bi050285y	37	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10706	10713		10.1074/jbc.M808501200	http://dx.doi.org/10.1074/jbc.M808501200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19228694	Green Published, hybrid			2022-12-27	WOS:000265104600044
J	Redig, AJ; Sassano, A; Majchrzak-Kita, B; Katsoulidis, E; Liu, H; Altman, JK; Fish, EN; Wickrema, A; Platanias, LC				Redig, Amanda J.; Sassano, Antonella; Majchrzak-Kita, Beata; Katsoulidis, Efstratios; Liu, Hui; Altman, Jessica K.; Fish, Eleanor N.; Wickrema, Amittha; Platanias, Leonidas C.			Activation of Protein Kinase C eta by Type I Interferons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MESSENGER-RNA TRANSLATION; HUMAN HEMATOPOIETIC PROGENITORS; IMATINIB MESYLATE STI571; P70 S6 KINASE; PKC-ETA; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; MAMMALIAN TARGET; CELLS RESPOND; ALPHA	Type I interferons (IFNs) are cytokines with diverse biological properties, including antiviral, growth inhibitory, and immunomodulatory effects. Although several signaling pathways are activated during engagement of the type I IFN receptor and participate in the induction of IFN responses, the mechanisms of generation of specific signals for distinct biological effects remain to be elucidated. Weprovide evidence that a novel member of the protein kinase C (PKC) family of proteins is rapidly phosphorylated and activated during engagement of the type I IFN receptor. In contrast to other members of the PKC family that are also regulated by IFN receptors, PKC eta does not regulate IFN-inducible transcription of interferon-stimulated genes or generation of antiviral responses. However, its function promotes cell cycle arrest and is essential for the generation of the suppressive effects of IFN alpha on normal and leukemic human myeloid (colony-forming unit-granulocyte macrophage) bone marrow progenitors. Altogether, our studies establish PKC eta as a unique element in IFN signaling that plays a key and essential role in the generation of the regulatory effects of type I IFNs on normal and leukemic hematopoiesis.	[Liu, Hui; Wickrema, Amittha] Univ Chicago, Canc Res Ctr, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Toronto Res Inst, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; [Redig, Amanda J.; Sassano, Antonella; Katsoulidis, Efstratios; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Redig, Amanda J.; Sassano, Antonella; Katsoulidis, Efstratios; Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Redig, Amanda J.; Sassano, Antonella; Katsoulidis, Efstratios; Altman, Jessica K.; Platanias, Leonidas C.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	University of Chicago; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			NCI NIH HHS [CA77816, CA121192, CA098550, CA100579] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA098550, R01CA100579] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Ghanem S, 2007, CANCER BIOL THER, V6, P1375; Aziz MH, 2007, MOL CARCINOGEN, V46, P646, DOI 10.1002/mc.20356; Barragan M, 2003, LEUKEMIA LYMPHOMA, V44, P1865, DOI 10.1080/1042819031000110964; Bassini A, 1999, BLOOD, V93, P1178, DOI 10.1182/blood.V93.4.1178.404k28_1178_1188; Beck J, 1998, BRIT J CANCER, V77, P87, DOI 10.1038/bjc.1998.13; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; BROXMEYER HE, 1985, J IMMUNOL, V135, P2502; Chen YB, 2008, EXPERT OPIN INV DRUG, V17, P939, DOI 10.1517/13543784.17.6.939 ; Chida K, 2003, CANCER RES, V63, P2404; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Di Baldassarre A, 2007, J CELL BIOCHEM, V101, P411, DOI 10.1002/jcb.21189; Fahrmann M, 2008, CURR MED CHEM, V15, P1175, DOI 10.2174/092986708784310413; Fields AP, 2007, BIOCHEM SOC T, V35, P996, DOI 10.1042/BST0350996; Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Grander D, 1997, EUR J HAEMATOL, V59, P129; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hanauske AR, 2004, CURR PHARM DESIGN, V10, P1923, DOI 10.2174/1381612043384376; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kashiwagi M, 2002, J BIOCHEM, V132, P853, DOI 10.1093/oxfordjournals.jbchem.a003297; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kaur S, 2008, CELL CYCLE, V7, P2112, DOI 10.4161/cc.7.14.6258; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Livneh E, 1996, ONCOGENE, V12, P1545; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Magnifico A, 2007, CANCER RES, V67, P5308, DOI 10.1158/0008-5472.CAN-06-3936; Martin PM, 2005, EXPERT OPIN THER TAR, V9, P299, DOI 10.1517/14728222.9.2.299; MEANS RT, 1993, J CLIN INVEST, V91, P416, DOI 10.1172/JCI116216; Moschos S, 2005, CANC TREAT, V126, P207, DOI 10.1007/0-387-24361-5_9; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; Oshevski S, 1999, BIOCHEM BIOPH RES CO, V263, P603, DOI 10.1006/bbrc.1999.1425; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; RAEFSKY EL, 1985, J IMMUNOL, V135, P2507; Redig AJ, 2008, LEUKEMIA LYMPHOMA, V49, P1255, DOI 10.1080/10428190802007726; Redig AJ, 2007, J INTERF CYTOK RES, V27, P623, DOI 10.1089/jir.2007.0007; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Uddin S, 1997, BLOOD, V90, P2574; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; VANTHULL E, 1978, CANCER RES, V38, P911; Venkatesan BA, 2006, CELL SIGNAL, V18, P508, DOI 10.1016/j.cellsig.2005.05.022; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Vitale M, 2006, EUR J HISTOCHEM, V50, P15; Weekx SFA, 1998, EXP HEMATOL, V26, P1034; Wu TT, 2008, J CELL BIOCHEM, V103, P9, DOI 10.1002/jcb.21378; Yanagisawa K, 1998, BLOOD, V91, P641, DOI 10.1182/blood.V91.2.641.641_641_648; Zhao KW, 2005, J BIOL CHEM, V280, P42707, DOI 10.1074/jbc.M506178200	83	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10301	10314		10.1074/jbc.M807254200	http://dx.doi.org/10.1074/jbc.M807254200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19211565	hybrid, Green Published			2022-12-27	WOS:000265104600004
J	Sakamoto, K; Ito, Y; Hatanaka, T; Soni, PB; Mori, T; Sugimura, K				Sakamoto, Kotaro; Ito, Yuji; Hatanaka, Takaaki; Soni, Preeti Brijiral; Mori, Toshiyuki; Sugimura, Kazuhisa			Discovery and Characterization of a Peptide Motif That Specifically Recognizes a Non-native Conformation of Human IgG Induced by Acidic pH Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; PHAGE DISPLAY; PROTEIN-A; AFFINITY PURIFICATION; SYNTHETIC LIGAND; IMMUNOGLOBULIN-G; LIBRARY; BINDING; DESIGN; REGION	In therapeutic antibody preparation, acidic pH conditions are generally used for elution from Protein A affinity column of IgG or for its viral inactivation. Exposing IgG to low pH conditions induces conformational changes, leading to its functional damage or loss, although the mechanisms have not been fully elucidated. In this study using random peptide T7 phage display libraries, we isolated a unique and novel peptide motif that specifically recognized the non-native conformer ( acid conformer) of human IgG that was generated by the low pH treatment, but not the native conformer. We examined the generation conditions and biochemical properties of acid conformer using the peptide motif as an affinity ligand. The acid conformer was easily generated at acidic pH (<pH 3.0) and at moderate temperatures (20-40 degrees C). The conformer was present in a monomeric form functionally maintaining antigen or Fc receptor binding, but showed a tendency to aggregate with a long incubation time at neutral pH (>25 degrees C). The peptides isolated here could contribute to the elucidation of the mechanisms of antibody dysfunction or aggregation during acid exposure as well as storage of human IgG.	[Sakamoto, Kotaro; Ito, Yuji; Hatanaka, Takaaki; Sugimura, Kazuhisa] Kagoshima Univ, Fac Engn, Kagoshima 8900065, Japan; [Mori, Toshiyuki] NCI, Mol Targets Dev Program, Ctr Canc Res, NIH, Ft Detrick, MD 21702 USA; [Ito, Yuji; Soni, Preeti Brijiral] Japan Sci & Technol Agcy, Innovat Satellite Miyazaki, Miyazaki 8800805, Japan	Kagoshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Japan Science & Technology Agency (JST)	Ito, Y (corresponding author), Kagoshima Univ, Fac Engn, Kagoshima 8900065, Japan.	yito@be.kagoshima-u.ac.jp		Hatanaka, Takaaki/0000-0002-1154-6004	National Institutes of Health NCI Center for Cancer Research; Japan Science and Technology Agency.	National Institutes of Health NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Science and Technology Agency.(Japan Science & Technology Agency (JST))	This work was supported, in whole or in part, by the National Institutes of Health NCI Center for Cancer Research ( Intramural Research Program). This work was also supported by funds from the Japan Science and Technology Agency.	Boonyarattanakalin S, 2006, J AM CHEM SOC, V128, P11463, DOI 10.1021/ja062377w; Brorson K, 2003, BIOTECHNOL BIOENG, V82, P321, DOI 10.1002/bit.10574; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Castagnoli L, 2001, COMB CHEM HIGH T SCR, V4, P121; D'Agostino B, 2008, J IMMUNOL METHODS, V333, P126, DOI 10.1016/j.jim.2008.01.014; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; Ehrlich GK, 1998, J MOL RECOGNIT, V11, P121, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<121::AID-JMR406>3.0.CO;2-Z; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Fassina G, 1998, J MOL RECOGNIT, V11, P128, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<128::AID-JMR408>3.0.CO;2-8; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Herman RE, 2007, J BIOL CHEM, V282, P9813, DOI 10.1074/jbc.M610722200; Krook M, 1998, J IMMUNOL METHODS, V221, P151, DOI 10.1016/S0022-1759(98)00177-X; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Li RX, 1998, NAT BIOTECHNOL, V16, P190, DOI 10.1038/nbt0298-190; MARTSEV SP, 1995, FEBS LETT, V361, P173, DOI 10.1016/0014-5793(95)00145-Y; Newkirk MM, 2002, CLIN IMMUNOL, V104, P1, DOI 10.1006/clim.2002.5210; Sethuraman N, 2006, CURR OPIN BIOTECH, V17, P341, DOI 10.1016/j.copbio.2006.06.010; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; Verdoliva A, 2005, CHEMBIOCHEM, V6, P1242, DOI 10.1002/cbic.200400368; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002	22	30	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9986	9993		10.1074/jbc.M807618200	http://dx.doi.org/10.1074/jbc.M807618200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233852	Green Published, hybrid			2022-12-27	WOS:000264892900041
J	Sinha, PK; Torres-Bacete, J; Nakamaru-Ogiso, E; Castro-Guerrero, N; Matsuno-Yagi, A; Yagi, T				Sinha, Prem Kumar; Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao			Critical Roles of Subunit NuoH (ND1) in the Assembly of Peripheral Subunits with the Membrane Domain of Escherichia coli NDH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; MITOCHONDRIAL COMPLEX-I; HEREDITARY OPTIC NEUROPATHY; UBIQUINONE REDUCTION KINETICS; CONSERVED CHARGED RESIDUES; PARACOCCUS-DENITRIFICANS; BINDING SUBUNIT; STRUCTURAL ORGANIZATION; GLUCOSE-DEHYDROGENASE; STRUCTURE PREDICTION	The bacterial proton-translocating NADH: quinone oxidoreductase (NDH-1) consists of two domains, a peripheral arm and a membrane arm. NuoH is a counterpart of ND1, which is one of seven mitochondrially encoded hydrophobic subunits, and is considered to be involved in quinone/inhibitor binding. Sequence comparison in a wide range of species showed that NuoH is comprehensively conserved, particularly with charged residues in the cytoplasmic side loops. We have constructed 40 mutants of 27 conserved residues predicted to be in the cytoplasmic side loops of Escherichia coli NuoH by utilizing the chromosomal DNA manipulation technique and investigated roles of these residues. Mutants of Arg(37), Arg(46), Asp(63), Gly(134), Gly(145), Arg(148), Glu(220), and Glu(228) showed low deamino-NADH-K3Fe(CN)(6) reductase activity, undetectable NDH-1 in Blue Native gels, low contents of peripheral subunits ( especially NuoB and NuoCD) bound to the membranes, and a significant loss of the membrane potential and proton-pumping function coupled to deamino-NADH oxidation. The results indicated that these conserved residues located in the cytoplasmic side loops are essential for the assembly of the peripheral subunits with the membrane arm. Implications for the involvement of NuoH (ND1) in maintaining the structure and function of NDH-1 are discussed.	[Sinha, Prem Kumar; Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Castro-Guerrero, Norma; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, MEM-256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930; Castro Guerrero, Norma/0000-0002-8645-2694	National Institutes of Health [R01GM033712]; The Scripps Research Institute, La Jolla, CA [19803-MEM]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Scripps Research Institute, La Jolla, CA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM033712 ( to T. Y. and A. M.- Y.). This is Publication 19803-MEM from The Scripps Research Institute, La Jolla, CA.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Di Bernardo S, 2001, FEBS LETT, V508, P385, DOI 10.1016/S0014-5793(01)03111-8; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Horvath R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Kervinen M, 2006, HUM MOL GENET, V15, P2543, DOI 10.1093/hmg/ddl176; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunkel A, 1998, EUR J BIOCHEM, V252, P467, DOI 10.1046/j.1432-1327.1998.2520467.x; Kurki S, 2000, BIOCHEMISTRY-US, V39, P13496, DOI 10.1021/bi001134s; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Miyoshi H, 2001, J BIOENERG BIOMEMBR, V33, P223, DOI 10.1023/A:1010735019982; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; MURPHY E, 1985, EMBO J, V4, P3357, DOI 10.1002/j.1460-2075.1985.tb04089.x; Ohnishi T, 2005, FEBS LETT, V579, P4555, DOI 10.1016/j.febslet.2005.06.086; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Roth R, 2001, BBA-BIOENERGETICS, V1504, P352, DOI 10.1016/S0005-2728(00)00265-6; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schuler F, 2001, BBA-BIOENERGETICS, V1506, P79, DOI 10.1016/S0005-2728(01)00183-9; Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; Vgenopoulou I, 2006, J BACTERIOL, V188, P3264, DOI 10.1128/JB.188.9.3264-3272.2006; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; YAGI T, 1990, BIOCHEMISTRY-US, V29, P5515, DOI 10.1021/bi00475a015; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; YAGI T, 1988, J BIOL CHEM, V263, P16150; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606; Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555	71	52	53	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9814	9823		10.1074/jbc.M809468200	http://dx.doi.org/10.1074/jbc.M809468200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19189973	Green Published, hybrid			2022-12-27	WOS:000264892900022
J	Ferreras, C; Hernandez, ED; Martinez-Costa, OH; Aragon, JJ				Ferreras, Cristina; Hernandez, Eloy D.; Martinez-Costa, Oscar H.; Aragon, Juan J.			Subunit Interactions and Composition of the Fructose 6-Phosphate Catalytic Site and the Fructose 2,6-Bisphosphate Allosteric Site of Mammalian Phosphofructokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; ASCITES TUMOR-CELLS; DICTYOSTELIUM-DISCOIDEUM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP; INHIBITION; ENZYME; YEAST; FRUCTOSE-1,6-BISPHOSPHATASE	Mammalian phosphofructokinase originated by duplication, fusion, and divergence of a primitive prokaryotic gene, with the duplicated fructose 6-phosphate catalytic site in the C-terminal half becoming an allosteric site for the activator fructose 2,6-bisphosphate. It has been suggested that both sites are shared across the interface between subunits aligned in an antiparallel orientation, the N-terminal half of one subunit facing the C-terminal half of the other. The composition of these binding sites and the way in which subunits interact to form the dimer within the tetrameric enzyme have been reexamined by systematic point mutations to alanine of key amino acid residues of human muscle phosphofructokinase. We found that residues His-199, His-298, Arg-201, and Arg-292 contribute to the catalytic site and not to the allosteric site, because their mutation decreased the affinity for fructose 6-phosphate without affecting the activation by fructose 2,6-bisphosphate or its binding affinity. In contrast, residues Arg-566, Arg-655, and His-661 were critical components of the fructose bisphosphate allosteric site, because their mutation strongly reduced the action and affinity of the activator, with no alteration of substrate binding to the active site. Our results suggest that mammalian phosphofructokinase subunits associate with the N-terminal halves facing each other to form the two catalytic sites/dimer and the C-terminal halves forming the allosteric sites. Additionally, mutation of certain residues eliminated activation by fructose 1,6-bisphosphate, but not its binding, with little effect on activation by fructose 2,6-bisphosphate, indicating a divergence in the signal transduction route despite their binding to the same site.	[Martinez-Costa, Oscar H.] Univ Autonoma Madrid, Fac Med, Dept Bioquim, E-28029 Madrid, Spain; Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cienti, Fac Med, E-28029 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Martinez-Costa, OH (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Bioquim, Arzobispo Morcillo 4, E-28029 Madrid, Spain.	oscar.martinez@uam.es; juanjose.aragon@uam.es	Martinez-Costa, Oscar/B-7275-2014	Martinez-Costa, Oscar/0000-0003-4893-2205	Direccion General de Investigacion del Ministerio de Ciencia y Tecnologia [BMC2002-00769, BFU2005-09071]	Direccion General de Investigacion del Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BMC2002-00769 and BFU2005-09071 from the Direccion General de Investigacion del Ministerio de Ciencia y Tecnologia.	ARAGON JJ, 1986, EUR J BIOCHEM, V161, P757, DOI 10.1111/j.1432-1033.1986.tb10504.x; Barcena M, 2007, J STRUCT BIOL, V159, P135, DOI 10.1016/j.jsb.2007.03.004; Benjamin S, 2007, J STRUCT BIOL, V159, P498, DOI 10.1016/j.jsb.2007.06.001; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang SH, 2002, BIOCHEM BIOPH RES CO, V290, P670, DOI 10.1006/bbrc.2001.6262; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; ESTEVEZ AM, 1995, FEBS LETT, V374, P100, DOI 10.1016/0014-5793(95)01085-S; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FOE LG, 1985, J BIOL CHEM, V260, P726; GONZALEZMATEOS F, 1993, J BIOL CHEM, V268, P7809; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; KITAJIMA S, 1983, J BIOL CHEM, V258, P7352; KUNDROT CE, 1991, BIOCHEMISTRY-US, V30, P1478, DOI 10.1021/bi00220a005; LAD PM, 1973, BIOCHEMISTRY-US, V12, P4303, DOI 10.1021/bi00746a001; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Martinez-Costa OH, 2004, BIOCHEM J, V377, P77, DOI 10.1042/BJ20031032; Martinez-Costa OH, 2007, FEBS LETT, V581, P3033, DOI 10.1016/j.febslet.2007.05.059; Martinez-Oyanedel J, 2007, J MOL BIOL, V366, P1185, DOI 10.1016/j.jmb.2006.10.019; MARTINEZCOSTA OH, 1994, EUR J BIOCHEM, V226, P1007, DOI 10.1111/j.1432-1033.1994.01007.x; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1995, AM J HUM GENET, V56, P131; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; Santamaria B, 2002, J BIOL CHEM, V277, P1210, DOI 10.1074/jbc.M109480200; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; SOLS A, 1981, CURR TOP CELL REGUL, V19, P77; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; TORNHEIM K, 1985, J BIOL CHEM, V260, P7985; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315	35	17	17	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9124	9131		10.1074/jbc.M807737200	http://dx.doi.org/10.1074/jbc.M807737200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19218242	hybrid, Green Published			2022-12-27	WOS:000264669100016
J	Lain, E; Carnejac, S; Escher, P; Wilson, MC; Lomo, T; Gajendran, N; Brenner, HR				Lain, Enzo; Carnejac, Soizic; Escher, Pascal; Wilson, Marieangela C.; Lomo, Terje; Gajendran, Nadesan; Brenner, Hans Rudolf			A Novel Role for Embigin to Promote Sprouting of Motor Nerve Terminals at the Neuromuscular Junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CELL-ADHESION MOLECULE; N-CAM; IMMUNOGLOBULIN SUPERFAMILY; SKELETAL-MUSCLE; SYNAPSE FORMATION; MESSENGER-RNAS; BASIGIN CD147; SCHWANN-CELLS; MICE	Adult skeletal muscle accepts ectopic innervation by foreign motor axons only after section of its own nerve, suggesting that the formation of new neuromuscular junctions is promoted by muscle denervation. With the aim to identify new proteins involved in neuromuscular junction formation we performed an mRNA differential display on innervated versus denervated adult rat muscles. We identified transcripts encoding embigin, a transmembrane protein of the immunoglobulin superfamily (IgSF) class of cell adhesion molecules to be strongly regulated by the state of innervation. In innervated muscle it is preferentially localized to neuromuscular junctions. Forced overexpression in innervated muscle of a full-length embigin transgene, but not of an embigin fragment lacking the intracellular domain, promotes nerve terminal sprouting and the formation of additional acetylcholine receptor clusters at synaptic sites without affecting terminal Schwann cell number or morphology, and it delays the retraction of terminal sprouts following re-innervation of denervated endplates. Conversely, knockdown of embigin by RNA interference in wild-type muscle accelerates terminal sprout retraction, both by itself and synergistically with deletion of neural cell adhesion molecule. These findings indicate that embigin enhances neural cell adhesion molecule-dependent neuromuscular adhesion and thereby modulates neuromuscular junction formation and plasticity.	[Brenner, Hans Rudolf] Univ Basel, Dept Biomed, Inst Physiol, CH-4056 Basel, Switzerland; [Wilson, Marieangela C.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Lomo, Terje] Univ Oslo, Dept Physiol, N-0317 Oslo, Norway	University of Basel; University of Bristol; University of Oslo	Brenner, HR (corresponding author), Univ Basel, Dept Biomed, Inst Physiol, Klingelbergstr 50, CH-4056 Basel, Switzerland.	Hans-Rudolf.Brenner@unibas.ch		Wilson, Marieangela/0000-0001-6218-3533; , Nadesan/0000-0002-7463-4220	Swiss National Science Foundation; Swiss Foundation for Research on Muscle Diseases; Kanton Basel-Stadt	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscle Diseases; Kanton Basel-Stadt	This work was supported by grants from the Swiss National Science Foundation, the Swiss Foundation for Research on Muscle Diseases, and by the Kanton Basel-Stadt. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936; BROWN MC, 1977, NATURE, V265, P459, DOI 10.1038/265459a0; BROWN MC, 1979, NATURE, V282, P724, DOI 10.1038/282724a0; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; Cotman SL, 1999, EXP CELL RES, V249, P54, DOI 10.1006/excr.1999.4463; COVAULT J, 1986, J CELL BIOL, V102, P731, DOI 10.1083/jcb.102.3.731; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Fan QW, 1998, DEV GROWTH DIFFER, V40, P277; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GATCHALIAN CL, 1989, J CELL BIOL, V108, P1873, DOI 10.1083/jcb.108.5.1873; Hayworth CR, 2006, J NEUROSCI, V26, P6873, DOI 10.1523/JNEUROSCI.1086-06.2006; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; HUANG RP, 1990, DIFFERENTIATION, V45, P76, DOI 10.1111/j.1432-0436.1990.tb00460.x; HUANG RP, 1993, DEV BIOL, V155, P307, DOI 10.1006/dbio.1993.1030; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lomo T, 2003, J NEUROCYTOL, V32, P835, DOI 10.1023/B:NEUR.0000020627.18156.b1; LOMO T, 1978, J PHYSIOL-LONDON, V275, P391, DOI 10.1113/jphysiol.1978.sp012196; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; MOORE SE, 1985, EMBO J, V4, P623, DOI 10.1002/j.1460-2075.1985.tb03675.x; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Storms SD, 1996, EXP CELL RES, V223, P385, DOI 10.1006/excr.1996.0093; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Walsh FS, 2000, MOL CELL NEUROSCI, V15, P244, DOI 10.1006/mcne.1999.0815; WEHRLEHALLER B, 1993, J CELL SCI, V106, P597; WIGSTON DJ, 1989, J NEUROSCI, V9, P639; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125	47	27	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8921	8930		10.1074/jbc.M809491200	http://dx.doi.org/10.1074/jbc.M809491200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164284	Green Published, hybrid			2022-12-27	WOS:000264397800075
J	Suwan, K; Choocheep, K; Hatano, S; Kongtawelert, P; Kimata, K; Watanabe, H				Suwan, Keittisak; Choocheep, Kanyamas; Hatano, Sonoko; Kongtawelert, Prachya; Kimata, Koji; Watanabe, Hideto			Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CREST CELL-MIGRATION; CHONDROITIN SULFATE; PG-M/VERSICAN; LEUKOCYTE ADHESION; TUMOR-CELLS; PROLIFERATION; PROTEOGLYCAN; BINDING; DOMAIN	Versican/PG-M is a large chondroitin sulfate proteoglycan of the extracellular matrix which interacts with hyaluronan at the N-terminal G1 domain, composed of A, B, and B' subdomains. Recently, we generated knock-in mice Cspg2(Delta 3/Delta 3), whose versican, without the A subdomain, has decreased hyaluronan ( HA) binding affinity, thereby exhibiting reduced deposition of versican in the extracellular matrix. Here, we show that the Cspg2(Delta 3/Delta 3) fibroblasts within 20 passages proliferate more slowly and acquire senescence. Whereas the extracellular matrix of the wild type fibroblasts exhibited a network structure of hyaluronan and versican, that of the Cspg2(Delta 3/Delta 3) fibroblasts exhibited similar to 35 and similar to 85% deposition of versican and HA, without such a structure. The Cspg2(Delta 3/Delta 3) fibroblasts showed a substantial increase of ERK1/2 phosphorylation and expression of senescence markers p53, p21, and p16. Treatment of wild type fibroblasts with hyaluronidase and exogenous hyaluronan enhanced ERK1/2 phosphorylation, and treatment with an anti-CD44 antibody that blocks HA-CD44 interaction inhibited the phosphorylation. These results demonstrate that versican is essential for matrix assembly involving hyaluronan and that diminished versican deposition increases free hyaluronan fragments that interact with CD44 and increase phosphorylation of ERK1/2, leading to cellular senescence.	[Suwan, Keittisak; Choocheep, Kanyamas; Hatano, Sonoko; Kimata, Koji; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Suwan, Keittisak; Choocheep, Kanyamas; Kongtawelert, Prachya] Chiang Mai Univ, Thailand Excellence Ctr Tissue Engn, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand	Aichi Medical University; Chiang Mai University	Watanabe, H (corresponding author), Karimata 21, Nagakute, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp		Suwan, Keittisak/0000-0001-6542-5841; Watanabe, Hideto/0000-0001-5291-0696; kongtawelert, prachya/0000-0002-5963-2796	Scientific Research B and C KAKENHI	Scientific Research B and C KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research B and C KAKENHI ( to H. W.) and Grants- in- aid for Priority Areas ( to H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domenzain C, 2003, BBA-MOL CELL RES, V1642, P107, DOI 10.1016/S0167-4889(03)00104-6; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Kamiya N, 2006, J BIOL CHEM, V281, P2390, DOI 10.1074/jbc.M509341200; KIMATA K, 1985, J EMBRYOL EXP MORPH, V89, P243; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Mazzucato M, 2002, FASEB J, V16, P1903, DOI 10.1096/fj.02-0382com; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; Tsujii M, 2006, HISTOL HISTOPATHOL, V21, P511, DOI 10.14670/HH-21.511; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; YAMAGATA M, 1994, J CELL SCI, V107, P2581; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	40	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8596	8604		10.1074/jbc.M806927200	http://dx.doi.org/10.1074/jbc.M806927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19164294	Green Published, hybrid			2022-12-27	WOS:000264397800044
J	Yamasaki, T; Takahashi, A; Pan, JZ; Yamaguchi, N; Yokoyama, KK				Yamasaki, Takahito; Takahashi, Akinori; Pan, Jianzhi; Yamaguchi, Naoto; Yokoyama, Kazunari K.			Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-INDUCED DIFFERENTIATION; RETINOIC ACID; F9 CELLS; INTRAMOLECULAR INHIBITION; HEMATOPOIETIC-CELLS; MAMMARY-TUMORS; ATF-2; AP-1; DOMAIN; ALPHA	Activation transcription factor-2 (ATF-2) is phosphorylated by various protein kinases, such as JNK/p38/ERK, calmodulin kinase IV, protein kinase A, and protein kinase C (PKC), in response to a variety of stimuli. However, the role of the phosphorylation of ATF-2 by PKC in vivo in the transcriptional control of genes that include the activation protein-1 (AP-1)/cyclic AMP-response element remains to be defined. Using antibodies against the phosphorylated serine residue (Ser(P)) at position 121 of ATF-2, we have demonstrated that PKC phosphorylates ATF-2 at Ser-121 and that phosphorylation of Ser-121 (to yield ATF-2pS121) becomes detectable at the late stage of the response of HeLa cells to 12-O-tetradecanoylphorbol-13-acetate (TPA) and is maintained for more than 2 h. By contrast, phosphorylation of ATF-2 at threonine residues 69 and 71 (Thr69/71, to yield ATF-2pT69/71) and at Ser-340 and Ser-367 (to yield ATF-2pS340 and ATF-2pS367) is detectable as an immediate early response. Unlike levels of ATF-2pT69/71 and ATF2pS340, the level of ATF-2pS121 increases in the nuclei of HeLa cells in response to TPA. A serine-to-alanine mutation at position 121 of ATF-2 represses the c-Jun-dependent transcription of AP-1/cyclic AMP-response element reporter genes and also the p300-mediated activation of a Gal4-reporter gene in response to TPA. Our results suggest that the phosphorylation of ATF-2 at Ser-121 plays a key role in the c-Jun-mediated activation of transcription that occurs in response to TPA.	[Yamasaki, Takahito; Pan, Jianzhi; Yokoyama, Kazunari K.] RIKEN, BioResource Ctr, Gene Engn Div, Tsukuba, Ibaraki 3050074, Japan; [Takahashi, Akinori; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Chiba 2608675, Japan	RIKEN; Chiba University	Yokoyama, KK (corresponding author), RIKEN, BioResource Ctr, Gene Engn Div, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	kazu@brc.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19041069]; Naito Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Memorial Foundation(Naito Memorial Foundation)	This work was supported by Grant 19041069 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Naito Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bocco JL, 1996, ONCOGENE, V12, P1971; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHATTON B, 1994, ONCOGENE, V9, P375; Cho YH, 1998, CELL GROWTH DIFFER, V9, P147; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HERR I, 1994, CARCINOGENESIS, V15, P1105, DOI 10.1093/carcin/15.6.1105; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Khuri FR, 1996, CELL GROWTH DIFFER, V7, P595; KINDREGAN HC, 1994, J BIOL CHEM, V269, P27756; KITABAYASHI I, 1995, EMBO J, V14, P3496, DOI 10.1002/j.1460-2075.1995.tb07356.x; KITABAYASHI I, 1992, EMBO J, V11, P167, DOI 10.1002/j.1460-2075.1992.tb05039.x; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; SAKURAI A, 1991, BIOCHEM BIOPH RES CO, V181, P629, DOI 10.1016/0006-291X(91)91237-7; Sano Y, 1998, J BIOL CHEM, V273, P29098, DOI 10.1074/jbc.273.44.29098; Schmalz D, 1998, J CELL SCI, V111, P1823; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Szczepanowska J, 1998, P NATL ACAD SCI USA, V95, P4146, DOI 10.1073/pnas.95.8.4146; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; TSENG CP, 1994, CARCINOGENESIS, V15, P707, DOI 10.1093/carcin/15.4.707; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170	44	38	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8567	8581		10.1074/jbc.M808719200	http://dx.doi.org/10.1074/jbc.M808719200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176525	Green Published, hybrid			2022-12-27	WOS:000264397800041
J	Brookheart, RT; Michel, CI; Listenberger, LL; Ory, DS; Schaffer, JE				Brookheart, Rita T.; Michel, Carlos I.; Listenberger, Laura L.; Ory, Daniel S.; Schaffer, Jean E.			The Non-coding RNA gadd7 Is a Regulator of Lipid-induced Oxidative and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITATE-INDUCED APOPTOSIS; UNFOLDED PROTEIN RESPONSE; FATTY-ACID OXIDATION; LIPOTOXIC CELL-DEATH; HEPATIC STEATOSIS; NAD(P)H OXIDASE; LIVER-INJURY; RAT-HEART; EXPRESSION; OBESITY	In obesity and diabetes, an imbalance in fatty acid uptake and fatty acid utilization leads to excess accumulation of lipid in non-adipose tissues. This lipid overload is associated with cellular dysfunction and cell death, which contribute to organ failure, a phenomenon termed lipotoxicity. To elucidate the molecular mechanism of lipid-mediated cell death, we generated and characterized a mutant Chinese hamster ovary cell line that is resistant to palmitate-induced cell death. In this mutant, random insertion of a retroviral promoter trap has disrupted the gene for the non-coding RNA, growth arrested DNA-damage inducible gene 7 (gadd7). Here we report that gadd7 is induced by lipotoxic stress in a reactive oxygen species (ROS)-dependent fashion and is necessary for both lipid-and general oxidative stress-mediated cell death. Depletion of gadd7 by mutagenesis or short hairpin RNA knockdown significantly reduces lipid and nonlipid induced ROS. Furthermore, depletion of gadd7 delays and diminishes ROS-induced endoplasmic reticulum stress. Together these data are the first to implicate a non-coding RNA in a feed-forward loop with oxidative stress and its induction of the endoplasmic reticulum stress response.	[Brookheart, Rita T.; Michel, Carlos I.; Listenberger, Laura L.; Ory, Daniel S.; Schaffer, Jean E.] Cardiovasc Res Ctr, Dept Internal Med, St Louis, MO 63110 USA; [Ory, Daniel S.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Schaffer, Jean E.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Cardiovasc Res Ctr, Dept Internal Med, Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	jschaff@wustl.edu			National Institutes of Health [DK064989]; Burroughs Wellcome Foundation [1005935]; Predoctoral Fellowship [DK077583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK077583, R01DK064989, R56DK064989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Predoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK064989 (to J.E.S.) and Predoctoral Fellowship DK077583 (to R.T.B.). This work was also supported by Burroughs Wellcome Foundation Grant 1005935 (to J.E.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S.C.Section 1734 solely to indicate this fact.	Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cacicedo JM, 2005, DIABETES, V54, P1838, DOI 10.2337/diabetes.54.6.1838; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Crawford DR, 1996, ARCH BIOCHEM BIOPHYS, V329, P137, DOI 10.1006/abbi.1996.0202; Crawford DR, 1996, ARCH BIOCHEM BIOPHYS, V325, P256, DOI 10.1006/abbi.1996.0032; Darmaun D, 2005, DIABETES, V54, P190, DOI 10.2337/diabetes.54.1.190; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Hollander MC, 1996, NUCLEIC ACIDS RES, V24, P1589, DOI 10.1093/nar/24.9.1589; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Ji J, 2005, EXP TOXICOL PATHOL, V56, P369, DOI 10.1016/j.etp.2005.02.003; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Leichman JG, 2006, AM J CLIN NUTR, V84, P336; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nollen EAA, 2002, J CELL SCI, V115, P2809; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	45	65	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7446	7454		10.1074/jbc.M806209200	http://dx.doi.org/10.1074/jbc.M806209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150982	hybrid, Green Published			2022-12-27	WOS:000264195600008
J	Filip, AM; Klug, J; Cayli, S; Frohlich, S; Henke, T; Lacher, P; Eickhoff, R; Bulau, P; Linder, M; Carlsson-Skwirut, C; Leng, L; Bucala, R; Kraemer, S; Bernhagen, J; Meinhardt, A				Filip, Ana-Maria; Klug, Joerg; Cayli, Sevil; Froehlich, Suada; Henke, Tamara; Lacher, Philipp; Eickhoff, Regina; Bulau, Patrick; Linder, Monika; Carlsson-Skwirut, Christine; Leng, Lin; Bucala, Richard; Kraemer, Sandra; Bernhagen, Juergen; Meinhardt, Andreas			Ribosomal Protein S19 Interacts with Macrophage Migration Inhibitory Factor and Attenuates Its Pro-inflammatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MIF; RHEUMATOID-ARTHRITIS; CYTOKINE; CELLS; BINDING; SITE; LINK; PURIFICATION; RECRUITMENT; RECEPTOR	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been implicated in the pathogenesis of inflammatory disorders such as infection, sepsis, and autoimmune disease. MIF exists preformed in cytoplasmic pools and exhibits an intrinsic tautomerase and oxidoreductase activity. MIF levels are elevated in the serum of animals and patients with infection or different inflammatory disorders. To elucidate how MIF actions are controlled, we searched for endogenous MIF-interacting proteins with the potential to interfere with key MIF functions. Using in vivo biotin-tagging and endogenous co-immunoprecipitation, the ribosomal protein S19 (RPS19) was identified as a novel MIF binding partner. Surface plasmon resonance and pulldown experiments with wild type and mutant MIF revealed a direct physical interaction of the two proteins (K-D = 1.3 x 10(-6) M). As RPS19 is released in inflammatory lesions by apoptotic cells, we explored whether it affects MIF function and inhibits its binding to receptors CD74 and CXCR2. Low doses of RPS19 were found to strongly inhibit MIF-CD74 interaction. Furthermore, RPS19 significantly compromised CXCR2-dependent MIF-triggered adhesion of monocytes to endothelial cells under flow conditions. We, therefore, propose that RPS19 acts as an extracellular negative regulator of MIF.	[Filip, Ana-Maria; Klug, Joerg; Cayli, Sevil; Froehlich, Suada; Henke, Tamara; Lacher, Philipp; Eickhoff, Regina; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, D-35385 Giessen, Germany; [Bulau, Patrick] Univ Giessen, Med Clin 2, D-35385 Giessen, Germany; [Linder, Monika] Univ Giessen, Dept Biochem, D-35385 Giessen, Germany; [Carlsson-Skwirut, Christine] Karolinska Inst, Astrid Lindgren Childrens Hosp, Paediat Endocrinol Unit, Dept Woman & Child Hlth, S-17116 Stockholm, Sweden; [Carlsson-Skwirut, Christine] St Gorans Univ Hosp, S-17116 Stockholm, Sweden; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Kraemer, Sandra; Bernhagen, Juergen] Rhein Westfal TH Aachen, Univ Hosp, Inst Biochem, Dept Biochem & Mol Cell Biol, D-52074 Aachen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Karolinska Institutet; Saint Goran's Hospital; Yale University; RWTH Aachen University; RWTH Aachen University Hospital	Meinhardt, A (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Aulweg 123, D-35385 Giessen, Germany.	andreas.meinhardt@anatomie.med.uni-giessen.de	Meinhardt, Andreas/B-3688-2009; Cayli, Sevil/V-2342-2019	Bulau, Patrick/0000-0002-7121-2954; Cayli, Sevil/0000-0003-2465-5389; Leng, Lin/0000-0002-0605-358X	Deutsche Forschungsgemeinschaft [1323/2-4]; University Medical Centre Giessen and Marburg; SFB [542/TP A7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Centre Giessen and Marburg; SFB(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Grants Me 1323/2-4 (to A. M.) and SFB 542/TP A7 (J. B.) and a research grant of the University Medical Centre Giessen and Marburg (to A. M.).	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Berndt K, 2008, MOL CELL BIOCHEM, V307, P265, DOI 10.1007/s11010-007-9578-3; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bucala R, 2005, DRUG NEWS PERSPECT, V18, P417, DOI 10.1358/dnp.2005.18.7.939345; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962; Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Degryse B, 2003, FEBS LETT, V553, P11, DOI 10.1016/S0014-5793(03)01027-5; Denkinger CM, 2003, J IMMUNOL, V170, P1274, DOI 10.4049/jimmunol.170.3.1274; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; GU J, 1994, BIOTECHNIQUES, V17, P257; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; KIM M, 2003, THESIS PHILIPPS U MA; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; Leech M, 2000, ARTHRITIS RHEUM, V43, P827, DOI 10.1002/1529-0131(200004)43:4<827::AID-ANR13>3.0.CO;2-K; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Ni J, 2000, ANN NY ACAD SCI, V923, P25; Nishimura T, 2001, J BIOCHEM-TOKYO, V129, P445, DOI 10.1093/oxfordjournals.jbchem.a002876; Nishiura H, 1996, J BIOL CHEM, V271, P878, DOI 10.1074/jbc.271.2.878; Nishiura H, 1998, LAB INVEST, V78, P1615; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; RISCHITOR G, 2005, THESIS PHILIPPS U MA; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sambrook J., 2001, MOL CLONING; Santos L, 2001, CLIN EXP IMMUNOL, V123, P309, DOI 10.1046/j.1365-2249.2001.01423.x; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soulet F, 2001, BIOCHEM BIOPH RES CO, V289, P591, DOI 10.1006/bbrc.2001.5960; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Swope MD, 1999, REV PHYSIOL BIOCH P, V139, P1, DOI 10.1007/BFb0033647; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; WEBER C, 1993, EUR J IMMUNOL, V23, P852, DOI 10.1002/eji.1830230413; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xiao F, 2005, MOL ENDOCRINOL, V19, P2964, DOI 10.1210/me.2004-0408	48	49	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7977	7985		10.1074/jbc.M808620200	http://dx.doi.org/10.1074/jbc.M808620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155217	hybrid, Green Published			2022-12-27	WOS:000264195600060
J	Sommers, JA; Rawtani, N; Gupta, R; Bugreev, DV; Mazin, AV; Cantor, SB; Brosh, RM				Sommers, Joshua A.; Rawtani, Nina; Gupta, Rigu; Bugreev, Dmitry V.; Mazin, Alexander V.; Cantor, Sharon B.; Brosh, Robert M.			FANCJ Uses Its Motor ATPase to Destabilize Protein-DNA Complexes, Unwind Triplexes, and Inhibit RAD51 Strand Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; BREAST-CANCER; NUCLEOPROTEIN FILAMENTS; SUBSTRATE-SPECIFICITY; GENOMIC STABILITY; SYNDROME HELICASE; REPLICATION-FORK; BINDING PROTEIN; RECQ HELICASES; IN-VIVO	Mutations in the FANCJ helicase predispose individuals to breast cancer and are genetically linked to the Fanconi anemia (FA) complementation group J.FA is a chromosomal instability disorder characterized by multiple congenital anomalies, progressive bone marrow failure, and high cancer risk. FANCJ has been proposed to function downstream of FANCD2 monoubi-quitination, a critical event in the FA pathway. Evidence supports a role for FANCJ in a homologous recombination pathway of double strand break repair. In an effort to understand the molecular functions of FANCJ, we have investigated the ability of purified FANCJ recombinant protein to use its motor ATPase function for activities in addition to unwinding of conventional duplex DNA substrates. These efforts have led to the discovery that FANCJ ATP hydrolysis can be used to destabilize protein-DNA complexes and unwind triple helix alternate DNA structures. These novel catalytic functions of FANCJ may be important for its role in cellular DNA repair, recombination, or resolving DNA structural obstacles to replication. Consistent with this, we show that FANCJ can inhibit RAD51 strand exchange, an activity that is likely to be important for its role in controlling DNA repair through homologous recombination.	[Sommers, Joshua A.; Rawtani, Nina; Gupta, Rigu; Brosh, Robert M.] NIA, Lab Mol Gerontol, NIH, Natl Inst Hlth Biomed Res Ctr, Baltimore, MD 21224 USA; [Bugreev, Dmitry V.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Cantor, Sharon B.] Univ Massachusetts, Sch Med, Womens Canc Program, UMass Mem Canc Ctr,Dept Canc Biol, Worcester, MA 01605 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Natl Inst Hlth Biomed Res Ctr, 251 Bayview Dr,Suite 100,Rm 06B125, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020		National Institutes of Health Intramural Research Program; NIA; National Institutes of Health [CA100839, MH084119]; Fanconi Anemia Research Fund; Leukemia and Lymphoma Society Scholar Award [1054-09]; NATIONAL CANCER INSTITUTE [R01CA100839, R56CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH084119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Fund; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program; NIA, National Institutes of Health; and National Institutes of Health Grants CA100839 and MH084119. This work was also supported by the Fanconi Anemia Research Fund (to R.M.B.) and by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A.V.M.).	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang GL, 2004, P NATL ACAD SCI USA, V101, P13448, DOI 10.1073/pnas.0405116101; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	49	83	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7505	7517		10.1074/jbc.M809019200	http://dx.doi.org/10.1074/jbc.M809019200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150983	Green Published, hybrid			2022-12-27	WOS:000264195600014
J	Sheng, F; Jia, XF; Yep, A; Preiss, J; Geiger, JH				Sheng, Fang; Jia, Xiaofei; Yep, Alejandra; Preiss, Jack; Geiger, James H.			The Crystal Structures of the Open and Catalytically Competent Closed Conformation of Escherichia coli Glycogen Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; D-GLUCOPYRANOSYL FLUORIDE; GLY-GLY SEQUENCE; MALTODEXTRIN PHOSPHORYLASE; BACTERIAL GLYCOGEN; ACTIVE-SITE; X-RAY; REGULATORY ENZYME; SMALL MOLECULES; BINDING-SITE	Escherichia coli glycogen synthase (EcGS, EC 2.4.1.21) is a retaining glycosyltransferase (GT) that transfers glucose from adenosine diphosphate glucose to a glucan chain acceptor with retention of configuration at the anomeric carbon. EcGS belongs to the GT-B structural superfamily. Here we report several EcGS x-ray structures that together shed considerable light on the structure and function of these enzymes. The structure of the wild-type enzyme bound to ADP and glucose revealed a 15.2 degrees overall domain-domain closure and provided for the first time the structure of the catalytically active, closed conformation of a glycogen synthase. The main chain carbonyl group of His-161, Arg-300, and Lys-305 are suggested by the structure to act as critical catalytic residues in the transglycosylation. Glu-377, previously thought to be catalytic is found on the alpha-face of the glucose and plays an electrostatic role in the active site and as a glucose ring locator. This is also consistent with the structure of the EcGS(E377A)-ADP-HEPPSO complex where the glucose moiety is either absent or disordered in the active site.	[Geiger, James H.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Yep, Alejandra; Preiss, Jack] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	geiger@chemistry.msu.edu	Jia, Xiaofei/O-3258-2013; Jia, Xiaofei/B-4721-2014	Geiger, James/0000-0002-9443-4488	Department of Energy [DE-FG02-06ER15822]	Department of Energy(United States Department of Energy (DOE))	This work was supported by Department of Energy Grant DE-FG02-06ER15822.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BANAIT NS, 1991, J AM CHEM SOC, V113, P7951, DOI 10.1021/ja00021a021; BANAIT NS, 1991, J AM CHEM SOC, V113, P7958, DOI 10.1021/ja00021a022; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; BOYER C, 1977, BIOCHEMISTRY-US, V16, P3693, DOI 10.1021/bi00635a029; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Campagnolo M, 2008, ARCH BIOCHEM BIOPHYS, V471, P11, DOI 10.1016/j.abb.2007.11.023; Chiappe C, 1997, TETRAHEDRON, V53, P10471, DOI 10.1016/S0040-4020(97)00660-1; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; CLELAND WW, 1967, ANNU REV BIOCHEM, V36, P77, DOI 10.1146/annurev.bi.36.070167.000453; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; CRISTINA H, 2006, J BIOL CHEM, V281, P2923; DeLano W.L, PYMOL MOL GRAPHICS S; FOX J, 1976, BIOCHEMISTRY-US, V15, P849, DOI 10.1021/bi00649a019; FURUKAWA K, 1993, J BIOL CHEM, V268, P23837; FURUKAWA K, 1990, J BIOL CHEM, V265, P2086; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Geremia S, 2002, J MOL BIOL, V322, P413, DOI 10.1016/S0022-2836(02)00771-4; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; GOLDSMITH EJ, 1989, SCIENCE, V245, P528, DOI 10.1126/science.2756432; HOWARD AJ, 2000, CRYSTALLOGRAPHIC COM, V7, P1; Iglesias A.A., 1992, BIOCHEM EDUC, V20, P196, DOI 10.1016/0307-4412(92)90191-N; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KLEIN HW, 1986, EUR J BIOCHEM, V157, P107, DOI 10.1111/j.1432-1033.1986.tb09645.x; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lariviere L, 2005, J MOL BIOL, V352, P139, DOI 10.1016/j.jmb.2005.07.007; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; PREISS J, 1989, ADV MICROB PHYSIOL, V30, P183; PREISS J, 1999, COMPREHENSIVE NATURA, P441; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; SCHINZEL R, 1990, BIOCHEMISTRY-US, V29, P9956, DOI 10.1021/bi00494a028; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SINNOTT ML, 1980, J AM CHEM SOC, V102, P2026, DOI 10.1021/ja00526a043; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619; Watson KA, 1997, EMBO J, V16, P1, DOI 10.1093/emboj/16.1.1; Yep A, 2004, BIOCHEM BIOPH RES CO, V316, P960, DOI 10.1016/j.bbrc.2004.02.136; Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200; Yep A, 2006, ARCH BIOCHEM BIOPHYS, V453, P188, DOI 10.1016/j.abb.2006.07.003	50	65	65	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17796	17807		10.1074/jbc.M809804200	http://dx.doi.org/10.1074/jbc.M809804200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19244233	Green Published, hybrid			2022-12-27	WOS:000267202500045
J	Akhtar, K; Gupta, V; Koul, A; Alam, N; Bhat, R; Bamezai, RNK				Akhtar, Kamal; Gupta, Vibhor; Koul, Anita; Alam, Neelima; Bhat, Rajiv; Bamezai, Rameshwar N. K.			Differential Behavior of Missense Mutations in the Intersubunit Contact Domain of the Human Pyruvate Kinase M-2 Isozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; MUSCLE; M2; BINDING; ENZYME; GENE; METABOLISM	In this study, we attempted to understand the mechanism of regulation of the activity and allosteric behavior of the pyruvate kinase M-2 enzyme and two of its missense mutations, H391Y and K422R, found in cells from Bloom syndrome patients, prone to develop cancer. Results show that despite the presence of mutations in the intersubunit contact domain, the K422R and H391Y mutant proteins maintained their homotetrameric structure, similar to the wild-type protein, but showed a loss of activity of 75 and 20%, respectively. Interestingly, H391Y showed a 6-fold increase in affinity for its substrate phosphoenolpyruvate and behaved like a non-allosteric protein with compromised cooperative binding. However, the affinity for phosphoenolpyruvate was lost significantly in K422R. Unlike K422R, H391Y showed enhanced thermal stability, stability over a range of pH values, a lesser effect of the allosteric inhibitor Phe, and resistance toward structural alteration upon binding of the activator (fructose 1,6-bisphosphate) and inhibitor (Phe). Both mutants showed a slight shift in the pH optimum from 7.4 to 7.0. Although this study signifies the importance of conserved amino acid residues in long-range communications between the subunits of multimeric proteins, the altered behavior of mutants is suggestive of their probable role in tumor-promoting growth and metabolism in Bloom syndrome patients with defective pyruvate kinase M-2.	[Akhtar, Kamal; Gupta, Vibhor; Koul, Anita; Alam, Neelima; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India; [Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India.	bamezai@hotmail.com		Bamezai, R.N.K/0000-0002-5128-2859	University Grant Commission (New Delhi, India)	University Grant Commission (New Delhi, India)(University Grants Commission, India)	The work performed in the National Centre of Applied Human Genetics was supported by the University Grant Commission (New Delhi, India).	Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDENAS JM, 1982, METHOD ENZYMOL, V90, P140; CARDENAS JM, 1975, ISOZYMES, V1, P523; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; CONSLER TG, 1989, BIOCHEMISTRY-US, V28, P8756, DOI 10.1021/bi00448a012; Demina A, 1998, BLOOD, V92, P647, DOI 10.1182/blood.V92.2.647.414k13_647_652; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Friesen RHE, 1998, J BIOL CHEM, V273, P14772, DOI 10.1074/jbc.273.24.14772; Friesen RHE, 1998, BIOCHEMISTRY-US, V37, P15266, DOI 10.1021/bi981273y; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; IMAMURA K, 1982, METHOD ENZYMOL, V90, P150; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; KUO DJ, 1979, J AM CHEM SOC, V101, P5024; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; MUIRHEAD H, 1990, BIOCHEM SOC T, V18, P193, DOI 10.1042/bst0180193; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Reddy BSN, 2000, INT J DERMATOL, V39, P760, DOI 10.1046/j.1365-4362.2000.00047.x; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; TAKENAKA M, 1991, EUR J BIOCHEM, V198, P101, DOI 10.1111/j.1432-1033.1991.tb15991.x; TAKENAKA M, 1989, J BIOL CHEM, V264, P2363; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; vanSolinge WW, 1997, BLOOD, V90, P4987, DOI 10.1182/blood.V90.12.4987.4987_4987_4995; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Wang Y, 2006, STARCH-STARKE, V58, P501, DOI 10.1002/star.200600493; Wooll JO, 2001, J MOL BIOL, V312, P525, DOI 10.1006/jmbi.2001.4978; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	43	17	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11971	11981		10.1074/jbc.M808761200	http://dx.doi.org/10.1074/jbc.M808761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265196	Green Published, hybrid			2022-12-27	WOS:000265494600029
J	Chiku, T; Padovani, D; Zhu, WD; Singh, S; Vitvitsky, V; Banerjee, R				Chiku, Taurai; Padovani, Dominique; Zhu, Weidong; Singh, Sangita; Vitvitsky, Victor; Banerjee, Ruma			H2S Biogenesis by Human Cystathionine gamma-Lyase Leads to the Novel Sulfur Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of Hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; AMINO-ACID; BOVINE BRAIN; ACCUMULATION; HOMOCYSTEINE; INFLAMMATION; INHIBITION; MEDIATOR; CYSTEINE; INJURY	Although there is a growing recognition of the significance of hydrogen sulfide (H2S) as a biological signaling molecule involved in vascular and nervous system functions, its biogenesis and regulation are poorly understood. It is widely assumed that desulfhydration of cysteine is the major source of H2S in mammals and is catalyzed by the transsulfuration pathway enzymes, cystathionine beta-synthase and cystathionine gamma-lyase (CSE). In this study, we demonstrate that the profligacy of human CSE results in a variety of reactions that generate H2S from cysteine and homocysteine. The gamma-replacement reaction, which condenses two molecules of homocysteine, yields H2S and a novel biomarker, homolanthionine, which has been reported in urine of homocystinuric patients, whereas a beta-replacement reaction, which condenses two molecules of cysteine, generates lanthionine. Kinetic simulations at physiologically relevant concentrations of cysteine and homocysteine, reveal that the alpha,beta-elimination of cysteine accounts for similar to 70% of H2S generation. However, the relative importance of homocysteine-derived H2S increases progressively with the grade of hyperhomocysteinemia, and under conditions of severely elevated homocysteine (200 mu M), the alpha,beta-elimination and gamma-replacement reactions of homocysteine together are predicted to account for similar to 90% of H2S generation by CSE. Excessive H2S production in hyperhomocysteinemia may contribute to the associated cardiovascular pathology.	[Chiku, Taurai; Padovani, Dominique; Singh, Sangita; Vitvitsky, Victor; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Zhu, Weidong; Singh, Sangita] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022; Vitvitsky, Victor/ABA-2967-2021	Vitvitsky, Victor/0000-0001-6251-6115; PADOVANI, Dominique/0000-0003-1166-5801	National Institutes of Health [HL58984]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984 (to R.B.). This work was also supported by an American Heart Association postdoctoral fellowship award (to W.Z.).	Abe K, 1996, J NEUROSCI, V16, P1066; ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; Aitken SM, 2005, ARCH BIOCHEM BIOPHYS, V433, P166, DOI 10.1016/j.abb.2004.08.024; Alvarez MP, 2006, GEN COMP ENDOCR, V146, P257, DOI 10.1016/j.ygcen.2005.11.021; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; BRAUNSTEIN AE, 1984, ADV ENZYMOL RAMB, V56, P1; CANEVARI L, 1992, ANAL BIOCHEM, V205, P137, DOI 10.1016/0003-2697(92)90590-4; CAVALLINI D, 1962, ARCH BIOCHEM BIOPHYS, V96, P456, DOI 10.1016/0003-9861(62)90436-8; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2004, J NEUROSCI, V24, P5649; Eto K, 2002, J NEUROSCI, V22, P3386; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; FONTANA M, 1990, BIOCHEM BIOPH RES CO, V171, P480, DOI 10.1016/0006-291X(90)91418-R; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; HUANG HT, 1963, BIOCHEMISTRY-US, V2, P296, DOI 10.1021/bi00902a018; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kromer JO, 2006, J BACTERIOL, V188, P609, DOI 10.1128/JB.188.2.609-618.2006; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; NEUBERGER A, 1973, BIOCHEM J, V136, P477, DOI 10.1042/bj1360477; PASZEWSKI A, 1975, ACTA BIOCHIM POL, V22, P263; PERRY TL, 1966, SCIENCE, V152, P1750, DOI 10.1126/science.152.3730.1750; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; RICCI G, 1989, BIOCHIM BIOPHYS ACTA, V990, P211, DOI 10.1016/S0304-4165(89)80036-4; SODA K, 1968, ANAL BIOCHEM, V25, P228, DOI 10.1016/0003-2697(68)90095-X; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; SZCZEPKOWSKI TW, 1967, BIOCHIM BIOPHYS ACTA, V139, P469, DOI 10.1016/0005-2744(67)90050-2; TALLAN HH, 1971, BIOCHEM BIOPH RES CO, V43, P303, DOI 10.1016/0006-291X(71)90753-4; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; UELAND PM, 1995, CLIN CHEM, V41, P340; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; WILLHARDT I, 1975, ANAL BIOCHEM, V63, P263, DOI 10.1016/0003-2697(75)90213-4; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	47	329	346	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11601	11612		10.1074/jbc.M808026200	http://dx.doi.org/10.1074/jbc.M808026200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261609	Green Published, hybrid			2022-12-27	WOS:000265494500064
J	Harburger, DS; Bouaouina, M; Calderwood, DA				Harburger, David S.; Bouaouina, Mohamed; Calderwood, David A.			Kindlin-1 and-2 Directly Bind the C-terminal Region of beta Integrin Cytoplasmic Tails and Exert Integrin-specific Activation Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MATRIX ADHESION; STRUCTURAL BASIS; PLATELET-AGGREGATION; TALIN BINDING; IN-VIVO; DOMAIN; PROTEINS; COMPETITION; MEMBRANE; FILAMIN	Integrin activation, the rapid conversion of integrin adhesion receptors from low to high affinity, occurs in response to intracellular signals that act on the short cytoplasmic tails of integrin beta subunits. Talin binding to integrin beta tails provides one key activation signal, but additional factors are likely to cooperate with talin to regulate integrin activation. The integrin beta tail-binding proteins kindlin-2 and kindlin-3 were recently identified as integrin co-activators. Here we report an analysis of kindlin-1 and kindlin-2 interactions with beta 1 and beta 3 integrin tails and describe the effect of kindlin expression on integrin activation. We demonstrate a direct interaction of kindlin-1 and -2 with recombinant integrin beta tails in pulldown binding assays. Our mutational analysis shows that the second conserved NXXY motif (Tyr(795)), a preceding threonine-containing region (Thr(788) and Thr(789)) of the integrin beta 1A tail, and a conserved tryptophan in the F3 subdomain of the kindlin FERM domain (kindlin-1 Trp(612) and kindlin-2 Trp(615)) are required for direct kindlin-integrin interactions. Similar interactions were observed for integrin beta 3 tails. Using fluorescence-activated cell sorting we further show that transient expression of kindlin-1 or -2 in Chinese hamster ovary cells inhibits the activation of endogenous alpha 5 beta 1 or stably expressed alpha IIb beta 3 integrins. This inhibition is not dependent on direct kindlin-integrin interactions because mutant kindlins exhibiting impaired integrin binding activity effectively inhibit integrin activation. Consistent with previous reports, we find that when co-expressed with the talin head, kindlin-1 or -2 can activate alpha IIb beta 3. This effect is dependent on an intact integrin-binding site in kindlin. Notably however, even when co-expressed with activating levels of talin head, neither kindlin-1 or -2 can cooperate with talin to activate beta 1 integrins; instead they strongly inhibit talin-mediated activation. We suggest that kindlins are adaptor proteins that regulate integrin activation, that kindlin expression levels determine their effects, and that kindlins may exert integrin-specific effects.	[Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdepartmental Program Vasc Biol & Transplanta, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142	National Institutes of Health [RO1 GM068600, R21 HL089433]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM068600 and R21 HL089433. This work was also supported by a National Science Foundation Graduate Research Fellowship Award (to D. S. H.).	Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Heckmann D, 2007, ANGEW CHEM INT EDIT, V46, P3571, DOI 10.1002/anie.200700008; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weinstein EJ, 2003, BBA-MOL BASIS DIS, V1637, P207, DOI 10.1016/S0925-4439(03)00035-8; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	48	231	239	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11485	11497		10.1074/jbc.M809233200	http://dx.doi.org/10.1074/jbc.M809233200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240021	hybrid, Green Published			2022-12-27	WOS:000265494500053
J	Oshima, M; Mimura, J; Sekine, H; Okawa, H; Fujii-Kuriyama, Y				Oshima, Motohiko; Mimura, Junsei; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki			SUMO Modification Regulates the Transcriptional Repressor Function of Aryl Hydrocarbon Receptor Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSLOCATOR ARNT; AHR REPRESSOR; DIOXIN RECEPTOR; EXPRESSION; GENE; SUMOYLATION; CONJUGATION; MECHANISM; FAMILY; SWITCH	The aryl hydrocarbon receptor (AhR) repressor (AhRR) inhibits the AhR activity. AhRR acts by competing with AhR for heterodimer formation with the AhR nuclear translocator (Arnt) and preventing the AhR.Arnt complex from binding the xenobiotic-responsive elements. Here, we report that AhRR has three evolutionarily conserved SUMOylation consensus sequences within its C-terminal repression domain and that Lys-542, Lys-583, and Lys-660 at the SUMOylation sites are modified by SUMO-1 in vivo. Arginine mutation of the three lysines results in a significant reduction of transcriptional repression activity. SUMOylation of the three lysine residues is important for the interaction between AhRR and ANKRA2, HDAC4, and HDAC5, which are important corepressors for AhRR. Arnt, a heterodimer partner for AhRR, markedly enhanced the SUMOylation of AhRR. AhRR, but not AhR, also significantly enhanced the SUMOylation of Arnt. The SUMOylation of both AhRR and Arnt is important for the efficient transcriptional repression activity of the AhRR/Arnt heterodimer.	[Oshima, Motohiko; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Oshima, Motohiko; Mimura, Junsei; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; [Mimura, Junsei] Hirosaki Univ, Grad Sch Med, Dept Stress Response Sci, Aomori 0368562, Japan; [Oshima, Motohiko; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	University of Tsukuba; University of Tsukuba; Hirosaki University; Japan Science & Technology Agency (JST)	Fujii-Kuriyama, Y (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	ykfujii@tara.tsukuba.ac.jp	Mimura, Junsei/E-7893-2013		Ministry of Health, Labor, and Welfare of Japan and Solution Oriented Research for Science and Technology, Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare of Japan and Solution Oriented Research for Science and Technology, Japan Science and Technology Agency(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a scientific research grant from the Ministry of Health, Labor, and Welfare of Japan and Solution Oriented Research for Science and Technology, Japan Science and Technology Agency.	Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hosoya T, 2008, BIOCHEM BIOPH RES CO, V365, P562, DOI 10.1016/j.bbrc.2007.11.016; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kanno Y, 2006, BIOL PHARM BULL, V29, P1254, DOI 10.1248/bpb.29.1254; Karchner SI, 2002, J BIOL CHEM, V277, P6949, DOI 10.1074/jbc.M110779200; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Nishihashi H, 2006, BIOL PHARM BULL, V29, P640, DOI 10.1248/bpb.29.640; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Oshima M, 2007, BIOCHEM BIOPH RES CO, V364, P276, DOI 10.1016/j.bbrc.2007.09.131; Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	23	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11017	11026		10.1074/jbc.M808694200	http://dx.doi.org/10.1074/jbc.M808694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251700	hybrid, Green Published			2022-12-27	WOS:000265494500006
J	Tian, L; Gu, LY; Li, GM				Tian, Lei; Gu, Liya; Li, Guo-Min			Distinct Nucleotide Binding/Hydrolysis Properties and Molar Ratio of MutS alpha and MutS beta Determine Their Differential Mismatch Binding Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; REPAIR PROTEIN MUTS; ATPASE ACTIVITY; DNA MISMATCH; HMUTS-ALPHA; RECOGNITION COMPLEX; MOLECULAR SWITCH; HUMAN-CELLS; HYDROLYSIS; SUBUNIT	MutS alpha (MSH2/MSH6) and MutS beta (MSH2/MSH3) are eukaryotic mismatch recognition proteins that preferentially process base-base and small insertion/deletion (ID) mispairs, respectively, despite the fact that cells contain a MutS alpha:MutS beta ratio of 10:1. To explore the mechanism underlying the differential mismatch recognition by these two proteins, purified human alpha MutS and MutS beta were analyzed individually and competitively for their abilities to interact with a T-G and an ID substrate. We show that MutS alpha has K-D values of 26.5 and 38.2 nM for the G-T and ID substrates, respectively, and that MutS beta has K-D values of 76.5 and 23.5 nM for G-T and ID, respectively. Consistent with these results, competitive binding assays revealed the following relative binding affinities: MutS beta-ID > MutS alpha-T-G > MutS alpha-ID >> MutS beta-T-G. Interestingly, binding of MutS beta to ID heteroduplexes is greatly stimulated when the MutS alpha:MutS beta ratio is >= 10. Distinct ATP/ADP binding and ATPase activities of MutS alpha and MutS beta were also observed. In the absence of DNA, ADP binding and ATPase activities of MutS beta are significantly higher than those of MutS alpha. However, interaction with DNA significantly stimulates the MutS alpha ATPase activity and reduces the MutS beta ATPase activity, the consequence being that both proteins exhibit the same level of hydrolytic activity. We conclude that the preferential processing of base-base and ID heteroduplexes by MutS alpha and MutS beta is determined by their significant differences in ATPase activity, ADP binding activity, and high cellular MutS alpha:MutS beta ratio.	[Li, Guo-Min] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Li, GM (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	gmli@uky.edu	Li, Guo-Min/I-5016-2014	Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [GM072756, CA115942, CA104333]; NATIONAL CANCER INSTITUTE [R01CA115942, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072756 and CA115942 (to G.-M. L.) and CA104333 (to L. G.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Biswas I, 1996, J BIOL CHEM, V271, P5040; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gu LY, 2006, METHOD ENZYMOL, V408, P303, DOI 10.1016/S0076-6879(06)08019-0; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; McCulloch SD, 2003, J BIOL CHEM, V278, P3891, DOI 10.1074/jbc.M210687200; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	32	32	32	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11557	11562		10.1074/jbc.M900908200	http://dx.doi.org/10.1074/jbc.M900908200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19228687	hybrid, Green Published			2022-12-27	WOS:000265494500059
J	Chen, WQ; Huang, TT; He, XY; Meng, QQ; You, DL; Bai, LQ; Li, JL; Wu, MX; Li, R; Xie, ZJ; Zhou, HC; Zhou, XF; Tan, HR; Deng, ZX				Chen, Wenqing; Huang, Tingting; He, Xinyi; Meng, Qingqing; You, Delin; Bai, Linquan; Li, Jialiang; Wu, Mingxuan; Li, Rui; Xie, Zhoujie; Zhou, Huchen; Zhou, Xiufen; Tan, Huarong; Deng, Zixin			Characterization of the Polyoxin Biosynthetic Gene Cluster from Streptomyces cacaoi and Engineered Production of Polyoxin H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE PEPTIDE ANTIBIOTICS; CO-TRANSCRIBED GENES; NIKKOMYCIN BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; COELICOLOR A3(2); ANTIFUNGAL ANTIBIOTICS; GENOME SEQUENCE; CLONING; ACID; ANSOCHROMOGENES	A gene cluster (pol) essential for the biosynthesis of polyoxin, a nucleoside antibiotic widely used for the control of phytopathogenic fungi, was cloned from Streptomyces cacaoi. A 46,066-bp region was sequenced, and 20 of 39 of the putative open reading frames were defined as necessary for polyoxin biosynthesis as evidenced by its production in a heterologous host, Streptomyces lividans TK24. The role of PolO and PolA in polyoxin synthesis was demonstrated by in vivo experiments, and their functions were unambiguously characterized as O-carbamoyltransferase and UMP-enolpyruvyltransferase, respectively, by in vitro experiments, which enabled the production of a modified compound differing slightly from that proposed earlier. These studies should provide a solid foundation for the elucidation of the molecular mechanisms for polyoxin biosynthesis, and set the stage for combinatorial biosynthesis using genes encoding different pathways for nucleoside antibiotics.	[Chen, Wenqing; Huang, Tingting; He, Xinyi; You, Delin; Bai, Linquan; Li, Jialiang; Zhou, Xiufen; Deng, Zixin] Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China; [Chen, Wenqing; Huang, Tingting; He, Xinyi; You, Delin; Bai, Linquan; Li, Jialiang; Zhou, Xiufen; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Meng, Qingqing; Wu, Mingxuan; Zhou, Huchen] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Li, Rui; Xie, Zhoujie; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.	tanhr@im.ac.cn; zxdeng@sjtu.edu.cn	BAI, Linquan/AAI-9833-2020; Wu, Mingxuan/G-8519-2017	Li, Rui/0000-0001-5796-2778; Chen, Wenqing/0000-0003-2557-8960	Ministry of Science and Technology [973, 863]; National Science Foundation of China; Shanghai Municipal Council of Science and Technology; Shanghai Leading Academic Discipline Project [B203]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by Grants 973 and 863 from the Ministry of Science and Technology, the National Science Foundation of China, the Shanghai Municipal Council of Science and Technology, and Shanghai Leading Academic Discipline Project B203.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bai L, 2006, CHEM BIOL, V13, P387, DOI 10.1016/j.chembiol.2006.02.002; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bruntner C, 1999, MOL GEN GENET, V262, P102; Bruntner C, 1998, EUR J BIOCHEM, V254, P347, DOI 10.1046/j.1432-1327.1998.2540347.x; Carrell CJ, 2007, STRUCTURE, V15, P928, DOI 10.1016/j.str.2007.06.010; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen W, 2000, CURR MICROBIOL, V41, P312, DOI 10.1007/s002840010141; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; FIEDLER HP, 1984, J CHROMATOGR, V316, P487, DOI 10.1016/S0021-9673(00)96176-4; FUNAYAMA S, 1977, BIOCHEMISTRY-US, V16, P3121, DOI 10.1021/bi00633a013; FUNAYAMA S, 1975, BIOCHEMISTRY-US, V14, P5568, DOI 10.1021/bi00697a005; Garcia M, 2000, TETRAHEDRON-ASYMMETR, V11, P991, DOI 10.1016/S0957-4166(00)00020-3; Ginj C, 2005, CHEMBIOCHEM, V6, P1974, DOI 10.1002/cbic.200500208; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HINDLE Z, 1994, MICROBIOL-SGM, V140, P311, DOI 10.1099/13500872-140-2-311; HORI M, 1974, J ANTIBIOT, V27, P260, DOI 10.7164/antibiotics.27.260; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; ISONO K, 1976, ARCH BIOCHEM BIOPHYS, V173, P141, DOI 10.1016/0003-9861(76)90244-7; ISONO K, 1975, BIOCHEMISTRY-US, V14, P2992, DOI 10.1021/bi00684a031; ISONO K, 1965, AGR BIOL CHEM TOKYO, V29, P848, DOI 10.1080/00021369.1965.10858475; ISONO K, 1967, AGR BIOL CHEM TOKYO, V31, P190, DOI 10.1080/00021369.1967.10858788; ISONO K, 1978, J AM CHEM SOC, V100, P3937, DOI 10.1021/ja00480a052; ISONO K, 1988, J ANTIBIOT, V41, P1711, DOI 10.7164/antibiotics.41.1711; KIESER T, 2000, PRACTICAL STREPTOMYC, P169; LACALLE RA, 1992, EMBO J, V11, P785, DOI 10.1002/j.1460-2075.1992.tb05112.x; Lauer B, 2000, EUR J BIOCHEM, V267, P1698, DOI 10.1046/j.1432-1327.2000.01162.x; Lauer B, 2001, MOL GEN GENET, V264, P662, DOI 10.1007/s004380000352; Lauer B, 2000, J ANTIBIOT, V53, P385, DOI 10.7164/antibiotics.53.385; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Li YR, 2004, CURR MICROBIOL, V49, P128, DOI 10.1007/s00284-004-4260-4; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Ostash B, 2007, CHEM BIOL, V14, P257, DOI 10.1016/j.chembiol.2007.01.008; Sambrook J., 2002, MOL CLONING LAB MANU; Sun YH, 2002, MICROBIOL-SGM, V148, P361, DOI 10.1099/00221287-148-2-361; Tahlan K, 2004, CAN J MICROBIOL, V50, P803, DOI 10.1139/W04-070; VANRHIJN P, 1994, APPL ENVIRON MICROB, V60, P3615, DOI 10.1128/AEM.60.10.3615-3623.1994; WEN Z, 2004, CHINESE J BIOL, V21, P36; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zhang D, 1999, CURR PHARM DESIGN, V5, P73	41	65	72	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10627	10638		10.1074/jbc.M807534200	http://dx.doi.org/10.1074/jbc.M807534200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233844	Green Published, hybrid			2022-12-27	WOS:000265104600037
J	Gerin, I; Bommer, GT; Lidell, ME; Cederberg, A; Enerback, S; MacDougald, OA				Gerin, Isabelle; Bommer, Guido T.; Lidell, Martin E.; Cederberg, Anna; Enerback, Sven; MacDougald, Ormond A.			On the Role of FOX Transcription Factors in Adipocyte Differentiation and Insulin-stimulated Glucose Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-ALPHA; ADIPONECTIN GENE-EXPRESSION; C/EBP-ALPHA; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; ADIPOSE-TISSUE; RECEPTOR-GAMMA; ADIPOGENESIS; METABOLISM; INHIBITION	In this study, we explore the effects of several FOX and mutant FOX transcription factors on adipocyte determination, differentiation, and metabolism. In addition to Foxc2 and Foxo1, we report that Foxf2, Foxp1, and Foxa1 are other members of the Fox family that show regulated expression during adipogenesis. Although enforced expression of FOXC2 inhibits adipogenesis, Foxf2 slightly enhances the rate of differentiation. Constitutively active FOXC2-VP16 inhibits adipogenesis through multiple mechanisms. FOXC2-VP16 impairs the transient induction of C/EBP beta during adipogenesis and induces expression of the transcriptional repressor Hey1 as well as the activator of Wnt/beta-catenin signaling, Wnt10b. The constitutive transcriptional repressor, FOXC2-Eng, enhances adipogenesis of preadipocytes and multipotent mesenchymal precursors and determines NIH-3T3 and C2C12 cells to the adipocyte lineage. Although PPAR gamma ligand or C/EBP alpha are not necessary for stimulation of adipogenesis by FOXC2-Eng, at least low levels of PPAR gamma protein are absolutely required. Finally, expression of FOXC2-Eng in adipocytes increases insulin-stimulated glucose uptake, further expanding the profound and pleiotropic effects of FOX transcription factors on adipocyte biology.	[Gerin, Isabelle; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Bommer, Guido T.; MacDougald, Ormond A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lidell, Martin E.; Cederberg, Anna; Enerback, Sven] Univ Gothenburg, Ctr Genet, Dept Med & Clin Genet, Sahlgrenska Acad,Inst Biomed, SE-40530 Gothenburg, Sweden	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Gothenburg	MacDougald, OA (corresponding author), 7708A Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	macdouga@umich.edu	; Bommer, Guido/A-8425-2011	MacDougald, Ormond/0000-0001-6907-7960; Bommer, Guido/0000-0001-6898-4884	National Institutes of Health [DK51563, DK62876]; Belgian Fonds National de la Recherche Scientifique; Center for Organogenesis; Michigan Metabolomics and Obesity Center, European Commission [LSHMCT-2005-018734]; Swedish Research Council [K2005-32BI-15324-01A]; European Union [QLK3-CT-2002-02149, LSHM-CT-2003-503041]; Arne and Inga Britt Foundation; Soderberg Foundation; Swedish Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062876, R56DK062876, R01DK051563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Center for Organogenesis; Michigan Metabolomics and Obesity Center, European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Arne and Inga Britt Foundation; Soderberg Foundation; Swedish Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51563 and DK62876 (to O.A.M.). This work was also supported by the Belgian Fonds National de la Recherche Scientifique and the Center for Organogenesis (to I. G.), the Michigan Metabolomics and Obesity Center, European Commission Contract LSHMCT-2005-018734 under Project HEPADIP, Swedish Research Council Grant K2005-32BI-15324-01A (to S. E.), European Union Grants QLK3-CT-2002-02149 and LSHM-CT-2003-503041, the Arne and Inga Britt Foundation, the Soderberg Foundation, and the Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research.	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; BURATOWSKI S, 2003, CURRENT PROTOCOLS MO, P1221; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Davis KE, 2004, J BIOL CHEM, V279, P42453, DOI 10.1074/jbc.M402197200; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gronning LM, 2006, FEBS LETT, V580, P4126, DOI 10.1016/j.febslet.2006.06.058; Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Jarikji ZH, 2007, DEV BIOL, V304, P786, DOI 10.1016/j.ydbio.2007.01.027; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim JK, 2005, DIABETES, V54, P1657, DOI 10.2337/diabetes.54.6.1657; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Raichur S, 2007, J MOL ENDOCRINOL, V39, P29, DOI 10.1677/jme.1.00010; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steiner AB, 2006, DEVELOPMENT, V133, P4827, DOI 10.1242/dev.02663; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wijchers PJEC, 2006, BRAIN RES, V1068, P23, DOI 10.1016/j.brainres.2005.11.022; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	44	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10755	10763		10.1074/jbc.M809115200	http://dx.doi.org/10.1074/jbc.M809115200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244248	Green Published, hybrid			2022-12-27	WOS:000265104600050
J	Katzenberger, RJ; Marengo, MS; Wassarman, DA				Katzenberger, Rebeccah J.; Marengo, Matthew S.; Wassarman, David A.			Control of Alternative Splicing by Signal-dependent Degradation of Splicing-regulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CELL-CYCLE PROGRESSION; DNA-DAMAGE; TOPOISOMERASE-I; RADIOSENSITIZING AGENT; TRANSDUCTION PATHWAYS; PROTEOMIC ANALYSIS; RECOGNITION MOTIF; GENE-EXPRESSION; HUMAN GENOME	Alternative pre-mRNA splicing is a major gene expression regulatory mechanism in metazoan organisms. Proteins that bind pre-mRNA elements and control assembly of splicing complexes regulate utilization of pre-mRNA alternative splice sites. To understand how signaling pathways impact this mechanism, an RNA interference screen in Drosophila S2 cells was used to identify proteins that regulate TAF1 (TBP-associated factor 1) alternative splicing in response to activation of the ATR (ATMRAD3-related) signaling pathway by the chemotherapeutic drug camptothecin (CPT). The screen identified 15 proteins that, when knocked down, caused the same change in TAF1 alternative splicing as CPT treatment. However, combined RNA interference and CPT treatment experiments indicated that only a subset of the identified proteins are targets of the CPT-induced signal, suggesting that multiple independent pathways regulate TAF1 alternative splicing. To understand how signals modulate the function of splicing factors, we characterized one of the CPT targets, Tra2 (Transformer-2). CPT was found to down-regulate Tra2 protein levels. CPT-induced Tra2 down-regulation was ATR-dependent and temporally paralleled the change in TAF1 alternative splicing, supporting the conclusion that Tra2 directly regulates TAF1 alternative splicing. Additionally, CPT-induced Tra2 down-regulation occurred independently of new protein synthesis, suggesting a post-translational mechanism. The proteasome inhibitor MG132 reduced CPT-induced Tra2 degradation and TAF1 alternative splicing, and mutation of evolutionarily conserved Tra2 lysine 81, a potential ubiquitin conjugation site, to arginine inhibited CPT-induced Tra2 degradation, supporting a proteasome-dependent alternative splicing mechanism. We conclude that CPT-induced TAF1 alternative splicing occurs through ATR-signaled degradation of a subset of splicing-regulatory proteins.	[Katzenberger, Rebeccah J.; Marengo, Matthew S.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA; [Marengo, Matthew S.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wassarman, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	dawassarman@wisc.edu			National Institutes of Health [T32 GM08688]; National Science Foundation [MCB-0614059, MCB-0743403]; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 GM08688 (to M. S. M.). This work was also supported by National Science Foundation Grants MCB-0614059 and MCB-0743403 (to D. A. W.) and by a predoctoral fellowship from the PhRMA Foundation (to M. S. M.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BRAND SF, 1995, GENE, V154, P187, DOI 10.1016/0378-1119(94)00840-O; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chandler DS, 2003, MOL CELL BIOL, V23, P5174, DOI 10.1128/MCB.23.15.5174-5185.2003; Chen BS, 2002, CURR BIOL, V12, pR620, DOI 10.1016/S0960-9822(02)01134-X; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dembla-Rajpal N, 2004, BBA-GENE STRUCT EXPR, V1680, P34, DOI 10.1016/j.bbaexp.2004.08.008; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lai MC, 2003, BIOCHEM J, V371, P937, DOI 10.1042/BJ20021827; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lynch KW, 2007, ADV EXP MED BIOL, V623, P161, DOI 10.1007/978-0-387-77374-2_10; Marengo MS, 2008, RNA, V14, P1681, DOI 10.1261/rna.1048808; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matangkasombut O, 2004, ADV PROTEIN CHEM, V67, P67; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Mollet I, 2006, FEBS J, V273, P4807, DOI 10.1111/j.1742-4658.2006.05502.x; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Qi JL, 2006, NUCLEIC ACIDS RES, V34, P6256, DOI 10.1093/nar/gkl755; Saeki K, 2005, AM J PHYSIOL-ENDOC M, V289, pE419, DOI 10.1152/ajpendo.00512.2004; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sciabica KS, 2006, NUCLEIC ACIDS RES, V34, P6612, DOI 10.1093/nar/gkl984; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Solier S, 2004, MOL CANCER RES, V2, P53; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Venables JP, 2004, HUM MOL GENET, V13, P1525, DOI 10.1093/hmg/ddh165; Venables JP, 2005, HUM MOL GENET, V14, P2289, DOI 10.1093/hmg/ddi233; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I	67	26	27	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10737	10746		10.1074/jbc.M809506200	http://dx.doi.org/10.1074/jbc.M809506200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218244	Green Published, hybrid			2022-12-27	WOS:000265104600048
J	Nakade, K; Pan, JZ; Yamasaki, T; Murata, T; Wasylyk, B; Yokoyama, KK				Nakade, Koji; Pan, Jianzhi; Yamasaki, Takahito; Murata, Takehide; Wasylyk, Bohdan; Yokoyama, Kazunari K.			JDP2 (Jun Dimerization Protein 2)-deficient Mouse Embryonic Fibroblasts Are Resistant to Replicative Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; HEMATOPOIETIC STEM-CELLS; POLYCOMB GROUP PROTEINS; PREMATURE SENESCENCE; INSERTIONAL MUTAGENESIS; DEPENDENT TRANSCRIPTION; P16(INK4A) EXPRESSION; HISTONE ACETYLATION; AP-1 REPRESSOR; DNA-DAMAGE	JDP2 (Jun dimerization protein 2, an AP-1 transcription factor) is involved in the regulation of the differentiation and proliferation of cells. We report here that JDP2-deficient mouse embryonic fibroblasts (Jdp2(-/-) MEF) are resistant to replicative senescence. In the absence of JDP2, the level of expression of p16(Ink4a), which is known to rise as normal fibroblasts age, fell significantly when cells were cultured for more than 2 months. Conversely, the overexpression of JDP2 induced the expression of genes for p16(Ink4a) and p19(Arf). Moreover, at the promoter of the gene for p16(Ink4a) in Jdp2(-/-) MEF, the extent of methylation of lysine 27 of histone H3 (H3K27), which is important for gene silencing, increased. Polycomb-repressive complexes (PRC-1 and PRC-2), which are responsible for histone methylation, bound efficiently to the promoter to repress the expression of the gene for p16(Ink4a). As a result, JDP2-deficient MEF became resistant to replicative senescence. Our results indicate that JDP2 is involved in the signaling pathway for senescence via epigenetic regulation of the expression of the gene for p16(Ink4a).	[Nakade, Koji; Pan, Jianzhi; Yamasaki, Takahito; Murata, Takehide; Yokoyama, Kazunari K.] RIKEN, BioResource Ctr, Gene Engn Div, Tsukuba, Ibaraki 3050074, Japan; [Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Ctr Excellence Environm Med, Kaohsiung 80708, Taiwan	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kaohsiung Medical University	Nakade, K (corresponding author), RIKEN, BioResource Ctr, Gene Engn Div, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	nakade@rtc.riken.jp; kazu@brc.riken.jp	Wasylyk, Bohdan/ABG-6778-2020; Yokoyama, Kazunari K./B-3671-2010	Wasylyk, Bohdan/0000-0002-1718-1237; 	RIKEN Bioresource Project; Ministry of Education, Culture, Sport, Science and Technology of Japan [18770185, 20570193, 19041069]	RIKEN Bioresource Project; Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the RIKEN Bioresource Project (to K. K. Y.) and from the Ministry of Education, Culture, Sport, Science and Technology of Japan 18770185 and 20570193 (to K. N.) and 19041069 (to K. K. Y.).	Ameyar-Zazoua M, 2005, ONCOGENE, V24, P2298, DOI 10.1038/sj.onc.1208424; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Cherasse Y, 2008, FEBS LETT, V582, P1537, DOI 10.1016/j.febslet.2008.03.050; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; JIN C, 2002, NUCLEIC ACIDS RES, V2, pS97; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Meng AM, 2003, CANCER RES, V63, P5414; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Pavey S, 1999, CANCER RES, V59, P4185; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Ugai H, 2005, BIOCHEM BIOPH RES CO, V331, P1053, DOI 10.1016/j.bbrc.2005.03.227; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	47	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10808	10817		10.1074/jbc.M808333200	http://dx.doi.org/10.1074/jbc.M808333200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233846	Green Published, hybrid			2022-12-27	WOS:000265104600055
J	Semenova, NP; Abarca-Heidemann, K; Loranc, E; Rothberg, BS				Semenova, Nina P.; Abarca-Heidemann, Karin; Loranc, Eva; Rothberg, Brad S.			Bimane Fluorescence Scanning Suggests Secondary Structure near the S3-S4 Linker of BK Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; VOLTAGE-SENSOR ACTIVATION; CONFORMATIONAL-CHANGES; ION CHANNELS; CLAMP FLUOROMETRY; C-TERMINUS; N-TERMINUS; SPECTROSCOPY; MEMBRANE	Gating of large conductance Ca2+-activated K+ channels (BK or maxi-K channels) is controlled by a Ca2+-sensor, formed by the channel cytoplasmic C-terminal domain, and a voltage sensor, formed by its S0-S4 transmembrane helices. Here we analyze structural properties of a portion of the BK channel voltage sensing domain, the S3-S4 linker, using fluorescence lifetime spectroscopy. Single residues in the S3-S4 linker region were substituted with cysteine, and the cysteine-substituted mutants were expressed in CHO cells and covalently labeled with the sulfhydryl-reactive fluorophore monobromo-trimethylammonio-bimane (qBBr). qBBr fluorescence is quenched by tryptophan and, to a lesser extent, tyrosine side chains. We found that qBBr fluorescence in several of the labeled cysteine-substituted channels shows position-specific quenching, as indicated by increase of the brief lifetime component of the qBBr fluorescence decay. Quenching was reduced with the mutation W203F (in the S4 segment), suggesting that Trp-203 acts as a quenching group. Our results suggest a working hypothesis for the secondary structure of the BK channel S3-S4 region, and places residues Leu-204, Gly-205, and Leu-206 within the extracellular end of the S4 helix.	[Semenova, Nina P.; Abarca-Heidemann, Karin; Loranc, Eva; Rothberg, Brad S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Rothberg, BS (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3440 N Broad St, Philadelphia, PA 19140 USA.	rothberg@temple.edu	Rothberg, Brad/AAD-1260-2022	Rothberg, Brad/0000-0003-1982-2269	National Institutes of Health [GM68523]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68523 (to B. S. R.).	Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HUANG TTF, 1984, BIOL REPROD, V31, P797, DOI 10.1095/biolreprod31.4.797; Islas LD, 2006, J GEN PHYSIOL, V128, P337, DOI 10.1085/jgp.200609556; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kachel K, 1998, J BIOL CHEM, V273, P22950, DOI 10.1074/jbc.273.36.22950; KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P585, DOI 10.1113/jphysiol.1983.sp014957; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; MATE KE, 1994, MOL REPROD DEV, V37, P318, DOI 10.1002/mrd.1080370311; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SATO E, 1988, BIOORG CHEM, V16, P298, DOI 10.1016/0045-2068(88)90017-X; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Silvius Jr, 1999, METH MOL B, V116, P177; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	50	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10684	10693		10.1074/jbc.M808891200	http://dx.doi.org/10.1074/jbc.M808891200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244238	Green Published, hybrid			2022-12-27	WOS:000265104600042
J	Xiao, ZY; Deng, PY; Rojanathammanee, L; Yang, CX; Grisanti, L; Permpoonputtana, K; Weinshenker, D; Doze, VA; Porter, JE; Lei, S				Xiao, Zhaoyang; Deng, Pan-Yue; Rojanathammanee, Lalida; Yang, Chuanxiu; Grisanti, Laurel; Permpoonputtana, Kannika; Weinshenker, David; Doze, Van A.; Porter, James E.; Lei, Saobo			Noradrenergic Depression of Neuronal Excitability in the Entorhinal Cortex via Activation of TREK-2K(+) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKGROUND POTASSIUM CHANNELS; DOMAIN K+ CHANNELS; PROTEIN-COUPLED RECEPTORS; TEMPORAL-LOBE EPILEPSY; SYSTEM IN-VITRO; GABAERGIC TRANSMISSION; PARAHIPPOCAMPAL REGION; INTRINSIC CONNECTIONS; DENTATE GYRUS; RAT-BRAIN	The entorhinal cortex is closely associated with the consolidation and recall of memories, Alzheimer disease, schizophrenia, and temporal lobe epilepsy. Norepinephrine is a neurotransmitter that plays a significant role in these physiological functions and neurological diseases. Whereas the entorhinal cortex receives profuse noradrenergic innervations from the locus coeruleus of the pons and expresses high densities of adrenergic receptors, the function of norepinephrine in the entorhinal cortex is still elusive. Accordingly, we examined the effects of norepinephrine on neuronal excitability in the entorhinal cortex and explored the underlying cellular and molecular mechanisms. Application of norepinephrine-generated hyperpolarization and decreased the excitability of the neurons in the superficial layers with no effects on neuronal excitability in the deep layers of the entorhinal cortex. Norepinephrine-induced hyperpolarization was mediated by alpha(2A) adrenergic receptors and required the functions of G alpha(i) proteins, adenylyl cyclase, and protein kinase A. Norepinephrine-mediated depression on neuronal excitability was mediated by activation of TREK-2, a type of two-pore domain K+ channel, and mutation of the protein kinase A phosphorylation site on TREK-2 channels annulled the effects of norepinephrine. Our results indicate a novel action mode in which norepinephrine depresses neuronal excitability in the entorhinal cortex by disinhibiting protein kinase A-mediated tonic inhibition of TREK-2 channels.	[Xiao, Zhaoyang; Deng, Pan-Yue; Yang, Chuanxiu; Grisanti, Laurel; Doze, Van A.; Porter, James E.; Lei, Saobo] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Rojanathammanee, Lalida; Permpoonputtana, Kannika] Mahidol Univ, Inst Sci & Technol Res & Dev, Neurobehav Biol Ctr, Salaya Nakornpathom 73170, Thailand; [Rojanathammanee, Lalida; Permpoonputtana, Kannika] Mahidol Univ, Fac Sci, Ctr Neurosci, Bangkok 10400, Thailand; [Rojanathammanee, Lalida; Permpoonputtana, Kannika] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Weinshenker, David] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University of North Dakota Grand Forks; Mahidol University; Mahidol University; Mahidol University; Emory University	Lei, S (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, 501 N Columbia Rd, Grand Forks, ND 58203 USA.	slei@medicine.nodak.edu	Weinshenker, David/V-3998-2019	Permpoonputtana, Kannika/0000-0001-6442-8629; Doze, Van/0000-0002-5288-9564	National Institutes of Health [R01MH082881, 5P20RR017699]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01MH082881 (to S. L.) and 5P20RR017699 (to S. L.).	Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; BOOZE RM, 1993, SYNAPSE, V13, P206, DOI 10.1002/syn.890130303; BOYAJIAN CL, 1987, J PHARMACOL EXP THER, V241, P1079; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buffalari DM, 2007, J NEUROSCI, V27, P12358, DOI 10.1523/JNEUROSCI.2007-07.2007; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Deng PY, 2007, J NEUROPHYSIOL, V97, P727, DOI 10.1152/jn.01089.2006; Deng PY, 2006, J PHYSIOL-LONDON, V572, P425, DOI 10.1113/jphysiol.2005.104463; DENG PY, 2006, J PHYSL, P497; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; DU F, 1992, NEUROSCI LETT, V147, P185, DOI 10.1016/0304-3940(92)90591-T; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; FALLON JH, 1978, J COMP NEUROL, V180, P509, DOI 10.1002/cne.901800308; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Galeotti N, 2004, BEHAV BRAIN RES, V153, P409, DOI 10.1016/j.bbr.2003.12.016; Galeotti N, 2004, NEUROSCIENCE, V126, P451, DOI 10.1016/j.neuroscience.2004.04.001; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Haapalinna A, 1998, EUR J PHARMACOL, V347, P29, DOI 10.1016/S0014-2999(98)00077-6; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Joyal CC, 2002, BIOL PSYCHIAT, V51, P1005, DOI 10.1016/S0006-3223(01)01368-3; Kang D, 2007, EXP DERMATOL, V16, P1016, DOI 10.1111/j.1600-0625.2007.00626.x; Kang D, 2007, J PHYSIOL-LONDON, V583, P57, DOI 10.1113/jphysiol.2007.136150; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Lei S, 2007, J NEUROPHYSIOL, V98, P2868, DOI 10.1152/jn.00679.2007; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Majak K, 2003, EUR J NEUROSCI, V18, P1652, DOI 10.1046/j.1460-9568.2003.02854.x; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Mulders WHAM, 1997, J COMP NEUROL, V385, P83; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; PALKOVITS M, 1979, BRAIN RES BULL, V4, P593, DOI 10.1016/0361-9230(79)90099-6; PRALONG E, 1994, NEUROSCI LETT, V179, P145, DOI 10.1016/0304-3940(94)90955-5; Pralong E, 1995, EUR J NEUROSCI, V7, P2370, DOI 10.1111/j.1460-9568.1995.tb01034.x; Prasad KMR, 2004, AM J PSYCHIAT, V161, P1612, DOI 10.1176/appi.ajp.161.9.1612; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; STANTON PK, 1987, EPILEPSY RES, V1, P53, DOI 10.1016/0920-1211(87)90051-9; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Stoop R, 2000, NEUROSCI LETT, V287, P5, DOI 10.1016/S0304-3940(00)01154-X; Szot P, 2004, NEUROSCIENCE, V126, P795, DOI 10.1016/j.neuroscience.2004.04.030; UNNERSTALL JR, 1984, BRAIN RES REV, V7, P69, DOI 10.1016/0165-0173(84)90030-4; UNNERSTALL JR, 1985, PHARMACOL BIOCHEM BE, V22, P859, DOI 10.1016/0091-3057(85)90538-6; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; WILCOX BJ, 1990, SYNAPSE, V6, P284, DOI 10.1002/syn.890060308; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398	64	57	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10980	10991		10.1074/jbc.M806760200	http://dx.doi.org/10.1074/jbc.M806760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244246	Green Published, hybrid			2022-12-27	WOS:000265104600070
J	Horak, M; Wenthold, RJ				Horak, Martin; Wenthold, Robert J.			Different Roles of C-terminal Cassettes in the Trafficking of Full-length NR1 Subunits to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; NMDA RECEPTOR SUBUNITS; D-ASPARTATE RECEPTORS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; SPLICE VARIANTS; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; MOTIF	N-Methyl-D-aspartate (NMDA) receptors are glutamategated ion channels composed of NR1 and NR2 subunits. When expressed alone, the most prevalent NR1 splice variant and all NR2 subunits are retained in the endoplasmic reticulum (ER), whereas other NR1 splice variants reach the cell surface to varying degrees. Because similar trafficking patterns have been seen for single transmembrane domain chimeric proteins with appended C termini of NMDA receptor subunits, these chimeric proteins have been used as a model for studying the mechanisms underlying the ER retention and surface trafficking of NMDA receptors. Using this approach, an RRR motif in the C1 cassette has been identified as a major ER retention signal present in NR1 subunits, and the surface localization of other NR1 splice variants has been explained by the absence of the C1 cassette or by the presence of a PDZ/coatomer protein complex II-binding domain in the C2' cassette. However, when we tested these conclusions using full-length NR1 constructs, a more complex role of the C-terminal cassettes in the trafficking of NR1 subunits emerged. Our experiments showed that two independent ER retention motifs in the C1 cassette, KKK and RRR, are the signals mediating ER retention of the full-length NR1 subunits and that the C2 cassette has an additional inhibitory effect on the forward trafficking of NR1 subunits. On the other hand, C0 and C2' cassettes had an enhancing effect on the trafficking of NR1 subunits to the cell surface. Our observations identify the unique roles of C-terminal cassettes in the trafficking of full-length NR1 subunits.	[Horak, Martin; Wenthold, Robert J.] NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Horak, M (corresponding author), NIDCD, Neurochem Lab, NIH, Rm 4146,50 S Dr, Bethesda, MD 20892 USA.	horakm@nidcd.nih.gov	Horak, Martin/A-7297-2010; Horak, Martin/F-9819-2010	Horak, Martin/0000-0002-4359-051X	National Institutes of Health NIDCD Intramural Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	National Institutes of Health NIDCD Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by the National Institutes of Health NIDCD Intramural Program.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Davey F, 2005, J NEUROCHEM, V94, P1243, DOI 10.1111/j.1471-4159.2005.03271.x; Ehlers MD, 1998, J NEUROSCI, V18, P720; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; ISHII T, 1993, J BIOL CHEM, V268, P2836; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin JW, 1998, J NEUROSCI, V18, P2017; Matsuda I, 2000, BIOCHEM BIOPH RES CO, V275, P565, DOI 10.1006/bbrc.2000.3351; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Okabe S, 1999, J NEUROSCI, V19, P7781; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4	29	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9683	9691		10.1074/jbc.M807050200	http://dx.doi.org/10.1074/jbc.M807050200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19188369	Green Published, hybrid			2022-12-27	WOS:000264892900008
J	Imtiyaz, HXZ; Zhou, XH; Zhang, HB; Chen, DH; Hu, TS; Zhang, JK				Imtiyaz, Hongxia Z.; Zhou, Xiaohui; Zhang, Haibing; Chen, Dehua; Hu, Taishan; Zhang, Jianke			The Death Domain of FADD Is Essential for Embryogenesis, Lymphocyte Development, and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; HEMATOPOIETIC STEM-CELLS; TNF RECEPTOR; INDUCED APOPTOSIS; MICE LACKING; SIGNAL-TRANSDUCTION; CYCLE PROGRESSION; DEFICIENT MICE; CD95 FAS/APO-1; CUTTING EDGE	The Fas-associated death domain-containing protein ( FADD) is an adaptor for relaying apoptotic signals initiated by death receptors such as Fas. Whereas a lack of death receptors has no effect on mouse development, FADD deficiency results in early embryonic lethality, indicating that FADD has additional functions independent of death receptors. We have previously shown that conditional deletion of FADD not only impairs apoptosis but also leads to defective lymphocyte proliferation. The non-apoptotic signaling mediated by FADD remains poorly understood. Earlier studies have suggested that FADD carboxyl terminal serine phosphorylation likely plays a role in FADD-mediated proliferation signaling in T cells. The FADD death domain is presumably only required for apoptotic signaling, as it interacts with death receptors which are dispensable during embryonic development and lymphocyte proliferation. To test this hypothesis, we have performed mutational analyses of the FADD death domain and identified a mutant, R117Q, which lacks binding to Fas and, thus, is incapable of apoptotic signaling in cell lines. Unexpectedly, this death domain point mutation disrupted mouse embryonic development as shown by in vivo functional reconstitution analyses. Interestingly, a second FADD death domain mutant, V121N, retained normal Fas binding and apoptotic signaling ability but also failed to support mouse development. Furthermore, lymphocyte proliferation responses were impaired by V121N. This reverse genetic study has revealed a previously unappreciated role of the FADD death domain, which likely functions as a molecular switch regulating two distinct signals leading to apoptosis and cell proliferation and is critical for embryogenesis, lymphocyte development, and proliferation.	[Imtiyaz, Hongxia Z.; Zhou, Xiaohui; Zhang, Haibing; Chen, Dehua; Hu, Taishan; Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Zhang, JK (corresponding author), 233 S 10th St,731 BLSB, Philadelphia, PA 19107 USA.	jzhang@mail.jci.tju.edu	Lin, Zongli/L-6084-2019	Zhang, Jianke/0000-0002-5822-2226	National Institutes of Health [RO1 CA95454]; W. W. Smith Charitable Trust; CORNCERN Foundation; Thomas Jefferson University Grants [920011, 910580]; NATIONAL CANCER INSTITUTE [R01CA095454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust; CORNCERN Foundation; Thomas Jefferson University Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA95454 ( NCI). This work was also supported by the W. W. Smith Charitable Trust, CORNCERN Foundation, and Thomas Jefferson University Grants 920011 and 910580 ( to J. Z.).	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; CHINNAIYAN AM, 1995, CELL, V81, P512; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Imtiyaz HZ, 2005, J BIOL CHEM, V280, P31360, DOI 10.1074/jbc.M504138200; ITOH N, 1993, J BIOL CHEM, V268, P10932; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kambe N, 2004, BLOOD, V103, P860, DOI 10.1182/blood-2003-04-1160; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Peng SL, 1996, J EXP MED, V184, P1149, DOI 10.1084/jem.184.3.1149; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; RATHMELL JC, 2002, CELL S, V109, P97; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; WATANABEFUKUNAG.R, 1992, NATURE, V356, P317; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033; Zhou T, 1996, J IMMUNOL, V156, P2661; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	58	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9917	9926		10.1074/jbc.M900249200	http://dx.doi.org/10.1074/jbc.M900249200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203997	Green Published, hybrid			2022-12-27	WOS:000264892900034
J	Mayerhofer, PU; Cook, JP; Wahlman, J; Pinheiro, TTJ; Moore, KAH; Lord, JM; Johnson, AE; Roberts, LM				Mayerhofer, Peter U.; Cook, Jonathan P.; Wahlman, Judit; Pinheiro, Teresa T. J.; Moore, Katherine A. H.; Lord, J. Michael; Johnson, Arthur E.; Roberts, Lynne M.			Ricin A Chain Insertion into Endoplasmic Reticulum Membranes Is Triggered by a Temperature Increase to 37 degrees C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; TOXIN A1 POLYPEPTIDE; CHOLERA-TOXIN; RETROGRADE TRANSPORT; MISFOLDED GLYCOPROTEINS; PSEUDOMONAS EXOTOXIN; STRUCTURAL-CHANGES; PERTUSSIS TOXIN; TRANSFER-RNA; SHIGA TOXIN	After endocytic uptake by mammalian cells, the heterodimeric plant toxin ricin is transported to the endoplasmic reticulum (ER), where the ricin A chain (RTA) must cross the ER membrane to reach its ribosomal substrates. Here, using gel filtration chromatography, sedimentation, fluorescence, fluorescence resonance energy transfer, and circular dichroism, we show that both fluorescently labeled and unlabeled RTA bind both to ER microsomal membranes and to negatively charged liposomes. The binding of RTA to the membrane at 0-30 degrees C exposes certain RTA residues to the nonpolar lipid core of the bilayer with little change in the secondary structure of the protein. However, major structural rearrangements in RTA occur when the temperature is increased. At 37 degrees C, membrane-bound toxin loses some of its helical content, and its C terminus moves closer to the membrane surface where it inserts into the bilayer. RTA is then stably bound to the membrane because it is nonextractable with carbonate. The sharp temperature dependence of the structural changes does not coincide with a lipid phase change because little change in fluorescence-detected membrane mobility occurred between 30 and 37 degrees C. Instead, the structural rearrangements may precede or initiate toxin retrotranslocation through the ER membrane to the cytosol. The sharp temperature dependence of these changes in RTA further suggests that they occur optimally in mammalian targets of the plant toxin.	[Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Cook, Jonathan P.; Pinheiro, Teresa T. J.; Moore, Katherine A. H.; Lord, J. Michael; Roberts, Lynne M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Warwick; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, 116 Reynolds Med Bldg, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu; Lynne.Roberts@warwick.ac.uk	Johnson, Arthur E/G-3457-2012; Cook, Jonathan/D-5704-2011	Cook, Jonathan/0000-0003-3690-555X	National Institutes of Health [GM26494]; Wellcome Trust Program [080566Z/06/Z]; Robert A. Welch Foundation Chair [BE-0017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Program(Wellcome Trust); Robert A. Welch Foundation Chair(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26494 (to A. E. J.). This work was also supported by Wellcome Trust Program Grant 080566Z/06/Z (to J. M. L. and L. M. R.) and by Robert A. Welch Foundation Chair Grant BE-0017 (to A. E. J.).	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; ARGENT RH, 1994, J BIOL CHEM, V269, P26705; Beaumelle B, 1997, J BIOL CHEM, V272, P22097, DOI 10.1074/jbc.272.35.22097; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Carbonetti NH, 1999, INFECT IMMUN, V67, P602, DOI 10.1128/IAI.67.2.602-607.1999; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; Day PJ, 2001, J BIOL CHEM, V276, P7202, DOI 10.1074/jbc.M009499200; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; DEJONGH HHJ, 1992, BIOCHEMISTRY-US, V31, P1636, DOI 10.1021/bi00121a008; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Haugland R.P., 2002, HDB FLUORESCENT PROB; HIGGINS JA, 1977, BIOCHIM BIOPHYS ACTA, V470, P342, DOI 10.1016/0005-2736(77)90126-2; Jackson ME, 1999, J CELL SCI, V112, P467; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; JOHNSON AE, 1982, J MOL BIOL, V156, P113, DOI 10.1016/0022-2836(82)90462-4; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; KREITMAN RJ, 1995, BIOCHEM J, V307, P29, DOI 10.1042/bj3070029; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Plaut RD, 2008, CELL MICROBIOL, V10, P1130, DOI 10.1111/j.1462-5822.2007.01115.x; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; SIMPSON JC, 1995, EUR J BIOCHEM, V232, P458; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; YE J, 1991, J BIOL CHEM, V266, P23016; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	48	46	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10232	10242		10.1074/jbc.M808387200	http://dx.doi.org/10.1074/jbc.M808387200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211561	Green Published, hybrid			2022-12-27	WOS:000264892900065
J	Paulusma, CC; de Waart, DR; Kunne, C; Mok, KS; Elferink, RPJO				Paulusma, Coen C.; de Waart, D. Rudi; Kunne, Cindy; Mok, Kam S.; Elferink, Ronald P. J. Oude			Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; LIPID-COMPOSITION; PLASMA-MEMBRANES; ATP8B1 MUTATIONS; INSECT CELLS; HUMAN ABCG2; RAT-LIVER; MICE; EXPRESSION; SECRETION	Mutations in ATP8B1 cause severe inherited liver disease. The disease is characterized by impaired biliary bile salt excretion (cholestasis), but the mechanism whereby impaired ATP8B1 function results in cholestasis is poorly understood. ATP8B1 is a type 4 P-type ATPase and is a flippase for phosphatidylserine. Atp8b1-deficient mice display a dramatic increase in the biliary extraction of cholesterol from the canalicular ( apical) membrane of the hepatocyte. Here we studied the hypothesis that disproportionate cholesterol extraction from the canalicular membrane impairs the activity of the bile salt transporter, ABCB11, and as a consequence causes cholestasis. Using single pass liver perfusions, we show that not only ABCB11-mediated transport but also Abcc2-mediated transport were reduced at least 4-fold in Atp8b1 deficiency. Weshow that canalicular membranes of cholestatic Atp8b1-deficient mice have a dramatically reduced cholesterol to phospholipid ratio, i.e. 0.75 +/- 0.24 versus 2.03 +/- 0.71 for wild type. In vitro depletion of cholesterol from mouse liver plasma membranes using methyl-beta-cyclodextrin demonstrated a near linear relation between cholesterol content of the membranes and ATP-dependent taurocholate transport. Abcc2-mediated transport activity was not affected up to 30% of membrane cholesterol depletion but declined to negligible levels at 70% of membrane cholesterol depletion. These effects were reversible as cholesterol repletion of the liver membranes completely restored Abcb11- and Abcc2-mediated transport. Our data demonstrate that membrane cholesterol content is a critical determinant of ABCB11/ABCC2 transport activity, provide an explanation for the etiology of ATP8B1 disease, and suggest a novel mechanism protecting the canalicular membrane against luminal bile salt overload.	[Paulusma, Coen C.; de Waart, D. Rudi; Kunne, Cindy; Mok, Kam S.; Elferink, Ronald P. J. Oude] Acad Med Ctr, AMC Liver Ctr, NL-1105 BK Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Paulusma, CC (corresponding author), Acad Med Ctr, AMC Liver Ctr, S 1-168,Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands.	c.c.paulusma@amc.uva.nl	Paulusma, Coen/AAR-7943-2021	Paulusma, Coen/0000-0001-7284-1974				Amigo L, 1999, J LIPID RES, V40, P533; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Waart DR, 2006, LIVER INT, V26, P362, DOI 10.1111/j.1478-3231.2005.01234.x; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052; Elferink RPJO, 2000, SEMIN LIVER DIS, V20, P293, DOI 10.1055/s-2000-9385; GIMPL G, 1995, BIOCHEMISTRY-US, V34, P13794, DOI 10.1021/bi00042a010; Groen A, 2008, GASTROENTEROLOGY, V134, P2091, DOI 10.1053/j.gastro.2008.02.097; Groen A, 2007, J HEPATOL, V47, P114, DOI 10.1016/j.jhep.2007.02.011; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Kosters A, 2006, J LIPID RES, V47, P1959, DOI 10.1194/jlr.M500511-JLR200; Kurbegov AC, 2003, GASTROENTEROLOGY, V125, P1227, DOI 10.1016/S0016-5085(03)01199-5; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mazzone A, 2006, HEPATOLOGY, V43, P287, DOI 10.1002/hep.21039; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; Mullenbach R, 2005, GUT, V54, P829, DOI 10.1136/gut.2004.058115; Nibbering CP, 1999, J MEMBRANE BIOL, V167, P165, DOI 10.1007/s002329900480; Painter JN, 2005, EUR J HUM GENET, V13, P435, DOI 10.1038/sj.ejhg.5201355; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Stapelbroek JM, 2006, HEPATOLOGY, V43, P51, DOI 10.1002/hep.20998; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; van Mil SWC, 2005, J MED GENET, V42, P449, DOI 10.1136/jmg.2004.026187; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1	31	88	90	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9947	9954		10.1074/jbc.M808667200	http://dx.doi.org/10.1074/jbc.M808667200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19228692	hybrid, Green Published			2022-12-27	WOS:000264892900037
J	Ling, F; Yoshida, M; Shibata, T				Ling, Feng; Yoshida, Minoru; Shibata, Takehiko			Heteroduplex Joint Formation Free of Net Topological Change by Mhr1, a Mitochondrial Recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED FRAGMENTS; HUMAN RAD52 PROTEIN; HOMOLOGOUS GENETIC-RECOMBINATION; COLI RECT PROTEIN; ESCHERICHIA-COLI; SUPERHELICAL DNA; CRYSTAL-STRUCTURE; REVERSE GYRASE; YEAST; EXCHANGE	Homologous pairing, an essential process for homologous recombination, is the formation of a heteroduplex joint by an invading single-stranded DNA tail and a complementary sequence within double-strandedDNA(dsDNA). The base rotation of the parental dsDNA, to switch from parental base pairs to heteroduplex ones with the invading single-stranded DNA, sterically requires vertical extension between adjacent base pairs, which inevitably induces untwisting of the dsDNA. RecA is a prototype of the RecA/Rad51/Dmc1 family proteins, which promote ATP-dependent homologous pairing in homologous DNA recombination in vivo, except in mitochondria. As predicted by the requirement for the untwisting, dsDNA bound to RecA is extended and untwisted, and homologous pairing by RecA in vitro is extensively stimulated by the negative supercoils of dsDNA substrates. D-loop formation in negatively super-coiled dsDNA, which serves as an assay for homologous pairing, is also catalyzed in an ATP-independent manner by proteins structurally unrelated to RecA, such as Mhr1. Mhr1 is required for yeast mitochondrial DNA recombination instead of RecA family proteins. Inconsistent with the topological requirements, tests for the effects of negative supercoils revealed that Mhr1 catalyzes homologous pairing with relaxed closed circular dsDNA much more efficiently than with negatively supercoiled dsDNA. Topological analyses indicated that neither the process nor the products of homologous pairing by Mhr1 involve a net topological change of closed circular dsDNA. This would be favorable for homologous recombination in mitochondria, where dsDNA is unlikely to be under topological stress toward unwinding. We propose a novel topological mechanism wherein Mhr1 induces untwisting without net topological change.	[Ling, Feng; Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genet Lab, Wako, Saitama 3510198, Japan; [Shibata, Takehiko] RIKEN, Adv Sci Inst, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Ling, F (corresponding author), RIKEN, Adv Sci Inst, Chem Genet Lab, Hirosawa 2-1, Wako, Saitama 3510198, Japan.	ling@postman.riken.go.jp; tshibata@postman.riken.go.jp	Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674	Bioarchitect Research Program of RIKEN; Life Science Foundation of Japan; Japan Society for the Promotion of Science [18570168, 20570171, 19370004]	Bioarchitect Research Program of RIKEN; Life Science Foundation of Japan(Life Science Foundation of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Bioarchitect Research Program of RIKEN (to F.L. and M.Y.), a grant from the Life Science Foundation of Japan (to F.L.), Grants-in-Aid for Scientific Research (C) 18570168 and 20570171 from the Japan Society for the Promotion of Science (to F.L.), Grant-in-Aid (B) 19370004 from the Japan Society for the Promotion of Science (to T.S.), and a grant from the RIKEN Strategic Research Program (to F.L.).	BEATTIE KL, 1977, J MOL BIOL, V116, P783, DOI 10.1016/0022-2836(77)90271-6; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; COHEN A, 1986, J BACTERIOL, V167, P327, DOI 10.1128/jb.167.1.327-335.1986; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; HALL SD, 1993, J BACTERIOL, V175, P277, DOI 10.1128/JB.175.1.277-287.1993; HOLLOMAN WK, 1975, P NATL ACAD SCI USA, V72, P2394, DOI 10.1073/pnas.72.6.2394; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KOCHOYAN M, 1987, J MOL BIOL, V196, P599, DOI 10.1016/0022-2836(87)90036-2; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x; Ling F, 2004, MOL BIOL CELL, V15, P310, DOI 10.1091/mbc.E03-07-0508; Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466; Ling F, 2000, NUCLEIC ACIDS RES, V28, P4956, DOI 10.1093/nar/28.24.4956; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MUNIYAPPA K, 1986, J BIOL CHEM, V261, P7472; NAKASU S, 1985, EMBO J, V4, P2705, DOI 10.1002/j.1460-2075.1985.tb03990.x; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Noirot P, 1998, J BIOL CHEM, V273, P12274, DOI 10.1074/jbc.273.20.12274; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; RADDING CM, 1977, J MOL BIOL, V116, P825, DOI 10.1016/0022-2836(77)90273-X; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SHIBATA T, 1982, J BIOL CHEM, V257, P3981; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vlieghe D, 1996, SCIENCE, V273, P1702, DOI 10.1126/science.273.5282.1702; WU AM, 1982, CELL, V30, P37, DOI 10.1016/0092-8674(82)90009-5; Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9341	9353		10.1074/jbc.M900023200	http://dx.doi.org/10.1074/jbc.M900023200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193646	Green Published, hybrid			2022-12-27	WOS:000264669100040
J	Deng, M; Li, FH; Ballif, BA; Li, S; Chen, X; Guo, L; Ye, X				Deng, Min; Li, Fahui; Ballif, Bryan A.; Li, Shan; Chen, Xi; Guo, Lin; Ye, Xin			Identification and Functional Analysis of a Novel Cyclin E/Cdk2 Substrate Ankrd17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE GENE-TRANSCRIPTION; S-PHASE PROGRESSION; CELL-CYCLE; ANKYRIN-REPEAT; CENTROSOME DUPLICATION; MAMMALIAN-CELLS; G1/S TRANSITION; DNA-SYNTHESIS; COMPLEX; PHOSPHORYLATION	Cyclin E/Cdk2 is a key regulator in G1-S transition. We have identified a novel cyclin E/Cdk2 substrate called Ankrd17 (ankyrin repeat protein 17) using the TAP tag purification technique. Ankrd17 protein contains two clusters of a total 25 ankyrin repeats at its N terminus, one NES (nuclear exporting signal) and one NLS (nuclear localization signal) in the middle, and one RXL motif at its C terminus. Ankrd17 is expressed in various tissues and associates with cyclin E/Cdk2 in an RXL-dependent manner. It can be phosphorylated by cyclin E/Cdk2 at 3 phosphorylation sites (Ser1791, Ser1794, and Ser2150). Overexpression of Ankrd17 promotes S phase entry, whereas depletion of Ankrd17 expression by small interfering RNA inhibits DNA replication and blocks cell cycle progression as well as up-regulates the expression of p53 and p21. Ankrd17 is localized to the nucleus and interacts with DNA replication factors including MCM family members, Cdc6 and PCNA. Depletion of Ankrd17 results in decreased loading of Cdc6 and PCNA onto DNA suggesting that Ankrd17 may be directly involved in the DNA replication process. Taken together, these data indicate that Ankrd17 is an important downstream effector of cyclin E/Cdk2 and positively regulates G1/S transition.	[Deng, Min; Li, Fahui; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Dept Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Ballif, Bryan A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Li, Shan] Shandong Normal Univ, Jinan 250014, Shandong, Peoples R China; [Chen, Xi; Guo, Lin] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Deng, Min; Li, Fahui] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Harvard University; Harvard Medical School; Shandong Normal University; Wuhan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Dept Pathogen Microbiol & Immunol, 3 Datun Rd,Rm A318, Beijing 100101, Peoples R China.	yex@im.ac.cn						Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Choi BY, 2005, NAT STRUCT MOL BIOL, V12, P699, DOI 10.1038/nsmb960; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fujita M, 1999, J BIOL CHEM, V274, P25927, DOI 10.1074/jbc.274.36.25927; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hofmann S, 2005, MOL CELL PROTEOMICS, V4, P1888, DOI 10.1074/mcp.M500076-MCP200; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ortiz CM, 2008, INT J CANCER, V122, P325, DOI 10.1002/ijc.23106; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Prior M, 2007, J VIROL, V81, P11195, DOI 10.1128/JVI.02559-06; Reed SI, 1997, CANCER SURV, V29, P7; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Scanlan M J, 2001, Cancer Immun, V1, P4; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wang HT, 2007, J BIOL CHEM, V282, P24679, DOI 10.1074/jbc.M705066200; Watt AJ, 2001, MECH DEVELOP, V100, P205, DOI 10.1016/S0925-4773(00)00530-X; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Wheeler LW, 2008, CELL CYCLE, V7, P2179, DOI 10.4161/cc.7.14.6270; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700	53	27	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7875	7888		10.1074/jbc.M807827200	http://dx.doi.org/10.1074/jbc.M807827200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19150984	Green Published, hybrid			2022-12-27	WOS:000264195600049
J	Rhoads, RE				Rhoads, Robert E.			eIF4E: New Family Members, New Binding Partners, New Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INITIATION-FACTOR 4E; CAP-DEPENDENT TRANSLATION; MESSENGER-RNA CAP; CAENORHABDITIS-ELEGANS; PHYLOGENETIC ANALYSIS; SHUTTLING PROTEIN; DROSOPHILA CUP; INHIBITION; INTERACTS; ISOFORMS	Eukaryotic initiation factor 4E (eIF4E) has long been known as the cap-binding protein that participates in recruitment of mRNA to the ribosome. A number of recent advances have not only increased our understanding of how eIF4E acts in translation but also uncovered non-translational roles. New structures have been determined for eIF4E in complex with various ligands and for other cap-binding proteins. We have also learned that most eukaryotic organisms express multiple eIF4E family members, some involved in general translation but others having specialized functions, including repression of translation. A number of new eIF4E-binding proteins have been reported, some of which tether it to specific mRNAs.	Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Rhoads, RE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.	rrhoad@lsuhsc.edu			National Institutes of Health [2R01GM20818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM20818 from NIGMS. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Amiri A, 2001, DEVELOPMENT, V128, P3899; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DeFatta RJ, 2002, CANCER GENE THER, V9, P573, DOI 10.1038/sj.cgt.7700468; Deshmukh MV, 2008, MOL CELL, V29, P324, DOI 10.1016/j.molcel.2007.11.027; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Evsikov AV, 2009, DEV GENES EVOL, V219, P111, DOI 10.1007/s00427-008-0268-2; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Freire MA, 2000, PLANT MOL BIOL, V44, P129, DOI 10.1023/A:1006494628892; Freire MA, 2005, GENE, V345, P271, DOI 10.1016/j.gene.2004.11.030; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Jankowska-Anyszka M, 1998, J BIOL CHEM, V273, P10538, DOI 10.1074/jbc.273.17.10538; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Ptushkina M, 2004, EMBO REP, V5, P311, DOI 10.1038/sj.embor.7400088; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Robalino J, 2004, J BIOL CHEM, V279, P10532, DOI 10.1074/jbc.M313688200; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; Ruud KA, 1998, J BIOL CHEM, V273, P10325, DOI 10.1074/jbc.273.17.10325; Svitkin YV, 2001, RNA, V7, P1743; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Zappavigna V, 2004, P NATL ACAD SCI USA, V101, P14800, DOI 10.1073/pnas.0406451101	50	120	122	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16711	16715		10.1074/jbc.R900002200	http://dx.doi.org/10.1074/jbc.R900002200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19237539	Green Published, hybrid			2022-12-27	WOS:000266962400005
J	Newman, RA; Prehoda, KE				Newman, Rhonda A.; Prehoda, Kenneth E.			Intramolecular Interactions Between the Src Homology 3 and Guanylate Kinase Domains of Discs Large Regulate Its Function in Asymmetric Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROBLAST SELF-RENEWAL; LARGE TUMOR-SUPPRESSOR; SIZE-DISTRIBUTION ANALYSIS; NONMUSCLE MYOSIN-II; DROSOPHILA NEUROBLASTS; SCAFFOLDING PROTEINS; SPINDLE ORIENTATION; CORTICAL POLARITY; LOCALIZATION; BINDING	Membrane-associated guanylate kinases (MAGUKs) regulate the formation and function of molecular assemblies at specialized regions of the membrane. Allosteric regulation of an intramolecular interaction between the Src homology 3 (SH3) and guanylate kinase (GK) domains of MAGUKs is thought to play a central role in regulating MAGUK function. Here we show that a mutant of the DrosophilaMAGUKDiscs large (Dlg), dlgsw, encodes a form of Dlg that disrupts the intramolecular association while leaving the SH3 and GK domains intact, providing an excellent model system to assess the role of the SH3-GK intramolecular interaction in MAGUK function. Analysis of asymmetric cell division of maternal-zygotic dlgsw embryonic neuroblasts demonstrates that the intramolecular interaction is not required for Dlg localization but is necessary for cell fate determinant segregation to the basal cortex and mitotic spindle alignment with the cortical polarity axis. These defects ultimately result in improper patterning of the embryonic central nervous system. Furthermore, we demonstrate that the sw mutation of Dlg results in unregulated complex assembly as assessed by GukHolder association with the SH3-GK versus PDZ-SH3-GK modules of Dlgsw. From these studies, we conclude that allosteric regulation of the SH3-GK intramolecular interaction is required for regulation of MAGUK function in asymmetric cell division, possibly through regulation of complex assembly.	Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Prehoda, KE (corresponding author), 1229 Univ Oregon, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu			National Institutes of Health [GM068032]; National Research Service Award Postdoctoral Fellowship National Institutes of Health [F32 GM080018]; American Heart Association [0850140Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032, F32GM080018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068032 (to K. E. P.). This work was also supported by a Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship National Institutes of Health Grant F32 GM080018 (to R.A.N.) and American Heart Association Grant 0850140Z (to K. E. P.).	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Avila-Flores A, 2001, BIOCHEM J, V360, P295, DOI 10.1042/0264-6021:3600295; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Brenman JE, 1998, J NEUROSCI, V18, P8805; Chabu C, 2008, DEVELOPMENT, V135, P2739, DOI 10.1242/dev.024059; De Lorenzo C, 1999, CANCER METAST REV, V18, P295, DOI 10.1023/A:1006381526008; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fukunaga Y, 2005, J BIOCHEM, V138, P177, DOI 10.1093/jb/mvi107; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Liu SL, 2008, J BIOL CHEM, V283, P380, DOI 10.1074/jbc.M703924200; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; Marfatia SM, 2000, J BIOL CHEM, V275, P13759, DOI 10.1074/jbc.275.18.13759; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mendoza C, 2003, J NEUROSCI, V23, P2093; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Odden JP, 2002, J NEUROSCI, V22, P9143; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Paarmann I, 2002, J BIOL CHEM, V277, P40832, DOI 10.1074/jbc.M205618200; Paarmann I, 2008, PROTEIN SCI, V17, P1946, DOI 10.1110/ps.035550.108; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamada KH, 2007, BIOCHEMISTRY-US, V46, P10039, DOI 10.1021/bi701169w; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	59	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12924	12932		10.1074/jbc.M809304200	http://dx.doi.org/10.1074/jbc.M809304200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19261607	hybrid, Green Published			2022-12-27	WOS:000265688300038
J	French, ME; Kretzmann, BR; Hicke, L				French, Michael E.; Kretzmann, Benjamin R.; Hicke, Linda			Regulation of the RSP5 Ubiquitin Ligase by an Intrinsic Ubiquitin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PROTEIN LIGASE; SACCHAROMYCES-CEREVISIAE; HECT DOMAIN; POLYUBIQUITIN CHAINS; MEMBRANE-PROTEIN; NUCLEAR EXPORT; MESSENGER-RNA; LARGE SUBUNIT; DNA-REPAIR	Rsp5 is a homologous to E6AP C terminus (HECT) ubiquitin ligase (E3) that controls many different cellular processes in budding yeast. Although Rsp5 targets a number of different substrates for ubiquitination, the mechanisms that regulate Rsp5 activity remain poorly understood. Here we demonstrate that Rsp5 carries a noncovalent ubiquitin-binding site in its catalytic HECT domain. The N-terminal lobe of the HECT domain mediates binding to ubiquitin, and point mutations that disrupt interactions with ubiquitin alter the ability of the Rsp5 HECT domain to assemble polyubiquitin chains in vitro. Point mutations that disrupt ubiquitin binding also result in temperature sensitive growth defects in yeast, indicating that the Rsp5 ubiquitin binding site is important for Rsp5 function in vivo. The Nedd4 HECT domain N-lobe also contains ubiquitin-binding activity, suggesting that interactions between the N-lobe and ubiquitin are conserved within the Nedd4 family of ubiquitin ligases. We propose that a subset of HECT E3s are regulated by a conserved ubiquitin-binding site that functions to restrict the length of polyubiquitin chains synthesized by the HECT domain.	[French, Michael E.; Kretzmann, Benjamin R.; Hicke, Linda] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Hicke, L (corresponding author), Hogan 2-100,2205 Tech Dr, Evanston, IL 60208 USA.	l-hicke@northwestern.edu			National Institutes of Health [DK53257, DK61299]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053257, R01DK061299, R56DK061299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53257 and DK61299.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Krsmanovic T, 2004, FEBS LETT, V577, P215, DOI 10.1016/j.febslet.2004.10.006; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stamenova SD, 2007, MOL CELL, V25, P273, DOI 10.1016/j.molcel.2006.12.016; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	58	62	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12071	12079		10.1074/jbc.M901106200	http://dx.doi.org/10.1074/jbc.M901106200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19252184	hybrid, Green Published			2022-12-27	WOS:000265494600039
J	Ippel, JH; de Haas, CJC; Bunschoten, A; van Strijp, JAG; Kruijtzer, JAW; Liskamp, RMJ; Kemmink, J				Ippel, Johannes H.; de Haas, Carla J. C.; Bunschoten, Anton; van Strijp, Jos A. G.; Kruijtzer, John A. W.; Liskamp, Rob M. J.; Kemmink, Johan			Structure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; CHEMOKINE RECEPTORS; BINDING DOMAIN; ANAPHYLATOXIN; ANTAGONIST; MODULATION; CONTRIBUTE; DISEASE	Complement component C5a is a potent pro-inflammatory agent inducing chemotaxis of leukocytes toward sites of infection and injury. C5a mediates its effects via its G protein-coupled C5a receptor (C5aR). Although under normal conditions highly beneficial, excessive levels of C5a can be deleterious to the host and have been related to numerous inflammatory diseases. A natural inhibitor of the C5aR is chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS). CHIPS is a 121-residue protein excreted by S. aureus. It binds the N terminus of the C5aR (residues 1-35) with nanomolar affinity and thereby potently inhibits C5a-mediated responses in human leukocytes. Therefore, CHIPS provides a starting point for the development of new anti-inflammatory agents. Two O-sulfated tyrosine residues located at positions 11 and 14 within the C5aR N terminus play a critical role in recognition of C5a, but their role in CHIPS binding has not been established so far. By isothermal titration calorimetry, using synthetic Tyr-11-and Tyr-14-sulfated and non-sulfated C5aR N-terminal peptides, we demonstrate that the sulfate groups are essential for tight binding between the C5aR and CHIPS. In addition, the NMR structure of the complex of CHIPS and a sulfated C5aR N-terminal peptide reveals the precise binding motif as well as the distinct roles of sulfated tyrosine residues sY11 and sY14. These results provide a molecular framework for the design of novel CHIPS-based C5aR inhibitors.	[Ippel, Johannes H.; Bunschoten, Anton; Kruijtzer, John A. W.; Liskamp, Rob M. J.; Kemmink, Johan] Univ Utrecht, Dept Med Chem & Chem Biol, NL-3584 CA Utrecht, Netherlands; [de Haas, Carla J. C.; van Strijp, Jos A. G.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Kemmink, J (corresponding author), Univ Utrecht, Dept Med Chem & Chem Biol, Sorbonnelaan 16, NL-3584 CA Utrecht, Netherlands.	j.kemmink@uu.nl	Liskamp, Rob M/I-5889-2012; van Strijp, Jos A.G./J-9549-2014; Ippel, Hans/D-6917-2016	Liskamp, Rob M/0000-0001-8897-8975; van Strijp, Jos A.G./0000-0001-6253-0830; Bunschoten, Anton/0000-0002-4167-5077	Dutch Technology Foundation; Applied Science Division of NWO; Ministry of Economic Affairs [UKG.06609]	Dutch Technology Foundation(Technologiestichting STW); Applied Science Division of NWO(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs	This work was supported in part by the Dutch Technology Foundation STW, Applied Science Division of NWO, and the Technology Program of the Ministry of Economic Affairs (UKG.06609).	Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen ZG, 1998, J BIOL CHEM, V273, P10411, DOI 10.1074/jbc.273.17.10411; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Haas PJ, 2005, J MOL BIOL, V353, P859, DOI 10.1016/j.jmb.2005.09.014; Heller T, 1999, J IMMUNOL, V163, P985; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; March DR, 2004, MOL PHARMACOL, V65, P868, DOI 10.1124/mol.65.4.868; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Postma B, 2005, J BIOL CHEM, V280, P2020, DOI 10.1074/jbc.M412230200; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Strachan AJ, 2000, J IMMUNOL, V164, P6560, DOI 10.4049/jimmunol.164.12.6560; VANEPPS DE, 1993, J IMMUNOL, V150, P246; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp KE, 2000, INFECT IMMUN, V68, P5908, DOI 10.1128/IAI.68.10.5908-5913.2000; Wright AJ, 2007, MOL IMMUNOL, V44, P2507, DOI 10.1016/j.molimm.2006.12.022; Zhang XL, 1997, PROTEINS, V28, P261, DOI 10.1002/(SICI)1097-0134(199706)28:2<261::AID-PROT13>3.0.CO;2-G; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P172, DOI 10.1021/bi00427a025	25	31	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12363	12372		10.1074/jbc.M808179200	http://dx.doi.org/10.1074/jbc.M808179200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251703	Green Published, hybrid			2022-12-27	WOS:000265494600067
J	Lakshmana, MK; Yoon, IS; Chen, E; Bianchi, E; Koo, EH; Kang, DE				Lakshmana, Madepalli K.; Yoon, Il-Sang; Chen, Eunice; Bianchi, Elizabetta; Koo, Edward H.; Kang, David E.			Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid beta Peptide Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; LIPID RAFTS; SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; ENDOCYTIC PATHWAY; PLASMA-MEMBRANE; DENSITY; LRP; CELLS	Accumulation of the amyloid beta(A beta) peptide derived from the proteolytic processing of amyloid precursor protein (APP) is the defining pathological hallmark of Alzheimer disease. We previously demonstrated that the C-terminal 37 amino acids of lipoprotein receptor-related protein (LRP) robustly promoted A beta generation independent of FE65 and specifically interacted with Ran-binding protein 9 (RanBP9). In this study we found that RanBP9 strongly increased BACE1 cleavage of APP and A beta generation. This pro-amyloidogenic activity of RanBP9 did not depend on the KPI domain or the Swedish APP mutation. In cells expressing wild type APP, RanBP9 reduced cell surface APP and accelerated APP internalization, consistent with enhanced beta-secretase processing in the endocytic pathway. The N-terminal half of RanBP9 containing SPRY-LisH domains not only interacted with LRP but also with APP and BACE1. Overexpression of RanBP9 resulted in the enhancement of APP interactions with LRP and BACE1 and increased lipid raft association of APP. Importantly, knockdown of endogenous RanBP9 significantly reduced A beta generation in Chinese hamster ovary cells and in primary neurons, demonstrating its physiological role in BACE1 cleavage of APP. These findings not only implicate RanBP9 as a novel and potent regulator of APP processing but also as a potential therapeutic target for Alzheimer disease.	[Lakshmana, Madepalli K.; Yoon, Il-Sang; Chen, Eunice; Koo, Edward H.; Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kang, David E.] Seoul Natl Univ, Coll Med, World Class Univ Neurocyt Program, Seoul 110799, South Korea; [Bianchi, Elizabetta] Inst Pasteur, Dept Immunol, Immunoregulat Lab, F-75724 Paris, France	University of California System; University of California San Diego; Seoul National University (SNU); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci 0691, Leichtag Biomed Res 3A17,9500 Gilman Dr, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	Kang, David E./0000-0002-7132-821X	National Institutes of Health [AG 005131-24S1]; American Health Assistance Foundation [A2007-05]; Alzheimer's Association [NIRG-07-60584]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association)	This work was supported, in whole or in part, by National Institutes of Health Grant AG 005131-24S1 (NIA, to D. E. K.). This work was also supported in part by the American Health Assistance Foundation Grant A2007-05 (to D. E. K.) and Alzheimer's Association Grant NIRG-07-60584 (to M. K. L.).	Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; De Strooper B, 2000, J CELL SCI, V113, P1857; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hafizi S, 2005, INT J BIOCHEM CELL B, V37, P2344, DOI 10.1016/j.biocel.2005.05.006; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lakshmana MK, 2008, J CELL MOL MED, V12, P2665, DOI 10.1111/j.1582-4934.2008.00320.x; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Reiner O, 2006, NEUROMOL MED, V8, P547, DOI 10.1385/NMM:8:4:547; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wickham L, 2005, J NEUROCHEM, V92, P93, DOI 10.1111/j.1471-4159.2004.02840.x; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200	41	71	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11863	11872		10.1074/jbc.M807345200	http://dx.doi.org/10.1074/jbc.M807345200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251705	Green Published, hybrid			2022-12-27	WOS:000265494600018
J	Kravchenko-Balasha, N; Mizrachy-Schwartz, S; Klein, S; Levitzki, A				Kravchenko-Balasha, Nataly; Mizrachy-Schwartz, Sarit; Klein, Shoshana; Levitzki, Alexander			Shift from Apoptotic to Necrotic Cell Death during Human Papillomavirus-induced Transformation of Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CISPLATIN-INDUCED APOPTOSIS; GENE-EXPRESSION; CERVICAL-CANCER; ERK ACTIVATION; DNA-DAMAGE; NECROSIS; TYPE-16; DIFFERENTIATION; FORM	Oncogenic transformation is a complex, multistep process, which goes through several stages before complete malignant transformation occurs. To identify early processes in carcinogenesis, we used an in vitro model, based on the initiating event in cervical cancer, papillomavirus transformation of keratinocytes. We compared gene expression in primary keratinocytes (K) and papillomavirus-transformed keratinocytes from early (E) and late (L) passages and from benzo[a] pyrene-treated L cells (BP). The transformed cells exhibit similar transcriptional changes to clinical cervical carcinoma. The number of transcripts expressed progressively decreased during the evolution from K to BP cells. Bioinformatic analysis, validated by detailed biochemical analysis, revealed substantial contraction of both pro-and antiapoptotic networks during transformation. Nonetheless, L and BP cells were not resistant to apoptotic stimuli. At doses of cisplatin that led to 30-60% apoptosis of K and E cells, transformed L and BP cells underwent 80% necrotic cell death, which became the default response to genotoxic stress. Moreover, appreciable necrotic fractions were observed in the cervical carcinoma cell line, HeLa, in response to comparable doses of cisplatin. The shrinkage of biochemical networks, including the apoptotic network, may allow a cancer cell to economize on energy usage to facilitate enhanced proliferation but leaves it vulnerable to stress. This study supports the hypothesis that the process of cancer transformation may be accompanied by a shift from apoptosis to necrosis.	[Kravchenko-Balasha, Nataly; Mizrachy-Schwartz, Sarit; Klein, Shoshana; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Safra Campus, IL-91904 Jerusalem, Israel.	levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	Deutsches Krebsforschungszentrum (DKFZ); Israel's Ministry of Science and Technology (MOST)	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Israel's Ministry of Science and Technology (MOST)	This work was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Science and Technology (MOST).	Ahn WS, 2004, INT J GYNECOL CANCER, V14, P475, DOI 10.1111/j.1048-891x.2004.14308.x; Arechaga-Ocampo E, 2008, GYNECOL ONCOL, V108, P10, DOI 10.1016/j.ygyno.2007.08.070; Bae Su Mi, 2003, Cancer Res Treat, V35, P549, DOI 10.4143/crt.2003.35.6.549; Baldus SE, 2005, ONCOGENE, V24, P810, DOI 10.1038/sj.onc.1208235; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; BARBOSA MS, 1989, ONCOGENE, V4, P1529; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; DURST M, 1987, ONCOGENE, V1, P251; DURST M, 1991, J VIROL, V65, P796; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Geiger T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000605; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; MITRANIROSENBAUM S, 1992, INTERVIROLOGY, V33, P76, DOI 10.1159/000150234; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; MONTGOMERY KD, 1995, GENE CHROMOSOME CANC, V14, P97, DOI 10.1002/gcc.2870140203; Okada M, 2004, BLOOD, V103, P2299, DOI 10.1182/blood-2003-05-1605; PIRISI L, 1988, CARCINOGENESIS, V9, P1573, DOI 10.1093/carcin/9.9.1573; POLAKOWSKA RR, 1994, DEV DYNAM, V199, P176, DOI 10.1002/aja.1001990303; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Reddy SPM, 2003, J BIOL CHEM, V278, P21378, DOI 10.1074/jbc.M212258200; Sanchez-Perez I, 2002, MOL BIOL CELL, V13, P2933, DOI 10.1091/mbc.E02-01-0022; Santin AD, 2005, VIROLOGY, V331, P269, DOI 10.1016/j.virol.2004.09.045; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheridan MT, 2001, INT J RADIAT ONCOL, V50, P503, DOI 10.1016/S0360-3016(01)01496-1; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Szabo C, 2005, CRIT CARE MED, V33, pS530, DOI 10.1097/01.CCM.0000187002.88999.CF; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; WOODWORTH CD, 1988, CANCER RES, V48, P4620; Yeh PY, 2002, BIOCHEM PHARMACOL, V63, P1423, DOI 10.1016/S0006-2952(02)00908-5; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zeh HJ, 2005, J IMMUNOTHER, V28, P1, DOI 10.1097/00002371-200501000-00001; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	52	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11717	11727		10.1074/jbc.M900217200	http://dx.doi.org/10.1074/jbc.M900217200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19221178	Green Published, hybrid			2022-12-27	WOS:000265494500074
J	Lai, J; Bernhard, OK; Turville, SG; Harman, AN; Wilkinson, J; Cunningham, AL				Lai, Joey; Bernhard, Oliver K.; Turville, Stuart G.; Harman, Andrew N.; Wilkinson, John; Cunningham, Anthony L.			Oligomerization of the Macrophage Mannose Receptor Enhances gp120-mediated Binding of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CARBOHYDRATE-RECOGNITION DOMAINS; HUMAN DENDRITIC CELLS; CYSTEINE-RICH DOMAIN; C-TYPE LECTIN; DC-SIGN; MASS-SPECTROMETRY; LIGAND-BINDING; IN-VITRO; INFECTION	C-type lectin receptors expressed on the surface of dendritic cells and macrophages are able to bind glycoproteins of microbial pathogens via mannose, fucose, and N-acetylglucosamine. Langerin on Langerhans cells, dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin on dendritic cells, and mannose receptor (MR) on dendritic cells and macrophages bind the human immunodeficiency virus (HIV) envelope protein gp120 principally via high mannose oligosaccharides. These C-type lectin receptors can also oligomerize to facilitate enhanced ligand binding. This study examined the effect of oligomerization of MR on its ability to bind to mannan, monomeric gp120, native trimeric gp140, and HIV type 1 BaL. Mass spectrometry analysis of crosslinked MR showed homodimerization on the surface of primary monocyte-derived dendritic cells and macrophages. Both monomeric and dimeric MR were precipitated by mannan, but only the dimeric form was co-immunoprecipitated by gp120. These results were confirmed independently by flow cytometry analysis of soluble monomeric and trimeric HIV envelope and a cellular HIV virion capture assay. As expected, mannan bound to the carbohydrate recognition domains of MR dimers mostly in a calcium-dependent fashion. Unexpectedly, gp120-mediated binding of HIV to dimers on MR-transfected Rat-6 cells and macrophages was not calcium-dependent, was only partially blocked by mannan, and was also partially inhibited by N-acetylgalactosamine 4-sulfate. Thus gp120-mediated HIV binding occurs via the calcium-dependent, non-calcium-dependent carbohydrate recognition domains and the cysteine-rich domain at the C terminus of MR dimers, presenting a much broader target for potential inhibitors of gp120-MR binding.	[Lai, Joey; Turville, Stuart G.; Harman, Andrew N.; Wilkinson, John; Cunningham, Anthony L.] Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia; [Bernhard, Oliver K.] Ludwig Inst Canc Res, Joint Prote Lab, Melbourne, Vic 3050, Australia	University of Sydney; Westmead Institute for Medical Research; Ludwig Institute for Cancer Research	Cunningham, AL (corresponding author), Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW 2145, Australia.	tony_cunningham@wmi.usyd.edu.au	Cunningham, Tony L/B-7011-2013; Harman, Andrew N/K-5256-2012	Cunningham, Tony L/0000-0002-6744-5667; Harman, Andrew N/0000-0003-1535-1279; Turville, Stuart/0000-0003-1918-5343; wilkinson, john/0000-0001-8728-4146				BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Bernhard OK, 2004, BIOCHEMISTRY-US, V43, P256, DOI 10.1021/bi034847u; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chang J, 1996, J VIROL, V70, P7792, DOI 10.1128/JVI.70.11.7792-7803.1996; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; GEYER H, 1988, J BIOL CHEM, V263, P11760; Grandjean C, 2001, CHEMBIOCHEM, V2, P747, DOI 10.1002/1439-7633(20011001)2:10<747::AID-CBIC747>3.0.CO;2-O; Kapp EA, 2003, ANAL CHEM, V75, P6251, DOI 10.1021/ac034616t; KOUP RA, 2001, CURRENT PROTOCOLS IM; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LARGENT BL, 1984, J BIOL CHEM, V259, P1764; LEE RT, 1984, BIOCHEMISTRY-US, V23, P4255, DOI 10.1021/bi00313a037; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Liu Y, 2001, J MOL BIOL, V305, P481, DOI 10.1006/jmbi.2000.4326; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MERKLE RK, 1991, ARCH BIOCHEM BIOPHYS, V290, P248, DOI 10.1016/0003-9861(91)90616-Q; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; SHEPHERD VL, 1981, P NATL ACAD SCI-BIOL, V78, P1019, DOI 10.1073/pnas.78.2.1019; Soilleux EJ, 2002, J PATHOL, V198, P511, DOI 10.1002/path.1205; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	48	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11027	11038		10.1074/jbc.M809698200	http://dx.doi.org/10.1074/jbc.M809698200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19224860	hybrid, Green Published			2022-12-27	WOS:000265494500007
J	Yu, JZ; Dave, RH; Allen, JA; Sarma, T; Rasenick, MM				Yu, Jiang-Zhou; Dave, Rahul H.; Allen, John A.; Sarma, Tulika; Rasenick, Mark M.			Cytosolic G alpha(s) Acts as an Intracellular Messenger to Increase Microtubule Dynamics and Promote Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; GTP-BINDING PROTEINS; ALPHA-SUBUNIT; SUBCELLULAR REDISTRIBUTION; BASAL GANGLIA; GS-ALPHA; GROWTH; TUBULIN; SIGNAL; CAMP	It is now evident that G alpha(s) traffics into cytosol following G protein-coupled receptor activation, and alpha subunits of some heterotrimeric G-proteins, including G alpha(s) bind to tubulin in vitro. Nevertheless, many features of G-protein-microtubule interaction and possible intracellular effects of G protein alpha subunits remain unclear. In this study, several biochemical approaches demonstrated that activated G alpha(s) directly bound to tubulin and cellular microtubules, and fluorescence microscopy showed that cholera toxin-activated G alpha(s) colocalized with microtubules. The activated, GTP-bound, G alpha(s) mimicked tubulin in serving as a GTPase activator for alpha-tubulin. As a result, activated G alpha(s) made microtubules more dynamic, both in vitro and in cells, decreasing the pool of insoluble microtubules without changing total cellular tubulin content. The amount of acetylated tubulin (an indicator of microtubule stability) was reduced in the presence of G alpha(s) activated by mutation. Previous studies showed that cholera toxin and cAMP analogs may stimulate neurite outgrowth in PC12 cells. However, in this study, overexpression of a constitutively activated G alpha(s) or activation of G alpha(s) with cholera toxin in protein kinase A-deficient PC12 cells promoted neurite outgrowth in a cAMP-independent manner. Thus, it is suggested that activated G alpha(s) acts as an intracellular messenger to regulate directly microtubule dynamics and promote neurite outgrowth. These data serve to link G-protein signaling with modulation of the cytoskeleton and cell morphology.	[Yu, Jiang-Zhou; Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yu, JZ (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, 835 S Wolcott Ave M C 901, Chicago, IL 60612 USA.	yujz64@uic.edu; raz@uic.edu	Allen, John A/D-6141-2011		National Institutes of Health [AG 15482, MH 57391, MH 78200, T32-HL07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078200, R01MH057391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 15482, MH 57391, MH 78200, and T32-HL07692.	AHNERTHILGER G, 1994, EUR J CELL BIOL, V65, P26; ALBRERT B, 1994, MOL BIOL CELL, P805; ALLEN JA, 2005, MOL PHARM, V20, P1452; AMOS LA, 1974, J CELL SCI, V14, P523; AOKI CY, 1992, BRAIN RES, V596, P189, DOI 10.1016/0006-8993(92)91547-R; ARONIN N, 1992, J NEUROSCI, V12, P3435; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CARLIER MF, 1991, J BIOL CHEM, V266, P12361; CASSIMERIS L, 1993, CELL MOTIL CYTOSKEL, V26, P275, DOI 10.1002/cm.970260402; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Chen NF, 2003, J BIOL CHEM, V278, P15285, DOI 10.1074/jbc.M300841200; Churcher I, 2006, CURR TOP MED CHEM, V6, P579, DOI 10.2174/156802606776743057; Cote M, 1997, ENDOCRINOLOGY, V138, P69, DOI 10.1210/en.138.1.69; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Drmota T, 1999, BIOCHEM J, V340, P529, DOI 10.1042/0264-6021:3400529; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Eiden RD, 2007, DEV PSYCHOL, V43, P1187, DOI 10.1037/0012-1649.43.5.1187; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; GINTY DD, 1991, J BIOL CHEM, V266, P15325; GINTY DD, 1991, J BIOL CHEM, V266, P17454; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Gundersen GG, 1998, BIOL BULL, V194, P358, DOI 10.2307/1543112; Holtje M, 2000, J NEUROSCI, V20, P2131; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; Hynes Thomas R., 2003, V237, P233; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Igarashi M, 1997, J NEUROSCI, V17, P1460; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; KEHLENBACH RH, 1994, NATURE, V372, P804; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Layden BT, 2008, BBA-MOL CELL RES, V1783, P964, DOI 10.1016/j.bbamcr.2008.02.017; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDER ME, 1991, METHOD ENZYMOL, V195, P202; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Mejillano MR, 1996, ARCH BIOCHEM BIOPHYS, V336, P130, DOI 10.1006/abbi.1996.0540; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Montminy M, 1997, NATURE, V387, P654, DOI 10.1038/42594; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; RASENICK MM, 1988, J NEUROCHEM, V51, P300, DOI 10.1111/j.1471-4159.1988.tb04870.x; RASENICK MM, 1984, J NEUROCHEM, V43, P1447, DOI 10.1111/j.1471-4159.1984.tb05407.x; RASENICK MM, 1989, BRAIN RES, V488, P105, DOI 10.1016/0006-8993(89)90698-7; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Rosenbaum J, 2000, CURR BIOL, V10, pR801, DOI 10.1016/S0960-9822(00)00767-3; ROYCHOWDHURY S, 1994, BIOCHEMISTRY-US, V33, P9800, DOI 10.1021/bi00198a052; Roychowdhury S, 2008, FEBS J, V275, P4654, DOI 10.1111/j.1742-4658.2008.06614.x; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; SOLOMON F, 1979, CELL, V18, P431, DOI 10.1016/0092-8674(79)90062-X; WANG N, 1991, BIOCHEMISTRY-US, V30, P10957, DOI 10.1021/bi00109a021; WANG N, 1990, J BIOL CHEM, V265, P1239; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zera EM, 1996, J BIOL CHEM, V271, P12925, DOI 10.1074/jbc.271.22.12925	66	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10462	10472		10.1074/jbc.M809166200	http://dx.doi.org/10.1074/jbc.M809166200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19237344	Green Published, hybrid			2022-12-27	WOS:000265104600020
J	Yamazaki, Y; Matsunaga, Y; Tokunaga, Y; Obayashi, S; Saito, M; Morita, T				Yamazaki, Yasuo; Matsunaga, Yukiko; Tokunaga, Yuko; Obayashi, Shinya; Saito, Mai; Morita, Takashi			Snake Venom Vascular Endothelial Growth Factors (VEGF-Fs) Exclusively Vary Their Structures and Functions among Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCELERATED EVOLUTION; ORF-VIRUS; PHOSPHOLIPASE-A2 ISOZYMES; CRYSTAL-STRUCTURE; FLT-1 RECEPTOR; BINDING; PERMEABILITY; NEUROPILIN-1; HEPARIN; DOMAIN	Vascular endothelial growth factor (VEGF-A) and its family proteins are crucial regulators of blood vessel formation and vascular permeability. Snake venom has recently been shown to be an exogenous source of unique VEGF (known as VEGF-F), and now, two types of VEGF-F with distinct biochemical properties have been reported. Here, we show that VEGF-Fs (venomtype VEGFs) are highly variable in structure and function among species, in contrast to endogenous tissue-type VEGFs (VEGFAs) of snakes. Although the structures of tissue-type VEGFs are highly conserved among venomous snake species and even among all vertebrates, including humans, those of venom-type VEGFs are extensively variegated, especially in the regions around receptor-binding loops and C-terminal putative coreceptor-binding regions, indicating that highly frequent variations are located around functionally key regions of the proteins. Genetic analyses suggest that venom-type VEGF gene may have developed from a tissue-type gene and that the unique sequence of its C-terminal region was generated by an alteration in the translation frame in the corresponding exons. We further verified that a novel venom-type VEGF from Bitis arietans displays unique properties distinct from already known VEGFs. Our results may provide evidence of a novel mechanism causing the generation of multiple snake toxins and also of a new model of molecular evolution.	[Yamazaki, Yasuo; Matsunaga, Yukiko; Tokunaga, Yuko; Obayashi, Shinya; Saito, Mai; Morita, Takashi] Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan	Meiji Pharmaceutical University	Morita, T (corresponding author), Meiji Pharmaceut Univ, Dept Biochem, 2-522-1 Noshio, Tokyo 2048588, Japan.	tmorita@my-pharm.ac.jp		Yamazaki, Yasuo/0000-0001-5297-9837; Matsunaga, Yukiko/0000-0002-1392-5681	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to T. M.). The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number( s) FJ554642, FJ554643, FJ554635, FJ554636, FJ554637, FJ554638, FJ554639, FJ554640, FJ554641.	Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Chen YL, 2005, THROMB HAEMOSTASIS, V93, P331, DOI 10.1160/TH04-09-0568; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Gasmi A, 2000, BIOCHEM BIOPH RES CO, V268, P69, DOI 10.1006/bbrc.2000.2078; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kiba A, 2003, J BIOL CHEM, V278, P13453, DOI 10.1074/jbc.M210931200; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Komori Y, 1999, BIOCHEMISTRY-US, V38, P11796, DOI 10.1021/bi990562z; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mercer AA, 2002, J GEN VIROL, V83, P2845, DOI 10.1099/0022-1317-83-11-2845; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Ogawa T, 2005, TOXICON, V45, P1, DOI 10.1016/j.toxicon.2004.07.028; OGAWA T, 1992, P NATL ACAD SCI USA, V89, P8557, DOI 10.1073/pnas.89.18.8557; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Suto K, 2005, J BIOL CHEM, V280, P2126, DOI 10.1074/jbc.M411395200; Takahashi H, 2004, J BIOL CHEM, V279, P46304, DOI 10.1074/jbc.M403687200; Tokunaga Y, 2006, BIOCHEM BIOPH RES CO, V348, P957, DOI 10.1016/j.bbrc.2006.07.117; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Yamazaki Y, 2005, BIOCHEMISTRY-US, V44, P8858, DOI 10.1021/bi050197d; Yamazaki Y, 2003, J BIOL CHEM, V278, P51985, DOI 10.1074/jbc.C300454200; Yamazaki Y, 2007, CURR PHARM DESIGN, V13, P2872, DOI 10.2174/138161207782023775; Yamazaki Y, 2007, BIOCHEM BIOPH RES CO, V355, P693, DOI 10.1016/j.bbrc.2007.02.038; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3	31	56	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9885	9891		10.1074/jbc.M809071200	http://dx.doi.org/10.1074/jbc.M809071200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208624	Green Published, hybrid			2022-12-27	WOS:000264892900030
J	Yang, SH; Sarkar, SN; Liu, R; Perez, EJ; Wang, XF; Wen, Y; Yan, LJ; Simpkins, JW				Yang, Shao-Hua; Sarkar, Saumyendra N.; Liu, Ran; Perez, Evelyn J.; Wang, Xiaofei; Wen, Yi; Yan, Liang-Jun; Simpkins, James W.			Estrogen Receptor beta as a Mitochondrial Vulnerability Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-BETA; SUBCELLULAR-DISTRIBUTION; GENE-EXPRESSION; ALPHA; LOCALIZATION; CELLS; PROLIFERATION; EXTRANUCLEAR; GENERATION; PROSTATE	We recently demonstrated mitochondrial localization of estrogen receptor beta ( ER beta). We herein confirm the mitochondrial localization of ER beta by the loss of mitochondrial ER beta immunoreactivity in ER beta knockdown cells. Aphenotype change characterized as an increase in resistance to oxidative stressors is associated with ER beta knockdown. ER beta knockdown results in a lower resting mitochondrial membrane potential (Delta psi m) and increase in resistance to hydrogen peroxide-induced Delta psi m depolarization in both immortal hippocampal cells and primary hippocampal neurons. ER beta knockdown cells maintained ATP concentrations despite insults that compromise ATP production and produce less mitochondrial superoxide under oxidative stress. Furthermore, similar mitochondrial phenotype changes were identified in primary hippocampal neurons derived from ER beta knock-out mice. These data demonstrate that ER beta is expressed in mitochondria and function as a mitochondrial vulnerability factor involved in Delta psi m maintenance, potentially through a mitochondrial transcription dependent mechanism.	[Yang, Shao-Hua; Sarkar, Saumyendra N.; Liu, Ran; Perez, Evelyn J.; Wang, Xiaofei; Wen, Yi; Yan, Liang-Jun; Simpkins, James W.] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Yang, SH (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76017 USA.	syang@hsc.unt.edu	Yang, Shaohua/D-1738-2013; Wen, Yi/C-6013-2009	Yan, Liang-Jun/0000-0002-5815-5430; Liu, Ran/0000-0002-3882-0616	National Institutes of Health; NINDS [NS054651, NS054687, AG10485, AG22550, AG27956]; American Heart Association, Inc., Texas Affiliate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054687, R01NS054651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027956, P01AG010485, P01AG022550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association, Inc., Texas Affiliate(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grants NS054651 (to S. Y.), NS054687 (to S. Y.), AG10485 (to J. W. S.), AG22550 (to J. W. S.), and AG27956 (to J. W. S.). This work was also supported by a grant from the American Heart Association, Inc., Texas Affiliate (to S. Y.).	Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Batistatou A, 2004, J CANCER RES CLIN, V130, P405, DOI 10.1007/s00432-004-0548-9; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Cammarata PR, 2004, EXP EYE RES, V78, P861, DOI 10.1016/j.exer.2003.09.027; Cammarata PR, 2005, EXP EYE RES, V81, P165, DOI 10.1016/j.exer.2005.01.019; Chen JQ, 2005, BBA-MOL CELL RES, V1746, P1, DOI 10.1016/j.bbamcr.2005.08.001; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Cowley SM, 1999, J STEROID BIOCHEM, V69, P165, DOI 10.1016/S0960-0760(99)00055-2; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Felty Quentin, 2005, J Carcinog, V4, P1, DOI 10.1186/1477-3163-4-1; Fried G, 2004, EUR J NEUROSCI, V20, P2345, DOI 10.1111/j.1460-9568.2004.03693.x; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Klein RL, 2002, METHODS, V28, P286, DOI 10.1016/S1046-2023(02)00234-7; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lazennec G, 2006, CANCER LETT, V231, P151, DOI 10.1016/j.canlet.2005.01.021; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; McEwen B, 2001, P NATL ACAD SCI USA, V98, P7093, DOI 10.1073/pnas.121146898; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Milner TA, 2001, J COMP NEUROL, V429, P355; Moats RK, 1998, BIOL REPROD, V58, P531, DOI 10.1095/biolreprod58.2.531; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2004, CNS NEUROL DISORD-DR, V3, P297, DOI 10.2174/1568007043337193; O'Lone R, 2007, MOL ENDOCRINOL, V21, P1281, DOI 10.1210/me.2006-0497; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Sarkar SN, 2003, J NEUROCHEM, V87, P333, DOI 10.1046/j.1471-4159.2003.02006.x; Sherwin BB, 1999, J PSYCHIATR NEUROSCI, V24, P315; Signoretti S, 2001, AM J PATHOL, V159, P13, DOI 10.1016/S0002-9440(10)61666-5; Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Solakidi S, 2005, BBA-MOL CELL RES, V1745, P382, DOI 10.1016/j.bbamcr.2005.05.010; Stevenson JC, 2000, J STEROID BIOCHEM, V74, P387, DOI 10.1016/S0960-0760(00)00117-5; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Treeck O, 2007, MOL CELL ENDOCRINOL, V264, P50, DOI 10.1016/j.mce.2006.10.003; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Wang XF, 2003, INVEST OPHTH VIS SCI, V44, P2067, DOI 10.1167/iovs.02-0841; Wise PM, 2006, NEUROSCIENCE, V138, P831, DOI 10.1016/j.neuroscience.2005.08.046; Wise PM, 2002, RECENT PROG HORM RES, V57, P235, DOI 10.1210/rp.57.1.235; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang SH, 2005, CNS NEUROL DISORD-DR, V4, P169, DOI 10.2174/1568007053544174; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	60	60	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9540	9548		10.1074/jbc.M808246200	http://dx.doi.org/10.1074/jbc.M808246200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189968	Green Published, hybrid			2022-12-27	WOS:000264669100060
J	Green, S; Squire, CJ; Nieuwenhuizen, NJ; Baker, EN; Laing, W				Green, Sol; Squire, Christopher J.; Nieuwenhuizen, Niels J.; Baker, Edward N.; Laing, William			Defining the Potassium Binding Region in an Apple Terpene Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA-FARNESENE; ARISTOLOCHENE SYNTHASE; GERANYL PYROPHOSPHATE; TRICHODIENE SYNTHASE; PARTIAL-PURIFICATION; ASPERGILLUS-TERREUS; LIMONENE SYNTHASE; PEEL TISSUE; BIOSYNTHESIS	Terpene synthases are a family of enzymes largely responsible for synthesizing the vast array of terpenoid compounds known to exist in nature. Formation of terpenoids from their respective 10-, 15-, or 20- carbon atom prenyl diphosphate precursors is initiated by divalent (M2+) metal ion-assisted electrophilic attack. In addition to M2+, monovalent cations (M+) have also been shown to be essential for the activity of certain terpene synthases most likely by facilitating substrate binding or catalysis. An apple alpha-farnesene synthase (MdAFS1), which has a dependence upon potassium (K+), was used to identify active site regions that may be important for M+ binding. Protein homology modeling revealed a surface-exposed loop (H-alpha l loop) in MdAFS1 that fulfilled the necessary requirements for a K+ binding region. Site-directed mutagenesis analysis of specific residues within this loop then revealed their crucial importance to this K+ response and strongly implicated specific residues in direct K+ binding. The role of the H-alpha l loop in terpene synthase K+ coordination was confirmed in a Conifer pinene synthase also using site-directed mutagenesis. These findings provide the first direct evidence for a specific M+ binding region in two functionally and phylogenetically divergent terpene synthases. They also provide a basis for understanding K+ activation in other terpene synthases and establish a new role for the H-alpha l loop region in terpene synthase catalysis.	New Zealand Inst Plant & Food Res, Auckland, New Zealand; [Green, Sol; Squire, Christopher J.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Green, Sol; Squire, Christopher J.; Baker, Edward N.] Univ Auckland, Ctr Mol Biodiscovery, Auckland 1, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; University of Auckland	Green, S (corresponding author), DSIR, Mt Albert Res Ctr, Plant & Food Res, 120 Mt Albert Rd,Private Bag 92169, Auckland, New Zealand.	sol.green@hortresearch.co.nz	Laing, William A/E-3636-2010; Green, Sol A/D-1949-2011	Laing, William A/0000-0003-0458-6590; Nieuwenhuizen, Niels/0000-0003-2514-7570; Baker, Edward/0000-0003-2456-7661; Squire, Christopher/0000-0001-9212-0461	NewZealand Foundation for Research, Science, and Technology [C06X0403]	NewZealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology)	This work was supported by NewZealand Foundation for Research, Science, and Technology Grant C06X0403 and Plant & Food Internal Investment funding. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANET EFLJ, 1970, AUST J CHEM, V23, P2101, DOI 10.1071/CH9702101; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; BEILBY MJ, 1986, PLANT PHYSIOL, V82, P417, DOI 10.1104/pp.82.2.417; Boyer Paul D., 1942, JOUR BIOL CHEM, V146, P673; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Cane DE, 2000, ARCH BIOCHEM BIOPHYS, V376, P354, DOI 10.1006/abbi.2000.1734; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; CROTEAU R, 1989, J BIOL CHEM, V264, P15309; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; CROTEAU R, 1989, J BIOL CHEM, V264, P2075; CROTEAU R, 1988, J BIOL CHEM, V263, P10063; CROTEAU R, 1990, ARCH BIOCHEM BIOPHYS, V277, P374, DOI 10.1016/0003-9861(90)90593-N; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; DUEBER MT, 1978, PLANT PHYSIOL, V62, P598, DOI 10.1104/pp.62.4.598; EVANS HJ, 1966, ANN REV PLANT PHYSIO, V17, P47, DOI 10.1146/annurev.pp.17.060166.000403; FROST RG, 1977, PLANT PHYSIOL, V59, P22, DOI 10.1104/pp.59.1.22; Gapper NE, 2006, POSTHARVEST BIOL TEC, V41, P225, DOI 10.1016/j.postharvbio.2006.04.014; Green S, 2007, PHYTOCHEMISTRY, V68, P176, DOI 10.1016/j.phytochem.2006.10.017; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McKay SAB, 2003, PLANT PHYSIOL, V133, P368, DOI 10.1104/pp.103.022723; MUDD SH, 1958, J BIOL CHEM, V231, P481; MURRAY KE, 1969, AUST J CHEM, V22, P197, DOI 10.1071/CH9690197; OBRIEN MC, 1995, J BIOL CHEM, V270, P2247, DOI 10.1074/jbc.270.5.2247; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pechous SW, 2005, POSTHARVEST BIOL TEC, V35, P125, DOI 10.1016/j.postharvbio.2004.08.005; Pechous SW, 2004, PLANTA, V219, P84, DOI 10.1007/s00425-003-1191-4; ROBINSON DR, 1970, BIOCHEMISTRY-US, V9, P80, DOI 10.1021/bi00803a011; Rynkiewicz MJ, 2002, BIOCHEMISTRY-US, V41, P1732, DOI 10.1021/bi011960g; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAVAGE TJ, 1994, J BIOL CHEM, V269, P4012; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Zuckerkandl E, 1965, EVOLUTIONARY DIVERGE	54	35	42	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8652	8660		10.1074/jbc.M807140200	http://dx.doi.org/10.1074/jbc.M807140200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19181671	hybrid, Green Published			2022-12-27	WOS:000264397800050
J	Kolbel, K; Ihling, C; Bellmann-Sickert, K; Neundorf, I; Beck-Sickinger, AG; Sinz, A; Kuhn, U; Wahle, E				Koelbel, Knut; Ihling, Christian; Bellmann-Sickert, Kathrin; Neundorf, Ines; Beck-Sickinger, Annette G.; Sinz, Andrea; Kuehn, Uwe; Wahle, Elmar			Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR POLY(A)-BINDING PROTEIN; MESSENGER-RNA POLYADENYLATION; SM PROTEINS; H3K4 TRIMETHYLATION; SUBSTRATE PEPTIDES; HISTONE H3R2; METHYLATION; COMPLEX; BINDING; PROTEIN-ARGININE-METHYLTRANSFERASE-1	Asymmetric dimethylation of arginine residues is a common posttranslational modification of proteins carried out by type I protein arginine methyltransferases, including PRMT1 and -3. We report that the consecutive transfer of two methyl groups to a single arginine side chain by PRMT1 and -3 occurs in a distributive manner, i.e. with intermittent release of the monomethylated intermediate. The oligomeric state of PRMTs together with the clustering of methylated arginine residues in most proteins carrying this type of modification suggests that multiple methyl transfers to a single polypeptide chain might proceed in a processive manner by cooperation of multiple active sites. However, three different types of experiments provide evidence that the reaction is distributive even with substrates containing multiple methyl-accepting arginines, including one with 13 such residues. PRMT1 also does not prefer substrates already containing one or more singly or doubly methylated arginine residues. Even though the reaction is distributive, the efficiency of methylation of one particular protein strongly depends on the number of methyl-accepting arginine residues it contains.	[Kuehn, Uwe; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Ihling, Christian; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany; [Bellmann-Sickert, Kathrin; Neundorf, Ines; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leipzig University	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de	Bellmann-Sickert, Kathrin/AFP-0609-2022	Bellmann-Sickert, Kathrin/0000-0002-0007-008X; Wahle, Elmar/0000-0003-2504-0677; Neundorf, Ines/0000-0001-6450-3991	European Union [LSHM-CT-2005-018675]; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by European Union Grant LSHM-CT-2005-018675, the Deutsche Forschungsgemeinschaft, and the Fonds der Chemischen Industrie.	Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; GARY JD, 1998, NUCLEIC ACIDS RES, V98, P65; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; SMITH BC, 2008, BIOCHIM BIOPHYS ACTA, V1789, P45; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	35	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8274	8282		10.1074/jbc.M809547200	http://dx.doi.org/10.1074/jbc.M809547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158082	hybrid, Green Published			2022-12-27	WOS:000264397800011
J	Gao, SY; Li, EM; Cui, L; Lu, XF; Meng, LY; Yuan, HM; Xie, JJ; Du, ZP; Pang, JX; Xu, LY				Gao, Shu-Ying; Li, En-Min; Cui, Lei; Lu, Xiao-Feng; Meng, Ling-Ying; Yuan, Hua-Min; Xie, Jian-Jun; Du, Ze-Peng; Pang, Jian-Xin; Xu, Li-Yan			Sp1 and AP-1 Regulate Expression of the Human Gene VIL2 in Esophageal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; GROWTH-FACTOR; C-FOS; EZRIN EXPRESSION; EPITHELIAL-CELLS; ORGANIZER EZRIN; PROTEIN-KINASE; LINKER EZRIN; ACTIVATION; PHOSPHORYLATION	Ezrin, encoded by VIL2, is a membrane-cytoskeletal linker protein that has been suggested to be involved in tumorigenesis. Ezrin expression in esophageal squamous cell carcinoma (ESCC) was described recently, but its clinical significance and the molecular mechanism underlying its regulated expression remain unclear. Thus, we retrospectively evaluated ezrin expression by immunohistochemistry in a tissue microarray representing 193 ESCCs. Ezrin overexpression in 90 of 193 tumors (46.6%) was associated with poor survival (p = 0.048). We then explored the mechanism by which ezrin expression is controlled in ESCC by assessing the transcriptional regulatory regions of human VIL2 by fusing deletions or site-directed mutants of the 5'-flanking region of the gene to a luciferase reporter. We found that the region -87/-32 containing consensus Sp1 (-75/-69) and AP-1 (-64/-58) binding sites is crucial for VIL2 promoter activity in esophageal carcinoma cells (EC109) derived from ESCC. AP-1 is comprised of c-Jun and c-Fos. Electrophoretic mobility shift and chromatin immunoprecipitation experiments demonstrated that Sp1 and c-Jun bound specifically to their respective binding sites within the VIL2 promoter. In addition, transient expression of Sp1, c-Jun, or c-Fos increased ezrin expression and VIL2 promoter activity. Use of selective inhibitors revealed that VIL2 transactivation required the MEK1/2 signal transduction pathway but not JNK or p38 MAPK. Taken together, we propose a possible signal transduction pathway whereby MEK1/2 phosphorylates ERK1/2, which phosphorylates Sp1 and AP-1 that in turn bind to their respective binding sites to regulate the expression of human VIL2 in ESCC cells.	[Gao, Shu-Ying; Li, En-Min; Cui, Lei; Meng, Ling-Ying; Xie, Jian-Jun; Du, Ze-Peng] Shantou Univ, Dept Biochem & Mol Biol, Shantou 515041, Peoples R China; [Gao, Shu-Ying; Lu, Xiao-Feng; Yuan, Hua-Min; Xu, Li-Yan] Shantou Univ, Inst Oncol Pathol, Coll Med, Shantou 515041, Peoples R China; [Pang, Jian-Xin] So Med Univ, Sch Pharmaceut Sci, Ctr Drug Evaluat & Res, Guangzhou 510515, Guangdong, Peoples R China	Shantou University; Shantou University; Southern Medical University - China	Li, EM (corresponding author), Shantou Univ, Dept Biochem & Mol Biol, Shantou 515041, Peoples R China.	nmli@stu.edu.cn; liyanxu1130@yahoo.com.cn	xu, li/GNH-3667-2022		National High Technology Research and Development Program of China [2006AA02A403]; National Natural Science Foundation of China [30772485, 30672376, 30570849]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20050560002, 20050560003]; Guangdong Scientific Fund Key Items [7118419, 37788, 05104541]; Natural Science Foundation of Guangdong Province [7301043]; National Science Foundation for Post-doctoral Scientists of China [20070410846]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong Scientific Fund Key Items; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China Grant 2006AA02A403, National Natural Science Foundation of China Grants 30772485, 30672376, and 30570849, Specialized Research Fund for the Doctoral Program of Higher Education of China Grants 20050560002 and 20050560003, Guangdong Scientific Fund Key Items (7118419, 37788, and 05104541), Natural Science Foundation of Guangdong Province Grant 7301043, and the National Science Foundation for Post-doctoral Scientists of China Grant 20070410846.	Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; BALL AR, 1988, COLD SPRING HARB SYM, V53, P687, DOI 10.1101/SQB.1988.053.01.078; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; BESSEREAU JL, 1993, EMBO J, V12, P443, DOI 10.1002/j.1460-2075.1993.tb05676.x; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Ge XK, 2002, CANCER LETT, V179, P133, DOI 10.1016/S0304-3835(02)00004-6; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hapgood JP, 2001, CELL BIOL INT, V25, P17, DOI 10.1006/cbir.2000.0674; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hiscox S, 1999, J CELL SCI, V112, P3081; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Jiang WG, 1996, ANTICANCER RES, V16, P861; JOOSS KU, 1995, ONCOGENE, V10, P603; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; MATSUI M, 1990, ONCOGENE, V5, P249; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Noti JD, 1996, MOL CELL BIOL, V16, P2940; Ogino W, 2007, J PEDIAT HEMATOL ONC, V29, P435, DOI 10.1097/MPH.0b013e3180640d18; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Pan Q G, 1980, Zhonghua Zhong Liu Za Zhi, V2, P187; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SAMBROOK J, 2000, MOL CLONING LAB MANU; Shen ZY, 2003, WORLD J GASTROENTERO, V9, P1182, DOI 10.3748/wjg.v9.i6.1182; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; XIE JJ, 2009, INT J CANC IN PRESS; Xu R, 2007, BIOCHEM BIOPH RES CO, V356, P286, DOI 10.1016/j.bbrc.2007.02.140; Yeh TS, 2005, ARCH SURG-CHICAGO, V140, P1184, DOI 10.1001/archsurg.140.12.1184; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zeng HM, 2006, J HISTOCHEM CYTOCHEM, V54, P889, DOI 10.1369/jhc.5A6881.2006; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; Zhang FR, 2008, J HISTOCHEM CYTOCHEM, V56, P193, DOI 10.1369/jhc.7A7353.2007; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5	60	54	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7995	8004		10.1074/jbc.M809734200	http://dx.doi.org/10.1074/jbc.M809734200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19164283	Green Published, hybrid			2022-12-27	WOS:000264195600062
J	Kamenecka, T; Habel, J; Duckett, D; Chen, WM; Ling, YY; Frackowiak, B; Jiang, R; Shin, YS; Song, XY; LoGrasso, P				Kamenecka, Ted; Habel, Jeff; Duckett, Derek; Chen, Weimin; Ling, Yuan Yuan; Frackowiak, Bozena; Jiang, Rong; Shin, Youseung; Song, Xinyi; LoGrasso, Philip			Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PALLADIUM-CATALYZED AMINATION; ORALLY BIOAVAILABLE INHIBITOR; MAP KINASE; IMIDAZOLE INHIBITORS; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; HIV-1 PROTEASE; DESIGN; POTENT	c-Jun N-terminal kinase 3 alpha 1 (JNK3 alpha 1) is a mitogen-activated protein kinase family member expressed primarily in the brain that phosphorylates protein transcription factors, including c-Jun and activating transcription factor-2 (ATF-2) upon activation by a variety of stress-based stimuli. In this study, we set out to design JNK3-selective inhibitors that had > 1000-fold selectivity over p38, another closely related mitogen-activated protein kinase family member. To do this we employed traditional medicinal chemistry principles coupled with structure-based drug design. Inhibitors from the aminopyrazole class, such as SR-3576, were found to be very potent JNK3 inhibitors (IC50 = 7 nM) with > 2800-fold selectivity over p38 (p38 IC50 > 20 mu M) and had cell-based potency of similar to 1 mu M. In contrast, indazole-based inhibitors exemplified by SR-3737 were potent inhibitors of both JNK3 (IC50 = 12 nM) and p38 (IC50 = 3 nM). These selectivity differences between the indazole class and the aminopyrazole class came despite nearly identical binding (root mean square deviation = 0.33 angstrom) of these two compound classes to JNK3. The structural features within the compounds giving rise to the selectivity in the aminopyrazole class include the highly planar nature of the pyrazole, N-linked phenyl structures, which better occupied the smaller active site of JNK3 compared with the larger active site of p38.	[LoGrasso, Philip] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, P (corresponding author), Scripps Res Inst, Dept Mol Therapeut, 130 Scripps Way,2A2, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Frackowiak-Wojtasek, Bozena/0000-0002-0203-4066	National Institutes of Health [U01-NS057153]; Stanford Synchrotron Radiation Laboratory (SSRL); U.S. Dept. of Energy, Office of Basic Energy Sciences; SSRL Structural Molecular Biology Program; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources; NIH; Biomedical Technology Program; NIGMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Synchrotron Radiation Laboratory (SSRL); U.S. Dept. of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SSRL Structural Molecular Biology Program; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01-NS057153 (to P.L.). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the U.S. Dept. of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Dept. of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, NIH, Biomedical Technology Program, and NIGMS, NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angell RM, 2007, BIOORG MED CHEM LETT, V17, P1296, DOI 10.1016/j.bmcl.2006.12.003; Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; CHEN ZG, 1994, J BIOL CHEM, V269, P26344; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Dios A, 2005, J MED CHEM, V48, P2270, DOI 10.1021/jm048978k; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421; DORSEY BD, 1994, J MED CHEM, V37, P3443, DOI 10.1021/jm00047a001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Gaillard P, 2005, J MED CHEM, V48, P4596, DOI 10.1021/jm0310986; GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0; Goldstein DM, 2006, J MED CHEM, V49, P1562, DOI 10.1021/jm050736c; Gross RS, 2005, J MED CHEM, V48, P5780, DOI 10.1021/jm049085v; Haddad J J, 2001, Curr Opin Investig Drugs, V2, P1070; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang XH, 2003, J AM CHEM SOC, V125, P6653, DOI 10.1021/ja035483w; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee MR, 2005, CURR MED CHEM, V12, P2979, DOI 10.2174/092986705774462914; LINDLEY J, 1984, TETRAHEDRON, V40, P1433, DOI 10.1016/S0040-4020(01)91791-0; Lisnock JM, 1998, BIOCHEMISTRY-US, V37, P16573, DOI 10.1021/bi981591x; Liverton NJ, 1999, J MED CHEM, V42, P2180, DOI 10.1021/jm9805236; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMITH GM, 1994, PROTEIN SCI, V3, P118, DOI 10.1002/pro.5560030115; Stelmach JE, 2003, BIOORG MED CHEM LETT, V13, P277, DOI 10.1016/S0960-894X(02)00752-7; Swahn BM, 2006, BIOORG MED CHEM LETT, V16, P1397, DOI 10.1016/j.bmcl.2005.11.039; Swahn BM, 2005, BIOORG MED CHEM LETT, V15, P5095, DOI 10.1016/j.bmcl.2005.06.083; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; Wolfe JP, 2000, J ORG CHEM, V65, P1158, DOI 10.1021/jo991699y; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang BH, 1999, J ORGANOMET CHEM, V576, P125, DOI 10.1016/S0022-328X(98)01054-7; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhao HY, 2006, J MED CHEM, V49, P4455, DOI 10.1021/jm060465l	52	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12853	12861		10.1074/jbc.M809430200	http://dx.doi.org/10.1074/jbc.M809430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19261605	Green Published, hybrid			2022-12-27	WOS:000265688300031
J	Schmid, AW; Chiappe, D; Pignat, V; Grimminger, V; Hang, I; Moniatte, M; Lashuel, HA				Schmid, Adrien W.; Chiappe, Diego; Pignat, Verene; Grimminger, Valerie; Hang, Ivan; Moniatte, Marc; Lashuel, Hilal A.			Dissecting the Mechanisms of Tissue Transglutaminase-induced Cross-linking of alpha-Synuclein IMPLICATIONS FOR THE PATHOGENESIS OF PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; POLYGLUTAMINE DOMAINS; HUNTINGTON-DISEASE; FIBRIL FORMATION; AMYLOID PROTEIN; LEWY BODIES; AGGREGATION; TAU; MUTATION; REPEATS	Tissue transglutaminase (tTG) has been implicated in the pathogenesis of Parkinson disease (PD). However, exactly how tTG modulates the structural and functional properties of alpha-synuclein (alpha-syn) and contributes to the pathogenesis of PD remains unknown. Using site-directed mutagenesis combined with detailed biophysical and mass spectrometry analyses, we sought to identify the exact residues involved in tTG-catalyzed cross-linking of wild-type alpha-syn and alpha-syn mutants associated with PD. To better understand the structural consequences of each cross-linking reaction, we determined the effect of tTG-catalyzed cross-linking on the oligomerization, fibrillization, and membrane binding of alpha-syn in vitro. Our findings show that tTG-catalyzed cross-linking of monomeric alpha-syn involves multiple cross-links (specifically 2-3). We subjected tTG-catalyzed cross-linked monomeric alpha-syn composed of either wild-type or Gln -> Asn mutants to sequential proteolysis by multiple enzymes and peptide mapping by mass spectrometry. Using this approach, we identified the glutamine and lysine residues involved in tTG-catalyzed intramolecular cross-linking of alpha-syn. These studies demonstrate for the first time that Gln(79) and Gln(109) serve as the primary tTG reactive sites. Mutating both residues to asparagine abolishes tTG-catalyzed cross-linking of alpha-syn and tTG-induced inhibition of alpha-syn fibrillization in vitro. To further elucidate the sequence and structural basis underlying these effects, we identified the lysine residues that form isopeptide bonds with Gln(79) and Gln(109). This study provides mechanistic insight into the sequence and structural basis of the inhibitory effects of tTG on alpha-syn fibrillogenesis in vivo, and it sheds light on the potential role of tTG cross-linking on modulating the physiological and pathogenic properties of alpha-syn.	[Schmid, Adrien W.; Pignat, Verene; Grimminger, Valerie; Hang, Ivan; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Chiappe, Diego; Moniatte, Marc; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Prote Core Facil, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Schmid, Adrien/CAG-1527-2022	Moniatte, Marc/0000-0003-2235-4523	Swiss Federal Institute of Technology Lausanne	Swiss Federal Institute of Technology Lausanne	This work was supported by the Swiss Federal Institute of Technology Lausanne.	Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bonelli RM, 2002, NEUROBIOL DIS, V11, P106, DOI 10.1006/nbdi.2002.0535; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chun WJ, 2001, J CELL BIOL, V153, P25, DOI 10.1083/jcb.153.1.25; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AJL, 2002, NEUROCHEM INT, V40, P53, DOI 10.1016/S0197-0186(01)00058-4; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; De Vivo G, 2008, CNS NEUROL DISORD-DR, V7, P370, DOI 10.2174/187152708786441821; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; DUDEK SM, 1993, J NEUROCHEM, V61, P1159, DOI 10.1111/j.1471-4159.1993.tb03636.x; Emanuelsson Cecilia Sundby, 2005, J Biomol Tech, V16, P197; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gentile V, 1998, ARCH BIOCHEM BIOPHYS, V352, P314, DOI 10.1006/abbi.1998.0592; Goedert M, 1997, NATURE, V388, P232, DOI 10.1038/40767; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; HO GJ, 1994, FEBS LETT, V349, P151, DOI 10.1016/0014-5793(94)00663-6; IKURA K, 1993, FEBS LETT, V326, P109, DOI 10.1016/0014-5793(93)81772-R; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kim SY, 2005, NEUROCHEM RES, V30, P1245, DOI 10.1007/s11064-005-8796-x; Konno T, 2005, BIOCHEMISTRY-US, V44, P2072, DOI 10.1021/bi047722d; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai TS, 2004, J NEUROCHEM, V88, P1253, DOI 10.1046/j.1471-4159.2003.02249.x; Lesort M, 2002, NEUROCHEM INT, V40, P37, DOI 10.1016/S0197-0186(01)00059-6; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; MILLER ML, 1995, J NEUROCHEM, V65, P1760; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park SC, 1999, J GERONTOL A-BIOL, V54, pB78, DOI 10.1093/gerona/54.2.B78; POLLANEN MS, 1993, BRAIN RES, V603, P121, DOI 10.1016/0006-8993(93)91307-E; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Riess O, 1998, MOL MED TODAY, V4, P438, DOI 10.1016/S1357-4310(98)01343-4; Segers-Nolten IMJ, 2008, PROTEIN SCI, V17, P1395, DOI 10.1110/ps.036103.108; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tucholski J, 1999, J NEUROCHEM, V73, P1871; Violante V, 2001, BRAIN RES BULL, V56, P169, DOI 10.1016/S0361-9230(01)00576-7; Wang DS, 2008, INT J CLIN EXP PATHO, V1, P5; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zemaitaitis MO, 2000, J NEUROPATH EXP NEUR, V59, P983, DOI 10.1093/jnen/59.11.983; Zhang JW, 1998, J NEUROCHEM, V71, P240	45	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13128	13142		10.1074/jbc.M809067200	http://dx.doi.org/10.1074/jbc.M809067200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19164286	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000265688300060
J	Couve, S; Mace-Aime, G; Rosselli, F; Saparbaev, MK				Couve, Sophie; Mace-Aime, Gaetane; Rosselli, Filippo; Saparbaev, Murat K.			The Human Oxidative DNA Glycosylase NEIL1 Excises Psoralen-induced Interstrand DNA Cross-links in a Three-stranded DNA Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-VIII; CELL NUCLEAR ANTIGEN; ABC EXCINUCLEASE; DAMAGED DNA; IN-VITRO; REPAIR; RECOMBINATION; REMOVAL; RECA; RECOGNITION	Previously, we have demonstrated that human oxidative DNA glycosylase NEIL1 excises photoactivated psoralen-induced monoadducts but not genuine interstrand cross-links (ICLs) in duplexDNA. It has been postulated that the repair of ICLs in mammalian cells is mainly linked to DNA replication and proceeds via dual incisions in one DNA strand that bracket the cross-linked site. This process, known as "unhooking," enables strand separation and translesion DNA synthesis through the gap, yielding a three-stranded DNA repair intermediate composed of a short unhooked oligomer covalently bound to the duplex. At present, the detailed molecular mechanism of ICL repair in mammalian cells remains unclear. Here, we constructed and characterized three-stranded DNA structures containing a single ICL as substrates for the base excision repair proteins. We show that NEIL1 excises with high efficiency the unhooked ICL fragment within a three-stranded DNA structure. Complete reconstitution of the repair of unhooked ICL shows that it can be processed in a short patch base excision repair pathway. The new substrate specificity of NEIL1 points to a preferential involvement in the replication-associated repair of ICLs. Based on these data, we propose a model for the mechanism of ICL repair in mammalian cells that implicates the DNA glycosylase activity of NEIL1 downstream of Xeroderma Pigmentosum group F/Excision Repair Cross-Complementing 1 endonuclease complex (XPF/ERCC1) and translesion DNA synthesis repair steps. Finally, our data demonstrate that Nei-like proteins from Escherichia coli to human cells can excise bulky unhooked psoralen-induced ICLs via hydrolysis of glycosidic bond between crosslinked base and deoxyribose sugar, thus providing an alternative heuristic solution for the removal of complex DNA lesions.	[Couve, Sophie; Saparbaev, Murat K.] Univ Paris Sud, Inst Cancerol Gustave Roussy, Grp Reparat ADN, CNRS,UMR 8126, F-94805 Villejuif, France; [Mace-Aime, Gaetane; Rosselli, Filippo] Univ Paris Sud, Inst Cancerol Gustave Roussy, Grp Voie FANC BRCA & Canc, CNRS,Commissariat Energie Atom LRC43V,FRE2939, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Saparbaev, MK (corresponding author), Inst Gustave Roussy, PR1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	smurat@igr.fr	Saparbaev, Murat/AAC-5478-2020; Saparbaev, Murat K/N-3225-2015; Filippo, Rosselli/AAO-6393-2020	Saparbaev, Murat/0000-0002-4630-1074; Saparbaev, Murat K/0000-0002-4630-1074; Filippo, Rosselli/0000-0003-1080-5745	Fondation pour la Recherche Medicale; FP6 Euroatom Grant [RISC-RAD FI6R-CT-2003-508842]; CNRS France-Pologne [GRDE 182]; Institut National du Cancer (INCa); Electricite de France (EDF); National Center for Biotechnology, Kazakhstan; La Ligue Contre le Cancer; INCa	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); FP6 Euroatom Grant(European Commission); CNRS France-Pologne; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Electricite de France (EDF)(Electricite de France (EDF)); National Center for Biotechnology, Kazakhstan(National Center for Biotechnology (NCB)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France)	This work was supported by grants from the Fondation pour la Recherche Medicale "EQUIPES FRM 2007," FP6 Euroatom Grant RISC-RAD FI6R-CT-2003-508842, CNRS France-Pologne GRDE 182, Institut National du Cancer (INCa), Electricite de France (EDF), and National Center for Biotechnology, Kazakhstan (to M. K. S.) and from La Ligue Contre le Cancer "Equipe Labellisee 2006," EDF, and INCa (to F. R.).	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; BOITEUX S, 1989, CARCINOGENESIS, V10, P1905, DOI 10.1093/carcin/10.10.1905; CHENG S, 1988, J BIOL CHEM, V263, P15110; CHENG S, 1991, NUCLEIC ACIDS RES, V19, P657, DOI 10.1093/nar/19.3.657; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cipak L, 2006, NAT STRUCT MOL BIOL, V13, P729, DOI 10.1038/nsmb1120; COLE RS, 1971, BIOCHIM BIOPHYS ACTA, V254, P30, DOI 10.1016/0005-2787(71)90111-0; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Eichman BF, 2001, J MOL BIOL, V308, P15, DOI 10.1006/jmbi.2001.4567; Fang QM, 2008, BIOCHEMISTRY-US, V47, P10892, DOI 10.1021/bi8008664; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; HOY CA, 1985, CANCER RES, V45, P1737; Hwang GS, 1996, BIOCHEM BIOPH RES CO, V219, P191, DOI 10.1006/bbrc.1996.0204; Jia L, 2007, BIOCHEMISTRY-US, V46, P5305, DOI 10.1021/bi062269m; JOHNSTON BH, 1981, BIOCHEMISTRY-US, V20, P739, DOI 10.1021/bi00507a012; KANNE D, 1984, J MED CHEM, V27, P531, DOI 10.1021/jm00370a017; KUMARESAN KR, 1992, BIOCHEMISTRY-US, V31, P6774, DOI 10.1021/bi00144a018; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Parsons JL, 2007, BIOCHEMISTRY-US, V46, P4158, DOI 10.1021/bi0622569; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; SLADEK FM, 1989, J BIOL CHEM, V264, P6755; SPIELMANN HP, 1995, P NATL ACAD SCI USA, V92, P2345, DOI 10.1073/pnas.92.6.2345; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; VANHOUTEN B, 1986, J BIOL CHEM, V261, P14135; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	44	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11963	11970		10.1074/jbc.M900746200	http://dx.doi.org/10.1074/jbc.M900746200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258314	hybrid, Green Published			2022-12-27	WOS:000265494600028
J	Fan, WQ; Imamura, T; Sonoda, N; Sears, DD; Patsouris, D; Kim, JJ; Olefsky, JM				Fan, WuQiang; Imamura, Takeshi; Sonoda, Noriyuki; Sears, Dorothy D.; Patsouris, David; Kim, Jane J.; Olefsky, Jerrold M.			FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor gamma Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; PPAR-GAMMA; PROTEIN-KINASE; ANDROGEN RECEPTOR; 3T3-L1 ADIPOCYTES; NUCLEAR RECEPTOR; LXXLL MOTIF; PHOSPHORYLATION; SENSITIVITY; THIAZOLIDINEDIONES	The transcriptional factor FoxO1 plays an important role in metabolic homeostasis. Herein we identify a novel transrepressional function that converts FoxO1 from an activator of transcription to a promoter-specific repressor of peroxisome proliferator-activated receptor gamma (PPAR gamma) target genes that regulate adipocyte biology. FoxO1 transrepresses PPAR gamma via direct protein-protein interactions; it is recruited to PPAR response elements (PPRE) on PPAR gamma target genes by PPAR gamma bound to PPRE and interferes with promoter DNA occupancy of the receptor. The FoxO1 transrepressional function, which is independent and dissectible from the transactivational effects, does not require a functional FoxO1 DNA binding domain, but dose require an evolutionally conserved 31 amino acids LXXLL-containing domain. Insulin induces FoxO1 phosphorylation and nuclear exportation, which prevents FoxO1-PPAR gamma interactions and rescues transrepression. Adipocytes from insulin resistant mice show reduced phosphorylation and increased nuclear accumulation of FoxO1, which is coupled to lowered expression of endogenous PPAR gamma target genes. Thus the innate FoxO1 transrepression function enables insulin to augment PPAR gamma activity, which in turn leads to insulin sensitization, and this feed-forward cycle represents positive reinforcing connections between insulin and PPAR gamma signaling.	[Fan, WuQiang; Imamura, Takeshi; Sonoda, Noriyuki; Sears, Dorothy D.; Patsouris, David; Kim, Jane J.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Sears, Dorothy D/AHE-5524-2022	Sears, Dorothy D/0000-0002-9260-3540; Kim, Jane/0000-0002-0228-0128	National Institutes of Health [DK 033651, DK 074868]; University of California Discovery Program Project [bio03-10383]; Pfizer Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, R01DK033651, P01DK074868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Discovery Program Project; Pfizer Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 033651 and DK 074868 (to J. M. O.). This work was also supported by University of California Discovery Program Project bio03-10383 (BioStar) with matching funds from Pfizer Incorporated.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Camp HS, 1997, J BIOL CHEM, V272, P10811; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Eubank DW, 2001, J BIOL CHEM, V276, P30561, DOI 10.1074/jbc.M103019200; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Fan WQ, 2005, ENDOCRINOLOGY, V146, P85, DOI 10.1210/en.2004-1046; Fan WQ, 2004, MOL ENDOCRINOL, V18, P127, DOI 10.1210/me.2003-0110; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Roberts VL, 2005, CLIN THER, V27, P1535, DOI 10.1016/j.clinthera.2005.10.017; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Vollenweider P, 1999, MOL CELL BIOL, V19, P1081; Wu Y, 2006, MOL CELL BIOL, V26, P6633, DOI 10.1128/MCB.01534-05; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	40	83	85	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12188	12197		10.1074/jbc.M808915200	http://dx.doi.org/10.1074/jbc.M808915200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246449	Green Published, hybrid			2022-12-27	WOS:000265494600050
J	Isaji, T; Sato, Y; Fukuda, T; Gu, JG				Isaji, Tomoya; Sato, Yuya; Fukuda, Tomohiko; Gu, Jianguo			N-Glycosylation of the I-like Domain of beta 1 Integrin Is Essential for beta 1 Integrin Expression and Biological Function IDENTIFICATION OF THE MINIMAL N-GLYCOSYLATION REQUIREMENT FOR alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID FIBRONECTIN RECEPTORS; CELL-ADHESION; LINKED OLIGOSACCHARIDES; BETA(1) INTEGRINS; SIGNALING PATHWAY; STRUCTURAL BASIS; LIGAND-BINDING; ALPHA-SUBUNIT; GROWTH-FACTOR; MIGRATION	N-Glycosylation of integrin alpha 5 beta 1 plays a crucial role in cell spreading, cell migration, ligand binding, and dimer formation, but the detailed mechanisms by which N-glycosylation mediates these functions remain unclear. In a previous study, we showed that three potential N-glycosylation sites (alpha 5S3-5) on the beta-propeller of the alpha 5 subunit are essential to the functional expression of the subunit. In particular, site 5 (alpha 5S5) is the most important for its expression on the cell surface. In this study, the function of the N-glycans on the integrin beta 1 subunit was investigated using sequential site-directed mutagenesis to remove the combined putative N-glycosylation sites. Removal of the N-glycosylation sites on the I-like domain of the beta 1 subunit (i.e. the Delta 4-6 mutant) decreased both the level of expression and heterodimeric formation, resulting in inhibition of cell spreading. Interestingly, cell spreading was observed only when the beta 1 subunit possessed these three N-glycosylation sites (i.e. the Delta 4-6 mutant). Furthermore, the S4-6 mutant could form heterodimers with either alpha 5S3-5 or alpha 5S5 mutant of the alpha 5 subunit. Taken together, the results of the present study reveal for the first time that N-glycosylation of the I-like domain of the beta 1 subunit is essential to both the heterodimer formation and biological function of the subunit. Moreover, because the alpha 5S3-5/beta 1S4-6 mutant represents the minimal N-glycosylation required for functional expression of the beta 1 subunit, it might also be useful for the study of molecular structures.	[Isaji, Tomoya; Sato, Yuya; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation, Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was supported in part by the Core Research for Evolutional Science and Technology, the Japan Science and Technology Agency, the "Academic Frontier" Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the core to core program and a grant-in-aid for young scientists ( B) ( to T. I.), Japan Society for the Promotion of Science, and Takeda Science Foundation, Japan.	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Berditchevski F, 2001, J CELL SCI, V114, P4143; CHAMMAS R, 1991, J BIOL CHEM, V266, P3349; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; GIPSON IK, 1984, DEV BIOL, V101, P212, DOI 10.1016/0012-1606(84)90131-3; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Guo HB, 2002, CANCER RES, V62, P6837; HEINO J, 1989, J BIOL CHEM, V264, P380; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3156, DOI 10.1073/pnas.94.7.3156; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Liu YM, 2008, PROTEINS, V73, P989, DOI 10.1002/prot.22126; Meng XB, 2005, J CELL SCI, V118, P4009, DOI 10.1242/jcs.02520; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Miyoshi Hiroyuki, 2004, Methods Mol Biol, V246, P429; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	53	81	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12207	12216		10.1074/jbc.M807920200	http://dx.doi.org/10.1074/jbc.M807920200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261610	Green Published, hybrid			2022-12-27	WOS:000265494600052
J	Martinez-Caballero, S; Dejean, LM; Kinnally, MS; Oh, KJ; Mannella, CA; Kinnally, KW				Martinez-Caballero, Sonia; Dejean, Laurent M.; Kinnally, Michael S.; Oh, Kyoung Joon; Mannella, Carmen A.; Kinnally, Kathleen W.			Assembly of the Mitochondrial Apoptosis-induced Channel, MAC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY PROTEINS; CELL-DEATH; BAX OLIGOMERIZATION; CONDUCTANCE CHANNEL; CERAMIDE CHANNELS; PROAPOPTOTIC BAX; MEMBRANE-BINDING; FORMING ACTIVITY; ACTIVATION	Although Bcl-2 family proteins control intrinsic apoptosis, the mechanisms underlying this regulation are incompletely understood. Patch clamp studies of mitochondria isolated from cells deficient in one or both of the pro-apoptotic proteins Bax and Bak show that at least one of the proteins must be present for formation of the cytochrome c-translocating channel, mitochondrial apoptosis-induced channel (MAC), and that the single channel behaviors of MACs containing exclusively Bax or Bak are similar. Truncated Bid catalyzes MAC formation in isolated mitochondria containing Bax and/or Bak with a time course of minutes and does not require VDAC1 or VDAC3. Mathematical analysis of the stepwise changes in conductance associated with MAC formation is consistent with pore assembly by a barrel-stave model. Assuming the staves are two transmembrane alpha-helices in Bax and Bak, mature MAC pores would typically contain similar to 9 monomers and have diameters of 5.5-6 nm. The mitochondrial permeability data are inconsistent with formation of lipidic pores capable of transporting megadaltonsized macromolecules as observed with recombinant Bax in liposomes.	[Martinez-Caballero, Sonia; Dejean, Laurent M.; Kinnally, Kathleen W.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA; [Martinez-Caballero, Sonia] Ctr Cirugia Minima Invas Jesus Uson, Dept Cell Therapy, Caceres 10071, Spain; [Kinnally, Michael S.] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Oh, Kyoung Joon] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Mannella, Carmen A.] Wadsworth Ctr, Albany, NY 12201 USA	New York University; University of California System; University of California San Diego; Rosalind Franklin University Medical & Science; Wadsworth Center	Kinnally, KW (corresponding author), NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA.	kck1@nyu.edu	Caballero, Sonia Martinez/B-7583-2013; Martínez-Caballero, Sonia/AAB-8481-2022	Martínez-Caballero, Sonia/0000-0002-4401-6165; OH, KYOUNG JOON/0000-0002-4729-9674	National Institutes of Health [GM57249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57249 (to K. W. K.).	Anishkin A, 2006, BIOPHYS J, V90, P2414, DOI 10.1529/biophysj.105.071977; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Guihard G, 2004, J BIOL CHEM, V279, P46542, DOI 10.1074/jbc.M405153200; Guo L, 2004, AM J PHYSIOL-CELL PH, V286, pC1109, DOI 10.1152/ajpcell.00183.2003; HILLE B, 2001, IONIC CHANNELS EXCIT, P291; Hirokawa T, 2000, PROTEIN ENG, V13, P771, DOI 10.1093/protein/13.11.771; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kandasamy K, 2003, CANCER RES, V63, P1712; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lartigue L, 2008, J CELL SCI, V121, P3515, DOI 10.1242/jcs.029587; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MANNELLA CA, 1981, BIOCHIM BIOPHYS ACTA, V645, P33, DOI 10.1016/0005-2736(81)90508-3; Martinez-Caballero S, 2005, J BIOENERG BIOMEMBR, V37, P155, DOI 10.1007/s10863-005-6570-z; Martinez-Caballero S, 2004, FEBS LETT, V568, P35, DOI 10.1016/j.febslet.2004.05.006; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Murphy RC, 2001, FEBS LETT, V497, P73, DOI 10.1016/S0014-5793(01)02440-1; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Parikh N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-16; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Polster BM, 2001, J BIOL CHEM, V276, P37887; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; SANSOM MSP, 1991, EUR BIOPHYS J, V20, P229, DOI 10.1007/BF00183460; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2	58	87	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12235	12245		10.1074/jbc.M806610200	http://dx.doi.org/10.1074/jbc.M806610200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261612	hybrid, Green Published			2022-12-27	WOS:000265494600055
J	Rudinskiy, N; Grishchuk, Y; Vaslin, A; Puyal, J; Delacourte, A; Hirling, H; Clarke, PGH; Luthi-Carter, R				Rudinskiy, Nikita; Grishchuk, Yulia; Vaslin, Anne; Puyal, Julien; Delacourte, Andre; Hirling, Harald; Clarke, Peter G. H.; Luthi-Carter, Ruth			Calpain Hydrolysis of alpha- and beta 2-Adaptins Decreases Clathrin-dependent Endocytosis and May Promote Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ADAPTER COMPLEX; VESICLE ENDOCYTOSIS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; CORTICAL-NEURONS; COATED VESICLES; RAT-BRAIN; APOPTOSIS; DEGRADATION	Clathrin-dependent endocytosis is mediated by a tightly regulated network of molecular interactions that provides essential protein-protein and protein-lipid binding activities. Here we report the hydrolysis of the alpha- and beta 2-subunits of the tetrameric adaptor protein complex 2 by calpain. Calcium-dependent alpha- and beta 2-adaptin hydrolysis was observed in several rat tissues, including brain and primary neuronal cultures. Neuronal alpha- and beta 2-adaptin cleavage was inducible by glutamate stimulation and was accompanied by the decreased endocytosis of transferrin. Heterologous expression of truncated forms of the beta 2-adaptin subunit significantly decreased the membrane recruitment of clathrin and inhibited clathrin-mediated receptor endocytosis. Moreover, the presence of truncated beta 2-adaptin sensitized neurons to glutamate receptor-mediated excitotoxicity. Proteolysis of alpha- and beta 2-adaptins, as well as the accessory clathrin adaptors epsin 1, adaptor protein 180, and the clathrin assembly lymphoid myeloid leukemia protein, was detected in brain tissues after experimentally induced ischemia and in cases of human Alzheimer disease. The present study further clarifies the central role of calpain in regulating clathrin-dependent endocytosis and provides evidence for a novel mechanism through which calpain activation may promote neurodegeneration: the sensitization of cells to glutamate-mediated excitotoxicity via the decreased internalization of surface receptors.	[Rudinskiy, Nikita; Grishchuk, Yulia; Hirling, Harald; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Vaslin, Anne; Puyal, Julien; Clarke, Peter G. H.] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; [Delacourte, Andre] Jean Pierre Aubert Res Ctr, INSERM, U837, F-59045 Lille, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Luthi-Carter, R (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Stn 15, CH-1015 Lausanne, Switzerland.	ruth.luthi-carter@epfl.ch	Puyal, Julien P/G-4210-2018	Puyal, Julien P/0000-0002-8140-7026; Hirling, Harald/0000-0003-2070-100X	Swiss National Science Foundation; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by the Swiss National Science Foundation and the Ecole Polytechnique Federale de Lausanne.	Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kim JA, 2001, EXP MOL MED, V33, P245, DOI 10.1038/emm.2001.40; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Ohkawa K, 2000, NEUROREPORT, V11, P4007, DOI 10.1097/00001756-200012180-00021; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Ray SK, 2006, NEUROSCIENCE, V139, P577, DOI 10.1016/j.neuroscience.2005.12.057; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Vaslin A, 2007, J NEUROCHEM, V102, P789, DOI 10.1111/j.1471-4159.2007.04564.x; Wu Y, 2007, EMBO J, V26, P2981, DOI 10.1038/sj.emboj.7601741; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yao PJ, 1999, NEUROSCIENCE, V94, P389, DOI 10.1016/S0306-4522(99)00360-7; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017	47	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12447	12458		10.1074/jbc.M804740200	http://dx.doi.org/10.1074/jbc.M804740200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19240038	Green Published, hybrid			2022-12-27	WOS:000265494600074
J	Yan, WS; Chen, XB				Yan, Wensheng; Chen, Xinbin			Identification of GRO1 as a Critical Determinant for Mutant p53 Gain of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-REGULATED ONCOGENE; BREAST-CANCER CELLS; BONE MORPHOGENETIC PROTEIN-7; GENE-EXPRESSION; NEGATIVE REGULATION; SIGNALING PATHWAY; ALPHA-GENE; ANGIOGENESIS; CXCL1	Mutant p53 gain of function contributes to cancer progression, increased invasion and metastasis potentials, and resistance to anticancer therapy. The ability of mutant p53 to acquire its gain of function is shown to correlate with increased expression of progrowth genes, such as c-MYC, MDR1, and NF-kappa B2. However, most of the published studies to identify mutant p53 target genes were performed in a cell system that artificially overexpresses mutant p53. Thus, it remains unclear whether such mutant p53 targets can be regulated by endogenous physiological levels of mutant p53. Here, we utilized SW480 and MIA-PaCa-2 cells, in which endogenous mutant p53 can be inducibly knocked down, to identify mutant p53 target genes that potentially mediate mutant p53 gain of function. We found that knockdown of mutant p53 inhibits GRO1 expression, whereas ectopic expression of mutant R175H in p53-null HCT116 cells increases GRO1 expression. In addition, we found that endogenous mutant p53 is capable of binding to and activating the GRO1 promoter. Interestingly, ectopic expression of GRO1 can rescue the proliferative defect in SW480 and MIA-PaCa-2 cells induced by knockdown of mutant p53. Conversely, knockdown of endogenous GRO1 inhibits cell proliferation and thus abrogates mutant p53 gain of function in SW480 cells. Taken together, our findings define a novel mechanism by which mutant p53 acquires its gain of function via transactivating the GRO1 gene in cancer cells. Thus, targeting GRO1 for cancer therapy would be applicable to a large portion of human tumors with mutant p53, but the exploration of GRO1 as a potential target should take the mutation status of p53 into consideration.	[Yan, Wensheng; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [R01CA121137]; NATIONAL CANCER INSTITUTE [R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA121137.	Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; ANISOWICZ A, 1991, J IMMUNOL, V147, P520; Atema A, 2002, CANCER LETT, V185, P103, DOI 10.1016/S0304-3835(02)00318-X; Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; Bechara C, 2007, MED SCI MONITOR, V13, pRA87; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger M, 2005, ONCOGENE, V24, P2067, DOI 10.1038/SJ.ONC.1208442; Caunt M, 2006, CANCER RES, V66, P4125, DOI 10.1158/0008-5472.CAN-05-2570; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Engl T, 2006, LIFE SCI, V78, P1784, DOI 10.1016/j.lfs.2005.08.019; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Karl E, 2005, CANCER RES, V65, P5063, DOI 10.1158/0008-5472.CAN-05-0140; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lane BR, 2002, J VIROL, V76, P11570, DOI 10.1128/JVI.76.22.11570-11583.2002; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Loukinova E, 2000, ONCOGENE, V19, P3477, DOI 10.1038/sj.onc.1203687; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Nirodi C, 2001, J BIOL CHEM, V276, P26122, DOI 10.1074/jbc.M102872200; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Rennekampff HO, 1997, ARCH DERMATOL RES, V289, P204, DOI 10.1007/s004030050181; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Warner KA, 2008, NEOPLASIA, V10, P131, DOI 10.1593/neo.07815; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wood LD, 1995, J BIOL CHEM, V270, P30619, DOI 10.1074/jbc.270.51.30619; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Wu Kenneth K., 2006, V338, P281; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Zhou Y, 2005, CARCINOGENESIS, V26, P2058, DOI 10.1093/carcin/bgi182; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	39	57	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12178	12187		10.1074/jbc.M900994200	http://dx.doi.org/10.1074/jbc.M900994200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258312	Green Published, hybrid			2022-12-27	WOS:000265494600049
J	Grewal, S; Defamie, N; Zhang, X; De Gois, S; Shawki, A; Mackenzie, B; Chen, C; Varoqui, H; Erickson, JD				Grewal, Sukhjeevan; Defamie, Norah; Zhang, Xiong; De Gois, Stephanie; Shawki, Ali; Mackenzie, Bryan; Chen, Chu; Varoqui, Helene; Erickson, Jeffrey D.			SNAT2 Amino Acid Transporter Is Regulated by Amino Acids of the SLC6 gamma-Aminobutyric Acid Transporter Subfamily in Neocortical Neurons and May Play No Role in Delivering Glutamine for Glutamatergic Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; RAT CEREBRAL-CORTEX; SYSTEM-A; VESICULAR GLUTAMATE; TAURINE-TRANSPORTER; ADAPTIVE REGULATION; SYNAPTIC-TRANSMISSION; CEREBROSPINAL-FLUID; GENE-EXPRESSION; BETA-ALANINE	System A transporters SNAT1 and SNAT2 mediate uptake of neutral alpha-amino acids (e.g. glutamine, alanine, and proline) and are expressed in central neurons. We tested the hypothesis that SNAT2 is required to support neurotransmitter glutamate synthesis by examining spontaneous excitatory activity after inducing or repressing SNAT2 expression for prolonged periods. We stimulated de novo synthesis of SNAT2 mRNA and increased SNAT2 mRNA stability and total SNAT2 protein and functional activity, whereas SNAT1 expression was unaffected. Increased endogenous SNAT2 expression did not affect spontaneous excitatory action-potential frequency over control. Long term glutamine exposure strongly repressed SNAT2 expression but increased excitatory action-potential frequency. Quantal size was not altered following SNAT2 induction or repression. These results suggest that spontaneous glutamatergic transmission in pyramidal neurons does not rely on SNAT2. To our surprise, repression of SNAT2 activity was not limited to System A substrates. Taurine, gamma-aminobutyric acid, and beta-alanine (substrates of the SLC6 gamma-aminobutyric acid transporter family) repressed SNAT2 expression more potently (10x) than did System A substrates; however, the responses to System A substrates were more rapid. Since ATF4 (activating transcription factor 4) and CCAAT/enhancer-binding protein are known to bind to an amino acid response element within the SNAT2 promoter and mediate induction of SNAT2 in peripheral cell lines, we tested whether either factor was similarly induced by amino acid deprivation in neurons. We found that glutamine and taurine repressed the induction of both transcription factors. Our data revealed that SNAT2 expression is constitutively low in neurons under physiological conditions but potently induced, together with the taurine transporter TauT, in response to depletion of neutral amino acids.	[Grewal, Sukhjeevan; Defamie, Norah; Zhang, Xiong; De Gois, Stephanie; Chen, Chu; Varoqui, Helene; Erickson, Jeffrey D.] Louisiana State Univ, Ctr Neurosci, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Shawki, Ali; Mackenzie, Bryan] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; University of Cincinnati	Erickson, JD (corresponding author), Louisiana State Univ, Ctr Neurosci, Hlth Sci Ctr, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	jerick@lsuhsc.edu	defamie, norah/AAB-7702-2020	defamie, norah/0000-0002-7504-7538; Shawki, Ali/0000-0002-6413-5313; Mackenzie, Bryan/0000-0002-9661-8838	National Institutes of Health [1P29RR16816, NS36936]; University of Cincinnati; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1P29RR16816 (to H.V.) and NS36936 (to J.D.E.). This work was also supported by the University of Cincinnati (to B.M.).	Albers A, 2001, PFLUG ARCH EUR J PHY, V443, P92, DOI 10.1007/s004240100663; BOERNER P, 1985, J CELL PHYSIOL, V122, P308, DOI 10.1002/jcp.1041220221; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; BRACY DS, 1986, J BIOL CHEM, V261, P1514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burkhalter J, 2007, J BIOL CHEM, V282, P5152, DOI 10.1074/jbc.M608548200; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; CONTI F, 1994, J HISTOCHEM CYTOCHEM, V42, P717, DOI 10.1177/42.6.7910617; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; DallAsta V, 1996, BIOCHEM SOC T, V24, P864, DOI 10.1042/bst0240864; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Dolinska M, 2004, NEUROCHEM INT, V44, P75, DOI 10.1016/S0197-0186(03)00123-2; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fastje CD, 2004, FASEB J, V18, pA461; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Fujita T, 2006, PHARM RES-DORDR, V23, P689, DOI 10.1007/s11095-006-9745-3; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Gazzola RF, 2001, FEBS LETT, V490, P11; GJESSING LR, 1972, J NEUROCHEM, V19, P1807, DOI 10.1111/j.1471-4159.1972.tb06226.x; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Han X, 2006, ACTA PHYSIOL, V187, P61, DOI 10.1111/j.1748-1716.2006.01573.x; HANDLOGTEN ME, 1984, J BIOL CHEM, V259, P3519; HEATON JH, 1977, J BIOL CHEM, V252, P2900; Hertz L, 2004, NEUROCHEM INT, V45, P285, DOI 10.1016/j.neuint.2003.08.016; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2004, EUR J NEUROSCI, V20, P1752, DOI 10.1111/j.1460-9568.2004.03628.x; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; JENSTAD M, 2009, CEREB CORTE IN PRESS; Jessen H, 1997, BBA-BIOMEMBRANES, V1325, P309, DOI 10.1016/S0005-2736(97)00006-0; JONES DP, 1990, KIDNEY INT, V38, P219, DOI 10.1038/ki.1990.189; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Kanamori K, 2004, J NEUROCHEM, V90, P203, DOI 10.1111/j.1471-4159.2004.02478.x; KILBERG MS, 1985, J CELL PHYSIOL, V122, P290, DOI 10.1002/jcp.1041220219; LEHMANN A, 1991, J NEUROCHEM, V56, P690, DOI 10.1111/j.1471-4159.1991.tb08204.x; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; Liu MP, 1999, AM J PHYSIOL-GASTR L, V276, pG206, DOI 10.1152/ajpgi.1999.276.1.G206; LIU QR, 1993, J BIOL CHEM, V268, P2106; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Maallem S, 2008, NEUROSCIENCE, V153, P95, DOI 10.1016/j.neuroscience.2008.01.047; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; MACKENZIE B, 1999, BIOMEMBRANE TRANSPOR; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; Melone M, 2006, NEUROSCIENCE, V140, P281, DOI 10.1016/j.neuroscience.2006.02.042; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; MINELLI A, 1995, J NEUROSCI, V15, P7734, DOI 10.1523/jneurosci.15-11-07734.1995; Minelli A, 2003, DEV BRAIN RES, V142, P7, DOI 10.1016/S0165-3806(03)00007-5; MOFFETT J, 1984, MOL CELL BIOL, V4, P799, DOI 10.1128/MCB.4.4.799; Morimura H, 1997, MOL BRAIN RES, V44, P245, DOI 10.1016/S0169-328X(96)00226-4; Nelson N, 1998, J NEUROCHEM, V71, P1785; Novak D, 2006, BIOCHIMIE, V88, P39, DOI 10.1016/j.biochi.2005.07.002; Olsen M, 2005, NEUROCHEM RES, V30, P855, DOI 10.1007/s11064-005-6879-3; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; PALII SS, 2009, AMINOACIDS IN PRESS; Pastor-Anglada M, 2005, J GEN PHYSIOL, V125, P41, DOI 10.1085/jgp.200409201; Peterson WM, 1995, J GEN PHYSIOL, V106, P1089, DOI 10.1085/jgp.106.6.1089; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; ROY G, 1994, J EXP ZOOL, V268, P121, DOI 10.1002/jez.1402680208; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; SCHOUSBOE A, 1992, ADV EXP MED BIOL, V315, P391; Su TZ, 1997, BRAIN RES, V757, P69, DOI 10.1016/S0006-8993(97)00139-X; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; Tamarappoo BK, 1997, J NEUROCHEM, V68, P954; Thurlow RJ, 1996, BRIT J PHARMACOL, V118, P449, DOI 10.1111/j.1476-5381.1996.tb15424.x; Tomi M, 2008, BBA-BIOMEMBRANES, V1778, P2138, DOI 10.1016/j.bbamem.2008.04.012; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200	98	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11224	11236		10.1074/jbc.M806470200	http://dx.doi.org/10.1074/jbc.M806470200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240036	hybrid, Green Published			2022-12-27	WOS:000265494500026
J	Mostowy, S; Danckaert, A; Tham, TN; Machu, C; Guadagnini, S; Pizarro-Cerda, J; Cossart, P				Mostowy, Serge; Danckaert, Anne; Tham, To Nam; Machu, Christophe; Guadagnini, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale			Septin 11 Restricts InlB-mediated Invasion by Listeria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEPTIN; FILAMENT FORMATION; MONOCYTOGENES; CELLS; ORGANIZATION; CYTOKINESIS; PROTEIN; INTERNALIZATION; MICROTUBULES; SUFFICIENT	Septins are filament-forming GTPases implicated in several cellular functions, including cytokinesis. We previously showed that SEPT2, SEPT9, and SEPT11 colocalize with several bacteria entering into mammalian non-phagocytic cells, and SEPT2 was identified as essential for this process. Here, we investigated the function of SEPT11, an interacting partner of SEPT9 whose function is still poorly understood. In uninfected HeLa cells, SEPT11 depletion by siRNA increased cell size but surprisingly did not affect actin filament formation or the colocalization of SEPT9 with actin filaments. SEPT11 depletion increased Listeria invasion, and incubating SEPT11-depleted cells with beads coated with the Listeria surface protein InlB also led to increased entry as compared with control cells. Strikingly, as shown by fluorescence resonance energy transfer, the InlB-mediated stimulation of Met signaling remained intact in SEPT11-depleted cells. Taken together, our results show that SEPT11 is not required for the bacterial entry process and rather restricts its efficacy. Because SEPT2 is essential for the InlB-mediated entry of Listeria, but SEPT11 is not, our findings distinguish the roles of different mammalian septins.	[Mostowy, Serge; Tham, To Nam; Pizarro-Cerda, Javier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mostowy, Serge; Tham, To Nam; Pizarro-Cerda, Javier; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Mostowy, Serge; Tham, To Nam; Pizarro-Cerda, Javier; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Machu, Christophe; Guadagnini, Stephanie] Inst Pasteur, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr		Mostowy, Serge/0000-0002-7286-6503	Canadian Institutes of Health Research; Canadian Foundation Louis Pasteur	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation Louis Pasteur	Supported by a long-term fellowship from the Canadian Institutes of Health Research and the Canadian Foundation Louis Pasteur.	Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; NOBUHIRO H, 2004, FEBS LETT, V568, P83; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; SPILIOTIS ET, 2008, SEPTINS, P229; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042	34	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11613	11621		10.1074/jbc.M900231200	http://dx.doi.org/10.1074/jbc.M900231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19234302	hybrid, Green Published			2022-12-27	WOS:000265494500065
J	Browne, LE; Blaney, FE; Yusaf, SP; Clare, JJ; Wray, D				Browne, Liam E.; Blaney, Frank E.; Yusaf, Shahnaz P.; Clare, Jeff J.; Wray, Dennis			Structural Determinants of Drugs Acting on the Na(v)1.8 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT SODIUM-CHANNEL; TRANSMEMBRANE SEGMENT IVS6; MODULATE BINDING-AFFINITY; USE-DEPENDENT BLOCK; MOLECULAR-BASIS; LOCAL-ANESTHETICS; NEUROPATHIC PAIN; POINT MUTATIONS; ALPHA-SUBUNIT; EXPRESSION	The aim of this work is to study the role of pore residues on drug binding in the Na(V)1.8 channel. Alanine mutations were made in the S6 segments, chosen on the basis of their roles in other Na-V subtypes; whole cell patch clamp recordings were made from mammalian ND7/23 cells. Mutations of some residues caused shifts in voltage dependence of activation and inactivation, and gave faster time course of inactivation, indicating that the residues mutated play important roles in both activation and inactivation in the Na(V)1.8 channel. The resting and inactivated state affinities of tetracaine for the channel were reduced by mutations I381A, F1710A, and Y1717A (for the latter only inactivated state affinity was measured), and by mutation F1710A for the Na(V)1.8-selective compound A-803467, showing the involvement of these residues for each compound, respectively. For both compounds, mutation L1410A caused the unexpected appearance of a complete resting block even at extremely low concentrations. Resting block of native channels by compound A-803467 could be partially removed ("disinhibition") by repetitive stimulation or by a test pulse after recovery from inactivation; the magnitude of the latter effect was increased for all the mutants studied. Tetracaine did not show this effect for native channels, but disinhibition was seen particularly for mutants L1410A and F1710A. The data suggest differing, but partially overlapping, areas of binding of A-803467 and tetracaine. Docking of the ligands into a three-dimensional model of the Na(V)1.8 channel gave interesting insight as to how the ligands may interact with pore residues.	[Browne, Liam E.; Wray, Dennis] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Blaney, Frank E.] GlaxoSmithKline, Computat & Struct Chem, Harlow CM19 5AW, Essex, England; [Yusaf, Shahnaz P.] GlaxoSmithKline, Biol Reagents & Assay Dev, Harlow CM19 5AW, Essex, England; [Clare, Jeff J.] Ion Channel Grp, Cambridge CB5 8PB, England	University of Leeds; GlaxoSmithKline; GlaxoSmithKline	Wray, D (corresponding author), Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	d.wray@leeds.ac.uk		Browne, Liam/0000-0002-5693-7703	Biotechnology and Biological Sciences Research Council and GlaxoSmithKline	Biotechnology and Biological Sciences Research Council and GlaxoSmithKline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Akiba I, 2003, RECEPTOR CHANNEL, V9, P291, DOI 10.3109/713745174; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Blaney Frank E., 1996, P161; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carboni M, 2005, J MEMBRANE BIOL, V207, P107, DOI 10.1007/s00232-005-0805-0; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins Theodore R, 2007, Expert Rev Neurother, V7, P1597, DOI 10.1586/14737175.7.11.1597; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Kondratiev A, 2003, MOL PHARMACOL, V64, P741, DOI 10.1124/mol.64.3.741; Kuo CC, 1998, MOL PHARMACOL, V54, P712; KUO CC, 1994, MOL PHARMACOL, V46, P716; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Laird JMA, 2002, J NEUROSCI, V22, P8352; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Liu G, 2003, NEUROPHARMACOLOGY, V44, P413, DOI 10.1016/S0028-3908(02)00400-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Nau C, 2003, MOL PHARMACOL, V63, P1398, DOI 10.1124/mol.63.6.1398; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Nau C, 1999, MOL PHARMACOL, V56, P404, DOI 10.1124/mol.56.2.404; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; ROY ML, 1992, J NEUROSCI, V12, P2104; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; Yarov-Yarovoy V, 2002, J BIOL CHEM, V277, P35393, DOI 10.1074/jbc.M206126200	46	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10523	10536		10.1074/jbc.M807569200	http://dx.doi.org/10.1074/jbc.M807569200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233853	hybrid, Green Published			2022-12-27	WOS:000265104600026
J	Chepurny, OG; Leech, CA; Kelley, GG; Dzhura, I; Dzhura, E; Li, XQ; Rindler, MJ; Schwede, F; Genieser, HG; Holz, GG				Chepurny, Oleg G.; Leech, Colin A.; Kelley, Grant G.; Dzhura, Igor; Dzhura, Elvira; Li, Xiangquan; Rindler, Michael J.; Schwede, Frank; Genieser, Hans G.; Holz, George G.			Enhanced Rap1 Activation and Insulin Secretagogue Properties of an Acetoxymethyl Ester of an Epac-selective Cyclic AMP Analog in Rat INS-1 Cells STUDIES WITH 8-pCPT-2 '-O-Me-cAMP-AM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PROTEIN-KINASE-A; GLUCAGON-LIKE PEPTIDE-1; GENE PROMOTER ACTIVITY; CAMP SENSOR EPAC; CA2+-INDUCED CA2+ RELEASE; SIGNAL-TRANSDUCTION; INDEPENDENT ACTIVATION; REGULATED EXOCYTOSIS; RESPONSE ELEMENT	To ascertain the identities of cyclic nucleotide-binding proteins that mediate the insulin secretagogue action of cAMP, the possible contributions of the exchange protein directly activated by cAMP (Epac) and protein kinase A (PKA) were evaluated in a pancreatic beta cell line (rat INS-1 cells). Assays of Rap1 activation, CREB phosphorylation, and PKA-dependent gene expression were performed in combination with live cell imaging and high throughput screening of afluorescence resonance energy transfer-based cAMP sensor (Epac1-camps) to validate the selectivity with which acetoxymethyl esters(AM-esters) of cAMP analogs preferentially activate Epac or PKA. Selective activation of Epac or PKA was achieved following exposure of INS-1 cells to 8-pCPT-2'-O-Me-cAMP-AM or Bt(2)cAMP-AM, respectively. Both cAMP analogs exerted dose-dependent and glucose metabolism-dependent actions to stimulate insulin secretion, and when each was co-administered with the other, a supra-additive effect was observed. Because 2.4-fold more insulin was secreted in response to a saturating concentration (10 mu M) of Bt(2)cAMP-AM as compared with 8-pCPT-2'-O-Me-cAMPAM, and because the action of Bt(2)cAMP-AM but not 8-pCPT-2'-O-Me-cAMP-AM was nearly abrogated by treatment with 3 mu M of the PKA inhibitor H-89, it is concluded that for INS-1 cells, it is PKA that acts as the dominant cAMP-binding protein in support of insulin secretion. Unexpectedly, 10-100 mu M of the non-AM-ester of 8-pCPT-2'-O-Me-cAMP failed to stimulate insulin secretion and was a weak activator of Rap1 in INS-1 cells. Moreover, 10 mu M of the AM-ester of 8-pCPT-2'-O-Me-cAMP stimulated insulin secretion from mouse islets, whereas the non-AM-ester did not. Thus, themembrane permeability of 8-pCPT-2'-O-Me-cAMP ininsulin-secreting cells is so low as to limit its biological activity. It is concluded that prior reports documenting the failure of 8-pCPT-2'-O-Me-cAMP to act in beta cells, or other cell types, need to be re-evaluated through the use of the AM-ester of this cAMP analog.	[Chepurny, Oleg G.; Leech, Colin A.; Kelley, Grant G.; Dzhura, Igor; Dzhura, Elvira; Li, Xiangquan; Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Kelley, Grant G.; Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Rindler, Michael J.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Schwede, Frank; Genieser, Hans G.] BIOLOG Life Sci Inst, D-28071 Bremen, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; New York University	Holz, GG (corresponding author), IHP Rm 4310,505 Irving Ave, Syracuse, NY 13210 USA.	holzg@upstate.edu	Holz, George G/A-3386-2012	Genieser, Hans-Gottfried/0000-0002-4904-5790; Holz, George/0000-0002-1781-3580	National Institutes of Health [DK045817, DK069575]; American Diabetes Association Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045817, R01DK069575, R29DK045817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research Award(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK045817 and DK069575 (to G. G. H.). This work was also supported by a American Diabetes Association Research Award ( to C. A. L.).	AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bartsch M, 2003, BIOL CHEM, V384, P1321, DOI 10.1515/BC.2003.148; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chepurny OG, 2002, ENDOCRINOLOGY, V143, P2303, DOI 10.1210/en.143.6.2303; Chepurny OG, 2002, CELL TISSUE RES, V307, P191, DOI 10.1007/s00441-001-0494-7; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gambaryan S, 2006, AM J PHYSIOL-ENDOC M, V290, pE423, DOI 10.1152/ajpendo.00128.2005; Gonzalez-Iglesias AE, 2006, MOL ENDOCRINOL, V20, P2231, DOI 10.1210/me.2005-0363; HARBECK MC, 2006, SCI STKE, pPL6; Hashiguchi H, 2006, DIABETES-METAB RES, V22, P64, DOI 10.1002/dmrr.580; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz George G, 2005, Sci STKE, V2005, ppe2; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Holz GG, 2003, CURR MED CHEM, V10, P2471, DOI 10.2174/0929867033456648; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kang GX, 2008, J PHYSIOL-LONDON, V586, P1307, DOI 10.1113/jphysiol.2007.143818; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Liu GH, 2006, J PHARMACOL EXP THER, V318, P152, DOI 10.1124/jpet.105.097477; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PEPE S, 1991, CANCER RES, V51, P6263; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; SCHULTZ C, 1993, J BIOL CHEM, V268, P6316; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Skoglund G, 2000, DIABETES, V49, P1156, DOI 10.2337/diabetes.49.7.1156; Thams P, 2005, EUR J ENDOCRINOL, V152, P671, DOI 10.1530/eje.1.01885; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wan QF, 2004, J GEN PHYSIOL, V124, P653, DOI 10.1085/jgp.200409082; Yang Y, 2004, J GEN PHYSIOL, V124, P641, DOI 10.1085/jgp.200409081; Zhao CN, 2006, J NEUROSCI RES, V84, P389, DOI 10.1002/jnr.20875	61	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10728	10736		10.1074/jbc.M900166200	http://dx.doi.org/10.1074/jbc.M900166200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244230	Green Published, hybrid			2022-12-27	WOS:000265104600047
J	Cho, IT; Kim, DH; Kang, YH; Lee, CH; Amangyelid, T; Nguyen, TA; Hurwitz, J; Seo, YS				Cho, Il-taeg; Kim, Do-hyung; Kang, Young-Hoon; Lee, Chul-Hwan; Amangyelid, Tamir; Nguyen, Tuan Anh; Hurwitz, Jerard; Seo, Yeon-Soo			Human Replication Factor C Stimulates Flap Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-DELTA; ATP UTILIZATION; SACCHAROMYCES-CEREVISIAE; OKAZAKI FRAGMENTS; COMPLEX-FORMATION; GENOME STABILITY; SYNDROME PROTEIN; EXCISION-REPAIR; HUMAN FEN1	Flap endonuclease 1 (FEN1) is the enzyme responsible for specifically removing the flap structure produced during DNA replication, repair, and recombination. Here we report that the human replication factor C(RFC) complex stimulates the nuclease activity of human FEN1 in an ATP-independent manner. Although proliferating cell nuclear antigen is also known to stimulate FEN1, less RFC was required for comparable FEN1 stimulation. Kinetic analyses indicate that the mechanism by which RFC stimulates FEN1 is distinct from that by proliferating cell nuclear antigen. Heat-denatured RFC or its subunit retained, fully or partially, the ability to stimulate FEN1. Via systematic deletion analyses, we have defined three specific regions of RFC4 capable of stimulating FEN1. The region of RFC4 with the highest activity spans amino acids 170-194 and contains RFC box VII. Four amino acid residues (i.e. Tyr-182, Glu-188, Pro-189, and Ser-192) are especially important for FEN1 stimulatory activity. Thus, RFC, via several stimulatory motifs per molecule, potently activates FEN1. This function makes RFC a critical partner with FEN1 for the processing of eukaryotic Okazaki fragments.	[Cho, Il-taeg; Kim, Do-hyung; Kang, Young-Hoon; Lee, Chul-Hwan; Amangyelid, Tamir; Nguyen, Tuan Anh; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea; [Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Korea Advanced Institute of Science & Technology (KAIST); Memorial Sloan Kettering Cancer Center	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Lee, Chul-Hwan/0000-0003-0643-0100; Nguyen, Tuan Anh/0000-0001-7793-2699	Ministry of Education, Science and Technology	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation grants funded by the Ministry of Education, Science and Technology.	AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Brosh RM, 2001, EMBO J, V20, P5791; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; Cai JS, 1996, P NATL ACAD SCI USA, V93, P12896, DOI 10.1073/pnas.93.23.12896; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Greene AL, 1999, HUM MOL GENET, V8, P2263, DOI 10.1093/hmg/8.12.2263; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kang YH, 2009, J BIOL CHEM, V284, P10376, DOI 10.1074/jbc.M808894200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Miyata T, 2004, NAT STRUCT MOL BIOL, V11, P632, DOI 10.1038/nsmb788; Negritto MC, 2001, MOL CELL BIOL, V21, P2349, DOI 10.1128/MCB.21.7.2349-2358.2001; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Sharma S, 2004, HUM MOL GENET, V13, P2247, DOI 10.1093/hmg/ddh234; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wu XH, 1999, NUCLEIC ACIDS RES, V27, P956, DOI 10.1093/nar/27.4.956; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	62	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10387	10399		10.1074/jbc.M808893200	http://dx.doi.org/10.1074/jbc.M808893200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208620	hybrid, Green Published			2022-12-27	WOS:000265104600013
J	Grou, CP; Carvalho, AF; Pinto, MP; Huybrechts, SJ; Sa-Miranda, C; Fransen, M; Azevedo, JE				Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Huybrechts, Sofie J.; Sa-Miranda, Clara; Fransen, Marc; Azevedo, Jorge E.			Properties of the Ubiquitin-Pex5p Thiol Ester Conjugate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL CYCLING RECEPTOR; HUMAN PTS1 RECEPTOR; IMPORT RECEPTOR; PROTEIN IMPORT; CONSERVED CYSTEINE; ZELLWEGER-SYNDROME; PEX5P; UBIQUITINATION; MEMBRANE; IDENTIFICATION	Pex5p, the peroxisomal protein cycling receptor, binds newly synthesized peroxisomal matrix proteins in the cytosol and promotes their translocation across the organelle membrane. During its transient passage through the membrane, Pex5p is monoubiquitinated at a conserved cysteine residue, a requisite for its subsequent ATP-dependent export back into the cytosol. Here we describe the properties of the soluble and membrane-bound monoubiquitinated Pex5p species (Ub-Pex5p). Our data suggest that 1) Ub-Pex5p is deubiquitinated by a combination of context-dependent enzymatic and nonenzymatic mechanisms; 2) soluble Ub-Pex5p retains the capacity to interact with the peroxisomal import machinery in a cargo-dependent manner; and 3) substitution of the conserved cysteine residue of Pex5p by a lysine results in a quite functional protein both in vitro and in vivo. Additionally, we show that MG132, a proteasome inhibitor, blocks the import of a peroxisomal reporter protein in vivo.	[Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Azevedo, Jorge E.] Inst Ciencias Biomed Abel Salazar ICBAS, P-4009003 Oporto, Portugal; [Huybrechts, Sofie J.; Fransen, Marc] Katholieke Univ Leuven, Dept Mol Celbiol, Fac Geneeskunde, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Azevedo, Jorge E/A-4113-2008; Fransen, Marc/C-6262-2008; Fransen, Marc/ADL-0723-2022; Grou, Claudia P/K-5472-2013; Pinto, Manuel/K-6425-2013; Carvalho, Andreia/J-9013-2015; sá Miranda, Maria Clara/K-3920-2013	Azevedo, Jorge E/0000-0001-7714-5302; Fransen, Marc/0000-0001-9284-1197; Grou, Claudia P/0000-0001-5197-2270; Pinto, Manuel/0000-0001-9778-2093; Carvalho, Andreia/0000-0001-8781-5680; sá Miranda, Maria Clara/0000-0003-0123-5525	Fundacao para a Ciencia e Tecnologia (Programa em Todos os Dominios Cientificos); Fundo Europeu de Desenvolvimento Regional, Portugal; European Union [LSHG-CT-2004-512018]; Flemish Government Geconcerteerde Onderzoeksacties [GOA2004/08]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen Onderzoeksproject [G.0237.04]	Fundacao para a Ciencia e Tecnologia (Programa em Todos os Dominios Cientificos)(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional, Portugal; European Union(European Commission); Flemish Government Geconcerteerde Onderzoeksacties; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen Onderzoeksproject(FWO)	The work done in Porto was supported by grants from Fundacao para a Ciencia e Tecnologia (Programa em Todos os Dominios Cientificos) and Fundo Europeu de Desenvolvimento Regional, Portugal, and by the European Union VI Framework program Grant LSHG-CT-2004-512018, Peroxisomes in Health and Disease. The work done in Leuven was supported by Flemish Government Geconcerteerde Onderzoeksacties Grant GOA2004/08 and the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen Onderzoeksproject Grant G.0237.04.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Esteban-Pretel G, 2006, FREE RADICAL BIO MED, V41, P610, DOI 10.1016/j.freeradbiomed.2006.05.004; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fransen M, 2008, BBA-MOL CELL RES, V1783, P864, DOI 10.1016/j.bbamcr.2008.02.013; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Haas AL, 1997, FASEB J, V11, P1257; Haddad JJE, 2000, AM J PHYSIOL-LUNG C, V278, pL492, DOI 10.1152/ajplung.2000.278.3.L492; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Huybrechts SJ, 2008, J MED GENET, V45, P376, DOI 10.1136/jmg.2007.056697; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lindorff-Larsen K, 2000, ANAL BIOCHEM, V286, P308, DOI 10.1006/abio.2000.4807; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROSE IA, 1983, BIOCHEMISTRY-US, V22, P4234, DOI 10.1021/bi00287a012; Strajbl M, 2000, INT J QUANTUM CHEM, V77, P44, DOI 10.1002/(SICI)1097-461X(2000)77:1<44::AID-QUA6>3.0.CO;2-A; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	56	64	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10504	10513		10.1074/jbc.M808978200	http://dx.doi.org/10.1074/jbc.M808978200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208625	Green Published, hybrid			2022-12-27	WOS:000265104600024
J	Mikkelsen, SS; Jensen, SB; Chiliveru, S; Melchjorsen, J; Julkunen, I; Gaestel, M; Arthur, JSC; Flavell, RA; Ghosh, S; Paludan, SR				Mikkelsen, Susie S.; Jensen, Sren B.; Chiliveru, Srikanth; Melchjorsen, Jesper; Julkunen, Ilkka; Gaestel, Matthias; Arthur, J. Simon C.; Flavell, Richard A.; Ghosh, Sankar; Paludan, Sren R.			RIG-I-mediated Activation of p38 MAPK Is Essential for Viral Induction of Interferon and Activation of Dendritic Cells DEPENDENCE ON TRAF2 AND TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; HELICASE ANTIVIRAL PATHWAY; NF-KAPPA-B; IMMUNE-RESPONSES; ADAPTER PROTEIN; TNF-ALPHA; SIGNALING PATHWAYS; GENE-EXPRESSION; INNATE; KINASE	The innate immune system provides an initial defense system against microbial infections and contributes to the development of adaptive immune response. Type I interferons play a pivotal role for the first line of defense against virus infections, and dendritic cells (DCs) are important sensors of pathogens responsible for priming of adaptive immune responses in lymphoid organs. Here we have investigated the role and mechanisms of activation of the MAPK pathway in innate immune responses induced by Sendai virus, a negative sense single-stranded RNA virus. Both p38 and JNK were activated in fibroblasts and DCs after infection with Sendai virus in a manner dependent on virus replication and RIG-I. Virus replication was also required for stimulation of interferon production in both cell types and interleukin-12 production in DCs. Blocking of p38 MAPK activation by the specific inhibitor SB202190 abolished the expression of these cytokines. p38 MAPK exerted its function independent of the MAPK-activated protein kinases MK2, MNK, and MSK1/2. We also observed that TRAF2 and TAK1 were essential for RIG-I-mediated activation of p38 MAPK. Interestingly, the kinase activity of p38 MAPK was required for its own phosphorylation, which was kinetically associated with TAB1 interaction. By contrast, the canonical p38 upstream kinase MKK3 was not involved in the p38-dependent response. Thus, activation of p38 MAPK by RIG-I proceeds via a TRAF2-TAK1-dependent pathway, where the enzymatic activity of the kinase plays an essential role. The p38 MAPK in turn stimulates important processes in the innate antiviral response.	[Mikkelsen, Susie S.; Jensen, Sren B.; Chiliveru, Srikanth; Melchjorsen, Jesper; Paludan, Sren R.] Univ Aarhus, Inst Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark; [Melchjorsen, Jesper] Skejby Hosp, Dept Infect Dis, DK-8200 Aarhus, Denmark; [Julkunen, Ilkka] Natl Publ Hlth Inst, Dept Virus Dis & Immunol, FI-00300 Helsinki, Finland; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Arthur, J. Simon C.] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Flavell, Richard A.; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Aarhus University; Aarhus University; Finland National Institute for Health & Welfare; Hannover Medical School; University of Dundee; Yale University; Howard Hughes Medical Institute; Yale University	Paludan, SR (corresponding author), Univ Aarhus, Inst Med Microbiol & Immunol, Bartholin Bldg, DK-8000 Aarhus C, Denmark.	srp@microbiology.au.dk	Arthur, J. Simon/B-8058-2010; Gaestel, Matthias/A-6560-2013	Arthur, J. Simon/0000-0002-8135-1958; Gaestel, Matthias/0000-0002-4944-4652; Mikkelsen, Susie Sommer/0000-0003-1744-9106	Danish Medical Research Council [27106-0438]; Danish Natural Science Research Council [272-05-0222]; Lundbeck Foundation [116/06, R17-A1526]; Kathrine og Vigo Skovgards Fond; Aarhus University Research Foundation; Research Program in Molecular Medicine, Faculty of Health Science, Aarhus University; Lundbeck Foundation [R17-2007-1526] Funding Source: researchfish; Medical Research Council [MC_U127081014] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER; MRC [MC_U127081014] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Kathrine og Vigo Skovgards Fond; Aarhus University Research Foundation; Research Program in Molecular Medicine, Faculty of Health Science, Aarhus University; Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Danish Medical Research Council Grant 27106-0438), Danish Natural Science Research Council Grant 272-05-0222, Lundbeck Foundation Grants 116/06 and R17-A1526, the Kathrine og Vigo Skovgards Fond, the Aarhus University Research Foundation, and the Research Program in Molecular Medicine, Faculty of Health Science, Aarhus University.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Mogensen TH, 2005, J MOL MED, V83, P180, DOI 10.1007/s00109-004-0620-6; OGANESYAN G, 2005, NATURE, V439, P211; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Petersen MS, 2000, SCAND J IMMUNOL, V51, P586; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; SATO S, 2005, NAT IMMUNOL, V6, P2668; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yanagawa Y, 2002, J LEUKOCYTE BIOL, V71, P125; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	51	85	88	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10774	10782		10.1074/jbc.M807272200	http://dx.doi.org/10.1074/jbc.M807272200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224920	Green Published, hybrid			2022-12-27	WOS:000265104600052
J	Mishra, A; Godavarthi, SK; Maheshwari, M; Goswami, A; Jana, NR				Mishra, Amit; Godavarthi, Swetha K.; Maheshwari, Megha; Goswami, Anand; Jana, Nihar Ranjan			The Ubiquitin Ligase E6-AP Is Induced and Recruited to Aggresomes in Response to Proteasome Inhibition and May Be Involved in the Ubiquitination of Hsp70-bound Misfolded Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-CHAPERONE CHIP; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; QUALITY-CONTROL; ANGELMAN-SYNDROME; IN-VIVO; NEURODEGENERATIVE DISEASE; POLYGLUTAMINE PROTEIN; DEPENDENT DEGRADATION; CONFERS PROTECTION	Cells are equipped with an efficient quality control system to selectively eliminate abnormally folded and damaged proteins. Initially the cell tries to refold the unfolded proteins with the help of molecular chaperones, and failure to refold leads to their degradation by the ubiquitin proteasome system. But how this proteolytic machinery recognizes the abnormally folded proteins is poorly understood. Here, we report that E6-AP, a HECT domain family ubiquitin ligase implicated in Angelman syndrome, interacts with the substrate binding domain of Hsp70/Hsc70 chaperones and promotes the degradation of chaperone bound substrates. The expression of E6-AP was dramatically induced under a variety of stresses, and overexpression of E6-AP was found to protect against endoplasmic reticulum stress-induced cell death. The inhibition of proteasome function not only increases the expression of E6-AP but also causes its redistribution around microtubule-organizing center, a subcellular structure for the degradation of the cytoplasmic misfolded proteins. E6-AP is also recruited to aggresomes containing the cystic fibrosis transmembrane conductance regulator or expanded polyglutamine proteins. Finally, we demonstrate that E6-AP ubiquitinates misfolded luciferase that is bound by Hsp70. Our results suggest that E6-AP functions as a cellular quality control ubiquitin ligase and, therefore, can be implicated not only in the pathogenesis of Angelman syndrome but also in the biology of neurodegenerative disorders involving protein aggregation.	[Mishra, Amit; Godavarthi, Swetha K.; Maheshwari, Megha; Goswami, Anand; Jana, Nihar Ranjan] Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Manesar 122050, Gurgaon, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in		Godavarthi, Swetha/0000-0003-4665-4627; Jana, Nihar/0000-0002-6549-4211; Mishra, Amit/0000-0001-9401-4400	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mishra A, 2008, CELL MOL LIFE SCI, V65, P656, DOI 10.1007/s00018-007-7476-1; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scott Melissa D, 2003, Methods Mol Biol, V232, P67; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106	51	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10537	10545		10.1074/jbc.M806804200	http://dx.doi.org/10.1074/jbc.M806804200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233847	Green Published, hybrid			2022-12-27	WOS:000265104600027
J	Wan, YZ; Xiao, H; Affolter, J; Kim, TW; Bulek, K; Chaudhuri, S; Carlson, D; Hamilton, T; Mazumder, B; Stark, GR; Thomas, J; Li, XX				Wan, Youzhong; Xiao, Hui; Affolter, Jeremy; Kim, Tae Whan; Bulek, Katarzyna; Chaudhuri, Sujan; Carlson, Deborah; Hamilton, Thomas; Mazumder, Barsanjit; Stark, George R.; Thomas, James; Li, Xiaoxia			Interleukin-1 Receptor-associated Kinase 2 Is Critical for Lipopolysaccharide-mediated Post-transcriptional Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INITIATION-FACTOR 4E; TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; INNATE; PHOSPHORYLATION; MACROPHAGES; EXPRESSION; RESPONSIVENESS	IRAK2, a member of the interleukin-1 receptor-associated kinase (IRAK) family, has been implicated in Toll-like receptor (TLR)-mediated signaling. We generated IRAK2-deficient mice to examine its function in detail. These mice are resistant to lipopolysaccharide-induced septic shock, because of impaired TLR4-mediated induction of pro-inflammatory cytokines and chemokines. Although IRAK2 deficiency did not affect TLR4-mediated NF kappa B activation, a reduction of lipopolysaccharide (LPS)-mediated mRNA stabilization contributed to the reduced cytokine and chemokine production observed in bone marrow-derived macrophages from IRAK2-deficient mice. Furthermore, the ratios of LPS-induced cytokine and chemokine mRNAs in translation-active (polysomal) versus translation-inactive (free ribosomes) pools were reduced in IRAK2-deficient macrophages compared with wild type macrophages. Importantly, LPS-induced phosphorylation of MKK3/6, MNK1, and eIF4E was significantly reduced in IRAK2-deficient macrophages compared with wild type macrophages. Moreover, LPS stimulation induced an interaction of IRAK2 with TRAF6, MKK3/6, and MK2, implicating a critical role for mitogen-activated protein kinase signaling in LPS-induced IRAK2-mediated post-transcriptional control. These results reveal that IRAK2 is required for LPS-mediated post-transcriptional control of cytokine and chemokine expression, which plays an essential role in TLR4-induced septic shock.	[Xiao, Hui; Kim, Tae Whan; Bulek, Katarzyna; Hamilton, Thomas; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Wan, Youzhong; Stark, George R.] Cleveland Clin Fdn, Dept Mol Genet, Cleveland, OH 44195 USA; [Affolter, Jeremy; Carlson, Deborah; Thomas, James] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Affolter, Jeremy; Carlson, Deborah; Thomas, James] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chaudhuri, Sujan; Mazumder, Barsanjit] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Wan, Youzhong; Stark, George R.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Kim, Tae Whan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Cleveland State University; Case Western Reserve University; Case Western Reserve University	Thomas, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	james.thomas@utsouthwestern.edu; lix@ccf.org	Bulek, Katarzyna/L-7517-2015	Mazumder, Barsanjit/0000-0003-3069-7833; Hamilton, Thomas/0000-0002-9817-242X	National Institutes of Health [GM060020, RO1 AI50019, P50 GM021681, RO1 HL 79164]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020, P50GM021681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060020 (to X.L.), RO1 AI50019 (to J.T.), P50 GM021681 (to J.T.), and RO1 HL 79164 (to B.M.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; MEDZHITOV R, 1997, NATURE, V388, P397; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	35	65	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10367	10375		10.1074/jbc.M807822200	http://dx.doi.org/10.1074/jbc.M807822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19224918	Green Published, hybrid			2022-12-27	WOS:000265104600011
J	Dong, YM; Dimopoulos, G				Dong, Yuemei; Dimopoulos, George			Anopheles Fibrinogen-related Proteins Provide Expanded Pattern Recognition Capacity against Bacteria and Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNAIL BIOMPHALARIA-GLABRATA; INNATE IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; PLASMODIUM-FALCIPARUM; ANTIMICROBIAL PEPTIDE; GENE-EXPRESSION; LIFE-CYCLE; IN-VIVO; GAMBIAE; MOSQUITO	The fibrinogen-related protein family (FREP, also known as FBN) is an evolutionarily conserved immune gene family found in mammals and invertebrates. It is the largest pattern recognition receptor gene family in Anopheles gambiae, with as many as 59 putative members, while the Drosophila melanogaster genome has only 14 known FREP members. Our sequence and phylogenetic analysis suggest that this remarkable gene expansion in the mosquito is the result of tandem duplication of the fibrinogen domain. We found that the majority of the FREP genes displayed immune-responsive transcription after challenge with bacteria, fungi, or Plasmodium, and these expression patterns correlated strongly with gene phylogeny and chromosomal location. Using RNAi-mediated gene-silencing assays, we further demonstrated that some FREP members are essential factors of the mosquito innate immune system that are required for maintaining immune homeostasis, and members of this family have complementary and synergistic functions. One of the most potent anti-Plasmodium FREP proteins, FBN9, was found to interact with both Gram-negative and Gram-positive bacteria and strongly co-localized with both rodent and human malaria parasites in the mosquito midgut epithelium, suggesting that its defensive activity involves direct interaction with the pathogen. Interestingly, FBN9 formed dimers that bound to the bacterial surfaces with different affinities. Our findings indicate that the A. gambiae FREP gene family plays a central role in the mosquito innate immune system and provides an expanded pattern recognition and anti-microbial defense repertoire.	[Dong, Yuemei; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), 615 N Wolfe Str Rm E4209, Baltimore, MD 21205 USA.	gdimopou@jhsph.edu		Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899	NIAID [1R01AI061576-01A1]; Ellison Medical Foundation; World Health Organization/TDR; Johns Hopkins School of Public Health Faculty Innovation; Johns Hopkins Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation); World Health Organization/TDR(World Health Organization); Johns Hopkins School of Public Health Faculty Innovation; Johns Hopkins Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI061576-01A1 from NIAID. This work was also supported by the Ellison Medical Foundation, the World Health Organization/TDR, a Johns Hopkins School of Public Health Faculty Innovation Grant, and the Johns Hopkins Malaria Research Institute.	Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Benedict M. Q., 1997, The molecular biology of insect disease vectors: a methods manual., P3; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2004, CURR OPIN IMMUNOL, V16, P16, DOI 10.1016/j.coi.2003.11.010; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Carter R, 1993, Methods Mol Biol, V21, P67; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Endo Y, 2006, IMMUNOBIOLOGY, V211, P283, DOI 10.1016/j.imbio.2006.01.003; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gorkun OV, 1997, BLOOD, V89, P4407, DOI 10.1182/blood.V89.12.4407; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang YG, 2006, DEV COMP IMMUNOL, V30, P855, DOI 10.1016/j.dci.2005.12.004; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kenjo A, 2001, J BIOL CHEM, V276, P19959, DOI 10.1074/jbc.M011723200; KOBAYASHI R, 1994, BIOCHEM BIOPH RES CO, V198, P1262, DOI 10.1006/bbrc.1994.1178; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; Kurtz J, 2006, TRENDS IMMUNOL, V27, P493, DOI 10.1016/j.it.2006.09.001; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Middha S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-260; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Perovic-Ottstadt S, 2004, EUR J BIOCHEM, V271, P1924, DOI 10.1111/j.1432-1033.2004.04102.x; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Stalker J, 2004, GENOME RES, V14, P951, DOI 10.1101/gr.1863004; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang X, 2004, INSECT MOL BIOL, V13, P273, DOI 10.1111/j.0962-1075.2004.00484.x; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang SM, 2008, INNATE IMMUN-LONDON, V14, P175, DOI 10.1177/1753425908093800; Zhang SM, 2008, DEV COMP IMMUNOL, V32, P1119, DOI 10.1016/j.dci.2008.03.001; Zhang SM, 2004, GENE, V341, P255, DOI 10.1016/j.gene.2004.07.003; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069; Zhang SM, 2003, DEV COMP IMMUNOL, V27, P175, DOI 10.1016/S0145-305X(02)00091-5	65	149	156	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9835	9844		10.1074/jbc.M807084200	http://dx.doi.org/10.1074/jbc.M807084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193639	hybrid, Green Published			2022-12-27	WOS:000264892900024
J	Koksal, AC; Nardozzi, JD; Cingolani, G				Koksal, Adem C.; Nardozzi, Jonathan D.; Cingolani, Gino			Dimeric Quaternary Structure of the Prototypical Dual Specificity Phosphatase VH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA VIRUS; TYROSINE PHOSPHORYLATION; PROTEIN PHOSPHATASES; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; H1 PHOSPHATASE; DNA-BINDING; IN-VITRO; STAT1; DEPHOSPHORYLATION	The Vaccinia virus H1 gene product, VH1, is a dual specificity phosphatase that down-regulates the cellular antiviral response by dephosphorylating STAT1. The crystal structure of VH1, determined at 1.32 angstrom resolution, reveals a novel dimeric quaternary structure, which exposes two active sites spaced similar to 39 angstrom away from each other. VH1forms a stable dimer via an extensive domain swap of the N-terminal helix ( residues 1-20). In vitro, VH1 can dephosphorylate activated STAT1, in a reaction that is competed by the nuclear transport adapter importin alpha 5. Interestingly, VH1 is inactive with respect to STAT1 bound to DNA, suggesting that the viral phosphatase acts predominantly on the cytoplasmic pool of activated STAT1. We propose that the dimeric quaternary structure of VH1 is essential for specific recognition of activated STAT1, which prevents its nuclear translocation, thus blocking interferon-gamma signal transduction and antiviral response.	[Koksal, Adem C.; Nardozzi, Jonathan D.; Cingolani, Gino] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cingolani, G (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cingolag@upstate.edu		Nardozzi, Jonathan/0000-0002-6655-4765; Koksal, Adem/0000-0002-3163-7421	National Institutes of Health [GM074846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846.	Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; Becker S, 1998, FEBS LETT, V441, P141, DOI 10.1016/S0014-5793(98)01543-9; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W, 2002, PYMOL 0 99; Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Krause CD, 2007, CYTOKINE GROWTH F R, V18, P473, DOI 10.1016/j.cytogfr.2007.06.009; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113; Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phan J, 2007, ACTA CRYSTALLOGR D, V63, P698, DOI 10.1107/S0907444907014904; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; VERLINDE CLMJ, 1991, EUR J BIOCHEM, V198, P53, DOI 10.1111/j.1432-1033.1991.tb15985.x; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	34	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10129	10137		10.1074/jbc.M808362200	http://dx.doi.org/10.1074/jbc.M808362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19211553	Green Published, hybrid			2022-12-27	WOS:000264892900055
J	Furlow, PW; Percy, MJ; Sutherland, S; Bierl, C; McMullin, MF; Master, SR; Lappin, TRJ; Lee, FS				Furlow, Paul W.; Percy, Melanie J.; Sutherland, Scott; Bierl, Charlene; McMullin, Mary Frances; Master, Stephen R.; Lappin, Terence R. J.; Lee, Frank S.			Erythrocytosis-associated HIF-2 alpha Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TUMOR-SUPPRESSOR GENE; FAMILIAL ERYTHROCYTOSIS; CONGENITAL POLYCYTHEMIA; OXYGEN HOMEOSTASIS; DOMAIN PROTEIN-2; HIF2A GENE; HYDROXYLATION; HIF-1-ALPHA; PHD2	A classic physiologic response to hypoxia in humans is the up-regulation of the ERYTHROPOIETIN (EPO) gene, which is the central regulator of red blood cell mass. The EPO gene, in turn, is activated by hypoxia inducible factor (HIF). HIF is a transcription factor consisting of an alpha subunit (HIF-alpha) and a beta subunit (HIF-beta). Under normoxic conditions, prolyl hydroxylase domain protein (PHD, also known as HIF prolyl hydroxylase and egg laying-defective nine protein) site specifically hydroxylates HIF-alpha in a conserved LXXLAP motif (where underlining indicates the hydroxylacceptor proline). This provides a recognition motif for the von Hippel Lindau protein, a component of an E3 ubiquitin ligase complex that targets hydroxylated HIF-alpha for degradation. Under hypoxic conditions, this inherently oxygen-dependent modification is arrested, thereby stabilizing HIF-alpha and allowing it to activate the EPO gene. We previously identified and characterized an erythrocytosis-associated HIF2A mutation, G537W. More recently, we reported two additional erythrocytosis-associated HIF2A mutations, G537R and M535V. Here, we describe the functional characterization of these two mutants as well as a third novel erythrocytosis-associated mutation, P534L. These mutations affect residues C-terminal to the LXXLAP motif. We find that all result in impaired degradation and thus aberrant stabilization of HIF-2 alpha. However, each exhibits a distinct profile with respect to their effects on PHD2 binding and von Hippel Lindau interaction. These findings reinforce the importance of HIF-2 alpha in human EPO regulation, demonstrate heterogeneity of functional defects arising from these mutations, and point to a critical role for residues C-terminal to the LXXLAP motif in HIF-alpha.	[Furlow, Paul W.; Sutherland, Scott; Bierl, Charlene; Master, Stephen R.; Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Percy, Melanie J.; McMullin, Mary Frances] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [McMullin, Mary Frances; Lappin, Terence R. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7AB, Antrim, North Ireland	University of Pennsylvania; Belfast City Hospital; Queens University Belfast	Lee, FS (corresponding author), 605 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	McMullin, Mary F/AAF-6472-2020; McMullin, Mary Frances/AAG-6078-2021	McMullin, Mary Frances/0000-0002-0773-0204; Lee, Frank/0000-0003-2511-1834; Master, Stephen/0000-0002-6808-631X; Furlow, Paul/0000-0002-0754-4962	National Institutes of Health [R01-CA090261]; University of Pennsylvania Research Foundation; NATIONAL CANCER INSTITUTE [R01CA090261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01-CA090261 (to F.S.L.). This work was also supported by a University of Pennsylvania Research Foundation grant (to F.S.L.).	Al-Sheikh M, 2008, BLOOD CELL MOL DIS, V40, P160, DOI 10.1016/j.bcmd.2007.07.017; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Cario H, 2005, HAEMATOLOGICA, V90, P19; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gordeuk VR, 2005, HAEMATOLOGICA, V90, P109; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Lee FS, 2008, BLOOD REV, V22, P321, DOI 10.1016/j.blre.2008.04.003; Lee FS, 2006, CELL CYCLE, V5, P941, DOI 10.4161/cc.5.9.2723; Linke S, 2007, METHOD ENZYMOL, V435, P61, DOI 10.1016/S0076-6879(07)35004-0; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Pastore Y, 2003, AM J HUM GENET, V73, P412, DOI 10.1086/377108; Percy MJ, 2008, HAEMATOL-HEMATOL J, V93, P963, DOI 10.3324/haematol.13250; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Percy MJ, 2003, BLOOD, V102, P1097, DOI 10.1182/blood-2002-10-3246; PERCY MJ, 2008, BLOOD, V112, P481; Perrotta S, 2006, BLOOD, V107, P514, DOI 10.1182/blood-2005-06-2422; Perrotta S, 2008, NEW ENGL J MED, V358, P1966; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136	37	43	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9050	9058		10.1074/jbc.M808737200	http://dx.doi.org/10.1074/jbc.M808737200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19208626	Green Published, hybrid			2022-12-27	WOS:000264669100007
J	Gyamfi, MA; Wan, YJY				Gyamfi, Maxwell Afari; Wan, Yu-Jui Yvonne			Mechanisms of Resistance of Hepatocyte Retinoid X Receptor alpha-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; PPAR-ALPHA; PEROXISOME PROLIFERATORS; DEFICIENT MICE; BILE-ACIDS; RXR-ALPHA; LIPOPROTEIN METABOLISM; MEDIATED PATHWAYS; GENE-EXPRESSION; LIVER-INJURY	Peroxisome proliferators, such as the lipid-lowering fibrates that function as agonists for peroxisome proliferator-activated receptor alpha (PPAR alpha), induce liver tumors in rodents and may produce cholestasis in humans. Considerable attention has focused on peroxisome proliferator-induced hepatocellular carcinoma, a phenomenon not noted in man, whereas limited studies examine fibrates and other therapeutic drugs that induce cholestasis, a common finding in humans. Moreover, the mechanisms by which fibrates induce hepatocyte proliferation and cholestasis are still not fully understood. We have examined the role of hepatocyte retinoid X receptor alpha (RXR alpha), an essential partner of PPAR alpha, in modulating WY-14,643-induced hepatocyte proliferation and cholestasis. WY-14,643 treatment induced hepatomegaly in wild type (WT) mice that was also accompanied by induction of the expression of cyclins D1, D3, A2, and B1 and Cdc2 as well as inhibition of Wee 1. Such changes were either absent or greatly reduced in hepatocyte RXR alpha-null mice. Furthermore, neither WY-14,643 treatment nor RXR alpha deficiency affected apoptosis, indicating the importance of PPAR alpha/RXR alpha in regulating Wee 1-mediated Cdc2/cyclin B1 expression for cells to enter into mitosis. WY-14,643 treatment also induced cholestasis and liver injury, which is evidenced by induction of alanine aminotransferase, alkaline phosphatase, and hepatic bile acid levels in WT mice. Hepatocyte RXR alpha deficiency protected the mice from WY-14,643-induced liver injury. WY-14,643-mediated induction of the small heterodimer partner, Mrp3, and Cyp3a11 levels was greater in hepatocyte RXR alpha-null than in WT mouse livers suggesting enhanced repression of bile acid synthesis and increased efflux of bile acids into blood for renal excretion as well as hydroxylation of bile acids because of hepatocyte RXR alpha deficiency. These data establish a crucial role of hepatocyte RXR alpha in regulating WY-14,643-mediated cell cycle progression as well as bile acid homeostasis.	[Gyamfi, Maxwell Afari; Wan, Yu-Jui Yvonne] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Wan, YJY (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	ywan@kumc.edu			National Institutes of Health [AA14147, CA53596, AA12081, P20RR021940]; NATIONAL CANCER INSTITUTE [R29CA053596, R01CA053596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012081, R01AA014147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA14147, CA53596, AA12081, and P20RR021940. The costs of publication of this article were defrayed in part by the payment of page charges.	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai Y, 2002, EUR J PHARM SCI, V15, P89, DOI 10.1016/S0928-0987(01)00211-1; Cattley Russell C, 2004, Toxicol Pathol, V32 Suppl 2, P6, DOI 10.1080/01926230490451680; Cherrington NJ, 2003, DRUG METAB DISPOS, V31, P1315, DOI 10.1124/dmd.31.11.1315; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chung JG, 2001, CARCINOGENESIS, V22, P1213, DOI 10.1093/carcin/22.8.1213; Dohmen K, 2005, WORLD J GASTROENTERO, V11, P7702, DOI 10.3748/wjg.v11.i48.7702; GARIOT P, 1983, ARCH TOXICOL, V53, P151; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; INESTROSA NC, 1979, BIOCHEM J, V182, P779, DOI 10.1042/bj1820779; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lucena MI, 2006, WORLD J GASTROENTERO, V12, P5244; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; MARSMAN DS, 1988, CANCER RES, V48, P6739; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Phillips A, 2005, DRUG METAB DISPOS, V33, P233, DOI 10.1124/dmd.104.001461; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; Roberts RA, 2000, TOXICOL LETT, V112, P49, DOI 10.1016/S0378-4274(99)00243-X; Roberts RA, 2001, TOXICOL LETT, V120, P301, DOI 10.1016/S0378-4274(01)00282-X; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Schoonjans K, 1996, J LIPID RES, V37, P907; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; TSUDA H, 1984, GANN, V75, P871; URA H, 1987, JPN J CANCER RES, V78, P216; Wan YJY, 2000, J BIOL CHEM, V275, P28285; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wan YJY, 2003, ENDOCRINOLOGY, V144, P605, DOI 10.1210/en.2002-221003; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; West DA, 1999, HEPATOLOGY, V30, P1417, DOI 10.1002/hep.510300612; WOLOWIEC D, 1995, INT J CANCER, V61, P381; Wu Y, 2004, EXP MOL PATHOL, V76, P24, DOI 10.1016/j.yexmp.2003.10.009; Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005	46	12	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9321	9330		10.1074/jbc.M808861200	http://dx.doi.org/10.1074/jbc.M808861200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19176532	Green Published, hybrid			2022-12-27	WOS:000264669100038
J	Brozzi, F; Arcuri, C; Giambanco, I; Donato, R				Brozzi, Flora; Arcuri, Cataldo; Giambanco, Ileana; Donato, Rosario			S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; INTERMEDIATE-FILAMENTS; S-100 PROTEIN; BETA-SUBUNIT; RHO-GTPASES; BRAIN; EXPRESSION; BINDING; GFAP	S100B is a Ca2(+)-binding protein of the EF-hand type that is abundantly expressed in astrocytes and has been implicated in the regulation of several intracellular activities, including proliferation and differentiation. We show here that reducing S100B levels in the astrocytoma cell line GL15 and the Muller cell line MIO-M1 by small interference RNA technique results in a rapid disassembly of stress fibers, collapse of F-actin onto the plasma membrane and reduced migration, and acquisition of a stellate shape. Also, S100B-silenced GL15 and MIO-M1 Muller cells show a higher abundance of glial fibrillary acidic protein filaments, which mark differentiated astrocytes, compared with control cells. These effects are dependent on reduced activation of the phosphatidylinositol 3-kinase (PI3K) downstream effectors, Akt and RhoA, and consequently elevated activity of GSK3 beta and Rac1 and decreased activity of the RhoA-associated kinase. Also, rat primary astrocytes transiently down-regulate S100B expression when exposed to the differentiating agent dibutyryl cyclic AMP and re-express S100B at later stages of dibutyryl cyclic AMP-induced differentiation. Moreover, reducing S100B levels results in a remarkably slow resumption of S100B expression, suggesting the S100B might regulate its own expression. Finally, we show that S100B interacts with Src kinase, thereby stimulating the PI3K/Akt and PI3K/RhoA pathways. These results suggest that S100B might contribute to reduce the differentiation potential of cells of the astrocytic lineage and participate in the astrocyte activation process in the case of brain insult and in invasive properties of glioma cells.	[Brozzi, Flora; Arcuri, Cataldo; Giambanco, Ileana; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, I-06122 Perugia, Italy	University of Perugia	Donato, R (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, CP 81 Succ 3, I-06122 Perugia, Italy.	donato@unipg.it	Donato, Rosario/I-3943-2019	Giambanco, Ileana/0000-0003-0286-6302; Arcuri, Cataldo/0000-0002-3114-8812	Ministero dell'Universita e della Ricerca-University of Perugia FIRB 2001 [RBAU014TJ8_001]; Consorzio Interuniversitario per le Biotecnologie; Fondazione Cassa di Risparmio di Perugia [2004.0282.020_001]	Ministero dell'Universita e della Ricerca-University of Perugia FIRB 2001(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Consorzio Interuniversitario per le Biotecnologie; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by Ministero dell'Universita e della Ricerca-University of Perugia FIRB 2001 Grant RBAU014TJ8_001, Consorzio Interuniversitario per le Biotecnologie, and Fondazione Cassa di Risparmio di Perugia Project 2004.0282.020_001 (to R.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; BIANCHI R, 1993, J BIOL CHEM, V268, P12669; BOCCHINI V, 1991, CELL TISSUE RES, V265, P73, DOI 10.1007/BF00318141; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Ciccarelli R, 1999, GLIA, V27, P275, DOI 10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DONATO R, 1988, J BIOL CHEM, V263, P106; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Edwards MM, 2006, J NEURAL TRANSM, V113, P1709, DOI 10.1007/s00702-006-0479-5; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Fischer AJ, 2003, GLIA, V43, P70, DOI 10.1002/glia.10218; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Hachem S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-17; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Koivisto L, 2003, J CELL SCI, V116, P3749, DOI 10.1242/jcs.00693; LANDRY CF, 1989, MOL BRAIN RES, V6, P251, DOI 10.1016/0169-328X(89)90071-5; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Markowitz J, 2007, MINI-REV MED CHEM, V7, P609; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Perez V, 2005, EUR J NEUROSCI, V21, P26, DOI 10.1111/j.1460-9568.2004.03845.x; Pinto SS, 2000, FEBS LETT, V486, P203, DOI 10.1016/S0014-5793(00)02301-2; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; RAMBOTTI MG, 1990, J HISTOCHEM CYTOCHEM, V38, P1583, DOI 10.1177/38.11.2212618; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Reh TA, 2006, METHOD ENZYMOL, V419, P52, DOI 10.1016/S0076-6879(06)19003-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; SELINFREUND RH, 1990, J CELL BIOL, V111, P2021, DOI 10.1083/jcb.111.5.2021; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Sorci G, 1998, BBA-MOL CELL RES, V1448, P277, DOI 10.1016/S0167-4889(98)00134-7; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Tardy M, 1990, Adv Exp Med Biol, V265, P41; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	72	102	108	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8788	8802		10.1074/jbc.M805897200	http://dx.doi.org/10.1074/jbc.M805897200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19147496	Green Published, hybrid			2022-12-27	WOS:000264397800063
J	Noh, YH; Baek, JY; Jeong, W; Rhee, SG; Chang, TS				Noh, You Hyun; Baek, Jin Young; Jeong, Woojin; Rhee, Sue Goo; Chang, Tong-Shin			Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; DEPENDENT PEROXIDE REDUCTASE; OXIDATIVE STRESS; LIFE-SPAN; MAMMALIAN PEROXIREDOXIN; SITE CYSTEINE; GENE PROTECTS; ACTIVE-SITE; ANTIOXIDANT; EXPRESSION	The mitochondria are the major intracellular source of reactive oxygen species (ROS), which are generated during cellular respiration. The role of peroxiredoxin (Prx) III, a 2-Cys Prx family member, in the scavenging of mitochondrial H2O2 has recently been emphasized. While eliminating H2O2, Prx can become overoxidized and inactivated by modifying the active cysteine into cysteine sulfinic acid (Cys-SO2H). When 2-Cys Prxs are inactivated in vitro, sulfiredoxin (Srx) reduces the cysteine sulfinic acid to cysteines. However, whereas Srx is localized in the cytoplasm, Prx III is present exclusively in the mitochondria. Although Srx reduces sulfinic Prx III in vitro, it remains unclear whether the reduction of Prx III in cells is actually mediated by Srx. Our gain- and loss-of-function experiments show that Srx is responsible for reducing not only sulfinic cytosolic Prxs (I and II) but also sulfinic mitochondrial Prx III. We further demonstrate that Srx translocates from the cytosol to mitochondria in response to oxidative stress. Overexpression of mitochondrion-targeted Srx promotes the regeneration of sulfinic Prx III and results in cellular resistance to apoptosis, with enhanced elimination of mitochondrial H2O2 and decreased rates of mitochondrial membrane potential collapse. These results indicate that Srx plays a crucial role in the reactivation of sulfinic mitochondrial Prx III and that its mitochondrial translocation is critical in maintaining the balance between mitochondrial H2O2 production and elimination.	[Noh, You Hyun; Baek, Jin Young; Jeong, Woojin; Rhee, Sue Goo; Chang, Tong-Shin] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Chang, Tong-Shin] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Chang, TS (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Sci Bldg C,11-1 Daehyun Dong, Seoul 120750, South Korea.	changts@ewha.ac.kr			Korea Research Foundation funded by the Korean government [KRF-2006-331-C00195]; Korea Science and Engineering Foundation; Bio R& D Program funded by the Korean government [M10642040002-07N4204- 00210]; National Core Research Center program of the MEST, KOSEF [R15-2006-020]	Korea Research Foundation funded by the Korean government(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Bio R& D Program funded by the Korean government; National Core Research Center program of the MEST, KOSEF(Korea Science and Engineering Foundation)	This work was supported by the Korea Research Foundation funded by the Korean government ( the Ministry of Education and Human Resources Development, Grant KRF-2006-331-C00195 to T. S. C.), an Ewha Womans University Research Grant for 2005 ( to T. S. C.), the Korea Science and Engineering Foundation ( KOSEF) Bio R& D Program funded by the Korean government ( MEST, Grant M10642040002-07N4204- 00210 to T. S. C.), Grant R15-2006-020 from the National Core Research Center program of the MEST, KOSEF through the Center for Cell Signaling & Drug Discovery Research at Ewha Womans University, the SeoulR& BDProgram ( Grant 10527 to T. S. C.), and the second stage of the Brain Korea 21 Project ( to Y. H. N. and J. Y. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Halliwell B., 2007, FREE RADICAL BIO MED, P488; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Li LQ, 2008, FEBS LETT, V582, P2431, DOI 10.1016/j.febslet.2008.05.050; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nonn L, 2003, MOL CANCER RES, V1, P682; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	54	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8470	8477		10.1074/jbc.M808981200	http://dx.doi.org/10.1074/jbc.M808981200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176523	Green Published, hybrid			2022-12-27	WOS:000264397800031
J	Pimkin, M; Pimkina, J; Markham, GD				Pimkin, Maxim; Pimkina, Julia; Markham, George D.			A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; DOMINANT RETINITIS-PIGMENTOSA; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; MUTATIONS; KINASE; MUTANT; GENE; INHIBITION	The Bateman domain (CBS subdomain) of IMP dehydrogenase (IMPDH), a rate-limiting enzyme of the de novo GMP biosynthesis, is evolutionarily conserved but has no established function. Deletion of the Bateman domain has no effect on the in vitro IMPDH activity. We report that in vivo deletion of the Bateman domain of IMPDH in Escherichia coli (guaB(Delta CBS)) sensitizes the bacterium to growth arrest by adenosine and inosine. These nucleosides exert their growth inhibitory effect via a dramatic increase in the intracellular adenylate nucleotide pool, which results in the enhanced allosteric inhibition of PRPP synthetase and consequently a PRPP deficit. The ensuing starvation for pyrimidine nucleotides culminates in growth arrest. Thus, deletion of the Bateman domain of IMPDH derepresses the synthesis of AMP from IMP. The growth inhibitory effect of inosine can be rescued by second-site suppressor mutations in the genes responsible for the conversion of inosine to AMP (gsk, purA, and purB) as well as by the prsA1 allele, which encodes a PRPP synthetase that is insensitive to allosteric inhibition by adenylate nucleotides. Importantly, the guaB(Delta CBS) phenotype can be complemented in trans by a mutant guaB allele, which encodes a catalytically disabled IMPDHC305A protein containing an intact Bateman domain. We conclude that the Bateman domain of IMPDH is a negative trans-regulator of adenylate nucleotide synthesis, and that this role is independent of the catalytic function of IMPDH in the de novo GMP biosynthesis.	[Pimkin, Maxim; Pimkina, Julia; Markham, George D.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Markham, GD (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	gd_markham@fccc.edu			National Institutes of Health [GM072425, CA06927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072425 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute, or any other sponsoring organization.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOWER SG, 1989, J BIOL CHEM, V264, P10287; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; GILBERT HJ, 1979, BIOCHEM J, V183, P481, DOI 10.1042/bj1830481; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; Hedstrom L, 2008, NUCLEOS NUCLEOT NUCL, V27, P839, DOI 10.1080/15257770802146486; Hedstrom L, 2006, CURR OPIN CHEM BIOL, V10, P520, DOI 10.1016/j.cbpa.2006.08.005; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; JOCHIMSEN BU, 1985, J GEN MICROBIOL, V131, P245; JUANG RH, 1993, ARCH BIOCHEM BIOPHYS, V304, P392, DOI 10.1006/abbi.1993.1367; Kawasaki H, 2000, BIOSCI BIOTECH BIOCH, V64, P972, DOI 10.1271/bbb.64.972; KELLN RA, 1975, J BACTERIOL, V124, P764, DOI 10.1128/JB.124.2.764-774.1975; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MORI H, 1995, J BACTERIOL, V177, P4921, DOI 10.1128/jb.177.17.4921-4926.1995; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; NYGAARD P, 1983, METABOLISM NUCLEOTID, P27; Pankiewicz K.W., 2003, INOSINE MONOPHOSPHAT; Pankiewicz KW, 2004, CURR MED CHEM, V11, P887, DOI 10.2174/0929867043455648; Petersen C, 1999, J BIOL CHEM, V274, P5348, DOI 10.1074/jbc.274.9.5348; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; ROYBURMAN S, 1975, J BIOL CHEM, V250, P9270; Sambrook J., 2001, MOL CLONING LAB MANU; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Xu D, 2008, ARCH BIOCHEM BIOPHYS, V472, P100, DOI 10.1016/j.abb.2008.02.012; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816; ZALKIN H, 1996, ESCHERICHIA COLI SAL, P561; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	43	35	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7960	7969		10.1074/jbc.M808541200	http://dx.doi.org/10.1074/jbc.M808541200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19153081	hybrid, Green Published			2022-12-27	WOS:000264195600058
J	Barry, EF; Felquer, FA; Powell, JA; Biggs, L; Stomski, FC; Urbani, A; Ramshaw, H; Hoffmann, P; Wilce, MC; Grimbaldeston, MA; Lopez, AF; Guthridge, MA				Barry, Emma F.; Felquer, Fernando A.; Powell, Jason A.; Biggs, Lisa; Stomski, Frank C.; Urbani, Andrea; Ramshaw, Hayley; Hoffmann, Peter; Wilce, Matthew C.; Grimbaldeston, Michele A.; Lopez, Angel F.; Guthridge, Mark A.			14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GM-CSF; PHOSPHORYLATION; PROTEINS; RECEPTOR; 14-3-3-PROTEINS; SPECIFICITY; IL-3; APOPTOSIS; SHC	Integrated cascades of protein tyrosine and serine/threonine phosphorylation play essential roles in transducing signals in response to growth factors and cytokines. How adaptor or scaffold proteins assemble signaling complexes through both phosphotyrosine and phosphoserine/threonine residues to regulate specific signaling pathways and biological responses is unclear. We show in multiple cell types that endogenous 14-3-3 zeta is phosphorylated on Tyr(179) in response to granulocyte macrophage colony-stimulating factor. Importantly, 14-3-3 zeta can function as an intermolecular bridge that couples to phosphoserine residues and also directly binds the SH2 domain of Shc via Tyr(179). The assembly of these 14-3-3:Shc scaffolds is specifically required for the recruitment of a phosphatidylinositol 3-kinase signaling complex and the regulation of CTL-EN cell survival in response to cytokine. The biological significance of these findings was further demonstrated using primary bone marrow-derived mast cells from 14-3-3 zeta(-/-) mice. We show that cytokine was able to promote Akt phosphorylation and viability of primary mast cells derived from 14-3-3 zeta(-/-) mice when reconstituted with wild type 14-3-3 zeta, but the Akt phosphorylation and survival response was reduced in cells reconstituted with the Y179F mutant. Together, these results show that 14-3-3:Shc scaffolds can act as multivalent signaling nodes for the integration of both phosphoserine/threonine and phosphotyrosine pathways to regulate specific cellular responses.	[Barry, Emma F.; Felquer, Fernando A.; Powell, Jason A.; Guthridge, Mark A.] Inst Med & Vet Sci, Div Human Immunol, Cell Growth & Differentiat Lab, Hanson Inst, Adelaide, SA 5000, Australia; [Felquer, Fernando A.; Stomski, Frank C.; Ramshaw, Hayley; Lopez, Angel F.] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Cytokine Receptor Lab, Adelaide, SA 5000, Australia; [Biggs, Lisa; Grimbaldeston, Michele A.] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Mast Cell Lab, Adelaide, SA 5000, Australia; [Lopez, Angel F.; Guthridge, Mark A.] Univ Adelaide, Dept Med, Adelaide, SA 5000, Australia; [Hoffmann, Peter] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia; [Urbani, Andrea] Univ Roma Tor Vergata, Dept Internal Med, Fdn S Lucia Ist Ricovero & Cura Carattere Sci, I-00133 Rome, Italy; [Wilce, Matthew C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; Hanson Institute; Institute Medical & Veterinary Science Australia; Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide; University of Rome Tor Vergata; Monash University	Guthridge, MA (corresponding author), Inst Med & Vet Sci, Div Human Immunol, Cell Growth & Differentiat Lab, Hanson Inst, Frome Rd, Adelaide, SA 5000, Australia.	mark.guthridge@imvs.sa.gov.au	Urbani, Andrea/AAD-1675-2022; Ramshaw, Hayley/F-3828-2013; Hoffmann, Peter/U-5996-2017; Urbani, Andrea/B-2953-2012; Lopez, Angel F/E-2260-2011; guthridge, mark a/I-1889-2014	Hoffmann, Peter/0000-0001-8493-2208; guthridge, mark a/0000-0002-0536-3471; Lopez, Angel F/0000-0001-7430-0135; Barry, Emma/0000-0003-2742-5650; Ramshaw, Hayley/0000-0001-9909-282X; Powell, jason/0000-0001-8493-9178	National Health and Medical Research Council of Australia; Peter Nelson Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peter Nelson Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia and the Peter Nelson Foundation.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Giacometti S, 2004, PLANT BIOLOGY, V6, P422, DOI 10.1055/s-2004-820933; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Guthridge MA, 1997, MOL CELL BIOL, V17, P5485, DOI 10.1128/MCB.17.9.5485; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Stomski FC, 1999, BLOOD, V94, P1933; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	33	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12080	12090		10.1074/jbc.M807637200	http://dx.doi.org/10.1074/jbc.M807637200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19218246	Green Published, hybrid			2022-12-27	WOS:000265494600040
J	Hunter, RW; MacKintosh, C; Hers, I				Hunter, Roger W.; MacKintosh, Carol; Hers, Ingeborg			Protein Kinase C-mediated Phosphorylation and Activation of PDE3A Regulate cAMP Levels in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PHOSPHODIESTERASE 3A; INSULIN; NUCLEOTIDES; CELLS; PKB; 3B; AGGREGATION; STIMULATION; INVOLVEMENT	The elevation of [cAMP](i) is an important mechanism of platelet inhibition and is regulated by the opposing activity of adenylyl cyclase and phosphodiesterase (PDE). In this study, we demonstrate that a variety of platelet agonists, including thrombin, significantly enhance the activity of PDE3A in a phosphorylation-dependent manner. Stimulation of platelets with the PAR-1 agonist SFLLRN resulted in rapid and transient phosphorylation of PDE3A on Ser(312), Ser(428), Ser(438), Ser(465), and Ser(492), in parallel with the PKC (protein kinase C) substrate, pleckstrin. Furthermore, phosphorylation and activation of PDE3A required the activation of PKC, but not of PI3K/PKB, mTOR/p70S6K, or ERK/RSK. Activation of PKC by phorbol esters also resulted in phosphorylation of the same PDE3A sites in a PKC-dependent, PKB-independent manner. This was further supported by the finding that IGF-1, which strongly activates PI3K/PKB, but not PKC, did not regulate PDE3A. Platelet activation also led to a PKC-dependent association between PDE3Aand 14-3-3 proteins. In contrast, cAMP-elevating agents such as PGE(1) and forskolin-induced phosphorylation of Ser312 and increased PDE3A activity, but did not stimulate 14-3-3 binding. Finally, complete antagonism of PGE(1)-evoked cAMP accumulation by thrombin required bothGi andPKCactivation. Together, these results demonstrate that platelet activation stimulates PKC-dependent phosphorylation of PDE3A on Ser(312), Ser(428), Ser(438), Ser(465), and Ser(492) leading to a subsequent increase in cAMP hydrolysis and 14-3-3 binding.	[Hunter, Roger W.; Hers, Ingeborg] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England; [MacKintosh, Carol] Univ Dundee, MRC, Prot Phosphorylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Bristol; University of Dundee	Hers, I (corresponding author), Univ Bristol, Dept Biochem, Sch Med Sci, Univ Walk, Bristol BS8 1TD, Avon, England.	i.hers@bris.ac.uk	Hers, Ingeborg/ABG-3357-2020; MacKintosh, Carol/B-8210-2011	MacKintosh, Carol/0000-0001-9166-589X; Hers, Ingeborg/0000-0002-6467-5715; Hunter, Roger/0000-0003-0177-1512	British Heart Foundation [FS/05/047, FS/04/027]; British Heart Foundation [PG/08/056/25325] Funding Source: researchfish; Medical Research Council [MC_U127084354] Funding Source: researchfish; MRC [MC_U127084354] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation (Grants FS/05/047 and FS/04/027).	Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Banfic H, 1998, J BIOL CHEM, V273, P11630, DOI 10.1074/jbc.273.19.11630; DEGERMAN E, 1994, BBA-PROTEIN STRUCT M, V1205, P189, DOI 10.1016/0167-4838(94)90233-X; Dickinson NT, 1997, BIOCHEM J, V323, P371, DOI 10.1042/bj3230371; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Elbatarny HS, 2005, AM J PHYSIOL-ENDOC M, V289, pE695, DOI 10.1152/ajpendo.00125.2005; Feijge MAH, 2004, BIOCHEM PHARMACOL, V67, P1559, DOI 10.1016/j.bcp.2003.12.028; GIESBERTS AN, 1995, BIOCHEM J, V309, P613, DOI 10.1042/bj3090613; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Hanson MS, 2008, AM J PHYSIOL-HEART C, V295, pH786, DOI 10.1152/ajpheart.00349.2008; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hers I, 1998, ARTERIOSCL THROM VAS, V18, P404, DOI 10.1161/01.ATV.18.3.404; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hunter RW, 2008, J THROMB HAEMOST, V6, P1923, DOI 10.1111/j.1538-7836.2008.03140.x; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; LAGARDE M, 1977, BIOMED EXPRESS, V27, P110; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; LOPEZAPARICIO P, 1993, BIOCHEM BIOPH RES CO, V193, P1137, DOI 10.1006/bbrc.1993.1744; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; Manns JM, 2002, THROMB HAEMOSTASIS, V87, P873, DOI 10.1055/s-0037-1613099; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Onuma H, 2002, DIABETES, V51, P3362, DOI 10.2337/diabetes.51.12.3362; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Sheth SB, 1997, THROMB HAEMOSTASIS, V77, P155; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; Yu HW, 1996, MOL PHARMACOL, V50, P549; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	33	68	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12339	12348		10.1074/jbc.M807536200	http://dx.doi.org/10.1074/jbc.M807536200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261611	hybrid, Green Published			2022-12-27	WOS:000265494600065
J	El-Tahir, HM; Abouzied, MM; Gallitzendoerfer, R; Gieselmann, V; Franken, S				El-Tahir, Heba M.; Abouzied, Mekky M.; Gallitzendoerfer, Rainer; Gieselmann, Volkmar; Franken, Sebastian			Hepatoma-derived Growth Factor-related Protein-3 Interacts with Microtubules and Promotes Neurite Outgrowth in Mouse Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SULFATED GLYCOSAMINOGLYCANS; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-FACTOR; BINDING PROTEINS; PWWP DOMAIN; GENE FAMILY; EXPRESSION; DYNAMICS; DNA	Hepatoma-derived growth factor-related proteins (HRP) comprise a family of 6 members, which the biological functions are still largely unclear. Here we show that during embryogenesis HRP-3 is strongly expressed in the developing nervous system. At early stages of development HRP-3 is located in the cytoplasm and neurites of cortical neurons. Upon maturation HRP-3 relocalizes continuously to the nuclei and in the majority of neurons of adult mice it is located exclusively in the nucleus. This redistribution from neurites to nuclei is also found in embryonic cortical neurons maturing in cell culture. We show that HRP-3 is necessary for proper neurite outgrowth in primary cortical neurons. To identify possible mechanisms of how HRP-3 modulate neuritogenesis we isolated HRP-3 interaction partners and demonstrate that it binds tubulin through the N-terminal so called HATH region, which is strongly conserved among members of the HRP family. It promotes tubulin polymerization, stabilizes and bundles microtubules. This activity depends on the extranuclear localization of HRP-3. HRP-3 thus could play an important role during neuronal development by its modulation of the neuronal cytoskeleton.	[El-Tahir, Heba M.; Abouzied, Mekky M.; Gallitzendoerfer, Rainer; Gieselmann, Volkmar; Franken, Sebastian] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Franken, S (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	franken@ibmb.uni-bonn.de	Eltahir, Heba M/S-6533-2019	Abouzied, mekky/0000-0001-5309-3552; Franken, Sebastian/0000-0003-4844-6389; eltahir, heba/0000-0003-3308-1137				Abouzied MM, 2004, BIOCHEM J, V378, P169, DOI 10.1042/BJ20030916; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; AVILA J, 1994, INT J DEV BIOL, V38, P13; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; El-Tahir HM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-6; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hasan MR, 2005, FEBS J, V272, P822, DOI 10.1111/j.1742-4658.2004.04520.x; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Ikegame K, 1999, BIOCHEM BIOPH RES CO, V266, P81, DOI 10.1006/bbrc.1999.1733; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Kishima Y, 2002, J BIOL CHEM, V277, P10315, DOI 10.1074/jbc.M111122200; KREMER L, 1988, ANAL BIOCHEM, V175, P91, DOI 10.1016/0003-2697(88)90365-X; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Marubuchi S, 2006, J NEUROCHEM, V99, P70, DOI 10.1111/j.1471-4159.2006.04021.x; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Ortega-Paino E, 2008, BLOOD, V111, P1617, DOI 10.1182/blood-2007-02-068791; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sue SC, 2004, J MOL BIOL, V343, P1365, DOI 10.1016/j.jmb.2004.09.014; Sue SC, 2007, J MOL BIOL, V367, P456, DOI 10.1016/j.jmb.2007.01.010; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Yamamoto S, 2006, CLIN CANCER RES, V12, P117, DOI 10.1158/1078-0432.CCR-05-1347; Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101; Yang J, 2009, J MOL BIOL, V386, P938, DOI 10.1016/j.jmb.2008.12.080; Yoshida K, 2006, ANN SURG ONCOL, V13, P159, DOI 10.1245/ASO.2006.11.035; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zhou ZW, 2004, J BIOL CHEM, V279, P27320, DOI 10.1074/jbc.M308650200	43	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11637	11651		10.1074/jbc.M901101200	http://dx.doi.org/10.1074/jbc.M901101200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19237540	Green Published, hybrid			2022-12-27	WOS:000265494500067
J	Hellmann, RA; Martinis, SA				Hellmann, Rachel A.; Martinis, Susan A.			Defects in Transient tRNA Translocation Bypass tRNA Synthetase Quality Control Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RIBONUCLEIC-ACID; LEUCYL-TRANSFER; AMINO-ACID; CRYSTAL-STRUCTURE; STERIC EXCLUSION; ACTIVE-SITE; SIEVE; AMINOACYLATION; PRETRANSFER; POLYMERASE	Quality control mechanisms during protein synthesis are essential to fidelity and cell survival. Leucyl-tRNA synthetase (LeuRS) misactivates non-leucine amino acids including isoleucine, methionine, and norvaline. To prevent translational errors, mischarged tRNA products are translocated 30 A from the canonical aminoacylation core to a hydrolytic editing-active site within a completely separate domain. Because it is transient, the tRNA translocation mechanism has been difficult to isolate. We have identified a "translocation peptide" within Escherichia coli LeuRS. Mutations in the translocation peptide cause tRNA to selectively bypass the editing-active site, resulting in mischarging that is lethal to the cell. This bypass mechanism also rescues aminoacylation of an editing site mutation that hydrolyzes correctly charged Leu-tRNA(Leu). Thus, these LeuRS mutants charge tRNALeu but fail to translocate these products to the hydrolytic site, where they are cleared to guard against genetic code ambiguities.	[Martinis, Susan A.] Univ Illinois, Dept Biochem, Roger Adams Lab 419, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Roger Adams Lab 419, Box B4,600 S Mathews Ave, Urbana, IL 61801 USA.	martinis@life.uiuc.edu		Martinis, Susan/0000-0001-5730-8346	National Institutes of Health [GM 063789]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 063789 (to S.A.M.).	Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Ellinger T, 1998, BIOTECHNIQUES, V24, P718, DOI 10.2144/98245bm03; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Hendrickson TL, 2003, MOL B INT U, P34; JOHNSON KA, 2005, ENCY LIFE SCI, V1, P1; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee KW, 2004, PROTEINS, V54, P693, DOI 10.1002/prot.10300; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LOW B, 1971, J BACTERIOL, V108, P742, DOI 10.1128/JB.108.2.742-750.1971; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; MASCARENHAS A, 2007, PROTEIN ENG; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1989, BIOCHEMISTRY-US, V28, P8479, DOI 10.1021/bi00447a031; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618	36	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11478	11484		10.1074/jbc.M807395200	http://dx.doi.org/10.1074/jbc.M807395200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258309	hybrid, Green Published			2022-12-27	WOS:000265494500052
J	Zhong, Y; Armbrecht, HJ; Christakos, S				Zhong, Yan; Armbrecht, Harvey J.; Christakos, Sylvia			Calcitonin, a Regulator of the 25-Hydroxyvitamin D-3 1 alpha-Hydroxylase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING PROTEINS; VITAMIN-D-RECEPTOR; NUCLEAR RECEPTOR; D-3-1-ALPHA-HYDROXYLASE GENE; TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; BETA; EXPRESSION; HORMONE; SWI/SNF	Although parathyroid hormone (PTH) induces 25-hydroxyvitamin D-3 (25(OH)D-3) 1 alpha-hydroxylase (1 alpha(OH) ase) under hypocalcemic conditions, previous studies showed that calcitonin, not PTH, has an important role in the maintenance of serum 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) under normocalcemic conditions. In this study we report that 1 alpha(OH) ase transcription is strongly induced by calcitonin in kidney cells and indicate mechanisms that underlie this regulation. The transcription factor C/EBP beta is up-regulated by calcitonin in kidney cells and results in a significant enhancement of calcitonin induction of 1 alpha(OH) ase transcription and protein expression. Mutation constructs of the 1 alpha(OH) ase promoter demonstrate the importance of the C/EBP beta binding site at -79/-73 for activation of the 1 alpha(OH) ase promoter by calcitonin. The SWI/SNF chromatin remodeling complex was found to cooperate with calcitonin in the regulation of 1 alpha(OH) ase. Chromatin immunoprecipitation analysis showed that calcitonin recruits C/EBP beta to the 1 alpha(OH) ase promoter, and Re-chromatin immunoprecipitation analysis (sequential chromatin immunoprecipitations using different antibodies) showed that C/EBP beta and BRG1, an ATPase that is a component of the SWI/SNF complex, bind simultaneously to the 1 alpha(OH)ase promoter. These findings are the first to address the dynamics between calcitonin, C/EBP beta, and SWI/SNF in the regulation of 1 alpha(OH) aseandprovideamechanism, forthefirsttime, for calcitonin induction of 1 alpha(OH) ase. Because plasma calcitonin as well as 1,25(OH)(2)D-3 have been reported to be increased during pregnancy and lactation and in early development, these findings suggest a mechanism that may account, at least in part, for the increase in plasma 1,25(OH)(2)D-3 during these times of increased calcium requirement.	[Zhong, Yan; Christakos, Sylvia] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Armbrecht, Harvey J.] St Louis Vet Affairs Med Ctr, Geriatr Ctr, St Louis, MO 63125 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Christakos, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	christak@umdnj.edu			National Institutes of Health [DK-38961]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-38961 (to S. C.).	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Armbrecht HJ, 2007, J STEROID BIOCHEM, V103, P330, DOI 10.1016/j.jsbmb.2006.12.035; Bikle D., 2008, PRIMER METABOLIC BON, P141; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; Brenza HL, 2001, ARCH BIOCHEM BIOPHYS, V388, P121, DOI 10.1006/abbi.2001.2279; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Chew CH, 2007, INT J BIOCHEM CELL B, V39, P1975, DOI 10.1016/j.biocel.2007.05.015; COOPER CW, 1977, ENDOCRINOLOGY, V101, P1657, DOI 10.1210/endo-101-6-1657; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; Di-Poi N, 2005, J BIOL CHEM, V280, P38700, DOI 10.1074/jbc.M507782200; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; EMMERTSEN K, 1984, ACTA ENDOCRINOL-COP, V106, P346, DOI 10.1530/acta.0.1060346; EMMERTSEN K, 1982, METAB BONE DIS RELAT, V4, P17, DOI 10.1016/0221-8747(82)90004-2; Esteban L, 2004, J STEROID BIOCHEM, V89-90, P131, DOI 10.1016/j.jsbmb.2004.03.092; GALANTE L, 1972, NATURE, V238, P271, DOI 10.1038/238271a0; Gao XH, 2002, INT J BIOCHEM CELL B, V34, P921, DOI 10.1016/S1357-2725(01)00165-0; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Gutierrez J, 2007, J BIOL CHEM, V282, P9445, DOI 10.1074/jbc.M609847200; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Henry HL, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P69; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; JAEGER P, 1986, J CLIN INVEST, V78, P456, DOI 10.1172/JCI112597; KAWASHIMA H, 1981, NATURE, V291, P327, DOI 10.1038/291327a0; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Kong XF, 1999, P NATL ACAD SCI USA, V96, P6988, DOI 10.1073/pnas.96.12.6988; Kovacs CS, 2002, AM J PHYSIOL-ENDOC M, V282, pE721, DOI 10.1152/ajpendo.00369.2001; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KUMAR R, 1979, J CLIN INVEST, V63, P342, DOI 10.1172/JCI109308; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nakamura M, 2007, J MOL ENDOCRINOL, V39, P375, DOI 10.1677/JME-07-0036; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; NISHIOKA T, 1988, EUR J PEDIATR, V147, P148, DOI 10.1007/BF00442212; Omdahl JL, 2003, J CELL BIOCHEM, V88, P356, DOI 10.1002/jcb.10366; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Segawa N, 2001, CANCER RES, V61, P6060; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shinki T, 1999, P NATL ACAD SCI USA, V96, P8253, DOI 10.1073/pnas.96.14.8253; StArnaud R, 1997, J BONE MINER RES, V12, P1552, DOI 10.1359/jbmr.1997.12.10.1552; STEVENSON JC, 1979, LANCET, V2, P769, DOI 10.1016/S0140-6736(79)92117-2; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Thomas S, 2006, MOL ENDOCRINOL, V20, P1894, DOI 10.1210/me.2005-0284; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang YQ, 2003, ENDOCRINOLOGY, V144, P2164, DOI 10.1210/en.2002-220740; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9; Zierold C, 2007, ARCH BIOCHEM BIOPHYS, V460, P233, DOI 10.1016/j.abb.2006.11.028	60	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11059	11069		10.1074/jbc.M806561200	http://dx.doi.org/10.1074/jbc.M806561200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261615	Green Published, hybrid			2022-12-27	WOS:000265494500010
J	Veverka, V; Henry, AJ; Slocombe, PM; Ventom, A; Mulloy, B; Muskett, FW; Muzylak, M; Greenslade, K; Moore, A; Zhang, L; Gong, JH; Qian, XM; Paszty, C; Taylor, RJ; Robinson, MK; Carr, MD				Veverka, Vaclav; Henry, Alistair J.; Slocombe, Patrick M.; Ventom, Andrew; Mulloy, Barbara; Muskett, Frederick W.; Muzylak, Mariusz; Greenslade, Kevin; Moore, Adrian; Zhang, Li; Gong, Jianhua; Qian, Xueming; Paszty, Chris; Taylor, Richard J.; Robinson, Martyn K.; Carr, Mark D.			Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE DETERMINATION; HEPARIN-BINDING SITES; TERMINAL MA-3 DOMAIN; CRYSTAL-STRUCTURE; GROWTH-FACTOR; NEUROTROPHIC FACTOR; TISSUE INHIBITOR; NMR ASSIGNMENT; PROTEIN; RESOLUTION	The secreted glycoprotein sclerostin has recently emerged as a key negative regulator of Wnt signaling in bone and has stimulated considerable interest as a potential target for therapeutics designed to treat conditions associated with low bone mass, such as osteoporosis. We have determined the structure of sclerostin, which resulted in the identification of a previously unknown binding site for heparin, suggestive of a functional role in localizing sclerostin to the surface of target cells. We have also mapped the interaction site for an antibody that blocks the inhibition of Wnt signaling by sclerostin. This shows minimal overlap with the heparin binding site and highlights a key role for this region of sclerostin in protein interactions associated with the inhibition of Wnt signaling. The conserved N- and C-terminal arms of sclerostin were found to be unstructured, highly flexible, and unaffected by heparin binding, which suggests a role in stabilizing interactions with target proteins.	[Veverka, Vaclav; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Henry, Alistair J.; Slocombe, Patrick M.; Ventom, Andrew; Muzylak, Mariusz; Greenslade, Kevin; Moore, Adrian; Taylor, Richard J.; Robinson, Martyn K.] UCB Celltech, Slough SL1 4EN, Berks, England; [Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Zhang, Li; Gong, Jianhua; Qian, Xueming; Paszty, Chris] Amgen Inc, Thousand Oaks, CA 91320 USA	University of Leicester; Celltech Group Ltd; National Institute for Biological Standards & Control; Amgen	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk	Veverka, Vaclav/P-5251-2019; Veverka, Vaclav/G-9174-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996	UCB-Celltech Ltd; Wellcome Trust	UCB-Celltech Ltd(UCB Pharma SA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by UCB-Celltech Ltd and the Wellcome Trust.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Babcook JS, 1996, P NATL ACAD SCI USA, V93, P7843, DOI 10.1073/pnas.93.15.7843; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; Cattaruzza S, 2006, MACROMOL BIOSCI, V6, P667, DOI 10.1002/mabi.200600100; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Forster M, 2006, BIOCHEM SOC T, V34, P431, DOI 10.1042/BST0340431; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Mulloy B, 1997, THROMB HAEMOSTASIS, V77, P668; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; Ominsky MS, 2006, J BONE MINER RES, V21, pS44; Padhi D, 2007, J BONE MINER RES, V22, pS37; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Winkler DG, 2004, J BIOL CHEM, V279, P36293, DOI 10.1074/jbc.M400521200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Zhang L, 2006, J BONE MINER RES, V21, pS259	64	177	222	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10890	10900		10.1074/jbc.M807994200	http://dx.doi.org/10.1074/jbc.M807994200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208630	hybrid, Green Published			2022-12-27	WOS:000265104600062
J	Giliberto, L; Borghi, R; Piccini, A; Mangerini, R; Sorbi, S; Cirmena, G; Garuti, A; Ghetti, B; Tagliavini, F; Mughal, MR; Mattson, MP; Zhu, XW; Wang, XL; Guglielmotto, M; Tamagno, E; Tabatona, M				Giliberto, Luca; Borghi, Roberta; Piccini, Alessandra; Mangerini, Rosa; Sorbi, Sandro; Cirmena, Gabriella; Garuti, Anna; Ghetti, Bernardino; Tagliavini, Fabrizio; Mughal, Mohamed R.; Mattson, Mark P.; Zhu, Xiongwei; Wang, Xinglong; Guglielmotto, Michela; Tamagno, Elena; Tabatona, Massimo			Mutant Presenilin 1 Increases the Expression and Activity of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE PATHOGENESIS; NF-KAPPA-B; BETA-SECRETASE; OXIDATIVE STRESS; A-BETA; TRANSCRIPTIONAL REGULATION; INTRACELLULAR DOMAINS; TERMINAL FRAGMENT	Mutations of the presenilin 1 (PS1) gene are the most common cause of early onset familial Alzheimer disease (FAD). PS1 mutations alter the activity of the gamma-secretase on the beta-amyloid precursor protein (APP), leading to selective overproduction of beta-amyloid (A beta) 42 peptides, the species that forms oligomers that may exert toxic effects on neurons. Here we show that PS1 mutations, expressed both transiently and stably, in non-neuronal and neuronal cell lines increase the expression and the activity of the beta-secretase (BACE1), the rate-limiting step of A beta production. Also, BACE1 expression and activity are elevated in brains of PS1 mutant knock-in mice compared with wild type littermates as well as in cerebral cortex of FAD cases bearing various PS1 mutations compared with in sporadic AD cases and controls. The up-regulation of BACE1 by PS1 mutations requires the gamma-secretase cleavage of APP and is proportional to the amount of secreted A beta 42. A beta 42, and not AICD (APP intracellular domain), is indeed the APP derivative that mediates the overexpression of BACE1. The effect of PS1 mutations on BACE1 may contribute to determine the wide clinical and pathological phenotype of early onset FAD.	[Giliberto, Luca; Borghi, Roberta; Tabatona, Massimo] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy; [Cirmena, Gabriella; Garuti, Anna] Univ Genoa, Dept Internal Med & Med Specialties, I-16132 Genoa, Italy; [Piccini, Alessandra] Natl Inst Canc Res, Dept Cell Biol, I-16132 Genoa, Italy; [Mangerini, Rosa] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; [Mangerini, Rosa] Natl Canc Inst, I-16132 Genoa, Italy; [Sorbi, Sandro] Univ Florence, Dept Neurol & Psychiat Sci, I-50134 Florence, Italy; [Ghetti, Bernardino] Indiana Univ, Sch Med, Indiana Alzheimer Dis Ctr, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Tagliavini, Fabrizio] Ist Nazl Neurol Carlo Besta, Div Neuropathol & Neurol, I-20133 Milan, Italy; [Mughal, Mohamed R.; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Zhu, Xiongwei; Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Guglielmotto, Michela; Tamagno, Elena] Univ Turin, Dept Expt Med & Oncol, I-10125 Turin, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Florence; Indiana University System; Indiana University-Purdue University Indianapolis; IRCCS Istituto Neurologico Besta; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; University of Turin	Tabatona, M (corresponding author), Univ Genoa, Dept Neurosci Ophthalmol & Genet, Via De Toni 5, I-16132 Genoa, Italy.	mtabaton@neurologia.unige.it	/C-1310-2010; Zhu, Xiongwei/A-9629-2009; Mattson, Mark P/F-6038-2012; GUGLIELMOTTO, MICHELA/AAC-4843-2022; Tagliavini, Fabrizio/AAO-7891-2021	Zhu, Xiongwei/0000-0003-2092-6508; Tagliavini, Fabrizio/0000-0003-1039-7315; Wang, Xinglong/0000-0001-8657-0159; sorbi, sandro/0000-0002-0380-6670; Cirmena, Gabriella/0000-0002-5794-2766	Minister of Health, Italy; Telethon Foundation [GGP06009]; CARISA Foundation; Intramural Research Program of the NIA, National Institutes of Health; National Institutes of Health Public Health Service [AG10133]; National Institutes of Health [AG024028]; NATIONAL INSTITUTE ON AGING [ZIAAG000314, ZIAAG000312, P30AG010133, R01AG024028] Funding Source: NIH RePORTER	Minister of Health, Italy; Telethon Foundation(Fondazione Telethon); CARISA Foundation; Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Minister of Health (to M. T.), Italy and Telethon Foundation Grant GGP06009 (to M. T.), CARISA Foundation (to M. T.), by the Intramural Research Program of the NIA, National Institutes of Health (to M. P. M.), National Institutes of Health Public Health Service Grant AG10133(to B. G.), and National Institutes of Health Grant AG024028 (to X. Z.).	Assini A, 2003, NEUROLOGY, V60, P150, DOI 10.1212/01.WNL.0000040252.43269.83; Borghi R, 2007, NEUROBIOL AGING, V28, P1009, DOI 10.1016/j.neurobiolaging.2006.05.004; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; CLARK RF, 1995, HUM MOL GENET, V4, P1347, DOI 10.1093/hmg/4.8.1347; DE SB, 1999, NATURE, V398, P518; DU Y.S., 1997, P NATL ACAD SCI USA, V94, P5296; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; HAASS C, 1992, NATURE, V359, P325; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Lee HG, 2006, FREE RADICAL BIO MED, V41, P188, DOI 10.1016/j.freeradbiomed.2006.03.014; Lee PH, 2006, NEUROCHEM RES, V31, P821, DOI 10.1007/s11064-006-9086-y; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Mowrer KR, 2008, J BIOL CHEM, V283, P18694, DOI 10.1074/jbc.M801322200; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Piccini A, 2007, ARCH NEUROL-CHICAGO, V64, P738, DOI 10.1001/archneur.64.5.738; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tabaton M, 2006, J ALZHEIMERS DIS, V9, P127; Tagami S, 2008, NEURODEGENER DIS, V5, P160, DOI 10.1159/000113690; Takao M, 2001, J NEUROPATH EXP NEUR, V60, P1137, DOI 10.1093/jnen/60.12.1137; TAMAGNO E, 2008, NEUROBIOL A IN PRESS; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tamagno E, 2006, FREE RADICAL BIO MED, V41, P202, DOI 10.1016/j.freeradbiomed.2006.01.021; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xue SF, 2006, NEUROSCI LETT, V405, P231, DOI 10.1016/j.neulet.2006.07.013; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	65	40	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9027	9038		10.1074/jbc.M805685200	http://dx.doi.org/10.1074/jbc.M805685200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19196715	hybrid, Green Published			2022-12-27	WOS:000264669100005
J	Zhang, HW; Hong, H; Li, DM; Ma, SW; Di, Y; Stoten, A; Haig, N; Di Gleria, K; Yu, ZR; Xu, XN; McMichael, A; Jiang, SS				Zhang, Hongwei; Hong, Hai; Li, Demin; Ma, Shiwu; Di, Ying; Stoten, Adam; Haig, Neil; Di Gleria, Katalin; Yu, Zhanru; Xu, Xiao-Ning; McMichael, Andrew; Jiang, Shisong			Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8(+) and CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC-CLASS-I; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; ANTIBODY-RESPONSES; MOLECULES; ANTIGEN; INNATE; VIRUS; PHAGOCYTOSIS; MACROPHAGES	To better understand the mechanisms of intracellular trafficking and presentation of exogenous peptides by antigen-presenting cells (APC), we compared the handling of overlapping 24-mer peptides from HIV Nef either mixed or covalently linked in tandem in one protein. Once internalized, peptides trafficked not only to endosomes but also to cytosol, and activated CD8(+) and CD4(+) Tcells. In contrast, whole protein was found to traffic only to the endosomal compartments, and primarily activated CD4(+) T cells. Finally, with adjuvant, overlapping peptides were capable of protecting against lethal viral challenge, whereas the intact protein was less protective. These data suggest that overlapping long peptides are cross-presented through more varied intracellular routes and are more efficient in priming protective immunity than the whole protein.	[Zhang, Hongwei; Hong, Hai; Li, Demin; Ma, Shiwu; Di, Ying; Haig, Neil; Di Gleria, Katalin; Yu, Zhanru; Xu, Xiao-Ning; McMichael, Andrew; Jiang, Shisong] John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England; [Zhang, Hongwei] Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China; [Stoten, Adam] Univ Oxford, Isis Innovat Ltd, Oxford OX2 7SG, England	University of Oxford; Capital Medical University; University of Oxford	Jiang, SS (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford OX3 9DS, England.	shisong.jiang@imm.ox.ac.uk	Li, Demin/O-4065-2019	Li, Demin/0000-0002-7118-3401	Mary Kinross Charitable Trust's Fund; University of Oxford's Proof of Concept Fund; MRC [MC_U137881015, MC_U137884177] Funding Source: UKRI; Medical Research Council [MC_U137881015, MC_U137884177] Funding Source: researchfish	Mary Kinross Charitable Trust's Fund; University of Oxford's Proof of Concept Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Mary Kinross Charitable Trust's Fund and University of Oxford's Proof of Concept Fund (to S.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Jiang SS, 2006, VACCINE, V24, P6356, DOI 10.1016/j.vaccine.2006.04.070; Jiang SS, 2002, J GEN VIROL, V83, P429, DOI 10.1099/0022-1317-83-2-429; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kropshofer H, 1999, IMMUNOL REV, V172, P267, DOI 10.1111/j.1600-065X.1999.tb01371.x; Lovitch SB, 2007, J IMMUNOL, V178, P122, DOI 10.4049/jimmunol.178.1.122; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Met O, 2003, CELL IMMUNOL, V222, P126, DOI 10.1016/S0008-8749(03)00128-X; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen ZH, 1997, J IMMUNOL, V158, P2723; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; Watts C, 2001, SEMIN IMMUNOL, V13, P373; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730	33	60	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9184	9191		10.1074/jbc.M809456200	http://dx.doi.org/10.1074/jbc.M809456200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193636	Green Published, hybrid			2022-12-27	WOS:000264669100024
J	Lian, XJ; Gallouzi, IE				Lian, Xian Jin; Gallouzi, Imed-Eddine			Oxidative Stress Increases the Number of Stress Granules in Senescent Cells and Triggers a Rapid Decrease in p21(waf1/cip1) Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILIZATION; HUMAN-DIPLOID FIBROBLASTS; CELLULAR SENESCENCE; PROCESSING BODIES; PROTEIN OXIDATION; BINDING PROTEINS; HEAT-SHOCK; IN-VIVO; CANCER; HUR	Very little is known as to how the accumulation of senescent cells during aging may affect our ability to cope with various stresses. Here we show that the assembly of stress granules (SGs) is part of the early events used by senescent cells to respond to certain stresses. Although SGs can form in response to stress during senescence activation, their number significantly increases once the cells are fully senescent. This increase correlates with a rapid decrease in the expression levels of the cyclin kinase inhibitor p21, an important activator of senescence. Throughout stress, p21 mRNA is stabilized and localizes to SGs, but only during late senescence does this localization interferes with its translation. Additionally, we observed that when the stress is relieved, senescent cells produce lower levels of p21 protein, which correlates with a small delay in SG disassembly. Therefore, our data suggest that SG formation and the reduction in p21 protein levels represent two main events by which senescent cells respond to stress.	[Lian, Xian Jin; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 904,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca			Fonds de Recherche Scientifique de Quebec Master of Science fellowship; Canadian Institutes of Health Research Operating Grant [MOP-67026]	Fonds de Recherche Scientifique de Quebec Master of Science fellowship; Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by a Fonds de Recherche Scientifique de Quebec Master of Science fellowship (to X. L.) and Canadian Institutes of Health Research Operating Grant MOP-67026 (to I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bruunsgaard H, 2000, IMMUNOL CELL BIOL, V78, P523, DOI 10.1046/j.1440-1711.2000.00965.x; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CAMPISI J, 2002, SCI AGING KNOWLEDGE, pPE1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; EFFROS RB, 1994, J GERONTOL, V49, pB65, DOI 10.1093/geronj/49.2.B65; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0; Hayflick L, 1985, Clin Geriatr Med, V1, P15; Helenius M, 1999, EXP CELL RES, V248, P194, DOI 10.1006/excr.1999.4393; HONDA S, 1987, MECH AGEING DEV, V40, P81, DOI 10.1016/0047-6374(87)90036-4; Hsieh JK, 2000, ARTERIOSCL THROM VAS, V20, P973, DOI 10.1161/01.ATV.20.4.973; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673; Krtolica A, 2003, Adv Gerontol, V11, P109; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; LUCE MC, 1992, EXP CELL RES, V202, P9, DOI 10.1016/0014-4827(92)90398-R; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Merker K, 2000, ARCH BIOCHEM BIOPHYS, V375, P50, DOI 10.1006/abbi.1999.1657; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rosenfeldt F, 2004, ANN NY ACAD SCI, V1019, P78, DOI 10.1196/annals.1297.016; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Servais S, 2005, FREE RADICAL RES, V39, P305, DOI 10.1080/10715760400011098; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zarzhevsky N, 2001, ANN NY ACAD SCI, V928, P212	63	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8868	8878		10.1074/jbc.M806372200	http://dx.doi.org/10.1074/jbc.M806372200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176530	Green Published, hybrid			2022-12-27	WOS:000264397800070
J	Tanimura, A; Morita, T; Nezu, A; Shitara, A; Hashimoto, N; Tojyo, Y				Tanimura, Akihiko; Morita, Takao; Nezu, Akihiro; Shitara, Akiko; Hashimoto, Noboru; Tojyo, Yosuke			Use of Fluorescence Resonance Energy Transfer-based Biosensors for the Quantitative Analysis of Inositol 1,4,5-Trisphosphate Dynamics in Calcium Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; CA2+ OSCILLATIONS; LUMINAL CA2+; HSY CELLS; TRISPHOSPHATE; RECEPTOR; IDENTIFICATION; FREQUENCY; RELEASE; IP3	Inositol 1,4,5-trisphosphate (IP3) is an intracellular messenger that elicits a wide range of spatial and temporal Ca2+ signals, and this signaling versatility is exploited to regulate diverse cellular responses. In this study, we have developed a series of IP3 biosensors that exhibit strong pH stability and varying affinities for IP3, as well as a method for the quantitative measurement of cytosolic concentrations of I3 ([I3](i)) in single living cells. We applied this method to elucidate IP3 dynamics during agonist-induced Ca2+ oscillations, and we demonstrated cell type-dependent differences in IP3 dynamics, a nonfluctuating rise in [IP3] i and repetitive IP3 spikes during Ca2+ oscillations in COS-7 cells and HSY-EA1 cells, respectively. The size of the IP3 spikes in HSY-EA1 cells varied from 10 to 100 nM, and the [IP3](i) spike peak was preceded by a Ca2+ spike peak. These results suggest that repetitive IP3 spikes in HSY-EA1 cells are passive reflections of Ca2+ oscillations, and are unlikely to be essential for driving Ca2+ oscillations. In addition, the interspike periods of Ca2+ oscillations that occurred during the slow rise in [IP3](i) were not shortened by the rise in [IP3](i), indicating that IP3-dependent and -independent mechanisms may regulate the frequency of Ca2+ oscillations. The novel method described herein as well as the quantitative information obtained by using this method should provide a valuable and sound basis for future studies on the spatial and temporal regulations of IP3 and Ca2+.	[Tanimura, Akihiko; Morita, Takao; Nezu, Akihiro; Shitara, Akiko; Tojyo, Yosuke] Hlth Sci Univ Hokkaido, Sch Dent, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan; [Hashimoto, Noboru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Integrated Human Sci, Ishikari, Hokkaido 0610293, Japan	Health Sciences University of Hokkaido; Health Sciences University of Hokkaido	Tanimura, A (corresponding author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan.	tanimura@hoku-iryo-u.ac.jp		Shitara, Akiko/0000-0003-4899-8538	Ministry of Education, Culture, Sports, Science and Technology of Japan [16390532]; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grant-in-aid for Scientific Research 16390532 (to A. T.), by HAITEKU (2007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dupont G, 2007, INT REV CYTOL, V261, P193, DOI 10.1016/S0074-7696(07)61005-5; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nezu A, 2006, BBA-GEN SUBJECTS, V1760, P1274, DOI 10.1016/j.bbagen.2006.04.004; PARKER I, 1992, AM J PHYSIOL, V263, pC154, DOI 10.1152/ajpcell.1992.263.1.C154; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Sato M, 2005, ANAL CHEM, V77, P4751, DOI 10.1021/ac040195j; Sneyd J, 2006, P NATL ACAD SCI USA, V103, P1675, DOI 10.1073/pnas.0506135103; Tanimura A, 1996, J CELL BIOL, V132, P607, DOI 10.1083/jcb.132.4.607; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Tanimura A, 2004, J BIOL CHEM, V279, P38095, DOI 10.1074/jbc.C400312200; Tanimura A, 2002, J BIOL CHEM, V277, P29054, DOI 10.1074/jbc.M201130200; Tojyo Y, 2001, BBA-MOL CELL RES, V1539, P114, DOI 10.1016/S0167-4889(01)00098-2; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhang LY, 2007, CHEMMEDCHEM, V2, P1281, DOI 10.1002/cmdc.200700071	28	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8901	8908		10.1074/jbc.M805865200	http://dx.doi.org/10.1074/jbc.M805865200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19158094	Green Published, hybrid			2022-12-27	WOS:000264397800073
J	Maarouf, AB; Sheng, N; Chen, JX; Winarski, KL; Okumura, S; Carattino, MD; Boyd, CR; Kleyman, TR; Sheng, SH				Maarouf, Ahmad B.; Sheng, Nan; Chen, Jingxin; Winarski, Katie L.; Okumura, Sora; Carattino, Marcelo D.; Boyd, Cary R.; Kleyman, Thomas R.; Sheng, Shaohu			Novel Determinants of Epithelial Sodium Channel Gating within Extracellular Thumb Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; HELICAL MEMBRANE-PROTEINS; HISTIDINE-RESIDUES; ALPHA-SUBUNIT; GAMMA-SUBUNIT; PORE REGION; ENAC; FURIN; TEMPERATURE; SELECTIVITY	Activity of the epithelial Na+ channel (ENaC) is modulated by Na+ self-inhibition, an allosteric down-regulation of channel open probability by extracellular Na+. We searched for determinants of Na+ self-inhibition by analyzing changes in this inhibitory response resulting from specific mutations within the extracellular domains of mouse ENaC subunits. Mutations at gamma Met(438) altered the Na+ self-inhibition response in a substitution-specific manner. Fourteen substitutions (Ala, Arg, Asp, Cys, Gln, Glu, His, Ile, Phe, Pro, Ser, Thr, Tyr, and Val) significantly suppressed Na+ self-inhibition, whereas three mutations (Asn, Gly, and Leu) moderately enhanced the inhibition. Met to Lys mutation did not alter Na+ self-inhibition. Mutations at the homologous site in the alpha subunit (G481A, G481C, and G481M) dramatically increased the magnitude and speed of Na+ self-inhibition. Mutations at the homologous beta Ala(422) resulted in minimal or no change in Na+ self-inhibition. Low, high, and intermediate open probabilities were observed in oocytes expressing alpha G481M beta gamma, alpha beta gamma M438V, and alpha G481M/beta gamma M438V, respectively. This pair of residues map to the alpha 5 helixin the extracellular thumb domain in the chicken acid sensing ion channel 1 structure. Both residues likely reside near the channel surface because both alpha G481C beta gamma and alpha beta gamma M438C channels were inhibited by an externally applied and membrane-impermeant sulfhydryl reagent. Our results demonstrate that alpha Gly(481) and gamma Met(438) are functional determinants of Na+ self-inhibition and of ENaC gating and suggest that the thumb domain contributes to the channel gating machinery.	[Maarouf, Ahmad B.; Sheng, Nan; Chen, Jingxin; Winarski, Katie L.; Okumura, Sora; Carattino, Marcelo D.; Boyd, Cary R.; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu; shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 DK054354, R01 ES014701, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK054354, R01 ES014701, and P30 DK079307. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chraibi A, 2003, PFLUG ARCH EUR J PHY, V447, P316, DOI 10.1007/s00424-003-1178-9; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Horisberger Jean-Daniel, 2004, Nephron, V96, pp37, DOI 10.1159/000076406; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Palmer LG, 1998, J PHYSIOL-LONDON, V509, P151, DOI 10.1111/j.1469-7793.1998.151bo.x; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; SCHULZ AR, 1994, ENZYME KINETICS DIS, P38; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shahrestanifar MS, 1996, NEUROCHEM RES, V21, P1295, DOI 10.1007/BF02532370; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; [No title captured]	39	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7756	7765		10.1074/jbc.M807060200	http://dx.doi.org/10.1074/jbc.M807060200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158091	hybrid, Green Published			2022-12-27	WOS:000264195600037
J	Marty, C; Chaligne, R; Lacout, C; Constantinescu, SN; Vainchenker, W; Villeval, JL				Marty, Caroline; Chaligne, Ronan; Lacout, Catherine; Constantinescu, Stefan N.; Vainchenker, William; Villeval, Jean-Luc			Ligand-independent Thrombopoietin Mutant Receptor Requires Cell Surface Localization for Endogenous Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MPL LIGAND; ERYTHROPOIETIN RECEPTOR; PLATELET PRODUCTION; POLYCYTHEMIA-VERA; ACTIVATION; DOMAIN; MUTATIONS; MYELOFIBROSIS; TUMORIGENICITY; SUPERFAMILY	The activating W515L mutation in the thrombopoietin receptor (MPL) has been identified in primary myelofibrosis and essential thrombocythemia. MPL belongs to a subset of the cytokine receptor superfamily that requires the JAK2 kinase for signaling. We examined whether the ligand-independent MPLW515L mutant could signal intracellularly. Addition of the endoplasmic reticulum (ER) retention KDEL sequence to the receptor C terminus efficiently locked MPLW515L within its natural ER/Golgi maturation pathway. In contrast to cells expressing the parental MPLW515L, MPLW515L-KDEL-expressing FDC-P1 cells were unable to grow autonomously and to produce tumors in nude mice. When observed, tumor nodules resulted from in vivo selection of cells leaking the receptor at their surface. JAK2 co-immunoprecipitated with MPLW515L-KDEL but was not phosphorylated. We generated disulfide-bonded MPLW515L homodimers by the S402C substitution, both in the normal and KDEL context. Unlike MPLW515L-KDEL, MPLW515L-S402C-KDEL signaled constitutively and exhibited cell surface localization. These data establish that MPLW515L with appended JAK2 matures through the ER/Golgi system in an inactive conformation and suggest that the MPLW515L/JAK2 complex requires membrane localization for JAK2 phosphorylation, resulting in autonomous receptor signaling.	[Villeval, Jean-Luc] Inst Gustave Roussy, INSERM, U790, F-94805 Villejuif, France; [Marty, Caroline; Chaligne, Ronan; Lacout, Catherine; Vainchenker, William; Villeval, Jean-Luc] Univ Paris 11, F-94805 Villejuif, France; [Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Univ Catholique Louvain, Christian Duve Inst, B-1200 Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Villeval, JL (corresponding author), Inst Gustave Roussy, INSERM, U790, PR1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	villeval@igr.fr	MARTY, Caroline/I-1721-2017; Constantinescu, Stefan N/E-5277-2012	MARTY, Caroline/0000-0003-4350-2302; Chaligne, Ronan/0000-0003-4332-3291; Constantinescu, Stefan N./0000-0002-8599-2699; Vainchenker, William/0000-0003-4705-202X; Villeval, Jean-Luc/0000-0002-0562-925X; Chaligne, Ronan/0000-0001-5788-5848	INSERM; Institut Gustave Roussy (IGR); Institut National du Cancer (INCa); Canceropole Ile-de-France; La Ligue Nationale Contre le Cancer (labeled team 2006)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Gustave Roussy (IGR); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); La Ligue Nationale Contre le Cancer (labeled team 2006)	This work was supported in part by grants from INSERM, Institut Gustave Roussy (IGR), Institut National du Cancer (INCa), Canceropole Ile-de-France, and by special funding from La Ligue Nationale Contre le Cancer (labeled team 2006).	ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Beer PA, 2008, BLOOD, V112, P141, DOI 10.1182/blood-2008-01-131664; BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; BROUDY VC, 1995, J LEUKOCYTE BIOL, V57, P719, DOI 10.1002/jlb.57.5.719; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chaligne R, 2007, BLOOD, V110, P3735, DOI 10.1182/blood-2007-05-089003; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; DANDREA AD, 1990, J CLIN INVEST, V86, P681, DOI 10.1172/JCI114763; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MIESENBOCK G, 1995, J CELL BIOL, V129, P309, DOI 10.1083/jcb.129.2.309; Moliterno AR, 1999, BLOOD, V94, P2555, DOI 10.1182/blood.V94.8.2555.420k14_2555_2561; Otto KG, 2001, BLOOD, V98, P2077, DOI 10.1182/blood.V98.7.2077; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Tefferi A, 2000, BLOOD, V96, P771; VAINCHENKER W, 1995, THROMB HAEMOSTASIS, V74, P526; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Wendling F, 1999, HAEMATOLOGICA, V84, P158; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0	34	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11781	11791		10.1074/jbc.M808703200	http://dx.doi.org/10.1074/jbc.M808703200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261614	Green Published, hybrid			2022-12-27	WOS:000265494600010
J	Cattaneo, M; Lotti, LV; Martino, S; Cardano, M; Orlandi, R; Mariani-Costantini, R; Biunno, I				Cattaneo, Monica; Lotti, Lavinia Vittoria; Martino, Simone; Cardano, Marina; Orlandi, Rosaria; Mariani-Costantini, Renato; Biunno, Ida			Functional Characterization of Two Secreted SEL1L Isoforms Capable of Exporting Unassembled Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HEPATOCELLULAR-CARCINOMA; EXPRESSION; PROTEINS; PROTEASOME; ANTIBODY; REGION; HRD1	SEL1L-A, a transmembrane glycoprotein residing in the endoplasmic reticulum (ER), is a component of the ER-associated degradation (ERAD) pathway. Alternative splicing generates two smaller SEL1L isoforms, -B and -C, that lack the SEL1L-A membrane-spanning region but retain some sel-1-like repeats, known to be involved in multi-protein interactions and signal transduction. In this study the functional characteristics of SEL1L-B and -C were investigated in human cell models. We show that these two isoforms are induced upon ER stress and activation of the unfolded protein response, together with SEL1L-A. Using transient transfection experiments (based on wild-type and mutant SEL1L constructs) combined with several biochemical tests we show that SEL1L-B and, more prominently, SEL1L-C are secreted glycoproteins. Although SEL1L-C is in monomeric form, SEL1L-B is engaged in intramolecular/intermolecular disulfide bonds. Both isoforms localize in secretory and degradative cellular compartments and in areas of cell-cell contact. However, whereas SEL1L-B is mainly associated with membranes, SEL1L-C shows the typical intralumenal localization of soluble proteins and is present in intercellular spaces. Furthermore, because of its peroxisomal domain, SEL1L-C localizes to peroxisomes. Both SEL1L-B and -C are involved in sorting and exporting unassembled Ig-mu(s) but do not affect two other ERAD substrates, the null Hong Kong variant of alpha(1)-antitrypsin, and mutant alpha(1)-AT Z. Overall these findings suggest that SEL1L-B and -C participate to novel molecular pathways that, in parallel with ERAD, contribute to the disposure of misfolded/unfolded or orphan proteins through degradation or secretion.	[Cattaneo, Monica; Biunno, Ida] CNR, Inst Biomed Technol, I-20090 Milan, Italy; [Lotti, Lavinia Vittoria; Martino, Simone] Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; [Cardano, Marina; Biunno, Ida] Integrated Syst Engn, I-20138 Milan, Italy; [Orlandi, Rosaria] Dept Expt Oncol, Mol Targeting Unit, I-20133 Milan, Italy; [Mariani-Costantini, Renato] Univ G DAnnunzio, Dept Oncol & Neurosci, I-66100 Chieti, Italy; [Mariani-Costantini, Renato] Univ G dAnnunzio, Ctr Excellence Aging CeSI, I-66100 Chieti, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Biunno, I (corresponding author), ITB CNR, Via Flli Cervi 93, I-20090 Milan, Italy.	ida.biunno@itb.cnr.it	Orlandi, Rosaria/C-1182-2017; Mariani-Costantini, Renato/B-6637-2012	Orlandi, Rosaria/0000-0002-0533-9041; Mariani-Costantini, Renato/0000-0002-4440-1848; , IDA_2/0000-0002-1068-4763; /0000-0002-1866-5866	MUR-FIRB nRBIP064CRT; MAP-LOMBARDIA [CO1/00692/00/X01]; Faculty of Medicine, G. d'Annunzio University; Faculty of Medicine, La Sapienza University	MUR-FIRB nRBIP064CRT; MAP-LOMBARDIA; Faculty of Medicine, G. d'Annunzio University; Faculty of Medicine, La Sapienza University	This work was supported by grants from MUR-FIRB nRBIP064CRT, MAP-LOMBARDIA, Grant CO1/00692/00/X01, 2007/2008 MUR 60% funds from the Faculty of Medicine, G. d'Annunzio University (to R. M.-C.), and 2007/2008 MUR 60% funds from the Faculty of Medicine, La Sapienza University (to L. V. L.).	Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Cattaneo M, 2004, GENE, V326, P149, DOI 10.1016/j.gene.2003.10.021; Cattaneo M, 2001, DNA CELL BIOL, V20, P1, DOI 10.1089/10445490150504648; Cattaneo M, 2000, INT J BIOL MARKER, V15, P26, DOI 10.1177/172460080001500105; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lainez B, 2004, INT IMMUNOL, V16, P169, DOI 10.1093/intimm/dxh014; Le Naour F, 2002, MOL CELL PROTEOMICS, V1, P197, DOI 10.1074/mcp.M100029-MCP200; Lomas DA, 2004, THORAX, V59, P529, DOI 10.1136/thx.2003.006528; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Mittl PRE, 2003, CLIN DIAGN LAB IMMUN, V10, P542, DOI 10.1128/CDLI.10.4.542-545.2003; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Platta HW, 2007, FEBS LETT, V581, P2811, DOI 10.1016/j.febslet.2007.04.001; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731	29	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11405	11415		10.1074/jbc.M805408200	http://dx.doi.org/10.1074/jbc.M805408200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19204006	hybrid, Green Published			2022-12-27	WOS:000265494500045
J	Kumar, P; Kumar, D; Parikh, A; Rananaware, D; Gupta, M; Singh, Y; Nandicoori, VK				Kumar, Pawan; Kumar, Devanand; Parikh, Amit; Rananaware, Dimple; Gupta, Meetu; Singh, Yogendra; Nandicoori, Vinay Kumar			The Mycobacterium tuberculosis Protein Kinase K Modulates Activation of Transcription from the Promoter of Mycobacterial Monooxygenase Operon through Phosphorylation of the Transcriptional Regulator VirS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SER/THR KINASE; SERINE/THREONINE KINASE; CELL-DIVISION; ABC TRANSPORTER; MYMA OPERON; FHA DOMAINS; IN-VIVO; PKNB; SYSTEM	Mycobacterium tuberculosis encodes for 11 eukaryotic-like serine/threonine protein kinases. Genetic and biochemical studies show that these kinases regulate various cellular processes including cell shape and morphology, glucose and glutamine transport, phagosome-lysosome fusion and the expression, and/or activity of transcription factors. PknK is the largest predicted serine/threonine protein kinase in M. tuberculosis. Here, we have cloned, overexpressed, and purified protein kinaseK(PknK) to near homogeneity and show that its ability to phosphorylate proteins is dependent on the invariant lysine (Lys(55)), and on two conserved threonine residues present in its activation loop. Despite being devoid of any apparent transmembrane domain, PknK is localized to the cell wall fraction, suggesting probable anchoring of the kinase to the cell membrane region. The pknK gene is located in the vicinity of the virS gene, which is known to regulate the expression of the mycobacterial monooxygenase (mymA) operon. We report here for the first time that VirS is in fact a substrate of PknK. In addition, four of the proteins encoded by mymA operon are also found to be substrates of PknK. Results show that VirS is a bona fide substrate of PknK in vivo, and PknK-mediated phosphorylation of VirS increases its affinity for mym promoter DNA. Reporter assays reveal that PknK modulates VirS-mediated stimulation of transcription from the mym promoter. These findings suggest that the expression of mymA operon genes is regulated through PknK-mediated phosphorylation of VirS.	[Kumar, Devanand; Parikh, Amit; Rananaware, Dimple; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Kumar, Pawan; Gupta, Meetu; Singh, Yogendra] Inst Genom & Integrat Biol, Delhi 110007, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in		Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology India; Council of Scientific and Industrial Research [NWP-0038]	Department of Biotechnology India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the generous funding provided by the Department of Biotechnology India (to V. K. N.) and Project NWP-0038 of the Council of Scientific and Industrial Research (to Y. S.).	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HIRSCHFIELD GR, 1990, J BACTERIOL, V172, P1005, DOI 10.1128/jb.172.2.1005-1013.1990; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nourry Claire, 2003, Sci STKE, V2003, pRE7; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Purbey PK, 2006, NAT PROTOC, V1, P1820, DOI 10.1038/nprot.2006.310; RICHET E, 1989, EMBO J, V8, P981, DOI 10.1002/j.1460-2075.1989.tb03461.x; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh R, 2005, TUBERCULOSIS, V85, P325, DOI 10.1016/j.tube.2005.08.015; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	52	53	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11090	11099		10.1074/jbc.M808705200	http://dx.doi.org/10.1074/jbc.M808705200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251699	Green Published, hybrid			2022-12-27	WOS:000265494500013
J	Rauhamaki, V; Bloch, DA; Verkhovsky, MI; Wikstrom, M				Rauhamaki, Virve; Bloch, Dmitry A.; Verkhovsky, Michael I.; Wikstrom, Marten			Active Site of Cytochrome cbb(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS CONTAINS; NITRIC-OXIDE REDUCTASE; C-OXIDASE; RESPIRATORY-CHAIN; HEME CENTERS; SPHAEROIDES; EVOLUTION; IDENTIFICATION; PEROXIDASE; GENOMICS	Cytochrome cbb(3) is the most distant member of the heme-copper oxidase family still retaining the following major feature typical of these enzymes: reduction of molecular oxygen to water coupled to proton translocation across the membrane. The thermodynamic properties of the six redox centers, five hemes and a copper ion, in cytochrome cbb(3) from Rhodobacter sphaeroides were studied using optical and EPR spectroscopy. The low spin heme b in the catalytic subunit was shown to have the highest midpoint redox potential (E-m,E-7 +418 mV), whereas the three hemes c in the two other subunits titrated with apparent midpoint redox potentials of +351, +320, and +234 mV. The active site high spin heme b(3) has a very low potential (E-m,E-7 -59 mV) as opposed to the copper center (Cu-B), which has a high potential (E-m,E-7 +330 mV). The EPR spectrum of the ferric heme b(3) has rhombic symmetry. To explain the origins of the rhombicity, the Glu-383 residue located on the proximal side of heme b(3) was mutated to aspartate and to glutamine. The latter mutation caused a 10 nm blue shift in the optical reduced minus oxidized heme b(3) spectrum, and a dramatic change of the EPR signal toward more axial symmetry, whereas mutation to aspartate had far less severe consequences. These results strongly suggest that Glu-383 is involved in hydrogen bonding to the proximal His-405 ligand of heme b(3), a unique interaction among heme-copper oxidases.	[Rauhamaki, Virve; Bloch, Dmitry A.; Verkhovsky, Michael I.; Wikstrom, Marten] Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, Program Struct Biol & Biophys, Helsinki 00014, Finland	University of Helsinki	Rauhamaki, V (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, Program Struct Biol & Biophys, POB 65,Viikinkaari 1, Helsinki 00014, Finland.	virve.rauhamaki@helsinki.fi		Wikstrom, Marten/0000-0002-7527-4415	National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Academy of Finland	National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Academy of Finland(Academy of Finland)	This work was supported by the National Graduate School in Informational and Structural Biology (to V.R.), by the Sigrid Juselius Foundation, Magnus Ehrnrooth Foundation, Biocentrum Helsinki, and the Academy of Finland.	Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; CASTRESANA J, 1995, TRENDS BIOCHEM SCI, V20, P443, DOI 10.1016/S0968-0004(00)89098-2; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Euro L, 2008, BIOCHEMISTRY-US, V47, P3185, DOI 10.1021/bi702063t; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Forte E, 2001, EUR J BIOCHEM, V268, P6486, DOI 10.1046/j.0014-2956.2001.02597.x; GARCIAHORSMAN JA, 1994, BIOCHEMISTRY-US, V33, P3113, DOI 10.1021/bi00176a046; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; Hemp J, 2005, BIOCHEMISTRY-US, V44, P10766, DOI 10.1021/bi050464f; Hemp James, 2008, V45, P1, DOI 10.1007/400_2007_046; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hemp J, 2006, BIOCHEMISTRY-US, V45, P15405, DOI 10.1021/bi062026u; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; MITCHELL R, 1991, FEBS LETT, V280, P321, DOI 10.1016/0014-5793(91)80321-S; Murgida DH, 2005, PHYS CHEM CHEM PHYS, V7, P3773, DOI 10.1039/b507989f; Oh JI, 2002, J BIOL CHEM, V277, P16220, DOI 10.1074/jbc.M200198200; PEISACH J, 1971, J BIOL CHEM, V246, P3342; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pereira MM, 2000, J BIOENERG BIOMEMBR, V32, P143, DOI 10.1023/A:1005555829301; PETTIGREW GW, 1987, CYTOCHROMES C BIOL A, P25; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, J BIOL CHEM, V277, P31474, DOI 10.1074/jbc.M204103200; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; RAITIO M, 1994, BBA-BIOENERGETICS, V1186, P100, DOI 10.1016/0005-2728(94)90140-6; Rauhamaki V, 2006, P NATL ACAD SCI USA, V103, P16135, DOI 10.1073/pnas.0606254103; Sharma V, 2008, BIOCHEMISTRY-US, V47, P4221, DOI 10.1021/bi702088r; Sharma V, 2006, BIOCHEMISTRY-US, V45, P5754, DOI 10.1021/bi060169a; Sinclair R, 1996, BIOCHEMISTRY-US, V35, P15120, DOI 10.1021/bi961064i; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Stavrakis S, 2002, J AM CHEM SOC, V124, P3814, DOI 10.1021/ja0169825; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Toledo-Cuevas M, 1998, BBA-BIOENERGETICS, V1365, P421, DOI 10.1016/S0005-2728(98)00095-4; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; VAROTSIS C, 1995, J PHYS CHEM-US, V99, P16817, DOI 10.1021/j100046a004; Verissimo AF, 2007, BIOCHEMISTRY-US, V46, P13245, DOI 10.1021/bi700733g; WANG JL, 1995, J AM CHEM SOC, V117, P9363, DOI 10.1021/ja00141a033; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Ye T, 2008, J AM CHEM SOC, V130, P6682, DOI 10.1021/ja801071n; Zufferey R, 1998, J BIOL CHEM, V273, P6452, DOI 10.1074/jbc.273.11.6452	45	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11301	11308		10.1074/jbc.M808839200	http://dx.doi.org/10.1074/jbc.M808839200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19252222	Green Published, hybrid			2022-12-27	WOS:000265494500034
J	Shin, DJ; Osborne, TF				Shin, Dong-Ju; Osborne, Timothy F.			FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; 7 ALPHA-HYDROXYLASE; CULTURED RAT HEPATOCYTES; N-TERMINAL KINASE; NUCLEAR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; FEEDBACK-REGULATION; FACTOR FKHR; COORDINATED RECRUITMENT	The current studies show FGF15 signaling decreases hepatic forkhead transcription factor 1 (FoxO1) activity through phosphatidylinositol (PI) 3-kinase-dependent phosphorylation. The bile acid receptor FXR (farnesoid X receptor) activates expression of fibroblast growth factor (FGF) 15 in the intestine, which acts through hepatic FGFR4 to suppress cholesterol-7 alpha hydroxylase (CYP7A1) and limit bile acid production. Because FoxO1 activity and CYP7A1 gene expression are both increased by fasting, we hypothesized CYP7A1 might be a FoxO1 target gene. Consistent with recently reported results, we show CYP7A1 is a direct target of FoxO1. Additionally, we show that the PI 3-kinase pathway is key for both the induction of CYP7A1 by fasting and the suppression by FGF15. FGFR4 is the major hepatic FGF receptor isoform and is responsible for the hepatic effects of FGF15. We also show that expression of FGFR4 in liver was decreased by fasting, increased by insulin, and reduced by streptozotocin-induced diabetes, implicating FGFR4 as a primary target of insulin regulation. Because insulin and FGF both target the PI 3-kinase pathway, these observations suggest FoxO1 is a key node in the convergence of FGF and insulin signaling pathways and functions as a key integrator for the regulation of glucose and bile acid metabolism.	[Osborne, Timothy F.] Univ Calif Irvine, Sch Biol Sci, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Diabet Res & Treatment, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Osborne, TF (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Mol Biol & Biochem, 3244 McGaugh Hall, Irvine, CA 92697 USA.	tim.osborne@uci.edu			National Institutes of Health [DK71021]; American Heart Association Scientist Development [0730189N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK71021 (to T.O.). This work was also supported by American Heart Association Scientist Development Grant 0730189N (to D.-J.S.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Cooper AD, 1997, J BIOL CHEM, V272, P3444, DOI 10.1074/jbc.272.6.3444; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Han SL, 2004, HEPATOLOGY, V39, P456, DOI 10.1002/hep.20043; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lamothe B, 2004, MOL CELL BIOL, V24, P5657, DOI 10.1128/MCB.24.13.5657-5666.2004; LeCluyse E L, 1996, Pharm Biotechnol, V8, P121; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2008, J LIPID RES, V49, P1981, DOI 10.1194/jlr.M800140-JLR200; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NESS GC, 1994, BBA-LIPID LIPID MET, V1214, P229, DOI 10.1016/0005-2760(94)90068-X; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Qiao DH, 2000, J BIOL CHEM, V275, P15090, DOI 10.1074/jbc.M908890199; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Shin DJ, 2006, NUCLEIC ACIDS RES, V34, P3853, DOI 10.1093/nar/gkl506; Stravitz RT, 1996, AM J PHYSIOL-GASTR L, V271, pG293, DOI 10.1152/ajpgi.1996.271.2.G293; TWISK J, 1995, HEPATOLOGY, V21, P501, DOI 10.1016/0270-9139(95)90113-2; Wang DP, 1996, J LIPID RES, V37, P1831; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	73	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11110	11120		10.1074/jbc.M808747200	http://dx.doi.org/10.1074/jbc.M808747200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19237543	Green Published, hybrid			2022-12-27	WOS:000265494500015
J	Walker, P; Doenecke, D; Kahle, J				Walker, Patrick; Doenecke, Detlef; Kahle, Joerg			Importin 13 Mediates Nuclear Import of Histone Fold-containing Chromatin Accessibility Complex Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE PATHWAYS; CRYSTAL-STRUCTURE; PROTEIN; ISWI; TRANSCRIPTION; SUBUNITS; CLONING; BINDING; EXPORT; BETA	The histone fold is a structural element that facilitates heterodimerization, and histone fold heterodimers play crucial roles in gene regulation. Here, we investigated the nuclear import of two human histone fold pairs, which belong to the H2A/H2B family: CHRAC-15/CHRAC-17 and p12/CHRAC-17. Our results from in vitro nuclear import assays with permeabilized cells and in vivo cotransfection experiments reveal that importin 13 facilitates nuclear import of both histone fold heterodimers. Using glutathione S-transferase pulldown experiments, we provide evidence that heterodimers are required for efficient binding of importin 13 because the monomers alone do not significantly interact. Mutational analysis shows that stepwise substitution of basic amino acid residues conserved among the histone fold subunits leads to a progressive loss of importin 13 binding and nuclear accumulation of CHRAC-15/CHRAC-17 and p12/CHRAC-17. The distribution of basic amino acid residues among the histone fold subunits essential for nuclear uptake suggests that heterodimerization of the histone fold motif-containing proteins forms an importin 13-specific binding platform.	[Walker, Patrick; Doenecke, Detlef; Kahle, Joerg] Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Doenecke, D (corresponding author), Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, Humboldtallee 23, D-37073 Gottingen, Germany.	ddoenec@gwdg.de			Deutsche Forschungsgemeinschaft [523]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 523: Protein und Membrantransport zwischen zellularen Kompartimenten).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Langst G, 2001, J CELL SCI, V114, P2561; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Neves-Costa A, 2006, RES PRO CEL, V41, P91, DOI 10.1007/007; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NISHI K, 1994, J BIOL CHEM, V269, P6320; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Sondermann H, 2003, STRUCTURE, V11, P1583, DOI 10.1016/j.str.2003.10.015; Spiga MG, 2004, NUCLEIC ACIDS RES, V32, P4945, DOI 10.1093/nar/gkh811; Strom AC, 2001, GENOME BIOL, V2; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; Tao T, 2004, AM J RESP CELL MOL, V30, P350, DOI 10.1165/rcmb.2003-0126OC; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	56	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11652	11662		10.1074/jbc.M806820200	http://dx.doi.org/10.1074/jbc.M806820200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19218565	Green Published, hybrid			2022-12-27	WOS:000265494500068
J	Zhou, YJ; Jiang, L; Rui, LY				Zhou, Yingjiang; Jiang, Lin; Rui, Liangyou			Identification of MUP1 as a Regulator for Glucose and Lipid Metabolism in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR URINARY PROTEINS; INSULIN-RESISTANCE; OBESITY; FGF-21; LIVER; AKT2	Major urinary protein (MUP) 1 is a lipocalin family member abundantly secreted into the circulation by the liver. MUP1 binds to lipophilic pheromones and is excreted in urine. Urinary MUP1/pheromone complexes mediate chemical communication in rodents. However, it is unclear whether circulatory MUP1 has additional physiological functions. Here we show that MUP1 regulates glucose and lipid metabolism. MUP1 expression was markedly reduced in both genetic and dietary fat-induced obesity and diabetes. Mice were infected with MUP1 adenoviruses via tail vein injection, and recombinant MUP1 was overexpressed in the liver and secreted into the bloodstream. Recombinant MUP1 markedly attenuated hyperglycemia and glucose intolerance in genetic (db/db) and dietary fat-induced type 2 diabetic mice as well as in streptozotocin-induced type 1 diabetic mice. MUP1 inhibited the expression of both gluconeogenic genes and lipogenic genes in the liver. Moreover, recombinant MUP1 directly decreased glucose production in primary hepatocyte cultures by inhibiting the expression of gluconeogenic genes. These data suggest that MUP1 regulates systemic glucose and/or lipid metabolism through the paracrine/autocrine regulation of the hepatic gluconeogenic and/or lipogenic programs, respectively.	[Zhou, Yingjiang; Jiang, Lin; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	Jiang, Lin/E-7468-2012		National Institutes of Health [RO1 DK 065122, RO1 DK073601]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK034933, R01DK073601, R01DK065122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 065122 and RO1 DK073601 ( to L. R.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BERGER FG, 1981, BIOCHEM GENET, V19, P1261, DOI 10.1007/BF00484578; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clemmons DR, 2006, CURR OPIN PHARMACOL, V6, P620, DOI 10.1016/j.coph.2006.08.006; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Macek P, 2006, FEBS LETT, V580, P682, DOI 10.1016/j.febslet.2005.12.088; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Vasylyeva TL, 2007, DIABETES RES CLIN PR, V76, P177, DOI 10.1016/j.diabres.2006.09.012; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	23	113	115	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11152	11159		10.1074/jbc.M900754200	http://dx.doi.org/10.1074/jbc.M900754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258313	Green Published, hybrid			2022-12-27	WOS:000265494500019
J	Essaghir, A; Dif, N; Marbehant, CY; Coffer, PJ; Demoulin, JB				Essaghir, Ahmed; Dif, Nicolas; Marbehant, Catherine Y.; Coffer, Paul J.; Demoulin, Jean-Baptiste			The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELL-SURVIVAL; FORKHEAD BOX; EXPRESSION; PDGF; ACTIVATION; RECEPTOR; PHOSPHORYLATION; PROLIFERATION; CANCER	FOXO (Forkhead box O) transcription factors induce cell growth arrest and apoptosis, which can be prevented by FOXO phosphorylation by AKT in response to growth factors such as platelet-derived growth factors (PDGF) and insulin-like growth factor I (IGF-I). In addition to this well characterized post-translational modification, we showed that FOXO1, FOXO3, and FOXO4 were also regulated at the transcriptional level. PDGF, fibroblast growth factors (FGF), and IGF-I repressed the expression of FOXO genes in human fibroblasts. This process was sensitive to phosphatidylinositol 3-kinase inhibition by LY294002. FOXO1-specific shRNA decreased FOXO1 mRNA expression and enhanced fibroblast proliferation, mimicking the effects of growth factors. Conversely, ectopic FOXO3 activation blocked the proliferation of fibroblasts and induced the expression of FOXO1, FOXO4, and p27-KIP1. Using luciferase reporter assays and chromatin immunoprecipitations, we identified a conserved FOXO-binding site in the promoter of the FOXO1 gene, which was required for regulation by PDGF, and mediated the up-regulation of FOXO1 by itself and by FOXO3. Altogether, our results suggest that the expression of FOXO1 and FOXO4 genes is stimulated by FOXO3 and possibly by other FOXO factors in a positive feedback loop, which is disrupted by growth factors.	[Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Unite Med Expt MEXP UCL 74 30, BE-1200 Brussels, Belgium; [Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Immunol, Mol Immunol Lab, NL-3584 EA Utrecht, Netherlands	Universite Catholique Louvain; Utrecht University; Utrecht University Medical Center	Demoulin, JB (corresponding author), Catholic Univ Louvain, De Duve Inst, Unite Med Expt MEXP UCL 74 30, Ave Hippocrate 74-75, BE-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be	Demoulin, Jean-Baptiste/E-5847-2010; Coffer, Paul/AAF-7970-2020	Demoulin, Jean-Baptiste/0000-0002-8016-6689	Action de Recherches Concertees (Communaute Francaise de Belgique); Fonds de la Recherche Scientifique; WALEO (TransMaze project, Region Wallonne)	Action de Recherches Concertees (Communaute Francaise de Belgique); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); WALEO (TransMaze project, Region Wallonne)	This work was supported by grants from "Action de Recherches Concertees" (Communaute Francaise de Belgique), from Fonds de la Recherche Scientifique, and from WALEO (TransMaze project, Region Wallonne).	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Demoulin JB, 2006, GROWTH FACTORS, V24, P184, DOI 10.1080/08977190600696430; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kallin A, 2004, J BIOL CHEM, V279, P17897, DOI 10.1074/jbc.M312996200; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Lynch RL, 2005, MOL CANCER RES, V3, P163, DOI 10.1158/1541-7786.MCR-04-0163; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vantler M, 2005, J BIOL CHEM, V280, P14168, DOI 10.1074/jbc.M413310200; Vantler M, 2006, FEBS LETT, V580, P6769, DOI 10.1016/j.febslet.2006.11.034; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	42	165	171	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10334	10342		10.1074/jbc.M808848200	http://dx.doi.org/10.1074/jbc.M808848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244250	Green Published, hybrid			2022-12-27	WOS:000265104600007
J	Garcia, R; Rodriguez-Pena, JM; Bermejo, C; Nombela, C; Arroyo, J				Garcia, Raul; Rodriguez-Pena, Jose M.; Bermejo, Clara; Nombela, Cesar; Arroyo, Javier			The High Osmotic Response and Cell Wall Integrity Pathways Cooperate to Regulate Transcriptional Responses to Zymolyase-induced Cell Wall Stress in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GENOME-WIDE ANALYSIS; KINASE PATHWAY; SIGNALING PATHWAY; MAPK PATHWAYS; SHO1 BRANCH; YEAST HOG; ACTIVATION; EXPRESSION; SLT2	The adaptation of Saccharomyces cerevisiae to situations in which cell wall integrity is seriously compromised mainly involves the cell wall integrity (CWI) pathway. However, in a recent work (Bermejo, C., Rodriguez, E., Garcia, R., Rodriguez-Pena, J. M., Rodriguez de la Concepcion, M. L., Rivas, C., Arias, P., Nombela, C., Posas, F., and Arroyo, J. (2008) Mol. Biol. Cell 19, 1113-1124) we have demonstrated the co-participation of the high osmotic response (HOG) pathway to ensure yeast survival to cell wall stress mediated by zymolyase, which hydrolyzes the beta-1,3 glucan network. Here we have characterized the role of both pathways in the regulation of the overall yeast transcriptional responses to zymolyase treatment using whole genome expression profiling. A main group of yeast genes is dependent on both MAPKs, Slt2 and Hog1, for their induction. The transcriptional activation of these genes depends on the MAPKKK Bck1, the transcription factor Rlm1, and elements of the sho1 branch of the HOG pathway, but not on the sensors of the CWI pathway. A second group of genes is dependent on Slt2 but not Hog1 or Pbs2. However, the induction of these genes is dependent on upstream elements of the HOG pathway such as Sho1, Ste50, and Ste11, in accordance with a sequential activation of the HOG and CWI pathways. Zymolyase also promotes an osmotic-like transcriptional response with the activation of a group of genes dependent on elements of the Sho1 branch of HOG pathway but not on Slt2, with the induction of many of them dependent on Msn2/4. Additionally, in the absence of Hog1, zymolyase induces an alternative response related to mating and filamentation as a consequence of the cross-talk between these pathways and the HOG pathway. Finally, in the absence of Slt2, zymolyase increases the induction of genes associated with osmotic adaptation with respect to the wild type, suggesting an inhibitory effect of the CWI pathway over the HOG pathway. These studies clearly reveal the complexity of the signal transduction machinery responsible for regulating yeast adaptation responses to cell wall stress.	[Garcia, Raul; Rodriguez-Pena, Jose M.; Bermejo, Clara; Nombela, Cesar; Arroyo, Javier] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	Complutense University of Madrid	Arroyo, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Pza Ramon & Cajal S-N, E-28040 Madrid, Spain.	jarroyo@farm.ucm.es	Arroyo, Javier/E-9308-2016; Sanchez, Raúl García/E-9303-2016; Nombela Cano, César/H-2565-2015; Rodriguez-Peña, Jose M/E-9624-2016	Arroyo, Javier/0000-0002-1971-1721; Sanchez, Raúl García/0000-0002-7389-4696; Nombela Cano, César/0000-0003-0757-4034; Rodriguez-Peña, Jose M/0000-0002-8792-362X	Ministerio de Educacion y Ciencia (Spanish government) [BIO2007-67821]; EU STREP FUNGWALL [LSBH-CT-2004-511952]; Comunidad de Madrid [S-SAL-0246/2006]	Ministerio de Educacion y Ciencia (Spanish government)(Spanish Government); EU STREP FUNGWALL(European Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by projects BIO2007-67821 from the Ministerio de Educacion y Ciencia (Spanish government), EU STREP FUNGWALL LSBH-CT-2004-511952 and S-SAL-0246/2006 from the Comunidad de Madrid.	Amberg DC., 2005, METHODS YEAST GENETI; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Davenport KD, 1999, GENETICS, V153, P1091; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; Imazu H, 2005, EUKARYOT CELL, V4, P1050, DOI 10.1128/EC.4.6.1050-1056.2005; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mattison CP, 2000, GENE DEV, V14, P1229; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SENGUPTA P, 1990, MOL CELL BIOL, V10, P6809, DOI 10.1128/MCB.10.12.6809; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	45	120	120	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10901	10911		10.1074/jbc.M808693200	http://dx.doi.org/10.1074/jbc.M808693200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19234305	Green Published, hybrid			2022-12-27	WOS:000265104600063
J	Montani, L; Gerrits, B; Gehrig, P; Kempf, A; Dimou, L; Wollscheid, B; Schwab, ME				Montani, Laura; Gerrits, Bertran; Gehrig, Peter; Kempf, Anissa; Dimou, Leda; Wollscheid, Bernd; Schwab, Martin E.			Neuronal Nogo-A Modulates Growth Cone Motility via Rho-GTP/LIMK1/Cofilin in the Unlesioned Adult Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; AXON REGENERATION; LIM KINASE; SLINGSHOT PHOSPHATASE; FUNCTIONAL RECOVERY; PROTEOMIC ANALYSIS; NEURITE OUTGROWTH; RAT CEREBELLUM; DEFICIENT MICE; MESSENGER-RNA	Nogo-A has been extensively studied as a myelin-associated neurite outgrowth inhibitor in the lesioned adult central nervous system. However, its role in the intact central nervous system has not yet been clarified. Analysis of the intact adult nervous system of C57BL/6 Nogo-A knock-out (KO) versus wild-type (WT) mice by a combined two-dimensional gel electrophoresis and isotope-coded affinity tagging approach revealed regulation of cytoskeleton-, transport-, and signaling growth-related proteins, pointing to regulation of the actin cytoskeleton, the neuronal growth machinery, and in particular the Rho-GTPase/LIMK1/cofilin pathway. Nogo-A KO adult neurons showed enlarged, more motile growth cones compared with WT neurons. The phenotype was reproduced by acute in vitro neutralization of neuronal Nogo-A. LIMK1 phosphorylation was increased in Nogo-A KO growth cones, and its reduction caused the decrease of KO growth cone motility to WT levels. Our study suggests that in the unlesioned adult nervous system, neuronal Nogo-A can restrict neuronal growth through negative modulation of growth cone motility.	[Montani, Laura; Kempf, Anissa; Dimou, Leda; Schwab, Martin E.] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Gerrits, Bertran; Gehrig, Peter] Univ Zurich, Funct Genom Ctr, CH-8057 Zurich, Switzerland; [Montani, Laura; Kempf, Anissa; Dimou, Leda; Schwab, Martin E.] Swiss Fed Inst Technol, Dept Biol, CH-8057 Zurich, Switzerland; [Wollscheid, Bernd] Swiss Fed Inst Technol, Mol Syst Biol Inst, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Montani, L (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	montani@hifo.uzh.ch	Dimou, Leda/E-7968-2012; Wollscheid, Bernd/E-8909-2010; Montani, Laura/M-9583-2017; Schwab, Martin E/B-6818-2016	Wollscheid, Bernd/0000-0002-3923-1610; Montani, Laura/0000-0002-8243-6734	Swiss National Science Foundation [31-63633.00]; National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher and Dana Reeve Foundation [2005(1)]; Transregio-Sonderforschungsbereich Konstanz-Zurich [34150609]; NeuroNe Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases (Sixth Framework Programme)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher and Dana Reeve Foundation(Swiss National Science Foundation (SNSF)); Transregio-Sonderforschungsbereich Konstanz-Zurich; NeuroNe Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases (Sixth Framework Programme)(European Commission)	This work was supported by Swiss National Science Foundation Grant 31-63633.00, the National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher and Dana Reeve Foundation (Project MSC 2005(1)), the Transregio-Sonderforschungsbereich Konstanz-Zurich (Project 34150609), and the NeuroNe Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases (Sixth Framework Programme).	Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Buffo A, 2000, J NEUROSCI, V20, P2275; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; Figueroa JD, 2006, J NEUROSCI RES, V84, P1438, DOI 10.1002/jnr.21048; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Gianola S, 2003, J NEUROSCI, V23, P4613; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Huber AB, 2002, J NEUROSCI, V22, P3553; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jin WL, 2003, J COMP NEUROL, V458, P1, DOI 10.1002/cne.10547; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Liu YY, 2003, NEUROSCI LETT, V346, P153, DOI 10.1016/S0304-3940(03)00508-1; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Nyatia E, 2007, RES VET SCI, V83, P287, DOI 10.1016/j.rvsc.2007.01.011; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Trifunovski A, 2006, NEUROREPORT, V17, P913, DOI 10.1097/01.wnr.0000221831.95598.a3; Wang XX, 2002, J NEUROSCI, V22, P5505; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	44	87	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10793	10807		10.1074/jbc.M808297200	http://dx.doi.org/10.1074/jbc.M808297200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19208621	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000265104600054
J	Wang, CC; Houng, HC; Chen, CL; Wang, PJ; Kuo, CF; Lin, YS; Wu, JJ; Lin, MT; Liu, CC; Huang, W; Chuang, WJ				Wang, Chih-Chieh; Houng, Hsiang-Chee; Chen, Chun-Liang; Wang, Pei-Ju; Kuo, Chih-Feng; Lin, Yee-Shin; Wu, Jiunn-Jong; Lin, Ming T.; Liu, Ching-Chuan; Huang, Wenya; Chuang, Woei-Jer			Solution Structure and Backbone Dynamics of Streptopain INSIGHT INTO DIVERSE SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; PYROGENIC EXOTOXIN-B; MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; CYSTEINE PROTEASE; INVASIVE DISEASE; VIRULENCE FACTOR; CHEMICAL-SHIFT; PYOGENES; NMR	Streptococcal pyrogenic exotoxin B (SPE B) is a cysteine protease expressed by Streptococcus pyogenes. The D9N, G163S, G163S/A172S, and G239D mutant proteins were expressed to study the effect of the allelic variants on their protease activity. In contrast to other mutants, the G239D mutant was similar to 12-fold less active. The Gly-239 residue is located within the C-terminal S230-G239 region, which cannot be observed in the x-ray structure. The three-dimensional structure and backbone dynamics of the 28-kDa mature SPE B (mSPE B) were determined. Unlike the x-ray structure of the 40-kDa zymogen SPE B (proSPE B), we observed the interactions between the C-terminal loop and the active site residues in mSPE B. The structural differences between mSPE B and proSPE B were the conformation of the C-terminal loop and the orientation of the catalytic His-195 residue, suggesting that activation and inactivation of SPE B is involved in the His-195 side-chain rotation. Dynamics analysis of mSPEB and them SPEB/inhibitor complexes showed that the catalytic and C-terminal loops were the most flexible regions with low order parameter values of 0.5 to 0.8 and exhibited the motion on the ps/ns timescale. These findings suggest that the flexible C-terminal loop of SPE B may play an important role in controlling the substrate binding, resulting in its broad substrate specificity.	[Wang, Chih-Chieh; Houng, Hsiang-Chee; Chen, Chun-Liang; Wang, Pei-Ju; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Wu, Jiunn-Jong; Huang, Wenya] Natl Cheng Kung Univ, Coll Med, Dept Med Technol, Tainan 701, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 701, Taiwan; [Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung 840, Taiwan; [Lin, Ming T.] Tsu Chi Univ, Coll Med, Inst Med Sci, Hualien 970, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; I Shou University; Tzu Chi University	Chuang, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem, 1 Univ Rd, Tainan 701, Taiwan.	wjcnmr@mail.ncku.edu.tw	Wu, Jiunn-Jong/E-6075-2011; Huang, Wenya/G-9115-2011	Chen, Chun-Liang/0000-0003-4625-4340	National Health Research Institutes [NHRI-EX959429SP]; National Science Council of ROC [NSC-95-2323-B006-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-EX959429SP and National Science Council of ROC Grant NSC-95-2323-B006-MY3. NMR spectra were obtained at National Cheng Kung University or the High-Field Biomacromolecular NMR Core Facility supported by the National Research Program for Genomic Medicine.	Aiyar A, 1996, Methods Mol Biol, V57, P177; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; BRUNGER A, 1992, T X PLOR VERSION 3 1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Gubba S, 1998, INFECT IMMUN, V66, P765, DOI 10.1128/IAI.66.2.765-770.1998; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Luo SC, 2003, J BIOMOL NMR, V25, P165, DOI 10.1023/A:1022291604936; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; MCINTOSH LP, 1990, BIOCHEMISTRY-US, V29, P6341, DOI 10.1021/bi00479a003; Molinari G, 1999, CURR OPIN MICROBIOL, V2, P56, DOI 10.1016/S1369-5274(99)80010-1; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; MUSSER JM, 1997, SUPERANTIGENS MOL BI, P281; NILGES M, 1998, FEBS LETT, V229, P129; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Reid SD, 2001, J CLIN INVEST, V107, P393, DOI 10.1172/JCI11972; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Tamura F, 2004, INFECT IMMUN, V72, P4836, DOI 10.1128/IAI.72.8.4836-4847.2004; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Turk B, 1997, BIOL CHEM, V378, P141; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; Wang BN, 2006, P NATL ACAD SCI USA, V103, P2380, DOI 10.1073/pnas.0506668103; Wuthrich K, 1986, NMR PROTEINS NUCL AC	51	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10957	10967		10.1074/jbc.M807624200	http://dx.doi.org/10.1074/jbc.M807624200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19237546	hybrid, Green Published			2022-12-27	WOS:000265104600068
J	Jin, Y; Duan, L; Lee, SH; Kloosterboer, HJ; Blair, IA; Penning, TM				Jin, Yi; Duan, Ling; Lee, Seon Hwa; Kloosterboer, Helenius J.; Blair, Ian A.; Penning, Trevor M.			Human Cytosolic Hydroxysteroid Dehydrogenases of the Aldo-ketoreductase Superfamily Catalyze Reduction of Conjugated Steroids IMPLICATIONS FOR PHASE I AND PHASE II STEROID HORMONE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE ENZYMES; KETO REDUCTASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; TISSUE DISTRIBUTION; CRYSTAL-STRUCTURE; PHARMACOKINETIC PARAMETERS; POSTMENOPAUSAL WOMEN; RECEPTOR REGULATION; HUMAN PROSTATE; BINDING-SITE	Aldo-ketoreductase 1C (AKR1C) enzymes catalyze the NADPH-dependent reduction of ketosteroids to hydroxysteroids. They are Phase I metabolizing enzymes for natural and synthetic steroid hormones. They convert 5 alpha-dihydrotestosterone (Dht, potent androgen) to 3 alpha/beta-androstanediols ( inactive androgens) and the prodrug tibolone (Tib) to estrogenic 3 alpha/beta-hydroxytibolones. Herein we demonstrate for the first time that human AKR1C enzymes (AKR1C1-4) are able to reduce conjugated steroids such as Dht-17 beta-glucuronide (DhtG), Dht-17 beta-sulfate (DhtS), and Tib-17 beta-sulfate (TibS). Product identities were characterized by liquid chromatography-mass spectrometry, and kinetic parameters of the reactions were determined. The product profile of the reduction of each steroid conjugate by the individual AKR1C isoform was similar to that of the corresponding free steroid except for the reduction of DhtG catalyzed by AKR1C2, where a complete inversion in stereochemical preference to 3 beta-reduction (with DhtG) from 3 alpha-reduction (with Dht and DhtS) was observed. The catalytic efficiency of 3-keto reduction was modestly affected by the presence of a 17-sulfate group but severely impaired by the presence of a 17-glucuronide group for AKR1C1-3 isoforms. AKR1C4, however, showed superior catalytic efficiencies versus the other isoforms, and those were unaffected by steroid conjugation. Our findings provide evidence for alternative pathways of steroid metabolism where the phase I reaction (reduction) occurs after the phase II reaction (conjugation). Specifically, it is indicated that Dht is metabolized to its metabolite 3 alpha-andro-stanediol-17-glucuronide via the previously unrecognized "conjugation pathway" involving the sequential reactions of UGT2B17 and AKR1C4 in liver but via the conventional "reduction pathway" involving the sequential reactions of AKR1C2 and UGT2B15/17 in prostate.	[Jin, Yi; Duan, Ling; Lee, Seon Hwa; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Jin, Yi; Duan, Ling; Lee, Seon Hwa; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Kloosterboer, Helenius J.] NV Organon, Res & Dev Labs, NL-5340 BH Oss, Netherlands	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Merck & Company	Penning, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Ctr Excellence Environm Toxicol, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@mail.med.upenn.edu	Blair, Ian A/B-3320-2010	Penning, Trevor/0000-0002-3937-1066; Lee, Seon Hwa/0000-0003-1095-5516	National Institutes of Health [R01-DK47015, R01-CA90744, P30 ES015857]; NIH Grant [P30 ES015857]; NATIONAL CANCER INSTITUTE [R01CA090744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK47015, R01-CA90744, and P30 ES015857 ( to T. M. P.). This work was also supported by a pilot project fund from NIH Grant P30 ES015857 ( to Y.J.).	Bauman DR, 2006, ENDOCRINOLOGY, V147, P5806, DOI 10.1210/en.2006-0627; Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Belanger A, 2003, TRENDS ENDOCRIN MET, V14, P473, DOI 10.1016/j.tem.2003.10.005; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; Burczynski ME, 1999, BIOCHEMISTRY-US, V38, P10626, DOI 10.1021/bi995085z; Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8; Chouinard S, 2008, J STEROID BIOCHEM, V109, P247, DOI 10.1016/j.jsbmb.2008.03.016; Cooper WC, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703414200; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Dixit BL, 2000, J BIOL CHEM, V275, P21587, DOI 10.1074/jbc.M909235199; Falany JL, 2004, J STEROID BIOCHEM, V88, P383, DOI 10.1016/j.jsbmb.2004.01.005; Geese WJ, 2001, BIOCHEM BIOPH RES CO, V288, P280, DOI 10.1006/bbrc.2001.5746; Guillemette C, 1995, J STEROID BIOCHEM, V55, P355, DOI 10.1016/0960-0760(95)00183-2; Guillemette C, 1996, AM J PHYSIOL-ENDOC M, V271, pE348, DOI 10.1152/ajpendo.1996.271.2.E348; HOCHBERG RB, 1974, BIOCHEMISTRY-US, V13, P1938, DOI 10.1021/bi00706a025; JACOBSOHN GM, 1968, J BIOL CHEM, V243, P2985; Jin Y, 2006, STEROIDS, V71, P380, DOI 10.1016/j.steroids.2005.12.002; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; MULDER GJ, 1992, ANNU REV PHARMACOL, V32, P25; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t; RITTMASTER RS, 1993, ENDOCR REV, V14, P121, DOI 10.1210/er.14.1.121; RITTMASTER RS, 1988, J CLIN ENDOCR METAB, V66, P212, DOI 10.1210/jcem-66-1-212; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SHEN PD, 1994, BIOPHYS J, V67, P1414, DOI 10.1016/S0006-3495(94)80615-0; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; Steckelbroeck S, 2004, MOL PHARMACOL, V66, P1702, DOI 10.1124/mol.104.004515; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1112, DOI 10.1124/dmd.106.014159; Verheul HAM, 2007, CLIN PHARMACOL THER, V81, P573, DOI 10.1038/sj.clpt.6100094; Verheul HAM, 2007, REPROD SCI, V14, P160, DOI 10.1177/1933719106298684; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299	43	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10013	10022		10.1074/jbc.M809465200	http://dx.doi.org/10.1074/jbc.M809465200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19218247	hybrid, Green Published			2022-12-27	WOS:000264892900044
J	Ochiai, A; Itoh, T; Mikami, B; Hashimoto, W; Murata, K				Ochiai, Akihito; Itoh, Takafumi; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Structural Determinants Responsible for Substrate Recognition and Mode of Action in Family 11 Polysaccharide Lyases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL DEGRADATION; SP GL1 XANTHAN; PLANT-CELL; CRYSTAL-STRUCTURE; RHAMNOGALACTURONAN LYASE; PECTIC POLYSACCHARIDE; ERWINIA-CHRYSANTHEMI; ALGINATE LYASE; EXO-MODE; COMPLEX	A saprophytic Bacillus subtilis secretes two types of rhamnogalacturonan (RG) lyases, endotype YesW and exotype YesX, which are responsible for an initial cleavage of the RG type I (RG-I) region of plant cell wall pectin. Polysaccharide lyase family 11 YesW and YesX with a significant sequence identity (67.8%) cleave glycoside bonds between rhamnose and galacturonic acid residues in RG-I through a beta-elimination reaction. Here we show the structural determinants for substrate recognition and the mode of action in polysaccharide lyase family 11 lyases. The crystal structures of YesW in complex with rhamnose and ligand-free YesX were determined at 1.32 and 1.65 A resolution, respectively. The YesW amino acid residues such as Asn(152), Asp(172), Asn(532), Gly(533), Thr(534), and Tyr(595) in the active cleft bind to rhamnose molecules through hydrogen bonds and van der Waals contacts. Other rhamnose molecules are accommodated at the noncatalytic domain far from the active cleft, revealing that the domain possibly functions as a novel carbohydrate-binding module. A structural comparison between YesW and YesX indicates that a specific loop in YesX for recognizing the terminal saccharide molecule sterically inhibits penetration of the polymer over the active cleft. The loop-deficient YesX mutant exhibits YesW-like endotype activity, demonstrating that molecular conversion regarding the mode of action is achieved by the addition/removal of the loop for recognizing the terminal saccharide. This is the first report on a structural insight into RG-I recognition and molecular conversion of exotype to endotype in polysaccharide lyases.	[Ochiai, Akihito; Itoh, Takafumi; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (to K. M. and W. H.) and by Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Part of this work was supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (to A. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; COUTINHO PM, 1999, CARBOHYDRATE ACTIVE; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; MCNEIL M, 1980, PLANT PHYSIOL, V66, P1128, DOI 10.1104/pp.66.6.1128; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P438, DOI 10.1107/S1744309106011894; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4727-4733.2003; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yao YY, 2008, PROTEIN ENG DES SEL, V21, P561, DOI 10.1093/protein/gzn033; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; YODER MD, 1995, PLANT PHYSIOL, V107, P349, DOI 10.1104/pp.107.2.349; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011	44	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10181	10189		10.1074/jbc.M807799200	http://dx.doi.org/10.1074/jbc.M807799200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19193638	Green Published, hybrid			2022-12-27	WOS:000264892900060
J	Harris, KS; Casey, JL; Coley, AM; Karas, JA; Sabo, JK; Tan, YY; Dolezal, O; Norton, RS; Hughes, AB; Scanlon, D; Foley, M				Harris, Karen S.; Casey, Joanne L.; Coley, Andrew M.; Karas, John A.; Sabo, Jennifer K.; Tan, Yen Yee; Dolezal, Olan; Norton, Raymond S.; Hughes, Andrew B.; Scanlon, Denis; Foley, Michael			Rapid Optimization of a Peptide Inhibitor of Malaria Parasite Invasion by Comprehensive N-Methyl Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM APICAL-MEMBRANE-ANTIGEN-1; NUCLEAR-MAGNETIC-RESONANCE; VACCINE CANDIDATE; CRYSTAL-STRUCTURE; ERYTHROCYTE INVASION; NMR-SPECTROSCOPY; SELF-ASSOCIATION; AMINO-ACIDS; SOLID-PHASE	Apical membrane antigen 1 (AMA1) of the malaria parasite Plasmodium falciparum has been implicated in the invasion of host erythrocytes and is an important vaccine candidate. We have previously described a 20-residue peptide, R1, that binds to AMA1 and subsequently blocks parasite invasion. Because this peptide appears to target a site critical for AMA1 function, it represents an important lead compound for anti-malarial drug development. However, the effectiveness of this peptide inhibitor was limited to a subset of parasite isolates, indicating a requirement for broader strain specificity. Furthermore, a barrier to the utility of any peptide as a potential therapeutic is its susceptibility to rapid proteolytic degradation. In this study, we sought to improve the proteolytic stability and AMA1 binding properties of the R1 peptide by systematic methylation of backbone amides (N-methylation). The inclusion of a single N-methyl group in the R1 peptide backbone dramatically increased AMA1 affinity, bioactivity, and proteolytic stability without introducing global structural alterations. In addition, N-methylation of multiple R1 residues further improved these properties. Therefore, we have shown that modifications to a biologically active peptide can dramatically enhance activity. This approach could be applied to many lead peptides or peptide therapeutics to simultaneously optimize a number of parameters.	[Hughes, Andrew B.] La Trobe Univ, Dept Chem, Bundoora, Vic 3086, Australia; [Harris, Karen S.; Casey, Joanne L.; Coley, Andrew M.; Foley, Michael] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Casey, Joanne L.; Foley, Michael] AdAlta Pty Ltd, Bundoora, Vic 3083, Australia; [Karas, John A.; Scanlon, Denis] Univ Melbourne, BIO21 Mol Sci & Biotechnol Inst, Melbourne, Vic 3010, Australia; [Sabo, Jennifer K.; Tan, Yen Yee; Norton, Raymond S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Dolezal, Olan] CSIRO Mol & Hlth Technol, Parkville, Vic 3052, Australia	La Trobe University; La Trobe University; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hughes, AB (corresponding author), La Trobe Univ, Dept Chem, Bundoora, Vic 3086, Australia.	a.hughes@latrobe.edu.au; m.foley@latrobe.edu.au	Karas, John/AAE-9729-2019; Dolezal, Olan/E-1691-2015	Karas, John/0000-0002-3800-5152; Norton, Raymond/0000-0001-8893-0584; Foley, Michael/0000-0003-1349-4698	National Institutes of Health [NIH RO1AI59229]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant NIH RO1AI59229. This work was also supported by the National Health and Medical Research Council of Australia. The authors declare that they have no competing financial interests. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Aurelio L, 2003, J ORG CHEM, V68, P2652, DOI 10.1021/jo026722l; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bergseng E, 2005, J BIOL CHEM, V280, P21791, DOI 10.1074/jbc.M501558200; Bowman MJ, 2004, BIOORG MED CHEM LETT, V14, P1395, DOI 10.1016/j.bmcl.2003.09.099; Bruehlmeier M, 2002, NUCL MED BIOL, V29, P321, DOI 10.1016/S0969-8051(01)00304-3; CASEY JL, 2007, AFFINITY CHROMATOGR, P111; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; EBATA M, 1966, B CHEM SOC JPN, V39, P2535, DOI 10.1246/bcsj.39.2535; Egleton RD, 1997, PEPTIDES, V18, P1431, DOI 10.1016/S0196-9781(97)00242-8; FAIRLIE DP, 1995, CURR MED CHEM, V2, P654; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; GOODMAN M, 1974, J AM CHEM SOC, V96, P1479, DOI 10.1021/ja00812a034; HANCOCK WS, 1976, ANAL BIOCHEM, V71, P260, DOI 10.1016/0003-2697(76)90034-8; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Keizer DW, 2003, BIOCHEMISTRY-US, V42, P9915, DOI 10.1021/bi034376b; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Li F, 2002, J BIOL CHEM, V277, P50303, DOI 10.1074/jbc.M207985200; LUDVIGSEN S, 1992, J BIOMOL NMR, V2, P227, DOI 10.1007/BF01875318; Manfredi R, 2006, CURR MED CHEM, V13, P2369, DOI 10.2174/092986706777935069; Miller SC, 1997, J AM CHEM SOC, V119, P2301, DOI 10.1021/ja9635443; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; Papalia GA, 2006, ANAL BIOCHEM, V359, P112, DOI 10.1016/j.ab.2006.08.032; PETTIT GR, 1993, TETRAHEDRON, V49, P9151, DOI 10.1016/0040-4020(93)80003-C; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Rajeswaran WG, 2001, J MED CHEM, V44, P1305, DOI 10.1021/jm0005048; Ramanjulu JM, 1997, J ORG CHEM, V62, P4961, DOI 10.1021/jo9623696; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Sagan S, 2004, CURR MED CHEM, V11, P2799, DOI 10.2174/0929867043364108; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Trzepalka E, 2004, J PEPT RES, V63, P333, DOI 10.1111/j.1399-3011.2004.00103.x; TULIP WR, 1992, J MOL BIOL, V227, P122, DOI 10.1016/0022-2836(92)90687-F; VOJKOVSKY T, 1995, PEPTIDE RES, V8, P236; WENGER RM, 1984, HELV CHIM ACTA, V67, P502, DOI 10.1002/hlca.19840670220; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724	58	48	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9361	9371		10.1074/jbc.M808762200	http://dx.doi.org/10.1074/jbc.M808762200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19164290	Green Published, hybrid			2022-12-27	WOS:000264669100042
J	Juarez, O; Morgan, JE; Barquera, B				Juarez, Oscar; Morgan, Joel E.; Barquera, Blanca			The Electron Transfer Pathway of the Na+-pumping NADH: Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; COMPLEX-I; ALGINOLYTICUS; REDUCTASE; NQR; FAD; STOICHIOMETRY; PURIFICATION; RIBOFLAVIN	The Na+-pumping NADH: quinone oxidoreductase (Na+-NQR) is the only respiratory enzyme that operates as a Na+ pump. This redox-driven Na+ pump is amenable to experimental approaches not available for H+ pumps, providing an excellent system for mechanistic studies of ion translocation. An understanding of the internal electron transfer steps and their Na+ dependence is an essential prerequisite for such studies. To this end, we analyzed the reduction kinetics of the wild type Na+-NQR, as well as site-directed mutants of the enzyme, which lack specific cofactors. NADH and ubiquinol were used as reductants in separate experiments, and a full spectrum UV-visible stopped flow kinetic method was employed. The results make it possible to define the complete sequence of redox carriers in the electrons transfer pathway through the enzyme. Electrons flow from NADH to quinone through the FAD in subunit F, the 2Fe-2S center, the FMN in subunit C, the FMN in subunit B, and finally riboflavin. The reduction of the FMNC to its anionic flavosemiquinone state is the first Na+-dependent process, suggesting that reduction of this site is linked to Na+ uptake. During the reduction reaction, two FMNs are transformed to their anionic flavosemiquinone in a single kinetic step. Subsequently, FMNC is converted to the flavohydroquinone, accounting for the single anionic flavosemiquinone radical in the fully reduced enzyme. A model of the electron transfer steps in the catalytic cycle of Na+-NQR is presented to account for the kinetic and spectroscopic data.	[Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, 110 8th St, Troy, NY 12180 USA.	barqub@rpi.edu		Juarez, Oscar/0000-0002-2915-8413	NIGMS NIH HHS [GM 060036] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; BEATTIE P, 1994, FEBS LETT, V356, P333, DOI 10.1016/0014-5793(94)01275-X; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P449, DOI 10.1016/0005-2728(86)90113-1; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; HAYASHI M, 1986, FEBS LETT, V202, P327, DOI 10.1016/0014-5793(86)80711-6; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Steuber J, 1997, EUR J BIOCHEM, V249, P770, DOI 10.1111/j.1432-1033.1997.t01-2-00770.x; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao M, 2008, J INORG BIOCHEM, V102, P1366, DOI 10.1016/j.jinorgbio.2008.01.009; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697	24	49	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8963	8972		10.1074/jbc.M809395200	http://dx.doi.org/10.1074/jbc.M809395200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19155212	hybrid, Green Published			2022-12-27	WOS:000264397800079
J	Zhou, QW; Kojic, M; Holloman, WK				Zhou, Qingwen; Kojic, Milorad; Holloman, William K.			DNA-binding Domain within the Brh2 N Terminus Is the Primary Interaction Site for Association with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRCA2; RECOMBINATIONAL REPAIR; GENOME STABILITY; PROTEIN; RAD51; MECHANISM; FILAMENTS; STABILIZATION; INTERPLAY; INSIGHTS	The C-terminal region of Brh2 (Brh2(CT)), the BRCA2 homolog in Ustilago maydis, is highly conserved and aligns with the DSS1/DNA-binding domain (DBD) of mammalian BRCA2, while the N-terminal region (Brh2(NT)) is poorly conserved and has no obvious functional domain except for the single Rad51-interacting BRC element. Paradoxically, Brh2(NT), but not Brh2(CT), complements the DNA repair and recombination deficiency of the brh2 mutant. We show here that Brh2(NT) exhibits an unexpected DNA binding activity with properties similar to that of the full-length protein. Deletion mapping localized the region responsible for the DNA binding activity to a stretch of residues between the BRC element and the canonical DBD. A heterologous DNA-binding domain from the large subunit of replication protein A substituted for the endogenous binding region within Brh2(NT) in supporting DNA repair. Rad51-promoted strand invasion was stimulated by Brh2(NT), but required the presence of the BRC element. The findings suggest a model in which Brh2(NT) serves as the principal site for association with DNA, while the Brh2(CT) provides a means for regulation.	[Zhou, Qingwen; Kojic, Milorad; Holloman, William K.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Holloman, WK (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10021 USA.	wkhollo@med.cornell.edu		Kojic, Milorad/0000-0002-0507-4231	National Institutes of Health [GM42482, GM79859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079859, R01GM042482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM42482 and GM79859.	Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friedman LS, 1998, CANCER RES, V58, P1338; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Kojic M, 2005, MOL CELL BIOL, V25, P2547, DOI 10.1128/MCB.25.7.2547-2557.2005; Kojic M, 2003, MOL CELL, V12, P1043, DOI 10.1016/S1097-2765(03)00367-8; Kojic M, 2006, MOL CELL BIOL, V26, P678, DOI 10.1128/MCB.26.2.678-688.2006; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Lo T, 2003, DNA REPAIR, V2, P1015, DOI 10.1016/S1568-7864(03)00097-1; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhou QW, 2007, MOL CELL BIOL, V27, P2512, DOI 10.1128/MCB.01907-06	40	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8265	8273		10.1074/jbc.M809226200	http://dx.doi.org/10.1074/jbc.M809226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19182269	hybrid, Green Published			2022-12-27	WOS:000264397800010
J	Guan, RB; Feng, XY; Wu, XQ; Zhang, ML; Zhang, XS; Hebert, TE; Segaloff, DL				Guan, Rongbin; Feng, Xiuyan; Wu, Xueqing; Zhang, Meilin; Zhang, Xuesen; Hebert, Terence E.; Segaloff, Deborah L.			Bioluminescence Resonance Energy Transfer Studies Reveal Constitutive Dimerization of the Human Lutropin Receptor and a Lack of Correlation between Receptor Activation and the Propensity for Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; LUTEINIZING-HORMONE-RECEPTOR; MUTATION-INDUCED ACTIVATION; CELL-SURFACE; LUTROPIN/CHORIOGONADOTROPIN RECEPTOR; GONADOTROPIN RECEPTOR; ENDOPLASMIC-RETICULUM; SELF-ASSOCIATION; CB1 RECEPTOR; LH RECEPTOR	Previous studies from our laboratory using co-immunoprecipitation techniques suggested that the human lutropin receptor (hLHR) constitutively self-associates into dimers/oligomers and that agonist treatment of cells either increased hLHR dimerization/oligomerization and/or stabilized hLHR dimers/ oligomers to detergent solubilization (Tao, Y.X., Johnson, N.B., and Segaloff, D.L. (2004) J.Biol. Chem. 279, 5904-5914). In this study, bioluminescence resonance energy transfer (BRET2) analyses confirmed that the hLHR constitutively self-associates in living cells. After subcellular fractionation, hLHR dimers/ oligomers were detected in both the plasma membrane and endoplasmic reticulum (ER). Further evidence supporting the constitutive formation of hLHR dimer/oligomers in the ER is provided by data showing homodimerization of misfolded hLHR mutants that are retained in the ER. These mutants, when co-expressed with wild-type receptor, are shown by BRET2 to heterodimerize, accounting for their dominant-negative effects on cell surface receptor expression. Hormone desorption assays using intact cells demonstrate allosterism between hLHR protomers, indicating functional cell surface hLHR dimers. However, quantitative BRET2 analyses in intact cells indicate a lack of effect of agonist on the propensity of the hLHR to dimerize. Using purified plasma membranes, human chorionic gonadotropin was similarly observed to have no effect on the BRET2 signal. An examination of the propensity for constitutively active and signaling inactive hLHR mutants to dimerize further showed no correlation between dimerization and the activation state of the hLHR. Taken altogether, our data suggest that hLHR dimers/ oligomers are formed early in the biosynthetic pathway in the ER, are constitutively expressed on the plasma membrane, and are not affected by the activation state of the hLHR.	[Guan, Rongbin; Feng, Xiuyan; Wu, Xueqing; Zhang, Meilin; Zhang, Xuesen; Segaloff, Deborah L.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	University of Iowa; McGill University	Segaloff, DL (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, 5-470 Bowen Sci Bldg, Iowa City, IA 52242 USA.	deborah-segaloff@uiowa.edu			National Institutes of Health [DK068614, HD22196]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD022196] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068614 and HD22196 (to D.L.S.). This work was also supported by grants from the Canadian Institutes of Health Research (to T.E.H.).	AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Angelova K, 2002, J BIOL CHEM, V277, P32202, DOI 10.1074/jbc.M203272200; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Ascoli M, 2007, MOL CELL ENDOCRINOL, V260, P244, DOI 10.1016/j.mce.2005.09.016; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CRINE P, 1984, ANN NY ACAD SCI, V438, P224, DOI 10.1111/j.1749-6632.1984.tb38289.x; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Fabritz J, 1998, BIOCHEMISTRY-US, V37, P664, DOI 10.1021/bi972355+; Fanelli F, 2000, J MOL BIOL, V296, P1333, DOI 10.1006/jmbi.2000.3516; Fanelli F, 2004, MOL ENDOCRINOL, V18, P1499, DOI 10.1210/me.2003-0050; Fanelli F, 2001, IUBMB LIFE, V51, P149, DOI 10.1080/152165401753544214; Feng XY, 2008, ENDOCRINOLOGY, V149, P1705, DOI 10.1210/en.2007-1341; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hirakawa T, 2003, ENDOCRINOLOGY, V144, P3872, DOI 10.1210/en.2003-0365; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Horvat RD, 2001, MOL ENDOCRINOL, V15, P695, DOI 10.1210/me.15.5.695; Hunzicker-Dunn M, 2003, J BIOL CHEM, V278, P42744, DOI 10.1074/jbc.M306133200; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jaquette J, 2002, MOL CELL ENDOCRINOL, V194, P211, DOI 10.1016/S0303-7207(02)00220-4; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kishi M, 2001, MOL ENDOCRINOL, V15, P1624, DOI 10.1210/me.15.9.1624; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Kroeger KM, 2001, J BIOL CHEM, V276, P12736, DOI 10.1074/jbc.M011311200; KUSUDA S, 1988, J BIOL CHEM, V263, P3046; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Latronico AC, 1999, AM J HUM GENET, V65, P949, DOI 10.1086/302602; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Lee CW, 2002, J BIOL CHEM, V277, P15795, DOI 10.1074/jbc.M111818200; Lei Y, 2007, MOL CELL ENDOCRINOL, V260, P65, DOI 10.1016/j.mce.2005.11.046; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pidasheva S, 2006, HUM MOL GENET, V15, P2200, DOI 10.1093/hmg/ddl145; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Thomas RM, 2007, ENDOCRINOLOGY, V148, P1987, DOI 10.1210/en.2006-1672; Toledo SPA, 1996, J CLIN ENDOCR METAB, V81, P3850, DOI 10.1210/jc.81.11.3850; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; WONG HMS, 1986, BIOCHEMISTRY-US, V25, P6995, DOI 10.1021/bi00370a037; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; Zhang ML, 2007, J BIOL CHEM, V282, P25527, DOI 10.1074/jbc.M703500200; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	79	46	46	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7483	7494		10.1074/jbc.M809150200	http://dx.doi.org/10.1074/jbc.M809150200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147490	Green Published, hybrid			2022-12-27	WOS:000264195600012
J	Miyagi, H; Kawai, S; Murata, K				Miyagi, Hikaru; Kawai, Shigeyuki; Murata, Kousaku			Two Sources of Mitochondrial NADPH in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOCITRATE DEHYDROGENASE; MOLECULAR-CLONING; STRUCTURAL GENE; KINASE; IDENTIFICATION; SEQUENCE; ACID; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; DISRUPTION; EXPRESSION	Cells of the yeast Saccharomyces cerevisiae contain three NAD kinases; namely, cytosolic Utr1p, cytosolic Yef1p, and mitochondrial Pos5p. Previously, the NADH kinase reaction catalyzed by Pos5p, rather than the NAD kinase reaction followed by the NADP(+)-dependent dehydrogenase reaction, had been regarded as a critical source of mitochondrial NADPH, which plays vital roles in various mitochondrial functions. This study demonstrates that the mitochondrial NADH kinase reaction is dispensable as a source of mitochondrial NADPH and emphasizes the importance of the NAD kinase reaction, followed by the mitochondrial NADP(+)-dependent dehydrogenase reaction. Of the potential dehydrogenases (malic enzyme, Mae1p; isocitrate dehydrogenase, Idp1p; and acetaldehyde dehydrogenases, Ald4/5p), evidence is presented that acetaldehyde dehydrogenases, and in particular Ald4p, play a prominent role in generating mitochondrial NADPH in the absence of the NADH kinase reaction. The physiological significance of the mitochondrial NADH kinase reaction in the absence of Ald4p is also demonstrated. In addition, Pos5p is confirmed to have a considerably higher NADH kinase activity than NAD kinase activity. Taking these results together, it is proposed that there are two sources of mitochondrial NADPH in yeast: one is the mitochondrial Pos5p NADH kinase reaction and the other is the mitochondrial Pos5p NAD kinase reaction followed by the mitochondrial NADP(+)-dependent acetaldehyde dehydrogenase reaction.	[Miyagi, Hikaru; Kawai, Shigeyuki; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Dept Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan	Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Dept Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Boles E, 1998, J BACTERIOL, V180, P2875, DOI 10.1128/JB.180.11.2875-2882.1998; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAUM G, 1982, J BIOL CHEM, V257, P3028; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EVANS TC, 1985, ARCH BIOCHEM BIOPHYS, V243, P492, DOI 10.1016/0003-9861(85)90526-0; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P3; HASELBECK RJ, 1991, J BIOL CHEM, V266, P2339; IWAHASHI Y, 1989, J BIOCHEM-TOKYO, V105, P588, DOI 10.1093/oxfordjournals.jbchem.a122709; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Kawai S, 2001, FEMS MICROBIOL LETT, V200, P181, DOI 10.1111/j.1574-6968.2001.tb10712.x; Minard KI, 1998, J BIOL CHEM, V273, P31486, DOI 10.1074/jbc.273.47.31486; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; NOLTMANN E, 1961, J BIOL CHEM, V236, P1225; Ochiai A, 2004, PROTEIN EXPRES PURIF, V36, P124, DOI 10.1016/j.pep.2004.03.012; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; SIKORSKI RS, 1989, GENETICS, V122, P19; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B	37	39	47	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7553	7560		10.1074/jbc.M804100200	http://dx.doi.org/10.1074/jbc.M804100200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19158096	Green Published, hybrid			2022-12-27	WOS:000264195600018
J	Sato, I; Shimizu, M; Hoshino, T; Takaya, N				Sato, Ikuo; Shimizu, Motoyuki; Hoshino, Takayuki; Takaya, Naoki			The Glutathione System of Aspergillus nidulans Involves a Fungus-specific Glutathione S-Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; GENE; EXPRESSION; MECHANISM; REDUCTASE; PROTEINS; IDENTIFICATION; GROWTH; MITOCHONDRIAL; EVOLUTION	The tripeptide glutathione is involved in cellular defense mechanisms for xenobiotics and reactive oxygen species. This study investigated glutathione-dependent mechanisms in the model organism Aspergillus nidulans. A recombinant dimeric protein of A. nidulans glutathione reductase (GR) contained FAD and reduced oxidized glutathione (GSSG) using NADPH as an electron donor. A deletion strain of the GR gene (glrA) accumulated less intracellular reduced glutathione (GSH), indicating that the fungal GR contributes to GSSG reduction in vivo. Growth of the deletion strain of glrA was temperature-sensitive, and this phenotype was suppressed by adding GSH to the medium. The strain subsequently accumulated more intracellular superoxide, and cell-free respiration activity was partly defective. Growth of the strain decreased in the presence of oxidants, which induced glrA expression 1.5-6-fold. These results indicated that the fungal glutathione system functions as an antioxidant mechanism in A. nidulans. Our findings further revealed an initial proteomic differential display on GR-depleted and wild type strains. Up-regulation of thioredoxin reductase, peroxiredoxins, catalases, and cytochrome c peroxidase in the glrA-deletion strain revealed interplay between the glutathione system and both the thioredoxin system and hydrogen peroxide defense mechanisms. We also identified a hypothetical, up-regulated protein in the GR-depleted strains as glutathione S-transferase, which is unique among Ascomycetes fungi.	[Sato, Ikuo; Shimizu, Motoyuki; Hoshino, Takayuki; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ntakaya@sakura.cc.tsukuba.ac.jp	SATO, Ikuo/F-8365-2012		Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Bio-oriented Technology Research Advancement Institution and a grant-in-aid for Scientific Research from the Ministry of Education, Science, Culture, and Sports, Japan.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; BARRATT RW, 1965, GENETICS, V52, P233; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; BEERS RF, 1952, J BIOL CHEM, V195, P133; Burns C, 2005, FUNGAL GENET BIOL, V42, P319, DOI 10.1016/j.fgb.2005.01.001; Cann JH, 2000, QUATERNARY RES, V54, P439, DOI 10.1006/qres.2000.2184; Carberry S, 2006, BIOCHEM BIOPH RES CO, V341, P1096, DOI 10.1016/j.bbrc.2006.01.078; Cha CJ, 2002, BIOCHEM J, V368, P589, DOI 10.1042/BJ20020400; Cho YW, 2002, BBA-GENE STRUCT EXPR, V1574, P399, DOI 10.1016/S0167-4781(01)00363-3; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; GOODHEW CF, 1990, BIOCHEM J, V271, P707, DOI 10.1042/bj2710707; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HANKINSON O, 1974, J BIOL CHEM, V249, P2344; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang HH, 2008, BIOCHEMISTRY-US, V47, P1721, DOI 10.1021/bi702040u; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kim HG, 2001, BBA-GENE STRUCT EXPR, V1520, P179, DOI 10.1016/S0167-4781(01)00265-2; Klein M, 2002, FEBS LETT, V520, P63, DOI 10.1016/S0014-5793(02)02767-9; Lee J, 1997, J BIOL CHEM, V272, P23042, DOI 10.1074/jbc.272.37.23042; MASSEY V, 1965, J BIOL CHEM, V240, P4470; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Navarro RE, 1996, CURR GENET, V29, P352, DOI 10.1007/s002940050056; Oberegger H, 2000, FEBS LETT, V485, P113, DOI 10.1016/S0014-5793(00)02206-7; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; SAHLMAN L, 1989, J BIOL CHEM, V264, P8033; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Scherer M, 2002, EUKARYOT CELL, V1, P725, DOI 10.1128/EC.1.5.725-735.2002; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; SIEGEL LM, 1974, J BIOL CHEM, V249, P1572; Song JY, 2006, EUKARYOT CELL, V5, P1857, DOI 10.1128/EC.00244-06; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Tamaki H, 1999, J BACTERIOL, V181, P2958, DOI 10.1128/JB.181.9.2958-2962.1999; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; TUGGLE CK, 1985, J BACTERIOL, V162, P448, DOI 10.1128/JB.162.1.448-450.1985	49	46	102	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					8042	8053		10.1074/jbc.M807771200	http://dx.doi.org/10.1074/jbc.M807771200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19171936	hybrid, Green Published			2022-12-27	WOS:000264195600067
J	Handy, DE; Lubos, E; Yang, Y; Galbraith, JD; Kelly, N; Zhang, YY; Leopold, JA; Loscalzo, J				Handy, Diane E.; Lubos, Edith; Yang, Yi; Galbraith, John D.; Kelly, Neil; Zhang, Ying-Yi; Leopold, Jane A.; Loscalzo, Joseph			Glutathione Peroxidase-1 Regulates Mitochondrial Function to Modulate Redox-dependent Cellular Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; NF-KAPPA-B; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; KNOCKOUT MOUSE; ENDOTHELIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE; KINASE ACTIVITY; OVEREXPRESSION	Glutathione peroxidase-1 (GPx-1) is a selenocysteine-containing enzyme that plays a major role in the reductive detoxification of peroxides in cells. In permanently transfected cells with approximate 2-fold overexpression of GPx-1, we found that intracellular accumulation of oxidants in response to exogenous hydrogen peroxide was diminished, as was epidermal growth factor receptor (EGFR)-mediated Akt activation in response to hydrogen peroxide or EGF stimulation. Knockdown of GPx-1 augmented EGFR-mediated Akt activation, whereas overexpression of catalase decreased Akt activation, suggesting that EGFR signaling is regulated by redox mechanisms. To determine whether mitochondrial oxidants played a role in these processes, cells were pretreated with a mitochondrial uncoupler prior to EGF stimulation. Inhibition of mitochondrial function attenuated EGF-mediated activation of Akt in control cells but had no additional effect in GPx-1-overexpressing cells, suggesting that GPx-1 overexpression decreased EGFR signaling by decreasing mitochondrial oxidants. Consistent with this finding, GPx-1 overexpression decreased global protein disulfide bond formation, which is dependent on mitochondrially produced oxidants. GPx-1 overexpression, in permanently transfected or adenovirus-treated cells, also caused overall mitochondrial dysfunction with a decrease in mitochondrial potential and a decrease in ATP production. GPx-1 overexpression also decreased EGF- and serum-mediated [H-3] thymidine incorporation, indicating that alterations in GPx-1 can attenuate cell proliferation. Taken together, these data suggest that GPx-1 can modulate redox-dependent cellular responses by regulating mitochondrial function.	[Handy, Diane E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Handy, DE (corresponding author), Brigham & Womens Hosp, Dept Med, HMS NRB 0630,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021; Yang, Yi/C-1297-2013	Handy, Diane/0000-0002-4310-8527; Yang, Yi/0000-0001-7896-1184	National Institutes of Health [HL 58976, HL 61795, NO1 HV 28178, HL 81587]; Deutsche Forschungsgemeinschaft [LU 1452/1-1]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058976, R01HL061795, P01HL081587, R37HL061795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 58976, HL 61795, NO1 HV 28178, and HL 81587. This work was also supported by Deutsche Forschungsgemeinschaft Grant LU 1452/1-1.	Arita Y, 2006, AM J PHYSIOL-LUNG C, V290, pL978, DOI 10.1152/ajplung.00296.2005; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Banning A, 2008, ANTIOXID REDOX SIGN, V10, P1491, DOI 10.1089/ars.2008.2047; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Chen Y, 2004, NITRIC OXIDE-BIOL CH, V11, P121; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; Choi Y, 2002, ONCOGENE, V21, P5289, DOI 10.1038/sj.onc.1205650; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Crack PJ, 2006, STROKE, V37, P1533, DOI 10.1161/01.STR.0000221708.17159.64; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; de Haan JB, 2004, FREE RADICAL BIO MED, V36, P53, DOI 10.1016/j.freeradbiomed.2003.10.020; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; DeYulia GJ, 2005, P NATL ACAD SCI USA, V102, P5044, DOI 10.1073/pnas.0501154102; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Finch JS, 2006, FREE RADICAL BIO MED, V40, P863, DOI 10.1016/j.freeradbiomed.2005.10.036; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Heirman I, 2006, FREE RADICAL BIO MED, V40, P285, DOI 10.1016/j.freeradbiomed.2005.08.033; Hoehn B, 2003, STROKE, V34, P2489, DOI 10.1161/01.STR.0000091268.25816.19; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Liu JR, 2006, HUM GENE THER, V17, P105, DOI 10.1089/hum.2006.17.105; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Madamanchi NR, 2001, ARTERIOSCL THROM VAS, V21, P321, DOI 10.1161/01.ATV.21.3.321; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Nakagawa Y, 2004, BIOL PHARM BULL, V27, P956, DOI 10.1248/bpb.27.956; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sakamoto H, 2002, J BIOL CHEM, V277, P50431, DOI 10.1074/jbc.M204190200; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shi MJ, 2004, AM J HYPERTENS, V17, P450, DOI 10.1016/j.amjhyper.2003.12.019; Shiomi T, 2004, CIRCULATION, V109, P544, DOI 10.1161/01.CIR.0000109701.77059.E9; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Wenk J, 2004, J BIOL CHEM, V279, P45634, DOI 10.1074/jbc.M408893200; Yang Y, 2007, P NATL ACAD SCI USA, V104, P10813, DOI 10.1073/pnas.0702027104; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang YF, 2005, CIRC RES, V96, P831, DOI 10.1161/01.RES.0000164401.21929.CF; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267	64	135	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11913	11921		10.1074/jbc.M900392200	http://dx.doi.org/10.1074/jbc.M900392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254950	Green Published, hybrid			2022-12-27	WOS:000265494600023
J	Uetani, T; Nakayama, H; Okayama, H; Okura, T; Higaki, J; Inoue, H; Higashiyama, S				Uetani, Teruyoshi; Nakayama, Hironao; Okayama, Hideki; Okura, Takafumi; Higaki, Jitsuo; Inoue, Hirofumi; Higashiyama, Shigeki			Insufficiency of Pro-heparin-binding Epidermal Growth Factor-like Growth Factor Shedding Enhances Hypoxic Cell Death in H9c2 Cardiomyoblasts via the Activation of Caspase-3 and c-Jun N-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; MITOCHONDRIAL COMPLEX-III; HB-EGF; MYOCARDIAL-INFARCTION; RECEPTOR LIGANDS; EPITHELIAL-CELLS; EXPRESSION; APOPTOSIS; BAG-1; MEMBRANE	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a cardiogenic and cardiohypertrophic growth factor. ProHB-EGF, a product of the Hb-egf gene and the precursor of HB-EGF, is anchored to the plasma membrane. Its ectodomain region is shed by a disintegrin and metalloproteases (ADAMs) when activated by various stimulations. It has been reported that an uncleavable mutant of Hb-egf, uc-Hb-egf, produces uc-proHB-EGF, which is not cleaved by ADAMs and causes dilation of the heart in knock-in mice. This suggests that the shedding of proHB-EGF is essential for the development and survival of cardiomyocytes: however, the molecular mechanism involved has remained unclear. In this study, we investigated the relationship between uc-proHB-EGF expression and cardiomyocyte survival. Human uc-proHB-EGF was adenovirally introduced into the rat cardiomyoblast cell line H9c2, and the cells were cultured under normoxic and hypoxic conditions. Uc-proHB-EGF-expressing H9c2 cells underwent apoptosis under normoxic conditions, which distinctly increased under hypoxic conditions. Furthermore, we observed an increased Caspase-3 activity, reactive oxygen species accumulation, and an increased c-Jun N-terminal kinase (JNK) activity in the ucproHB-EGF-expressing H9c2 cells. Treatment of the uc-proHB-EGF transfectants with inhibitors of Caspase-3, reactive oxygen species, and JNK, namely, Z-VAD-fmk, N-acetylcysteine, and SP600125, respectively, significantly reduced hypoxic cell death. These data indicate that insufficiency of proHB-EGF shedding under hypoxic stress leads to cardiomyocyte apoptosis via Caspase-3- and JNK-dependent pathways.	[Uetani, Teruyoshi; Nakayama, Hironao; Inoue, Hirofumi; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan; [Uetani, Teruyoshi; Okayama, Hideki; Okura, Takafumi; Higaki, Jitsuo] Ehime Univ, Grad Sch Med, Dept Integrated Med & Informat, Toon, Ehime 7910295, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Prot Network Lab, CEREM, Toon, Ehime 7910295, Japan	Ehime University; Ehime University; Ehime University	Inoue, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan.	hinoue66@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [17390081]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-Aid 17390081 for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Takeda Science Foundation (to S. H.).	Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Feng JX, 2006, PEPTIDES, V27, P1589, DOI 10.1016/j.peptides.2005.11.013; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Horikawa M, 1999, FEBS LETT, V459, P100, DOI 10.1016/S0014-5793(99)01213-2; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2002, J NEUROSCI, V22, P5365; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; Krieg T, 2004, J MOL CELL CARDIOL, V36, P435, DOI 10.1016/j.yjmcc.2003.12.013; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Nanba D, 2008, J CELL PHYSIOL, V214, P465, DOI 10.1002/jcp.21233; PERRELLA MA, 1994, J BIOL CHEM, V269, P27045; Pillai SB, 1998, J PEDIATR SURG, V33, P973, DOI 10.1016/S0022-3468(98)90517-6; Pillai SB, 1999, J SURG RES, V87, P225, DOI 10.1006/jsre.1999.5764; Sakai M, 2001, EXP NEPHROL, V9, P28; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Schulz JB, 1997, J NEUROCHEM, V69, P2075; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tanaka N, 2002, BIOCHEM BIOPH RES CO, V297, P375, DOI 10.1016/S0006-291X(02)02197-6; Tanaka N, 1999, BRAIN RES, V827, P130, DOI 10.1016/S0006-8993(99)01319-0; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yucel D, 2002, SCAND J CLIN LAB INV, V62, P463, DOI 10.1080/00365510260390019	42	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12399	12409		10.1074/jbc.M900463200	http://dx.doi.org/10.1074/jbc.M900463200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19193634	hybrid, Green Published			2022-12-27	WOS:000265494600070
J	Cho, SH; Beckwith, J				Cho, Seung-Hyun; Beckwith, Jon			Two Snapshots of Electron Transport across the Membrane INSIGHTS INTO THE STRUCTURE AND FUNCTION OF DsbD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; REDOX-ACTIVE CYSTEINES; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN DSBD; ISOMERASE; PERIPLASM; EXCHANGE; SYSTEM; MECHANISM	In Escherichia coli, the periplasmic protein disulfide isomerase, DsbC, is maintained reduced by transfer of electrons from cytoplasmic thioredoxin-1 (Trx1) via the cytoplasmic membrane protein, DsbD. The transmembrane domain of DsbD (DsbD beta), which comprises eight transmembrane segments (TMs), contains two redox-active cysteines (Cys-163 and Cys-285), each of which is water-exposed to both sides of the membrane. Cys-163 in TM1 and Cys-285 in TM4 can interact with cytoplasmic Trx1 and a periplasmic Trx-like domain of DsbD, respectively. When Cys-163 and Cys-285 are disulfide-bonded, the C-terminal halves of TM1 and TM4 are water-exposed, whereas the N-terminal halves of these TMs are not. To assess possible conformational changes of DsbD beta when its two cysteines are reduced, we have determined the accessibility of portions of TM1 and TM4. We substituted cysteines for amino acids in these TM segments and determined alkylation accessibility. We find that the alkylation accessibility of single Cys replacements in TM1 and TM4 is the same in oxidized and reduced DsbD beta, indicating a relatively static conformation of DsbD beta between the two redox states. We also find that the accessibility of amino acids of TM2 and TM3 when Cys-163 and Cys-285 are oxidized or reduced shows no change. Together, these results support a relatively static structure of DsbD beta in the switch between the oxidized and the reduced state but raise the possibility of conformational changes when interacting with Trx proteins. In addition, we also find water-exposed residues in the cytoplasmic proximal portion of TM3, allowing a more detailed characterization of the cavity in DsbD beta.	[Cho, Seung-Hyun; Beckwith, Jon] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jbeckwith@hms.harvard.edu		cho, seung-hyun/0000-0002-5548-4239	National Institutes of Health [GMO55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMO55090 (to J. B.).	Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Cho SH, 2007, EMBO J, V26, P3509, DOI 10.1038/sj.emboj.7601799; Cho SH, 2006, J BACTERIOL, V188, P5066, DOI 10.1128/JB.00368-06; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hiniker A, 2006, J BACTERIOL, V188, P7317, DOI 10.1128/JB.00383-06; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Katzen F, 2003, P NATL ACAD SCI USA, V100, P10471, DOI 10.1073/pnas.1334136100; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Kimball RA, 2003, J MOL MICROB BIOTECH, V5, P133, DOI 10.1159/000070263; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Rozhkova A, 2008, J MOL BIOL, V380, P783, DOI 10.1016/j.jmb.2008.05.050; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Walker KW, 1997, J BIOL CHEM, V272, P8845; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	33	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11416	11424		10.1074/jbc.M900651200	http://dx.doi.org/10.1074/jbc.M900651200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258316	hybrid, Green Published			2022-12-27	WOS:000265494500046
J	Zoeller, JJ; Pimtong, W; Corby, H; Goldoni, S; Iozzo, AE; Owens, RT; Ho, SY; Iozzo, RV				Zoeller, Jason J.; Pimtong, Wittaya; Corby, Helen; Goldoni, Silvia; Iozzo, Alex E.; Owens, Rick T.; Ho, Shiu-Ying; Iozzo, Renato V.			A Central Role for Decorin during Vertebrate Convergent Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LEUCINE-RICH PROTEOGLYCANS; IN-VIVO; ZEBRAFISH GASTRULATION; TARGETED DISRUPTION; MUSCULAR-DYSTROPHY; DOWN-REGULATION; CELL POLARITY; BREAST-CANCER; FACTOR-BETA	Decorin, an archetypal member of the small leucine-rich proteoglycan gene family, regulates collagen fibrillogenesis and cell growth. To further explore its biological function, we examined the role of Decorin during zebrafish development. Zebrafish Decorin is a chondroitin sulfate proteoglycan that exhibits a high degree of conservation with its mammalian counterpart and displays a unique spatiotemporal expression pattern. Morpholino-mediated knockdown of zebrafish decorin identified a developmental role during medial-lateral convergence and anterior-posterior extension of the body plan, as well as in craniofacial cartilage formation. decorin morphants displayed a pronounced shortening of the head-to-tail axis as well as compression, flattening, and extension of the jaw cartilages. The morphant phenotype was efficiently rescued by zebrafish decorin mRNA. Unexpectedly, microinjection of excess zebrafish decorin mRNA or proteoglycan/protein core into one-cell stage embryos caused cyclopia. The morphant and overexpression phenotype represent a convergent extension defect. Our results indicate a central function for Decorin during early embryogenesis.	[Zoeller, Jason J.; Pimtong, Wittaya; Corby, Helen; Goldoni, Silvia; Iozzo, Alex E.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Zoeller, Jason J.; Pimtong, Wittaya; Corby, Helen; Goldoni, Silvia; Iozzo, Alex E.; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Ho, Shiu-Ying] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Rm 249 JAH, Philadelphia, PA 19107 USA.	iozzo@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Pimtong, Wittaya/0000-0003-0138-2146	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA120975]; NATIONAL CANCER INSTITUTE [R01CA120975, R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA120975 (to R.V.I.).	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dugan TA, 2006, J BIOL CHEM, V281, P38208, DOI 10.1074/jbc.M607244200; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Ouyang M, 2008, GENE EXPR PATTERNS, V8, P171, DOI 10.1016/j.gep.2007.10.011; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wang H, 2007, J BIOL CHEM, V282, P14586, DOI 10.1074/jbc.M609193200; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	56	33	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11728	11737		10.1074/jbc.M808991200	http://dx.doi.org/10.1074/jbc.M808991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19211552	Green Published, hybrid			2022-12-27	WOS:000265494500075
J	Dimitrova, LN; Kuroha, K; Tatematsu, T; Inada, T				Dimitrova, Lyudmila N.; Kuroha, Kazushige; Tatematsu, Tsuyako; Inada, Toshifumi			Nascent Peptide-dependent Translation Arrest Leads to Not4p-mediated Protein Degradation by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTOP MESSENGER-RNA; RIBOSOMAL EXIT TUNNEL; CYSTATHIONINE GAMMA-SYNTHASE; SACCHAROMYCES-CEREVISIAE; CCR4-NOT COMPLEX; TERMINATION CODON; YEAST; PURIFICATION; ARABIDOPSIS; ELONGATION	The potentially deleterious effects of aberrant mRNA lacking a termination codon (nonstop mRNA) are ameliorated by translation arrest, proteasome-mediated protein destabilization, and rapid mRNA degradation. Because polylysine synthesis via translation of the poly(A) mRNA tail leads to translation arrest and protein degradation by the proteasome, we examined the effects of other amino acid sequences. Insertion of 12 consecutive basic amino acids between GFP and HIS3 reporter genes, but not a stem-loop structure, resulted in degradation of the truncated green fluorescent protein (GFP) products by the proteasome. Translation arrest products derived from GFP-R12-FLAG-HIS3 or GFP-K12-FLAG-HIS3 mRNA were detected in a not4 Delta mutant, and MG132 treatment did not affect the levels of the truncated arrest products. Deletion of other components of the Ccr4-Not complex did not increase the levels of the translation arrest products or reporter mRNAs. A L35A substitution in the Not4p RING finger domain, which disrupted its interaction with the Ubc4/Ubc5E2 enzyme and its activity as an ubiquitin-protein ligase, also abrogated the degradation of arrest products. These results suggest that Not4p, a component of the Ccr4-Not complex, may act as an E3 ubiquitin-protein ligase for translation arrest products. The results let us propose that the interaction between basic amino acid residues and the negatively charged exit tunnel of the ribosome leads to translation arrest followed by Not4p-mediated ubiquitination and protein degradation by the proteasome.	[Dimitrova, Lyudmila N.; Kuroha, Kazushige; Inada, Toshifumi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tatematsu, Tsuyako; Inada, Toshifumi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Inada, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	p47294a@nucc.cc.nagoya-u.ac.jp	Inada, Toshifumi/AAE-1517-2019	Dimitrova-Paternoga, Lyudmila/0000-0001-5673-6373	Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Naito Foundation (to T. I.).	Akimitsu N, 2007, EMBO J, V26, P2327, DOI 10.1038/sj.emboj.7601679; AMBERG DC, 2005, METHODS YEAST GENETI, P262; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Isono E, 2005, J BIOL CHEM, V280, P6537, DOI 10.1074/jbc.M409364200; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu JL, 2007, J MOL BIOL, V371, P1378, DOI 10.1016/j.jmb.2007.06.038; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mulder KW, 2007, GENETICS, V176, P181, DOI 10.1534/genetics.106.060640; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Onouchi H, 2004, BIOCHEM SOC T, V32, P597, DOI 10.1042/BST0320597; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; Sambrook J, 2006, CONDENSED PROTOCOLS, P237; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	35	172	173	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10343	10352		10.1074/jbc.M808840200	http://dx.doi.org/10.1074/jbc.M808840200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19204001	Green Published, hybrid			2022-12-27	WOS:000265104600008
J	Nemoto, S; Nakamura, M; Osawa, Y; Kono, S; Itoh, Y; Okano, Y; Murate, T; Hara, A; Ueda, H; Nozawa, Y; Banno, Y				Nemoto, Satoshi; Nakamura, Mitsuhiro; Osawa, Yosuke; Kono, Saki; Itoh, Yoshinori; Okano, Yukio; Murate, Takashi; Hara, Akira; Ueda, Hiroshi; Nozawa, Yoshinori; Banno, Yoshiko			Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; UP-REGULATION; SPHINGOLIPID BIOSYNTHESIS; INHIBITS APOPTOSIS; EXPRESSION; P53; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; LEUKEMIA; GROWTH	The relationship between sphingosine kinase (SPHK), cellular ceramide concentration and chemosensitivity was investigated in human colon cancer cell lines. Among nine colon cancer cell lines, SPHK1 and SPHK2 activity and protein expression was highest in RKO cells and lowest in HCT116 cells. A viability assay revealed that HCT116 cells were sensitive to the effects of oxaliplatin (L-OHP), whereas RKO cells were resistant to those of L-OHP. Treatment with 5 mu g/ml L-OHP induced a marked time-dependent increase in various ceramides (C16, C24, C24:1) in HCT116 cells but not in RKO cells, as indicated by liquid chromatography/mass spectrometry. The increase in ceramide and caspase activation induced by L-OHP in the sensitive HCT116 cells was abolished by pretreatment with a neutral sphingomyelinase inhibitor, suggesting that the ceramide formation was due to the activation of neutral, rather than acid, sphingomyelinase. In contrast, in L-OHP-resistant RKO cells, treatment with an SPHK inhibitor or SPHK1 and SPHK2 silencing by RNA interference suppressed cell viability and increased caspase activity and cellular ceramide formation after L-OHP treatment. The elevated ceramide formation induced by SPHK inhibition and L-OHP was inhibited by fumonisin B1 but not myriocin, suggesting that ceramide formation was through the salvage pathway. Endogenous phosphorylated Akt levels were much higher in the resistant RKO cells than in the sensitive HCT116 cells. Either SPHK1 or SPHK2 silencing in RKO cells decreased phosphorylated Akt levels and increased p53 and p21 protein levels as well as poly(ADP-ribose) polymerase cleavage in response to L-OHP treatment. These findings indicate that SPHK isoforms and neutral sphingomyelinase contribute to the regulation of chemosensitivity by controlling ceramide formation and the downstream Akt pathway in human colon cancer cells.	[Nemoto, Satoshi; Banno, Yoshiko] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu 5011194, Japan; [Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu 5028585, Japan; [Okano, Yukio] Gifu Univ, Grad Sch Med, Dept Biomed Sci, Gifu 5011194, Japan; [Kono, Saki; Itoh, Yoshinori] Gifu Univ, Grad Sch Med, Dept Pharm, Gifu 5011194, Japan; [Osawa, Yosuke] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Ueda, Hiroshi] Gifu Univ, Fac Engn, Gifu 5011193, Japan; [Hara, Akira] Gifu Pharmaceut Univ, Dept Biochem, Gifu 5028585, Japan; [Murate, Takashi] Nagoya Univ, Grad Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4618673, Japan; [Nozawa, Yoshinori] Gifu Int Inst Biotechnol, Kakamigahara 5040838, Japan	Gifu University; Gifu Pharmaceutical University; Gifu University; Gifu University; Gifu University; Gifu University; Gifu Pharmaceutical University; Nagoya University	Banno, Y (corresponding author), Yanagido 1-1, Gifu 5011194, Japan.	yobanno@gifu-u.ac.jp		Nakamura, Mitsuhiro/0000-0002-5062-5522	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20590055]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research (C) 20590055 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHARLES S, 2007, CANCER CELL, V11, P498; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; French KJ, 2003, CANCER RES, V63, P5962; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Koda M, 2005, BBA-MOL CELL BIOL L, V1733, P101, DOI 10.1016/j.bbalip.2004.12.006; Koivusalo R, 2002, CANCER RES, V62, P7364; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Linn SC, 2001, BIOCHEM SOC T, V29, P831, DOI 10.1042/0300-5127:0290831; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Manic S, 2003, CURR CANCER DRUG TAR, V3, P21, DOI 10.2174/1568009033333727; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; RAINES MA, 1993, J BIOL CHEM, V268, P14572; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Selzner M, 2001, CANCER RES, V61, P1233; Sobue S, 2008, INT J HEMATOL, V87, P266, DOI 10.1007/s12185-008-0052-0; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takeda Y, 1999, J BIOL CHEM, V274, P10654, DOI 10.1074/jbc.274.15.10654; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182	49	77	80	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10422	10432		10.1074/jbc.M900735200	http://dx.doi.org/10.1074/jbc.M900735200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240026	Green Published, hybrid			2022-12-27	WOS:000265104600016
J	Tonhosolo, R; D'Alexandri, FL; de Rosso, VV; Gazarini, ML; Matsumura, MY; Peres, VJ; Merino, EF; Carlton, JM; Wunderlich, G; Mercadante, AZ; Kimura, EA; Katzin, AM				Tonhosolo, Renata; D'Alexandri, Fabio L.; de Rosso, Veridiana V.; Gazarini, Marcos L.; Matsumura, Miriam Y.; Peres, Valnice J.; Merino, Emilio F.; Carlton, Jane M.; Wunderlich, Gerhard; Mercadante, Adriana Z.; Kimura, Emilia A.; Katzin, Alejandro M.			Carotenoid Biosynthesis in Intraerythrocytic Stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOENE SYNTHASE; OXIDATIVE STRESS; INFECTED ERYTHROCYTES; BIFUNCTIONAL ENZYME; TOXOPLASMA-GONDII; MOLECULAR-CLONING; IDENTIFICATION; MITOCHONDRION; ANTIOXIDANT; CHLOROQUINE	Carotenoids are widespread lipophilic pigments synthesized by all photosynthetic organisms and some nonphotosynthetic fungi and bacteria. All carotenoids are derived from the C40 isoprenoid precursor geranylgeranyl pyrophosphate, and their chemical and physical properties are associated with light absorption, free radical scavenging, and antioxidant activity. Carotenoids are generally synthesized in well defined subcellular organelles, the plastids, which are also present in the phylum Apicomplexa, which comprises a number of important human parasites, such as Plasmodium and Toxoplasma. Recently, it was demonstrated that Toxoplasma gondii synthesizes abscisic acid. We therefore asked if Plasmodium falciparum is also capable of synthesizing carotenoids. Herein, biochemical findings demonstrated the presence of carotenoid biosynthesis in the intraerythrocytic stages of the apicomplexan parasite P. falciparum. Using metabolic labeling with radioisotopes, in vitro inhibition tests with norflurazon, a specific inhibitor of plant carotenoid biosynthesis, the results showed that intraerythrocytic stages of P. falciparum synthesize carotenoid compounds. A plasmodial enzyme that presented phytoene synthase activity was also identified and characterized. These findings not only contribute to the current understanding of P. falciparum evolution but shed light on a pathway that could serve as a chemotherapeutic target.	[Tonhosolo, Renata; D'Alexandri, Fabio L.; Matsumura, Miriam Y.; Peres, Valnice J.; Wunderlich, Gerhard; Kimura, Emilia A.; Katzin, Alejandro M.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508000 Sao Paulo, Brazil; [de Rosso, Veridiana V.; Mercadante, Adriana Z.] Univ Estadual Campinas, UNICAMP, Fac Food Engn, Dept Food Sci, BR-13081970 Campinas, SP, Brazil; [Gazarini, Marcos L.] Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, Brazil; [Merino, Emilio F.; Carlton, Jane M.] NYU, Langone Med Ctr, Dept Med Parasitol, New York, NY 10010 USA	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); New York University; NYU Langone Medical Center	Katzin, AM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Lineu Prestes 1374, BR-05508000 Sao Paulo, Brazil.	amkatzin@icb.usp.br	Gazarini, Marcos L/D-6022-2012; Wunderlich, Gerhard/G-8245-2012; de Rosso, Veridiana/P-4675-2019; de Rosso, Veridiana/B-7956-2012; Gazarini, Marcos L./O-7413-2019; Gazarini, Marcos/AFR-3473-2022; Mercadante, Adriana Z/C-4445-2012; Katzin, Alejandro/E-9862-2013; Tonhosolo, Renata/S-3544-2019	Wunderlich, Gerhard/0000-0003-1724-0337; de Rosso, Veridiana/0000-0001-7327-7471; de Rosso, Veridiana/0000-0001-7327-7471; Gazarini, Marcos/0000-0002-3882-6831; Mercadante, Adriana Z/0000-0003-4547-6064; Katzin, Alejandro/0000-0002-4782-2162; 	FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from FAPESP and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; BENAMOTZ A, 1986, BRIT POULTRY SCI, V27, P613, DOI 10.1080/00071668608416920; BEYER P, 1994, PURE APPL CHEM, V66, P1047, DOI 10.1351/pac199466051047; Breitenbach J, 2001, J AGR FOOD CHEM, V49, P5270, DOI 10.1021/jf0106751; BRITTON G, 1998, CAROTENOIDS BIOSYNTH, P110; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Couto AS, 1999, BIOCHEM J, V341, P629, DOI 10.1042/0264-6021:3410629; CREMER G, 1995, EXP PARASITOL, V81, P1, DOI 10.1006/expr.1995.1086; D'Alexandri FL, 2006, FEBS LETT, V580, P6343, DOI 10.1016/j.febslet.2006.10.042; D'Alexandri FL, 2006, ANAL BIOCHEM, V355, P189, DOI 10.1016/j.ab.2006.06.014; Dame JB, 1996, MOL BIOCHEM PARASIT, V79, P1, DOI 10.1016/0166-6851(96)02641-2; de Macedo CS, 2002, FEMS MICROBIOL LETT, V207, P13, DOI 10.1111/j.1574-6968.2002.tb11021.x; de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DOGBO O, 1988, P NATL ACAD SCI USA, V85, P7054, DOI 10.1073/pnas.85.19.7054; Famin O, 2003, PARASITE, V10, P39, DOI 10.1051/parasite/2003101p39; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; Ginsburg H, 1999, DRUG RESIST UPDATE, V2, P180, DOI 10.1054/drup.1999.0085; Goulart HR, 2004, ANTIMICROB AGENTS CH, V48, P2502, DOI 10.1128/AAC.48.7.2502-2509.2004; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Gunther S, 2005, BIOCHEM SOC T, V33, P977, DOI 10.1042/BST20050977; HUNT NH, 1990, BLOOD CELLS, V16, P499; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; KLEINIG H, 1985, METHOD ENZYMOL, V110, P267; KOYAMA T, 1985, METHOD ENZYMOL, V110, P153; Lacker T, 1999, J CHROMATOGR A, V854, P37, DOI 10.1016/S0021-9673(99)00584-1; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; Lin CY, 2007, BRIT J NUTR, V98, P226, DOI 10.1017/S0007114507691752; Ling Y, 2007, J BIOL CHEM, V282, P30804, DOI 10.1074/jbc.M703178200; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Mijts BN, 2003, CURR OPIN BIOTECH, V14, P597, DOI 10.1016/j.copbio.2003.09.009; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Neudert U, 1998, BBA-LIPID LIPID MET, V1392, P51, DOI 10.1016/S0005-2760(98)00017-4; Obornik M, 2002, GENE, V285, P109, DOI 10.1016/S0378-1119(02)00427-4; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Roos DS, 2002, PHILOS T R SOC B, V357, P35, DOI 10.1098/rstb.2001.1047; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Schofield A, 2005, PLANT PHYSIOL BIOCH, V43, P1052, DOI 10.1016/j.plaphy.2005.10.006; Sharpless KE, 1996, J CHROMATOGR B, V678, P187, DOI 10.1016/0378-4347(95)00494-7; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; SIMOES APCF, 1992, ARCH BIOCHEM BIOPHYS, V298, P651, DOI 10.1016/0003-9861(92)90462-6; Snow RW, 2006, AM J TROP MED HYG, V74, P189, DOI 10.4269/ajtmh.2006.74.189; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Sullivan M, 2000, MOL BIOCHEM PARASIT, V109, P17, DOI 10.1016/S0166-6851(00)00226-7; Tao NG, 2007, PLANT CELL REP, V26, P837, DOI 10.1007/s00299-006-0289-0; Tonhosolo R, 2005, BIOCHEM J, V392, P117, DOI 10.1042/BJ20050441; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; VIAL HJ, 1984, MOL BIOCHEM PARASIT, V13, P53, DOI 10.1016/0166-6851(84)90101-4	58	60	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9974	9985		10.1074/jbc.M807464200	http://dx.doi.org/10.1074/jbc.M807464200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19203994	hybrid, Green Published			2022-12-27	WOS:000264892900040
J	Weimer, KME; Shane, BL; Brunetto, M; Bhattacharyya, S; Hati, S				Weimer, Kristina Mary Ellen; Shane, Brianne Leigh; Brunetto, Michael; Bhattacharyya, Sudeep; Hati, Sanchita			Evolutionary Basis for the Coupled-domain Motions in Thermus thermophilus Leucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NORMAL-MODE ANALYSIS; ACYL-COA DEHYDROGENASE; VIBRATIONAL-MODES; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; ENZYME CATALYSIS; DRUG-RESISTANCE; HIV-1 INTEGRASE; NETWORK MODEL	Aminoacyl-tRNA synthetases are multidomain proteins that catalyze the covalent attachment of amino acids to their cognate transfer RNA. Various domains of an aminoacyl-tRNA synthetase perform their specific functions in a highly coordinated manner to maintain high accuracy in protein synthesis in cells. The coordination of their function, therefore, requires communication between domains. In this study we explored the relevance of enzyme motion in domain-domain communications. Specifically, we attempted to probe whether the communication between distantly located domains of a multidomain protein is accomplished through a coordinated movement of structural elements. We investigated the collective motion in Thermus thermophilus leucyl-tRNA synthetase by studying the low frequency normal modes. We identified the mode that best described the experimentally observed conformational changes of T. thermophilus leucyl-tRNA synthetase upon substrate binding and analyzed the correlated and anticorrelated motions between different domains. Furthermore, we used statistical coupling analysis to explore if the amino acid pairs and/or clusters whose motions are thermally coupled have also coevolved. Our study demonstrates that a small number of residues belong to the category whose coupled thermal motions correspond to evolutionary coupling as well. These residue clusters constitute a distinguished set of interacting networks that are sparsely distributed in the domain interface. Residues of these networking clusters are within van der Waals contact, and we suggest that they are critical in the propagation of long range mechanochemical motions in T. thermophilus leucyl-tRNA synthetase.	[Weimer, Kristina Mary Ellen; Shane, Brianne Leigh; Brunetto, Michael; Bhattacharyya, Sudeep; Hati, Sanchita] Univ Wisconsin, Dept Chem, Eau Claire, WI 54702 USA	University of Wisconsin System	Hati, S (corresponding author), Univ Wisconsin, Dept Chem, Eau Claire, WI 54702 USA.	hatis@uwec.edu	Bhattacharyay, Sudeep/AAW-4015-2021	Bhattacharyay, Sudeep/0000-0002-3960-1239; BRUNETTO, MAURIZIA ROSSANA/0000-0001-8364-9152	Cottrell College Science Award, Research Corp. (Tucson, AZ); Office of Research and Sponsored Programs, University of Wisconsin, Eau Claire, WI	Cottrell College Science Award, Research Corp. (Tucson, AZ); Office of Research and Sponsored Programs, University of Wisconsin, Eau Claire, WI	This work was supported by the Cottrell College Science Award, Research Corp. (Tucson, AZ) (to S. H.) and the Office of Research and Sponsored Programs, University of Wisconsin, Eau Claire, WI.	Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barreca ML, 2003, BIOPHYS J, V84, P1450, DOI 10.1016/S0006-3495(03)74958-3; Bartlett GJ, 2008, PROTEINS, V71, P950, DOI 10.1002/prot.21779; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2006, SCIENCE, V312, P208, DOI 10.1126/science.1127654; Bhattacharyya S, 2005, BIOCHEMISTRY-US, V44, P16549, DOI 10.1021/bi051630m; Bhattacharyya S, 2007, J PHYS CHEM A, V111, P5729, DOI 10.1021/jp07l526+; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Brigo A, 2005, PROTEINS, V59, P723, DOI 10.1002/prot.20447; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Budiman ME, 2007, PROTEINS, V68, P670, DOI 10.1002/prot.21426; Chen JF, 2001, BIOCHEMISTRY-US, V40, P1144, DOI 10.1021/bi0017226; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Du X, 2002, BIOCHEMISTRY-US, V41, P10623, DOI 10.1021/bi026000o; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Hammes-Schiffer S, 2002, BIOCHEMISTRY-US, V41, P13335, DOI 10.1021/bi0267137; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; HARRISON RW, 1984, BIOPOLYMERS, V23, P2943, DOI 10.1002/bip.360231216; HARTE WE, 1990, P NATL ACAD SCI USA, V87, P8864, DOI 10.1073/pnas.87.22.8864; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hawkins RJ, 2006, BIOPHYS J, V91, P2055, DOI 10.1529/biophysj.106.082180; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Karplus M, 2002, ACCOUNTS CHEM RES, V35, P321, DOI 10.1021/ar020082r; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Li T, 1999, BIOCHEMISTRY-US, V38, P13063, DOI 10.1021/bi990384+; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lue SW, 2007, BIOCHEMISTRY-US, V46, P4466, DOI 10.1021/bi0618215; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; MASCARENHAS A, 2009, PROTEIN ENG, P153; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Mursinna RS, 2004, BIOCHEMISTRY-US, V43, P155, DOI 10.1021/bi034919h; Mustata GI, 2003, BIOPOLYMERS, V70, P186, DOI 10.1002/bip.10425; Nascimento AS, 2008, J MOL BIOL, V382, P763, DOI 10.1016/j.jmb.2008.07.043; Nawaz MH, 2007, J MOL BIOL, V367, P384, DOI 10.1016/j.jmb.2006.12.051; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soares TA, 2002, BIOPOLYMERS, V65, P313, DOI 10.1002/bip.10252; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Truhlar DG, 2004, INT J QUANTUM CHEM, V100, P1136, DOI 10.1002/qua.20205; Truhlar DG, 2002, ACCOUNTS CHEM RES, V35, P341, DOI 10.1021/ar0100226; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Vu MT, 2007, BIOCHEMISTRY-US, V46, P5170, DOI 10.1021/bi062078j; Williams AM, 2006, P NATL ACAD SCI USA, V103, P3586, DOI 10.1073/pnas.0507362103; Yidirim Y, 2004, J BIOMOL STRUCT DYN, V22, P267, DOI 10.1080/07391102.2004.10507000; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023; Zhang CM, 2005, BIOCHEMISTRY-US, V44, P7240, DOI 10.1021/bi050285y; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103	71	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10088	10099		10.1074/jbc.M807361200	http://dx.doi.org/10.1074/jbc.M807361200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19188368	hybrid, Green Published			2022-12-27	WOS:000264892900051
J	Yamada, L; Saito, T; Taniguchi, H; Sawada, H; Harada, Y				Yamada, Lixy; Saito, Takako; Taniguchi, Hisaaki; Sawada, Hitoshi; Harada, Yoshito			Comprehensive Egg Coat Proteome of the Ascidian Ciona intestinalis Reveals Gamete Recognition Molecules Involved in Self-sterility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA GENES; SELF/NONSELF RECOGNITION; SPERM RECEPTOR; LC-MS/MS; IDENTIFICATION; ALLORECOGNITION; DOMAIN; FERTILIZATION; MECHANISM; EVOLUTION	Despite central roles of egg coat proteins in gamete recognition, their functions and composition are poorly understood. Here, we report that the proteome of the egg coat in the solitary ascidian Ciona intestinalis, called vitelline coat (VC) fraction, contains more than 800 proteins identified by mass spectrometry-based analyses. Over 100 proteins were enriched in the VC fraction compared with the VC-free egg proteome. The most abundant component in the VC was an apolipoprotein-like protein. The VC contained multiple homologs of mammalian zona pellucida (ZP) proteins, the number of which was unexpectedly large and most of which possessed epidermal growth factor-like repeats. Furthermore, the present study revealed that two fibrinogen-like proteins, v-Themis-A and -B, both of which are expressed in the VC, are the molecules responsible for the two self-sterility loci that were identified by our previous genetic study in this species.	[Saito, Takako; Sawada, Hitoshi; Harada, Yoshito] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan; [Yamada, Lixy; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Div Dis Prote, Tokushima 7708503, Japan; [Taniguchi, Hisaaki] Japan Sci & Technol Agcy JST, Inst Bioinformat Res & Dev BIRD, Chiyoda Ku, Tokyo 1028666, Japan	Nagoya University; Tokushima University; Japan Science & Technology Agency (JST)	Sawada, H (corresponding author), Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan.	hsawada@bio.nagoya-u.ac.jp; yharada@bio.nagoya-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012	Saito, Takako/0000-0002-3969-9192	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19370041, 19659080, 16659021, 19659018, 18770198]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research fellowship of the Japan Society for the Promotion of Science (JSPS) for young scientists (to L. Y.), the 21st COE program "Disease Proteomics" and Grants-in-aid for Scientific Research 19370041 and 19659080 by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to H. T.), Grants-in-aid for Exploratory Research 16659021 and 19659018 from MEXT (to H. S.), and Grant-in-aid 18770198 for Young Scientists (B) from MEXT (to Y. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aagaard JE, 2006, P NATL ACAD SCI USA, V103, P17302, DOI 10.1073/pnas.0603125103; Allet N, 2004, PROTEOMICS, V4, P2333, DOI 10.1002/pmic.200300840; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; Ban S, 2005, DEV BIOL, V286, P440, DOI 10.1016/j.ydbio.2005.08.004; Colinge J, 2005, ANAL CHEM, V77, P596, DOI 10.1021/ac0488513; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Goudet G, 2008, BIOL REPROD, V78, P796, DOI 10.1095/biolreprod.107.064568; Harada Y, 2008, INT J DEV BIOL, V52, P637, DOI 10.1387/ijdb.072544yh; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; Harada Y, 2007, MOL REPROD DEV, V74, P1178, DOI 10.1002/mrd.20616; Heller M, 2007, MOL CELL PROTEOMICS, V6, P1059, DOI 10.1074/mcp.M600326-MCP200; Howes E, 2001, J CELL SCI, V114, P4127; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; KAWAMURA K, 1991, DEV GROWTH DIFFER, V33, P139; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kuern U, 2007, DEV COMP IMMUNOL, V31, P1242, DOI 10.1016/j.dci.2007.03.011; Kurn U, 2007, DEV COMP IMMUNOL, V31, P360, DOI 10.1016/j.dci.2006.06.008; Lee YH, 1999, DEVELOPMENT, V126, P3857; Marino R, 1998, DEVELOPMENT, V125, P899; MORGAN TH, 1910, ROUX ARCH ENTWICKLUN, V30, P206; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; ROSATI F, 1978, EXP CELL RES, V112, P111, DOI 10.1016/0014-4827(78)90531-1; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Stein KK, 2006, PROTEOMICS, V6, P3533, DOI 10.1002/pmic.200500845; Urayama S, 2008, J BIOL CHEM, V283, P21725, DOI 10.1074/jbc.M802631200; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193	31	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9402	9410		10.1074/jbc.M809672200	http://dx.doi.org/10.1074/jbc.M809672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193647	hybrid, Green Published			2022-12-27	WOS:000264669100046
J	Gillet, L; Roger, S; Besson, P; Lecaille, F; Gore, J; Bougnoux, P; Lalmanach, G; Le Guennec, JY				Gillet, Ludovic; Roger, Sebastien; Besson, Pierre; Lecaille, Fabien; Gore, Jacques; Bougnoux, Philippe; Lalmanach, Gilles; Le Guennec, Jean-Yves			Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; PROTEASES; INHIBITORS; PH; REPRESSOR; TARGETS; MATRIX; ROLES	Voltage-gated sodium channels (Na-V) are functionally expressed in highly metastatic cancer cells derived from nonexcitable epithelial tissues (breast, prostate, lung, and cervix). MDA-MB-231 breast cancer cells express functional sodium channel complexes, consisting of Na(V)1.5 and associated auxiliary beta-subunits, that are responsible for a sustained inward sodium current at the membrane potential. Although these channels do not regulate cellular multiplication or migration, their inhibition by the specific blocker tetrodotoxin impairs both the extracellular gelatinolytic activity (monitored with DQ-gelatin) and cell invasiveness leading to the attenuation of colony growth and cell spreading in three-dimensional Matrigel (R)-composed matrices. MDA-MB-231 cells express functional cysteine cathepsins, which we found play a predominant role (similar to 65%) in cancer invasiveness. Matrigel (R) invasion is significantly decreased in the presence of specific inhibitors of cathepsins Band S (CA-074 and Z-FL-COCHO, respectively), and co-application of tetrodotoxin does not further reduce cell invasion. This suggests that cathepsins B and S are involved in invasiveness and that their proteolytic activity partly depends on NaV function. Inhibiting NaV has no consequence for cathepsins at the transcription, translation, and secretion levels. However, NaV activity leads to an intracellular alkalinization and a perimembrane acidification favorable for the extracellular activity of these acidic proteases. We propose that Na-v enhance the invasiveness of cancer cells by favoring the pH-dependent activity of cysteine cathepsins. This general mechanism could lead to the identification of new targets allowing the therapeutic prevention of metastases.	[Gillet, Ludovic; Roger, Sebastien; Besson, Pierre; Gore, Jacques; Bougnoux, Philippe; Le Guennec, Jean-Yves] Univ Tours, Fac Med, INSERM, U921, F-37032 Tours, France; [Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, Fac Med, INSERM, U618, F-37032 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Roger, S (corresponding author), Univ Tours, Fac Med, INSERM, U921, 10 Blvd Tonnelle, F-37032 Tours, France.	sebastien.roger@univ-tours.fr	LE GUENNEC, Jean-Yves/P-1067-2016; Lecaille, Fabien/GRY-5313-2022	Bougnoux, Philippe/0000-0002-8717-055X; Gillet, Ludovic/0000-0002-4990-6212; Lalmanach, Gilles/0000-0001-8562-4821; Roger, Sebastien/0000-0002-9852-5248; Lecaille, Fabien/0000-0003-1060-4222	Ligue contre le Cancer - Region Centre; Association pour la Recherche contre le Cancer; IFR 135-Imagerie Fonctionnelle; Ministere de la Recherche et des Technologies; Institut National de la Sante et de la Recherche Medicale (INSERM)	Ligue contre le Cancer - Region Centre(Region Centre-Val de Loire); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); IFR 135-Imagerie Fonctionnelle; Ministere de la Recherche et des Technologies; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by a grant from the Ligue contre le Cancer - Region Centre, the Association pour la Recherche contre le Cancer, the IFR 135-Imagerie Fonctionnelle, the Ministere de la Recherche et des Technologies, and the Institut National de la Sante et de la Recherche Medicale (INSERM). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adachi K, 2004, ONCOGENE, V23, P7791, DOI 10.1038/sj.onc.1208067; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; BROMME D, 1989, BIOCHEM J, V264, P475; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chowdhury SF, 2002, J MED CHEM, V45, P5321, DOI 10.1021/jm020238t; Coulson JM, 2000, CANCER RES, V60, P1840; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Izumi H, 2003, CANCER TREAT REV, V29, P541, DOI 10.1016/S0305-7372(03)00106-3; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Jude S, 2006, PROG BIOPHYS MOL BIO, V90, P299, DOI 10.1016/j.pbiomolbio.2005.05.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Roger S, 2003, BBA-BIOMEMBRANES, V1616, P107, DOI 10.1016/j.bbamem.2003.07.001; Roger S, 2007, INT J BIOCHEM CELL B, V39, P774, DOI 10.1016/j.biocel.2006.12.007; Roger S, 2006, CURR PHARM DESIGN, V12, P3681, DOI 10.2174/138161206778522047; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; Walker B, 2000, BIOCHEM BIOPH RES CO, V275, P401, DOI 10.1006/bbrc.2000.3311; Wang D, 2002, BIOCHEMISTRY-US, V41, P8849, DOI 10.1021/bi0257080; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033	42	151	164	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8671	8682		10.1074/jbc.M806891200	http://dx.doi.org/10.1074/jbc.M806891200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19176528	Green Published, hybrid			2022-12-27	WOS:000264397800052
J	Graziane, NM; Yuen, EY; Yan, Z				Graziane, Nicholas M.; Yuen, Eunice Y.; Yan, Zhen			Dopamine D-4 Receptors Regulate GABA(A) Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; DEFICIT HYPERACTIVITY DISORDER; PREFRONTAL CORTICAL-NEURONS; ACTIN DEPOLYMERIZING FACTOR; PROTEIN-KINASE-C; WORKING-MEMORY; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; AMPA RECEPTORS; A RECEPTORS	The GABAA receptor-mediated inhibitory transmission in prefrontal cortex (PFC) is implicated in cognitive processes such as working memory. Our previous study has found that GABA(A)R current is subject to the regulation of dopamine D-4 receptors, a PFC-enriched neuromodulator critically involved in various mental disorders associated with PFC dysfunction. In this study, we have investigated the cellular mechanism underlying D-4 modulation of GABA(A)Rs. We found that the density of surface clusters of GABA(A)R beta 2/3 subunits was reduced by D-4, suggesting that the D-4 reduction of GABA(A)R current is associated with a decrease in functional GABA(A)Rs at the plasma membrane. Moreover, the D-4 reduction of GABA(A)R current was blocked by the actin stabilizer phalloidin and was occluded by the actin destabilizer latrunculin, suggesting that D-4 regulates GABA(A)R trafficking via an actin-dependent mechanism. Cofilin, a major actin depolymerizing factor whose activity is strongly increased by dephosphorylation at Ser(3), provides the possible link between D-4 signaling and the actin dynamics. Because myosin motor proteins are important for the transport of vesicles along actin filaments, we also tested the potential involvement of myosin in D-4 regulation of GABA(A)R trafficking. We found that dialysis with a myosin peptide, which competes with endogenous myosin proteins for actin-binding sites, prevented the D-4 reduction of GABA(A)R current. These results suggest that D-4 receptor activation increases cofilin activity presumably via its dephosphorylation, resulting in actin depolymerization, thus causing a decrease in the myosin-based transport of GABA(A)R clusters to the surface.	[Graziane, Nicholas M.; Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Graziane, Nicholas/0000-0002-7055-7029	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants ( to Z. Y.).	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Cai XA, 2002, J BIOL CHEM, V277, P36553, DOI 10.1074/jbc.M203752200; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Glase SA, 1997, J MED CHEM, V40, P1771, DOI 10.1021/jm970021c; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jentsch JD, 1997, SCIENCE, V277, P953, DOI 10.1126/science.277.5328.953; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2002, MOL NEUROBIOL, V26, P251, DOI 10.1385/MN:26:2-3:251; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LEWIS DA, 1986, HUM NEUROBIOL, V5, P181; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rowe DC, 1998, MOL PSYCHIATR, V3, P419, DOI 10.1038/sj.mp.4000432; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SEEMAN P, 1993, NATURE, V365, P441, DOI 10.1038/365441a0; Shen L, 2000, J NEUROSCI, V20, P7932; TEHRANI MHJ, 1993, J NEUROCHEM, V60, P1755; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Volk DW, 2002, CEREB CORTEX, V12, P1063, DOI 10.1093/cercor/12.10.1063; Wang X, 2002, J NEUROSCI, V22, P9185; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	65	29	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8329	8336		10.1074/jbc.M807387200	http://dx.doi.org/10.1074/jbc.M807387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19179335	Green Published, hybrid			2022-12-27	WOS:000264397800017
J	Kallen, J; Goepfert, A; Blechschmidt, A; Izaac, A; Geiser, M; Tavares, G; Ramage, P; Furet, P; Masuya, K; Lisztwan, J				Kallen, Joerg; Goepfert, Arnaud; Blechschmidt, Anke; Izaac, Aude; Geiser, Martin; Tavares, Gisele; Ramage, Paul; Furet, Pascal; Masuya, Keiichi; Lisztwan, Joanna			Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR TRANSACTIVATION DOMAIN; EMBRYONIC LETHALITY; IN-VIVO; MDM2-DEFICIENT MICE; PROTEIN; ACTIVATION; PATHWAY; ANTAGONISTS; RESCUE; CELLS	p53 tumor suppressor activity is negatively regulated through binding to the oncogenic proteins Hdm2 and HdmX. The p53 residues Leu(26), Trp(23), and Phe(19) are crucial to mediate these interactions. Inhibiting p53 binding to both Hdm2 and HdmX should be a promising clinical approach to reactivate p53 in the cancer setting, but previous studies have suggested that the discovery of dual Hdm2/HdmX inhibitors will be difficult. We have determined the crystal structures at 1.3A of the N-terminal domain of HdmX bound to two p53 peptidomimetics without and with a 6-chlorine substituent on the indole (which binds in the same subpocket as Trp23 of p53). The latter compound is the most potent peptide-based antagonist of the p53-Hdm2 interaction yet to be described. The x-ray structures revealed surprising conformational changes of the binding cleft of HdmX, including an "open conformation" of Tyr(99) and unexpected "cross-talk" between the Trp and Leu pockets. Notably, the 6-chloro p53 peptidomimetic bound with high affinity to both HdmX and Hdm2(K-d values of 36 and 7 nM, respectively). Our results suggest that the development of potent dual inhibitors for HdmX and Hdm2 should be feasible. They also reveal possible conformational states of HdmX, which should lead to a better prediction of its interactions with potential biological partners.	[Kallen, Joerg] Novartis Inst BioMed Res, Prot Struct Unit, CH-4002 Basel, Switzerland	Novartis	Kallen, J (corresponding author), Novartis Inst BioMed Res, Prot Struct Unit, CH-4002 Basel, Switzerland.	joerg.kallen@novartis.com						Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Dudkina AS, 2007, CURR TOP MED CHEM, V7, P952, DOI 10.2174/156802607780906762; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finch RA, 2002, CANCER RES, V62, P3221; Garcia-Echeverria C, 2000, J MED CHEM, V43, P3205, DOI 10.1021/jm990966p; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LAMZIN VS, 2006, INT TABLES CRYSTALLO, P720; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LUNA RMD, 1995, NATURE, V378, P203; Macchiarulo A, 2008, J CHEM INF MODEL, V48, P1999, DOI 10.1021/ci800146m; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Sakurai K, 2006, J AM CHEM SOC, V128, P11000, DOI 10.1021/ja063102j; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	38	65	77	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8803	8812		10.1074/jbc.M809096200	http://dx.doi.org/10.1074/jbc.M809096200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19153082	Green Published, hybrid			2022-12-27	WOS:000264397800064
J	Pratt, EB; Yan, FF; Gay, JW; Stanley, CA; Shyng, SL				Pratt, Emily B.; Yan, Fei-Fei; Gay, Joel W.; Stanley, Charles A.; Shyng, Show-Ling			Sulfonylurea Receptor 1 Mutations That Cause Opposite Insulin Secretion Defects with Chemical Chaperone Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; K-ATP CHANNELS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; CORRECT TRAFFICKING DEFECTS; CONGENITAL HYPERINSULINISM; KIR6.2; DISEASE; BINDING; INFANCY; GLIBENCLAMIDE	The beta-cell ATP-sensitive potassium (K-ATP) channel composed of sulfonylurea receptor SUR1 and potassium channel Kir6.2 serves a key role in insulin secretion regulation by linking glucose metabolism to cell excitability. Mutations in SUR1 or Kir6.2 that decrease channel function are typically associated with congenital hyperinsulinism, whereas those that increase channel function are associated with neonatal diabetes. Here we report that two hyperinsulinism-associated SUR1 missense mutations, R74W and E128K, surprisingly reduce channel inhibition by intracellular ATP, a gating defect expected to yield the opposite disease phenotype neonatal diabetes. Under normal conditions, both mutant channels showed poor surface expression due to retention in the endoplasmic reticulum, accounting for the loss of channel function phenotype in the congenital hyperinsulinism patients. This trafficking defect, however, could be corrected by treating cells with the oral hypoglycemic drugs sulfonylureas, which we have shown previously to act as small molecule chemical chaperones for K-ATP channels. The R74W and E128K mutants thus rescued to the cell surface paradoxically exhibited ATP sensitivity 6-and 12-fold lower than wild-type channels, respectively. Further analyses revealed a nucleotide-independent decrease in mutant channel intrinsic open probability, suggesting the mutations may reduce ATP sensitivity by causing functional uncoupling between SUR1 and Kir6.2. In insulin-secreting cells, rescue of both mutant channels to the cell surface led to hyperpolarized membrane potentials and reduced insulin secretion upon glucose stimulation. Our results show that sulfonylureas, as chemical chaperones, can dictate manifestation of the two opposite insulin secretion defects by altering the expression levels of the disease mutants.	[Pratt, Emily B.; Yan, Fei-Fei; Gay, Joel W.; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA	Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		STANLEY, CHARLES/0000-0003-4881-9392	National Institutes of Health Predoctoral Fellowship [F30DK081305, R01DK57699, DK66485, R01DK56268, UL1-RRO24134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056268, R01DK066485, R01DK057699, F30DK081305] Funding Source: NIH RePORTER	National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Fellowship F30DK081305 (to E. B. P.), Grants R01DK57699 and DK66485 (to S.-L. S.), and Grants R01DK56268 and UL1-RRO24134 (to C. A. S.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; Dempster J., 2001, LAB COMPUTER PRACTIC; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; GULLO D, 1991, J ENDOCRINOL INVEST, V14, P287, DOI 10.1007/BF03346813; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Henwood MJ, 2005, J CLIN ENDOCR METAB, V90, P789, DOI 10.1210/jc.2004-1604; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kawaki J, 1999, DIABETES, V48, P2001, DOI 10.2337/diabetes.48.10.2001; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Neagoe I, 2005, J MOL CELL CARDIOL, V38, P887, DOI 10.1016/j.yjmcc.2004.11.023; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Proks P, 2005, HUM MOL GENET, V14, P2717, DOI 10.1093/hmg/ddi305; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Suchi M, 2006, MODERN PATHOL, V19, P122, DOI 10.1038/modpathol.3800497; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	39	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7951	7959		10.1074/jbc.M807012200	http://dx.doi.org/10.1074/jbc.M807012200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19151370	Green Published, hybrid			2022-12-27	WOS:000264195600057
J	Patterson, ST; Li, J; Kang, JA; Wickrema, A; Williams, DB; Reithmeier, RAF				Patterson, Sian T.; Li, Jing; Kang, Jeong-Ah; Wickrema, Amittha; Williams, David B.; Reithmeier, Reinhart A. F.			Loss of Specific Chaperones Involved in Membrane Glycoprotein Biosynthesis during the Maturation of Human Erythroid Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; ENDOPLASMIC-RETICULUM; ANION-EXCHANGER; QUALITY-CONTROL; HEREDITARY SPHEROCYTOSIS; N-GLYCOSYLATION; XENOPUS OOCYTES; WILD-TYPE; PROTEINS; CALNEXIN	The production of erythrocytes requires the massive synthesis of red cell-specific proteins including hemoglobin, cytoskeletal proteins, as well as membrane glycoproteins glycophorin A (GPA) and anion exchanger 1 (AE1). We found that during the terminal differentiation of human CD34(+) erythroid progenitor cells in culture, key components of the endoplasmic reticulum (ER) protein translocation (Sec61 alpha), glycosylation (OST48), and protein folding machinery, chaperones BiP, calreticulin (CRT), and Hsp90 were maintained to allow efficient red cell glycoprotein biosynthesis. Unexpected was the loss of calnexin (CNX), an ER glycoprotein chaperone, and ERp57, a protein-disulfide isomerase, as well as a major decrease of the cytosolic chaperones, Hsc70 and Hsp70, components normally involved in membrane glycoprotein folding and quality control. AE1 can traffic to the cell surface in mouse embryonic fibroblasts completely deficient in CNX or CRT, whereas disruption of the CNX/CRT-glycoprotein interactions in human K562 cells using castanospermine did not affect the cell-surface levels of endogenous GPA or expressed AE1. These results demonstrate that CNX and ERp57 are not required for major glycoprotein biosynthesis during red cell development, in contrast to their role in glycoprotein folding and quality control in other cells.	[Patterson, Sian T.; Li, Jing; Williams, David B.; Reithmeier, Reinhart A. F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kang, Jeong-Ah; Wickrema, Amittha] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Toronto; University of Chicago	Reithmeier, RAF (corresponding author), Univ Toronto, Dept Biochem, MSB5216,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	r.reithmeier@utoronto.ca			Canadian Institutes of Health Research [FRN15266]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant FRN15266 (to R.A.F.R.).	Arrigo AP, 2005, J CELL BIOCHEM, V94, P241, DOI 10.1002/jcb.20349; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; CHERNOVA MN, 1995, J MEMBRANE BIOL, V148, P203; Cheung JC, 2005, BIOCHEM J, V392, P425, DOI 10.1042/BJ20051076; DAVID V, 1993, J BIOL CHEM, V268, P9585; DAVIS JQ, 1986, J BIOL CHEM, V261, P5368; Demaurex N., 2003, CALRETICULIN, P134; Dudeja PK, 1999, AM J PHYSIOL-LUNG C, V276, pL971, DOI 10.1152/ajplung.1999.276.6.L971; Fishelson Z, 2001, INT IMMUNOL, V13, P983, DOI 10.1093/intimm/13.8.983; Fraser SA, 1998, BIOCHEM CELL BIOL, V76, P881, DOI 10.1139/bcb-76-5-881; Geminard C, 2002, BIOCELL, V26, P205; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Izak G, 1977, Prog Hematol, V10, P1; JAROLIM P, 1995, BLOOD, V85, P634, DOI 10.1182/blood.V85.3.634.bloodjournal853634; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Krebs MP, 2004, TRENDS BIOCHEM SCI, V29, P648, DOI 10.1016/j.tibs.2004.10.009; Li J, 2000, BIOCHEM J, V349, P51, DOI 10.1042/0264-6021:3490051; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; LUX S, BLOOD PRINCIPLES PRA, P1383; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Popov M, 1999, J BIOL CHEM, V274, P17635, DOI 10.1074/jbc.274.25.17635; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; SARABIA VE, 1993, J BIOL CHEM, V268, P10676; SINGH MK, 1984, NATURE, V309, P631, DOI 10.1038/309631a0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; WICKREMA A, 1994, J CELL PHYSIOL, V160, P417, DOI 10.1002/jcp.1041600304; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Yeates LC, 1997, BIOCHEM BIOPH RES CO, V238, P66, DOI 10.1006/bbrc.1997.7238; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Young MT, 2000, BIOCHEM J, V350, P53, DOI 10.1042/0264-6021:3500053; Zaric J, 1998, COMP HAEMATOL INT, V8, P205, DOI 10.1007/BF02752850; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	46	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14547	14557		10.1074/jbc.M809076200	http://dx.doi.org/10.1074/jbc.M809076200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19258325	hybrid, Green Published			2022-12-27	WOS:000266286100061
J	Patil, SM; Xu, SH; Sheftic, SR; Alexandrescu, AT				Patil, Sharadrao M.; Xu, Shihao; Sheftic, Sarah R.; Alexandrescu, Andrei T.			Dynamic alpha-Helix Structure of Micelle-bound Human Amylin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET AMYLOID POLYPEPTIDE; SODIUM DODECYL-SULFATE; COUPLING-CONSTANTS; CHEMICAL-SHIFTS; SDS MICELLES; CONFORMATIONAL PREFERENCES; SECONDARY STRUCTURE; BACKBONE DYNAMICS; PROTEIN; NMR	Amylin is an endocrine hormone that regulates metabolism. In patients afflicted with type 2 diabetes, amylin is found in fibrillar deposits in the pancreas. Membranes are thought to facilitate the aggregation of amylin, and membrane-bound oligomers may be responsible for the islet beta-cell toxicity that develops during type 2 diabetes. To better understand the structural basis for the interactions between amylin and membranes, we determined the NMR structure of human amylin bound to SDS micelles. The first four residues in the structure are constrained to form a hairpin loop by the single disulfide bond in amylin. The last nine residues near the C terminus are unfolded. The core of the structure is an alpha-helix that runs from about residues 5-28. A distortion or kink near residues 18-22 introduces pliancy in the angle between the N- and C-terminal segments of the alpha-helix. Mobility, as determined by N-15 relaxation experiments, increases from the N to the C terminus and is strongly correlated with the accessibility of the polypeptide to spin probes in the solution phase. The spin probe data suggest that the segment between residues 5 and 17 is positioned within the hydrophobic lipid environment, whereas the amyloidogenic segment between residues 20 and 29 is at the interface between the lipid and solvent. This orientation may direct the aggregation of amylin on membranes, whereas coupling between the two segments may mediate the transition to a toxic structure.	[Patil, Sharadrao M.; Xu, Shihao; Sheftic, Sarah R.; Alexandrescu, Andrei T.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Alexandrescu, AT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	andrei@uconn.edu	Xu, Shihao/B-5422-2018		National Institutes of Health [1S10RR016760]; American Parkinson Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1S10RR016760 from NCRR (NMR instrumentation). This work was also supported by a Roger C. Duvoisin, M. D., research grant from the American Parkinson Disease Association.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 2008, PROTEIN MISFOLDING; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger A. T., 1992, SYSTEM XRAY CRYSTALL; CASE DA, 1994, METHOD ENZYMOL, V239, P392; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dux P, 1997, J BIOMOL NMR, V10, P301, DOI 10.1023/A:1018393225804; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gangabadage CS, 2008, J PHYS CHEM B, V112, P4242, DOI 10.1021/jp710045e; GIERASCH LM, 1982, BIOPHYS J, V37, P275, DOI 10.1016/S0006-3495(82)84676-6; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jarvet J, 1997, BIOCHEMISTRY-US, V36, P8153, DOI 10.1021/bi970193b; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; JIMENEZ MA, 1992, EUR J BIOCHEM, V207, P39, DOI 10.1111/j.1432-1033.1992.tb17017.x; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lim YA, 2008, FEBS LETT, V582, P2188, DOI 10.1016/j.febslet.2008.05.006; Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Lycknert K, 2002, J PHYS CHEM B, V106, P5275, DOI 10.1021/jp0136462; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Mascioni A, 2003, BIOPOLYMERS, V69, P29, DOI 10.1002/bip.10305; MCLEISH MJ, 1994, BIOCHEMISTRY-US, V33, P11174, DOI 10.1021/bi00203a013; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Nesmelova IV, 2004, J MAGN RESON, V166, P129, DOI 10.1016/j.jmr.2003.09.004; Pappalardo G, 2007, CHEM-EUR J, V13, P10204, DOI 10.1002/chem.200700576; PAUL BC, 1993, B CHEM SOC JPN, V66, P703, DOI 10.1246/bcsj.66.703; Petersen M, 2003, DIABETES CARE, V26, P917; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Wiltscheck R, 1997, PROTEIN SCI, V6, P1734, DOI 10.1002/pro.5560060814; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Young Andrew, 2005, Adv Pharmacol, V52, P67, DOI 10.1016/S1054-3589(05)52004-0; Young Andrew, 2005, Adv Pharmacol, V52, P47, DOI 10.1016/S1054-3589(05)52003-9; Zdrojewicz Z., 2006, DIABETOLOGIA DOOESWI, V6, P169; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	64	149	151	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11982	11991		10.1074/jbc.M809085200	http://dx.doi.org/10.1074/jbc.M809085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244249	hybrid, Green Published			2022-12-27	WOS:000265494600030
J	Sheng, MHC; Amoui, M; Stiffel, V; Srivastava, AK; Wergedal, JE; Lau, KHW				Sheng, Matilda H. -C.; Amoui, Mehran; Stiffel, Virginia; Srivastava, Apurva K.; Wergedal, Jon E.; Lau, K. -H. William			Targeted Transgenic Expression of an Osteoclastic Transmembrane Protein-tyrosine Phosphatase in Cells of Osteoclastic Lineage Increases Bone Resorption and Bone Loss in Male Young Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; POSITIVE REGULATOR; MOLECULAR-CLONING; PTP-OC; DIFFERENTIATION; GENE; PROMOTER; C3H/HEJ; DISEASE; GLEPP1	This study evaluated whether transgenic expression of PTP-oc (osteoclastic transmembrane protein-tyrosine phosphatase) in cells of the osteoclast lineage would affect bone resorption and bone density in young adult mice. Transgenic mice were generated with a transgenic construct using a tartrate-resistant acid phosphatase exon 1C promoter to drive expression of rabbit PTP-oc in osteoclastic cells. pQCT evaluation of femurs of young adult male progeny of three lines showed that transgenic mice had reduced bone volume and area, cortical and trabecular bone mineral content, and density. Histomorphometric analyses at secondary spongiosa of the femur and at metaphysis of the L4 vertebra confirmed that male transgenic mice had decreased trabecular surface, reduced percentage of trabecular area, decreased trabecular number, increased trabecular separation, and increased osteoclast number per bone surface length. Consistent with an increase in bone resorption, the serum C-telopeptide level was 25% higher in transgenic mice than in wild-type littermates. However, the bone phenotype was not readily observed in female young adult transgenic mice. This could in part be due to potential interactions between estrogen and PTP-oc signaling, since the bone loss phenotype was seen in young adult ovariectomized transgenic mice by microcomputed tomography analysis. In vitro, the average pit area per resorption pit created by marrow-derived transgenic osteoclasts was similar to 50% greater than that created by wild-type osteoclasts. Transgenic osteoclasts showed a lower c-Src phosphotyrosine 527 level, greater c-Src kinase activity, and increased tyrosine phosphorylation of paxillin. In summary, this study provides compelling in vivo evidence that PTP-oc is a positive regulator of osteoclasts.	[Sheng, Matilda H. -C.; Amoui, Mehran; Stiffel, Virginia; Srivastava, Apurva K.; Wergedal, Jon E.; Lau, K. -H. William] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr 151, Loma Linda, CA 92357 USA; [Sheng, Matilda H. -C.; Amoui, Mehran; Srivastava, Apurva K.; Wergedal, Jon E.; Lau, K. -H. William] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA	Loma Linda University	Lau, KHW (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr 151, 11201 Benton St, Loma Linda, CA 92357 USA.	William.Lau@med.va.gov		Lau, Kin-Hing/0000-0003-1109-5052	Veterans Affairs Merit Review grant	Veterans Affairs Merit Review grant(US Department of Veterans Affairs)	This work was supported in part by a Veterans Affairs Merit Review grant and by a special appropriation to the Jerry L. Pettis Memorial Veterans Affairs Medical Center, Musculoskeletal Disease Center. Preliminary results were presented in abstract form (43).	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Amoui M, 2004, AM J PHYSIOL-CELL PH, V287, pC874, DOI 10.1152/ajpcell.00294.2003; Amoui M, 2003, J BIOL CHEM, V278, P44273, DOI 10.1074/jbc.M303933200; Amoui M, 2007, ARCH BIOCHEM BIOPHYS, V463, P47, DOI 10.1016/j.abb.2007.02.025; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Bischof JM, 2005, PHYSIOL GENOMICS, V22, P191, DOI 10.1152/physiolgenomics.00071.2005; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; IVEY JL, 1981, METAB BONE DIS RELAT, V3, P3, DOI 10.1016/S0221-8747(81)80016-1; Jacob ST, 2005, CANCER GENE THER, V12, P665, DOI 10.1038/sj.cgt.7700828; Lau KHW, 2006, J CELL BIOCHEM, V97, P940, DOI 10.1002/jcb.20667; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miyazaki Tsuyoshi, 2006, Mod Rheumatol, V16, P68; Mohan S, 1996, HORM RES, V45, P59, DOI 10.1159/000184833; MOSEKILDE L, 1978, ACTA MED SCAND, V204, P97; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Pan WH, 2005, J BIOL CHEM, V280, P4888, DOI 10.1074/jbc.M409052200; PARISIEN M, 1990, ENDOCRIN METAB CLIN, V19, P19, DOI 10.1016/S0889-8529(18)30337-2; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Rundle CH, 2008, J GENE MED, V10, P229, DOI 10.1002/jgm.1148; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; SEIMIYA H, 1995, ONCOGENE, V10, P1731; Seimiya H, 1998, J BIOL CHEM, V273, P21187, DOI 10.1074/jbc.273.33.21187; Sheng MHC, 2002, BONE, V30, P486, DOI 10.1016/S8756-3282(01)00693-7; SHENG MHC, 2007, M AM SOC BON MIN RES; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Srivastava AK, 2001, BONE, V29, P361, DOI 10.1016/S8756-3282(01)00581-6; Suhr SM, 2001, J BONE MINER RES, V16, P1795, DOI 10.1359/jbmr.2001.16.10.1795; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wergedal JE, 2005, BONE, V36, P111, DOI 10.1016/j.bone.2004.09.012; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; WIGGINS RC, 1995, GENOMICS, V27, P174, DOI 10.1006/geno.1995.1021; Wu LW, 1996, BIOCHEM J, V316, P515, DOI 10.1042/bj3160515; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Xiong WC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1219, DOI 10.2741/1117; Yang JH, 2007, ARCH BIOCHEM BIOPHYS, V465, P72, DOI 10.1016/j.abb.2007.04.032; Yang JH, 2007, FEBS LETT, V581, P2503, DOI 10.1016/j.febslet.2007.04.063; Zhang ZY, 2000, J BIOL CHEM, V275, P37219, DOI 10.1074/jbc.M001818200	42	22	24	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11531	11545		10.1074/jbc.M808324200	http://dx.doi.org/10.1074/jbc.M808324200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244239	Green Published, hybrid			2022-12-27	WOS:000265494500057
J	Miyai, K; Yoneda, M; Hasegawa, U; Toita, S; Izu, Y; Hemmi, H; Hayata, T; Ezura, Y; Mizutani, S; Miyazono, K; Akiyoshi, K; Yamamoto, T; Nodaa, M				Miyai, Kentaro; Yoneda, Mitsuhiro; Hasegawa, Urara; Toita, Sayaka; Izu, Yayoi; Hemmi, Hiroaki; Hayata, Tadayoshi; Ezura, Yoichi; Mizutani, Shuki; Miyazono, Kohei; Akiyoshi, Kazunari; Yamamoto, Tadashi; Nodaa, Masaki			ANA Deficiency Enhances Bone Morphogenetic Protein-induced Ectopic Bone Formation via Transcriptional Events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTOPIC OSSIFICATION; TOB/BTG1 FAMILY; TOB; EXPRESSION; MEMBER; GENE; COMPONENT; MICE; IDENTIFICATION; CLONING	Ectopic bone formation after joint replacement or brain injury in humans is a serious complication that causes immobility of joints and severe pain. However, mechanisms underlying such ectopic bone formation are not fully understood. Bone morphogenetic protein (BMPs) are defined as inducers of ectopic bone formation, and they are regulated by several types of inhibitors. ANA is an antiproliferative molecule that belongs to Tob/BTG family, but its activity in bone metabolism has not been known. Here, we examined the role of ANA on ectopic bone formation activity of BMP. In ANA-deficient and wild-type mice, BMP2 was implanted to induce ectopic bone formation in muscle. ANA deficiency increased mass of newly formed bone in vivo compared with wild-type based on 3D-mu CT analyses. ANA mRNA was expressed in bone in vivo as well as in osteoblastic cells in vitro. Such ANA mRNA levels were increased by BMP2 treatment in MC3T3-E1 osteoblastic cells. Overexpression of ANA suppressed BMP-induced expression of luciferase reporter gene linked to BMP response elements in these cells. Conversely, ANA mRNA knockdown by small interference RNA enhanced the BMP-dependent BMP response element reporter expression. It also enhanced BMP-induced osteoblastic differentiation in muscle-derived C2C12 cells. Immunoprecipitation assay indicated that ANA interacts with Smad8. Thus, ANA is a suppressor of ectopic bone formation induced by BMP, and this inhibitory ANA activity is a part of the negative feedback regulation of BMP function.	[Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, Tokyo 1088639, Japan; [Miyai, Kentaro; Izu, Yayoi; Hemmi, Hiroaki; Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan; [Miyai, Kentaro; Izu, Yayoi; Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Chiyoda Ku, Tokyo 1010062, Japan; [Hasegawa, Urara; Toita, Sayaka; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; [Miyai, Kentaro; Mizutani, Shuki] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med, Bunkyo Ku, Tokyo 1138519, Japan; [Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hemmi, Hiroaki] Tokyo Med & Dent Univ, Med Top Track Program, Med Res Inst, Tokyo 1010062, Japan; [Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Adv Bone & Joint Sci Strateg Res Network Project, Japan Soc Promot Sci, Core Core Program, Tokyo 1010062, Japan; [Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1010062, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp; noda.mph@mri.tmd.ac.jp	Ezura, Yoichi/L-9485-2016; Hayata, Tadayoshi/AAE-9712-2021		Japanese Ministry of Education [18109011, 18659438, 18123456, 20013014]; Japan Space forum; Japan Aerospace Exploration Agency; Advanced Bone and Joint Science Strategic Research Networks Projects; Japan Society for Promotion of Science Core to Core Program	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space forum; Japan Aerospace Exploration Agency; Advanced Bone and Joint Science Strategic Research Networks Projects; Japan Society for Promotion of Science Core to Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid from the Japanese Ministry of Education (Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Grants 18109011, 18659438, 18123456, and 20013014), grants from the Japan Space forum, Japan Aerospace Exploration Agency, and Advanced Bone and Joint Science Strategic Research Networks Projects, and the Japan Society for Promotion of Science Core to Core Program, Research for the Future Program, Genome Science.	Ajima R, 2008, FEBS LETT, V582, P1313, DOI 10.1016/j.febslet.2008.03.012; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Bellows CG, 1998, BONE, V23, P119, DOI 10.1016/S8756-3282(98)00084-2; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kato N, 2007, J CELL BIOCHEM, V101, P1063, DOI 10.1002/jcb.21160; Kodach LL, 2008, CANCER, V112, P300, DOI 10.1002/cncr.23160; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsuda S, 1996, ONCOGENE, V12, P705; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; SHAFFER B, 1989, B HOSP JOINT DIS ORT, V49, P55; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Toom A, 2007, CALCIFIED TISSUE INT, V80, P259, DOI 10.1007/s00223-007-9000-x; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Usui M, 2000, J BONE MINER RES, V15, pS190; Usui M, 2004, P NATL ACAD SCI USA, V101, P6653, DOI 10.1073/pnas.0303093101; Washio-Oikawa K, 2007, J BONE MINER RES, V22, P1217, DOI 10.1359/JBMR.070411; Washio-Oikawa K, 2006, J CELL BIOCHEM, V99, P538, DOI 10.1002/jcb.20854; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Yoshida Y, 2001, JPN J CANCER RES, V92, P592, DOI 10.1111/j.1349-7006.2001.tb01135.x	34	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10593	10600		10.1074/jbc.M807677200	http://dx.doi.org/10.1074/jbc.M807677200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19234306	hybrid, Green Published			2022-12-27	WOS:000265104600033
J	Bur, IM; Cohen-Solal, AM; Carmignac, D; Abecassis, PY; Chauvet, N; Martin, AO; van der Horst, GTJ; Robinson, ICAF; Maurel, P; Mollard, P; Bonnefont, X				Bur, Isabelle M.; Cohen-Solal, Anne M.; Carmignac, Danielle; Abecassis, Pierre-Yves; Chauvet, Norbert; Martin, Agnes O.; van der Horst, Gijsbertus T. J.; Robinson, Iain C. A. F.; Maurel, Patrick; Mollard, Patrice; Bonnefont, Xavier			The Circadian Clock Components CRY1 and CRY2 Are Necessary to Sustain Sex Dimorphism in Mouse Liver Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE-SECRETION; HEPATIC GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; DEFICIENT MICE; PATTERNED INFUSIONS; ELECTRICAL-ACTIVITY; MICROARRAY ANALYSIS; ANTERIOR-PITUITARY; SIGNAL TRANSDUCER; TRANSCRIPTION 5B	In mammals, males and females exhibit anatomical, hormonal, and metabolic differences. A major example of such sex dimorphism in mouse involves hepatic drug metabolism, which is also a noticeable target of circadian timekeeping. However, whether the circadian clock itself contributes to sex-biased metabolism has remained unknown, although several daily output parameters differ between sexes in a number of species, including humans. Here we show that dimorphic liver metabolism is altered when the circadian regulators Cryptochromes, Cry1 and Cry2, are inactivated. Indeed, double mutant Cry1(-/-) Cry2(-/-) male mice that lack a functional circadian clock express a number of sex-specific liver products, including several cytochrome P450 enzymes, at levels close to those measured in females. In addition, body growth of Cry-deficient mice is impaired, also in a sex-biased manner, and this phenotype goes along with an altered pattern of circulating growth hormone (GH) in mutant males, specifically. It is noteworthy that hormonal injections able to mimic male GH pulses reversed the feminized gene expression profile in the liver of Cry1(-/-) Cry2(-/-) males. Altogether, our observations suggest that the 24-h clock paces the dimorphic ultradian pulsatility of GH that is responsible for sex-dependent liver activity. We thus conclude that circadian timing, sex dimorphism, and liver metabolism are finely interconnected.	[Bur, Isabelle M.; Cohen-Solal, Anne M.; Chauvet, Norbert; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] CNRS, Inst Genom Fonct, UMR 5203, F-34094 Montpellier 5, France; [Bur, Isabelle M.; Cohen-Solal, Anne M.; Chauvet, Norbert; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] CNRS, INSERM, U661, F-34094 Montpellier, France; [Bur, Isabelle M.; Cohen-Solal, Anne M.; Chauvet, Norbert; Martin, Agnes O.; Mollard, Patrice; Bonnefont, Xavier] Univ Montpellier, F-34094 Montpellier, France; [Carmignac, Danielle; Robinson, Iain C. A. F.] Natl Inst Med Res, Div Mol Neuroendocrinol, London NW7 1AA, England; [Abecassis, Pierre-Yves] Sanofi Aventis, Discovery Metab & Pharmacokinet Safety DMPK S, F-94140 Alfortville, France; [van der Horst, Gijsbertus T. J.] Erasmus Univ, Med Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Maurel, Patrick] INSERM, U632, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; MRC National Institute for Medical Research; Sanofi-Aventis; Sanofi France; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bonnefont, X (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, 141 Rue Cardonille, F-34094 Montpellier 5, France.	Xavier.Bonnefont@igf.cnrs.fr	Chauvet, Norbert/D-7333-2016; BONNEFONT, Xavier/AAH-3882-2019; van der Horst, Gijsbertus TJ/E-3661-2015	Chauvet, Norbert/0000-0003-4388-6422; BONNEFONT, Xavier/0000-0003-4778-4060; van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Martin, Agnes/0000-0001-6680-7139	Netherlands Organization for Scientific Research [ZonMW Vici 918.36.619]; European Community; Region Languedoc-Roussillon; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Medical Research Council [MC_U117531708] Funding Source: researchfish; MRC [MC_U117531708] Funding Source: UKRI	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Netherlands Organization for Scientific Research Grant ZonMW Vici 918.36.619 to G.T.J.v.d.H., a Marie Curie European Reintegration Grant from the European Community (to X. B.), a grant from the Region Languedoc-Roussillon (to P. M.), a grant from the Institut National de la Sante et de la Recherche Medicale (to P. M. and X. B.), and a grant from the Centre National de la Recherche Scientifique (to P. M. and X. B.).	Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Bonnefont X, 2000, ENDOCRINOLOGY, V141, P868, DOI 10.1210/en.141.3.868; Bonnefont X, 2005, P NATL ACAD SCI USA, V102, P16880, DOI 10.1073/pnas.0508202102; Bonnefont X, 2003, FEBS LETT, V548, P49, DOI 10.1016/S0014-5793(03)00727-0; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; CLARK RG, 1988, ENDOCRINOLOGY, V122, P2675, DOI 10.1210/endo-122-6-2675; CLARK RG, 1985, J ENDOCRINOL, V104, P53, DOI 10.1677/joe.0.1040053; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; DAAN S, 1975, P NATL ACAD SCI USA, V72, P3744, DOI 10.1073/pnas.72.9.3744; Davies JS, 2004, ENDOCRINOLOGY, V145, P2950, DOI 10.1210/en.2003-1236; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100; Fauquier T, 2001, P NATL ACAD SCI USA, V98, P8891, DOI 10.1073/pnas.151339598; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Giacchetti S, 2006, J CLIN ONCOL, V24, P3562, DOI 10.1200/JCO.2006.06.1440; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; GUSTAFSSON JA, 1978, ENDOCRINOLOGY, V103, P141, DOI 10.1210/endo-103-1-141; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Isensee J, 2007, GENDER MED, V4, pS75, DOI 10.1016/S1550-8579(07)80049-0; Jarukamjorn K, 2006, TOXICOLOGY, V219, P97, DOI 10.1016/j.tox.2005.11.014; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuwahara S, 2004, BRAIN RES, V998, P164, DOI 10.1016/j.brainres.2003.10.060; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Low MJ, 2001, J CLIN INVEST, V107, P1571, DOI 10.1172/JCI11941; MACLEOD JN, 1991, J ENDOCRINOL, V131, P395, DOI 10.1677/joe.0.1310395; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; REINERINK EJM, 1991, J CHROMATOGR, V553, P233, DOI 10.1016/S0021-9673(01)88493-4; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Schwartz JB, 2003, CLIN PHARMACOKINET, V42, P107, DOI 10.2165/00003088-200342020-00001; Sun YM, 2006, J BIOMED SCI, V13, P845, DOI 10.1007/s11373-006-9108-4; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vida B, 2008, J NEUROENDOCRINOL, V20, P1270, DOI 10.1111/j.1365-2826.2008.01787.x; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; WILLOUGHBY JO, 1978, BRAIN RES, V151, P413, DOI 10.1016/0006-8993(78)90899-5; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang GY, 2008, COMMUN STAT-SIMUL C, V37, P106, DOI 10.1080/03610910701723930	52	62	63	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9066	9073		10.1074/jbc.M808360200	http://dx.doi.org/10.1074/jbc.M808360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19211562	Green Published, hybrid			2022-12-27	WOS:000264669100009
J	Grishko, V; Xu, M; Ho, R; Mates, A; Watson, S; Kim, JT; Wilson, GL; Pearsall, AW				Grishko, Valentina; Xu, Min; Ho, Renee; Mates, Aaron; Watson, Scott; Kim, Jong T.; Wilson, Glenn L.; Pearsall, Albert W.			Effects of Hyaluronic Acid on Mitochondrial Function and Mitochondria-driven Apoptosis following Oxidative Stress in Human Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GENE-EXPRESSION; REPAIR CAPACITY; DNA-DAMAGE; CELL-DEATH; OSTEOARTHRITIS; MECHANISMS; CYTOKINES; MATRIX	Hyaluronic acid is widely used in the treatment of osteoarthritis and exerts significant chondroprotective effects. The exact mechanisms of its chondroprotective action are not yet fully elucidated. Human articular chondrocytes actively produce reactive oxygen and nitrogen species capable of causing cellular dysfunction and death. A growing body of evidence indicates that mitochondrial dysfunction and mitochondrial DNA damage play a causal role in disorders linked to excessive generation of oxygen free radicals. We hypothesized that the chondroprotective effects of hyaluronic acid on oxidatively stressed chondrocytes are due to preservation of mitochondrial function and amelioration of mitochondria-driven apoptosis. When primary human chondrocyte cultures were exposed to reactive oxygen or nitrogen species generators, mitochondrial DNA damage along with mitochondrial dysfunction and mitochondria-driven apoptosis accumulated as a consequence. In addition, cytokine-treated primary human chondrocytes showed increased levels of mitochondrial DNA damage. Pretreatment of chondrocytes with hyaluronic acid caused a decrease of mitochondrial DNA damage, enhanced mitochondrial DNA repair capacity and cell viability, preservation of ATP levels, and amelioration of apoptosis. The results of these studies demonstrate that enhanced chondrocyte survival and improved mitochondrial function under conditions of oxidative injury are probably important therapeutic mechanisms for the actions of hyaluronic acid in osteoarthritis.	[Grishko, Valentina; Xu, Min; Ho, Renee; Mates, Aaron; Watson, Scott; Kim, Jong T.; Pearsall, Albert W.] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Grishko, Valentina; Wilson, Glenn L.] Univ S Alabama, Dept Orthopaed Surg, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Grishko, V (corresponding author), 307 Univ Blvd,MSB 1201, Mobile, AL 36688 USA.	vgrishko@jaguar1.usouthal.edu						Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Brun P, 2003, OSTEOARTHR CARTILAGE, V11, P208, DOI 10.1016/S1063-4584(02)00352-7; Corrado E. M., 1995, European Journal of Rheumatology and Inflammation, V15, P47; Creamer P, 1994, Osteoarthritis Cartilage, V2, P133, DOI 10.1016/S1063-4584(05)80063-9; Dobson AW, 2002, AM J PHYSIOL-LUNG C, V283, pL205, DOI 10.1152/ajplung.00443.2001; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Grishko VI, 2009, OSTEOARTHR CARTILAGE, V17, P107, DOI 10.1016/j.joca.2008.05.009; Grishko VI, 1997, MUTAT RES-DNA REPAIR, V384, P73, DOI 10.1016/S0921-8777(97)00017-7; HIRASAWA K, 1999, OSTEOARTHR CARTILAGE, V7, P182; Hosono K, 2007, AM J PATHOL, V171, P274, DOI 10.2353/ajpath.2007.060828; Jansen EJP, 2008, J ORTHOP RES, V26, P624, DOI 10.1002/jor.20569; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Kirwan JR, 1997, BAILLIERE CLIN RHEUM, V11, P769, DOI 10.1016/S0950-3579(97)80009-X; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kuhn K, 2003, J CELL PHYSIOL, V197, P379, DOI 10.1002/jcp.10372; Lakshman M, 2004, EXP MOL PATHOL, V76, P196, DOI 10.1016/j.yexmp.2003.12.009; Lee RB, 1997, BIOCHEM J, V321, P95, DOI 10.1042/bj3210095; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Martin G, 2004, ARTHRITIS RHEUM-US, V50, P3549, DOI 10.1002/art.20596; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; PRESTI D, 1994, CELL BIOCHEM FUNCT, V12, P281, DOI 10.1002/cbf.290120409; Punzi L, 2001, CLIN EXP RHEUMATOL, V19, P242; Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200; SCHIAVINATO A, 1989, CLIN ORTHOP RELAT R, P286; SMITH MM, 1987, RHEUMATOL INT, V7, P113, DOI 10.1007/BF00270463; Takahashi K, 2000, J RHEUMATOL, V27, P1713; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Vieira HLA, 1999, CELL MOL LIFE SCI, V56, P971, DOI 10.1007/s000180050486; Wang CT, 2006, OSTEOARTHR CARTILAGE, V14, P1237, DOI 10.1016/j.joca.2006.05.009; Weber GF, 2002, CANCER RES, V62, P2281; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhao H, 2008, INT J ONCOL, V32, P1159	37	86	90	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9132	9139		10.1074/jbc.M804178200	http://dx.doi.org/10.1074/jbc.M804178200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193642	Green Published, hybrid			2022-12-27	WOS:000264669100017
J	Mulero, MC; Aubareda, A; Orzaez, M; Messeguer, J; Serrano-Candelas, E; Martinez-Hoyer, S; Messeguer, A; Perez-Paya, E; Perez-Riba, M				Mulero, M. Carme; Aubareda, Anna; Orzaez, Mar; Messeguer, Joaquim; Serrano-Candelas, Eva; Martinez-Hoyer, Sergio; Messeguer, Angel; Perez-Paya, Enrique; Perez-Riba, Merce			Inhibiting the Calcineurin-NFAT (Nuclear Factor of Activated T Cells) Signaling Pathway with a Regulator of Calcineurin-derived Peptide without Affecting General Calcineurin Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; SMALL ORGANIC-MOLECULES; DOWN-SYNDROME; COMBINATORIAL LIBRARY; SELECTIVE-INHIBITION; CYCLOSPORINE-A; BINDING-SITE; IN-VIVO; IDENTIFICATION; EXPRESSION	Calcineurin phosphatase plays a crucial role in T cell activation. Dephosphorylation of the nuclear factors of activated T cells (NFATs) by calcineurin is essential for activating cytokine gene expression and, consequently, the immune response. Current immunosuppressive protocols are based mainly on calcineurin inhibitors, cyclosporine A and FK506. Unfortunately, these drugs are associated with severe side effects. Therefore, immunosuppressive agents with higher selectivity and lower toxicity must be identified. The immunosuppressive role of the family of proteins regulators of calcineurin (RCAN, formerly known as DSCR1) which regulate the calcineurin-NFAT signaling pathway, has been described recently. Here, we identify and characterize the minimal RCAN sequence responsible for the inhibition of calcineurin-NFAT signaling in vivo. The RCAN-derived peptide spanning this sequence binds to calcineurin with high affinity. This interaction is competed by a peptide spanning the NFAT PXIXIT sequence, which binds to calcineurin and facilitates NFAT dephosphorylation and activation. Interestingly, the RCAN-derived peptide does not inhibit general calcineurin phosphatase activity, which suggests that it may have a specific immunosuppressive effect on the calcineurin-NFAT signaling pathway. As such, the RCAN-derived peptide could either be considered a highly selective immunosuppressive compound by itself or be used as a new tool for identifying innovative immunosuppressive agents. We developed a low throughput assay, based on the RCAN1-calcineurin interaction, which identifies dipyridamole as an efficient in vivo inhibitor of the calcineurin-NFAT pathway that does not affect calcineurin phosphatase activity.	[Mulero, M. Carme; Aubareda, Anna; Serrano-Candelas, Eva; Martinez-Hoyer, Sergio; Perez-Riba, Merce] Inst Invest Biomed & Bellvitge IDIBELL, Med & Mol Genet Ctr, Barcelona 08907, Spain; [Orzaez, Mar; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Dept Med Chem, Valencia 46013, Spain; [Perez-Paya, Enrique] CSIC, Inst Biomed Valencia, Valencia 46010, Spain; [Messeguer, Joaquim; Messeguer, Angel] CSIC, IIQAB, Dept Biol Organ Chem, ES-08034 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC)	Perez-Riba, M (corresponding author), Inst Invest Biomed & Bellvitge IDIBELL, Med & Mol Genet Ctr, Gran Via S-N Km 2-7, Barcelona 08907, Spain.	mpr@idibell.org	Orzaez, Mar/B-4992-2014; Perez-Riba, Merce/AAA-6880-2019; Serrano Candelas, Eva/I-1892-2015	Orzaez, Mar/0000-0003-3231-5835; Serrano Candelas, Eva/0000-0002-8929-5364; Perez-Riba, Merce/0000-0003-1604-4617; Messeguer, Angel/0000-0002-8358-9425	Fundacio La Marato de TV3 [030830]; Generalitat de Catalunya [2006 BE 00051]; Spanish Ministry of Education and Science [SAF2006-04815, BIO2004-00998, BIO2007-60066, CTQ2005-00995/BQU]; Fundacion Mutua Madrilena 2007	Fundacio La Marato de TV3; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education and Science(Spanish Government); Fundacion Mutua Madrilena 2007	This work was supported by grants from the Fundacio La Marato de TV3 (Reference 030830), the Generalitat de Catalunya (Reference 2006 BE 00051), the Spanish Ministry of Education and Science (Grants SAF2006-04815, BIO2004-00998, BIO2007-60066, CTQ2005-00995/BQU), and the Fundacion Mutua Madrilena 2007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Canela N, 2006, J BIOL CHEM, V281, P35942, DOI 10.1074/jbc.M603511200; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; DESCHRYVER EL, 2003, COCHRANE DB SYST REV, V1; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Humet M, 2003, J COMB CHEM, V5, P597, DOI 10.1021/cc020075u; Kang SH, 2005, J BIOL CHEM, V280, P37698, DOI 10.1074/jbc.M502247200; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malet G, 2006, CELL DEATH DIFFER, V13, P1523, DOI 10.1038/sj.cdd.4401828; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Mora P, 2005, J MED CHEM, V48, P1265, DOI 10.1021/jm040834i; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; PerezPaya E, 1997, BBA-BIOMEMBRANES, V1329, P223, DOI 10.1016/S0005-2736(97)00112-0; Rodriguez A, 2005, J BIOL CHEM, V280, P9980, DOI 10.1074/jbc.C400401200; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Vilar M, 2001, J BIOL CHEM, V276, P18122, DOI 10.1074/jbc.M100706200; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5	40	49	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9394	9401		10.1074/jbc.M805889200	http://dx.doi.org/10.1074/jbc.M805889200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19189965	Green Published, hybrid			2022-12-27	WOS:000264669100045
J	Webber, J; Meran, S; Steadman, R; Phillips, A				Webber, Jason; Meran, Soma; Steadman, Robert; Phillips, Aled			Hyaluronan Orchestrates Transforming Growth Factor-beta 1-dependent Maintenance of Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; MUSCLE ACTIN EXPRESSION; GRANULATION-TISSUE; PULMONARY-FIBROSIS; TGF-BETA; PROMOTES; DIFFERENTIATION; PROGRESSION; RECEPTOR; CD44	The differentiation of resident fibroblasts to myofibroblasts is central to wound healing. In the context of organ fibrosis, however, persistence of these myofibroblasts is associated with progressive disease. This study examines mechanisms controlling the maintenance of the myofibroblast phenotype. Myofibroblasts were induced by adding transforming growth factor-beta 1 (TGF-beta 1) (10 ng/ml) to fibroblasts for 72 h. The phenotype was maintained for up to 120 h following removal of TGF-beta 1. Western blot for pSmad2 and -3 demonstrated persistent phosphorylation despite removal of exogenous TGF-beta 1. This persistence was because of autocrine synthesis of TGF-beta 1, which was inhibited by both anti-TGF-beta 1 antibody and the ALK5 inhibitor SB431542. Persistence of phenotype was also associated with increased hyaluronan (HA) generation, synthesis of the hyaladherin TSG6, and HA pericellular coat formation. These were all inhibited by TGF-beta receptor blockade. To further investigate the importance of HA synthesis, 4-methylumbelliferone was used to deplete the cytoplasmic pool of UDP-glucuronic acid, essential for HA chain elongation. This prevented formation of the pericellular HA matrix and decreased expression of alpha-SMA. 4-Methylumbelliferone had no effect, however, on Smad2 and -3 phosphorylation. Similarly inhibition of HAS2 by short interfering RNA prevented phenotypic activation without altering TGF-beta 1-dependent Smad phosphorylation, thus suggesting that HA-dependent regulation of cell phenotype was independent of Smad activation. These data suggest that myofibroblasts in areas of fibrosis maintain their own phenotype through autocrine TGF-beta 1 action and that extracellular HA matrices are an essential mediator of this. We propose a model in which the formation of the pericellular HA matrix regulates the outcome of Smad-dependent autocrine TGF-beta 1-activated signaling, and therefore persistence of the myofibroblast phenotype.	[Webber, Jason; Meran, Soma; Steadman, Robert; Phillips, Aled] Cardiff Univ, Sch Med, Cardiff Inst Tissue Engn & Repair, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Phillips, A (corresponding author), Cardiff Univ, Sch Med, Cardiff Inst Tissue Engn & Repair, Inst Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	phillipsao@cf.ac.uk	Webber, Jason P/O-1960-2017; Steadman, Robert/O-1614-2016	Webber, Jason P/0000-0003-4772-3014; Steadman, Robert/0000-0002-1303-2496	Kidney Wales Foundation	Kidney Wales Foundation	This work was supported by the Kidney Wales Foundation.	Anttila MA, 2000, CANCER RES, V60, P150; Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Desmouliere A, 1996, MOL CELLULAR BIOL WO, P391; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GOUMENOS DS, 1994, NEPHROL DIAL TRANSPL, V9, P1418; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Koch RM, 2000, WOUND REPAIR REGEN, V8, P179, DOI 10.1046/j.1524-475x.2000.00179.x; Kosaki R, 1999, CANCER RES, V59, P1141; KUHN C, 1991, AM J PATHOL, V138, P1257; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; SAPPINO AP, 1990, LAB INVEST, V63, P144; SATO Y, 1993, J CELL BIOL, V123, P1249, DOI 10.1083/jcb.123.5.1249; Schmid P, 1998, AM J PATHOL, V152, P485; Schuppan D, 2000, ACTA GASTRO-ENT BELG, V63, P366; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Yu Q, 2000, GENE DEV, V14, P163; Zhang HY, 1996, AM J PATHOL, V148, P527; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	50	99	103	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9083	9092		10.1074/jbc.M806989200	http://dx.doi.org/10.1074/jbc.M806989200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19193641	Green Published, hybrid			2022-12-27	WOS:000264669100011
J	Rechtman, MM; Nakaryakov, A; Shapira, KE; Ehrlich, M; Henis, YI				Rechtman, Maya Mouler; Nakaryakov, Alex; Shapira, Keren E.; Ehrlich, Marcelo; Henis, Yoav I.			Different Domains Regulate Homomeric and Heteromeric Complex Formation among Type I and Type II Transforming Growth Factor-beta Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; HETEROOLIGOMERIC COMPLEXES; EXTRACELLULAR DOMAIN; OLIGOMERIC STRUCTURE; CYTOPLASMIC DOMAIN; CELL-MEMBRANE; PROTEIN; SIGNAL; FORM; MECHANISMS	Transforming growth factor-beta(TGF-beta) binds to and signals via two serine-threonine kinase receptors, type I (T beta RI) and type II (T beta RII). The oligomerization of TGF-beta receptors modulates ligand binding and receptor trafficking and may contribute to signal diversification. However, numerous features of the molecular domains that determine the homo- and hetero-oligomerization of full-length receptors at the cell surface and the mode of these interactions remain unclear. Here, we address these questions through computerized immunofluorescence co-patching and patch/fluorescence recovery after photo-bleaching measurements of different combinations of epitope-tagged receptors and their mutants in live cells. We show that T beta RI and T beta RII are present on the plasma membrane both as monomers and homo- and hetero-oligomers. The homodimerization of T beta RII depends on a cytoplasmic juxtamembrane region (amino acid residues 200-220). In contrast, the cytoplasmic domain of T beta RI is dispensable for its homodimerization. T beta RI.T beta RII hetero-oligomerization depends on the cytoplasmic domain of T beta RI and on a C-terminal region of T beta RII (residues 419-565). TGF-beta 1 elevates T beta RII homodimerization to some degree and strongly enhances T beta RI.T beta RII heteromeric complex formation. Both ligand-induced effects depend on the region encompassed between residues 200-242 of T beta RII. Furthermore, the kinase activity of T beta RI is also necessary for the latter effect. All forms of the homo- and hetero-oligomers, whether constitutively present on the membrane or formed upon TGF-beta 1 stimulation, were stable in the time-scale of our patch/FRAP measurements. We suggest that the different forms of receptor oligomerization may serve as a basis for the heterogeneity of TGF-beta signaling responses.	[Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Rechtman, Maya Mouler; Nakaryakov, Alex; Shapira, Keren E.; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Ehrlich, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	marceloe@tauex.tau.ac.il; henis@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808; Henis, Yoav/0000-0002-1408-3877	Israel Science Foundation [185/05]; Israel Cancer Research Fund; Israel Cancer Association	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Israel Cancer Association	This work was supported in part by Israel Science Foundation Grant 185/05 and by The Israel Cancer Research Fund and The Israel Cancer Association (to Y.I.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALEXANDROW MG, 1995, CANCER RES, V55, P1452; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Ehrlich M, 2001, J CELL SCI, V114, P1777; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Hu PPC, 1998, ENDOCR REV, V19, P349, DOI 10.1210/er.19.3.349; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Keren T, 2001, J BIOL CHEM, V276, P28356, DOI 10.1074/jbc.M102235200; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; LAIHO M, 1991, J BIOL CHEM, V266, P9108; Letourneur O, 1996, BIOCHEM BIOPH RES CO, V224, P709, DOI 10.1006/bbrc.1996.1088; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Luo KX, 1996, EMBO J, V15, P4485, DOI 10.1002/j.1460-2075.1996.tb00826.x; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; RODRIGUEZ C, 1995, J BIOL CHEM, V270, P15919, DOI 10.1074/jbc.270.27.15919; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shvartsman DE, 2003, J CELL BIOL, V163, P879, DOI 10.1083/jcb.200308142; Stockwell BR, 1998, CURR BIOL, V8, P761, DOI 10.1016/S0960-9822(98)70299-4; WeisGarcia F, 1996, EMBO J, V15, P276, DOI 10.1002/j.1460-2075.1996.tb00358.x; Wells RG, 1999, J BIOL CHEM, V274, P5716, DOI 10.1074/jbc.274.9.5716; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Zhu HJ, 1999, J BIOL CHEM, V274, P29220, DOI 10.1074/jbc.274.41.29220; Zuniga JE, 2005, J MOL BIOL, V354, P1052, DOI 10.1016/j.jmb.2005.10.014	48	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7843	7852		10.1074/jbc.M809215200	http://dx.doi.org/10.1074/jbc.M809215200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19147499	hybrid, Green Published			2022-12-27	WOS:000264195600046
J	Yang, KS; Ilagan, MXG; Piwnica-Worms, D; Pike, LJ				Yang, Katherine S.; Ilagan, Ma. Xenia G.; Piwnica-Worms, David; Pike, Linda J.			Luciferase Fragment Complementation Imaging of Conformational Changes in the Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; EGF RECEPTOR; PROTEIN INTERACTIONS; AUTOPHOSPHORYLATION SITES; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; IN-VIVO; PHOSPHORYLATION; ACTIVATION; DIMERIZATION	Crystal structures of the epidermal growth factor (EGF) receptor suggest that its activation is associated with extensive conformational changes in both the extracellular and intracellular domains. However, evidence of these structural dynamics in intact cells has been lacking. Here we use luciferase complementation imaging to follow EGF-induced conformational changes in its receptor in real time in live cells. When the luciferase fragments are fused to the C terminus of an EGF receptor lacking the cytoplasmic domain, EGF stimulates a rapid increase in luciferase activity, consistent with ligand-induced receptor dimerization. However, when the luciferase fragments are fused to the C terminus of the full-length receptor, EGF induces a rapid but transient decrease in luciferase activity. The decrease requires tyrosine kinase activity, whereas the subsequent recovery requires MAP kinase activity. Our data demonstrate the utility of the luciferase system for in vivo imaging changes in EGF receptor dimerization and conformation. They also identify two sequential ligand-induced conformational changes in the EGF receptor.	[Yang, Katherine S.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Yang, Katherine S.; Pike, Linda J.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		Ilagan, Ma Xenia/0000-0003-2888-4859	NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025973] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA94056] Funding Source: Medline; NIA NIH HHS [R01 AG025973] Funding Source: Medline; NIGMS NIH HHS [R01 GM064491, R01 GM064491-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Blakely BT, 2000, NAT BIOTECHNOL, V18, P218, DOI 10.1038/72686; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Lee NY, 2006, PROTEIN SCI, V15, P1142, DOI 10.1110/ps.052045306; Lee NY, 2005, PROTEIN SCI, V14, P2793, DOI 10.1110/ps.051630305; Li WR, 2008, CANCER RES, V68, P4990, DOI 10.1158/0008-5472.CAN-07-5984; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Lichtner RB, 2001, CANCER RES, V61, P5790; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	41	28	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7474	7482		10.1074/jbc.M808041200	http://dx.doi.org/10.1074/jbc.M808041200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19171934	Green Published, hybrid			2022-12-27	WOS:000264195600011
J	Lee, CL; Pang, PC; Yeung, WSB; Tissot, B; Panico, M; Lao, TTH; Chu, IK; Lee, KF; Chung, MK; Lam, KKW; Koistinen, R; Koistinen, H; Seppala, M; Morris, HR; Dell, A; Chiu, PCN				Lee, Cheuk-Lun; Pang, Poh-Choo; Yeung, William S. B.; Tissot, Berangere; Panico, Maria; Lao, Terence T. H.; Chu, Ivan K.; Lee, Kai-Fai; Chung, Man-Kin; Lam, Kevin K. W.; Koistinen, Riitta; Koistinen, Hannu; Seppala, Markku; Morris, Howard R.; Dell, Anne; Chiu, Philip C. N.			Effects of Differential Glycosylation of Glycodelins on Lymphocyte Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FOLLICULAR-FLUID; PROTEIN-GLYCAN INTERACTIONS; HUMAN PLACENTAL PROTEIN-14; ZONA PELLUCIDA BINDING; INHIBITORY FACTOR-I; APOPTOTIC ACTIVITY; SIALIDASE NEU3; N-ACETYLGLUCOSAMINE; HUMAN SPERMATOZOA; PLASMA-MEMBRANE	Glycodelin is a human glycoprotein with four reported glycoforms, namely glycodelin-A (GdA), glycodelin-F (GdF), glycodelin-C (GdC), and glycodelin-S (GdS). These glycoforms have the same protein core and appear to differ in their N-glycosylation. The glycosylation of GdA is completely different from that of GdS. GdA inhibits proliferation and induces cell death of T cells. However, the glycosylation and immunomodulating activities of GdF and GdC are not known. This study aimed to use ultra-high sensitivity mass spectrometry to compare the glycomes of GdA, GdC, and GdF and to study the relationship between the immunological activity and glycosylation pattern among glycodelin glycoforms. Using MALDI-TOF strategies, the glycoforms were shown to contain an enormous diversity of bi-, tri-, and tetra-antennary complex-type glycans carrying Gal beta 1-4GlcNAc (lacNAc) and/ or GalNAc beta 1-4GlcNAc (lacdiNAc) antennae backbones with varying levels of fucose and sialic acid substitution. Interestingly, they all carried a family of Sda (NeuAc alpha 2-3(GalNAc beta 1-4)Gal)-containing glycans, which were not identified in the earlier study because of less sensitive methodologies used. Among the three glycodelins, GdA is the most heavily sialylated. Virtually all the sialic acid on GdC is located on the Sda antennae. With the exception of the Sda epitope, the GdC N-glycome appears to be the asialylated counterpart of the GdA/GdF glycomes. Sialidase activity, which may be responsible for transforming GdA/GdF to GdC, was detected in cumulus cells. Both GdA and GdF inhibited the proliferation, induced cell death, and suppressed interleukin-2 secretion of Jurkat cells and peripheral blood mononuclear cells. In contrast, no immunosuppressive effect was observed for GdS and GdC.	[Pang, Poh-Choo; Tissot, Berangere; Panico, Maria; Morris, Howard R.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; [Lee, Cheuk-Lun; Yeung, William S. B.; Lee, Kai-Fai; Chung, Man-Kin; Lam, Kevin K. W.; Chiu, Philip C. N.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Lun; Chu, Ivan K.] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Lao, Terence T. H.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Koistinen, Riitta] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki 00029, Hus, Finland; [Morris, Howard R.] M SCAN Ltd, Wokingham RG41 2TZ, Berks, England	Imperial College London; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital	Dell, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England.	a.dell@imperial.ac.uk; pchiucn@hkucc.hku.hk	Chu, Ivan Keung/D-3065-2009; Koistinen, Hannu/AGU-1279-2022; Lee, Cheuk Lun/AGX-5720-2022; /C-7476-2009; Seppala, Markku/AAT-6618-2021; Chung, Man Kin/B-9613-2012; Chiu, Chi Ngong/C-4245-2009; Chiu, Philip/A-4019-2009; Lee, Calvin Kai Fai/C-4328-2009	Koistinen, Hannu/0000-0003-0926-3109; Chung, Man Kin/0000-0003-4239-4311; Chiu, Chi Ngong/0000-0001-6217-1970; Chiu, Philip/0000-0001-9292-112X; Lee, Calvin Kai Fai/0000-0001-5957-439X; Lee, Cheuk Lun/0000-0003-1553-3478	Research Grants Council (RGC) [HKU 764706M, HKU 764007M]; Biotechnology and Biological Sciences Research Council (BBSRC) [B19088, SF19107]; Imperial College London Scholarships; Malaysian Institute of Strategic and International Studies (ISIS) Perdana Scholarship; Biotechnology and Biological Sciences Research Council [B19088, SF19107] Funding Source: researchfish	Research Grants Council (RGC)(Hong Kong Research Grants Council); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College London Scholarships; Malaysian Institute of Strategic and International Studies (ISIS) Perdana Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Research Grants Council (RGC) Grants HKU 764706M and HKU 764007M, by Grants B19088 and SF19107 from the Biotechnology and Biological Sciences Research Council (BBSRC), including a BBSRC Professorial Fellowship (to A. D.), and by Imperial College London Scholarships and the Malaysian Institute of Strategic and International Studies (ISIS) Perdana Scholarship (to P.-C. P.).	Azuma Y, 2007, BIOL PHARM BULL, V30, P1680, DOI 10.1248/bpb.30.1680; Bianco GA, 2006, AUTOIMMUN REV, V5, P349, DOI 10.1016/j.autrev.2006.02.003; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chian RC, 1999, FERTIL STERIL, V71, P61, DOI 10.1016/S0015-0282(98)00416-6; Chiu PCN, 2005, J BIOL CHEM, V280, P25580, DOI 10.1074/jbc.M504103200; Chiu PCN, 2004, BIOL REPROD, V70, P1710, DOI 10.1095/biolreprod.103.023259; Chiu PCN, 2003, BIOL REPROD, V69, P365, DOI 10.1095/biolreprod.102.012658; Chiu PCN, 2003, J BIOL CHEM, V278, P13570, DOI 10.1074/jbc.M212086200; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; CONZELMANN A, 1988, J EXP MED, V167, P119, DOI 10.1084/jem.167.1.119; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ha KT, 2004, MOL CELLS, V17, P267; Haslam SM, 2006, CURR OPIN STRUC BIOL, V16, P584, DOI 10.1016/j.sbi.2006.08.006; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Jayachandran R, 2004, J BIOL CHEM, V279, P8585, DOI 10.1074/jbc.M310480200; Jayachandran R, 2006, GLYCOBIOLOGY, V16, P1052, DOI 10.1093/glycob/cwl024; Jeschke U, 2007, ANTICANCER RES, V27, P2101; JULKUNEN M, 1988, P NATL ACAD SCI USA, V85, P8845, DOI 10.1073/pnas.85.23.8845; Klisch K, 2008, GLYCOBIOLOGY, V18, P42, DOI 10.1093/glycob/cwm113; Koistinen H, 2003, BIOL REPROD, V69, P1545, DOI 10.1095/biolreprod.103.017830; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Miller RE, 1998, FEBS LETT, V436, P455, DOI 10.1016/S0014-5793(98)01184-3; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P8577, DOI 10.1074/jbc.M306673200; Ng EHY, 2000, HUM REPROD, V15, P772; OEHNINGER S, 1995, FERTIL STERIL, V63, P377; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKAMOTO N, 1991, AM J REPROD IMMUNOL, V26, P137, DOI 10.1111/j.1600-0897.1991.tb00713.x; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; POCKLEY AG, 1989, CLIN EXP IMMUNOL, V77, P252; Poornima BL, 2007, FEBS LETT, V581, P4366, DOI 10.1016/j.febslet.2007.07.078; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Seppala M, 2007, HUM REPROD UPDATE, V13, P275, DOI 10.1093/humupd/dmm004; Seppala M, 2004, INT J GYNECOL OBSTET, V85, P105, DOI 10.1016/j.ijgo.2004.01.007; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shiyan SD, 1997, GLYCOCONJUGATE J, V14, P631, DOI 10.1023/A:1018544711767; Skornicka EL, 2004, CELL IMMUNOL, V232, P144, DOI 10.1016/j.cellimm.2005.03.007; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; Toscano MA, 2006, MEDICINA-BUENOS AIRE, V66, P357; TSUJI T, 1987, J BIOCHEM-TOKYO, V101, P241, DOI 10.1093/oxfordjournals.jbchem.a121897; Tulsiani DRP, 2003, MICROSC RES TECHNIQ, V61, P18, DOI 10.1002/jemt.10313; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 1999, ESSENTIALS GLYCOBIOL; WAGNER H, 1980, NATURE, V284, P278, DOI 10.1038/284278a0; Yaniv E, 2003, CELL IMMUNOL, V222, P156, DOI 10.1016/S0008-8749(03)00129-1; Yao YQ, 1998, HUM REPROD, V13, P2541, DOI 10.1093/humrep/13.9.2541; Yeung William S B, 2007, Soc Reprod Fertil Suppl, V63, P143; Yeung WSB, 2006, MOL CELL ENDOCRINOL, V250, P149, DOI 10.1016/j.mce.2005.12.038	56	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15084	15096		10.1074/jbc.M807960200	http://dx.doi.org/10.1074/jbc.M807960200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19240032	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000266288200044
J	Friedman, MS; Oyserman, SM; Hankenson, KD				Friedman, Michael S.; Oyserman, Sivan M.; Hankenson, Kurt D.			Wnt11 Promotes Osteoblast Maturation and Mineralization through R-spondin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; DENTIN MATRIX PROTEIN-1; APICAL ECTODERMAL RIDGE; BETA-CATENIN; BONE-FORMATION; IN-VIVO; DIFFERENTIATION; EXPRESSION; LRP6; GENE	Wnt11 signals through both canonical (beta-catenin) and non-canonical pathways and is up-regulated during osteoblast differentiation and fracture healing. In these studies, we evaluated the role of Wnt11 during osteoblastogenesis. Wnt11 overexpression in MC3T3E1 pre-osteoblasts increases beta-catenin accumulation and promotes bone morphogenetic protein (BMP)-induced expression of alkaline phosphatase and mineralization. Wnt11 dramatically increases expression of the osteoblast-associated genes Dmp1 (dentin matrix protein 1), Phex (phosphate-regulating endopeptidase homolog), and Bsp (bone sialoprotein). Wnt11 also increases expression of Rspo2 (R-spondin 2), a secreted factor known to enhance Wnt signaling. Overexpression of Rspo2 is sufficient for increasing Dmp1, Phex, and Bsp expression and promotes bone morphogenetic protein-induced mineralization. Knockdown of Rspo2 abrogates Wnt11-mediated osteoblast maturation. Antagonism of T-cell factor (Tcf)/beta-catenin signaling with dominant negative Tcf blocks Wnt11-mediated expression of Dmp1, Phex, and Rspo2 and decreases mineralization. However, dominant negative Tcf fails to block the osteogenic effects of Rspo2 overexpression. These studies show that Wnt11 signals through beta-catenin, activating Rspo2 expression, which is then required for Wnt11-mediated osteoblast maturation.	[Friedman, Michael S.; Oyserman, Sivan M.] ThermoGenesis Corp, Rancho Cordova, CA 95742 USA; [Hankenson, Kurt D.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19103 USA	University of Pennsylvania	Hankenson, KD (corresponding author), 311 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	kdhank@vet.upenn.edu	Hankenson, Kurt/ABI-1547-2020; Hankenson, Kurt/AFS-9417-2022	Hankenson, Kurt/0000-0001-6361-143X	National Institutes of Health [R01DE017471, R01AR028922]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE017471 and R01AR028922.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Chakladar A, 2005, BIOCHEM BIOPH RES CO, V336, P190, DOI 10.1016/j.bbrc.2005.08.061; Fischer L, 2002, J BIOL CHEM, V277, P30870, DOI 10.1074/jbc.M109330200; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; WENYAN L, 2008, FEBS LETT, V582, P643; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702	38	79	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14117	14125		10.1074/jbc.M808337200	http://dx.doi.org/10.1074/jbc.M808337200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19213727	hybrid, Green Published			2022-12-27	WOS:000266286100018
J	Choi, WI; Jeon, BN; Yun, CO; Kim, PH; Kim, SE; Choi, KY; Kim, SH; Hur, MW				Choi, Won-Il; Jeon, Bu-Nam; Yun, Chae-Ok; Kim, Pyung-Hwan; Kim, Sung-Eun; Choi, Kang-Yell; Kim, Se Hoon; Hur, Man-Wook			Proto-oncogene FBI-1 Represses Transcription of p21CIP1 by Inhibition of Transcription Activation by p53 and Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN INTERACTION MOTIF; CENTER B-CELLS; ZINC-FINGER PROTEIN; NF-KAPPA-B; POZ-DOMAIN; DNA-BINDING; HISTONE DEACETYLASE; P21(WAF1/CIP1) GENE; BTB/POZ DOMAIN	Aberrant transcriptional repression through chromatin remodeling and histone deacetylation has been postulated as the driving force for tumorigenesis. FBI-1 (formerly called Pokemon) is a member of the POK family of transcriptional repressors. Recently, FBI-1 was characterized as a critical oncogenic factor that specifically represses transcription of the tumor suppressor gene ARF, potentially leading indirectly to p53 inactivation. Our investigations on transcriptional repression of the p53 pathway revealed that FBI-1 represses transcription of ARF, Hdm2 (human analogue of mouse double minute oncogene), and p21CIP1 (hereafter indicated as p21) but not of p53. FBI-1 showed a more potent repressive effect on p21 than on p53. Our data suggested that FBI-1 is a master controller of the ARF-Hdm2-p53-p21 pathway, ultimately impinging on cell cycle arrest factor p21, by inhibiting upstream regulators at the transcriptional and protein levels. FBI-1 acted as a competitive transcriptional repressor of p53 and Sp1 and was shown to bind the proximal Sp1-3 GC-box and the distal p53-responsive elements of p21. Repression involved direct binding competition of FBI-1 with Sp1 and p53. FBI-1 also interacted with corepressors, such as mSin3A, NCoR, and SMRT, thereby deacetylating Ac-H3 and Ac-H4 histones at the promoter. FBI-1 caused cellular transformation, promoted cell cycle proliferation, and significantly increased the number of cells in S phase. FBI-1 is aberrantly overexpressed in many human solid tumors, particularly in adenocarcinomas and squamous carcinomas. The role of FBI-1 as a master controller of the p53 pathway therefore makes it an attractive therapeutic target.	[Choi, Won-Il; Jeon, Bu-Nam; Hur, Man-Wook] Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Project BK21, Seoul 120752, South Korea; [Yun, Chae-Ok; Kim, Pyung-Hwan] Yonsei Univ, Sch Med, Inst Canc Res, Seoul 120752, South Korea; [Kim, Sung-Eun; Choi, Kang-Yell] Yonsei Univ, Dept Biotechnol, Seoul 120752, South Korea; [Kim, Se Hoon] Yonsei Univ, Sch Med, Dept Pathol, Seoul 120752, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Project BK21, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Kim, Sung-Eun/ABC-8837-2020; Yun, Chae-Ok/P-3698-2015	Kim, Sung-Eun/0000-0001-8667-3887; Hur, Man-Wook/0000-0002-3416-1334; CHOI, WONIL/0000-0002-4837-0436; Kim, Se Hoon/0000-0001-7516-7372; Yun, Chae-Ok/0000-0002-9466-4531	National Research Laboratory Research [ROA-2003-000-10318-0]; Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology [R13-2002-054-05002-0]; Korean Ministry for Health, Welfare, and Family [00001561]	National Research Laboratory Research(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology(Korea Science and Engineering Foundation); Korean Ministry for Health, Welfare, and Family	This work was supported by National Research Laboratory Research Grant ROA-2003-000-10318-0 (to M. W. H.) and Medical Research Center Grant R13-2002-054-05002-0 (to M. W. H.) from the Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology and in part by National R & D Program for Cancer Control Affairs Grant 00001561 (to M. W. H.) from the Korean Ministry for Health, Welfare, and Family.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Baron BW, 2007, P NATL ACAD SCI USA, V104, P7449, DOI 10.1073/pnas.0701770104; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Huynh KD, 2000, GENE DEV, V14, P1810; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; KACZYNSKI J, 2004, GENOME BIOL, V4; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Laudes M, 2008, J MOL MED, V86, P597, DOI 10.1007/s00109-008-0326-2; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334	57	62	70	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12633	12644		10.1074/jbc.M809794200	http://dx.doi.org/10.1074/jbc.M809794200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19244234	hybrid, Green Published			2022-12-27	WOS:000265688300007
J	Minasov, G; Padavattan, S; Shuvalova, L; Brunzelle, JS; Miller, DJ; Basle, A; Massa, C; Collart, FR; Schirmer, T; Anderson, WF				Minasov, George; Padavattan, Sivaraman; Shuvalova, Ludmilla; Brunzelle, Joseph S.; Miller, Darcie J.; Basle, Arnaud; Massa, Claudia; Collart, Frank R.; Schirmer, Tilman; Anderson, Wayne F.			Crystal Structures of YkuI and Its Complex with Second Messenger Cyclic Di-GMP Suggest Catalytic Mechanism of Phosphodiester Bond Cleavage by EAL Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC CONTROL; ACETOBACTER-XYLINUM; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; PROTEIN; DIGUANYLATE; FOLD; BLUF; CLASSIFICATION; DIMERIZATION	Cyclic di-GMP (c-di-GMP) is a ubiquitous bacterial second messenger that is involved in the regulation of cell surface-associated traits and the persistence of infections. Omnipresent GGDEF and EAL domains, which occur in various combinations with regulatory domains, catalyze c-di-GMP synthesis and degradation, respectively. Thecrystal structure of full-length YkuI from Bacillus subtilis, composed of an EAL domain and a C-terminal PAS-like domain, has been determined in its native form and in complex with c-di-GMP and Ca2+. The EAL domain exhibits a triose-phosphate isomerase-barrel fold with one antiparallel beta-strand. The complex with c-di-GMP-Ca2+ defines the active site of the putative phosphodiesterase located at the C-terminal end of the beta-barrel. The EAL motif is part of the active site with Glu-33 of the motif being involved in cation coordination. The structure of the complex allows the proposal of a phosphodiesterase mechanism, in which the divalent cation and the general base Glu-209 activate a catalytic water molecule for nucleophilic in-line attack on the phosphorus. The C-terminal domain closely resembles the PAS-fold. Its pocket-like structure could accommodate a yet unknown ligand. YkuI forms a tight dimer via EAL-EAL and trans EAL-PAS-like domain association. The possible regulatory significance of the EAL-EAL interface and a mechanism for signal transduction between sensory and catalytic domains of c-di-GMP-specific phosphodiesterases are discussed.	[Minasov, George; Shuvalova, Ludmilla; Miller, Darcie J.; Anderson, Wayne F.] NW Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Minasov, George; Shuvalova, Ludmilla; Miller, Darcie J.; Anderson, Wayne F.] NW Feinberg Sch Med, Midwest Ctr Struct Genom, Chicago, IL 60611 USA; [Padavattan, Sivaraman; Massa, Claudia; Schirmer, Tilman] Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland; [Brunzelle, Joseph S.] Argonne Natl Lab, Adv Photon Source, LS CAT, Argonne, IL 60439 USA; [Miller, Darcie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Collart, Frank R.] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Basel; United States Department of Energy (DOE); Argonne National Laboratory; St Jude Children's Research Hospital; United States Department of Energy (DOE); Argonne National Laboratory	Schirmer, T (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.	tilman.schirmer@unibas.ch; wf-anderson@northwestern.edu		Collart, Frank/0000-0001-6942-4483; Padavattan, Sivaraman/0000-0002-1732-5421; Basle, Arnaud/0000-0002-4899-3086; Minasov, George/0000-0001-5460-3462	National Institutes of Health [U54 GM074942]; Swiss National Science Foundation [3100A0-10587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 GM074942 (Midwest Center for Structural Genomics). This work was also supported by Swiss National Science Foundation Grant 3100A0-10587.	Amiot N, 2006, SYNTHESIS-STUTTGART, P4230, DOI 10.1055/s-2006-950361; Anderson S, 2004, ACTA CRYSTALLOGR D, V60, P1008, DOI 10.1107/S090744490400616X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hasegawa K, 2006, BIOCHEMISTRY-US, V45, P3785, DOI 10.1021/bi051820x; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEBIODA L, 1989, J BIOL CHEM, V264, P3685; LESLIE A, 1992, JOINT CCP4 ESF EACBM, V27; LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nakasone Y, 2007, J AM CHEM SOC, V129, P7028, DOI 10.1021/ja065682q; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rau A, 2001, J BIOL CHEM, V276, P31994, DOI 10.1074/jbc.M102591200; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; ROUSSEL A, 1989, SILICON GRAPHICS PAR; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schroeder C, 2008, CHEMBIOCHEM, V9, P2463, DOI 10.1002/cbic.200800280; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	54	71	74	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13174	13184		10.1074/jbc.M808221200	http://dx.doi.org/10.1074/jbc.M808221200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19244251	Green Published, hybrid			2022-12-27	WOS:000265688300064
J	Forsee, WT; Cartee, RT; Yother, J				Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet			A Kinetic Model for Chain Length Modulation of Streptococcus pneumoniae Cellubiuronan Capsular Polysaccharide by Nucleotide Sugar Donor Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHONDROITIN SULFATE; N-ACETYLGLUCOSAMINE; ALPHA-LACTALBUMIN; CRYSTAL-STRUCTURE; TYPE-3 SYNTHASE; BINDING-SITE; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; MECHANISM	The chain length of Streptococcus pneumoniae type 3 capsular polysaccharide (cellubiuronic acid) is tightly regulated by the cellubiuronic acid synthase through an assembly process involving a catalytic motif that is potentially conserved over a wide range of related processive beta-glucan synthases. Cellubiuronic acid is initiated on a lipid and is composed of alternating beta-1,3-Glc and beta-1,4-glucuronic acid (GlcUA) linkages. The entire assembly process is carried out by a polypeptide synthase thought to contain a single active site, suggesting that the donor specificity is controlled by the terminal nonreducing sugar in the acceptor subsite. Shortly after initiation, the synthase undergoes an allosteric transition accompanied by the tight binding of the nascent chain via its nonreducing oligosaccharide terminal segment to the carbohydrate acceptor recognition site. The chain length of polysaccharide assembled by recombinant synthase in Escherichia coli membranes was determined by an ejection mechanism that appeared to be a reversal of the allosteric transition of the synthase from the transitory to the fully processive state. The rates of both ejection and transition were shown to be highly sensitive to the concentration of UDP-GlcUA. As the concentration of UDP-GlcUA was increased, both the rate of synthesis and the processive turnover time increased. The product of the processive turnover time and the rate of synthesis predicted a marked increase in polysaccharide chain size (from 50 to 1150 kDa) over a relatively narrow concentration range of 1-11.5 mu M UDP-GlcUA. The kinetic model chain length predictions were in close agreement with chemically determined sizes of polysaccharides synthesized at the same UDP-sugar concentrations. The model indicates that translocation occurs following the addition of GlcUA to the chain terminus, whereas UDP-Glc drives chain termination when inadequate levels of UDP-GlcUA are present. In sum, type 3 synthase appears to modulate polysaccharide chain length by functioning as a concentration-dependent kinetic timing device.	[Forsee, W. Thomas; Cartee, Robert T.; Yother, Janet] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Yother, J (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S,BBRB 661-12, Birmingham, AL 35294 USA.	jyother@uab.edu			National Institutes of Health [R01 GM53017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01 GM53017.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Cartee RT, 2005, J BACTERIOL, V187, P4470, DOI 10.1128/JB.187.13.4470-4479.2005; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Cartee RT, 2001, J BIOL CHEM, V276, P48831, DOI 10.1074/jbc.M106481200; Carter JA, 2007, MICROBIOL-SGM, V153, P3499, DOI 10.1099/mic.0.2007/010066-0; Charnock SJ, 2001, PLANT PHYSIOL, V125, P527, DOI 10.1104/pp.125.2.527; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Forsee WT, 2009, J BIOL CHEM, V284, P11826, DOI 10.1074/jbc.M900386200; Forsee WT, 2000, J BIOL CHEM, V275, P25972, DOI 10.1074/jbc.M002613200; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; KHARTA BS, 1974, EUR J BIOCHEM, V44, P537; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LIDHOLT K, 1988, BIOCHEM J, V254, P571, DOI 10.1042/bj2540571; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; MITCHELL D, 1982, BIOCHEM J, V202, P387, DOI 10.1042/bj2020387; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Pummill PE, 1998, J BIOL CHEM, V273, P4976, DOI 10.1074/jbc.273.9.4976; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Rodeheffer C, 2002, BBA-GEN SUBJECTS, V1573, P258, DOI 10.1016/S0304-4165(02)00392-6; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; TELSER A, 1966, ARCH BIOCHEM BIOPHYS, V116, P458, DOI 10.1016/0003-9861(66)90053-1; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	35	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11836	11844		10.1074/jbc.M900379200	http://dx.doi.org/10.1074/jbc.M900379200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19228689	Green Published, hybrid			2022-12-27	WOS:000265494600015
J	Mehta, H; Glogauer, M; Becart, S; Altman, A; Coggeshall, KM				Mehta, Harshini; Glogauer, Michael; Becart, Stephane; Altman, Amnon; Coggeshall, K. Mark			Adaptor Protein SLAT Modulates Fc gamma Receptor-mediated Phagocytosis in Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; ALDRICH-SYNDROME PROTEIN; SIGNAL-TRANSDUCTION; IMMUNOLOGICAL SYNAPSE; HUMAN NEUTROPHILS; RHO GTPASES; ACTIVATION; RAC1; CDC42; CELLS	SLAT (SWAP-70-like adaptor protein of T cells) is an adaptor protein expressed in cells of the hematopoietic system. SLAT interacts with and alters the function of small GTPase Rac1 in fibroblasts. In these nonhematopoietic models, the SLAT-Rac interaction leads to changes in F-actin and causes cytoskeletal reorganization. In T cells, SLAT expression regulates the development of T helper cells through Cdc42- and Rac1-mediated activation of the NF-AT transcription factor. Here we show that SLAT is expressed in macrophages. Overexpression of SLAT in a macrophage cell line inhibits the IgG Fc gamma receptor-mediated phagocytic ability of THP1 cells. In bone marrow-derived macrophages, SLAT protein is recruited to the early phagosomes formed via Fc gamma receptor engagement. SLAT recruitment to the phagosome was most efficient when the macrophages express at least one isoform of Rac (Rac1 or Rac2), because SLAT recruitment was reduced in macrophages of Rac-deficient mice. Macrophages derived from animals lacking SLAT show an elevation in the rate of Fc gamma receptor-mediated phagocytosis. The absence of SLAT is associated with an increase in the amount of F-actin formed around these phagosomes as well as an increase in the amount of Rac1 protein recruited to the phagosome. Our results suggest that SLAT acts as a gatekeeper for the amount of Rac recruited to the phagosomes formed by Fc gamma receptor engagement and thus is able to regulate F-actin re-organization and consequently phagocytosis.	[Mehta, Harshini; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Program Immunobiol & Canc, Oklahoma City, OK 73104 USA; [Mehta, Harshini; Coggeshall, K. Mark] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Glogauer, Michael] Univ Toronto, Fac Dent, Canadian Inst Hlth Res Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Becart, Stephane; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Toronto; La Jolla Institute for Immunology	Coggeshall, KM (corresponding author), Oklahoma Med Res Fdn, Program Immunobiol & Canc, 825 NE 13th St, Oklahoma City, OK 73104 USA.	coggeshallm@omrf.ouhsc.edu	Glogauer, Michael/D-2504-2011	Glogauer, Michael/0000-0002-6248-5977	National Institutes of Health [AI068320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068320 (to A.A).	Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bonilla FA, 2000, P NATL ACAD SCI USA, V97, P1725, DOI 10.1073/pnas.040543597; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Castellano F, 2000, J CELL SCI, V113, P2955; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; Coppolino MG, 2001, J CELL SCI, V114, P4307; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Duchemin AM, 1997, J IMMUNOL, V158, P865; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Lee WL, 2007, J BIOL CHEM, V282, P11135, DOI 10.1074/jbc.M700823200; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Taylor L S, 2000, Rev Immunogenet, V2, P204; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zandman-Goddard Gisele, 2005, Clin Dev Immunol, V12, P107, DOI 10.1080/17402520500116723	51	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11882	11891		10.1074/jbc.M809712200	http://dx.doi.org/10.1074/jbc.M809712200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251698	Green Published, hybrid			2022-12-27	WOS:000265494600020
J	Autefage, H; Albinet, V; Garcia, V; Berges, H; Nicolau, ML; Therville, N; Altie, MF; Caillaud, C; Levade, T; Andrieu-Abadie, N				Autefage, Helene; Albinet, Virginie; Garcia, Virginie; Berges, Hortense; Nicolau, Marie-Laure; Therville, Nicole; Altie, Marie-Francoise; Caillaud, Catherine; Levade, Thierry; Andrieu-Abadie, Nathalie			Lysosomal Serine Protease CLN2 Regulates Tumor Necrosis Factor-alpha-mediated Apoptosis in a Bid-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPEPTIDYL-PEPTIDASE-I; CATHEPSIN-D DEFICIENCY; CYTOCHROME-C; CELL-DEATH; OXIDATIVE STRESS; SUBUNIT C; CYSTEINE CATHEPSINS; CASPASE ACTIVATION; GENE-PRODUCT; INVOLVEMENT	Apoptosis is a highly organized, energy-dependent program by which multicellular organisms eliminate damaged, superfluous, and potentially harmful cells. Although caspases are the most prominent group of proteases involved in the apoptotic process, the role of lysosomes has only recently been unmasked. This study investigated the role of the lysosomal serine protease CLN2 in apoptosis. We report that cells isolated from patients affected with late infantile neuronal ceroid lipofuscinosis (LINCL) having a deficient activity of CLN2 are resistant to the toxic effect of death ligands such as tumor necrosis factor (TNF), CD95 ligand, or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not to receptor-independent stress agents. CLN2-deficient cells exhibited a defect in TNF-induced Bid cleavage, release of cytochrome c, and caspase-9 and -3 activation. Moreover, extracts from CLN2-overexpressing cells or a CLN2 recombinant protein were able to catalyze the in vitro cleavage of Bid. Noteworthy, correction of the lysosomal enzyme defect of LINCL fibroblasts using a medium enriched in CLN2 protein enabled restoration of TNF-induced Bid and caspase-3 processing and toxicity. Conversely, transfection of CLN2-corrected cells with small interfering RNA targeting Bid abrogated TNF-induced cell death. Altogether, our study demonstrates that genetic deletion of the lysosomal serine protease CLN2 and the subsequent loss of its catalytic function confer resistance to TNF in non-neuronal somatic cells, indicating that CLN2 plays a yet unsuspected role in TNF-induced cell death.	[Andrieu-Abadie, Nathalie] Inst Med Mol Rangueil, INSERM, U858, F-31432 Toulouse, France; [Autefage, Helene; Albinet, Virginie; Garcia, Virginie; Berges, Hortense; Nicolau, Marie-Laure; Therville, Nicole; Altie, Marie-Francoise; Levade, Thierry; Andrieu-Abadie, Nathalie] Univ Toulouse 3, Inst Med Mol Rangueil, IFR31, F-31432 Toulouse, France; [Caillaud, Catherine] Univ Paris 05, Inst Cochin Genet Mol, CNRS,UMR 8104, INSERM,U567, F-75014 Paris, France; [Levade, Thierry] CHU Toulouse, Lab Biochem Metab, F-31432 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse	Andrieu-Abadie, N (corresponding author), Inst Med Mol Rangueil, INSERM, U858, BP84225, F-31432 Toulouse, France.	nathalie.andrieu@inserm.fr	Andrieu-Abadie, Nathalie/N-6793-2013; GARCIA, Virginie/W-8313-2019; Therville, Nicole/P-2371-2014; Levade, Thierry/O-8948-2014	Andrieu-Abadie, Nathalie/0000-0003-2698-1970; GARCIA, Virginie/0000-0002-9761-7036; Therville, Nicole/0000-0002-7068-1361; 	INSERM; Universite Paul Sabatier; Association Vaincre les Maladies Lysosomales; Federation pour la Recherche sur le Cerveau; Groupement d'Interet Scientifique Institut des Maladies Rares	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paul Sabatier; Association Vaincre les Maladies Lysosomales; Federation pour la Recherche sur le Cerveau; Groupement d'Interet Scientifique Institut des Maladies Rares	This work was supported by grants from INSERM, Universite Paul Sabatier, the Association Vaincre les Maladies Lysosomales, the Federation pour la Recherche sur le Cerveau, and Groupement d'Interet Scientifique Institut des Maladies Rares.	Bernardini F, 2001, Eur J Paediatr Neurol, V5 Suppl A, P69, DOI 10.1053/ejpn.2000.0438; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Brunk UT, 1999, REDOX REP, V4, P3, DOI 10.1179/135100099101534675; Chatelut M, 1997, CLIN CHIM ACTA, V262, P61, DOI 10.1016/S0009-8981(97)06527-3; Cho SG, 2000, J NEUROCHEM, V74, P1478, DOI 10.1046/j.1471-4159.2000.0741478.x; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Emert-Sedlak L, 2005, MOL CANCER THER, V4, P733, DOI 10.1158/1535-7163.MCT-04-0301; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; Ezaki J, 1999, J NEUROCHEM, V72, P2573, DOI 10.1046/j.1471-4159.1999.0722573.x; Ezaki J, 2000, J BIOCHEM-TOKYO, V128, P509, DOI 10.1093/oxfordjournals.jbchem.a022781; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Huc L, 2006, J CELL PHYSIOL, V208, P527, DOI 10.1002/jcp.20686; Junaid MA, 2000, J NEUROCHEM, V74, P287, DOI 10.1046/j.1471-4159.2000.0740287.x; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kopan S, 2004, BIOCHEM BIOPH RES CO, V319, P58, DOI 10.1016/j.bbrc.2004.04.142; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Liu CG, 1998, GENOMICS, V50, P206, DOI 10.1006/geno.1998.5328; Liu MJ, 2007, BIOCHEM BIOPH RES CO, V362, P295, DOI 10.1016/j.bbrc.2007.07.118; Lyly A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-22; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MCDONALD JK, 1985, BIOCHEM BIOPH RES CO, V126, P63, DOI 10.1016/0006-291X(85)90571-6; Miao Q, 2008, J BIOL CHEM, V283, P8218, DOI 10.1074/jbc.M709789200; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Nagaraj NS, 2007, APOPTOSIS, V12, P125, DOI 10.1007/s10495-006-0490-1; Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Paris C, 2007, APOPTOSIS, V12, P1257, DOI 10.1007/s10495-007-0052-1; Puranam KL, 1999, MOL GENET METAB, V66, P294, DOI 10.1006/mgme.1999.2834; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Segal MS, 2001, AM J PHYSIOL-CELL PH, V281, pC1196, DOI 10.1152/ajpcell.2001.281.4.C1196; Shacka JJ, 2007, AUTOPHAGY, V3, P474, DOI 10.4161/auto.4341; Shimizu M, 1999, J IMMUNOL, V162, P7350; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 1999, J NEUROCHEM, V73, P700, DOI 10.1046/j.1471-4159.1999.0730700.x; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Stoka V, 2007, BIOL CHEM, V388, P555, DOI 10.1515/BC.2007.064; Tardy C, 2004, J BIOL CHEM, V279, P52914, DOI 10.1074/jbc.M408261200; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Terman A, 2002, EXP CELL RES, V274, P9, DOI 10.1006/excr.2001.5441; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Walus M, 2005, FEBS LETT, V579, P1383, DOI 10.1016/j.febslet.2005.01.035; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Zhao M, 2000, FEBS LETT, V485, P104, DOI 10.1016/S0014-5793(00)02195-5; Zhao M, 2001, FEBS LETT, V509, P405, DOI 10.1016/S0014-5793(01)03185-4	68	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11507	11516		10.1074/jbc.M807151200	http://dx.doi.org/10.1074/jbc.M807151200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19246452	hybrid, Green Published			2022-12-27	WOS:000265494500055
J	Hagen, N; Van Veldhoven, PP; Proia, RL; Park, H; Merrill, AH; van Echten-Deckert, G				Hagen, Nadine; Van Veldhoven, Paul P.; Proia, Richard L.; Park, Hyejung; Merrill, Alfred H., Jr.; van Echten-Deckert, Gerhild			Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CYCLIN D1; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID METABOLISM; POSTMITOTIC NEURONS; MOLECULAR-CLONING; KINASE TYPE-2; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; PROTEIN	Cerebellar granule cells from sphingosine 1-phosphate (S1P) lyase-deficient mice were used to study the toxicity of this potent sphingolipid metabolite in terminally differentiated postmitotic neurons. Based on earlier findings with the lyase-stable, semi-synthetic, cis-4-methylsphingosine phosphate, we hypothesized that accumulation of S1P above a certain threshold induces neuronal apoptosis. The present studies confirmed this conclusion and further revealed that for S1P to induce apoptosis in lyase-deficient neurons it must also be produced by sphingosine-kinase2 (SK2). These conclusions are based on the finding that incubation of lyase-deficient neurons with either sphingosine or S1P results in a similar elevation in cellular S1P; however, only S1P addition to the culture medium induces apoptosis. This was not due to S1P acting on the S1P receptor but to hydrolysis of S1P to sphingosine that was phosphorylated by the cells, as described before for cis-4-methylsphingosine. Although the cells produced S1P from both exogenously added sphingosine as well as sphingosine derived from exogenous S1P, the S1P from these two sources were not equivalent, because the former was primarily produced by SK1, whereas the latter was mainly formed by SK2 (as also was cis-4-methylsphingosine phosphate), based on studies in neurons lacking SK1 or SK2 activity. Thus, these investigations show that, due to the existence of at least two functionally distinct intracellular origins for S1P, exogenous S1P can be neurotoxic. In this model, S1P accumulated due to a defective lyase, however, this cause of toxicity might also be important in other cases, as illustrated by the neurotoxicity of cis-4-methylsphingosine phosphate.	[Hagen, Nadine; van Echten-Deckert, Gerhild] Univ Bonn, Kekule Inst, D-53121 Bonn, Germany; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Bonn; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	van Echten-Deckert, G (corresponding author), Univ Bonn, Kekule Inst, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	g.echten.deckert@uni-bonn.de	Proia, Richard L/A-7908-2012; , Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564; Proia, Richard/0000-0003-0456-1270; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health, NIDDK Intramural Research Program; NIH [GM069338]; Deutsche Forschungsgemeinschaft [EC 118/2-2]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0405.02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056016, ZIADK056018, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK Intramural Research Program (to R. L. P.). This work was also supported by NIH Grant GM069338 for the Sphingolipid Core of the Lipid MAPS Consortium (to A. H. M.) for the mass spectrometric analyses, the Deutsche Forschungsgemeinschaft (Grant EC 118/2-2 to G. v. E.-D.), and the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (Grant G.0405.02 to P. P. V. V.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BRACHTENDORF S, 2005, THESIS U BONN; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Long JS, 2008, BIOCHEM J, V411, P371, DOI 10.1042/BJ20071607; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala SM, 2001, PROSTAG OTH LIPID M, V64, P143, DOI 10.1016/S0090-6980(01)00111-3; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Naetzker S, 2006, GENES CELLS, V11, P269, DOI 10.1111/j.1365-2443.2006.00933.x; Natzker S, 2002, BIOL CHEM, V383, P1885, DOI 10.1515/BC.2002.212; Peest U, 2008, J CELL BIOCHEM, V104, P756, DOI 10.1002/jcb.21665; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sakai K, 1999, J NEUROSCI RES, V58, P396, DOI 10.1002/(SICI)1097-4547(19991101)58:3<396::AID-JNR5>3.3.CO;2-B; Sato K, 2007, BIOCHEM BIOPH RES CO, V359, P649, DOI 10.1016/j.bbrc.2007.05.131; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Suzuki E, 2004, P NATL ACAD SCI USA, V101, P14788, DOI 10.1073/pnas.0406536101; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Terai K, 2003, NEUROSCIENCE, V116, P1053, DOI 10.1016/S0306-4522(02)00791-1; van Echten-Deckert G, 1998, J BIOL CHEM, V273, P23585, DOI 10.1074/jbc.273.36.23585; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Van Veldhoven PP, 2005, CHEM PHYS LIPIDS, V136, P164; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Yu NC, 2004, GLIA, V45, P17, DOI 10.1002/glia.10297; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	37	75	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11346	11353		10.1074/jbc.M807336200	http://dx.doi.org/10.1074/jbc.M807336200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251691	hybrid, Green Published			2022-12-27	WOS:000265494500039
J	Kakiashvili, E; Speight, P; Waheed, F; Seth, R; Lodyga, M; Tanimura, S; Kohno, M; Rotstein, OD; Kapus, A; Szaszi, K				Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Tanimura, Susumu; Kohno, Michiaki; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin			GEF-H1 Mediates Tumor Necrosis Factor-alpha-induced Rho Activation and Myosin Phosphorylation ROLE IN THE REGULATION OF TUBULAR PARACELLULAR PERMEABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TNF-ALPHA; TIGHT JUNCTION; EPITHELIAL BARRIER; KINASE; EXPRESSION; PATHWAY; KIDNEY; CELLS; MODULATION	Tumor necrosis factor-alpha(TNF-alpha), an inflammatory cytokine, has been shown to activate the small GTPase Rho, but the underlying signaling mechanisms remained undefined. This general problem is particularly important in the kidney, because TNF-alpha, a major mediator of kidney injury, is known to increase paracellular permeability in tubular epithelia. Here we aimed to determine the effect of TNF-alpha on the Rho pathway in tubular cells (LLC-PK1 and Madin-Darby canine kidney), define the upstream signaling, and investigate the role of the Rho pathway in the TNF-alpha-induced alterations of paracellular permeability. We show that TNF-alpha induced a rapid and sustained RhoA activation that led to stress fiber formation and Rho kinase-dependent myosin light chain (MLC) phosphorylation. To identify new regulators connecting the TNF receptor to Rho signaling, we applied an affinity precipitation assay with a Rho mutant (RhoG17A), which captures activated GDP-GTP exchange factors (GEFs). Mass spectrometry analysis of the RhoG17A-precipitated proteins identified GEF-H1 as a TNF-alpha-activated Rho GEF. Consistent with a central role of GEF-H1, its down-regulation by small interfering RNA prevented the activation of the Rho pathway. Moreover GEF-H1 and Rho activation are downstream of ERK signaling as the MEK1/2 inhibitor PD98059 mitigated TNF-alpha-induced activation of these proteins. Importantly TNF-alpha enhanced the ERK pathway-dependent phosphorylation of Thr-678 of GEF-H1 that was key for activation. Finally the TNF-alpha-induced paracellular permeability increase was absent in LLC-PK1 cells stably expressing a non-phosphorylatable, dominant negative MLC. In summary, we have identified the ERK/GEF-H1/Rho/Rho kinase/phospho-MLC pathway as the mechanism mediating TNF-alpha-induced elevation of tubular epithelial permeability, which in turn might contribute to kidney injury.	[Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Tanimura, Susumu; Kohno, Michiaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, Nagasaki 8528521, Japan	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Nagasaki University	Szaszi, K (corresponding author), St Michaels Hosp, Keenan Res Ctr, Queen Wing 7-009,30 Bond St, Toronto, ON M5B 1W8, Canada.	szaszik@smh.toronto.on.ca	Szaszi, Katalin/J-7522-2012; Kohno, Michiaki/R-6532-2019	Kohno, Michiaki/0000-0002-7644-0059; Szaszi, Katalin/0000-0002-2490-8422	Natural Sciences and Engineering Research Council of Canada (NSERC) [480619]; Banting Foundation; Kidney Foundation of Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting Foundation; Kidney Foundation of Canada	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC Grant 480619) and the Banting Foundation (to K. S.) and by the Kidney Foundation of Canada (to A. K. and K. S.).	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Biancone L, 1997, EXP NEPHROL, V5, P330; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Di Ciano-Oliveira C, 2005, AM J PHYSIOL-CELL PH, V289, pC68, DOI 10.1152/ajpcell.00631.2004; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Domnina LV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P737, DOI 10.1023/A:1016336421582; Donnahoo KK, 2001, IMMUNOLOGY, V102, P53, DOI 10.1046/j.1365-2567.2001.01141.x; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Hayashi H, 2008, GENES CELLS, V13, P941, DOI 10.1111/j.1365-2443.2008.01218.x; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; Kapus A, 2006, BIOCHEM CELL BIOL, V84, P870, DOI 10.1139/O06-202; KOHNO M, 1990, BIOCHEM J, V267, P91, DOI 10.1042/bj2670091; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Mankertz J, 2000, J CELL SCI, V113, P2085; Marano CW, 1998, J MEMBRANE BIOL, V161, P263, DOI 10.1007/s002329900333; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; MULLIN JM, 1992, AM J PHYSIOL, V263, pF915, DOI 10.1152/ajprenal.1992.263.5.F915; Mullin JM, 1997, J CELL PHYSIOL, V171, P226, DOI 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B; Navarro Juan F, 2005, Kidney Int Suppl, pS98, DOI 10.1111/j.1523-1755.2005.09918.x; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; NOIRI E, 1994, AM J PATHOL, V144, P1159; Nubel T, 2004, FASEB J, V18, P140, DOI 10.1096/fj.03-0261fje; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Papakonstanti EA, 2004, MOL BIOL CELL, V15, P1273, DOI 10.1091/mbc.E03-07-0491; Pascher A, 2005, BIODRUGS, V19, P211, DOI 10.2165/00063030-200519040-00002; Patrick David M, 2006, BMC Physiol, V6, P2, DOI 10.1186/1472-6793-6-2; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Petrache I, 2003, BIOCHEM BIOPH RES CO, V306, P244, DOI 10.1016/S0006-291X(03)00945-8; Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sato H, 2004, INT J EXP PATHOL, V85, P345, DOI 10.1111/j.0959-9673.2004.00403.x; Schmitz H, 1999, J CELL SCI, V112, P137; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Soler AP, 1999, EUR J CELL BIOL, V78, P56, DOI 10.1016/S0171-9335(99)80007-7; Szaszi K, 2005, AM J PHYSIOL-CELL PH, V289, pC673, DOI 10.1152/ajpcell.00481.2004; Turner JR, 2000, ADV DRUG DELIVER REV, V41, P265, DOI 10.1016/S0169-409X(00)00046-6; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; VandenBerg E, 2004, J CELL BIOCHEM, V91, P926, DOI 10.1002/jcb.20011; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh SV, 2000, ADV DRUG DELIVER REV, V41, P303, DOI 10.1016/S0169-409X(00)00048-X; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; YARD BA, 1992, KIDNEY INT, V42, P383, DOI 10.1038/ki.1992.299; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	67	81	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11454	11466		10.1074/jbc.M805933200	http://dx.doi.org/10.1074/jbc.M805933200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261619	Green Published, hybrid			2022-12-27	WOS:000265494500050
J	Wang, EM; Cambi, F				Wang, Erming; Cambi, Franca			Heterogeneous Nuclear Ribonucleoproteins H and F Regulate the Proteolipid Protein/DM20 Ratio by Recruiting U1 Small Nuclear Ribonucleoprotein through a Complex Array of G Runs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SPLICE-SITE SELECTION; HNRNP-H; BCL-X; GENE-EXPRESSION; ENHANCER; BINDING; EXON; MYELIN; INTRON	In this study, we sought to investigate the mechanism by which heterogeneous nuclear ribonucleoprotein (hnRNP) H and F regulate proteolipid protein (PLP)/DM20 alternative splicing. G-rich sequences in exon 3B, G1 and M2, are required for hnRNPH- and F-mediated regulation of the PLP/DM20 ratio and, when placed between competing 5' splice sites in an alpha-globin minigene, direct hnRNPH/F-regulated alternative splicing. In contrast, the activity of the intronic splicing enhancer, which is necessary for PLP splicing, is only modestly reduced by removal of hnRNPH/F both in PLP and alpha-globin gene context. In vivo, hnRNPH reversed reduction of DM20 splicing induced by hnRNPH/F removal, whereas hnRNPF had little effect. Tethering of the MS2-hnRNPH fusion protein downstream of the DM20 5' splice site increased DM20 splicing, whereas MS2-hnRNPF did not. Binding of U1 small nuclear ribonucleoprotein (U1snRNP) to DM20 is greatly impaired by mutation of G1 and M2 and depletion of hnRNPH and F. Reconstitution of hnRNPH/F-depleted extracts with either hn RNPH or F restored U1snRNP binding. We conclude that hnRNPH and F regulate DM20 splicing by recruiting U1snRNP and that hnRNPH plays a primary role in DM20 splice site selection in vivo. Decreased expression of hnRNPH/F in differentiated oligodendrocytes may regulate the PLP/DM20 ratio by reducing DM20 5' splice site recognition by U1snRNP.	[Cambi, Franca] Univ Kentucky, Dept Neurol, Kentucky Clin L445, Lexington, KY 40536 USA	University of Kentucky	Cambi, F (corresponding author), Univ Kentucky, Dept Neurol, Kentucky Clin L445, Lexington, KY 40536 USA.	franca.cambi@uky.edu			National Institutes of Health [RO1NS053905]; European Leukodystrophy Association; NCRR/NIH [P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Leukodystrophy Association; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant RO1NS053905 from NINDS. This work was also supported by the European Leukodystrophy Association. The mass spectrometric analysis was performed at the University of Kentucky, Center for Structural Biology Protein Core Facility. This core facility is supported in part by funds from NCRR/NIH Grant P20 RR020171.	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Carlo T, 1996, RNA, V2, P342; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chou MY, 1999, MOL CELL BIOL, V19, P69; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kurihara T, 1997, BIOCHEM BIOPH RES CO, V237, P559, DOI 10.1006/bbrc.1997.7179; LEVINE SM, 1990, DEV NEUROSCI-BASEL, V12, P235, DOI 10.1159/000111853; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NcNally LM, 2006, J BIOL CHEM, V281, P2478, DOI 10.1074/jbc.M511215200; NUSSINOV R, 1988, J THEOR BIOL, V133, P73, DOI 10.1016/S0022-5193(88)80025-0; NUSSINOV R, 1989, J BIOMOL STRUCT DYN, V6, P985, DOI 10.1080/07391102.1989.10506526; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang E, 2008, EXP NEUROL, V214, P322, DOI 10.1016/j.expneurol.2008.09.001	45	33	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11194	11204		10.1074/jbc.M809373200	http://dx.doi.org/10.1074/jbc.M809373200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244236	Green Published, hybrid			2022-12-27	WOS:000265494500023
J	Katschke, KJ; Stawicki, S; Yin, JP; Steffek, M; Xi, HK; Sturgeon, L; Hass, PE; Loyet, KM; DeForge, L; Wu, Y; Campagne, MV; Wiesmann, C				Katschke, Kenneth J., Jr.; Stawicki, Scott; Yin, Jianping; Steffek, Micah; Xi, Hongkang; Sturgeon, Lizette; Hass, Philip E.; Loyet, Kelly M.; DeForge, Laura; Wu, Yan; Campagne, Menno van Lookeren; Wiesmann, Christian			Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPONENT C3; FACTOR-H; ACTIVATION; CONVERTASE; INSIGHTS; CR-1; THIOESTER; PROTEASE; REVEALS; BINDING	Amplification of the complement cascade through the alternative pathway can lead to excessive inflammation. Targeting C3b, a component central to the alternative pathway of complement, provides a powerful approach to inhibit complement-mediated immune responses and tissue injury. In the present study, phage display technology was employed to generate an antibody that selectively recognizes C3b but not the non-activated molecule C3. The crystal structure of C3b in complex with a Fab fragment of this antibody (S77) illustrates the structural basis for this selectivity. Cleavage of C3 to C3b results in a plethora of structural changes within C3, including the rearrangement of macroglobulin domain 6 enabling binding of S77 to the adjacent macroglobulin domain 7 domain. S77 blocks binding of factor B to C3b inhibiting the first step in the formation of the alternative pathway C3 convertase. In addition, S77 inhibits C5 binding to C3b. This results in significantly reduced formations of anaphylatoxins and membrane-attack complexes. This study for the first time demonstrates the structural basis for complement inhibition by a C3b-selective antibody and provides insights into the molecular mechanisms of alternative pathway complement activation.	[Katschke, Kenneth J., Jr.; Xi, Hongkang; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Stawicki, Scott; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Yin, Jianping; Steffek, Micah; Wiesmann, Christian] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Sturgeon, Lizette; Loyet, Kelly M.; DeForge, Laura] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Hass, Philip E.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com; wiesmann.christian@gene.com	Loyet, Kelly/AAD-7544-2021	Wiesmann, Christian/0000-0002-4092-9880				BECHERER JD, 1992, BIOCHEMISTRY-US, V31, P1787, DOI 10.1021/bi00121a029; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; DiLillo DJ, 2006, MOL IMMUNOL, V43, P1010, DOI 10.1016/j.molimm.2005.05.003; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; HACK CE, 1988, J IMMUNOL, V141, P1602; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lambris JD, 1996, J IMMUNOL, V156, P4821; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Undar A, 2002, ANN THORAC SURG, V74, P355, DOI 10.1016/S0003-4975(02)03656-1; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	31	49	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10473	10479		10.1074/jbc.M809106200	http://dx.doi.org/10.1074/jbc.M809106200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19196712	Green Published, hybrid			2022-12-27	WOS:000265104600021
J	Yue, L; Mazzone, T				Yue, Lili; Mazzone, Theodore			Peroxisome Proliferator-activated Receptor gamma Stimulation of Adipocyte ApoE Gene Transcription Mediated by the Liver Receptor X Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E GENE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; GLUCOSE-METABOLISM; EXPRESSION; MACROPHAGES; STORAGE; FAT	Peroxisome proliferator-activated receptor (PPAR gamma) agonists increase insulin sensitivity in humans and are useful for treating human diabetes. Treatment with these agonists leads to increased apoE expression and triglyceride accumulation in adipocytes. The importance of apoE for adipocyte triglyceride accumulation is demonstrated by observations that triglyceride accumulation is impaired in apoE knockout adipocytes treated with PPAR gamma agonists. The current studies investigate the molecular mechanism for PPAR gamma stimulation of the adipocyte apoE gene and demonstrate that the liver receptor X (LXR) response element within an apoE gene downstream enhancer is required for the apoE response to PPAR gamma agonists. The response of the apoE gene to treatment with PPAR gamma agonists was delayed beyond 12 h suggesting the involvement of an intermediary pathway. The combined addition of PPAR gamma and LXR agonists did not increase apoE response beyond that observed with addition of either alone. Deletion or mutation of the LXR response element completely eliminated the adipocyte apoE gene response to a PPAR gamma agonist. Chromatin immunoprecipitation analyses performed using isolated adipocytes, or adipose tissue from mice treated with PPAR gamma agonists, showed increased LXR binding to the apoE gene after PPAR gamma agonist treatment. Knockdown of LXR expression completely eliminated the increase in apoE message, protein, and triglyceride in response to PPAR gamma stimulation. The LXR response element has been previously shown to mediate sterol responsiveness of the apoE gene, and apoE expression plays an important role in adipocyte triglyceride balance. The current observations suggest that the PPAR gamma- LXR-apoE regulatory cascade could be an important molecular link for cross-talk between adipocyte triglyceride and cholesterol homeostasis.	[Mazzone, Theodore] Univ Illinois, Dept Human Nutr, Chicago, IL 60612 USA; [Mazzone, Theodore] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Yue, Lili; Mazzone, Theodore] Univ Illinois, Dept Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mazzone, T (corresponding author), Univ Illinois, Sect Endocrinol Diabet & Metab MC 797, 1819 W Polk St, Chicago, IL 60612 USA.	tmazzone@uic.edu			National Institutes of Health [DK71711]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071711, R56DK071711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK71711 (to T.M.).	Bodles AM, 2006, J LIPID RES, V47, P2080, DOI 10.1194/jlr.M600235-JLR200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Dugail I, 2003, HORM METAB RES, V35, P204, DOI 10.1055/s-2003-39475; Espiritu DJ, 2008, DIABETES, V57, P2992, DOI 10.2337/db08-0592; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Huang ZH, 2007, AM J PHYSIOL-ENDOC M, V293, pE203, DOI 10.1152/ajpendo.00118.2007; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KOVANEN PT, 1975, J LIPID RES, V16, P211; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Le Lay S, 2003, J LIPID RES, V44, P1499, DOI 10.1194/jlr.M200466-JLR200; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Lin CY, 1999, J LIPID RES, V40, P1618; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; MAZZONE T, 1994, J LIPID RES, V35, P1345; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Rao P, 2007, J CLIN ENDOCR METAB, V92, P4366, DOI 10.1210/jc.2007-1592; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Yue L, 2008, ENDOCRINOLOGY, V149, P4051, DOI 10.1210/en.2008-0340; Yue LL, 2004, J BIOL CHEM, V279, P47626, DOI 10.1074/jbc.M408461200; ZECHNER R, 1991, J BIOL CHEM, V266, P10583	30	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10453	10461		10.1074/jbc.M808482200	http://dx.doi.org/10.1074/jbc.M808482200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19218241	Green Published, hybrid			2022-12-27	WOS:000265104600019
J	Coddens, A; Diswall, M; Angstrom, J; Breimer, ME; Goddeeris, B; Cox, E; Teneberg, S				Coddens, Annelies; Diswall, Mette; Angstrom, Jonas; Breimer, Michael E.; Goddeeris, Bruno; Cox, Eric; Teneberg, Susann			Recognition of Blood Group ABH Type 1 Determinants by the FedF Adhesin of F18-fimbriated Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE MEMBRANES; EPITHELIAL-CELLS; SMALL-INTESTINE; HELICOBACTER-PYLORI; FIMBRIAL ADHESIN; GROUP ANTIGENS; EDEMA DISEASE; GROUP GLYCOSPHINGOLIPIDS; MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY	F18-fimbriated Escherichia coli are associated with porcine postweaning diarrhea and edema disease. Adhesion of F18-fimbriated bacteria to the small intestine of susceptible pigs is mediated by the minor fimbrial subunit FedF. However, the target cell receptor for FedF has remained unidentified. Here we report that F18-fimbriated E. coli selectively interact with glycosphingolipids having blood group ABH determinants on type 1 core, and blood group A type 4 heptaglycosylceramide. The minimal binding epitope was identified as the blood group H type 1 determinant (Fuc alpha 2Gal beta 3GlcNAc), while an optimal binding epitope was created by addition of the terminal alpha 3-linked galactose or N-acetylgalactosamine of the blood group B type 1 determinant (Gal alpha 3(Fuc alpha 2)Gal beta 3GlcNAc) and the blood group A type 1 determinant (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GlcNAc). To assess the role of glycosphingolipid recognition by F18-fimbriated E. coli in target tissue adherence, F18-binding glycosphingolipids were isolated from the small intestinal epithelium of blood group O and A pigs and characterized by mass spectrometry and proton NMR. The only glycosphingolipid with F18-binding activity of the blood group O pig was an H type 1 pentaglycosylceramide (Fuc alpha 2Gal beta 3GlcNAc-beta 3Gal beta 4Glc beta 1Cer). In contrast, the blood group A pig had a number of F18-binding glycosphingolipids, characterized as A type 1 hexaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer), A type 4 heptaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GalNAc beta 3Gal alpha 4Gal beta 4Glc beta 1Cer), A type 1 octaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GlcNAc beta 3-Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer), and repetitive A type 1 nonaglycosylceramide (GalNAc alpha 3(Fuc alpha 2)Gal beta 3GalNAc alpha 3-(Fuc alpha 2)Gal beta 3GlcNAc beta 3Gal beta 4Glc beta 1Cer). No blood group antigen-carrying glycosphingolipids were recognized by a mutant E. coli strain with deletion of the FedF adhesin, demonstrating that FedF is the structural element mediating binding of F18-fimbriated bacteria to blood group ABH determinants.	[Coddens, Annelies; Goddeeris, Bruno; Cox, Eric] Univ Ghent, Lab Vet Immunol, Fac Vet Med, B-9820 Ghent, Belgium; [Diswall, Mette; Angstrom, Jonas; Breimer, Michael E.] Sahlgrens Univ Hosp, Dept Surg, SE-41345 Gothenburg, Sweden; [Goddeeris, Bruno] Katholieke Univ Leuven, Fac Biosci Engn, Div Gene Technol, Dept Biosyst, B-3001 Heverlee, Belgium; [Teneberg, Susann] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden	Ghent University; Sahlgrenska University Hospital; KU Leuven; University of Gothenburg	Cox, E (corresponding author), Univ Ghent, Lab Vet Immunol, Fac Vet Med, Salisburylaan 133, B-9820 Ghent, Belgium.	eric.cox@UGent.be; Susann.Teneberg@medkem.gu.se	Goddeeris, Bruno Maria/L-2440-2015	Goddeeris, Bruno Maria/0000-0003-3729-7592; Cox, Eric/0000-0003-4281-2990	Swedish Research Council/Medicine [11612, 12628]; Swedish Cancer Foundation; Magnus Bergvalls Foundation; UGent and FWO-Flanders [G001305N, 3G038907]	Swedish Research Council/Medicine(Swedish Research Council); Swedish Cancer Foundation; Magnus Bergvalls Foundation; UGent and FWO-Flanders(FWO)	This work was supported in part by the Swedish Research Council/Medicine ( Grant 11612 to S. T. and Grant 12628 to M. E. B.), the Swedish Cancer Foundation ( to S. T.), and Magnus Bergvalls Foundation ( to S. T.). The UGent and FWO-Flanders ( Grants G001305N and 3G038907) are acknowledged for their financial support.	Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backer AE, 1997, GLYCOBIOLOGY, V7, P943, DOI 10.1093/glycob/7.7.943; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; Bertschinger H. U., 1994, P193; BERTSCHINGER HU, 1993, VET MICROBIOL, V35, P79, DOI 10.1016/0378-1135(93)90117-P; BERTSCHINGER HU, 1990, VET MICROBIOL, V25, P267, DOI 10.1016/0378-1135(90)90083-8; BOCK K, 1985, J BIOL CHEM, V260, P8545; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BOUHOURS D, 1991, J BIOL CHEM, V266, P18613; BREIMER ME, 1982, J BIOL CHEM, V257, P557; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Chester MA, 1998, EUR J BIOCHEM, V257, P293; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CLAUSEN H, 1985, P NATL ACAD SCI USA, V82, P1199, DOI 10.1073/pnas.82.4.1199; CLAUSEN H, 1986, BIOCHEMISTRY-US, V25, P7075, DOI 10.1021/bi00370a048; CLAUSEN H, 1984, BIOCHEM BIOPH RES CO, V124, P523, DOI 10.1016/0006-291X(84)91585-7; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Cohney S, 1999, INT J MOL MED, V3, P199; COX E, 1993, VET MICROBIOL, V34, P7, DOI 10.1016/0378-1135(93)90003-P; De Kerpel M, 2006, ACTA CRYSTALLOGR F, V62, P1278, DOI 10.1107/S1744309106049281; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; HOLGERSSON J, 1990, J BIOL CHEM, V265, P20790; HULTGREN SJ, 1989, P NATL ACAD SCI USA, V86, P4357, DOI 10.1073/pnas.86.12.4357; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; IMBERECHTS H, 1992, INFECT IMMUN, V60, P1963, DOI 10.1128/IAI.60.5.1963-1971.1992; Imberechts H, 1996, MICROB PATHOGENESIS, V21, P183, DOI 10.1006/mpat.1996.0053; ITO M, 1989, J BIOL CHEM, V264, P9510; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KING TP, 1995, GLYCOBIOLOGY, V5, P525, DOI 10.1093/glycob/5.5.525; KOSCIELAK J, 1973, EUR J BIOCHEM, V37, P214, DOI 10.1111/j.1432-1033.1973.tb02978.x; KYOGASHIMA M, 1989, ARCH BIOCHEM BIOPHYS, V270, P391, DOI 10.1016/0003-9861(89)90042-8; KYPRIANOU P, 1990, GLYCOCONJUGATE J, V7, P573, DOI 10.1007/BF01189078; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Lindhorst TK, 1998, GLYCOCONJUGATE J, V15, P605, DOI 10.1023/A:1006920027641; Liu YH, 1998, J HISTOCHEM CYTOCHEM, V46, P69, DOI 10.1177/002215549804600109; Mathieu S, 2004, AM J PATHOL, V164, P371, DOI 10.1016/S0002-9440(10)63127-6; Meijerink E, 2000, IMMUNOGENETICS, V52, P129, DOI 10.1007/s002510000263; Meijerink E, 1997, MAMM GENOME, V8, P736, DOI 10.1007/s003359900556; NAGY B, 1992, INFECT IMMUN, V60, P1285, DOI 10.1128/IAI.60.4.1285-1294.1992; NYHOLM PG, 1989, J MOL RECOGNIT, V3, P103; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; Parente F, 2003, HELICOBACTER, V8, P252, DOI 10.1046/j.1523-5378.2003.00152.x; PRASADARAO NV, 1993, J BIOL CHEM, V268, P10356; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; SAKO F, 1990, ARCH BIOCHEM BIOPHYS, V278, P228, DOI 10.1016/0003-9861(90)90252-T; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; Smeds A, 2001, INFECT IMMUN, V69, P7941, DOI 10.1128/IAI.69.12.7941-7945.2001; Snoeck V, 2004, VET MICROBIOL, V100, P241, DOI 10.1016/j.vetmic.2004.03.001; STELLNER K, 1973, BIOCHEMISTRY-US, V12, P656, DOI 10.1021/bi00728a014; TENEBERG S, 1990, FEBS LETT, V263, P10, DOI 10.1016/0014-5793(90)80693-D; TENEBERG S, 1994, J BIOCHEM, V116, P560, DOI 10.1093/oxfordjournals.jbchem.a124562; Ukkonen P, 2000, LANCET, V356, P1398, DOI 10.1016/S0140-6736(00)02843-9; Verdonck F, 2002, VACCINE, V20, P2995, DOI 10.1016/S0264-410X(02)00220-7; Vogeli P, 1996, ANIM GENET, V27, P321; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040	65	58	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9713	9726		10.1074/jbc.M807866200	http://dx.doi.org/10.1074/jbc.M807866200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19208633	Green Published, hybrid			2022-12-27	WOS:000264892900011
J	Gill, J; Yogavel, M; Kumar, A; Belrhali, H; Jain, SK; Rug, M; Brown, M; Maier, AG; Sharma, A				Gill, Jasmita; Yogavel, Manickam; Kumar, Anuj; Belrhali, Hassan; Jain, S. K.; Rug, Melanie; Brown, Monica; Maier, Alexander G.; Sharma, Amit			Crystal Structure of Malaria Parasite Nucleosome Assembly Protein DISTINCT MODES OF PROTEIN LOCALIZATION AND HISTONE RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CORE; EXPRESSION; SOFTWARE; SYSTEM; VPS75	Nucleosome assembly proteins (NAPs) are histone chaperones that are essential for the transfer and incorporation of histones into nucleosomes. NAPs participate in assembly and disassembly of nucleosomes and in chromatin structure organization. Human malaria parasite Plasmodium falciparum contains two nucleosome assembly proteins termed PfNapL and PfNapS. To gain structural insights into the mechanism of NAPs, we have determined and analyzed the crystal structure of PfNapL at 2.3 angstrom resolution. PfNapL, an ortholog of eukaryotic NAPs, is dimeric in nature and adopts a characteristic fold seen previously for yeast NAP-1 and Vps75 and for human SET/TAF-1b (beta)/INHAT. The PfNapL monomer is comprised of domain I, containing a dimerization alpha-helix, and a domain II, composed of alpha-helices and a beta-subdomain. Structural comparisons reveal that the "accessory domain," which is inserted between the domain I and domain II in yeast NAP-1 and other eukaryotic NAPs, is surprisingly absent in PfNapL. Expression of green fluorescent protein-tagged PfNapL confirmed its exclusive localization to the parasite cytoplasm. Attempts to disrupt the PfNapL gene were not successful, indicating its essential role for the malaria parasite. A detailed analysis of PfNapL structure suggests unique histone binding properties. The crucial structural differences observed between parasite and yeast NAPs shed light on possible new modes of histone recognition by nucleosome assembly proteins.	[Gill, Jasmita; Yogavel, Manickam; Kumar, Anuj; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Belrhali, Hassan] European Mol Biol Lab, F-38042 Grenoble 9, France; [Jain, S. K.] Hamdard Univ, Dept Biotechnol, New Delhi 110062, India; [Rug, Melanie; Brown, Monica; Maier, Alexander G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; European Molecular Biology Laboratory (EMBL); Jamia Hamdard University; Walter & Eliza Hall Institute	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com	Rug, Melanie/B-5417-2015; Kumar, Anuj/M-9040-2013; Manickam, Yogavel/O-4570-2015; Rug, Melanie/A-9504-2011; Maier, Alex G/A-6499-2009	Kumar, Anuj/0000-0002-8814-3625; Manickam, Yogavel/0000-0002-2119-062X; Maier, Alex G/0000-0001-7369-1058; Gill, Jasmita/0000-0002-7004-2850	Department of Biotechnology, Govt. of India; Wellcome Trust	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a grant from the Department of Biotechnology, Govt. of India. The x-ray facility at the International Centre for Genetic Engineering and Biotechnology, New Delhi, is funded by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANNUNZIATO AT, 1983, MOL CELL BIOCHEM, V55, P99, DOI 10.1007/BF00673705; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; Crabb BS, 2004, METH MOL B, V270, P263; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Lankenau S, 2003, GENETICS, V163, P611; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Navadgi VM, 2006, J BIOL CHEM, V281, P16978, DOI 10.1074/jbc.M602243200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez P, 1997, GENOMICS, V44, P253, DOI 10.1006/geno.1997.4868; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147	37	26	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10076	10087		10.1074/jbc.M808633200	http://dx.doi.org/10.1074/jbc.M808633200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19176479	Green Published, hybrid			2022-12-27	WOS:000264892900050
J	Cantini, F; Veggi, D; Dragonetti, S; Savino, S; Scarselli, M; Romagnoli, G; Pizza, M; Banci, L; Rappuoli, R				Cantini, Francesca; Veggi, Daniele; Dragonetti, Sara; Savino, Silvana; Scarselli, Maria; Romagnoli, Giacomo; Pizza, Mariagrazia; Banci, Lucia; Rappuoli, Rino			Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; VACCINE; COMPLEX; GNA1870; DOMAIN	Factor H-binding protein is a 27-kDa lipoprotein of Neisseria meningitidis discovered while screening the bacterial genome for vaccine candidates. In addition to being an important component of a vaccine against meningococcus in late stage of development, the protein is essential for pathogenesis because it allows the bacterium to survive and grow in human blood by binding the human complement factor H. We recently reported the solution structure of the C-terminal domain of factor H-binding protein, which contains the immunodominant epitopes. In the present study, we report the structure of the full-length molecule, determined by nuclear magnetic resonance spectroscopy. The protein is composed of two independent barrels connected by a short link. Mapping the residues recognized by monoclonal antibodies with bactericidal or factor H binding inhibition properties allowed us to predict the sites involved in the function of the protein. The structure therefore provides the basis for designing improved vaccine molecules.	[Cantini, Francesca; Dragonetti, Sara; Banci, Lucia] Magnet Resonance Ctr CERM, I-50019 Sesto Fiorentino, Italy; [Veggi, Daniele; Savino, Silvana; Scarselli, Maria; Romagnoli, Giacomo; Pizza, Mariagrazia; Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy	Novartis	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	banci@cerm.unifi.it; rino.rappuoli@novartis.com	Cantini, Francesca/O-1220-2015	Cantini, Francesca/0000-0003-0526-6732; BANCI, LUCIA/0000-0003-0562-5774	Ministero dell'Istruzione, Universita e della Ricerca Scientifica-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) [RBLA032ZM7]	Ministero dell'Istruzione, Universita e della Ricerca Scientifica-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by Ministero dell'Istruzione, Universita e della Ricerca Scientifica-Fondo per gli Investimenti della Ricerca di Base (MIUR-FIRB) Grant RBLA032ZM7.	Banci L, 1998, J AM CHEM SOC, V120, P12903, DOI 10.1021/ja981791w; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; Farady CJ, 2008, J MOL BIOL, V380, P351, DOI 10.1016/j.jmb.2008.05.009; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Girard MP, 2006, VACCINE, V24, P4692, DOI 10.1016/j.vaccine.2006.03.034; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Nabuurs SB, 2003, J AM CHEM SOC, V125, P12026, DOI 10.1021/ja035440f; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606	31	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9022	9026		10.1074/jbc.C800214200	http://dx.doi.org/10.1074/jbc.C800214200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19196709	hybrid, Green Published			2022-12-27	WOS:000264669100004
J	Tucker, DE; Ghosh, M; Ghomashchi, F; Loper, R; Suram, S; John, BS; Girotti, M; Bollinger, JG; Gelb, MH; Leslie, CC				Tucker, Dawn E.; Ghosh, Moumita; Ghomashchi, Farideh; Loper, Robyn; Suram, Saritha; John, Bonnie St.; Girotti, Milena; Bollinger, James G.; Gelb, Michael H.; Leslie, Christina C.			Role of Phosphorylation and Basic Residues in the Catalytic Domain of Cytosolic Phospholipase A(2)alpha in Regulating Interfacial Kinetics and Binding and Cellular Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ACTIVATED PROTEIN-KINASE; PRODUCT-CONTAINING VESICLES; PHORBOL-MYRISTATE ACETATE; SMOOTH-MUSCLE-CELLS; C2 DOMAIN; HYDROLYZING PHOSPHOLIPASE-A2; ANIONIC PHOSPHOLIPIDS; CALCIUM REQUIREMENT; CRYSTAL-STRUCTURE	Group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) is regulated by phosphorylation and calcium-induced translocation to membranes. Immortalized mouse lung fibroblasts lacking endogenous cPLA(2)alpha(IMLF-/-) were reconstituted with wild type and cPLA(2)alpha mutants to investigate how calcium, phosphorylation, and the putative phosphatidylinositol 4,5-bisphosphate (PIP2) binding site regulate translocation and arachidonic acid (AA) release. Agonists that elicit distinct modes of calcium mobilization were used. Serum induced cPLA(2)alpha translocation to Golgi within seconds that temporally paralleled the initial calcium transient. However, the subsequent influx of extracellular calcium was essential for stable binding of cPLA(2)alpha to Golgi and AA release. In contrast, phorbol 12-myristate 13-acetate induced low amplitude calcium oscillations, slower translocation of cPLA(2)alpha to Golgi, and much less AA release, which were blocked by chelating extracellular calcium. AA release from IMLF-/- expressing phosphorylation site (S505A) and PIP2 binding site (K488N/K543N/K544N) mutants was partially reduced compared with cells expressing wild type cPLA(2)alpha, but calcium-induced translocation was not impaired. Consistent with these results, Ser-505 phosphorylation did not change the calcium requirement for interfacial binding and catalysis in vitro but increased activity by 2-fold. Mutations in basic residues in the catalytic domain of cPLA(2)alpha reduced activation by PIP2 but did not affect the concentration of calcium required for interfacial binding or phospholipid hydrolysis. The results demonstrate that Ser-505 phosphorylation and basic residues in the catalytic domain principally act to regulate cPLA(2)alpha hydrolytic activity.	[Ghomashchi, Farideh; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Ghomashchi, Farideh; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Tucker, Dawn E.; Ghosh, Moumita; Loper, Robyn; Suram, Saritha; John, Bonnie St.; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; [Girotti, Milena] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Jewish Health; University of Colorado System; University of Colorado Boulder; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Campus Box 351700, Seattle, WA 98195 USA.	gelb@chem.washington.edu; lesliec@njc.org		gelb, michael/0000-0001-7000-5219	National Institutes of Health [HL61378, HL34303, HL50040]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050040, P01HL034303, R01HL061378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL61378 (to C. C. L.), HL34303 (to C. C. L.), and HL50040 (to M. H. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADEREM AA, 1986, J EXP MED, V163, P139, DOI 10.1084/jem.163.1.139; ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; Bayburt T, 1997, BIOCHEMISTRY-US, V36, P3216, DOI 10.1021/bi961659d; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; BITTERMAN PB, 1992, AM J MED, V92, pS39, DOI 10.1016/0002-9343(92)90606-C; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BONNEY RJ, 1980, BIOCHIM BIOPHYS ACTA, V633, P410, DOI 10.1016/0304-4165(80)90199-3; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; BURKHARDT A, 1989, AM REV RESPIR DIS, V140, P513, DOI 10.1164/ajrccm/140.2.513; Casas J, 2006, MOL BIOL CELL, V17, P155, DOI 10.1091/mbc.e05-06-0545; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; HANEL AM, 1993, BIOCHEMISTRY-US, V32, P5949, DOI 10.1021/bi00074a005; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; KRAMER RM, 1993, J BIOL CHEM, V268, P26796; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KURIMURA T, 1980, J GEN VIROL, V46, P237, DOI 10.1099/0022-1317-46-1-237; Leslie CC, 2004, PROSTAG LEUKOTR ESS, V70, P373, DOI 10.1016/j.plefa.2003.12.012; LESLIE CC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P261, DOI 10.1016/0005-2760(90)90129-L; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MCNEIL PL, 1985, J CELL BIOL, V101, P372, DOI 10.1083/jcb.101.2.372; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Muthalif MM, 1996, J BIOL CHEM, V271, P30149, DOI 10.1074/jbc.271.47.30149; Muthalif MM, 2001, J BIOL CHEM, V276, P39653, DOI 10.1074/jbc.M103136200; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Rzigalinski BA, 1996, BBA-LIPID LIPID MET, V1299, P342, DOI 10.1016/0005-2760(95)00224-3; Schalkwijk CG, 1996, BIOCHEM J, V313, P91, DOI 10.1042/bj3130091; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stewart A, 2002, J BIOL CHEM, V277, P29526, DOI 10.1074/jbc.M204856200; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202	66	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9596	9611		10.1074/jbc.M807299200	http://dx.doi.org/10.1074/jbc.M807299200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19176526	Green Published, hybrid			2022-12-27	WOS:000264669100066
J	Cellini, B; Montioli, R; Paiardini, A; Lorenzetto, A; Voltattorni, CB				Cellini, Barbara; Montioli, Riccardo; Paiardini, Alessandro; Lorenzetto, Antonio; Voltattorni, Carla Borri			Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine: Glyoxylate Aminotransferase and the F152I Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HYPEROXALURIA TYPE-1; I PRIMARY HYPEROXALURIA; PHENOTYPE; GENOTYPE	Human liver peroxisomal alanine: glyoxylate aminotransferase (AGT) is a pyridoxal 5'- phosphate (PLP)-dependent enzyme that converts glyoxylate into glycine. AGT deficiency causes primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, due to a marked increase in hepatic oxalate production. Normal human AGT exists as two polymorphic variants: the major (AGT-Ma) and the minor (AGT-Mi) allele. AGT-Mi causes the PH1 disease only when combined with some mutations. In this study, the molecular basis of the synergism between AGT-Mi and F152I mutation has been investigated through a detailed biochemical characterization of AGT-Mi and the Phe(152) variants combined either with the major (F152I-Ma, F152A-Ma) or the minor allele (F152I-Mi). Although these species show spectral features, kinetic parameters, and PLP binding affinity similar to those of AGT-Ma, the Phe(152) variants exhibit the following differences with respect to AGT-Ma and AGT-Mi: (i) pyridoxamine 5'-phosphate (PMP) is released during the overall transamination leading to the conversion into apoenzymes, and (ii) the PMP binding affinity is at least 200-1400-fold lower. Thus, Phe152 is not an essential residue for transaminase activity, but plays a role in selectively stabilizing the AGT-PMP complex, by a proper orientation of Trp(108), as suggested by bioinformatic analysis. These data, together with the finding that apoF152I-Mi is the only species that at physiological temperature undergoes a time-dependent inactivation and concomitant aggregation, shed light on the molecular defects resulting from the association of the F152I mutation with AGT-Mi, and allow to speculate on the responsiveness to pyridoxine therapy of PH1 patients carrying this mutation.	[Cellini, Barbara; Montioli, Riccardo; Lorenzetto, Antonio; Voltattorni, Carla Borri] Univ Verona, Fac Med & Chirurg, Dipartimento Sci Morfol Biomed, Sez Chim Biol, I-37134 Verona, Italy; [Paiardini, Alessandro] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Paiardini, Alessandro] Univ Roma La Sapienza, Ctr Biol Mol, CNR, I-00185 Rome, Italy	University of Verona; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Voltattorni, CB (corresponding author), Univ Verona, Fac Med & Chirurg, Dipartimento Sci Morfol Biomed, Sez Chim Biol, Str Grazie 8, I-37134 Verona, Italy.	carla.borrivoltattorni@univr.it	Paiardini, Alessandro/G-8058-2011; Cellini, Barbara/AAC-6401-2019	Cellini, Barbara/0000-0002-5221-9288; Paiardini, Alessandro/0000-0001-9078-7545	Oxalosis and Hyperoxaluria Foundation (OHF); Ministero dell'Universita e della Ricerca (PRIN 2007)	Oxalosis and Hyperoxaluria Foundation (OHF); Ministero dell'Universita e della Ricerca (PRIN 2007)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants from the Oxalosis and Hyperoxaluria Foundation (OHF) and Ministero dell'Universita e della Ricerca (PRIN 2007) to C. B. V.).	Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cellini B, 2003, FEBS LETT, V554, P306, DOI 10.1016/S0014-5793(03)01178-5; Cellini B, 2008, PROTEIN PEPTIDE LETT, V15, P153; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; DANPURE CJ, 1994, J INHERIT METAB DIS, V17, P27, DOI 10.1007/BF00735393; DANPURE CJ, 1993, AM J HUM GENET, V53, P417; DANPURE CJ, 1988, CLIN SCI, V75, P315, DOI 10.1042/cs0750315; DeLano W.L, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; MACKIE MBC, 2008, MOL GENET METAB, V94, P368; Monico CG, 2005, AM J NEPHROL, V25, P183, DOI 10.1159/000085411; Monico CG, 2005, KIDNEY INT, V67, P1704, DOI 10.1111/j.1523-1755.2005.00267.x; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	17	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8349	8358		10.1074/jbc.M808965200	http://dx.doi.org/10.1074/jbc.M808965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19155213	Green Published, hybrid			2022-12-27	WOS:000264397800019
J	Gil, M; McCormack, FX; Levine, AM				Gil, Malgorzata; McCormack, Francis X.; Levine, Ann Marie			Surfactant Protein A Modulates Cell Surface Expression of CR3 on Alveolar Macrophages and Enhances CR3-mediated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING LECTIN SITE; MYCOBACTERIUM-TUBERCULOSIS; HOST-DEFENSE; STREPTOCOCCUS-PNEUMONIAE; RECEPTOR; CD11B/CD18; LUNG; INFECTION; MICE; AGGREGATION	Pulmonary surfactant protein A (SP-A), a member of the collectin family, plays an important role in innate immune defense of the lung. In this study, we examined the role of SP-A in modulating complement receptor-mediated phagocytosis. Complement receptors (CR), CR3 (CD11b), and CR4 (CD11c) were expressed at reduced levels on the surface of alveolar macrophages from Sp-a(-/-) compared with Sp-a(-/-) mice. Administration of intratracheal SP-A to Sp-a(+/+) mice induced the translocation of CR3 from alveolar macrophage intracellular pools to the cell surface. Intratracheal challenge with Haemophilus influenza enhanced CR3 expression on the surface of alveolar macrophages from Sp-a(-/-) and Sp-a(+/+) mice, but relative expression remained lower in the Sp-a(-/-) mice at all time points post-inoculation. The effects of SP-A on macrophage and neutrophil CR3 redistribution between intracellular and cell surface pools were restricted to cells isolated from the lung. SP-A augmented CR3-mediated phagocytosis in a manner that was attenuated by N-glycanase or collagenase treatment of SP- A, implicating the N-linked sugar and collagen-like domains in that function. The binding of CR3 to SP-A was calcium dependent and mediated by the I-domain of CR3 and to a lesser extent by the CR3 lectin domain. Mapping of the domains of SP- A that were required for optimal binding to CR3 revealed that the N-linked sugars were more critical than the collagen-like domain or the extent of oligomeric assembly. We conclude that SP-A modulates the cell surface expression of CR3 on alveolar macrophages, binds to CR3, and enhances CR3-mediated phagocytosis.	[Gil, Malgorzata; Levine, Ann Marie] Univ Florida, Dept Pediat, Div Crit Care Med, Gainesville, FL 32610 USA; [McCormack, Francis X.] Univ Cincinnati, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Internal Med, Cincinnati, OH 45267 USA	State University System of Florida; University of Florida; University System of Ohio; University of Cincinnati	Levine, AM (corresponding author), 1600 SW Archer Rd,RG114, Gainesville, FL 32610 USA.	levineam@peds.ufl.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071522] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL071522] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAU H, 1994, AM J PHYSIOL, V266, pL148, DOI 10.1152/ajplung.1994.266.2.L148; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; CAMPBELL JR, 1991, INFECT IMMUN, V59, P1978, DOI 10.1128/IAI.59.6.1978-1983.1991; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; FALLMAN M, 1993, J IMMUNOL, V151, P330; GAYNOR CD, 1995, J IMMUNOL, V155, P5343; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877; Hu CG, 2000, J IMMUNOL, V165, P2596, DOI 10.4049/jimmunol.165.5.2596; Kabha K, 1997, AM J PHYSIOL-LUNG C, V272, pL344, DOI 10.1152/ajplung.1997.272.2.L344; KHOOR A, 1993, J HISTOCHEM CYTOCHEM, V41, P1311, DOI 10.1177/41.9.8354874; Korfhagen TR, 2001, AM J RESP CELL MOL, V25, P668, DOI 10.1165/ajrcmb.25.6.f221; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; McCormack FX, 1997, BIOCHEMISTRY-US, V36, P13963, DOI 10.1021/bi970745q; MCCORMACK FX, 1994, J BIOL CHEM, V269, P29801; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; Melo MD, 2000, CELL IMMUNOL, V205, P13, DOI 10.1006/cimm.2000.1710; NOEL GJ, 1988, J INFECT DIS, V157, P85, DOI 10.1093/infdis/157.1.85; OHMERSCHROCK D, 1995, J CELL SCI, V108, P3695; Prince JE, 2001, J IMMUNOL, V166, P7362, DOI 10.4049/jimmunol.166.12.7362; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; ROSS GD, 1985, J IMMUNOL, V134, P3307; Sano H, 1999, J IMMUNOL, V163, P387; SENTT AP, 2007, AM J PHYSIOL, V292, pL469; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; Thornton BP, 1996, J IMMUNOL, V156, P1235; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VONASMUTH EJU, 1991, J IMMUNOL, V147, P3869; Watford WT, 2001, J IMMUNOL, V167, P6593, DOI 10.4049/jimmunol.167.11.6593; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Xia Y, 1999, J IMMUNOL, V162, P7285; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200	38	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7495	7504		10.1074/jbc.M808643200	http://dx.doi.org/10.1074/jbc.M808643200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19155216	hybrid, Green Published			2022-12-27	WOS:000264195600013
J	Ujino, S; Yamaguchi, S; Shimotohno, K; Takaku, H				Ujino, Saneyuki; Yamaguchi, Saori; Shimotohno, Kunitada; Takaku, Hiroshi			Heat-shock Protein 90 Is Essential for Stabilization of the Hepatitis C Virus Nonstructural Protein NS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; 3' NONTRANSLATED REGION; SERINE-TYPE PROTEINASE; AMINO-TERMINAL DOMAIN; PROTEASOMAL DEGRADATION; IN-VITRO; NON-A; REPLICATION; IDENTIFICATION; GELDANAMYCIN	The hepatitis C virus (HCV) is a major cause of chronic liver disease. Here, we report a new and effective strategy for inhibiting HCV replication using 17-allylaminogeldanamycin (17-AAG), an inhibitor of heat-shock protein 90 (Hsp90). Hsp90 is a molecular chaperone with a key role in stabilizing the conformation of many oncogenic signaling proteins. We examined the inhibitory effects of 17-AAG on HCV replication in an HCV replicon cell culture system. In HCV replicon cells treated with 17-AAG, we found that HCV RNA replication was suppressed in a dose-dependent manner, and interestingly, the only HCV protein degraded in these cells was NS3 (nonstructural protein 3). Immunoprecipitation experiments showed that NS3 directly interacted with Hsp90, as did proteins expressed from Delta NS3 protease expression vectors. These results suggest that the suppression of HCV RNA replication is due to the destabilization of NS3 in disruption of the Hsp90 chaperone complex by 17-AAG.	[Ujino, Saneyuki; Yamaguchi, Saori; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan; [Takaku, Hiroshi] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Narashino, Chiba 2750016, Japan; [Shimotohno, Kunitada] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan	Chiba Institute of Technology; Chiba Institute of Technology; Chiba Institute of Technology; Keio University	Takaku, H (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hiroshi.takaku@it-chiba.ac.jp						ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; BARTENSCHLAGER R, 1993, J VIROL, V67, P3835, DOI 10.1128/JVI.67.7.3835-3844.1993; Bartenschlager R, 2001, ANTIVIR RES, V52, P1, DOI 10.1016/S0166-3542(01)00164-4; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bonvini P, 2004, CANCER RES, V64, P3256, DOI 10.1158/0008-5472.CAN-03-3531; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; FAILLA C, 1995, J VIROL, V69, P1769, DOI 10.1128/JVI.69.3.1769-1777.1995; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Glue P, 2000, HEPATOLOGY, V32, P647, DOI 10.1053/jhep.2000.16661; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kishine H, 2002, BIOCHEM BIOPH RES CO, V293, P993, DOI 10.1016/S0006-291X(02)00342-X; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Smith DF, 1998, PHARMACOL REV, V50, P493; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Waxman L, 2001, P NATL ACAD SCI USA, V98, P13931, DOI 10.1073/pnas.241510898; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003	46	65	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6841	6846		10.1074/jbc.M806452200	http://dx.doi.org/10.1074/jbc.M806452200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19150985	Green Published, hybrid			2022-12-27	WOS:000263919000030
